ID   CNG18_ARATH             Reviewed;         706 AA.
AC   Q9LEQ3;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   20-DEC-2017, entry version 124.
DE   RecName: Full=Cyclic nucleotide-gated ion channel 18 {ECO:0000303|PubMed:11500563};
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 18 {ECO:0000303|PubMed:11500563};
GN   Name=CNGC18 {ECO:0000303|PubMed:11500563};
GN   OrderedLocusNames=At5g14870 {ECO:0000312|Araport:AT5G14870};
GN   ORFNames=T9L3_170 {ECO:0000312|EMBL:CAC01886.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K.,
RA   Kohara M., Matsumoto M., Matsuno A., Muraki A., Nakayama S.,
RA   Nakazaki N., Naruo K., Okumura S., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Sato S., de la Bastide M.,
RA   Huang E., Spiegel L., Gnoj L., O'Shaughnessy A., Preston R.,
RA   Habermann K., Murray J., Johnson D., Rohlfing T., Nelson J.,
RA   Stoneking T., Pepin K., Spieth J., Sekhon M., Armstrong J., Becker M.,
RA   Belter E., Cordum H., Cordes M., Courtney L., Courtney W., Dante M.,
RA   Du H., Edwards J., Fryman J., Haakensen B., Lamar E., Latreille P.,
RA   Leonard S., Meyer R., Mulvaney E., Ozersky P., Riley A., Strowmatt C.,
RA   Wagner-McPherson C., Wollam A., Yoakum M., Bell M., Dedhia N.,
RA   Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D., Baker J.,
RA   Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S.,
RA   Langham S.-A., McCullagh B., Robben J., Grymonprez B., Zimmermann W.,
RA   Ramsperger U., Wedler H., Balke K., Wedler E., Peters S.,
RA   van Staveren M., Dirkse W., Mooijman P., Klein Lankhorst R.,
RA   Weitzenegger T., Bothe G., Rose M., Hauf J., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Villarroel R., Gielen J., Ardiles W.,
RA   Bents O., Lemcke K., Kolesov G., Mayer K.F.X., Rudd S., Schoof H.,
RA   Schueller C., Zaccaria P., Mewes H.-W., Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:823-826(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=17726111; DOI=10.1073/pnas.0701781104;
RA   Frietsch S., Wang Y.F., Sladek C., Poulsen L.R., Romanowsky S.M.,
RA   Schroeder J.I., Harper J.F.;
RT   "A cyclic nucleotide-gated channel is essential for polarized tip
RT   growth of pollen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14531-14536(2007).
RN   [5]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=24380879; DOI=10.1093/mp/sst174;
RA   Gao Q.F., Fei C.F., Dong J.Y., Gu L.L., Wang Y.F.;
RT   "Arabidopsis CNGC18 is a Ca(2+)-permeable channel.";
RL   Mol. Plant 7:739-743(2014).
RN   [6]
RP   FUNCTION, INTERACTION WITH CPK32, AND SUBCELLULAR LOCATION.
RX   PubMed=24121288; DOI=10.1093/mp/sst125;
RA   Zhou L., Lan W., Jiang Y., Fang W., Luan S.;
RT   "A calcium-dependent protein kinase interacts with and activates a
RT   calcium channel to regulate pollen tube growth.";
RL   Mol. Plant 7:369-376(2014).
RN   [7]
RP   FUNCTION, MUTAGENESIS OF ARG-491 AND ARG-578, AND DOMAIN.
RX   PubMed=26929345; DOI=10.1073/pnas.1524629113;
RA   Gao Q.F., Gu L.L., Wang H.Q., Fei C.F., Fang X., Hussain J., Sun S.J.,
RA   Dong J.Y., Liu H., Wang Y.F.;
RT   "Cyclic nucleotide-gated channel 18 is an essential Ca2+ channel in
RT   pollen tube tips for pollen tube guidance to ovules in Arabidopsis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:3096-3101(2016).
CC   -!- FUNCTION: Cyclic nucleotide-gated ion channel required for
CC       directional pollen tube growth into the transmitting tract
CC       (PubMed:17726111, PubMed:26929345). Acts as a Ca(2+)-permeable
CC       divalent cation-selective channel inhibited by either lanthanum or
CC       gadolinium (PubMed:24380879). Regulated by CPK32 to mediate Ca(2+)
CC       transport across the plasma membrane in response to Ca(2+)
CC       oscillation (PubMed:24121288). {ECO:0000269|PubMed:17726111,
CC       ECO:0000269|PubMed:24121288, ECO:0000269|PubMed:24380879,
CC       ECO:0000269|PubMed:26929345}.
CC   -!- SUBUNIT: Homomultimer (PubMed:24380879). Interacts with CPK32
CC       (PubMed:24121288). {ECO:0000269|PubMed:24121288,
CC       ECO:0000269|PubMed:24380879}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17726111,
CC       ECO:0000269|PubMed:24121288}; Multi-pass membrane protein
CC       {ECO:0000305}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:17726111}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=focused at the cell perimeter of the growing
CC       pollen tube tip. {ECO:0000269|PubMed:17726111,
CC       ECO:0000269|PubMed:24121288}.
CC   -!- TISSUE SPECIFICITY: Expressed in pollen grains. Not detected in
CC       leaves, roots or root hairs. {ECO:0000269|PubMed:17726111}.
CC   -!- DOMAIN: The transmembrane domains are indispensable for pollen
CC       tube guidance. {ECO:0000269|PubMed:26929345}.
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Male sterility.
CC       {ECO:0000269|PubMed:17726111}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL391149; CAC01886.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED92084.1; -; Genomic_DNA.
DR   PIR; T51432; T51432.
DR   RefSeq; NP_196991.1; NM_121491.3.
DR   UniGene; At.31874; -.
DR   ProteinModelPortal; Q9LEQ3; -.
DR   SMR; Q9LEQ3; -.
DR   BioGrid; 16616; 19.
DR   MINT; MINT-8062281; -.
DR   STRING; 3702.AT5G14870.1; -.
DR   TCDB; 1.A.1.5.26; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q9LEQ3; -.
DR   EnsemblPlants; AT5G14870.1; AT5G14870.1; AT5G14870.
DR   GeneID; 831339; -.
DR   Gramene; AT5G14870.1; AT5G14870.1; AT5G14870.
DR   KEGG; ath:AT5G14870; -.
DR   Araport; AT5G14870; -.
DR   TAIR; locus:2185510; AT5G14870.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; Q9LEQ3; -.
DR   KO; K05391; -.
DR   OMA; ETREYYY; -.
DR   OrthoDB; EOG093603YI; -.
DR   PhylomeDB; Q9LEQ3; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q9LEQ3; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q9LEQ3; baseline and differential.
DR   Genevisible; Q9LEQ3; AT.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:TAIR.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005262; F:calcium channel activity; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:TAIR.
DR   GO; GO:0009860; P:pollen tube growth; IMP:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Calmodulin-binding; cAMP; cAMP-binding; Cell membrane; cGMP;
KW   cGMP-binding; Complete proteome; Cytoplasmic vesicle; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    706       Cyclic nucleotide-gated ion channel 18.
FT                                /FTId=PRO_0000219346.
FT   TOPO_DOM      1     53       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM     75     86       Extracellular. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    108    142       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    164    174       Extracellular. {ECO:0000255}.
FT   TRANSMEM    175    195       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    196    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    239    345       Extracellular. {ECO:0000255}.
FT   TRANSMEM    346    366       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    367    706       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      585    614       IQ.
FT   NP_BIND     449    579       cNMP.
FT   REGION      565    580       Calmodulin-binding. {ECO:0000250}.
FT   BINDING     520    520       cNMP. {ECO:0000250}.
FT   MUTAGEN     491    491       R->Q: Impaired cGMP activation of the
FT                                Ca(2+) channel and strong defects in
FT                                pollen tube guidance.
FT                                {ECO:0000269|PubMed:26929345}.
FT   MUTAGEN     578    578       R->K: Impaired cGMP activation of the
FT                                Ca(2+) channel and strong defects in
FT                                pollen tube guidance.
FT                                {ECO:0000269|PubMed:26929345}.
SQ   SEQUENCE   706 AA;  80364 MW;  05122006E5A59CEB CRC64;
     MNKIRSLRCL LPETITSAST AASNRGSDGS QFSVLWRHQI LDPDSNIVTY WNHVFLITSI
     LALFLDPFYF YVPYVGGPAC LSIDISLAAT VTFFRTVADI FHLLHIFMKF RTAFVARSSR
     VFGRGELVMD SREIAMRYLK TDFLIDVAAM LPLPQLVIWL VIPAATNGTA NHANSTLALI
     VLVQYIPRSF IIFPLNQRII KTTGFIAKTA WAGAAYNLLL YILASHVLGA MWYLSSIGRQ
     FSCWSNVCKK DNALRVLDCL PSFLDCKSLE QPERQYWQNV TQVLSHCDAT SSTTNFKFGM
     FAEAFTTQVA TTDFVSKYLY CLWWGLRNLS SYGQNITTSV YLGETLFCIT ICIFGLILFT
     LLIGNMQSSL QSMSVRVEEW RVKRRDTEEW MRHRQLPPEL QERVRRFVQY KWLATRGVDE
     ESILHSLPTD LRREIQRHLC LSLVRRVPFF SQMDDQLLDA ICGCLVSSLS TAGTYIFREG
     DPVNEMLFVI RGQIESSTTN GGRSGFFNST TLRPGDFCGE ELLTWALMPN STLNLPSSTR
     SVRALSEVEA FALSAEDLKF VAHQFKRLQS KKLQHAFRYY SHQWRAWGAC FVQSAWRRYK
     RRKLAKELSL HESSGYYYPD ETGYNEEDEE TREYYYGSDE EGGSMDNTNL GATILASKFA
     ANTRRGTNQK ASSSSTGKKD GSSTSLKMPQ LFKPDEPDFS IDKEDV
//
ID   CNGC4_ARATH             Reviewed;         694 AA.
AC   Q94AS9; Q9XFS2;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   21-NOV-2003, sequence version 2.
DT   20-DEC-2017, entry version 130.
DE   RecName: Full=Cyclic nucleotide-gated ion channel 4;
DE            Short=AtCNGC4;
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 4;
DE            Short=AtHLM1;
GN   Name=CNGC4; Synonyms=HLM1; OrderedLocusNames=At5g54250;
GN   ORFNames=MDK4.7;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=cv. Columbia;
RX   PubMed=10341447; DOI=10.1046/j.1365-313X.1999.00422.x;
RA   Koehler C., Merkle T., Neuhaus G.;
RT   "Characterisation of a novel gene family of putative cyclic
RT   nucleotide- and calmodulin-regulated ion channels in Arabidopsis
RT   thaliana.";
RL   Plant J. 18:97-104(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9679202; DOI=10.1093/dnares/5.2.131;
RA   Kaneko T., Kotani H., Nakamura Y., Sato S., Asamizu E., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. V. Sequence
RT   features of the regions of 1,381,565 bp covered by twenty one
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:131-145(1998).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12566578; DOI=10.1105/tpc.006999;
RA   Balague C., Lin B., Alcon C., Flottes G., Malmstroem S., Koehler C.,
RA   Neuhaus G., Pelletier G., Gaymard F., Roby D.;
RT   "HLM1, an essential signaling component in the hypersensitive
RT   response, is a member of the cyclic nucleotide-gated channel ion
RT   channel family.";
RL   Plant Cell 15:365-379(2003).
CC   -!- FUNCTION: Acts as cyclic nucleotide-gated ion channel. Permeable
CC       to potassium and sodium in a cyclic nucleotide-dependent fashion
CC       (cAMP or cGMP). Might constitute a common downstream component of
CC       the signaling pathways leading to hypersensitive response (HR).
CC       {ECO:0000269|PubMed:12566578}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q94AS9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q94AS9-2; Sequence=VSP_008985, VSP_008986;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Induced by both ethylene and methyl jasmonate
CC       treatments, or after pathogen attack.
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Loss-of-function mutation results in the
CC       loss of the hypersensitive response leading to broad spectrum
CC       disease resistance, and displays a lesion-mimic phenotype.
CC       {ECO:0000269|PubMed:12566578}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17912; CAB40129.1; -; mRNA.
DR   EMBL; AB010695; BAB10748.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96473.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96474.1; -; Genomic_DNA.
DR   EMBL; CP002688; ANM70509.1; -; Genomic_DNA.
DR   EMBL; AY045822; AAK76496.1; -; mRNA.
DR   EMBL; AY057691; AAL15321.1; -; mRNA.
DR   EMBL; AY133734; AAM91668.1; -; mRNA.
DR   PIR; T52574; T52574.
DR   RefSeq; NP_001332114.1; NM_001345080.1. [Q94AS9-1]
DR   RefSeq; NP_200236.1; NM_124805.3. [Q94AS9-1]
DR   RefSeq; NP_851188.1; NM_180857.2. [Q94AS9-1]
DR   UniGene; At.401; -.
DR   ProteinModelPortal; Q94AS9; -.
DR   SMR; Q94AS9; -.
DR   STRING; 3702.AT5G54250.1; -.
DR   TCDB; 1.A.1.5.7; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q94AS9; -.
DR   PaxDb; Q94AS9; -.
DR   EnsemblPlants; AT5G54250.1; AT5G54250.1; AT5G54250. [Q94AS9-1]
DR   EnsemblPlants; AT5G54250.2; AT5G54250.2; AT5G54250. [Q94AS9-1]
DR   EnsemblPlants; AT5G54250.4; AT5G54250.4; AT5G54250. [Q94AS9-1]
DR   GeneID; 835513; -.
DR   Gramene; AT5G54250.1; AT5G54250.1; AT5G54250. [Q94AS9-1]
DR   Gramene; AT5G54250.2; AT5G54250.2; AT5G54250. [Q94AS9-1]
DR   Gramene; AT5G54250.4; AT5G54250.4; AT5G54250. [Q94AS9-1]
DR   KEGG; ath:AT5G54250; -.
DR   Araport; AT5G54250; -.
DR   TAIR; locus:2162605; AT5G54250.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; Q94AS9; -.
DR   OMA; WGETINA; -.
DR   OrthoDB; EOG0936045S; -.
DR   PhylomeDB; Q94AS9; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q94AS9; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q94AS9; baseline and differential.
DR   Genevisible; Q94AS9; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008324; F:cation transmembrane transporter activity; IDA:TAIR.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0009626; P:plant-type hypersensitive response; IMP:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calmodulin-binding; cAMP; cAMP-binding;
KW   Cell membrane; cGMP; cGMP-binding; Complete proteome;
KW   Hypersensitive response; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding; Plant defense;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    694       Cyclic nucleotide-gated ion channel 4.
FT                                /FTId=PRO_0000219332.
FT   TOPO_DOM      1     92       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     93    113       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    114    126       Extracellular. {ECO:0000255}.
FT   TRANSMEM    127    147       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    148    187       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    209    216       Extracellular. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    238    251       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    252    272       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    273    392       Extracellular. {ECO:0000255}.
FT   TRANSMEM    393    413       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    414    694       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      631    660       IQ.
FT   NP_BIND     496    626       cNMP.
FT   REGION      610    626       Calmodulin-binding. {ECO:0000250}.
FT   COMPBIAS     25     52       Glu-rich.
FT   BINDING     565    565       cNMP. {ECO:0000250}.
FT   VAR_SEQ     274    293       AAGACWYLLGVQRSAKCLKE -> VSYLINCFVLLNILVNT
FT                                KFQ (in isoform 2).
FT                                {ECO:0000303|PubMed:14593172}.
FT                                /FTId=VSP_008985.
FT   VAR_SEQ     294    694       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14593172}.
FT                                /FTId=VSP_008986.
SQ   SEQUENCE   694 AA;  80081 MW;  E3F843AE1B0F1EA0 CRC64;
     MATEQEFTRA SRFSRDSSSV GYYSEEDNTE EEDEEEEEME EIEEEEEEEE EEDPRIGLTC
     GGRRNGSSNN NKWMMLGRIL DPRSKWVREW NKVFLLVCAT GLFVDPLFLY TLSVSDTCMC
     LLVDGWLALT VTALRSMTDL LHLWNIWIQF KIARRWPYPG GDSDGDTNKG GGTRGSTRVA
     PPYVKKNGFF FDLFVILPLP QVVLWVVIPS LLKRGSVTLV VSVLLVTFLF QYLPKIYHSI
     RHLRRNATLS GYIFGTVWWG IALNMIAYFV AAHAAGACWY LLGVQRSAKC LKEQCENTIG
     CDLRMLSCKE PVYYGTTVMV LDRARLAWAQ NHQARSVCLD INTNYTYGAY QWTIQLVSSE
     SRLEKILFPI FWGLMTLSTF GNLESTTEWS EVVFNIIVLT SGLLLVTMLI GNIKVFLHAT
     TSKKQAMHLK MRNIEWWMKK RHLPIGFRQR VRNYERQRWA AMRGVDECEM VQNLPEGLRR
     DIKYHLCLDL VRQVPLFQHM DDLVLENICD RVKSLIFTKG ETIQKEGDAV QRMLFVVRGH
     LQSSQLLRDG VKSCCMLGPG NFSGDELLSW CLRRPFVERL PPSSSTLVTL ETTEAFGLDA
     EDVKYVTQHF RYTFVNEKVK RSARYYSPGW RTWAAVAVQL AWRRYKHRLT LTSLSFIRPR
     RPLSRCASLG EDKLRLYAAI LTSPKPNPDD FDDY
//
ID   CN15A_MEDTR             Reviewed;         710 AA.
AC   G7IBJ4;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   25-JAN-2012, sequence version 1.
DT   25-OCT-2017, entry version 36.
DE   RecName: Full=Protein CNGC15a {ECO:0000303|PubMed:27230377};
DE   AltName: Full=Cyclic nucleotide-gated ion channel protein 15 a {ECO:0000303|PubMed:27230377};
GN   Name=CNGC15A {ECO:0000303|PubMed:27230377};
GN   OrderedLocusNames=MTR_1g064240 {ECO:0000312|EnsemblPlants:AES60733};
OS   Medicago truncatula (Barrel medic) (Medicago tribuloides).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; fabids; Fabales; Fabaceae; Papilionoideae;
OC   Trifolieae; Medicago.
OX   NCBI_TaxID=3880 {ECO:0000312|Proteomes:UP000002051};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Jemalong A17;
RX   PubMed=22089132; DOI=10.1038/nature10625;
RA   Young N.D., Debelle F., Oldroyd G.E.D., Geurts R., Cannon S.B.,
RA   Udvardi M.K., Benedito V.A., Mayer K.F.X., Gouzy J., Schoof H.,
RA   Van de Peer Y., Proost S., Cook D.R., Meyers B.C., Spannagl M.,
RA   Cheung F., De Mita S., Krishnakumar V., Gundlach H., Zhou S.,
RA   Mudge J., Bharti A.K., Murray J.D., Naoumkina M.A., Rosen B.,
RA   Silverstein K.A.T., Tang H., Rombauts S., Zhao P.X., Zhou P.,
RA   Barbe V., Bardou P., Bechner M., Bellec A., Berger A., Berges H.,
RA   Bidwell S., Bisseling T., Choisne N., Couloux A., Denny R.,
RA   Deshpande S., Dai X., Doyle J.J., Dudez A.-M., Farmer A.D.,
RA   Fouteau S., Franken C., Gibelin C., Gish J., Goldstein S.,
RA   Gonzalez A.J., Green P.J., Hallab A., Hartog M., Hua A.,
RA   Humphray S.J., Jeong D.-H., Jing Y., Jocker A., Kenton S.M.,
RA   Kim D.-J., Klee K., Lai H., Lang C., Lin S., Macmil S.L.,
RA   Magdelenat G., Matthews L., McCorrison J., Monaghan E.L., Mun J.-H.,
RA   Najar F.Z., Nicholson C., Noirot C., O'Bleness M., Paule C.R.,
RA   Poulain J., Prion F., Qin B., Qu C., Retzel E.F., Riddle C.,
RA   Sallet E., Samain S., Samson N., Sanders I., Saurat O., Scarpelli C.,
RA   Schiex T., Segurens B., Severin A.J., Sherrier D.J., Shi R., Sims S.,
RA   Singer S.R., Sinharoy S., Sterck L., Viollet A., Wang B.-B., Wang K.,
RA   Wang M., Wang X., Warfsmann J., Weissenbach J., White D.D.,
RA   White J.D., Wiley G.B., Wincker P., Xing Y., Yang L., Yao Z., Ying F.,
RA   Zhai J., Zhou L., Zuber A., Denarie J., Dixon R.A., May G.D.,
RA   Schwartz D.C., Rogers J., Quetier F., Town C.D., Roe B.A.;
RT   "The Medicago genome provides insight into the evolution of rhizobial
RT   symbioses.";
RL   Nature 480:520-524(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Jemalong A17;
RX   PubMed=24767513; DOI=10.1186/1471-2164-15-312;
RA   Tang H., Krishnakumar V., Bidwell S., Rosen B., Chan A., Zhou S.,
RA   Gentzbittel L., Childs K.L., Yandell M., Gundlach H., Mayer K.F.,
RA   Schwartz D.C., Town C.D.;
RT   "An improved genome release (version Mt4.0) for the model legume
RT   Medicago truncatula.";
RL   BMC Genomics 15:312-312(2014).
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   DMI1, GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=27230377; DOI=10.1126/science.aae0109;
RA   Charpentier M., Sun J., Martins T.V., Radhakrishnan G.V., Findlay K.,
RA   Soumpourou E., Thouin J., Very A.A., Sanders D., Morris R.J.,
RA   Oldroyd G.E.;
RT   "Nuclear-localized cyclic nucleotide-gated channels mediate symbiotic
RT   calcium oscillations.";
RL   Science 352:1102-1105(2016).
CC   -!- FUNCTION: Cyclic nucleotide-gated channel involved in the
CC       establishment of both rhizobial and mycorrhizal associations
CC       (PubMed:27230377). Required for full activation of nuclear-
CC       localized Ca(2+) oscillations by Nod and Myc factors
CC       (PubMed:27230377). Simultaneous activation of the K(+)-permeable
CC       channel DMI1 and the Ca(2+) channel CNGC15 can give rise to
CC       sustained Ca(2+) oscillations (PubMed:27230377). May function
CC       during fertilization in both female and male gametophytic Ca(2+)
CC       signaling (PubMed:27230377). {ECO:0000269|PubMed:27230377}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with DMI1 (via c-terminus).
CC       The Nod factor has no effect on this interaction, implying that
CC       the complex is maintained after activation.
CC       {ECO:0000269|PubMed:27230377}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane
CC       {ECO:0000269|PubMed:27230377}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in roots, stems, leaves, flowers and
CC       pods. {ECO:0000269|PubMed:27230377}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CM001217; AES60733.1; -; Genomic_DNA.
DR   RefSeq; XP_003590482.1; XM_003590434.2.
DR   SMR; G7IBJ4; -.
DR   EnsemblPlants; AES60733; AES60733; MTR_1g064240.
DR   GeneID; 11433273; -.
DR   Gramene; AES60733; AES60733; MTR_1g064240.
DR   KEGG; mtr:MTR_1g064240; -.
DR   KO; K05391; -.
DR   OMA; LCTPGTC; -.
DR   OrthoDB; EOG093603GN; -.
DR   Proteomes; UP000002051; Chromosome 1.
DR   Proteomes; UP000002051; Unassembled WGS sequence.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0036377; P:arbuscular mycorrhizal association; IMP:UniProtKB.
DR   GO; GO:0009877; P:nodulation; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleus; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    710       Protein CNGC15a.
FT                                /FTId=PRO_0000437092.
FT   TRANSMEM     85    105       Helical. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical. {ECO:0000255}.
FT   TRANSMEM    174    194       Helical. {ECO:0000255}.
FT   TRANSMEM    207    226       Helical. {ECO:0000255}.
FT   TRANSMEM    248    268       Helical. {ECO:0000255}.
FT   TRANSMEM    368    388       Helical. {ECO:0000255}.
FT   NP_BIND     474    559       cNMP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00060}.
SQ   SEQUENCE   710 AA;  81946 MW;  1CFA701DD65423D9 CRC64;
     MASVISRAVR FHDDLEKEKL QEGEESHMEM RAYEMSSEYK HGKDAINKPS SNGRGLSRVF
     SEDYDAGEIL VFDPRGPRIN LWNKIFLAAC LISLFVDPLF FYLPVAKKEK CIDMSIGLEV
     SLTIIRTFVD AFYIIHIYIR FQTAYIAPSS RVSGRGELII DSSKIASNYM KKELWSDLVA
     ALPLPQVLIW AVIPNIKGSE MIASRHVVRL VSIFQYLLRL YLIYPLSSKI TKASGVMMEK
     AWAGAAYYLT LYMLASHVLG STWYLLSIER QDECWKKACT LQYPHCQYHY LDCQSLSDPN
     RNAWLKSSNL SGLCDQNSHF FQFGIFDDAV TLEITSSNFL TKYYYCLWWG LRNLSSSGEN
     LLTSTHVAEI NFAVIVAILG LVLFALLIGN MQTYLQSTTI RLEEWRIRRT DTERWMHHRQ
     LPHYLKENVR RHDQFRWVAT RGVDEEAILR DLPVDLRRDI KRHLCLNLVR QVPLFDQMDD
     RMLDAICERL KPTLCTPGTC IVREGDPVDE MLFIVRGRLD SCTTNGGRTG FFNTCRIGSG
     DFCGEELLPW ALDPRPTAVL PSSTRTVRAI TEVEAFALIA EDLKFVAAQF RRLHSKQLRQ
     TFRFYSHQWR TWAACFIQAA WFRYKRMKET NEVKEKENLM MMSNVKYYGN DDSQYFSAPL
     QVPKGSSYSM YSGKLVGSLR RGRSMRYGSE LDMLGTLRKP IEPDFNDDGD
//
ID   IR40A_DROME             Reviewed;         732 AA.
AC   Q9V9N1; B3DNK0;
DT   15-FEB-2017, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 4.
DT   27-SEP-2017, entry version 116.
DE   RecName: Full=Ionotropic receptor 40a {ECO:0000303|PubMed:27161501};
DE   Flags: Precursor;
GN   Name=Ir40a {ECO:0000303|PubMed:27161501,
GN   ECO:0000312|FlyBase:FBgn0259683};
GN   ORFNames=CG42352 {ECO:0000312|FlyBase:FBgn0259683};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000312|EMBL:ACD99552.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 460-732.
RA   Carlson J., Booth B., Frise E., Park S., Wan K., Yu C., Celniker S.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27161501; DOI=10.1016/j.cub.2016.03.049;
RA   Enjin A., Zaharieva E.E., Frank D.D., Mansourian S., Suh G.S.,
RA   Gallio M., Stensmyr M.C.;
RT   "Humidity Sensing in Drosophila.";
RL   Curr. Biol. 26:1352-1358(2016).
RN   [5] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=27656904; DOI=10.7554/eLife.17879;
RA   Knecht Z.A., Silbering A.F., Ni L., Klein M., Budelli G., Bell R.,
RA   Abuin L., Ferrer A.J., Samuel A.D., Benton R., Garrity P.A.;
RT   "Distinct combinations of variant ionotropic glutamate receptors
RT   mediate thermosensation and hygrosensation in Drosophila.";
RL   Elife 5:0-0(2016).
CC   -!- FUNCTION: Integral part of a neural sensory system in the antenna
CC       that provides the neural basis for the response to environmental
CC       changes in humidity (hygrosensation) (PubMed:27161501,
CC       PubMed:27656904). Together with Ir25a and Ir93a, mediates the
CC       response of the hygrosensory sacculus neurons to changes in
CC       relative humidity and is required for dry detection behavior
CC       (PubMed:27161501, PubMed:27656904). {ECO:0000269|PubMed:27161501,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: In the antenna, detected in sacculus neurons
CC       which innervate the first and second chambers (at protein level).
CC       {ECO:0000269|PubMed:27656904}.
CC   -!- DISRUPTION PHENOTYPE: Response of sacculus neurons to changes in
CC       humidity is abolished and consequently larvae fail to move towards
CC       their preferred humidity. {ECO:0000269|PubMed:27161501,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014134; AAF57255.4; -; Genomic_DNA.
DR   EMBL; BT032988; ACD99552.1; -; mRNA.
DR   RefSeq; NP_610140.4; NM_136296.4.
DR   UniGene; Dm.26855; -.
DR   ProteinModelPortal; Q9V9N1; -.
DR   STRING; 7227.FBpp0290308; -.
DR   PaxDb; Q9V9N1; -.
DR   PRIDE; Q9V9N1; -.
DR   EnsemblMetazoa; FBtr0336971; FBpp0307914; FBgn0259683.
DR   GeneID; 35449; -.
DR   KEGG; dme:Dmel_CG42352; -.
DR   UCSC; CG42352-RC; d. melanogaster.
DR   CTD; 35449; -.
DR   FlyBase; FBgn0259683; Ir40a.
DR   eggNOG; ENOG410IUI8; Eukaryota.
DR   eggNOG; ENOG410XY2S; LUCA.
DR   InParanoid; Q9V9N1; -.
DR   OMA; VLMHLFE; -.
DR   OrthoDB; EOG091G08XY; -.
DR   GenomeRNAi; 35449; -.
DR   PRO; PR:Q9V9N1; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0259683; -.
DR   ExpressionAtlas; Q9V9N1; differential.
DR   Genevisible; Q9V9N1; DM.
DR   GO; GO:0016021; C:integral component of membrane; ISM:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; ISM:FlyBase.
DR   GO; GO:0007610; P:behavior; IEA:UniProtKB-KW.
DR   GO; GO:0050907; P:detection of chemical stimulus involved in sensory perception; IEP:FlyBase.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   Pfam; PF00060; Lig_chan; 1.
PE   1: Evidence at protein level;
KW   Behavior; Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Sensory transduction; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    732       Ionotropic receptor 40a. {ECO:0000255}.
FT                                /FTId=PRO_5004334452.
FT   TOPO_DOM     20    369       Extracellular. {ECO:0000305}.
FT   TRANSMEM    370    390       Helical. {ECO:0000255}.
FT   TOPO_DOM    391    465       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    466    486       Helical. {ECO:0000255}.
FT   TOPO_DOM    487    688       Extracellular. {ECO:0000305}.
FT   TRANSMEM    689    709       Helical. {ECO:0000255}.
FT   TOPO_DOM    710    732       Cytoplasmic. {ECO:0000305}.
FT   CARBOHYD     18     18       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    235    235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    531    531       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
SQ   SEQUENCE   732 AA;  84084 MW;  D6BD5B95EC34C13B CRC64;
     MHKFLALGLL PYLLGLLNST RLTFIGNDES DTAIALTQIV RGLQQSSLAI LALPSLALSD
     GVCQKERNVY LDDFLQRLHR SNYKSVVFSQ TELFFQHIEE NLQGANECIS LILDEPNQLL
     NSLHDRHLGH RLSLFIFYWG ARWPPSSRVI RFREPLRVVV VTRPRKKAFR IYYNQARPCS
     DSQLQLVNWY DGDNLGLQRI PLLPTALSVY ANFKGRTFRV PVFHSPPWFW VTYCNNSFEE
     DEEFNSLDSI EKRKVRVTGG RDHRLLMLLS KHMNFRFKYI EAPGRTQGSM RSEDGKDSND
     SFTGGIGLLQ SGQADFFLGD VGLSWERRKA IEFSFFTLAD SGAFATHAPR RLNEALAIMR
     PFKQDIWPHL ILTIIFSGPI FYGIIALPYI WRRRWANSDV EHLGELYIHM TYLKEITPRL
     LKLKPRTVLS AHQMPHQLFQ KCIWFTLRLF LKQSCNELHN GYRAKFLTIV YWIAATYVLA
     DVYSAQLTSQ FARPAREPPI NTLQRLQAAM IHDGYRLYVE KESSSLEMLE NGTELFRQLY
     ALMRQQVIND PQGFFIDSVE AGIKLIAEGG EDKAVLGGRE TLFFNVQQYG SNNFQLSQKL
     YTRYSAVAVQ IGCPFLGSLN NVLMQLFESG ILDKMTAAEY AKQYQEVEAT RIYKGSVQAK
     NSEAYSRTES YDSTVISPLN LRMLQGAFIA LGVGSLAAGV ILLLEIVFIK LDQARLWMLC
     SRLQWIRYDR KV
//
ID   CNGC2_ARATH             Reviewed;         726 AA.
AC   O65718;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   20-DEC-2017, entry version 139.
DE   RecName: Full=Cyclic nucleotide-gated ion channel 2;
DE            Short=AtCNGC2;
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 2;
DE   AltName: Full=Protein DEFENSE NO DEATH 1;
GN   Name=CNGC2; Synonyms=DND1; OrderedLocusNames=At5g15410;
GN   ORFNames=T20K14_20;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RC   STRAIN=cv. Columbia;
RA   Koehler C., Neuhaus G.;
RT   "Cloning and partial characterization of two putative cyclic
RT   nucleotide-regulated ion channels from Arabidopsis thaliana,
RT   designated CNGC1 and CNGC2.";
RL   (er) Plant Gene Register PGR98-062(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=10557223; DOI=10.1104/pp.121.3.753;
RA   Leng Q., Mercier R.W., Yao W., Berkowitz G.A.;
RT   "Cloning and first functional characterization of a plant cyclic
RT   nucleotide-gated cation channel.";
RL   Plant Physiol. 121:753-761(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND MUTANT DND1-1.
RC   STRAIN=cv. Columbia;
RX   PubMed=10900264; DOI=10.1073/pnas.150005697;
RA   Clough S.J., Fengler K.A., Yu I.-C., Lippok B., Smith R.K. Jr.,
RA   Bent A.F.;
RT   "The Arabidopsis dnd1 'defense, no death' gene encodes a mutated
RT   cyclic nucleotide-gated ion channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9323-9328(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K.,
RA   Kohara M., Matsumoto M., Matsuno A., Muraki A., Nakayama S.,
RA   Nakazaki N., Naruo K., Okumura S., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Sato S., de la Bastide M.,
RA   Huang E., Spiegel L., Gnoj L., O'Shaughnessy A., Preston R.,
RA   Habermann K., Murray J., Johnson D., Rohlfing T., Nelson J.,
RA   Stoneking T., Pepin K., Spieth J., Sekhon M., Armstrong J., Becker M.,
RA   Belter E., Cordum H., Cordes M., Courtney L., Courtney W., Dante M.,
RA   Du H., Edwards J., Fryman J., Haakensen B., Lamar E., Latreille P.,
RA   Leonard S., Meyer R., Mulvaney E., Ozersky P., Riley A., Strowmatt C.,
RA   Wagner-McPherson C., Wollam A., Yoakum M., Bell M., Dedhia N.,
RA   Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D., Baker J.,
RA   Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S.,
RA   Langham S.-A., McCullagh B., Robben J., Grymonprez B., Zimmermann W.,
RA   Ramsperger U., Wedler H., Balke K., Wedler E., Peters S.,
RA   van Staveren M., Dirkse W., Mooijman P., Klein Lankhorst R.,
RA   Weitzenegger T., Bothe G., Rose M., Hauf J., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Villarroel R., Gielen J., Ardiles W.,
RA   Bents O., Lemcke K., Kolesov G., Mayer K.F.X., Rudd S., Schoof H.,
RA   Schueller C., Zaccaria P., Mewes H.-W., Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:823-826(2000).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH CALMODULIN.
RX   PubMed=10341447; DOI=10.1046/j.1365-313X.1999.00422.x;
RA   Koehler C., Merkle T., Neuhaus G.;
RT   "Characterisation of a novel gene family of putative cyclic
RT   nucleotide- and calmodulin-regulated ion channels in Arabidopsis
RT   thaliana.";
RL   Plant J. 18:97-104(1999).
RN   [7]
RP   CALMODULIN-BINDING DOMAIN.
RX   PubMed=10767408; DOI=10.1016/S0014-5793(00)01383-1;
RA   Koehler C., Neuhaus G.;
RT   "Characterisation of calmodulin binding to cyclic nucleotide-gated ion
RT   channels from Arabidopsis thaliana.";
RL   FEBS Lett. 471:133-136(2000).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11506354; DOI=10.1007/s004250000510;
RA   Koehler C., Merkle T., Roby D., Neuhaus G.;
RT   "Developmentally regulated expression of a cyclic nucleotide-gated ion
RT   channel from Arabidopsis indicates its involvement in programmed cell
RT   death.";
RL   Planta 213:327-332(2001).
RN   [9]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [10]
RP   NULL MUTANTS.
RX   PubMed=12805601; DOI=10.1104/pp.102.019216;
RA   Chan C.W.M., Schorrak L.M., Smith R.K. Jr., Bent A.F., Sussman M.R.;
RT   "A cyclic nucleotide-gated ion channel, CNGC2, is crucial for plant
RT   development and adaptation to calcium stress.";
RL   Plant Physiol. 132:728-731(2003).
CC   -!- FUNCTION: Acts as cyclic nucleotide-gated ion channel. Permeable
CC       to potassium and calcium in a cyclic nucleotide-dependent fashion
CC       (cAMP or cGMP). Could also transport lithium, cesium and rubium
CC       and displays a strong selectivity against sodium. Seems to
CC       directly participate in pathogen-induced calcium influx. May
CC       function in homeostasis, re-establishing ionic balance after
CC       defense action and/or other stimuli. Could mediate the initiation
CC       of the developmentally regulated cell death programs.
CC       {ECO:0000269|PubMed:10900264, ECO:0000269|PubMed:11506354}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer (Potential). Binds
CC       calmodulin-1/4 with a higher affinity than calmodulin-2/3/5.
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms are produced. According to EST
CC         sequences.;
CC       Name=1;
CC         IsoId=O65718-1; Sequence=Displayed;
CC   -!- TISSUE SPECIFICITY: Expressed in the whole plant but only weakly
CC       in roots. Strongly expressed in the expanded cotyledons of 14-day-
CC       old seedlings and detected later in leaves after the transition to
CC       flowering. Also detected in flowers during organ senescence and in
CC       the dehiscence zone of siliques. {ECO:0000269|PubMed:11506354}.
CC   -!- INDUCTION: Up-regulated by light. Transiently induced during leaf
CC       and culture senescence. {ECO:0000269|PubMed:11506354}.
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Loss-of-function mutations cngc2-1 (dnd1-1) or
CC       cncg2-2 results in the loss of the hypersensitive response and
CC       leads to a broad spectrum disease resistance. These mutations lead
CC       to a specific and dramatic calcium hypersensitivity that results
CC       in severe reductions in plant size and seed yield.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y16328; CAA76179.1; -; Genomic_DNA.
DR   EMBL; AF067798; AAC78613.1; -; mRNA.
DR   EMBL; AF280939; AAF86351.1; -; Genomic_DNA.
DR   EMBL; AL391143; CAC01740.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED92158.1; -; Genomic_DNA.
DR   PIR; T51519; T51519.
DR   RefSeq; NP_197045.1; NM_121545.5. [O65718-1]
DR   UniGene; At.20813; -.
DR   UniGene; At.74751; -.
DR   ProteinModelPortal; O65718; -.
DR   SMR; O65718; -.
DR   STRING; 3702.AT5G15410.1; -.
DR   TCDB; 1.A.1.5.6; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; O65718; -.
DR   EnsemblPlants; AT5G15410.1; AT5G15410.1; AT5G15410. [O65718-1]
DR   GeneID; 831393; -.
DR   Gramene; AT5G15410.1; AT5G15410.1; AT5G15410. [O65718-1]
DR   KEGG; ath:AT5G15410; -.
DR   Araport; AT5G15410; -.
DR   TAIR; locus:2180867; AT5G15410.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; O65718; -.
DR   KO; K05391; -.
DR   OMA; TEQFRYK; -.
DR   OrthoDB; EOG0936045S; -.
DR   PhylomeDB; O65718; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:O65718; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; O65718; baseline and differential.
DR   Genevisible; O65718; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005262; F:calcium channel activity; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; TAS:TAIR.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:TAIR.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; IMP:TAIR.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IGI:TAIR.
DR   GO; GO:0070509; P:calcium ion import; IDA:TAIR.
DR   GO; GO:0006952; P:defense response; TAS:TAIR.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IMP:TAIR.
DR   GO; GO:0009626; P:plant-type hypersensitive response; IMP:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; cAMP; cAMP-binding;
KW   Cell membrane; cGMP; cGMP-binding; Complete proteome; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Plant defense; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    726       Cyclic nucleotide-gated ion channel 2.
FT                                /FTId=PRO_0000219330.
FT   TOPO_DOM      1    127       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    128    148       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    149    162       Extracellular. {ECO:0000255}.
FT   TRANSMEM    163    183       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    184    219       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    220    240       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    241    254       Extracellular. {ECO:0000255}.
FT   TRANSMEM    255    275       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    276    282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    304    424       Extracellular. {ECO:0000255}.
FT   TRANSMEM    425    445       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    446    726       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      666    695       IQ.
FT   NP_BIND     531    661       cNMP.
FT   REGION      645    661       Calmodulin-binding. {ECO:0000250}.
FT   BINDING     600    600       cNMP. {ECO:0000250}.
SQ   SEQUENCE   726 AA;  83241 MW;  450097F2C392D8D4 CRC64;
     MPSHPNFIFR WIGLFSDKFR RQTTGIDENS NLQINGGDSS SSGSDETPVL SSVECYACTQ
     VGVPAFHSTS CDQAHAPEWR ASAGSSLVPI QEGSVPNPAR TRFRRLKGPF GEVLDPRSKR
     VQRWNRALLL ARGMALAVDP LFFYALSIGR TTGPACLYMD GAFAAVVTVL RTCLDAVHLW
     HVWLQFRLAY VSRESLVVGC GKLVWDPRAI ASHYARSLTG FWFDVIVILP VPQAVFWLVV
     PKLIREEKVK LIMTILLLIF LFQFLPKIYH CICLMRRMQK VTGYIFGTIW WGFALNLIAY
     FIASHVAGGC WYVLAIQRVA SCIRQQCMRT GNCNLSLACK EEVCYQFVSP TSTVGYPCLS
     GNLTSVVNKP MCLDSNGPFR YGIYRWALPV ISSNSLAVKI LYPIFWGLMT LSTFANDLEP
     TSNWLEVIFS IVMVLSGLLL FTLLIGNIQV FLHAVMAKKR KMQIRCRDME WWMKRRQLPS
     RLRQRVRRFE RQRWNALGGE DELELIHDLP PGLRRDIKRY LCFDLINKVP LFRGMDDLIL
     DNICDRAKPR VFSKDEKIIR EGDPVQRMIF IMRGRVKRIQ SLSKGVLATS TLEPGGYLGD
     ELLSWCLRRP FLDRLPPSSA TFVCLENIEA FSLGSEDLRY ITDHFRYKFA NERLKRTARY
     YSSNWRTWAA VNIQMAWRRR RKRTRGENIG GSMSPVSENS IEGNSERRLL QYAAMFMSIR
     PHDHLE
//
ID   ACHB2_MOUSE             Reviewed;         501 AA.
AC   Q9ERK7; Q8BGP7;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-SEP-2013, sequence version 2.
DT   25-OCT-2017, entry version 129.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-2;
DE   Flags: Precursor;
GN   Name=Chrnb2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Long sleep selected line;
RX   PubMed=11434511; DOI=10.1097/00008571-200106000-00008;
RA   Stitzel J.A., Dobelis P., Jimenez M., Collins A.C.;
RT   "Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+
RT   efflux and alpha4 nicotinic receptor subunit cDNA sequence.";
RL   Pharmacogenetics 11:331-339(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Spinal cord, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane permeable to sodiun ions. {ECO:0000250}.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of
CC       subunits: alpha and beta. Beta-2 subunit can be combined to alpha-
CC       2, alpha-3 or alpha-4 to give rise to functional receptors,
CC       complexes with beta-2 may be heteropentamers. Alpha-2/4:beta-2
CC       nAChR complexes are proposed to exist in two subtypes: LS (low
CC       agonist sensitivity) with a (alpha-2/4)3:(beta-2)2 and HS (high
CC       agonist sensitivity) with a (alpha-2/4)2:(beta-2)3 stoichiometry;
CC       the subtypes differ in their subunit binding interfaces which are
CC       involved in ligand binding. Interacts with RIC3; which is required
CC       for proper folding and assembly. Interacts with LYPD6. The
CC       heteropentamer alpha3-beta-2 interacts with alpha-cconotoxins
CC       BuIA, MII, ImI, ImII, PnIA and GID (By similarity). The
CC       heteropentamer alpha-4-beta-2 interacts with the alpha-conotoxins
CC       PnIA, GID and MII (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P12390, ECO:0000250|UniProtKB:P17787}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       2/CHRNB2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF299083; AAG23697.1; -; mRNA.
DR   EMBL; AY574267; AAS90363.1; -; mRNA.
DR   EMBL; AK049722; BAC33893.1; -; mRNA.
DR   EMBL; AK051742; BAC34749.1; -; mRNA.
DR   EMBL; AC102392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466547; EDL15184.1; -; Genomic_DNA.
DR   EMBL; BC065103; AAH65103.1; -; mRNA.
DR   CCDS; CCDS17515.1; -.
DR   RefSeq; NP_033732.2; NM_009602.4.
DR   UniGene; Mm.35088; -.
DR   ProteinModelPortal; Q9ERK7; -.
DR   SMR; Q9ERK7; -.
DR   DIP; DIP-48730N; -.
DR   IntAct; Q9ERK7; 3.
DR   STRING; 10090.ENSMUSP00000029562; -.
DR   BindingDB; Q9ERK7; -.
DR   ChEMBL; CHEMBL3301382; -.
DR   iPTMnet; Q9ERK7; -.
DR   PhosphoSitePlus; Q9ERK7; -.
DR   MaxQB; Q9ERK7; -.
DR   PaxDb; Q9ERK7; -.
DR   PRIDE; Q9ERK7; -.
DR   Ensembl; ENSMUST00000029562; ENSMUSP00000029562; ENSMUSG00000027950.
DR   GeneID; 11444; -.
DR   KEGG; mmu:11444; -.
DR   UCSC; uc008qaa.2; mouse.
DR   CTD; 1141; -.
DR   MGI; MGI:87891; Chrnb2.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q9ERK7; -.
DR   KO; K04813; -.
DR   OMA; TTHTMPP; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-MMU-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-MMU-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-MMU-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   PRO; PR:Q9ERK7; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   Bgee; ENSMUSG00000027950; -.
DR   ExpressionAtlas; Q9ERK7; baseline and differential.
DR   Genevisible; Q9ERK7; MM.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:MGI.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0044853; C:plasma membrane raft; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; ISO:MGI.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISO:MGI.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:MGI.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IDA:MGI.
DR   GO; GO:0001508; P:action potential; IMP:MGI.
DR   GO; GO:0008306; P:associative learning; IGI:MGI.
DR   GO; GO:0042113; P:B cell activation; IMP:MGI.
DR   GO; GO:0035095; P:behavioral response to nicotine; IMP:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IGI:MGI.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; IMP:MGI.
DR   GO; GO:0021952; P:central nervous system projection neuron axonogenesis; IMP:MGI.
DR   GO; GO:0050890; P:cognition; ISO:MGI.
DR   GO; GO:0001661; P:conditioned taste aversion; IMP:MGI.
DR   GO; GO:0021771; P:lateral geniculate nucleus development; IMP:MGI.
DR   GO; GO:0007612; P:learning; IMP:MGI.
DR   GO; GO:0007626; P:locomotory behavior; IMP:MGI.
DR   GO; GO:0051899; P:membrane depolarization; IMP:MGI.
DR   GO; GO:0007613; P:memory; IMP:MGI.
DR   GO; GO:0045759; P:negative regulation of action potential; IMP:MGI.
DR   GO; GO:0050877; P:nervous system process; ISO:MGI.
DR   GO; GO:0021631; P:optic nerve morphogenesis; IMP:MGI.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IGI:MGI.
DR   GO; GO:0033603; P:positive regulation of dopamine secretion; IMP:MGI.
DR   GO; GO:0032226; P:positive regulation of synaptic transmission, dopaminergic; IMP:MGI.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IMP:MGI.
DR   GO; GO:0042320; P:regulation of circadian sleep/wake cycle, REM sleep; IMP:MGI.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; IMP:MGI.
DR   GO; GO:0042053; P:regulation of dopamine metabolic process; IMP:MGI.
DR   GO; GO:0014059; P:regulation of dopamine secretion; IMP:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0051963; P:regulation of synapse assembly; IMP:MGI.
DR   GO; GO:0032225; P:regulation of synaptic transmission, dopaminergic; IMP:MGI.
DR   GO; GO:0042220; P:response to cocaine; IMP:MGI.
DR   GO; GO:0045471; P:response to ethanol; IMP:MGI.
DR   GO; GO:0001666; P:response to hypoxia; IMP:MGI.
DR   GO; GO:0035094; P:response to nicotine; IMP:MGI.
DR   GO; GO:0019233; P:sensory perception of pain; IMP:MGI.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:MGI.
DR   GO; GO:0007165; P:signal transduction; ISO:MGI.
DR   GO; GO:0006939; P:smooth muscle contraction; IGI:MGI.
DR   GO; GO:0035176; P:social behavior; IMP:MGI.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; IGI:MGI.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   GO; GO:0021562; P:vestibulocochlear nerve development; IMP:MGI.
DR   GO; GO:0008542; P:visual learning; IMP:MGI.
DR   GO; GO:0007601; P:visual perception; IMP:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR032932; CHRNB2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF80; PTHR18945:SF80; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    501       Neuronal acetylcholine receptor subunit
FT                                beta-2.
FT                                /FTId=PRO_0000000380.
FT   TOPO_DOM     26    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical. {ECO:0000255}.
FT   TOPO_DOM    260    267       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    268    288       Helical. {ECO:0000255}.
FT   TOPO_DOM    289    300       Extracellular. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical. {ECO:0000255}.
FT   TOPO_DOM    322    459       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    460    480       Helical. {ECO:0000255}.
FT   SITE         84     84       Key residue that may interfere with
FT                                effective access of the conotoxin BuIA to
FT                                the channel binding site.
FT                                {ECO:0000250|UniProtKB:P12390}.
FT   SITE        136    136       Key residue for a rapid dissociation
FT                                (K(off)) from the conotoxin BuIA.
FT                                {ECO:0000250|UniProtKB:P12390}.
FT   SITE        144    144       Key residue for a rapid dissociation
FT                                (K(off)) from the conotoxin BuIA.
FT                                {ECO:0000250|UniProtKB:P12390}.
FT   CARBOHYD     51     51       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    168    168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250}.
FT   CONFLICT    380    380       E -> K (in Ref. 1; AAG23697).
FT                                {ECO:0000305}.
SQ   SEQUENCE   501 AA;  57113 MW;  7FFAD47BD86B4493 CRC64;
     MARCSNSMAL LFSFGLLWLC SGVLGTDTEE RLVEHLLDPS RYNKLIRPAT NGSELVTVQL
     MVSLAQLISV HEREQIMTTN VWLTQEWEDY RLTWKPEDFD NMKKVRLPSK HIWLPDVVLY
     NNADGMYEVS FYSNAVVSYD GSIFWLPPAI YKSACKIEVK HFPFDQQNCT MKFRSWTYDR
     TEIDLVLKSD VASLDDFTPS GEWDIIALPG RRNENPDDST YVDITYDFII RRKPLFYTIN
     LIIPCVLITS LAILVFYLPS DCGEKMTLCI SVLLALTVFL LLISKIVPPT SLDVPLVGKY
     LMFTMVLVTF SIVTSVCVLN VHHRSPTTHT MAPWVKVVFL EKLPTLLFLQ QPRHRCARQR
     LRLRRRQRER EGAGTLFFRE GPAADPCTCF VNPASMQGLA GAFQAEPAAA GLGRSMGPCS
     CGLREAVDGV RFIADHMRSE DDDQSVREDW KYVAMVIDRL FLWIFVFVCV FGTIGMFLQP
     LFQNYTATTF LHSDHSAPSS K
//
ID   GBRB4_CHICK             Reviewed;         488 AA.
AC   P24045; Q6LBM6;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   25-OCT-2017, entry version 140.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-4;
DE   AltName: Full=GABA(A) receptor subunit beta-4;
DE   Flags: Precursor;
GN   Name=GABRB4;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS BETA-4 AND
RP   BETA-4').
RC   STRAIN=Rhode Island; TISSUE=Brain, and Liver;
RX   PubMed=1848280; DOI=10.1111/j.1471-4159.1991.tb11443.x;
RA   Bateson A.N., Lasham A., Darlison M.G.;
RT   "Gamma-aminobutyric acid A receptor heterogeneity is increased by
RT   alternative splicing of a novel beta-subunit gene transcript.";
RL   J. Neurochem. 56:1437-1440(1991).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-4';
CC         IsoId=P24045-1; Sequence=Displayed;
CC       Name=Beta-4;
CC         IsoId=P24045-2; Sequence=VSP_000089;
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRB4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X56647; CAA39969.1; -; mRNA.
DR   EMBL; X56648; CAA39970.1; ALT_SEQ; mRNA.
DR   EMBL; X56646; CAA39968.1; -; Genomic_DNA.
DR   PIR; JH0359; JH0359.
DR   RefSeq; NP_001161175.1; NM_001167703.1. [P24045-1]
DR   RefSeq; NP_001161176.1; NM_001167704.1. [P24045-2]
DR   UniGene; Gga.428; -.
DR   ProteinModelPortal; P24045; -.
DR   SMR; P24045; -.
DR   STRING; 9031.ENSGALP00000011732; -.
DR   PaxDb; P24045; -.
DR   Ensembl; ENSGALT00000055905; ENSGALP00000058040; ENSGALG00000033183. [P24045-1]
DR   GeneID; 396288; -.
DR   KEGG; gga:396288; -.
DR   CTD; 55879; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P24045; -.
DR   KO; K05192; -.
DR   OMA; GMSIHIS; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P24045; -.
DR   TreeFam; TF315453; -.
DR   PRO; PR:P24045; -.
DR   Proteomes; UP000000539; Chromosome 4.
DR   Bgee; ENSGALG00000007255; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25
FT   CHAIN        26    488       Gamma-aminobutyric acid receptor subunit
FT                                beta-4.
FT                                /FTId=PRO_0000000466.
FT   TOPO_DOM     26    244       Extracellular. {ECO:0000305}.
FT   TRANSMEM    245    266       Helical. {ECO:0000305}.
FT   TRANSMEM    271    292       Helical. {ECO:0000305}.
FT   TRANSMEM    304    326       Helical. {ECO:0000305}.
FT   TOPO_DOM    327    465       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    466    487       Helical. {ECO:0000305}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    160    174       {ECO:0000250}.
FT   VAR_SEQ     361    364       Missing (in isoform Beta-4).
FT                                {ECO:0000303|PubMed:1848280}.
FT                                /FTId=VSP_000089.
SQ   SEQUENCE   488 AA;  56069 MW;  164A75314BDB2C12 CRC64;
     MWTFQADRLS GIVSALAALC VACCAQSPST GNISVVKEIV DKLLKGYDVR LRPDFGGNPV
     TVGMSIHISS IDQISEVNMD YTITMYFQQS WRDKRLAYND LPLNLTLDNR VADQLWLPDT
     YFLNDKKSFL HGVTVKNRMI RLHPDGTVLY GLRITTTAAC MMDLRRYPLD QQNCTLEIES
     YGYTVDDIVF FWQGNDSAVT GMEVLELPQF TIIEQRLVSR EVVFTTGSYL RLSLSFRIKR
     NIGYFILQTY MPSILITILS WVSFWINYDA SAARVALGVT TVLTMTTINT HLRETLPKIP
     YVKAIDVYLM GCFVFVFLAL LEYAFVNYIF FGRGPRQQKK QSERISKANN ERHRYEEKRV
     REQVDPYGNI LLSTLDMNNE LLATDMMSSV GDSRNSVMSF EGSGIQFRKP LASRDGFGHH
     PTLDRHVPLT HHAAARNRAN CRLRRRSSKL KLKIPDLTDV STIDKWSRII FPITFGFFNL
     VYWLYYVN
//
ID   ACH91_ONCMY             Reviewed;         572 AA.
AC   Q8JFN7;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   25-OCT-2017, entry version 76.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-9-I;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-9-I;
DE            Short=NACHR alpha-9-I;
DE   Flags: Precursor;
GN   Name=nachra9;
OS   Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii;
OC   Salmoniformes; Salmonidae; Salmoninae; Oncorhynchus.
OX   NCBI_TaxID=8022;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Saccule;
RX   PubMed=15283971; DOI=10.1016/j.neuroscience.2004.05.037;
RA   Drescher D.G., Ramakrishnan N.A., Drescher M.J., Chun W., Wang X.,
RA   Myers S.F., Green G.E., Sadrazodi K., Karadaghy A.A., Poopat N.,
RA   Karpenko A.N., Khan K.M., Hatfield J.S.;
RT   "Cloning and characterization of alpha9 subunits of the nicotinic
RT   acetylcholine receptor expressed by saccular hair cells of the rainbow
RT   trout (Oncorhynchus mykiss).";
RL   Neuroscience 127:737-752(2004).
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the liver, olfactory mucosa,
CC       pituitary gland, hair cells of the saccule and spleen.
CC       {ECO:0000269|PubMed:15283971}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY037940; AAK72491.1; -; mRNA.
DR   RefSeq; NP_001117911.1; NM_001124439.1.
DR   UniGene; Omy.90; -.
DR   ProteinModelPortal; Q8JFN7; -.
DR   GeneID; 100136152; -.
DR   CTD; 662452; -.
DR   HOVERGEN; HBG003756; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    572       Neuronal acetylcholine receptor subunit
FT                                alpha-9-I.
FT                                /FTId=PRO_0000000374.
FT   TOPO_DOM     20    232       Extracellular. {ECO:0000255}.
FT   TRANSMEM    233    253       Helical. {ECO:0000255}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical. {ECO:0000255}.
FT   TOPO_DOM    318    550       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    551    571       Helical. {ECO:0000255}.
FT   CARBOHYD     51     51       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    149    163       {ECO:0000250}.
FT   DISULFID    213    214       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   572 AA;  65590 MW;  EB27F30AC97AA352 CRC64;
     MKTVVLLTWI SCWIDVCTSA QGRYAQKLLN DLMENYSSAL RPVEDTDKTL NVTLQITLSQ
     IKDMDERNQV LTTYLWIRQT WFDAYLKWDK EEYDGLEVIR IPSNLVWRPD IVLYNKADEE
     ASGPADTNVV LRYNGEITWD MPAITKSSCV VDVSYFPFDW QWCNLTFGSW TYNGNQVDIA
     MGMDSGDLSD FVENVEWECH GMPAVRNVIM YGCCSDPYPD ITYTLHLKRR SLFYIFNLLL
     PCFLISFLAP LGFYLPADSG EKVSLGVTVL LALTVFQLMV AESMPPSESV PYIGKYYIAT
     MTMITASTSL TIFIMNIHFC GAEAKPVPHW AKVLIIDYMS KILFVYEVGE NCTTPESERT
     PLYSEEPMSG NSALARNHYH DDLYHDGGCY QDDCHRLRPY QYGNGHLQNH HSTHQNHLDN
     CRYANGGHRD DHYSNRSNQN HHSNRSQTSK GEGGEEKREP LRHYHHIGRE ELDYQAPPPG
     NLQNGGLNEP LPYPKEKHLN PASAPACSCP CPHHKQVVYN IQYIANCFRE QRATCAKGAE
     WKKVAKVMDR FFMWIFFIMV FLMSILIIGK AT
//
ID   LGC46_CAEEL             Reviewed;         508 AA.
AC   Q95Y52;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   20-DEC-2017, entry version 133.
DE   RecName: Full=Probable ligand-gated ion channel 46 {ECO:0000312|WormBase:Y71D11A.5};
DE   Flags: Precursor;
GN   Name=lgc-46 {ECO:0000312|WormBase:Y71D11A.5};
GN   ORFNames=Y71D11A.5 {ECO:0000312|WormBase:Y71D11A.5};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF 301-PRO--ALA-302 AND
RP   MET-314.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Probable component of a ligand-gated anion channel.
CC       Negatively regulates synaptic transmission and synaptic vesicle
CC       release in response to acetylcholine in cholinergic motor neurons.
CC       Role in synaptic vesicle release kinetics may be in association
CC       with the ligand-gated ion channel protein acc-4.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell
CC       membrane {ECO:0000269|PubMed:27782882}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000269|PubMed:27782882}. Cytoplasmic vesicle, secretory
CC       vesicle, synaptic vesicle {ECO:0000269|PubMed:27782882}.
CC   -!- TISSUE SPECIFICITY: Expressed in the nervous system, with high
CC       expression in cholinergic motor neurons and weak expression in
CC       GABAergic motor neurons. {ECO:0000269|PubMed:27782882}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the dorsal nerve cord of L1
CC       larva and on the dorsal side only of L4 larva and adults.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- DISRUPTION PHENOTYPE: Viable, with normal growth, reproduction and
CC       locomotion. Increased sensitivity to the acetylcholine esterase
CC       inhibitor aldicarb, but normal sensitivity to levamisole, an
CC       agonist for postsynaptic acetylcholine receptors on muscles. In
CC       response to induced acetylcholine release, the amplitude and rise
CC       phase of excitatory postsynaptic currents (eEPSCs) during synaptic
CC       transmission is as wild-type, but there is prolonged and slow
CC       decay of eEPSCs during the late phase of synaptic transmission,
CC       which results in increased release of synaptic vesicles in
CC       cholinergic motor neurons. {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284603; CCD72054.1; -; Genomic_DNA.
DR   RefSeq; NP_497338.2; NM_064937.5.
DR   UniGene; Cel.6380; -.
DR   ProteinModelPortal; Q95Y52; -.
DR   SMR; Q95Y52; -.
DR   STRING; 6239.Y71D11A.5; -.
DR   PaxDb; Q95Y52; -.
DR   EnsemblMetazoa; Y71D11A.5; Y71D11A.5; WBGene00022106.
DR   GeneID; 175279; -.
DR   KEGG; cel:CELE_Y71D11A.5; -.
DR   UCSC; Y71D11A.5; c. elegans.
DR   CTD; 175279; -.
DR   WormBase; Y71D11A.5; CE29908; WBGene00022106; lgc-46.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q95Y52; -.
DR   OMA; RTTEEYP; -.
DR   OrthoDB; EOG091G07NS; -.
DR   PhylomeDB; Q95Y52; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00022106; -.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasmic vesicle; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    508       Probable ligand-gated ion channel 46.
FT                                {ECO:0000305}.
FT                                /FTId=PRO_5004322281.
FT   TOPO_DOM     19    274       Extracellular. {ECO:0000305}.
FT   TRANSMEM    275    295       Helical. {ECO:0000255}.
FT   TOPO_DOM    296    301       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    302    321       Helical. {ECO:0000255}.
FT   TOPO_DOM    322    335       Extracellular. {ECO:0000305}.
FT   TRANSMEM    336    356       Helical. {ECO:0000255}.
FT   TOPO_DOM    357    480       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    481    501       Helical. {ECO:0000255}.
FT   TOPO_DOM    502    508       Extracellular. {ECO:0000305}.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    175    175       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    190    204       {ECO:0000250|UniProtKB:P02712}.
FT   MUTAGEN     301    302       PA->E: Does not suppress the increased
FT                                number of convulsions in the acr-2
FT                                (acetylcholine-gated cation channel) gain
FT                                of function mutant; when associated with
FT                                I-314. {ECO:0000269|PubMed:27782882}.
FT   MUTAGEN     314    314       M->I: In ju825; gain of function
FT                                mutation. Irregular "curly" body posture
FT                                and slow locomotion. Slow locomotion
FT                                defect suppressed in an acc-4 null
FT                                background. Reduces the amplitude and
FT                                suppresses synaptic vesicle release from
FT                                the presynaptic membrane of cholinergic
FT                                motor neurons during the late phase of
FT                                synaptic transmission. Fully suppresses
FT                                sensitivity to the acetylcholine esterase
FT                                inhibitor aldicarb in lgc-46 null
FT                                mutants. Suppresses the increased number
FT                                of convulsions in the double acr-2 gain
FT                                of function and acc-4 null mutant
FT                                background. Does not suppress the
FT                                increased number of convulsions in the
FT                                acr-2 gain of function mutant; when
FT                                associated with E-301.
FT                                {ECO:0000269|PubMed:27782882}.
SQ   SEQUENCE   508 AA;  58461 MW;  FD9CE28A3E6D8F88 CRC64;
     MQYLQFLSLV VLLLMCHARK SVYRRNSPSL RRLTRNYDWE VDEHGGLKPI INPAKVERAT
     KNCANDSFIL GTIMSNYNRH KIPGGQVDVE VEVWVQEITT ISDITSDFQL DIYIYETWYD
     PALNYAFMNP CKYNLSLNSV LLEKLWTPNS CFINSKTADI HKSPFPNIFL MIYANGTVWT
     NYRLKLQGPC IMDLTKFPFD NVTCSLTFES FNYNTDEVKM DWSVNGVQKM RDKMELADYE
     LVDIHKIRTT EEYPAGYWHE LTMSFEFKRR AGWYILQAYL PTYLTICISW ISFALGSKAI
     PARTMLGVNS LLAMTFQFGN IIRNLPRVSY VKAIDVWMLS CMTFVFCSLL ELAWVGYLSR
     EEEPTSAKCL QPSAQVAPKP CHPPPVQQNA NNSSVHRRQK QPKNEEESAL LSLRDNDYGY
     IPPGFGLNGN VANAMKSFSS SCSCEPTNVV NLMLDEAETI PTSTSSSLSR KQRREILAHK
     IDSVSVFMFP FLFVLFNIAY WQHYLRGY
//
ID   LGC4_CAEEL              Reviewed;         635 AA.
AC   P54245;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   22-NOV-2017, entry version 135.
DE   RecName: Full=Ligand-gated ion channel 4;
DE   Flags: Precursor;
GN   Name=lgc-4; ORFNames=F18G5.4;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=17503100; DOI=10.1007/s10158-007-0049-z;
RA   Jones A.K., Davis P., Hodgkin J., Sattelle D.B.;
RT   "The nicotinic acetylcholine receptor gene family of the nematode
RT   Caenorhabditis elegans: an update on nomenclature.";
RL   Invertebr. Neurosci. 7:129-131(2007).
CC   -!- FUNCTION: Possible acetylcholine receptor.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO080202; CCD61933.1; -; Genomic_DNA.
DR   PIR; A89606; A89606.
DR   RefSeq; NP_509556.4; NM_077155.4.
DR   UniGene; Cel.5251; -.
DR   ProteinModelPortal; P54245; -.
DR   STRING; 6239.F18G5.4; -.
DR   PaxDb; P54245; -.
DR   EnsemblMetazoa; F18G5.4; F18G5.4; WBGene00017580.
DR   GeneID; 181155; -.
DR   KEGG; cel:CELE_F18G5.4; -.
DR   CTD; 181155; -.
DR   WormBase; F18G5.4; CE45725; WBGene00017580; lgc-4.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000113319; -.
DR   InParanoid; P54245; -.
DR   OMA; WSHDITE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PRO; PR:P54245; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00017580; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    635       Ligand-gated ion channel 4.
FT                                /FTId=PRO_0000000405.
FT   TOPO_DOM     25    324       Extracellular. {ECO:0000255}.
FT   TRANSMEM    325    345       Helical. {ECO:0000255}.
FT   TRANSMEM    355    375       Helical. {ECO:0000255}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    599       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    600    620       Helical. {ECO:0000255}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    282    282       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    625    625       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    238    252       {ECO:0000250}.
SQ   SEQUENCE   635 AA;  72916 MW;  7A3623E4E80B1948 CRC64;
     MIICYSCLTV SILLTIKFVP CRFAGIEHQN TKSRVHFSLL DSRQENDTNH FEIAEAKFQK
     PHNEENTIGT ITKFAPSVQE QHSSAVIPMP HFDQNRLEQA LRIKGSIDGT EEALYRSLLD
     HTVYEKDVRP CIHHSQPTNV TFGFLLNQIV EMDERNQALT TRSWLNINWM DPRLSWNESL
     WSEIKAIYIP HARIWKPDII LVNNAIREYY ASLVSTDVMV TSDGNVTWLF SALFRSSCPI
     RVRYYPFDDQ QCDLKFASWS HDITEINLGL NTDKGDLSSY MNNSEFDLVD MTAVREVVTF
     PSDTNSDWPI IVIRIHMHRR PLFYVFNHIV PCVLISSMAV LGFLMPPETG EKINMIITTL
     LSMGVYLQSI TESIPPTSEG VPLIGMYYVS SLLMVCLATC VNVITLNMHR NGAANQGRHV
     PAWMQKWILG YLATFMRMSI REPDSIALLK ASQSKKSTIR RSSILRDLKR VKNMSNVRAK
     SKEQNANREC ECMDPLVHIY AESIMSCLAA DTKPMNGSTI REDFASESTF LGRVVSDGIM
     PRISASSNSV LTEFETRFRR ILKRVYRSLQ QHEIREEILD ERSRIQWQWQ QLASVVDRLL
     LCLFCTATLF TIICLLIVPV AYRDNDSMLS FLNFF
//
ID   ACHA9_HUMAN             Reviewed;         479 AA.
AC   Q9UGM1; Q14CY7; Q4W5A2; Q9NYV2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-9;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-9;
DE            Short=NACHR alpha-9;
DE   Flags: Precursor;
GN   Name=CHRNA9; Synonyms=NACHRA9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CHRNA10,
RP   SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANT
RP   SER-442.
RC   TISSUE=Embryo;
RX   PubMed=11752216; DOI=10.1124/mol.61.1.150;
RA   Sgard F., Charpantier E., Bertrand S., Walker N., Caput D., Graham D.,
RA   Bertrand D., Besnard F.;
RT   "A novel human nicotinic receptor subunit, alpha10, that confers
RT   functionality to the alpha9-subunit.";
RL   Mol. Pharmacol. 61:150-159(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-442.
RX   PubMed=12697997; DOI=10.1159/000069804;
RA   Lustig L.R., Peng H.;
RT   "Chromosome location and characterization of the human nicotinic
RT   acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) gene.";
RL   Cytogenet. Genome Res. 98:154-159(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-442.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-476, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11021840; DOI=10.1016/S0002-9440(10)64651-2;
RA   Nguyen V.T., Ndoye A., Grando S.A.;
RT   "Novel human alpha9 acetylcholine receptor regulating keratinocyte
RT   adhesion is targeted by Pemphigus vulgaris autoimmunity.";
RL   Am. J. Pathol. 157:1377-1391(2000).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15531379; DOI=10.1016/j.lfs.2004.05.031;
RA   Peng H., Ferris R.L., Matthews T., Hiel H., Lopez-Albaitero A.,
RA   Lustig L.R.;
RT   "Characterization of the human nicotinic acetylcholine receptor
RT   subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in
RT   lymphocytes.";
RL   Life Sci. 76:263-280(2004).
RN   [7]
RP   MUTAGENESIS OF ILE-86, AND SUBUNIT.
RX   PubMed=22774872; DOI=10.1111/j.1471-4159.2012.07867.x;
RA   Azam L., McIntosh J.M.;
RT   "Molecular basis for the differential sensitivity of rat and human
RT   alpha9alpha10 nAChRs to alpha-conotoxin RgIA.";
RL   J. Neurochem. 122:1137-1144(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) OF 26-237, FUNCTION,
RP   SUBCELLULAR LOCATION, DISULFIDE BOND, AND GLYCOSYLATION.
RX   PubMed=25282151; DOI=10.1038/nsmb.2900;
RA   Zouridakis M., Giastas P., Zarkadas E., Chroni-Tzartou D.,
RA   Bregestovski P., Tzartos S.J.;
RT   "Crystal structures of free and antagonist-bound states of human
RT   alpha9 nicotinic receptor extracellular domain.";
RL   Nat. Struct. Mol. Biol. 21:976-980(2014).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the
CC       modulation of auditory stimuli. Agonist binding induces a
CC       conformation change that leads to the opening of an ion-conducting
CC       channel across the plasma membrane (PubMed:11752216,
CC       PubMed:25282151). The channel is permeable to a range of divalent
CC       cations including calcium, the influx of which may activate a
CC       potassium current which hyperpolarizes the cell membrane
CC       (PubMed:11752216, PubMed:25282151). In the ear, this may lead to a
CC       reduction in basilar membrane motion, altering the activity of
CC       auditory nerve fibers and reducing the range of dynamic hearing.
CC       This may protect against acoustic trauma. May also regulate
CC       keratinocyte adhesion (PubMed:11021840).
CC       {ECO:0000269|PubMed:11021840, ECO:0000269|PubMed:11752216,
CC       ECO:0000269|PubMed:25282151, ECO:0000305}.
CC   -!- SUBUNIT: Can form homo- or heterooligomeric channels in
CC       conjunction with CHRNA10 (PubMed:11752216). The native outer hair
CC       cell receptor may be composed of CHRNA9-CHRNA10 heterooligomers.
CC       Interacts with the alpha-conotoxon RgIA (PubMed:22774872).
CC       {ECO:0000269|PubMed:11752216, ECO:0000269|PubMed:22774872}.
CC   -!- INTERACTION:
CC       P60616:- (xeno); NbExp=2; IntAct=EBI-9008641, EBI-16123259;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000269|PubMed:25282151}; Multi-pass membrane
CC       protein {ECO:0000305|PubMed:25282151}.
CC   -!- TISSUE SPECIFICITY: Expressed in cochlea, keratinocytes, pituitary
CC       gland, B-cells and T-cells. {ECO:0000269|PubMed:11021840,
CC       ECO:0000269|PubMed:11752216, ECO:0000269|PubMed:15531379}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25282151}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9
CC       and CHRNA10 has an atypical pharmacological profile, binding
CC       several non-nicotinic ligands including strychnine (a glycine
CC       receptor antagonist) and atropine (a muscarinic acetylcholine
CC       receptor antagonist). {ECO:0000305|PubMed:11752216}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       9/CHRNA9 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243342; CAB65091.1; -; mRNA.
DR   EMBL; AY123244; AAM74523.1; -; Genomic_DNA.
DR   EMBL; AC118275; AAY40986.1; -; Genomic_DNA.
DR   EMBL; BC113549; AAI13550.1; -; mRNA.
DR   EMBL; BC113575; AAI13576.1; -; mRNA.
DR   EMBL; AF227732; AAF61920.1; -; mRNA.
DR   CCDS; CCDS3459.1; -.
DR   RefSeq; NP_060051.2; NM_017581.3.
DR   UniGene; Hs.272278; -.
DR   PDB; 4D01; X-ray; 1.80 A; A=26-237.
DR   PDB; 4UXU; X-ray; 1.71 A; A/B=26-237.
DR   PDB; 4UY2; X-ray; 2.70 A; A/B=26-237.
DR   PDBsum; 4D01; -.
DR   PDBsum; 4UXU; -.
DR   PDBsum; 4UY2; -.
DR   ProteinModelPortal; Q9UGM1; -.
DR   SMR; Q9UGM1; -.
DR   BioGrid; 120731; 75.
DR   CORUM; Q9UGM1; -.
DR   DIP; DIP-61053N; -.
DR   IntAct; Q9UGM1; 1.
DR   STRING; 9606.ENSP00000312663; -.
DR   BindingDB; Q9UGM1; -.
DR   ChEMBL; CHEMBL2184; -.
DR   DrugBank; DB05069; ATG003.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB05137; Lobeline.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB05740; RPI-78M.
DR   DrugBank; DB08837; Tetraethylammonium.
DR   GuidetoPHARMACOLOGY; 469; -.
DR   iPTMnet; Q9UGM1; -.
DR   PhosphoSitePlus; Q9UGM1; -.
DR   BioMuta; CHRNA9; -.
DR   DMDM; 308153406; -.
DR   MaxQB; Q9UGM1; -.
DR   PaxDb; Q9UGM1; -.
DR   PeptideAtlas; Q9UGM1; -.
DR   PRIDE; Q9UGM1; -.
DR   DNASU; 55584; -.
DR   Ensembl; ENST00000310169; ENSP00000312663; ENSG00000174343.
DR   GeneID; 55584; -.
DR   KEGG; hsa:55584; -.
DR   UCSC; uc003gva.2; human.
DR   CTD; 55584; -.
DR   DisGeNET; 55584; -.
DR   EuPathDB; HostDB:ENSG00000174343.5; -.
DR   GeneCards; CHRNA9; -.
DR   H-InvDB; HIX0031380; -.
DR   HGNC; HGNC:14079; CHRNA9.
DR   MIM; 605116; gene.
DR   neXtProt; NX_Q9UGM1; -.
DR   OpenTargets; ENSG00000174343; -.
DR   PharmGKB; PA26493; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q9UGM1; -.
DR   KO; K04810; -.
DR   OMA; ATKNVIM; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q9UGM1; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   ChiTaRS; CHRNA9; human.
DR   GeneWiki; CHRNA9; -.
DR   GenomeRNAi; 55584; -.
DR   PRO; PR:Q9UGM1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000174343; -.
DR   CleanEx; HS_CHRNA9; -.
DR   Genevisible; Q9UGM1; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Calcium channel; Calcium transport;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    479       Neuronal acetylcholine receptor subunit
FT                                alpha-9.
FT                                /FTId=PRO_0000000371.
FT   TOPO_DOM     26    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    262       Helical. {ECO:0000255}.
FT   TRANSMEM    269    287       Helical. {ECO:0000255}.
FT   TRANSMEM    302    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    457       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    458    476       Helical. {ECO:0000255}.
FT   SITE        146    146       Key residue important for potent
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA (AC P0C1D0).
FT                                {ECO:0000250|UniProtKB:P43144}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000269|PubMed:25282151}.
FT   DISULFID    219    220       {ECO:0000269|PubMed:25282151}.
FT   VARIANT      96     96       R -> Q (in dbSNP:rs10024518).
FT                                /FTId=VAR_031151.
FT   VARIANT     315    315       A -> V (in dbSNP:rs55633891).
FT                                /FTId=VAR_060996.
FT   VARIANT     442    442       N -> S (in dbSNP:rs10009228).
FT                                {ECO:0000269|PubMed:11752216,
FT                                ECO:0000269|PubMed:12697997,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_025425.
FT   MUTAGEN      86     86       I->T: The CHRNA9-CHRNA10 receptor is 250-
FT                                fold more potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   HELIX        30     39       {ECO:0000244|PDB:4UXU}.
FT   STRAND       49     51       {ECO:0000244|PDB:4UY2}.
FT   STRAND       56     71       {ECO:0000244|PDB:4UXU}.
FT   TURN         72     75       {ECO:0000244|PDB:4UXU}.
FT   STRAND       76     93       {ECO:0000244|PDB:4UXU}.
FT   HELIX        96     98       {ECO:0000244|PDB:4UXU}.
FT   TURN         99    101       {ECO:0000244|PDB:4UXU}.
FT   STRAND      104    108       {ECO:0000244|PDB:4UXU}.
FT   HELIX       109    111       {ECO:0000244|PDB:4UXU}.
FT   STRAND      117    119       {ECO:0000244|PDB:4UXU}.
FT   STRAND      134    138       {ECO:0000244|PDB:4UXU}.
FT   STRAND      140    154       {ECO:0000244|PDB:4UXU}.
FT   STRAND      156    158       {ECO:0000244|PDB:4UXU}.
FT   STRAND      164    177       {ECO:0000244|PDB:4UXU}.
FT   TURN        180    182       {ECO:0000244|PDB:4UXU}.
FT   STRAND      183    191       {ECO:0000244|PDB:4UXU}.
FT   STRAND      201    207       {ECO:0000244|PDB:4UXU}.
FT   STRAND      209    217       {ECO:0000244|PDB:4UXU}.
FT   TURN        218    220       {ECO:0000244|PDB:4UXU}.
FT   STRAND      224    235       {ECO:0000244|PDB:4UXU}.
SQ   SEQUENCE   479 AA;  54807 MW;  AA6B46B559D6111D CRC64;
     MNWSHSCISF CWIYFAASRL RAAETADGKY AQKLFNDLFE DYSNALRPVE DTDKVLNVTL
     QITLSQIKDM DERNQILTAY LWIRQIWHDA YLTWDRDQYD GLDSIRIPSD LVWRPDIVLY
     NKADDESSEP VNTNVVLRYD GLITWDAPAI TKSSCVVDVT YFPFDNQQCN LTFGSWTYNG
     NQVDIFNALD SGDLSDFIED VEWEVHGMPA VKNVISYGCC SEPYPDVTFT LLLKRRSSFY
     IVNLLIPCVL ISFLAPLSFY LPAASGEKVS LGVTILLAMT VFQLMVAEIM PASENVPLIG
     KYYIATMALI TASTALTIMV MNIHFCGAEA RPVPHWARVV ILKYMSRVLF VYDVGESCLS
     PHHSRERDHL TKVYSKLPES NLKAARNKDL SRKKDMNKRL KNDLGCQGKN PQEAESYCAQ
     YKVLTRNIEY IAKCLKDHKA TNSKGSEWKK VAKVIDRFFM WIFFIMVFVM TILIIARAD
//
ID   ACH3_CAEEL              Reviewed;         564 AA.
AC   P54244;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-NOV-2017, entry version 131.
DE   RecName: Full=Acetylcholine receptor subunit alpha-type deg-3;
DE   Flags: Precursor;
GN   Name=deg-3; ORFNames=K03B8.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND MUTAGENESIS OF ILE-314.
RC   STRAIN=Bristol N2;
RX   PubMed=7718248; DOI=10.1016/0896-6273(95)90231-7;
RA   Treinin M., Chalfie M.;
RT   "A mutated acetylcholine receptor subunit causes neuronal degeneration
RT   in C. elegans.";
RL   Neuron 14:871-877(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   INTERACTION WITH DES-2, AND FUNCTION.
RX   PubMed=9860996; DOI=10.1073/pnas.95.26.15492;
RA   Treinin M., Gillo B., Liebman L., Chalfie M.;
RT   "Two functionally dependent acetylcholine subunits are encoded in a
RT   single Caenorhabditis elegans operon.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15492-15495(1998).
RN   [4]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=11273652; DOI=10.1006/mcne.2000.0944;
RA   Yassin L., Gillo B., Kahan T., Halevi S., Eshel M., Treinin M.;
RT   "Characterization of the deg-3/des-2 receptor: a nicotinic
RT   acetylcholine receptor that mutates to cause neuronal degeneration.";
RL   Mol. Cell. Neurosci. 17:589-599(2001).
RN   [5]
RP   INTERACTION WITH DES-2 AND RIC-3.
RX   PubMed=11867529; DOI=10.1093/emboj/21.5.1012;
RA   Halevi S., McKay J., Palfreyman M., Yassin L., Eshel M., Jorgensen E.,
RA   Treinin M.;
RT   "The C. elegans ric-3 gene is required for maturation of nicotinic
RT   acetylcholine receptors.";
RL   EMBO J. 21:1012-1020(2002).
RN   [6]
RP   INTERACTION WITH DES-2 AND RIC-3.
RX   PubMed=15932871; DOI=10.1074/jbc.M504369200;
RA   Ben-Ami H.C., Yassin L., Farah H., Michaeli A., Eshel M., Treinin M.;
RT   "RIC-3 affects properties and quantity of nicotinic acetylcholine
RT   receptors via a mechanism that does not require the coiled-coil
RT   domains.";
RL   J. Biol. Chem. 280:28053-28060(2005).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-37, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [8]
RP   MUTAGENESIS OF ILE-314.
RX   PubMed=17891142; DOI=10.1038/nn1981;
RA   Van Buskirk C., Sternberg P.W.;
RT   "Epidermal growth factor signaling induces behavioral quiescence in
RT   Caenorhabditis elegans.";
RL   Nat. Neurosci. 10:1300-1307(2007).
CC   -!- FUNCTION: Subunit of the non-synaptic neuronal acetylcholine
CC       receptor, which may play a role in chemotaxis towards choline.
CC       After binding choline or acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane (PubMed:9860996, PubMed:11273652).
CC       {ECO:0000269|PubMed:11273652, ECO:0000269|PubMed:9860996}.
CC   -!- SUBUNIT: The functional receptor is a heteromer of deg-3 and des-
CC       2. Interacts with ric-3; which is required for proper receptor
CC       folding. {ECO:0000269|PubMed:11867529,
CC       ECO:0000269|PubMed:15932871, ECO:0000269|PubMed:9860996}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:11273652}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:11273652}. Cell membrane
CC       {ECO:0000269|PubMed:11273652}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11273652}. Note=Enriched in the sensory
CC       endings of sensory neurons.
CC   -!- MISCELLANEOUS: This locus is redundant or nonessential as
CC       suppression of deg-3 function results in wild-type revertants.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U19747; AAA92689.1; -; mRNA.
DR   EMBL; U19746; AAA92688.1; -; Genomic_DNA.
DR   EMBL; Z74039; CAA98507.1; -; Genomic_DNA.
DR   PIR; T23269; T23269.
DR   RefSeq; NP_505897.1; NM_073496.5.
DR   UniGene; Cel.34237; -.
DR   UniGene; Cel.39272; -.
DR   ProteinModelPortal; P54244; -.
DR   STRING; 6239.K03B8.9.1; -.
DR   iPTMnet; P54244; -.
DR   PaxDb; P54244; -.
DR   EnsemblMetazoa; K03B8.9.1; K03B8.9.1; WBGene00000951.
DR   EnsemblMetazoa; K03B8.9.2; K03B8.9.2; WBGene00000951.
DR   GeneID; 3565200; -.
DR   KEGG; cel:CELE_K03B8.9; -.
DR   UCSC; K03B8.9.2; c. elegans.
DR   CTD; 3565200; -.
DR   WormBase; K03B8.9; CE06083; WBGene00000951; deg-3.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000019549; -.
DR   InParanoid; P54244; -.
DR   OMA; HEYKYAC; -.
DR   OrthoDB; EOG091G046I; -.
DR   PhylomeDB; P54244; -.
DR   Reactome; R-CEL-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P54244; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00000951; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0043067; P:regulation of programmed cell death; IMP:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    564       Acetylcholine receptor subunit alpha-type
FT                                deg-3.
FT                                /FTId=PRO_0000000397.
FT   TOPO_DOM     21    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TRANSMEM    302    319       Helical. {ECO:0000255}.
FT   TRANSMEM    329    353       Helical. {ECO:0000255}.
FT   TOPO_DOM    354    526       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    527    547       Helical. {ECO:0000255}.
FT   CARBOHYD     25     25       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     37     37       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    125    125       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    185    199       {ECO:0000250}.
FT   DISULFID    248    249       {ECO:0000250}.
FT   MUTAGEN     314    314       I->N: In u662; degeneration of a set of
FT                                touch receptor neurons, including ALA
FT                                neurons, probably due to channel
FT                                hyperactivity (gain-of-function).
FT                                Uncoordinated, insensitive to both gentle
FT                                and harsh stimuli, and display vacuolated
FT                                cell death. Restores normal pharyngeal
FT                                pumping rate in animals overexpressing
FT                                lin-3. {ECO:0000269|PubMed:17891142,
FT                                ECO:0000269|PubMed:7718248}.
SQ   SEQUENCE   564 AA;  64927 MW;  BA38F7F05B987B9E CRC64;
     MTLKIRTIII LFCVISVTTT SQSLNATLKT FDPRLLNSTA DRDIAMKNVP LVRLTRHLLS
     PERYDVRVRP ILDHKKSLKV HISISLYQII EVDEPSQNIK LNVWMIQKWR DEYLDWNPNE
     YGMINSTIIP FHHLWIPDTY LYNSVKMSRD ETERYMNIQA TSNYWKGEKG AELSFLYPAI
     YTITCRLNIR FFPYDRQNCT LTISSWTNSK SALDYYADTE VSMQSFIPNE EWQVKSFKIH
     RHEYKYACCA EPWVILQASL VIQRKPLYYL VNLIIPTSII TLVAITGFFT PASTDDDRTE
     KINLGITTLL AMSILMLMVS DQMPTTSEFV PLIAWFYLSI IIIISIGTFL TSVVLSVQGR
     RQYGRNPPQF IRYIFFVLLP QVLLLNVPPP LQTLWGELDD DPLNVRRRKK SHYLSRNVNN
     GSTKMASPMS TLRVPQSAGS VSEKRQSFQM IDVTSPNSPN TARSRAPSLA PSTAKATMWE
     GTMSALAGTN TQLRRTSNVF NKEVDEMRRK RQCSLEWEFL ATVLDRFLLI VFVGAVVIVT
     AGLILVGRMA QYSYDHPDDR FFNV
//
ID   ACH4_DROME              Reviewed;         519 AA.
AC   P25162; O18403; Q8IMW6; Q8SXP7; Q9VC71;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 3.
DT   25-OCT-2017, entry version 164.
DE   RecName: Full=Acetylcholine receptor subunit beta-like 2;
DE   AltName: Full=Nicotinic acetylcholine receptor beta 2;
DE   Flags: Precursor;
GN   Name=nAChRbeta2; Synonyms=Acr96Ac, AcrF, nAcRbeta-96, SBD;
GN   ORFNames=CG6798;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-519 (ISOFORM A), TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   STRAIN=Canton-S; TISSUE=Embryo;
RX   PubMed=2121539; DOI=10.1016/0014-5793(90)81078-3;
RA   Sawruk E., Udri C., Betz H., Schmitt B.;
RT   "SBD, a novel structural subunit of the Drosophila nicotinic
RT   acetylcholine receptor, shares its genomic localization with two
RT   alpha-subunits.";
RL   FEBS Lett. 273:177-181(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-65.
RX   PubMed=9109505;
RA   Lansdell S.J., Schmitt B., Betz H., Sattelle D.B., Millar N.S.;
RT   "Temperature-sensitive expression of Drosophila neuronal nicotinic
RT   acetylcholine receptors.";
RL   J. Neurochem. 68:1812-1819(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   RNA EDITING OF POSITION 278.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=P25162-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P25162-2; Sequence=VSP_007411, VSP_007412;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: CNS in embryos. {ECO:0000269|PubMed:2121539}.
CC   -!- DEVELOPMENTAL STAGE: Late embryonic and late pupal stages.
CC       {ECO:0000269|PubMed:2121539}.
CC   -!- RNA EDITING: Modified_positions=278 {ECO:0000269|PubMed:12907802};
CC       Note=Partially edited.;
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL90236.1; Type=Frameshift; Positions=237; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X55676; CAA39211.1; -; mRNA.
DR   EMBL; Y14678; CAA74994.1; -; mRNA.
DR   EMBL; AE014297; AAF56304.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13998.1; -; Genomic_DNA.
DR   EMBL; AY089498; AAL90236.1; ALT_FRAME; mRNA.
DR   PIR; S12899; S12899.
DR   RefSeq; NP_524483.1; NM_079759.4. [P25162-1]
DR   RefSeq; NP_733002.1; NM_170147.3. [P25162-2]
DR   UniGene; Dm.4978; -.
DR   ProteinModelPortal; P25162; -.
DR   SMR; P25162; -.
DR   STRING; 7227.FBpp0084061; -.
DR   ChEMBL; CHEMBL2366470; -.
DR   PaxDb; P25162; -.
DR   PRIDE; P25162; -.
DR   EnsemblMetazoa; FBtr0084681; FBpp0084061; FBgn0004118. [P25162-1]
DR   EnsemblMetazoa; FBtr0084682; FBpp0084062; FBgn0004118. [P25162-2]
DR   GeneID; 42920; -.
DR   KEGG; dme:Dmel_CG6798; -.
DR   CTD; 42920; -.
DR   FlyBase; FBgn0004118; nAChRbeta2.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   InParanoid; P25162; -.
DR   KO; K05312; -.
DR   OMA; ITVCVLN; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P25162; -.
DR   Reactome; R-DME-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-DME-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-DME-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 42920; -.
DR   PRO; PR:P25162; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0004118; -.
DR   ExpressionAtlas; P25162; differential.
DR   Genevisible; P25162; DM.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; ISS:FlyBase.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:FlyBase.
DR   GO; GO:0017085; P:response to insecticide; IMP:FlyBase.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IEP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; RNA editing; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    519       Acetylcholine receptor subunit beta-like
FT                                2.
FT                                /FTId=PRO_0000000302.
FT   TOPO_DOM     19    244       Extracellular.
FT   TRANSMEM    245    269       Helical. {ECO:0000255}.
FT   TRANSMEM    277    295       Helical. {ECO:0000255}.
FT   TRANSMEM    311    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    462       Cytoplasmic.
FT   TRANSMEM    463    481       Helical. {ECO:0000255}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    154    168       {ECO:0000250}.
FT   VAR_SEQ     279    304       LCISILVSLTVFFLLLAEIIPPTSLA -> KMDPPNSMIKN
FT                                LRVIPSFLWHVACFC (in isoform B).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_007411.
FT   VAR_SEQ     305    519       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_007412.
FT   VARIANT     278    278       T -> A (in RNA edited version).
FT   CONFLICT    344    344       P -> R (in Ref. 1; CAA39211).
FT                                {ECO:0000305}.
SQ   SEQUENCE   519 AA;  60140 MW;  DDE67674529D2FCB CRC64;
     MWHWSLLCVF LLVPLANSTA PISFEANPDT KRLYDDLLSN YNRLIRPVVN NTETLTVWLG
     LKLSQLIEVN LKNQVMTTNL WVKQRWFDYK LRWDPEEYGG VEQLYVPSEH IWVPDIVLYN
     NWDGNYEVTL MTKATLKYTG EVFWEPPAIY KSSCEMNVEY FPYDEQICFM KFGSWTYNGA
     QVDLKHLDQI PGSNLVQVGI DLTEFYLSVE WDILEVPATK NEEYYPDTLE PFSDITFKLT
     MRRKTLFYTV NLIVPCVALT FLTVLVFYLP SDSGEKVTLC ISILVSLTVF FLLLAEIIPP
     TSLAVPLLGK YLLFTMILVS LSVWTTVCVL NIHFRSPSTH NMSPLVRKLF LHFMPKLMMM
     RRTQYTLPDY DDSTPSNGYT NEIDVRDSIS DFPSEFKDSQ DGAYDNGMQN SVDSDNVIPR
     NLTPEVLQAL RAVRFIAQHI KDADKDNEIV EDWKFVSMVL DRFFLWLFTL SCVFGTLAII
     CQSPSLYDTR SPIDRQLSEI PLRKNNFMLP PDIVRQVLT
//
ID   ACH1_MANSE              Reviewed;         516 AA.
AC   P91766;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   25-OCT-2017, entry version 95.
DE   RecName: Full=Acetylcholine receptor subunit alpha-like;
DE   AltName: Full=MARA1;
DE   Flags: Precursor;
GN   Name=ARA1;
OS   Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Lepidoptera; Glossata; Ditrysia;
OC   Bombycoidea; Sphingidae; Sphinginae; Sphingini; Manduca.
OX   NCBI_TaxID=7130;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9753155; DOI=10.1046/j.1460-9568.1998.00095.x;
RA   Eastham H.M., Lind R.J., Eastlake J.L., Clarke B.S., Towner P.,
RA   Reynolds S.E., Wolstenholme A.J., Wonnacott S.;
RT   "Characterization of a nicotinic acetylcholine receptor from the
RT   insect Manduca sexta.";
RL   Eur. J. Neurosci. 10:879-889(1998).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y09795; CAA70928.1; -; mRNA.
DR   ProteinModelPortal; P91766; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 2.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    516       Acetylcholine receptor subunit alpha-
FT                                like.
FT                                /FTId=PRO_0000000303.
FT   TOPO_DOM     22    243       Extracellular. {ECO:0000255}.
FT   TRANSMEM    244    264       Helical. {ECO:0000255}.
FT   TRANSMEM    274    294       Helical. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TOPO_DOM    327    465       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    466    486       Helical. {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    132    132       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    233    233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    149    163       {ECO:0000250}.
FT   DISULFID    222    223       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   516 AA;  58720 MW;  E7A71E8C45D13BD2 CRC64;
     MRSVTKYYLH GVVLFATGCA GNPDAKRLYD DLLSNYNKLV RPVLNVSDAL TVRIKLKLSQ
     LIDVNLKNQI MTTNLWVEQS WYDYKLSWEP REYGGVEMLH VPSDHIWRPD IVLYNNADGN
     FEVTLATKAT LNYTGRVEWR PPAIYKSSCE IDVEYFPFDQ QTCVMKFGSW TYDGFQVDLR
     HIDEVRGTNV VELGVDLSEF YTSVEWDILE VPAVRNEKFY TCCDEPYLDI TFNITMRRKT
     LFYTVNLIIP CMGISFLTVL VFYLPSDSGE KVSLSISILL SLTVFFLLLA EIIPPTSLVV
     PLLGKFVLFT MILDTFSICV TVVVLNVHFR SPQTHTMSPW VRRVFIHVLP RLLVMRRPHY
     RLDPHRSRFA GLVTGAGETT LWDEGSPGVP APPRPPPCAP PLAPCAACAP AEAPALCDAL
     RRWHRCPELH KAIDGINYIA DQTRKEEEST RVKEDWKYVA MVLDRPFLWI FTLAVVVGSA
     GIILQAPTLY DERAPIDVRL SEIAYTAAKP RPPPPR
//
ID   GBRA5_HUMAN             Reviewed;         462 AA.
AC   P31644; A8K338; Q14DC2; Q53XL6; Q9NYT3; Q9NYT4; Q9NYT5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   20-DEC-2017, entry version 178.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-5;
DE   AltName: Full=GABA(A) receptor subunit alpha-5;
DE   Flags: Precursor;
GN   Name=GABRA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8388764; DOI=10.1093/hmg/2.2.183;
RA   Knoll J.H., Sinnett D., Wagstaff J., Glatt K.A., Wilcox A.S.,
RA   Whiting P.J., Wingrove P., Sikela J.M., Lalande M.;
RT   "FISH ordering of reference markers and of the gene for the alpha 5
RT   subunit of the gamma-aminobutyric acid receptor (GABRA5) within the
RT   Angelman and Prader-Willi syndrome chromosomal regions.";
RL   Hum. Mol. Genet. 2:183-189(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1321750; DOI=10.1042/bst020018s;
RA   Wingrove P., Hadingham K., Wafford K., Kemp J.A., Ragan C.I.,
RA   Whiting P.;
RT   "Cloning and expression of a cDNA encoding the human GABA-A receptor
RT   alpha 5 subunit.";
RL   Biochem. Soc. Trans. 20:18S-18S(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29.
RC   TISSUE=Fetal brain;
RX   PubMed=9205108; DOI=10.1006/geno.1997.4770;
RA   Kim Y., Glatt H., Xie W., Sinnett D., Lalande M.;
RT   "Human gamma-aminobutyric acid-type A receptor alpha5 subunit gene
RT   (GABRA5): characterization and structural organization of the 5'
RT   flanking region.";
RL   Genomics 42:378-387(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 71-166; 195-241 AND 294-363.
RA   Kim S.-J., Gonen D., Yang Z.-Y., Reliford A., Dy A., Leventhal B.L.,
RA   Cook E.H. Jr.;
RT   "Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 5
RT   subunit gene (GABRA5).";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-355, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=17370265; DOI=10.1002/pmic.200600410;
RA   Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
RT   "Tryptic digestion of ubiquitin standards reveals an improved strategy
RT   for identifying ubiquitinated proteins by mass spectrometry.";
RL   Proteomics 7:868-874(2007).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA5 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L08485; AAA58490.1; -; mRNA.
DR   EMBL; AK290453; BAF83142.1; -; mRNA.
DR   EMBL; BT009830; AAP88832.1; -; mRNA.
DR   EMBL; BC111979; AAI11980.1; -; mRNA.
DR   EMBL; BC113422; AAI13423.1; -; mRNA.
DR   EMBL; AF061785; AAC31809.1; -; Genomic_DNA.
DR   EMBL; AF228447; AAF62508.1; -; Genomic_DNA.
DR   EMBL; AF228448; AAF62509.1; -; Genomic_DNA.
DR   EMBL; AF228449; AAF62510.1; -; Genomic_DNA.
DR   CCDS; CCDS45194.1; -.
DR   PIR; A48933; A48933.
DR   RefSeq; NP_000801.1; NM_000810.3.
DR   RefSeq; NP_001158509.1; NM_001165037.1.
DR   RefSeq; XP_005268315.1; XM_005268258.2.
DR   RefSeq; XP_006720522.1; XM_006720459.2.
DR   UniGene; Hs.24969; -.
DR   PDB; 5O8F; X-ray; 3.20 A; A/B/C/D/E=261-346, A/B/C/D/E=424-462.
DR   PDBsum; 5O8F; -.
DR   ProteinModelPortal; P31644; -.
DR   SMR; P31644; -.
DR   BioGrid; 108832; 1.
DR   STRING; 9606.ENSP00000335592; -.
DR   BindingDB; P31644; -.
DR   ChEMBL; CHEMBL5112; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB05087; Ganaxolone.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 408; -.
DR   iPTMnet; P31644; -.
DR   PhosphoSitePlus; P31644; -.
DR   BioMuta; GABRA5; -.
DR   DMDM; 399519; -.
DR   EPD; P31644; -.
DR   MaxQB; P31644; -.
DR   PaxDb; P31644; -.
DR   PeptideAtlas; P31644; -.
DR   PRIDE; P31644; -.
DR   DNASU; 2558; -.
DR   Ensembl; ENST00000335625; ENSP00000335592; ENSG00000186297.
DR   Ensembl; ENST00000355395; ENSP00000347557; ENSG00000186297.
DR   Ensembl; ENST00000400081; ENSP00000382953; ENSG00000186297.
DR   GeneID; 2558; -.
DR   KEGG; hsa:2558; -.
DR   UCSC; uc001zbd.3; human.
DR   CTD; 2558; -.
DR   DisGeNET; 2558; -.
DR   EuPathDB; HostDB:ENSG00000186297.11; -.
DR   GeneCards; GABRA5; -.
DR   GeneReviews; GABRA5; -.
DR   HGNC; HGNC:4079; GABRA5.
DR   HPA; HPA077031; -.
DR   MIM; 137142; gene.
DR   neXtProt; NX_P31644; -.
DR   OpenTargets; ENSG00000186297; -.
DR   PharmGKB; PA28493; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P31644; -.
DR   KO; K05175; -.
DR   OMA; MTHPPNI; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P31644; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; GABRA5; -.
DR   GenomeRNAi; 2558; -.
DR   PRO; PR:P31644; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000186297; -.
DR   CleanEx; HS_GABRA5; -.
DR   ExpressionAtlas; P31644; baseline and differential.
DR   Genevisible; P31644; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0032809; C:neuronal cell body membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0050811; F:GABA receptor binding; IEA:Ensembl.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:Ensembl.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0008306; P:associative learning; IEA:Ensembl.
DR   GO; GO:0001662; P:behavioral fear response; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:0060119; P:inner ear receptor cell development; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005435; GABBAa5_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01618; GABAARALPHA5.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Isopeptide bond; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32    462       Gamma-aminobutyric acid receptor subunit
FT                                alpha-5.
FT                                /FTId=PRO_0000000444.
FT   TOPO_DOM     32    259       Extracellular. {ECO:0000255}.
FT   TRANSMEM    260    281       Helical. {ECO:0000255}.
FT   TRANSMEM    286    307       Helical. {ECO:0000255}.
FT   TRANSMEM    319    341       Helical. {ECO:0000255}.
FT   TOPO_DOM    342    427       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    428    449       Helical. {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    207    207       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    236    236       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    173    187       {ECO:0000250}.
FT   CROSSLNK    355    355       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:17370265}.
SQ   SEQUENCE   462 AA;  52146 MW;  260A8B554113AFF9 CRC64;
     MDNGMFSGFI MIKNLLLFCI SMNLSSHFGF SQMPTSSVKD ETNDNITIFT RILDGLLDGY
     DNRLRPGLGE RITQVRTDIY VTSFGPVSDT EMEYTIDVFF RQSWKDERLR FKGPMQRLPL
     NNLLASKIWT PDTFFHNGKK SIAHNMTTPN KLLRLEDDGT LLYTMRLTIS AECPMQLEDF
     PMDAHACPLK FGSYAYPNSE VVYVWTNGST KSVVVAEDGS RLNQYHLMGQ TVGTENISTS
     TGEYTIMTAH FHLKRKIGYF VIQTYLPCIM TVILSQVSFW LNRESVPART VFGVTTVLTM
     TTLSISARNS LPKVAYATAM DWFIAVCYAF VFSALIEFAT VNYFTKRGWA WDGKKALEAA
     KIKKKREVIL NKSTNAFTTG KMSHPPNIPK EQTPAGTSNT TSVSVKPSEE KTSESKKTYN
     SISKIDKMSR IVFPVLFGTF NLVYWATYLN REPVIKGAAS PK
//
ID   CNG12_ARATH             Reviewed;         649 AA.
AC   Q8GWD2; Q9SKD5;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   21-NOV-2003, sequence version 2.
DT   20-DEC-2017, entry version 131.
DE   RecName: Full=Probable cyclic nucleotide-gated ion channel 12;
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 12;
GN   Name=CNGC12; OrderedLocusNames=At2g46450; ORFNames=F11C10.14;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
CC   -!- FUNCTION: Probable cyclic nucleotide-gated ion channel.
CC   -!- SUBUNIT: Homotetramer or heterotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8GWD2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8GWD2-2; Sequence=VSP_008989, VSP_008990;
CC         Note=May be due to a competing acceptor splice site. No
CC         experimental confirmation available.;
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD23055.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC006526; AAD23055.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002685; AEC10697.1; -; Genomic_DNA.
DR   EMBL; CP002685; ANM62322.1; -; Genomic_DNA.
DR   EMBL; AK118918; BAC43501.1; -; mRNA.
DR   PIR; A84903; A84903.
DR   RefSeq; NP_001324486.1; NM_001337192.1. [Q8GWD2-1]
DR   RefSeq; NP_850454.5; NM_180123.6. [Q8GWD2-1]
DR   UniGene; At.36508; -.
DR   UniGene; At.50596; -.
DR   ProteinModelPortal; Q8GWD2; -.
DR   STRING; 3702.AT2G46450.1; -.
DR   PaxDb; Q8GWD2; -.
DR   EnsemblPlants; AT2G46450.1; AT2G46450.1; AT2G46450. [Q8GWD2-1]
DR   EnsemblPlants; AT2G46450.4; AT2G46450.4; AT2G46450. [Q8GWD2-1]
DR   GeneID; 819253; -.
DR   Gramene; AT2G46450.1; AT2G46450.1; AT2G46450. [Q8GWD2-1]
DR   Gramene; AT2G46450.4; AT2G46450.4; AT2G46450. [Q8GWD2-1]
DR   KEGG; ath:AT2G46450; -.
DR   Araport; AT2G46450; -.
DR   TAIR; locus:2039114; AT2G46450.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; Q8GWD2; -.
DR   KO; K05391; -.
DR   OMA; NENIPQG; -.
DR   OrthoDB; EOG0936058Y; -.
DR   PhylomeDB; Q8GWD2; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q8GWD2; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q8GWD2; baseline and differential.
DR   Genevisible; Q8GWD2; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005261; F:cation channel activity; IMP:TAIR.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006952; P:defense response; IGI:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0009617; P:response to bacterium; IGI:TAIR.
DR   GO; GO:0009620; P:response to fungus; IMP:TAIR.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50096; IQ; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calmodulin-binding; cAMP; cAMP-binding;
KW   Cell membrane; cGMP; cGMP-binding; Complete proteome; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    649       Probable cyclic nucleotide-gated ion
FT                                channel 12.
FT                                /FTId=PRO_0000219340.
FT   TOPO_DOM      1     43       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     44     64       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM     65     76       Extracellular. {ECO:0000255}.
FT   TRANSMEM     77     97       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM     98    128       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    129    149       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    150    162       Extracellular. {ECO:0000255}.
FT   TRANSMEM    163    183       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    184    200       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    222    329       Extracellular. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    351    649       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      565    594       IQ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND     436    559       cNMP.
FT   REGION      545    560       Calmodulin-binding. {ECO:0000250}.
FT   BINDING     507    507       cNMP. {ECO:0000250}.
FT   VAR_SEQ     316    368       SALGQNLETSNSAGEIFFAIIICVSGLLLFAVLIGNVQKYL
FT                                QSSTTRVDEMEE -> RLIHSTVLWAKTWRQATLQGRFSLL
FT                                SSYVSLVYSCLLCSLETFRSTCNHLLLE (in isoform
FT                                2). {ECO:0000303|PubMed:11910074}.
FT                                /FTId=VSP_008989.
FT   VAR_SEQ     369    649       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11910074}.
FT                                /FTId=VSP_008990.
SQ   SEQUENCE   649 AA;  74806 MW;  0737B9857B6C4EBB CRC64;
     MNHRRSKFAR IDSMGVDGKL KSVRGRLKKV YGKMKTLENW RKTVLLACVV ALAIDPLFLF
     IPLIDSQRFC FTFDKTLVAV VCVIRTFIDT FYVIHIIYYL ITETIAPRSQ ASLRGEIVVH
     SKATLKTRLL FHFIVDIISV LPIPQVVVLT LIPLSASLVS ERILKWIILS QYVPRIIRMY
     PLYKEVTRAF GTVAESKWAG AALNLFLYML HSYVFGAFWY LSSIERKSKC WRAACARTSD
     CNLTVTDLLC KRAGSDNIRF LNTSCPLIDP AQITNSTDFD FGMYIDALKS GVLEVKPKDF
     PRKFVYCFWW GLRNISALGQ NLETSNSAGE IFFAIIICVS GLLLFAVLIG NVQKYLQSST
     TRVDEMEEKR RDTEKWMSYR VIPEYLKERI RRFEDYKWRE TKGTEEEALL RSLPKDLRLE
     TKRYLYLDML KRVPWLNIMD DGWLLEAVCD RVKSVFYLAN SFIVREGHPV EEMLIVTRGK
     LKSTTGSHEM GVRNNCCDLQ DGDICGELLF NGSRLPTSTR TVMTLTEVEG FILLPDDIKF
     IASHLNVFQR QKLQRTFRLY SQQWRSWAAF FIQAAWRKHC KRKLSKTRDN ENIPQGTQLN
     LASTLYVSRF VSKALQNRRK DTADCSSSPD MSPPVPHKPA DLEFAKAEA
//
ID   GLUCL_DROME             Reviewed;         456 AA.
AC   Q94900; O77295; Q0Q0M3; Q2PDQ5; Q59DV9; Q8IN68; Q9GQ52; Q9GQ53;
AC   Q9VDU5;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   22-NOV-2017, entry version 133.
DE   RecName: Full=Glutamate-gated chloride channel;
DE            Short=DrosGluCl;
DE   Flags: Precursor;
GN   Name=GluClalpha; Synonyms=GluCl {ECO:0000312|EMBL:AAC47266.1};
GN   ORFNames=CG7535;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC47266.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), FUNCTION, SUBUNIT,
RP   DEVELOPMENTAL STAGE, AND RNA EDITING OF POSITIONS 27; 241 AND 345.
RC   STRAIN=Oregon-R {ECO:0000312|EMBL:AAC47266.1};
RC   TISSUE=Head {ECO:0000312|EMBL:AAC47266.1};
RX   PubMed=8702744; DOI=10.1074/jbc.271.33.20187;
RA   Cully D.F., Paress P.S., Liu K.K., Schaeffer J.M., Arena J.P.;
RT   "Identification of a Drosophila melanogaster glutamate-gated chloride
RT   channel sensitive to the antiparasitic agent avermectin.";
RL   J. Biol. Chem. 271:20187-20191(1996).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAA05260.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), VARIANT SER-299, AND RNA
RP   EDITING OF POSITIONS 27; 63; 66 AND 241.
RC   TISSUE=Head {ECO:0000269|PubMed:9886055};
RX   PubMed=9886055; DOI=10.1046/j.1471-4159.1999.0720066.x;
RA   Semenov E.P., Pak W.L.;
RT   "Diversification of Drosophila chloride channel gene by multiple
RT   posttranscriptional mRNA modifications.";
RL   J. Neurochem. 72:66-72(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAG40735.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1-336 (ISOFORM B), FUNCTION, VARIANT SER-299, AND RNA EDITING OF
RP   POSITIONS 27; 63; 66; 241 AND 345.
RX   PubMed=11095718; DOI=10.1073/pnas.240464697;
RA   Kane N.S., Hirschberg B., Qian S., Hunt D., Thomas B., Brochu R.,
RA   Ludmerer S.W., Zheng Y., Smith M., Arena J.P., Cohen C.J., Schmatz D.,
RA   Warmke J., Cully D.F.;
RT   "Drug-resistant Drosophila indicate glutamate-gated chloride channels
RT   are targets for the antiparasitics nodulisporic acid and ivermectin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:13949-13954(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM D), AND RNA EDITING OF POSITIONS
RP   27; 63; 66; 241 AND 345.
RA   Wang X., Xiang W., Wang X., Jiang L., Lin S., Gao A., Wang L., Sun L.,
RA   Jing B., Xi D.;
RT   "Cloning and functional expression of a Drosophila melanogaster
RT   glutamate-gated chloride channel.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAF55695.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND RNA EDITING OF
RP   POSITION 63; 66 AND 345.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAF55695.1}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [7] {ECO:0000305}
RP   RNA EDITING OF POSITIONS 27; 63; 66; 241 AND 345.
RX   PubMed=10966106; DOI=10.1016/S0092-8674(00)00049-0;
RA   Palladino M.J., Keegan L.P., O'Connell M.A., Reenan R.A.;
RT   "A-to-I pre-mRNA editing in Drosophila is primarily involved in adult
RT   nervous system function and integrity.";
RL   Cell 102:437-449(2000).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit. Glutamate
CC       binding triggers a rapidly reversible current, while the anti-
CC       helmintic drug ivermectin triggers a permanently open channel
CC       configuration. {ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744}.
CC   -!- SUBUNIT: Pentamer (By similarity). Homomultimer.
CC       {ECO:0000250|UniProtKB:G5EBR3, ECO:0000269|PubMed:8702744}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=F;
CC         IsoId=Q94900-1; Sequence=Displayed;
CC       Name=A {ECO:0000303|PubMed:10731132};
CC         IsoId=Q94900-3; Sequence=VSP_051645;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=B {ECO:0000269|PubMed:9886055};
CC         IsoId=Q94900-2; Sequence=VSP_051644, VSP_051646, VSP_051647;
CC         Note=No experimental confirmation available.;
CC       Name=C;
CC         IsoId=Q94900-4; Sequence=VSP_026113, VSP_051646, VSP_051647;
CC         Note=No experimental confirmation available.;
CC       Name=D;
CC         IsoId=Q94900-5; Sequence=VSP_051644, VSP_026114, VSP_051647;
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development.
CC       {ECO:0000269|PubMed:8702744}.
CC   -!- RNA EDITING: Modified_positions=27 {ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:8702744,
CC       ECO:0000269|PubMed:9886055, ECO:0000269|Ref.4}, 63
CC       {ECO:0000269|PubMed:10731132, ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:9886055,
CC       ECO:0000269|Ref.4}, 66 {ECO:0000269|PubMed:10731132,
CC       ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:9886055, ECO:0000269|Ref.4}, 241
CC       {ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744, ECO:0000269|PubMed:9886055,
CC       ECO:0000269|Ref.4}, 345 {ECO:0000269|PubMed:10731132,
CC       ECO:0000269|PubMed:10966106, ECO:0000269|PubMed:11095718,
CC       ECO:0000269|PubMed:8702744, ECO:0000269|Ref.4}; Note=Partially
CC       edited. Edited by Adar. {ECO:0000269|PubMed:10966106,
CC       ECO:0000269|PubMed:9886055};
CC   -!- MISCELLANEOUS: Channels desensitize rapidly in the continued
CC       presence of glutamate and are activated by the glutamate analog
CC       ibotenate. In Xenopus oocytes, avermectins and nodulisporic acid
CC       directly activate channel conductance.
CC       {ECO:0000269|PubMed:11095718, ECO:0000269|PubMed:8702744}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glutamate-gated chloride channel (TC 1.A.9.4) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U58776; AAC47266.1; -; mRNA.
DR   EMBL; AJ002232; CAA05260.1; -; mRNA.
DR   EMBL; AF297500; AAG40735.1; -; mRNA.
DR   EMBL; AF297501; AAG40736.1; -; mRNA.
DR   EMBL; DQ665648; ABG57261.1; -; mRNA.
DR   EMBL; AE014297; AAF55695.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13808.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAX52967.1; -; Genomic_DNA.
DR   EMBL; AE014297; ABC66182.1; -; Genomic_DNA.
DR   RefSeq; NP_001014641.2; NM_001014641.4.
DR   RefSeq; NP_001034061.2; NM_001038972.4.
DR   RefSeq; NP_650827.3; NM_142570.4.
DR   RefSeq; NP_732447.2; NM_169873.4.
DR   UniGene; Dm.20644; -.
DR   ProteinModelPortal; Q94900; -.
DR   BioGrid; 67340; 2.
DR   MINT; MINT-813042; -.
DR   STRING; 7227.FBpp0099473; -.
DR   TCDB; 1.A.9.4.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q94900; -.
DR   PRIDE; Q94900; -.
DR   GeneID; 42350; -.
DR   KEGG; dme:Dmel_CG7535; -.
DR   UCSC; CG7535-RA; d. melanogaster. [Q94900-1]
DR   CTD; 42350; -.
DR   FlyBase; FBgn0024963; GluClalpha.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   InParanoid; Q94900; -.
DR   KO; K05273; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q94900; -.
DR   Reactome; R-DME-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GenomeRNAi; 42350; -.
DR   PRO; PR:Q94900; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0024963; -.
DR   ExpressionAtlas; Q94900; differential.
DR   Genevisible; Q94900; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IC:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008068; F:extracellular-glutamate-gated chloride channel activity; IDA:FlyBase.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; RNA editing;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    456       Glutamate-gated chloride channel.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000000497.
FT   TOPO_DOM     23    245       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    246    268       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    269    273       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    274    295       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    296    302       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    303    323       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    324    426       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    427    450       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    451    456       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      71     71       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      90     90       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     154    154       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     183    183       Glutamate; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    163    177       {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    222    233       {ECO:0000250|UniProtKB:G5EBR3}.
FT   VAR_SEQ      60     79       GPAIVRINLFVRSIMTISDI -> NKATNVSVNMFLRSISK
FT                                IDDY (in isoform C). {ECO:0000305}.
FT                                /FTId=VSP_026113.
FT   VAR_SEQ      68     80       LFVRSIMTISDIK -> IFVRSISKIDDVT (in
FT                                isoform B and isoform D).
FT                                {ECO:0000303|PubMed:11095718,
FT                                ECO:0000303|PubMed:9886055,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_051644.
FT   VAR_SEQ     230    232       EYS -> T (in isoform A).
FT                                {ECO:0000303|PubMed:10731132}.
FT                                /FTId=VSP_051645.
FT   VAR_SEQ     335    341       GSNKANM -> DV (in isoform D).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_026114.
FT   VAR_SEQ     417    420       Missing (in isoform B and isoform C).
FT                                {ECO:0000303|PubMed:11095718,
FT                                ECO:0000303|PubMed:9886055}.
FT                                /FTId=VSP_051646.
FT   VAR_SEQ     456    456       E -> ETF (in isoform B, isoform C and
FT                                isoform D). {ECO:0000303|PubMed:11095718,
FT                                ECO:0000303|PubMed:9886055,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_051647.
FT   VARIANT      27     27       I -> V (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106,
FT                                ECO:0000269|PubMed:9886055}.
FT   VARIANT      63     63       I -> V (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106}.
FT   VARIANT      66     66       I -> V (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106}.
FT   VARIANT     241    241       K -> R (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106,
FT                                ECO:0000269|PubMed:9886055}.
FT   VARIANT     299    299       P -> S (resistant to nodulisporic acid).
FT                                {ECO:0000269|PubMed:11095718,
FT                                ECO:0000269|PubMed:9886055}.
FT   VARIANT     345    345       S -> N (in RNA edited version).
FT                                {ECO:0000269|PubMed:10966106,
FT                                ECO:0000269|PubMed:9886055}.
FT   CONFLICT     50     50       I -> V (in Ref. 4; ABG57261).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       P -> S (in Ref. 3; AAG40736).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       V -> A (in Ref. 4; ABG57261).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  52307 MW;  AE892B338B79A060 CRC64;
     MGSGHYFWAI LYFASLCSAS LANNAKINFR EKEKKVLDQI LGAGKYDARI RPSGINGTDG
     PAIVRINLFV RSIMTISDIK MEYSVQLTFR EQWTDERLKF DDIQGRLKYL TLTEANRVWM
     PDLFFSNEKE GHFHNIIMPN VYIRIFPNGS VLYSIRISLT LACPMNLKLY PLDRQICSLR
     MASYGWTTND LVFLWKEGDP VQVVKNLHLP RFTLEKFLTD YCNSKTNTGE YSCLKVDLLF
     KREFSYYLIQ IYIPCCMLVI VSWVSFWLDQ GAVPARVSLG VTTLLTMATQ TSGINASLPP
     VSYTKAIDVW TGVCLTFVFG ALLEFALVNY ASRSGSNKAN MHKESMKKKR RDLEQASLDA
     ASDLLDTDSN ATFAMKPLVR HPGDPLALEK RLQCEVHMQA PKRPNCCKTW LSKFPTRQCS
     RSKRIDVISR ITFPLVFALF NLVYWSTYLF REEEDE
//
ID   P2RX7_MOUSE             Reviewed;         595 AA.
AC   Q9Z1M0;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   20-DEC-2017, entry version 145.
DE   RecName: Full=P2X purinoceptor 7;
DE            Short=P2X7;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=P2Z receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx7; Synonyms=P2x7;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9849870; DOI=10.1016/S0014-5793(98)01332-5;
RA   Chessell I.P., Simon J., Hibell A.D., Michel A.D., Barnard E.A.,
RA   Humphrey P.P.;
RT   "Cloning and functional characterisation of the mouse P2X7 receptor.";
RL   FEBS Lett. 439:26-30(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   ADP-RIBOSYLATION AT ARG-125 AND ARG-133 BY ART2B, AND MUTAGENESIS OF
RP   ARG-125 AND ARG-133.
RX   PubMed=17928361; DOI=10.1096/fj.07-9294com;
RA   Adriouch S., Bannas P., Schwarz N., Fliegert R., Guse A.H., Seman M.,
RA   Haag F., Koch-Nolte F.;
RT   "ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a
RT   covalent ligand to its nucleotide binding site.";
RL   FASEB J. 22:861-869(2008).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel. Responsible for ATP-dependent lysis of macrophages
CC       through the formation of membrane pores permeable to large
CC       molecules. Could function in both fast synaptic transmission and
CC       the ATP-mediated lysis of antigen-presenting cells. In the absence
CC       of its natural ligand, ATP, functions as a scavenger receptor in
CC       the recognition and engulfment of apoptotic cells.
CC       {ECO:0000250|UniProtKB:Q99572}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. Interacts with LAMA3, ITGB2, ACTB, ACTN4,
CC       SVIL, MPP3, HSPA1, HSPCB, HSPA8, PIK230 and PTPRB (By similarity).
CC       Interacts (via C-terminus) with EMP2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q99572}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q99572}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- PTM: Phosphorylation results in its inactivation.
CC       {ECO:0000250|UniProtKB:Q99572}.
CC   -!- PTM: ADP-ribosylation at Arg-125 is necessary and sufficient to
CC       activate P2RX7 and gate the channel.
CC   -!- PTM: Palmitoylation of several cysteines in the C-terminal
CC       cytoplasmic tail is required for efficient localization to cell
CC       surface. {ECO:0000250|UniProtKB:Q99572}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ009823; CAA08853.1; -; mRNA.
DR   EMBL; AC114632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS19652.1; -.
DR   RefSeq; NP_035157.2; NM_011027.3.
DR   UniGene; Mm.42026; -.
DR   ProteinModelPortal; Q9Z1M0; -.
DR   SMR; Q9Z1M0; -.
DR   BioGrid; 202002; 2.
DR   STRING; 10090.ENSMUSP00000098303; -.
DR   BindingDB; Q9Z1M0; -.
DR   ChEMBL; CHEMBL5183; -.
DR   iPTMnet; Q9Z1M0; -.
DR   PhosphoSitePlus; Q9Z1M0; -.
DR   SwissPalm; Q9Z1M0; -.
DR   MaxQB; Q9Z1M0; -.
DR   PaxDb; Q9Z1M0; -.
DR   PRIDE; Q9Z1M0; -.
DR   Ensembl; ENSMUST00000100737; ENSMUSP00000098303; ENSMUSG00000029468.
DR   GeneID; 18439; -.
DR   KEGG; mmu:18439; -.
DR   UCSC; uc008zlq.2; mouse.
DR   CTD; 5027; -.
DR   MGI; MGI:1339957; P2rx7.
DR   eggNOG; ENOG410IK4U; Eukaryota.
DR   eggNOG; ENOG4110DDY; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; Q9Z1M0; -.
DR   KO; K05220; -.
DR   OMA; YPGYNFR; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-MMU-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-MMU-418346; Platelet homeostasis.
DR   Reactome; R-MMU-844456; The NLRP3 inflammasome.
DR   PRO; PR:Q9Z1M0; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000029468; -.
DR   ExpressionAtlas; Q9Z1M0; baseline and differential.
DR   Genevisible; Q9Z1M0; MM.
DR   GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IMP:MGI.
DR   GO; GO:0015267; F:channel activity; IMP:MGI.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IMP:MGI.
DR   GO; GO:0001530; F:lipopolysaccharide binding; IDA:MGI.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; ISO:MGI.
DR   GO; GO:0004872; F:receptor activity; IMP:MGI.
DR   GO; GO:0000187; P:activation of MAPK activity; IMP:MGI.
DR   GO; GO:0032060; P:bleb assembly; IMP:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0006812; P:cation transport; IMP:MGI.
DR   GO; GO:0000902; P:cell morphogenesis; IMP:MGI.
DR   GO; GO:0006884; P:cell volume homeostasis; IDA:MGI.
DR   GO; GO:0071359; P:cellular response to dsRNA; IMP:MGI.
DR   GO; GO:0031668; P:cellular response to extracellular stimulus; IMP:MGI.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:MGI.
DR   GO; GO:0032963; P:collagen metabolic process; IMP:MGI.
DR   GO; GO:0019835; P:cytolysis; IDA:MGI.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IMP:MGI.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:MGI.
DR   GO; GO:0010467; P:gene expression; IMP:MGI.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; IMP:MGI.
DR   GO; GO:0006954; P:inflammatory response; IMP:MGI.
DR   GO; GO:0051899; P:membrane depolarization; ISO:MGI.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IMP:MGI.
DR   GO; GO:0007005; P:mitochondrion organization; IDA:MGI.
DR   GO; GO:0044254; P:multicellular organismal protein catabolic process; IDA:MGI.
DR   GO; GO:0043132; P:NAD transport; IMP:MGI.
DR   GO; GO:0045779; P:negative regulation of bone resorption; IMP:MGI.
DR   GO; GO:0045794; P:negative regulation of cell volume; IMP:UniProtKB.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; IDA:MGI.
DR   GO; GO:0001845; P:phagolysosome assembly; IMP:MGI.
DR   GO; GO:0017121; P:phospholipid scrambling; ISO:MGI.
DR   GO; GO:0006649; P:phospholipid transfer to membrane; IMP:MGI.
DR   GO; GO:0045332; P:phospholipid translocation; IDA:MGI.
DR   GO; GO:0007009; P:plasma membrane organization; IDA:MGI.
DR   GO; GO:0046931; P:pore complex assembly; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:MGI.
DR   GO; GO:1904172; P:positive regulation of bleb assembly; ISO:MGI.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:MGI.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; ISO:MGI.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IMP:MGI.
DR   GO; GO:0050715; P:positive regulation of cytokine secretion; IMP:MGI.
DR   GO; GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IMP:MGI.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:MGI.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IMP:MGI.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; ISO:MGI.
DR   GO; GO:0050717; P:positive regulation of interleukin-1 alpha secretion; IMP:MGI.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; IMP:MGI.
DR   GO; GO:0050718; P:positive regulation of interleukin-1 beta secretion; IMP:MGI.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IMP:MGI.
DR   GO; GO:0034767; P:positive regulation of ion transmembrane transport; ISO:MGI.
DR   GO; GO:0070230; P:positive regulation of lymphocyte apoptotic process; IMP:MGI.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:MGI.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; IMP:MGI.
DR   GO; GO:0045778; P:positive regulation of ossification; IMP:MGI.
DR   GO; GO:0032308; P:positive regulation of prostaglandin secretion; IMP:MGI.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:MGI.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IDA:MGI.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IMP:MGI.
DR   GO; GO:0012501; P:programmed cell death; IDA:MGI.
DR   GO; GO:0051259; P:protein oligomerization; IDA:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:MGI.
DR   GO; GO:0016485; P:protein processing; IMP:MGI.
DR   GO; GO:0035590; P:purinergic nucleotide receptor signaling pathway; ISO:MGI.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IMP:MGI.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:MGI.
DR   GO; GO:0033198; P:response to ATP; IDA:MGI.
DR   GO; GO:0009617; P:response to bacterium; IMP:MGI.
DR   GO; GO:0051592; P:response to calcium ion; IDA:MGI.
DR   GO; GO:0042493; P:response to drug; IMP:MGI.
DR   GO; GO:0051602; P:response to electrical stimulus; IMP:MGI.
DR   GO; GO:0034405; P:response to fluid shear stress; IMP:MGI.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IDA:MGI.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:MGI.
DR   GO; GO:0014070; P:response to organic cyclic compound; IDA:MGI.
DR   GO; GO:0010033; P:response to organic substance; IMP:MGI.
DR   GO; GO:0010043; P:response to zinc ion; IMP:MGI.
DR   GO; GO:0019233; P:sensory perception of pain; IMP:BHF-UCL.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IMP:MGI.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; IMP:MGI.
DR   GO; GO:0043029; P:T cell homeostasis; IMP:MGI.
DR   GO; GO:0042098; P:T cell proliferation; IMP:MGI.
DR   GO; GO:0006900; P:vesicle budding from membrane; IMP:MGI.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003050; P2X7_purinoceptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF13; PTHR10125:SF13; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PRINTS; PR01314; P2X7RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   ADP-ribosylation; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    595       P2X purinoceptor 7.
FT                                /FTId=PRO_0000161561.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     47    334       Extracellular. {ECO:0000255}.
FT   TRANSMEM    335    355       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    356    595       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     125    125       ADP-ribosylarginine; by ART2B.
FT                                {ECO:0000269|PubMed:17928361}.
FT   MOD_RES     133    133       ADP-ribosylarginine; by ART2B.
FT                                {ECO:0000269|PubMed:17928361}.
FT   MOD_RES     390    390       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99572}.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    187    187       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    213    213       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    241    241       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    119    168       {ECO:0000250}.
FT   DISULFID    129    152       {ECO:0000250}.
FT   DISULFID    135    162       {ECO:0000250}.
FT   DISULFID    216    226       {ECO:0000250}.
FT   DISULFID    260    269       {ECO:0000250}.
FT   MUTAGEN     125    125       R->K: Abolishes calcium responses to NAD.
FT                                {ECO:0000269|PubMed:17928361}.
FT   MUTAGEN     133    133       R->K: No effect on calcium responses to
FT                                NAD. {ECO:0000269|PubMed:17928361}.
FT   CONFLICT     11     11       L -> F (in Ref. 1; CAA08853).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       T -> A (in Ref. 1; CAA08853).
FT                                {ECO:0000305}.
FT   CONFLICT    283    283       T -> M (in Ref. 1; CAA08853).
FT                                {ECO:0000305}.
SQ   SEQUENCE   595 AA;  68388 MW;  BE007FE195AF50A4 CRC64;
     MPACCSWNDV LQYETNKVTR IQSTNYGTVK WVLHMIVFSY ISFALVSDKL YQRKEPVISS
     VHTKVKGIAE VTENVTEGGV TKLGHSIFDT ADYTFPLQGN SFFVMTNYVK SEGQVQTLCP
     EYPRRGAQCS SDRRCKKGWM DPQSKGIQTG RCVPYDKTRK TCEVSAWCPT EEEKEAPRPA
     LLRSAENFTV LIKNNIHFPG HNYTTRNILP TMNGSCTFHK TWDPQCSIFR LGDIFQEAGE
     NFTEVAVQGG IMGIEIYWDC NLDSWSHHCR PRYSFRRLDD KNTDESFVPG YNFRYAKYYK
     ENNVEKRTLI KAFGIRFDIL VFGTGGKFDI IQLVVYIGST LSYFGLATVC IDLLINTYSS
     AFCRSGVYPY CKCCEPCTVN EYYYRKKCES IMEPKPTLKY VSFVDEPHIR MVDQQLLGKS
     LQVVKGQEVP RPQMDFSDLS RLSLSLHDSP LTPGQSEEIQ LLHEEVAPKS GDSPSWCQCG
     NCLPSRLPEQ RRALEELCCR RKPGRCITTS KLFHKLVLSR DTLQLLLLYQ DPLLVLGEEA
     TNSRLRHRAY RCYATWRFGS QDMADFAILP SCCRWRIRKE FPKTEGQYSG FKYPY
//
ID   ACHE_HUMAN              Reviewed;         493 AA.
AC   Q04844; D3DTK6;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   25-OCT-2017, entry version 169.
DE   RecName: Full=Acetylcholine receptor subunit epsilon;
DE   Flags: Precursor;
GN   Name=CHRNE; Synonyms=ACHRE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Muscle fibroblast;
RX   PubMed=7688301; DOI=10.1111/j.1432-1033.1993.tb18027.x;
RA   Beeson D.M.W., Brydson M., Betty M., Jeremiah S., Povey S.,
RA   Vincent A., Newsom-Davis J.;
RT   "Primary structure of the human muscle acetylcholine receptor. cDNA
RT   cloning of the gamma and epsilon subunits.";
RL   Eur. J. Biochem. 215:229-238(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Abicht A., Stucka R., Lochmuller H.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human
RT   alpha7 nicotinic acetylcholine receptor and distinguish human
RT   nicotinic receptor subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [5]
RP   VARIANT CMS4A PHE-289.
RX   PubMed=7538206; DOI=10.1212/WNL.45.5.982;
RA   Gomez C.M., Gammack J.T.;
RT   "A leucine-to-phenylalanine substitution in the acetylcholine receptor
RT   ion channel in a family with the slow-channel syndrome.";
RL   Neurology 45:982-985(1995).
RN   [6]
RP   VARIANT CMS4A PRO-284, AND CHARACTERIZATION OF VARIANT CMS4A PRO-284.
RX   PubMed=7531341; DOI=10.1073/pnas.92.3.758;
RA   Ohno K., Hutchinson D.O., Milone M., Brengman J.M., Bouzat C.,
RA   Sine S.M., Engel A.G.;
RT   "Congenital myasthenic syndrome caused by prolonged acetylcholine
RT   receptor channel openings due to a mutation in the M2 domain of the
RT   epsilon subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:758-762(1995).
RN   [7]
RP   VARIANT CMS4A PHE-289, AND CHARACTERIZATION OF VARIANT CMS4A PHE-289.
RX   PubMed=8872460; DOI=10.1093/hmg/5.9.1217;
RA   Engel A.G., Ohno K., Milone M., Wang H.-L., Nakano S., Bouzat C.,
RA   Pruitt J.N. II, Hutchinson D.O., Brengman J.M., Bren N., Sieb J.P.,
RA   Sine S.M.;
RT   "New mutations in acetylcholine receptor subunit genes reveal
RT   heterogeneity in the slow-channel congenital myasthenic syndrome.";
RL   Hum. Mol. Genet. 5:1217-1227(1996).
RN   [8]
RP   VARIANTS CMS4B ARG-13; LEU-141 AND LEU-163, AND CHARACTERIZATION OF
RP   VARIANTS CMS4B ARG-13; LEU-141 AND LEU-163.
RX   PubMed=8755487; DOI=10.1016/S0896-6273(00)80289-5;
RA   Ohno K., Wang H.-L., Milone M., Bren N., Brengman J.M., Nakano S.,
RA   Quiram P., Pruitt J.N. II, Sine S.M., Engel A.G.;
RT   "Congenital myasthenic syndrome caused by decreased agonist binding
RT   affinity due to a mutation in the acetylcholine receptor epsilon
RT   subunit.";
RL   Neuron 17:157-170(1996).
RN   [9]
RP   VARIANTS CMS4C LEU-167; LEU-265 AND TRP-331, AND CHARACTERIZATION OF
RP   VARIANTS CMS4C LEU-167; LEU-265 AND TRP-331.
RX   PubMed=9158150; DOI=10.1093/hmg/6.5.753;
RA   Ohno K., Quiram P.A., Milone M., Wang H.-L., Harper M.C.,
RA   Pruitt J.N. II, Brengman J.M., Pao L., Fischbeck K.H., Crawford T.O.,
RA   Sine S.M., Engel A.G.;
RT   "Congenital myasthenic syndromes due to heteroallelic
RT   nonsense/missense mutations in the acetylcholine receptor epsilon
RT   subunit gene: identification and functional characterization of six
RT   new mutations.";
RL   Hum. Mol. Genet. 6:753-766(1997).
RN   [10]
RP   VARIANT CMS4B PRO-431, AND CHARACTERIZATION OF VARIANT CMS4B PRO-431.
RX   PubMed=10962020; DOI=10.1085/jgp.116.3.449;
RA   Wang H.-L., Ohno K., Milone M., Brengman J.M., Evoli A.,
RA   Batocchi A.-P., Middleton L.T., Christodoulou K., Engel A.G.,
RA   Sine S.M.;
RT   "Fundamental gating mechanism of nicotinic receptor channel revealed
RT   by mutation causing a congenital myasthenic syndrome.";
RL   J. Gen. Physiol. 116:449-462(2000).
RN   [11]
RP   VARIANTS CMS4A PRO-98 AND PHE-241.
RX   PubMed=12141316; DOI=10.1212/WNL.59.2.162;
RA   Croxen R., Hatton C., Shelley C., Brydson M., Chauplannaz G.,
RA   Oosterhuis H., Vincent A., Newsom-Davis J., Colquhoun D., Beeson D.;
RT   "Recessive inheritance and variable penetrance of slow-channel
RT   congenital myasthenic syndromes.";
RL   Neurology 59:162-168(2002).
RN   [12]
RP   VARIANT CMS4B ARG-75, AND CHARACTERIZATION OF VARIANT CMS4B ARG-75.
RX   PubMed=22592360; DOI=10.1212/WNL.0b013e31825b5bda;
RA   Shen X.M., Brengman J.M., Edvardson S., Sine S.M., Engel A.G.;
RT   "Highly fatal fast-channel syndrome caused by AChR epsilon subunit
RT   mutation at the agonist binding site.";
RL   Neurology 79:449-454(2012).
RN   [13]
RP   VARIANT CMS4A ALA-285, CHARACTERIZATION OF VARIANT CMS4A ALA-285, AND
RP   FUNCTION.
RX   PubMed=27375219; DOI=10.1002/humu.23043;
RA   Shen X.M., Okuno T., Milone M., Otsuka K., Takahashi K., Komaki H.,
RA   Giles E., Ohno K., Engel A.G.;
RT   "Mutations causing slow-channel myasthenia reveal that a valine ring
RT   in the channel pore of muscle AChR is optimized for stabilizing
RT   channel gating.";
RL   Hum. Mutat. 37:1051-1059(2016).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000269|PubMed:27375219}.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (PubMed:15609996). {ECO:0000269|PubMed:15609996}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- DISEASE: Note=The muscle AChR is the major target antigen in the
CC       autoimmune disease myasthenia gravis. Myasthenia gravis is
CC       characterized by sporadic muscular fatigability and weakness,
CC       occurring chiefly in muscles innervated by cranial nerves, and
CC       characteristically improved by cholinesterase-inhibiting drugs.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 4A, slow-channel (CMS4A)
CC       [MIM:605809]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS4A is a slow-channel myasthenic syndrome. It is caused
CC       by kinetic abnormalities of the AChR, resulting in prolonged AChR
CC       channel opening episodes, prolonged endplate currents, and
CC       depolarization block. This is associated with calcium overload,
CC       which may contribute to subsequent degeneration of the endplate
CC       and postsynaptic membrane. {ECO:0000269|PubMed:12141316,
CC       ECO:0000269|PubMed:27375219, ECO:0000269|PubMed:7531341,
CC       ECO:0000269|PubMed:7538206, ECO:0000269|PubMed:8872460}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 4B, fast-channel (CMS4B)
CC       [MIM:616324]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS4B is a fast-channel myasthenic syndrome. It is caused
CC       by kinetic abnormalities of the AChR, resulting in brief opening
CC       and activity of the channel, with a rapid decay in endplate
CC       current, failure to achieve threshold depolarization of the
CC       endplate and consequent failure to fire an action potential.
CC       {ECO:0000269|PubMed:10962020, ECO:0000269|PubMed:22592360,
CC       ECO:0000269|PubMed:8755487}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 4C, associated with
CC       acetylcholine receptor deficiency (CMS4C) [MIM:608931]: A form of
CC       congenital myasthenic syndrome, a group of disorders characterized
CC       by failure of neuromuscular transmission, including pre-synaptic,
CC       synaptic, and post-synaptic disorders that are not of autoimmune
CC       origin. Clinical features are easy fatigability and muscle
CC       weakness affecting the axial and limb muscles (with hypotonia in
CC       early-onset forms), the ocular muscles (leading to ptosis and
CC       ophthalmoplegia), and the facial and bulbar musculature (affecting
CC       sucking and swallowing, and leading to dysphonia). The symptoms
CC       fluctuate and worsen with physical effort. CMS4C is an autosomal
CC       recessive disorder of postsynaptic neuromuscular transmission, due
CC       to deficiency of AChR at the endplate that results in low
CC       amplitude of the miniature endplate potential and current.
CC       {ECO:0000269|PubMed:9158150}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       Epsilon/CHRNE sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66403; CAA47030.1; -; mRNA.
DR   EMBL; AF105999; AAD24503.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90395.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90396.1; -; Genomic_DNA.
DR   CCDS; CCDS11058.1; -.
DR   PIR; S34775; S34775.
DR   RefSeq; NP_000071.1; NM_000080.3.
DR   UniGene; Hs.654535; -.
DR   PDB; 2DF9; Model; -; A=240-332.
DR   PDBsum; 2DF9; -.
DR   ProteinModelPortal; Q04844; -.
DR   BioGrid; 107567; 2.
DR   STRING; 9606.ENSP00000293780; -.
DR   BindingDB; Q04844; -.
DR   ChEMBL; CHEMBL2484; -.
DR   DrugBank; DB00674; Galantamine.
DR   TCDB; 1.A.9.1.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; Q04844; -.
DR   PhosphoSitePlus; Q04844; -.
DR   BioMuta; CHRNE; -.
DR   DMDM; 1168301; -.
DR   MaxQB; Q04844; -.
DR   PaxDb; Q04844; -.
DR   PeptideAtlas; Q04844; -.
DR   PRIDE; Q04844; -.
DR   Ensembl; ENST00000293780; ENSP00000293780; ENSG00000108556.
DR   GeneID; 1145; -.
DR   KEGG; hsa:1145; -.
DR   UCSC; uc002fzk.2; human.
DR   CTD; 1145; -.
DR   DisGeNET; 1145; -.
DR   EuPathDB; HostDB:ENSG00000108556.7; -.
DR   GeneCards; CHRNE; -.
DR   GeneReviews; CHRNE; -.
DR   H-InvDB; HIX0027273; -.
DR   HGNC; HGNC:1966; CHRNE.
DR   MalaCards; CHRNE; -.
DR   MIM; 100725; gene.
DR   MIM; 254200; phenotype.
DR   MIM; 605809; phenotype.
DR   MIM; 608931; phenotype.
DR   MIM; 616324; phenotype.
DR   neXtProt; NX_Q04844; -.
DR   OpenTargets; ENSG00000108556; -.
DR   Orphanet; 98913; Postsynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA26498; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q04844; -.
DR   KO; K04817; -.
DR   OMA; ESTRDQE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q04844; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   GeneWiki; CHRNE; -.
DR   GenomeRNAi; 1145; -.
DR   PRO; PR:Q04844; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108556; -.
DR   CleanEx; HS_CHRNE; -.
DR   Genevisible; Q04844; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; TAS:ProtInc.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; TAS:ProtInc.
DR   GO; GO:0008324; F:cation transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Complete proteome;
KW   Congenital myasthenic syndrome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     20
FT   CHAIN        21    493       Acetylcholine receptor subunit epsilon.
FT                                /FTId=PRO_0000000329.
FT   TOPO_DOM     21    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    264       Helical. {ECO:0000255}.
FT   TOPO_DOM    265    272       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    273    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    306       Extracellular. {ECO:0000255}.
FT   TRANSMEM    307    328       Helical. {ECO:0000255}.
FT   TOPO_DOM    329    456       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    457    480       Helical. {ECO:0000255}.
FT   TOPO_DOM    481    493       Extracellular. {ECO:0000255}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    148    162       {ECO:0000250}.
FT   VARIANT      13     13       G -> R (in CMS4B; impaired association
FT                                with alpha CHRNA1 subunit of AChR;
FT                                dbSNP:rs372635387).
FT                                {ECO:0000269|PubMed:8755487}.
FT                                /FTId=VAR_021213.
FT   VARIANT      18     18       G -> V (in dbSNP:rs4790235).
FT                                /FTId=VAR_048170.
FT   VARIANT      75     75       W -> R (in CMS4B; strongly reduces
FT                                agonist affinity and gating efficiency;
FT                                dbSNP:rs193919341).
FT                                {ECO:0000269|PubMed:22592360}.
FT                                /FTId=VAR_071629.
FT   VARIANT      98     98       L -> P (in CMS4A; rare example of
FT                                recessive inheritance; dbSNP:rs28929768).
FT                                {ECO:0000269|PubMed:12141316}.
FT                                /FTId=VAR_019567.
FT   VARIANT     141    141       P -> L (in CMS4B; marked decrease in rate
FT                                of AChR channel opening; reduction in
FT                                frequency of open channel state and
FT                                resistance to desensitization by ACh;
FT                                dbSNP:rs121909512).
FT                                {ECO:0000269|PubMed:8755487}.
FT                                /FTId=VAR_000289.
FT   VARIANT     163    163       S -> L (in CMS4B; fails to assemble with
FT                                alpha CHRNA1 subunit of AChR;
FT                                dbSNP:rs121909516).
FT                                {ECO:0000269|PubMed:8755487}.
FT                                /FTId=VAR_021214.
FT   VARIANT     167    167       R -> L (in CMS4C; significantly reduced
FT                                AChR expression; dbSNP:rs121909514).
FT                                {ECO:0000269|PubMed:9158150}.
FT                                /FTId=VAR_000290.
FT   VARIANT     241    241       L -> F (in CMS4A; mild form with variable
FT                                penetrance; dbSNP:rs28999110).
FT                                {ECO:0000269|PubMed:12141316}.
FT                                /FTId=VAR_019568.
FT   VARIANT     265    265       P -> L (in CMS4C; prolongs burst open
FT                                duration 2-fold by slowing the rate of
FT                                channel closing; dbSNP:rs759226183).
FT                                {ECO:0000269|PubMed:9158150}.
FT                                /FTId=VAR_000291.
FT   VARIANT     284    284       T -> P (in CMS4A; markedly prolonged
FT                                channel openings in presence of agonist;
FT                                as well as opening in the absence of
FT                                agonist; dbSNP:rs121909510).
FT                                {ECO:0000269|PubMed:7531341}.
FT                                /FTId=VAR_000292.
FT   VARIANT     285    285       V -> A (in CMS4A; slow-channel mutation;
FT                                increases gating equilibrium constant by
FT                                25-fold, owing to increased opening rate
FT                                and decreased closing rate; no effect on
FT                                the choline dissociation rate constant).
FT                                {ECO:0000269|PubMed:27375219}.
FT                                /FTId=VAR_077364.
FT   VARIANT     289    289       L -> F (in CMS4A; slows rate of AChR
FT                                channel closure and increases apparent
FT                                affinity for ACh; causes pathologic
FT                                channel openings even in the absence of
FT                                ACh resulting in a leaky channel;
FT                                dbSNP:rs121909511).
FT                                {ECO:0000269|PubMed:7538206,
FT                                ECO:0000269|PubMed:8872460}.
FT                                /FTId=VAR_000293.
FT   VARIANT     331    331       R -> W (in CMS4C; shortens burst duration
FT                                2-fold by slowing the rate of channel
FT                                opening and speeding the rate of ACh
FT                                dissociation; has a mild fast-channel
FT                                kinetic effect on the AChR by shortening
FT                                the long burst and increasing the decay
FT                                of the endplate current;
FT                                dbSNP:rs121909515).
FT                                {ECO:0000269|PubMed:9158150}.
FT                                /FTId=VAR_000294.
FT   VARIANT     431    431       A -> P (in CMS4B; causes an increase in
FT                                distributions of rates for channel
FT                                opening and closing increasing the range
FT                                of activation kinetics;
FT                                dbSNP:rs121909517).
FT                                {ECO:0000269|PubMed:10962020}.
FT                                /FTId=VAR_021215.
SQ   SEQUENCE   493 AA;  54697 MW;  A34AF273AF8B31FE CRC64;
     MARAPLGVLL LLGLLGRGVG KNEELRLYHH LFNNYDPGSR PVREPEDTVT ISLKVTLTNL
     ISLNEKEETL TTSVWIGIDW QDYRLNYSKD DFGGIETLRV PSELVWLPEI VLENNIDGQF
     GVAYDANVLV YEGGSVTWLP PAIYRSVCAV EVTYFPFDWQ NCSLIFRSQT YNAEEVEFTF
     AVDNDGKTIN KIDIDTEAYT ENGEWAIDFC PGVIRRHHGG ATDGPGETDV IYSLIIRRKP
     LFYVINIIVP CVLISGLVLL AYFLPAQAGG QKCTVSINVL LAQTVFLFLI AQKIPETSLS
     VPLLGRFLIF VMVVATLIVM NCVIVLNVSQ RTPTTHAMSP RLRHVLLELL PRLLGSPPPP
     EAPRAASPPR RASSVGLLLR AEELILKKPR SELVFEGQRH RQGTWTAAFC QSLGAAAPEV
     RCCVDAVNFV AESTRDQEAT GEEVSDWVRM GNALDNICFW AALVLFSVGS SLIFLGAYFN
     RVPDLPYAPC IQP
//
ID   GBRA1_HUMAN             Reviewed;         456 AA.
AC   P14867; D3DQK6; Q8N629;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-JAN-2003, sequence version 3.
DT   20-DEC-2017, entry version 193.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-1;
DE   AltName: Full=GABA(A) receptor subunit alpha-1;
DE   Flags: Precursor;
GN   Name=GABRA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=2465923; DOI=10.1016/0014-5793(89)80563-0;
RA   Schofield P.R., Pritchett D.B., Sontheimer H., Kettenmann H.,
RA   Seeburg P.H.;
RT   "Sequence and expression of human GABAA receptor alpha 1 and beta 1
RT   subunits.";
RL   FEBS Lett. 244:361-364(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-365.
RC   TISSUE=Cerebellum;
RX   PubMed=2847710; DOI=10.1016/S0006-291X(88)80949-5;
RA   Garrett K.M., Duman R.S., Saito N., Blume A.J., Vitek M.P.,
RA   Tallman J.F.;
RT   "Isolation of a cDNA clone for the alpha subunit of the human GABA-A
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 156:1039-1045(1988).
RN   [5]
RP   INVOLVEMENT IN EIG13, VARIANT EIG13 ASN-219, AND CHARACTERIZATION OF
RP   VARIANT EIG13 ASN-219.
RX   PubMed=21714819; DOI=10.1111/j.1460-9568.2011.07767.x;
RA   Lachance-Touchette P., Brown P., Meloche C., Kinirons P., Lapointe L.,
RA   Lacasse H., Lortie A., Carmant L., Bedford F., Bowie D., Cossette P.;
RT   "Novel alpha1 and gamma2 GABAA receptor subunit mutations in families
RT   with idiopathic generalized epilepsy.";
RL   Eur. J. Neurosci. 34:237-249(2011).
RN   [6]
RP   INVOLVEMENT IN EIEE19, AND VARIANTS EIEE19 GLN-112; SER-251 AND
RP   THR-306.
RX   PubMed=24623842; DOI=10.1212/WNL.0000000000000291;
RA   Carvill G.L., Weckhuysen S., McMahon J.M., Hartmann C., Moller R.S.,
RA   Hjalgrim H., Cook J., Geraghty E., O'Roak B.J., Petrou S., Clarke A.,
RA   Gill D., Sadleir L.G., Muhle H., von Spiczak S., Nikanorova M.,
RA   Hodgson B.L., Gazina E.V., Suls A., Shendure J., Dibbens L.M.,
RA   De Jonghe P., Helbig I., Berkovic S.F., Scheffer I.E., Mefford H.C.;
RT   "GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.";
RL   Neurology 82:1245-1253(2014).
RN   [7]
RP   VARIANT EJM5 ASP-322.
RX   PubMed=11992121; DOI=10.1038/ng885;
RA   Cossette P., Liu L., Brisebois K., Dong H., Lortie A., Vanasse M.,
RA   Saint-Hilaire J.-M., Carmant L., Verner A., Lu W.-Y., Tian Wang Y.,
RA   Rouleau G.A.;
RT   "Mutation of GABRA1 in an autosomal dominant form of juvenile
RT   myoclonic epilepsy.";
RL   Nat. Genet. 31:184-189(2002).
RN   [8]
RP   INVOLVEMENT IN ECA4.
RX   PubMed=16718694; DOI=10.1002/ana.20874;
RA   Maljevic S., Krampfl K., Cobilanschi J., Tilgen N., Beyer S.,
RA   Weber Y.G., Schlesinger F., Ursu D., Melzer W., Cossette P.,
RA   Bufler J., Lerche H., Heils A.;
RT   "A mutation in the GABA(A) receptor alpha(1)-subunit is associated
RT   with absence epilepsy.";
RL   Ann. Neurol. 59:983-987(2006).
RN   [9]
RP   VARIANT EIEE19 MET-146.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha, beta,
CC       gamma, delta and rho chains. Interacts with UBQLN1. Interacts with
CC       TRAK1. Interacts with KIF21B. {ECO:0000250|UniProtKB:P62812,
CC       ECO:0000250|UniProtKB:P62813}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:2465923}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:P62813}.
CC   -!- DISEASE: Epilepsy, childhood absence 4 (ECA4) [MIM:611136]: A
CC       subtype of idiopathic generalized epilepsy characterized by an
CC       onset at age 6-7 years, frequent absence seizures (several per
CC       day) and bilateral, synchronous, symmetric 3-Hz spike waves on
CC       EEG. Tonic-clonic seizures often develop in adolescence. Absence
CC       seizures may either remit or persist into adulthood.
CC       {ECO:0000269|PubMed:16718694}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epilepsy, idiopathic generalized 13 (EIG13) [MIM:611136]:
CC       A disorder characterized by recurring generalized seizures in the
CC       absence of detectable brain lesions and/or metabolic
CC       abnormalities. Generalized seizures arise diffusely and
CC       simultaneously from both hemispheres of the brain. Seizure types
CC       include juvenile myoclonic seizures, absence seizures, and
CC       generalized tonic-clonic seizures. {ECO:0000269|PubMed:21714819}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Juvenile myoclonic epilepsy 5 (EJM5) [MIM:611136]: A
CC       subtype of idiopathic generalized epilepsy. Patients have afebrile
CC       seizures only, with onset in adolescence (rather than in
CC       childhood) and myoclonic jerks which usually occur after awakening
CC       and are triggered by sleep deprivation and fatigue.
CC       {ECO:0000269|PubMed:11992121}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 19 (EIEE19)
CC       [MIM:615744]: A severe neurologic disorder characterized by onset
CC       of seizures in the first months of life and usually associated
CC       with EEG abnormalities. Affected infants have convulsive seizures
CC       (hemiclonic or generalized) that are often prolonged and triggered
CC       by fever. Other seizure types include focal, myoclonic, absence
CC       seizures, and drop attacks. Development is normal in the first
CC       year of life with later slowing and intellectual disability.
CC       {ECO:0000269|PubMed:24623842, ECO:0000269|PubMed:27864847}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA1 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14766; CAA32874.1; -; mRNA.
DR   EMBL; CH471062; EAW61538.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61539.1; -; Genomic_DNA.
DR   EMBL; BC030696; AAH30696.1; -; mRNA.
DR   EMBL; X13584; CAA31925.1; -; mRNA.
DR   CCDS; CCDS4357.1; -.
DR   PIR; A31588; A31588.
DR   PIR; A60652; A60652.
DR   RefSeq; NP_000797.2; NM_000806.5.
DR   RefSeq; NP_001121115.1; NM_001127643.1.
DR   RefSeq; NP_001121116.1; NM_001127644.1.
DR   RefSeq; NP_001121117.1; NM_001127645.1.
DR   RefSeq; NP_001121120.1; NM_001127648.1.
DR   UniGene; Hs.175934; -.
DR   ProteinModelPortal; P14867; -.
DR   SMR; P14867; -.
DR   BioGrid; 108828; 8.
DR   CORUM; P14867; -.
DR   IntAct; P14867; 1.
DR   STRING; 9606.ENSP00000023897; -.
DR   BindingDB; P14867; -.
DR   ChEMBL; CHEMBL1962; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB01341; Dihydroquinidine barbiturate.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB05087; Ganaxolone.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB01587; Ketazolam.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB00474; Methohexital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00466; Picrotoxin.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00837; Progabide.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01346; Quinidine barbiturate.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB01154; Thiamylal.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   DrugBank; DB00962; Zaleplon.
DR   DrugBank; DB00425; Zolpidem.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 404; -.
DR   TCDB; 1.A.9.5.4; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P14867; -.
DR   PhosphoSitePlus; P14867; -.
DR   BioMuta; GABRA1; -.
DR   DMDM; 27808653; -.
DR   EPD; P14867; -.
DR   MaxQB; P14867; -.
DR   PaxDb; P14867; -.
DR   PeptideAtlas; P14867; -.
DR   PRIDE; P14867; -.
DR   DNASU; 2554; -.
DR   Ensembl; ENST00000023897; ENSP00000023897; ENSG00000022355.
DR   Ensembl; ENST00000393943; ENSP00000377517; ENSG00000022355.
DR   Ensembl; ENST00000428797; ENSP00000393097; ENSG00000022355.
DR   Ensembl; ENST00000437025; ENSP00000415441; ENSG00000022355.
DR   Ensembl; ENST00000635880; ENSP00000489738; ENSG00000022355.
DR   Ensembl; ENST00000636573; ENSP00000490320; ENSG00000022355.
DR   Ensembl; ENST00000637827; ENSP00000490804; ENSG00000022355.
DR   Ensembl; ENST00000638112; ENSP00000489839; ENSG00000022355.
DR   GeneID; 2554; -.
DR   KEGG; hsa:2554; -.
DR   UCSC; uc003lyx.5; human.
DR   CTD; 2554; -.
DR   DisGeNET; 2554; -.
DR   EuPathDB; HostDB:ENSG00000022355.15; -.
DR   GeneCards; GABRA1; -.
DR   HGNC; HGNC:4075; GABRA1.
DR   HPA; CAB022502; -.
DR   HPA; HPA055746; -.
DR   MalaCards; GABRA1; -.
DR   MIM; 137160; gene.
DR   MIM; 611136; phenotype.
DR   MIM; 615744; phenotype.
DR   neXtProt; NX_P14867; -.
DR   OpenTargets; ENSG00000022355; -.
DR   Orphanet; 64280; Childhood absence epilepsy.
DR   Orphanet; 33069; Dravet syndrome.
DR   Orphanet; 307; Juvenile myoclonic epilepsy.
DR   PharmGKB; PA28489; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P14867; -.
DR   KO; K05175; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P14867; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; Gamma-aminobutyric_acid_(GABA)_A_receptor,_alpha_1; -.
DR   GeneWiki; Gamma-aminobutyric_acid_receptor_subunit_alpha-1; -.
DR   GenomeRNAi; 2554; -.
DR   PRO; PR:P14867; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000022355; -.
DR   CleanEx; HS_GABRA1; -.
DR   ExpressionAtlas; P14867; baseline and differential.
DR   Genevisible; P14867; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1902710; C:GABA receptor complex; ISS:BHF-UCL.
DR   GO; GO:1902711; C:GABA-A receptor complex; IDA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008144; F:drug binding; ISS:BHF-UCL.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:ProtInc.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:GO_Central.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; IEA:Ensembl.
DR   GO; GO:0071420; P:cellular response to histamine; IEA:Ensembl.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:GO_Central.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; ISS:BHF-UCL.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005431; GABBAa1_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01614; GABAARALPHA1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Cytoplasmic vesicle; Disease mutation;
KW   Disulfide bond; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    456       Gamma-aminobutyric acid receptor subunit
FT                                alpha-1.
FT                                /FTId=PRO_0000000428.
FT   TOPO_DOM     28    251       Extracellular. {ECO:0000305}.
FT   TRANSMEM    252    273       Helical. {ECO:0000305}.
FT   TRANSMEM    279    300       Helical. {ECO:0000305}.
FT   TRANSMEM    313    334       Helical. {ECO:0000305}.
FT   TOPO_DOM    335    421       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    422    443       Helical. {ECO:0000305}.
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    166    180       {ECO:0000250}.
FT   VARIANT     112    112       R -> Q (in EIEE19; dbSNP:rs587777308).
FT                                {ECO:0000269|PubMed:24623842}.
FT                                /FTId=VAR_071809.
FT   VARIANT     146    146       L -> M (in EIEE19).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078222.
FT   VARIANT     219    219       D -> N (in EIG13; the mutant protein is
FT                                partially retained in the endoplasmic
FT                                reticulum and has decreased expression at
FT                                the plasma membrane; causes decreased
FT                                current amplitude in response to GABA
FT                                compared to wild-type and alters receptor
FT                                gating kinetics including faster
FT                                desensitization; dbSNP:rs587777364).
FT                                {ECO:0000269|PubMed:21714819}.
FT                                /FTId=VAR_071810.
FT   VARIANT     251    251       G -> S (in EIEE19; dbSNP:rs587777307).
FT                                {ECO:0000269|PubMed:24623842}.
FT                                /FTId=VAR_071811.
FT   VARIANT     306    306       K -> T (in EIEE19; dbSNP:rs587777309).
FT                                {ECO:0000269|PubMed:24623842}.
FT                                /FTId=VAR_071812.
FT   VARIANT     322    322       A -> D (in EJM5; dbSNP:rs121434579).
FT                                {ECO:0000269|PubMed:11992121}.
FT                                /FTId=VAR_013642.
FT   CONFLICT    122    122       W -> R (in Ref. 1; CAA32874).
FT                                {ECO:0000305}.
FT   CONFLICT    128    140       Missing (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
FT   CONFLICT    204    204       R -> H (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
FT   CONFLICT    315    315       W -> WDW (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
FT   CONFLICT    362    365       IKKN -> FPNS (in Ref. 4; CAA31925).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  51802 MW;  F81EC9ECBE64E94D CRC64;
     MRKSPGLSDC LWAWILLLST LTGRSYGQPS LQDELKDNTT VFTRILDRLL DGYDNRLRPG
     LGERVTEVKT DIFVTSFGPV SDHDMEYTID VFFRQSWKDE RLKFKGPMTV LRLNNLMASK
     IWTPDTFFHN GKKSVAHNMT MPNKLLRITE DGTLLYTMRL TVRAECPMHL EDFPMDAHAC
     PLKFGSYAYT RAEVVYEWTR EPARSVVVAE DGSRLNQYDL LGQTVDSGIV QSSTGEYVVM
     TTHFHLKRKI GYFVIQTYLP CIMTVILSQV SFWLNRESVP ARTVFGVTTV LTMTTLSISA
     RNSLPKVAYA TAMDWFIAVC YAFVFSALIE FATVNYFTKR GYAWDGKSVV PEKPKKVKDP
     LIKKNNTYAP TATSYTPNLA RGDPGLATIA KSATIEPKEV KPETKPPEPK KTFNSVSKID
     RLSRIAFPLL FGIFNLVYWA TYLNREPQLK APTPHQ
//
ID   ACR5_CAEEL              Reviewed;         598 AA.
AC   P54246; Q3Y417;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 4.
DT   22-NOV-2017, entry version 131.
DE   RecName: Full=Acetylcholine receptor subunit alpha-type acr-5;
DE   Flags: Precursor;
GN   Name=acr-5; ORFNames=K03F8.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Possible acetylcholine receptor. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO080466; CCD63926.1; -; Genomic_DNA.
DR   PIR; T16546; T16546.
DR   RefSeq; NP_498437.2; NM_066036.2.
DR   UniGene; Cel.10980; -.
DR   ProteinModelPortal; P54246; -.
DR   STRING; 6239.K03F8.2; -.
DR   TCDB; 1.A.9.1.5; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; P54246; -.
DR   EnsemblMetazoa; K03F8.2; K03F8.2; WBGene00000044.
DR   GeneID; 191596; -.
DR   KEGG; cel:CELE_K03F8.2; -.
DR   UCSC; K03F8.2; c. elegans.
DR   CTD; 191596; -.
DR   WormBase; K03F8.2; CE38967; WBGene00000044; acr-5.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000019549; -.
DR   InParanoid; P54246; -.
DR   OMA; WVMLYAH; -.
DR   OrthoDB; EOG091G0402; -.
DR   Reactome; R-CEL-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P54246; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00000044; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    598       Acetylcholine receptor subunit alpha-type
FT                                acr-5.
FT                                /FTId=PRO_0000000402.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TRANSMEM    357    377       Helical. {ECO:0000255}.
FT   TRANSMEM    392    412       Helical. {ECO:0000255}.
FT   TRANSMEM    564    584       Helical. {ECO:0000255}.
FT   CARBOHYD     54     54       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    178    178       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   598 AA;  70280 MW;  344A1CD70C521429 CRC64;
     MLPNIILILL IRYCSCGAGS RVYEKYGKQV QLSPATTSSY REWYDSNREH STRNNTNVDD
     FQTQLKKSLE NTTAAYNATF MQELIEERQR YLEKLNEGQF INDQRRLVEE LLDPNYYEKT
     VHPKRDYTRP TRVNLSMSLY QILDVDEHMQ SIEVNVWMVQ HWYDEFLDWN PVDYGMINRT
     IVPYHQIWIP DTYLYNSEEL EQKKTESLMN AQLETGHWNQ KKDGAKVQLM FPAIYKLSCR
     MDVRWFPYDR QNYKTSFKPM KLLQQTIDYW PLSSTVNLGN MARNDEWEVI SFEFVRVEET
     FKCCTAPWVM LYAHLVIRRK PLYYMINLVV PTSIITIVAV TGFFTPTSSS SERDEKLYLG
     INTLLTMSVM MLMVCNQMPS TSTYVPLMSW YYIGIIMVIV VGTFLATGVL AIHGQKHYNK
     PISDRIRKLI YNPVVEFFIL SPPTSLIDLW TEFGVISEQR HSTHLDPLLL QHMDPISHTT
     RADPQHFFGS ISSQMCDLQS TYSYTARLAT ITRQYTQHAK MKALRKNQYR MSMDTSQARG
     VKKQKMQRRC SLEWEFLANV LDRILLTIFC GFTFAVFIIL IGFDSFFTFH TDSPPKTM
//
ID   ACHA5_RAT               Reviewed;         452 AA.
AC   P20420;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   22-NOV-2017, entry version 138.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-5;
DE   Flags: Precursor;
GN   Name=Chrna5; Synonyms=Acra5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1689727;
RA   Boulter J., O'Shea-Greenfield A., Duvoisin R.M., Connolly J.G.,
RA   Wada E., Jensen A., Gardner P.D., Ballivet M., Deneris E.S.,
RA   McKinnon D., Heinemann S.F., Patrick J.;
RT   "Alpha 3, alpha 5, and beta 4: three members of the rat neuronal
RT   nicotinic acetylcholine receptor-related gene family form a gene
RT   cluster.";
RL   J. Biol. Chem. 265:4472-4482(1990).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different types
CC       of subunits: alpha and non-alpha (beta). Interacts with LYPD6.
CC       {ECO:0000250|UniProtKB:P30532}.
CC   -!- INTERACTION:
CC       P09483:Chrna4; NbExp=6; IntAct=EBI-10828372, EBI-7842410;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       5/CHRNA5 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05231; AAA74475.1; -; mRNA.
DR   PIR; A35721; A35721.
DR   UniGene; Rn.40125; -.
DR   ProteinModelPortal; P20420; -.
DR   IntAct; P20420; 3.
DR   STRING; 10116.ENSRNOP00000062227; -.
DR   ChEMBL; CHEMBL2094110; -.
DR   PaxDb; P20420; -.
DR   PRIDE; P20420; -.
DR   UCSC; RGD:2347; rat.
DR   RGD; 2347; Chrna5.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P20420; -.
DR   PhylomeDB; P20420; -.
DR   PRO; PR:P20420; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISO:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    452       Neuronal acetylcholine receptor subunit
FT                                alpha-5.
FT                                /FTId=PRO_0000000358.
FT   TOPO_DOM     28    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    260       Helical. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TOPO_DOM    323    414       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    415    435       Helical. {ECO:0000255}.
FT   TOPO_DOM    436    452       Extracellular. {ECO:0000255}.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    168    168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250}.
FT   DISULFID    219    220       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   452 AA;  51874 MW;  7CEB24553936B2E7 CRC64;
     MVQLLAGRWR PTGARRGTRG GLPELSSAAK HEDSLFRDLF EDYERWVRPV EHLSDKIKIK
     FGLAISQLVD VDEKNQLMTT NVWLKQEWID VKLRWNPDDY GGIKIIRVPS DSLWIPDIVL
     FDNADGRFEG ASTKTVVRYN GTVTWTQPAN YKSSCTIDVT FFPFDLQNCS MKFGSWTYDG
     SQVDIILEDQ DVDRTDFFDN GEWEIMSAMG SKGNRTDSCC WYPYITYSFV IKRLPLFYTL
     FLIIPCIGLS FLTVVVFYLP SNEGEKISLC TSVLVSLTVF LLVIEEIIPS SSKVIPLIGE
     YLVFTMIFVT LSIMVTVFAI NIHHRSSSTH NAMAPWVRKI FLHKLPKLLC MRSHADRYFT
     QREEAESGAG PKSRNTLEAA LDCIRYITRH VVKENDVREV VEDWKFIAQV LDRMFLWTFL
     LVSIIGTLGL FVPVIYKWAN IIVPVHIGNT IK
//
ID   ACHA_MOUSE              Reviewed;         457 AA.
AC   P04756;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   25-OCT-2017, entry version 170.
DE   RecName: Full=Acetylcholine receptor subunit alpha;
DE   Flags: Precursor;
GN   Name=Chrna1; Synonyms=Acra;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3755237; DOI=10.1093/nar/14.12.5111;
RA   Isenberg K.E., Mudd J., Shah V., Merlie J.P.;
RT   "Nucleotide sequence of the mouse muscle nicotinic acetylcholine
RT   receptor alpha subunit.";
RL   Nucleic Acids Res. 14:5111-5111(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Boulter J.;
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 13-457.
RX   PubMed=2993547;
RA   Boulter J., Luyten W., Evans K., Mason P., Ballivet M., Goldman D.J.,
RA   Stengelin S.F., Martin G., Heinemann S.F., Patrick J.;
RT   "Isolation of a clone coding for the alpha-subunit of a mouse
RT   acetylcholine receptor.";
RL   J. Neurosci. 5:2545-2552(1985).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 21-231 IN COMPLEX WITH
RP   ALPHA-BUNGAROTOXIN, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-161.
RX   PubMed=17643119; DOI=10.1038/nn1942;
RA   Dellisanti C.D., Yao Y., Stroud J.C., Wang Z.Z., Chen L.;
RT   "Crystal structure of the extracellular domain of nAChR alpha1 bound
RT   to alpha-bungarotoxin at 1.94 A resolution.";
RL   Nat. Neurosci. 10:953-962(2007).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains (PubMed:17643119). The muscle heteropentamer
CC       composed of alpha-1, beta-1, delta, epsilon subunits interacts
CC       with the alpha-conotoxin ImII (By similarity).
CC       {ECO:0000250|UniProtKB:P02708, ECO:0000269|PubMed:17643119}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       1/CHRNA1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03986; CAA27624.1; -; mRNA.
DR   EMBL; M17640; AAB53942.1; -; mRNA.
DR   EMBL; AK029177; BAC26337.1; -; mRNA.
DR   CCDS; CCDS16132.1; -.
DR   PIR; A24383; A24383.
DR   PIR; I49458; I49458.
DR   RefSeq; NP_031415.2; NM_007389.5.
DR   UniGene; Mm.4583; -.
DR   PDB; 2QC1; X-ray; 1.94 A; B=21-231.
DR   PDB; 5HBV; X-ray; 2.70 A; B=22-231.
DR   PDBsum; 2QC1; -.
DR   PDBsum; 5HBV; -.
DR   ProteinModelPortal; P04756; -.
DR   SMR; P04756; -.
DR   BioGrid; 197931; 4.
DR   DIP; DIP-59594N; -.
DR   IntAct; P04756; 2.
DR   MINT; MINT-8388618; -.
DR   STRING; 10090.ENSMUSP00000028515; -.
DR   BindingDB; P04756; -.
DR   ChEMBL; CHEMBL3137264; -.
DR   iPTMnet; P04756; -.
DR   PhosphoSitePlus; P04756; -.
DR   SwissPalm; P04756; -.
DR   PaxDb; P04756; -.
DR   PRIDE; P04756; -.
DR   Ensembl; ENSMUST00000028515; ENSMUSP00000028515; ENSMUSG00000027107.
DR   GeneID; 11435; -.
DR   KEGG; mmu:11435; -.
DR   UCSC; uc008kcy.2; mouse.
DR   CTD; 1134; -.
DR   MGI; MGI:87885; Chrna1.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P04756; -.
DR   KO; K04803; -.
DR   OMA; DFAIIHE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P04756; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-MMU-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-MMU-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   EvolutionaryTrace; P04756; -.
DR   PRO; PR:P04756; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000027107; -.
DR   ExpressionAtlas; P04756; baseline and differential.
DR   Genevisible; P04756; MM.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IPI:MGI.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISO:MGI.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; ISO:MGI.
DR   GO; GO:0050881; P:musculoskeletal movement; ISO:MGI.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:MGI.
DR   GO; GO:0050905; P:neuromuscular process; ISO:MGI.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; ISO:MGI.
DR   GO; GO:0070050; P:neuron cellular homeostasis; ISO:MGI.
DR   GO; GO:0019228; P:neuronal action potential; ISO:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IGI:MGI.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0003009; P:skeletal muscle contraction; ISO:MGI.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; ISO:MGI.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     20
FT   CHAIN        21    457       Acetylcholine receptor subunit alpha.
FT                                /FTId=PRO_0000000306.
FT   TOPO_DOM     21    230       Extracellular.
FT   TRANSMEM    231    255       Helical.
FT   TRANSMEM    263    281       Helical.
FT   TRANSMEM    297    316       Helical.
FT   TOPO_DOM    317    428       Cytoplasmic.
FT   TRANSMEM    429    447       Helical.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17643119}.
FT   DISULFID    148    162       {ECO:0000269|PubMed:17643119}.
FT   DISULFID    212    213       Associated with receptor activation.
FT                                {ECO:0000269|PubMed:17643119}.
FT   CONFLICT     13     13       C -> S (in Ref. 2; AAB53942 and 4; no
FT                                nucleotide entry). {ECO:0000305}.
FT   HELIX        22     32       {ECO:0000244|PDB:2QC1}.
FT   STRAND       37     39       {ECO:0000244|PDB:2QC1}.
FT   STRAND       49     64       {ECO:0000244|PDB:2QC1}.
FT   TURN         65     68       {ECO:0000244|PDB:2QC1}.
FT   STRAND       69     81       {ECO:0000244|PDB:2QC1}.
FT   HELIX        89     92       {ECO:0000244|PDB:2QC1}.
FT   STRAND       97    100       {ECO:0000244|PDB:2QC1}.
FT   HELIX       102    104       {ECO:0000244|PDB:2QC1}.
FT   STRAND      110    112       {ECO:0000244|PDB:2QC1}.
FT   TURN        116    118       {ECO:0000244|PDB:2QC1}.
FT   STRAND      128    131       {ECO:0000244|PDB:2QC1}.
FT   STRAND      135    138       {ECO:0000244|PDB:2QC1}.
FT   STRAND      141    150       {ECO:0000244|PDB:2QC1}.
FT   STRAND      153    156       {ECO:0000244|PDB:2QC1}.
FT   STRAND      159    170       {ECO:0000244|PDB:2QC1}.
FT   TURN        173    175       {ECO:0000244|PDB:2QC1}.
FT   STRAND      176    181       {ECO:0000244|PDB:2QC1}.
FT   STRAND      194    210       {ECO:0000244|PDB:2QC1}.
FT   STRAND      218    229       {ECO:0000244|PDB:2QC1}.
SQ   SEQUENCE   457 AA;  51939 MW;  5CB606D144F29436 CRC64;
     MELSTVLLLL GLCSAGLVLG SEHETRLVAK LFEDYSSVVR PVEDHREIVQ VTVGLQLIQL
     INVDEVNQIV TTNVRLKQQW VDYNLKWNPD DYGGVKKIHI PSEKIWRPDV VLYNNADGDF
     AIVKFTKVLL DYTGHITWTP PAIFKSYCEI IVTHFPFDEQ NCSMKLGTWT YDGSVVAINP
     ESDQPDLSNF MESGEWVIKE ARGWKHWVFY SCCPTTPYLD ITYHFVMQRL PLYFIVNVII
     PCLLFSFLTS LVFYLPTDSG EKMTLSISVL LSLTVFLLVI VELIPSTSSA VPLIGKYMLF
     TMVFVIASII ITVIVINTHH RSPSTHIMPE WVRKVFIDTI PNIMFFSTMK RPSRDKQEKR
     IFTEDIDISD ISGKPGPPPM GFHSPLIKHP EVKSAIEGVK YIAETMKSDQ ESNNAAEEWK
     YVAMVMDHIL LGVFMLVCLI GTLAVFAGRL IELHQQG
//
ID   ACH1_SCHGR              Reviewed;         557 AA.
AC   P23414;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 1.
DT   22-NOV-2017, entry version 101.
DE   RecName: Full=Acetylcholine receptor subunit alpha-L1;
DE   Flags: Precursor;
OS   Schistocerca gregaria (Desert locust).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Polyneoptera; Orthoptera; Caelifera; Acrididea;
OC   Acridomorpha; Acridoidea; Acrididae; Cyrtacanthacridinae;
OC   Schistocerca.
OX   NCBI_TaxID=7010;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1702381;
RA   Marshall J., Buckingham S.D., Shingai R., Lunt G.G., Goosey M.W.,
RA   Darlison M.G., Sattelle D.B., Barnard E.A.;
RT   "Sequence and functional expression of a single alpha subunit of an
RT   insect nicotinic acetylcholine receptor.";
RL   EMBO J. 9:4391-4398(1990).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X55439; CAA39081.1; -; mRNA.
DR   PIR; S12359; S12359.
DR   ProteinModelPortal; P23414; -.
DR   SMR; P23414; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    557       Acetylcholine receptor subunit alpha-L1.
FT                                /FTId=PRO_0000000299.
FT   TOPO_DOM     24    244       Extracellular.
FT   TRANSMEM    245    266       Helical.
FT   TRANSMEM    274    294       Helical.
FT   TRANSMEM    308    329       Helical.
FT   TOPO_DOM    330    500       Cytoplasmic.
FT   TRANSMEM    501    523       Helical.
FT   COMPBIAS    382    400       Ala/Ser-rich.
FT   COMPBIAS    406    422       His-rich.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    235    235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
FT   DISULFID    224    225       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   557 AA;  63027 MW;  168389C887DFDF3E CRC64;
     MAAALPPMLL LLLLLLLHHP AAANPDAKRL YDDLLSNYNR LIRPVSNNTD TVLVKLGLRL
     SQLIDLNLKD QILTTNVWLE HEWQDHKFRW DPAEYGGVTE LYVPSEHIWL PDIVLYNNAD
     GEYVVTTMTK AVLHHTGKVV WTPPAIFKSS CEIDVRYFPF DQQTCFMKFG SWTYDGDQID
     LKHINQKYDD NKVKVGIDLR EYYPSVEWDI LGVPAERHEK YYPCCAEPYP DIFFNITLRR
     KTLFYTVNLI VPCVGISYLS VLVFYLPADS GEKIALCISI LLSQTMFFLL ISEIIPSTSL
     ALPLLGKYLL FTMVLVGLSV VITIMVLNVH YRKPSTHKMA PWVRKVFIRR LPKLLLMRVP
     EQLLADLASK RLLRHAHNSK LSAAAAAAVA AAASSSAASS PDSLRHHHLH QHQHQHHLQL
     HHLQRPGGCN GLHSATNRFG GSAGAFGGLP SVVGLDGSLS DVATRKKYPF ELEKAIHNVL
     FIQNHMQRQD EFDAEDQDWG FVAMVLDRLF LWIFTIASIV GTFAILCEAP ALYDDTKPID
     MELSSVAQQQ FLPDIDF
//
ID   5HT3E_HUMAN             Reviewed;         456 AA.
AC   A5X5Y0; A8IKD7; E9PGF1; Q495G1; Q495G3; Q6V706; Q6V707; Q7Z6B2;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 1.
DT   20-DEC-2017, entry version 107.
DE   RecName: Full=5-hydroxytryptamine receptor 3E;
DE            Short=5-HT3-E;
DE            Short=5-HT3E;
DE   AltName: Full=Serotonin receptor 3E;
DE   Flags: Precursor;
GN   Name=HTR3E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RX   PubMed=12801637; DOI=10.1016/S0378-1119(03)00503-1;
RA   Niesler B., Frank B., Kapeller J., Rappold G.A.;
RT   "Cloning, physical mapping and expression analysis of the human 5-HT3
RT   serotonin receptor-like genes HTR3C, HTR3D and HTR3E.";
RL   Gene 310:101-111(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4), AND TISSUE SPECIFICITY.
RX   PubMed=14597179; DOI=10.1016/S0378-1119(03)00803-5;
RA   Karnovsky A.M., Gotow L.F., McKinley D.D., Piechan J.L., Ruble C.L.,
RA   Mills C.J., Schellin K.A.B., Slightom J.L., Fitzgerald L.R.,
RA   Benjamin C.W., Roberds S.L.;
RT   "A cluster of novel serotonin receptor 3-like genes on human
RT   chromosome 3.";
RL   Gene 319:137-148(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), ALTERNATIVE SPLICING,
RP   SUBCELLULAR LOCATION, AND VARIANT THR-71.
RX   PubMed=19012743; DOI=10.1111/j.1471-4159.2008.05775.x;
RA   Holbrook J.D., Gill C.H., Zebda N., Spencer J.P., Leyland R.,
RA   Rance K.H., Trinh H., Balmer G., Kelly F.M., Yusaf S.P., Courtenay N.,
RA   Luck J., Rhodes A., Modha S., Moore S.E., Sanger G.J., Gunthorpe M.J.;
RT   "Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits:
RT   evolution, distribution and function.";
RL   J. Neurochem. 108:384-396(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex. {ECO:0000269|PubMed:17392525}.
CC   -!- INTERACTION:
CC       P46098:HTR3A; NbExp=5; IntAct=EBI-11174612, EBI-9008743;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17392525,
CC       ECO:0000269|PubMed:19012743}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:17392525, ECO:0000269|PubMed:19012743}.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=A5X5Y0-1; Sequence=Displayed;
CC       Name=2; Synonyms=5-HT3c1;
CC         IsoId=A5X5Y0-2; Sequence=VSP_029804;
CC       Name=3;
CC         IsoId=A5X5Y0-3; Sequence=VSP_029803;
CC       Name=4; Synonyms=5-HT3c1 long;
CC         IsoId=A5X5Y0-4; Sequence=VSP_029803, VSP_029804;
CC       Name=5; Synonyms=HTR3E_V3;
CC         IsoId=A5X5Y0-6; Sequence=VSP_029803, VSP_029804, VSP_045573;
CC   -!- TISSUE SPECIFICITY: Expressed in adult colon and intestine.
CC       {ECO:0000269|PubMed:12801637, ECO:0000269|PubMed:14597179}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3E
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY349352; AAQ93476.1; -; mRNA.
DR   EMBL; AY349353; AAQ93477.1; -; mRNA.
DR   EMBL; AY159813; AAO38167.2; -; mRNA.
DR   EMBL; DQ644022; ABG35128.1; -; mRNA.
DR   EMBL; EU165354; ABW05298.1; -; mRNA.
DR   EMBL; AC131235; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101182; AAI01183.1; -; mRNA.
DR   EMBL; BC101183; AAI01184.1; -; mRNA.
DR   EMBL; BC101185; AAI01186.1; -; mRNA.
DR   CCDS; CCDS3251.1; -. [A5X5Y0-3]
DR   CCDS; CCDS58868.1; -. [A5X5Y0-1]
DR   CCDS; CCDS58869.1; -. [A5X5Y0-2]
DR   CCDS; CCDS58870.1; -. [A5X5Y0-4]
DR   CCDS; CCDS58871.1; -. [A5X5Y0-6]
DR   RefSeq; NP_001243542.1; NM_001256613.1. [A5X5Y0-1]
DR   RefSeq; NP_001243543.1; NM_001256614.1. [A5X5Y0-6]
DR   RefSeq; NP_872395.2; NM_182589.2. [A5X5Y0-3]
DR   RefSeq; NP_938055.1; NM_198313.2. [A5X5Y0-2]
DR   RefSeq; NP_938056.1; NM_198314.2. [A5X5Y0-4]
DR   UniGene; Hs.449179; -.
DR   ProteinModelPortal; A5X5Y0; -.
DR   SMR; A5X5Y0; -.
DR   BioGrid; 130056; 6.
DR   IntAct; A5X5Y0; 1.
DR   STRING; 9606.ENSP00000335511; -.
DR   BindingDB; A5X5Y0; -.
DR   ChEMBL; CHEMBL2094132; -.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB13025; Tiapride.
DR   iPTMnet; A5X5Y0; -.
DR   PhosphoSitePlus; A5X5Y0; -.
DR   BioMuta; HTR3E; -.
DR   PaxDb; A5X5Y0; -.
DR   PRIDE; A5X5Y0; -.
DR   Ensembl; ENST00000335304; ENSP00000335511; ENSG00000186038. [A5X5Y0-3]
DR   Ensembl; ENST00000415389; ENSP00000401444; ENSG00000186038. [A5X5Y0-1]
DR   Ensembl; ENST00000425359; ENSP00000401900; ENSG00000186038. [A5X5Y0-2]
DR   Ensembl; ENST00000436361; ENSP00000395833; ENSG00000186038. [A5X5Y0-4]
DR   Ensembl; ENST00000440596; ENSP00000406050; ENSG00000186038. [A5X5Y0-6]
DR   GeneID; 285242; -.
DR   KEGG; hsa:285242; -.
DR   UCSC; uc003fml.5; human. [A5X5Y0-1]
DR   CTD; 285242; -.
DR   DisGeNET; 285242; -.
DR   EuPathDB; HostDB:ENSG00000186038.9; -.
DR   GeneCards; HTR3E; -.
DR   HGNC; HGNC:24005; HTR3E.
DR   HPA; HPA049764; -.
DR   MIM; 610123; gene.
DR   neXtProt; NX_A5X5Y0; -.
DR   OpenTargets; ENSG00000186038; -.
DR   PharmGKB; PA134900226; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; A5X5Y0; -.
DR   KO; K04819; -.
DR   OMA; EFMDVDK; -.
DR   OrthoDB; EOG091G042C; -.
DR   PhylomeDB; A5X5Y0; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; HTR3E; -.
DR   GenomeRNAi; 285242; -.
DR   PRO; PR:A5X5Y0; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000186038; -.
DR   CleanEx; HS_HTR3E; -.
DR   ExpressionAtlas; A5X5Y0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IDA:CACAO.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    456       5-hydroxytryptamine receptor 3E.
FT                                /FTId=PRO_0000312294.
FT   TOPO_DOM     26    248       Extracellular. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    270    282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    304    307       Extracellular. {ECO:0000255}.
FT   TRANSMEM    308    328       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    329    433       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    434    454       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    455    456       Extracellular. {ECO:0000255}.
FT   CARBOHYD    175    175       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    162    176       {ECO:0000250}.
FT   VAR_SEQ       1     22       MEGSWFHRKRFSFYLLLGFLLQ -> MLAFILSRATPRPAL
FT                                GPLSYREHRVALLHLTHSMSTT (in isoform 3,
FT                                isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:12801637,
FT                                ECO:0000303|PubMed:14597179,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17392525,
FT                                ECO:0000303|PubMed:19012743}.
FT                                /FTId=VSP_029803.
FT   VAR_SEQ      79     93       Missing (in isoform 2, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:14597179,
FT                                ECO:0000303|PubMed:19012743}.
FT                                /FTId=VSP_029804.
FT   VAR_SEQ     129    129       E -> ELCVSRAGQREVPSPGSHRDHSLPLGP (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:19012743}.
FT                                /FTId=VSP_045573.
FT   VARIANT      71     71       A -> T (in dbSNP:rs7627615).
FT                                {ECO:0000269|PubMed:19012743}.
FT                                /FTId=VAR_037481.
FT   VARIANT     430    430       A -> T (in dbSNP:rs13324468).
FT                                /FTId=VAR_037482.
FT   CONFLICT     44     44       A -> T (in Ref. 6; AAI01183/AAI01184).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  51438 MW;  4BFA6561BA309E83 CRC64;
     MEGSWFHRKR FSFYLLLGFL LQGRGVTFTI NCSGFGQHGA DPTALNSVFN RKPFRPVTNI
     SVPTQVNISF AMSAILDVNE QLHLLSSFLW LEMVWDNPFI SWNPEECEGI TKMSMAAKNL
     WLPDIFIIEL MDVDKTPKGL TAYVSNEGRI RYKKPMKVDS ICNLDIFYFP FDQQNCTLTF
     SSFLYTVDSM LLDMEKEVWE ITDASRNILQ THGEWELLGL SKATAKLSRG GNLYDQIVFY
     VAIRRRPSLY VINLLVPSGF LVAIDALSFY LPVKSGNRVP FKITLLLGYN VFLLMMSDLL
     PTSGTPLIGV YFALCLSLMV GSLLETIFIT HLLHVATTQP PPLPRWLHSL LLHCNSPGRC
     CPTAPQKENK GPGLTPTHLP GVKEPEVSAG QMPGPAEAEL TGGSEWTRAQ REHEAQKQHS
     VELWLQFSHA MDAMLFRLYL LFMASSIITV ICLWNT
//
ID   NMDE2_XENLA             Reviewed;        1448 AA.
AC   A7XY94;
DT   25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   22-NOV-2017, entry version 65.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2B;
DE            Short=GluN2B;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2B;
DE            Short=NMDAR2B;
DE            Short=NR2B {ECO:0000303|PubMed:18177891};
DE   Flags: Precursor;
GN   Name=grin2b;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355 {ECO:0000312|EMBL:ABU84989.1};
RN   [1] {ECO:0000312|EMBL:ABU84989.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, SUBUNIT,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Oocyte {ECO:0000303|PubMed:18177891};
RX   PubMed=18177891; DOI=10.1016/j.jmb.2007.11.105;
RA   Schmidt C., Hollmann M.;
RT   "Apparent homomeric NR1 currents observed in Xenopus oocytes are
RT   caused by an endogenous NR2 subunit.";
RL   J. Mol. Biol. 376:658-670(2008).
RN   [2] {ECO:0000312|Proteomes:UP000186698}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=J {ECO:0000312|Proteomes:UP000186698};
RX   PubMed=27762356; DOI=10.1038/nature19840;
RA   Session A.M., Uno Y., Kwon T., Chapman J.A., Toyoda A., Takahashi S.,
RA   Fukui A., Hikosaka A., Suzuki A., Kondo M., van Heeringen S.J.,
RA   Quigley I., Heinz S., Ogino H., Ochi H., Hellsten U., Lyons J.B.,
RA   Simakov O., Putnam N., Stites J., Kuroki Y., Tanaka T., Michiue T.,
RA   Watanabe M., Bogdanovic O., Lister R., Georgiou G., Paranjpe S.S.,
RA   van Kruijsbergen I., Shu S., Carlson J., Kinoshita T., Ohta Y.,
RA   Mawaribuchi S., Jenkins J., Grimwood J., Schmutz J., Mitros T.,
RA   Mozaffari S.V., Suzuki Y., Haramoto Y., Yamamoto T.S., Takagi C.,
RA   Heald R., Miller K., Haudenschild C., Kitzman J., Nakayama T.,
RA   Izutsu Y., Robert J., Fortriede J., Burns K., Lotay V., Karimi K.,
RA   Yasuoka Y., Dichmann D.S., Flajnik M.F., Houston D.W., Shendure J.,
RA   DuPasquier L., Vize P.D., Zorn A.M., Ito M., Marcotte E.M.,
RA   Wallingford J.B., Ito Y., Asashima M., Ueno N., Matsuda Y.,
RA   Veenstra G.J., Fujiyama A., Harland R.M., Taira M., Rokhsar D.S.;
RT   "Genome evolution in the allotetraploid frog Xenopus laevis.";
RL   Nature 538:336-343(2016).
RN   [3] {ECO:0000244|PDB:4TLL, ECO:0000244|PDB:4TLM}
RP   X-RAY CRYSTALLOGRAPHY (3.59 ANGSTROMS) OF 20-839 IN COMPLEX WITH GRIN1
RP   AND SYNTHETIC AGONIST, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   TOPOLOGY, DOMAIN, GLYCOSYLATION AT ASN-336 AND ASN-685, AND DISULFIDE
RP   BONDS.
RX   PubMed=25008524; DOI=10.1038/nature13548;
RA   Lee C.H., Lu W., Michel J.C., Goehring A., Du J., Song X., Gouaux E.;
RT   "NMDA receptor structures reveal subunit arrangement and pore
RT   architecture.";
RL   Nature 511:191-197(2014).
RN   [4] {ECO:0000244|PDB:5IOU, ECO:0000244|PDB:5IOV, ECO:0000244|PDB:5IPQ}
RP   STRUCTURE BY ELECTRON MICROSCOPY (7.00 ANGSTROMS) OF 1-839 IN COMPLEX
RP   WITH GRIN1 AND GLUTAMATE, AND SUBUNIT.
RX   PubMed=27062927; DOI=10.1016/j.cell.2016.03.028;
RA   Zhu S., Stein R.A., Yoshioka C., Lee C.H., Goehring A.,
RA   Mchaourab H.S., Gouaux E.;
RT   "Mechanism of NMDA Receptor Inhibition and Activation.";
RL   Cell 165:704-714(2016).
RN   [5] {ECO:0000244|PDB:5UOW, ECO:0000244|PDB:5UP2}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.50 ANGSTROMS) OF 1-840 IN COMPLEX
RP   WITH GRIN1 AND GRIN2A, SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT,
RP   FUNCTION, DOMAIN, GLYCOSYLATION AT ASN-336 AND ASN-685, AND DISULFIDE
RP   BONDS.
RX   PubMed=28232581; DOI=10.1126/science.aal3729;
RA   Lu W., Du J., Goehring A., Gouaux E.;
RT   "Cryo-EM structures of the triheteromeric NMDA receptor and its
RT   allosteric modulation.";
RL   Science 355:0-0(2017).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium.
CC       Channel activation requires binding of the neurotransmitter
CC       glutamate to the epsilon subunit, glycine binding to the zeta
CC       subunit, plus membrane depolarization to eliminate channel
CC       inhibition by Mg(2+) (PubMed:18177891, PubMed:25008524,
CC       PubMed:28232581). Sensitivity to glutamate and channel kinetics
CC       depend on the subunit composition (Probable).
CC       {ECO:0000269|PubMed:18177891, ECO:0000269|PubMed:25008524,
CC       ECO:0000269|PubMed:28232581, ECO:0000305}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
CC       of two zeta subunits (grin1), and two epsilon subunits (grin2a,
CC       grin2b, grin2c or grin2d) (in vitro) (PubMed:18177891,
CC       PubMed:25008524, PubMed:27062927, PubMed:28232581). In vivo, the
CC       subunit composition may depend on the expression levels of the
CC       different subunits (Probable). {ECO:0000269|PubMed:18177891,
CC       ECO:0000269|PubMed:25008524, ECO:0000269|PubMed:27062927,
CC       ECO:0000269|PubMed:28232581, ECO:0000305}.
CC   -!- INTERACTION:
CC       C0KD15:-; NbExp=3; IntAct=EBI-16113306, EBI-16113290;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18177891,
CC       ECO:0000269|PubMed:25008524, ECO:0000269|PubMed:28232581}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:25008524,
CC       ECO:0000269|PubMed:28232581}. Cell junction, synapse, postsynaptic
CC       cell membrane {ECO:0000255|SAAS:SAAS00582638}.
CC   -!- TISSUE SPECIFICITY: Detected in oocytes.
CC       {ECO:0000269|PubMed:18177891}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of
CC       a transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000305|PubMed:25008524, ECO:0000305|PubMed:28232581}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR2B/GRIN2B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU104357; ABU84989.1; -; mRNA.
DR   EMBL; CM004473; OCT82994.1; -; Genomic_DNA.
DR   RefSeq; NP_001104191.1; NM_001110721.1.
DR   RefSeq; XP_018114751.1; XM_018259262.1.
DR   UniGene; Xl.83851; -.
DR   PDB; 4TLL; X-ray; 3.59 A; B/D=20-839.
DR   PDB; 4TLM; X-ray; 3.77 A; B/D=20-839.
DR   PDB; 5IOU; EM; 7.00 A; B/D=1-839.
DR   PDB; 5IOV; EM; 7.50 A; B/D=1-839.
DR   PDB; 5IPQ; EM; 13.50 A; B/D=1-839.
DR   PDB; 5IPR; EM; 14.10 A; B/D=1-839.
DR   PDB; 5IPS; EM; 13.50 A; B/D=1-839.
DR   PDB; 5IPT; EM; 14.10 A; B/D=1-839.
DR   PDB; 5IPU; EM; 15.40 A; B/D=1-839.
DR   PDB; 5IPV; EM; 9.25 A; B/D=1-839.
DR   PDB; 5UOW; EM; 4.50 A; D=1-840.
DR   PDB; 5UP2; EM; 6.00 A; D=1-840.
DR   PDBsum; 4TLL; -.
DR   PDBsum; 4TLM; -.
DR   PDBsum; 5IOU; -.
DR   PDBsum; 5IOV; -.
DR   PDBsum; 5IPQ; -.
DR   PDBsum; 5IPR; -.
DR   PDBsum; 5IPS; -.
DR   PDBsum; 5IPT; -.
DR   PDBsum; 5IPU; -.
DR   PDBsum; 5IPV; -.
DR   PDBsum; 5UOW; -.
DR   PDBsum; 5UP2; -.
DR   SMR; A7XY94; -.
DR   DIP; DIP-61037N; -.
DR   IntAct; A7XY94; 1.
DR   GeneID; 100126610; -.
DR   CTD; 100126610; -.
DR   HOVERGEN; HBG052635; -.
DR   Proteomes; UP000186698; Chromosome 4s.
DR   Proteomes; UP000186698; Unassembled WGS sequence.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0032026; P:response to magnesium ion; IDA:UniProtKB.
DR   GO; GO:0010043; P:response to zinc ion; IDA:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell junction; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Magnesium; Membrane;
KW   Metal-binding; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25   1448       Glutamate receptor ionotropic, NMDA 2B.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_5010821104.
FT   TOPO_DOM     25    554       Extracellular.
FT                                {ECO:0000269|PubMed:25008524}.
FT   TRANSMEM    555    573       Helical. {ECO:0000269|PubMed:25008524}.
FT   TOPO_DOM    574    600       Cytoplasmic.
FT                                {ECO:0000269|PubMed:25008524}.
FT   INTRAMEM    601    620       Discontinuously helical.
FT                                {ECO:0000269|PubMed:25008524}.
FT   TOPO_DOM    621    627       Cytoplasmic.
FT                                {ECO:0000269|PubMed:25008524}.
FT   TRANSMEM    628    643       Helical. {ECO:0000269|PubMed:25008524}.
FT   TOPO_DOM    644    819       Extracellular.
FT                                {ECO:0000269|PubMed:25008524}.
FT   TRANSMEM    820    839       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    840   1448       Cytoplasmic.
FT                                {ECO:0000269|PubMed:25008524}.
FT   REGION      601    620       Pore-forming.
FT                                {ECO:0000305|PubMed:25008524}.
FT   REGION      687    688       Glutamate binding.
FT                                {ECO:0000250|UniProtKB:Q00959}.
FT   BINDING     511    511       Glutamate. {ECO:0000305|PubMed:25008524}.
FT   BINDING     516    516       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   BINDING     729    729       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4TLL,
FT                                ECO:0000244|PDB:5UOW,
FT                                ECO:0000244|PDB:5UP2,
FT                                ECO:0000269|PubMed:25008524,
FT                                ECO:0000269|PubMed:28232581}.
FT   CARBOHYD    685    685       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4TLM,
FT                                ECO:0000244|PDB:5UOW,
FT                                ECO:0000244|PDB:5UP2,
FT                                ECO:0000269|PubMed:25008524,
FT                                ECO:0000269|PubMed:28232581}.
FT   DISULFID     81    316       {ECO:0000244|PDB:4TLL,
FT                                ECO:0000244|PDB:4TLM,
FT                                ECO:0000244|PDB:5UOW,
FT                                ECO:0000269|PubMed:25008524,
FT                                ECO:0000269|PubMed:28232581}.
FT   DISULFID    426    453       {ECO:0000244|PDB:4TLL,
FT                                ECO:0000244|PDB:4TLM,
FT                                ECO:0000244|PDB:5UOW,
FT                                ECO:0000269|PubMed:25008524,
FT                                ECO:0000269|PubMed:28232581}.
FT   DISULFID    433    454       {ECO:0000244|PDB:4TLL,
FT                                ECO:0000244|PDB:4TLM,
FT                                ECO:0000244|PDB:5UOW,
FT                                ECO:0000269|PubMed:25008524,
FT                                ECO:0000269|PubMed:28232581}.
FT   DISULFID    743    798       {ECO:0000244|PDB:4TLL,
FT                                ECO:0000244|PDB:4TLM,
FT                                ECO:0000244|PDB:5UOW,
FT                                ECO:0000269|PubMed:25008524,
FT                                ECO:0000269|PubMed:28232581}.
SQ   SEQUENCE   1448 AA;  163913 MW;  EBF9301FEE749D5D CRC64;
     MRPTEACCYL KISLIILFYM GCYAQKHPNM DIAVILVGTT EEVAIKDVHE KDDFHHLPVT
     PRVALVTMNE SDPKSIITRI CDLMSDKKVQ GVVFGDDTDQ EAIAQILDFI SVQTLTPILG
     IHGGSSMIMA DKEEASMFFQ FGPSIEQQAS VMLNIMEEYD WYIFSIVTTY FPGYQDFENK
     VRSTIENSFV GWELEEVIHL DMSLDDIDSK IQNQLKKLQS PVILLYCTKE EATYIFEVAH
     SVGLTGYGFT WIVPSLVAGD TDTVPDEFPT GLISVSYDEW DYDLPARVRD GIAIITTAAS
     TMLSEHNSIP QSKSSCNNIQ ESRVYEAHML KRYLINVTFE GRNLSFSEDG YQMHPKLVII
     LLNQERKWER VGKYKDRSLK MKYYVWPVFD LYPNSEEHKD EHLSIVTLEE APFVIVEDVD
     PLSGTCMRNT VPCRKQIRPE NRTEEGGNYI KRCCKGFCID ILKKIAKTVK FTYDLYLVTN
     GKHGKKINGT WNGMIGEVVT KRAYMAVGSL TINEERSEVV DFSVPFIETG ISVMVSRSNG
     TVSPSAFLEP FSADVWVMMF VMLLIVSAVA VFVFEYFSPV GYNRCLADGR EPGGPSFTIG
     KAIWLLWGLV FNNSVPVQNP KGTTSKIMVS VWAFFAVIFL ASYTANLAAF MIQEEYVDQV
     SGLSDKKFQR PNDFSPAFRF GTVPNGSTER NIRNNYLEMH SYMVKFNQRS VQDALLSLKS
     GKLDAFIYDA AVLNYMAGRD EGCKLVTIGS GKVFATTGYG IAIQKDSGWK RQVDLAILQL
     FGDGEMEELE ALWLTGICHN EKNEVMSSQL DIDNMAGVFY MLAAAMALSL ITFIMEHLFF
     WQLRHCFMGV CSGKPGMVFS ISRGIYSCIH GVAIEDRQSA LDSPSATMNN THSNILRLLR
     TAKNMANLSG VNGSPQSALD FIRRESSVYD ISEHRRSFTH SDCKSFQPEE NLFSDYISEV
     ERTFGNLQLK DSNVYQDHFH HHRPHSIGSN SSIDGLYDCD NAPFTTQPRS LSKKPLDIGL
     PSKHPSPQIG DLYGKFSFKS DHYGAPDDLI RSDVSDISTH TVTYGNIEGN AKRRKQYKDS
     LKKRPASAKS RREFDEIELA YRRRQRSPDH KRYFRDKEGL RDFYLDQFRT KENNPHWEHV
     DLTHIYAERA DDFKHDTSCS NRQHQKHVGE FVQTDRKHGS GGNAWEKNMS NIEWEDRASS
     NFCRNCPSKM HNYTGQNTNR PACIRCEVCK KAGNLYDISE DNSLQDLEAR PIQAPNSKYP
     QSPNGKAQKR NRSKLHRQHS YDTFVDLQKE DVTLAPRSVS LKDKERFLDG SPYAHMFEMP
     NETSFTSKSH GPTHNPGGYM LSRSLYPDRV TQNPFIPTFG DDQCLLHGSK PYYFRQPAIG
     GLKGRADFRG AGKSLSAQHS GPSGHFQKDI CIGNQPNACV SNNKNPRSFN NSTNGHVYEK
     LSSIESDV
//
ID   IR25A_DROME             Reviewed;         947 AA.
AC   E9NA96;
DT   06-JUL-2016, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   25-OCT-2017, entry version 55.
DE   RecName: Full=Ionotropic receptor 25a {ECO:0000312|EMBL:ADU79032.1};
DE   Flags: Precursor;
GN   Name=Ir25a {ECO:0000312|FlyBase:FBgn0031634};
GN   ORFNames=CG15627 {ECO:0000312|FlyBase:FBgn0031634};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|EMBL:ADU79032.1};
RN   [1] {ECO:0000312|EMBL:ADU79032.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=21220098; DOI=10.1016/j.neuron.2010.11.042;
RA   Abuin L., Bargeton B., Ulbrich M.H., Isacoff E.Y., Kellenberger S.,
RA   Benton R.;
RT   "Functional architecture of olfactory ionotropic glutamate
RT   receptors.";
RL   Neuron 69:44-60(2011).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4] {ECO:0000305}
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19135896; DOI=10.1016/j.cell.2008.12.001;
RA   Benton R., Vannice K.S., Gomez-Diaz C., Vosshall L.B.;
RT   "Variant ionotropic glutamate receptors as chemosensory receptors in
RT   Drosophila.";
RL   Cell 136:149-162(2009).
RN   [5] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH NOCTE, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DISRUPTION PHENOTYPE, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=26580016; DOI=10.1038/nature16148;
RA   Chen C., Buhl E., Xu M., Croset V., Rees J.S., Lilley K.S., Benton R.,
RA   Hodge J.J., Stanewsky R.;
RT   "Drosophila ionotropic receptor 25a mediates circadian clock resetting
RT   by temperature.";
RL   Nature 527:516-520(2015).
RN   [6] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=27126188; DOI=10.7554/eLife.13254;
RA   Ni L., Klein M., Svec K.V., Budelli G., Chang E.C., Ferrer A.J.,
RA   Benton R., Samuel A.D., Garrity P.A.;
RT   "The ionotropic receptors IR21a and IR25a mediate cool sensing in
RT   Drosophila.";
RL   Elife 5:0-0(2016).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27161501; DOI=10.1016/j.cub.2016.03.049;
RA   Enjin A., Zaharieva E.E., Frank D.D., Mansourian S., Suh G.S.,
RA   Gallio M., Stensmyr M.C.;
RT   "Humidity Sensing in Drosophila.";
RL   Curr. Biol. 26:1352-1358(2016).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=27656904; DOI=10.7554/eLife.17879;
RA   Knecht Z.A., Silbering A.F., Ni L., Klein M., Budelli G., Bell R.,
RA   Abuin L., Ferrer A.J., Samuel A.D., Benton R., Garrity P.A.;
RT   "Distinct combinations of variant ionotropic glutamate receptors
RT   mediate thermosensation and hygrosensation in Drosophila.";
RL   Elife 5:0-0(2016).
CC   -!- FUNCTION: Integral part of various neural sensory systems in the
CC       antenna that provide the neural basis for the response to
CC       environmental changes in temperature (thermosensation), humidity
CC       (hygrosensation) and odor detection (PubMed:21220098,
CC       PubMed:27161501, PubMed:27656904). Required for odor-evoked
CC       electrophysiological responses in multiple neuron classes in the
CC       antenna and is likely to function as part of an olfactory receptor
CC       complex with Ir76a and Ir76b (PubMed:21220098). Together with
CC       Ir21a and Ir93a, mediates the response of the larval dorsal organ
CC       cool cells, a trio of cool-responsive neurons, to cooling and is
CC       required for cool avoidance behavior (PubMed:27126188,
CC       PubMed:27161501, PubMed:27656904). Required in chordonotal organ
CC       neurons for behavioral synchronization to low-amplitude
CC       temperature cycles and mediates circadian clock resetting by
CC       temperature (PubMed:26580016). Together with Ir40a and Ir93a,
CC       mediates the response of the hydrosensory sacculus neurons to
CC       changes in relative humidity, and is required for dry detection
CC       and humidiy preference behavior (PubMed:27161501,
CC       PubMed:27656904). {ECO:0000269|PubMed:21220098,
CC       ECO:0000269|PubMed:26580016, ECO:0000269|PubMed:27126188,
CC       ECO:0000269|PubMed:27161501, ECO:0000269|PubMed:27656904}.
CC   -!- SUBUNIT: Interacts with nocte. {ECO:0000269|PubMed:26580016}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000269|PubMed:19135896}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:19135896, ECO:0000269|PubMed:26580016,
CC       ECO:0000269|PubMed:27126188}. Perikaryon
CC       {ECO:0000269|PubMed:19135896, ECO:0000269|PubMed:26580016}. Cell
CC       projection, cilium {ECO:0000269|PubMed:19135896}. Note=Low levels
CC       detected in the axon segment adjacent to the perikaryon in some
CC       sensory neurons of the antenna but not detected along axons as
CC       they enter the brain or at synapses within antennal lobe
CC       glomeruli. In coeloconic neurons, prominently expressed both in
CC       the perikaryon and in the distal tip of the dendrite which
CC       corresponds to the ciliated outer dendritic segment innervating
CC       the sensory hair. Relatively low levels detected in inner
CC       dendrites (PubMed:19135896). Detected in dendritic bulbs of the
CC       dorsal organ cool cells (PubMed:27126188).
CC       {ECO:0000269|PubMed:19135896, ECO:0000269|PubMed:27126188}.
CC   -!- TISSUE SPECIFICITY: In the antenna, detected in neurons of the
CC       arista and also detected in sacculus neurons which innervate the
CC       first and second chambers (at protein level) (PubMed:21220098,
CC       PubMed:19135896, PubMed:27656904). Throughout the main body of the
CC       antenna, expressed in neurons which innervate the coeloconic class
CC       of olfactory sensilla (at protein level) (PubMed:21220098,
CC       PubMed:19135896). Expressed in multiple cells of the dorsal organ
CC       including the dorsal organ cool cells (at protein level)
CC       (PubMed:27126188, PubMed:27656904). Detected in femur and retina
CC       (PubMed:26580016). Expressed in a subset of femur chordonotal
CC       neurons and antennal Johnston's Organ neurons (PubMed:26580016).
CC       {ECO:0000269|PubMed:19135896, ECO:0000269|PubMed:21220098,
CC       ECO:0000269|PubMed:26580016, ECO:0000269|PubMed:27126188,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype (PubMed:21220098).
CC       Viable and fertile but their response to environmental cues such
CC       as temperature, humidity and odorants is impaired
CC       (PubMed:21220098, PubMed:26580016, PubMed:27126188,
CC       PubMed:27161501, PubMed:27656904). Response of ac4 coeloconic
CC       sensilla neurons to agonist phenylethylamine and of ac2 sensilla
CC       neurons to agonist 1,4-diaminobutane is abolished
CC       (PubMed:21220098). Response of dorsal organ cool cells to changes
CC       in temperature is abolished and consequently larvae fail to avoid
CC       cool temperatures (PubMed:27126188, PubMed:27161501,
CC       PubMed:27656904). Response of sacculus neurons to changes in
CC       humidity is also abolished and consequently larvae fail to move
CC       towards their preferred humidity (PubMed:27161501,
CC       PubMed:27656904). Failure to synchronize in constant light or
CC       constant dark to shallow temperature cycles with an amplitude of 2
CC       degrees Celsius (PubMed:26580016). In constant light, mutants
CC       display constant activity throughout the temperature cycle in
CC       contrast to controls which show a clear activity peak in the
CC       second part of the warm period before and after a 6 hour shift of
CC       the temperature cycle (PubMed:26580016). In constant dark, mutants
CC       do not shift their evening peak during the temperature cycle in
CC       contrast to controls which advance or delay their evening activity
CC       peak during phase-advanced or phase-delayed temperature cycles
CC       (PubMed:26580016). Barely detectable levels of circadian rhythm
CC       protein tim in dorsal neurons DN1 and DN2 (PubMed:26580016). RNAi-
CC       mediated knockdown in chordonotal neurons disrupts synchronization
CC       of locomotor activity rhythms with temperature cycles
CC       (PubMed:26580016). {ECO:0000269|PubMed:21220098,
CC       ECO:0000269|PubMed:26580016, ECO:0000269|PubMed:27126188,
CC       ECO:0000269|PubMed:27161501, ECO:0000269|PubMed:27656904}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000255|SAAS:SAAS00586618}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ600588; ADU79032.1; -; mRNA.
DR   EMBL; AE014134; AGB92585.1; -; Genomic_DNA.
DR   RefSeq; NP_001260049.1; NM_001273120.1.
DR   UniGene; Dm.23844; -.
DR   ProteinModelPortal; E9NA96; -.
DR   STRING; 7227.FBpp0304756; -.
DR   TCDB; 1.A.10.1.14; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   PaxDb; E9NA96; -.
DR   EnsemblMetazoa; FBtr0332480; FBpp0304756; FBgn0031634.
DR   GeneID; 33683; -.
DR   KEGG; dme:Dmel_CG15627; -.
DR   CTD; 33683; -.
DR   FlyBase; FBgn0031634; Ir25a.
DR   eggNOG; ENOG410ISR5; Eukaryota.
DR   eggNOG; ENOG410ZMC3; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   KO; K05313; -.
DR   OMA; TKMWQAM; -.
DR   OrthoDB; EOG091G01NW; -.
DR   GenomeRNAi; 33683; -.
DR   PRO; PR:E9NA96; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0031634; -.
DR   ExpressionAtlas; E9NA96; differential.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; IDA:FlyBase.
DR   GO; GO:0016021; C:integral component of membrane; ISM:FlyBase.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0071683; C:sensory dendrite; IDA:FlyBase.
DR   GO; GO:0015026; F:coreceptor activity; IMP:FlyBase.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; ISM:FlyBase.
DR   GO; GO:0007610; P:behavior; IEA:UniProtKB-KW.
DR   GO; GO:0050907; P:detection of chemical stimulus involved in sensory perception; IEP:FlyBase.
DR   GO; GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; IMP:FlyBase.
DR   GO; GO:0009649; P:entrainment of circadian clock; IMP:FlyBase.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0010378; P:temperature compensation of the circadian clock; IMP:FlyBase.
DR   GO; GO:0019226; P:transmission of nerve impulse; IMP:FlyBase.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Behavior; Biological rhythms; Cell membrane; Cell projection;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Olfaction; Receptor;
KW   Reference proteome; Sensory transduction; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31    947       Ionotropic receptor 25a.
FT                                /FTId=PRO_5007189792.
FT   TOPO_DOM     31    562       Extracellular. {ECO:0000305}.
FT   TRANSMEM    563    583       Helical. {ECO:0000255}.
FT   TOPO_DOM    584    641       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    642    662       Helical. {ECO:0000255}.
FT   TOPO_DOM    663    858       Extracellular. {ECO:0000305}.
FT   TRANSMEM    859    879       Helical. {ECO:0000255}.
FT   TOPO_DOM    880    947       Cytoplasmic. {ECO:0000305}.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    277    277       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    687    687       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    715    715       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    762    762       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
SQ   SEQUENCE   947 AA;  108122 MW;  E8834A2127F6FE77 CRC64;
     MILMNPKTSK ILWLLGFLSL LSSFSLEIAA QTTQNINVLF INEVDNEPAA KAVEVVLTYL
     KKNIRYGLSV QLDSIEANKS DAKVLLEAIC NKYATSIEKK QTPHLILDTT KSGIASETVK
     SFTQALGLPT ISASYGQQGD LRQWRDLDEA KQKYLLQVMP PADIIPEAIR SIVIHMNITN
     AAILYDDSFV MDHKYKSLLQ NIQTRHVITA IAKDGKRERE EQIEKLRNLD INNFFILGTL
     QSIRMVLESV KPAYFERNFA WHAITQNEGE ISSQRDNATI MFMKPMAYTQ YRDRLGLLRT
     TYNLNEEPQL SSAFYFDLAL RSFLTIKEML QSGAWPKDME YLNCDDFQGG NTPQRNLDLR
     DYFTKITEPT SYGTFDLVTQ STQPFNGHSF MKFEMDINVL QIRGGSSVNS KSIGKWISGL
     NSELIVKDEE QMKNLTADTV YRIFTVVQAP FIMRDETAPK GYKGYCIDLI NEIAAIVHFD
     YTIQEVEDGK FGNMDENGQW NGIVKKLMDK QADIGLGSMS VMAEREIVID FTVPYYDLVG
     ITIMMQRPSS PSSLFKFLTV LETNVWLCIL AAYFFTSFLM WIFDRWSPYS YQNNREKYKD
     DEEKREFNLK ECLWFCMTSL TPQGGGEAPK NLSGRLVAAT WWLFGFIIIA SYTANLAAFL
     TVSRLDTPVE SLDDLAKQYK ILYAPLNGSS AMTYFERMSN IEQMFYEIWK DLSLNDSLTA
     VERSKLAVWD YPVSDKYTKM WQAMQEAKLP ATLDEAVARV RNSTAATGFA FLGDATDIRY
     LQLTNCDLQV VGEEFSRKPY AIAVQQGSHL KDQFNNAILT LLNKRQLEKL KEKWWKNDEA
     LAKCDKPEDQ SDGISIQNIG GVFIVIFVGI GMACITLVFE YWWYRYRKNP RIIDVAEANA
     ERSNAADHPG KLVDGVILGH SGEKFEKSKA ALRPRFNQYP ATFKPRF
//
ID   ACC3_CAEEL              Reviewed;         517 AA.
AC   G5EDN0;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   20-DEC-2017, entry version 64.
DE   RecName: Full=Acetylcholine-gated chloride channel subunit acc-3 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-3 {ECO:0000312|WormBase:F55D10.5};
GN   ORFNames=F55D10.5 {ECO:0000312|WormBase:F55D10.5};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Probable acetylcholine-gated chloride channel regulatory
CC       subunit. Does not have ion channel activity alone as a
CC       homopentamer, but forms a functional heteropentameric ion channel
CC       with acc-1. {ECO:0000269|PubMed:15579462}.
CC   -!- SUBUNIT: Does not form a functional homopentameric ion channel.
CC       Forms a functional heteropentameric ion channel composed of acc-1
CC       and acc-3. May interact with acc-2; the interaction does not
CC       result in significant heteropentameric ion channel activity.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:15579462};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY849796; AAW34234.1; -; mRNA.
DR   EMBL; BX284606; CCD67091.1; -; Genomic_DNA.
DR   PIR; T16458; T16458.
DR   RefSeq; NP_508810.2; NM_076409.4.
DR   UniGene; Cel.25513; -.
DR   STRING; 6239.F55D10.5; -.
DR   EnsemblMetazoa; F55D10.5; F55D10.5; WBGene00018880.
DR   GeneID; 186307; -.
DR   KEGG; cel:CELE_F55D10.5; -.
DR   CTD; 186307; -.
DR   WormBase; F55D10.5; CE38372; WBGene00018880; acc-3.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   OMA; IFQAYIP; -.
DR   OrthoDB; EOG091G07NS; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00018880; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    517       Acetylcholine-gated chloride channel
FT                                subunit acc-3. {ECO:0000305}.
FT                                /FTId=PRO_5008958394.
FT   TOPO_DOM     20    277       Extracellular. {ECO:0000305}.
FT   TRANSMEM    278    298       Helical. {ECO:0000255}.
FT   TOPO_DOM    299    304       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    305    324       Helical. {ECO:0000255}.
FT   TOPO_DOM    325    338       Extracellular. {ECO:0000305}.
FT   TRANSMEM    339    359       Helical. {ECO:0000255}.
FT   TOPO_DOM    360    494       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    495    515       Helical. {ECO:0000255}.
FT   TOPO_DOM    516    517       Extracellular. {ECO:0000305}.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    246    246       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    191    205       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   517 AA;  59497 MW;  689E41C60A78C2F2 CRC64;
     MIRTRHVFLF AVLLAFASSQ TPTPEAKSSE QSLEENKFFP LPPTTPFPTN AVAATDEDGE
     ELCTSDKTII EKLLNNYKSF RTPSESGVIV WIEVWVQEVN SVNEITSDFD MDIYVTELWM
     DSALRYEHLN PCKYNLSLNS EILDQIWKPN TVFINSKSAN IHKSPFKNVF LMIYPNGTVW
     VNYRVQVKGP CSMDFSAFPM DQQSCHLTLE SFSYNNQEVD MQWMNWTTPL SLLKKEIVLP
     DFVMSNYSTS LKHEIYPAGV WNELTMTFVF SRRYGWYIFQ AYIPTYLTIF ISWISFCLGP
     KMIPARTMLG VNSLLALTFQ FGNIMRNLPR VSYVKALDVW MLVCLTFVFC SLLELAIIGS
     MGARSENRQA QQQKQQDEEA TKHQKGRENS TCSHLMSPSS CPNSPRICRN HIPNDVPQSF
     KSYGSTDPRM RKRLIIASSS TISHAPNANR SEKVLLLDGL EETQFSQVET KFSSMASIKM
     KKHWTTEEID RLSMIMFPGL FTLFNIIYWT YYLTVNT
//
ID   ACH23_CAEEL             Reviewed;         545 AA.
AC   G5EG88;
DT   19-MAR-2014, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   22-NOV-2017, entry version 54.
DE   RecName: Full=Betaine receptor acr-23 {ECO:0000303|PubMed:24212673};
DE   AltName: Full=Acetylcholine receptor subunit alpha-type acr-23;
DE   Flags: Precursor;
GN   Name=acr-23 {ECO:0000312|EMBL:CCD72123.1,
GN   ECO:0000312|WormBase:F59B1.9a}; ORFNames=5E130, F59B1.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000312|EMBL:CCD72123.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CCD72123.1};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000312|EMBL:AAR89634.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kohara Y., Shin-i T., Suzuki Y., Sugano S., Thierry-Mieg D.,
RA   Thierry-Mieg J.;
RT   "The Caenorhabditis elegans transcriptome project, a complementary
RT   view of the genome.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305}
RP   IDENTIFICATION.
RX   PubMed=11967372; DOI=10.1110/ps.3040102;
RA   Mongan N.P., Jones A.K., Smith G.R., Sansom M.S., Sattelle D.B.;
RT   "Novel alpha7-like nicotinic acetylcholine receptor subunits in the
RT   nematode Caenorhabditis elegans.";
RL   Protein Sci. 11:1162-1171(2002).
RN   [4] {ECO:0000305}
RP   SUBCELLULAR LOCATION, FUNCTION, TISSUE SPECIFICITY, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF ILE-301 AND PRO-311.
RC   STRAIN=Bristol N2 {ECO:0000269|PubMed:24212673};
RX   PubMed=24212673; DOI=10.1038/nn.3575;
RA   Peden A.S., Mac P., Fei Y.J., Castro C., Jiang G., Murfitt K.J.,
RA   Miska E.A., Griffin J.L., Ganapathy V., Jorgensen E.M.;
RT   "Betaine acts on a ligand-gated ion channel in the nervous system of
RT   the nematode C. elegans.";
RL   Nat. Neurosci. 16:1794-1801(2013).
RN   [5] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF ASP-112 AND ALA-321.
RC   STRAIN=Bristol N2 {ECO:0000269|PubMed:23950710};
RX   PubMed=23950710; DOI=10.1371/journal.ppat.1003524;
RA   Rufener L., Bedoni N., Baur R., Rey S., Glauser D.A., Bouvier J.,
RA   Beech R., Sigel E., Puoti A.;
RT   "acr-23 encodes a monepantel-sensitive channel in Caenorhabditis
RT   elegans.";
RL   PLoS Pathog. 9:E1003524-E1003524(2013).
CC   -!- FUNCTION: Betaine receptor that functions as a ligand-gated non-
CC       selective monovalent cation channel in mechanosensory neurons to
CC       maintain basal levels of locomotion. The channel is permeable to
CC       Na(+) and K(+) but not to Ba(2+) or Ca(2+) ions. Elicits current
CC       in response to betaine, very weak current in response to choline,
CC       virtually no current in response to acetylcholine and nicotine,
CC       and no current in response to glycine and GABA.
CC       {ECO:0000269|PubMed:23950710, ECO:0000269|PubMed:24212673}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23950710,
CC       ECO:0000269|PubMed:24212673}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24212673, ECO:0000305|PubMed:23950710}.
CC   -!- TISSUE SPECIFICITY: Expressed in the body wall muscles that are
CC       arranged into four longitudinal bundles, some mechanosensory
CC       neurons, the head muscles and multiple interneurons. Not expressed
CC       in motor neurons (at protein level). {ECO:0000269|PubMed:23950710,
CC       ECO:0000269|PubMed:24212673}.
CC   -!- DEVELOPMENTAL STAGE: Not expressed in embryos and L1 stage but
CC       expressed from L2 stage to adulthood in the body wall muscles (at
CC       protein level). {ECO:0000269|PubMed:23950710}.
CC   -!- DISRUPTION PHENOTYPE: Mutant worms are morphologically similar to
CC       the wild-type but exhibit mild swimming defects and are lethargic
CC       with their movement being interrupted by frequent pauses when
CC       crawling on a food-free environment (PubMed:24212673). On the same
CC       environment, in other occasions they display decreased rates of
CC       spontaneous reversal and steering, and slightly increased average
CC       speed (PubMed:23950710). Homozygotes are fully resistant to
CC       monepantel but heterozygotes are partially affected by the drug
CC       with reduced fertility and slightly impaired movement.
CC       {ECO:0000269|PubMed:23950710, ECO:0000269|PubMed:24212673}.
CC   -!- MISCELLANEOUS: Suppresses snf-3 mutant phenotype growth defects.
CC       Elicits no current in response to the broad-spectrum antiparasitic
CC       medicine ivermectin. This channel is allosterically sensitive to
CC       monepantel, an anthelmintic of the amino-acetonitrile derivatives
CC       (AADs) class, leading to muscle paralysis upon treatment with
CC       monepantel. {ECO:0000269|PubMed:23950710,
CC       ECO:0000269|PubMed:24212673}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO081512; CCD72123.1; -; Genomic_DNA.
DR   EMBL; AY519853; AAR89634.1; -; mRNA.
DR   PIR; A89008; A89008.
DR   RefSeq; NP_504024.2; NM_071623.4.
DR   UniGene; Cel.9478; -.
DR   ProteinModelPortal; G5EG88; -.
DR   STRING; 6239.F59B1.9; -.
DR   PaxDb; G5EG88; -.
DR   PeptideAtlas; G5EG88; -.
DR   EnsemblMetazoa; F59B1.9; F59B1.9; WBGene00000062.
DR   GeneID; 191606; -.
DR   CTD; 191606; -.
DR   WormBase; F59B1.9a; CE36939; WBGene00000062; acr-23.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG4110I2V; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   InParanoid; G5EG88; -.
DR   OMA; IIQVNEP; -.
DR   OrthoDB; EOG091G05EA; -.
DR   PhylomeDB; G5EG88; -.
DR   Reactome; R-CEL-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:G5EG88; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00000062; -.
DR   ExpressionAtlas; G5EG88; baseline.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    545       Betaine receptor acr-23. {ECO:0000255}.
FT                                /FTId=PRO_0000425863.
FT   TOPO_DOM     20    244       Extracellular. {ECO:0000255}.
FT   TRANSMEM    245    265       Helical. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical. {ECO:0000255}.
FT   TRANSMEM    317    337       Helical. {ECO:0000255}.
FT   TOPO_DOM    338    512       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    513    533       Helical. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    228    228       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    276    276       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    157    171       {ECO:0000250|UniProtKB:P02708}.
FT   DISULFID    224    225       Associated with receptor activation.
FT                                {ECO:0000250|UniProtKB:P02708}.
FT   MUTAGEN     112    112       D->N: In cb101; highly resistant to
FT                                monepantel.
FT                                {ECO:0000269|PubMed:23950710}.
FT   MUTAGEN     301    301       I->N: Increases sensitivity to betaine.
FT                                Leads to death during larval development
FT                                in most cases, with escapees reaching to
FT                                adulthood but being hypercontracted and
FT                                uncoordinated.
FT                                {ECO:0000269|PubMed:24212673}.
FT   MUTAGEN     311    311       P->L: In ox429; mild swimming defects and
FT                                lethargic movement when crawling on a
FT                                food-free environment.
FT                                {ECO:0000269|PubMed:24212673}.
FT   MUTAGEN     321    321       A->T: In cb103; highly resistant to
FT                                monepantel.
FT                                {ECO:0000269|PubMed:23950710}.
SQ   SEQUENCE   545 AA;  62549 MW;  E23060B59A170221 CRC64;
     MHRIYTFLIF ISQLALGLSN NPDIPIQYEL ANNIMENYQK GLIPKVRKGS PINVTLSLQL
     YQIIQVNEPQ QYLLLNAWAV ERWVDQMLGW DPSEFDNETE IMARHDDIWL PDTTLYNSLE
     MDDSASKKLT HVKLTTLGKN QGAMVELLYP TIYKISCLLN LKYFPFDTQT CRMTFGSWSF
     DNSLIDYFPR TFTNGPIGLA NFLENDAWSV LGTKVNREEK KYTCCPVNYT LLHYDVVIQR
     KPLYYVLNLI APTAVITFIS IIGFFTSVNP FTNFCNVSSS VHDLRQEKIT LGITTLLSMS
     IMIFMVSDKM PSTSTCVPLI ALFYTLMITI ISVGTLAASS VIFVQKLGSI GNPPASKTMK
     WTHRIAPFVL IQMPLVMKQA YAKRAKEEKH RKRMSRKNSM WTKVYHLARD HSKLMETVPD
     GAVKFNQISD FKNNDIGNME SPRMAESQTS ETFAAPMDTS FTESLHIPEL NRVASSNSIQ
     SVLKPTEIQL TPYCTRNIVE LEWDWVAAVL ERVFLIFFTI CFLFSAIGIN LYGWYIWYTE
     NHFLF
//
ID   CN15B_MEDTR             Reviewed;         620 AA.
AC   G7JND3; A0A0C3WX45;
DT   07-SEP-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2014, sequence version 2.
DT   25-OCT-2017, entry version 36.
DE   RecName: Full=Protein CNGC15b {ECO:0000303|PubMed:27230377};
DE   AltName: Full=Cyclic nucleotide-gated ion channel protein 15 b {ECO:0000303|PubMed:27230377};
GN   Name=CNGC15B {ECO:0000303|PubMed:27230377};
GN   OrderedLocusNames=MTR_4g058730 {ECO:0000312|EnsemblPlants:AES88563};
OS   Medicago truncatula (Barrel medic) (Medicago tribuloides).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; fabids; Fabales; Fabaceae; Papilionoideae;
OC   Trifolieae; Medicago.
OX   NCBI_TaxID=3880 {ECO:0000312|Proteomes:UP000002051};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Jemalong A17;
RX   PubMed=22089132; DOI=10.1038/nature10625;
RA   Young N.D., Debelle F., Oldroyd G.E.D., Geurts R., Cannon S.B.,
RA   Udvardi M.K., Benedito V.A., Mayer K.F.X., Gouzy J., Schoof H.,
RA   Van de Peer Y., Proost S., Cook D.R., Meyers B.C., Spannagl M.,
RA   Cheung F., De Mita S., Krishnakumar V., Gundlach H., Zhou S.,
RA   Mudge J., Bharti A.K., Murray J.D., Naoumkina M.A., Rosen B.,
RA   Silverstein K.A.T., Tang H., Rombauts S., Zhao P.X., Zhou P.,
RA   Barbe V., Bardou P., Bechner M., Bellec A., Berger A., Berges H.,
RA   Bidwell S., Bisseling T., Choisne N., Couloux A., Denny R.,
RA   Deshpande S., Dai X., Doyle J.J., Dudez A.-M., Farmer A.D.,
RA   Fouteau S., Franken C., Gibelin C., Gish J., Goldstein S.,
RA   Gonzalez A.J., Green P.J., Hallab A., Hartog M., Hua A.,
RA   Humphray S.J., Jeong D.-H., Jing Y., Jocker A., Kenton S.M.,
RA   Kim D.-J., Klee K., Lai H., Lang C., Lin S., Macmil S.L.,
RA   Magdelenat G., Matthews L., McCorrison J., Monaghan E.L., Mun J.-H.,
RA   Najar F.Z., Nicholson C., Noirot C., O'Bleness M., Paule C.R.,
RA   Poulain J., Prion F., Qin B., Qu C., Retzel E.F., Riddle C.,
RA   Sallet E., Samain S., Samson N., Sanders I., Saurat O., Scarpelli C.,
RA   Schiex T., Segurens B., Severin A.J., Sherrier D.J., Shi R., Sims S.,
RA   Singer S.R., Sinharoy S., Sterck L., Viollet A., Wang B.-B., Wang K.,
RA   Wang M., Wang X., Warfsmann J., Weissenbach J., White D.D.,
RA   White J.D., Wiley G.B., Wincker P., Xing Y., Yang L., Yao Z., Ying F.,
RA   Zhai J., Zhou L., Zuber A., Denarie J., Dixon R.A., May G.D.,
RA   Schwartz D.C., Rogers J., Quetier F., Town C.D., Roe B.A.;
RT   "The Medicago genome provides insight into the evolution of rhizobial
RT   symbioses.";
RL   Nature 480:520-524(2011).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Jemalong A17;
RX   PubMed=24767513; DOI=10.1186/1471-2164-15-312;
RA   Tang H., Krishnakumar V., Bidwell S., Rosen B., Chan A., Zhou S.,
RA   Gentzbittel L., Childs K.L., Yandell M., Gundlach H., Mayer K.F.,
RA   Schwartz D.C., Town C.D.;
RT   "An improved genome release (version Mt4.0) for the model legume
RT   Medicago truncatula.";
RL   BMC Genomics 15:312-312(2014).
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   DMI1, GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=27230377; DOI=10.1126/science.aae0109;
RA   Charpentier M., Sun J., Martins T.V., Radhakrishnan G.V., Findlay K.,
RA   Soumpourou E., Thouin J., Very A.A., Sanders D., Morris R.J.,
RA   Oldroyd G.E.;
RT   "Nuclear-localized cyclic nucleotide-gated channels mediate symbiotic
RT   calcium oscillations.";
RL   Science 352:1102-1105(2016).
CC   -!- FUNCTION: Cyclic nucleotide-gated channel involved in the
CC       establishment of both rhizobial and mycorrhizal associations
CC       (PubMed:27230377). Required for full activation of nuclear-
CC       localized Ca(2+) oscillations by Nod and Myc factors
CC       (PubMed:27230377). Simultaneous activation of the K(+)-permeable
CC       channel DMI1 and the Ca(2+) channel CNGC15 can give rise to
CC       sustained Ca(2+) oscillations (PubMed:27230377). May function
CC       during fertilization in both female and male gametophytic Ca(2+)
CC       signaling (PubMed:27230377). {ECO:0000269|PubMed:27230377}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with DMI1 (via c-terminus).
CC       The Nod factor has no effect on this interaction, implying that
CC       the complex is maintained after activation.
CC       {ECO:0000269|PubMed:27230377}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane
CC       {ECO:0000269|PubMed:27230377}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in roots, stems, leaves, flowers and
CC       pods. {ECO:0000269|PubMed:27230377}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CM001220; AES88563.2; -; Genomic_DNA.
DR   RefSeq; XP_003606366.2; XM_003606318.2.
DR   EnsemblPlants; AES88563; AES88563; MTR_4g058730.
DR   GeneID; 11412066; -.
DR   Gramene; AES88563; AES88563; MTR_4g058730.
DR   KEGG; mtr:MTR_4g058730; -.
DR   KO; K05391; -.
DR   OrthoDB; EOG093603GN; -.
DR   Proteomes; UP000002051; Chromosome 4.
DR   Proteomes; UP000002051; Unassembled WGS sequence.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   GO; GO:0036377; P:arbuscular mycorrhizal association; IMP:UniProtKB.
DR   GO; GO:0009877; P:nodulation; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleus; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    620       Protein CNGC15b.
FT                                /FTId=PRO_0000437093.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TRANSMEM    198    218       Helical. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical. {ECO:0000255}.
FT   TRANSMEM    356    376       Helical. {ECO:0000255}.
FT   NP_BIND     462    559       cNMP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00060}.
FT   COMPBIAS     55     58       Poly-Arg. {ECO:0000255}.
FT   COMPBIAS    199    202       Poly-Ile. {ECO:0000255}.
SQ   SEQUENCE   620 AA;  71425 MW;  DAA300299FBBF9B4 CRC64;
     MVTPKFMSDL FEGDHLELAK LTSPNGDNGI KFNEKHVAPR VLSRVFSEDY KRVKRRRRIF
     DPRGQTIHQW NKIFLVACLI SLFVDPLFFY LPIVQDEVCI DIGIAVEVFL IIIRSIADVF
     YVIHIFMRFH TAYVAPSSRV FGRGELVIDS SKIASRYLHK GFFLDFIAAL PLPQVLIWIV
     IPNLGGSTIA NTKNVLRFII IIQYLPRLFL IFPLSSQIVK ATGVVTETAW AGAAYNLMLY
     MLASHVLGAC WYLLSIERQE ACWKSVCKLE ESSCQFDFFD CNMVKDSLRV SWFVTSNVTN
     LCSPNSLFYQ FGIYGDAVTS KVTTSAFFNK YFFCLWWGLR NLSSLGQGLL TSTFVGEIMF
     AIVIATLGLV LFALLIGNMQ TYLQSTTVRL EEWRVKRTDT EQWMHHRQLP QELRQSVRKY
     DQYKWIATRG VDEESLLRGL PLDLRRDIKR HLCLELVRRV PLFDAMDERM LDAICERLKP
     ALCTENTYLV REGDPVNEML FIIRGNLDSY TTDGGRTGFF NSCRIGPGDF CGEELLTWAL
     DPRPTMVIPS STRTVKAISE VEAFALIAED LKFVASQFRR LHSKQLRNKL RFHSHQWRTW
     AACFIQVAWR RTIQEKKGSC
//
ID   GLR21_ARATH             Reviewed;         901 AA.
AC   O04660; Q0WSC5;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   27-SEP-2017, entry version 128.
DE   RecName: Full=Glutamate receptor 2.1;
DE   AltName: Full=Ligand-gated ion channel 2.1;
DE            Short=AtGLR3;
DE   Flags: Precursor;
GN   Name=GLR2.1; Synonyms=GLR3; OrderedLocusNames=At5g27100;
GN   ORFNames=A_TM021B04.3, T21B4.10;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K.,
RA   Kohara M., Matsumoto M., Matsuno A., Muraki A., Nakayama S.,
RA   Nakazaki N., Naruo K., Okumura S., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Sato S., de la Bastide M.,
RA   Huang E., Spiegel L., Gnoj L., O'Shaughnessy A., Preston R.,
RA   Habermann K., Murray J., Johnson D., Rohlfing T., Nelson J.,
RA   Stoneking T., Pepin K., Spieth J., Sekhon M., Armstrong J., Becker M.,
RA   Belter E., Cordum H., Cordes M., Courtney L., Courtney W., Dante M.,
RA   Du H., Edwards J., Fryman J., Haakensen B., Lamar E., Latreille P.,
RA   Leonard S., Meyer R., Mulvaney E., Ozersky P., Riley A., Strowmatt C.,
RA   Wagner-McPherson C., Wollam A., Yoakum M., Bell M., Dedhia N.,
RA   Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D., Baker J.,
RA   Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S.,
RA   Langham S.-A., McCullagh B., Robben J., Grymonprez B., Zimmermann W.,
RA   Ramsperger U., Wedler H., Balke K., Wedler E., Peters S.,
RA   van Staveren M., Dirkse W., Mooijman P., Klein Lankhorst R.,
RA   Weitzenegger T., Bothe G., Rose M., Hauf J., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Villarroel R., Gielen J., Ardiles W.,
RA   Bents O., Lemcke K., Kolesov G., Mayer K.F.X., Rudd S., Schoof H.,
RA   Schueller C., Zaccaria P., Mewes H.-W., Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:823-826(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Totoki Y., Seki M., Ishida J., Nakajima M., Enju A., Kamiya A.,
RA   Narusaka M., Shin-i T., Nakagawa M., Sakamoto N., Oishi K., Kohara Y.,
RA   Kobayashi M., Toyoda A., Sakaki Y., Sakurai T., Iida K., Akiyama K.,
RA   Satou M., Toyoda T., Konagaya A., Carninci P., Kawai J.,
RA   Hayashizaki Y., Shinozaki K.;
RT   "Large-scale analysis of RIKEN Arabidopsis full-length (RAFL) cDNAs.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots. First
CC       strongly detected in all cell types of the root except at the
CC       apex. Later expressed at the root-shoot junction.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB61068.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF007271; AAB61068.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002688; AED93650.1; -; Genomic_DNA.
DR   EMBL; AK228008; BAE99973.1; -; mRNA.
DR   PIR; T01809; T01809.
DR   RefSeq; NP_198062.2; NM_122592.4.
DR   UniGene; At.30826; -.
DR   ProteinModelPortal; O04660; -.
DR   SMR; O04660; -.
DR   BioGrid; 18042; 8.
DR   IntAct; O04660; 1.
DR   MINT; MINT-8066559; -.
DR   STRING; 3702.AT5G27100.1; -.
DR   iPTMnet; O04660; -.
DR   PaxDb; O04660; -.
DR   EnsemblPlants; AT5G27100.1; AT5G27100.1; AT5G27100.
DR   GeneID; 832768; -.
DR   Gramene; AT5G27100.1; AT5G27100.1; AT5G27100.
DR   KEGG; ath:AT5G27100; -.
DR   Araport; AT5G27100; -.
DR   TAIR; locus:2181196; AT5G27100.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG410XQQV; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; O04660; -.
DR   KO; K05387; -.
DR   OMA; GRTIGFW; -.
DR   OrthoDB; EOG093601T8; -.
DR   PhylomeDB; O04660; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:O04660; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   Genevisible; O04660; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    901       Glutamate receptor 2.1.
FT                                /FTId=PRO_0000011596.
FT   TOPO_DOM     26    574       Extracellular. {ECO:0000255}.
FT   TRANSMEM    575    595       Helical. {ECO:0000255}.
FT   TOPO_DOM    596    604       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    605    625       Helical. {ECO:0000255}.
FT   TOPO_DOM    626    629       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    630    650       Helical. {ECO:0000255}.
FT   TOPO_DOM    651    823       Extracellular. {ECO:0000255}.
FT   TRANSMEM    824    844       Helical. {ECO:0000255}.
FT   TOPO_DOM    845    901       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    331    331       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    477    477       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    536    536       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   901 AA;  100905 MW;  45E29E2CC5A26DE8 CRC64;
     MKRENNLVLS LLFFVIVFLM QVGEAQNRIT NVNVGIVNDI GTAYSNMTLL CINMSLSDFY
     SSHPETQTRL VTTVVDSKND VVTAAAAALD LITNKEVKAI LGPWTSMQAQ FMIEMGQKSQ
     VPIVTYSATS PSLASIRSQY FFRATYDDSS QVHAIKEIIK LFGWREVAPV YVDDTFGEGI
     MPRLTDVLQE INVRIPYRTV ISPNATDDEI SVELLRMMTL PTRVFVVHLV ELLASRFFAK
     ATEIGLMKQG YVWILTNTIT DVLSIMNETE IETMQGVLGV KTYVPRSKEL ENFRSRWTKR
     FPISDLNVYG LWAYDATTAL ALAIEEAGTS NLTFVKMDAK RNVSELQGLG VSQYGPKLLQ
     TLSRVRFQGL AGDFQFINGE LQPSVFEIVN VNGQGGRTIG FWMKEYGLFK NVDQKPASKT
     TFSSWQDRLR PIIWPGDTTS VPKGWEIPTN GKRLQIGVPV NNTFQQFVKA TRDPITNSTI
     FSGFSIDYFE AVIQAIPYDI SYDFIPFQDG GYDALVYQVY LGKYDAVVAD TTISSNRSMY
     VDFSLPYTPS GVGLVVPVKD SVRRSSTIFL MPLTLALWLI SLLSFFIIGL VVWVLEHRVN
     PDFDGPGQYQ LSTIFWFSFS IMVFAPRERV LSFWARVVVI IWYFLVLVLT QSYTASLASL
     LTTQHLHPTV TNINSLLAKG ESVGYQSSFI LGRLRDSGFS EASLVSYGSP EHCDALLSKG
     QAEGGVSAVL MEVPYVRIFL GQYCNKYKMV QTPFKVDGLG FVFPIGSPLV ADISRAILKV
     EESNKANQLE NAWFKPIDES CPDPLTNPDP NPSVSFRQLG FDSFWVLFLV AAIVCTMALL
     KFVYQFLKEN PNQRNLRVLW EKFNEPDQKS YIKDVTKCQC SSGQGMPKNG QEGANAVNNG
     N
//
ID   NMDE4_HUMAN             Reviewed;        1336 AA.
AC   O15399;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   20-DEC-2017, entry version 162.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2D;
DE            Short=GluN2D;
DE   AltName: Full=EB11;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-4;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2D;
DE            Short=NMDAR2D;
DE            Short=NR2D;
DE   Flags: Precursor;
GN   Name=GRIN2D; Synonyms=GluN2D, NMDAR2D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RC   TISSUE=Fetal brain;
RX   PubMed=9489750;
RA   Hess S.D., Daggett L.P., Deal C., Lu C.-C., Johnson E.C.,
RA   Velicelebi G.;
RT   "Functional characterization of human N-methyl-D-aspartate subtype
RT   1A/2D receptors.";
RL   J. Neurochem. 70:1269-1279(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   FUNCTION, INVOLVEMENT IN EIEE46, VARIANT EIEE46 ILE-667, AND
RP   CHARACTERIZATION OF VARIANT EIEE46 ILE-667.
RX   PubMed=27616483; DOI=10.1016/j.ajhg.2016.07.013;
RA   Li D., Yuan H., Ortiz-Gonzalez X.R., Marsh E.D., Tian L.,
RA   McCormick E.M., Kosobucki G.J., Chen W., Schulien A.J., Chiavacci R.,
RA   Tankovic A., Naase C., Brueckner F., von Stuelpnagel-Steinbeis C.,
RA   Hu C., Kusumoto H., Hedrich U.B., Elsen G., Hoertnagel K.,
RA   Aizenman E., Lemke J.R., Hakonarson H., Traynelis S.F., Falk M.J.;
RT   "GRIN2D recurrent de novo dominant mutation causes a severe epileptic
RT   encephalopathy treatable with NMDA receptor channel blockers.";
RL   Am. J. Hum. Genet. 99:802-816(2016).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=26875626; DOI=10.1016/j.neuron.2016.01.016;
RA   Hackos D.H., Lupardus P.J., Grand T., Chen Y., Wang T.M., Reynen P.,
RA   Gustafson A., Wallweber H.J., Volgraf M., Sellers B.D., Schwarz J.B.,
RA   Paoletti P., Sheng M., Zhou Q., Hanson J.E.;
RT   "Positive Allosteric Modulators of GluN2A-Containing NMDARs with
RT   Distinct Modes of Action and Impacts on Circuit Function.";
RL   Neuron 89:983-999(2016).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND MUTAGENESIS OF MET-845.
RX   PubMed=28126851; DOI=10.1124/mol.116.106781;
RA   Chen W., Tankovic A., Burger P.B., Kusumoto H., Traynelis S.F.,
RA   Yuan H.;
RT   "Functional evaluation of a de novo GRIN2A mutation identified in a
RT   patient with profound global developmental delay and refractory
RT   epilepsy.";
RL   Mol. Pharmacol. 91:317-330(2017).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF PRO-580.
RX   PubMed=28095420; DOI=10.1371/journal.pgen.1006536;
RA   Ogden K.K., Chen W., Swanger S.A., McDaniel M.J., Fan L.Z., Hu C.,
RA   Tankovic A., Kusumoto H., Kosobucki G.J., Schulien A.J., Su Z.,
RA   Pecha J., Bhattacharya S., Petrovski S., Cohen A.E., Aizenman E.,
RA   Traynelis S.F., Yuan H.;
RT   "Molecular mechanism of disease-associated mutations in the pre-M1
RT   helix of NMDA receptors and potential rescue pharmacology.";
RL   PLoS Genet. 13:E1006536-E1006536(2017).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-140; ARG-286 AND GLY-527.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [8]
RP   VARIANTS VAL-466; LEU-592; VAL-733; HIS-872; ILE-883; VAL-922;
RP   THR-926; PRO-982 AND SER-1317.
RX   PubMed=22833210; DOI=10.1038/tp.2011.52;
RG   S2D team;
RA   Tarabeux J., Kebir O., Gauthier J., Hamdan F.F., Xiong L., Piton A.,
RA   Spiegelman D., Henrion E., Millet B., Fathalli F., Joober R.,
RA   Rapoport J.L., DeLisi L.E., Fombonne E., Mottron L., Forget-Dubois N.,
RA   Boivin M., Michaud J.L., Drapeau P., Lafreniere R.G., Rouleau G.A.,
RA   Krebs M.O.;
RT   "Rare mutations in N-methyl-D-aspartate glutamate receptors in autism
RT   spectrum disorders and schizophrenia.";
RL   Transl. Psychiatry 1:E55-E55(2011).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium.
CC       Channel activation requires binding of the neurotransmitter
CC       glutamate to the epsilon subunit, glycine binding to the zeta
CC       subunit, plus membrane depolarization to eliminate channel
CC       inhibition by Mg(2+) (PubMed:9489750, PubMed:27616483,
CC       PubMed:26875626, PubMed:28126851). Sensitivity to glutamate and
CC       channel kinetics depend on the subunit composition
CC       (PubMed:9489750). {ECO:0000269|PubMed:26875626,
CC       ECO:0000269|PubMed:27616483, ECO:0000269|PubMed:28095420,
CC       ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:9489750}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
CC       of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A,
CC       GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:9489750,
CC       PubMed:26875626, PubMed:28126851). In vivo, the subunit
CC       composition may depend on the expression levels of the different
CC       subunits (Probable). Interacts with PDZ domains of PATJ and DLG4
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:26875626,
CC       ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:9489750,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q62936:Dlg3 (xeno); NbExp=2; IntAct=EBI-1754030, EBI-349596;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26875626,
CC       ECO:0000269|PubMed:28126851, ECO:0000269|PubMed:9489750}; Multi-
CC       pass membrane protein. Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of
CC       a transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:Q00960}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 46 (EIEE46)
CC       [MIM:617162]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent.
CC       {ECO:0000269|PubMed:27616483}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR2D/GRIN2D subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U77783; AAC15910.1; -; mRNA.
DR   EMBL; AC008403; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011527; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS12719.1; -.
DR   RefSeq; NP_000827.2; NM_000836.2.
DR   RefSeq; XP_011525174.1; XM_011526872.1.
DR   UniGene; Hs.445015; -.
DR   ProteinModelPortal; O15399; -.
DR   BioGrid; 109163; 3.
DR   IntAct; O15399; 4.
DR   MINT; MINT-130143; -.
DR   STRING; 9606.ENSP00000263269; -.
DR   BindingDB; O15399; -.
DR   ChEMBL; CHEMBL2591; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB06151; Acetylcysteine.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB06741; Gavestinel.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB04896; Milnacipran.
DR   DrugBank; DB01173; Orphenadrine.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01520; Tenocyclidine.
DR   iPTMnet; O15399; -.
DR   PhosphoSitePlus; O15399; -.
DR   BioMuta; GRIN2D; -.
DR   PaxDb; O15399; -.
DR   PeptideAtlas; O15399; -.
DR   PRIDE; O15399; -.
DR   Ensembl; ENST00000263269; ENSP00000263269; ENSG00000105464.
DR   GeneID; 2906; -.
DR   KEGG; hsa:2906; -.
DR   UCSC; uc002pjc.4; human.
DR   CTD; 2906; -.
DR   DisGeNET; 2906; -.
DR   EuPathDB; HostDB:ENSG00000105464.3; -.
DR   GeneCards; GRIN2D; -.
DR   H-InvDB; HIX0040164; -.
DR   HGNC; HGNC:4588; GRIN2D.
DR   MalaCards; GRIN2D; -.
DR   MIM; 602717; gene.
DR   MIM; 617162; phenotype.
DR   neXtProt; NX_O15399; -.
DR   OpenTargets; ENSG00000105464; -.
DR   PharmGKB; PA28982; -.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   HOGENOM; HOG000113803; -.
DR   HOVERGEN; HBG052637; -.
DR   InParanoid; O15399; -.
DR   KO; K05212; -.
DR   OMA; WDYLPPR; -.
DR   OrthoDB; EOG091G09KH; -.
DR   PhylomeDB; O15399; -.
DR   TreeFam; TF314731; -.
DR   Reactome; R-HSA-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-HSA-442729; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; R-HSA-442982; Ras activation uopn Ca2+ infux through NMDA receptor.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6794361; Neurexins and neuroligins.
DR   Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
DR   SignaLink; O15399; -.
DR   GeneWiki; GRIN2D; -.
DR   GenomeRNAi; 2906; -.
DR   PRO; PR:O15399; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105464; -.
DR   CleanEx; HS_GRIN2D; -.
DR   Genevisible; O15399; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; IDA:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0001964; P:startle response; IEA:Ensembl.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Cell membrane; Complete proteome;
KW   Disease mutation; Disulfide bond; Epilepsy; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Magnesium; Membrane;
KW   Methylation; Phosphoprotein; Polymorphism; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28   1336       Glutamate receptor ionotropic, NMDA 2D.
FT                                /FTId=PRO_0000011583.
FT   TOPO_DOM     28    584       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TRANSMEM    585    603       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    604    630       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   INTRAMEM    631    650       Discontinuously helical.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    651    657       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TRANSMEM    658    673       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    674    844       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TRANSMEM    845    864       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    865   1336       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   REGION      539    541       Glutamate binding.
FT                                {ECO:0000250|UniProtKB:Q00959}.
FT   REGION      631    650       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   REGION      717    718       Glutamate binding.
FT                                {ECO:0000250|UniProtKB:Q00959}.
FT   MOTIF      1334   1336       PDZ-binding. {ECO:0000250}.
FT   COMPBIAS    281    286       Poly-Gly.
FT   COMPBIAS    908    916       Poly-Pro.
FT   COMPBIAS   1035   1040       Poly-Ala.
FT   COMPBIAS   1209   1213       Poly-Pro.
FT   COMPBIAS   1244   1247       Poly-Ala.
FT   BINDING     541    541       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   BINDING     546    546       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   BINDING     759    759       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   SITE        642    642       Functional determinant of NMDA receptors.
FT                                {ECO:0000250}.
FT   MOD_RES    1316   1316       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q03391}.
FT   MOD_RES    1326   1326       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03391}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    352    352       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    366    366       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    467    467       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    569    569       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    104    348       {ECO:0000250|UniProtKB:Q00959}.
FT   DISULFID    455    483       {ECO:0000250|UniProtKB:Q00959}.
FT   DISULFID    462    484       {ECO:0000250|UniProtKB:Q00959}.
FT   DISULFID    773    828       {ECO:0000250|UniProtKB:Q00959}.
FT   VARIANT     140    140       P -> S (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035698.
FT   VARIANT     286    286       G -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035699.
FT   VARIANT     466    466       L -> V (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079975.
FT   VARIANT     527    527       E -> G (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035700.
FT   VARIANT     592    592       M -> L (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079976.
FT   VARIANT     667    667       V -> I (in EIEE46; gain-of-function
FT                                mutation that potentiates ionotropic
FT                                glutamate receptor signaling; mutant
FT                                receptors are activated by lower
FT                                concentrations of glutamate and glycine
FT                                and show slower deactivation after
FT                                agonist removal as well as decreased
FT                                sensitivity to allosteric inhibitors
FT                                indicating that NMDA glutamate receptor
FT                                activity is changed; dbSNP:rs886040861).
FT                                {ECO:0000269|PubMed:27616483}.
FT                                /FTId=VAR_077103.
FT   VARIANT     733    733       M -> V (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079977.
FT   VARIANT     872    872       R -> H (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079978.
FT   VARIANT     883    883       M -> I. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079979.
FT   VARIANT     922    922       A -> V (found in patients with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079980.
FT   VARIANT     926    926       A -> T (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079981.
FT   VARIANT     982    982       A -> P. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079982.
FT   VARIANT    1317   1317       G -> S. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079983.
FT   MUTAGEN     580    580       P->R: Changed glutamate-gated calcium ion
FT                                channel activity characterized by
FT                                increased glutamate and glycine potency.
FT                                {ECO:0000269|PubMed:28095420}.
FT   MUTAGEN     845    845       M->V: Increased glutamate and glycine
FT                                agonist potency.
FT                                {ECO:0000269|PubMed:28126851}.
FT   CONFLICT    924    924       R -> G (in Ref. 1; AAC15910).
FT                                {ECO:0000305}.
FT   CONFLICT   1005   1005       P -> A (in Ref. 1; AAC15910).
FT                                {ECO:0000305}.
FT   CONFLICT   1097   1097       R -> C (in Ref. 1; AAC15910).
FT                                {ECO:0000305}.
FT   CONFLICT   1130   1130       E -> D (in Ref. 1; AAC15910).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1336 AA;  143752 MW;  0DB7559056AE4593 CRC64;
     MRGAGGPRGP RGPAKMLLLL ALACASPFPE EAPGPGGAGG PGGGLGGARP LNVALVFSGP
     AYAAEAARLG PAVAAAVRSP GLDVRPVALV LNGSDPRSLV LQLCDLLSGL RVHGVVFEDD
     SRAPAVAPIL DFLSAQTSLP IVAVHGGAAL VLTPKEKGST FLQLGSSTEQ QLQVIFEVLE
     EYDWTSFVAV TTRAPGHRAF LSYIEVLTDG SLVGWEHRGA LTLDPGAGEA VLSAQLRSVS
     AQIRLLFCAR EEAEPVFRAA EEAGLTGSGY VWFMVGPQLA GGGGSGAPGE PPLLPGGAPL
     PAGLFAVRSA GWRDDLARRV AAGVAVVARG AQALLRDYGF LPELGHDCRA QNRTHRGESL
     HRYFMNITWD NRDYSFNEDG FLVNPSLVVI SLTRDRTWEV VGSWEQQTLR LKYPLWSRYG
     RFLQPVDDTQ HLTVATLEER PFVIVEPADP ISGTCIRDSV PCRSQLNRTH SPPPDAPRPE
     KRCCKGFCID ILKRLAHTIG FSYDLYLVTN GKHGKKIDGV WNGMIGEVFY QRADMAIGSL
     TINEERSEIV DFSVPFVETG ISVMVARSNG TVSPSAFLEP YSPAVWVMMF VMCLTVVAVT
     VFIFEYLSPV GYNRSLATGK RPGGSTFTIG KSIWLLWALV FNNSVPVENP RGTTSKIMVL
     VWAFFAVIFL ASYTANLAAF MIQEEYVDTV SGLSDRKFQR PQEQYPPLKF GTVPNGSTEK
     NIRSNYPDMH SYMVRYNQPR VEEALTQLKA GKLDAFIYDA AVLNYMARKD EGCKLVTIGS
     GKVFATTGYG IALHKGSRWK RPIDLALLQF LGDDEIEMLE RLWLSGICHN DKIEVMSSKL
     DIDNMAGVFY MLLVAMGLSL LVFAWEHLVY WRLRHCLGPT HRMDFLLAFS RGMYSCCSAE
     AAPPPAKPPP PPQPLPSPAY PAPRPAPGPA PFVPRERASV DRWRRTKGAG PPGGAGLADG
     FHRYYGPIEP QGLGLGLGEA RAAPRGAAGR PLSPPAAQPP QKPPPSYFAI VRDKEPAEPP
     AGAFPGFPSP PAPPAAAATA VGPPLCRLAF EDESPPAPAR WPRSDPESQP LLGPGAGGAG
     GTGGAGGGAP AAPPPCRAAP PPCPYLDLEP SPSDSEDSES LGGASLGGLE PWWFADFPYP
     YAERLGPPPG RYWSVDKLGG WRAGSWDYLP PRSGPAAWHC RHCASLELLP PPRHLSCSHD
     GLDGGWWAPP PPPWAAGPLP RRRARCGCPR SHPHRPRASH RTPAAAAPHH HRHRRAAGGW
     DLPPPAPTSR SLEDLSSCPR AAPARRLTGP SRHARRCPHA AHWGPPLPTA SHRRHRGGDL
     GTRRGSAHFS SLESEV
//
ID   P2RX6_HUMAN             Reviewed;         441 AA.
AC   O15547; F6V3D7; Q32MB6; Q58F04; Q6IC33; Q9UL50;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   22-NOV-2017, entry version 158.
DE   RecName: Full=P2X purinoceptor 6;
DE            Short=P2X6;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=P2XM;
DE   AltName: Full=Purinergic receptor;
DE   AltName: Full=Purinergic receptor P2X-like 1;
GN   Name=P2RX6; Synonyms=P2RXL1, P2X6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=9242461;
RA   Urano T., Nishimori H., Han H., Furuhata T., Kimura Y., Nakamura Y.,
RA   Tokino T.;
RT   "Cloning of P2XM, a novel human P2X receptor gene regulated by p53.";
RL   Cancer Res. 57:3281-3287(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 6-441 (ISOFORM 1), AND VARIANT HIS-242.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-441 (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RA   Cheng X., Jin H., Huang C.-C.;
RT   "Cloning and tissue distribution of a human cDNA encoding P2X6
RT   purinoceptor.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PHOSPHORYLATION AT TYR-64.
RX   PubMed=12112843;
RX   DOI=10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I;
RA   Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G.,
RA   Fitzgerald D.J.;
RT   "Identification of the phosphotyrosine proteome from thrombin
RT   activated platelets.";
RL   Proteomics 2:642-648(2002).
RN   [7]
RP   SUBUNIT, AND GLYCOSYLATION.
RX   PubMed=15657042; DOI=10.1074/jbc.M412265200;
RA   Barrera N.P., Ormond S.J., Henderson R.M., Murrell-Lagnado R.D.,
RA   Edwardson J.M.;
RT   "Atomic force microscopy imaging demonstrates that P2X2 receptors are
RT   trimers but that P2X6 receptor subunits do not oligomerize.";
RL   J. Biol. Chem. 280:10759-10765(2005).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel. {ECO:0000250}.
CC   -!- SUBUNIT: Unlike most P2XRs, P2RX6 does not seem to form
CC       homotrimers or heterotrimers. {ECO:0000269|PubMed:15657042}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15547-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15547-2; Sequence=VSP_044799;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in skeletal muscle.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:15657042}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-11 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF13303.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAF13303.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAH33488.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAI09210.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA22046.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA22047.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P2X receptor entry;
CC       URL="https://en.wikipedia.org/wiki/P2X_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB002059; BAA22047.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AB002058; BAA22046.1; ALT_INIT; mRNA.
DR   EMBL; CR456535; CAG30421.1; -; mRNA.
DR   EMBL; AC002472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033488; AAH33488.1; ALT_INIT; mRNA.
DR   EMBL; BC109209; AAI09210.1; ALT_INIT; mRNA.
DR   EMBL; AF065385; AAF13303.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS13788.2; -. [O15547-1]
DR   CCDS; CCDS54504.1; -. [O15547-2]
DR   RefSeq; NP_001153026.1; NM_001159554.1. [O15547-2]
DR   RefSeq; NP_005437.2; NM_005446.3. [O15547-1]
DR   UniGene; Hs.113275; -.
DR   ProteinModelPortal; O15547; -.
DR   SMR; O15547; -.
DR   BioGrid; 114575; 4.
DR   IntAct; O15547; 1.
DR   STRING; 9606.ENSP00000416193; -.
DR   BindingDB; O15547; -.
DR   ChEMBL; CHEMBL2670; -.
DR   iPTMnet; O15547; -.
DR   PhosphoSitePlus; O15547; -.
DR   BioMuta; P2RX6; -.
DR   PaxDb; O15547; -.
DR   PeptideAtlas; O15547; -.
DR   PRIDE; O15547; -.
DR   DNASU; 9127; -.
DR   Ensembl; ENST00000401443; ENSP00000385309; ENSG00000099957. [O15547-2]
DR   Ensembl; ENST00000413302; ENSP00000416193; ENSG00000099957. [O15547-1]
DR   GeneID; 9127; -.
DR   KEGG; hsa:9127; -.
DR   UCSC; uc002ztz.3; human. [O15547-1]
DR   CTD; 9127; -.
DR   DisGeNET; 9127; -.
DR   EuPathDB; HostDB:ENSG00000099957.16; -.
DR   GeneCards; P2RX6; -.
DR   HGNC; HGNC:8538; P2RX6.
DR   HPA; HPA028776; -.
DR   HPA; HPA028777; -.
DR   MIM; 608077; gene.
DR   neXtProt; NX_O15547; -.
DR   OpenTargets; ENSG00000099957; -.
DR   PharmGKB; PA162398523; -.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; O15547; -.
DR   KO; K05221; -.
DR   OMA; HYSFQLQ; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; O15547; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-418346; Platelet homeostasis.
DR   GeneWiki; P2RX6; -.
DR   GenomeRNAi; 9127; -.
DR   PRO; PR:O15547; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000099957; -.
DR   CleanEx; HS_P2RX6; -.
DR   ExpressionAtlas; O15547; baseline and differential.
DR   Genevisible; O15547; HS.
DR   GO; GO:0030054; C:cell junction; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; NAS:BHF-UCL.
DR   GO; GO:0015267; F:channel activity; TAS:ProtInc.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IPI:BHF-UCL.
DR   GO; GO:0033198; P:response to ATP; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003049; P2X6_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF21; PTHR10125:SF21; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01313; P2X6RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    441       P2X purinoceptor 6.
FT                                /FTId=PRO_0000161557.
FT   TOPO_DOM     11     39       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     40     60       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     61    333       Extracellular. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    355    441       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      64     64       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:12112843}.
FT   CARBOHYD    165    165       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    210    210       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    127    177       {ECO:0000250}.
FT   DISULFID    138    161       {ECO:0000250}.
FT   DISULFID    144    171       {ECO:0000250}.
FT   DISULFID    228    238       {ECO:0000250}.
FT   DISULFID    272    281       {ECO:0000250}.
FT   VAR_SEQ      30     55       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044799.
FT   VARIANT      38     38       V -> G (in dbSNP:rs2006846).
FT                                /FTId=VAR_057664.
FT   VARIANT     242    242       R -> H (in dbSNP:rs2277838).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_020338.
FT   CONFLICT    393    393       L -> F (in Ref. 5; AAF13303).
FT                                {ECO:0000305}.
SQ   SEQUENCE   441 AA;  48829 MW;  EFD45BDC81234A64 CRC64;
     MCPQLAGAGS MGSPGATTGW GLLDYKTEKY VMTRNWRVGA LQRLLQFGIV VYVVGWALLA
     KKGYQERDLE PQFSIITKLK GVSVTQIKEL GNRLWDVADF VKPPQGENVF FLVTNFLVTP
     AQVQGRCPEH PSVPLANCWV DEDCPEGEGG THSHGVKTGQ CVVFNGTHRT CEIWSWCPVE
     SGVVPSRPLL AQAQNFTLFI KNTVTFSKFN FSKSNALETW DPTYFKHCRY EPQFSPYCPV
     FRIGDLVAKA GGTFEDLALL GGSVGIRVHW DCDLDTGDSG CWPHYSFQLQ EKSYNFRTAT
     HWWEQPGVEA RTLLKLYGIR FDILVTGQAG KFGLIPTAVT LGTGAAWLGV VTFFCDLLLL
     YVDREAHFYW RTKYEEAKAP KATANSVWRE LALASQARLA ECLRRSSAPA PTATAAGSQT
     QTPGWPCPSS DTHLPTHSGS L
//
ID   GBRB_CAEEL              Reviewed;         550 AA.
AC   O18276; Q8ITG2;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 3.
DT   22-NOV-2017, entry version 123.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta;
DE   AltName: Full=GABA(A) receptor subunit beta;
DE   Flags: Precursor;
GN   Name=gab-1; ORFNames=ZC482.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=12421359; DOI=10.1046/j.1471-4159.2002.01199.x;
RA   Feng X.-P., Hayashi J., Beech R.N., Prichard R.K.;
RT   "Study of the nematode putative GABA type-A receptor subunits:
RT   evidence for modulation by ivermectin.";
RL   J. Neurochem. 83:870-878(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel. {ECO:0000250, ECO:0000269|PubMed:12421359}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF498370; AAN65376.1; -; mRNA.
DR   EMBL; Z93397; CAB07719.3; -; Genomic_DNA.
DR   PIR; T27614; T27614.
DR   RefSeq; NP_499661.2; NM_067260.3.
DR   UniGene; Cel.9592; -.
DR   ProteinModelPortal; O18276; -.
DR   SMR; O18276; -.
DR   STRING; 6239.ZC482.1; -.
DR   PaxDb; O18276; -.
DR   EnsemblMetazoa; ZC482.1; ZC482.1; WBGene00001512.
DR   GeneID; 176691; -.
DR   KEGG; cel:CELE_ZC482.1; -.
DR   UCSC; ZC482.1; c. elegans.
DR   CTD; 176691; -.
DR   WormBase; ZC482.1; CE33742; WBGene00001512; gab-1.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   InParanoid; O18276; -.
DR   KO; K05181; -.
DR   OMA; EIPIDEM; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; O18276; -.
DR   Reactome; R-CEL-977441; GABA A receptor activation.
DR   PRO; PR:O18276; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00001512; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IC:WormBase.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IDA:WormBase.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:WormBase.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:WormBase.
DR   GO; GO:0006811; P:ion transport; IDA:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    550       Gamma-aminobutyric acid receptor subunit
FT                                beta.
FT                                /FTId=PRO_0000255714.
FT   TOPO_DOM     25    264       Extracellular. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical. {ECO:0000255}.
FT   TRANSMEM    292    311       Helical. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TOPO_DOM    345    527       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    528    548       Helical. {ECO:0000255}.
FT   COMPBIAS    355    360       Poly-Gly.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    193    193       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    180    194       {ECO:0000250}.
FT   CONFLICT     16     16       L -> S (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
FT   CONFLICT    188    188       P -> S (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
FT   CONFLICT    267    267       Q -> E (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
FT   CONFLICT    273    273       V -> D (in Ref. 1; AAN65376).
FT                                {ECO:0000305}.
SQ   SEQUENCE   550 AA;  62457 MW;  5DF089E1101438E5 CRC64;
     MRRSKTRRIF HVSITLLLVS TIFCQNGTKP HNNSTSDQMS SSWSNRSQTM YSNASSLLSD
     LLLDYDIRLR PGFGGDALLL TMDIIIASFD SISEVDMDYT LTMYLHQYWT DERLRWSNEI
     PIDEMTLSGE FSQNIWVPDT FLANDKHSYL HEVTERNKML RINVDGKVAY GMRLTSTLSC
     SMNLRNFPLD SQNCTVEIES YGYTTSEVLM KWNYPLAVHG VEQADVPQFT ITGFHTEDSI
     VSTATGSYQR LSLVFQLRRS VGYFIFQTYL PCVLIVMLSW VSFWINHEAT SARVALGITT
     VLTMTTISTG VRQSLPRISY VKSIDIYLVM CFVFVFAALL EYAAVNYSYW GRERGKGGGG
     NEWPVNGANK EDRESAVNVQ KWVPSGLMDG VPQPQDRRVE ALEEAMSTSN TAAQNNNFES
     TSKPKKRSSS PIPPLCRAGN TISEESESPD YPRYSTTSLK GARPHASLNH KTHHLKGRSS
     ARAKRRMTLA RMNVSMKQSI SGIGRRARKV IPTIRVRDVN LIDKYSRVVF PVCFIVFNLF
     YWSYYMMVPS
//
ID   GRID2_HUMAN             Reviewed;        1007 AA.
AC   O43424; E9PH24; Q4KKU8; Q4KKU9; Q4KKV0; Q59FZ1;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   20-DEC-2017, entry version 159.
DE   RecName: Full=Glutamate receptor ionotropic, delta-2;
DE            Short=GluD2;
DE            Short=GluR delta-2 subunit;
DE   Flags: Precursor;
GN   Name=GRID2; Synonyms=GLURD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=9465309; DOI=10.1006/geno.1997.5108;
RA   Hu W., Zuo J., De Jager P.L., Heintz N.;
RT   "The human glutamate receptor delta 2 gene (GRID2) maps to chromosome
RT   4q22.";
RL   Genomics 47:143-145(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-68.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 24-440, DISULFIDE BONDS,
RP   INTERACTION WITH CBLN1, MUTAGENESIS OF ASP-24; SER-25; ILE-26; THR-60;
RP   GLU-61; PHE-76; LEU-342; GLU-343; ASP-344; ARG-345; LYS-346; HIS-348;
RP   SER-349; MET-350; SER-352; GLN-364 AND LEU-434, SUBUNIT, FUNCTION,
RP   REGION, SITE, AND CHARACTERIZATION OF VARIANT SCAR18 THR-654.
RX   PubMed=27418511; DOI=10.1126/science.aae0104;
RA   Elegheert J., Kakegawa W., Clay J.E., Shanks N.F., Behiels E.,
RA   Matsuda K., Kohda K., Miura E., Rossmann M., Mitakidis N.,
RA   Motohashi J., Chang V.T., Siebold C., Greger I.H., Nakagawa T.,
RA   Yuzaki M., Aricescu A.R.;
RT   "Structural basis for integration of GluD receptors within synaptic
RT   organizer complexes.";
RL   Science 353:295-299(2016).
RN   [6]
RP   INVOLVEMENT IN SCAR18.
RX   PubMed=23611888; DOI=10.1177/0883073813484967;
RA   Utine G.E., Haliloglu G., Salanci B., Cetinkaya A., Kiper P.O.,
RA   Alanay Y., Aktas D., Boduroglu K., Alikasifoglu M.;
RT   "A homozygous deletion in GRID2 causes a human phenotype with
RT   cerebellar ataxia and atrophy.";
RL   J. Child Neurol. 28:926-932(2013).
RN   [7]
RP   INVOLVEMENT IN SCAR18.
RX   PubMed=24078737; DOI=10.1212/WNL.0b013e3182a841a3;
RA   Hills L.B., Masri A., Konno K., Kakegawa W., Lam A.T., Lim-Melia E.,
RA   Chandy N., Hill R.S., Partlow J.N., Al-Saffar M., Nasir R.,
RA   Stoler J.M., Barkovich A.J., Watanabe M., Yuzaki M., Mochida G.H.;
RT   "Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia
RT   and tonic upgaze in humans.";
RL   Neurology 81:1378-1386(2013).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-209.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [9]
RP   VARIANTS SCAR18 ASP-654; THR-654 AND VAL-656.
RX   PubMed=25841024; DOI=10.1212/WNL.0000000000001524;
RA   Coutelier M., Burglen L., Mundwiller E., Abada-Bendib M.,
RA   Rodriguez D., Chantot-Bastaraud S., Rougeot C., Cournelle M.A.,
RA   Milh M., Toutain A., Bacq D., Meyer V., Afenjar A., Deleuze J.F.,
RA   Brice A., Heron D., Stevanin G., Durr A.;
RT   "GRID2 mutations span from congenital to mild adult-onset cerebellar
RT   ataxia.";
RL   Neurology 84:1751-1759(2015).
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. Promotes synaptogenesis and mediates the D-Serine-
CC       dependent long term depression signals and AMPA receptor
CC       endocytosis of cerebellar parallel fiber-Purkinje cell (PF-PC)
CC       synapses through the beta-NRX1-CBLN1-GRID2 triad complex
CC       (PubMed:27418511). {ECO:0000269|PubMed:27418511}.
CC   -!- SUBUNIT: Tetramer; dimer of dimers (PubMed:27418511). Interacts
CC       with EML2, MAGI2 (via PDZ domains) and AP4M1 (By similarity).
CC       Interacts with BECN1, GOPC, GRID2IP, SHANK1 and SHANK2. Interacts
CC       with CBLN2, but not with CBLN4 (By similarity). Interacts with
CC       CBLN1 (via C1q domain); the interaction is CBLN1-NRX1 complex
CC       formation-dependent; CBLN1-binding is calcium-independent; CBLN1
CC       hexamers anchor GRID2 N-terminal domain dimers to monomeric NRXN1
CC       isoform beta; promotes synaptogenesis and mediates the D-Serine-
CC       dependent long term depression signals and AMPA receptor
CC       endocytosis (PubMed:27418511). {ECO:0000250|UniProtKB:Q61625,
CC       ECO:0000250|UniProtKB:Q63226, ECO:0000269|PubMed:27418511}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43424-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43424-2; Sequence=VSP_054704;
CC   -!- DOMAIN: The PDZ-binding motif mediates interaction with GOPC.
CC       {ECO:0000250}.
CC   -!- DISEASE: Spinocerebellar ataxia, autosomal recessive, 18 (SCAR18)
CC       [MIM:616204]: Spinocerebellar ataxia defines a clinically and
CC       genetically heterogeneous group of cerebellar disorders. Patients
CC       show progressive incoordination of gait and often poor
CC       coordination of hands, speech and eye movements, due to
CC       degeneration of the cerebellum with variable involvement of the
CC       brainstem and spinal cord. SCAR18 features include progressive
CC       cerebellar atrophy, delayed psychomotor development, severely
CC       impaired gait, ocular movement abnormalities, and intellectual
CC       disability. {ECO:0000269|PubMed:23611888,
CC       ECO:0000269|PubMed:24078737, ECO:0000269|PubMed:25841024,
CC       ECO:0000269|PubMed:27418511}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRID2 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92555.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF009014; AAC39579.1; -; mRNA.
DR   EMBL; AB209318; BAD92555.1; ALT_INIT; mRNA.
DR   EMBL; AC020699; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022317; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093596; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC095059; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096769; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104077; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108158; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110800; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC099652; AAH99652.1; -; mRNA.
DR   EMBL; BC099653; AAH99653.1; -; mRNA.
DR   EMBL; BC099654; AAH99654.1; -; mRNA.
DR   CCDS; CCDS3637.1; -. [O43424-1]
DR   CCDS; CCDS68758.1; -. [O43424-2]
DR   RefSeq; NP_001273767.1; NM_001286838.1. [O43424-2]
DR   RefSeq; NP_001501.2; NM_001510.3. [O43424-1]
DR   UniGene; Hs.162727; -.
DR   UniGene; Hs.480281; -.
DR   PDB; 5KC8; X-ray; 1.75 A; A=24-440.
DR   PDB; 5KCA; X-ray; 3.10 A; A=24-440.
DR   PDBsum; 5KC8; -.
DR   PDBsum; 5KCA; -.
DR   ProteinModelPortal; O43424; -.
DR   SMR; O43424; -.
DR   BioGrid; 109152; 7.
DR   MINT; MINT-257823; -.
DR   STRING; 9606.ENSP00000282020; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   iPTMnet; O43424; -.
DR   PhosphoSitePlus; O43424; -.
DR   BioMuta; GRID2; -.
DR   EPD; O43424; -.
DR   MaxQB; O43424; -.
DR   PaxDb; O43424; -.
DR   PeptideAtlas; O43424; -.
DR   PRIDE; O43424; -.
DR   Ensembl; ENST00000282020; ENSP00000282020; ENSG00000152208. [O43424-1]
DR   Ensembl; ENST00000510992; ENSP00000421257; ENSG00000152208. [O43424-2]
DR   GeneID; 2895; -.
DR   KEGG; hsa:2895; -.
DR   UCSC; uc011cdt.4; human. [O43424-1]
DR   CTD; 2895; -.
DR   DisGeNET; 2895; -.
DR   EuPathDB; HostDB:ENSG00000152208.11; -.
DR   GeneCards; GRID2; -.
DR   H-InvDB; HIX0031353; -.
DR   HGNC; HGNC:4576; GRID2.
DR   HPA; HPA056253; -.
DR   HPA; HPA058538; -.
DR   MalaCards; GRID2; -.
DR   MIM; 602368; gene.
DR   MIM; 616204; phenotype.
DR   neXtProt; NX_O43424; -.
DR   OpenTargets; ENSG00000152208; -.
DR   Orphanet; 363432; Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency.
DR   PharmGKB; PA28971; -.
DR   eggNOG; ENOG410ISR9; Eukaryota.
DR   eggNOG; ENOG410YYDD; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000264260; -.
DR   HOVERGEN; HBG051840; -.
DR   InParanoid; O43424; -.
DR   KO; K05207; -.
DR   OMA; GVRKLGC; -.
DR   OrthoDB; EOG091G010L; -.
DR   PhylomeDB; O43424; -.
DR   TreeFam; TF352434; -.
DR   ChiTaRS; GRID2; human.
DR   GeneWiki; GRID2; -.
DR   GenomeRNAi; 2895; -.
DR   PRO; PR:O43424; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000152208; -.
DR   CleanEx; HS_GRID2; -.
DR   ExpressionAtlas; O43424; baseline and differential.
DR   Genevisible; O43424; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043197; C:dendritic spine; ISS:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISS:BHF-UCL.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0008066; F:glutamate receptor activity; TAS:ProtInc.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; ISS:BHF-UCL.
DR   GO; GO:0034613; P:cellular protein localization; ISS:BHF-UCL.
DR   GO; GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:1904861; P:excitatory synapse assembly; IMP:UniProtKB.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:1900454; P:positive regulation of long term synaptic depression; IMP:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IMP:UniProtKB.
DR   GO; GO:0060134; P:prepulse inhibition; ISS:BHF-UCL.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0010975; P:regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISS:BHF-UCL.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Neurodegeneration;
KW   Phosphoprotein; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1007       Glutamate receptor ionotropic, delta-2.
FT                                /FTId=PRO_0000011564.
FT   TOPO_DOM     24    566       Extracellular. {ECO:0000255}.
FT   TRANSMEM    567    587       Helical. {ECO:0000255}.
FT   TOPO_DOM    588    635       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    636    656       Helical. {ECO:0000255}.
FT   TOPO_DOM    657    830       Extracellular. {ECO:0000255}.
FT   TRANSMEM    831    851       Helical. {ECO:0000255}.
FT   TOPO_DOM    852   1007       Cytoplasmic. {ECO:0000255}.
FT   REGION       24    345       Interaction with CBLN1 homotrimer.
FT                                {ECO:0000269|PubMed:27418511}.
FT   REGION      921    991       Interaction with AP4M1.
FT                                {ECO:0000250|UniProtKB:Q63226}.
FT   MOTIF      1005   1007       PDZ-binding. {ECO:0000250}.
FT   SITE         76     76       Essential for dimerization.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MOD_RES     883    883       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61625}.
FT   MOD_RES     886    886       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q61625}.
FT   MOD_RES     890    890       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61625}.
FT   MOD_RES    1006   1006       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63226}.
FT   CARBOHYD    293    293       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     83    355       {ECO:0000244|PDB:5KC8,
FT                                ECO:0000244|PDB:5KCA,
FT                                ECO:0000269|PubMed:27418511}.
FT   DISULFID     99    131       {ECO:0000244|PDB:5KC8,
FT                                ECO:0000244|PDB:5KCA,
FT                                ECO:0000269|PubMed:27418511}.
FT   DISULFID    298    310       {ECO:0000244|PDB:5KC8,
FT                                ECO:0000244|PDB:5KCA,
FT                                ECO:0000269|PubMed:27418511}.
FT   VAR_SEQ      82    176       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054704.
FT   VARIANT      68     68       T -> M (in dbSNP:rs34144324).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_055016.
FT   VARIANT     209    209       T -> N (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035697.
FT   VARIANT     398    398       F -> S (in dbSNP:rs34796082).
FT                                /FTId=VAR_055017.
FT   VARIANT     490    490       V -> I (in dbSNP:rs10034345).
FT                                /FTId=VAR_055018.
FT   VARIANT     654    654       A -> D (in SCAR18).
FT                                {ECO:0000269|PubMed:25841024}.
FT                                /FTId=VAR_074166.
FT   VARIANT     654    654       A -> T (in SCAR18; constitutively open
FT                                the extracellular-glutamate-gated ion
FT                                channel). {ECO:0000269|PubMed:25841024,
FT                                ECO:0000269|PubMed:27418511}.
FT                                /FTId=VAR_074167.
FT   VARIANT     656    656       L -> V (in SCAR18).
FT                                {ECO:0000269|PubMed:25841024}.
FT                                /FTId=VAR_074168.
FT   MUTAGEN      24     24       D->A: Reduces binding to CBLN1; when
FT                                associated with D76. Abolishes CBLN1
FT                                binding; when associated with A-26; A-61;
FT                                D-76 and A-345. Abolishes synapse
FT                                assembly; when associated with A-26; A-61
FT                                and A-345. Abolishes cerebellar parallel
FT                                fiber-Purkinje cell synapse formation;
FT                                when associated with A-26; A-61 and A-
FT                                345. Abolishes D-Serine-dependent long
FT                                term synaptic depression at PF-PC
FT                                synapses; when associated with A-26; A-61
FT                                and A-345. {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN      25     25       S->A: Reduces binding to CBLN1; when
FT                                associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN      26     26       I->A: Reduces binding to CBLN1; when
FT                                associated with D76. Abolishes CBLN1
FT                                binding; when associated with A-24; A-61;
FT                                D-76 and A-345. Abolishes synapse
FT                                assembly; when associated with A-24; A-61
FT                                and A-345. Abolishes cerebellar parallel
FT                                fiber-Purkinje cell synapse formation;
FT                                when associated with A-24; A-61 and A-
FT                                345. Abolishes D-Serine-dependent long
FT                                term synaptic depression at PF-PC
FT                                synapses; when associated with A-24; A-61
FT                                and A-345. {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN      60     60       T->A: No effect on CBLN1 interaction;
FT                                when associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN      61     61       E->A: Reduces binding to CBLN1; when
FT                                associated with D76. Abolishes CBLN1
FT                                binding; when associated with A-24; A-26;
FT                                D-76 and A-345. Abolishes synapse
FT                                assembly; when associated with A-24; A-26
FT                                and A-345. Abolishes cerebellar parallel
FT                                fiber-Purkinje cell synapse formation;
FT                                when associated with A-24; A-26 and A-
FT                                345. Abolishes D-Serine-dependent long
FT                                term synaptic depression at PF-PC
FT                                synapses; when associated with A-24; A-26
FT                                and A-345. {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN      76     76       F->D: Monomeric form. Does not dimerize.
FT                                Weakly interacts with C1q domain of
FT                                CBLN1. Forms intermediate synapse.
FT                                Abolishes cerebellar parallel fiber-
FT                                Purkinje cell synapse formation.
FT                                Abolishes D-Serine?dependent long term
FT                                synaptic depression at PF-PC synapses.
FT                                Does not recover motor coordination in
FT                                experiment of tranfection in Grid2-null
FT                                mice. {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     342    342       L->A: Reduces binding to CBLN1; when
FT                                associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     343    343       E->A: No effect on CBLN1 interaction;
FT                                when associated with D76. No effect on
FT                                CBLN1 binding; when associated with D-76;
FT                                A-346; A-349 and A-350. No effect on
FT                                synapse assembly; when associated with A-
FT                                346; A-349 and A-350. No effect on
FT                                cerebellar parallel fiber-Purkinje cell
FT                                synapse formation; when associated with
FT                                A-346; A-349 and A-350. Does not affect
FT                                D-Serine?dependent long term synaptic
FT                                depression at PF-PC synapses; when
FT                                associated with A-346; A-349 and A-350.
FT                                Does not affect motor coordination; when
FT                                associated with A-346; A-349 and A-350.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     344    344       D->A: No effect on CBLN1 interaction;
FT                                when associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     345    345       R->A: Reduces binding to CBLN1; when
FT                                associated with D76. Abolishes CBLN1
FT                                binding; when associated with A-24; A-26;
FT                                A-61 and D-76. Abolishes synapse
FT                                assembly; when associated with A-24; A-26
FT                                and A-61. Abolishes cerebellar parallel
FT                                fiber-Purkinje cell synapse formation;
FT                                when associated with A-24; A-26 and A-61.
FT                                Abolishes D-Serine-dependent long term
FT                                synaptic depression at PF-PC synapses;
FT                                when associated with A-24; A-26 and A-61.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     346    346       K->A: No effect on CBLN1 interaction;
FT                                when associated with D76. No effect on
FT                                CBLN1 binding; when associated with D-76;
FT                                A-343; A-349 and A-350. No effect on
FT                                synapse assembly; when associated with A-
FT                                343; A-349 and A-350. No effect on
FT                                cerebellar parallel fiber-Purkinje cell
FT                                synapse formation; when associated with
FT                                A-343; A-349 and A-350. Does not affect
FT                                D-Serine?dependent long term synaptic
FT                                depression at PF-PC synapses; when
FT                                associated with A-343; A-349 and A-350.
FT                                Does not affect motor coordination; when
FT                                associated with A-343; A-349 and A-350.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     348    348       H->A: Reduces binding to CBLN1; when
FT                                associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     349    349       S->A: No effect on CBLN1 interaction;
FT                                when associated with D76. No effect on
FT                                CBLN1 binding; when associated with D-76;
FT                                A-343; A-346 and A-350. No effect on
FT                                synapse assembly; when associated with A-
FT                                343; A-346 and A-350. No effect on
FT                                cerebellar parallel fiber-Purkinje cell
FT                                synapse formation; when associated with
FT                                A-343; A-346 and A-350. Does not affect
FT                                D-Serine?dependent long term synaptic
FT                                depression at PF-PC synapses; when
FT                                associated with A-343; A-346 and A-350.
FT                                Does not affect motor coordination; when
FT                                associated with A-343; A-346 and A-350.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     350    350       M->A: No effect on CBLN1 interaction;
FT                                when associated with D76. No effect on
FT                                CBLN1 binding; when associated with D-76;
FT                                A-343; A-346 and A-349. No effect on
FT                                synapse assembly; when associated with A-
FT                                343; A-346 and A-349. No effect on
FT                                cerebellar parallel fiber-Purkinje cell
FT                                synapse formation; when associated with
FT                                A-343; A-346 and A-349. Does not affect
FT                                D-Serine?dependent long term synaptic
FT                                depression at PF-PC synapses; when
FT                                associated with A-343; A-346 and A-349.
FT                                Does not affect motor coordination; when
FT                                associated with A-343; A-346 and A-349.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     352    352       S->A: Reduces binding to CBLN1; when
FT                                associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     364    364       Q->A: No effect on CBLN1 interaction;
FT                                when associated with D76.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MUTAGEN     434    434       L->ELSNGTDGAS: Impairs the ability of the
FT                                LBD to induce pore closure. No effect on
FT                                synapse assembly. No effect on cerebellar
FT                                parallel fiber-Purkinje cell synapse
FT                                formation. Abolishes D-Serine?dependent
FT                                long term synaptic depression at PF-PC
FT                                synapses. Does not affect motor
FT                                coordination.
FT                                {ECO:0000269|PubMed:27418511}.
FT   CONFLICT      6      6       F -> L (in Ref. 1; AAC39579 and 4;
FT                                AAH99652/AAH99653/AAH99654).
FT                                {ECO:0000305}.
FT   CONFLICT      8      8       L -> F (in Ref. 4; AAH99652).
FT                                {ECO:0000305}.
FT   CONFLICT    290    290       V -> I (in Ref. 1; AAC39579).
FT                                {ECO:0000305}.
FT   CONFLICT    462    462       G -> C (in Ref. 1; AAC39579).
FT                                {ECO:0000305}.
FT   CONFLICT    557    557       D -> E (in Ref. 4; AAH99652).
FT                                {ECO:0000305}.
FT   CONFLICT    752    752       N -> Y (in Ref. 1; AAC39579).
FT                                {ECO:0000305}.
FT   STRAND       27     34       {ECO:0000244|PDB:5KC8}.
FT   HELIX        38     53       {ECO:0000244|PDB:5KC8}.
FT   STRAND       63     70       {ECO:0000244|PDB:5KC8}.
FT   HELIX        75     88       {ECO:0000244|PDB:5KC8}.
FT   STRAND       93     97       {ECO:0000244|PDB:5KC8}.
FT   HELIX        99    112       {ECO:0000244|PDB:5KC8}.
FT   STRAND      116    120       {ECO:0000244|PDB:5KC8}.
FT   STRAND      137    139       {ECO:0000244|PDB:5KCA}.
FT   STRAND      143    145       {ECO:0000244|PDB:5KC8}.
FT   HELIX       152    162       {ECO:0000244|PDB:5KC8}.
FT   STRAND      167    172       {ECO:0000244|PDB:5KC8}.
FT   HELIX       178    181       {ECO:0000244|PDB:5KC8}.
FT   HELIX       182    190       {ECO:0000244|PDB:5KC8}.
FT   STRAND      194    199       {ECO:0000244|PDB:5KC8}.
FT   HELIX       204    214       {ECO:0000244|PDB:5KC8}.
FT   HELIX       217    226       {ECO:0000244|PDB:5KC8}.
FT   STRAND      229    234       {ECO:0000244|PDB:5KC8}.
FT   HELIX       236    248       {ECO:0000244|PDB:5KC8}.
FT   STRAND      257    261       {ECO:0000244|PDB:5KC8}.
FT   HELIX       267    276       {ECO:0000244|PDB:5KC8}.
FT   STRAND      279    287       {ECO:0000244|PDB:5KC8}.
FT   HELIX       294    297       {ECO:0000244|PDB:5KC8}.
FT   STRAND      298    300       {ECO:0000244|PDB:5KC8}.
FT   HELIX       307    310       {ECO:0000244|PDB:5KC8}.
FT   HELIX       315    318       {ECO:0000244|PDB:5KC8}.
FT   HELIX       322    343       {ECO:0000244|PDB:5KC8}.
FT   STRAND      355    357       {ECO:0000244|PDB:5KC8}.
FT   HELIX       366    374       {ECO:0000244|PDB:5KC8}.
FT   STRAND      377    380       {ECO:0000244|PDB:5KC8}.
FT   STRAND      383    386       {ECO:0000244|PDB:5KC8}.
FT   STRAND      397    402       {ECO:0000244|PDB:5KC8}.
FT   STRAND      414    420       {ECO:0000244|PDB:5KC8}.
FT   TURN        421    423       {ECO:0000244|PDB:5KC8}.
FT   STRAND      424    427       {ECO:0000244|PDB:5KC8}.
SQ   SEQUENCE   1007 AA;  113356 MW;  8EF938AB7F1D6D26 CRC64;
     MEVFPFLLVL SVWWSRTWDS ANADSIIHIG AIFDESAKKD DEVFRTAVGD LNQNEEILQT
     EKITFSVTFV DGNNPFQAVQ EACELMNQGI LALVSSIGCT SAGSLQSLAD AMHIPHLFIQ
     RSTAGTPRSG CGLTRSNRND DYTLSVRPPV YLHDVILRVV TEYAWQKFII FYDSEYDIRG
     IQEFLDKVSQ QGMDVALQKV ENNINKMITT LFDTMRIEEL NRYRDTLRRA ILVMNPATAK
     SFITEVVETN LVAFDCHWII INEEINDVDV QELVRRSIGR LTIIRQTFPV PQNISQRCFR
     GNHRISSTLC DPKDPFAQNM EISNLYIYDT VLLLANAFHK KLEDRKWHSM ASLSCIRKNS
     KPWQGGRSML ETIKKGGVSG LTGELEFGEN GGNPNVHFEI LGTNYGEELG RGVRKLGCWN
     PVTGLNGSLT DKKLENNMRG VVLRVVTVLE EPFVMVSENV LGKPKKYQGF SIDVLDALSN
     YLGFNYEIYV APDHKYGSPQ EDGTWNGLVG ELVFKRADIG ISALTITPDR ENVVDFTTRY
     MDYSVGVLLR RAEKTVDMFA CLAPFDLSLW ACIAGTVLLV GLLVYLLNWL NPPRLQMGSM
     TSTTLYNSMW FVYGSFVQQG GEVPYTTLAT RMMMGAWWLF ALIVISSYTA NLAAFLTITR
     IESSIQSLQD LSKQTEIPYG TVLDSAVYEH VRMKGLNPFE RDSMYSQMWR MINRSNGSEN
     NVLESQAGIQ KVKYGNYAFV WDAAVLEYVA INDPDCSFYT IGNTVADRGY GIALQHGSPY
     RDVFSQRILE LQQNGDMDIL KHKWWPKNGQ CDLYSSVDTK QKGGALDIKS FAGVFCILAA
     GIVLSCFIAM LETWWNKRKG SRVPSKEDDK EIDLEHLHRR VNSLCTDDDS PHKQFSTSSI
     DLTPLDIDTL PTRQALEQIS DFRNTHITTT TFIPEQIQTL SRTLSAKAAS GFTFGNVPEH
     RTGPFRHRAP NGGFFRSPIK TMSSIPYQPT PTLGLNLGND PDRGTSI
//
ID   NMD3B_HUMAN             Reviewed;        1043 AA.
AC   O60391; Q5EAK7; Q7RTW9;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   20-DEC-2017, entry version 143.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 3B;
DE            Short=GluN3B;
DE   AltName: Full=N-methyl-D-aspartate receptor subtype 3B;
DE            Short=NMDAR3B;
DE            Short=NR3B;
DE   Flags: Precursor;
GN   Name=GRIN3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   IDENTIFICATION.
RX   PubMed=11735224; DOI=10.1006/geno.2001.6666;
RA   Andersson O., Stenqvist A., Attersand A., von Euler G.;
RT   "Nucleotide sequence, genomic organization, and chromosomal
RT   localization of genes encoding the human NMDA receptor subunits NR3A
RT   and NR3B.";
RL   Genomics 78:178-184(2001).
RN   [3]
RP   IDENTIFICATION.
RX   PubMed=11717388;
RA   Nishi M., Hinds H., Lu H.-P., Kawata M., Hayashi Y.;
RT   "Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate
RT   receptor subunit that works in a dominant-negative manner.";
RL   J. Neurosci. 21:RC185.1-RC185.6(2001).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=15722182; DOI=10.1016/j.neulet.2004.11.064;
RA   Bendel O., Meijer B., Hurd Y., von Euler G.;
RT   "Cloning and expression of the human NMDA receptor subunit NR3B in the
RT   adult human hippocampus.";
RL   Neurosci. Lett. 377:31-36(2005).
RN   [5]
RP   VARIANTS CYS-180; TRP-194; GLN-247; TRP-247; GLY-285; LYS-332;
RP   CYS-336; HIS-350; LEU-381; HIS-470; PRO-472; SER-515; VAL-583;
RP   CYS-598; HIS-608; MET-641; LEU-678; ASP-919; MET-928 AND VAL-948.
RX   PubMed=22833210; DOI=10.1038/tp.2011.52;
RG   S2D team;
RA   Tarabeux J., Kebir O., Gauthier J., Hamdan F.F., Xiong L., Piton A.,
RA   Spiegelman D., Henrion E., Millet B., Fathalli F., Joober R.,
RA   Rapoport J.L., DeLisi L.E., Fombonne E., Mottron L., Forget-Dubois N.,
RA   Boivin M., Michaud J.L., Drapeau P., Lafreniere R.G., Rouleau G.A.,
RA   Krebs M.O.;
RT   "Rare mutations in N-methyl-D-aspartate glutamate receptors in autism
RT   spectrum disorders and schizophrenia.";
RL   Transl. Psychiatry 1:E55-E55(2011).
CC   -!- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels
CC       with reduced single-channel conductance, low calcium permeability
CC       and low voltage-dependent sensitivity to magnesium. Mediated by
CC       glycine.
CC   -!- SUBUNIT: Forms heteromeric channel of a zeta subunit (GRIN1), a
CC       epsilon subunit (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and a third
CC       subunit (GRIN3A or GRIN3B). Does not form functional homomeric
CC       channels. Found in a complex containing GRIN1 and GRIN2A (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250}. Note=Requires the
CC       presence of GRIN1 to be targeted at the plasma membrane.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR3B/GRIN3B subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC12680.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004528; AAC12680.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BK000070; DAA00018.1; -; mRNA.
DR   EMBL; BK004079; DAA04570.1; -; mRNA.
DR   CCDS; CCDS32861.1; -.
DR   RefSeq; NP_619635.1; NM_138690.2.
DR   UniGene; Hs.660378; -.
DR   ProteinModelPortal; O60391; -.
DR   BioGrid; 125509; 2.
DR   MINT; MINT-6630966; -.
DR   STRING; 9606.ENSP00000234389; -.
DR   ChEMBL; CHEMBL2094124; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB06741; Gavestinel.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB04896; Milnacipran.
DR   DrugBank; DB01173; Orphenadrine.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01520; Tenocyclidine.
DR   iPTMnet; O60391; -.
DR   PhosphoSitePlus; O60391; -.
DR   BioMuta; GRIN3B; -.
DR   PaxDb; O60391; -.
DR   PRIDE; O60391; -.
DR   Ensembl; ENST00000234389; ENSP00000234389; ENSG00000116032.
DR   GeneID; 116444; -.
DR   KEGG; hsa:116444; -.
DR   UCSC; uc002lqo.2; human.
DR   CTD; 116444; -.
DR   DisGeNET; 116444; -.
DR   EuPathDB; HostDB:ENSG00000116032.5; -.
DR   GeneCards; GRIN3B; -.
DR   HGNC; HGNC:16768; GRIN3B.
DR   MIM; 606651; gene.
DR   neXtProt; NX_O60391; -.
DR   OpenTargets; ENSG00000116032; -.
DR   PharmGKB; PA28984; -.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   HOGENOM; HOG000231528; -.
DR   HOVERGEN; HBG052634; -.
DR   InParanoid; O60391; -.
DR   KO; K05214; -.
DR   OMA; HLQLDWA; -.
DR   OrthoDB; EOG091G00PT; -.
DR   PhylomeDB; O60391; -.
DR   TreeFam; TF314731; -.
DR   SignaLink; O60391; -.
DR   GeneWiki; GRIN3B; -.
DR   GenomeRNAi; 116444; -.
DR   PRO; PR:O60391; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000116032; -.
DR   CleanEx; HS_GRIN3B; -.
DR   Genevisible; O60391; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005262; F:calcium channel activity; IEA:Ensembl.
DR   GO; GO:0005261; F:cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0016594; F:glycine binding; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0042165; F:neurotransmitter binding; ISS:UniProtKB.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; ISS:UniProtKB.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051205; P:protein insertion into membrane; ISS:UniProtKB.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISS:UniProtKB.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell junction; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Magnesium; Membrane; Polymorphism; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1043       Glutamate receptor ionotropic, NMDA 3B.
FT                                /FTId=PRO_0000011570.
FT   TOPO_DOM     23    564       Extracellular. {ECO:0000255}.
FT   TRANSMEM    565    585       Helical. {ECO:0000255}.
FT   TOPO_DOM    586    648       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    649    669       Helical. {ECO:0000255}.
FT   TOPO_DOM    670    830       Extracellular. {ECO:0000255}.
FT   TRANSMEM    831    851       Helical. {ECO:0000255}.
FT   TOPO_DOM    852   1043       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     69     69       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    344    344       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    451    451       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    465    465       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    786    786       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     157    157       T -> M (in dbSNP:rs2240154).
FT                                /FTId=VAR_019676.
FT   VARIANT     180    180       R -> C. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079909.
FT   VARIANT     194    194       R -> W. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079910.
FT   VARIANT     247    247       R -> Q. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079911.
FT   VARIANT     247    247       R -> W. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079912.
FT   VARIANT     285    285       A -> G (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079913.
FT   VARIANT     332    332       E -> K. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079914.
FT   VARIANT     336    336       R -> C (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079915.
FT   VARIANT     350    350       R -> H. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079916.
FT   VARIANT     381    381       P -> L (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079917.
FT   VARIANT     404    404       R -> W (in dbSNP:rs4807399).
FT                                /FTId=VAR_019677.
FT   VARIANT     414    414       W -> R (in dbSNP:rs2240157).
FT                                /FTId=VAR_019678.
FT   VARIANT     470    470       R -> H (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079918.
FT   VARIANT     472    472       L -> P (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079919.
FT   VARIANT     515    515       G -> S. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079920.
FT   VARIANT     577    577       T -> M (in dbSNP:rs2240158).
FT                                /FTId=VAR_019679.
FT   VARIANT     583    583       A -> V. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079921.
FT   VARIANT     598    598       R -> C. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079922.
FT   VARIANT     608    608       R -> H. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079923.
FT   VARIANT     612    612       T -> A (in dbSNP:rs60621387).
FT                                /FTId=VAR_061188.
FT   VARIANT     641    641       T -> M (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079924.
FT   VARIANT     678    678       S -> L. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079925.
FT   VARIANT     845    845       A -> T (in dbSNP:rs2285906).
FT                                /FTId=VAR_019680.
FT   VARIANT     919    919       E -> D (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079926.
FT   VARIANT     928    928       V -> M. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079927.
FT   VARIANT     948    948       A -> V (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079928.
SQ   SEQUENCE   1043 AA;  112992 MW;  B7DEB2BEECD6AFEC CRC64;
     MEFVRALWLG LALALGPGSA GGHPQPCGVL ARLGGSVRLG ALLPRAPLAR ARARAALARA
     ALAPRLPHNL SLELVVAAPP ARDPASLTRG LCQALVPPGV AALLAFPEAR PELLQLHFLA
     AATETPVLSL LRREARAPLG APNPFHLQLH WASPLETLLD VLVAVLQAHA WEDVGLALCR
     TQDPGGLVAL WTSRAGRPPQ LVLDLSRRDT GDAGLRARLA PMAAPVGGEA PVPAAVLLGC
     DIARARRVLE AVPPGPHWLL GTPLPPKALP TAGLPPGLLA LGEVARPPLE AAIHDIVQLV
     ARALGSAAQV QPKRALLPAP VNCGDLQPAG PESPGRFLAR FLANTSFQGR TGPVWVTGSS
     QVHMSRHFKV WSLRRDPRGA PAWATVGSWR DGQLDLEPGG ASARPPPPQG AQVWPKLRVV
     TLLEHPFVFA RDPDEDGQCP AGQLCLDPGT NDSATLDALF AALANGSAPR ALRKCCYGYC
     IDLLERLAED TPFDFELYLV GDGKYGALRD GRWTGLVGDL LAGRAHMAVT SFSINSARSQ
     VVDFTSPFFS TSLGIMVRAR DTASPIGAFM WPLHWSTWLG VFAALHLTAL FLTVYEWRSP
     YGLTPRGRNR STVFSYSSAL NLCYAILFRR TVSSKTPKCP TGRLLMNLWA IFCLLVLSSY
     TANLAAVMVG DKTFEELSGI HDPKLHHPAQ GFRFGTVWES SAEAYIKKSF PDMHAHMRRH
     SAPTTPRGVA MLTSDPPKLN AFIMDKSLLD YEVSIDADCK LLTVGKPFAI EGYGIGLPQN
     SPLTSNLSEF ISRYKSSGFI DLLHDKWYKM VPCGKRVFAV TETLQMSIYH FAGLFVLLCL
     GLGSALLSSL GEHAFFRLAL PRIRKGSRLQ YWLHTSQKIH RALNTEPPEG SKEETAEAEP
     SGPEVEQQQQ QQDQPTAPEG WKRARRAVDK ERRVRFLLEP AVVVAPEADA EAEAAPREGP
     VWLCSYGRPP AARPTGAPQP GELQELERRI EVARERLRQA LVRRGQLLAQ LGDSARHRPR
     RLLQARAAPA EAPPHSGRPG SQE
//
ID   HCN1_HUMAN              Reviewed;         890 AA.
AC   O60741;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   20-DEC-2017, entry version 147.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 1;
DE            Short=BCNG-1;
GN   Name=HCN1; Synonyms=BCNG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 122-862, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9630217; DOI=10.1016/S0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R.,
RA   Siegelbaum S.A., Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=15351778; DOI=10.1038/sj.bjp.0705945;
RA   Gill C.H., Randall A., Bates S.A., Hill K., Owen D., Larkman P.M.,
RA   Cairns W., Yusaf S.P., Murdock P.R., Strijbos P.J., Powell A.J.,
RA   Benham C.D., Davies C.H.;
RT   "Characterization of the human HCN1 channel and its inhibition by
RT   capsazepine.";
RL   Br. J. Pharmacol. 143:411-421(2004).
RN   [4] {ECO:0000244|PDB:5U6O, ECO:0000244|PDB:5U6P}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF APOPROTEIN AND IN
RP   COMPLEX WITH CAMP, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT,
RP   AND ENZYME REGULATION.
RX   PubMed=28086084; DOI=10.1016/j.cell.2016.12.023;
RA   Lee C.H., MacKinnon R.;
RT   "Structures of the human HCN1 hyperpolarization-activated channel.";
RL   Cell 168:111-120(2017).
RN   [5]
RP   INVOLVEMENT IN EIEE24, VARIANTS EIEE24 VAL-47; PHE-100; PRO-272;
RP   TYR-279; THR-297 AND HIS-401, AND CHARACTERIZATION OF VARIANTS EIEE24
RP   PHE-100; PRO-272; TYR-279; THR-297 AND HIS-401.
RX   PubMed=24747641; DOI=10.1038/ng.2952;
RG   EuroEPINOMICS RES Consortium;
RA   Nava C., Dalle C., Rastetter A., Striano P., de Kovel C.G.,
RA   Nabbout R., Cances C., Ville D., Brilstra E.H., Gobbi G., Raffo E.,
RA   Bouteiller D., Marie Y., Trouillard O., Robbiano A., Keren B.,
RA   Agher D., Roze E., Lesage S., Nicolas A., Brice A., Baulac M.,
RA   Vogt C., El Hajj N., Schneider E., Suls A., Weckhuysen S., Gormley P.,
RA   Lehesjoki A.E., De Jonghe P., Helbig I., Baulac S., Zara F.,
RA   Koeleman B.P., Haaf T., LeGuern E., Depienne C.;
RT   "De novo mutations in HCN1 cause early infantile epileptic
RT   encephalopathy.";
RL   Nat. Genet. 46:640-645(2014).
RN   [6]
RP   VARIANTS EIEE24 ILE-153 AND ASP-391.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions (PubMed:28086084).
CC       Contributes to the native pacemaker currents in heart (If) and in
CC       neurons (Ih). May mediate responses to sour stimuli.
CC       {ECO:0000269|PubMed:15351778, ECO:0000269|PubMed:28086084}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding promotes
CC       tetramerization and formation of an active channel. Compared to
CC       other family members, cAMP has less stimulatory effect on HCN1
CC       because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low. Inhibited by Cs(1+),
CC       zatebradine, capsazepine and ZD7288. {ECO:0000269|PubMed:15351778,
CC       ECO:0000269|PubMed:28086084}.
CC   -!- SUBUNIT: Homotetramer (PubMed:28086084). Heterotetramer with HCN2.
CC       The potassium channel is composed of a homo- or heterotetrameric
CC       complex of pore-forming subunits. Interacts with KCNE2. Interacts
CC       with the SH3 domain of CSK (By similarity).
CC       {ECO:0000250|UniProtKB:O88704, ECO:0000269|PubMed:28086084}.
CC   -!- INTERACTION:
CC       Q4ACU6-1:Shank3 (xeno); NbExp=4; IntAct=EBI-11173743, EBI-16201983;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15351778,
CC       ECO:0000269|PubMed:28086084}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15351778, ECO:0000269|PubMed:28086084}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, in particular in amygdala
CC       and hippocampus, while expression in caudate nucleus, corpus
CC       callosum, substantia nigra, subthalamic nucleus and thalamus is
CC       very low or not detectable. Detected at very low levels in muscle
CC       and pancreas. {ECO:0000269|PubMed:9630217}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000305|PubMed:28086084}.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 24 (EIEE24)
CC       [MIM:615871]: A disease characterized by early-onset seizures,
CC       intellectual disability of varying degrees, and behavioral
CC       disturbances or autistic features in most individuals.
CC       {ECO:0000269|PubMed:24747641, ECO:0000269|PubMed:27864847}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC39759.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC099514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117529; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138520; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF064876; AAC39759.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS3952.1; -.
DR   RefSeq; NP_066550.2; NM_021072.3.
DR   UniGene; Hs.353176; -.
DR   PDB; 5U6O; EM; 3.50 A; A/B/C/D=1-890.
DR   PDB; 5U6P; EM; 3.51 A; A/B/C/D=1-890.
DR   PDBsum; 5U6O; -.
DR   PDBsum; 5U6P; -.
DR   ProteinModelPortal; O60741; -.
DR   SMR; O60741; -.
DR   BioGrid; 131543; 5.
DR   DIP; DIP-62038N; -.
DR   IntAct; O60741; 1.
DR   STRING; 9606.ENSP00000307342; -.
DR   BindingDB; O60741; -.
DR   ChEMBL; CHEMBL1795171; -.
DR   GuidetoPHARMACOLOGY; 400; -.
DR   iPTMnet; O60741; -.
DR   PhosphoSitePlus; O60741; -.
DR   BioMuta; HCN1; -.
DR   MaxQB; O60741; -.
DR   PaxDb; O60741; -.
DR   PeptideAtlas; O60741; -.
DR   PRIDE; O60741; -.
DR   Ensembl; ENST00000303230; ENSP00000307342; ENSG00000164588.
DR   GeneID; 348980; -.
DR   KEGG; hsa:348980; -.
DR   UCSC; uc003jok.4; human.
DR   CTD; 348980; -.
DR   DisGeNET; 348980; -.
DR   EuPathDB; HostDB:ENSG00000164588.5; -.
DR   GeneCards; HCN1; -.
DR   H-InvDB; HIX0004850; -.
DR   HGNC; HGNC:4845; HCN1.
DR   HPA; HPA019195; -.
DR   MalaCards; HCN1; -.
DR   MIM; 602780; gene.
DR   MIM; 615871; phenotype.
DR   neXtProt; NX_O60741; -.
DR   OpenTargets; ENSG00000164588; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA77; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; O60741; -.
DR   KO; K04954; -.
DR   OMA; TRTFHYA; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; O60741; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   ChiTaRS; HCN1; human.
DR   GeneWiki; HCN1; -.
DR   GenomeRNAi; 348980; -.
DR   PRO; PR:O60741; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164588; -.
DR   CleanEx; HS_HCN1; -.
DR   ExpressionAtlas; O60741; baseline and differential.
DR   Genevisible; O60741; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0098855; C:HCN channel complex; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; NAS:UniProtKB.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:0045176; P:apical protein localization; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0046549; P:retinal cone cell development; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF373; PTHR10217:SF373; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding; Polymorphism;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    890       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                1.
FT                                /FTId=PRO_0000054107.
FT   TOPO_DOM      1    142       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    143    164       Helical; Name=Segment S1.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    165    173       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    174    194       Helical; Name=Segment S2.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    195    215       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    216    236       Helical; Name=Segment S3.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    237    260       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    261    281       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    282    295       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    296    318       Helical; Name=Segment S5.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    319    344       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   INTRAMEM    345    366       Pore-forming; Name=Segment H5.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    367    371       Extracellular.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TRANSMEM    372    392       Helical; Name=Segment S6.
FT                                {ECO:0000269|PubMed:28086084}.
FT   TOPO_DOM    393    890       Cytoplasmic.
FT                                {ECO:0000269|PubMed:28086084}.
FT   NP_BIND     539    542       cAMP. {ECO:0000244|PDB:5U6P,
FT                                ECO:0000305|PubMed:28086084}.
FT   NP_BIND     549    550       cAMP. {ECO:0000244|PDB:5U6P,
FT                                ECO:0000305|PubMed:28086084}.
FT   NP_BIND     590    593       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   REGION        1     93       Intrinsically disordered.
FT                                {ECO:0000305|PubMed:28086084}.
FT   MOTIF       358    362       Selectivity filter.
FT                                {ECO:0000305|PubMed:28086084}.
FT   COMPBIAS      1     80       Gly-rich.
FT   COMPBIAS    726    756       Gln-rich.
FT   COMPBIAS    857    863       Poly-Pro.
FT   CARBOHYD    338    338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      42     42       P -> S (in dbSNP:rs56164833).
FT                                /FTId=VAR_061105.
FT   VARIANT      47     47       G -> V (in EIEE24; unknown pathological
FT                                significance; dbSNP:rs544994462).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071825.
FT   VARIANT     100    100       S -> F (in EIEE24; dominant-negative
FT                                mutation resulting in gain of channel
FT                                function; dbSNP:rs587777492).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071826.
FT   VARIANT     153    153       M -> I (in EIEE24; dbSNP:rs1057519548).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078216.
FT   VARIANT     272    272       S -> P (in EIEE24; dominant-negative
FT                                mutation resulting in loss of channel
FT                                currents; dbSNP:rs587777493).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071827.
FT   VARIANT     279    279       H -> Y (in EIEE24; results in a gain of
FT                                channel function; dbSNP:rs587777495).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071828.
FT   VARIANT     297    297       R -> T (in EIEE24; dominant-negative
FT                                mutation resulting in loss of channel
FT                                currents; dbSNP:rs587777494).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071829.
FT   VARIANT     391    391       G -> D (in EIEE24; dbSNP:rs1057519547).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078217.
FT   VARIANT     401    401       D -> H (in EIEE24; results in a gain of
FT                                channel function; dbSNP:rs587777491).
FT                                {ECO:0000269|PubMed:24747641}.
FT                                /FTId=VAR_071830.
FT   CONFLICT    786    786       L -> F (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    789    789       S -> W (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    841    841       L -> F (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    857    857       P -> L (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   CONFLICT    861    861       P -> L (in Ref. 2; AAC39759).
FT                                {ECO:0000305}.
FT   HELIX        95    102       {ECO:0000244|PDB:5U6O}.
FT   HELIX       108    114       {ECO:0000244|PDB:5U6O}.
FT   HELIX       117    127       {ECO:0000244|PDB:5U6O}.
FT   STRAND      130    133       {ECO:0000244|PDB:5U6O}.
FT   HELIX       140    166       {ECO:0000244|PDB:5U6O}.
FT   HELIX       173    195       {ECO:0000244|PDB:5U6O}.
FT   TURN        209    211       {ECO:0000244|PDB:5U6O}.
FT   HELIX       212    218       {ECO:0000244|PDB:5U6O}.
FT   TURN        219    221       {ECO:0000244|PDB:5U6O}.
FT   HELIX       222    229       {ECO:0000244|PDB:5U6O}.
FT   HELIX       232    241       {ECO:0000244|PDB:5U6O}.
FT   HELIX       253    264       {ECO:0000244|PDB:5U6O}.
FT   HELIX       265    269       {ECO:0000244|PDB:5U6O}.
FT   HELIX       270    289       {ECO:0000244|PDB:5U6O}.
FT   HELIX       293    322       {ECO:0000244|PDB:5U6O}.
FT   HELIX       330    333       {ECO:0000244|PDB:5U6O}.
FT   STRAND      337    339       {ECO:0000244|PDB:5U6O}.
FT   HELIX       341    357       {ECO:0000244|PDB:5U6O}.
FT   STRAND      362    364       {ECO:0000244|PDB:5U6O}.
FT   HELIX       369    400       {ECO:0000244|PDB:5U6O}.
FT   HELIX       402    421       {ECO:0000244|PDB:5U6O}.
FT   HELIX       425    439       {ECO:0000244|PDB:5U6O}.
FT   HELIX       446    452       {ECO:0000244|PDB:5U6O}.
FT   HELIX       455    472       {ECO:0000244|PDB:5U6O}.
FT   TURN        474    477       {ECO:0000244|PDB:5U6O}.
FT   HELIX       481    490       {ECO:0000244|PDB:5U6O}.
FT   STRAND      492    496       {ECO:0000244|PDB:5U6O}.
FT   STRAND      501    503       {ECO:0000244|PDB:5U6O}.
FT   STRAND      505    507       {ECO:0000244|PDB:5U6O}.
FT   STRAND      511    523       {ECO:0000244|PDB:5U6O}.
FT   STRAND      525    527       {ECO:0000244|PDB:5U6O}.
FT   STRAND      541    545       {ECO:0000244|PDB:5U6O}.
FT   STRAND      551    565       {ECO:0000244|PDB:5U6O}.
FT   HELIX       566    575       {ECO:0000244|PDB:5U6O}.
FT   HELIX       577    584       {ECO:0000244|PDB:5U6O}.
SQ   SEQUENCE   890 AA;  98796 MW;  A62F5E79C01257A2 CRC64;
     MEGGGKPNSS SNSRDDGNSV FPAKASATGA GPAAAEKRLG TPPGGGGAGA KEHGNSVCFK
     VDGGGGGGGG GGGGEEPAGG FEDAEGPRRQ YGFMQRQFTS MLQPGVNKFS LRMFGSQKAV
     EKEQERVKTA GFWIIHPYSD FRFYWDLIML IMMVGNLVII PVGITFFTEQ TTTPWIIFNV
     ASDTVFLLDL IMNFRTGTVN EDSSEIILDP KVIKMNYLKS WFVVDFISSI PVDYIFLIVE
     KGMDSEVYKT ARALRIVRFT KILSLLRLLR LSRLIRYIHQ WEEIFHMTYD LASAVVRIFN
     LIGMMLLLCH WDGCLQFLVP LLQDFPPDCW VSLNEMVNDS WGKQYSYALF KAMSHMLCIG
     YGAQAPVSMS DLWITMLSMI VGATCYAMFV GHATALIQSL DSSRRQYQEK YKQVEQYMSF
     HKLPADMRQK IHDYYEHRYQ GKIFDEENIL NELNDPLREE IVNFNCRKLV ATMPLFANAD
     PNFVTAMLSK LRFEVFQPGD YIIREGAVGK KMYFIQHGVA GVITKSSKEM KLTDGSYFGE
     ICLLTKGRRT ASVRADTYCR LYSLSVDNFN EVLEEYPMMR RAFETVAIDR LDRIGKKNSI
     LLQKFQKDLN TGVFNNQENE ILKQIVKHDR EMVQAIAPIN YPQMTTLNST SSTTTPTSRM
     RTQSPPVYTA TSLSHSNLHS PSPSTQTPQP SAILSPCSYT TAVCSPPVQS PLAARTFHYA
     SPTASQLSLM QQQPQQQVQQ SQPPQTQPQQ PSPQPQTPGS STPKNEVHKS TQALHNTNLT
     REVRPLSASQ PSLPHEVSTL ISRPHPTVGE SLASIPQPVT AVPGTGLQAG GRSTVPQRVT
     LFRQMSSGAI PPNRGVPPAP PPPAAALPRE SSSVLNTDPD AEKPRFASNL
//
ID   CNGC1_ARATH             Reviewed;         716 AA.
AC   O65717;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   20-DEC-2017, entry version 137.
DE   RecName: Full=Cyclic nucleotide-gated ion channel 1;
DE            Short=AtCNGC1;
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 1;
GN   Name=CNGC1; OrderedLocusNames=At5g53130; ORFNames=MFH8.6;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=cv. Columbia;
RA   Koehler C., Neuhaus G.;
RT   "Cloning and partial characterization of two putative cyclic
RT   nucleotide-regulated ion channels from Arabidopsis thaliana,
RT   designated CNGC1 and CNGC2.";
RL   (er) Plant Gene Register PGR98-062(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RA   Kaneko T., Katoh T., Asamizu E., Sato S., Nakamura Y., Kotani H.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. XI.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   INTERACTION WITH CALMODULIN.
RX   PubMed=10341447; DOI=10.1046/j.1365-313X.1999.00422.x;
RA   Koehler C., Merkle T., Neuhaus G.;
RT   "Characterisation of a novel gene family of putative cyclic
RT   nucleotide- and calmodulin-regulated ion channels in Arabidopsis
RT   thaliana.";
RL   Plant J. 18:97-104(1999).
RN   [6]
RP   CALMODULIN-BINDING DOMAIN.
RX   PubMed=10767408; DOI=10.1016/S0014-5793(00)01383-1;
RA   Koehler C., Neuhaus G.;
RT   "Characterisation of calmodulin binding to cyclic nucleotide-gated ion
RT   channels from Arabidopsis thaliana.";
RL   FEBS Lett. 471:133-136(2000).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11115134; DOI=10.1046/j.1365-313x.2000.00901.x;
RA   Sunkar R., Kaplan B., Bouche N., Arazi T., Dolev D., Talke I.N.,
RA   Maathuis F.J.M., Sanders D., Bouchez D., Fromm H.;
RT   "Expression of a truncated tobacco NtCBP4 channel in transgenic plants
RT   and disruption of the homologous Arabidopsis CNGC1 gene confer Pb2+
RT   tolerance.";
RL   Plant J. 24:533-542(2000).
RN   [8]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
RN   [9]
RP   CHARACTERIZATION, AND FUNCTION.
RX   PubMed=11842144; DOI=10.1104/pp.010832;
RA   Leng Q., Mercier R.W., Hua B.-G., Fromm H., Berkowitz G.A.;
RT   "Electrophysiological analysis of cloned cyclic nucleotide-gated ion
RT   channels.";
RL   Plant Physiol. 128:400-410(2002).
CC   -!- FUNCTION: Acts as cyclic nucleotide-gated ion channel. Can be
CC       activated by cyclic AMP which leads to an opening of the cation
CC       channel. May be responsible for cAMP-induced calcium entry in
CC       cells and thus should be involved in the calcium signal
CC       transduction. Could transport K(+), Na(+) and Pb(2+).
CC       {ECO:0000269|PubMed:11115134, ECO:0000269|PubMed:11842144}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer (Potential). Binds
CC       calmodulin-2/3/5 with a higher affinity than calmodulin-1/4.
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the whole plant but only weakly
CC       in roots.
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Plants exhibit an improved tolerance to
CC       Pb(2+). {ECO:0000269|PubMed:11115134}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y16327; CAA76178.1; -; mRNA.
DR   EMBL; AB025622; BAB08416.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96311.1; -; Genomic_DNA.
DR   EMBL; AF370139; AAK43954.1; -; mRNA.
DR   EMBL; BT000991; AAN41391.1; -; mRNA.
DR   PIR; T51354; T51354.
DR   RefSeq; NP_200125.1; NM_124692.3.
DR   UniGene; At.21042; -.
DR   UniGene; At.49166; -.
DR   ProteinModelPortal; O65717; -.
DR   SMR; O65717; -.
DR   BioGrid; 20638; 4.
DR   STRING; 3702.AT5G53130.1; -.
DR   TCDB; 1.A.1.5.5; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; O65717; -.
DR   PaxDb; O65717; -.
DR   EnsemblPlants; AT5G53130.1; AT5G53130.1; AT5G53130.
DR   GeneID; 835393; -.
DR   Gramene; AT5G53130.1; AT5G53130.1; AT5G53130.
DR   KEGG; ath:AT5G53130; -.
DR   Araport; AT5G53130; -.
DR   TAIR; locus:2163776; AT5G53130.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; O65717; -.
DR   KO; K05391; -.
DR   OMA; SVPMFEN; -.
DR   OrthoDB; EOG09360404; -.
DR   PhylomeDB; O65717; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:O65717; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; O65717; baseline and differential.
DR   Genevisible; O65717; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005216; F:ion channel activity; IEA:InterPro.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Calmodulin-binding; cAMP; cAMP-binding; Cell membrane; cGMP;
KW   cGMP-binding; Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    716       Cyclic nucleotide-gated ion channel 1.
FT                                /FTId=PRO_0000219329.
FT   TOPO_DOM      1     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    119    132       Extracellular. {ECO:0000255}.
FT   TRANSMEM    133    153       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    154    187       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    188    208       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    209    220       Extracellular. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    242    259       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    260    280       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    281    379       Extracellular. {ECO:0000255}.
FT   TRANSMEM    380    400       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    401    716       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      622    651       IQ.
FT   NP_BIND     486    610       cNMP.
FT   REGION      602    617       Calmodulin-binding.
FT   BINDING     557    557       cNMP. {ECO:0000250}.
SQ   SEQUENCE   716 AA;  83097 MW;  5883CA949B6E7BF2 CRC64;
     MNFRQEKFVR FQDWKSDKTS SDVEYSGKNE IQTGIFQRTI SSISDKFYRS FESSSARIKL
     FKRSYKSYSF KEAVSKGIGS THKILDPQGP FLQRWNKIFV LACIIAVSLD PLFFYVPIID
     DAKKCLGIDK KMEITASVLR SFTDVFYVLH IIFQFRTGFI APSSRVFGRG VLVEDKREIA
     KRYLSSHFII DILAVLPLPQ MVILIIIPHM RGSSSLNTKN MLKFIVFFQY IPRFIRIYPL
     YKEVTRTSGI LTETAWAGAA FNLFLYMLAS HVFGAFWYLF SIERETVCWK QACERNNPPC
     ISKLLYCDPE TAGGNAFLNE SCPIQTPNTT LFDFGIFLDA LQSGVVESQD FPQKFFYCFW
     WGLQNLSSLG QNLKTSTYIW EICFAVFISI AGLVLFSFLI GNMQTYLQST TTRLEEMRVK
     RRDAEQWMSH RLLPENLRKR IRRYEQYKWQ ETRGVDEENL LSNLPKDLRR DIKRHLCLAL
     LMRVPMFEKM DEQLLDALCD RLQPVLYTEE SYIVREGDPV DEMLFIMRGK LLTITTNGGR
     TGFLNSEYLG AGDFCGEELL TWALDPHSSS NLPISTRTVR ALMEVEAFAL KADDLKFVAS
     QFRRLHSKQL RHTFRYYSQQ WKTWAACFIQ AAWRRYIKKK LEESLKEEEN RLQDALAKEA
     CGSSPSLGAT IYASRFAANI LRTIRRSGSV RKPRMPERMP PMLLQKPAEP DFNSDD
//
ID   GLRA3_HUMAN             Reviewed;         464 AA.
AC   O75311; D3DP44; O75816; Q5D0E3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 172.
DE   RecName: Full=Glycine receptor subunit alpha-3;
DE   Flags: Precursor;
GN   Name=GLRA3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS ALPHA-3K AND
RP   ALPHA-3L), FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9677400; DOI=10.1074/jbc.273.31.19708;
RA   Nikolic Z., Laube B., Weber R.G., Lichter P., Kioschis P., Poustka A.,
RA   Muelhardt C., Becker C.-M.;
RT   "The human glycine receptor subunit alpha3. GLRA3 gene structure,
RT   chromosomal localization, and functional characterization of
RT   alternative transcripts.";
RL   J. Biol. Chem. 273:19708-19714(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-3L).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000244|PDB:5CFB}
RP   X-RAY CRYSTALLOGRAPHY (3.04 ANGSTROMS) OF 34-342 AND 419-460 IN
RP   COMPLEX WITH STRYCHNINE, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   TOPOLOGY, DISULFIDE BONDS, GLYCOSYLATION AT ASN-71, AND DOMAIN.
RX   PubMed=26416729; DOI=10.1038/nature14972;
RA   Huang X., Chen H., Michelsen K., Schneider S., Shaffer P.L.;
RT   "Crystal structure of human glycine receptor-alpha3 bound to
RT   antagonist strychnine.";
RL   Nature 526:277-280(2015).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       Channel opening is triggered by extracellular glycine
CC       (PubMed:9677400, PubMed:26416729). Channel characteristics depend
CC       on the subunit composition; heteropentameric channels display
CC       faster channel closure (By similarity). Plays an important role in
CC       the down-regulation of neuronal excitability (By similarity).
CC       Contributes to the generation of inhibitory postsynaptic currents
CC       (By similarity). Contributes to increased pain perception in
CC       response to increased prostaglandin E2 levels (By similarity).
CC       Plays a role in cellular responses to ethanol (By similarity).
CC       {ECO:0000250|UniProtKB:P24524, ECO:0000250|UniProtKB:Q91XP5,
CC       ECO:0000269|PubMed:26416729, ECO:0000269|PubMed:9677400}.
CC   -!- SUBUNIT: Homopentamer (in vitro) (PubMed:26416729). Heteropentamer
CC       composed of GLRA3 and GLRB. Both homopentamers and heteropentamers
CC       form functional ion channels, but their characteristics are subtly
CC       different (By similarity). {ECO:0000250|UniProtKB:P24524,
CC       ECO:0000269|PubMed:26416729}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:P24524}; Multi-pass membrane
CC       protein {ECO:0000305}. Perikaryon {ECO:0000250|UniProtKB:P24524}.
CC       Cell projection, dendrite {ECO:0000250|UniProtKB:P24524}. Cell
CC       junction, synapse {ECO:0000250|UniProtKB:P24524}. Cell membrane
CC       {ECO:0000269|PubMed:26416729, ECO:0000269|PubMed:9677400}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:26416729}.
CC       Note=Partially colocalizes with GPHN that is known to mediate
CC       receptor clustering at postsynaptic membranes.
CC       {ECO:0000250|UniProtKB:P24524}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha-3L;
CC         IsoId=O75311-1; Sequence=Displayed;
CC       Name=Alpha-3K;
CC         IsoId=O75311-2; Sequence=VSP_000084;
CC   -!- TISSUE SPECIFICITY: Widely distributed throughout the central
CC       nervous system. {ECO:0000269|PubMed:9677400}.
CC   -!- DOMAIN: The N-terminal domain carries structural determinants
CC       essential for agonist and antagonist binding. The channel pore is
CC       formed by pentameric assembly of the second transmembrane domain
CC       from all five subunits (PubMed:26416729). The cytoplasmic loop is
CC       an important determinant of channel inactivation kinetics.
CC       {ECO:0000269|PubMed:26416729, ECO:0000305}.
CC   -!- PTM: Phosphorylated by PKA; this causes down-regulation of channel
CC       activity. {ECO:0000250|UniProtKB:P24524}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:26416729}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRA3 sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF017724; AAC39919.1; -; Genomic_DNA.
DR   EMBL; AF017715; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017716; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017717; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017718; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017719; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017720; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017721; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017722; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; AF017723; AAC39919.1; JOINED; Genomic_DNA.
DR   EMBL; U93917; AAC39917.1; -; mRNA.
DR   EMBL; CH471056; EAX04730.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04732.1; -; Genomic_DNA.
DR   EMBL; BC036086; AAH36086.1; -; mRNA.
DR   CCDS; CCDS3822.1; -. [O75311-1]
DR   CCDS; CCDS43283.1; -. [O75311-2]
DR   RefSeq; NP_001036008.1; NM_001042543.2. [O75311-2]
DR   RefSeq; NP_006520.2; NM_006529.3. [O75311-1]
DR   UniGene; Hs.413099; -.
DR   PDB; 5CFB; X-ray; 3.04 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5TIN; X-ray; 2.61 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5TIO; X-ray; 3.25 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5VDH; X-ray; 2.85 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDB; 5VDI; X-ray; 3.10 A; A/B/C/D/E=34-342, A/B/C/D/E=419-460.
DR   PDBsum; 5CFB; -.
DR   PDBsum; 5TIN; -.
DR   PDBsum; 5TIO; -.
DR   PDBsum; 5VDH; -.
DR   PDBsum; 5VDI; -.
DR   ProteinModelPortal; O75311; -.
DR   SMR; O75311; -.
DR   BioGrid; 113705; 1.
DR   DIP; DIP-61773N; -.
DR   STRING; 9606.ENSP00000274093; -.
DR   BindingDB; O75311; -.
DR   ChEMBL; CHEMBL1075092; -.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB00431; Lindane.
DR   DrugBank; DB00466; Picrotoxin.
DR   GuidetoPHARMACOLOGY; 425; -.
DR   TCDB; 1.A.9.3.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; O75311; -.
DR   PhosphoSitePlus; O75311; -.
DR   PaxDb; O75311; -.
DR   PRIDE; O75311; -.
DR   DNASU; 8001; -.
DR   Ensembl; ENST00000274093; ENSP00000274093; ENSG00000145451. [O75311-1]
DR   Ensembl; ENST00000340217; ENSP00000345284; ENSG00000145451. [O75311-2]
DR   GeneID; 8001; -.
DR   KEGG; hsa:8001; -.
DR   UCSC; uc003ity.3; human. [O75311-1]
DR   CTD; 8001; -.
DR   DisGeNET; 8001; -.
DR   EuPathDB; HostDB:ENSG00000145451.12; -.
DR   GeneCards; GLRA3; -.
DR   HGNC; HGNC:4328; GLRA3.
DR   MIM; 600421; gene.
DR   neXtProt; NX_O75311; -.
DR   OpenTargets; ENSG00000145451; -.
DR   PharmGKB; PA28729; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; O75311; -.
DR   KO; K05195; -.
DR   OMA; MPMSPSD; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; O75311; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; GLRA3; -.
DR   GenomeRNAi; 8001; -.
DR   PRO; PR:O75311; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145451; -.
DR   CleanEx; HS_GLRA3; -.
DR   Genevisible; O75311; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016935; C:glycine-gated chloride channel complex; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IEA:InterPro.
DR   GO; GO:0022852; F:glycine-gated chloride ion channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0043200; P:response to amino acid; IBA:GO_Central.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008130; Glycine_rcpt_A3.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01676; GLYRALPHA3.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Metal-binding; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     33       {ECO:0000255}.
FT   CHAIN        34    464       Glycine receptor subunit alpha-3.
FT                                /FTId=PRO_0000000419.
FT   TOPO_DOM     34    255       Extracellular.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    256    277       Helical; Name=1.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    278    282       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    283    303       Helical; Name=2.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    304    314       Extracellular.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    315    335       Helical; Name=3.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    336    430       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TRANSMEM    431    451       Helical; Name=4.
FT                                {ECO:0000269|PubMed:26416729}.
FT   TOPO_DOM    452    464       Extracellular.
FT                                {ECO:0000269|PubMed:26416729}.
FT   REGION      235    240       Strychnine-binding.
FT                                {ECO:0000269|PubMed:26416729}.
FT   METAL       225    225       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       227    227       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       248    248       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   SITE        294    294       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000269|PubMed:26416729}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91XP5}.
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q91XP5}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5CFB, ECO:0000255,
FT                                ECO:0000269|PubMed:26416729}.
FT   DISULFID    171    185       {ECO:0000244|PDB:5CFB,
FT                                ECO:0000269|PubMed:26416729}.
FT   DISULFID    231    242       {ECO:0000244|PDB:5CFB,
FT                                ECO:0000269|PubMed:26416729}.
FT   VAR_SEQ     358    372       Missing (in isoform Alpha-3K).
FT                                {ECO:0000303|PubMed:9677400}.
FT                                /FTId=VSP_000084.
FT   CONFLICT    460    460       H -> HH (in Ref. 1; AAC39919).
FT                                {ECO:0000305}.
FT   HELIX        43     51       {ECO:0000244|PDB:5TIN}.
FT   TURN         53     55       {ECO:0000244|PDB:5TIN}.
FT   TURN         63     66       {ECO:0000244|PDB:5TIN}.
FT   STRAND       70     85       {ECO:0000244|PDB:5TIN}.
FT   TURN         86     89       {ECO:0000244|PDB:5TIN}.
FT   STRAND       90    102       {ECO:0000244|PDB:5TIN}.
FT   HELIX       104    106       {ECO:0000244|PDB:5TIN}.
FT   STRAND      114    118       {ECO:0000244|PDB:5TIN}.
FT   HELIX       120    125       {ECO:0000244|PDB:5TIN}.
FT   STRAND      131    133       {ECO:0000244|PDB:5TIN}.
FT   STRAND      136    141       {ECO:0000244|PDB:5TIN}.
FT   STRAND      144    146       {ECO:0000244|PDB:5TIN}.
FT   STRAND      149    154       {ECO:0000244|PDB:5TIN}.
FT   STRAND      157    170       {ECO:0000244|PDB:5TIN}.
FT   TURN        176    179       {ECO:0000244|PDB:5TIN}.
FT   STRAND      182    193       {ECO:0000244|PDB:5TIN}.
FT   TURN        196    198       {ECO:0000244|PDB:5TIN}.
FT   STRAND      199    203       {ECO:0000244|PDB:5TIN}.
FT   STRAND      208    211       {ECO:0000244|PDB:5TIN}.
FT   STRAND      218    222       {ECO:0000244|PDB:5TIN}.
FT   STRAND      227    230       {ECO:0000244|PDB:5TIN}.
FT   STRAND      233    235       {ECO:0000244|PDB:5TIN}.
FT   STRAND      238    240       {ECO:0000244|PDB:5TIN}.
FT   STRAND      242    251       {ECO:0000244|PDB:5TIN}.
FT   HELIX       254    259       {ECO:0000244|PDB:5TIN}.
FT   HELIX       261    273       {ECO:0000244|PDB:5TIN}.
FT   HELIX       274    276       {ECO:0000244|PDB:5TIN}.
FT   HELIX       282    302       {ECO:0000244|PDB:5TIN}.
FT   TURN        303    306       {ECO:0000244|PDB:5TIN}.
FT   HELIX       315    340       {ECO:0000244|PDB:5TIN}.
FT   HELIX       419    450       {ECO:0000244|PDB:5TIN}.
SQ   SEQUENCE   464 AA;  53800 MW;  8E17A30B3C6E648D CRC64;
     MAHVRHFRTL VSGFYFWEAA LLLSLVATKE TDSARSRSAP MSPSDFLDKL MGRTSGYDAR
     IRPNFKGPPV NVTCNIFINS FGSIAETTMD YRVNIFLRQK WNDPRLAYSE YPDDSLDLDP
     SMLDSIWKPD LFFANEKGAN FHEVTTDNKL LRIFKNGNVL YSIRLTLTLS CPMDLKNFPM
     DVQTCIMQLE SFGYTMNDLI FEWQDEAPVQ VAEGLTLPQF LLKEEKDLRY CTKHYNTGKF
     TCIEVRFHLE RQMGYYLIQM YIPSLLIVIL SWVSFWINMD AAPARVALGI TTVLTMTTQS
     SGSRASLPKV SYVKAIDIWM AVCLLFVFSA LLEYAAVNFV SRQHKELLRF RRKRKNKTEA
     FALEKFYRFS DMDDEVRESR FSFTAYGMGP CLQAKDGMTP KGPNHPVQVM PKSPDEMRKV
     FIDRAKKIDT ISRACFPLAF LIFNIFYWVI YKILRHEDIH QQQD
//
ID   ACH4_CAEEL              Reviewed;         548 AA.
AC   O76554;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-NOV-2017, entry version 134.
DE   RecName: Full=Acetylcholine receptor subunit alpha-type des-2;
DE   Flags: Precursor;
GN   Name=des-2; Synonyms=acr-4; ORFNames=T26H10.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH DEG-3, AND FUNCTION.
RX   PubMed=9860996; DOI=10.1073/pnas.95.26.15492;
RA   Treinin M., Gillo B., Liebman L., Chalfie M.;
RT   "Two functionally dependent acetylcholine subunits are encoded in a
RT   single Caenorhabditis elegans operon.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15492-15495(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=11273652; DOI=10.1006/mcne.2000.0944;
RA   Yassin L., Gillo B., Kahan T., Halevi S., Eshel M., Treinin M.;
RT   "Characterization of the deg-3/des-2 receptor: a nicotinic
RT   acetylcholine receptor that mutates to cause neuronal degeneration.";
RL   Mol. Cell. Neurosci. 17:589-599(2001).
RN   [4]
RP   INTERACTION WITH DEG-3 AND RIC-3.
RX   PubMed=11867529; DOI=10.1093/emboj/21.5.1012;
RA   Halevi S., McKay J., Palfreyman M., Yassin L., Eshel M., Jorgensen E.,
RA   Treinin M.;
RT   "The C. elegans ric-3 gene is required for maturation of nicotinic
RT   acetylcholine receptors.";
RL   EMBO J. 21:1012-1020(2002).
RN   [5]
RP   INTERACTION WITH DEG-3 AND RIC-3.
RX   PubMed=15932871; DOI=10.1074/jbc.M504369200;
RA   Ben-Ami H.C., Yassin L., Farah H., Michaeli A., Eshel M., Treinin M.;
RT   "RIC-3 affects properties and quantity of nicotinic acetylcholine
RT   receptors via a mechanism that does not require the coiled-coil
RT   domains.";
RL   J. Biol. Chem. 280:28053-28060(2005).
CC   -!- FUNCTION: Subunit of the non-synaptic neuronal acetylcholine
CC       receptor (AChR), which may play a role in chemotaxis towards
CC       choline. After binding choline or acetylcholine, the AChR responds
CC       by an extensive change in conformation that affects all subunits
CC       and leads to opening of an ion-conducting channel across the
CC       plasma membrane. {ECO:0000269|PubMed:11273652,
CC       ECO:0000269|PubMed:9860996}.
CC   -!- SUBUNIT: The functional receptor is a heteromer of deg-3 and des-
CC       2. Interacts with ric-3; which is required for proper receptor
CC       folding. {ECO:0000269|PubMed:11867529,
CC       ECO:0000269|PubMed:15932871, ECO:0000269|PubMed:9860996}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11273652};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11273652}.
CC       Note=Enriched in the sensory endings of sensory neurons.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077307; AAC98095.1; -; mRNA.
DR   EMBL; Z74044; CAA98550.1; -; Genomic_DNA.
DR   EMBL; Z74039; CAA98550.1; JOINED; Genomic_DNA.
DR   PIR; T23270; T23270.
DR   RefSeq; NP_001256320.1; NM_001269391.1.
DR   UniGene; Cel.19736; -.
DR   ProteinModelPortal; O76554; -.
DR   IntAct; O76554; 1.
DR   STRING; 6239.T26H10.1; -.
DR   iPTMnet; O76554; -.
DR   EPD; O76554; -.
DR   PaxDb; O76554; -.
DR   EnsemblMetazoa; T26H10.1a; T26H10.1a; WBGene00000955.
DR   GeneID; 179574; -.
DR   KEGG; cel:CELE_T26H10.1; -.
DR   UCSC; T26H10.1; c. elegans.
DR   CTD; 179574; -.
DR   WormBase; T26H10.1a; CE21208; WBGene00000955; des-2.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000019549; -.
DR   InParanoid; O76554; -.
DR   PhylomeDB; O76554; -.
DR   Reactome; R-CEL-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:O76554; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00000955; -.
DR   ExpressionAtlas; O76554; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:WormBase.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    548       Acetylcholine receptor subunit alpha-type
FT                                des-2.
FT                                /FTId=PRO_0000302736.
FT   TOPO_DOM     21    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    260       Helical. {ECO:0000255}.
FT   TRANSMEM    274    294       Helical. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical. {ECO:0000255}.
FT   TRANSMEM    517    537       Helical. {ECO:0000255}.
FT   TOPO_DOM    538    548       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     96     96       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    224    224       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   548 AA;  62096 MW;  A7495B31CFF5ACE5 CRC64;
     MLIIIQSLLL ATTASLCIAD TPVPTQIRLV HDLLDNYDKK AKPMWDNSKP INVSFSMDLY
     QILELNEPQQ YILLNAWIIE RWFDEFLYWN PDDYENITEL RLPYDSIWLP DTTLYNSLVM
     KDDDTRRLLN SKLTTDTHRR AALIELLYPT IYKFSCLLDL RFFPFDVQVC TMTFSSWTYD
     QKGIDYFPYS DKIGTSNYLE NEGWYILQTK IKRQEVKYAC CPNNYTLLQL TLYLRRKPLF
     YLVNLIIPTS IITLIAIVGF FTTSSASGMR EEKVSLGITT LLSMSILMLM VSDQMPTTST
     FIPLIGWFIL AMIIVISLGT VVSSVIIAIQ KRGSLGERMS KRALKFAKVL AWFTCTSLPP
     HVEKEHMMEA FDAPTPLVEV RPLQLASVKE SVRNKWVSGA RRATQRGNSG LALISDKSTD
     PLIHLSPTAH QPDESISPSA PPVPSSSPLP PPLTPGPADD VVSVASELSS KFLTSRMRPK
     SQKDNTFAAM QSSIKANRQL AVAEFEWFAT VVERTCFVIF VVAFLIITFG INFIGFIHWH
     QAGVEYGG
//
ID   GLR24_ARATH             Reviewed;         896 AA.
AC   O81776; F4JSR5;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   25-OCT-2017, entry version 119.
DE   RecName: Full=Glutamate receptor 2.4;
DE   AltName: Full=Ligand-gated ion channel 2.4;
DE   Flags: Precursor;
GN   Name=GLR2.4; OrderedLocusNames=At4g31710; ORFNames=F28M20.100;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617198; DOI=10.1038/47134;
RA   Mayer K.F.X., Schueller C., Wambutt R., Murphy G., Volckaert G.,
RA   Pohl T., Duesterhoeft A., Stiekema W., Entian K.-D., Terryn N.,
RA   Harris B., Ansorge W., Brandt P., Grivell L.A., Rieger M.,
RA   Weichselgartner M., de Simone V., Obermaier B., Mache R., Mueller M.,
RA   Kreis M., Delseny M., Puigdomenech P., Watson M., Schmidtheini T.,
RA   Reichert B., Portetelle D., Perez-Alonso M., Boutry M., Bancroft I.,
RA   Vos P., Hoheisel J., Zimmermann W., Wedler H., Ridley P.,
RA   Langham S.-A., McCullagh B., Bilham L., Robben J.,
RA   van der Schueren J., Grymonprez B., Chuang Y.-J., Vandenbussche F.,
RA   Braeken M., Weltjens I., Voet M., Bastiaens I., Aert R., Defoor E.,
RA   Weitzenegger T., Bothe G., Ramsperger U., Hilbert H., Braun M.,
RA   Holzer E., Brandt A., Peters S., van Staveren M., Dirkse W.,
RA   Mooijman P., Klein Lankhorst R., Rose M., Hauf J., Koetter P.,
RA   Berneiser S., Hempel S., Feldpausch M., Lamberth S., Van den Daele H.,
RA   De Keyser A., Buysshaert C., Gielen J., Villarroel R., De Clercq R.,
RA   van Montagu M., Rogers J., Cronin A., Quail M.A., Bray-Allen S.,
RA   Clark L., Doggett J., Hall S., Kay M., Lennard N., McLay K., Mayes R.,
RA   Pettett A., Rajandream M.A., Lyne M., Benes V., Rechmann S.,
RA   Borkova D., Bloecker H., Scharfe M., Grimm M., Loehnert T.-H.,
RA   Dose S., de Haan M., Maarse A.C., Schaefer M., Mueller-Auer S.,
RA   Gabel C., Fuchs M., Fartmann B., Granderath K., Dauner D., Herzl A.,
RA   Neumann S., Argiriou A., Vitale D., Liguori R., Piravandi E.,
RA   Massenet O., Quigley F., Clabauld G., Muendlein A., Felber R.,
RA   Schnabl S., Hiller R., Schmidt W., Lecharny A., Aubourg S.,
RA   Chefdor F., Cooke R., Berger C., Monfort A., Casacuberta E.,
RA   Gibbons T., Weber N., Vandenbol M., Bargues M., Terol J., Torres A.,
RA   Perez-Perez A., Purnelle B., Bent E., Johnson S., Tacon D., Jesse T.,
RA   Heijnen L., Schwarz S., Scholler P., Heber S., Francs P., Bielke C.,
RA   Frishman D., Haase D., Lemcke K., Mewes H.-W., Stocker S.,
RA   Zaccaria P., Bevan M., Wilson R.K., de la Bastide M., Habermann K.,
RA   Parnell L., Dedhia N., Gnoj L., Schutz K., Huang E., Spiegel L.,
RA   Sekhon M., Murray J., Sheet P., Cordes M., Abu-Threideh J.,
RA   Stoneking T., Kalicki J., Graves T., Harmon G., Edwards J.,
RA   Latreille P., Courtney L., Cloud J., Abbott A., Scott K., Johnson D.,
RA   Minx P., Bentley D., Fulton B., Miller N., Greco T., Kemp K.,
RA   Kramer J., Fulton L., Mardis E., Dante M., Pepin K., Hillier L.W.,
RA   Nelson J., Spieth J., Ryan E., Andrews S., Geisel C., Layman D.,
RA   Du H., Ali J., Berghoff A., Jones K., Drone K., Cotton M., Joshu C.,
RA   Antonoiu B., Zidanic M., Strong C., Sun H., Lamar B., Yordan C.,
RA   Ma P., Zhong J., Preston R., Vil D., Shekher M., Matero A., Shah R.,
RA   Swaby I.K., O'Shaughnessy A., Rodriguez M., Hoffman J., Till S.,
RA   Granat S., Shohdy N., Hasegawa A., Hameed A., Lodhi M., Johnson A.,
RA   Chen E., Marra M.A., Martienssen R., McCombie W.R.;
RT   "Sequence and analysis of chromosome 4 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:769-777(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA19752.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB79889.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL031004; CAA19752.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161579; CAB79889.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002687; AEE85948.2; -; Genomic_DNA.
DR   PIR; T05099; T05099.
DR   RefSeq; NP_001320108.1; NM_001342106.1.
DR   ProteinModelPortal; O81776; -.
DR   BioGrid; 14585; 1.
DR   STRING; 3702.AT4G31710.1; -.
DR   PaxDb; O81776; -.
DR   EnsemblPlants; AT4G31710.1; AT4G31710.1; AT4G31710.
DR   GeneID; 829299; -.
DR   Gramene; AT4G31710.1; AT4G31710.1; AT4G31710.
DR   KEGG; ath:AT4G31710; -.
DR   Araport; AT4G31710; -.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG410XQQV; LUCA.
DR   InParanoid; O81776; -.
DR   KO; K05387; -.
DR   OrthoDB; EOG0936061T; -.
DR   PhylomeDB; O81776; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:O81776; -.
DR   Proteomes; UP000006548; Chromosome 4.
DR   ExpressionAtlas; O81776; baseline and differential.
DR   Genevisible; O81776; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    896       Glutamate receptor 2.4.
FT                                /FTId=PRO_0000011599.
FT   TOPO_DOM     25    565       Extracellular. {ECO:0000255}.
FT   TRANSMEM    566    586       Helical. {ECO:0000255}.
FT   TOPO_DOM    587    595       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    596    616       Helical. {ECO:0000255}.
FT   TOPO_DOM    617    620       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    621    641       Helical. {ECO:0000255}.
FT   TOPO_DOM    642    815       Extracellular. {ECO:0000255}.
FT   TRANSMEM    816    836       Helical. {ECO:0000255}.
FT   TOPO_DOM    837    896       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    331    331       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    527    527       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   896 AA;  99406 MW;  D0C21643B68B48F8 CRC64;
     MKRHLNDVVL VFLVFIFGVK LGKGQNTTIQ VINVGVVTDV GTTASNLSLL AINMSLSDFY
     SSRPESRTRL LLNFADSRDD VVGAAAAALD LIKNKEVKAI LGPRTTMQAS FVIEVGQKSQ
     VPIISFSATS PFLDSGRSPY FFRSTYDDSS QVQAISEIIK VFGWREVVPV YENNAFGEGI
     MPGLTDALQA INIRIPYRTV ISPNATDDEI SVDLLKLMTK PTRVFVVHMN RFLASRVFSK
     ARETGLMKQG YAWILTNGVI DHLVLMNGTD IEAMQGVIGI RTHFPISEEL QTFRSRLAKA
     FPVSELNIYG LRAYDATTAL AMAVEEAGTT NLTFSKMDGR NISDLEALSV SEYGPKLIRS
     LSQIQFKGLS GDYHFVDGQL HASVFEIVNV IDGGGILVGF WTQDKGLVKD LSPSSGTTRT
     FSSWKNHLNP ILWPGITLTV PKGWEIPTNG KELQIGVPVG TFPQFVKVTT DPLTHETIVT
     GFCIDFFEAV IQAMPYDVSH RFIPFGDDDG KTNVFDAVVG DTTILANRSS YVDFTLPYTT
     SGVGMVVPLK DNVARSSLIF FKPLTPGLWG MTLGSFFVVG FVVWILEHRV NSEFTGPPQY
     QISTMFWFAF SIMVFAPRER VMSFTARVVV ITWYFIVLVL TQSYTASLSS LLTTQQLNPT
     ETSIKNVLAK GGPVAYQRDS FVLGKLRESG FPESRLVPFT SPEKCEELLN KGPSKGGVSA
     AFMEVPYVRV FLGQYCKKYK MVEVPFDVDG FGFVFPIGSP LVADVSRAIL KVAESNKATQ
     LETAWFKNID KTCPDPMNNP DPNPTVSFRK LSLDSFLLLF VAAATVCTLA LLKFVICFLI
     QNRIILNDEF YRGKRMKEMW LKFMESDGES YISRVRSTCP QVLIQPREED IDPING
//
ID   HCN2_MOUSE              Reviewed;         863 AA.
AC   O88703; O70506;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   20-DEC-2017, entry version 159.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 2;
DE            Short=BCNG-2;
DE   AltName: Full=Hyperpolarization-activated cation channel 1;
DE            Short=HAC-1;
GN   Name=Hcn2; Synonyms=Bcng2, Hac1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=BALB/cJ;
RX   PubMed=9634236; DOI=10.1038/31255;
RA   Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M.;
RT   "A family of hyperpolarization-activated cation channels.";
RL   Nature 393:587-591(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 150-653, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9630217; DOI=10.1016/S0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R.,
RA   Siegelbaum S.A., Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-225; ASP-231;
RP   ASP-267; ASP-275; LYS-291; ARG-294; ARG-297; ARG-300; LYS-303;
RP   SER-306; ARG-309; ARG-312; ARG-315 AND ARG-318.
RX   PubMed=10962006; DOI=10.1074/jbc.M007034200;
RA   Chen J., Mitcheson J.S., Lin M., Sanguinetti M.C.;
RT   "Functional roles of charged residues in the putative voltage sensor
RT   of the HCN2 pacemaker channel.";
RL   J. Biol. Chem. 275:36465-36471(2000).
RN   [4]
RP   INTERACTION WITH KCNE2.
RX   PubMed=11420311; DOI=10.1161/hh1201.093511;
RA   Yu H., Wu J., Potapova I., Wymore R.T., Holmes B., Zuckerman J.,
RA   Pan Z., Wang H., Shi W., Robinson R.B., El-Maghrabi M.R., Benjamin W.,
RA   Dixon J.E., McKinnon D., Cohen I.S., Wymore R.;
RT   "MinK-related peptide 1: a beta subunit for the HCN ion channel
RT   subunit family enhances expression and speeds activation.";
RL   Circ. Res. 88:E84-E87(2001).
RN   [5]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   HIS-321.
RX   PubMed=11096117; DOI=10.1074/jbc.M010326200;
RA   Zong X., Stieber J., Ludwig A., Hofmann F., Biel M.;
RT   "A single histidine residue determines the pH sensitivity of the
RT   pacemaker channel HCN2.";
RL   J. Biol. Chem. 276:6313-6319(2001).
RN   [6]
RP   MUTAGENESIS OF ARG-318; GLU-324; TYR-331 AND ARG-339.
RX   PubMed=11553787; DOI=10.1073/pnas.201250598;
RA   Chen J., Mitcheson J.S., Tristani-Firouzi M., Lin M.,
RA   Sanguinetti M.C.;
RT   "The S4-S5 linker couples voltage sensing and activation of pacemaker
RT   channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11277-11282(2001).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF SER-306.
RX   PubMed=11741901; DOI=10.1074/jbc.M106974200;
RA   Proenza C., Angoli D., Agranovich E., Macri V., Accili E.A.;
RT   "Pacemaker channels produce an instantaneous current.";
RL   J. Biol. Chem. 277:5101-5109(2002).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH HCN1.
RX   PubMed=12034718; DOI=10.1074/jbc.M200504200;
RA   Proenza C., Tran N., Angoli D., Zahynacz K., Balcar P., Accili E.A.;
RT   "Different roles for the cyclic nucleotide binding domain and amino
RT   terminus in assembly and expression of hyperpolarization-activated,
RT   cyclic nucleotide-gated channels.";
RL   J. Biol. Chem. 277:29634-29642(2002).
RN   [9]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=12193608; DOI=10.1074/jbc.M208477200;
RA   Tran N., Proenza C., Macri V., Petigara F., Sloan E., Samler S.,
RA   Accili E.A.;
RT   "A conserved domain in the NH2 terminus important for assembly and
RT   functional expression of pacemaker channels.";
RL   J. Biol. Chem. 277:43588-43592(2002).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119; SER-743; SER-750;
RP   SER-757; SER-840; SER-842 AND SER-847, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   PHOSPHORYLATION AT SER-641.
RX   PubMed=21347269; DOI=10.1371/journal.pone.0017078;
RA   Hammelmann V., Zong X., Hofmann F., Michalakis S., Biel M.;
RT   "The cGMP-dependent protein kinase II Is an inhibitory modulator of
RT   the hyperpolarization-activated HCN2 channel.";
RL   PLoS ONE 6:E17078-E17078(2011).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   SER-594.
RX   PubMed=23103389; DOI=10.1016/j.str.2012.09.017;
RA   Xu X., Marni F., Wu S., Su Z., Musayev F., Shrestha S., Xie C.,
RA   Gao W., Liu Q., Zhou L.;
RT   "Local and global interpretations of a disease-causing mutation near
RT   the ligand entry path in hyperpolarization-activated cAMP-gated
RT   channel.";
RL   Structure 20:2116-2123(2012).
RN   [13]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-728, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 443-643 IN COMPLEXES WITH
RP   CAMP AND CGMP, FUNCTION, ENZYME REGULATION, NUCLEOTIDE-BINDING, AND
RP   SUBUNIT.
RX   PubMed=12968185; DOI=10.1038/nature01922;
RA   Zagotta W.N., Olivier N.B., Black K.D., Young E.C., Olson R.,
RA   Gouaux E.;
RT   "Structural basis for modulation and agonist specificity of HCN
RT   pacemaker channels.";
RL   Nature 425:200-205(2003).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 443-640, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, AND NUCLEOTIDE-BINDING.
RX   PubMed=17562314; DOI=10.1016/j.str.2007.04.008;
RA   Flynn G.E., Black K.D., Islas L.D., Sankaran B., Zagotta W.N.;
RT   "Structure and rearrangements in the carboxy-terminal region of SpIH
RT   channels.";
RL   Structure 15:671-682(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 443-640 IN COMPLEX WITH
RP   CAMP, SUBUNIT, AND NUCLEOTIDE-BINDING.
RX   PubMed=18367452; DOI=10.1074/jbc.M710463200;
RA   Craven K.B., Olivier N.B., Zagotta W.N.;
RT   "C-terminal movement during gating in cyclic nucleotide-modulated
RT   channels.";
RL   J. Biol. Chem. 283:14728-14738(2008).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 443-640 IN COMPLEX WITH
RP   CAMP, AND NUCLEOTIDE-BINDING.
RX   PubMed=19525958; DOI=10.1038/nmeth.1341;
RA   Taraska J.W., Puljung M.C., Olivier N.B., Flynn G.E., Zagotta W.N.;
RT   "Mapping the structure and conformational movements of proteins with
RT   transition metal ion FRET.";
RL   Nat. Methods 6:532-537(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 857-863 IN COMPLEX WITH
RP   PEX5L, AND SUBUNIT.
RX   PubMed=22550182; DOI=10.1073/pnas.1201997109;
RA   Bankston J.R., Camp S.S., DiMaio F., Lewis A.S., Chetkovich D.M.,
RA   Zagotta W.N.;
RT   "Structure and stoichiometry of an accessory subunit TRIP8b
RT   interaction with hyperpolarization-activated cyclic nucleotide-gated
RT   channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:7899-7904(2012).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). Can
CC       also transport ammonium in the distal nephron. Produces a large
CC       instantaneous current. {ECO:0000269|PubMed:10962006,
CC       ECO:0000269|PubMed:11096117, ECO:0000269|PubMed:11741901,
CC       ECO:0000269|PubMed:12034718, ECO:0000269|PubMed:12193608,
CC       ECO:0000269|PubMed:12968185, ECO:0000269|PubMed:17562314,
CC       ECO:0000269|PubMed:23103389}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding causes a conformation
CC       change that leads to the assembly of an active tetramer and
CC       channel opening. Channel activity is modulated by intracellular
CC       chloride ions and pH; acidic pH shifts the activation to more
CC       negative voltages. {ECO:0000269|PubMed:11096117,
CC       ECO:0000269|PubMed:12968185, ECO:0000269|PubMed:17562314,
CC       ECO:0000269|PubMed:23103389}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN1. The potassium
CC       channel is composed of a homo- or heterotetrameric complex of
CC       pore-forming subunits. Forms an obligate 4:4 complex with
CC       accessory subunit PEX5L. Interacts with KCNE2.
CC       {ECO:0000269|PubMed:11420311, ECO:0000269|PubMed:12034718,
CC       ECO:0000269|PubMed:12193608, ECO:0000269|PubMed:12968185,
CC       ECO:0000269|PubMed:17562314, ECO:0000269|PubMed:18367452,
CC       ECO:0000269|PubMed:19525958, ECO:0000269|PubMed:22550182}.
CC   -!- INTERACTION:
CC       Q8IYB4-6:PEX5L (xeno); NbExp=18; IntAct=EBI-771231, EBI-16150786;
CC       P00523:SRC (xeno); NbExp=5; IntAct=EBI-771231, EBI-848039;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10962006,
CC       ECO:0000269|PubMed:11096117, ECO:0000269|PubMed:12034718,
CC       ECO:0000269|PubMed:12193608, ECO:0000269|PubMed:17562314,
CC       ECO:0000269|PubMed:23103389}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10962006, ECO:0000269|PubMed:11096117,
CC       ECO:0000269|PubMed:12034718, ECO:0000269|PubMed:12193608,
CC       ECO:0000269|PubMed:17562314, ECO:0000269|PubMed:23103389}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain. Detected at low
CC       levels in heart, in ventricle, atrium and in sinoatrial node
CC       (SAN). {ECO:0000269|PubMed:9630217}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Phosphorylation at Ser-641 by PRKG2 shifts the voltage-
CC       dependence to more negative voltages, hence counteracting the
CC       stimulatory effect of cGMP on gating.
CC       {ECO:0000269|PubMed:21347269}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ225122; CAA12406.1; -; mRNA.
DR   EMBL; AF064873; AAC40125.1; -; mRNA.
DR   CCDS; CCDS23986.1; -.
DR   RefSeq; NP_032252.1; NM_008226.2.
DR   UniGene; Mm.12956; -.
DR   PDB; 1Q3E; X-ray; 1.90 A; A/B=443-645.
DR   PDB; 1Q43; X-ray; 2.00 A; A/B=443-645.
DR   PDB; 1Q5O; X-ray; 2.30 A; A=443-645.
DR   PDB; 2Q0A; X-ray; 2.25 A; A/B=443-640.
DR   PDB; 3BPZ; X-ray; 1.65 A; A/B/C/D=443-640.
DR   PDB; 3ETQ; X-ray; 1.90 A; A/B=443-640.
DR   PDB; 3FFQ; X-ray; 2.40 A; A/B=443-640.
DR   PDB; 4EQF; X-ray; 3.00 A; B=857-863.
DR   PDB; 5JON; X-ray; 2.04 A; A/B=494-640.
DR   PDB; 5KHG; X-ray; 2.24 A; A=443-643.
DR   PDB; 5KHH; X-ray; 1.77 A; A=443-643.
DR   PDB; 5KHI; X-ray; 2.10 A; A=443-643.
DR   PDB; 5KHJ; X-ray; 2.01 A; A/B=443-643.
DR   PDB; 5KHK; X-ray; 2.07 A; A=443-643.
DR   PDBsum; 1Q3E; -.
DR   PDBsum; 1Q43; -.
DR   PDBsum; 1Q5O; -.
DR   PDBsum; 2Q0A; -.
DR   PDBsum; 3BPZ; -.
DR   PDBsum; 3ETQ; -.
DR   PDBsum; 3FFQ; -.
DR   PDBsum; 4EQF; -.
DR   PDBsum; 5JON; -.
DR   PDBsum; 5KHG; -.
DR   PDBsum; 5KHH; -.
DR   PDBsum; 5KHI; -.
DR   PDBsum; 5KHJ; -.
DR   PDBsum; 5KHK; -.
DR   ProteinModelPortal; O88703; -.
DR   SMR; O88703; -.
DR   BioGrid; 200253; 3.
DR   DIP; DIP-29326N; -.
DR   IntAct; O88703; 4.
DR   MINT; MINT-155013; -.
DR   STRING; 10090.ENSMUSP00000020581; -.
DR   BindingDB; O88703; -.
DR   ChEMBL; CHEMBL1250408; -.
DR   GuidetoPHARMACOLOGY; 401; -.
DR   iPTMnet; O88703; -.
DR   PhosphoSitePlus; O88703; -.
DR   SwissPalm; O88703; -.
DR   MaxQB; O88703; -.
DR   PaxDb; O88703; -.
DR   PRIDE; O88703; -.
DR   Ensembl; ENSMUST00000020581; ENSMUSP00000020581; ENSMUSG00000020331.
DR   Ensembl; ENSMUST00000099513; ENSMUSP00000097113; ENSMUSG00000020331.
DR   GeneID; 15166; -.
DR   KEGG; mmu:15166; -.
DR   UCSC; uc007fzn.1; mouse.
DR   CTD; 610; -.
DR   MGI; MGI:1298210; Hcn2.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; O88703; -.
DR   KO; K04955; -.
DR   OMA; CPQVARP; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; O88703; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-MMU-1296061; HCN channels.
DR   EvolutionaryTrace; O88703; -.
DR   PRO; PR:O88703; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   Bgee; ENSMUSG00000020331; -.
DR   Genevisible; O88703; MM.
DR   GO; GO:0098855; C:HCN channel complex; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISO:MGI.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; ISO:MGI.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; ISO:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:MGI.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; ISO:MGI.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:MGI.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Methylation; Nucleotide-binding; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Sodium;
KW   Sodium channel; Sodium transport; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    863       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                2.
FT                                /FTId=PRO_0000054112.
FT   TOPO_DOM      1    188       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    210    213       Extracellular. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    235    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    282       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    283    290       Extracellular. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    312    342       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    343    363       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    364    386       Extracellular. {ECO:0000255}.
FT   INTRAMEM    387    408       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    409    413       Extracellular. {ECO:0000255}.
FT   TRANSMEM    414    434       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    435    863       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     581    584       cAMP. {ECO:0000269|PubMed:18367452,
FT                                ECO:0000269|PubMed:19525958}.
FT   NP_BIND     591    592       cAMP. {ECO:0000269|PubMed:18367452,
FT                                ECO:0000269|PubMed:19525958}.
FT   NP_BIND     632    635       cAMP. {ECO:0000269|PubMed:18367452,
FT                                ECO:0000269|PubMed:19525958}.
FT   REGION      131    182       Involved in subunit assembly.
FT   COMPBIAS     10     58       Pro-rich.
FT   COMPBIAS    688    835       Pro-rich.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     641    641       Phosphoserine; by PKG/PRKG2.
FT                                {ECO:0000269|PubMed:21347269}.
FT   MOD_RES     726    726       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     728    728       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     743    743       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     757    757       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     840    840       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     842    842       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     847    847       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    380    380       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     225    225       D->N: Abolishes surface expression and
FT                                channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     231    231       D->N: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     267    267       D->N: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     275    275       D->N: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     291    291       K->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     294    294       R->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     297    297       R->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     300    300       R->Q: Shifts voltage dependence of
FT                                activation to more negative values.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     303    303       K->Q: Decreases current amplitude.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     306    306       S->Q: Decreases current amplitude.
FT                                {ECO:0000269|PubMed:10962006,
FT                                ECO:0000269|PubMed:11741901}.
FT   MUTAGEN     309    309       R->Q: Abolishes surface expression and
FT                                channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     312    312       R->Q: Reduces surface expression and
FT                                decreases current amplitude.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     315    315       R->Q: Reduces surface expression and
FT                                abolishes channel activity.
FT                                {ECO:0000269|PubMed:10962006}.
FT   MUTAGEN     318    318       R->Q: Reduces surface expression and
FT                                disrupts channel closure.
FT                                {ECO:0000269|PubMed:10962006,
FT                                ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     321    321       H->E: Shifts voltage dependence of
FT                                activation to more positive values and
FT                                abolishes pH-sensitivity.
FT                                {ECO:0000269|PubMed:11096117}.
FT   MUTAGEN     321    321       H->Q: Abolishes pH-sensitivity.
FT                                {ECO:0000269|PubMed:11096117}.
FT   MUTAGEN     321    321       H->R: Abolishes pH-sensitivity.
FT                                {ECO:0000269|PubMed:11096117}.
FT   MUTAGEN     324    324       E->Q: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     331    331       Y->A: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     331    331       Y->S: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     339    339       R->Q: Disrupts channel closure.
FT                                {ECO:0000269|PubMed:11553787}.
FT   MUTAGEN     594    594       S->R: Shifts channel activation to more
FT                                negative voltage, slows channel opening
FT                                and speeds up channel closure. Reduces
FT                                sensitivity to activation by cAMP.
FT                                {ECO:0000269|PubMed:23103389}.
FT   CONFLICT    486    486       F -> S (in Ref. 2; AAC40125).
FT                                {ECO:0000305}.
FT   CONFLICT    642    642       I -> T (in Ref. 2; AAC40125).
FT                                {ECO:0000305}.
FT   HELIX       444    462       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       467    481       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       488    494       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       497    507       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       509    513       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       516    519       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       523    532       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      534    538       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      543    545       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      553    559       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      561    565       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      567    569       {ECO:0000244|PDB:2Q0A}.
FT   STRAND      572    575       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      579    581       {ECO:0000244|PDB:5KHK}.
FT   HELIX       582    587       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      588    590       {ECO:0000244|PDB:5KHH}.
FT   STRAND      592    599       {ECO:0000244|PDB:3BPZ}.
FT   STRAND      601    607       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       608    617       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       619    621       {ECO:0000244|PDB:3BPZ}.
FT   HELIX       622    635       {ECO:0000244|PDB:3BPZ}.
SQ   SEQUENCE   863 AA;  94722 MW;  17CDC4DFF07AC039 CRC64;
     MDARGGGGRP GDSPGTTPAP GPPPPPPPPA PPQPQPPPAP PPNPTTPSHP ESADEPGPRA
     RLCSRDSACT PGAAKGGANG ECGRGEPQCS PEGPARGPKV SFSCRGAASG PSAAEEAGSE
     EAGPAGEPRG SQASFLQRQF GALLQPGVNK FSLRMFGSQK AVEREQERVK SAGAWIIHPY
     SDFRFYWDFT MLLFMVGNLI IIPVGITFFK DETTAPWIVF NVVSDTFFLM DLVLNFRTGI
     VIEDNTEIIL DPEKIKKKYL RTWFVVDFVS SIPVDYIFLI VEKGIDSEVY KTARALRIVR
     FTKILSLLRL LRLSRLIRYI HQWEEIFHMT YDLASAVMRI CNLISMMLLL CHWDGCLQFL
     VPMLQDFPSD CWVSINNMVN HSWSELYSFA LFKAMSHMLC IGYGRQAPES MTDIWLTMLS
     MIVGATCYAM FIGHATALIQ SLDSSRRQYQ EKYKQVEQYM SFHKLPADFR QKIHDYYEHR
     YQGKMFDEDS ILGELNGPLR EEIVNFNCRK LVASMPLFAN ADPNFVTAML TKLKFEVFQP
     GDYIIREGTI GKKMYFIQHG VVSVLTKGNK EMKLSDGSYF GEICLLTRGR RTASVRADTY
     CRLYSLSVDN FNEVLEEYPM MRRAFETVAI DRLDRIGKKN SILLHKVQHD LSSGVFNNQE
     NAIIQEIVKY DREMVQQAEL GQRVGLFPPP PPPQVTSAIA TLQQAVAMSF CPQVARPLVG
     PLALGSPRLV RRAPPGPLPP AASPGPPAAS PPAAPSSPRA PRTSPYGVPG SPATRVGPAL
     PARRLSRASR PLSASQPSLP HGVPAPSPAA SARPASSSTP RLGPAPTART AAPSPDRRDS
     ASPGAASGLD PLDSARSRLS SNL
//
ID   GLRA1_DANRE             Reviewed;         444 AA.
AC   O93430;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-NOV-2017, entry version 136.
DE   RecName: Full=Glycine receptor subunit alphaZ1;
DE   Flags: Precursor;
GN   Name=glra1;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10188956; DOI=10.1016/S0306-4522(98)00430-8;
RA   David-Watine B., Goblet C., de Saint Jan D., Fucile S., Devignot V.,
RA   Bregestovski P., Korn H.;
RT   "Cloning, expression and electrophysiological characterization of
RT   glycine receptor alpha subunit from zebrafish.";
RL   Neuroscience 90:303-317(1999).
RN   [2] {ECO:0000244|PDB:3JAD, ECO:0000244|PDB:3JAE, ECO:0000244|PDB:3JAF}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.80 ANGSTROMS) OF 34-434 IN
RP   COMPLEXES WITH GLYCINE; IVERMECTINE AND STRYCHNINE, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY, DOMAIN, DISULFIDE
RP   BONDS, AND GLYCOSYLATION AT ASN-62.
RX   PubMed=26344198; DOI=10.1038/nature14853;
RA   Du J., Lu W., Wu S., Cheng Y., Gouaux E.;
RT   "Glycine receptor mechanism elucidated by electron cryo-microscopy.";
RL   Nature 526:224-229(2015).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       Channel opening is triggered by extracellular glycine
CC       (PubMed:10188956, PubMed:26344198). Plays an important role in the
CC       down-regulation of neuronal excitability. Contributes to the
CC       generation of inhibitory postsynaptic currents. Channel activity
CC       is potentiated by ethanol (By similarity).
CC       {ECO:0000250|UniProtKB:P23415, ECO:0000269|PubMed:10188956,
CC       ECO:0000269|PubMed:26344198}.
CC   -!- ENZYME REGULATION: Activated by glycine and taurine. Inhibited by
CC       strychnine (PubMed:10188956, PubMed:26344198). Allosterically
CC       activated by ivermectin (PubMed:26344198). Inhibited by
CC       picrotoxinin (PubMed:26344198). Strychnine binding locks the
CC       channel in a closed conformation and prevents channel opening in
CC       response to extracellular glycine (PubMed:26344198). Can also be
CC       activated by GABA and inhibited by bicuculline, but this requires
CC       heterologous expression in human cells (PubMed:10188956).
CC       {ECO:0000269|PubMed:10188956, ECO:0000269|PubMed:26344198}.
CC   -!- SUBUNIT: Homopentamer (in vitro) (PubMed:26344198). Heteropentamer
CC       composed of glra1 and glrb (By similarity). Both homopentamers and
CC       heteropentamers form functional ion channels (By similarity).
CC       {ECO:0000250|UniProtKB:P23415, ECO:0000269|PubMed:26344198}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q64018}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q64018}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q64018}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q64018}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q64018}. Cell membrane
CC       {ECO:0000269|PubMed:10188956, ECO:0000269|PubMed:26344198}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:26344198}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain.
CC       {ECO:0000269|PubMed:10188956}.
CC   -!- DOMAIN: The channel pore is formed by pentameric assembly of the
CC       second transmembrane domain from all five subunits. Channel
CC       opening is effected by an outward rotation of the transmembrane
CC       domains that increases the diameter of the pore.
CC       {ECO:0000269|PubMed:26344198}.
CC   -!- MISCELLANEOUS: Highly sensitive to activation by taurine despite
CC       the presence of Val in position 135. In mammals, Val-135 causes a
CC       drastic loss of taurine efficacy. {ECO:0000269|PubMed:10188956}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:10188956, ECO:0000269|PubMed:26344198}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRA1 sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ005812; CAA06711.1; -; mRNA.
DR   RefSeq; NP_571477.1; NM_131402.1.
DR   UniGene; Dr.75842; -.
DR   PDB; 3JAD; EM; 3.90 A; A/B/C/D/E=34-434.
DR   PDB; 3JAE; EM; 3.90 A; A/B/C/D/E=34-434.
DR   PDB; 3JAF; EM; 3.80 A; A/B/C/D/E=34-434.
DR   PDBsum; 3JAD; -.
DR   PDBsum; 3JAE; -.
DR   PDBsum; 3JAF; -.
DR   ProteinModelPortal; O93430; -.
DR   SMR; O93430; -.
DR   DIP; DIP-61772N; -.
DR   STRING; 7955.ENSDARP00000066196; -.
DR   iPTMnet; O93430; -.
DR   PaxDb; O93430; -.
DR   PRIDE; O93430; -.
DR   Ensembl; ENSDART00000005499; ENSDARP00000003268; ENSDARG00000012019.
DR   GeneID; 30676; -.
DR   KEGG; dre:30676; -.
DR   CTD; 2741; -.
DR   ZFIN; ZDB-GENE-991117-1; glra1.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; O93430; -.
DR   KO; K05193; -.
DR   Reactome; R-DRE-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:O93430; -.
DR   Proteomes; UP000000437; Chromosome 14.
DR   Bgee; ENSDARG00000012019; -.
DR   ExpressionAtlas; O93430; baseline.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:ZFIN.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:ZFIN.
DR   GO; GO:0016594; F:glycine binding; IDA:ZFIN.
DR   GO; GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   GO; GO:0071361; P:cellular response to ethanol; ISS:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; ISS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; IMP:ZFIN.
DR   GO; GO:0006811; P:ion transport; IDA:ZFIN.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:ZFIN.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IMP:ZFIN.
DR   GO; GO:0043200; P:response to amino acid; IDA:ZFIN.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008128; Glycine_rcpt_A1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01674; GLYRALPHA1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Metal-binding; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    444       Glycine receptor subunit alphaZ1.
FT                                /FTId=PRO_0000000415.
FT   TOPO_DOM     25    246       Extracellular.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    247    268       Helical; Name=1.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    269    273       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    274    294       Helical; Name=2.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    295    305       Extracellular.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    306    326       Helical; Name=3.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    327    412       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TRANSMEM    413    433       Helical; Name=4.
FT                                {ECO:0000269|PubMed:26344198}.
FT   TOPO_DOM    434    444       Extracellular.
FT                                {ECO:0000269|PubMed:26344198}.
FT   REGION      226    231       Strychnine-binding.
FT                                {ECO:0000269|PubMed:26344198}.
FT   METAL       216    216       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       218    218       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   METAL       239    239       Zinc. {ECO:0000250|UniProtKB:P23415}.
FT   SITE        285    285       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000269|PubMed:26344198}.
FT   CARBOHYD     62     62       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:26344198}.
FT   DISULFID    162    176       {ECO:0000250|UniProtKB:P23415}.
FT   DISULFID    222    233       {ECO:0000269|PubMed:26344198}.
SQ   SEQUENCE   444 AA;  50766 MW;  77F6FC8C14E80581 CRC64;
     MFALGIYLWE TIVFFSLAAS QQAAARKAAS PMPPSEFLDK LMGKVSGYDA RIRPNFKGPP
     VNVTCNIFIN SFGSIAETTM DYRVNIFLRQ QWNDPRLAYS EYPDDSLDLD PSMLDSIWKP
     DLFFANEKGA NFHEVTTDNK LLRISKNGNV LYSIRITLVL ACPMDLKNFP MDVQTCIMQL
     ESFGYTMNDL IFEWDEKGAV QVADGLTLPQ FILKEEKDLR YCTKHYNTGK FTCIEARFHL
     ERQMGYYLIQ MYIPSLLIVI LSWVSFWINM DAAPARVGLG ITTVLTMTTQ SSGSRASLPK
     VSYVKAIDIW MAVCLLFVFS ALLEYAAVNF IARQHKELLR FQRRRRHLKE DEAGDGRFSF
     AAYGMGPACL QAKDGMAIKG NNNNAPTSTN PPEKTVEEMR KLFISRAKRI DTVSRVAFPL
     VFLIFNIFYW ITYKIIRSED IHKQ
//
ID   5HT3B_HUMAN             Reviewed;         441 AA.
AC   O95264; B0YJ23; Q0VJC3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=5-hydroxytryptamine receptor 3B;
DE            Short=5-HT3-B;
DE            Short=5-HT3B;
DE   AltName: Full=Serotonin receptor 3B;
DE   Flags: Precursor;
GN   Name=HTR3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   PubMed=10521471; DOI=10.1074/jbc.274.43.30799;
RA   Dubin A.E., Huvar R., D'Andrea M.R., Pyati J., Zhu J.Y., Joy K.C.,
RA   Wilson S.J., Galindo J.E., Glass C.A., Luo L., Jackson M.R.,
RA   Lovenberg T.W., Erlander M.G.;
RT   "The pharmacological and functional characteristics of the serotonin
RT   5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor
RT   subunit.";
RL   J. Biol. Chem. 274:30799-30810(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SUBUNIT.
RX   PubMed=9950429; DOI=10.1038/16941;
RA   Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J.,
RA   Hales T.G., Kirkness E.F.;
RT   "The 5-HT3B subunit is a major determinant of serotonin-receptor
RT   function.";
RL   Nature 397:359-363(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT SER-129.
RC   TISSUE=Brain;
RX   PubMed=17010535; DOI=10.1016/j.gene.2006.08.002;
RA   Tzvetkov M.V., Meineke C., Oetjen E., Hirsch-Ernst K., Brockmoller J.;
RT   "Tissue-specific alternative promoters of the serotonin receptor gene
RT   HTR3B in human brain and intestine.";
RL   Gene 386:52-62(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   FUNCTION, AND REGION.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
RN   [7]
RP   SUBUNIT.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [8]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-52; ASN-96; ASN-138;
RP   ASN-168 AND ASN-203, AND MUTAGENESIS OF ASN-52; ASN-96; ASN-138;
RP   ASN-168 AND ASN-203.
RX   PubMed=21138434; DOI=10.1111/j.1471-4159.2010.07129.x;
RA   Massoura A.N., Dover T.J., Newman A.S., Barnes N.M.;
RT   "The identification of N-glycosylated residues of the human 5-HT3B
RT   receptor subunit: importance for cell membrane expression.";
RL   J. Neurochem. 116:975-983(2011).
RN   [9]
RP   VARIANTS SER-129; ARG-156 AND ILE-183.
RX   PubMed=15389765; DOI=10.1002/ajmg.b.30070;
RA   Frank B., Niesler B., Noethen M.M., Neidt H., Propping P., Bondy B.,
RA   Rietschel M., Maier W., Albus M., Rappold G.;
RT   "Investigation of the human serotonin receptor gene HTR3B in bipolar
RT   affective and schizophrenic patients.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 131:1-5(2004).
RN   [10]
RP   VARIANTS SER-129; ARG-156 AND ILE-183.
RX   PubMed=15293096; DOI=10.1007/s10067-004-0927-2;
RA   Frank B., Niesler B., Bondy B., Spaeth M., Pongratz D.E.,
RA   Ackenheil M., Fischer C., Rappold G.;
RT   "Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in
RT   fibromyalgia patients.";
RL   Clin. Rheumatol. 23:338-344(2004).
RN   [11]
RP   VARIANTS SER-129; THR-143 AND ILE-183.
RX   PubMed=16487942; DOI=10.1016/j.biopsych.2005.11.008;
RA   Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T.,
RA   Takao H., Minabe Y., Nakatani N., Higuchi T., Detera-Wadleigh S.D.,
RA   Yoshikawa T.;
RT   "Distinguishable haplotype blocks in the HTR3A and HTR3B region in the
RT   Japanese reveal evidence of association of HTR3B with female major
RT   depression.";
RL   Biol. Psychiatry 60:192-201(2006).
RN   [12]
RP   VARIANT ARG-156.
RX   PubMed=21179162; DOI=10.1038/nature09629;
RA   Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T.,
RA   Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A.,
RA   Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J.,
RA   Peltonen L., Virkkunen M., Goldman D.;
RT   "A population-specific HTR2B stop codon predisposes to severe
RT   impulsivity.";
RL   Nature 468:1061-1066(2010).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC       {ECO:0000269|PubMed:12867984}.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex. {ECO:0000269|PubMed:17392525,
CC       ECO:0000269|PubMed:9950429}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21138434};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:21138434}.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95264-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95264-2; Sequence=VSP_029796;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain cortex, in the caudate
CC       nucleus, the hyppocampus, the thalamus and the amygdala. Detected
CC       in the kidney and testis as well as in monocytes of the spleen,
CC       small and large intestine, uterus, prostate, ovary and placenta.
CC       {ECO:0000269|PubMed:10521471, ECO:0000269|PubMed:9950429}.
CC   -!- PTM: N-glycosylation required for membrane localization.
CC       {ECO:0000269|PubMed:21138434}.
CC   -!- MISCELLANEOUS: The HA-stretch region of HTR3B seems to confer
CC       increased conductance to HTR3A/HTR3B heteromers compared to that
CC       of HTR3A homomers.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3B
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169255; AAF03691.1; -; mRNA.
DR   EMBL; AF080582; AAD12242.1; -; mRNA.
DR   EMBL; AM293589; CAL25321.1; -; mRNA.
DR   EMBL; EF444985; ACA06001.1; -; Genomic_DNA.
DR   EMBL; AK314268; BAG36930.1; -; mRNA.
DR   CCDS; CCDS8364.1; -. [O95264-1]
DR   RefSeq; NP_006019.1; NM_006028.4. [O95264-1]
DR   RefSeq; XP_011541365.1; XM_011543063.1. [O95264-2]
DR   UniGene; Hs.241377; -.
DR   ProteinModelPortal; O95264; -.
DR   IntAct; O95264; 1.
DR   STRING; 9606.ENSP00000260191; -.
DR   BindingDB; O95264; -.
DR   ChEMBL; CHEMBL2111332; -.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB13025; Tiapride.
DR   GuidetoPHARMACOLOGY; 374; -.
DR   iPTMnet; O95264; -.
DR   PhosphoSitePlus; O95264; -.
DR   BioMuta; HTR3B; -.
DR   PaxDb; O95264; -.
DR   PeptideAtlas; O95264; -.
DR   PRIDE; O95264; -.
DR   TopDownProteomics; O95264-1; -. [O95264-1]
DR   DNASU; 9177; -.
DR   Ensembl; ENST00000260191; ENSP00000260191; ENSG00000149305. [O95264-1]
DR   Ensembl; ENST00000537778; ENSP00000443118; ENSG00000149305. [O95264-2]
DR   GeneID; 9177; -.
DR   KEGG; hsa:9177; -.
DR   UCSC; uc001pok.4; human. [O95264-1]
DR   CTD; 9177; -.
DR   DisGeNET; 9177; -.
DR   EuPathDB; HostDB:ENSG00000149305.6; -.
DR   GeneCards; HTR3B; -.
DR   HGNC; HGNC:5298; HTR3B.
DR   HPA; HPA039559; -.
DR   MIM; 604654; gene.
DR   neXtProt; NX_O95264; -.
DR   OpenTargets; ENSG00000149305; -.
DR   PharmGKB; PA29556; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; O95264; -.
DR   KO; K04819; -.
DR   OMA; VGYTVFR; -.
DR   OrthoDB; EOG091G08WI; -.
DR   PhylomeDB; O95264; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; HTR3B; -.
DR   GenomeRNAi; 9177; -.
DR   PRO; PR:O95264; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000149305; -.
DR   CleanEx; HS_HTR3B; -.
DR   ExpressionAtlas; O95264; baseline and differential.
DR   Genevisible; O95264; HS.
DR   GO; GO:0009986; C:cell surface; IDA:CACAO.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:InterPro.
DR   GO; GO:1904602; C:serotonin-activated cation-selective channel complex; IGI:GO_Central.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IGI:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008134; 5HT3_rcpt_B.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01710; 5HT3BRECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    441       5-hydroxytryptamine receptor 3B.
FT                                /FTId=PRO_0000312289.
FT   TOPO_DOM     22    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    260    268       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    269    286       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    287    303       Extracellular. {ECO:0000255}.
FT   TRANSMEM    304    324       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    325    414       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    415    435       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    436    441       Extracellular. {ECO:0000255}.
FT   REGION      381    413       HA-stretch.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21138434}.
FT   CARBOHYD     96     96       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21138434}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21138434}.
FT   CARBOHYD    168    168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21138434}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21138434}.
FT   CARBOHYD    287    287       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250}.
FT   VAR_SEQ       1     17       MLSSVMAPLWACILVAA -> MIVYFP (in isoform
FT                                2). {ECO:0000303|PubMed:17010535}.
FT                                /FTId=VSP_029796.
FT   VARIANT     129    129       Y -> S (in dbSNP:rs1176744).
FT                                {ECO:0000269|PubMed:15293096,
FT                                ECO:0000269|PubMed:15389765,
FT                                ECO:0000269|PubMed:16487942,
FT                                ECO:0000269|PubMed:17010535}.
FT                                /FTId=VAR_037472.
FT   VARIANT     143    143       I -> T (in dbSNP:rs34550504).
FT                                {ECO:0000269|PubMed:16487942}.
FT                                /FTId=VAR_037473.
FT   VARIANT     156    156       S -> R (in dbSNP:rs72466469).
FT                                {ECO:0000269|PubMed:15293096,
FT                                ECO:0000269|PubMed:15389765,
FT                                ECO:0000269|PubMed:21179162}.
FT                                /FTId=VAR_037474.
FT   VARIANT     183    183       V -> I (in dbSNP:rs17116138).
FT                                {ECO:0000269|PubMed:15293096,
FT                                ECO:0000269|PubMed:15389765,
FT                                ECO:0000269|PubMed:16487942}.
FT                                /FTId=VAR_037475.
FT   MUTAGEN      52     52       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT                                {ECO:0000269|PubMed:21138434}.
FT   MUTAGEN      96     96       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT                                {ECO:0000269|PubMed:21138434}.
FT   MUTAGEN     138    138       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT                                {ECO:0000269|PubMed:21138434}.
FT   MUTAGEN     168    168       N->S: Reduced molecular weight and cell
FT                                membrane expression.
FT                                {ECO:0000269|PubMed:21138434}.
FT   MUTAGEN     203    203       N->S: Reduced molecular weight. Very
FT                                little expression in the cell membrane.
FT                                {ECO:0000269|PubMed:21138434}.
SQ   SEQUENCE   441 AA;  50292 MW;  2ED59E4E11400648 CRC64;
     MLSSVMAPLW ACILVAAGIL ATDTHHPQDS ALYHLSKQLL QKYHKEVRPV YNWTKATTVY
     LDLFVHAILD VDAENQILKT SVWYQEVWND EFLSWNSSMF DEIREISLPL SAIWAPDIII
     NEFVDIERYP DLPYVYVNSS GTIENYKPIQ VVSACSLETY AFPFDVQNCS LTFKSILHTV
     EDVDLAFLRS PEDIQHDKKA FLNDSEWELL SVSSTYSILQ SSAGGFAQIQ FNVVMRRHPL
     VYVVSLLIPS IFLMLVDLGS FYLPPNCRAR IVFKTSVLVG YTVFRVNMSN QVPRSVGSTP
     LIGHFFTICM AFLVLSLAKS IVLVKFLHDE QRGGQEQPFL CLRGDTDADR PRVEPRAQRA
     VVTESSLYGE HLAQPGTLKE VWSQLQSISN YLQTQDQTDQ QEAEWLVLLS RFDRLLFQSY
     LFMLGIYTIT LCSLWALWGG V
//
ID   ACHA_HUMAN              Reviewed;         482 AA.
AC   P02708; B4DRV6; D3DPE8;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 2.
DT   22-NOV-2017, entry version 200.
DE   RecName: Full=Acetylcholine receptor subunit alpha;
DE   Flags: Precursor;
GN   Name=CHRNA1; Synonyms=ACHRA, CHNRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6688857; DOI=10.1038/305818a0;
RA   Noda M., Furutani Y., Takahashi H., Toyosato M., Tanabe T.,
RA   Shimizu S., Kikyotani S., Kayano T., Hirose T., Inayama S., Numa S.;
RT   "Cloning and sequence analysis of calf cDNA and human genomic DNA
RT   encoding alpha-subunit precursor of muscle acetylcholine receptor.";
RL   Nature 305:818-823(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3338555; DOI=10.1016/0014-5793(88)81430-3;
RA   Schoepfer R., Luther M., Lindstrom J.M.;
RT   "The human medulloblastoma cell line TE671 expresses a muscle-like
RT   acetylcholine receptor. Cloning of the alpha-subunit cDNA.";
RL   FEBS Lett. 226:235-240(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   2).
RC   TISSUE=Muscle;
RX   PubMed=1694127;
RA   Beeson D., Morris A., Vincent A., Newsom-Davis J.;
RT   "The human muscle nicotinic acetylcholine receptor alpha-subunit exist
RT   as two isoforms: a novel exon.";
RL   EMBO J. 9:2101-2106(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=7725386;
RA   Gattenloehner S., Brabletz T., Schultz A., Marx A.,
RA   Mueller-Hermelink H.-K., Kirchner T.;
RT   "Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit
RT   from a thymoma associated with myasthenia gravis.";
RL   Thymus 23:103-113(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PROTEIN SEQUENCE OF 21-482 (ISOFORM 1).
RX   PubMed=2449458; DOI=10.1172/JCI113369;
RA   Hohlfeld R., Toyka K.V., Miner L.L., Walgrave S.L.,
RA   Conti-Tronconi B.M.;
RT   "Amphipathic segment of the nicotinic receptor alpha subunit contains
RT   epitopes recognized by T lymphocytes in myasthenia gravis.";
RL   J. Clin. Invest. 81:657-660(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 78-113.
RX   PubMed=8441631; DOI=10.1093/nar/21.2.233;
RA   Talib S., Okarma T.B., Lebkowski J.S.;
RT   "Differential expression of human nicotinic acetylcholine receptor
RT   alpha subunit variants in muscle and non-muscle tissues.";
RL   Nucleic Acids Res. 21:233-237(1993).
RN   [9]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human
RT   alpha7 nicotinic acetylcholine receptor and distinguish human
RT   nicotinic receptor subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF VAL-300.
RX   PubMed=27375219; DOI=10.1002/humu.23043;
RA   Shen X.M., Okuno T., Milone M., Otsuka K., Takahashi K., Komaki H.,
RA   Giles E., Ohno K., Engel A.G.;
RT   "Mutations causing slow-channel myasthenia reveal that a valine ring
RT   in the channel pore of muscle AChR is optimized for stabilizing
RT   channel gating.";
RL   Hum. Mutat. 37:1051-1059(2016).
RN   [12]
RP   VARIANT CMS1A SER-198.
RX   PubMed=7619526; DOI=10.1016/0896-6273(95)90080-2;
RA   Sine S.M., Ohno K., Bouzat C., Auerbach A., Milone M., Pruitt J.N. II,
RA   Engel A.G.;
RT   "Mutation of the acetylcholine receptor alpha subunit causes a slow-
RT   channel myasthenic syndrome by enhancing agonist binding affinity.";
RL   Neuron 15:229-239(1995).
RN   [13]
RP   VARIANT CMS1A LYS-262.
RX   PubMed=8872460; DOI=10.1093/hmg/5.9.1217;
RA   Engel A.G., Ohno K., Milone M., Wang H.-L., Nakano S., Bouzat C.,
RA   Pruitt J.N. II, Hutchinson D.O., Brengman J.M., Bren N., Sieb J.P.,
RA   Sine S.M.;
RT   "New mutations in acetylcholine receptor subunit genes reveal
RT   heterogeneity in the slow-channel congenital myasthenic syndrome.";
RL   Hum. Mol. Genet. 5:1217-1227(1996).
RN   [14]
RP   VARIANTS CMS1A SER-198; MET-201; ILE-299 AND ILE-314.
RX   PubMed=9158151; DOI=10.1093/hmg/6.5.767;
RA   Croxen R., Newland C., Beeson D., Oosterhuis H., Chauplannaz G.,
RA   Vincent A., Newsom-Davis J.;
RT   "Mutations in different functional domains of the human muscle
RT   acetylcholine receptor alpha subunit in patients with the slow-channel
RT   congenital myasthenic syndrome.";
RL   Hum. Mol. Genet. 6:767-774(1997).
RN   [15]
RP   VARIANT CMS1A PHE-294, AND CHARACTERIZATION OF VARIANT CMS1A PHE-294.
RX   PubMed=9221765;
RA   Milone M., Wang H.-L., Ohno K., Fukudome T., Pruitt J.N. II, Bren N.,
RA   Sine S.M., Engel A.G.;
RT   "Slow-channel myasthenic syndrome caused by enhanced activation,
RT   desensitization, and agonist binding affinity attributable to mutation
RT   in the M2 domain of the acetylcholine receptor alpha subunit.";
RL   J. Neurosci. 17:5651-5665(1997).
RN   [16]
RP   VARIANTS CMS1B VAL-278 AND ILE-330, AND CHARACTERIZATION OF VARIANTS
RP   CMS1B VAL-278 AND ILE-330.
RX   PubMed=10195214; DOI=10.1038/6326;
RA   Wang H.-L., Milone M., Ohno K., Shen X.-M., Tsujino A.,
RA   Batocchi A.-P., Tonali P., Brengman J., Engel A.G., Sine S.M.;
RT   "Acetylcholine receptor M3 domain: stereochemical and volume
RT   contributions to channel gating.";
RL   Nat. Neurosci. 2:226-233(1999).
RN   [17]
RP   ERRATUM.
RA   Wang H.-L., Milone M., Ohno K., Shen X.-M., Tsujino A.,
RA   Batocchi A.-P., Tonali P., Brengman J., Engel A.G., Sine S.M.;
RL   Nat. Neurosci. 2:485-485(1999).
RN   [18]
RP   VARIANT CMS1B LEU-177, AND CHARACTERIZATION OF VARIANT CMS1B LEU-177.
RX   PubMed=12588888; DOI=10.1172/JCI16997;
RA   Shen X.-M., Ohno K., Tsujino A., Brengman J.M., Gingold M., Sine S.M.,
RA   Engel A.G.;
RT   "Mutation causing severe myasthenia reveals functional asymmetry of
RT   AChR signature cystine loops in agonist binding and gating.";
RL   J. Clin. Invest. 111:497-505(2003).
RN   [19]
RP   VARIANT CMS1B LEU-301, AND CHARACTERIZATION OF VARIANT CMS1B LEU-301.
RX   PubMed=15079006; DOI=10.1212/01.WNL.0000118205.99701.41;
RA   Webster R., Brydson M., Croxen R., Newsom-Davis J., Vincent A.,
RA   Beeson D.;
RT   "Mutation in the AChR ion channel gate underlies a fast channel
RT   congenital myasthenic syndrome.";
RL   Neurology 62:1090-1096(2004).
RN   [20]
RP   VARIANT CMS1A TRP-463, AND CHARACTERIZATION OF VARIANT CMS1A TRP-463.
RX   PubMed=16685696; DOI=10.1002/ana.20861;
RA   Shen X.-M., Deymeer F., Sine S.M., Engel A.G.;
RT   "Slow-channel mutation in acetylcholine receptor alphaM4 domain and
RT   its efficient knockdown.";
RL   Ann. Neurol. 60:128-136(2006).
RN   [21]
RP   VARIANT LMPS LEU-254.
RX   PubMed=18252226; DOI=10.1016/j.ajhg.2007.11.006;
RA   Michalk A., Stricker S., Becker J., Rupps R., Pantzar T., Miertus J.,
RA   Botta G., Naretto V.G., Janetzki C., Yaqoob N., Ott C.-E., Seelow D.,
RA   Wieczorek D., Fiebig B., Wirth B., Hoopmann M., Walther M.,
RA   Koerber F., Blankenburg M., Mundlos S., Heller R., Hoffmann K.;
RT   "Acetylcholine receptor pathway mutations explain various fetal
RT   akinesia deformation sequence disorders.";
RL   Am. J. Hum. Genet. 82:464-476(2008).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000269|PubMed:27375219}.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (PubMed:15609996). {ECO:0000269|PubMed:15609996}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=P02708-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P02708-2; Sequence=VSP_000071;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is only expressed in skeletal
CC       muscle. Isoform 2 is constitutively expressed in skeletal muscle,
CC       brain, heart, kidney, liver, lung and thymus.
CC   -!- DISEASE: Multiple pterygium syndrome, lethal type (LMPS)
CC       [MIM:253290]: Multiple pterygia are found infrequently in children
CC       with arthrogryposis and in fetuses with fetal akinesia syndrome.
CC       In lethal multiple pterygium syndrome there is intrauterine growth
CC       retardation, multiple pterygia, and flexion contractures causing
CC       severe arthrogryposis and fetal akinesia. Subcutaneous edema can
CC       be severe, causing fetal hydrops with cystic hygroma and lung
CC       hypoplasia. Oligohydramnios and facial anomalies are frequent.
CC       {ECO:0000269|PubMed:18252226}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=The alpha subunit is the main focus for antibody
CC       binding in myasthenia gravis. Myasthenia gravis is characterized
CC       by sporadic muscular fatigability and weakness, occurring chiefly
CC       in muscles innervated by cranial nerves, and characteristically
CC       improved by cholinesterase-inhibiting drugs.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A)
CC       [MIM:601462]: A common congenital myasthenic syndrome. Congenital
CC       myasthenic syndromes are characterized by muscle weakness
CC       affecting the axial and limb muscles (with hypotonia in early-
CC       onset forms), the ocular muscles (leading to ptosis and
CC       ophthalmoplegia), and the facial and bulbar musculature (affecting
CC       sucking and swallowing, and leading to dysphonia). The symptoms
CC       fluctuate and worsen with physical effort. CMS1A is a slow-channel
CC       myasthenic syndrome. It is caused by kinetic abnormalities of the
CC       AChR, resulting in prolonged AChR channel opening episodes,
CC       prolonged endplate currents, and depolarization block. This is
CC       associated with calcium overload, which may contribute to
CC       subsequent degeneration of the endplate and postsynaptic membrane.
CC       {ECO:0000269|PubMed:16685696, ECO:0000269|PubMed:7619526,
CC       ECO:0000269|PubMed:8872460, ECO:0000269|PubMed:9158151,
CC       ECO:0000269|PubMed:9221765}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 1B, fast-channel (CMS1B)
CC       [MIM:608930]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS1B is a fast-channel myasthenic syndrome. It is caused
CC       by kinetic abnormalities of the AChR, resulting in brief opening
CC       and activity of the channel, with a rapid decay in endplate
CC       current, failure to achieve threshold depolarization of the
CC       endplate and consequent failure to fire an action potential.
CC       {ECO:0000269|PubMed:10195214, ECO:0000269|PubMed:12588888,
CC       ECO:0000269|PubMed:15079006}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       1/CHRNA1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA49705.1; Type=Frameshift; Positions=104; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X02502; CAA26344.1; -; Genomic_DNA.
DR   EMBL; X02503; CAA26344.1; JOINED; Genomic_DNA.
DR   EMBL; X02504; CAA26344.1; JOINED; Genomic_DNA.
DR   EMBL; X02505; CAA26344.1; JOINED; Genomic_DNA.
DR   EMBL; X02506; CAA26344.1; JOINED; Genomic_DNA.
DR   EMBL; X02507; CAA26344.1; JOINED; Genomic_DNA.
DR   EMBL; X02508; CAA26344.1; JOINED; Genomic_DNA.
DR   EMBL; Y00762; CAA68731.1; -; mRNA.
DR   EMBL; X17104; CAA34960.1; -; Genomic_DNA.
DR   EMBL; AK299445; BAG61418.1; -; mRNA.
DR   EMBL; CH471058; EAX11125.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11127.1; -; Genomic_DNA.
DR   EMBL; S77094; AAD14247.1; -; mRNA.
DR   EMBL; X70108; CAA49705.1; ALT_FRAME; Genomic_DNA.
DR   CCDS; CCDS2261.1; -. [P02708-2]
DR   CCDS; CCDS33331.1; -. [P02708-1]
DR   PIR; A03168; ACHUA1.
DR   PIR; S10148; S10148.
DR   RefSeq; NP_000070.1; NM_000079.3. [P02708-2]
DR   RefSeq; NP_001034612.1; NM_001039523.2. [P02708-1]
DR   UniGene; Hs.434479; -.
DR   PDB; 1Y5P; Model; -; B=230-235.
DR   PDB; 1Y5T; Model; -; B=230-235.
DR   PDB; 1Y6C; Model; -; B=230-235.
DR   PDB; 4ZJS; X-ray; 2.23 A; A/B/C/D/E=21-50, A/B/C/D/E=106-126.
DR   PDB; 5HBT; X-ray; 2.61 A; B=21-256.
DR   PDBsum; 1Y5P; -.
DR   PDBsum; 1Y5T; -.
DR   PDBsum; 1Y6C; -.
DR   PDBsum; 4ZJS; -.
DR   PDBsum; 5HBT; -.
DR   ProteinModelPortal; P02708; -.
DR   SMR; P02708; -.
DR   BioGrid; 107556; 4.
DR   IntAct; P02708; 3.
DR   STRING; 9606.ENSP00000261007; -.
DR   BindingDB; P02708; -.
DR   ChEMBL; CHEMBL4808; -.
DR   DrugBank; DB08838; Agmatine.
DR   DrugBank; DB00674; Galantamine.
DR   GuidetoPHARMACOLOGY; 462; -.
DR   TCDB; 1.A.9.1.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P02708; -.
DR   PhosphoSitePlus; P02708; -.
DR   BioMuta; CHRNA1; -.
DR   DMDM; 113071; -.
DR   PaxDb; P02708; -.
DR   PeptideAtlas; P02708; -.
DR   PRIDE; P02708; -.
DR   DNASU; 1134; -.
DR   Ensembl; ENST00000261007; ENSP00000261007; ENSG00000138435. [P02708-1]
DR   Ensembl; ENST00000348749; ENSP00000261008; ENSG00000138435. [P02708-2]
DR   GeneID; 1134; -.
DR   KEGG; hsa:1134; -.
DR   UCSC; uc002ujd.3; human. [P02708-1]
DR   CTD; 1134; -.
DR   DisGeNET; 1134; -.
DR   EuPathDB; HostDB:ENSG00000138435.14; -.
DR   GeneCards; CHRNA1; -.
DR   GeneReviews; CHRNA1; -.
DR   HGNC; HGNC:1955; CHRNA1.
DR   HPA; HPA071554; -.
DR   MalaCards; CHRNA1; -.
DR   MIM; 100690; gene.
DR   MIM; 253290; phenotype.
DR   MIM; 254200; phenotype.
DR   MIM; 601462; phenotype.
DR   MIM; 608930; phenotype.
DR   neXtProt; NX_P02708; -.
DR   OpenTargets; ENSG00000138435; -.
DR   Orphanet; 33108; Lethal multiple pterygium syndrome.
DR   Orphanet; 98913; Postsynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA26487; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P02708; -.
DR   KO; K04803; -.
DR   OMA; DFAIIHE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P02708; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   SIGNOR; P02708; -.
DR   GeneWiki; Cholinergic_receptor,_nicotinic,_alpha_1; -.
DR   GenomeRNAi; 1134; -.
DR   PRO; PR:P02708; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138435; -.
DR   CleanEx; HS_CHRNA1; -.
DR   ExpressionAtlas; P02708; baseline and differential.
DR   Genevisible; P02708; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; ISS:BHF-UCL.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0045211; C:postsynaptic membrane; NAS:BHF-UCL.
DR   GO; GO:0042166; F:acetylcholine binding; IEA:Ensembl.
DR   GO; GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:MGI.
DR   GO; GO:0005216; F:ion channel activity; TAS:ProtInc.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; IMP:BHF-UCL.
DR   GO; GO:0050881; P:musculoskeletal movement; IMP:BHF-UCL.
DR   GO; GO:0007528; P:neuromuscular junction development; IMP:MGI.
DR   GO; GO:0050905; P:neuromuscular process; IMP:BHF-UCL.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IMP:MGI.
DR   GO; GO:0070050; P:neuron cellular homeostasis; IMP:BHF-UCL.
DR   GO; GO:0019228; P:neuronal action potential; IMP:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:BHF-UCL.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0003009; P:skeletal muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; IMP:BHF-UCL.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 2.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 2.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Congenital myasthenic syndrome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:2449458}.
FT   CHAIN        21    482       Acetylcholine receptor subunit alpha.
FT                                /FTId=PRO_0000000305.
FT   TOPO_DOM     21    255       Extracellular.
FT   TRANSMEM    256    280       Helical.
FT   TRANSMEM    288    306       Helical.
FT   TRANSMEM    322    341       Helical.
FT   TOPO_DOM    342    453       Cytoplasmic.
FT   TRANSMEM    454    472       Helical.
FT   CARBOHYD    186    186       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    173    187
FT   DISULFID    237    238       Associated with receptor activation.
FT   VAR_SEQ      79    103       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:3338555,
FT                                ECO:0000303|PubMed:7725386}.
FT                                /FTId=VSP_000071.
FT   VARIANT     177    177       V -> L (in CMS1B; mutant channel shows an
FT                                approximately 30-fold decrease of ACh
FT                                binding affinity for the second of 2
FT                                closed-state binding sites but only a 2-
FT                                fold decrease in gating efficiency;
FT                                dbSNP:rs137852807).
FT                                {ECO:0000269|PubMed:12588888}.
FT                                /FTId=VAR_038599.
FT   VARIANT     198    198       G -> S (in CMS1A; dbSNP:rs137852801).
FT                                {ECO:0000269|PubMed:7619526,
FT                                ECO:0000269|PubMed:9158151}.
FT                                /FTId=VAR_000282.
FT   VARIANT     201    201       V -> M (in CMS1A; dbSNP:rs137852799).
FT                                {ECO:0000269|PubMed:9158151}.
FT                                /FTId=VAR_000283.
FT   VARIANT     254    254       R -> L (in LMPS; dbSNP:rs137852809).
FT                                {ECO:0000269|PubMed:18252226}.
FT                                /FTId=VAR_043904.
FT   VARIANT     262    262       N -> K (in CMS1A; dbSNP:rs137852798).
FT                                {ECO:0000269|PubMed:8872460}.
FT                                /FTId=VAR_000284.
FT   VARIANT     278    278       F -> V (in CMS1B; markedly reduced
FT                                protein expression; dbSNP:rs137852805).
FT                                {ECO:0000269|PubMed:10195214}.
FT                                /FTId=VAR_021206.
FT   VARIANT     294    294       V -> F (in CMS1A; causes increased
FT                                channel opening in absence of ACh;
FT                                prolonged opening in presence of ACh;
FT                                increased affinity for ACh and enhanced
FT                                desensitization; dbSNP:rs137852803).
FT                                {ECO:0000269|PubMed:9221765}.
FT                                /FTId=VAR_021207.
FT   VARIANT     299    299       T -> I (in CMS1A; dbSNP:rs137852800).
FT                                {ECO:0000269|PubMed:9158151}.
FT                                /FTId=VAR_000285.
FT   VARIANT     301    301       F -> L (in CMS1B; fewer and shorter ion
FT                                channel activations with decreased
FT                                channel opening rate and increased
FT                                channel closing rate; dbSNP:rs137852806).
FT                                {ECO:0000269|PubMed:15079006}.
FT                                /FTId=VAR_021208.
FT   VARIANT     314    314       S -> I (in CMS1A; dbSNP:rs137852802).
FT                                {ECO:0000269|PubMed:9158151}.
FT                                /FTId=VAR_000286.
FT   VARIANT     330    330       V -> I (in CMS1B; abnormally slow channel
FT                                opening and closing resulting in
FT                                abnormally brief current;
FT                                dbSNP:rs137852804).
FT                                {ECO:0000269|PubMed:10195214}.
FT                                /FTId=VAR_021209.
FT   VARIANT     383    383       D -> V (in dbSNP:rs6739001).
FT                                /FTId=VAR_038600.
FT   VARIANT     463    463       C -> W (in CMS1A; increases the rate of
FT                                channel opening and slows the rate of
FT                                channel closing but has no effect on
FT                                agonist binding; dbSNP:rs137852808).
FT                                {ECO:0000269|PubMed:16685696}.
FT                                /FTId=VAR_038601.
FT   MUTAGEN     300    300       V->A: Increased length of channel
FT                                opening. {ECO:0000269|PubMed:27375219}.
FT   CONFLICT    415    415       P -> F (in Ref. 4; AAD14247).
FT                                {ECO:0000305}.
FT   HELIX        23     31       {ECO:0000244|PDB:4ZJS}.
FT   STRAND       37     39       {ECO:0000244|PDB:5HBT}.
FT   STRAND       49     52       {ECO:0000244|PDB:4ZJS}.
FT   TURN         65     68       {ECO:0000244|PDB:5HBT}.
FT   STRAND       69     78       {ECO:0000244|PDB:5HBT}.
FT   STRAND      106    111       {ECO:0000244|PDB:4ZJS}.
FT   HELIX       114    117       {ECO:0000244|PDB:4ZJS}.
FT   STRAND      122    126       {ECO:0000244|PDB:4ZJS}.
FT   HELIX       127    129       {ECO:0000244|PDB:5HBT}.
FT   STRAND      135    138       {ECO:0000244|PDB:5HBT}.
FT   STRAND      140    145       {ECO:0000244|PDB:5HBT}.
FT   STRAND      152    156       {ECO:0000244|PDB:5HBT}.
FT   STRAND      159    163       {ECO:0000244|PDB:5HBT}.
FT   STRAND      166    172       {ECO:0000244|PDB:5HBT}.
FT   STRAND      184    195       {ECO:0000244|PDB:5HBT}.
FT   TURN        198    200       {ECO:0000244|PDB:5HBT}.
FT   STRAND      201    209       {ECO:0000244|PDB:5HBT}.
FT   STRAND      219    235       {ECO:0000244|PDB:5HBT}.
FT   STRAND      243    254       {ECO:0000244|PDB:5HBT}.
SQ   SEQUENCE   482 AA;  54546 MW;  8B307AD69B91A28B CRC64;
     MEPWPLLLLF SLCSAGLVLG SEHETRLVAK LFKDYSSVVR PVEDHRQVVE VTVGLQLIQL
     INVDEVNQIV TTNVRLKQGD MVDLPRPSCV TLGVPLFSHL QNEQWVDYNL KWNPDDYGGV
     KKIHIPSEKI WRPDLVLYNN ADGDFAIVKF TKVLLQYTGH ITWTPPAIFK SYCEIIVTHF
     PFDEQNCSMK LGTWTYDGSV VAINPESDQP DLSNFMESGE WVIKESRGWK HSVTYSCCPD
     TPYLDITYHF VMQRLPLYFI VNVIIPCLLF SFLTGLVFYL PTDSGEKMTL SISVLLSLTV
     FLLVIVELIP STSSAVPLIG KYMLFTMVFV IASIIITVIV INTHHRSPST HVMPNWVRKV
     FIDTIPNIMF FSTMKRPSRE KQDKKIFTED IDISDISGKP GPPPMGFHSP LIKHPEVKSA
     IEGIKYIAET MKSDQESNNA AAEWKYVAMV MDHILLGVFM LVCIIGTLAV FAGRLIELNQ
     QG
//
ID   ACHE_BOVIN              Reviewed;         491 AA.
AC   P02715; Q547R5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   25-OCT-2017, entry version 133.
DE   RecName: Full=Acetylcholine receptor subunit epsilon;
DE   Flags: Precursor;
GN   Name=CHRNE;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3839289; DOI=10.1038/315761a0;
RA   Takai T., Noda M., Mishina M., Shimizu S., Furutani Y., Kayano T.,
RA   Ikeda T., Kubo T., Takahashi H., Takahashi T., Kuno M., Numa S.;
RT   "Cloning, sequencing and expression of cDNA for a novel subunit of
RT   acetylcholine receptor from calf muscle.";
RL   Nature 315:761-764(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14592869; DOI=10.1196/annals.1254.014;
RA   Sieb J.P., Kraner S., Thompson P.N., Steinlein O.K.;
RT   "Congenital myasthenic syndrome in cattle due to homozygosity for a
RT   truncating mutation in the acetylcholine receptor (AChR) epsilon-
RT   subunit gene.";
RL   Ann. N. Y. Acad. Sci. 998:125-127(2003).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (By similarity). {ECO:0000250|UniProtKB:Q04844}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       Epsilon/CHRNE sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X02597; CAA26442.1; -; mRNA.
DR   EMBL; AF457659; AAN76988.1; -; Genomic_DNA.
DR   EMBL; AF457656; AAN76988.1; JOINED; Genomic_DNA.
DR   EMBL; AF457657; AAN76988.1; JOINED; Genomic_DNA.
DR   EMBL; AF457658; AAN76988.1; JOINED; Genomic_DNA.
DR   PIR; A03174; ACBOE.
DR   RefSeq; NP_776697.1; NM_174272.2.
DR   UniGene; Bt.4231; -.
DR   ProteinModelPortal; P02715; -.
DR   STRING; 9913.ENSBTAP00000042804; -.
DR   PaxDb; P02715; -.
DR   PRIDE; P02715; -.
DR   Ensembl; ENSBTAT00000045415; ENSBTAP00000042804; ENSBTAG00000004908.
DR   GeneID; 281688; -.
DR   KEGG; bta:281688; -.
DR   CTD; 1145; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P02715; -.
DR   KO; K04817; -.
DR   OMA; ESTRDQE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-BTA-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Proteomes; UP000009136; Chromosome 19.
DR   Bgee; ENSBTAG00000004908; -.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:Ensembl.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20
FT   CHAIN        21    491       Acetylcholine receptor subunit epsilon.
FT                                /FTId=PRO_0000000328.
FT   TOPO_DOM     21    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    264       Helical. {ECO:0000255}.
FT   TOPO_DOM    265    272       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    273    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    306       Extracellular. {ECO:0000255}.
FT   TRANSMEM    307    328       Helical. {ECO:0000255}.
FT   TOPO_DOM    329    456       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    457    480       Helical. {ECO:0000255}.
FT   TOPO_DOM    481    491       Extracellular. {ECO:0000255}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    148    162       {ECO:0000250}.
SQ   SEQUENCE   491 AA;  54565 MW;  30E301DA117FA395 CRC64;
     MAGALLCALL LLQLLGRGEG KNEELRLYHY LFDTYDPGRR PVQEPEDTVT ISLKVTLTNL
     ISLNEKEETL TTSVWIGIDW QDYRLNYSKG DFGGVETLRV PSELVWLPEI VLENNIDGQF
     GVAYEANVLV SEGGYLSWLP PAIYRSTCAV EVTYFPFDWQ NCSLVFRSQT YNAEEVEFVF
     AVDDEGKTIS KIDIDTEAYT ENGEWAIDFC PGVIRRHDGD SAGGPGETDV IYSLIIRRKP
     LFYVINIIVP CVLISGLVLL AYFLPAQAGG QKCTVSINVL LAQTVFLFLI AQKTPETSLS
     VPLLGRYLIF VMVVATLIVM NCVIVLNVSL RTPTTHAMSP RLRYVLLELL PQLLGSGAPP
     EIPRAASPPR RASSLGLLLR AEELILKKPR SELVFEQQRH RHGTWTATLC QNLGAAAPEI
     RCCVDAVNFV ASSTRDQEAT GEEVSDWVRM GKALDSICFW AALVLFLVGS SLIFLGAYFN
     RVPQLPYPPC M
//
ID   ACHD_CHICK              Reviewed;         513 AA.
AC   P02717;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   25-OCT-2017, entry version 135.
DE   RecName: Full=Acetylcholine receptor subunit delta;
DE   Flags: Precursor;
GN   Name=CHRND;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6096871; DOI=10.1073/pnas.81.24.7975;
RA   Nef P., Mauron A., Stalder R., Alliod C., Ballivet M.;
RT   "Structure linkage, and sequence of the two genes encoding the delta
RT   and gamma subunits of the nicotinic acetylcholine receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:7975-7979(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-14.
RX   PubMed=2311580;
RA   Wang X.M., Tsay H.J., Schmidt J.;
RT   "Expression of the acetylcholine receptor delta-subunit gene in
RT   differentiating chick muscle cells is activated by an element that
RT   contains two 16 bp copies of a segment of the alpha-subunit
RT   enhancer.";
RL   EMBO J. 9:783-790(1990).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma chains.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02903; AAB59944.1; -; Genomic_DNA.
DR   EMBL; X52010; CAA36259.1; -; Genomic_DNA.
DR   PIR; A03176; ACCHD1.
DR   ProteinModelPortal; P02717; -.
DR   STRING; 9031.ENSGALP00000012809; -.
DR   PaxDb; P02717; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P02717; -.
DR   PhylomeDB; P02717; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     18
FT   CHAIN        19    513       Acetylcholine receptor subunit delta.
FT                                /FTId=PRO_0000000325.
FT   TOPO_DOM     19    244       Extracellular.
FT   TRANSMEM    245    269       Helical.
FT   TRANSMEM    277    295       Helical.
FT   TRANSMEM    311    332       Helical.
FT   TOPO_DOM    333    467       Cytoplasmic.
FT   TRANSMEM    468    490       Helical.
FT   MOD_RES     388    388       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000250}.
FT   CARBOHYD     88     88       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    148    162       {ECO:0000250}.
SQ   SEQUENCE   513 AA;  59011 MW;  0C35772CC57E12CF CRC64;
     MAVLLALFGA LVLSGGLCVN QEERLIHHLF EERGYNKEVR PVASADEVVD VYLALTLSNL
     ISLKEVDETL TTNVWVEQSW TDYRLQWNTS EFGGVDVLRL LPEMLWLPEI VLENNNDGLF
     EVAYYCNVLV YNTGYVYWLP PAIFRSACPI NVNFFPFDWQ NCTLKFSSLA YNAQEINMHL
     KEESDPETEK NYRVEWIIID PEGFTENGEW EIIHRPARKN IHPSYPTESS EHQDITFYLI
     IKRKPLFYVI NIVTPCVLIA FMAILVFYLP ADSGEKMTLV ISVLLAQSVF LLLVSQRLPA
     TSHAIPLIGK YLLFIMLLVT AVVVICVVVL NFHFRTPSTH VMSDWVRGVF LEILPRLLHM
     SHPAESPAGA PCIRRCSSAG YIAKAEEYYS VKSRSELMFE KQSERHGLAS RVTPARFAPA
     ATSEEQLYDH LKPTLDEANF IVKHMREKNS YNEEKDNWNR VARTLDRLCL FLITPMLVVG
     TLWIFLMGIY NHPPPLPFSG DPFDYREENK RYI
//
ID   ACHD_TETCF              Reviewed;         522 AA.
AC   P02718;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   25-OCT-2017, entry version 124.
DE   RecName: Full=Acetylcholine receptor subunit delta;
DE   Flags: Precursor;
GN   Name=chrnd;
OS   Tetronarce californica (Pacific electric ray) (Torpedo californica).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes;
OC   Elasmobranchii; Batoidea; Torpediniformes; Torpedinidae; Tetronarce.
OX   NCBI_TaxID=7787;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6687403; DOI=10.1038/301251a0;
RA   Noda M., Takahashi H., Tanabe T., Toyosato M., Kikyotani S.,
RA   Hirose T., Asai M., Takashima H., Inayama S., Miyata T., Numa S.;
RT   "Primary structures of beta- and delta-subunit precursors of Torpedo
RT   californica acetylcholine receptor deduced from cDNA sequences.";
RL   Nature 301:251-255(1983).
RN   [2]
RP   PROTEIN SEQUENCE OF 125-134 AND 139-145, GLYCOSYLATION AT ASN-164, AND
RP   DISULFIDE BOND.
RX   PubMed=2742850; DOI=10.1021/bi00434a048;
RA   Kellaris K.V., Ware D.K., Smith S., Kyte J.;
RT   "Assessment of the number of free cysteines and isolation and
RT   identification of cystine-containing peptides from acetylcholine
RT   receptor.";
RL   Biochemistry 28:3469-3482(1989).
RN   [3]
RP   PHOSPHORYLATION AT TYR-393.
RX   PubMed=1721053;
RA   Wagner K., Edson K., Heginbotham L., Post M., Huganir R.L.,
RA   Czernik A.J.;
RT   "Determination of the tyrosine phosphorylation sites of the nicotinic
RT   acetylcholine receptor.";
RL   J. Biol. Chem. 266:23784-23789(1991).
RN   [4]
RP   STRUCTURE BY NMR OF 276-298.
RX   PubMed=10201407; DOI=10.1038/7610;
RA   Opella S.J., Marassi F.M., Gesell J.J., Valente A.P., Kim Y.,
RA   Oblatt-Montal M., Montal M.;
RT   "Structures of the M2 channel-lining segments from nicotinic
RT   acetylcholine and NMDA receptors by NMR spectroscopy.";
RL   Nat. Struct. Biol. 6:374-379(1999).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma chains.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J00965; AAA49275.1; -; mRNA.
DR   PIR; A03177; ACRYD1.
DR   PDB; 1EQ8; NMR; -; A/B/C/D/E=276-298.
DR   PDB; 1LK1; Model; -; B=23-246.
DR   PDB; 1OED; EM; 4.00 A; C=246-505.
DR   PDB; 1OLK; Model; -; D=24-246.
DR   PDBsum; 1EQ8; -.
DR   PDBsum; 1LK1; -.
DR   PDBsum; 1OED; -.
DR   PDBsum; 1OLK; -.
DR   ProteinModelPortal; P02718; -.
DR   SMR; P02718; -.
DR   ELM; P02718; -.
DR   IntAct; P02718; 3.
DR   MINT; MINT-8146728; -.
DR   BindingDB; P02718; -.
DR   ChEMBL; CHEMBL3916; -.
DR   TCDB; 1.A.9.1.9; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P02718; -.
DR   SwissPalm; P02718; -.
DR   UniCarbKB; P02718; -.
DR   HOVERGEN; HBG003756; -.
DR   EvolutionaryTrace; P02718; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     21
FT   CHAIN        22    522       Acetylcholine receptor subunit delta.
FT                                /FTId=PRO_0000000326.
FT   TOPO_DOM     22    245       Extracellular.
FT   TRANSMEM    246    270       Helical.
FT   TRANSMEM    278    295       Helical.
FT   TRANSMEM    312    333       Helical.
FT   TOPO_DOM    334    476       Cytoplasmic.
FT   TRANSMEM    477    497       Helical.
FT   MOD_RES     393    393       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000269|PubMed:1721053}.
FT   CARBOHYD     91     91       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:2742850}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000269|PubMed:2742850}.
FT   HELIX       277    297       {ECO:0000244|PDB:1EQ8}.
SQ   SEQUENCE   522 AA;  59891 MW;  568CF9C3D3E91E28 CRC64;
     MGNIHFVYLL ISCLYYSGCS GVNEEERLIN DLLIVNKYNK HVRPVKHNNE VVNIALSLTL
     SNLISLKETD ETLTSNVWMD HAWYDHRLTW NASEYSDISI LRLPPELVWI PDIVLQNNND
     GQYHVAYFCN VLVRPNGYVT WLPPAIFRSS CPINVLYFPF DWQNCSLKFT ALNYDANEIT
     MDLMTDTIDG KDYPIEWIII DPEAFTENGE WEIIHKPAKK NIYPDKFPNG TNYQDVTFYL
     IIRRKPLFYV INFITPCVLI SFLASLAFYL PAESGEKMST AISVLLAQAV FLLLTSQRLP
     ETALAVPLIG KYLMFIMSLV TGVIVNCGIV LNFHFRTPST HVLSTRVKQI FLEKLPRILH
     MSRADESEQP DWQNDLKLRR SSSVGYISKA QEYFNIKSRS ELMFEKQSER HGLVPRVTPR
     IGFGNNNENI AASDQLHDEI KSGIDSTNYI VKQIKEKNAY DEEVGNWNLV GQTIDRLSMF
     IITPVMVLGT IFIFVMGNFN HPPAKPFEGD PFDYSSDHPR CA
//
ID   ACH3_DROME              Reviewed;         521 AA.
AC   P04755; Q9VZC3;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   22-NOV-2017, entry version 161.
DE   RecName: Full=Acetylcholine receptor subunit beta-like 1;
DE   AltName: Full=Nicotinic acetylcholine receptor beta 1;
DE   Flags: Precursor;
GN   Name=nAChRbeta1; Synonyms=Acr64B, AcrD, ard, nAcRbeta-64B;
GN   ORFNames=CG11348;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=16453690;
RA   Hermans-Borgmeyer I., Zopf D., Ryseck R.-P., Hovemann B., Betz H.,
RA   Gundelfinger E.D.;
RT   "Primary structure of a developmentally regulated nicotinic
RT   acetylcholine receptor protein from Drosophila.";
RL   EMBO J. 5:1503-1508(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3136037; DOI=10.1016/0014-5793(88)81230-4;
RA   Sawruk E., Hermans-Borgmeyer I., Betz H., Gundelfinger E.D.;
RT   "Characterization of an invertebrate nicotinic acetylcholine receptor
RT   gene: the ard gene of Drosophila melanogaster.";
RL   FEBS Lett. 235:40-46(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2832736; DOI=10.1128/MCB.8.2.778;
RA   Wadsworth S.C., Rosenthal L.S., Kammermeyer K.L., Potter M.B.,
RA   Nelson D.J.;
RT   "Expression of a Drosophila melanogaster acetylcholine receptor-
RT   related gene in the central nervous system.";
RL   Mol. Cell. Biol. 8:778-785(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: CNS in embryos. {ECO:0000269|PubMed:16453690}.
CC   -!- DEVELOPMENTAL STAGE: Late embryonic and late pupal stages.
CC       {ECO:0000269|PubMed:16453690}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04016; CAA27641.1; -; mRNA.
DR   EMBL; X07956; CAA30778.1; -; Genomic_DNA.
DR   EMBL; X07957; CAA30778.1; JOINED; Genomic_DNA.
DR   EMBL; X07958; CAA30778.1; JOINED; Genomic_DNA.
DR   EMBL; M20316; AAA28311.1; -; mRNA.
DR   EMBL; AE014296; AAF47900.1; -; Genomic_DNA.
DR   PIR; S03012; ACFFNN.
DR   RefSeq; NP_523927.2; NM_079203.3.
DR   UniGene; Dm.2738; -.
DR   ProteinModelPortal; P04755; -.
DR   BioGrid; 64020; 1.
DR   STRING; 7227.FBpp0073155; -.
DR   ChEMBL; CHEMBL3350223; -.
DR   PaxDb; P04755; -.
DR   PRIDE; P04755; -.
DR   GeneID; 38545; -.
DR   KEGG; dme:Dmel_CG11348; -.
DR   CTD; 38545; -.
DR   FlyBase; FBgn0000038; nAChRbeta1.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   InParanoid; P04755; -.
DR   KO; K05312; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P04755; -.
DR   Reactome; R-DME-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-DME-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-DME-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   ChiTaRS; nAcRbeta-64B; fly.
DR   GenomeRNAi; 38545; -.
DR   PRO; PR:P04755; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0000038; -.
DR   ExpressionAtlas; P04755; differential.
DR   Genevisible; P04755; DM.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; ISS:FlyBase.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:FlyBase.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:FlyBase.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IEP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    521       Acetylcholine receptor subunit beta-like
FT                                1.
FT                                /FTId=PRO_0000000301.
FT   TOPO_DOM     25    235       Extracellular.
FT   TRANSMEM    236    260       Helical.
FT   TRANSMEM    268    286       Helical.
FT   TRANSMEM    302    323       Helical.
FT   TOPO_DOM    324    481       Cytoplasmic.
FT   TRANSMEM    482    500       Helical.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    152    166       {ECO:0000250}.
FT   VARIANT      73     73       V -> I.
FT   CONFLICT    383    384       EL -> DV (in Ref. 3; AAA28311).
FT                                {ECO:0000305}.
SQ   SEQUENCE   521 AA;  59902 MW;  FF9BA2ABC0C3AA62 CRC64;
     MESSCKSWLL CSILVLVAFS LVSASEDEER LVRDLFRGYN KLIRPVQNMT QKVGVRFGLA
     FVQLINVNEK NQVMKSNVWL RLVWYDYQLQ WDEADYGGIG VLRLPPDKVW KPDIVLFNNA
     DGNYEVRYKS NVLIYPTGEV LWVPPAIYQS SCTIDVTYFP FDQQTCIMKF GSWTFNGDQV
     SLALYNNKNF VDLSDYWKSG TWDIIEVPAY LNVYEGDSNH PTETDITFYI IIRRKTLFYT
     VNLILPTVLI SFLCVLVFYL PAEAGEKVTL GISILLSLVV FLLLVSKILP PTSLVLPLIA
     KYLLFTFIMN TVSILVTVII INWNFRGPRT HRMPMYIRSI FLHYLPAFLF MKRPRKTRLR
     WMMEMPGMSM PAHPHPSYGS PAELPKHISA IGGKQSKMEV MELSDLHHPN CKINRKVNSG
     GELGLGDGCR RESESSDSIL LSPEASKATE AVEFIAEHLR NEDLYIQTRE DWKYVAMVID
     RLQLYIFFIV TTAGTVGILM DAPHIFEYVD QDRIIEIYRG K
//
ID   ACHA3_RAT               Reviewed;         499 AA.
AC   P04757;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   22-NOV-2017, entry version 146.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-3;
DE   Flags: Precursor;
GN   Name=Chrna3; Synonyms=Acra3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3753746; DOI=10.1038/319368a0;
RA   Boulter J., Evans K., Goldman D.J., Martin G., Treco D.,
RA   Heinemann S.F., Patrick J.;
RT   "Isolation of a cDNA clone coding for a possible neural nicotinic
RT   acetylcholine receptor alpha-subunit.";
RL   Nature 319:368-374(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2444984; DOI=10.1073/pnas.84.21.7763;
RA   Boulter J., Connolly J.G., Deneris E.S., Goldman D.J., Heinemann S.F.,
RA   Patrick J.;
RT   "Functional expression of two neuronal nicotinic acetylcholine
RT   receptors from cDNA clones identifies a gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7763-7767(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21.
RC   TISSUE=Liver;
RX   PubMed=8144606;
RA   Yang X., McDonough J., Fyodorov D., Morris M., Wang F., Deneris E.S.;
RT   "Characterization of an acetylcholine receptor alpha 3 gene promoter
RT   and its activation by the POU domain factor SCIP/Tst-1.";
RL   J. Biol. Chem. 269:10252-10264(1994).
RN   [4]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human
RT   alpha7 nicotinic acetylcholine receptor and distinguish human
RT   nicotinic receptor subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [5]
RP   SUBUNIT.
RX   PubMed=15929983; DOI=10.1074/jbc.M504229200;
RA   Dutertre S., Nicke A., Lewis R.J.;
RT   "Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the
RT   nicotinic acetylcholine receptor.";
RL   J. Biol. Chem. 280:30460-30468(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407 AND SER-410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of
CC       subunits: alpha and beta. Alpha-3 subunit can be combined to beta-
CC       2 or beta-4 to give rise to functional receptors. Interacts with
CC       RIC3; which is required for proper folding and assembly. Interacts
CC       with LYPD6. The heteropentamer alpha-3-beta-2 interacts with
CC       alpha-conotoxins ImI, ImII, PnIA, GID and MII (PubMed:15609996,
CC       PubMed:15929983). {ECO:0000250|UniProtKB:P32297,
CC       ECO:0000269|PubMed:15609996, ECO:0000269|PubMed:15929983}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       3/CHRNA3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03440; CAA27170.1; -; mRNA.
DR   EMBL; L31621; AAA41673.1; -; mRNA.
DR   EMBL; U04961; AAA18001.1; -; Unassigned_DNA.
DR   PIR; A24572; A24572.
DR   PIR; A53733; A53733.
DR   UniGene; Rn.10996; -.
DR   PDB; 1OLF; Model; -; A/C=28-235.
DR   PDB; 1OLJ; Model; -; A/C=28-235.
DR   PDBsum; 1OLF; -.
DR   PDBsum; 1OLJ; -.
DR   ProteinModelPortal; P04757; -.
DR   IntAct; P04757; 1.
DR   STRING; 10116.ENSRNOP00000019307; -.
DR   BindingDB; P04757; -.
DR   ChEMBL; CHEMBL3818; -.
DR   GuidetoPHARMACOLOGY; 464; -.
DR   iPTMnet; P04757; -.
DR   PhosphoSitePlus; P04757; -.
DR   PaxDb; P04757; -.
DR   PRIDE; P04757; -.
DR   UCSC; RGD:2345; rat.
DR   RGD; 2345; Chrna3.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P04757; -.
DR   PhylomeDB; P04757; -.
DR   PRO; PR:P04757; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0044853; C:plasma membrane raft; IGI:ARUK-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; IDA:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IBA:GO_Central.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0014056; P:regulation of acetylcholine secretion, neurotransmission; ISO:RGD.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0006937; P:regulation of muscle contraction; ISO:RGD.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:1905144; P:response to acetylcholine; IGI:ARUK-UCL.
DR   GO; GO:0042493; P:response to drug; IDA:RGD.
DR   GO; GO:0010035; P:response to inorganic substance; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    499       Neuronal acetylcholine receptor subunit
FT                                alpha-3.
FT                                /FTId=PRO_0000000348.
FT   TOPO_DOM     26    234       Extracellular.
FT   TRANSMEM    235    259       Helical.
FT   TRANSMEM    267    285       Helical.
FT   TRANSMEM    301    322       Helical.
FT   TOPO_DOM    323    471       Cytoplasmic.
FT   TRANSMEM    472    491       Helical.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000244|PubMed:16641100}.
FT   MOD_RES     410    410       Phosphoserine.
FT                                {ECO:0000244|PubMed:16641100}.
FT   CARBOHYD     49     49       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    153    167       {ECO:0000250}.
FT   DISULFID    217    218       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   499 AA;  56998 MW;  D66C491E832B9C34 CRC64;
     MGVVLLPPPL SMLMLVLMLL PAASASEAEH RLFQYLFEDY NEIIRPVANV SHPVIIQFEV
     SMSQLVKVDE VNQIMETNLW LKQIWNDYKL KWKPSDYQGV EFMRVPAEKI WKPDIVLYNN
     ADGDFQVDDK TKALLKYTGE VTWIPPAIFK SSCKIDVTYF PFDYQNCTMK FGSWSYDKAK
     IDLVLIGSSM NLKDYWESGE WAIIKAPGYK HEIKYNCCEE IYQDITYSLY IRRLPLFYTI
     NLIIPCLLIS FLTVLVFYLP SDCGEKVTLC ISVLLSLTVF LLVITETIPS TSLVIPLIGE
     YLLFTMIFVT LSIVITVFVL NVHYRTPTTH TMPTWVKAVF LNLLPRVMFM TRPTSGEGDT
     PKTRTFYGAE LSNLNCFSRA DSKSCKEGYP CQDGTCGYCH HRRVKISNFS ANLTRSSSSE
     SVNAVLSLSA LSPEIKEAIQ SVKYIAENMK AQNVAKEIQD DWKYVAMVID RIFLWVFILV
     CILGTAGLFL QPLMARDDT
//
ID   ACHG_HUMAN              Reviewed;         517 AA.
AC   P07510; B3KWM8; Q14DU4; Q53RG2;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   25-OCT-2017, entry version 175.
DE   RecName: Full=Acetylcholine receptor subunit gamma;
DE   Flags: Precursor;
GN   Name=CHRNG; Synonyms=ACHRG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3967651; DOI=10.1111/j.1432-1033.1985.tb08614.x;
RA   Shibahara S., Kubo T., Perski H.J., Takahashi H., Noda M., Numa S.;
RT   "Cloning and sequence analysis of human genomic DNA encoding gamma
RT   subunit precursor of muscle acetylcholine receptor.";
RL   Eur. J. Biochem. 146:15-22(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle fibroblast;
RX   PubMed=7688301; DOI=10.1111/j.1432-1033.1993.tb18027.x;
RA   Beeson D.M.W., Brydson M., Betty M., Jeremiah S., Povey S.,
RA   Vincent A., Newsom-Davis J.;
RT   "Primary structure of the human muscle acetylcholine receptor. cDNA
RT   cloning of the gamma and epsilon subunits.";
RL   Eur. J. Biochem. 215:229-238(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANT EVMPS CYS-239, AND VARIANT LMPS CYS-239.
RX   PubMed=16826520; DOI=10.1086/506257;
RA   Hoffmann K., Mueller J.S., Stricker S., Megarbane A., Rajab A.,
RA   Lindner T.H., Cohen M., Chouery E., Adaimy L., Ghanem I., Delague V.,
RA   Boltshauser E., Talim B., Horvath R., Robinson P.N., Lochmueller H.,
RA   Huebner C., Mundlos S.;
RT   "Escobar syndrome is a prenatal myasthenia caused by disruption of the
RT   acetylcholine receptor fetal gamma subunit.";
RL   Am. J. Hum. Genet. 79:303-312(2006).
RN   [7]
RP   VARIANT EVMPS GLY-107, AND VARIANT LMPS GLY-107.
RX   PubMed=16826531; DOI=10.1086/506256;
RA   Morgan N.V., Brueton L.A., Cox P., Greally M.T., Tolmie J., Pasha S.,
RA   Aligianis I.A., van Bokhoven H., Marton T., Al-Gazali L.,
RA   Morton J.E.V., Oley C., Johnson C.A., Trembath R.C., Brunner H.G.,
RA   Maher E.R.;
RT   "Mutations in the embryonal subunit of the acetylcholine receptor
RT   (CHRNG) cause lethal and Escobar variants of multiple pterygium
RT   syndrome.";
RL   Am. J. Hum. Genet. 79:390-395(2006).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains.
CC   -!- INTERACTION:
CC       Q6UY14-3:ADAMTSL4; NbExp=3; IntAct=EBI-11979451, EBI-10173507;
CC       A8MQ03:CYSRT1; NbExp=4; IntAct=EBI-11979451, EBI-3867333;
CC       Q15323:KRT31; NbExp=5; IntAct=EBI-11979451, EBI-948001;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-9008836, EBI-10172290;
CC       P60409-2:KRTAP10-7; NbExp=3; IntAct=EBI-11979451, EBI-10695388;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-11979451, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=5; IntAct=EBI-11979451, EBI-10172052;
CC       Q9BYQ3:KRTAP9-3; NbExp=4; IntAct=EBI-11979451, EBI-1043191;
CC       Q99750:MDFI; NbExp=5; IntAct=EBI-11979451, EBI-724076;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-11979451, EBI-748397;
CC       Q7Z3S9:NOTCH2NL; NbExp=7; IntAct=EBI-11979451, EBI-945833;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-11979451, EBI-742487;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P07510-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P07510-2; Sequence=VSP_055775;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Multiple pterygium syndrome, lethal type (LMPS)
CC       [MIM:253290]: Multiple pterygia are found infrequently in children
CC       with arthrogryposis and in fetuses with fetal akinesia syndrome.
CC       In lethal multiple pterygium syndrome there is intrauterine growth
CC       retardation, multiple pterygia, and flexion contractures causing
CC       severe arthrogryposis and fetal akinesia. Subcutaneous edema can
CC       be severe, causing fetal hydrops with cystic hygroma and lung
CC       hypoplasia. Oligohydramnios and facial anomalies are frequent.
CC       {ECO:0000269|PubMed:16826520, ECO:0000269|PubMed:16826531}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Multiple pterygium syndrome, Escobar variant (EVMPS)
CC       [MIM:265000]: Non-lethal form of arthrogryposis multiplex
CC       congenita. It is an autosomal recessive condition characterized by
CC       excessive webbing (pterygia), congenital contractures
CC       (arthrogryposis), and scoliosis. Variable other features include
CC       intrauterine death, congenital respiratory distress, short
CC       stature, faciocranial dysmorphism, ptosis, low-set ears,
CC       arachnodactyly and cryptorchism in males. Congenital contractures
CC       are common and may be caused by reduced fetal movements at
CC       sensitive times of development. Possible causes of decreased fetal
CC       mobility include space constraints such as oligohydramnion, drugs,
CC       metabolic conditions or neuromuscular disorders including
CC       myasthenia gravis. {ECO:0000269|PubMed:16826520,
CC       ECO:0000269|PubMed:16826531}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Gamma/CHRNG
CC       sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY24103.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAA25861.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X01715; CAA25861.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X01716; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; X01717; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; X01718; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; X01719; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; X01720; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; X01721; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; X04759; CAA25861.1; JOINED; Genomic_DNA.
DR   EMBL; AK125362; BAG54190.1; -; mRNA.
DR   EMBL; AC092165; AAY24103.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC111802; AAI11803.1; -; mRNA.
DR   CCDS; CCDS33400.1; -. [P07510-1]
DR   PIR; A23261; A23261.
DR   RefSeq; NP_005190.4; NM_005199.4. [P07510-1]
DR   UniGene; Hs.248101; -.
DR   ProteinModelPortal; P07510; -.
DR   BioGrid; 107568; 8.
DR   IntAct; P07510; 16.
DR   STRING; 9606.ENSP00000374145; -.
DR   BindingDB; P07510; -.
DR   ChEMBL; CHEMBL1907588; -.
DR   DrugBank; DB00674; Galantamine.
DR   TCDB; 1.A.9.1.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P07510; -.
DR   PhosphoSitePlus; P07510; -.
DR   BioMuta; CHRNG; -.
DR   DMDM; 126302510; -.
DR   PaxDb; P07510; -.
DR   PeptideAtlas; P07510; -.
DR   PRIDE; P07510; -.
DR   Ensembl; ENST00000389492; ENSP00000374143; ENSG00000196811. [P07510-2]
DR   Ensembl; ENST00000389494; ENSP00000374145; ENSG00000196811. [P07510-1]
DR   GeneID; 1146; -.
DR   KEGG; hsa:1146; -.
DR   UCSC; uc002vsx.1; human. [P07510-1]
DR   CTD; 1146; -.
DR   DisGeNET; 1146; -.
DR   EuPathDB; HostDB:ENSG00000196811.11; -.
DR   GeneCards; CHRNG; -.
DR   HGNC; HGNC:1967; CHRNG.
DR   MalaCards; CHRNG; -.
DR   MIM; 100730; gene.
DR   MIM; 253290; phenotype.
DR   MIM; 265000; phenotype.
DR   neXtProt; NX_P07510; -.
DR   OpenTargets; ENSG00000196811; -.
DR   Orphanet; 2990; Autosomal recessive multiple pterygium syndrome.
DR   Orphanet; 33108; Lethal multiple pterygium syndrome.
DR   PharmGKB; PA26499; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P07510; -.
DR   KO; K04818; -.
DR   OMA; EEWFLVG; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P07510; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   GeneWiki; CHRNG; -.
DR   GenomeRNAi; 1146; -.
DR   PRO; PR:P07510; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000196811; -.
DR   CleanEx; HS_CHRNG; -.
DR   Genevisible; P07510; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0015267; F:channel activity; TAS:ProtInc.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    517       Acetylcholine receptor subunit gamma.
FT                                /FTId=PRO_0000000334.
FT   TOPO_DOM     23    240       Extracellular. {ECO:0000255}.
FT   TRANSMEM    241    265       Helical. {ECO:0000255}.
FT   TRANSMEM    275    293       Helical. {ECO:0000255}.
FT   TRANSMEM    309    330       Helical. {ECO:0000255}.
FT   TOPO_DOM    331    474       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    475    495       Helical. {ECO:0000255}.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    150    164       {ECO:0000250}.
FT   VAR_SEQ     117    169       NVDGVFEVALYCNVLVSPDGCIYWLPPAIFRSACSISVTYF
FT                                PFDWQNCSLIFQ -> K (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055775.
FT   VARIANT     107    107       V -> G (in EVMPS and LMPS;
FT                                dbSNP:rs267606726).
FT                                {ECO:0000269|PubMed:16826531}.
FT                                /FTId=VAR_030753.
FT   VARIANT     149    149       A -> T (in dbSNP:rs2289080).
FT                                /FTId=VAR_030754.
FT   VARIANT     239    239       R -> C (in EVMPS and LMPS;
FT                                dbSNP:rs121912670).
FT                                {ECO:0000269|PubMed:16826520}.
FT                                /FTId=VAR_030755.
FT   CONFLICT    189    189       T -> S (in Ref. 5; AAI11803).
FT                                {ECO:0000305}.
SQ   SEQUENCE   517 AA;  57883 MW;  7C78F533D4997D7A CRC64;
     MHGGQGPLLL LLLLAVCLGA QGRNQEERLL ADLMQNYDPN LRPAERDSDV VNVSLKLTLT
     NLISLNEREE ALTTNVWIEM QWCDYRLRWD PRDYEGLWVL RVPSTMVWRP DIVLENNVDG
     VFEVALYCNV LVSPDGCIYW LPPAIFRSAC SISVTYFPFD WQNCSLIFQS QTYSTNEIDL
     QLSQEDGQTI EWIFIDPEAF TENGEWAIQH RPAKMLLDPA APAQEAGHQK VVFYLLIQRK
     PLFYVINIIA PCVLISSVAI LIHFLPAKAG GQKCTVAINV LLAQTVFLFL VAKKVPETSQ
     AVPLISKYLT FLLVVTILIV VNAVVVLNVS LRSPHTHSMA RGVRKVFLRL LPQLLRMHVR
     PLAPAAVQDT QSRLQNGSSG WSITTGEEVA LCLPRSELLF QQWQRQGLVA AALEKLEKGP
     ELGLSQFCGS LKQAAPAIQA CVEACNLIAC ARHQQSHFDN GNEEWFLVGR VLDRVCFLAM
     LSLFICGTAG IFLMAHYNRV PALPFPGDPR PYLPSPD
//
ID   ACH1_DROME              Reviewed;         567 AA.
AC   P09478; Q9VC74;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   09-MAY-2003, sequence version 2.
DT   25-OCT-2017, entry version 165.
DE   RecName: Full=Acetylcholine receptor subunit alpha-like 1;
DE   AltName: Full=Nicotinic acetylcholine receptor alpha 1;
DE   Flags: Precursor;
GN   Name=nAChRalpha1; Synonyms=Acr96Aa, AcrB, als, nAcRalpha-96Aa;
GN   ORFNames=CG5610;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   STRAIN=Oregon-R;
RX   PubMed=2840281;
RA   Bossy B., Ballivet M., Spierer P.;
RT   "Conservation of neural nicotinic acetylcholine receptors from
RT   Drosophila to vertebrate central nervous systems.";
RL   EMBO J. 7:611-618(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: CNS in embryos. {ECO:0000269|PubMed:2840281}.
CC   -!- DEVELOPMENTAL STAGE: Late embryonic, late pupal and second instar
CC       larvae stages. {ECO:0000269|PubMed:2840281}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07194; CAA30172.1; -; mRNA.
DR   EMBL; AE014297; AAF56301.2; -; Genomic_DNA.
DR   PIR; S00381; ACFFA1.
DR   RefSeq; NP_001262917.1; NM_001275988.2.
DR   RefSeq; NP_524481.2; NM_079757.4.
DR   UniGene; Dm.2364; -.
DR   ProteinModelPortal; P09478; -.
DR   BioGrid; 67844; 1.
DR   STRING; 7227.FBpp0303342; -.
DR   ChEMBL; CHEMBL3350223; -.
DR   PaxDb; P09478; -.
DR   PRIDE; P09478; -.
DR   EnsemblMetazoa; FBtr0084619; FBpp0084003; FBgn0000036.
DR   EnsemblMetazoa; FBtr0334916; FBpp0306936; FBgn0000036.
DR   GeneID; 42918; -.
DR   KEGG; dme:Dmel_CG5610; -.
DR   CTD; 42918; -.
DR   FlyBase; FBgn0000036; nAChRalpha1.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   InParanoid; P09478; -.
DR   KO; K05312; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P09478; -.
DR   Reactome; R-DME-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-DME-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-DME-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 42918; -.
DR   PRO; PR:P09478; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0000036; -.
DR   ExpressionAtlas; P09478; differential.
DR   Genevisible; P09478; DM.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:FlyBase.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:FlyBase.
DR   GO; GO:0098655; P:cation transmembrane transport; IDA:FlyBase.
DR   GO; GO:0017085; P:response to insecticide; IMP:FlyBase.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IEP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     21
FT   CHAIN        22    567       Acetylcholine receptor subunit alpha-like
FT                                1.
FT                                /FTId=PRO_0000000298.
FT   TOPO_DOM     22    240       Extracellular.
FT   TRANSMEM    241    264       Helical.
FT   TRANSMEM    272    290       Helical.
FT   TRANSMEM    306    325       Helical.
FT   TOPO_DOM    326    513       Cytoplasmic.
FT   TRANSMEM    514    532       Helical.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    233    233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    149    163       {ECO:0000250}.
FT   DISULFID    222    223       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   VARIANT     538    538       Y -> H.
FT   CONFLICT    108    108       L -> H (in Ref. 1; CAA30172).
FT                                {ECO:0000305}.
SQ   SEQUENCE   567 AA;  64019 MW;  08E1F721FB2A92AC CRC64;
     MGSVLFAAVF IALHFATGGL ANPDAKRLYD DLLSNYNRLI RPVGNNSDRL TVKMGLRLSQ
     LIDVNLKNQI MTTNVWVEQE WNDYKLKWNP DDYGGVDTLH VPSEHIWLPD IVLYNNADGN
     YEVTIMTKAI LHHTGKVVWK PPAIYKSFCE IDVEYFPFDE QTCFMKFGSW TYDGYMVDLR
     HLKQTADSDN IEVGIDLQDY YISVEWDIMR VPAVRNEKFY SCCEEPYLDI VFNLTLRRKT
     LFYTVNLIIP CVGISFLSVL VFYLPSDSGE KISLCISILL SLTVFFLLLA EIIPPTSLTV
     PLLGKYLLFT MMLVTLSVVV TIAVLNVNFR SPVTHRMAPW VQRLFIQILP KLLCIERPKK
     EEPEEDQPPE VLTDVYHLPP DVDKFVNYDS KRFSGDYGIP ALPASHRFDL AAAGGISAHC
     FAEPPLPSSL PLPGADDDLF SPSGLNGDIS PGCCPAAAAA AAADLSPTFE KPYAREMEKT
     IEGSRFIAQH VKNKDKFESV EEDWKYVAMV LDRMFLWIFA IACVVGTALI ILQAPSLYDQ
     SQPIDILYSK IAKKKFELLK MGSENTL
//
ID   ACHA4_RAT               Reviewed;         630 AA.
AC   P09483; O35769;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 3.
DT   22-NOV-2017, entry version 162.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-4;
DE   Flags: Precursor;
GN   Name=Chrna4; Synonyms=Acra4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-4-1), AND NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 5-630 (ISOFORM ALPHA-4-2).
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Hypothalamus;
RX   PubMed=3829125; DOI=10.1016/0092-8674(87)90705-7;
RA   Goldman D.J., Deneris E.S., Luyten W., Kochhar A., Patrick J.,
RA   Heinemann S.F.;
RT   "Members of a nicotinic acetylcholine receptor gene family are
RT   expressed in different regions of the mammalian central nervous
RT   system.";
RL   Cell 48:965-973(1987).
RN   [2]
RP   SEQUENCE REVISION.
RA   Hartley M., Goldman D.J., Heinemann S.F.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-4-2).
RA   Boulter J., Deneris E.S., Evans K., Heinemann S.F.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 31-47.
RX   PubMed=3609304; DOI=10.1016/0014-5793(87)80272-7;
RA   Whiting P., Esch F., Shimasaki S., Lindstrom J.;
RT   "Neuronal nicotinic acetylcholine receptor beta-subunit is coded for
RT   by the cDNA clone alpha 4.";
RL   FEBS Lett. 219:459-463(1987).
RN   [5]
RP   SUBUNIT.
RX   PubMed=15929983; DOI=10.1074/jbc.M504229200;
RA   Dutertre S., Nicke A., Lewis R.J.;
RT   "Beta2 subunit contribution to 4/7 alpha-conotoxin binding to the
RT   nicotinic acetylcholine receptor.";
RL   J. Biol. Chem. 280:30460-30468(2005).
RN   [6]
RP   PALMITOYLATION AT CYS-273, AND SUBCELLULAR LOCATION.
RX   PubMed=22593584; DOI=10.1074/jbc.M111.328294;
RA   Amici S.A., McKay S.B., Wells G.B., Robson J.I., Nasir M., Ponath G.,
RA   Anand R.;
RT   "A highly conserved cytoplasmic cysteine residue in the alpha4
RT   nicotinic acetylcholine receptor is palmitoylated and regulates
RT   protein expression.";
RL   J. Biol. Chem. 287:23119-23127(2012).
RN   [7]
RP   MUTAGENESIS OF 219-THR--ARG-242; 220-TYR--ARG-223 AND ARG-223.
RX   PubMed=22751014; DOI=10.1096/fj.12-204487;
RA   Kim H.W., McIntosh J.M.;
RT   "alpha6 nAChR subunit residues that confer alpha-conotoxin BuIA
RT   selectivity.";
RL   FASEB J. 26:4102-4110(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane permeable to sodium ions.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of
CC       subunits: alpha and beta. Alpha-4 subunit can be combined to beta-
CC       2 or beta-4 to give rise to functional receptors, complexes with
CC       beta-2 may be heteropentamers. Interacts with RIC3; which is
CC       required for proper folding and assembly. Interacts with LYPD6.
CC       The heteropentamer alpha-4-beta-2 interacts with alpha-conotoxins
CC       PnIA, GID and MII (PubMed:15929983).
CC       {ECO:0000250|UniProtKB:P43681, ECO:0000269|PubMed:15929983}.
CC   -!- INTERACTION:
CC       P20420:Chrna5; NbExp=6; IntAct=EBI-7842410, EBI-10828372;
CC       P12390:Chrnb2; NbExp=6; IntAct=EBI-7842410, EBI-9008812;
CC       P12392:Chrnb4; NbExp=4; IntAct=EBI-7842410, EBI-9008856;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:22593584}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:22593584}. Cell membrane
CC       {ECO:0000269|PubMed:22593584}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:22593584}. Cell membrane
CC       {ECO:0000269|PubMed:22593584}; Lipid-anchor
CC       {ECO:0000269|PubMed:22593584}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha-4-1;
CC         IsoId=P09483-1; Sequence=Displayed;
CC       Name=Alpha-4-2;
CC         IsoId=P09483-2; Sequence=VSP_000074;
CC   -!- TISSUE SPECIFICITY: In various regions of the central nervous
CC       system.
CC   -!- MISCELLANEOUS: The nAChR composed of alpha-4 and beta-2 subunits
CC       does not bind the conotoxin BuIA. {ECO:0000269|PubMed:22751014}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       4/CHRNA4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15682; AAA41676.1; -; mRNA.
DR   EMBL; L31620; AAC97071.1; -; mRNA.
DR   EMBL; AF007212; AAB64439.1; -; mRNA.
DR   RefSeq; NP_077330.1; NM_024354.1.
DR   UniGene; Rn.9697; -.
DR   PDB; 1OLE; Model; -; A/C=38-245.
DR   PDBsum; 1OLE; -.
DR   ProteinModelPortal; P09483; -.
DR   CORUM; P09483; -.
DR   IntAct; P09483; 4.
DR   MINT; MINT-198047; -.
DR   STRING; 10116.ENSRNOP00000009041; -.
DR   BindingDB; P09483; -.
DR   ChEMBL; CHEMBL307; -.
DR   GuidetoPHARMACOLOGY; 465; -.
DR   iPTMnet; P09483; -.
DR   PhosphoSitePlus; P09483; -.
DR   SwissPalm; P09483; -.
DR   PaxDb; P09483; -.
DR   PRIDE; P09483; -.
DR   GeneID; 25590; -.
DR   KEGG; rno:25590; -.
DR   UCSC; RGD:2346; rat. [P09483-1]
DR   CTD; 1137; -.
DR   RGD; 2346; Chrna4.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P09483; -.
DR   KO; K04806; -.
DR   PhylomeDB; P09483; -.
DR   PRO; PR:P09483; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISO:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0005216; F:ion channel activity; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001508; P:action potential; ISO:RGD.
DR   GO; GO:0042113; P:B cell activation; ISO:RGD.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0050890; P:cognition; ISO:RGD.
DR   GO; GO:0006281; P:DNA repair; ISO:RGD.
DR   GO; GO:0035640; P:exploration behavior; ISO:RGD.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0051899; P:membrane depolarization; ISO:RGD.
DR   GO; GO:0050877; P:nervous system process; ISO:RGD.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0033603; P:positive regulation of dopamine secretion; IDA:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:1903048; P:regulation of acetylcholine-gated cation channel activity; IMP:RGD.
DR   GO; GO:0014059; P:regulation of dopamine secretion; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0007585; P:respiratory gaseous exchange; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; ISO:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IMP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31    630       Neuronal acetylcholine receptor subunit
FT                                alpha-4.
FT                                /FTId=PRO_0000000354.
FT   TOPO_DOM     32    249       Extracellular. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical. {ECO:0000255}.
FT   TRANSMEM    279    299       Helical. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    604       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    605    625       Helical. {ECO:0000255}.
FT   MOD_RES     428    428       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     542    542       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70174}.
FT   MOD_RES     545    545       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70174}.
FT   LIPID       273    273       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:22593584}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    109    109       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    163    177       {ECO:0000250}.
FT   DISULFID    227    228       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   VAR_SEQ     629    630       AC -> GMI (in isoform Alpha-4-2).
FT                                {ECO:0000303|PubMed:3829125,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_000074.
FT   MUTAGEN     219    240       TYNTRKYECCAEIYPDITYAFI->YKHDIKYNCCEEIYTDI
FT                                TYSFY: >10000-fold increase in inhibition
FT                                of alpha-4-beta-2 nAChR by the conotoxin
FT                                BuIA. {ECO:0000269|PubMed:22751014}.
FT   MUTAGEN     220    223       YNTR->KHDI: >1700-fold increase in
FT                                inhibition of alpha-4-beta-2 nAChR by the
FT                                conotoxin BuIA.
FT                                {ECO:0000269|PubMed:22751014}.
FT   MUTAGEN     223    223       R->I: >10-fold increase in inhibition of
FT                                alpha-4-beta-2 nAChR by the conotoxin
FT                                BuIA. {ECO:0000269|PubMed:22751014}.
FT   CONFLICT      1      4       MANS -> MEIGGPGA (in Ref. 1; AAA41676).
FT                                {ECO:0000305}.
FT   CONFLICT      6      6       T -> P (in Ref. 3; AAB64439).
FT                                {ECO:0000305}.
FT   CONFLICT     58     58       A -> G (in Ref. 1; AAA41676 and 3;
FT                                AAB64439). {ECO:0000305}.
FT   CONFLICT    196    196       M -> I (in Ref. 1; AAA41676 and 3;
FT                                AAB64439). {ECO:0000305}.
FT   CONFLICT    301    301       Missing (in Ref. 1; AAA41676/AAC97071 and
FT                                3; AAB64439). {ECO:0000305}.
SQ   SEQUENCE   630 AA;  70193 MW;  1DFFC9E1378E5417 CRC64;
     MANSGTGAPP PLLLLPLLLL LGTGLLPASS HIETRAHAEE RLLKRLFSGY NKWSRPVANI
     SDVVLVRFGL SIAQLIDVDE KNQMMTTNVW VKQEWHDYKL RWDPGDYENV TSIRIPSELI
     WRPDIVLYNN ADGDFAVTHL TKAHLFYDGR VQWTPPAIYK SSCSIDVTFF PFDQQNCTMK
     FGSWTYDKAK IDLVSMHSRV DQLDFWESGE WVIVDAVGTY NTRKYECCAE IYPDITYAFI
     IRRLPLFYTI NLIIPCLLIS CLTVLVFYLP SECGEKVTLC ISVLLSLTVF LLLITEIIPS
     PTSLVIPLIG EYLLFTMIFV TLSIVITVFV LNVHHRSPRT HTMPAWVRRV FLDIVPRLLF
     MKRPSVVKDN CRRLIESMHK MANAPRFWPE PVGEPGILSD ICNQGLSPAP TFCNPTDTAV
     ETQPTCRSPP LEVPDLKTSE VEKASPCPSP GSCPPPKSSS GAPMLIKARS LSVQHVPSSQ
     EAAEDGIRCR SRSIQYCVSQ DGAASLADSK PTSSPTSLKA RPSQLPVSDQ ASPCKCTCKE
     PSPVSPVTVL KAGGTKAPPQ HLPLSPALTR AVEGVQYIAD HLKAEDTDFS VKEDWKYVAM
     VIDRIFLWMF IIVCLLGTVG LFLPPWLAAC
//
ID   ACHE_RAT                Reviewed;         494 AA.
AC   P09660; Q6LAD4;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 2.
DT   22-NOV-2017, entry version 143.
DE   RecName: Full=Acetylcholine receptor subunit epsilon;
DE   Flags: Precursor;
GN   Name=Chrne; Synonyms=Achre;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Muscle;
RX   PubMed=1702709; DOI=10.1111/j.1432-1033.1990.tb15637.x;
RA   Witzemann V., Stein E., Barg B., Konno T., Koenen M., Kues W.,
RA   Criado M., Hofmann M., Sakmann B.;
RT   "Primary structure and functional expression of the alpha-, beta-,
RT   gamma-, delta- and epsilon-subunits of the acetylcholine receptor from
RT   rat muscle.";
RL   Eur. J. Biochem. 194:437-448(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=3205730; DOI=10.1093/nar/16.22.10920;
RA   Criado M., Witzemann V., Koenen M., Sakmann B.;
RT   "Nucleotide sequence of the rat muscle acetylcholine receptor epsilon-
RT   subunit.";
RL   Nucleic Acids Res. 16:10920-10920(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-23.
RC   STRAIN=Fischer; TISSUE=Liver;
RX   PubMed=8034713;
RA   Walke W., Staple J., Adams L., Gnegy M., Chahine K., Goldman D.;
RT   "Calcium-dependent regulation of rat and chick muscle nicotinic
RT   acetylcholine receptor (nAChR) gene expression.";
RL   J. Biol. Chem. 269:19447-19456(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 202-305.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=3666131; DOI=10.1016/0014-5793(87)80518-5;
RA   Witzemann V., Barg B., Nishikawa Y., Sakmann B., Numa S.;
RT   "Differential regulation of muscle acetylcholine receptor gamma- and
RT   epsilon-subunit mRNAs.";
RL   FEBS Lett. 223:104-112(1987).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (By similarity). {ECO:0000250|UniProtKB:Q04844}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       Epsilon/CHRNE sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X74836; CAA52830.1; -; mRNA.
DR   EMBL; X13252; CAA31628.1; -; mRNA.
DR   EMBL; Z23062; CAA80597.1; -; Genomic_DNA.
DR   EMBL; X06365; CAA29663.1; -; Genomic_DNA.
DR   PIR; S01959; ACRTE.
DR   RefSeq; NP_058890.1; NM_017194.1.
DR   UniGene; Rn.10301; -.
DR   ProteinModelPortal; P09660; -.
DR   STRING; 10116.ENSRNOP00000005050; -.
DR   BindingDB; P09660; -.
DR   ChEMBL; CHEMBL4961; -.
DR   PaxDb; P09660; -.
DR   PRIDE; P09660; -.
DR   GeneID; 29422; -.
DR   KEGG; rno:29422; -.
DR   UCSC; RGD:2353; rat.
DR   CTD; 1145; -.
DR   RGD; 2353; Chrne.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P09660; -.
DR   KO; K04817; -.
DR   PhylomeDB; P09660; -.
DR   PRO; PR:P09660; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:RGD.
DR   GO; GO:0006812; P:cation transport; IDA:RGD.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0003009; P:skeletal muscle contraction; IDA:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000250}.
FT   CHAIN        21    494       Acetylcholine receptor subunit epsilon.
FT                                /FTId=PRO_0000000331.
FT   TOPO_DOM     21    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    264       Helical. {ECO:0000255}.
FT   TOPO_DOM    265    272       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    273    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    306       Extracellular. {ECO:0000255}.
FT   TRANSMEM    307    328       Helical. {ECO:0000255}.
FT   TOPO_DOM    329    457       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    458    481       Helical. {ECO:0000255}.
FT   TOPO_DOM    482    494       Extracellular. {ECO:0000255}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    148    162       {ECO:0000250}.
FT   CONFLICT    391    392       SE -> R (in Ref. 2; CAA31628).
FT                                {ECO:0000305}.
SQ   SEQUENCE   494 AA;  54948 MW;  6476E4C938A6A9B6 CRC64;
     MTMALLGTLL LLALFGRSQG KNEELSLYHH LFDNYDPECR PVRRPEDTVT ITLKVTLTNL
     ISLNEKEETL TTSVWIGIEW QDYRLNFSKD DFAGVEILRV PSEHVWLPEI VLENNIDGQF
     GVAYDCNVLV YEGGSVSWLP PAIYRSTCAV EVTYFPFDWQ NCSLIFRSQT YNAEEVELIF
     AVDDDGNAIN KIDIDTAAFT ENGEWAIDYC PGMIRHYEGG STEDPGETDV IYTLIIRRKP
     LFYVINIIVP CVLISGLVLL AYFLPAQAGG QKCTVSINVL LAQTVFLFLI AQKIPETSLS
     VPLLGRYLIF VMVVATLIVM NCVIVLNVSL RTPTTHATSP RLRQILLELL PRLLGLSPPP
     EDPGAASPAR RASSVGILLR AEELILKKPR SELVFEGQRH RHGTWTAAAL CQNLGAAAPE
     VRCCVDAVNF VAESTRDQEA TGEELSDWVR MGKALDNVCF WAALVLFSVG STLIFLGGYF
     NQVPDLPYPP CIQP
//
ID   KCSA_STRCO              Reviewed;         160 AA.
AC   P0A333; Q54397;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   20-DEC-2017, entry version 84.
DE   RecName: Full=pH-gated potassium channel KcsA;
GN   Name=kcsA; Synonyms=skc1; OrderedLocusNames=SCO7660;
GN   ORFNames=SC10F4.33;
OS   Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145).
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces; Streptomyces albidoflavus group.
OX   NCBI_TaxID=100226;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-471 / A3(2) / M145;
RX   PubMed=12000953; DOI=10.1038/417141a;
RA   Bentley S.D., Chater K.F., Cerdeno-Tarraga A.-M., Challis G.L.,
RA   Thomson N.R., James K.D., Harris D.E., Quail M.A., Kieser H.,
RA   Harper D., Bateman A., Brown S., Chandra G., Chen C.W., Collins M.,
RA   Cronin A., Fraser A., Goble A., Hidalgo J., Hornsby T., Howarth S.,
RA   Huang C.-H., Kieser T., Larke L., Murphy L.D., Oliver K., O'Neil S.,
RA   Rabbinowitsch E., Rajandream M.A., Rutherford K.M., Rutter S.,
RA   Seeger K., Saunders D., Sharp S., Squares R., Squares S., Taylor K.,
RA   Warren T., Wietzorrek A., Woodward J.R., Barrell B.G., Parkhill J.,
RA   Hopwood D.A.;
RT   "Complete genome sequence of the model actinomycete Streptomyces
RT   coelicolor A3(2).";
RL   Nature 417:141-147(2002).
CC   -!- FUNCTION: Acts as a pH-gated potassium ion channel; changing the
CC       cytosolic pH from 7 to 4 opens the channel. {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- DOMAIN: The cytoplasmic C-terminus is involved in the gating
CC       mechanism. {ECO:0000250}.
CC   -!- MISCELLANEOUS: The amino acids 62-79 are situated in the membrane
CC       and are important for channel structure and properties.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the potassium channel family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL939132; CAC16993.1; -; Genomic_DNA.
DR   RefSeq; NP_631700.1; NC_003888.3.
DR   RefSeq; WP_003971485.1; NC_003888.3.
DR   PDB; 1S5H; X-ray; 2.20 A; C=3-124.
DR   PDB; 2HFE; X-ray; 2.25 A; C=22-78, D=80-122.
DR   PDBsum; 1S5H; -.
DR   PDBsum; 2HFE; -.
DR   ProteinModelPortal; P0A333; -.
DR   SMR; P0A333; -.
DR   STRING; 100226.SCO7660; -.
DR   DrugBank; DB07416; (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE.
DR   EnsemblBacteria; CAC16993; CAC16993; CAC16993.
DR   GeneID; 1103098; -.
DR   GeneID; 29658155; -.
DR   KEGG; sco:SCO7660; -.
DR   PATRIC; fig|100226.15.peg.7779; -.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000113212; -.
DR   InParanoid; P0A333; -.
DR   KO; K10716; -.
DR   OMA; WFVGREQ; -.
DR   OrthoDB; POG091H04JJ; -.
DR   PhylomeDB; P0A333; -.
DR   EvolutionaryTrace; P0A333; -.
DR   Proteomes; UP000001973; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR028325; VG_K_chnl.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   PRINTS; PR00169; KCHANNEL.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Ion channel;
KW   Ion transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    160       pH-gated potassium channel KcsA.
FT                                /FTId=PRO_0000054101.
FT   TOPO_DOM      1     27       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     28     50       Helical. {ECO:0000250}.
FT   TOPO_DOM     51     61       Extracellular. {ECO:0000250}.
FT   INTRAMEM     62     72       Helical; Pore-forming. {ECO:0000255}.
FT   INTRAMEM     73     80       Pore-forming. {ECO:0000255}.
FT   TOPO_DOM     81     87       Extracellular. {ECO:0000250}.
FT   TRANSMEM     88    111       Helical. {ECO:0000250}.
FT   TOPO_DOM    112    160       Cytoplasmic. {ECO:0000250}.
FT   MOTIF        75     80       Selectivity filter.
FT   HELIX        24     51       {ECO:0000244|PDB:1S5H}.
FT   HELIX        62     73       {ECO:0000244|PDB:1S5H}.
FT   STRAND       79     81       {ECO:0000244|PDB:1S5H}.
FT   HELIX        86    121       {ECO:0000244|PDB:1S5H}.
SQ   SEQUENCE   160 AA;  17694 MW;  DEBD9E64384BF40C CRC64;
     MPPMLSGLLA RLVKLLLGRH GSALHWRAAG AATVLLVIVL LAGSYLAVLA ERGAPGAQLI
     TYPRALWWSV ETATTVGYGD LYPVTLWGRL VAVVVMVAGI TSFGLVTAAL ATWFVGREQE
     RRGHFVRHSE KAAEEAYTRT TRALHERFDR LERMLDDNRR
//
ID   ELIC_DICCH              Reviewed;         321 AA.
AC   P0C7B7;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 1.
DT   25-OCT-2017, entry version 42.
DE   RecName: Full=Cys-loop ligand-gated ion channel;
DE   AltName: Full=ELIC;
OS   Dickeya chrysanthemi (Pectobacterium chrysanthemi) (Erwinia
OS   chrysanthemi).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Pectobacteriaceae; Dickeya.
OX   NCBI_TaxID=556;
RN   [1]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS), FUNCTION, AND SUBUNIT.
RX   PubMed=18322461; DOI=10.1038/nature06717;
RA   Hilf R.J., Dutzler R.;
RT   "X-ray structure of a prokaryotic pentameric ligand-gated ion
RT   channel.";
RL   Nature 452:375-379(2008).
CC   -!- FUNCTION: Mediates cation-selective currents but does not
CC       discriminate between different monovalent cations.
CC       {ECO:0000269|PubMed:18322461}.
CC   -!- SUBUNIT: Homopentamer. {ECO:0000269|PubMed:18322461}.
CC   -!- INTERACTION:
CC       Self; NbExp=13; IntAct=EBI-15690068, EBI-15690068;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-
CC       pass membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   PDB; 2VL0; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J=1-321.
DR   PDB; 2YKS; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J=1-321.
DR   PDB; 2YOE; X-ray; 3.90 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 3ZKR; X-ray; 3.65 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 4A97; X-ray; 3.34 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 4A98; X-ray; 3.61 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 4TWD; X-ray; 3.20 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 4TWF; X-ray; 3.90 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 4TWH; X-ray; 3.60 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 4YEU; X-ray; 4.60 A; A/B/C/D/E=11-199.
DR   PDB; 5LID; X-ray; 4.50 A; A/B/C/D/E/F/G/H/I/J=11-316.
DR   PDB; 5SXV; X-ray; 3.40 A; A/B/C/D/E/F/G/H/I/J=1-321.
DR   PDBsum; 2VL0; -.
DR   PDBsum; 2YKS; -.
DR   PDBsum; 2YOE; -.
DR   PDBsum; 3ZKR; -.
DR   PDBsum; 4A97; -.
DR   PDBsum; 4A98; -.
DR   PDBsum; 4TWD; -.
DR   PDBsum; 4TWF; -.
DR   PDBsum; 4TWH; -.
DR   PDBsum; 4YEU; -.
DR   PDBsum; 5LID; -.
DR   PDBsum; 5SXV; -.
DR   ProteinModelPortal; P0C7B7; -.
DR   SMR; P0C7B7; -.
DR   DIP; DIP-58973N; -.
DR   TCDB; 1.A.9.9.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   EvolutionaryTrace; P0C7B7; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    321       Cys-loop ligand-gated ion channel.
FT                                /FTId=PRO_0000330947.
FT   TOPO_DOM      1    203       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical. {ECO:0000255}.
FT   TOPO_DOM    225    232       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    233    253       Helical. {ECO:0000255}.
FT   TOPO_DOM    254    263       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TOPO_DOM    285    300       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical. {ECO:0000255}.
FT   MOTIF       115    123       Cys-loop.
FT   STRAND       12     27       {ECO:0000244|PDB:4TWD}.
FT   TURN         28     31       {ECO:0000244|PDB:4TWD}.
FT   STRAND       32     44       {ECO:0000244|PDB:4TWD}.
FT   STRAND       51     54       {ECO:0000244|PDB:2YKS}.
FT   STRAND       56     59       {ECO:0000244|PDB:4TWD}.
FT   HELIX        61     68       {ECO:0000244|PDB:4TWD}.
FT   STRAND       76     78       {ECO:0000244|PDB:4TWD}.
FT   STRAND       81     83       {ECO:0000244|PDB:4TWD}.
FT   STRAND       86     94       {ECO:0000244|PDB:4TWD}.
FT   STRAND       98    111       {ECO:0000244|PDB:4TWD}.
FT   TURN        117    120       {ECO:0000244|PDB:4TWD}.
FT   STRAND      123    134       {ECO:0000244|PDB:4TWD}.
FT   TURN        137    139       {ECO:0000244|PDB:4TWD}.
FT   STRAND      140    149       {ECO:0000244|PDB:4TWD}.
FT   HELIX       155    157       {ECO:0000244|PDB:4TWD}.
FT   STRAND      158    162       {ECO:0000244|PDB:4TWD}.
FT   STRAND      166    173       {ECO:0000244|PDB:4TWD}.
FT   HELIX       178    180       {ECO:0000244|PDB:4A97}.
FT   STRAND      186    198       {ECO:0000244|PDB:4TWD}.
FT   HELIX       201    206       {ECO:0000244|PDB:4TWD}.
FT   HELIX       208    219       {ECO:0000244|PDB:4TWD}.
FT   HELIX       220    223       {ECO:0000244|PDB:4TWD}.
FT   HELIX       227    251       {ECO:0000244|PDB:4TWD}.
FT   HELIX       260    284       {ECO:0000244|PDB:4TWD}.
FT   STRAND      285    289       {ECO:0000244|PDB:4TWD}.
FT   HELIX       296    298       {ECO:0000244|PDB:4TWD}.
FT   HELIX       302    313       {ECO:0000244|PDB:4TWD}.
SQ   SEQUENCE   321 AA;  36808 MW;  C532E1C4B657896D CRC64;
     APADNAADAR PVDVSVSIFI NKIYGVNTLE QTYKVDGYIV AQWTGKPRKT PGDKPLIVEN
     TQIERWINNG LWVPALEFIN VVGSPDTGNK RLMLFPDGRV IYNARFLGSF SNDMDFRLFP
     FDRQQFVLEL EPFSYNNQQL RFSDIQVYTE NIDNEEIDEW WIRKASTHIS DIRYDHLSSV
     QPNQNEFSRI TVRIDAVRNP SYYLWSFILP LGLIIAASWS VFWLESFSER LQTSFTLMLT
     VVAYAFYTSN ILPRLPYTTV IDQMIIAGYG SIFAAILLII FAHHRQAMGV EDDLLIQRCR
     LAFPLGFLAI GCVLVIRGIT L
//
ID   ACHB_HUMAN              Reviewed;         501 AA.
AC   P11230; B7Z5H1; Q8IZ46; Q96FB8;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2002, sequence version 3.
DT   25-OCT-2017, entry version 198.
DE   RecName: Full=Acetylcholine receptor subunit beta;
DE   Flags: Precursor;
GN   Name=CHRNB1; Synonyms=ACHRB, CHRNB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2740233; DOI=10.1093/nar/17.11.4391;
RA   Beeson D.M.W., Brydson M., Newsom-Davis J.;
RT   "Nucleotide sequence of human muscle acetylcholine receptor beta-
RT   subunit.";
RL   Nucleic Acids Res. 17:4391-4391(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   GLY-32 AND TYR-124.
RC   TISSUE=Eye, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human
RT   alpha7 nicotinic acetylcholine receptor and distinguish human
RT   nicotinic receptor subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [6]
RP   VARIANT CMS2A MET-285.
RX   PubMed=8651643; DOI=10.1002/ana.410390607;
RA   Gomez C.M., Maselli R., Gammack J., Lasalde J., Tamamizu S.,
RA   Cornblath D.R., Lehar M., McNamee M., Kuncl R.W.;
RT   "A beta-subunit mutation in the acetylcholine receptor channel gate
RT   causes severe slow-channel syndrome.";
RL   Ann. Neurol. 39:712-723(1996).
RN   [7]
RP   VARIANT CMS2A MET-289.
RX   PubMed=8872460; DOI=10.1093/hmg/5.9.1217;
RA   Engel A.G., Ohno K., Milone M., Wang H.-L., Nakano S., Bouzat C.,
RA   Pruitt J.N. II, Hutchinson D.O., Brengman J.M., Bren N., Sieb J.P.,
RA   Sine S.M.;
RT   "New mutations in acetylcholine receptor subunit genes reveal
RT   heterogeneity in the slow-channel congenital myasthenic syndrome.";
RL   Hum. Mol. Genet. 5:1217-1227(1996).
RN   [8]
RP   VARIANT CMS2C 449-GLU--GLU-451 DEL, AND CHARACTERIZATION OF VARIANT
RP   CMS2C 449-GLU--GLU-451 DEL.
RX   PubMed=10562302; DOI=10.1172/JCI8179;
RA   Quiram P.A., Ohno K., Milone M., Patterson M.C., Pruitt J.N. II,
RA   Brengman J.M., Sine S.M., Engel A.G.;
RT   "Mutation causing congenital myasthenia reveals acetylcholine receptor
RT   beta/delta subunit interaction essential for assembly.";
RL   J. Clin. Invest. 104:1403-1410(1999).
RN   [9]
RP   VARIANT CMS2A ALA-289, CHARACTERIZATION OF VARIANT CMS2A ALA-289, AND
RP   FUNCTION.
RX   PubMed=27375219; DOI=10.1002/humu.23043;
RA   Shen X.M., Okuno T., Milone M., Otsuka K., Takahashi K., Komaki H.,
RA   Giles E., Ohno K., Engel A.G.;
RT   "Mutations causing slow-channel myasthenia reveal that a valine ring
RT   in the channel pore of muscle AChR is optimized for stabilizing
RT   channel gating.";
RL   Hum. Mutat. 37:1051-1059(2016).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000269|PubMed:27375219}.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (PubMed:15609996). {ECO:0000269|PubMed:15609996}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11230-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11230-2; Sequence=VSP_056675;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Myasthenic syndrome, congenital, 2A, slow-channel (CMS2A)
CC       [MIM:616313]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS2A is a slow-channel myasthenic syndrome. It is caused
CC       by kinetic abnormalities of the AChR, resulting in prolonged AChR
CC       channel opening episodes, prolonged endplate currents, and
CC       depolarization block. This is associated with calcium overload,
CC       which may contribute to subsequent degeneration of the endplate
CC       and postsynaptic membrane. {ECO:0000269|PubMed:27375219,
CC       ECO:0000269|PubMed:8651643, ECO:0000269|PubMed:8872460}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 2C, associated with
CC       acetylcholine receptor deficiency (CMS2C) [MIM:616314]: A form of
CC       congenital myasthenic syndrome, a group of disorders characterized
CC       by failure of neuromuscular transmission, including pre-synaptic,
CC       synaptic, and post-synaptic disorders that are not of autoimmune
CC       origin. Clinical features are easy fatigability and muscle
CC       weakness affecting the axial and limb muscles (with hypotonia in
CC       early-onset forms), the ocular muscles (leading to ptosis and
CC       ophthalmoplegia), and the facial and bulbar musculature (affecting
CC       sucking and swallowing, and leading to dysphonia). The symptoms
CC       fluctuate and worsen with physical effort. CMS2C is an autosomal
CC       recessive disorder of postsynaptic neuromuscular transmission, due
CC       to deficiency of AChR at the endplate that results in low
CC       amplitude of the miniature endplate potential and current. CMS2C
CC       is clinically characterized by early-onset muscle weakness with
CC       variable severity. {ECO:0000269|PubMed:10562302}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       1/CHRNB1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14830; CAA32939.1; -; mRNA.
DR   EMBL; AK298938; BAH12907.1; -; mRNA.
DR   EMBL; AC113189; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011371; AAH11371.1; -; mRNA.
DR   EMBL; BC023553; AAH23553.1; -; mRNA.
DR   CCDS; CCDS11106.1; -. [P11230-1]
DR   PIR; S04607; S04607.
DR   RefSeq; NP_000738.2; NM_000747.2. [P11230-1]
DR   UniGene; Hs.330386; -.
DR   ProteinModelPortal; P11230; -.
DR   BioGrid; 107562; 28.
DR   IntAct; P11230; 1.
DR   MINT; MINT-3007602; -.
DR   STRING; 9606.ENSP00000304290; -.
DR   BindingDB; P11230; -.
DR   ChEMBL; CHEMBL1907588; -.
DR   DrugBank; DB00674; Galantamine.
DR   TCDB; 1.A.9.1.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P11230; -.
DR   PhosphoSitePlus; P11230; -.
DR   BioMuta; CHRNB1; -.
DR   DMDM; 21903373; -.
DR   EPD; P11230; -.
DR   PaxDb; P11230; -.
DR   PeptideAtlas; P11230; -.
DR   PRIDE; P11230; -.
DR   DNASU; 1140; -.
DR   Ensembl; ENST00000306071; ENSP00000304290; ENSG00000170175. [P11230-1]
DR   Ensembl; ENST00000536404; ENSP00000439209; ENSG00000170175. [P11230-2]
DR   Ensembl; ENST00000639692; ENSP00000492221; ENSG00000283946. [P11230-1]
DR   Ensembl; ENST00000639993; ENSP00000491113; ENSG00000283946. [P11230-2]
DR   GeneID; 1140; -.
DR   KEGG; hsa:1140; -.
DR   UCSC; uc002ghb.4; human. [P11230-1]
DR   CTD; 1140; -.
DR   DisGeNET; 1140; -.
DR   EuPathDB; HostDB:ENSG00000170175.10; -.
DR   GeneCards; CHRNB1; -.
DR   GeneReviews; CHRNB1; -.
DR   HGNC; HGNC:1961; CHRNB1.
DR   HPA; CAB011200; -.
DR   HPA; HPA005822; -.
DR   MalaCards; CHRNB1; -.
DR   MIM; 100710; gene.
DR   MIM; 616313; phenotype.
DR   MIM; 616314; phenotype.
DR   neXtProt; NX_P11230; -.
DR   OpenTargets; ENSG00000170175; -.
DR   Orphanet; 98913; Postsynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA26494; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P11230; -.
DR   KO; K04812; -.
DR   OMA; FIDGPNR; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P11230; -.
DR   TreeFam; TF315605; -.
DR   ChiTaRS; CHRNB1; human.
DR   GeneWiki; CHRNB1; -.
DR   GenomeRNAi; 1140; -.
DR   PRO; PR:P11230; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000170175; -.
DR   CleanEx; HS_CHRNB1; -.
DR   ExpressionAtlas; P11230; baseline and differential.
DR   Genevisible; P11230; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IMP:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IMP:UniProtKB.
DR   GO; GO:0042166; F:acetylcholine binding; ISS:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:Ensembl.
DR   GO; GO:0015267; F:channel activity; IMP:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; IMP:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; IMP:UniProtKB.
DR   GO; GO:0048747; P:muscle fiber development; IMP:UniProtKB.
DR   GO; GO:0050877; P:nervous system process; IMP:UniProtKB.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0001941; P:postsynaptic membrane organization; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IMP:UniProtKB.
DR   GO; GO:0003009; P:skeletal muscle contraction; IEA:Ensembl.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IMP:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Congenital myasthenic syndrome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Phosphoprotein; Polymorphism; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23
FT   CHAIN        24    501       Acetylcholine receptor subunit beta.
FT                                /FTId=PRO_0000000315.
FT   TOPO_DOM     24    244       Extracellular. {ECO:0000255}.
FT   TRANSMEM    245    269       Helical. {ECO:0000255}.
FT   TRANSMEM    277    295       Helical. {ECO:0000255}.
FT   TRANSMEM    311    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    469       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    470    488       Helical. {ECO:0000255}.
FT   MOD_RES     390    390       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000250}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
FT   VAR_SEQ       1     72       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056675.
FT   VARIANT      32     32       E -> G (in dbSNP:rs17856697).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_048169.
FT   VARIANT     124    124       D -> Y (in dbSNP:rs17856698).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_070842.
FT   VARIANT     285    285       L -> M (in CMS2A; dbSNP:rs137852811).
FT                                {ECO:0000269|PubMed:8651643}.
FT                                /FTId=VAR_000287.
FT   VARIANT     289    289       V -> A (in CMS2A; slow-channel mutation;
FT                                increases gating equilibrium constant by
FT                                33-fold, owing to increased opening rate
FT                                and decreased closing rate; no effect on
FT                                the choline dissociation rate constant).
FT                                {ECO:0000269|PubMed:27375219}.
FT                                /FTId=VAR_077363.
FT   VARIANT     289    289       V -> M (in CMS2A; dbSNP:rs137852810).
FT                                {ECO:0000269|PubMed:8872460}.
FT                                /FTId=VAR_000288.
FT   VARIANT     449    451       Missing (in CMS2C; impairs AChR assembly
FT                                by disrupting a specific interaction
FT                                between beta and delta subunits).
FT                                {ECO:0000269|PubMed:10562302}.
FT                                /FTId=VAR_017494.
FT   CONFLICT     15     15       A -> P (in Ref. 1; CAA32939).
FT                                {ECO:0000305}.
FT   CONFLICT    210    210       I -> N (in Ref. 1; CAA32939).
FT                                {ECO:0000305}.
SQ   SEQUENCE   501 AA;  56698 MW;  365CBFA795A51394 CRC64;
     MTPGALLMLL GALGAPLAPG VRGSEAEGRL REKLFSGYDS SVRPAREVGD RVRVSVGLIL
     AQLISLNEKD EEMSTKVYLD LEWTDYRLSW DPAEHDGIDS LRITAESVWL PDVVLLNNND
     GNFDVALDIS VVVSSDGSVR WQPPGIYRSS CSIQVTYFPF DWQNCTMVFS SYSYDSSEVS
     LQTGLGPDGQ GHQEIHIHEG TFIENGQWEI IHKPSRLIQP PGDPRGGREG QRQEVIFYLI
     IRRKPLFYLV NVIAPCILIT LLAIFVFYLP PDAGEKMGLS IFALLTLTVF LLLLADKVPE
     TSLSVPIIIK YLMFTMVLVT FSVILSVVVL NLHHRSPHTH QMPLWVRQIF IHKLPLYLRL
     KRPKPERDLM PEPPHCSSPG SGWGRGTDEY FIRKPPSDFL FPKPNRFQPE LSAPDLRRFI
     DGPNRAVALL PELREVVSSI SYIARQLQEQ EDHDALKEDW QFVAMVVDRL FLWTFIIFTS
     VGTLVIFLDA TYHLPPPDPF P
//
ID   ACHB3_RAT               Reviewed;         464 AA.
AC   P12391;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   25-OCT-2017, entry version 145.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-3;
DE   Flags: Precursor;
GN   Name=Chrnb3; Synonyms=Acrb3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2703489;
RA   Deneris E.S., Boulter J., Swanson L.W., Patrick J., Heinemann S.F.;
RT   "Beta 3: a new member of nicotinic acetylcholine receptor gene family
RT   is expressed in brain.";
RL   J. Biol. Chem. 264:6268-6272(1989).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different types
CC       of subunits: alpha and beta.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       3/CHRNB3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04636; AAC28887.1; -; mRNA.
DR   PIR; A33523; A33523.
DR   RefSeq; NP_598281.1; NM_133597.1.
DR   UniGene; Rn.9694; -.
DR   ProteinModelPortal; P12391; -.
DR   SMR; P12391; -.
DR   STRING; 10116.ENSRNOP00000016656; -.
DR   BindingDB; P12391; -.
DR   ChEMBL; CHEMBL3137275; -.
DR   PhosphoSitePlus; P12391; -.
DR   PaxDb; P12391; -.
DR   Ensembl; ENSRNOT00000016656; ENSRNOP00000016656; ENSRNOG00000012448.
DR   GeneID; 171131; -.
DR   KEGG; rno:171131; -.
DR   UCSC; RGD:621544; rat.
DR   CTD; 1142; -.
DR   RGD; 621544; Chrnb3.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P12391; -.
DR   KO; K04814; -.
DR   OMA; LLCMKGH; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P12391; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-RNO-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-RNO-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   PRO; PR:P12391; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000012448; -.
DR   Genevisible; P12391; RN.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IC:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31    464       Neuronal acetylcholine receptor subunit
FT                                beta-3.
FT                                /FTId=PRO_0000000386.
FT   TOPO_DOM     31    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    263       Helical. {ECO:0000255}.
FT   TRANSMEM    271    288       Helical. {ECO:0000255}.
FT   TRANSMEM    305    326       Helical. {ECO:0000255}.
FT   TOPO_DOM    327    434       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    435    453       Helical. {ECO:0000255}.
FT   CARBOHYD     55     55       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    159    173       {ECO:0000250}.
SQ   SEQUENCE   464 AA;  53261 MW;  5D3B1F7DB934D1D8 CRC64;
     MTGFLRVFLV LSATLSGSWV TLTATAGLSS VAEHEDALLR HLFQGYQKWV RPVLNSSDII
     KVYFGLKISQ LVDVDEKNQL MTTNVWLKQE WTDQKLRWNP EEYGGINSIK VPSESLWLPD
     IVLFENADGR FEGSLMTKAI VKSSGTVSWT PPASYKSSCT MDVTFFPFDR QNCSMKFGSW
     TYDGTMVDLI LINENVDRKD FFDNGEWEIL NAKGMKGNRR EGFYSYPFVT YSFVLRRLPL
     FYTLFLIIPC LGLSFLTVLV FYLPSDEGEK LSLSTSVLVS LTVFLLVIEE IIPSSSKVIP
     LIGEYLLFIM IFVTLSIIVT VFVINVHHRS SSTYHPMAPW VKRLFLQRLP RWLCMKDPMD
     RFSFPDGKES DTAVRGKVSG KRKQTPASDG ERVLVAFLEK ASESIRYISR HVKKEHFISQ
     VVQDWKFVAQ VLDRIFLWLF LIASVLGSIL IFIPALKMWI HRFH
//
ID   ACHN2_CARAU             Reviewed;         462 AA.
AC   P13908;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   25-OCT-2017, entry version 102.
DE   RecName: Full=Neuronal acetylcholine receptor subunit non-alpha-2;
DE   AltName: Full=GFN-alpha-2;
DE   Flags: Precursor;
OS   Carassius auratus (Goldfish).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Carassius.
OX   NCBI_TaxID=7957;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=2465296; DOI=10.1083/jcb.108.2.637;
RA   Cauley K., Agranoff B.W., Goldman D.;
RT   "Identification of a novel nicotinic acetylcholine receptor structural
RT   subunit expressed in goldfish retina.";
RL   J. Cell Biol. 108:637-645(1989).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and beta.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14786; CAA32888.1; -; mRNA.
DR   PIR; S06893; S06893.
DR   ProteinModelPortal; P13908; -.
DR   HOVERGEN; HBG003756; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     30
FT   CHAIN        31    462       Neuronal acetylcholine receptor subunit
FT                                non-alpha-2.
FT                                /FTId=PRO_0000000393.
FT   TOPO_DOM     31    234       Extracellular.
FT   TRANSMEM    235    259       Helical.
FT   TRANSMEM    267    284       Helical.
FT   TRANSMEM    301    322       Helical.
FT   TOPO_DOM    323    428       Cytoplasmic.
FT   TRANSMEM    429    446       Helical.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    168    168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250}.
SQ   SEQUENCE   462 AA;  53195 MW;  306DBDD9E683F3F6 CRC64;
     MTLAVIGLFT LFTSIIAITP AREFVSLAER EDALLRELFQ GYQRWVRPVQ HANHSVKVRF
     GLKISQLVDV DEKNQLMTTN VWLWQEWLDY KLRWNPENYG GITSIRVPSE SIWLPDIVLY
     ENADGRFEGS LMTKAIVRYN GMITWTPPAS YKSACTMDVT FFPFDRQNCS MKFGSWTYDG
     NMVKLVLINQ QVDRSDFFDN GEWEILSATG VKGSRQDSHL SYPYITYSFI LKRLPLFYTL
     FLIIPCLGLS FLTVLVFYLP SDEGEKVSLS TSVLVSLTVF LLVIEEIIPS SSKVIPLIGE
     YLLFIMIFVT LSIIVTIFVI NVHHRSSATY HPMSPWVRSL FLQRLPHLLC MRGNTDRYHY
     PELEPHSPDL KPRNKKGPPG PEGEGQALIN LLEQATNSVR YISRHIKKEH FIREVVQDWK
     FVAQVLDRIF LWTFLTVSVL GTILIFTPAL KMFLRTPPPP SP
//
ID   GBRB1_RAT               Reviewed;         474 AA.
AC   P15431;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   22-NOV-2017, entry version 158.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-1;
DE   AltName: Full=GABA(A) receptor subunit beta-1;
DE   Flags: Precursor;
GN   Name=Gabrb1; Synonyms=Gabrb-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2548852;
RA   Ymer S., Schofield P.R., Draguhn A., Werner P., Koehler M.,
RA   Seeburg P.H.;
RT   "GABAA receptor beta subunit heterogeneity: functional expression of
RT   cloned cDNAs.";
RL   EMBO J. 8:1665-1670(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=1977069; DOI=10.1016/0169-328X(90)90017-8;
RA   Malherbe P., Draguhn A., Multhaup G., Beyreuther K., Mohler H.;
RT   "GABAA-receptor expressed from rat brain alpha- and beta-subunit cDNAs
RT   displays potentiation by benzodiazepine receptor ligands.";
RL   Brain Res. Mol. Brain Res. 8:199-208(1990).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18281286; DOI=10.1074/jbc.M709993200;
RA   Saras A., Gisselmann G., Vogt-Eisele A.K., Erlkamp K.S., Kletke O.,
RA   Pusch H., Hatt H.;
RT   "Histamine action on vertebrate GABAA receptors: direct channel gating
RT   and potentiation of GABA responses.";
RL   J. Biol. Chem. 283:10470-10475(2008).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel. {ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:1977069}.
CC   -!- SUBUNIT: Binds UBQLN1. Interacts with KCTD8, KCTD12 and KCTD16;
CC       this interaction determines the pharmacology and kinetics of the
CC       receptor response, the KCTD proteins markedly accelerating the
CC       GABA-B response, although to different extents (By similarity).
CC       Heteropentamer, formed by a combination of alpha, beta, gamma,
CC       delta and rho chains. {ECO:0000250, ECO:0000269|PubMed:18281286}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:18281286}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:18281286}. Cell membrane
CC       {ECO:0000269|PubMed:18281286}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18281286}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRB1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15466; CAA33493.1; -; mRNA.
DR   PIR; S04464; B60039.
DR   RefSeq; NP_037088.1; NM_012956.1.
DR   UniGene; Rn.207157; -.
DR   ProteinModelPortal; P15431; -.
DR   SMR; P15431; -.
DR   IntAct; P15431; 2.
DR   MINT; MINT-219840; -.
DR   STRING; 10116.ENSRNOP00000003170; -.
DR   ChEMBL; CHEMBL1907607; -.
DR   TCDB; 1.A.9.5.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P15431; -.
DR   PhosphoSitePlus; P15431; -.
DR   PRIDE; P15431; -.
DR   Ensembl; ENSRNOT00000003170; ENSRNOP00000003170; ENSRNOG00000002327.
DR   GeneID; 25450; -.
DR   KEGG; rno:25450; -.
DR   UCSC; RGD:2649; rat.
DR   CTD; 2560; -.
DR   RGD; 2649; Gabrb1.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231335; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P15431; -.
DR   KO; K05181; -.
DR   OMA; NAGYWIF; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P15431; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-RNO-977441; GABA A receptor activation.
DR   PRO; PR:P15431; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002327; -.
DR   Genevisible; P15431; RN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:1902711; C:GABA-A receptor complex; IMP:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043235; C:receptor complex; IDA:RGD.
DR   GO; GO:0005253; F:anion channel activity; IDA:RGD.
DR   GO; GO:0050811; F:GABA receptor binding; IPI:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:RGD.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; ISS:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IMP:UniProtKB.
DR   GO; GO:0071420; P:cellular response to histamine; IDA:UniProtKB.
DR   GO; GO:0021954; P:central nervous system neuron development; IEP:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0006821; P:chloride transport; TAS:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; IMP:UniProtKB.
DR   GO; GO:0042698; P:ovulation cycle; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IDA:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    474       Gamma-aminobutyric acid receptor subunit
FT                                beta-1.
FT                                /FTId=PRO_0000000458.
FT   TOPO_DOM     26    245       Extracellular. {ECO:0000305}.
FT   TRANSMEM    246    267       Helical. {ECO:0000305}.
FT   TRANSMEM    271    293       Helical. {ECO:0000305}.
FT   TRANSMEM    305    327       Helical. {ECO:0000305}.
FT   TOPO_DOM    328    451       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    452    473       Helical. {ECO:0000305}.
FT   REGION      120    122       Agonist binding. {ECO:0000250}.
FT   REGION      180    182       Agonist binding. {ECO:0000250}.
FT   REGION      290    311       Allosteric effector binding.
FT                                {ECO:0000250}.
FT   BINDING     225    225       Agonist. {ECO:0000250}.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    161    175       {ECO:0000250}.
FT   CONFLICT    420    420       R -> Q (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       R -> P (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   474 AA;  54072 MW;  986277FDBD66377A CRC64;
     MWTVQNRESL GLLSFPVMVA MVCCAHSSNE PSNMSYVKET VDRLLKGYDI RLRPDFGGPP
     VDVGMRIDVA SIDMVSEVNM DYTLTMYFQQ SWKDKRLSYS GIPLNLTLDN RVADQLWVPD
     TYFLNDKKSF VHGVTVKNRM IRLHPDGTVL YGLRITTTAA CMMDLRRYPL DEQNCTLEIE
     SYGYTTDDIE FYWNGGEGAV TGVNKIELPQ FSIVDYKMVS KKVEFTTGAY PRLSLSFRLK
     RNIGYFILQT YMPSTLITIL SWVSFWINYD ASAARVALGI TTVLTMTTIS THLRETLPKI
     PYVKAIDIYL MGCFVFVFLA LLEYAFVNYI FFGKGPQKKG ASKQDQSANE KNKLEMNKVQ
     VDAHGNILLS TLEIRNETSG SEVLTGVSDP KATMYSYDSA SIQYRKPLSS REGFGRGLDR
     HGVPGKGRIR RRASQLKVKI PDLTDVNSID KWSRMFFPIT FSLFNVVYWL YYVH
//
ID   ACH2_DROME              Reviewed;         576 AA.
AC   P17644; Q0KI18; Q9VC73;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   25-OCT-2017, entry version 173.
DE   RecName: Full=Acetylcholine receptor subunit alpha-like 2;
DE   AltName: Full=Nicotinic acetylcholine receptor alpha 2;
DE   Flags: Precursor;
GN   Name=nAChRalpha2; Synonyms=Acr96Ab, AcrE, nAcRalpha-96Ab, sad;
GN   ORFNames=CG6844;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Head;
RX   PubMed=2117557; DOI=10.1016/0014-5793(90)81170-S;
RA   Jonas P., Baumann A., Merz B., Gundelfinger E.D.;
RT   "Structure and developmental expression of the D alpha 2 gene encoding
RT   a novel nicotinic acetylcholine receptor protein of Drosophila
RT   melanogaster.";
RL   FEBS Lett. 269:264-268(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1697262;
RA   Sawruk E., Schloss P., Betz H., Schmitt B.;
RT   "Heterogeneity of Drosophila nicotinic acetylcholine receptors: SAD, a
RT   novel developmentally regulated alpha-subunit.";
RL   EMBO J. 9:2671-2677(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Head;
RX   PubMed=2114015; DOI=10.1093/nar/18.12.3640;
RA   Baumann A., Jonas P., Gundelfinger E.D.;
RT   "Sequence of D alpha 2, a novel alpha-like subunit of Drosophila
RT   nicotinic acetylcholine receptors.";
RL   Nucleic Acids Res. 18:3640-3640(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: CNS in embryos. {ECO:0000269|PubMed:2114015,
CC       ECO:0000269|PubMed:2117557}.
CC   -!- DEVELOPMENTAL STAGE: Late embryonic and late pupal stages.
CC       {ECO:0000269|PubMed:2114015, ECO:0000269|PubMed:2117557}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52274; CAA36517.1; -; mRNA.
DR   EMBL; X53583; CAA37652.1; -; mRNA.
DR   EMBL; AE014297; AAF56302.2; -; Genomic_DNA.
DR   EMBL; AY058446; AAL13675.1; -; mRNA.
DR   PIR; S11679; ACFFA2.
DR   RefSeq; NP_524482.1; NM_079758.3.
DR   RefSeq; NP_733001.1; NM_170146.2.
DR   UniGene; Dm.2363; -.
DR   ProteinModelPortal; P17644; -.
DR   SMR; P17644; -.
DR   BioGrid; 67845; 2.
DR   DIP; DIP-22674N; -.
DR   IntAct; P17644; 1.
DR   MINT; MINT-888559; -.
DR   STRING; 7227.FBpp0084023; -.
DR   ChEMBL; CHEMBL3350223; -.
DR   PaxDb; P17644; -.
DR   PRIDE; P17644; -.
DR   EnsemblMetazoa; FBtr0084639; FBpp0084023; FBgn0000039.
DR   EnsemblMetazoa; FBtr0084640; FBpp0084024; FBgn0000039.
DR   GeneID; 42919; -.
DR   KEGG; dme:Dmel_CG6844; -.
DR   CTD; 42919; -.
DR   FlyBase; FBgn0000039; nAChRalpha2.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   InParanoid; P17644; -.
DR   KO; K05312; -.
DR   OMA; HCKLLCL; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P17644; -.
DR   Reactome; R-DME-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-DME-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-DME-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 42919; -.
DR   PRO; PR:P17644; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0000039; -.
DR   Genevisible; P17644; DM.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:FlyBase.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:FlyBase.
DR   GO; GO:0098655; P:cation transmembrane transport; IDA:FlyBase.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IEP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000305}.
FT   CHAIN        22    576       Acetylcholine receptor subunit alpha-like
FT                                2.
FT                                /FTId=PRO_0000000300.
FT   TOPO_DOM     22    261       Extracellular. {ECO:0000255}.
FT   TRANSMEM    262    285       Helical. {ECO:0000255}.
FT   TRANSMEM    293    311       Helical. {ECO:0000255}.
FT   TRANSMEM    327    346       Helical. {ECO:0000255}.
FT   TOPO_DOM    347    526       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    527    545       Helical. {ECO:0000255}.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    254    254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    570    570       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    169    183       {ECO:0000250}.
FT   DISULFID    243    244       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   576 AA;  65506 MW;  97D6A46CADC3F42F CRC64;
     MAPGCCTTRP RPIALLAHIW RHCKPLCLLL VLLLLCETVQ ANPDAKRLYD DLLSNYNRLI
     RPVSNNTDTV LVKLGLRLSQ LIDLNLKDQI LTTNVWLEHE WQDHKFKWDP SEYGGVTELY
     VPSEHIWLPD IVLYNNADGE YVVTTMTKAI LHYTGKVVWT PPAIFKSSCE IDVRYFPFDQ
     QTCFMKFGSW TYDGDQIDLK HISQKNDKDN KVEIGIDLRE YYPSVEWDIL GVPAERHEKY
     YPCCAEPYPD IFFNITLRRK TLFYTVNLII PCVGISYLSV LVFYLPADSG EKIALCISIL
     LSQTMFFLLI SEIIPSTSLA LPLLGKYLLF TMLLVGLSVV ITIIILNIHY RKPSTHKMRP
     WIRSFFIKRL PKLLLMRVPK DLLRDLAANK INYGLKFSKT KFGQALMDEM QMNSGGSSPD
     SLRRMQGRVG AGGCNGMHVT TATNRFSGLV GALGGGLSTL SGYNGLPSVL SGLDDSLSDV
     AARKKYPFEL EKAIHNVMFI QHHMQRQDEF NAEDQDWGFV AMVMDRLFLW LFMIASLVGT
     FVILGEAPSL YDDTKAIDVQ LSDVAKQIYN LTEKKN
//
ID   ACHA3_CARAU             Reviewed;         512 AA.
AC   P18845;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   25-OCT-2017, entry version 108.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-3;
DE   AltName: Full=GF-alpha-3;
DE   Flags: Precursor;
GN   Name=chrna3;
OS   Carassius auratus (Goldfish).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Carassius.
OX   NCBI_TaxID=7957;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=2402459; DOI=10.1093/nar/18.17.5293;
RA   Hieber V.C., Bouchey J.E., Agranoff B.W., Goldman D.;
RT   "Nucleotide and deduced amino acid sequence of the goldfish neural
RT   nicotinic acetylcholine receptor alpha-3 subunit.";
RL   Nucleic Acids Res. 18:5293-5293(1990).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=2303867;
RA   Cauley K., Agranoff B.W., Goldman D.;
RT   "Multiple nicotinic acetylcholine receptor genes are expressed in
RT   goldfish retina and tectum.";
RL   J. Neurosci. 10:670-683(1990).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and non-alpha (beta).
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in retina and brain.
CC       {ECO:0000269|PubMed:2303867}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       3/CHRNA3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54051; CAA37985.1; -; mRNA.
DR   PIR; S11230; B37014.
DR   ProteinModelPortal; P18845; -.
DR   HOVERGEN; HBG003756; -.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISS:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:UniProtKB.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; ISS:UniProtKB.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; ISS:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 2.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    512       Neuronal acetylcholine receptor subunit
FT                                alpha-3.
FT                                /FTId=PRO_0000000350.
FT   TOPO_DOM     24    232       Extracellular.
FT   TRANSMEM    233    257       Helical.
FT   TRANSMEM    265    283       Helical.
FT   TRANSMEM    299    320       Helical.
FT   TOPO_DOM    321    485       Cytoplasmic.
FT   TRANSMEM    486    505       Helical.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
FT   DISULFID    215    216       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   512 AA;  58096 MW;  8D2F63E37ECE9077 CRC64;
     MNSASRITLF FLLTVLITQE CLSSKGEDRL FRRLFRRYNQ FIRPVENVSD PVTVEFEVSI
     SQLVKVDEVN QIMETNLWLR HIWNDYKLKW LPAEFDGIEF IRVPSNKIWR PDIVLYNNAV
     GDFLVEDKTK ALLKYDGTIT WVPPAIFKSS CPMDITYFPF DYQNCSMKFG SWTYDKAKID
     LVLIGSKVNL KDFWESGEWE IIDAPGYKHD IKYNCCEEIY PDITYSFYIR RLPLFYTINL
     IIPCLLISFL TILVFYLPSD CGEKVTLCIS VLLSLTVFLL VITETIPSTS LVIPLIGEYL
     LFTMIFVTLS IVITVFVLNV HYRTPMTHTM PSWVRTVFLR ALPRVMLMRR PIDLSESSGK
     GGGEIAGSSG TGGGRGAEGK KMKSSASQQG AMNSLEFGEG KAALEGKKGG CPCHPIKEAI
     EGDCGKVSRQ LTPQAINTVV TFSVVSPEIK QAIESVKYIA ENMRSRNKAK EVEDDWKYVA
     MVIDRIFLWV FVLVCVLGTL GLFLQPLIGF FS
//
ID   ACHB2_CARAU             Reviewed;         459 AA.
AC   P19370;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   25-OCT-2017, entry version 101.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-2;
DE   AltName: Full=GF-beta-2;
DE   Flags: Fragment;
GN   Name=chrnb2;
OS   Carassius auratus (Goldfish).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Carassius.
OX   NCBI_TaxID=7957;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=2402468; DOI=10.1093/nar/18.17.5307;
RA   Hieber V.C., Bouchey J.E., Agranoff B.W., Goldman D.;
RT   "Nucleotide and deduced amino acid sequence of the goldfish neural
RT   nicotinic acetylcholine receptor beta-2 subunit.";
RL   Nucleic Acids Res. 18:5307-5307(1990).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and non-alpha (beta). The pentamer alpha3-beta-
CC       2 interacts with the conotoxin BuIA and the conotoxin MII (By
CC       similarity). {ECO:0000250|UniProtKB:P12390}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       2/CHRNB2 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54052; CAA37986.1; -; mRNA.
DR   PIR; S14703; S14703.
DR   ProteinModelPortal; P19370; -.
DR   HOVERGEN; HBG003756; -.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; ISS:UniProtKB.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISS:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:UniProtKB.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISS:UniProtKB.
DR   GO; GO:0050890; P:cognition; ISS:UniProtKB.
DR   GO; GO:0007613; P:memory; ISS:UniProtKB.
DR   GO; GO:0050877; P:nervous system process; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; ISS:UniProtKB.
DR   GO; GO:0008542; P:visual learning; ISS:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR032932; CHRNB2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF80; PTHR18945:SF80; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN        <1    459       Neuronal acetylcholine receptor subunit
FT                                beta-2.
FT                                /FTId=PRO_0000076980.
FT   TOPO_DOM     <1    203       Extracellular. {ECO:0000255}.
FT   TRANSMEM    204    228       Helical. {ECO:0000255}.
FT   TOPO_DOM    229    235       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    236    254       Helical. {ECO:0000255}.
FT   TOPO_DOM    255    269       Extracellular. {ECO:0000255}.
FT   TRANSMEM    270    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    421       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    422    440       Helical. {ECO:0000255}.
FT   SITE         54     54       Key residue that may interfere with
FT                                effective access of the conotoxin BuIA to
FT                                the channel binding site.
FT                                {ECO:0000250|UniProtKB:P12390}.
FT   SITE        106    106       Key residue for a rapid dissociation
FT                                (K(off)) from the conotoxin BuIA.
FT                                {ECO:0000250|UniProtKB:P12390}.
FT   SITE        114    114       Key residue for a rapid dissociation
FT                                (K(off)) from the conotoxin BuIA.
FT                                {ECO:0000250|UniProtKB:P12390}.
FT   CARBOHYD     21     21       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    125    139       {ECO:0000250}.
FT   NON_TER       1      1
SQ   SEQUENCE   459 AA;  53040 MW;  860B1A011AA47CF6 CRC64;
     LRSDFLLGPE RYNKLIRPAV NKSQQVTIGI KVSLAQLISV NEREQIMTTN VWLTQEWTDY
     RLVWDPNEYE GIKKLRIPSQ HIWLPDIVLY NNADGVYEVS FYCNAVVSNT GDIFWLPPAI
     YKSACAIEVR NFPFDQQNCT LKFRSWTYDR TELDLVLTSD FASRDDYTPS GEWDIVSLPG
     RKNEDPNDLT YLDITYDFVI KRKPLFYTIN LIIPCVLITS LAILVFYLPS DCGEKVTLCM
     SVLLALTVFL LLISKIVPPT SLAVPLIGKY LMFTMVLVTF SIVTSVCVLN VHHRSPSTHY
     MPEWVKCVFL HKLPAFLLMR RPGRSNVRER FRRKHQRKSF SSHQDGDSFF LTDDPGRVCG
     AWRVGDLPEG SEFRQRVKVR HDQDVDEAID GVRFIAEHMK IEDDDEGIIE DWKYVAMVID
     RLFLWIFILV CVVGTLGLFV QPLFQSYNTP VAEEVYGDF
//
ID   GLRK_CHICK              Reviewed;         487 AA.
AC   P19439;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   27-SEP-2017, entry version 121.
DE   RecName: Full=Probable glutamate receptor;
DE   AltName: Full=Kainate-binding protein;
DE   Flags: Precursor;
GN   Name=KBP;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Cerebellum;
RX   PubMed=2480525; DOI=10.1038/342689a0;
RA   Gregor P., Mano I., Maoz I., McKeown M., Teichberg V.I.;
RT   "Molecular structure of the chick cerebellar kainate-binding subunit
RT   of a putative glutamate receptor.";
RL   Nature 342:689-692(1989).
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17700; CAA35693.1; -; mRNA.
DR   PIR; S07062; S07062.
DR   RefSeq; NP_990684.1; NM_205353.2.
DR   UniGene; Gga.42516; -.
DR   ProteinModelPortal; P19439; -.
DR   PaxDb; P19439; -.
DR   Ensembl; ENSGALT00000001776; ENSGALP00000001774; ENSGALG00000001172.
DR   GeneID; 396300; -.
DR   KEGG; gga:396300; -.
DR   CTD; 394374; -.
DR   eggNOG; ENOG410ISQU; Eukaryota.
DR   eggNOG; ENOG410XQTZ; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000234371; -.
DR   HOVERGEN; HBG104989; -.
DR   InParanoid; P19439; -.
DR   OMA; PFSKETW; -.
DR   OrthoDB; EOG091G066R; -.
DR   PhylomeDB; P19439; -.
DR   TreeFam; TF315232; -.
DR   PRO; PR:P19439; -.
DR   Proteomes; UP000000539; Chromosome 21.
DR   Bgee; ENSGALG00000001172; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23
FT   CHAIN        24    487       Probable glutamate receptor.
FT                                /FTId=PRO_0000011557.
FT   TOPO_DOM     24    169       Extracellular. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical. {ECO:0000255}.
FT   TOPO_DOM    191    235       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    419       Extracellular. {ECO:0000255}.
FT   TRANSMEM    420    440       Helical. {ECO:0000255}.
FT   TOPO_DOM    441    487       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   487 AA;  54356 MW;  45D71B2A94A27880 CRC64;
     MDKGLHFIFC VVTAVLLLRE SSQTGAMRND DAMIKPNDLR GPEENLPSLT VTTILEDPYV
     MVRSAELEGY CIDLLKALAS MLHFSYKVKV VGDGKYGAIS PSGNWTGMIG EILRQEADIA
     VAPLTVTSAR EEVVSFTTPF LQTGIGILLR KETISQEMSF FHFLAPFSKE TWTGLLFAYV
     LTCVCLFLVA RLSPCEWNEP KNEENHFTFL NSLWFGAGAL TLQGVTPRPK AFSVRVIAAI
     WWLFTIALLA AYIANFTALL SSGSEQLSIQ TFEDLVKQRK LEFGTLDGSS TFYFFKNSKN
     PIHRMVYEYM DKRRDHVLVK TYQEAVQRVM ESNYAFIGES ISQDLAAARH CNLIRAPEVI
     GARGFGIATA QASPWTKKLS VAVLKLRETG DLDYLRNKWW ESSCLHKSRE GWSPLQPQAL
     GGLFLTLAIG LALGVIAAMV ELSNKSRHAA GHIKKSCCSI FTEEMCTRLR IKENTRQTQE
     TSGRANA
//
ID   GRIA1_RAT               Reviewed;         907 AA.
AC   P19490;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   20-DEC-2017, entry version 180.
DE   RecName: Full=Glutamate receptor 1;
DE            Short=GluR-1;
DE   AltName: Full=AMPA-selective glutamate receptor 1;
DE   AltName: Full=GluR-A;
DE   AltName: Full=GluR-K1;
DE   AltName: Full=Glutamate receptor ionotropic, AMPA 1;
DE            Short=GluA1;
DE   Flags: Precursor;
GN   Name=Gria1; Synonyms=Glur1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLOP).
RC   TISSUE=Forebrain;
RX   PubMed=2480522; DOI=10.1038/342643a0;
RA   Hollmann M., O'Shea-Greenfield A., Rogers S.W., Heinemann S.F.;
RT   "Cloning by functional expression of a member of the glutamate
RT   receptor family.";
RL   Nature 342:643-648(1989).
RN   [2]
RP   SEQUENCE REVISION.
RA   Hartley M.;
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLOP).
RC   TISSUE=Brain;
RX   PubMed=2166337; DOI=10.1126/science.2166337;
RA   Keinaenen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A.,
RA   Sakmann B., Seeburg P.H.;
RT   "A family of AMPA-selective glutamate receptors.";
RL   Science 249:556-560(1990).
RN   [4]
RP   SEQUENCE REVISION TO 67; 248; 698; 710; 789 AND 893.
RA   Keinaenen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A.,
RA   Sakmann B., Seeburg P.H.;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLOP).
RX   PubMed=2168579; DOI=10.1126/science.2168579;
RA   Boulter J., Hollmann M., O'Shea-Greenfield A., Hartley M.,
RA   Deneris E.S., Maron C., Heinemann S.F.;
RT   "Molecular cloning and functional expression of glutamate receptor
RT   subunit genes.";
RL   Science 249:1033-1037(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FLIP), AND VARIANT THR-710.
RC   TISSUE=Brain;
RX   PubMed=1699275; DOI=10.1126/science.1699275;
RA   Sommer B., Keinaenen K., Verdoorn T.A., Wisden W., Burnashev N.,
RA   Herb A., Koehler M., Takagi T., Sakmann B., Seeburg P.H.;
RT   "Flip and flop: a cell-specific functional switch in glutamate-
RT   operated channels of the CNS.";
RL   Science 249:1580-1585(1990).
RN   [7]
RP   PHOSPHORYLATION AT SER-645.
RX   PubMed=7877986; DOI=10.1073/pnas.92.5.1376;
RA   Yakel J.L., Vissavajjhala P., Derkach V.A., Brickey D.A.,
RA   Soderling T.R.;
RT   "Identification of a Ca2+/calmodulin-dependent protein kinase II
RT   regulatory phosphorylation site in non-N-methyl-D-aspartate glutamate
RT   receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:1376-1380(1995).
RN   [8]
RP   VARIANT THR-710, AND PHOSPHORYLATION AT SER-710.
RX   PubMed=8848293; DOI=10.1016/0168-0102(95)00977-9;
RA   Nakazawa K., Tadakuma T., Nokihara K., Ito M.;
RT   "Antibody specific for phosphorylated AMPA-type glutamate receptors at
RT   GluR2 Ser-696.";
RL   Neurosci. Res. 24:75-86(1995).
RN   [9]
RP   PHOSPHORYLATION AT SER-849 AND SER-863, AND MUTAGENESIS OF SER-645 AND
RP   SER-849.
RX   PubMed=9405465; DOI=10.1074/jbc.272.51.32528;
RA   Mammen A.L., Kameyama K., Roche K.W., Huganir R.L.;
RT   "Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-
RT   propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent
RT   kinase II.";
RL   J. Biol. Chem. 272:32528-32533(1997).
RN   [10]
RP   INTERACTION WITH DLG1.
RX   PubMed=9677374; DOI=10.1074/jbc.273.31.19518;
RA   Leonard A.S., Davare M.A., Horne M.C., Garner C.C., Hell J.W.;
RT   "SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-
RT   4-propionic acid receptor GluR1 subunit.";
RL   J. Biol. Chem. 273:19518-19524(1998).
RN   [11]
RP   INTERACTION WITH DLG1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF THR-905 AND LEU-907.
RX   PubMed=12070168; DOI=10.1074/jbc.M204354200;
RA   Cai C., Coleman S.K., Niemi K., Keinaenen K.;
RT   "Selective binding of synapse-associated protein 97 to GluR-A alpha-
RT   amino-5-hydroxy-3-methyl-4-isoxazole propionate receptor subunit is
RT   determined by a novel sequence motif.";
RL   J. Biol. Chem. 277:31484-31490(2002).
RN   [12]
RP   INTERACTION WITH PDLIM4, AND SUBCELLULAR LOCATION.
RX   PubMed=15456832; DOI=10.1523/JNEUROSCI.2100-04.2004;
RA   Schulz T.W., Nakagawa T., Licznerski P., Pawlak V., Kolleker A.,
RA   Rozov A., Kim J., Dittgen T., Koehr G., Sheng M., Seeburg P.H.,
RA   Osten P.;
RT   "Actin/alpha-actinin-dependent transport of AMPA receptors in
RT   dendritic spines: role of the PDZ-LIM protein RIL.";
RL   J. Neurosci. 24:8584-8594(2004).
RN   [13]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND INTERACTION WITH CACNG2.
RX   PubMed=16793768; DOI=10.1074/jbc.M600679200;
RA   Bedoukian M.A., Weeks A.M., Partin K.M.;
RT   "Different domains of the AMPA receptor direct stargazin-mediated
RT   trafficking and stargazin-mediated modulation of kinetics.";
RL   J. Biol. Chem. 281:23908-23921(2006).
RN   [14]
RP   INTERACTION WITH LRFN1.
RX   PubMed=16630835; DOI=10.1016/j.neuron.2006.04.005;
RA   Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H.,
RA   Kaang B.-K., Kim E.;
RT   "SALM synaptic cell adhesion-like molecules regulate the
RT   differentiation of excitatory synapses.";
RL   Neuron 50:233-245(2006).
RN   [15]
RP   INTERACTION WITH PRKG2, PHOSPHORYLATION AT SER-863, AND MUTAGENESIS OF
RP   ARG-855 AND SER-863.
RX   PubMed=18031684; DOI=10.1016/j.neuron.2007.09.016;
RA   Serulle Y., Zhang S., Ninan I., Puzzo D., McCarthy M., Khatri L.,
RA   Arancio O., Ziff E.B.;
RT   "A GluR1-cGKII interaction regulates AMPA receptor trafficking.";
RL   Neuron 56:670-688(2007).
RN   [16]
RP   INTERACTION WITH CACNG5.
RX   PubMed=18817736; DOI=10.1016/j.neuron.2008.07.034;
RA   Kato A.S., Siuda E.R., Nisenbaum E.S., Bredt D.S.;
RT   "AMPA receptor subunit-specific regulation by a distinct family of
RT   type II TARPs.";
RL   Neuron 59:986-996(2008).
RN   [17]
RP   INTERACTION WITH CACNG5.
RX   PubMed=19234459; DOI=10.1038/nn.2266;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M.,
RA   Cull-Candy S.G.;
RT   "Selective regulation of long-form calcium-permeable AMPA receptors by
RT   an atypical TARP, gamma-5.";
RL   Nat. Neurosci. 12:277-285(2009).
RN   [18]
RP   ERRATUM.
RX   DOI=10.1038/nn0609-808c;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M.,
RA   Cull-Candy S.G.;
RL   Nat. Neurosci. 12:808-808(2009).
RN   [19]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19265014; DOI=10.1126/science.1167852;
RA   Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B.,
RA   Chisaka O., Jonas P., Schulte U., Fakler B., Kloecker N.;
RT   "Functional proteomics identify cornichon proteins as auxiliary
RT   subunits of AMPA receptors.";
RL   Science 323:1313-1319(2009).
RN   [20]
RP   INTERACTION WITH CNIH2 AND CACNG2.
RX   PubMed=20805473; DOI=10.1073/pnas.1011706107;
RA   Shi Y., Suh Y.H., Milstein A.D., Isozaki K., Schmid S.M., Roche K.W.,
RA   Nicoll R.A.;
RT   "Functional comparison of the effects of TARPs and cornichons on AMPA
RT   receptor trafficking and gating.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:16315-16319(2010).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.21 ANGSTROMS) OF 890-907 IN COMPLEX WITH
RP   DLG1, AND INTERACTION WITH DLG1.
RX   PubMed=17069616; DOI=10.1111/j.1742-4658.2006.05521.x;
RA   von Ossowski I., Oksanen E., von Ossowski L., Cai C., Sundberg M.,
RA   Goldman A., Keinanen K.;
RT   "Crystal structure of the second PDZ domain of SAP97 in complex with a
RT   GluR-A C-terminal peptide.";
RL   FEBS J. 273:5219-5229(2006).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-392, SUBUNIT,
RP   GLYCOSYLATION AT ASN-249; ASN-257 AND ASN-363, AND DISULFIDE BOND.
RX   PubMed=21639859; DOI=10.1042/BJ20110801;
RA   Yao G., Zong Y., Gu S., Zhou J., Xu H., Mathews I.I., Jin R.;
RT   "Crystal structure of the glutamate receptor GluA1 N-terminal
RT   domain.";
RL   Biochem. J. 438:255-263(2011).
CC   -!- FUNCTION: Ionotropic glutamate receptor. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. Binding of the excitatory neurotransmitter L-
CC       glutamate induces a conformation change, leading to the opening of
CC       the cation channel, and thereby converts the chemical signal to an
CC       electrical impulse. The receptor then desensitizes rapidly and
CC       enters a transient inactive state, characterized by the presence
CC       of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8,
CC       shows resensitization which is characterized by a delayed
CC       accumulation of current flux upon continued application of
CC       glutamate. {ECO:0000269|PubMed:16793768,
CC       ECO:0000269|PubMed:19265014}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits (PubMed:21639859). Tetramers may be formed by
CC       the dimerization of dimers (By similarity). Interacts with HIP1
CC       and RASGRF2. Interacts with SYNDIG1 and GRIA2 (By similarity).
CC       Interacts with DLG1 (via C-terminus) (PubMed:12070168,
CC       PubMed:17069616, PubMed:9677374). Interacts with LRFN1
CC       (PubMed:16630835). Interacts with PRKG2 (PubMed:18031684).
CC       Interacts with CNIH2 and CACNG2 (PubMed:20805473). Interacts with
CC       CACNG5 (PubMed:18817736, PubMed:19234459). Interacts (via C-
CC       terminus) with PDLIM4 (via LIM domain); this interaction as well
CC       as the interaction of PDLIM4 with alpha-actinin is required for
CC       their colocalization in early endosomes (PubMed:15456832). Found
CC       in a complex with GRIA2, GRIA3, GRIA4, CNIH2, CNIH3, CACNG2,
CC       CACNG3, CACNG4, CACNG5, CACNG7 and CACNG8 (PubMed:16793768,
CC       PubMed:19265014). Interacts with SNX27 (via PDZ domain); the
CC       interaction is required for recycling to the plasma membrane when
CC       endocytosed and prevent degradation in lysosomes. Interacts (via
CC       PDZ-binding motif) with SHANK3 (via PDZ domain) (By similarity).
CC       Interacts with CACNG3; associates GRIA1 with the adaptor protein
CC       complex 4 (AP-4) to target GRIA1 to the somatodendritic
CC       compartment of neurons (By similarity).
CC       {ECO:0000250|UniProtKB:P23818, ECO:0000250|UniProtKB:P42261,
CC       ECO:0000269|PubMed:12070168, ECO:0000269|PubMed:15456832,
CC       ECO:0000269|PubMed:16630835, ECO:0000269|PubMed:16793768,
CC       ECO:0000269|PubMed:17069616, ECO:0000269|PubMed:18031684,
CC       ECO:0000269|PubMed:18817736, ECO:0000269|PubMed:19234459,
CC       ECO:0000269|PubMed:19265014, ECO:0000269|PubMed:20805473,
CC       ECO:0000269|PubMed:21639859, ECO:0000269|PubMed:9677374}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-371642, EBI-371642;
CC       P10608:Adrb2; NbExp=3; IntAct=EBI-371642, EBI-7090342;
CC       Q71RJ2:Cacng2; NbExp=2; IntAct=EBI-371642, EBI-8538384;
CC       P19491:Gria2; NbExp=3; IntAct=EBI-371642, EBI-77718;
CC       P70569:Myo5b; NbExp=2; IntAct=EBI-371642, EBI-975940;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P23818}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23818}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15456832}; Multi-pass membrane protein
CC       {ECO:0000305}. Cell junction, synapse, postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:P23818}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23818}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000250|UniProtKB:P23818}; Multi-pass membrane protein
CC       {ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P23818}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:P23818}. Early endosome membrane
CC       {ECO:0000269|PubMed:15456832}; Multi-pass membrane protein
CC       {ECO:0000305}. Recycling endosome membrane
CC       {ECO:0000269|PubMed:15456832}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Interaction with CACNG2, CNIH2 and CNIH3
CC       promotes cell surface expression (PubMed:19265014). Colocalizes
CC       with PDLIM4 in early endosomes (PubMed:15456832). Displays a
CC       somatodendritic localization and is excluded from axons in neurons
CC       (By similarity). {ECO:0000250|UniProtKB:P23818,
CC       ECO:0000269|PubMed:15456832, ECO:0000269|PubMed:19265014}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Flop;
CC         IsoId=P19490-1; Sequence=Displayed;
CC       Name=Flip;
CC         IsoId=P19490-2; Sequence=VSP_000097, VSP_000098, VSP_000099,
CC                                  VSP_000100, VSP_000101;
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum (at protein level).
CC       {ECO:0000269|PubMed:12070168}.
CC   -!- DOMAIN: The M4 transmembrane segment mediates tetramerization and
CC       is required for cell surface expression. {ECO:0000250}.
CC   -!- PTM: Palmitoylated. Depalmitoylated upon glutamate stimulation.
CC       Cys-603 palmitoylation leads to Golgi retention and decreased cell
CC       surface expression. In contrast, Cys-829 palmitoylation does not
CC       affect cell surface expression but regulates stimulation-dependent
CC       endocytosis (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Ser-645 (PubMed:7877986). Phosphorylated at
CC       Ser-710 by PKC (PubMed:8848293). Phosphorylated at Ser-849 by PKC,
CC       PKA and CAMK2 (PubMed:9405465). Phosphorylated at Ser-863 by PKC,
CC       PKA and PRKG2 (PubMed:9405465, PubMed:18031684).
CC       {ECO:0000269|PubMed:18031684, ECO:0000269|PubMed:7877986,
CC       ECO:0000269|PubMed:8848293, ECO:0000269|PubMed:9405465}.
CC   -!- POLYMORPHISM: Both variants Ser-710 and Thr-710 are phosphorylated
CC       at this position.
CC   -!- MISCELLANEOUS: The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds AMPA (quisqualate) > glutamate >
CC       kainate.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIA1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17184; CAA35050.1; -; mRNA.
DR   EMBL; M36418; AAA41243.2; -; mRNA.
DR   EMBL; M38060; AAA63479.1; -; mRNA.
DR   PIR; A40170; A40170.
DR   PIR; S07059; ACRTK1.
DR   RefSeq; NP_113796.1; NM_031608.1. [P19490-1]
DR   UniGene; Rn.29971; -.
DR   PDB; 2AWW; X-ray; 2.21 A; C=890-907.
DR   PDB; 2G2L; X-ray; 2.35 A; C/D=890-907.
DR   PDB; 3SAJ; X-ray; 2.50 A; A/B/C/D=22-392.
DR   PDBsum; 2AWW; -.
DR   PDBsum; 2G2L; -.
DR   PDBsum; 3SAJ; -.
DR   ProteinModelPortal; P19490; -.
DR   SMR; P19490; -.
DR   BioGrid; 248399; 10.
DR   CORUM; P19490; -.
DR   DIP; DIP-30929N; -.
DR   ELM; P19490; -.
DR   IntAct; P19490; 25.
DR   MINT; MINT-726538; -.
DR   BindingDB; P19490; -.
DR   ChEMBL; CHEMBL3753; -.
DR   TCDB; 1.A.10.1.1; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; P19490; -.
DR   PhosphoSitePlus; P19490; -.
DR   SwissPalm; P19490; -.
DR   PRIDE; P19490; -.
DR   GeneID; 50592; -.
DR   KEGG; rno:50592; -.
DR   UCSC; RGD:621531; rat. [P19490-1]
DR   CTD; 2890; -.
DR   RGD; 621531; Gria1.
DR   HOVERGEN; HBG051839; -.
DR   InParanoid; P19490; -.
DR   KO; K05197; -.
DR   PhylomeDB; P19490; -.
DR   EvolutionaryTrace; P19490; -.
DR   PRO; PR:P19490; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0044308; C:axonal spine; ISO:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:ARUK-UCL.
DR   GO; GO:0032590; C:dendrite membrane; ISO:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:ARUK-UCL.
DR   GO; GO:0032591; C:dendritic spine membrane; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0044309; C:neuron spine; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0043234; C:protein complex; IDA:RGD.
DR   GO; GO:0055037; C:recycling endosome; ISO:RGD.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0036477; C:somatodendritic compartment; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IDA:SynGO-UCL.
DR   GO; GO:0097060; C:synaptic membrane; IMP:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0008179; F:adenylate cyclase binding; IDA:RGD.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0001540; F:amyloid-beta binding; IPI:ARUK-UCL.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:RGD.
DR   GO; GO:0031681; F:G-protein beta-subunit binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:RGD.
DR   GO; GO:0031489; F:myosin V binding; IPI:RGD.
DR   GO; GO:0099583; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:ARUK-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; TAS:UniProtKB.
DR   GO; GO:0051018; F:protein kinase A binding; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:SynGO-UCL.
DR   GO; GO:0031267; F:small GTPase binding; IPI:RGD.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0071418; P:cellular response to amine stimulus; IEP:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEP:RGD.
DR   GO; GO:0071359; P:cellular response to dsRNA; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; ISO:RGD.
DR   GO; GO:0060292; P:long term synaptic depression; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; IMP:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; IMP:UniProtKB.
DR   GO; GO:0045838; P:positive regulation of membrane potential; IMP:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0001919; P:regulation of receptor recycling; IMP:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:UniProtKB.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0010226; P:response to lithium ion; IEP:UniProtKB.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IMP:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; NAS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Lipoprotein; Membrane;
KW   Palmitate; Phosphoprotein; Polymorphism; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    907       Glutamate receptor 1.
FT                                /FTId=PRO_0000011531.
FT   TOPO_DOM     19    536       Extracellular. {ECO:0000250}.
FT   TRANSMEM    537    557       Helical. {ECO:0000250}.
FT   TOPO_DOM    558    584       Cytoplasmic. {ECO:0000250}.
FT   INTRAMEM    585    600       Helical; Pore-forming. {ECO:0000250}.
FT   INTRAMEM    601    603       {ECO:0000250}.
FT   TOPO_DOM    604    609       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    610    630       Helical. {ECO:0000250}.
FT   TOPO_DOM    631    805       Extracellular. {ECO:0000250}.
FT   TRANSMEM    806    826       Helical; Name=M4. {ECO:0000250}.
FT   TOPO_DOM    827    907       Cytoplasmic. {ECO:0000250}.
FT   REGION      492    494       Glutamate binding. {ECO:0000250}.
FT   REGION      668    669       Glutamate binding. {ECO:0000250}.
FT   MOTIF       904    907       PDZ-binding.
FT   BINDING     464    464       Glutamate. {ECO:0000250}.
FT   BINDING     499    499       Glutamate. {ECO:0000250}.
FT   BINDING     719    719       Glutamate. {ECO:0000250}.
FT   MOD_RES     645    645       Phosphoserine.
FT                                {ECO:0000269|PubMed:7877986}.
FT   MOD_RES     710    710       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:8848293}.
FT   MOD_RES     849    849       Phosphoserine; by PKC, PKA and CAMK2.
FT                                {ECO:0000269|PubMed:7877986,
FT                                ECO:0000269|PubMed:9405465}.
FT   MOD_RES     863    863       Phosphoserine; by PKC, PKA and PKG/PRKG2.
FT                                {ECO:0000269|PubMed:18031684,
FT                                ECO:0000269|PubMed:9405465}.
FT   LIPID       603    603       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       829    829       S-palmitoyl cysteine. {ECO:0000250}.
FT   CARBOHYD     63     63       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    249    249       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21639859}.
FT   CARBOHYD    257    257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21639859}.
FT   CARBOHYD    363    363       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21639859}.
FT   CARBOHYD    401    401       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    406    406       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     75    323       {ECO:0000269|PubMed:21639859}.
FT   DISULFID    732    787       {ECO:0000250}.
FT   VAR_SEQ     758    758       N -> G (in isoform Flip).
FT                                {ECO:0000303|PubMed:1699275}.
FT                                /FTId=VSP_000097.
FT   VAR_SEQ     768    768       N -> S (in isoform Flip).
FT                                {ECO:0000303|PubMed:1699275}.
FT                                /FTId=VSP_000098.
FT   VAR_SEQ     772    772       L -> V (in isoform Flip).
FT                                {ECO:0000303|PubMed:1699275}.
FT                                /FTId=VSP_000099.
FT   VAR_SEQ     778    778       N -> S (in isoform Flip).
FT                                {ECO:0000303|PubMed:1699275}.
FT                                /FTId=VSP_000100.
FT   VAR_SEQ     790    793       GGGD -> KDSG (in isoform Flip).
FT                                {ECO:0000303|PubMed:1699275}.
FT                                /FTId=VSP_000101.
FT   VARIANT     710    710       S -> T. {ECO:0000269|PubMed:1699275,
FT                                ECO:0000269|PubMed:8848293}.
FT   MUTAGEN     645    645       S->A: No effect on phosphorylation by
FT                                CaMK2. {ECO:0000269|PubMed:9405465}.
FT   MUTAGEN     849    849       S->A: Abolishes phosphorylation by CaMK2.
FT                                {ECO:0000269|PubMed:9405465}.
FT   MUTAGEN     855    855       R->A: Decreases binding efficiency to
FT                                PRKG2.
FT   MUTAGEN     855    855       R->E: Abolishes binding to PRKG2.
FT                                {ECO:0000269|PubMed:18031684}.
FT   MUTAGEN     863    863       S->A: Decreases synaptic insertion during
FT                                chemical-induced long term potentiation.
FT                                {ECO:0000269|PubMed:18031684}.
FT   MUTAGEN     905    905       T->A: Loss of interaction with DLG1.
FT                                {ECO:0000269|PubMed:12070168}.
FT   MUTAGEN     907    907       L->A: Loss of interaction with DLG1.
FT                                {ECO:0000269|PubMed:12070168}.
FT   CONFLICT     67     67       S -> T (in Ref. 6; AAA63479).
FT                                {ECO:0000305}.
FT   CONFLICT    248    248       A -> R (in Ref. 6; AAA63479).
FT                                {ECO:0000305}.
FT   CONFLICT    698    698       R -> L (in Ref. 6; AAA63479).
FT                                {ECO:0000305}.
FT   STRAND       23     32       {ECO:0000244|PDB:3SAJ}.
FT   STRAND       34     36       {ECO:0000244|PDB:3SAJ}.
FT   HELIX        37     46       {ECO:0000244|PDB:3SAJ}.
FT   STRAND       51     61       {ECO:0000244|PDB:3SAJ}.
FT   HELIX        67     79       {ECO:0000244|PDB:3SAJ}.
FT   STRAND       85     87       {ECO:0000244|PDB:3SAJ}.
FT   HELIX        91    104       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      108    110       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      122    124       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       130    139       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      144    149       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       156    168       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      171    176       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       177    179       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       183    187       {ECO:0000244|PDB:3SAJ}.
FT   TURN        188    191       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      196    203       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       206    208       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       209    218       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      225    233       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       235    237       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       240    245       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      250    254       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       261    276       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       288    309       {ECO:0000244|PDB:3SAJ}.
FT   HELIX       334    342       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      346    348       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      351    353       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      359    361       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      366    372       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      375    383       {ECO:0000244|PDB:3SAJ}.
FT   TURN        384    386       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      387    390       {ECO:0000244|PDB:3SAJ}.
FT   STRAND      905    907       {ECO:0000244|PDB:2AWW}.
SQ   SEQUENCE   907 AA;  101579 MW;  2D4CFA7CCD532838 CRC64;
     MPYIFAFFCT GFLGAVVGAN FPNNIQIGGL FPNQQSQEHA AFRFALSQLT EPPKLLPQID
     IVNISDSFEM TYRFCSQFSK GVYAIFGFYE RRTVNMLTSF CGALHVCFIT PSFPVDTSNQ
     FVLQLRPELQ EALISIIDHY KWQTFVYIYD ADRGLSVLQR VLDTAAEKNW QVTAVNILTT
     TEEGYRMLFQ DLEKKKERLV VVDCESERLN AILGQIVKLE KNGIGYHYIL ANLGFMDIDL
     NKFKESGANV TGFQLVNYTD TIPARIMQQW RTSDSRDHTR VDWKRPKYTS ALTYDGVKVM
     AEAFQSLRRQ RIDISRRGNA GDCLANPAVP WGQGIDIQRA LQQVRFEGLT GNVQFNEKGR
     RTNYTLHVIE MKHDGIRKIG YWNEDDKFVP AATDAQAGGD NSSVQNRTYI VTTILEDPYV
     MLKKNANQFE GNDRYEGYCV ELAAEIAKHV GYSYRLEIVS DGKYGARDPD TKAWNGMVGE
     LVYGRADVAV APLTITLVRE EVIDFSKPFM SLGISIMIKK PQKSKPGVFS FLDPLAYEIW
     MCIVFAYIGV SVVLFLVSRF SPYEWHSEEF EEGRDQTTSD QSNEFGIFNS LWFSLGAFMQ
     QGCDISPRSL SGRIVGGVWW FFTLIIISSY TANLAAFLTV ERMVSPIESA EDLAKQTEIA
     YGTLEAGSTK EFFRRSKIAV FEKMWTYMKS AEPSVFVRTT EEGMIRVRKS KGKYAYLLES
     TMNEYIEQRK PCDTMKVGGN LDSKGYGIAT PKGSALRNPV NLAVLKLNEQ GLLDKLKNKW
     WYDKGECGSG GGDSKDKTSA LSLSNVAGVF YILIGGLGLA MLVALIEFCY KSRSESKRMK
     GFCLIPQQSI NEAIRTSTLP RNSGAGASGG GGSGENGRVV SQDFPKSMQS IPCMSHSSGM
     PLGATGL
//
ID   GRIA4_RAT               Reviewed;         902 AA.
AC   P19493; Q64241;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   22-NOV-2017, entry version 167.
DE   RecName: Full=Glutamate receptor 4;
DE            Short=GluR-4;
DE            Short=GluR4;
DE   AltName: Full=AMPA-selective glutamate receptor 4;
DE   AltName: Full=GluR-D;
DE   AltName: Full=Glutamate receptor ionotropic, AMPA 4;
DE            Short=GluA4;
DE   Flags: Precursor;
GN   Name=Gria4; Synonyms=Glur4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=2166337; DOI=10.1126/science.2166337;
RA   Keinaenen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A.,
RA   Sakmann B., Seeburg P.H.;
RT   "A family of AMPA-selective glutamate receptors.";
RL   Science 249:556-560(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1977421; DOI=10.1016/0896-6273(90)90213-Y;
RA   Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A.,
RA   Deneris E.S., Moll C., Borgmeyer U., Hollmann M., Heinemann S.F.;
RT   "Cloning of a novel glutamate receptor subunit, GluR5: expression in
RT   the nervous system during development.";
RL   Neuron 5:583-595(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1699275; DOI=10.1126/science.1699275;
RA   Sommer B., Keinaenen K., Verdoorn T.A., Wisden W., Burnashev N.,
RA   Herb A., Koehler M., Takagi T., Sakmann B., Seeburg P.H.;
RT   "Flip and flop: a cell-specific functional switch in glutamate-
RT   operated channels of the CNS.";
RL   Science 249:1580-1585(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=1372042;
RA   Gallo V., Upson L.M., Hayes W.P., Vyklicky L. Jr., Winters C.A.,
RA   Buonanno A.;
RT   "Molecular cloning and development analysis of a new glutamate
RT   receptor subunit isoform in cerebellum.";
RL   J. Neurosci. 12:1010-1023(1992).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION AT ASN-407 AND ASN-414,
RP   SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS OF ASN-407 AND
RP   ASN-414.
RX   PubMed=12603841; DOI=10.1046/j.1471-4159.2003.01611.x;
RA   Pasternack A., Coleman S.K., Fethiere J., Madden D.R., LeCaer J.P.,
RA   Rossier J., Pasternack M., Keinaenen K.;
RT   "Characterization of the functional role of the N-glycans in the AMPA
RT   receptor ligand-binding domain.";
RL   J. Neurochem. 84:1184-1192(2003).
RN   [6]
RP   INTERACTION WITH PRKCABP (ISOFORM 3).
RX   PubMed=10027300; DOI=10.1016/S0896-6273(00)80689-3;
RA   Xia J., Zhang X., Staudinger J., Huganir R.L.;
RT   "Clustering of AMPA receptors by the synaptic PDZ domain-containing
RT   protein PICK1.";
RL   Neuron 22:179-187(1999).
RN   [7]
RP   PHOSPHORYLATION AT SER-862, INTERACTION WITH PRKCG, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12471040; DOI=10.1074/jbc.M205587200;
RA   Correia S.S., Duarte C.B., Faro C.J., Pires E.V., Carvalho A.L.;
RT   "Protein kinase C gamma associates directly with the GluR4 alpha-
RT   amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit.
RT   Effect on receptor phosphorylation.";
RL   J. Biol. Chem. 278:6307-6313(2003).
RN   [8]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH EPB41L1.
RX   PubMed=12574408;
RA   Coleman S.K., Cai C., Mottershead D.G., Haapalahti J.-P.,
RA   Keinaenen K.;
RT   "Surface expression of GluR-D AMPA receptor is dependent on an
RT   interaction between its C-terminal domain and a 4.1 protein.";
RL   J. Neurosci. 23:798-806(2003).
RN   [9]
RP   INTERACTION WITH CACNG5.
RX   PubMed=18817736; DOI=10.1016/j.neuron.2008.07.034;
RA   Kato A.S., Siuda E.R., Nisenbaum E.S., Bredt D.S.;
RT   "AMPA receptor subunit-specific regulation by a distinct family of
RT   type II TARPs.";
RL   Neuron 59:986-996(2008).
RN   [10]
RP   INTERACTION WITH CACNG5.
RX   PubMed=19234459; DOI=10.1038/nn.2266;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M.,
RA   Cull-Candy S.G.;
RT   "Selective regulation of long-form calcium-permeable AMPA receptors by
RT   an atypical TARP, gamma-5.";
RL   Nat. Neurosci. 12:277-285(2009).
RN   [11]
RP   ERRATUM.
RX   DOI=10.1038/nn0609-808c;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M.,
RA   Cull-Candy S.G.;
RL   Nat. Neurosci. 12:808-808(2009).
RN   [12]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19265014; DOI=10.1126/science.1167852;
RA   Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B.,
RA   Chisaka O., Jonas P., Schulte U., Fakler B., Kloecker N.;
RT   "Functional proteomics identify cornichon proteins as auxiliary
RT   subunits of AMPA receptors.";
RL   Science 323:1313-1319(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 416-795 IN COMPLEX WITH
RP   GLUTAMATE AND DIHYDROKAINIC ACID, FUNCTION, AND SUBUNIT.
RX   PubMed=19102704; DOI=10.1021/bi8013196;
RA   Gill A., Birdsey-Benson A., Jones B.L., Henderson L.P., Madden D.R.;
RT   "Correlating AMPA receptor activation and cleft closure across
RT   subunits: crystal structures of the GluR4 ligand-binding domain in
RT   complex with full and partial agonists.";
RL   Biochemistry 47:13831-13841(2008).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 415-796 IN COMPLEX WITH
RP   GLUTAMATE, AMPA BINDING, AND DISULFIDE BOND.
RX   PubMed=19022251; DOI=10.1016/j.febslet.2008.11.005;
RA   Kasper C., Frydenvang K., Naur P., Gajhede M., Pickering D.S.,
RA   Kastrup J.S.;
RT   "Molecular mechanism of agonist recognition by the ligand-binding core
RT   of the ionotropic glutamate receptor 4.";
RL   FEBS Lett. 582:4089-4094(2008).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 416-795 IN COMPLEX WITH
RP   GLUTAMATE AND DIHYDROKAINIC ACID, AND FUNCTION.
RX   PubMed=20107073; DOI=10.1523/JNEUROSCI.4558-09.2010;
RA   Birdsey-Benson A., Gill A., Henderson L.P., Madden D.R.;
RT   "Enhanced efficacy without further cleft closure: reevaluating twist
RT   as a source of agonist efficacy in AMPA receptors.";
RL   J. Neurosci. 30:1463-1470(2010).
CC   -!- FUNCTION: Receptor for glutamate that functions as ligand-gated
CC       ion channel in the central nervous system and plays an important
CC       role in excitatory synaptic transmission. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. Binding of the excitatory neurotransmitter L-
CC       glutamate induces a conformation change, leading to the opening of
CC       the cation channel, and thereby converts the chemical signal to an
CC       electrical impulse. The receptor then desensitizes rapidly and
CC       enters a transient inactive state, characterized by the presence
CC       of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8,
CC       shows resensitization which is characterized by a delayed
CC       accumulation of current flux upon continued application of
CC       glutamate (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:12603841, ECO:0000269|PubMed:19102704,
CC       ECO:0000269|PubMed:20107073}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits. Tetramers may be formed by the dimerization of
CC       dimers. Interacts with EPB41L1 via its C-terminus. Isoform 3
CC       interacts with PRKCABP. Found in a complex with GRIA1, GRIA2,
CC       GRIA3, CNIH2, CNIH3, CACNG2, CACNG3, CACNG4, CACNG5, CACNG7 and
CC       CACNG8. Interacts with CACNG5 and PRKCG.
CC       {ECO:0000269|PubMed:12471040, ECO:0000269|PubMed:12574408,
CC       ECO:0000269|PubMed:18817736, ECO:0000269|PubMed:19022251,
CC       ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:19234459,
CC       ECO:0000269|PubMed:19265014, ECO:0000269|PubMed:20107073}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-7761834, EBI-7761834;
CC       P19491-2:Gria2; NbExp=2; IntAct=EBI-15852899, EBI-15817825;
CC       P97879:Grip1; NbExp=3; IntAct=EBI-7761834, EBI-936113;
CC       P49185:Mapk8; NbExp=2; IntAct=EBI-7761834, EBI-7456505;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein. Cell projection, dendrite. Note=Interaction with
CC       CNIH2, CNIH3 and PRKCG promotes cell surface expression.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Flop;
CC         IsoId=P19493-1; Sequence=Displayed;
CC       Name=2; Synonyms=Flip;
CC         IsoId=P19493-2; Sequence=VSP_000123, VSP_000124, VSP_000125;
CC       Name=3; Synonyms=4C flop;
CC         IsoId=P19493-3; Sequence=VSP_000126;
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum (at protein level).
CC   -!- DOMAIN: The M4 transmembrane segment mediates tetramerization and
CC       is required for cell surface expression. {ECO:0000250}.
CC   -!- PTM: Palmitoylated. Depalmitoylated upon glutamate stimulation.
CC       Cys-611 palmitoylation leads to Golgi retention and decreased cell
CC       surface expression. In contrast, Cys-837 palmitoylation does not
CC       affect cell surface expression but regulates stimulation-dependent
CC       endocytosis (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Ser-862 by PRKCG; phosphorylation increases
CC       plasma membrane-associated GRI4 expression.
CC       {ECO:0000269|PubMed:12471040}.
CC   -!- MISCELLANEOUS: The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds AMPA (quisqualate) > glutamate >
CC       kainate.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIA4 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M36421; AAA41246.1; -; mRNA.
DR   EMBL; M85037; AAA41242.1; -; mRNA.
DR   EMBL; M38063; AAA63481.1; -; mRNA.
DR   EMBL; S94371; AAB21763.1; -; mRNA.
DR   PIR; A44839; A44839.
DR   PIR; D40170; D40170.
DR   RefSeq; NP_001106655.1; NM_001113184.1.
DR   RefSeq; NP_058959.2; NM_017263.2.
DR   UniGene; Rn.10938; -.
DR   PDB; 3EN3; X-ray; 2.43 A; A=416-528, A=654-795.
DR   PDB; 3EPE; X-ray; 1.85 A; A/B=416-528, A/B=654-795.
DR   PDB; 3FAS; X-ray; 1.40 A; A/B=415-528, A/B=654-796.
DR   PDB; 3FAT; X-ray; 1.90 A; A/B/C=415-528, A/B/C=654-796.
DR   PDB; 3KEI; X-ray; 1.90 A; A/B=416-528, A/B=654-795.
DR   PDB; 3KFM; X-ray; 2.20 A; A=416-528, A=654-795.
DR   PDB; 4GPA; X-ray; 2.25 A; A=22-401.
DR   PDB; 5FWX; X-ray; 2.50 A; B/D=22-401.
DR   PDBsum; 3EN3; -.
DR   PDBsum; 3EPE; -.
DR   PDBsum; 3FAS; -.
DR   PDBsum; 3FAT; -.
DR   PDBsum; 3KEI; -.
DR   PDBsum; 3KFM; -.
DR   PDBsum; 4GPA; -.
DR   PDBsum; 5FWX; -.
DR   ProteinModelPortal; P19493; -.
DR   SMR; P19493; -.
DR   BioGrid; 248252; 1.
DR   CORUM; P19493; -.
DR   DIP; DIP-41142N; -.
DR   IntAct; P19493; 5.
DR   MINT; MINT-86166; -.
DR   STRING; 10116.ENSRNOP00000009542; -.
DR   BindingDB; P19493; -.
DR   ChEMBL; CHEMBL3505; -.
DR   TCDB; 1.A.10.1.2; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; P19493; -.
DR   PhosphoSitePlus; P19493; -.
DR   SwissPalm; P19493; -.
DR   UniCarbKB; P19493; -.
DR   PRIDE; P19493; -.
DR   GeneID; 29629; -.
DR   KEGG; rno:29629; -.
DR   UCSC; RGD:61863; rat. [P19493-1]
DR   CTD; 2893; -.
DR   RGD; 61863; Gria4.
DR   HOGENOM; HOG000234372; -.
DR   HOVERGEN; HBG051839; -.
DR   InParanoid; P19493; -.
DR   KO; K05200; -.
DR   PhylomeDB; P19493; -.
DR   EvolutionaryTrace; P19493; -.
DR   PRO; PR:P19493; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:ARUK-UCL.
DR   GO; GO:1903561; C:extracellular vesicle; ISO:RGD.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; TAS:UniProtKB.
DR   GO; GO:0032983; C:kainate selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IMP:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; IMP:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IMP:UniProtKB.
DR   GO; GO:0050803; P:regulation of synapse structure or activity; TAS:UniProtKB.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    902       Glutamate receptor 4.
FT                                /FTId=PRO_0000011540.
FT   TOPO_DOM     22    544       Extracellular. {ECO:0000250}.
FT   TRANSMEM    545    565       Helical. {ECO:0000250}.
FT   TOPO_DOM    566    592       Cytoplasmic. {ECO:0000250}.
FT   INTRAMEM    593    608       Helical; Pore-forming. {ECO:0000250}.
FT   INTRAMEM    609    611       {ECO:0000250}.
FT   TOPO_DOM    612    617       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM    618    638       Helical. {ECO:0000250}.
FT   TOPO_DOM    639    813       Extracellular. {ECO:0000250}.
FT   TRANSMEM    814    834       Helical; Name=M4. {ECO:0000250}.
FT   TOPO_DOM    835    902       Cytoplasmic. {ECO:0000250}.
FT   REGION      500    502       Glutamate binding.
FT   REGION      676    677       Glutamate binding.
FT   BINDING     472    472       Glutamate. {ECO:0000269|PubMed:19022251,
FT                                ECO:0000269|PubMed:19102704,
FT                                ECO:0000269|PubMed:20107073}.
FT   BINDING     507    507       Glutamate. {ECO:0000269|PubMed:19022251,
FT                                ECO:0000269|PubMed:19102704,
FT                                ECO:0000269|PubMed:20107073}.
FT   BINDING     727    727       Glutamate. {ECO:0000250}.
FT   MOD_RES     862    862       Phosphoserine; by PKC/PRKCG.
FT                                {ECO:0000269|PubMed:12471040}.
FT   LIPID       611    611       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID       837    837       S-palmitoyl cysteine. {ECO:0000250}.
FT   CARBOHYD     56     56       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    258    258       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    371    371       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12603841}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12603841}.
FT   DISULFID     84    331       {ECO:0000250}.
FT   DISULFID    740    795       {ECO:0000269|PubMed:19022251}.
FT   VAR_SEQ     765    767       GNA -> RTP (in isoform 2).
FT                                {ECO:0000303|PubMed:1699275,
FT                                ECO:0000303|PubMed:1977421}.
FT                                /FTId=VSP_000123.
FT   VAR_SEQ     776    780       NEQGL -> SEAGV (in isoform 2).
FT                                {ECO:0000303|PubMed:1699275,
FT                                ECO:0000303|PubMed:1977421}.
FT                                /FTId=VSP_000124.
FT   VAR_SEQ     797    801       SGGGD -> PKDSG (in isoform 2).
FT                                {ECO:0000303|PubMed:1699275,
FT                                ECO:0000303|PubMed:1977421}.
FT                                /FTId=VSP_000125.
FT   VAR_SEQ     849    902       LTFSEATRNKARLSITGSVGENGRVLTPDCPKAVHTGTAIR
FT                                QSSGLAVIASDLP -> VAKSAQTFNPTSSQNTHNLATYRE
FT                                GYNVYGTESIKI (in isoform 3).
FT                                {ECO:0000303|PubMed:1372042}.
FT                                /FTId=VSP_000126.
FT   MUTAGEN     407    407       N->Q: No effect on surface expression and
FT                                channel activity; when associated with Q-
FT                                414. {ECO:0000269|PubMed:12603841}.
FT   MUTAGEN     414    414       N->Q: No effect on surface expression and
FT                                channel activity; when associated with Q-
FT                                407. {ECO:0000269|PubMed:12603841}.
FT   CONFLICT    111    112       SA -> RR (in Ref. 2; AAA41242).
FT                                {ECO:0000305}.
FT   CONFLICT    454    454       I -> S (in Ref. 2; AAA41242).
FT                                {ECO:0000305}.
FT   CONFLICT    734    734       T -> I (in Ref. 2; AAA41242).
FT                                {ECO:0000305}.
FT   CONFLICT    855    855       T -> I (in Ref. 2; AAA41242).
FT                                {ECO:0000305}.
FT   STRAND       25     33       {ECO:0000244|PDB:4GPA}.
FT   HELIX        38     52       {ECO:0000244|PDB:4GPA}.
FT   TURN         57     59       {ECO:0000244|PDB:4GPA}.
FT   STRAND       61     70       {ECO:0000244|PDB:4GPA}.
FT   HELIX        76     88       {ECO:0000244|PDB:4GPA}.
FT   STRAND       92     96       {ECO:0000244|PDB:4GPA}.
FT   TURN        100    102       {ECO:0000244|PDB:4GPA}.
FT   HELIX       103    112       {ECO:0000244|PDB:4GPA}.
FT   STRAND      116    119       {ECO:0000244|PDB:4GPA}.
FT   STRAND      129    133       {ECO:0000244|PDB:4GPA}.
FT   HELIX       139    148       {ECO:0000244|PDB:4GPA}.
FT   STRAND      153    158       {ECO:0000244|PDB:4GPA}.
FT   HELIX       165    175       {ECO:0000244|PDB:4GPA}.
FT   TURN        176    178       {ECO:0000244|PDB:4GPA}.
FT   STRAND      180    185       {ECO:0000244|PDB:4GPA}.
FT   HELIX       191    204       {ECO:0000244|PDB:4GPA}.
FT   STRAND      208    212       {ECO:0000244|PDB:4GPA}.
FT   HELIX       215    228       {ECO:0000244|PDB:4GPA}.
FT   STRAND      236    239       {ECO:0000244|PDB:4GPA}.
FT   STRAND      241    243       {ECO:0000244|PDB:4GPA}.
FT   HELIX       244    246       {ECO:0000244|PDB:4GPA}.
FT   HELIX       250    255       {ECO:0000244|PDB:4GPA}.
FT   STRAND      258    263       {ECO:0000244|PDB:4GPA}.
FT   HELIX       270    279       {ECO:0000244|PDB:4GPA}.
FT   TURN        284    286       {ECO:0000244|PDB:4GPA}.
FT   TURN        288    291       {ECO:0000244|PDB:4GPA}.
FT   HELIX       296    317       {ECO:0000244|PDB:4GPA}.
FT   HELIX       342    350       {ECO:0000244|PDB:4GPA}.
FT   STRAND      353    356       {ECO:0000244|PDB:4GPA}.
FT   STRAND      359    363       {ECO:0000244|PDB:4GPA}.
FT   STRAND      367    369       {ECO:0000244|PDB:5FWX}.
FT   STRAND      373    380       {ECO:0000244|PDB:4GPA}.
FT   STRAND      383    391       {ECO:0000244|PDB:4GPA}.
FT   TURN        392    394       {ECO:0000244|PDB:4GPA}.
FT   STRAND      395    398       {ECO:0000244|PDB:4GPA}.
FT   STRAND      416    421       {ECO:0000244|PDB:3FAS}.
FT   TURN        425    427       {ECO:0000244|PDB:3FAS}.
FT   STRAND      428    430       {ECO:0000244|PDB:3FAS}.
FT   HELIX       434    436       {ECO:0000244|PDB:3FAS}.
FT   HELIX       439    442       {ECO:0000244|PDB:3FAS}.
FT   STRAND      443    445       {ECO:0000244|PDB:3FAS}.
FT   HELIX       446    458       {ECO:0000244|PDB:3FAS}.
FT   STRAND      461    466       {ECO:0000244|PDB:3FAS}.
FT   TURN        477    479       {ECO:0000244|PDB:3FAS}.
FT   HELIX       484    490       {ECO:0000244|PDB:3FAS}.
FT   STRAND      495    497       {ECO:0000244|PDB:3FAS}.
FT   HELIX       505    508       {ECO:0000244|PDB:3FAS}.
FT   STRAND      511    513       {ECO:0000244|PDB:3FAS}.
FT   STRAND      517    520       {ECO:0000244|PDB:3FAS}.
FT   STRAND      522    527       {ECO:0000244|PDB:3FAS}.
FT   HELIX       658    662       {ECO:0000244|PDB:3FAS}.
FT   STRAND      665    670       {ECO:0000244|PDB:3FAS}.
FT   HELIX       676    683       {ECO:0000244|PDB:3FAS}.
FT   HELIX       687    698       {ECO:0000244|PDB:3FAS}.
FT   STRAND      705    707       {ECO:0000244|PDB:3FAS}.
FT   HELIX       708    717       {ECO:0000244|PDB:3FAS}.
FT   TURN        718    720       {ECO:0000244|PDB:3FAS}.
FT   STRAND      721    727       {ECO:0000244|PDB:3FAS}.
FT   HELIX       728    735       {ECO:0000244|PDB:3FAS}.
FT   STRAND      742    746       {ECO:0000244|PDB:3FAS}.
FT   STRAND      752    754       {ECO:0000244|PDB:3FAS}.
FT   STRAND      757    759       {ECO:0000244|PDB:3FAS}.
FT   HELIX       765    777       {ECO:0000244|PDB:3FAS}.
FT   HELIX       780    789       {ECO:0000244|PDB:3FAS}.
FT   TURN        790    792       {ECO:0000244|PDB:3FAS}.
SQ   SEQUENCE   902 AA;  100758 MW;  873D1B4C710C4459 CRC64;
     MRIICRQIVL LFSGFWGLAM GAFPSSVQIG GLFIRNTDQE YTAFRLAIFL HNTSPNASEA
     PFNLVPHVDN IETANSFAVT NAFCSQYSRG VFAIFGLYDK RSVHTLTSFC SALHISLITP
     SFPTEGESQF VLQLRPSLRG ALLSLLDHYE WNCFVFLYDT DRGYSILQAI MEKAGQNGWH
     VSAICVENFN DVSYRQLLEE LDRRQEKKFV IDCEIERLQN ILEQIVSVGK HVKGYHYIIA
     NLGFKDISLE RFIHGGANVT GFQLVDFNTP MVTKLMDRWK KLDQREYPGS ETPPKYTSAL
     TYDGVLVMAE TFRSLRRQKI DISRRGNAGD CLANPAAPWG QGIDMERTLK QVRIQGLTGN
     VQFDHYGRRV NYTMDVFELK STGPRKVGYW NDMDKLVLIQ DMPTLGNDTA AIENRTVVVT
     TIMESPYVMY KKNHEMFEGN DKYEGYCVDL ASEIAKHIGI KYKIAIVPDG KYGARDADTK
     IWNGMVGELV YGKAEIAIAP LTITLVREEV IDFSKPFMSL GISIMIKKPQ KSKPGVFSFL
     DPLAYEIWMC IVFAYIGVSV VLFLVSRFSP YEWHTEEPED GKEGPSDQPP NEFGIFNSLW
     FSLGAFMQQG CDISPRSLSG RIVGGVWWFF TLIIISSYTA NLAAFLTVER MVSPIESAED
     LAKQTEIAYG TLDSGSTKEF FRRSKIAVYE KMWTYMRSAE PSVFTRTTAE GVARVRKSKG
     KFAFLLESTM NEYTEQRKPC DTMKVGGNLD SKGYGVATPK GSSLGNAVNL AVLKLNEQGL
     LDKLKNKWWY DKGECGSGGG DSKDKTSALS LSNVAGVFYI LVGGLGLAML VALIEFCYKS
     RAEAKRMKLT FSEATRNKAR LSITGSVGEN GRVLTPDCPK AVHTGTAIRQ SSGLAVIASD
     LP
//
ID   RYR1_HUMAN              Reviewed;        5038 AA.
AC   P21817; Q16314; Q16368; Q9NPK1; Q9P1U4;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 3.
DT   20-DEC-2017, entry version 207.
DE   RecName: Full=Ryanodine receptor 1;
DE            Short=RYR-1;
DE            Short=RyR1;
DE   AltName: Full=Skeletal muscle calcium release channel;
DE   AltName: Full=Skeletal muscle ryanodine receptor;
DE   AltName: Full=Skeletal muscle-type ryanodine receptor;
DE   AltName: Full=Type 1 ryanodine receptor;
GN   Name=RYR1; Synonyms=RYDR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Skeletal muscle;
RX   PubMed=2298749;
RA   Zorzato F., Fujii J., Otsu K., Phillips M.S., Green N.M., Lai F.A.,
RA   Meissner G., Maclennan D.H.;
RT   "Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+
RT   release channel (ryanodine receptor) of skeletal muscle sarcoplasmic
RT   reticulum.";
RL   J. Biol. Chem. 265:2244-2256(1990).
RN   [2]
RP   SEQUENCE REVISION TO 2324; 2840 AND 3380, INVOLVEMENT IN MHS1, VARIANT
RP   MHS1 ARG-248, AND VARIANTS CYS-471; LEU-1787; CYS-2060 AND VAL-2550.
RC   TISSUE=Muscle;
RX   PubMed=1354642; DOI=10.1016/0888-7543(92)90042-Q;
RA   Gillard E.F., Otsu K., Fujii J., Duff C.L., de Leon S., Khanna V.K.,
RA   Britt B.A., Worton R.G., McLennan D.H.;
RT   "Polymorphisms and deduced amino acid substitutions in the coding
RT   sequence of the ryanodine receptor (RYR1) gene in individuals with
RT   malignant hyperthermia.";
RL   Genomics 13:1247-1254(1992).
RN   [3]
RP   SEQUENCE REVISION TO 1365-1368, VARIANT CCD HIS-2435, AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Muscle;
RX   PubMed=8220422; DOI=10.1038/ng0993-46;
RA   Zhang Y., Chen H.S., Khanna V.K., de Leon S., Phillips M.S.,
RA   Schappert K.T., Britt B.A., Brownell A.K.W., McLennan D.H.;
RT   "A mutation in the human ryanodine receptor gene associated with
RT   central core disease.";
RL   Nat. Genet. 5:46-50(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS
RP   ALA-1832 AND VAL-2550.
RX   PubMed=8661021; DOI=10.1006/geno.1996.0238;
RA   Phillips M.S., Fujii J., Khanna V.K., de Leon S., Yokobata K.,
RA   de Jong P.J., McLennan D.H.;
RT   "The structural organization of the human skeletal muscle ryanodine
RT   receptor (RYR1) gene.";
RL   Genomics 34:24-41(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 598-722.
RC   TISSUE=Skeletal muscle;
RX   PubMed=1639409; DOI=10.1016/0888-7543(92)90163-M;
RA   Otsu K., Phillips M.S., Khanna V.K., de Leon S., McLennan D.H.;
RT   "Refinement of diagnostic assays for a probable causal mutation for
RT   porcine and human malignant hyperthermia.";
RL   Genomics 13:835-837(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 603-641, AND VARIANT MHS1
RP   CYS-614.
RX   PubMed=1774074; DOI=10.1016/0888-7543(91)90084-R;
RA   Gillard E.F., Otsu K., Fujii J., Khanna V.K., de Leon S.,
RA   Derdemezi J., Britt B.A., Duff C.L., Worton R.G., MacLennan D.H.;
RT   "A substitution of cysteine for arginine 614 in the ryanodine receptor
RT   is potentially causative of human malignant hyperthermia.";
RL   Genomics 11:751-755(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 603-627, AND VARIANT MHS1
RP   CYS-614.
RX   PubMed=7751854; DOI=10.1007/BF00936884;
RA   Moroni I., Gonano E.F., Comi G.P., Tegazzin V., Prelle A., Bordoni A.,
RA   Bresolin N., Scarlato G.;
RT   "Ryanodine receptor gene point mutation and malignant hyperthermia
RT   susceptibility.";
RL   J. Neurol. 242:127-133(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4696-4974, AND SUBCELLULAR LOCATION.
RC   TISSUE=Myometrium;
RX   PubMed=7556644; DOI=10.1016/0014-5793(95)00924-X;
RA   Lynn S., Morgan J.M., Lamb H.K., Meissner G., Gillespie J.I.;
RT   "Isolation and partial cloning of ryanodine-sensitive Ca2+ release
RT   channel protein isoforms from human myometrial smooth muscle.";
RL   FEBS Lett. 372:6-12(1995).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=9607712; DOI=10.1016/S0306-4522(97)00612-X;
RA   Martin C., Chapman K.E., Seckl J.R., Ashley R.H.;
RT   "Partial cloning and differential expression of ryanodine
RT   receptor/calcium-release channel genes in human tissues including the
RT   hippocampus and cerebellum.";
RL   Neuroscience 85:205-216(1998).
RN   [11]
RP   INTERACTION WITH CALM AND S100A1, AND ENZYME REGULATION.
RX   PubMed=18650434; DOI=10.1074/jbc.M804432200;
RA   Wright N.T., Prosser B.L., Varney K.M., Zimmer D.B., Schneider M.F.,
RA   Weber D.J.;
RT   "S100A1 and calmodulin compete for the same binding site on ryanodine
RT   receptor.";
RL   J. Biol. Chem. 283:26676-26683(2008).
RN   [12]
RP   FUNCTION, PHOSPHORYLATION AT SER-2843, S-NITROSYLATION, AND
RP   IDENTIFICATION IN A COMPLEX WITH PDE4D; PKA; FKBP1A AND PROTEIN
RP   PHOSPHATASE 1.
RX   PubMed=18268335; DOI=10.1073/pnas.0711074105;
RA   Bellinger A.M., Reiken S., Dura M., Murphy P.W., Deng S.X.,
RA   Landry D.W., Nieman D., Lehnart S.E., Samaru M., LaCampagne A.,
RA   Marks A.R.;
RT   "Remodeling of ryanodine receptor complex causes 'leaky' channels: a
RT   molecular mechanism for decreased exercise capacity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2198-2202(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-4864 AND SER-4867, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   REVIEW.
RX   PubMed=20961976; DOI=10.1101/cshperspect.a003996;
RA   Lanner J.T., Georgiou D.K., Joshi A.D., Hamilton S.L.;
RT   "Ryanodine receptors: structure, expression, molecular details, and
RT   function in calcium release.";
RL   Cold Spring Harb. Perspect. Biol. 2:E3996-E3996(2010).
RN   [15]
RP   INVOLVEMENT IN SAMARITAN MYOPATHY, AND VARIANT CYS-1088.
RX   PubMed=22752422; DOI=10.1007/s00401-012-1007-3;
RA   Bohm J., Leshinsky-Silver E., Vassilopoulos S., Le Gras S.,
RA   Lerman-Sagie T., Ginzberg M., Jost B., Lev D., Laporte J.;
RT   "Samaritan myopathy, an ultimately benign congenital myopathy, is
RT   caused by a RYR1 mutation.";
RL   Acta Neuropathol. 124:575-581(2012).
RN   [16]
RP   VARIANTS CCD CYS-163 AND MET-403, AND VARIANTS MHS1 CYS-163 AND
RP   MET-403.
RX   PubMed=8220423; DOI=10.1038/ng0993-51;
RA   Quane K.A., Healy J.M.S., Keating K.E., Manning B.M., Couch F.J.,
RA   Palmucci L.M., Doriguzzi C., Fagerlund T.H., Berg K., Ording H.,
RA   Bendixen D., Mortier W., Linz U., Muller C.R., McCarthy T.V.;
RT   "Mutations in the ryanodine receptor gene in central core disease and
RT   malignant hyperthermia.";
RL   Nat. Genet. 5:51-55(1993).
RN   [17]
RP   VARIANT CCD SER-522.
RX   PubMed=7829078; DOI=10.1006/geno.1994.1483;
RA   Quane K.A., Keating K.E., Healy J.M.S., Manning B.M.,
RA   Krivosic-Horber R., Krivosic I., Monnier N., Lunardi J.,
RA   McCarthy T.V.;
RT   "Mutation screening of the RYR1 gene in malignant hyperthermia:
RT   detection of a novel Tyr to Ser mutation in a pedigree with associated
RT   central cores.";
RL   Genomics 23:236-239(1994).
RN   [18]
RP   VARIANT MHS1 ARG-341.
RX   PubMed=8012359; DOI=10.1093/hmg/3.3.471;
RA   Quane K.A., Keating K.E., Manning B.M., Healy J.M.S., Monsieurs K.,
RA   Heffron J.J.A., Lehane M., Heytens L., Krivosic-Horber R., Adnet P.,
RA   Ellis F.R., Monnier N., Lunardi J., McCarthy T.V.;
RT   "Detection of a novel common mutation in the ryanodine receptor gene
RT   in malignant hyperthermia: implications for diagnosis and
RT   heterogeneity studies.";
RL   Hum. Mol. Genet. 3:471-476(1994).
RN   [19]
RP   VARIANT MHS1 ARG-2434.
RX   PubMed=7849712; DOI=10.1093/hmg/3.10.1855;
RA   Keating K.E., Quane K.A., Manning B.M., Lehane M., Hartung E.,
RA   Censier K., Urwyler A., Klausnitzer M., Muller C.R., Heffron J.J.A.,
RA   McCarthy T.V.;
RT   "Detection of a novel RYR1 mutation in four malignant hyperthermia
RT   pedigrees.";
RL   Hum. Mol. Genet. 3:1855-1858(1994).
RN   [20]
RP   VARIANT MHS1 ARG-2434.
RX   PubMed=7881417; DOI=10.1093/hmg/3.12.2181;
RA   Phillips M.S., Khanna V.K., de Leon S., Frodis W., Britt B.A.,
RA   McLennan D.H.;
RT   "The substitution of Arg for Gly2433 in the human skeletal muscle
RT   ryanodine receptor is associated with malignant hyperthermia.";
RL   Hum. Mol. Genet. 3:2181-2186(1994).
RN   [21]
RP   VARIANT MHS1 ARG-35.
RX   PubMed=9066328; DOI=10.1097/00000542-199703000-00014;
RA   Lynch P.J., Krivosic-Horber R., Reyford H., Monnier N., Quane K.A.,
RA   Adnet P., Haudecoeur G., Krivosic I., McCarthy T.V., Lunardi J.;
RT   "Identification of heterozygous and homozygous individuals with the
RT   novel RYR1 mutation Cys35Arg in a large kindred.";
RL   Anesthesiology 86:620-626(1997).
RN   [22]
RP   VARIANT MHS1 LEU-614.
RX   PubMed=9389851; DOI=10.1093/bja/79.3.332;
RA   Quane K.A., Ording H., Keating K.E., Manning B.M., Heine R.,
RA   Bendixen D., Berg K., Krivosic-Horber R., Lehmann-Horn F.,
RA   Fagerlund T.H., McCarthy T.V.;
RT   "Detection of a novel mutation at amino acid position 614 in the
RT   ryanodine receptor in malignant hyperthermia.";
RL   Br. J. Anaesth. 79:332-337(1997).
RN   [23]
RP   VARIANT MHS1 TRP-552.
RX   PubMed=9138151; DOI=10.1136/jmg.34.4.291;
RA   Keating K.E., Giblin L., Lynch P.J., Quane K.A., Lehane M.,
RA   Heffron J.J.A., McCarthy T.V.;
RT   "Detection of a novel mutation in the ryanodine receptor gene in an
RT   Irish malignant hyperthermia pedigree: correlation of the IVCT
RT   response with the affected and unaffected haplotypes.";
RL   J. Med. Genet. 34:291-296(1997).
RN   [24]
RP   VARIANTS MHS1 CYS-2163; MET-2168 AND MET-2206, AND VARIANT CCD/MHS1
RP   HIS-2163.
RX   PubMed=9497245; DOI=10.1086/301748;
RA   Manning B.M., Quane K.A., Ording H., Urwyler A., Tegazzin V.,
RA   Lehane M., O'Halloran J., Hartung E., Giblin L.M., Lynch P.J.,
RA   Vaughan P., Censier K., Bendixen D., Comi G.P., Heytens L.,
RA   Monsieurs K., Fagerlund T.H., Wolz W., Heffron J.J.A., Mueller C.R.,
RA   McCarthy T.V.;
RT   "Identification of novel mutations in the ryanodine-receptor gene
RT   (RYR1) in malignant hyperthermia: genotype-phenotype correlation.";
RL   Am. J. Hum. Genet. 62:599-609(1998).
RN   [25]
RP   VARIANTS MHS1 CYS-2458 AND HIS-2458.
RX   PubMed=9450902;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.3.CO;2-H;
RA   Manning B.M., Quane K.A., Lynch P.J., Urwyler A., Tegazzin V.,
RA   Krivosic-Horber R., Censier K., Comi G.P., Adnet P., Wolz W.,
RA   Lunardi J., Muller C.R., McCarthy T.V.;
RT   "Novel mutations at a CpG dinucleotide in the ryanodine receptor in
RT   malignant hyperthermia.";
RL   Hum. Mutat. 11:45-50(1998).
RN   [26]
RP   VARIANTS MHS1.
RX   PubMed=10484775; DOI=10.1093/hmg/8.11.2055;
RA   Brandt A., Schleithoff L., Jurkat-Rott K., Klingler W., Baur C.,
RA   Lehmann-Horn F.;
RT   "Screening of the ryanodine receptor gene in 105 malignant
RT   hyperthermia families: novel mutations and concordance with the in
RT   vitro contracture test.";
RL   Hum. Mol. Genet. 8:2055-2062(1999).
RN   [27]
RP   VARIANTS MHS1 LEU-2435 AND HIS-2454.
RX   PubMed=10051009;
RA   Barone V., Massa O., Intravaia E., Bracco A., Di Martino A.,
RA   Tegazzin V., Cozzolino S., Sorrentino V.;
RT   "Mutation screening of the RYR1 gene and identification of two novel
RT   mutations in Italian malignant hyperthermia families.";
RL   J. Med. Genet. 36:115-118(1999).
RN   [28]
RP   VARIANT CCD THR-4898, AND CHARACTERIZATION OF VARIANT CCD THR-4898.
RX   PubMed=10097181; DOI=10.1073/pnas.96.7.4164;
RA   Lynch P.J., Tong J., Lehane M., Mallet A., Giblin L., Heffron J.J.A.,
RA   Vaughan P., Zafra G., MacLennan D.H., McCarthy T.V.;
RT   "A mutation in the transmembrane/luminal domain of the ryanodine
RT   receptor is associated with abnormal Ca(2+) release channel function
RT   and severe central core disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4164-4169(1999).
RN   [29]
RP   VARIANTS MHS1 TRP-2452 AND HIS-2454.
RX   PubMed=10823104; DOI=10.1093/oxfordjournals.bja.a013478;
RA   Chamley D., Pollock N.A., Stowell K.M., Brown R.L.;
RT   "Malignant hyperthermia in infancy and identification of novel RYR1
RT   mutation.";
RL   Br. J. Anaesth. 84:500-504(2000).
RN   [30]
RP   VARIANT MHS1 ILE-4826.
RX   PubMed=10888602; DOI=10.1093/hmg/9.10.1515;
RA   Brown R.L., Pollock A.N., Couchman K.G., Hodges M., Hutchinson D.O.,
RA   Waaka R., Lynch P., McCarthy T.V., Stowell K.M.;
RT   "A novel ryanodine receptor mutation and genotype-phenotype
RT   correlation in a large malignant hyperthermia New Zealand Maori
RT   pedigree.";
RL   Hum. Mol. Genet. 9:1515-1524(2000).
RN   [31]
RP   VARIANT MHS1 CYS-2454.
RX   PubMed=10612851;
RX   DOI=10.1002/(SICI)1098-1004(200001)15:1<122::AID-HUMU40>3.0.CO;2-A;
RA   Gencik M., Gencik A., Mortier W., Epplen J.T.;
RT   "Novel mutation in the RYR1 gene (R2454C) in a patient with malignant
RT   hyperthermia.";
RL   Hum. Mutat. 15:122-122(2000).
RN   [32]
RP   VARIANT CCD ALA-4637.
RX   PubMed=11113224; DOI=10.1212/WNL.55.11.1689;
RA   Scacheri P.C., Hoffman E.P., Fratkin J.D., Semino-Mora C., Senchak A.,
RA   Davis M.R., Laing N.G., Vedanarayanan V., Subramony S.H.;
RT   "A novel ryanodine receptor gene mutation causing both cores and rods
RT   in congenital myopathy.";
RL   Neurology 55:1689-1696(2000).
RN   [33]
RP   VARIANT MHS1 GLU-2347 DEL.
RX   PubMed=11389482; DOI=10.1086/321270;
RA   Sambuughin N., McWilliams S., de Bantel A., Sivakumar K., Nelson T.E.;
RT   "Single-amino-acid deletion in the RYR1 gene, associated with
RT   malignant hyperthermia susceptibility and unusual contraction
RT   phenotype.";
RL   Am. J. Hum. Genet. 69:204-208(2001).
RN   [34]
RP   VARIANTS MHS1 CYS-163; ARG-248; CYS-614; MET-2168; MET-2206; ILE-2214;
RP   THR-2367; ASN-2431; ARG-2434 AND HIS-2454.
RX   PubMed=11575529; DOI=10.1097/00000542-200109000-00009;
RA   Sambuughin N., Sei Y., Gallagher K.L., Wyre H.W., Madsen D.,
RA   Nelson T.E., Fletcher J.E., Rosenberg H., Muldoon S.M.;
RT   "North American malignant hyperthermia population: screening of the
RT   ryanodine receptor gene and identification of novel mutations.";
RL   Anesthesiology 95:594-599(2001).
RN   [35]
RP   VARIANTS CCD MET-2168; 4214-ARG--4216-PHE DEL; 4647-LEU-SER-4648 DEL;
RP   PRO-4793; CYS-4796; CYS-4825; PHE-4860 DEL; HIS-4861; TRP-4893;
RP   THR-4898; GLU-4899 AND GLY-4914.
RX   PubMed=11709545; DOI=10.1093/hmg/10.22.2581;
RA   Monnier N., Romero N.B., Lerale J., Landrieu P., Nivoche Y.,
RA   Fardeau M., Lunardi J.;
RT   "Familial and sporadic forms of central core disease are associated
RT   with mutations in the C-terminal domain of the skeletal muscle
RT   ryanodine receptor.";
RL   Hum. Mol. Genet. 10:2581-2592(2001).
RN   [36]
RP   VARIANTS CCD HIS-4861; ARG-4891; THR-4898; ARG-4899 AND VAL-4906,
RP   CHARACTERIZATION OF VARIANTS CCD MET-2168; HIS-4861; TRP-4893;
RP   THR-4898 AND ARG-4899, AND FUNCTION.
RX   PubMed=11741831; DOI=10.1093/hmg/10.25.2879;
RA   Tilgen N., Zorzato F., Halliger-Keller B., Muntoni F., Sewry C.,
RA   Palmucci L.M., Schneider C., Hauser E., Lehmann-Horn F., Mueller C.R.,
RA   Treves S.;
RT   "Identification of four novel mutations in the C-terminal membrane
RT   spanning domain of the ryanodine receptor 1: association with central
RT   core disease and alteration of calcium homeostasis.";
RL   Hum. Mol. Genet. 10:2879-2887(2001).
RN   [37]
RP   VARIANT MHS1 GLU-2129.
RX   PubMed=11241852; DOI=10.1002/humu.15;
RA   Rueffert H., Kraus H., Olthoff D., Deutrich C., Froster U.G.;
RT   "Identification of a novel mutation in the ryanodine receptor gene
RT   (RYR1) in patients with malignant hyperthermia.";
RL   Hum. Mutat. 17:238-238(2001).
RN   [38]
RP   VARIANT MHS1 THR-2350, AND CHARACTERIZATION OF VARIANT MHS1 THR-2350.
RX   PubMed=11525881; DOI=10.1016/S0960-8966(01)00202-4;
RA   Sambuughin N., Nelson T.E., Jankovic J., Xin C., Meissner G.,
RA   Mullakandov M., Ji J., Rosenberg H., Sivakumar K., Goldfarb L.G.;
RT   "Identification and functional characterization of a novel ryanodine
RT   receptor mutation causing malignant hyperthermia in North American and
RT   South American families.";
RL   Neuromuscul. Disord. 11:530-537(2001).
RN   [39]
RP   VARIANTS MHS1 CYS-163; ASN-166; ARG-341; HIS-401; CYS-614; GLU-2129;
RP   MET-2168; MET-2206; THR-2428; ARG-2434; HIS-2435; TRP-2452 AND
RP   HIS-2454.
RX   PubMed=12059893; DOI=10.1034/j.1399-6576.2002.460610.x;
RA   Rueffert H., Olthoff D., Deutrich C., Meinecke C.D., Froster U.G.;
RT   "Mutation screening in the ryanodine receptor 1 gene (RYR1) in
RT   patients susceptible to malignant hyperthermia who show definite IVCT
RT   results: identification of three novel mutations.";
RL   Acta Anaesthesiol. Scand. 46:692-698(2002).
RN   [40]
RP   VARIANTS MHS1 CYS-163; ARG-341; CYS-614; CYS-2454; MET-3916 AND
RP   LEU-4973.
RX   PubMed=12411788; DOI=10.1097/00000542-200211000-00007;
RA   Monnier N., Krivosic-Horber R., Payen J.-F., Kozak-Ribbens G.,
RA   Nivoche Y., Adnet P., Reyford H., Lunardi J.;
RT   "Presence of two different genetic traits in malignant hyperthermia
RT   families: implication for genetic analysis, diagnosis, and incidence
RT   of malignant hyperthermia susceptibility.";
RL   Anesthesiology 97:1067-1074(2002).
RN   [41]
RP   VARIANT CCD SER-3527.
RX   PubMed=12112081; DOI=10.1002/ana.10231;
RA   Ferreiro A., Monnier N., Romero N.B., Leroy J.-P., Boennemann C.,
RA   Haenggeli C.-A., Straub V., Voss W.D., Nivoche Y., Jungbluth H.,
RA   Lemainque A., Voit T., Lunardi J., Fardeau M., Guicheney P.;
RT   "A recessive form of central core disease, transiently presenting as
RT   multi-minicore disease, is associated with a homozygous mutation in
RT   the ryanodine receptor type 1 gene.";
RL   Ann. Neurol. 51:750-759(2002).
RN   [42]
RP   VARIANT MHS1 CYS-401.
RX   PubMed=12066726; DOI=10.1093/bja/88.4.508;
RA   Davis M., Brown R., Dickson A., Horton H., James D., Laing N.,
RA   Marston R., Norgate M., Perlman D., Pollock N., Stowell K.;
RT   "Malignant hyperthermia associated with exercise-induced
RT   rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation
RT   in New Zealand and Australian pedigrees.";
RL   Br. J. Anaesth. 88:508-515(2002).
RN   [43]
RP   VARIANTS MHS1 CYS-163; CYS-401; HIS-2163; MET-2206; ILE-2280;
RP   ARG-2434; LEU-2435; CYS-2458; SER-4136; LEU-4234; TRP-4737; VAL-4942
RP   AND LEU-4973.
RX   PubMed=12208234; DOI=10.1016/S0143-4160(02)00138-0;
RA   Galli L., Orrico A., Cozzolino S., Pietrini V., Tegazzin V.,
RA   Sorrentino V.;
RT   "Mutations in the RYR1 gene in Italian patients at risk for malignant
RT   hyperthermia: evidence for a cluster of novel mutations in the C-
RT   terminal region.";
RL   Cell Calcium 32:143-151(2002).
RN   [44]
RP   VARIANT MHS1 CYS-2355.
RX   PubMed=12123492; DOI=10.1034/j.1399-0004.2002.620111.x;
RA   McWilliams S., Nelson T., Sudo R.T., Zapata-Sudo G., Batti M.,
RA   Sambuughin N.;
RT   "Novel skeletal muscle ryanodine receptor mutation in a large
RT   Brazilian family with malignant hyperthermia.";
RL   Clin. Genet. 62:80-83(2002).
RN   [45]
RP   VARIANT MHS1 VAL-4838, AND VARIANTS ALA-1832; GLU-3756 AND SER-4668.
RX   PubMed=11928716; DOI=10.1254/jjp.88.159;
RA   Oyamada H., Oguchi K., Saitoh N., Yamazawa T., Hirose K., Kawana Y.,
RA   Wakatsuki K., Oguchi K., Tagami M., Hanaoka K., Endo M., Iino M.;
RT   "Novel mutations in C-terminal channel region of the ryanodine
RT   receptor in malignant hyperthermia patients.";
RL   Jpn. J. Pharmacol. 88:159-166(2002).
RN   [46]
RP   VARIANT CCD ILE-4849.
RX   PubMed=12136074; DOI=10.1212/WNL.59.2.284;
RA   Jungbluth H., Muller C.R., Halliger-Keller B., Brockington M.,
RA   Brown S.C., Feng L., Chattopadhyay A., Mercuri E., Manzur A.Y.,
RA   Ferreiro A., Laing N.G., Davis M.R., Roper H.P., Dubowitz V.,
RA   Bydder G., Sewry C.A., Muntoni F.;
RT   "Autosomal recessive inheritance of RYR1 mutations in a congenital
RT   myopathy with cores.";
RL   Neurology 59:284-287(2002).
RN   [47]
RP   VARIANT MHS1 TRP-328, AND CHARACTERIZATION OF VARIANT MHS1 TRP-328.
RX   PubMed=12883402; DOI=10.1097/00000542-200308000-00011;
RA   Loke J.C.P., Kraev N., Sharma P., Du G., Patel L., Kraev A.,
RA   MacLennan D.H.;
RT   "Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in
RT   a malignant hyperthermia family by sequencing of a leukocyte
RT   transcript.";
RL   Anesthesiology 99:297-302(2003).
RN   [48]
RP   VARIANTS CCD HIS-4861; CYS-4864; TRP-4893 AND THR-4940.
RX   PubMed=14670767; DOI=10.1136/adc.88.12.1051;
RA   Quinlivan R.M., Muller C.R., Davis M., Laing N.G., Evans G.A.,
RA   Dwyer J., Dove J., Roberts A.P., Sewry C.A.;
RT   "Central core disease: clinical, pathological, and genetic features.";
RL   Arch. Dis. Child. 88:1051-1055(2003).
RN   [49]
RP   VARIANTS CCD GLU-215; CYS-614; PRO-4650; GLN-4724 AND GLU-4899.
RX   PubMed=12937085; DOI=10.1093/brain/awg244;
RA   Romero N.B., Monnier N., Viollet L., Cortey A., Chevallay M.,
RA   Leroy J.P., Lunardi J., Fardeau M.;
RT   "Dominant and recessive central core disease associated with RYR1
RT   mutations and fetal akinesia.";
RL   Brain 126:2341-2349(2003).
RN   [50]
RP   VARIANTS MHS1 CYS-44; CYS-533; LEU-2117; PRO-2163; MET-2168; LEU-2435
RP   AND HIS-2454, AND VARIANT LYS-2101.
RX   PubMed=12709367; DOI=10.1373/49.5.761;
RA   Tammaro A., Bracco A., Cozzolino S., Esposito M., Di Martino A.,
RA   Savoia G., Zeuli L., Piluso G., Aurino S., Nigro V.;
RT   "Scanning for mutations of the ryanodine receptor (RYR1) gene by
RT   denaturing HPLC: detection of three novel malignant hyperthermia
RT   alleles.";
RL   Clin. Chem. 49:761-768(2003).
RN   [51]
RP   VARIANT CCD 4863-ARG--ASP-4869 DELINS TYR.
RX   PubMed=12566385; DOI=10.1093/hmg/ddg032;
RA   Zorzato F., Yamaguchi N., Xu L., Meissner G., Mueller C.R.,
RA   Pouliquin P., Muntoni F., Sewry C., Girard T., Treves S.;
RT   "Clinical and functional effects of a deletion in a COOH-terminal
RT   lumenal loop of the skeletal muscle ryanodine receptor.";
RL   Hum. Mol. Genet. 12:379-388(2003).
RN   [52]
RP   INVOLVEMENT IN MMDO.
RX   PubMed=12719381; DOI=10.1093/hmg/ddg121;
RA   Monnier N., Ferreiro A., Marty I., Labarre-Vila A., Mezin P.,
RA   Lunardi J.;
RT   "A homozygous splicing mutation causing a depletion of skeletal muscle
RT   RYR1 is associated with multi-minicore disease congenital myopathy
RT   with ophthalmoplegia.";
RL   Hum. Mol. Genet. 12:1171-1178(2003).
RN   [53]
RP   VARIANT CORE/ROD DISEASE ILE-4637, AND VARIANTS CCD ASP-4638;
RP   PRO-4651; CYS-4861; HIS-4861; GLN-4893; THR-4898; GLY-4914; THR-4914;
RP   4927-VAL-ILE-4928 DEL AND THR-4940.
RX   PubMed=12565913; DOI=10.1016/S0960-8966(02)00218-3;
RA   Davis M.R., Haan E., Jungbluth H., Sewry C., North K., Muntoni F.,
RA   Kuntzer T., Lamont P., Bankier A., Tomlinson P., Sanchez A., Walsh P.,
RA   Nagarajan L., Oley C., Colley A., Gedeon A., Quinlivan R., Dixon J.,
RA   James D., Mueller C.R., Laing N.G.;
RT   "Principal mutation hotspot for central core disease and related
RT   myopathies in the C-terminal transmembrane region of the RYR1 gene.";
RL   Neuromuscul. Disord. 13:151-157(2003).
RN   [54]
RP   VARIANTS MHS1 CYS-163; ARG-248; CYS-614; CYS-2163; MET-2168; MET-2206;
RP   ILE-2214; THR-2350; THR-2367; ASN-2431; ARG-2434; VAL-2437; HIS-2454
RP   AND PRO-4824.
RX   PubMed=15448513; DOI=10.1097/00000542-200410000-00005;
RA   Sei Y., Sambuughin N.N., Davis E.J., Sachs D., Cuenca P.B.,
RA   Brandom B.W., Tautz T., Rosenberg H., Nelson T.E., Muldoon S.M.;
RT   "Malignant hyperthermia in North America: genetic screening of the
RT   three hot spots in the type I ryanodine receptor gene.";
RL   Anesthesiology 101:824-830(2004).
RN   [55]
RP   VARIANTS MHS1 TRP-2676 AND SER-2787.
RX   PubMed=14732627; DOI=10.1001/archneur.61.1.106;
RA   Guis S., Figarella-Branger D., Monnier N., Bendahan D.,
RA   Kozak-Ribbens G., Mattei J.-P., Lunardi J., Cozzone P.J.,
RA   Pellissier J.-F.;
RT   "Multiminicore disease in a family susceptible to malignant
RT   hyperthermia: histology, in vitro contracture tests, and genetic
RT   characterization.";
RL   Arch. Neurol. 61:106-113(2004).
RN   [56]
RP   VARIANTS CCD GLY-160; ASP-4638; PHE-4814; HIS-4861 AND MET-4938, AND
RP   VARIANTS MHS1 CYS-614; MET-2346; GLY-2348; TRP-2452; HIS-2458;
RP   PRO-4824 AND GLU-4939.
RX   PubMed=14985404; DOI=10.1136/jmg.2003.014274;
RA   Shepherd S., Ellis F., Halsall J., Hopkins P., Robinson R.;
RT   "RYR1 mutations in UK central core disease patients: more than just
RT   the C-terminal transmembrane region of the RYR1 gene.";
RL   J. Med. Genet. 41:E33-E33(2004).
RN   [57]
RP   VARIANT MHS1 SER-2342.
RX   PubMed=15221887; DOI=10.1002/mus.20068;
RA   Marchant C.L., Ellis F.R., Halsall P.J., Hopkins P.M., Robinson R.L.;
RT   "Mutation analysis of two patients with hypokalemic periodic paralysis
RT   and suspected malignant hyperthermia.";
RL   Muscle Nerve 30:114-117(2004).
RN   [58]
RP   VARIANTS MHS1 ARG-35; CYS-163; LEU-163; ARG-165; ASN-166; CYS-177;
RP   CYS-178; VAL-227; ARG-248; TRP-328; ARG-341; SER-401; HIS-401;
RP   MET-403; SER-522; TRP-552; CYS-614; LEU-614; CYS-2163; HIS-2163;
RP   MET-2168; MET-2206; ARG-2206; ASP-2344; MET-2346; THR-2350; THR-2428;
RP   ARG-2434; HIS-2435; CYS-2454; HIS-2454; CYS-2458; TRP-2676; SER-2787;
RP   MET-3916; SER-4684; GLN-4737; TRP-4737; ILE-4826; VAL-4838; ILE-4849;
RP   ARG-4876; GLU-4939 AND LEU-4973, CHARACTERIZATION OF VARIANTS MHS1
RP   LEU-163; MET-2206; THR-2428; CYS-2454 AND HIS-2454, FUNCTION, AND
RP   ENZYME REGULATION.
RX   PubMed=16163667; DOI=10.1002/humu.20231;
RA   Monnier N., Kozak-Ribbens G., Krivosic-Horber R., Nivoche Y., Qi D.,
RA   Kraev N., Loke J., Sharma P., Tegazzin V., Figarella-Branger D.,
RA   Romero N., Mezin P., Bendahan D., Payen J.-F., Depret T.,
RA   Maclennan D.H., Lunardi J.;
RT   "Correlations between genotype and pharmacological, histological,
RT   functional, and clinical phenotypes in malignant hyperthermia
RT   susceptibility.";
RL   Hum. Mutat. 26:413-425(2005).
RN   [59]
RP   VARIANTS MMDO TRP-109 AND LYS-2423, AND VARIANTS VAL-485 AND CYS-2060.
RX   PubMed=16380615; DOI=10.1212/01.wnl.0000188870.37076.f2;
RA   Jungbluth H., Zhou H., Hartley L., Halliger-Keller B., Messina S.,
RA   Longman C., Brockington M., Robb S.A., Straub V., Voit T., Swash M.,
RA   Ferreiro A., Bydder G., Sewry C.A., Mueller C., Muntoni F.;
RT   "Minicore myopathy with ophthalmoplegia caused by mutations in the
RT   ryanodine receptor type 1 gene.";
RL   Neurology 65:1930-1935(2005).
RN   [60]
RP   VARIANT CCD VAL-4846.
RX   PubMed=17204054; DOI=10.1111/j.1399-0004.2006.00725.x;
RA   Gambelli S., Malandrini A., Berti G., Gaudiano C., Zicari E.,
RA   Brunori P., Perticoni G., Orrico A., Galli L., Sorrentino V.,
RA   Lunardi J., Federico A., Dotti M.T.;
RT   "Inheritance of a novel RYR1 mutation in a family with myotonic
RT   dystrophy type 1.";
RL   Clin. Genet. 71:93-94(2007).
RN   [61]
RP   VARIANTS CCD GLN-4558; VAL-4846; ILE-4849; HIS-4861; CYS-4861;
RP   VAL-4897 AND THR-4914.
RX   PubMed=17226826; DOI=10.1002/mus.20715;
RA   Kossugue P.M., Paim J.F., Navarro M.M., Silva H.C., Pavanello R.C.M.,
RA   Gurgel-Giannetti J., Zatz M., Vainzof M.;
RT   "Central core disease due to recessive mutations in RYR1 gene: is it
RT   more common than described?";
RL   Muscle Nerve 35:670-674(2007).
RN   [62]
RP   VARIANT CCD MET-4882.
RX   PubMed=18312400; DOI=10.1111/j.1468-1331.2008.02094.x;
RA   von der Hagen M., Kress W., Hahn G., Brocke K.S., Mitzscherling P.,
RA   Huebner A., Muller-Reible C., Stoltenburg-Didinger G., Kaindl A.M.;
RT   "Novel RYR1 missense mutation causes core rod myopathy.";
RL   Eur. J. Neurol. 15:E31-E32(2008).
RN   [63]
RP   VARIANTS CCD VAL-13; SER-1704; PRO-2421; LYS-2423; HIS-3539; GLN-3772;
RP   GLN-4558; MET-4842 AND ILE-4849.
RX   PubMed=18253926; DOI=10.1002/humu.20696;
RA   Monnier N., Marty I., Faure J., Castiglioni C., Desnuelle C.,
RA   Sacconi S., Estournet B., Ferreiro A., Romero N., Laquerriere A.,
RA   Lazaro L., Martin J.-J., Morava E., Rossi A., Van der Kooi A.,
RA   de Visser M., Verschuuren C., Lunardi J.;
RT   "Null mutations causing depletion of the type 1 ryanodine receptor
RT   (RYR1) are commonly associated with recessive structural congenital
RT   myopathies with cores.";
RL   Hum. Mutat. 29:670-678(2008).
RN   [64]
RP   VARIANTS MHS1 ARG-13; LYS-226; LEU-367; HIS-530; TYR-544; CYS-1043;
RP   GLY-1352; HIS-2336; LYS-2404; TRP-2676; GLY-2730; SER-2787; LYS-2880;
RP   PRO-3217; LYS-3290; TRP-3772; ARG-3806; LEU-4501; VAL-4838; ARG-4876
RP   AND THR-4938, AND VARIANTS GLY-1342; LEU-1787; ALA-1832; CYS-2060;
RP   VAL-2321; VAL-2550; GLN-3583 AND GLU-3756.
RX   PubMed=19191329; DOI=10.1002/humu.20878;
RA   Levano S., Vukcevic M., Singer M., Matter A., Treves S., Urwyler A.,
RA   Girard T.;
RT   "Increasing the number of diagnostic mutations in malignant
RT   hyperthermia.";
RL   Hum. Mutat. 30:590-598(2009).
RN   [65]
RP   VARIANT MHS1 CYS-2508, AND CHARACTERIZATION OF VARIANT MHS1 CYS-2508.
RX   PubMed=19685112; DOI=10.1007/s00540-009-0746-3;
RA   Migita T., Mukaida K., Hamada H., Yasuda T., Haraki T., Nishino I.,
RA   Murakami N., Kawamoto M.;
RT   "Functional analysis of ryanodine receptor type 1 p.R2508C mutation in
RT   exon 47.";
RL   J. Anesth. 23:341-346(2009).
RN   [66]
RP   VARIANTS MHS1 ASN-382; LYS-1058 AND ARG-1393, VARIANT CCD GLY-2508,
RP   AND VARIANT HIS-1679.
RX   PubMed=20142353; DOI=10.1213/ANE.0b013e3181cbd815;
RA   Vukcevic M., Broman M., Islander G., Bodelsson M., Ranklev-Twetman E.,
RA   Muller C.R., Treves S.;
RT   "Functional properties of RYR1 mutations identified in Swedish
RT   patients with malignant hyperthermia and central core disease.";
RL   Anesth. Analg. 111:185-190(2010).
RN   [67]
RP   VARIANTS MMDO THR-402; LEU-2035; LYS-3326 AND GLY-3402.
RX   PubMed=20583297; DOI=10.1002/humu.21278;
RA   Clarke N.F., Waddell L.B., Cooper S.T., Perry M., Smith R.L.L.,
RA   Kornberg A.J., Muntoni F., Lillis S., Straub V., Bushby K.,
RA   Guglieri M., King M.D., Farrell M.A., Marty I., Lunardi J.,
RA   Monnier N., North K.N.;
RT   "Recessive mutations in RYR1 are a common cause of congenital fiber
RT   type disproportion.";
RL   Hum. Mutat. 31:E1544-E1550(2010).
RN   [68]
RP   VARIANTS MHS1 ASN-1056; HIS-1127; ARG-1467; VAL-1571; GLN-2013;
RP   GLY-2400; GLY-2593; GLN-3410; TYR-3501 AND CYS-3933, AND VARIANTS
RP   LYS-899; CYS-2060; CYS-2248; TYR-2976 AND GLN-3360.
RX   PubMed=20681998; DOI=10.1111/j.1399-0004.2010.01493.x;
RA   Tammaro A., Di Martino A., Bracco A., Cozzolino S., Savoia G.,
RA   Andria B., Cannavo A., Spagnuolo M., Piluso G., Aurino S., Nigro V.;
RT   "Novel missense mutations and unexpected multiple changes of RYR1 gene
RT   in 75 malignant hyperthermia families.";
RL   Clin. Genet. 79:438-447(2011).
RN   [69]
RP   VARIANTS CCD GLY-160; GLN-2204; HIS-3366; CYS-3933 AND ASP-4743, AND
RP   VARIANTS LEU-1787; CYS-2060 AND ALA-4493.
RX   PubMed=21674524; DOI=10.1002/mus.22009;
RA   Duarte S.T., Oliveira J., Santos R., Pereira P., Barroso C.,
RA   Conceicao I., Evangelista T.;
RT   "Dominant and recessive RYR1 mutations in adults with core lesions and
RT   mild muscle symptoms.";
RL   Muscle Nerve 44:102-108(2011).
RN   [70]
RP   VARIANTS MHS1 HIS-1056; MET-2627 AND LEU-4234.
RX   PubMed=24013571; DOI=10.1097/ALN.0b013e3182a8a998;
RA   Kim J.H., Jarvik G.P., Browning B.L., Rajagopalan R., Gordon A.S.,
RA   Rieder M.J., Robertson P.D., Nickerson D.A., Fisher N.A.,
RA   Hopkins P.M.;
RT   "Exome sequencing reveals novel rare variants in the ryanodine
RT   receptor and calcium channel genes in malignant hyperthermia
RT   families.";
RL   Anesthesiology 119:1054-1065(2013).
RN   [71]
RP   VARIANTS MHS1 ALA-40; CYS-163; ARG-248; ARG-341; PRO-487; ALA-518;
RP   CYS-614; HIS-1043; HIS-2163; MET-2206; HIS-2248; HIS-2351; MET-2354;
RP   LEU-2358; GLN-2383; ARG-2434; HIS-2454; ARG-3711; VAL-4178; ARG-4230;
RP   GLU-4837; HIS-4861 AND GLY-4906, VARIANTS CCD TRP-975; MET-2168 AND
RP   GLY-3238, AND VARIANTS MET-974; LEU-1109; ARG-1393; LEU-1787; CYS-2060
RP   AND VAL-2321.
RX   PubMed=23558838; DOI=10.1213/ANE.0b013e31828a71ff;
RA   Brandom B.W., Bina S., Wong C.A., Wallace T., Visoiu M.,
RA   Isackson P.J., Vladutiu G.D., Sambuughin N., Muldoon S.M.;
RT   "Ryanodine receptor type 1 gene variants in the malignant
RT   hyperthermia-susceptible population of the United States.";
RL   Anesth. Analg. 116:1078-1086(2013).
RN   [72]
RP   VARIANTS CCD HIS-4861; ALA-4897 AND THR-4898.
RX   PubMed=24561095; DOI=10.1016/j.neulet.2014.02.015;
RA   Gu M., Zhang S., Hu J., Yuan Y., Wang Z., Da Y., Wu S.;
RT   "Novel RYR1 missense mutations in six Chinese patients with central
RT   core disease.";
RL   Neurosci. Lett. 566:32-35(2014).
RN   [73]
RP   CHARACTERIZATION OF VARIANT MHS1 CYS-2508, CHARACTERIZATION OF VARIANT
RP   CCD GLY-2508, AND MUTAGENESIS OF ARG-2508.
RX   PubMed=26381711; DOI=10.1213/ANE.0000000000000886;
RA   Miyoshi H., Yasuda T., Otsuki S., Kondo T., Haraki T., Mukaida K.,
RA   Nakamura R., Hamada H., Kawamoto M.;
RT   "Several ryanodine receptor type 1 gene mutations of p.Arg2508 are
RT   potential sources of malignant hyperthermia.";
RL   Anesth. Analg. 121:994-1000(2015).
RN   [74]
RP   CHARACTERIZATION OF VARIANTS MHS1 ARG-35; CYS-163; LEU-163; ARG-248;
RP   ARG-341; CYS-401; HIS-401; SER-522; CYS-614 AND LEU-614, AND
RP   MUTAGENESIS OF TYR-522.
RX   PubMed=26115329; DOI=10.1371/journal.pone.0130606;
RA   Murayama T., Kurebayashi N., Yamazawa T., Oyamada H., Suzuki J.,
RA   Kanemaru K., Oguchi K., Iino M., Sakurai T.;
RT   "Divergent activity profiles of type 1 ryanodine receptor channels
RT   carrying malignant hyperthermia and central core disease mutations in
RT   the amino-terminal Region.";
RL   PLoS ONE 10:E0130606-E0130606(2015).
RN   [75]
RP   CHARACTERIZATION OF VARIANTS MHS1 CYS-2163; HIS-2163; MET-2168;
RP   MET-2206; THR-2350; ARG-2434; HIS-2435; CYS-2454; HIS-2454; CYS-2458;
RP   HIS-2458 AND HIS-2508, CHARACTERIZATION OF VARIANT CCD CYS-2508, AND
RP   CHARACTERIZATION OF VARIANT ALA-2375 AND HIS-2508.
RX   PubMed=27586648; DOI=10.1002/humu.23072;
RA   Murayama T., Kurebayashi N., Ogawa H., Yamazawa T., Oyamada H.,
RA   Suzuki J., Kanemaru K., Oguchi K., Iino M., Sakurai T.;
RT   "Genotype-phenotype correlations of malignant hyperthermia and central
RT   core disease mutations in the central region of the RYR1 channel.";
RL   Hum. Mutat. 37:1231-1241(2016).
RN   [76]
RP   VARIANT MHS1 TRP-4737, AND CHARACTERIZATION OF VARIANT MHS1 TRP-4737.
RX   PubMed=26631338; DOI=10.1016/j.nmd.2015.11.001;
RA   Johannsen S., Treves S., Mueller C.R., Moegele S., Schneiderbanger D.,
RA   Roewer N., Schuster F.;
RT   "Functional characterization of the RYR1 mutation p.Arg4737Trp
RT   associated with susceptibility to malignant hyperthermia.";
RL   Neuromuscul. Disord. 26:21-25(2016).
RN   [77]
RP   VARIANT ARG-705.
RX   PubMed=27616680; DOI=10.1002/pd.4925;
RA   Casey J., Flood K., Ennis S., Doyle E., Farrell M., Lynch S.A.;
RT   "Intra-familial variability associated with recessive RYR1 mutation
RT   diagnosed prenatally by exome sequencing.";
RL   Prenat. Diagn. 36:1020-1026(2016).
RN   [78]
RP   VARIANTS CCD PRO-2963 AND ASP-4806.
RX   PubMed=27234031; DOI=10.1111/cge.12810;
RA   Fattahi Z., Kalhor Z., Fadaee M., Vazehan R., Parsimehr E.,
RA   Abolhassani A., Beheshtian M., Zamani G., Nafissi S., Nilipour Y.,
RA   Akbari M.R., Kahrizi K., Kariminejad A., Najmabadi H.;
RT   "Improved diagnostic yield of neuromuscular disorders applying
RT   clinical exome sequencing in patients arising from a consanguineous
RT   population.";
RL   Clin. Genet. 91:386-402(2017).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from
CC       the sarcoplasmic reticulum into the cytoplasm and thereby plays a
CC       key role in triggering muscle contraction following depolarization
CC       of T-tubules (PubMed:11741831, PubMed:16163667). Repeated very
CC       high-level exercise increases the open probability of the channel
CC       and leads to Ca(2+) leaking into the cytoplasm (PubMed:18268335).
CC       Can also mediate the release of Ca(2+) from intracellular stores
CC       in neurons, and may thereby promote prolonged Ca(2+) signaling in
CC       the brain. Required for normal embryonic development of muscle
CC       fibers and skeletal muscle. Required for normal heart
CC       morphogenesis, skin development and ossification during
CC       embryogenesis (By similarity). {ECO:0000250|UniProtKB:E9PZQ0,
CC       ECO:0000269|PubMed:18268335, ECO:0000305|PubMed:11741831,
CC       ECO:0000305|PubMed:16163667}.
CC   -!- ENZYME REGULATION: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high
CC       affinity. At low concentrations, ryanodine maintains the channel
CC       in an open conformation. High ryanodine concentrations inhibit
CC       channel activity (By similarity). Channel activity is regulated by
CC       calmodulin (CALM) (PubMed:18650434). The calcium release is
CC       activated by increased cytoplasmic calcium levels, by nitric oxyde
CC       (NO), caffeine and ATP (PubMed:18268335, PubMed:16163667). Channel
CC       activity is inhibited by magnesium ions, possibly by competition
CC       for calcium binding sites (By similarity).
CC       {ECO:0000250|UniProtKB:P11716, ECO:0000269|PubMed:16163667,
CC       ECO:0000269|PubMed:18268335, ECO:0000269|PubMed:18650434}.
CC   -!- SUBUNIT: Homotetramer. Can also form heterotetramers with RYR2 (By
CC       similarity). Identified in a complex composed of RYR1, PDE4D, PKA,
CC       FKBP1A and protein phosphatase 1 (PP1) (PubMed:18268335). Repeated
CC       very high-level exercise decreases interaction with PDE4D and
CC       protein phosphatase 1 (PP1) (PubMed:18268335). Interacts with
CC       CALM; CALM with bound calcium inhibits the RYR1 channel activity
CC       (PubMed:18650434). Interacts with S100A1 (PubMed:18650434).
CC       Interacts with FKBP1A; this stabilizes the closed conformation of
CC       the channel. Interacts with CACNA1S; interaction with CACNA1S is
CC       important for activation of the RYR1 channel. Interacts with
CC       CACNB1. Interacts with TRDN and ASPH; these interactions stimulate
CC       RYR1 channel activity. Interacts with SELENON (By similarity).
CC       {ECO:0000250|UniProtKB:E9PZQ0, ECO:0000250|UniProtKB:P11716,
CC       ECO:0000269|PubMed:18268335, ECO:0000269|PubMed:18650434}.
CC   -!- INTERACTION:
CC       P54296:MYOM2; NbExp=2; IntAct=EBI-1221290, EBI-5357134;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:7556644}; Multi-pass membrane protein
CC       {ECO:0000305}. Sarcoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P11716}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but the 3D-
CC       structures show the presence of six transmembrane regions. Both N-
CC       terminus and C-terminus are cytoplasmic.
CC       {ECO:0000250|UniProtKB:P11716}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=P21817-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21817-2; Sequence=VSP_005951;
CC       Name=3;
CC         IsoId=P21817-3; Sequence=VSP_005952;
CC   -!- TISSUE SPECIFICITY: Skeletal muscle and brain (cerebellum and
CC       hippocampus). {ECO:0000269|PubMed:9607712}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein
CC       constitutes the 'foot' structure spanning the junctional gap
CC       between the sarcoplasmic reticulum (SR) and the T-tubule. Pore
CC       opening is mediated via the cytoplasmic calcium-binding domains
CC       that mediate a small rotation of the channel-forming transmembrane
CC       regions that then leads to channel opening.
CC       {ECO:0000250|UniProtKB:P11716}.
CC   -!- PTM: Channel activity is modulated by phosphorylation.
CC       Phosphorylation at Ser-2843 may increase channel activity.
CC       Repeated very high-level exercise increases phosphorylation at
CC       Ser-2843. {ECO:0000269|PubMed:18268335}.
CC   -!- PTM: Activated by reversible S-nitrosylation (By similarity).
CC       Repeated very high-level exercise increases S-nitrosylation
CC       (PubMed:18268335). {ECO:0000250|UniProtKB:P11716,
CC       ECO:0000269|PubMed:18268335}.
CC   -!- DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal
CC       dominant pharmacogenetic disorder of skeletal muscle and is one of
CC       the main causes of death due to anesthesia. In susceptible people,
CC       an MH episode can be triggered by all commonly used inhalational
CC       anesthetics such as halothane and by depolarizing muscle relaxants
CC       such as succinylcholine. The clinical features of the myopathy are
CC       hyperthermia, accelerated muscle metabolism, contractures,
CC       metabolic acidosis, tachycardia and death, if not treated with the
CC       postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can
CC       be determined with the 'in vitro' contracture test (IVCT):
CC       observing the magnitude of contractures induced in strips of
CC       muscle tissue by caffeine alone and halothane alone. Patients with
CC       normal response are MH normal (MHN), those with abnormal response
CC       to caffeine alone or halothane alone are MH equivocal (MHE(C) and
CC       MHE(H) respectively). {ECO:0000269|PubMed:10051009,
CC       ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851,
CC       ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602,
CC       ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482,
CC       ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529,
CC       ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893,
CC       ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492,
CC       ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788,
CC       ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402,
CC       ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627,
CC       ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887,
CC       ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667,
CC       ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329,
CC       ECO:0000269|PubMed:19685112, ECO:0000269|PubMed:20142353,
CC       ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838,
CC       ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:26115329,
CC       ECO:0000269|PubMed:26381711, ECO:0000269|PubMed:26631338,
CC       ECO:0000269|PubMed:27586648, ECO:0000269|PubMed:7751854,
CC       ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417,
CC       ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:8220423,
CC       ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151,
CC       ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902,
CC       ECO:0000269|PubMed:9497245}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Central core disease of muscle (CCD) [MIM:117000]:
CC       Autosomal dominant congenital myopathy, but a severe autosomal
CC       recessive form also exists. Both clinical and histological
CC       variability is observed. Affected individuals typically display
CC       hypotonia and proximal muscle weakness in infancy, leading to the
CC       delay of motor milestones. The clinical course of the disorder is
CC       usually slow or nonprogressive in adulthood, and the severity of
CC       the symptoms may vary from normal to significant muscle weakness.
CC       Microscopic examination of CCD-affected skeletal muscle reveals a
CC       predominance of type I fibers containing amorphous-looking areas
CC       (cores) that do not stain with oxidative and phosphorylase
CC       histochemical techniques. {ECO:0000269|PubMed:10097181,
CC       ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545,
CC       ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081,
CC       ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913,
CC       ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085,
CC       ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404,
CC       ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826,
CC       ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400,
CC       ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524,
CC       ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095,
CC       ECO:0000269|PubMed:26381711, ECO:0000269|PubMed:27234031,
CC       ECO:0000269|PubMed:27586648, ECO:0000269|PubMed:7829078,
CC       ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423,
CC       ECO:0000269|PubMed:9497245}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Multiminicore disease with external ophthalmoplegia
CC       (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular
CC       disorder. General features include neonatal hypotonia, delayed
CC       motor development, and generalized muscle weakness and amyotrophy,
CC       which may progress slowly or remain stable. Muscle biopsy shows
CC       multiple, poorly circumscribed, short areas of sarcomere
CC       disorganization and mitochondria depletion (areas termed
CC       minicores) in most muscle fibers. Typically, no dystrophic signs,
CC       such as muscle fiber necrosis or regeneration or significant
CC       endomysial fibrosis, are present in multiminicore disease.
CC       {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615,
CC       ECO:0000269|PubMed:20583297}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in RYR1 may be a cause of Samaritan
CC       myopathy, a congenital myopathy with benign course. Patients
CC       display severe hypotonia and respiratory distress at birth. Unlike
CC       other congenital myopathies, the health status constantly improves
CC       and patients are minimally affected at adulthood.
CC   -!- MISCELLANEOUS: Coexpression of normal and mutant Thr-4898 RYR1 in
CC       a 1:1 ratio produces RYR1 channels with normal halothane and
CC       caffeine sensitivities, but maximal levels of Ca(2+) release are
CC       reduced by 67%. Binding of [3H]ryanodine indicates that the
CC       heterozygous channel is activated by Ca(2+) concentrations 4-fold
CC       lower than normal. Single-cell analysis of cotransfected cells
CC       shows a significantly increased resting cytoplasmic Ca(2+) level
CC       and a significantly reduced luminal Ca(2+) level. These data
CC       indicated a leaky channel, possibly caused by a reduction in the
CC       Ca(2+) concentration required for channel activation. Comparison
CC       with 2 other coexpressed mutant/normal channels suggests that the
CC       Thr-4898 mutation produces one of the most abnormal RYR1 channels
CC       that has been investigated, and this level of abnormality is
CC       reflected in the severe and penetrant phenotype of affected CCD
CC       individuals. {ECO:0000269|PubMed:10097181}.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       RYR1 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ryanodine receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Ryanodine_receptor";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=RYR1 entry;
CC       URL="https://en.wikipedia.org/wiki/RYR1";
CC   -!- WEB RESOURCE: Name=Leiden Muscular Dystrophy pages Ryanodine
CC       receptor 1 (skeletal) (RYR1); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://www.dmd.nl/nmdb2/home.php?select_db=RYR1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05200; AAA60294.1; -; mRNA.
DR   EMBL; U48508; AAC51191.1; -; Genomic_DNA.
DR   EMBL; U48449; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48450; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48451; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48452; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48453; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48454; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48455; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48456; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48457; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48458; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48459; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48460; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48461; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48462; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48463; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48464; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48465; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48466; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48467; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48468; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48469; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48470; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48471; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48472; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48473; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48474; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48475; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48476; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48477; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48478; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48479; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48480; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48481; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48482; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48483; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48484; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48485; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48486; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48487; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48488; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48489; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48490; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48491; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48492; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48493; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48494; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48495; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48496; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48497; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48498; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48499; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48500; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48501; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48502; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48503; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48504; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48505; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48506; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; U48507; AAC51191.1; JOINED; Genomic_DNA.
DR   EMBL; AC067969; AAF66076.1; -; Genomic_DNA.
DR   EMBL; AC005933; AAC71651.1; -; Genomic_DNA.
DR   EMBL; AC011469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M91455; AAA60295.1; -; Genomic_DNA.
DR   EMBL; S78717; AAB21245.2; -; Genomic_DNA.
DR   EMBL; S77392; AAB34356.1; -; Genomic_DNA.
DR   CCDS; CCDS33011.1; -. [P21817-1]
DR   CCDS; CCDS42563.1; -. [P21817-2]
DR   PIR; A35041; A35041.
DR   RefSeq; NP_000531.2; NM_000540.2. [P21817-1]
DR   RefSeq; NP_001036188.1; NM_001042723.1. [P21817-2]
DR   UniGene; Hs.466664; -.
DR   ProteinModelPortal; P21817; -.
DR   BioGrid; 112173; 8.
DR   DIP; DIP-29708N; -.
DR   ELM; P21817; -.
DR   IntAct; P21817; 12.
DR   MINT; MINT-1605046; -.
DR   STRING; 9606.ENSP00000352608; -.
DR   BindingDB; P21817; -.
DR   ChEMBL; CHEMBL1846; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB01219; Dantrolene.
DR   DrugBank; DB04786; Suramin.
DR   DrugBank; DB09085; Tetracaine.
DR   GuidetoPHARMACOLOGY; 747; -.
DR   TCDB; 1.A.3.1.2; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; P21817; -.
DR   PhosphoSitePlus; P21817; -.
DR   BioMuta; RYR1; -.
DR   DMDM; 108935904; -.
DR   PaxDb; P21817; -.
DR   PeptideAtlas; P21817; -.
DR   PRIDE; P21817; -.
DR   Ensembl; ENST00000355481; ENSP00000347667; ENSG00000196218. [P21817-2]
DR   Ensembl; ENST00000359596; ENSP00000352608; ENSG00000196218. [P21817-1]
DR   GeneID; 6261; -.
DR   KEGG; hsa:6261; -.
DR   UCSC; uc002oit.4; human. [P21817-1]
DR   CTD; 6261; -.
DR   DisGeNET; 6261; -.
DR   EuPathDB; HostDB:ENSG00000196218.11; -.
DR   GeneCards; RYR1; -.
DR   GeneReviews; RYR1; -.
DR   H-InvDB; HIX0039957; -.
DR   HGNC; HGNC:10483; RYR1.
DR   HPA; HPA056416; -.
DR   MalaCards; RYR1; -.
DR   MIM; 117000; phenotype.
DR   MIM; 145600; phenotype.
DR   MIM; 180901; gene.
DR   MIM; 255320; phenotype.
DR   neXtProt; NX_P21817; -.
DR   OpenTargets; ENSG00000196218; -.
DR   Orphanet; 169189; Autosomal dominant centronuclear myopathy.
DR   Orphanet; 324581; Benign Samaritan congenital myopathy.
DR   Orphanet; 597; Central core disease.
DR   Orphanet; 98905; Congenital multicore myopathy with external ophthalmoplegia.
DR   Orphanet; 99741; King-Denborough syndrome.
DR   Orphanet; 423; Malignant hyperthermia.
DR   Orphanet; 178145; Moderate multiminicore disease with hand involvement.
DR   PharmGKB; PA34896; -.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000231428; -.
DR   HOVERGEN; HBG006699; -.
DR   InParanoid; P21817; -.
DR   KO; K04961; -.
DR   OMA; DIPARRN; -.
DR   OrthoDB; EOG091G00T0; -.
DR   PhylomeDB; P21817; -.
DR   TreeFam; TF315244; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   SIGNOR; P21817; -.
DR   ChiTaRS; RYR1; human.
DR   GeneWiki; RYR1; -.
DR   GenomeRNAi; 6261; -.
DR   PRO; PR:P21817; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000196218; -.
DR   CleanEx; HS_RYR1; -.
DR   ExpressionAtlas; P21817; baseline and differential.
DR   Genevisible; P21817; HS.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031674; C:I band; IDA:UniProtKB.
DR   GO; GO:0031301; C:integral component of organelle membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0030314; C:junctional membrane complex; IEA:Ensembl.
DR   GO; GO:0014701; C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:1990425; C:ryanodine receptor complex; ISS:UniProtKB.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0014802; C:terminal cisterna; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0048763; F:calcium-induced calcium release activity; IMP:UniProtKB.
DR   GO; GO:0015278; F:calcium-release channel activity; TAS:ProtInc.
DR   GO; GO:0005516; F:calmodulin binding; ISS:BHF-UCL.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:CACAO.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISS:BHF-UCL.
DR   GO; GO:0071313; P:cellular response to caffeine; IMP:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; ISS:UniProtKB.
DR   GO; GO:0043931; P:ossification involved in bone maturation; ISS:UniProtKB.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISS:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0031000; P:response to caffeine; ISS:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; IDA:BHF-UCL.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB.
DR   GO; GO:0043588; P:skin development; ISS:UniProtKB.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR033215; RyR1.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   PANTHER; PTHR13715:SF15; PTHR13715:SF15; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Calcium channel;
KW   Calcium transport; Calmodulin-binding; Complete proteome;
KW   Developmental protein; Direct protein sequencing; Disease mutation;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; S-nitrosylation;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   5038       Ryanodine receptor 1.
FT                                /FTId=PRO_0000219358.
FT   TOPO_DOM      1   4559       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4560   4580       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4581   4641       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4642   4662       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4663   4780       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4781   4803       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4804   4804       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4805   4821       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4822   4836       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4837   4857       Helical; Name=5.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4858   4880       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   INTRAMEM   4881   4900       Pore-forming.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4901   4920       Lumenal. {ECO:0000250|UniProtKB:P11716}.
FT   TRANSMEM   4921   4941       Helical; Name=6.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   TOPO_DOM   4942   5038       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   DOMAIN       97    152       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      159    204       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      210    264       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      270    327       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      335    392       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      581    797       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      841    954       1.
FT   REPEAT      955   1068       2.
FT   DOMAIN     1013   1208       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     1344   1359       3; truncated.
FT   DOMAIN     1356   1570       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     1372   1387       4; truncated.
FT   REPEAT     2726   2845       5.
FT   REPEAT     2846   2959       6.
FT   DOMAIN     4074   4102       EF-hand. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   NP_BIND    4210   4214       ATP. {ECO:0000250|UniProtKB:P11716}.
FT   NP_BIND    4955   4960       ATP. {ECO:0000250|UniProtKB:P11716}.
FT   NP_BIND    4980   4986       ATP. {ECO:0000250|UniProtKB:P11716}.
FT   REGION      669    680       Interaction with FKBP1A.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   REGION      841   2959       6 X approximate repeats.
FT   REGION     3614   3643       Interaction with CALM.
FT                                {ECO:0000269|PubMed:18650434}.
FT   MOTIF      4895   4901       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   COMPBIAS   1873   1924       Glu-rich (acidic).
FT   COMPBIAS   4462   4532       Pro-rich.
FT   METAL      3892   3892       Calcium. {ECO:0000250|UniProtKB:P11716}.
FT   METAL      3966   3966       Calcium. {ECO:0000250|UniProtKB:P11716}.
FT   METAL      5002   5002       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   BINDING    4717   4717       Caffeine. {ECO:0000250|UniProtKB:P11716}.
FT   MOD_RES    1337   1337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    2345   2345       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    2843   2843       Phosphoserine; by PKA and PKG.
FT                                {ECO:0000250|UniProtKB:E9PZQ0}.
FT   MOD_RES    3635   3635       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P11716}.
FT   MOD_RES    4467   4467       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    4471   4471       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:F1LMY4}.
FT   MOD_RES    4864   4864       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   MOD_RES    4867   4867       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   VAR_SEQ    3481   3485       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:2298749}.
FT                                /FTId=VSP_005951.
FT   VAR_SEQ    3865   3869       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_005952.
FT   VARIANT      13     13       L -> R (in MHS1; dbSNP:rs193922744).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058560.
FT   VARIANT      13     13       L -> V (in CCD; autosomal recessive
FT                                form). {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045694.
FT   VARIANT      35     35       C -> R (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922747).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:9066328}.
FT                                /FTId=VAR_005589.
FT   VARIANT      40     40       G -> A (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071721.
FT   VARIANT      44     44       R -> C (in CCD and MHS1;
FT                                dbSNP:rs193922748).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045695.
FT   VARIANT     109    109       R -> W (in MMDO; dbSNP:rs118192173).
FT                                {ECO:0000269|PubMed:16380615}.
FT                                /FTId=VAR_032910.
FT   VARIANT     160    160       E -> G (in CCD; dbSNP:rs193922752).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_045696.
FT   VARIANT     163    163       R -> C (in CCD and MHS1; 2-3% of the
FT                                cases; increases calcium-induced calcium
FT                                release activity; dbSNP:rs118192161).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:8220423}.
FT                                /FTId=VAR_005590.
FT   VARIANT     163    163       R -> L (in MHS1; induces an increase
FT                                sensitivity to caffeine; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs193922753).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_045697.
FT   VARIANT     165    165       G -> R (in MHS1; dbSNP:rs193922754).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045698.
FT   VARIANT     166    166       D -> N (in MHS1; dbSNP:rs193922755).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045699.
FT   VARIANT     177    177       R -> C (in MHS1; dbSNP:rs193922757).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045700.
FT   VARIANT     178    178       Y -> C (in MHS1).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045701.
FT   VARIANT     215    215       G -> E (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192115).
FT                                {ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045702.
FT   VARIANT     226    226       M -> K (in MHS1; dbSNP:rs112596687).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058561.
FT   VARIANT     227    227       D -> V (in MHS1; dbSNP:rs193922760).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045703.
FT   VARIANT     248    248       G -> R (in MHS1; unknown pathological
FT                                significance; increases calcium-induced
FT                                calcium release activity;
FT                                dbSNP:rs1801086).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_005591.
FT   VARIANT     291    291       A -> T (in dbSNP:rs2229140).
FT                                /FTId=VAR_051890.
FT   VARIANT     328    328       R -> W (in MHS1; has increased
FT                                sensitivity to both caffeine and
FT                                halothane; dbSNP:rs193922762).
FT                                {ECO:0000269|PubMed:12883402,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045704.
FT   VARIANT     341    341       G -> R (in MHS1; 10% of the cases;
FT                                increases calcium-induced calcium release
FT                                activity; dbSNP:rs121918592).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:8012359}.
FT                                /FTId=VAR_005592.
FT   VARIANT     367    367       R -> L (in MHS1; dbSNP:rs113332073).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058562.
FT   VARIANT     382    382       H -> N (in MHS1).
FT                                {ECO:0000269|PubMed:20142353}.
FT                                /FTId=VAR_068510.
FT   VARIANT     401    401       R -> C (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922764).
FT                                {ECO:0000269|PubMed:12066726,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_045705.
FT   VARIANT     401    401       R -> H (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922766).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329}.
FT                                /FTId=VAR_045706.
FT   VARIANT     401    401       R -> S (in MHS1).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045707.
FT   VARIANT     402    402       M -> T (in MMDO; dbSNP:rs118192117).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063846.
FT   VARIANT     403    403       I -> M (in CCD and MHS1;
FT                                dbSNP:rs118192116).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:8220423}.
FT                                /FTId=VAR_005593.
FT   VARIANT     471    471       R -> C. {ECO:0000269|PubMed:1354642}.
FT                                /FTId=VAR_005594.
FT   VARIANT     485    485       M -> V (in dbSNP:rs147723844).
FT                                {ECO:0000269|PubMed:16380615}.
FT                                /FTId=VAR_032911.
FT   VARIANT     487    487       L -> P (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071722.
FT   VARIANT     518    518       V -> A (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071723.
FT   VARIANT     522    522       Y -> S (in CCD and MHS1; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs118192162).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:7829078}.
FT                                /FTId=VAR_005595.
FT   VARIANT     530    530       R -> H (in MHS1; dbSNP:rs111888148).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058563.
FT   VARIANT     533    533       R -> C (in MHS1; dbSNP:rs193922768).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045708.
FT   VARIANT     533    533       R -> H (in MHS1; dbSNP:rs144336148).
FT                                /FTId=VAR_008971.
FT   VARIANT     544    544       D -> Y (in MHS1; dbSNP:rs113812662).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058564.
FT   VARIANT     552    552       R -> W (in MHS1; dbSNP:rs193922770).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:9138151}.
FT                                /FTId=VAR_005596.
FT   VARIANT     614    614       R -> C (in CCD and MHS1; 3-5% of the
FT                                cases; increases calcium-induced calcium
FT                                release activity; dbSNP:rs118192172).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:12937085,
FT                                ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:1774074,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:7751854}.
FT                                /FTId=VAR_005597.
FT   VARIANT     614    614       R -> L (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922772).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26115329,
FT                                ECO:0000269|PubMed:9389851}.
FT                                /FTId=VAR_005598.
FT   VARIANT     705    705       G -> R (probable disease-associated
FT                                mutation found in primary myopathy
FT                                causing fetal akinesia and pregnancy
FT                                loss; dbSNP:rs565825739).
FT                                {ECO:0000269|PubMed:27616680}.
FT                                /FTId=VAR_078775.
FT   VARIANT     899    899       N -> K (in dbSNP:rs201401814).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071724.
FT   VARIANT     974    974       V -> M (in dbSNP:rs748676912).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071725.
FT   VARIANT     975    975       R -> W (in CCD; unknown pathological
FT                                significance; dbSNP:rs371278145).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071726.
FT   VARIANT    1043   1043       R -> C (in MHS1; dbSNP:rs111272095).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058565.
FT   VARIANT    1043   1043       R -> H (in MHS1; unknown pathological
FT                                significance; dbSNP:rs374776563).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071727.
FT   VARIANT    1056   1056       D -> H (in MHS1).
FT                                {ECO:0000269|PubMed:24013571}.
FT                                /FTId=VAR_071728.
FT   VARIANT    1056   1056       D -> N (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071729.
FT   VARIANT    1058   1058       E -> K (in MHS1).
FT                                {ECO:0000269|PubMed:20142353}.
FT                                /FTId=VAR_068511.
FT   VARIANT    1088   1088       Y -> C (probable disease-associated
FT                                mutation found in a family with Samaritan
FT                                myopathy). {ECO:0000269|PubMed:22752422}.
FT                                /FTId=VAR_068512.
FT   VARIANT    1109   1109       R -> K (in dbSNP:rs35719391).
FT                                /FTId=VAR_032912.
FT   VARIANT    1109   1109       R -> L. {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071730.
FT   VARIANT    1127   1127       R -> H (in MHS1; dbSNP:rs545579559).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071731.
FT   VARIANT    1342   1342       S -> G (in dbSNP:rs34694816).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_032913.
FT   VARIANT    1352   1352       A -> G (in MHS1; dbSNP:rs112105381).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058566.
FT   VARIANT    1393   1393       K -> R (in MHS1; unknown pathological
FT                                significance; dbSNP:rs137933390).
FT                                {ECO:0000269|PubMed:20142353,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_068513.
FT   VARIANT    1467   1467       K -> R (in MHS1; dbSNP:rs145573319).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071732.
FT   VARIANT    1489   1489       S -> N (in dbSNP:rs34404839).
FT                                /FTId=VAR_032914.
FT   VARIANT    1571   1571       I -> V (in MHS1; dbSNP:rs146429605).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071733.
FT   VARIANT    1679   1679       R -> H (may be associated with
FT                                susceptibility to malignant hyperthermia;
FT                                dbSNP:rs146504767).
FT                                {ECO:0000269|PubMed:20142353}.
FT                                /FTId=VAR_068514.
FT   VARIANT    1704   1704       G -> S (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922779).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045709.
FT   VARIANT    1787   1787       P -> L (in MHS1; dbSNP:rs34934920).
FT                                {ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:21674524,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_005599.
FT   VARIANT    1832   1832       G -> A (in dbSNP:rs193922784).
FT                                {ECO:0000269|PubMed:11928716,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:8661021}.
FT                                /FTId=VAR_045710.
FT   VARIANT    2013   2013       K -> Q (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071734.
FT   VARIANT    2035   2035       H -> L (in MMDO; dbSNP:rs367543056).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063847.
FT   VARIANT    2060   2060       G -> C (in MHS1; dbSNP:rs35364374).
FT                                {ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:16380615,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:20681998,
FT                                ECO:0000269|PubMed:21674524,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_005600.
FT   VARIANT    2101   2101       M -> K (in dbSNP:rs746818096).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045711.
FT   VARIANT    2117   2117       V -> L (in MHS1; dbSNP:rs193922788).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_045712.
FT   VARIANT    2129   2129       D -> E (in MHS1; dbSNP:rs117886618).
FT                                {ECO:0000269|PubMed:11241852,
FT                                ECO:0000269|PubMed:12059893}.
FT                                /FTId=VAR_045713.
FT   VARIANT    2163   2163       R -> C (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs118192175).
FT                                {ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005601.
FT   VARIANT    2163   2163       R -> H (in CCD and MHS1; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs118192163).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005602.
FT   VARIANT    2163   2163       R -> P (in MHS1; dbSNP:rs118192163).
FT                                {ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_008972.
FT   VARIANT    2168   2168       V -> M (in CCD and MHS1; no difference in
FT                                the thapsigargin-sensitive calcium stores
FT                                of cells carrying this mutation and the
FT                                wild-type; increases calcium-induced
FT                                calcium release activity;
FT                                dbSNP:rs118192176).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12709367,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005603.
FT   VARIANT    2204   2204       H -> Q (in CCD; dbSNP:rs141646642).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068515.
FT   VARIANT    2206   2206       T -> M (in MHS1; induces an increase
FT                                sensitivity to caffeine;
FT                                dbSNP:rs118192177).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9497245}.
FT                                /FTId=VAR_005604.
FT   VARIANT    2206   2206       T -> R (in MHS1; dbSNP:rs118192177).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_008973.
FT   VARIANT    2214   2214       V -> I (in MHS1; dbSNP:rs193922795).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045714.
FT   VARIANT    2248   2248       R -> C (in dbSNP:rs763352221).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071735.
FT   VARIANT    2248   2248       R -> H (in MHS1; unknown pathological
FT                                significance; dbSNP:rs140152019).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071736.
FT   VARIANT    2280   2280       V -> I (in MHS1; dbSNP:rs193922797).
FT                                {ECO:0000269|PubMed:12208234}.
FT                                /FTId=VAR_045715.
FT   VARIANT    2321   2321       I -> V (in dbSNP:rs34390345).
FT                                {ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_058567.
FT   VARIANT    2336   2336       R -> H (in MHS1; dbSNP:rs112563513).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058568.
FT   VARIANT    2342   2342       N -> S (in MHS1; dbSNP:rs147213895).
FT                                {ECO:0000269|PubMed:15221887}.
FT                                /FTId=VAR_045716.
FT   VARIANT    2344   2344       E -> D (in MHS1; unknown pathological
FT                                significance; dbSNP:rs193922798).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045717.
FT   VARIANT    2346   2346       V -> M (in MHS1; dbSNP:rs193922799).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045718.
FT   VARIANT    2347   2347       Missing (in MHS1).
FT                                {ECO:0000269|PubMed:11389482}.
FT                                /FTId=VAR_045719.
FT   VARIANT    2348   2348       E -> G (in MHS1; dbSNP:rs193922801).
FT                                {ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045720.
FT   VARIANT    2350   2350       A -> T (in MHS1; reveals an altered
FT                                calcium dependence and increased caffeine
FT                                sensitivity; increases calcium-induced
FT                                calcium release activity;
FT                                dbSNP:rs193922802).
FT                                {ECO:0000269|PubMed:11525881,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_045721.
FT   VARIANT    2351   2351       N -> H (in MHS1; unknown pathological
FT                                significance; dbSNP:rs376176332).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071738.
FT   VARIANT    2354   2354       V -> M (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071739.
FT   VARIANT    2355   2355       R -> C (in MHS1).
FT                                {ECO:0000269|PubMed:12123492}.
FT                                /FTId=VAR_045722.
FT   VARIANT    2358   2358       I -> L (in MHS1; unknown pathological
FT                                significance; dbSNP:rs759306349).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071740.
FT   VARIANT    2367   2367       A -> T (in MHS1; dbSNP:rs146306934).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045723.
FT   VARIANT    2375   2375       G -> A (increases calcium-induced calcium
FT                                release activity; dbSNP:rs193922807).
FT                                {ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_077682.
FT   VARIANT    2383   2383       A -> Q (in MHS1; requires 2 nucleotide
FT                                substitutions; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071741.
FT   VARIANT    2400   2400       D -> G (in MHS1; dbSNP:rs976108591).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071742.
FT   VARIANT    2404   2404       E -> K (in MHS1; dbSNP:rs111364296).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058569.
FT   VARIANT    2421   2421       A -> P (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922808).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045724.
FT   VARIANT    2423   2423       M -> K (in MMDO and CCD; autosomal
FT                                recessive form; dbSNP:rs118192174).
FT                                {ECO:0000269|PubMed:16380615,
FT                                ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_032915.
FT   VARIANT    2428   2428       A -> T (in MHS1; induces an increase
FT                                sensitivity to caffeine;
FT                                dbSNP:rs193922809).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045725.
FT   VARIANT    2431   2431       D -> N (in MHS1; dbSNP:rs193922810).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045726.
FT   VARIANT    2434   2434       G -> R (in MHS1; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs121918593).
FT                                {ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:7849712,
FT                                ECO:0000269|PubMed:7881417}.
FT                                /FTId=VAR_005605.
FT   VARIANT    2435   2435       R -> H (in CCD and MHS1; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs28933396).
FT                                {ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:8220422}.
FT                                /FTId=VAR_005606.
FT   VARIANT    2435   2435       R -> L (in MHS1; dbSNP:rs28933396).
FT                                {ECO:0000269|PubMed:10051009,
FT                                ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:12709367}.
FT                                /FTId=VAR_008974.
FT   VARIANT    2437   2437       A -> V (in MHS1; dbSNP:rs193922812).
FT                                {ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045727.
FT   VARIANT    2452   2452       R -> W (in MHS1; dbSNP:rs118192124).
FT                                {ECO:0000269|PubMed:10823104,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045728.
FT   VARIANT    2454   2454       R -> C (in MHS1; induces an increase
FT                                sensitivity to caffeine; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs193922816).
FT                                {ECO:0000269|PubMed:10612851,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_008975.
FT   VARIANT    2454   2454       R -> H (in MHS1; severe form; increases
FT                                calcium-induced calcium release activity;
FT                                dbSNP:rs118192122).
FT                                {ECO:0000269|PubMed:10051009,
FT                                ECO:0000269|PubMed:10823104,
FT                                ECO:0000269|PubMed:11575529,
FT                                ECO:0000269|PubMed:12059893,
FT                                ECO:0000269|PubMed:12709367,
FT                                ECO:0000269|PubMed:15448513,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_008976.
FT   VARIANT    2458   2458       R -> C (in MHS1; dbSNP:rs28933397).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9450902}.
FT                                /FTId=VAR_008977.
FT   VARIANT    2458   2458       R -> H (in MHS1; dbSNP:rs121918594).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:27586648,
FT                                ECO:0000269|PubMed:9450902}.
FT                                /FTId=VAR_008978.
FT   VARIANT    2508   2508       R -> C (in MHS1 and CCD; increases
FT                                sensitivity to caffeine and 4-chloro-m-
FT                                cresol; decreases protein abundance;
FT                                increases calcium-induced calcium release
FT                                activity; dbSNP:rs118192178).
FT                                {ECO:0000269|PubMed:19685112,
FT                                ECO:0000269|PubMed:26381711,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_075399.
FT   VARIANT    2508   2508       R -> G (in CCD; increases sensitivity to
FT                                caffeine and 4-chloro-m-cresol;
FT                                dbSNP:rs118192178).
FT                                {ECO:0000269|PubMed:20142353,
FT                                ECO:0000269|PubMed:26381711}.
FT                                /FTId=VAR_068516.
FT   VARIANT    2508   2508       R -> H (in MHS1; increases sensitivity to
FT                                caffeine and 4-chloro-m-cresol; decreases
FT                                protein abundance; increases calcium-
FT                                induced calcium release activity;
FT                                dbSNP:rs193922818).
FT                                {ECO:0000269|PubMed:26381711,
FT                                ECO:0000269|PubMed:27586648}.
FT                                /FTId=VAR_077683.
FT   VARIANT    2509   2509       V -> I (in dbSNP:rs2071088).
FT                                /FTId=VAR_051891.
FT   VARIANT    2550   2550       L -> V (in dbSNP:rs193922821).
FT                                {ECO:0000269|PubMed:1354642,
FT                                ECO:0000269|PubMed:19191329,
FT                                ECO:0000269|PubMed:8661021}.
FT                                /FTId=VAR_058570.
FT   VARIANT    2593   2593       R -> G (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071743.
FT   VARIANT    2627   2627       V -> M (in MHS1).
FT                                {ECO:0000269|PubMed:24013571}.
FT                                /FTId=VAR_071744.
FT   VARIANT    2676   2676       R -> W (in MHS1; located on the same
FT                                allele as S-2787; dbSNP:rs193922826).
FT                                {ECO:0000269|PubMed:14732627,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045729.
FT   VARIANT    2730   2730       D -> G (in MHS1; dbSNP:rs112196644).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058571.
FT   VARIANT    2779   2779       E -> K (in dbSNP:rs2915952).
FT                                /FTId=VAR_051892.
FT   VARIANT    2787   2787       T -> S (in MHS1; located on the same
FT                                allele as W-2676; dbSNP:rs35180584).
FT                                {ECO:0000269|PubMed:14732627,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045730.
FT   VARIANT    2880   2880       E -> K (in MHS1; dbSNP:rs112772310).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058572.
FT   VARIANT    2963   2963       L -> P (in CCD; dbSNP:rs756870293).
FT                                {ECO:0000269|PubMed:27234031}.
FT                                /FTId=VAR_076568.
FT   VARIANT    2976   2976       H -> Y. {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071745.
FT   VARIANT    3118   3118       A -> V (in dbSNP:rs2915960).
FT                                /FTId=VAR_045731.
FT   VARIANT    3217   3217       S -> P (in MHS1; dbSNP:rs113422327).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058573.
FT   VARIANT    3238   3238       E -> G (in CCD; unknown pathological
FT                                significance; dbSNP:rs200950673).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071746.
FT   VARIANT    3290   3290       E -> K (in MHS1; dbSNP:rs112151058).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058574.
FT   VARIANT    3326   3326       N -> K (in MMDO; dbSNP:rs367543057).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063848.
FT   VARIANT    3360   3360       P -> Q. {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071747.
FT   VARIANT    3366   3366       R -> H (in CCD; dbSNP:rs137932199).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068517.
FT   VARIANT    3402   3402       C -> G (in MMDO; dbSNP:rs367543058).
FT                                {ECO:0000269|PubMed:20583297}.
FT                                /FTId=VAR_063849.
FT   VARIANT    3410   3410       P -> Q (in MHS1).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071748.
FT   VARIANT    3501   3501       D -> Y (in MHS1; dbSNP:rs763259167).
FT                                {ECO:0000269|PubMed:20681998}.
FT                                /FTId=VAR_071749.
FT   VARIANT    3527   3527       P -> S (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192164).
FT                                {ECO:0000269|PubMed:12112081}.
FT                                /FTId=VAR_045732.
FT   VARIANT    3539   3539       R -> H (in CCD; autosomal recessive form;
FT                                dbSNP:rs143987857).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045733.
FT   VARIANT    3583   3583       E -> Q (in dbSNP:rs55876273).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058575.
FT   VARIANT    3711   3711       T -> R (in MHS1; unknown pathological
FT                                significance; dbSNP:rs375915752).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071750.
FT   VARIANT    3756   3756       Q -> E (in dbSNP:rs4802584).
FT                                {ECO:0000269|PubMed:11928716,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_032916.
FT   VARIANT    3772   3772       R -> Q (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922839).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045734.
FT   VARIANT    3772   3772       R -> W (in MHS1; dbSNP:rs763112609).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058576.
FT   VARIANT    3806   3806       G -> R (in MHS1; dbSNP:rs111565359).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058577.
FT   VARIANT    3916   3916       I -> M (in MHS1; dbSNP:rs193922840).
FT                                {ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045735.
FT   VARIANT    3933   3933       Y -> C (in CCD and MHS1;
FT                                dbSNP:rs147136339).
FT                                {ECO:0000269|PubMed:20681998,
FT                                ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068518.
FT   VARIANT    4136   4136       R -> S (in MHS1; dbSNP:rs193922849).
FT                                {ECO:0000269|PubMed:12208234}.
FT                                /FTId=VAR_045736.
FT   VARIANT    4178   4178       G -> V (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071751.
FT   VARIANT    4214   4216       Missing (in CCD).
FT                                /FTId=VAR_045737.
FT   VARIANT    4230   4230       M -> R (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071752.
FT   VARIANT    4234   4234       V -> L (in MHS1; dbSNP:rs193922852).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:24013571}.
FT                                /FTId=VAR_045738.
FT   VARIANT    4493   4493       P -> A (in dbSNP:rs149455643).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068519.
FT   VARIANT    4501   4501       P -> L (in MHS1; dbSNP:rs73933023).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058578.
FT   VARIANT    4558   4558       R -> Q (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192130).
FT                                {ECO:0000269|PubMed:17226826,
FT                                ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045739.
FT   VARIANT    4637   4637       T -> A (in CCD; dbSNP:rs118192166).
FT                                {ECO:0000269|PubMed:11113224}.
FT                                /FTId=VAR_045740.
FT   VARIANT    4637   4637       T -> I (in core/rod disease;
FT                                dbSNP:rs118192134).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045741.
FT   VARIANT    4638   4638       G -> D (in CCD; dbSNP:rs118192135).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045742.
FT   VARIANT    4647   4648       Missing (in CCD).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045743.
FT   VARIANT    4650   4650       L -> P (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192138).
FT                                {ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045744.
FT   VARIANT    4651   4651       H -> P (in CCD; dbSNP:rs118192139).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045745.
FT   VARIANT    4668   4668       P -> S (in dbSNP:rs193922863).
FT                                {ECO:0000269|PubMed:11928716}.
FT                                /FTId=VAR_045746.
FT   VARIANT    4684   4684       F -> S (in MHS1; dbSNP:rs193922864).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045747.
FT   VARIANT    4724   4724       K -> Q (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192141).
FT                                {ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045748.
FT   VARIANT    4737   4737       R -> Q (in MHS1; dbSNP:rs193922868).
FT                                {ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045749.
FT   VARIANT    4737   4737       R -> W (in MHS1; unknown pathological
FT                                significance; slightly increases Ca(2+)
FT                                release in response to 4-chloro-m-cresol;
FT                                dbSNP:rs193922867).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:26631338}.
FT                                /FTId=VAR_045750.
FT   VARIANT    4743   4743       G -> D (in CCD; dbSNP:rs193922869).
FT                                {ECO:0000269|PubMed:21674524}.
FT                                /FTId=VAR_068520.
FT   VARIANT    4793   4793       L -> P (in CCD; dbSNP:rs118192179).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045751.
FT   VARIANT    4796   4796       Y -> C (in CCD; dbSNP:rs118192167).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045752.
FT   VARIANT    4806   4806       N -> D (in CCD; dbSNP:rs886039586).
FT                                {ECO:0000269|PubMed:27234031}.
FT                                /FTId=VAR_076569.
FT   VARIANT    4814   4814       L -> F (in CCD; dbSNP:rs118192142).
FT                                {ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045753.
FT   VARIANT    4824   4824       L -> P (in MHS1; dbSNP:rs193922874).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:15448513}.
FT                                /FTId=VAR_045754.
FT   VARIANT    4825   4825       R -> C (in CCD; dbSNP:rs118192180).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045755.
FT   VARIANT    4826   4826       T -> I (in MHS1; dbSNP:rs121918595).
FT                                {ECO:0000269|PubMed:10888602,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045756.
FT   VARIANT    4837   4837       Q -> E (in MHS1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071753.
FT   VARIANT    4838   4838       L -> V (in MHS1; dbSNP:rs193922878).
FT                                {ECO:0000269|PubMed:11928716,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045757.
FT   VARIANT    4842   4842       V -> M (in CCD; autosomal recessive form;
FT                                dbSNP:rs193922879).
FT                                {ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045758.
FT   VARIANT    4846   4846       A -> V (in CCD; autosomal recessive form;
FT                                dbSNP:rs118192143).
FT                                {ECO:0000269|PubMed:17204054,
FT                                ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045759.
FT   VARIANT    4849   4849       V -> I (in MHS1 and CCD; autosomal
FT                                recessive form; dbSNP:rs118192168).
FT                                {ECO:0000269|PubMed:12136074,
FT                                ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:17226826,
FT                                ECO:0000269|PubMed:18253926}.
FT                                /FTId=VAR_045760.
FT   VARIANT    4860   4860       Missing (in CCD).
FT                                {ECO:0000269|PubMed:11709545}.
FT                                /FTId=VAR_045761.
FT   VARIANT    4861   4861       R -> C (in CCD; dbSNP:rs118192181).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045762.
FT   VARIANT    4861   4861       R -> H (in CCD and MHS1; release of
FT                                calcium from intracellular stores in the
FT                                absence of any pharmacological activator
FT                                of RYR; dbSNP:rs63749869).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:14670767,
FT                                ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:17226826,
FT                                ECO:0000269|PubMed:23558838,
FT                                ECO:0000269|PubMed:24561095}.
FT                                /FTId=VAR_045763.
FT   VARIANT    4863   4869       FYNKSED -> Y (in CCD).
FT                                /FTId=VAR_045764.
FT   VARIANT    4864   4864       Y -> C (in CCD; dbSNP:rs118192146).
FT                                {ECO:0000269|PubMed:14670767}.
FT                                /FTId=VAR_045765.
FT   VARIANT    4876   4876       K -> R (in MHS1; dbSNP:rs113210953).
FT                                {ECO:0000269|PubMed:16163667,
FT                                ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_045766.
FT   VARIANT    4882   4882       T -> M (in CCD; dbSNP:rs193922884).
FT                                {ECO:0000269|PubMed:18312400}.
FT                                /FTId=VAR_068521.
FT   VARIANT    4891   4891       G -> R (in CCD; dbSNP:rs118192149).
FT                                {ECO:0000269|PubMed:11741831}.
FT                                /FTId=VAR_045767.
FT   VARIANT    4893   4893       R -> Q (in CCD; dbSNP:rs118192151).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045768.
FT   VARIANT    4893   4893       R -> W (in CCD; release of calcium from
FT                                intracellular stores in the absence of
FT                                any pharmacological activator of RYR;
FT                                smaller thapsigargin-sensitive
FT                                intracellular calcium stores; normal
FT                                sensitivity of the calcium release to the
FT                                RYR inhibitor dantrolene;
FT                                dbSNP:rs118192150).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:14670767}.
FT                                /FTId=VAR_045769.
FT   VARIANT    4897   4897       G -> A (in CCD).
FT                                {ECO:0000269|PubMed:24561095}.
FT                                /FTId=VAR_071754.
FT   VARIANT    4897   4897       G -> V (in CCD; dbSNP:rs118192148).
FT                                {ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045770.
FT   VARIANT    4898   4898       I -> T (in CCD; severe phenotype;
FT                                dbSNP:rs118192170).
FT                                {ECO:0000269|PubMed:10097181,
FT                                ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:11741831,
FT                                ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:24561095}.
FT                                /FTId=VAR_045771.
FT   VARIANT    4899   4899       G -> E (in CCD; dbSNP:rs118192183).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:12937085}.
FT                                /FTId=VAR_045772.
FT   VARIANT    4899   4899       G -> R (in CCD; release of calcium from
FT                                intracellular stores in the absence of
FT                                any pharmacological activator of RYR;
FT                                smaller thapsigargin-sensitive
FT                                intracellular calcium stores; normal
FT                                sensitivity of the calcium release to the
FT                                RYR inhibitor dantrolene;
FT                                dbSNP:rs193922891).
FT                                {ECO:0000269|PubMed:11741831}.
FT                                /FTId=VAR_045773.
FT   VARIANT    4906   4906       A -> G (in MHS1; unknown pathological
FT                                significance; dbSNP:rs118192153).
FT                                {ECO:0000269|PubMed:23558838}.
FT                                /FTId=VAR_071755.
FT   VARIANT    4906   4906       A -> V (in CCD; dbSNP:rs118192153).
FT                                {ECO:0000269|PubMed:11741831}.
FT                                /FTId=VAR_045774.
FT   VARIANT    4914   4914       R -> G (in CCD; dbSNP:rs118192184).
FT                                {ECO:0000269|PubMed:11709545,
FT                                ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045775.
FT   VARIANT    4914   4914       R -> T (in CCD; dbSNP:rs118192154).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:17226826}.
FT                                /FTId=VAR_045776.
FT   VARIANT    4927   4928       Missing (in CCD).
FT                                {ECO:0000269|PubMed:12565913}.
FT                                /FTId=VAR_045777.
FT   VARIANT    4938   4938       I -> M (in CCD; dbSNP:rs118192159).
FT                                {ECO:0000269|PubMed:14985404}.
FT                                /FTId=VAR_045778.
FT   VARIANT    4938   4938       I -> T (in MHS1; dbSNP:rs111657878).
FT                                {ECO:0000269|PubMed:19191329}.
FT                                /FTId=VAR_058579.
FT   VARIANT    4939   4939       D -> E (in MHS1; dbSNP:rs193922895).
FT                                {ECO:0000269|PubMed:14985404,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045779.
FT   VARIANT    4940   4940       A -> T (in CCD; dbSNP:rs118192158).
FT                                {ECO:0000269|PubMed:12565913,
FT                                ECO:0000269|PubMed:14670767}.
FT                                /FTId=VAR_045780.
FT   VARIANT    4942   4942       G -> V (in MHS1; dbSNP:rs193922896).
FT                                {ECO:0000269|PubMed:12208234}.
FT                                /FTId=VAR_045781.
FT   VARIANT    4973   4973       P -> L (in MHS1; dbSNP:rs146876145).
FT                                {ECO:0000269|PubMed:12208234,
FT                                ECO:0000269|PubMed:12411788,
FT                                ECO:0000269|PubMed:16163667}.
FT                                /FTId=VAR_045782.
FT   MUTAGEN     522    522       Y->C: Increases calcium-induced calcium
FT                                release activity.
FT                                {ECO:0000269|PubMed:26115329}.
FT   MUTAGEN    2508   2508       R->K: Increases sensitivity to caffeine
FT                                and 4-chloro-m-cresol.
FT                                {ECO:0000269|PubMed:26381711}.
FT   MUTAGEN    2508   2508       R->S: Increases sensitivity to caffeine
FT                                and 4-chloro-m-cresol.
FT                                {ECO:0000269|PubMed:26381711}.
FT   CONFLICT   1365   1368       GEAQ -> RGA (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   2324   2324       N -> K (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   2840   2840       R -> A (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   3380   3380       R -> A (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
SQ   SEQUENCE   5038 AA;  565176 MW;  EC32277F4885CC7F CRC64;
     MGDAEGEDEV QFLRTDDEVV LQCSATVLKE QLKLCLAAEG FGNRLCFLEP TSNAQNVPPD
     LAICCFVLEQ SLSVRALQEM LANTVEAGVE SSQGGGHRTL LYGHAILLRH AHSRMYLSCL
     TTSRSMTDKL AFDVGLQEDA TGEACWWTMH PASKQRSEGE KVRVGDDIIL VSVSSERYLH
     LSTASGELQV DASFMQTLWN MNPICSRCEE GFVTGGHVLR LFHGHMDECL TISPADSDDQ
     RRLVYYEGGA VCTHARSLWR LEPLRISWSG SHLRWGQPLR VRHVTTGQYL ALTEDQGLVV
     VDASKAHTKA TSFCFRISKE KLDVAPKRDV EGMGPPEIKY GESLCFVQHV ASGLWLTYAA
     PDPKALRLGV LKKKAMLHQE GHMDDALSLT RCQQEESQAA RMIHSTNGLY NQFIKSLDSF
     SGKPRGSGPP AGTALPIEGV ILSLQDLIIY FEPPSEDLQH EEKQSKLRSL RNRQSLFQEE
     GMLSMVLNCI DRLNVYTTAA HFAEFAGEEA AESWKEIVNL LYELLASLIR GNRSNCALFS
     TNLDWLVSKL DRLEASSGIL EVLYCVLIES PEVLNIIQEN HIKSIISLLD KHGRNHKVLD
     VLCSLCVCNG VAVRSNQDLI TENLLPGREL LLQTNLINYV TSIRPNIFVG RAEGTTQYSK
     WYFEVMVDEV TPFLTAQATH LRVGWALTEG YTPYPGAGEG WGGNGVGDDL YSYGFDGLHL
     WTGHVARPVT SPGQHLLAPE DVISCCLDLS VPSISFRING CPVQGVFESF NLDGLFFPVV
     SFSAGVKVRF LLGGRHGEFK FLPPPGYAPC HEAVLPRERL HLEPIKEYRR EGPRGPHLVG
     PSRCLSHTDF VPCPVDTVQI VLPPHLERIR EKLAENIHEL WALTRIEQGW TYGPVRDDNK
     RLHPCLVDFH SLPEPERNYN LQMSGETLKT LLALGCHVGM ADEKAEDNLK KTKLPKTYMM
     SNGYKPAPLD LSHVRLTPAQ TTLVDRLAEN GHNVWARDRV GQGWSYSAVQ DIPARRNPRL
     VPYRLLDEAT KRSNRDSLCQ AVRTLLGYGY NIEPPDQEPS QVENQSRCDR VRIFRAEKSY
     TVQSGRWYFE FEAVTTGEMR VGWARPELRP DVELGADELA YVFNGHRGQR WHLGSEPFGR
     PWQPGDVVGC MIDLTENTII FTLNGEVLMS DSGSETAFRE IEIGDGFLPV CSLGPGQVGH
     LNLGQDVSSL RFFAICGLQE GFEPFAINMQ RPVTTWFSKG LPQFEPVPLE HPHYEVSRVD
     GTVDTPPCLR LTHRTWGSQN SLVEMLFLRL SLPVQFHQHF RCTAGATPLA PPGLQPPAED
     EARAAEPDPD YENLRRSAGG WSEAENGKEG TAKEGAPGGT PQAGGEAQPA RAENEKDATT
     EKNKKRGFLF KAKKVAMMTQ PPATPTLPRL PHDVVPADNR DDPEIILNTT TYYYSVRVFA
     GQEPSCVWAG WVTPDYHQHD MSFDLSKVRV VTVTMGDEQG NVHSSLKCSN CYMVWGGDFV
     SPGQQGRISH TDLVIGCLVD LATGLMTFTA NGKESNTFFQ VEPNTKLFPA VFVLPTHQNV
     IQFELGKQKN IMPLSAAMFQ SERKNPAPQC PPRLEMQMLM PVSWSRMPNH FLQVETRRAG
     ERLGWAVQCQ EPLTMMALHI PEENRCMDIL ELSERLDLQR FHSHTLRLYR AVCALGNNRV
     AHALCSHVDQ AQLLHALEDA HLPGPLRAGY YDLLISIHLE SACRSRRSML SEYIVPLTPE
     TRAITLFPPG RSTENGHPRH GLPGVGVTTS LRPPHHFSPP CFVAALPAAG AAEAPARLSP
     AIPLEALRDK ALRMLGEAVR DGGQHARDPV GGSVEFQFVP VLKLVSTLLV MGIFGDEDVK
     QILKMIEPEV FTEEEEEEDE EEEGEEEDEE EKEEDEEETA QEKEDEEKEE EEAAEGEKEE
     GLEEGLLQMK LPESVKLQMC HLLEYFCDQE LQHRVESLAA FAERYVDKLQ ANQRSRYGLL
     IKAFSMTAAE TARRTREFRS PPQEQINMLL QFKDGTDEED CPLPEEIRQD LLDFHQDLLA
     HCGIQLDGEE EEPEEETTLG SRLMSLLEKV RLVKKKEEKP EEERSAEESK PRSLQELVSH
     MVVRWAQEDF VQSPELVRAM FSLLHRQYDG LGELLRALPR AYTISPSSVE DTMSLLECLG
     QIRSLLIVQM GPQEENLMIQ SIGNIMNNKV FYQHPNLMRA LGMHETVMEV MVNVLGGGES
     KEIRFPKMVT SCCRFLCYFC RISRQNQRSM FDHLSYLLEN SGIGLGMQGS TPLDVAAASV
     IDNNELALAL QEQDLEKVVS YLAGCGLQSC PMLVAKGYPD IGWNPCGGER YLDFLRFAVF
     VNGESVEENA NVVVRLLIRK PECFGPALRG EGGSGLLAAI EEAIRISEDP ARDGPGIRRD
     RRREHFGEEP PEENRVHLGH AIMSFYAALI DLLGRCAPEM HLIQAGKGEA LRIRAILRSL
     VPLEDLVGII SLPLQIPTLG KDGALVQPKM SASFVPDHKA SMVLFLDRVY GIENQDFLLH
     VLDVGFLPDM RAAASLDTAT FSTTEMALAL NRYLCLAVLP LITKCAPLFA GTEHRAIMVD
     SMLHTVYRLS RGRSLTKAQR DVIEDCLMSL CRYIRPSMLQ HLLRRLVFDV PILNEFAKMP
     LKLLTNHYER CWKYYCLPTG WANFGVTSEE ELHLTRKLFW GIFDSLAHKK YDPELYRMAM
     PCLCAIAGAL PPDYVDASYS SKAEKKATVD AEGNFDPRPV ETLNVIIPEK LDSFINKFAE
     YTHEKWAFDK IQNNWSYGEN IDEELKTHPM LRPYKTFSEK DKEIYRWPIK ESLKAMIAWE
     WTIEKAREGE EEKTEKKKTR KISQSAQTYD PREGYNPQPP DLSAVTLSRE LQAMAEQLAE
     NYHNTWGRKK KQELEAKGGG THPLLVPYDT LTAKEKARDR EKAQELLKFL QMNGYAVTRG
     LKDMELDSSS IEKRFAFGFL QQLLRWMDIS QEFIAHLEAV VSSGRVEKSP HEQEIKFFAK
     ILLPLINQYF TNHCLYFLST PAKVLGSGGH ASNKEKEMIT SLFCKLAALV RHRVSLFGTD
     APAVVNCLHI LARSLDARTV MKSGPEIVKA GLRSFFESAS EDIEKMVENL RLGKVSQART
     QVKGVGQNLT YTTVALLPVL TTLFQHIAQH QFGDDVILDD VQVSCYRTLC SIYSLGTTKN
     TYVEKLRPAL GECLARLAAA MPVAFLEPQL NEYNACSVYT TKSPRERAIL GLPNSVEEMC
     PDIPVLERLM ADIGGLAESG ARYTEMPHVI EITLPMLCSY LPRWWERGPE APPSALPAGA
     PPPCTAVTSD HLNSLLGNIL RIIVNNLGID EASWMKRLAV FAQPIVSRAR PELLQSHFIP
     TIGRLRKRAG KVVSEEEQLR LEAKAEAQEG ELLVRDEFSV LCRDLYALYP LLIRYVDNNR
     AQWLTEPNPS AEELFRMVGE IFIYWSKSHN FKREEQNFVV QNEINNMSFL TADNKSKMAK
     AGDIQSGGSD QERTKKKRRG DRYSVQTSLI VATLKKMLPI GLNMCAPTDQ DLITLAKTRY
     ALKDTDEEVR EFLHNNLHLQ GKVEGSPSLR WQMALYRGVP GREEDADDPE KIVRRVQEVS
     AVLYYLDQTE HPYKSKKAVW HKLLSKQRRR AVVACFRMTP LYNLPTHRAC NMFLESYKAA
     WILTEDHSFE DRMIDDLSKA GEQEEEEEEV EEKKPDPLHQ LVLHFSRTAL TEKSKLDEDY
     LYMAYADIMA KSCHLEEGGE NGEAEEEVEV SFEEKQMEKQ RLLYQQARLH TRGAAEMVLQ
     MISACKGETG AMVSSTLKLG ISILNGGNAE VQQKMLDYLK DKKEVGFFQS IQALMQTCSV
     LDLNAFERQN KAEGLGMVNE DGTVINRQNG EKVMADDEFT QDLFRFLQLL CEGHNNDFQN
     YLRTQTGNTT TINIIICTVD YLLRLQESIS DFYWYYSGKD VIEEQGKRNF SKAMSVAKQV
     FNSLTEYIQG PCTGNQQSLA HSRLWDAVVG FLHVFAHMMM KLAQDSSQIE LLKELLDLQK
     DMVVMLLSLL EGNVVNGMIA RQMVDMLVES SSNVEMILKF FDMFLKLKDI VGSEAFQDYV
     TDPRGLISKK DFQKAMDSQK QFSGPEIQFL LSCSEADENE MINCEEFANR FQEPARDIGF
     NVAVLLTNLS EHVPHDPRLH NFLELAESIL EYFRPYLGRI EIMGASRRIE RIYFEISETN
     RAQWEMPQVK ESKRQFIFDV VNEGGEAEKM ELFVSFCEDT IFEMQIAAQI SEPEGEPETD
     EDEGAGAAEA GAEGAEEGAA GLEGTAATAA AGATARVVAA AGRALRGLSY RSLRRRVRRL
     RRLTAREAAT AVAALLWAAV TRAGAAGAGA AAGALGLLWG SLFGGGLVEG AKKVTVTELL
     AGMPDPTSDE VHGEQPAGPG GDADGEGASE GAGDAAEGAG DEEEAVHEAG PGGADGAVAV
     TDGGPFRPEG AGGLGDMGDT TPAEPPTPEG SPILKRKLGV DGVEEELPPE PEPEPEPELE
     PEKADAENGE KEEVPEPTPE PPKKQAPPSP PPKKEEAGGE FWGELEVQRV KFLNYLSRNF
     YTLRFLALFL AFAINFILLF YKVSDSPPGE DDMEGSAAGD VSGAGSGGSS GWGLGAGEEA
     EGDEDENMVY YFLEESTGYM EPALRCLSLL HTLVAFLCII GYNCLKVPLV IFKREKELAR
     KLEFDGLYIT EQPEDDDVKG QWDRLVLNTP SFPSNYWDKF VKRKVLDKHG DIYGRERIAE
     LLGMDLATLE ITAHNERKPN PPPGLLTWLM SIDVKYQIWK FGVIFTDNSF LYLGWYMVMS
     LLGHYNNFFF AAHLLDIAMG VKTLRTILSS VTHNGKQLVM TVGLLAVVVY LYTVVAFNFF
     RKFYNKSEDE DEPDMKCDDM MTCYLFHMYV GVRAGGGIGD EIEDPAGDEY ELYRVVFDIT
     FFFFVIVILL AIIQGLIIDA FGELRDQQEQ VKEDMETKCF ICGIGSDYFD TTPHGFETHT
     LEEHNLANYM FFLMYLINKD ETEHTGQESY VWKMYQERCW DFFPAGDCFR KQYEDQLS
//
ID   GLRA1_HUMAN             Reviewed;         457 AA.
AC   P23415; B2R6T3; Q14C77; Q6DJV9;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 192.
DE   RecName: Full=Glycine receptor subunit alpha-1;
DE   AltName: Full=Glycine receptor 48 kDa subunit;
DE   AltName: Full=Glycine receptor strychnine-binding subunit;
DE   Flags: Precursor;
GN   Name=GLRA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), FUNCTION, SUBCELLULAR
RP   LOCATION, AND ENZYME REGULATION.
RX   PubMed=2155780;
RA   Grenningloh G., Schmieden V., Schofield P.R., Seeburg P.H.,
RA   Siddique T., Mohandas T.K., Becker C.-M., Betz H.;
RT   "Alpha subunit variants of the human glycine receptor: primary
RT   structures, functional expression and chromosomal localization of the
RT   corresponding genes.";
RL   EMBO J. 9:771-776(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ALA-80.
RX   PubMed=7920629; DOI=10.1038/ng0694-131;
RA   Ryan S.G., Buckwalter M.S., Lynch J.W., Handford C.A., Segura L.,
RA   Shiang R., Wasmuth J.J., Camper S.A., Schofield P., O'Connell P.;
RT   "A missense mutation in the gene encoding the alpha 1 subunit of the
RT   inhibitory glycine receptor in the spasmodic mouse.";
RL   Nat. Genet. 7:131-135(1994).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND INTERACTION WITH GLRB.
RX   PubMed=14551753; DOI=10.1007/s00249-003-0286-y;
RA   Mohammadi B., Krampfl K., Cetinkaya C., Moschref H., Grosskreutz J.,
RA   Dengler R., Bufler J.;
RT   "Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta
RT   glycine receptor channels.";
RL   Eur. Biophys. J. 32:529-536(2003).
RN   [7]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   HIS-137; GLU-220; ASP-222 AND HIS-243.
RX   PubMed=16144831; DOI=10.1074/jbc.M508303200;
RA   Miller P.S., Da Silva H.M., Smart T.G.;
RT   "Molecular basis for zinc potentiation at strychnine-sensitive glycine
RT   receptors.";
RL   J. Biol. Chem. 280:37877-37884(2005).
RN   [8]
RP   DISULFIDE BONDS.
RX   PubMed=19861413; DOI=10.1074/jbc.M109.043448;
RA   Vogel N., Kluck C.J., Melzer N., Schwarzinger S., Breitinger U.,
RA   Seeber S., Becker C.M.;
RT   "Mapping of disulfide bonds within the amino-terminal extracellular
RT   domain of the inhibitory glycine receptor.";
RL   J. Biol. Chem. 284:36128-36136(2009).
RN   [9]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, INTERACTION WITH
RP   GLRB, AND SUBUNIT STOICHIOMETRY.
RX   PubMed=22715885; DOI=10.1021/bi300063m;
RA   Yang Z., Taran E., Webb T.I., Lynch J.W.;
RT   "Stoichiometry and subunit arrangement of alpha1beta glycine receptors
RT   as determined by atomic force microscopy.";
RL   Biochemistry 51:5229-5231(2012).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH GLRB, AND SUBUNIT
RP   STOICHIOMETRY.
RX   PubMed=22973015; DOI=10.1523/JNEUROSCI.2050-12.2012;
RA   Durisic N., Godin A.G., Wever C.M., Heyes C.D., Lakadamyali M.,
RA   Dent J.A.;
RT   "Stoichiometry of the human glycine receptor revealed by direct
RT   subunit counting.";
RL   J. Neurosci. 32:12915-12920(2012).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25973519; DOI=10.1111/acer.12735;
RA   Horani S., Stater E.P., Corringer P.J., Trudell J.R., Harris R.A.,
RA   Howard R.J.;
RT   "Ethanol modulation is quantitatively determined by the transmembrane
RT   domain of human alpha1 glycine receptors.";
RL   Alcohol. Clin. Exp. Res. 39:962-968(2015).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=25445488; DOI=10.1016/j.neuropharm.2014.10.026;
RA   Zhang Y., Dixon C.L., Keramidas A., Lynch J.W.;
RT   "Functional reconstitution of glycinergic synapses incorporating
RT   defined glycine receptor subunit combinations.";
RL   Neuropharmacology 89:391-397(2015).
RN   [13]
RP   STRUCTURE BY NMR OF 277-304.
RX   PubMed=12667090; DOI=10.1021/bi026767g;
RA   Yushmanov V.E., Mandal P.K., Liu Z., Tang P., Xu Y.;
RT   "NMR structure and backbone dynamics of the extended second
RT   transmembrane domain of the human neuronal glycine receptor alpha1
RT   subunit.";
RL   Biochemistry 42:3989-3995(2003).
RN   [14]
RP   STRUCTURE BY NMR OF 278-337.
RX   PubMed=15952785; DOI=10.1021/bi050256n;
RA   Ma D., Liu Z., Li L., Tang P., Xu Y.;
RT   "Structure and dynamics of the second and third transmembrane domains
RT   of human glycine receptor.";
RL   Biochemistry 44:8790-8800(2005).
RN   [15]
RP   STRUCTURE BY NMR OF 244-453, ELECTRON MICROSCOPY, FUNCTION, ENZYME
RP   REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY, AND DOMAIN.
RX   PubMed=23994010; DOI=10.1016/j.str.2013.07.014;
RA   Mowrey D.D., Cui T., Jia Y., Ma D., Makhov A.M., Zhang P., Tang P.,
RA   Xu Y.;
RT   "Open-channel structures of the human glycine receptor alpha1 full-
RT   length transmembrane domain.";
RL   Structure 21:1897-1904(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 246-338 AND 418-446,
RP   FUNCTION, ENZYME REGULATION, SUBUNIT, SUBCELLULAR LOCATION, TOPOLOGY,
RP   CHARACTERIZATION OF VARIANTS HKPX1 GLU-254; THR-278; GLN-299 AND
RP   MET-308, AND MUTAGENESIS OF GLY-282 AND LYS-304.
RX   PubMed=25730860; DOI=10.1073/pnas.1417864112;
RA   Moraga-Cid G., Sauguet L., Huon C., Malherbe L., Girard-Blanc C.,
RA   Petres S., Murail S., Taly A., Baaden M., Delarue M., Corringer P.J.;
RT   "Allosteric and hyperekplexic mutant phenotypes investigated on an
RT   alpha1 glycine receptor transmembrane structure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:2865-2870(2015).
RN   [17]
RP   VARIANTS HKPX1 LEU-299 AND GLN-299.
RX   PubMed=8298642; DOI=10.1038/ng1293-351;
RA   Shiang R., Ryan S.G., Zhu Y.-Z., Hahn A.F., O'Connell P.,
RA   Wasmuth J.J.;
RT   "Mutations in the alpha 1 subunit of the inhibitory glycine receptor
RT   cause the dominant neurologic disorder, hyperekplexia.";
RL   Nat. Genet. 5:351-357(1993).
RN   [18]
RP   VARIANT HKPX1 CYS-307.
RA   Shiang R., Ryan S.G., Zhu Y.-Z., O'Connell P., Wasmuth J.J.;
RT   "Mutational and haplotype analysis of the aplha1 subunit of the
RT   glycine receptor in hyperekplexia patients.";
RL   Am. J. Hum. Genet. 55:A242-A242(1994).
RN   [19]
RP   CHARACTERIZATION OF VARIANTS HKPX1 LEU-299 AND GLN-299, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=7925268;
RA   Langosch D., Laube B., Runstroem N., Schmieden V., Bormann J.,
RA   Betz H.;
RT   "Decreased agonist affinity and chloride conductance of mutant glycine
RT   receptors associated with human hereditary hyperekplexia.";
RL   EMBO J. 13:4223-4228(1994).
RN   [20]
RP   VARIANT HKPX1 LEU-299.
RX   PubMed=7981700; DOI=10.1093/hmg/3.7.1201;
RA   Schorderet D.F., Pescia G., Bernasconi A., Regli F.;
RT   "An additional family with Startle disease and a G1192A mutation at
RT   the alpha 1 subunit of the inhibitory glycine receptor gene.";
RL   Hum. Mol. Genet. 3:1201-1201(1994).
RN   [21]
RP   VARIANT HKPX1 ASN-272.
RX   PubMed=7881416; DOI=10.1093/hmg/3.12.2175;
RA   Rees M.I., Andrew M., Jawad S., Owen M.J.;
RT   "Evidence for recessive as well as dominant forms of startle disease
RT   (hyperekplexia) caused by mutations in the alpha 1 subunit of the
RT   inhibitory glycine receptor.";
RL   Hum. Mol. Genet. 3:2175-2179(1994).
RN   [22]
RP   VARIANT HKPX1 CYS-307.
RX   PubMed=7611730; DOI=10.1002/ana.410380115;
RA   Shiang R., Ryan S.G., Zhu Y.-Z., Fielder T.J., Allen R.J., Fryer A.,
RA   Yamashita S., O'Connell P., Wasmuth J.J.;
RT   "Mutational analysis of familial and sporadic hyperekplexia.";
RL   Ann. Neurol. 38:85-91(1995).
RN   [23]
RP   VARIANT HKPX1 HIS-294.
RX   PubMed=8571969;
RA   Milani N., Dalpra L., del Prete A., Zanini R., Larizza L.;
RT   "A novel mutation (Gln266-->His) in the alpha 1 subunit of the
RT   inhibitory glycine-receptor gene (GLRA1) in hereditary
RT   hyperekplexia.";
RL   Am. J. Hum. Genet. 58:420-422(1996).
RN   [24]
RP   VARIANT HKPX1 GLU-304.
RX   PubMed=8733061; DOI=10.1136/jmg.33.5.435;
RA   Elmslie F.V., Hutchings S.M., Spencer V., Curtis A., Covanis T.,
RA   Gardiner R.M., Rees M.;
RT   "Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel
RT   mutation in a family cosegregating for hyperekplexia and spastic
RT   paraparesis.";
RL   J. Med. Genet. 33:435-436(1996).
RN   [25]
RP   CHARACTERIZATION OF VARIANTS HKPX1 ASN-272; LEU-299; GLN-299; GLU-304
RP   AND CYS-307, FUNCTION, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=9009272; DOI=10.1093/emboj/16.1.110;
RA   Lynch J.W., Rajendra S., Pierce K.D., Handford C.A., Barry P.H.,
RA   Schofield P.R.;
RT   "Identification of intracellular and extracellular domains mediating
RT   signal transduction in the inhibitory glycine receptor chloride
RT   channel.";
RL   EMBO J. 16:110-120(1997).
RN   [26]
RP   VARIANT HKPX1 GLU-304.
RX   PubMed=9067762;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:2<185::AID-HUMU14>3.0.CO;2-Z;
RA   Seri M., Bolino A., Galietta L.J.V., Lerone M., Silengo M., Romeo G.;
RT   "Startle disease in an Italian family by mutation (K276E): the alpha-
RT   subunit of the inhibiting glycine receptor.";
RL   Hum. Mutat. 9:185-187(1997).
RN   [27]
RP   VARIANTS HKPX1 HIS-280 AND HIS-428.
RX   PubMed=10514101;
RX   DOI=10.1002/1531-8249(199910)46:4<634::AID-ANA12>3.0.CO;2-9;
RA   Vergouwe M.N., Tijssen M.A., Peters A.C., Wielaard R., Frants R.R.;
RT   "Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene
RT   mutations.";
RL   Ann. Neurol. 46:634-638(1999).
RN   [28]
RP   VARIANT HKPX1 THR-278.
RX   PubMed=9920650;
RA   Saul B., Kuner T., Sobetzko D., Brune W., Hanefeld F., Meinck H.-M.,
RA   Becker C.-M.;
RT   "Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia
RT   defines an intracellular determinant of glycine receptor channel
RT   gating.";
RL   J. Neurosci. 19:869-877(1999).
RN   [29]
RP   VARIANTS HKPX1 TRP-93; CYS-100; TRP-246; GLU-254; SER-258; PRO-319 AND
RP   ALA-424, CHARACTERIZATION OF VARIANTS HKPX1 TRP-93; CYS-100; TRP-246;
RP   GLU-254; SER-258; HIS-280; MET-308; PRO-319; ALA-424 AND HIS-450,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24108130; DOI=10.1074/jbc.M113.509240;
RA   Bode A., Wood S.E., Mullins J.G., Keramidas A., Cushion T.D.,
RA   Thomas R.H., Pickrell W.O., Drew C.J., Masri A., Jones E.A.,
RA   Vassallo G., Born A.P., Alehan F., Aharoni S., Bannasch G.,
RA   Bartsch M., Kara B., Krause A., Karam E.G., Matta S., Jain V.,
RA   Mandel H., Freilinger M., Graham G.E., Hobson E., Chatfield S.,
RA   Vincent-Delorme C., Rahme J.E., Afawi Z., Berkovic S.F., Howell O.W.,
RA   Vanbellinghen J.F., Rees M.I., Chung S.K., Lynch J.W.;
RT   "New hyperekplexia mutations provide insight into glycine receptor
RT   assembly, trafficking, and activation mechanisms.";
RL   J. Biol. Chem. 288:33745-33759(2013).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels
CC       (PubMed:23994010, PubMed:25730860). Channel opening is triggered
CC       by extracellular glycine (PubMed:2155780, PubMed:7920629,
CC       PubMed:14551753, PubMed:16144831, PubMed:22715885,
CC       PubMed:22973015, PubMed:25973519, PubMed:9009272). Channel opening
CC       is also triggered by taurine and beta-alanine (PubMed:16144831,
CC       PubMed:9009272). Channel characteristics depend on the subunit
CC       composition; heteropentameric channels are activated by lower
CC       glycine levels and display faster desensitization
CC       (PubMed:14551753). Plays an important role in the down-regulation
CC       of neuronal excitability (PubMed:8298642, PubMed:9009272).
CC       Contributes to the generation of inhibitory postsynaptic currents
CC       (PubMed:25445488). Channel activity is potentiated by ethanol
CC       (PubMed:25973519). Potentiation of channel activity by
CC       intoxicating levels of ethanol contribute to the sedative effects
CC       of ethanol (By similarity). {ECO:0000250|UniProtKB:Q64018,
CC       ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:16144831,
CC       ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:23994010,
CC       ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860,
CC       ECO:0000269|PubMed:25973519, ECO:0000269|PubMed:7920629,
CC       ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:9009272,
CC       ECO:0000305|PubMed:8298642}.
CC   -!- ENZYME REGULATION: Channel activity is potentiated by nanomolar
CC       concentrations of Zn(2+); half-maximal activation is observed with
CC       37 nM Zn(2+) (PubMed:16144831). Inhibited by higher Zn(2+) levels;
CC       haf-maximal inhibition occurs at 20 uM Zn(2+) (PubMed:16144831).
CC       Inhibited by strychnine (PubMed:2155780, PubMed:16144831,
CC       PubMed:25445488). Inhibited by lindane (PubMed:25445488).
CC       Inhibited by picrotoxin (PubMed:22715885, PubMed:23994010,
CC       PubMed:25730860). Strychnine binding locks the channel in a closed
CC       conformation and prevents channel opening in response to
CC       extracellular glycine (By similarity).
CC       {ECO:0000250|UniProtKB:O93430, ECO:0000269|PubMed:16144831,
CC       ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:23994010, ECO:0000269|PubMed:25445488,
CC       ECO:0000269|PubMed:25730860}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=A concentration of about 0.02 mM glycine results in half-
CC         maximal channel conductance for homopentamers. A concentration
CC         of 0.018 mM glycine results in half-maximal channel conductance
CC         for homopentamers upon heterologous expression in cultured human
CC         embryonic kidney cells (PubMed:9009272). A concentration of
CC         0.027 mM glycine results in half-maximal channel conductance for
CC         homopentamers upon heterologous expression in cultured human
CC         embryonic kidney cells (PubMed:7920629).
CC         {ECO:0000269|PubMed:7920629, ECO:0000269|PubMed:9009272};
CC   -!- SUBUNIT: Homopentamer (in vitro) (PubMed:22715885,
CC       PubMed:22973015, PubMed:23994010, PubMed:25730860). Interacts with
CC       GLRB to form heteropentameric channels; this is probably the
CC       predominant form in vivo (PubMed:22715885, PubMed:22973015,
CC       PubMed:25445488). Heteropentamer composed of two GLRA1 and three
CC       GLRB (PubMed:22715885). Heteropentamer composed of three GLRA1 and
CC       two GLRB (PubMed:22973015). Both homopentamers and heteropentamers
CC       form functional ion channels, but their characteristics are subtly
CC       different (PubMed:14551753, PubMed:22715885, PubMed:22973015,
CC       PubMed:25445488, PubMed:23994010, PubMed:25730860).
CC       {ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:23994010,
CC       ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q64018}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q64018}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q64018}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q64018}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q64018}. Cell membrane
CC       {ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:16144831,
CC       ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885,
CC       ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:24108130,
CC       ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860,
CC       ECO:0000269|PubMed:25973519, ECO:0000269|PubMed:7920629,
CC       ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:9009272}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:23994010,
CC       ECO:0000269|PubMed:25730860, ECO:0000305|PubMed:2155780}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a;
CC         IsoId=P23415-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P23415-2; Sequence=VSP_021142;
CC   -!- DOMAIN: The channel pore is formed by pentameric assembly of the
CC       second transmembrane domain from all five subunits. In the absence
CC       of the extracellular domain, the channel is in a constitutively
CC       open conformation (PubMed:23994010). Channel opening is effected
CC       by an outward rotation of the transmembrane domains that increases
CC       the diameter of the pore (By similarity).
CC       {ECO:0000250|UniProtKB:O93430, ECO:0000269|PubMed:23994010}.
CC   -!- DISEASE: Hyperekplexia 1 (HKPX1) [MIM:149400]: A neurologic
CC       disorder characterized by muscular rigidity of central nervous
CC       system origin, particularly in the neonatal period, and by an
CC       exaggerated startle response to unexpected acoustic or tactile
CC       stimuli. {ECO:0000269|PubMed:10514101,
CC       ECO:0000269|PubMed:24108130, ECO:0000269|PubMed:25730860,
CC       ECO:0000269|PubMed:7611730, ECO:0000269|PubMed:7881416,
CC       ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:7981700,
CC       ECO:0000269|PubMed:8298642, ECO:0000269|PubMed:8571969,
CC       ECO:0000269|PubMed:8733061, ECO:0000269|PubMed:9009272,
CC       ECO:0000269|PubMed:9067762, ECO:0000269|PubMed:9920650,
CC       ECO:0000269|Ref.18}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:2155780}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRA1 sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52009; CAA36258.1; -; mRNA.
DR   EMBL; AK312702; BAG35580.1; -; mRNA.
DR   EMBL; CH471062; EAW61657.1; -; Genomic_DNA.
DR   EMBL; BC074980; AAH74980.1; -; mRNA.
DR   EMBL; BC114947; AAI14948.1; -; mRNA.
DR   CCDS; CCDS4320.1; -. [P23415-2]
DR   CCDS; CCDS54942.1; -. [P23415-1]
DR   PIR; S12382; S12382.
DR   RefSeq; NP_000162.2; NM_000171.3. [P23415-2]
DR   RefSeq; NP_001139512.1; NM_001146040.1. [P23415-1]
DR   UniGene; Hs.121490; -.
DR   PDB; 1MOT; NMR; -; A=277-304.
DR   PDB; 1VRY; NMR; -; A=278-337.
DR   PDB; 2M6B; NMR; -; A=244-453.
DR   PDB; 2M6I; NMR; -; A/B/C/D/E=244-453.
DR   PDB; 4X5T; X-ray; 3.50 A; A/B/C/D/E=246-338, A/B/C/D/E=418-446.
DR   PDBsum; 1MOT; -.
DR   PDBsum; 1VRY; -.
DR   PDBsum; 2M6B; -.
DR   PDBsum; 2M6I; -.
DR   PDBsum; 4X5T; -.
DR   ProteinModelPortal; P23415; -.
DR   SMR; P23415; -.
DR   DIP; DIP-48768N; -.
DR   IntAct; P23415; 2.
DR   STRING; 9606.ENSP00000411593; -.
DR   BindingDB; P23415; -.
DR   ChEMBL; CHEMBL5845; -.
DR   DrugBank; DB03929; D-Serine.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB05417; GW 468816.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00431; Lindane.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   GuidetoPHARMACOLOGY; 423; -.
DR   TCDB; 1.A.9.3.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P23415; -.
DR   PhosphoSitePlus; P23415; -.
DR   BioMuta; GLRA1; -.
DR   DMDM; 116242495; -.
DR   EPD; P23415; -.
DR   PaxDb; P23415; -.
DR   PeptideAtlas; P23415; -.
DR   PRIDE; P23415; -.
DR   Ensembl; ENST00000274576; ENSP00000274576; ENSG00000145888. [P23415-2]
DR   Ensembl; ENST00000455880; ENSP00000411593; ENSG00000145888. [P23415-1]
DR   GeneID; 2741; -.
DR   KEGG; hsa:2741; -.
DR   UCSC; uc003lur.4; human. [P23415-1]
DR   CTD; 2741; -.
DR   DisGeNET; 2741; -.
DR   EuPathDB; HostDB:ENSG00000145888.10; -.
DR   GeneCards; GLRA1; -.
DR   GeneReviews; GLRA1; -.
DR   HGNC; HGNC:4326; GLRA1.
DR   HPA; HPA016502; -.
DR   MalaCards; GLRA1; -.
DR   MIM; 138491; gene.
DR   MIM; 149400; phenotype.
DR   neXtProt; NX_P23415; -.
DR   OpenTargets; ENSG00000145888; -.
DR   Orphanet; 3197; Hereditary hyperekplexia.
DR   PharmGKB; PA28727; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P23415; -.
DR   KO; K05193; -.
DR   OMA; FNFAYGM; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P23415; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   EvolutionaryTrace; P23415; -.
DR   GeneWiki; Glycine_receptor,_alpha_1; -.
DR   GenomeRNAi; 2741; -.
DR   PRO; PR:P23415; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000145888; -.
DR   CleanEx; HS_GLRA1; -.
DR   ExpressionAtlas; P23415; baseline and differential.
DR   Genevisible; P23415; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0060077; C:inhibitory synapse; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030977; F:taurine binding; IDA:UniProtKB.
DR   GO; GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IMP:UniProtKB.
DR   GO; GO:0007340; P:acrosome reaction; IEA:Ensembl.
DR   GO; GO:0001508; P:action potential; IEA:Ensembl.
DR   GO; GO:0007628; P:adult walking behavior; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IDA:UniProtKB.
DR   GO; GO:0071361; P:cellular response to ethanol; IDA:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; IMP:UniProtKB.
DR   GO; GO:0051970; P:negative regulation of transmission of nerve impulse; IMP:UniProtKB.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB.
DR   GO; GO:2000344; P:positive regulation of acrosome reaction; IMP:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl.
DR   GO; GO:0097305; P:response to alcohol; ISS:UniProtKB.
DR   GO; GO:0060013; P:righting reflex; IEA:Ensembl.
DR   GO; GO:0001964; P:startle response; IMP:UniProtKB.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; ISS:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:Ensembl.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008128; Glycine_rcpt_A1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01674; GLYRALPHA1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Chloride; Chloride channel; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Metal-binding;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport; Zinc.
FT   SIGNAL        1     28       {ECO:0000250|UniProtKB:P07727,
FT                                ECO:0000255}.
FT   CHAIN        29    457       Glycine receptor subunit alpha-1.
FT                                /FTId=PRO_0000000412.
FT   TOPO_DOM     29    250       Extracellular. {ECO:0000305}.
FT   TRANSMEM    251    272       Helical; Name=1.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TOPO_DOM    273    277       Cytoplasmic.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TRANSMEM    278    298       Helical; Name=2.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TOPO_DOM    299    309       Extracellular.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TRANSMEM    310    330       Helical; Name=3.
FT                                {ECO:0000269|PubMed:23994010,
FT                                ECO:0000269|PubMed:25730860}.
FT   TOPO_DOM    331    425       Cytoplasmic.
FT                                {ECO:0000269|PubMed:23994010}.
FT   TRANSMEM    426    446       Helical; Name=4.
FT                                {ECO:0000269|PubMed:23994010}.
FT   TOPO_DOM    447    457       Extracellular. {ECO:0000305}.
FT   REGION      230    235       Strychnine-binding.
FT                                {ECO:0000250|UniProtKB:O93430}.
FT   METAL       220    220       Zinc. {ECO:0000305|PubMed:16144831}.
FT   METAL       222    222       Zinc. {ECO:0000305|PubMed:16144831}.
FT   METAL       243    243       Zinc. {ECO:0000305|PubMed:16144831}.
FT   SITE        289    289       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000269|PubMed:25730860}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   DISULFID    166    180       {ECO:0000269|PubMed:19861413}.
FT   DISULFID    226    237       {ECO:0000269|PubMed:19861413}.
FT   VAR_SEQ     354    361       Missing (in isoform b).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2155780}.
FT                                /FTId=VSP_021142.
FT   VARIANT      93     93       R -> W (in HKPX1; impairs expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                compound heterozygote with S-258;
FT                                dbSNP:rs199547699).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075418.
FT   VARIANT     100    100       R -> C (in HKPX1; abolishes expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075419.
FT   VARIANT     246    246       R -> W (in HKPX1; abolishes expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs751659671).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075420.
FT   VARIANT     254    254       Q -> E (in HKPX1; strongly increases
FT                                sensitivity to extracellular glycine;
FT                                high leak currents in the absence of
FT                                glycine due to spontaneous channel
FT                                opening). {ECO:0000269|PubMed:24108130,
FT                                ECO:0000269|PubMed:25730860}.
FT                                /FTId=VAR_075421.
FT   VARIANT     258    258       P -> S (in HKPX1; impairs expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                compound heterozygote with W-93).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075422.
FT   VARIANT     272    272       I -> N (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918409).
FT                                {ECO:0000269|PubMed:7881416,
FT                                ECO:0000269|PubMed:9009272}.
FT                                /FTId=VAR_000296.
FT   VARIANT     278    278       P -> T (in HKPX1; requires much higher
FT                                glycine levels for channel activation and
FT                                displays an increased rate of
FT                                desensitization; dbSNP:rs121918413).
FT                                {ECO:0000269|PubMed:25730860,
FT                                ECO:0000269|PubMed:9920650}.
FT                                /FTId=VAR_010112.
FT   VARIANT     280    280       R -> H (in HKPX1; dbSNP:rs281864918).
FT                                {ECO:0000269|PubMed:10514101}.
FT                                /FTId=VAR_010113.
FT   VARIANT     294    294       Q -> H (in HKPX1; dbSNP:rs121918411).
FT                                {ECO:0000269|PubMed:8571969}.
FT                                /FTId=VAR_000297.
FT   VARIANT     299    299       R -> L (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918408).
FT                                {ECO:0000269|PubMed:7925268,
FT                                ECO:0000269|PubMed:7981700,
FT                                ECO:0000269|PubMed:8298642,
FT                                ECO:0000269|PubMed:9009272}.
FT                                /FTId=VAR_000298.
FT   VARIANT     299    299       R -> Q (in HKPX1; decreases unitary
FT                                channel conductance and requires much
FT                                higher glycine concentrations for
FT                                activation; dbSNP:rs121918408).
FT                                {ECO:0000269|PubMed:25730860,
FT                                ECO:0000269|PubMed:7925268,
FT                                ECO:0000269|PubMed:8298642,
FT                                ECO:0000269|PubMed:9009272}.
FT                                /FTId=VAR_000299.
FT   VARIANT     304    304       K -> E (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918412).
FT                                {ECO:0000269|PubMed:8733061,
FT                                ECO:0000269|PubMed:9009272,
FT                                ECO:0000269|PubMed:9067762}.
FT                                /FTId=VAR_000300.
FT   VARIANT     307    307       Y -> C (in HKPX1; requires much higher
FT                                glycine levels for channel activation;
FT                                dbSNP:rs121918410).
FT                                {ECO:0000269|PubMed:7611730,
FT                                ECO:0000269|PubMed:9009272,
FT                                ECO:0000269|Ref.18}.
FT                                /FTId=VAR_000301.
FT   VARIANT     308    308       V -> M (in HKPX1; high leak currents in
FT                                the absence of glycine due to spontaneous
FT                                channel opening).
FT                                {ECO:0000269|PubMed:24108130,
FT                                ECO:0000269|PubMed:25730860}.
FT                                /FTId=VAR_075423.
FT   VARIANT     319    319       L -> P (in HKPX1; impairs expression at
FT                                the cell membrane; requires much higher
FT                                glycine levels for channel activation;
FT                                compound heterozygote with A-424).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075424.
FT   VARIANT     424    424       D -> A (in HKPX1; abolishes expression at
FT                                the cell membrane; compound heterozygote
FT                                with P-319).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075425.
FT   VARIANT     428    428       R -> H (in HKPX1; dbSNP:rs281864919).
FT                                {ECO:0000269|PubMed:10514101}.
FT                                /FTId=VAR_010114.
FT   VARIANT     450    450       R -> H (in HKPX1; displays leak currents
FT                                in the absence of glycine due to
FT                                spontaneous channel opening;
FT                                dbSNP:rs200130685).
FT                                {ECO:0000269|PubMed:24108130}.
FT                                /FTId=VAR_075426.
FT   MUTAGEN      80     80       A->S: The mutant channel requires much
FT                                higher glycine concentrations for
FT                                activation. {ECO:0000269|PubMed:7920629}.
FT   MUTAGEN     137    137       H->F: Abolishes sensitivity of channel
FT                                activity to potentiation or inhibition by
FT                                Zn(2+); when associated with K-222.
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     137    137       H->N: Strongly decreases sensitivity to
FT                                inhibition by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     220    220       E->A: Abolishes potentiation of channel
FT                                activity by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     222    222       D->A: Abolishes potentiation of channel
FT                                activity by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     222    222       D->K: Abolishes sensitivity of channel
FT                                activity to potentiation or inhibition by
FT                                Zn(2+); when associated with F-137.
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     243    243       H->A: Strongly decreases potentiation of
FT                                channel activity by Zn(2+).
FT                                {ECO:0000269|PubMed:16144831}.
FT   MUTAGEN     282    282       G->A: Increased single-channel
FT                                conductance. No effect on glycine
FT                                sensitivity, but decreased rate of
FT                                activation.
FT                                {ECO:0000269|PubMed:25730860}.
FT   MUTAGEN     304    304       K->C: Decreases channel conductance; the
FT                                mutant channel requires much higher
FT                                glycine concentrations for activation.
FT                                {ECO:0000269|PubMed:25730860}.
FT   CONFLICT     12     14       WET -> SGA (in Ref. 1; CAA36258).
FT                                {ECO:0000305}.
FT   CONFLICT     33     33       P -> T (in Ref. 1; CAA36258).
FT                                {ECO:0000305}.
FT   TURN        246    248       {ECO:0000244|PDB:2M6B}.
FT   HELIX       249    254       {ECO:0000244|PDB:4X5T}.
FT   HELIX       256    267       {ECO:0000244|PDB:4X5T}.
FT   TURN        274    276       {ECO:0000244|PDB:2M6B}.
FT   HELIX       278    280       {ECO:0000244|PDB:4X5T}.
FT   HELIX       281    284       {ECO:0000244|PDB:4X5T}.
FT   HELIX       286    289       {ECO:0000244|PDB:4X5T}.
FT   HELIX       291    297       {ECO:0000244|PDB:4X5T}.
FT   HELIX       299    301       {ECO:0000244|PDB:4X5T}.
FT   TURN        310    312       {ECO:0000244|PDB:4X5T}.
FT   HELIX       316    323       {ECO:0000244|PDB:4X5T}.
FT   HELIX       325    335       {ECO:0000244|PDB:4X5T}.
FT   HELIX       416    419       {ECO:0000244|PDB:2M6B}.
FT   HELIX       420    423       {ECO:0000244|PDB:4X5T}.
FT   TURN        424    426       {ECO:0000244|PDB:4X5T}.
FT   HELIX       427    446       {ECO:0000244|PDB:4X5T}.
FT   TURN        449    453       {ECO:0000244|PDB:2M6B}.
SQ   SEQUENCE   457 AA;  52624 MW;  5ED80AF62B06A3AA CRC64;
     MYSFNTLRLY LWETIVFFSL AASKEAEAAR SAPKPMSPSD FLDKLMGRTS GYDARIRPNF
     KGPPVNVSCN IFINSFGSIA ETTMDYRVNI FLRQQWNDPR LAYNEYPDDS LDLDPSMLDS
     IWKPDLFFAN EKGAHFHEIT TDNKLLRISR NGNVLYSIRI TLTLACPMDL KNFPMDVQTC
     IMQLESFGYT MNDLIFEWQE QGAVQVADGL TLPQFILKEE KDLRYCTKHY NTGKFTCIEA
     RFHLERQMGY YLIQMYIPSL LIVILSWISF WINMDAAPAR VGLGITTVLT MTTQSSGSRA
     SLPKVSYVKA IDIWMAVCLL FVFSALLEYA AVNFVSRQHK ELLRFRRKRR HHKSPMLNLF
     QEDEAGEGRF NFSAYGMGPA CLQAKDGISV KGANNSNTTN PPPAPSKSPE EMRKLFIQRA
     KKIDKISRIG FPMAFLIFNM FYWIIYKIVR REDVHNQ
//
ID   ACHD_RAT                Reviewed;         517 AA.
AC   P25110;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   20-DEC-2017, entry version 153.
DE   RecName: Full=Acetylcholine receptor subunit delta;
DE   Flags: Precursor;
GN   Name=Chrnd; Synonyms=Acrd;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Muscle;
RX   PubMed=1702709; DOI=10.1111/j.1432-1033.1990.tb15637.x;
RA   Witzemann V., Stein E., Barg B., Konno T., Koenen M., Kues W.,
RA   Criado M., Hofmann M., Sakmann B.;
RT   "Primary structure and functional expression of the alpha-, beta-,
RT   gamma-, delta- and epsilon-subunits of the acetylcholine receptor from
RT   rat muscle.";
RL   Eur. J. Biochem. 194:437-448(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 1-17.
RX   PubMed=1638981;
RA   Chahine K.G., Walke W., Goldman D.J.;
RT   "A 102 base pair sequence of the nicotinic acetylcholine receptor
RT   delta-subunit gene confers regulation by muscle electrical activity.";
RL   Development 115:213-219(1992).
RN   [3]
RP   STRUCTURE BY NMR OF 276-298.
RX   PubMed=10201407; DOI=10.1038/7610;
RA   Opella S.J., Marassi F.M., Gesell J.J., Valente A.P., Kim Y.,
RA   Oblatt-Montal M., Montal M.;
RT   "Structures of the M2 channel-lining segments from nicotinic
RT   acetylcholine and NMDA receptors by NMR spectroscopy.";
RL   Nat. Struct. Biol. 6:374-379(1999).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (By similarity). {ECO:0000250|UniProtKB:Q07001}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Delta/CHRND
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X74835; CAA52829.1; -; mRNA.
DR   EMBL; X66531; CAA47142.1; -; Genomic_DNA.
DR   PIR; S13875; S13875.
DR   RefSeq; NP_062171.1; NM_019298.1.
DR   UniGene; Rn.41469; -.
DR   PDB; 1A11; NMR; -; A=276-298.
DR   PDB; 1CEK; NMR; -; A=276-298.
DR   PDBsum; 1A11; -.
DR   PDBsum; 1CEK; -.
DR   ProteinModelPortal; P25110; -.
DR   SMR; P25110; -.
DR   STRING; 10116.ENSRNOP00000026504; -.
DR   iPTMnet; P25110; -.
DR   PhosphoSitePlus; P25110; -.
DR   PaxDb; P25110; -.
DR   PRIDE; P25110; -.
DR   Ensembl; ENSRNOT00000026504; ENSRNOP00000026504; ENSRNOG00000019527.
DR   GeneID; 54240; -.
DR   KEGG; rno:54240; -.
DR   UCSC; RGD:2352; rat.
DR   CTD; 1144; -.
DR   RGD; 2352; Chrnd.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P25110; -.
DR   KO; K04816; -.
DR   OMA; VLISFMI; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P25110; -.
DR   Reactome; R-RNO-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   EvolutionaryTrace; P25110; -.
DR   PRO; PR:P25110; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000019527; -.
DR   Genevisible; P25110; RN.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IEA:Ensembl.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:RGD.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:RGD.
DR   GO; GO:0006812; P:cation transport; IDA:RGD.
DR   GO; GO:0050881; P:musculoskeletal movement; ISO:RGD.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0003009; P:skeletal muscle contraction; IDA:RGD.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000250}.
FT   CHAIN        22    517       Acetylcholine receptor subunit delta.
FT                                /FTId=PRO_0000000324.
FT   TOPO_DOM     22    245       Extracellular. {ECO:0000255}.
FT   TRANSMEM    246    270       Helical. {ECO:0000255}.
FT   TRANSMEM    278    296       Helical. {ECO:0000255}.
FT   TRANSMEM    312    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    471       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    472    490       Helical. {ECO:0000255}.
FT   MOD_RES     390    390       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000250}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    190    190       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
FT   HELIX       275    297       {ECO:0000244|PDB:1A11}.
SQ   SEQUENCE   517 AA;  58884 MW;  2E561B527788AE9B CRC64;
     MAGPVPTLGL LAALVVCGSW GLNEEQRLIQ HLFEEKGYNK ELRPVARKED IVDVALSLTL
     SNLISLKEVE ETLTTNVWID HAWIDSRLQW NANEFGNITV LRLPSDMVWL PEIVLENNND
     GSFQISYACN VLVSDSGHVT WLPPAIFRSS CPISVTYFPF DWQNCSLKFS SLKYTAKEIR
     LSLKQEEEDN RSYPIEWIII DPEGFTENGE WEIVHRAAKV NVDPSVPMDS TNHQDVTFYL
     IIRRKPLFYI INILVPCVLI SFMINLVFYL PGDCGEKTSV AISVLLAQSV FLLLISKRLP
     ATSMAIPLVG KFLLFGMVLV TMVVVICVIV LNIHFRTPST HVLSEGVKKF FLETLPKLLH
     MSRPEEEDPG PRALIRRTSS LGYISKAEEY FSLKSRSDLM FEKQSERHGL ARRLTTARKP
     PASSEQVQQE LFNEMKPAVD GANFIVNHMR DQNSYNEEKD NWNQVARTVD RLCLFVVTPV
     MVVGTAWIFL QGVYNQPPPQ PFPGDPFSYD EQDRRFI
//
ID   GBRB_DROME              Reviewed;         606 AA.
AC   P25123; P92138; Q24561; Q26302; Q7JPX8; Q8IQB5; Q8IQB6; Q961R4;
AC   Q9TX51; Q9VSV0;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   14-MAY-2014, sequence version 4.
DT   25-OCT-2017, entry version 160.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta;
DE   AltName: Full=GABA(A) receptor subunit beta;
DE   AltName: Full=Protein cyclodiene resistance;
DE   Flags: Precursor;
GN   Name=Rdl; ORFNames=CG10537;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C), AND RNA EDITING OF POSITION
RP   283.
RC   TISSUE=Embryo;
RX   PubMed=1651498; DOI=10.1073/pnas.88.16.7209;
RA   ffrench-Constant R.H., Mortlock D.P., Shaffer C.D., Macintyre R.J.,
RA   Roush R.T.;
RT   "Molecular cloning and transformation of cyclodiene resistance in
RT   Drosophila: an invertebrate gamma-aminobutyric acid subtype A receptor
RT   locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7209-7213(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND RNA EDITING OF POSITIONS
RP   122; 283 AND 360.
RC   TISSUE=Head;
RX   PubMed=8016117; DOI=10.1073/pnas.91.13.6069;
RA   Chen R., Belelli D., Reyes A., Lambert J.J., Peters J.A., Lan N.C.;
RT   "Cloning and functional expression of a Drosophila gamma-aminobutyric
RT   acid receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6069-6073(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D), AND RNA EDITING OF
RP   POSITION 283.
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 70-113 (ISOFORMS A/D).
RX   PubMed=7684073; DOI=10.1111/j.1471-4159.1993.tb03523.x;
RA   ffrench-Constant R.H., Rocheleau T.A.;
RT   "Drosophila gamma-aminobutyric acid receptor gene Rdl shows extensive
RT   alternative splicing.";
RL   J. Neurochem. 60:2323-2326(1993).
RN   [7]
RP   RNA EDITING.
RX   PubMed=12907802; DOI=10.1126/science.1086763;
RA   Hoopengardner B., Bhalla T., Staber C., Reenan R.;
RT   "Nervous system targets of RNA editing identified by comparative
RT   genomics.";
RL   Science 301:832-836(2003).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A; Synonyms=F;
CC         IsoId=P25123-2; Sequence=Displayed;
CC       Name=C;
CC         IsoId=P25123-1; Sequence=VSP_054455, VSP_054456;
CC       Name=D;
CC         IsoId=P25123-3; Sequence=VSP_054456, VSP_054457, VSP_054458;
CC   -!- RNA EDITING: Modified_positions=122 {ECO:0000269|PubMed:12907802,
CC       ECO:0000269|PubMed:8016117}, 283 {ECO:0000269|PubMed:12537569,
CC       ECO:0000269|PubMed:12907802, ECO:0000269|PubMed:1651498,
CC       ECO:0000269|PubMed:8016117}, 294 {ECO:0000269|PubMed:12907802},
CC       360 {ECO:0000269|PubMed:12907802, ECO:0000269|PubMed:8016117};
CC       Note=Partially edited.;
CC   -!- MISCELLANEOUS: Resistance is thought to be due to insensitivity of
CC       the cyclodiene/picrotoxinin binding site on the GABA(A) receptor-
CC       chloride ionophore complex.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA28557.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA28558.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAK92842.1; Type=Frameshift; Positions=448; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M69057; AAA28556.1; -; mRNA.
DR   EMBL; M69057; AAA28557.1; ALT_INIT; mRNA.
DR   EMBL; M69057; AAA28558.1; ALT_INIT; mRNA.
DR   EMBL; U02042; AAA19249.1; -; mRNA.
DR   EMBL; AE014296; AAF50311.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN11988.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN11989.2; -; Genomic_DNA.
DR   EMBL; AY051418; AAK92842.1; ALT_FRAME; mRNA.
DR   EMBL; S61113; AAB26669.1; -; mRNA.
DR   PIR; A41145; A41145.
DR   RefSeq; NP_001261616.1; NM_001274687.1. [P25123-2]
DR   RefSeq; NP_523991.2; NM_079267.4. [P25123-2]
DR   RefSeq; NP_729461.1; NM_168321.3. [P25123-1]
DR   RefSeq; NP_729462.2; NM_168322.3. [P25123-3]
DR   UniGene; Dm.2698; -.
DR   ProteinModelPortal; P25123; -.
DR   SMR; P25123; -.
DR   BioGrid; 64454; 6.
DR   STRING; 7227.FBpp0305970; -.
DR   PaxDb; P25123; -.
DR   PRIDE; P25123; -.
DR   EnsemblMetazoa; FBtr0076534; FBpp0076261; FBgn0004244. [P25123-2]
DR   EnsemblMetazoa; FBtr0076536; FBpp0076263; FBgn0004244. [P25123-1]
DR   EnsemblMetazoa; FBtr0309054; FBpp0301075; FBgn0004244. [P25123-3]
DR   EnsemblMetazoa; FBtr0333835; FBpp0305969; FBgn0004244. [P25123-2]
DR   GeneID; 39054; -.
DR   KEGG; dme:Dmel_CG10537; -.
DR   CTD; 39054; -.
DR   FlyBase; FBgn0004244; Rdl.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   InParanoid; P25123; -.
DR   KO; K05181; -.
DR   OrthoDB; EOG091G0805; -.
DR   GenomeRNAi; 39054; -.
DR   PRO; PR:P25123; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0004244; -.
DR   ExpressionAtlas; P25123; differential.
DR   Genevisible; P25123; DM.
DR   GO; GO:0030424; C:axon; IDA:FlyBase.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:FlyBase.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; TAS:FlyBase.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:FlyBase.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IDA:UniProtKB.
DR   GO; GO:0002121; P:inter-male aggressive behavior; IMP:FlyBase.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IMP:FlyBase.
DR   GO; GO:0042749; P:regulation of circadian sleep/wake cycle; IMP:FlyBase.
DR   GO; GO:0090328; P:regulation of olfactory learning; IMP:FlyBase.
DR   GO; GO:0042493; P:response to drug; IMP:FlyBase.
DR   GO; GO:0009612; P:response to mechanical stimulus; IGI:FlyBase.
DR   GO; GO:0030431; P:sleep; IMP:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 3.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; RNA editing;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     44       {ECO:0000255}.
FT   CHAIN        45    606       Gamma-aminobutyric acid receptor subunit
FT                                beta.
FT                                /FTId=PRO_0000000452.
FT   TOPO_DOM     45    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    291       Helical. {ECO:0000255}.
FT   TRANSMEM    297    316       Helical. {ECO:0000255}.
FT   TRANSMEM    333    356       Helical. {ECO:0000255}.
FT   TOPO_DOM    357    568       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    569    590       Helical. {ECO:0000255}.
FT   COMPBIAS    499    535       Gly-rich.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    253    253       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    185    199       {ECO:0000250}.
FT   VAR_SEQ      97    101       LSEVK -> VSEVL (in isoform C).
FT                                {ECO:0000303|PubMed:1651498}.
FT                                /FTId=VSP_054455.
FT   VAR_SEQ     216    248       KWNEGPNSVGVSSEVSLPQFKVLGHRQRAMEIS -> FWRD
FT                                GLSSVGMSSEVELPQFRVLGHRQRATEIN (in isoform
FT                                C and isoform D).
FT                                {ECO:0000303|PubMed:12537569,
FT                                ECO:0000303|PubMed:1651498}.
FT                                /FTId=VSP_054456.
FT   VAR_SEQ     448    476       Missing (in isoform D).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_054457.
FT   VAR_SEQ     552    552       K -> KKV (in isoform D).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_054458.
FT   VARIANT     122    122       R -> G (in RNA edited version).
FT   VARIANT     283    283       I -> V (in RNA edited version).
FT   VARIANT     294    294       N -> D (in RNA edited version).
FT   VARIANT     360    360       M -> V (in RNA edited version).
FT   CONFLICT     38     38       H -> N (in Ref. 2; AAA19249).
FT                                {ECO:0000305}.
FT   CONFLICT     68     68       V -> I (in Ref. 2; AAA19249).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       G -> R (in Ref. 2; AAA19249).
FT                                {ECO:0000305}.
SQ   SEQUENCE   606 AA;  65656 MW;  25BDDCB03DAD54F8 CRC64;
     MSDSKMDKLA RMAPLPRTPL LTIWLAINMA LIAQETGHKR IHTVQAATGG GSMLGDVNIS
     AILDSFSVSY DKRVRPNYGG PPVEVGVTMY VLSISSLSEV KMDFTLDFYF RQFWTDPRLA
     YRKRPGVETL SVGSEFIKNI WVPDTFFVNE KQSYFHIATT SNEFIRVHHS GSITRSIRLT
     ITASCPMNLQ YFPMDRQLCH IEIESFGYTM RDIRYKWNEG PNSVGVSSEV SLPQFKVLGH
     RQRAMEISLT TGNYSRLACE IQFVRSMGYY LIQIYIPSGL IVIISWVSFW LNRNATPARV
     ALGVTTVLTM TTLMSSTNAA LPKISYVKSI DVYLGTCFVM VFASLLEYAT VGYMAKRIQM
     RKQRFMAIQK IAEQKKQQLD GANQQQANPN PNANVGGPGG VGVGPGGPGG PGGGVNVGVG
     MGMGPEHGHG HGHHAHSHGH PHAPKQTVSN RPIGFSNIQQ NVGTRGCSIV GPLFQEVRFK
     VHDPKAHSKG GTLENTVNGG RGGPQSHGPG PGQGGGPPGG GGGGGGGGGP PEGGGDPEAA
     VPAHLLHPGK VKKDINKLLG ITPSDIDKYS RIVFPVCFVC FNLMYWIIYL HVSDVVADDL
     VLLGEE
//
ID   ACHB4_CHICK             Reviewed;         470 AA.
AC   P26153;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   25-OCT-2017, entry version 123.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-4;
DE   AltName: Full=Neuronal acetylcholine receptor non-alpha-3 chain;
DE            Short=N-alpha 3;
DE   Flags: Precursor; Fragment;
GN   Name=CHRNB4;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=White leghorn; TISSUE=Brain;
RX   PubMed=1698777;
RA   Couturier S., Erkman L., Valera S., Rungger D., Bertrand S.,
RA   Boulter J., Ballivet M., Bertrand D.;
RT   "Alpha 5, alpha 3, and non-alpha 3. Three clustered avian genes
RT   encoding neuronal nicotinic acetylcholine receptor-related subunits.";
RL   J. Biol. Chem. 265:17560-17567(1990).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and non-alpha (also called beta). A functional
CC       receptor seems to consist of two alpha-chains and three non-alpha
CC       chains. The pentamer alpha3-beta-4 interacts with the conotoxin
CC       BuIA. {ECO:0000250|UniProtKB:P12392}.
CC   -!- INTERACTION:
CC       P09481:CHRNA3; NbExp=3; IntAct=EBI-10686176, EBI-10686191;
CC       P26152:CHRNA5; NbExp=4; IntAct=EBI-10686176, EBI-10686157;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- DEVELOPMENTAL STAGE: High levels in the developing ciliary and
CC       superior cervical ganglia.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       4/CHRNB4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05643; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; A39218; A39218.
DR   UniGene; Gga.341; -.
DR   ProteinModelPortal; P26153; -.
DR   SMR; P26153; -.
DR   IntAct; P26153; 3.
DR   STRING; 9031.ENSGALP00000004740; -.
DR   PaxDb; P26153; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P26153; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL       <1      3       {ECO:0000255}.
FT   CHAIN         4    470       Neuronal acetylcholine receptor subunit
FT                                beta-4.
FT                                /FTId=PRO_0000000392.
FT   TOPO_DOM      4    216       Extracellular. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255}.
FT   TOPO_DOM    238    245       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    246    266       Helical. {ECO:0000255}.
FT   TOPO_DOM    267    278       Extracellular. {ECO:0000255}.
FT   TRANSMEM    279    299       Helical. {ECO:0000255}.
FT   TOPO_DOM    300    438       Cytoplasmic.
FT   TRANSMEM    439    459       Helical. {ECO:0000255}.
FT   TOPO_DOM    460    470       Extracellular. {ECO:0000255}.
FT   SITE        114    114       Key residue for a low dissociation
FT                                (K(off)) from the conotoxin BuIA.
FT                                {ECO:0000250|UniProtKB:P12392}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    118    118       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    133    147       {ECO:0000250}.
FT   NON_TER       1      1
SQ   SEQUENCE   470 AA;  53785 MW;  3117314772886B2D CRC64;
     STAADAEEKL MNHLLSPDRY NKLIRPAVNS SQLVSIELQV SLAQLISVNE REQIMTTNVW
     LNQEWIDYRL AWKPSDYEGI NMLRIPAKHI WLPDIVLYNN ADGTYEVSLY TNAIVQNNGS
     IRWLPPAIYK SACKIEVKHF PFDQQNCTLK FRSWTYDHTE IDMVLKTSMA SMDDFTPSGE
     WDIVALPGRR TENPLDPNYV DVTYDFIIKR KPLFYTINLI IPCVLITSLA ILVFYLPSDC
     GEKMTLCISV LLALTVFLLL ISKIVPPTSL DVPLIGKYLM FTMVLVTFSI VTSVCVLNVH
     HRSPSTHTMP PWVKLVFLER LPAYLFMKRP ENNSPRQKPA NCKKTRAENL CMDPADFYKN
     STYFVNTASA KKYDMKITDT LDNVSSHQDF RLRTGTKFSP EVQEAIDGVS FIAEHMKSDD
     NDQSVIEDWK YVAMVVDRLF LWIFVLVCVL GTVGLFLQPL FQNHIAATNP
//
ID   GLRK_LYMST              Reviewed;         917 AA.
AC   P26591;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   27-SEP-2017, entry version 83.
DE   RecName: Full=Glutamate receptor;
DE   Flags: Precursor;
OS   Lymnaea stagnalis (Great pond snail) (Helix stagnalis).
OC   Eukaryota; Metazoa; Lophotrochozoa; Mollusca; Gastropoda;
OC   Heterobranchia; Euthyneura; Panpulmonata; Hygrophila; Lymnaeoidea;
OC   Lymnaeidae; Lymnaea.
OX   NCBI_TaxID=6523;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1659993; DOI=10.1016/0014-5793(91)80846-U;
RA   Hutton M.L., Harvey R.J., Barnard E.A., Darlison M.G.;
RT   "Cloning of a cDNA that encodes an invertebrate glutamate receptor
RT   subunit.";
RL   FEBS Lett. 292:111-114(1991).
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60086; CAA42683.1; -; mRNA.
DR   PIR; S18443; ACGAE.
DR   ProteinModelPortal; P26591; -.
DR   SMR; P26591; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    917       Glutamate receptor.
FT                                /FTId=PRO_0000011560.
FT   TOPO_DOM     20    556       Extracellular. {ECO:0000255}.
FT   TRANSMEM    557    577       Helical. {ECO:0000255}.
FT   TOPO_DOM    578    631       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    632    652       Helical. {ECO:0000255}.
FT   TOPO_DOM    653    818       Extracellular. {ECO:0000255}.
FT   TRANSMEM    819    839       Helical. {ECO:0000255}.
FT   TOPO_DOM    840    917       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     62     62       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    125    125       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    251    251       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    261    261       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    272    272       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    419    419       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    424    424       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    775    775       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   917 AA;  103139 MW;  4928113CE2CA0527 CRC64;
     MDTCVFPLVV LWISMRITST LDEVPIGGIF DSRSVQALTA FRHEIHMFNR AYSHVYRYKL
     KNDTTILDVT DSFAVSNALC HHLSRGDLAI FGVSNASSLA TIQSYTDTFN VPFVTISMAQ
     NNSHNGSYQI YMRPMYINAL VDVIVHYRWE KVAFYYDSDE GLVRLQQLFQ ATNKYDKMII
     SIDTKRITSV ENGYHMLKEL HLMDPEMEHR VLLDVRTDKA EQIILKVMND SKINNAKFHF
     LLGDLGMLEI NTTHFKIGGV NITGFQLVDP FNSTSELFIS TWSSLDPVYW PGAGTNHVNY
     EAALAADSVR LFKSAFGSIL QKDPNFLRRS RSGTAGKSMK CTDDSEIKTG HGQMILEEMK
     KVKFEGVTGH VAFNEQGHRK DFTLGVYNVA MTRGTAKIGY WNEREGKLHA HNPRLFQNNS
     SDMNRTRIVT TIIKEPYVMV NNVIRDGKPL VGNEPVEGFC IDLTKAVAEK VGFDFVIQFV
     KDGSYGSVLS NGTWDGIVGE LIRHEADMAI APFTITADRS RVIDFTKPFM SLGISIMIKR
     PQPAGKHFFS FMEPLSSEIW MCIVFAYIGV SVVLFLVSRF SPNEWHLSEA HHSYIANDFS
     ISNSLWFSLG AFMQQGCDIS PRSMSGRIVG SVWWFFTLII ISSYTANLAA FLTVERMLTP
     IDSAEDLARQ TEIQYGTIMS GSTKAFFKNS QFQTYQRMWA YMTSAQPSVF VKTHEEGIQR
     VRQSNGKYAY LTESSTIDYV SNRKPCDTLK VGSNLNSDGF GIGTPVGSDL RDKLNFSVLE
     LRENGDLAKW EKIWFDRGEC PQHSSNKEGA QSALTLANVA GIFYILIGGL VVAVLSAAFE
     FLYKSRMDSR KSRMSFGSAL RTKARLSFKG HIDSEQKTTG NGTRRRSHNS VTYTYTGPTN
     VMGGSHAFED SNTHTEV
//
ID   GBRB_LYMST              Reviewed;         499 AA.
AC   P26714;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   25-OCT-2017, entry version 100.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta;
DE   AltName: Full=GABA(A) receptor;
DE   Flags: Precursor;
OS   Lymnaea stagnalis (Great pond snail) (Helix stagnalis).
OC   Eukaryota; Metazoa; Lophotrochozoa; Mollusca; Gastropoda;
OC   Heterobranchia; Euthyneura; Panpulmonata; Hygrophila; Lymnaeoidea;
OC   Lymnaeidae; Lymnaea.
OX   NCBI_TaxID=6523;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1655414;
RA   Harvey R.J., Vreugdenhil E., Zaman S.H., Bhandal N.S.,
RA   Usherwood P.N.R., Barnard E.A., Darlison M.G.;
RT   "Sequence of a functional invertebrate GABAA receptor subunit which
RT   can form a chimeric receptor with a vertebrate alpha subunit.";
RL   EMBO J. 10:3239-3245(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 201-334.
RX   PubMed=2164988; DOI=10.1042/bst0180438;
RA   Harvey R.J., Vreugdenhil E., Barnard E.A., Darlison M.G.;
RT   "Cloning of genomic and cDNA sequences encoding an invertebrate gamma-
RT   aminobutyric acid A receptor subunit.";
RL   Biochem. Soc. Trans. 18:438-439(1990).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA/benzodiazepine receptor and
CC       opening an integral chloride channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58638; CAA41495.1; -; mRNA.
DR   PIR; S17785; S17785.
DR   ProteinModelPortal; P26714; -.
DR   SMR; P26714; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    499       Gamma-aminobutyric acid receptor subunit
FT                                beta.
FT                                /FTId=PRO_0000000467.
FT   TOPO_DOM     24    251       Extracellular. {ECO:0000305}.
FT   TRANSMEM    252    273       Helical. {ECO:0000305}.
FT   TRANSMEM    278    299       Helical. {ECO:0000305}.
FT   TRANSMEM    311    333       Helical. {ECO:0000305}.
FT   TOPO_DOM    334    475       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    476    499       Helical. {ECO:0000305}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    106    106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    152    152       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    167    181       {ECO:0000250}.
FT   CONFLICT    232    232       S -> L (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   499 AA;  57082 MW;  F81C9F2A850D62F4 CRC64;
     MWGIIVPFFS ASLMCSLVAV VRCQQDTDHF ANVTNTIDSL LKGYDIRLRP SFGGAPLEIG
     IEVILASFDS ISEVDMDYTI TMYLNQYWRD ERLQFIFNES LDLGENRSVT TMTLTGAFAE
     KIWVPDTFLA NDKNSFLHDI TEKNKMVRLY GNGSLVYGMR FTTTLACMMD LHNYPLDHQE
     CTVEIESYGY TMDDIVLYWL NDRGAVTGVE DVSLPQFSIT NYATINKIEE LSTGDYQRLS
     LIFQLQRNIG YFIFQTYLPS ILIVMLSWVS FWINHEATSA RVALGITTVL TMTTISNGVR
     SSLPRISYVK AIDIYLVMCF VFVFAALLEY AAVNYTYWGA RAKRKAKRLR ERATSVRKRV
     DDGDQMNNTN MDTVELKEVH MVPTSVGVTN SQSFNLDLDD GSGDDTGFRV VPPIPRSFTH
     SHATTHGYIP TNVVRRRSSS HVPPRRRRLL SHFRQKAKSI KVKIPRVQDV NTIDKYARLM
     FPLLFIIFNT SYWSVYLLT
//
ID   GBRB3_HUMAN             Reviewed;         473 AA.
AC   P28472; B7Z2W1; B7Z825; F5H3D2; H7BYV8; Q14352; Q96FM5;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   20-DEC-2017, entry version 184.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-3;
DE   AltName: Full=GABA(A) receptor subunit beta-3;
DE   Flags: Precursor;
GN   Name=GABRB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1664410; DOI=10.1016/0888-7543(91)90034-C;
RA   Wagstaff J., Chaillet J.R., Lalande M.;
RT   "The GABAA receptor beta 3 subunit gene: characterization of a human
RT   cDNA from chromosome 15q11q13 and mapping to a region of conserved
RT   synteny on mouse chromosome 7.";
RL   Genomics 11:1071-1078(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-173.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-80 (ISOFORMS 1 AND 2).
RC   TISSUE=Fibroblast;
RX   PubMed=8382702;
RA   Kirkness E.F., Fraser C.M.;
RT   "A strong promoter element is located between alternative exons of a
RT   gene encoding the human gamma-aminobutyric acid-type A receptor beta 3
RT   subunit (GABRB3).";
RL   J. Biol. Chem. 268:4420-4428(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 81-153 AND 183-227.
RX   PubMed=1714232;
RA   Wagstaff J., Knoll J.H.M., Fleming J., Kirkness E.F.,
RA   Martin-Gallardo A., Greenberg F., Graham J.M. Jr., Menninger J.,
RA   Ward D., Venter J.C., Lalande M.;
RT   "Localization of the gene encoding the GABAA receptor beta 3 subunit
RT   to the Angelman/Prader-Willi region of human chromosome 15.";
RL   Am. J. Hum. Genet. 49:330-337(1991).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18281286; DOI=10.1074/jbc.M709993200;
RA   Saras A., Gisselmann G., Vogt-Eisele A.K., Erlkamp K.S., Kletke O.,
RA   Pusch H., Hatt H.;
RT   "Histamine action on vertebrate GABAA receptors: direct channel gating
RT   and potentiation of GABA responses.";
RL   J. Biol. Chem. 283:10470-10475(2008).
RN   [9]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=22243422; DOI=10.1021/bi201772m;
RA   Chiara D.C., Dostalova Z., Jayakar S.S., Zhou X., Miller K.W.,
RA   Cohen J.B.;
RT   "Mapping general anesthetic binding site(s) in human alpha1beta3
RT   gamma-aminobutyric acid type A receptors with [^3H]TDBzl-etomidate, a
RT   photoreactive etomidate analogue.";
RL   Biochemistry 51:836-847(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.97 ANGSTROMS) OF 26-473 IN COMPLEX WITH THE
RP   AGONIST BENZAMIDINE, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY,
RP   SUBUNIT, GLYCOSYLATION AT ASN-33; ASN-105 AND ASN-174, AND DISULFIDE
RP   BOND.
RX   PubMed=24909990; DOI=10.1038/nature13293;
RA   Miller P.S., Aricescu A.R.;
RT   "Crystal structure of a human GABAA receptor.";
RL   Nature 512:270-275(2014).
RN   [11]
RP   VARIANT HIS-217, AND CHARACTERIZATION OF VARIANT HIS-217.
RX   PubMed=12189488; DOI=10.1007/s00439-002-0766-7;
RA   Buhr A., Bianchi M.T., Baur R., Courtet P., Pignay V., Boulenger J.P.,
RA   Gallati S., Hinkle D.J., Macdonald R.L., Sigel E.;
RT   "Functional characterization of the new human GABA(A) receptor
RT   mutation beta3(R192H).";
RL   Hum. Genet. 111:154-160(2002).
RN   [12]
RP   VARIANT ECA5 ARG-32, CHARACTERIZATION OF VARIANT ECA5 ARG-32, VARIANTS
RP   ECA5 SER-11 AND PHE-15 (ISOFORM 2), CHARACTERIZATION OF VARIANTS ECA5
RP   SER-11 AND PHE-15 (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=18514161; DOI=10.1016/j.ajhg.2008.04.020;
RA   Tanaka M., Olsen R.W., Medina M.T., Schwartz E., Alonso M.E.,
RA   Duron R.M., Castro-Ortega R., Martinez-Juarez I.E.,
RA   Pascual-Castroviejo I., Machado-Salas J., Silva R., Bailey J.N.,
RA   Bai D., Ochoa A., Jara-Prado A., Pineda G., Macdonald R.L.,
RA   Delgado-Escueta A.V.;
RT   "Hyperglycosylation and reduced GABA currents of mutated GABRB3
RT   polypeptide in remitting childhood absence epilepsy.";
RL   Am. J. Hum. Genet. 82:1249-1261(2008).
RN   [13]
RP   CHARACTERIZATION OF VARIANT ECA5 ARG-32, FUNCTION, SUBCELLULAR
RP   LOCATION, AND SUBUNIT.
RX   PubMed=22303015; DOI=10.1074/jbc.M111.332528;
RA   Gurba K.N., Hernandez C.C., Hu N., Macdonald R.L.;
RT   "GABRB3 mutation, G32R, associated with childhood absence epilepsy
RT   alters alpha1beta3gamma2L gamma-aminobutyric acid type A (GABAA)
RT   receptor expression and channel gating.";
RL   J. Biol. Chem. 287:12083-12097(2012).
RN   [14]
RP   INVOLVEMENT IN EIEE43, AND VARIANT EIEE43 ASN-120.
RX   PubMed=23934111; DOI=10.1038/nature12439;
RG   Epi4K Consortium;
RG   Epilepsy Phenome/Genome Project;
RA   Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D.,
RA   Eichler E.E., Epstein M.P., Glauser T., Goldstein D.B., Han Y.,
RA   Heinzen E.L., Hitomi Y., Howell K.B., Johnson M.R., Kuzniecky R.,
RA   Lowenstein D.H., Lu Y.F., Madou M.R., Marson A.G., Mefford H.C.,
RA   Esmaeeli Nieh S., O'Brien T.J., Ottman R., Petrovski S., Poduri A.,
RA   Ruzzo E.K., Scheffer I.E., Sherr E.H., Yuskaitis C.J., Abou-Khalil B.,
RA   Alldredge B.K., Bautista J.F., Berkovic S.F., Boro A., Cascino G.D.,
RA   Consalvo D., Crumrine P., Devinsky O., Dlugos D., Epstein M.P.,
RA   Fiol M., Fountain N.B., French J., Friedman D., Geller E.B.,
RA   Glauser T., Glynn S., Haut S.R., Hayward J., Helmers S.L., Joshi S.,
RA   Kanner A., Kirsch H.E., Knowlton R.C., Kossoff E.H., Kuperman R.,
RA   Kuzniecky R., Lowenstein D.H., McGuire S.M., Motika P.V.,
RA   Novotny E.J., Ottman R., Paolicchi J.M., Parent J.M., Park K.,
RA   Poduri A., Scheffer I.E., Shellhaas R.A., Sherr E.H., Shih J.J.,
RA   Singh R., Sirven J., Smith M.C., Sullivan J., Lin Thio L., Venkat A.,
RA   Vining E.P., Von Allmen G.K., Weisenberg J.L., Widdess-Walsh P.,
RA   Winawer M.R.;
RT   "De novo mutations in epileptic encephalopathies.";
RL   Nature 501:217-221(2013).
RN   [15]
RP   VARIANT EIEE43 HIS-138 INS.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C.,
RA   Patry L., Massicotte C., Ambalavanan A., Spiegelman D., Diallo O.,
RA   Henrion E., Dionne-Laporte A., Fougerat A., Pshezhetsky A.V.,
RA   Venkateswaran S., Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
RN   [16]
RP   INVOLVEMENT IN EIEE43, AND VARIANTS EIEE43 ASN-120; MET-157; PHE-182;
RP   LYS-249; GLN-256; HIS-293 AND THR-305.
RX   PubMed=27476654; DOI=10.1016/j.ajhg.2016.06.003;
RG   Epi4K Consortium;
RT   "De novo mutations in SLC1A2 and CACNA1A are important causes of
RT   epileptic encephalopathies.";
RL   Am. J. Hum. Genet. 99:287-298(2016).
RN   [17]
RP   CHARACTERIZATION OF VARIANT EIEE43 ASN-120, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=26950270; DOI=10.1002/ana.24631;
RA   Janve V.S., Hernandez C.C., Verdier K.M., Hu N., Macdonald R.L.;
RT   "Epileptic encephalopathy de novo GABRB mutations impair GABAA
RT   receptor function.";
RL   Ann. Neurol. 0:0-0(2016).
RN   [18]
RP   VARIANT EIEE43 ILE-287.
RX   PubMed=26993267; DOI=10.1136/jmedgenet-2015-103263;
RA   Trump N., McTague A., Brittain H., Papandreou A., Meyer E., Ngoh A.,
RA   Palmer R., Morrogh D., Boustred C., Hurst J.A., Jenkins L.,
RA   Kurian M.A., Scott R.H.;
RT   "Improving diagnosis and broadening the phenotypes in early-onset
RT   seizure and severe developmental delay disorders through gene panel
RT   analysis.";
RL   J. Med. Genet. 53:310-317(2016).
RN   [19]
RP   VARIANT GLN-232.
RX   PubMed=28544625; DOI=10.1002/ajmg.a.38282;
RA   Le S.V., Le P.H.T., Le T.K.V., Kieu Huynh T.T., Hang Do T.T.;
RT   "A mutation in GABRB3 associated with Dravet syndrome.";
RL   Am. J. Med. Genet. A 173:2126-2131(2017).
RN   [20]
RP   VARIANTS EIEE43 PHE-124 AND PHE-254.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Component of the heteropentameric receptor for GABA, the
CC       major inhibitory neurotransmitter in the vertebrate brain.
CC       Functions also as histamine receptor and mediates cellular
CC       responses to histamine. Functions as receptor for diazepines and
CC       various anesthetics, such as pentobarbital; these are bound at a
CC       separate allosteric effector binding site. Functions as ligand-
CC       gated chloride channel. {ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22243422,
CC       ECO:0000269|PubMed:22303015, ECO:0000269|PubMed:24909990,
CC       ECO:0000269|PubMed:26950270}.
CC   -!- SUBUNIT: Heteropentamer, formed by a combination of alpha, beta,
CC       gamma, delta and rho chains (PubMed:22243422, PubMed:18281286,
CC       PubMed:18514161, PubMed:24909990). Can form functional
CC       homopentamers (in vitro) (PubMed:22303015). Interacts with UBQLN1
CC       (By similarity). May interact with KIF21B (By similarity).
CC       {ECO:0000250|UniProtKB:P63079, ECO:0000269|PubMed:18281286,
CC       ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22243422,
CC       ECO:0000269|PubMed:22303015, ECO:0000269|PubMed:24909990}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-6258252, EBI-6258252;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24909990}. Cell membrane
CC       {ECO:0000269|PubMed:18281286, ECO:0000269|PubMed:18514161,
CC       ECO:0000269|PubMed:22243422, ECO:0000269|PubMed:22303015,
CC       ECO:0000269|PubMed:24909990, ECO:0000269|PubMed:26950270}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:24909990}. Cytoplasmic
CC       vesicle membrane {ECO:0000250|UniProtKB:P63079}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Isoforms differ in their signal region.;
CC       Name=1;
CC         IsoId=P28472-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28472-2; Sequence=VSP_000088;
CC         Note=Variant in position: 11:P->S (in ECA5, the mutant protein
CC         is hyperglycosylated and has reduced mean current densities
CC         compared to wild-type, dbSNP:rs25409). Variant in position:
CC         15:S->F (in ECA5, the mutant protein is hyperglycosylated and
CC         has reduced mean current densities compared to wild-type).
CC         {ECO:0000269|PubMed:18514161};
CC       Name=3;
CC         IsoId=P28472-3; Sequence=VSP_046126;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P28472-4; Sequence=VSP_046676;
CC   -!- POLYMORPHISM: GABRB3 variants may be associated with insomnia, a
CC       condition of inability to initiate or maintain sleep [MIM:137192].
CC   -!- DISEASE: Epilepsy, childhood absence 5 (ECA5) [MIM:612269]: A
CC       subtype of idiopathic generalized epilepsy characterized by an
CC       onset at age 6-7 years, frequent absence seizures (several per
CC       day) and bilateral, synchronous, symmetric 3-Hz spike waves on
CC       EEG. Tonic-clonic seizures often develop in adolescence. Absence
CC       seizures may either remit or persist into adulthood.
CC       {ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22303015}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Epileptic encephalopathy, early infantile, 43 (EIEE43)
CC       [MIM:617113]: A form of epileptic encephalopathy, a heterogeneous
CC       group of severe childhood onset epilepsies characterized by
CC       refractory seizures, neurodevelopmental impairment, and poor
CC       prognosis. Development is normal prior to seizure onset, after
CC       which cognitive and motor delays become apparent. EIEE43
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:23934111,
CC       ECO:0000269|PubMed:25356899, ECO:0000269|PubMed:26950270,
CC       ECO:0000269|PubMed:26993267, ECO:0000269|PubMed:27476654,
CC       ECO:0000269|PubMed:27864847}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRB3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M82919; AAA52511.1; -; mRNA.
DR   EMBL; AK295167; BAH11997.1; -; mRNA.
DR   EMBL; AK302822; BAH13811.1; -; mRNA.
DR   EMBL; AC009878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC145167; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC145196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; EU606048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471151; EAW57655.1; -; Genomic_DNA.
DR   EMBL; BC010641; AAH10641.1; -; mRNA.
DR   EMBL; L04311; AAA52508.1; -; Genomic_DNA.
DR   EMBL; L04311; AAA52507.1; -; Genomic_DNA.
DR   CCDS; CCDS10018.1; -. [P28472-2]
DR   CCDS; CCDS10019.1; -. [P28472-1]
DR   CCDS; CCDS53920.1; -. [P28472-4]
DR   CCDS; CCDS53921.1; -. [P28472-3]
DR   PIR; A55275; A55275.
DR   PIR; B45468; B45468.
DR   RefSeq; NP_000805.1; NM_000814.5. [P28472-1]
DR   RefSeq; NP_001178249.1; NM_001191320.1. [P28472-4]
DR   RefSeq; NP_001178250.1; NM_001191321.2. [P28472-3]
DR   RefSeq; NP_001265560.1; NM_001278631.1. [P28472-4]
DR   RefSeq; NP_068712.1; NM_021912.4. [P28472-2]
DR   UniGene; Hs.302352; -.
DR   UniGene; Hs.727263; -.
DR   PDB; 4COF; X-ray; 2.97 A; A/B/C/D/E=26-332, A/B/C/D/E=447-473.
DR   PDB; 5O8F; X-ray; 3.20 A; A/B/C/D/E=26-246.
DR   PDBsum; 4COF; -.
DR   PDBsum; 5O8F; -.
DR   ProteinModelPortal; P28472; -.
DR   SMR; P28472; -.
DR   BioGrid; 108836; 10.
DR   DIP; DIP-61029N; -.
DR   IntAct; P28472; 1.
DR   STRING; 9606.ENSP00000299267; -.
DR   BindingDB; P28472; -.
DR   ChEMBL; CHEMBL1847; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00546; Adinazolam.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB01594; Cinolazepam.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01559; Clotiazepam.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01567; Fludiazepam.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB06716; Fospropofol.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00602; Ivermectin.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB00592; Piperazine.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   GuidetoPHARMACOLOGY; 412; -.
DR   TCDB; 1.A.9.5.4; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P28472; -.
DR   PhosphoSitePlus; P28472; -.
DR   BioMuta; GABRB3; -.
DR   DMDM; 120773; -.
DR   MaxQB; P28472; -.
DR   PaxDb; P28472; -.
DR   PeptideAtlas; P28472; -.
DR   PRIDE; P28472; -.
DR   DNASU; 2562; -.
DR   Ensembl; ENST00000299267; ENSP00000299267; ENSG00000166206. [P28472-2]
DR   Ensembl; ENST00000311550; ENSP00000308725; ENSG00000166206. [P28472-1]
DR   Ensembl; ENST00000400188; ENSP00000383049; ENSG00000166206. [P28472-3]
DR   Ensembl; ENST00000545868; ENSP00000439169; ENSG00000166206. [P28472-4]
DR   Ensembl; ENST00000622697; ENSP00000481004; ENSG00000166206. [P28472-4]
DR   Ensembl; ENST00000628124; ENSP00000486819; ENSG00000166206. [P28472-4]
DR   Ensembl; ENST00000636466; ENSP00000489768; ENSG00000166206. [P28472-4]
DR   GeneID; 2562; -.
DR   KEGG; hsa:2562; -.
DR   UCSC; uc001zaz.5; human. [P28472-1]
DR   CTD; 2562; -.
DR   DisGeNET; 2562; -.
DR   EuPathDB; HostDB:ENSG00000166206.13; -.
DR   GeneCards; GABRB3; -.
DR   GeneReviews; GABRB3; -.
DR   HGNC; HGNC:4083; GABRB3.
DR   MalaCards; GABRB3; -.
DR   MIM; 137192; gene+phenotype.
DR   MIM; 612269; phenotype.
DR   MIM; 617113; phenotype.
DR   neXtProt; NX_P28472; -.
DR   OpenTargets; ENSG00000166206; -.
DR   Orphanet; 106; Autism.
DR   Orphanet; 64280; Childhood absence epilepsy.
DR   PharmGKB; PA28497; -.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P28472; -.
DR   KO; K05181; -.
DR   PhylomeDB; P28472; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   SignaLink; P28472; -.
DR   ChiTaRS; GABRB3; human.
DR   GeneWiki; GABRB3; -.
DR   GenomeRNAi; 2562; -.
DR   PRO; PR:P28472; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166206; -.
DR   CleanEx; HS_GABRB3; -.
DR   ExpressionAtlas; P28472; baseline and differential.
DR   Genevisible; P28472; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1902711; C:GABA-A receptor complex; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; IMP:UniProtKB.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0071420; P:cellular response to histamine; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:GO_Central.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:0060119; P:inner ear receptor cell development; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0060021; P:palate development; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Chloride; Chloride channel; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disease mutation; Disulfide bond; Epilepsy;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    473       Gamma-aminobutyric acid receptor subunit
FT                                beta-3.
FT                                /FTId=PRO_0000000462.
FT   TOPO_DOM     26    245       Extracellular.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    246    267       Helical.
FT   TOPO_DOM    268    270       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    271    293       Helical.
FT   TOPO_DOM    294    304       Extracellular.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    305    327       Helical.
FT   TOPO_DOM    328    450       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24909990}.
FT   TRANSMEM    451    472       Helical.
FT   REGION      120    122       Agonist binding.
FT   REGION      180    182       Agonist binding.
FT   REGION      290    311       Allosteric effector binding.
FT   BINDING     225    225       Agonist.
FT   CARBOHYD     33     33       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24909990}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24909990}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24909990}.
FT   DISULFID    161    175       {ECO:0000269|PubMed:24909990}.
FT   VAR_SEQ       1     85       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046676.
FT   VAR_SEQ       1     26       MWGLAGGRLFGIFSAPVLVAVVCCAQ -> MCSGLLELLLP
FT                                IWLSWTLGTRGSEPR (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000088.
FT   VAR_SEQ       3     80       GLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDK
FT                                LLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNM ->
FT                                ATYQTEE (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046126.
FT   VARIANT      32     32       G -> R (in ECA5; the mutant protein is
FT                                hyperglycosylated and has reduced mean
FT                                current densities compared to wild-type;
FT                                dbSNP:rs71651682).
FT                                {ECO:0000269|PubMed:18514161,
FT                                ECO:0000269|PubMed:22303015}.
FT                                /FTId=VAR_047957.
FT   VARIANT     120    120       D -> N (in EIEE43; no effect on
FT                                localization to the plasma membrane;
FT                                decreased GABA-gated chloride ion channel
FT                                activity; decreased single channel open
FT                                probability; dbSNP:rs886037938).
FT                                {ECO:0000269|PubMed:23934111,
FT                                ECO:0000269|PubMed:26950270,
FT                                ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077076.
FT   VARIANT     124    124       L -> F (in EIEE43; dbSNP:rs1057519550).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078223.
FT   VARIANT     138    138       N -> NH (in EIEE43).
FT                                {ECO:0000269|PubMed:25356899}.
FT                                /FTId=VAR_078619.
FT   VARIANT     157    157       T -> M (in EIEE43; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077077.
FT   VARIANT     173    173       Q -> L (in dbSNP:rs17850679).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_047958.
FT   VARIANT     182    182       Y -> F (in EIEE43; dbSNP:rs886037939).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077078.
FT   VARIANT     217    217       R -> H (found in a subject suffering from
FT                                insomnia; functional analysis reveals a
FT                                slower rate of the fast phase of
FT                                desensitization compared with
FT                                alpha1beta3gamma2S GABA(A) receptors;
FT                                current deactivation is faster in the
FT                                mutated receptors; dbSNP:rs121913125).
FT                                {ECO:0000269|PubMed:12189488}.
FT                                /FTId=VAR_047959.
FT   VARIANT     232    232       R -> Q (found in patients with Dravet
FT                                syndrome; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:28544625}.
FT                                /FTId=VAR_079429.
FT   VARIANT     249    249       Q -> K (in EIEE43; dbSNP:rs886037940).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077079.
FT   VARIANT     254    254       S -> F (in EIEE43; dbSNP:rs1057519549).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078224.
FT   VARIANT     256    256       L -> Q (in EIEE43).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077080.
FT   VARIANT     287    287       T -> I (in EIEE43).
FT                                {ECO:0000269|PubMed:26993267}.
FT                                /FTId=VAR_078719.
FT   VARIANT     293    293       L -> H (in EIEE43; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077081.
FT   VARIANT     305    305       A -> T (in EIEE43; dbSNP:rs886037941).
FT                                {ECO:0000269|PubMed:27476654}.
FT                                /FTId=VAR_077082.
FT   CONFLICT     97     97       L -> H (in Ref. 2; BAH13811).
FT                                {ECO:0000305}.
FT   CONFLICT    193    193       W -> R (in Ref. 2; BAH11997).
FT                                {ECO:0000305}.
FT   HELIX        34     45       {ECO:0000244|PDB:4COF}.
FT   TURN         54     57       {ECO:0000244|PDB:4COF}.
FT   STRAND       61     76       {ECO:0000244|PDB:4COF}.
FT   TURN         77     80       {ECO:0000244|PDB:4COF}.
FT   STRAND       81     93       {ECO:0000244|PDB:4COF}.
FT   HELIX        95     97       {ECO:0000244|PDB:4COF}.
FT   STRAND      106    108       {ECO:0000244|PDB:4COF}.
FT   HELIX       110    115       {ECO:0000244|PDB:4COF}.
FT   STRAND      121    123       {ECO:0000244|PDB:4COF}.
FT   STRAND      126    131       {ECO:0000244|PDB:4COF}.
FT   STRAND      134    136       {ECO:0000244|PDB:4COF}.
FT   STRAND      138    143       {ECO:0000244|PDB:4COF}.
FT   STRAND      147    160       {ECO:0000244|PDB:4COF}.
FT   TURN        166    169       {ECO:0000244|PDB:4COF}.
FT   STRAND      172    183       {ECO:0000244|PDB:4COF}.
FT   TURN        186    188       {ECO:0000244|PDB:4COF}.
FT   STRAND      189    193       {ECO:0000244|PDB:4COF}.
FT   HELIX       196    198       {ECO:0000244|PDB:4COF}.
FT   STRAND      199    201       {ECO:0000244|PDB:4COF}.
FT   HELIX       203    205       {ECO:0000244|PDB:4COF}.
FT   STRAND      209    225       {ECO:0000244|PDB:4COF}.
FT   STRAND      228    241       {ECO:0000244|PDB:4COF}.
FT   HELIX       244    249       {ECO:0000244|PDB:4COF}.
FT   HELIX       251    262       {ECO:0000244|PDB:4COF}.
FT   HELIX       263    266       {ECO:0000244|PDB:4COF}.
FT   HELIX       272    295       {ECO:0000244|PDB:4COF}.
FT   HELIX       305    330       {ECO:0000244|PDB:4COF}.
FT   HELIX       447    471       {ECO:0000244|PDB:4COF}.
SQ   SEQUENCE   473 AA;  54116 MW;  D63597F7FBC69E71 CRC64;
     MWGLAGGRLF GIFSAPVLVA VVCCAQSVND PGNMSFVKET VDKLLKGYDI RLRPDFGGPP
     VCVGMNIDIA SIDMVSEVNM DYTLTMYFQQ YWRDKRLAYS GIPLNLTLDN RVADQLWVPD
     TYFLNDKKSF VHGVTVKNRM IRLHPDGTVL YGLRITTTAA CMMDLRRYPL DEQNCTLEIE
     SYGYTTDDIE FYWRGGDKAV TGVERIELPQ FSIVEHRLVS RNVVFATGAY PRLSLSFRLK
     RNIGYFILQT YMPSILITIL SWVSFWINYD ASAARVALGI TTVLTMTTIN THLRETLPKI
     PYVKAIDMYL MGCFVFVFLA LLEYAFVNYI FFGRGPQRQK KLAEKTAKAK NDRSKSESNR
     VDAHGNILLT SLEVHNEMNE VSGGIGDTRN SAISFDNSGI QYRKQSMPRE GHGRFLGDRS
     LPHKKTHLRR RSSQLKIKIP DLTDVNAIDR WSRIVFPFTF SLFNLVYWLY YVN
//
ID   CNGA1_HUMAN             Reviewed;         690 AA.
AC   P29973; A8K7K6; J3KPZ2; Q16279; Q16485; Q4W5E3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   25-OCT-2017, entry version 180.
DE   RecName: Full=cGMP-gated cation channel alpha-1;
DE   AltName: Full=Cyclic nucleotide-gated cation channel 1;
DE   AltName: Full=Cyclic nucleotide-gated channel alpha-1;
DE            Short=CNG channel alpha-1;
DE            Short=CNG-1;
DE            Short=CNG1;
DE   AltName: Full=Cyclic nucleotide-gated channel, photoreceptor;
DE   AltName: Full=Rod photoreceptor cGMP-gated channel subunit alpha;
GN   Name=CNGA1; Synonyms=CNCG, CNCG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=1372902;
RA   Pittler S.J., Lee A.K., Altherr M.R., Howard T.A., Seldin M.F.,
RA   Hurwitz R.L., Wasmuth J.J., Baehr W.;
RT   "Primary structure and chromosomal localization of human and mouse rod
RT   photoreceptor cGMP-gated cation channel.";
RL   J. Biol. Chem. 267:6257-6262(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=1379636;
RA   Dhallan R.S., Macke J.P., Eddy R.L., Shows T.B., Reed R.R., Yau K.-W.,
RA   Nathans J.;
RT   "Human rod photoreceptor cGMP-gated channel: amino acid sequence, gene
RT   structure, and functional expression.";
RL   J. Neurosci. 12:3248-3256(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 317-577.
RX   PubMed=7532814; DOI=10.1016/0028-3908(94)90027-2;
RA   Distler M., Biel M., Flockerzi V., Hofmann F.;
RT   "Expression of cyclic nucleotide-gated cation channels in non-sensory
RT   tissues and cells.";
RL   Neuropharmacology 33:1275-1282(1994).
RN   [7]
RP   VARIANT RP49 PHE-320, AND VARIANTS GLN-32 AND ASN-118.
RX   PubMed=7479749; DOI=10.1073/pnas.92.22.10177;
RA   Dryja T.P., Finn J.T., Peng Y.-W., McGee T.L., Berson E.L., Yau K.-W.;
RT   "Mutations in the gene encoding the alpha subunit of the rod cGMP-
RT   gated channel in autosomal recessive retinitis pigmentosa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10177-10181(1995).
RN   [8]
RP   INVOLVEMENT IN RP49.
RX   PubMed=15570217;
RA   Zhang Q., Zulfiqar F., Riazuddin S.A., Xiao X., Ahmad Z.,
RA   Riazuddin S., Hejtmancik J.F.;
RT   "Autosomal recessive retinitis pigmentosa in a Pakistani family mapped
RT   to CNGA1 with identification of a novel mutation.";
RL   Mol. Vis. 10:884-889(2004).
CC   -!- FUNCTION: Visual signal transduction is mediated by a G-protein
CC       coupled cascade using cGMP as second messenger. This protein can
CC       be activated by cyclic GMP which leads to an opening of the cation
CC       channel and thereby causing a depolarization of rod
CC       photoreceptors.
CC   -!- SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatory
CC       subunits. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q5ICW4:GRB14 (xeno); NbExp=4; IntAct=EBI-8417095, EBI-7639273;
CC       Q9JLM9:Grb14 (xeno); NbExp=2; IntAct=EBI-8417095, EBI-8347358;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P29973-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29973-2; Sequence=VSP_047170;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Rod cells in the retina.
CC   -!- DOMAIN: The C-terminal coiled-coil domain mediates
CC       homotrimerization of CNGA subunits. {ECO:0000250}.
CC   -!- DISEASE: Retinitis pigmentosa 49 (RP49) [MIM:613756]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:15570217,
CC       ECO:0000269|PubMed:7479749}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGA1 subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-5 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB22778.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mutations of the CNGA1 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/cnga1mut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M84741; AAA52010.1; -; mRNA.
DR   EMBL; S42457; AAB22778.1; ALT_INIT; mRNA.
DR   EMBL; AK292021; BAF84710.1; -; mRNA.
DR   EMBL; AC096749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107068; AAY40919.1; -; Genomic_DNA.
DR   EMBL; CH471069; EAW93048.1; -; Genomic_DNA.
DR   EMBL; S76062; AAD14206.1; -; Genomic_DNA.
DR   CCDS; CCDS43226.1; -. [P29973-1]
DR   CCDS; CCDS47050.1; -. [P29973-2]
DR   PIR; A42161; A42161.
DR   RefSeq; NP_000078.2; NM_000087.3. [P29973-1]
DR   RefSeq; NP_001136036.1; NM_001142564.1. [P29973-2]
DR   RefSeq; XP_011511925.1; XM_011513623.2. [P29973-1]
DR   RefSeq; XP_016863201.1; XM_017007712.1. [P29973-1]
DR   UniGene; Hs.1323; -.
DR   ProteinModelPortal; P29973; -.
DR   SMR; P29973; -.
DR   BioGrid; 107659; 1.
DR   IntAct; P29973; 2.
DR   MINT; MINT-7004260; -.
DR   STRING; 9606.ENSP00000384264; -.
DR   GuidetoPHARMACOLOGY; 394; -.
DR   TCDB; 1.A.1.5.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; P29973; -.
DR   PhosphoSitePlus; P29973; -.
DR   BioMuta; CNGA1; -.
DR   DMDM; 239938910; -.
DR   EPD; P29973; -.
DR   PaxDb; P29973; -.
DR   PeptideAtlas; P29973; -.
DR   PRIDE; P29973; -.
DR   DNASU; 1259; -.
DR   Ensembl; ENST00000358519; ENSP00000351320; ENSG00000198515. [P29973-1]
DR   Ensembl; ENST00000402813; ENSP00000384264; ENSG00000198515. [P29973-2]
DR   Ensembl; ENST00000420489; ENSP00000389881; ENSG00000198515. [P29973-1]
DR   Ensembl; ENST00000514170; ENSP00000426862; ENSG00000198515. [P29973-1]
DR   Ensembl; ENST00000544810; ENSP00000443401; ENSG00000198515. [P29973-2]
DR   GeneID; 1259; -.
DR   KEGG; hsa:1259; -.
DR   UCSC; uc003gxt.5; human. [P29973-1]
DR   CTD; 1259; -.
DR   DisGeNET; 1259; -.
DR   EuPathDB; HostDB:ENSG00000198515.13; -.
DR   GeneCards; CNGA1; -.
DR   GeneReviews; CNGA1; -.
DR   H-InvDB; HIX0031530; -.
DR   H-InvDB; HIX0031590; -.
DR   HGNC; HGNC:2148; CNGA1.
DR   HPA; HPA076168; -.
DR   MalaCards; CNGA1; -.
DR   MIM; 123825; gene.
DR   MIM; 613756; phenotype.
DR   neXtProt; NX_P29973; -.
DR   OpenTargets; ENSG00000198515; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA26658; -.
DR   eggNOG; KOG0500; Eukaryota.
DR   eggNOG; ENOG410YWWI; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000007898; -.
DR   HOVERGEN; HBG000281; -.
DR   InParanoid; P29973; -.
DR   KO; K04948; -.
DR   OMA; CMYFAIS; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; P29973; -.
DR   TreeFam; TF319048; -.
DR   Reactome; R-HSA-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   GeneWiki; Cyclic_nucleotide-gated_channel_alpha_1; -.
DR   GenomeRNAi; 1259; -.
DR   PRO; PR:P29973; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000198515; -.
DR   CleanEx; HS_CNGA1; -.
DR   ExpressionAtlas; P29973; baseline and differential.
DR   Genevisible; P29973; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0042622; C:photoreceptor outer segment membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; IEA:InterPro.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032406; CLZ_dom.
DR   InterPro; IPR032945; CNGA1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF387; PTHR10217:SF387; 1.
DR   Pfam; PF16526; CLZ; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cGMP; cGMP-binding; Coiled coil;
KW   Complete proteome; Disease mutation; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Retinitis pigmentosa;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1    690       cGMP-gated cation channel alpha-1.
FT                                /FTId=PRO_0000219308.
FT   TOPO_DOM      1    164       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    186    198       Extracellular. {ECO:0000255}.
FT   TRANSMEM    199    217       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    218    241       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    242    261       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    262    299       Extracellular. {ECO:0000255}.
FT   TRANSMEM    300    322       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    323    374       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    375    394       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    395    478       Extracellular. {ECO:0000255}.
FT   TRANSMEM    479    499       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    500    690       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     487    609       cGMP. {ECO:0000255}.
FT   COILED      623    666       {ECO:0000250}.
FT   BINDING     546    546       cGMP. {ECO:0000255}.
FT   BINDING     561    561       cGMP. {ECO:0000255}.
FT   CARBOHYD    425    425       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MESRSSPRLECSGAISAHCSLHLPDSSDFQLIFVFL
FT                                VEMGFHHVGQAGLELLISSDLPTSASQSAGITDM (in
FT                                isoform 2). {ECO:0000303|PubMed:1379636}.
FT                                /FTId=VSP_047170.
FT   VARIANT      32     32       R -> Q (in dbSNP:rs76537883).
FT                                {ECO:0000269|PubMed:7479749}.
FT                                /FTId=VAR_009295.
FT   VARIANT     118    118       D -> N (in dbSNP:rs28642966).
FT                                {ECO:0000269|PubMed:7479749}.
FT                                /FTId=VAR_009296.
FT   VARIANT     122    122       N -> D (in dbSNP:rs28642966).
FT                                /FTId=VAR_047385.
FT   VARIANT     320    320       S -> F (in RP49; dbSNP:rs62625014).
FT                                {ECO:0000269|PubMed:7479749}.
FT                                /FTId=VAR_009297.
FT   CONFLICT     35     35       E -> V (in Ref. 3; BAF84710).
FT                                {ECO:0000305}.
FT   CONFLICT     50     50       S -> Y (in Ref. 1; AAA52010).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       L -> I (in Ref. 1; AAA52010).
FT                                {ECO:0000305}.
FT   CONFLICT    150    151       EE -> HH (in Ref. 1; AAA52010).
FT                                {ECO:0000305}.
FT   CONFLICT    209    209       I -> V (in Ref. 3; BAF84710).
FT                                {ECO:0000305}.
FT   CONFLICT    543    543       Y -> T (in Ref. 1; AAA52010).
FT                                {ECO:0000305}.
FT   CONFLICT    681    682       GA -> WS (in Ref. 1; AAA52010).
FT                                {ECO:0000305}.
SQ   SEQUENCE   690 AA;  79586 MW;  F1045A210FE33DC0 CRC64;
     MKLSMKNNII NTQQSFVTMP NVIVPDIEKE IRRMENGACS SFSEDDDSAS TSEESENENP
     HARGSFSYKS LRKGGPSQRE QYLPGAIALF NVNNSSNKDQ EPEEKKKKKK EKKSKSDDKN
     ENKNDPEKKK KKKDKEKKKK EEKSKDKKEE EKKEVVVIDP SGNTYYNWLF CITLPVMYNW
     TMVIARACFD ELQSDYLEYW LILDYVSDIV YLIDMFVRTR TGYLEQGLLV KEELKLINKY
     KSNLQFKLDV LSLIPTDLLY FKLGWNYPEI RLNRLLRFSR MFEFFQRTET RTNYPNIFRI
     SNLVMYIVII IHWNACVFYS ISKAIGFGND TWVYPDINDP EFGRLARKYV YSLYWSTLTL
     TTIGETPPPV RDSEYVFVVV DFLIGVLIFA TIVGNIGSMI SNMNAARAEF QARIDAIKQY
     MHFRNVSKDM EKRVIKWFDY LWTNKKTVDE KEVLKYLPDK LRAEIAINVH LDTLKKVRIF
     ADCEAGLLVE LVLKLQPQVY SPGDYICKKG DIGREMYIIK EGKLAVVADD GVTQFVVLSD
     GSYFGEISIL NIKGSKAGNR RTANIKSIGY SDLFCLSKDD LMEALTEYPD AKTMLEEKGK
     QILMKDGLLD LNIANAGSDP KDLEEKVTRM EGSVDLLQTR FARILAEYES MQQKLKQRLT
     KVEKFLKPLI DTEFSSIEGP GAESGPIDST
//
ID   ITPR_DROME              Reviewed;        2838 AA.
AC   P29993; Q24309; Q9U981; Q9VNC8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 3.
DT   20-DEC-2017, entry version 171.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor;
DE   AltName: Full=InsP3 receptor;
DE            Short=IP3R;
DE            Short=InsP3R;
GN   Name=Itp-r83A; Synonyms=dip, InsP3R, itpr; ORFNames=CG1063;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=1322910;
RA   Yoshikawa S., Tanimura T., Miyawaki A., Nakamura M., Yuzaki M.,
RA   Furuichi T., Mikoshiba K.;
RT   "Molecular cloning and characterization of the inositol 1,4,5-
RT   trisphosphate receptor in Drosophila melanogaster.";
RL   J. Biol. Chem. 267:16613-16619(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RC   TISSUE=Embryo;
RX   PubMed=10375644; DOI=10.1016/S0378-1119(99)00158-4;
RA   Sinha M., Hasan G.;
RT   "Sequencing and exon mapping of the inositol 1,4,5-trisphosphate
RT   receptor cDNA from Drosophila embryos suggests the presence of
RT   differentially regulated forms of RNA and protein.";
RL   Gene 233:271-276(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 2370-2837, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=1338312;
RA   Hasan G., Rosbash M.;
RT   "Drosophila homologs of two mammalian intracellular Ca(2+)-release
RT   channels: identification and expression patterns of the inositol
RT   1,4,5-triphosphate and the ryanodine receptor genes.";
RL   Development 116:967-975(1992).
CC   -!- FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second
CC       messenger that mediates the release of intracellular calcium. May
CC       be involved in visual and olfactory transduction, and myoblast
CC       proliferation. {ECO:0000269|PubMed:1322910}.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B; Synonyms=Head;
CC         IsoId=P29993-1; Sequence=Displayed;
CC       Name=A; Synonyms=Embryo;
CC         IsoId=P29993-2; Sequence=VSP_002703;
CC   -!- TISSUE SPECIFICITY: Segmental expression of isoform B is first
CC       detected in stage 13 embryos in lateral and posterior epidermis.
CC       Expression extends to head region during stages 13-17: gnathal
CC       buds, clypeolabrum, procephalic lobe, labial organ and anterior
CC       sense organs. Adults exhibit high expression in antenna and lower
CC       expression in retina, head, legs and thorax.
CC       {ECO:0000269|PubMed:1322910, ECO:0000269|PubMed:1338312}.
CC   -!- DEVELOPMENTAL STAGE: Isoform A is expressed only in early embryos.
CC       Isoform B is expressed from mid-late embryos to adults.
CC       Predominant expression is in the adult.
CC       {ECO:0000269|PubMed:1338312}.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D90403; BAA14399.1; -; mRNA.
DR   EMBL; AJ238949; CAB51853.1; -; mRNA.
DR   EMBL; AE014297; AAF52015.2; -; Genomic_DNA.
DR   EMBL; AE014297; AAN13240.1; -; Genomic_DNA.
DR   EMBL; Z18535; CAA79220.1; -; mRNA.
DR   PIR; A43360; A43360.
DR   RefSeq; NP_001287180.1; NM_001300251.1.
DR   RefSeq; NP_730941.1; NM_169060.2.
DR   RefSeq; NP_730942.1; NM_169061.2.
DR   UniGene; Dm.4462; -.
DR   ProteinModelPortal; P29993; -.
DR   BioGrid; 65871; 16.
DR   IntAct; P29993; 5.
DR   STRING; 7227.FBpp0078336; -.
DR   TCDB; 1.A.3.2.2; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   PaxDb; P29993; -.
DR   PRIDE; P29993; -.
DR   GeneID; 40664; -.
DR   KEGG; dme:Dmel_CG1063; -.
DR   CTD; 40664; -.
DR   FlyBase; FBgn0010051; Itp-r83A.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   InParanoid; P29993; -.
DR   KO; K04958; -.
DR   OrthoDB; EOG091G00T2; -.
DR   PhylomeDB; P29993; -.
DR   Reactome; R-DME-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-DME-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-DME-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-DME-5578775; Ion homeostasis.
DR   Reactome; R-DME-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   ChiTaRS; Itp-r83A; fly.
DR   GenomeRNAi; 40664; -.
DR   PRO; PR:P29993; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0010051; -.
DR   ExpressionAtlas; P29993; differential.
DR   Genevisible; P29993; DM.
DR   GO; GO:0044295; C:axonal growth cone; IDA:FlyBase.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:FlyBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IDA:FlyBase.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:FlyBase.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IMP:FlyBase.
DR   GO; GO:0055089; P:fatty acid homeostasis; IMP:FlyBase.
DR   GO; GO:0007629; P:flight behavior; IMP:FlyBase.
DR   GO; GO:0030536; P:larval feeding behavior; IMP:FlyBase.
DR   GO; GO:0007591; P:molting cycle, chitin-based cuticle; IGI:FlyBase.
DR   GO; GO:0016319; P:mushroom body development; IMP:FlyBase.
DR   GO; GO:0000280; P:nuclear division; IDA:FlyBase.
DR   GO; GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IMP:FlyBase.
DR   GO; GO:0046000; P:positive regulation of ecdysteroid secretion; IMP:FlyBase.
DR   GO; GO:0060259; P:regulation of feeding behavior; IMP:FlyBase.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:FlyBase.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:FlyBase.
DR   GO; GO:0042594; P:response to starvation; IMP:FlyBase.
DR   GO; GO:0035071; P:salivary gland cell autophagic cell death; IMP:FlyBase.
DR   GO; GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW.
DR   GO; GO:0050909; P:sensory perception of taste; IDA:FlyBase.
DR   GO; GO:0030322; P:stabilization of membrane potential; IGI:FlyBase.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 2.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Developmental protein; Endoplasmic reticulum;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Olfaction; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1   2838       Inositol 1,4,5-trisphosphate receptor.
FT                                /FTId=PRO_0000153931.
FT   TOPO_DOM      1   2366       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2367   2387       Helical. {ECO:0000255}.
FT   TOPO_DOM   2388   2398       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2399   2419       Helical. {ECO:0000255}.
FT   TOPO_DOM   2420   2434       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2435   2455       Helical. {ECO:0000255}.
FT   TOPO_DOM   2456   2487       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2488   2508       Helical. {ECO:0000255}.
FT   TOPO_DOM   2509   2531       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2532   2552       Helical. {ECO:0000255}.
FT   TOPO_DOM   2553   2659       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2660   2680       Helical. {ECO:0000255}.
FT   TOPO_DOM   2681   2838       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      115    170       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      177    229       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      237    293       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      300    359       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      398    454       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      272    276       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      530    533       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      591    593       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   VAR_SEQ     981    989       Missing (in isoform A).
FT                                {ECO:0000303|PubMed:10375644}.
FT                                /FTId=VSP_002703.
FT   CONFLICT    183    183       Missing (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT    551    551       E -> Q (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT    726    726       P -> A (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   1079   1120       AASAASNEASQQQSQQQEPQTPGSSNETDPLDSAESVAAGA
FT                                A -> PLRPLAMRQVSSSRNNRNRRRLAAPMRLIPSTVPSL
FT                                WPPRC (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT   1150   1152       SDA -> TP (in Ref. 1; BAA14399).
FT                                {ECO:0000305}.
FT   CONFLICT   1394   1397       VQHF -> GVGHSV (in Ref. 2; CAB51853).
FT                                {ECO:0000305}.
FT   CONFLICT   1395   1395       Missing (in Ref. 1; BAA14399).
FT                                {ECO:0000305}.
FT   CONFLICT   1419   1419       A -> R (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   1466   1466       G -> R (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   2108   2108       L -> V (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   2333   2333       L -> V (in Ref. 3; AAF52015/AAN13240).
FT                                {ECO:0000305}.
FT   CONFLICT   2452   2452       V -> I (in Ref. 5). {ECO:0000305}.
FT   CONFLICT   2483   2497       QLLYHCIYIAFCFCG -> STYTALYSVLLLR (in Ref.
FT                                1 and 2). {ECO:0000305}.
FT   CONFLICT   2511   2511       D -> H (in Ref. 5). {ECO:0000305}.
FT   CONFLICT   2802   2802       N -> F (in Ref. 1; BAA14399).
FT                                {ECO:0000305}.
FT   CONFLICT   2807   2807       L -> V (in Ref. 5). {ECO:0000305}.
SQ   SEQUENCE   2838 AA;  319107 MW;  0718F04D15BE00BB CRC64;
     MGDNIIGSAS FLHLGDIVSL YAEGSVCGFL STLGLVDDRT VVCPEAGDLS CPPKKFRDCL
     IKICPMNRYS AQKQFWKAAK QSASSNTDPN LLKRLHHAAE IEKKQNETEN KKLLGTSIQY
     GRAVVQLLHL KSNKYLTVNK RLPSLLEKNA MRVYLDANGN EGSWFYIKPF YKLRSIGDYV
     VVVGDKVILS PVNADQQNLH VAANYELPDN PGCKEVNVLN SSTSWKISLF MEHKENQEHI
     LKGGDVVRLF HAEQEKFLTM DEYKKQYHVF LRTTGRTSAT AATSSKALWE IEVVQHDSCR
     GGAGDWNSLY RFKHLATGHY LAAEAEIDVS AGAMSATSAS GHDLHLGDCS KDSGLSCSTM
     NSTINDKPKG KQYRLVSVPY SADIASVFVL DATTMARPDS LVPQSSYVRL QHICSNTWVH
     ATSIPIDADD DKPVMSMVCC SPIKEDKEAF ALIPVSPVEV RDLDFANDAC KVLATVTSKL
     DNGSISINER RALISLLQDI VYFIAGMENE QNKTKALEFT IKNPIRDRQK LLREQYILKQ
     LFKILQGPFQ EHTAGDGPFL RLDELSDPKN SPYKNIFRLC YRILRLSQQD YRKNQEYIAK
     HFGLMQKQIG YDILAEDTIT ALLHNNRKLL EKHITAAEIE TFVGLVRKNM HNWDSRFLDY
     LSDLCVSNRK AIAVTQELIC KSVLSDKNKD ILIETQVKAL RTGSGPVRCY KGNSEDVCLA
     TLAEDPGDDE DRSDVQSTST TTTWDSASLN EDDGTPSTGD KYEIHLKWTG QPTSRSMADL
     ASCDGGELEA AILNYYRHQL NLFSNMCLNR QYLALNELSP RLDIDLILKC MSDETMPYEL
     RASFCRLMLH LHVDRDPQEP VTPVKYARLW SEIPSKMSIQ DYDGKNQQPD QNKQACRAKF
     NTTIAFVENY LCNVATKVWL FTDQEQNKLT FEVVKLARDL IYFGFYSFSD LLRLTKTLLS
     ILDCVSDTSS GEFASTDIDS VEEETNAEAE GGVLRSIGDI NTVMTSLALG SVGQAIAAPT
     ISLQQRKSVS QLMKEYPLVM DTKLKIIEIL QFILDVRLDY RISCLLSIFK REFDESEVAA
     SAASNEASQQ QSQQQEPQTP GSSNETDPLD SAESVAAGAA AAAATTARQK NIDLESIGVQ
     AEGIFDCERS DAANLDLDGQ GGRTFLRVLL HLIMHDYAPL VSGALHLLFR HFSQRQEVLQ
     AFRQVQLLVS DSDVESYKQI KSDLDILRQS VEKSELWVYK AKATDELGAT DAGGDAVSLE
     YNAALSQEQR NEYRKVKEIL IRMNKFCVTA SGPGSVVKPR KHEQRLLRNV GVHTVVLDLL
     QNPYDEKDDE LMKELMCLAH EFLQNFCLGN QQNQVLLHNH LDLFLNPGIL EAKTVCAIFK
     DNLALCNEVT DKVVQHFVHC IEIHGRHVAY LQFLQTVVAA ENQFIRRCQD MVMQELINSG
     EDVLVFYNDK GSFNHFVQMM QQQMLGMEKL SDDSPLKYHV ELVKLLACCT MGKNVYTEIK
     CNNLLSLDDI VTIICHPLCM PEVKEAYVDF LNHCYIDTEV EMKEIYASGH MWSLFEKSFL
     VDINQLITNP AAASNKTLQA YVLNGVTNLL GSFFASPFSD QSAIVQSRQL IFVQLLQAAH
     RITQCRWLSL GDRFNVENCI RTLTESAKMR SIALPPELEQ QVATMSSKTA MLTRQTTKWL
     LASKQPKYEA QQAASLMRWD RSIIEGLQDI VSLLEDQLKP VVEAELSLLV DILYRSELLF
     PAGTEARKRC ESGGFIRKLI KHTEKLLEEK EERMCVKVLR TLREMMAIDV NYGEKGDALR
     QTLLLRYFQT KSTPRLPEDE VPLLAAPLMD PAKQNHLVTH GPGAKYLQRA GKTLHEMQNH
     LDREGASDLV VELVIKSVHS PNIFVEAVEL GIALLEGGNP IIQKGMFQKF LSDDLNQAFF
     KVFFEKMKDA QQEIKSTVTV NTTDIAAKAH EHKQDTNLEL DKIARKHGLK SNGVVITEEL
     KRELHNAGLA TARAYGNARN IHSGEESSAI SVNSPLEDIL AEKLEKHKDS RDQRNQLSNK
     VLVMQPILRF LQLLCENHNP DMQNLLRNQN NKTNNNLVSE TLMFLDCICG STTGGLGLLG
     LYINEHNLAL INQTLEALTE YCQGPCHENQ NCIATHESNG LDIITALILN NINPLGENRM
     DLVLELKNNA SKLLLAIMES RGDSENAERI LYNMNPKQLV EVACKAYHQE ELIDEQDDGD
     EPDAGSDDDD ATVSPREVGH NIYILCHQLA QHNKELAGLL KASEDPQSAS FDAKTSQALM
     YYATHTAQIE IVRNDRTLEQ IVFPIPEICE YLTTDTKIKI LNTAERDDQG SKLADFFDKA
     EEMFNEMKWQ KKLRSQPLLF WISSYMSLWS NILFNCVVVI NMIVAFFYPF DNTVPELSSH
     ISLLFWIITI FSLVIVLALP RESGIRTFIG SVILRFIFLL GPESTLCLLG VVTVTLKSVH
     IVSIMGNKGT LEKQLIKIIT DFQLLYHCIY IAFCFCGLIF HPFFYSLLLF DVVYREETLV
     NVIRSVTRNG RSIVLTAVLA LILVYLFSII GYMFFKDDFL VSVDFEEQDN APPPSVPLTL
     SVPVSGDSCS APDDLGNCQA AKEVAPPSAG GGEVKERSCD SLVMCIVTTL NQGLRNGGGI
     GDILRAPSSK EGLFVARVIY DLLFFFIVII IVLNLIFGVI IDTFADLRSE KQQKEAILKT
     TCFICSLNRS AFDNKTVSFE EHIKSEHNMW HYLYFIVLVK VKDPTEFTGP ESYVYAMVKA
     GILEWFPRLR AMSLAAVDAD GEQIELRSMQ AQLLDTQLLI KNLSTQLHEL KDHMTEQRKQ
     KQRLGLLNTT ANSLLPFQ
//
ID   GBRA6_RAT               Reviewed;         453 AA.
AC   P30191;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-6;
DE   AltName: Full=GABA(A) receptor subunit alpha-6;
DE   Flags: Precursor;
GN   Name=Gabra6; Synonyms=Gabra-6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=2166916; DOI=10.1038/346648a0;
RA   Lueddens H., Pritchett D., Khler M., Killisch I., Keinaenen K.,
RA   Monyer H., Sprengel R., Seeburg P.H.;
RT   "Cerebellar GABAA receptor selective for a behavioural alcohol
RT   antagonist.";
RL   Nature 346:648-651(1990).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-403, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Binds UBQLN1 (By similarity). Generally pentameric. There
CC       are five types of GABA(A) receptor chains: alpha, beta, gamma,
CC       delta, and rho. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Only found in cerebellar granule cells.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L08495; AAC42034.1; -; Genomic_DNA.
DR   EMBL; X55742; CAA39273.1; -; Genomic_DNA.
DR   PIR; S11087; S11087.
DR   RefSeq; NP_068613.1; NM_021841.1.
DR   UniGene; Rn.29890; -.
DR   ProteinModelPortal; P30191; -.
DR   SMR; P30191; -.
DR   STRING; 10116.ENSRNOP00000004877; -.
DR   BindingDB; P30191; -.
DR   ChEMBL; CHEMBL293; -.
DR   iPTMnet; P30191; -.
DR   PhosphoSitePlus; P30191; -.
DR   PaxDb; P30191; -.
DR   PRIDE; P30191; -.
DR   GeneID; 29708; -.
DR   KEGG; rno:29708; -.
DR   UCSC; RGD:61861; rat.
DR   CTD; 2559; -.
DR   RGD; 61861; Gabra6.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P30191; -.
DR   KO; K05175; -.
DR   PhylomeDB; P30191; -.
DR   PRO; PR:P30191; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0043235; C:receptor complex; IDA:RGD.
DR   GO; GO:0005254; F:chloride channel activity; TAS:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0005237; F:inhibitory extracellular ligand-gated ion channel activity; IMP:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:0051291; P:protein heterooligomerization; IPI:RGD.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; IMP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005436; GABBAa6_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01619; GABAARALPHA6.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    453       Gamma-aminobutyric acid receptor subunit
FT                                alpha-6.
FT                                /FTId=PRO_0000000449.
FT   TOPO_DOM     20    242       Extracellular. {ECO:0000305}.
FT   TRANSMEM    243    264       Helical. {ECO:0000305}.
FT   TRANSMEM    269    290       Helical. {ECO:0000305}.
FT   TRANSMEM    301    324       Helical. {ECO:0000305}.
FT   TOPO_DOM    325    419       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    420    441       Helical. {ECO:0000305}.
FT   MOD_RES     375    375       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P16305}.
FT   MOD_RES     403    403       Phosphothreonine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   CARBOHYD     31     31       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    156    170       {ECO:0000250}.
SQ   SEQUENCE   453 AA;  51184 MW;  77EF2636A8B116F2 CRC64;
     MLLLLPWLFS LLWIENAQAQ LEDEGNFYSE NVSRILDNLL EGYDNRLRPG FGGAVTEVKT
     DIYVTSFGPV SDVEMEYTMD VFFRQTWTDE RLKFKGPAEI LSLNNLMVSK IWTPDTFFRN
     GKKSIAHNMT TPNKLFRLMH NGTILYTMRL TINADCPMRL VNFPMDGHAC PLKFGSYAYP
     KSEIIYTWKK GPLYSVEVPE ESSSLLQYDL IGQTVSSETI KSNTGEYVIM TVYFHLQRKM
     GYFMIQIYTP CIMTVILSQV SFWINKESVP ARTVFGITTV LTMTTLSISA RHSLPKVSYA
     TAMDWFIAVC FAFVFSALIE FAAVNYFTNL QSQKAERQAQ TAAKPPVAKS KTTESLEAEI
     VVHSDSKYHL KKRISSLTLP IVPSSEASKV LSRTPILPST PVTPPLLLPA IGGTSKIDQY
     SRILFPVAFA GFNLVYWIVY LSKDTMEVSS TVE
//
ID   ACHA5_HUMAN             Reviewed;         468 AA.
AC   P30532; Q15824; Q99554;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   25-OCT-2017, entry version 172.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-5;
DE   Flags: Precursor;
GN   Name=CHRNA5; Synonyms=NACHRA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1542648; DOI=10.1073/pnas.89.5.1572;
RA   Chini B., Clementi F., Hukovic N., Sher E.;
RT   "Neuronal-type alpha-bungarotoxin receptors and the alpha 5-nicotinic
RT   receptor subunit gene are expressed in neuronal and nonneuronal human
RT   cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1572-1576(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASN-398.
RX   PubMed=8906617; DOI=10.1007/BF02736842;
RA   Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A.,
RA   Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M.;
RT   "Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-
RT   beta 4 nicotinic acetylcholine receptor subunits and functional
RT   expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta
RT   4 subunits.";
RL   J. Mol. Neurosci. 7:217-228(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9009220; DOI=10.1016/S0014-5793(96)01383-X;
RA   Groot Kormelink P.J., Luyten W.H.M.L.;
RT   "Cloning and sequence of full-length cDNAs encoding the human neuronal
RT   nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and
RT   expression of seven nAChR subunits in the human neuroblastoma cell
RT   line SH-SY5Y and/or IMR-32.";
RL   FEBS Lett. 400:309-314(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-398.
RA   Duga S., Solda G., Asselta R., Bonati M.T., Dalpra L., Malcovati M.,
RA   Tenchini M.L.;
RT   "Characterization of the genomic structure of human nicotinic
RT   acetylcholine receptor CHRNA5/A3/B4 gene cluster: identification of
RT   two novel introns in the 3' untranslated region of CHRNA3 and of a
RT   tail-to-tail overlap between CHRNA3 and CHRNA5.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385720; DOI=10.1038/452537a;
RA   Chanock S.J., Hunter D.J.;
RT   "Genomics: when the smoke clears.";
RL   Nature 452:537-538(2008).
RN   [7]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385738; DOI=10.1038/nature06885;
RA   Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M.,
RA   Zaridze D., Mukeria A., Szeszenia-Dabrowska N., Lissowska J.,
RA   Rudnai P., Fabianova E., Mates D., Bencko V., Foretova L., Janout V.,
RA   Chen C., Goodman G., Field J.K., Liloglou T., Xinarianos G.,
RA   Cassidy A., McLaughlin J., Liu G., Narod S., Krokan H.E., Skorpen F.,
RA   Elvestad M.B., Hveem K., Vatten L., Linseisen J., Clavel-Chapelon F.,
RA   Vineis P., Bueno-de-Mesquita H.B., Lund E., Martinez C., Bingham S.,
RA   Rasmuson T., Hainaut P., Riboli E., Ahrens W., Benhamou S., Lagiou P.,
RA   Trichopoulos D., Holcatova I., Merletti F., Kjaerheim K., Agudo A.,
RA   Macfarlane G., Talamini R., Simonato L., Lowry R., Conway D.I.,
RA   Znaor A., Healy C., Zelenika D., Boland A., Delepine M., Foglio M.,
RA   Lechner D., Matsuda F., Blanche H., Gut I., Heath S., Lathrop M.,
RA   Brennan P.;
RT   "A susceptibility locus for lung cancer maps to nicotinic
RT   acetylcholine receptor subunit genes on 15q25.";
RL   Nature 452:633-637(2008).
RN   [8]
RP   INVOLVEMENT IN SQTL3 AND LUNG CANCER.
RX   PubMed=18385676; DOI=10.1038/ng.109;
RA   Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., Dong Q.,
RA   Zhang Q., Gu X., Vijayakrishnan J., Sullivan K., Matakidou A.,
RA   Wang Y., Mills G., Doheny K., Tsai Y.-Y., Chen W.V., Shete S.,
RA   Spitz M.R., Houlston R.S.;
RT   "Genome-wide association scan of tag SNPs identifies a susceptibility
RT   locus for lung cancer at 15q25.1.";
RL   Nat. Genet. 40:616-622(2008).
RN   [9]
RP   INTERACTION WITH LYPD6.
RX   PubMed=27344019; DOI=10.1111/jnc.13718;
RA   Arvaniti M., Jensen M.M., Soni N., Wang H., Klein A.B., Thiriet N.,
RA   Pinborg L.H., Muldoon P.P., Wienecke J., Imad Damaj M.,
RA   Kohlmeier K.A., Gondre-Lewis M.C., Mikkelsen J.D., Thomsen M.S.;
RT   "Functional interaction between Lypd6 and nicotinic acetylcholine
RT   receptors.";
RL   J. Neurochem. 138:806-820(2016).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and non-alpha (beta). Interacts with LYPD6
CC       (PubMed:27344019). {ECO:0000269|PubMed:27344019}.
CC   -!- INTERACTION:
CC       P17787:CHRNB2; NbExp=3; IntAct=EBI-6657490, EBI-9008612;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- POLYMORPHISM: Genetic variations in CHRNA5 have been associated
CC       with susceptibility to smoking-related behavioral traits and lung
CC       cancer, contributing to the smoking quantitative trait locus 3
CC       (SQTL3) [MIM:612052].
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       5/CHRNA5 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M83712; AAA58357.1; -; mRNA.
DR   EMBL; U62434; AAB40112.1; -; mRNA.
DR   EMBL; Y08419; CAA69696.1; -; mRNA.
DR   EMBL; AJ306481; CAC34820.1; -; Genomic_DNA.
DR   EMBL; AJ306482; CAC34820.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306483; CAC34820.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306484; CAC34820.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306485; CAC34820.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306486; CAC34820.1; JOINED; Genomic_DNA.
DR   EMBL; BC033639; AAH33639.1; -; mRNA.
DR   CCDS; CCDS10304.1; -.
DR   PIR; A38223; A38223.
DR   RefSeq; NP_000736.2; NM_000745.3.
DR   UniGene; Hs.1614; -.
DR   UniGene; Hs.719767; -.
DR   ProteinModelPortal; P30532; -.
DR   BioGrid; 107560; 9.
DR   IntAct; P30532; 4.
DR   STRING; 9606.ENSP00000299565; -.
DR   BindingDB; P30532; -.
DR   ChEMBL; CHEMBL3137273; -.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB00184; Nicotine.
DR   iPTMnet; P30532; -.
DR   PhosphoSitePlus; P30532; -.
DR   BioMuta; CHRNA5; -.
DR   DMDM; 2506126; -.
DR   EPD; P30532; -.
DR   MaxQB; P30532; -.
DR   PaxDb; P30532; -.
DR   PeptideAtlas; P30532; -.
DR   PRIDE; P30532; -.
DR   DNASU; 1138; -.
DR   Ensembl; ENST00000299565; ENSP00000299565; ENSG00000169684.
DR   GeneID; 1138; -.
DR   KEGG; hsa:1138; -.
DR   UCSC; uc002bdy.3; human.
DR   CTD; 1138; -.
DR   DisGeNET; 1138; -.
DR   EuPathDB; HostDB:ENSG00000169684.13; -.
DR   GeneCards; CHRNA5; -.
DR   HGNC; HGNC:1959; CHRNA5.
DR   HPA; HPA054381; -.
DR   MalaCards; CHRNA5; -.
DR   MIM; 118505; gene.
DR   MIM; 612052; phenotype.
DR   neXtProt; NX_P30532; -.
DR   OpenTargets; ENSG00000169684; -.
DR   PharmGKB; PA26491; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P30532; -.
DR   KO; K04807; -.
DR   OMA; RYFTQKE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P30532; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   GeneWiki; CHRNA5; -.
DR   GenomeRNAi; 1138; -.
DR   PRO; PR:P30532; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000169684; -.
DR   CleanEx; HS_CHRNA5; -.
DR   ExpressionAtlas; P30532; baseline and differential.
DR   Genevisible; P30532; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; TAS:DFLAT.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT.
DR   GO; GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:UniProtKB.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; NAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    468       Neuronal acetylcholine receptor subunit
FT                                alpha-5.
FT                                /FTId=PRO_0000000356.
FT   TOPO_DOM     23    254       Extracellular. {ECO:0000255}.
FT   TRANSMEM    255    275       Helical. {ECO:0000255}.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TRANSMEM    317    337       Helical. {ECO:0000255}.
FT   TOPO_DOM    338    429       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    430    451       Helical. {ECO:0000255}.
FT   TOPO_DOM    452    468       Extracellular. {ECO:0000255}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    183    183       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    170    184       {ECO:0000250}.
FT   DISULFID    234    235       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   VARIANT     134    134       V -> I (in dbSNP:rs2229961).
FT                                /FTId=VAR_046211.
FT   VARIANT     398    398       D -> N (associated with susceptibility to
FT                                lung cancer; dbSNP:rs16969968).
FT                                {ECO:0000269|PubMed:8906617,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_046212.
FT   CONFLICT     23     34       RCGLAGAAGGAQ -> ALRSSRARRAAR (in Ref. 1;
FT                                AAA58357). {ECO:0000305}.
FT   CONFLICT    128    128       V -> S (in Ref. 1; AAA58357).
FT                                {ECO:0000305}.
FT   CONFLICT    365    365       C -> S (in Ref. 1; AAA58357).
FT                                {ECO:0000305}.
FT   CONFLICT    405    405       R -> T (in Ref. 1; AAA58357).
FT                                {ECO:0000305}.
SQ   SEQUENCE   468 AA;  53054 MW;  7FE91A2E362289C0 CRC64;
     MAARGSGPRA LRLLLLVQLV AGRCGLAGAA GGAQRGLSEP SSIAKHEDSL LKDLFQDYER
     WVRPVEHLND KIKIKFGLAI SQLVDVDEKN QLMTTNVWLK QEWIDVKLRW NPDDYGGIKV
     IRVPSDSVWT PDIVLFDNAD GRFEGTSTKT VIRYNGTVTW TPPANYKSSC TIDVTFFPFD
     LQNCSMKFGS WTYDGSQVDI ILEDQDVDKR DFFDNGEWEI VSATGSKGNR TDSCCWYPYV
     TYSFVIKRLP LFYTLFLIIP CIGLSFLTVL VFYLPSNEGE KICLCTSVLV SLTVFLLVIE
     EIIPSSSKVI PLIGEYLVFT MIFVTLSIMV TVFAINIHHR SSSTHNAMAP LVRKIFLHTL
     PKLLCMRSHV DRYFTQKEET ESGSGPKSSR NTLEAALDSI RYITRHIMKE NDVREVVEDW
     KFIAQVLDRM FLWTFLFVSI VGSLGLFVPV IYKWANILIP VHIGNANK
//
ID   ACHB4_HUMAN             Reviewed;         498 AA.
AC   P30926; A4FTX5; E9PHE8; Q16607; Q4VBA5; Q8WXC8; Q9BQR4;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   25-OCT-2017, entry version 179.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-4;
DE   Flags: Precursor;
GN   Name=CHRNB4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8906617; DOI=10.1007/BF02736842;
RA   Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A.,
RA   Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M.;
RT   "Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-
RT   beta 4 nicotinic acetylcholine receptor subunits and functional
RT   expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta
RT   4 subunits.";
RL   J. Mol. Neurosci. 7:217-228(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9203638;
RA   Gerzanich V., Kuryatov A., Anand R., Lindstrom J.;
RT   "'Orphan' alpha6 nicotinic AChR subunit can form a functional
RT   heteromeric acetylcholine receptor.";
RL   Mol. Pharmacol. 51:320-327(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9009220; DOI=10.1016/S0014-5793(96)01383-X;
RA   Groot Kormelink P.J., Luyten W.H.M.L.;
RT   "Cloning and sequence of full-length cDNAs encoding the human neuronal
RT   nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and
RT   expression of seven nAChR subunits in the human neuroblastoma cell
RT   line SH-SY5Y and/or IMR-32.";
RL   FEBS Lett. 400:309-314(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Duga S., Solda G., Asselta R., Bonati M.T., Dalpra L., Malcovati M.,
RA   Tenchini M.L.;
RT   "Characterization of the genomic structure of human nicotinic
RT   acetylcholine receptor CHRNA5/A3/B4 gene cluster: identification of
RT   two novel introns in the 3' untranslated region of CHRNA3 and of a
RT   tail-to-tail overlap between CHRNA3 and CHRNA5.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS TRP-136;
RP   GLY-140 AND VAL-467.
RX   PubMed=11450844; DOI=10.1007/s100380170054;
RA   Lev-Lehman E., Bercovich D., Xu W., Stockton D.W., Beaudet A.L.;
RT   "Characterization of the human beta4 nAChR gene and polymorphisms in
RT   CHRNA3 and CHRNB4.";
RL   J. Hum. Genet. 46:362-366(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-198 (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-18.
RX   PubMed=11742001; DOI=10.1074/jbc.M110454200;
RA   Valor L.M., Campos-Caro A., Carrasco-Serrano C., Ortiz J.A.,
RA   Ballesta J.J., Criado M.;
RT   "Transcription factors NF-Y and Sp1 are important determinants of the
RT   promoter activity of the bovine and human neuronal nicotinic receptor
RT   beta 4 subunit genes.";
RL   J. Biol. Chem. 277:8866-8876(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 48-498.
RX   PubMed=1330682; DOI=10.1016/0014-5793(92)81411-E;
RA   Tarroni P., Rubboli F., Chini B., Zwart R., Oortgiesen M., Sher E.,
RA   Clementi F.;
RT   "Neuronal-type nicotinic receptors in human neuroblastoma and small-
RT   cell lung carcinoma cell lines.";
RL   FEBS Lett. 312:66-70(1992).
RN   [10]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human
RT   alpha7 nicotinic acetylcholine receptor and distinguish human
RT   nicotinic receptor subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [11]
RP   INTERACTION WITH RIC3.
RX   PubMed=16120769; DOI=10.1124/mol.105.017459;
RA   Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R.,
RA   Gibb A.J., Millar N.S.;
RT   "RIC-3 enhances functional expression of multiple nicotinic
RT   acetylcholine receptor subtypes in mammalian cells.";
RL   Mol. Pharmacol. 68:1431-1438(2005).
RN   [12]
RP   INTERACTION WITH LYPD6.
RX   PubMed=27344019; DOI=10.1111/jnc.13718;
RA   Arvaniti M., Jensen M.M., Soni N., Wang H., Klein A.B., Thiriet N.,
RA   Pinborg L.H., Muldoon P.P., Wienecke J., Imad Damaj M.,
RA   Kohlmeier K.A., Gondre-Lewis M.C., Mikkelsen J.D., Thomsen M.S.;
RT   "Functional interaction between Lypd6 and nicotinic acetylcholine
RT   receptors.";
RL   J. Neurochem. 138:806-820(2016).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of
CC       subunits: alpha and beta. Beta-4 subunit can be combined to alpha-
CC       2, alpha-3 or alpha-4 to give rise to functional receptors.
CC       Interacts with RIC3; which is required for proper folding and
CC       assembly (PubMed:16120769). Interacts with LYPD6
CC       (PubMed:27344019). The pentamer alpha3-beta-4 interacts with the
CC       conotoxin BuIA (By similarity). The heteropentamer composed of
CC       alpha-3 and beta-4 subunits interacts with the alpha-conotoxin ImI
CC       (PubMed:15609996). {ECO:0000250|UniProtKB:P12392,
CC       ECO:0000269|PubMed:15609996, ECO:0000269|PubMed:16120769,
CC       ECO:0000269|PubMed:27344019}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30926-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P30926-2; Sequence=VSP_046674, VSP_046675;
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       4/CHRNB4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U62439; AAB40117.1; -; mRNA.
DR   EMBL; U48861; AAA92123.1; -; mRNA.
DR   EMBL; Y08416; CAA69693.1; -; mRNA.
DR   EMBL; AJ306454; CAC34819.1; -; Genomic_DNA.
DR   EMBL; AJ306455; CAC34819.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306456; CAC34819.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306457; CAC34819.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306458; CAC34819.1; JOINED; Genomic_DNA.
DR   EMBL; AJ306459; CAC34819.1; JOINED; Genomic_DNA.
DR   EMBL; AF306329; AAL02062.1; -; Genomic_DNA.
DR   EMBL; AF306325; AAL02062.1; JOINED; Genomic_DNA.
DR   EMBL; AF306326; AAL02062.1; JOINED; Genomic_DNA.
DR   EMBL; AF306327; AAL02062.1; JOINED; Genomic_DNA.
DR   EMBL; AF306328; AAL02062.1; JOINED; Genomic_DNA.
DR   EMBL; AC022748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC067863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096080; AAH96080.1; -; mRNA.
DR   EMBL; BC096081; AAH96081.1; -; mRNA.
DR   EMBL; BC096083; AAH96083.1; -; mRNA.
DR   EMBL; BC096082; AAH96082.1; -; mRNA.
DR   EMBL; AF453877; AAL57840.1; -; Genomic_DNA.
DR   EMBL; X68275; CAA48336.1; -; mRNA.
DR   CCDS; CCDS10306.1; -. [P30926-1]
DR   CCDS; CCDS58392.1; -. [P30926-2]
DR   PIR; G02421; G02421.
DR   RefSeq; NP_000741.1; NM_000750.3. [P30926-1]
DR   RefSeq; NP_001243496.1; NM_001256567.1. [P30926-2]
DR   UniGene; Hs.624178; -.
DR   PDB; 2ASG; Model; -; B/D/E=262-284.
DR   PDBsum; 2ASG; -.
DR   ProteinModelPortal; P30926; -.
DR   SMR; P30926; -.
DR   BioGrid; 107565; 76.
DR   CORUM; P30926; -.
DR   IntAct; P30926; 2.
DR   STRING; 9606.ENSP00000261751; -.
DR   BindingDB; P30926; -.
DR   ChEMBL; CHEMBL3137285; -.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB01227; Levomethadyl Acetate.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01090; Pentolinium.
DR   iPTMnet; P30926; -.
DR   PhosphoSitePlus; P30926; -.
DR   BioMuta; CHRNB4; -.
DR   DMDM; 2506129; -.
DR   EPD; P30926; -.
DR   PaxDb; P30926; -.
DR   PRIDE; P30926; -.
DR   Ensembl; ENST00000261751; ENSP00000261751; ENSG00000117971. [P30926-1]
DR   Ensembl; ENST00000412074; ENSP00000416386; ENSG00000117971. [P30926-2]
DR   GeneID; 1143; -.
DR   KEGG; hsa:1143; -.
DR   UCSC; uc002bed.2; human. [P30926-1]
DR   CTD; 1143; -.
DR   DisGeNET; 1143; -.
DR   EuPathDB; HostDB:ENSG00000117971.11; -.
DR   GeneCards; CHRNB4; -.
DR   HGNC; HGNC:1964; CHRNB4.
DR   MIM; 118509; gene.
DR   neXtProt; NX_P30926; -.
DR   OpenTargets; ENSG00000117971; -.
DR   PharmGKB; PA26496; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P30926; -.
DR   KO; K04815; -.
DR   OMA; TFLFMKR; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P30926; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   GeneWiki; CHRNB4; -.
DR   GenomeRNAi; 1143; -.
DR   PRO; PR:P30926; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000117971; -.
DR   CleanEx; HS_CHRNB4; -.
DR   ExpressionAtlas; P30926; baseline and differential.
DR   Genevisible; P30926; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IC:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0042166; F:acetylcholine binding; IEA:Ensembl.
DR   GO; GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0001508; P:action potential; IEA:Ensembl.
DR   GO; GO:0035095; P:behavioral response to nicotine; IEA:Ensembl.
DR   GO; GO:0006811; P:ion transport; TAS:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; NAS:UniProtKB.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0006939; P:smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; IMP:UniProtKB.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    498       Neuronal acetylcholine receptor subunit
FT                                beta-4.
FT                                /FTId=PRO_0000000389.
FT   TOPO_DOM     22    236       Extracellular. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical. {ECO:0000255}.
FT   TOPO_DOM    258    265       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TOPO_DOM    287    298       Extracellular. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical. {ECO:0000255}.
FT   TOPO_DOM    320    460       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    461    481       Helical. {ECO:0000255}.
FT   TOPO_DOM    482    498       Extracellular. {ECO:0000255}.
FT   SITE         82     82       Key residue that facilitates effective
FT                                access of the conotoxin BuIA to the
FT                                channel binding site.
FT                                {ECO:0000250|UniProtKB:P12392}.
FT   SITE        134    134       Key residue for a low dissociation
FT                                (K(off)) from the conotoxin BuIA.
FT                                {ECO:0000250|UniProtKB:P12392}.
FT   CARBOHYD     36     36       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     93     93       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    153    167       {ECO:0000250}.
FT   VAR_SEQ     120    217       NADGTYEVSVYTNLIVRSNGSVLWLPPAIYKSACKIEVKYF
FT                                PFDQQNCTLKFRSWTYDHTEIDMVLMTPTASMDDFTPSGEW
FT                                DIVALPGRRTVNPQDP -> KSLRTGSTWLWWWTGCSCGCS
FT                                CLCASWALWGSSYRPSSRPMQLLRGPTLPSVTEGPLGCGVR
FT                                GCEWPGGHFAASFWVVADEALSKYVSIGHQPHQTSHSRGTG
FT                                KDGGLGCPL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046674.
FT   VAR_SEQ     218    498       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046675.
FT   VARIANT      91     91       T -> I (in dbSNP:rs12914008).
FT                                /FTId=VAR_048174.
FT   VARIANT     136    136       R -> W (in dbSNP:rs141876090).
FT                                {ECO:0000269|PubMed:11450844}.
FT                                /FTId=VAR_013241.
FT   VARIANT     140    140       S -> G (in dbSNP:rs56218866).
FT                                {ECO:0000269|PubMed:11450844}.
FT                                /FTId=VAR_013242.
FT   VARIANT     467    467       M -> V (in dbSNP:rs61737502).
FT                                {ECO:0000269|PubMed:11450844}.
FT                                /FTId=VAR_013243.
FT   CONFLICT     72     73       EQ -> DE (in Ref. 9; CAA48336).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       Missing (in Ref. 4; CAC34819).
FT                                {ECO:0000305}.
SQ   SEQUENCE   498 AA;  56380 MW;  0D48AB203F3FD03E CRC64;
     MRRAPSLVLF FLVALCGRGN CRVANAEEKL MDDLLNKTRY NNLIRPATSS SQLISIKLQL
     SLAQLISVNE REQIMTTNVW LKQEWTDYRL TWNSSRYEGV NILRIPAKRI WLPDIVLYNN
     ADGTYEVSVY TNLIVRSNGS VLWLPPAIYK SACKIEVKYF PFDQQNCTLK FRSWTYDHTE
     IDMVLMTPTA SMDDFTPSGE WDIVALPGRR TVNPQDPSYV DVTYDFIIKR KPLFYTINLI
     IPCVLTTLLA ILVFYLPSDC GEKMTLCISV LLALTFFLLL ISKIVPPTSL DVPLIGKYLM
     FTMVLVTFSI VTSVCVLNVH HRSPSTHTMA PWVKRCFLHK LPTFLFMKRP GPDSSPARAF
     PPSKSCVTKP EATATSTSPS NFYGNSMYFV NPASAASKSP AGSTPVAIPR DFWLRSSGRF
     RQDVQEALEG VSFIAQHMKN DDEDQSVVED WKYVAMVVDR LFLWVFMFVC VLGTVGLFLP
     PLFQTHAASE GPYAAQRD
//
ID   CUP4_CAEEL              Reviewed;         433 AA.
AC   P34271; Q6IZD3;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-2002, sequence version 2.
DT   25-OCT-2017, entry version 129.
DE   RecName: Full=Acetylcholine receptor-like protein cup-4;
DE   AltName: Full=Coelomocyte uptake defective protein 4;
DE   Flags: Precursor;
GN   Name=cup-4; ORFNames=C02C2.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF VAL-272.
RX   PubMed=15936276; DOI=10.1016/j.cub.2005.04.057;
RA   Patton A., Knuth S., Schaheen B., Dang H., Greenwald I., Fares H.;
RT   "Endocytosis function of a ligand-gated ion channel homolog in
RT   Caenorhabditis elegans.";
RL   Curr. Biol. 15:1045-1050(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11560892;
RA   Fares H., Greenwald I.;
RT   "Genetic analysis of endocytosis in Caenorhabditis elegans:
RT   coelomocyte uptake defective mutants.";
RL   Genetics 159:133-145(2001).
CC   -!- FUNCTION: Thought to regulate endocytosis in coelomocytes through
CC       modulation of phospholipase C activity. Possible acetylcholine
CC       receptor. {ECO:0000269|PubMed:11560892,
CC       ECO:0000269|PubMed:15936276}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:15936276}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15936276}.
CC   -!- TISSUE SPECIFICITY: Expressed in coelomocytes.
CC       {ECO:0000269|PubMed:15936276}.
CC   -!- DISRUPTION PHENOTYPE: Worms display a lack of uptake of GFP from
CC       the pseudocoelom into coelomocytes, suggesting a decrease or
CC       absence of endocytosis in coelomocytes. Mutants also display a
CC       slightly dumpy appearance with a low penetrance defect in distal
CC       tip cell leader function, indicating defects in coelomocyte
CC       function. {ECO:0000269|PubMed:11560892}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY611497; AAT42012.1; -; mRNA.
DR   EMBL; FO080276; CCD62529.1; -; Genomic_DNA.
DR   PIR; S44741; S44741.
DR   RefSeq; NP_498710.2; NM_066309.5.
DR   UniGene; Cel.19985; -.
DR   ProteinModelPortal; P34271; -.
DR   STRING; 6239.C02C2.3; -.
DR   EPD; P34271; -.
DR   PaxDb; P34271; -.
DR   PeptideAtlas; P34271; -.
DR   PRIDE; P34271; -.
DR   EnsemblMetazoa; C02C2.3; C02C2.3; WBGene00000845.
DR   GeneID; 176104; -.
DR   KEGG; cel:CELE_C02C2.3; -.
DR   UCSC; C02C2.3; c. elegans.
DR   CTD; 176104; -.
DR   WormBase; C02C2.3; CE30416; WBGene00000845; cup-4.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00390000014985; -.
DR   HOGENOM; HOG000112082; -.
DR   InParanoid; P34271; -.
DR   OMA; YARVKKW; -.
DR   OrthoDB; EOG091G0EUY; -.
DR   PhylomeDB; P34271; -.
DR   PRO; PR:P34271; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00000845; -.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:WormBase.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0015464; F:acetylcholine receptor activity; NAS:UniProtKB.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0005216; F:ion channel activity; TAS:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IMP:WormBase.
DR   GO; GO:1901046; P:positive regulation of oviposition; IMP:UniProtKB.
DR   GO; GO:0030100; P:regulation of endocytosis; IMP:UniProtKB.
DR   GO; GO:0061771; P:response to caloric restriction; IDA:UniProtKB.
DR   GO; GO:1901562; P:response to paraquat; IMP:UniProtKB.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasmic vesicle; Disulfide bond; Endocytosis;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    433       Acetylcholine receptor-like protein cup-
FT                                4.
FT                                /FTId=PRO_0000000404.
FT   TRANSMEM    282    302       Helical. {ECO:0000255}.
FT   TRANSMEM    307    327       Helical. {ECO:0000255}.
FT   TRANSMEM    337    357       Helical. {ECO:0000255}.
FT   TRANSMEM    413    433       Helical. {ECO:0000255}.
FT   CARBOHYD     41     41       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    237    237       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    249    249       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    178    192       {ECO:0000250}.
FT   MUTAGEN     272    272       V->D: In ar494; coelomocyte endocytosis
FT                                defect. {ECO:0000269|PubMed:15936276}.
SQ   SEQUENCE   433 AA;  49771 MW;  F56A3D4E13AC9F5D CRC64;
     MKIIIFVCFI LIFYLPIQKK HVNSQQQGID SDDGDAESFF NKSYSEHQSA LEQKIFRGYN
     PKNRPMKNAS FPTIVDVHWH IIHVSINQRE QTMTVHGHIY MRWFDEFLVW DPKDFNNIQY
     ARVKKWQVWQ PKIKVSNSAS GLGSAFDFST SAHVIIQMMG KDRAKVEMYP TFSIKVGCAF
     DFTDYPYDLN KCAINLFSTS TMADVQLQNL YAIPPTLSFG WEEQKMKRII SDFKIQNVSS
     SALYYTNGNI TSSAPITGFD LGSTWSMLAV TVSFVRHSPL FEAAVVTPCI VVASLISMTF
     FIDSLSSTFL LMMLHFYVQL IFLHDLVEKL PLSVSEIPFC IKLIGILMYT NGLTLVLHSS
     LLCGSYYKCP VPQQLNKIFV IEEYIPNTFK EKVQIKKEES NKSWRDLMKL IRPIIGFVLI
     ILLICMFFVC LLL
//
ID   GLR1_CAEEL              Reviewed;         962 AA.
AC   P34299; Q17363;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2003, sequence version 2.
DT   25-OCT-2017, entry version 147.
DE   RecName: Full=Glutamate receptor 1 {ECO:0000312|WormBase:C06E1.4};
DE   Flags: Precursor;
GN   Name=glr-1 {ECO:0000312|WormBase:C06E1.4};
GN   ORFNames=C06E1.4 {ECO:0000312|WormBase:C06E1.4};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Bristol N2;
RX   PubMed=7477293; DOI=10.1038/378078a0;
RA   Maricq A.V., Peckol E., Driscoll M., Bargmann C.I.;
RT   "Mechanosensory signalling in C. elegans mediated by the GLR-1
RT   glutamate receptor.";
RL   Nature 378:78-81(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11222641;
RA   Brockie P.J., Madsen D.M., Zheng Y., Mellem J., Maricq A.V.;
RT   "Differential expression of glutamate receptor subunits in the nervous
RT   system of Caenorhabditis elegans and their regulation by the
RT   homeodomain protein UNC-42.";
RL   J. Neurosci. 21:1510-1522(2001).
RN   [5]
RP   SUBCELLULAR LOCATION, UBIQUITINATION, AND MUTAGENESIS OF LYS-888.
RX   PubMed=12123612; DOI=10.1016/S0896-6273(02)00749-3;
RA   Burbea M., Dreier L., Dittman J.S., Grunwald M.E., Kaplan J.M.;
RT   "Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate
RT   receptors at postsynaptic elements in C. elegans.";
RL   Neuron 35:107-120(2002).
RN   [6]
RP   INTERACTION WITH SOL-1.
RX   PubMed=14749834; DOI=10.1038/nature02244;
RA   Zheng Y., Mellem J.E., Brockie P.J., Madsen D.M., Maricq A.V.;
RT   "SOL-1 is a CUB-domain protein required for GLR-1 glutamate receptor
RT   function in C. elegans.";
RL   Nature 427:451-457(2004).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17671168; DOI=10.1091/mbc.E06-09-0818;
RA   Juo P., Harbaugh T., Garriga G., Kaplan J.M.;
RT   "CDK-5 regulates the abundance of GLR-1 glutamate receptors in the
RT   ventral cord of Caenorhabditis elegans.";
RL   Mol. Biol. Cell 18:3883-3893(2007).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22252129; DOI=10.1038/emboj.2011.499;
RA   Park E.C., Ghose P., Shao Z., Ye Q., Kang L., Xu X.Z.,
RA   Powell-Coffman J.A., Rongo C.;
RT   "Hypoxia regulates glutamate receptor trafficking through an HIF-
RT   independent mechanism.";
RL   EMBO J. 31:1379-1393(2012).
RN   [9]
RP   INTERACTION WITH CNI-1, SUBCELLULAR LOCATION, GLYCOSYLATION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=24094107; DOI=10.1016/j.neuron.2013.07.028;
RA   Brockie P.J., Jensen M., Mellem J.E., Jensen E., Yamasaki T., Wang R.,
RA   Maxfield D., Thacker C., Hoerndli F., Dunn P.J., Tomita S.,
RA   Madsen D.M., Maricq A.V.;
RT   "Cornichons control ER export of AMPA receptors to regulate synaptic
RT   excitability.";
RL   Neuron 80:129-142(2013).
RN   [10]
RP   INTERACTION WITH USP-46, SUBCELLULAR LOCATION, AND DEUBIQUITINATION BY
RP   USP46.
RX   PubMed=24356955; DOI=10.1074/jbc.M113.507541;
RA   Dahlberg C.L., Juo P.;
RT   "The WD40-repeat proteins WDR-20 and WDR-48 bind and activate the
RT   deubiquitinating enzyme USP-46 to promote the abundance of the
RT   glutamate receptor GLR-1 in the ventral nerve cord of Caenorhabditis
RT   elegans.";
RL   J. Biol. Chem. 289:3444-3456(2014).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27223098; DOI=10.1371/journal.pgen.1006050;
RA   Campbell J.C., Polan-Couillard L.F., Chin-Sang I.D., Bendena W.G.;
RT   "NPR-9, a galanin-like G-protein coupled receptor, and GLR-1 regulate
RT   interneuronal circuitry underlying multisensory integration of
RT   environmental cues in Caenorhabditis elegans.";
RL   PLoS Genet. 12:E1006050-E1006050(2016).
CC   -!- FUNCTION: Non-NMDA (N-methyl-D-aspartate) ionotropic glutamate
CC       receptor (PubMed:7477293). L-glutamate acts as an excitatory
CC       neurotransmitter at many synapses in the central nervous system
CC       (PubMed:7477293). The postsynaptic actions of glutamate are
CC       mediated by a variety of receptors that are named according to
CC       their selective agonists (PubMed:7477293). May contribute to a
CC       sensory discrimination between mechanical and chemical stimuli
CC       (PubMed:7477293). Plays a role in controlling movement in response
CC       to environmental cues such as food availability and mechanosensory
CC       stimulation such as the nose touch response (PubMed:27223098). In
CC       AIB interneurons, promotes omega turns, a movement that frequently
CC       follows backwards locomotion or "reversals" in response to
CC       environmental cues while possibly playing an inhibitory role in
CC       alternative neurons to inhibit omega turns (PubMed:27223098).
CC       {ECO:0000269|PubMed:27223098, ECO:0000269|PubMed:7477293}.
CC   -!- SUBUNIT: Interacts with sol-1 (PubMed:14749834). Interacts with
CC       cni-1; the interaction negatively regulates export of glr-1 from
CC       the endoplasmic reticulum to synapses (PubMed:24094107). Interacts
CC       with usp-46; the interaction results in deubiquitination of glr-1
CC       (PubMed:24356955). {ECO:0000269|PubMed:14749834,
CC       ECO:0000269|PubMed:24094107, ECO:0000269|PubMed:24356955}.
CC   -!- INTERACTION:
CC       Q93212:sol-1; NbExp=2; IntAct=EBI-15564936, EBI-15564914;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:12123612,
CC       ECO:0000269|PubMed:24356955}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12123612, ECO:0000269|PubMed:24356955}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:24094107}. Cell
CC       junction, synapse {ECO:0000269|PubMed:17671168}. Cell membrane
CC       {ECO:0000269|PubMed:17671168, ECO:0000269|PubMed:22252129}.
CC       Recycling endosome {ECO:0000269|PubMed:17671168,
CC       ECO:0000269|PubMed:22252129}. Note=Partially co-localizes with
CC       lin-10 at synapses (PubMed:17671168). Trafficking between the
CC       plasma membrane and recycling endosomes in the ventral nerve cord
CC       is regulated by lin-10 (PubMed:17671168, PubMed:22252129). During
CC       hypoxia, accumulates in enlarged endosome-like compartments
CC       (PubMed:22252129). {ECO:0000269|PubMed:17671168,
CC       ECO:0000269|PubMed:22252129}.
CC   -!- TISSUE SPECIFICITY: Command interneurons of the locomotory control
CC       circuit (AIB, AVA, AVB, AVD, AVE and PVC) and motor neurons (RMD,
CC       RIM, SMD, AVG, PVQ and URY). {ECO:0000269|PubMed:11222641,
CC       ECO:0000269|PubMed:7477293}.
CC   -!- PTM: Ubiquitinated. Deubiquitinated by usp-46 which prevents its
CC       degradation. {ECO:0000269|PubMed:12123612,
CC       ECO:0000269|PubMed:24356955}.
CC   -!- PTM: Glycosylated. {ECO:0000303|PubMed:24094107}.
CC   -!- DISRUPTION PHENOTYPE: Decreased frequency of reversals,
CC       suppression of hyperreversal phenotype of cni-1 mutants, decreased
CC       tactile response and increased osmotic avoidance
CC       (PubMed:24094107). Overall, display increased omega turn frequency
CC       following reversals, however deletion in AIB interneurons
CC       specifically results in decreased omega turn frequency
CC       (PubMed:27223098). Decreased nose touch responses
CC       (PubMed:27223098). {ECO:0000269|PubMed:24094107,
CC       ECO:0000269|PubMed:27223098}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U34661; AAA92006.1; -; mRNA.
DR   EMBL; FO080280; CCD62564.1; -; Genomic_DNA.
DR   PIR; B88533; B88533.
DR   PIR; S60225; S60225.
DR   RefSeq; NP_498887.2; NM_066486.6.
DR   UniGene; Cel.6005; -.
DR   ProteinModelPortal; P34299; -.
DR   SMR; P34299; -.
DR   BioGrid; 41408; 3.
DR   IntAct; P34299; 1.
DR   STRING; 6239.C06E1.4; -.
DR   iPTMnet; P34299; -.
DR   PaxDb; P34299; -.
DR   EnsemblMetazoa; C06E1.4; C06E1.4; WBGene00001612.
DR   GeneID; 176204; -.
DR   KEGG; cel:CELE_C06E1.4; -.
DR   UCSC; C06E1.4; c. elegans.
DR   CTD; 176204; -.
DR   WormBase; C06E1.4; CE31407; WBGene00001612; glr-1.
DR   eggNOG; KOG1054; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000234372; -.
DR   InParanoid; P34299; -.
DR   KO; K05313; -.
DR   OMA; SQEIWVS; -.
DR   OrthoDB; EOG091G11CB; -.
DR   PhylomeDB; P34299; -.
DR   Reactome; R-CEL-204005; COPII (Coat Protein 2) Mediated Vesicle Transport.
DR   Reactome; R-CEL-399710; Activation of AMPA receptors.
DR   Reactome; R-CEL-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-CEL-5694530; Cargo concentration in the ER.
DR   PRO; PR:P34299; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00001612; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:WormBase.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; IPI:WormBase.
DR   GO; GO:0043005; C:neuron projection; IDA:WormBase.
DR   GO; GO:0032589; C:neuron projection membrane; IDA:WormBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0014069; C:postsynaptic density; IDA:WormBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; ISS:WormBase.
DR   GO; GO:0019899; F:enzyme binding; IPI:WormBase.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:WormBase.
DR   GO; GO:0008344; P:adult locomotory behavior; IMP:UniProtKB.
DR   GO; GO:0008306; P:associative learning; IMP:WormBase.
DR   GO; GO:0007631; P:feeding behavior; IMP:WormBase.
DR   GO; GO:0043056; P:forward locomotion; IMP:UniProtKB.
DR   GO; GO:0046959; P:habituation; IMP:WormBase.
DR   GO; GO:0006972; P:hyperosmotic response; IMP:UniProtKB.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:WormBase.
DR   GO; GO:1905852; P:positive regulation of backward locomotion; IMP:UniProtKB.
DR   GO; GO:1905850; P:positive regulation of forward locomotion; IGI:UniProtKB.
DR   GO; GO:0043058; P:regulation of backward locomotion; IMP:WormBase.
DR   GO; GO:0010035; P:response to inorganic substance; IMP:UniProtKB.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:UniProtKB.
DR   GO; GO:0050913; P:sensory perception of bitter taste; IMP:WormBase.
DR   GO; GO:0007614; P:short-term memory; IMP:WormBase.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IDA:WormBase.
DR   GO; GO:0001966; P:thigmotaxis; IMP:WormBase.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00062; PBPb; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome;
KW   Endoplasmic reticulum; Endosome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    962       Glutamate receptor 1.
FT                                /FTId=PRO_0000011590.
FT   TOPO_DOM     26    591       Extracellular. {ECO:0000255}.
FT   TRANSMEM    592    612       Helical. {ECO:0000255}.
FT   TOPO_DOM    613    668       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    669    689       Helical. {ECO:0000255}.
FT   TOPO_DOM    690    855       Extracellular. {ECO:0000255}.
FT   TRANSMEM    856    876       Helical. {ECO:0000255}.
FT   TOPO_DOM    877    962       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    190    190       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    220    220       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    333    333       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    441    441       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    482    482       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    852    852       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     888    888       K->R: Increased levels of glr-1.
FT                                {ECO:0000269|PubMed:12123612}.
SQ   SEQUENCE   962 AA;  108142 MW;  25488406566A5583 CRC64;
     MFSSFSFLNM FGVLFTVFNL TVVQPYPSHI IIKSFGNNEE VSRVALKAME YTSDHINSRD
     DVPFKLAFDH RVVEEGAAVS WNMVNAVCDE LKEGAMALLS SVDGKGREGI RGVSDALEMP
     LVSLTALSND DHQQQQFGNL FEVSVRPPIS ELLADFIVHK GWGEVLVLID PVHASLHLPS
     LWRHLRTRTN TSVKASMFDL PADEKQFEAY LMQFNMMRNN ETNRILIDCA SPKRLKKLLI
     NIRSAQFNQA NYHYVLANYD FLPYDQEMFQ NGNINISGFN IINKDGREYW SLKKHLKTSS
     SLGGGDDVSV EAAVGHDAML VTWHGFAKCL QANDSLFHGT FRHRRFFNRG FPGIYCDPLS
     DRSHPNRPFS SFEHGKTIGV AFRNMKIGHK EGTLTGNIEF DRFGNRKNFD VSIVDLVSNT
     KATFNSKEVL AWRQGVGFFS NRTVAQHSRK SQNDHKDNQV IVLTNLVAPF VMIKRECLEM
     ANLTECQGNN KFEGFCIDLL KLLADKIEEF NYEIKLGTKA GSKQADGSWD GMIGELLSGR
     AHAVVASLTI NQERERVVDF SKPFMTTGIS IMIKKPDKQE FSVFSFMQPL STEIWMYIIF
     AYIGVSVVIF LVSRFSPYEW RVEETSRGGF TISNDFSVYN CLWFTLAAFM QQGTDILPRS
     ISGRIASSAW WFFTMIIVSS YTANLAAFLT LEKMQAPIES VEDLAKQSKI KYGIQGGGST
     ASFFKYSSVQ IYQRMWRYME SQVPPVFVAS YAEGIERVRS HKGRYAFLLE ATANEYENTR
     KPCDTMKVGA NLNSIGYGIA TPFGSDWKDH INLAILALQE RGELKKLENK WWYDRGQCDA
     GITVDGSSAS LNLSKVAGIF YILMGGMVIS MLAALGEFLY RSRIEARKSN SNSMVANFAK
     NLKSALSSQL RLSVEGGAVA QPGSQSHNAI RRQQVAAFLP ANEKEAFNNV DRPANTLYNT
     AV
//
ID   NMDZ1_RAT               Reviewed;         938 AA.
AC   P35439; Q62646;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   20-DEC-2017, entry version 200.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 1;
DE            Short=GluN1;
DE   AltName: Full=Glutamate [NMDA] receptor subunit zeta-1;
DE   AltName: Full=N-methyl-D-aspartate receptor subunit NR1 {ECO:0000303|PubMed:1350383};
DE            Short=NMD-R1;
DE   Flags: Precursor;
GN   Name=Grin1; Synonyms=Nmdar1 {ECO:0000303|PubMed:1834949};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM A), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=1834949; DOI=10.1038/354031a0;
RA   Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N.,
RA   Nakanishi S.;
RT   "Molecular cloning and characterization of the rat NMDA receptor.";
RL   Nature 354:31-37(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=1386026; DOI=10.1016/0014-5793(92)80648-Z;
RA   Anantharam V., Panchal R., Wilson A., Koltchin V.V., Treistman S.N.,
RA   Bayley H.;
RT   "Combinatorial RNA splicing alters the surface charge on the NMDA
RT   receptor.";
RL   FEBS Lett. 305:27-30(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), ALTERNATIVE SPLICING,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1388270; DOI=10.1073/pnas.89.18.8552;
RA   Nakanishi N., Axel R., Shneider N.A.;
RT   "Alternative splicing generates functionally distinct N-methyl-D-
RT   aspartate receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8552-8556(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Forebrain;
RX   PubMed=7684237; DOI=10.1016/0896-6273(93)90209-A;
RA   Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G.,
RA   Heinemann S.F.;
RT   "Zinc potentiates agonist-induced currents at certain splice variants
RT   of the NMDA receptor.";
RL   Neuron 10:943-954(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-86.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8399301; DOI=10.1016/0005-2736(93)90249-Y;
RA   Bai G., Kusiak J.W.;
RT   "Cloning and analysis of the 5' flanking sequence of the rat N-methyl-
RT   D-aspartate receptor 1 (NMDAR1) gene.";
RL   Biochim. Biophys. Acta 1152:197-200(1993).
RN   [6]
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=1352681; DOI=10.1016/0006-291X(92)91701-Q;
RA   Sugihara H., Moriyoshi K., Ishii T., Masu M., Nakanishi S.;
RT   "Structures and properties of seven isoforms of the NMDA receptor
RT   generated by alternative splicing.";
RL   Biochem. Biophys. Res. Commun. 185:826-832(1992).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=1350383; DOI=10.1126/science.256.5060.1217;
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Heteromeric NMDA receptors: molecular and functional distinction of
RT   subtypes.";
RL   Science 256:1217-1221(1992).
RN   [8]
RP   SUBUNIT, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8428958;
RA   Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H.,
RA   Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., Nakanishi S.;
RT   "Molecular characterization of the family of the N-methyl-D-aspartate
RT   receptor subunits.";
RL   J. Biol. Chem. 268:2836-2843(1993).
RN   [9]
RP   PHOSPHORYLATION AT SER-897, DEPHOSPHORYLATION BY PPP2CB, AND
RP   IDENTIFICATION IN A COMPLEX WITH GRIN2A OR GRIN2B; GRIN3A AND PPP2CB.
RX   PubMed=11588171;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [10]
RP   CHARACTERIZATION, AND IDENTIFICATION IN A COMPLEX WITH GRIN2A OR
RP   GRIN2B AND GRIN3A.
RX   PubMed=11160393;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A.,
RA   Trimmer J.S., Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of
RT   NR3A-containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN2A OR GRIN2B AND GRIN3A.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B.,
RA   Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and
RT   NR2 subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN2A OR GRIN2B AND GRIN3A.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA
RT   receptor in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
RN   [13]
RP   INTERACTION WITH MPDZ AND DLG4.
RX   PubMed=15312654; DOI=10.1016/j.neuron.2004.08.003;
RA   Krapivinsky G., Medina I., Krapivinsky L., Gapon S., Clapham D.E.;
RT   "SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase
RT   activity and NMDA receptor-dependent synaptic AMPA receptor
RT   potentiation.";
RL   Neuron 43:563-574(2004).
RN   [14]
RP   PHOSPHORYLATION AT SER-890.
RX   PubMed=15936117; DOI=10.1016/j.neuint.2005.04.011;
RA   Sanchez-Perez A.M., Felipo V.;
RT   "Serines 890 and 896 of the NMDA receptor subunit NR1 are
RT   differentially phosphorylated by protein kinase C isoforms.";
RL   Neurochem. Int. 47:84-91(2005).
RN   [15]
RP   INTERACTION WITH LRFN2.
RX   PubMed=16495444; DOI=10.1523/JNEUROSCI.3799-05.2006;
RA   Wang C.Y., Chang K., Petralia R.S., Wang Y.X., Seabold G.K.,
RA   Wenthold R.J.;
RT   "A novel family of adhesion-like molecules that interacts with the
RT   NMDA receptor.";
RL   J. Neurosci. 26:2174-2183(2006).
RN   [16]
RP   INTERACTION WITH LRFN1.
RX   PubMed=16630835; DOI=10.1016/j.neuron.2006.04.005;
RA   Ko J., Kim S., Chung H.S., Kim K., Han K., Kim H., Jun H.,
RA   Kaang B.-K., Kim E.;
RT   "SALM synaptic cell adhesion-like molecules regulate the
RT   differentiation of excitatory synapses.";
RL   Neuron 50:233-245(2006).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=18177891; DOI=10.1016/j.jmb.2007.11.105;
RA   Schmidt C., Hollmann M.;
RT   "Apparent homomeric NR1 currents observed in Xenopus oocytes are
RT   caused by an endogenous NR2 subunit.";
RL   J. Mol. Biol. 376:658-670(2008).
RN   [18]
RP   INTERACTION WITH MYZAP.
RX   PubMed=18849881; DOI=10.1097/WNR.0b013e328317f05f;
RA   Roginski R.S., Goubaeva F., Mikami M., Fried-Cassorla E., Nair M.R.,
RA   Yang J.;
RT   "GRINL1A colocalizes with N-methyl D-aspartate receptor NR1 subunit
RT   and reduces N-methyl D-aspartate toxicity.";
RL   NeuroReport 19:1721-1726(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-877 (ISOFORM E),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-898 (ISOFORM G), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [20]
RP   IDENTIFICATION IN COMPLEX WITH DLG4 AND PRR7, IDENTIFICATION IN A
RP   COMPLEX WITH GRIN2B AND PRR7, AND INTERACTION WITH PRR7.
RX   PubMed=27458189; DOI=10.15252/embj.201593070;
RA   Kravchick D.O., Karpova A., Hrdinka M., Lopez-Rojas J., Iacobas S.,
RA   Carbonell A.U., Iacobas D.A., Kreutz M.R., Jordan B.A.;
RT   "Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and
RT   regulates NMDA-mediated excitotoxicity.";
RL   EMBO J. 35:1923-1934(2016).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=26912815; DOI=10.1124/mol.115.103036;
RA   Stroebel D., Buhl D.L., Knafels J.D., Chanda P.K., Green M.,
RA   Sciabola S., Mony L., Paoletti P., Pandit J.;
RT   "A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor
RT   GluN2B-selective Antagonists.";
RL   Mol. Pharmacol. 89:541-551(2016).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=28384476; DOI=10.1016/j.neuron.2017.03.018;
RA   Sun W., Hansen K.B., Jahr C.E.;
RT   "Allosteric Interactions between NMDA Receptor Subunits Shape the
RT   Developmental Shift in Channel Properties.";
RL   Neuron 94:58-64(2017).
RN   [23] {ECO:0000244|PDB:1PB7, ECO:0000244|PDB:1PB8, ECO:0000244|PDB:1PB9, ECO:0000244|PDB:1PBQ}
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 394-800 IN COMPLEXES WITH
RP   AGONIST SERINE AND ANTAGONIST, AND DISULFIDE BOND.
RX   PubMed=12805203; DOI=10.1093/emboj/cdg303;
RA   Furukawa H., Gouaux E.;
RT   "Mechanisms of activation, inhibition and specificity: crystal
RT   structures of the NMDA receptor NR1 ligand-binding core.";
RL   EMBO J. 22:2873-2885(2003).
RN   [24] {ECO:0000244|PDB:2A5T}
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 394-800 IN COMPLEX WITH
RP   GRIN2A; GLYCINE AND GLUTAMATE, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=16281028; DOI=10.1038/nature04089;
RA   Furukawa H., Singh S.K., Mancusso R., Gouaux E.;
RT   "Subunit arrangement and function in NMDA receptors.";
RL   Nature 438:185-192(2005).
RN   [25] {ECO:0000244|PDB:1Y1M, ECO:0000244|PDB:1Y1Z, ECO:0000244|PDB:1Y20}
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 394-800 IN COMPLEXES WITH
RP   AGONISTS, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=15996549; DOI=10.1016/j.neuron.2005.05.022;
RA   Inanobe A., Furukawa H., Gouaux E.;
RT   "Mechanism of partial agonist action at the NR1 subunit of NMDA
RT   receptors.";
RL   Neuron 47:71-84(2005).
RN   [26] {ECO:0000244|PDB:3Q41}
RP   X-RAY CRYSTALLOGRAPHY (3.40 ANGSTROMS) OF 21-393, SUBUNIT, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION AT ASN-61; ASN-203; ASN-239; ASN-276 AND
RP   ASN-368, AND DISULFIDE BONDS.
RX   PubMed=21389213; DOI=10.1523/JNEUROSCI.6041-10.2011;
RA   Farina A.N., Blain K.Y., Maruo T., Kwiatkowski W., Choe S.,
RA   Nakagawa T.;
RT   "Separation of domain contacts is required for heterotetrameric
RT   assembly of functional NMDA receptors.";
RL   J. Neurosci. 31:3565-3579(2011).
RN   [27] {ECO:0000244|PDB:4PE5}
RP   X-RAY CRYSTALLOGRAPHY (3.96 ANGSTROMS) OF 23-847 IN COMPLEX WITH
RP   GRIN2B; GLYCINE AND ALLOSTERIC INHIBITOR, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, TOPOLOGY, GLYCOSYLATION AT ASN-203; ASN-276;
RP   ASN-300; ASN-368 AND ASN-440, AND DISULFIDE BONDS.
RX   PubMed=24876489; DOI=10.1126/science.1251915;
RA   Karakas E., Furukawa H.;
RT   "Crystal structure of a heterotetrameric NMDA receptor ion channel.";
RL   Science 344:992-997(2014).
RN   [28] {ECO:0000244|PDB:5FXG, ECO:0000244|PDB:5FXH, ECO:0000244|PDB:5FXI, ECO:0000244|PDB:5FXJ, ECO:0000244|PDB:5FXK}
RP   STRUCTURE BY ELECTRON MICROSCOPY (6.10 ANGSTROMS) OF 23-847 IN COMPLEX
RP   WITH GRIN2A, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TOPOLOGY.
RX   PubMed=27135925; DOI=10.1038/nature17679;
RA   Tajima N., Karakas E., Grant T., Simorowski N., Diaz-Avalos R.,
RA   Grigorieff N., Furukawa H.;
RT   "Activation of NMDA receptors and the mechanism of inhibition by
RT   ifenprodil.";
RL   Nature 534:63-68(2016).
RN   [29] {ECO:0000244|PDB:5I56, ECO:0000244|PDB:5I57, ECO:0000244|PDB:5I58, ECO:0000244|PDB:5I59, ECO:0000244|PDB:5JTY}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 394-544 AND 663-800 IN
RP   COMPLEXES WITH GLYCINE AND GRIN2A, FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=27618671; DOI=10.1016/j.neuron.2016.08.014;
RA   Yi F., Mou T.C., Dorsett K.N., Volkmann R.A., Menniti F.S.,
RA   Sprang S.R., Hansen K.B.;
RT   "Structural Basis for Negative Allosteric Modulation of GluN2A-
RT   Containing NMDA Receptors.";
RL   Neuron 91:1316-1329(2016).
RN   [30] {ECO:0000244|PDB:5U8C}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 394-544 AND 663-800 IN
RP   COMPLEX WITH GRIN2A AND SYNTHETIC ANTAGONIST, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=28468946; DOI=10.1124/mol.116.107912;
RA   Romero-Hernandez A., Furukawa H.;
RT   "Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the
RT   Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed
RT   to NVP-AAM077.";
RL   Mol. Pharmacol. 92:22-29(2017).
RN   [31] {ECO:0000244|PDB:5DEX, ECO:0000244|PDB:5VIH, ECO:0000244|PDB:5VII, ECO:0000244|PDB:5VIJ}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 394-544 AND 663-800 IN
RP   COMPLEX WITH GRIN2A AND GLYCINE, AND DISULFIDE BONDS.
RA   Mou T.C., Sprang S.R., Hansen K.B.;
RT   "Crystal structure of GluN1/GluN2A NMDA receptor agonist binding
RT   domains with glycine and antagonist, phenyl-ACEPC.";
RL   Submitted (APR-2017) to the PDB data bank.
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium.
CC       Channel activation requires binding of the neurotransmitter
CC       glutamate to the epsilon subunit, glycine binding to the zeta
CC       subunit, plus membrane depolarization to eliminate channel
CC       inhibition by Mg(2+) (PubMed:1350383, PubMed:1834949,
CC       PubMed:1388270, PubMed:8428958, PubMed:18177891, PubMed:28384476,
CC       PubMed:15996549, PubMed:24876489, PubMed:27135925,
CC       PubMed:27618671, PubMed:28468946). Sensitivity to glutamate and
CC       channel kinetics depend on the subunit composition
CC       (PubMed:28384476). {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:1388270, ECO:0000269|PubMed:15996549,
CC       ECO:0000269|PubMed:18177891, ECO:0000269|PubMed:1834949,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27618671, ECO:0000269|PubMed:28384476,
CC       ECO:0000269|PubMed:28468946, ECO:0000269|PubMed:8428958}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
CC       of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A,
CC       GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:18177891,
CC       PubMed:28384476, PubMed:16281028, PubMed:15996549,
CC       PubMed:21389213, PubMed:24876489, PubMed:27135925,
CC       PubMed:28468946, Ref.31). Can also form heterotetrameric channels
CC       that contain at least one zeta subunit (GRIN1), an epsilon
CC       subunit, plus GRIN3A or GRIN3B (in vitro) (PubMed:11160393,
CC       PubMed:11929923, PubMed:12391275). In vivo, the subunit
CC       composition may vary in function of the expression levels of the
CC       different subunits (Probable). Found in a complex with GRIN2A or
CC       GRIN2B, GRIN3A and PPP2CB (PubMed:11588171). Found in a complex
CC       with GRIN2A or GRIN2B and GRIN3B (By similarity). Interacts with
CC       SNX27 (via PDZ domain); the interaction is required for recycling
CC       to the plasma membrane when endocytosed and prevent degradation in
CC       lysosomes (By similarity). Interacts with DLG4 and MPDZ
CC       (PubMed:15312654). Interacts with LRFN1 and LRFN2
CC       (PubMed:16495444, PubMed:16630835). Interacts with MYZAP
CC       (PubMed:18849881). Found in a complex with DLG4 and PRR7
CC       (PubMed:27458189). Found in a complex with GRIN2B and PRR7
CC       (PubMed:27458189). Interacts with PRR7; the interaction is reduced
CC       following NMDA receptor activity (PubMed:27458189).
CC       {ECO:0000250|UniProtKB:P35438, ECO:0000269|PubMed:11160393,
CC       ECO:0000269|PubMed:11588171, ECO:0000269|PubMed:11929923,
CC       ECO:0000269|PubMed:12391275, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:15312654, ECO:0000269|PubMed:15996549,
CC       ECO:0000269|PubMed:16281028, ECO:0000269|PubMed:16495444,
CC       ECO:0000269|PubMed:16630835, ECO:0000269|PubMed:18177891,
CC       ECO:0000269|PubMed:18849881, ECO:0000269|PubMed:21389213,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27458189, ECO:0000269|PubMed:27618671,
CC       ECO:0000269|PubMed:28384476, ECO:0000269|PubMed:28468946,
CC       ECO:0000269|PubMed:8428958, ECO:0000269|Ref.31, ECO:0000305}.
CC   -!- INTERACTION:
CC       P31016:Dlg4; NbExp=4; IntAct=EBI-877897, EBI-375655;
CC       Q00960:Grin2b; NbExp=12; IntAct=EBI-877897, EBI-396905;
CC       Q460M5:Lrfn2; NbExp=2; IntAct=EBI-877897, EBI-877185;
CC       Q80TG9:Lrfn2 (xeno); NbExp=2; IntAct=EBI-877897, EBI-877092;
CC       Q9JJ40:Pdzk1; NbExp=3; IntAct=EBI-877897, EBI-7713572;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:1388270, ECO:0000269|PubMed:15996549,
CC       ECO:0000269|PubMed:18177891, ECO:0000269|PubMed:1834949,
CC       ECO:0000269|PubMed:21389213, ECO:0000269|PubMed:24876489,
CC       ECO:0000269|PubMed:27135925, ECO:0000269|PubMed:27618671,
CC       ECO:0000269|PubMed:28384476, ECO:0000269|PubMed:28468946,
CC       ECO:0000269|PubMed:8428958}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925}. Cell
CC       junction, synapse, postsynaptic cell membrane {ECO:0000250}. Cell
CC       junction, synapse, postsynaptic cell membrane, postsynaptic
CC       density {ECO:0000250}. Note=Enriched in postsynaptic plasma
CC       membrane and postsynaptic densities. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=A;
CC         IsoId=P35439-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P35439-2; Sequence=VSP_000140;
CC       Name=C; Synonyms=NMDAR1-2a subunit;
CC         IsoId=P35439-3; Sequence=VSP_000141;
CC       Name=D;
CC         IsoId=P35439-4; Sequence=VSP_000144;
CC       Name=E;
CC         IsoId=P35439-5; Sequence=VSP_000142, VSP_000143;
CC         Note=Contains a phosphoserine at position 877.
CC         {ECO:0000244|PubMed:22673903};
CC       Name=F; Synonyms=NMDAR1-2b subunit;
CC         IsoId=P35439-6; Sequence=VSP_000140, VSP_000141;
CC       Name=G; Synonyms=NMDAR1-4b subunit;
CC         IsoId=P35439-7; Sequence=VSP_000140, VSP_000142, VSP_000143;
CC         Note=Contains a phosphoserine at position 898.
CC         {ECO:0000244|PubMed:22673903};
CC   -!- TISSUE SPECIFICITY: Detected throughout the brain, in brain
CC       cortex, cerebellum, thalamus and olfactory bulb.
CC       {ECO:0000269|PubMed:1350383}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of
CC       a transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:A0A1L8F5J9}.
CC   -!- PTM: NMDA is probably regulated by C-terminal phosphorylation of
CC       an isoform of NR1 by PKC. Dephosphorylated on Ser-897 probably by
CC       protein phosphatase 2A (PPP2CB). Its phosphorylated state is
CC       influenced by the formation of the NMDAR-PPP2CB complex and the
CC       NMDAR channel activity. {ECO:0000269|PubMed:11588171,
CC       ECO:0000269|PubMed:15936117}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR1/GRIN1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63255; CAA44914.1; -; mRNA.
DR   EMBL; AY157515; AAA16366.1; -; Genomic_DNA.
DR   EMBL; X65227; CAA46335.1; -; mRNA.
DR   EMBL; U08261; AAB50926.1; -; mRNA.
DR   EMBL; U08262; AAB50927.1; -; mRNA.
DR   EMBL; U08263; AAB50928.1; -; mRNA.
DR   EMBL; U08264; AAB50929.1; -; mRNA.
DR   EMBL; U08265; AAB50930.1; -; mRNA.
DR   EMBL; U08267; AAB50932.1; -; mRNA.
DR   EMBL; U08268; AAB50933.1; -; mRNA.
DR   EMBL; S39217; AAB22431.1; -; mRNA.
DR   EMBL; S39218; AAB22432.1; -; mRNA.
DR   EMBL; S39219; AAB22433.1; -; mRNA.
DR   EMBL; S39220; AAB22434.1; -; mRNA.
DR   EMBL; S39221; AAB22435.1; -; mRNA.
DR   PIR; JN0336; JN0336.
DR   PIR; JN0337; JN0337.
DR   PIR; JN0338; JN0338.
DR   PIR; JN0339; JN0339.
DR   PIR; JN0340; JN0340.
DR   PIR; JN0341; JN0341.
DR   PIR; JN0342; JN0342.
DR   PIR; S19710; S19710.
DR   RefSeq; NP_001257531.1; NM_001270602.1. [P35439-2]
DR   RefSeq; NP_001257532.1; NM_001270603.1. [P35439-6]
DR   RefSeq; NP_001257534.1; NM_001270605.1. [P35439-3]
DR   RefSeq; NP_001257537.1; NM_001270608.1. [P35439-7]
DR   RefSeq; NP_001257539.1; NM_001270610.1. [P35439-5]
DR   RefSeq; NP_001274352.1; NM_001287423.1. [P35439-4]
DR   RefSeq; NP_058706.1; NM_017010.2. [P35439-1]
DR   UniGene; Rn.9840; -.
DR   PDB; 1PB7; X-ray; 1.35 A; A=394-544, A=663-800.
DR   PDB; 1PB8; X-ray; 1.45 A; A=394-544, A=663-800.
DR   PDB; 1PB9; X-ray; 1.60 A; A=394-544, A=663-800.
DR   PDB; 1PBQ; X-ray; 1.90 A; A/B=394-544, A/B=663-800.
DR   PDB; 1Y1M; X-ray; 1.80 A; A/B=394-544, A/B=663-800.
DR   PDB; 1Y1Z; X-ray; 1.50 A; A=394-544, A=663-800.
DR   PDB; 1Y20; X-ray; 1.40 A; A=394-544, A=663-800.
DR   PDB; 2A5T; X-ray; 2.00 A; A=394-544.
DR   PDB; 3Q41; X-ray; 3.40 A; A/B/C=21-393.
DR   PDB; 4KCC; X-ray; 1.89 A; A=394-544, A=663-800.
DR   PDB; 4KFQ; X-ray; 2.20 A; A/B=394-544, A/B=663-800.
DR   PDB; 4NF4; X-ray; 2.00 A; A=394-544, A=663-800.
DR   PDB; 4NF5; X-ray; 1.90 A; A=394-544, A=663-800.
DR   PDB; 4NF6; X-ray; 2.10 A; A=394-544, A=663-800.
DR   PDB; 4NF8; X-ray; 1.86 A; A=394-544, A=663-800.
DR   PDB; 4PE5; X-ray; 3.96 A; A/C=23-847.
DR   PDB; 5DEX; X-ray; 2.40 A; A=394-544, A=663-800.
DR   PDB; 5FXG; EM; 6.80 A; A/C=23-863.
DR   PDB; 5FXH; EM; 6.10 A; A/C=23-863.
DR   PDB; 5FXI; EM; 6.40 A; A/C=23-863.
DR   PDB; 5FXJ; EM; 6.50 A; A/C=23-863.
DR   PDB; 5FXK; EM; 6.40 A; A/C=23-863.
DR   PDB; 5I56; X-ray; 2.28 A; A=394-544, A=663-800.
DR   PDB; 5I57; X-ray; 1.70 A; A=394-544, A=684-821.
DR   PDB; 5I58; X-ray; 2.52 A; A=394-544, A=663-800.
DR   PDB; 5I59; X-ray; 2.25 A; A=394-544, A=663-800.
DR   PDB; 5JTY; X-ray; 2.72 A; A=394-544, A=684-821.
DR   PDB; 5U8C; X-ray; 1.60 A; A=394-544, A=663-800.
DR   PDB; 5VIH; X-ray; 2.40 A; A=394-544, A=663-800.
DR   PDB; 5VII; X-ray; 1.95 A; A=394-544, A=663-800.
DR   PDB; 5VIJ; X-ray; 2.10 A; A=394-544, A=663-800.
DR   PDBsum; 1PB7; -.
DR   PDBsum; 1PB8; -.
DR   PDBsum; 1PB9; -.
DR   PDBsum; 1PBQ; -.
DR   PDBsum; 1Y1M; -.
DR   PDBsum; 1Y1Z; -.
DR   PDBsum; 1Y20; -.
DR   PDBsum; 2A5T; -.
DR   PDBsum; 3Q41; -.
DR   PDBsum; 4KCC; -.
DR   PDBsum; 4KFQ; -.
DR   PDBsum; 4NF4; -.
DR   PDBsum; 4NF5; -.
DR   PDBsum; 4NF6; -.
DR   PDBsum; 4NF8; -.
DR   PDBsum; 4PE5; -.
DR   PDBsum; 5DEX; -.
DR   PDBsum; 5FXG; -.
DR   PDBsum; 5FXH; -.
DR   PDBsum; 5FXI; -.
DR   PDBsum; 5FXJ; -.
DR   PDBsum; 5FXK; -.
DR   PDBsum; 5I56; -.
DR   PDBsum; 5I57; -.
DR   PDBsum; 5I58; -.
DR   PDBsum; 5I59; -.
DR   PDBsum; 5JTY; -.
DR   PDBsum; 5U8C; -.
DR   PDBsum; 5VIH; -.
DR   PDBsum; 5VII; -.
DR   PDBsum; 5VIJ; -.
DR   ProteinModelPortal; P35439; -.
DR   SMR; P35439; -.
DR   BioGrid; 246573; 7.
DR   CORUM; P35439; -.
DR   DIP; DIP-674N; -.
DR   IntAct; P35439; 17.
DR   MINT; MINT-101336; -.
DR   STRING; 10116.ENSRNOP00000029227; -.
DR   BindingDB; P35439; -.
DR   ChEMBL; CHEMBL330; -.
DR   GuidetoPHARMACOLOGY; 455; -.
DR   TCDB; 1.A.10.1.6; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; P35439; -.
DR   PhosphoSitePlus; P35439; -.
DR   UniCarbKB; P35439; -.
DR   PaxDb; P35439; -.
DR   PRIDE; P35439; -.
DR   Ensembl; ENSRNOT00000044246; ENSRNOP00000043301; ENSRNOG00000011726. [P35439-6]
DR   Ensembl; ENSRNOT00000049297; ENSRNOP00000049198; ENSRNOG00000011726. [P35439-1]
DR   GeneID; 24408; -.
DR   KEGG; rno:24408; -.
DR   UCSC; RGD:2736; rat. [P35439-1]
DR   CTD; 2902; -.
DR   RGD; 2736; Grin1.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   HOGENOM; HOG000231491; -.
DR   HOVERGEN; HBG052638; -.
DR   InParanoid; P35439; -.
DR   KO; K05208; -.
DR   OrthoDB; EOG091G0M5H; -.
DR   PhylomeDB; P35439; -.
DR   TreeFam; TF351405; -.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-RNO-442729; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; R-RNO-442982; Ras activation uopn Ca2+ infux through NMDA receptor.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   EvolutionaryTrace; P35439; -.
DR   PRO; PR:P35439; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000011726; -.
DR   ExpressionAtlas; P35439; baseline and differential.
DR   Genevisible; P35439; RN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:BHF-UCL.
DR   GO; GO:0044307; C:dendritic branch; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0043083; C:synaptic cleft; IDA:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IPI:ARUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0005261; F:cation channel activity; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0016595; F:glutamate binding; IDA:UniProtKB.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:RGD.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISO:RGD.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:RGD.
DR   GO; GO:0042165; F:neurotransmitter binding; IDA:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; IDA:RGD.
DR   GO; GO:0032403; F:protein complex binding; IPI:ARUK-UCL.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0005102; F:receptor binding; IPI:RGD.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IMP:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; ISO:RGD.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0006812; P:cation transport; ISO:RGD.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; ISO:RGD.
DR   GO; GO:0001661; P:conditioned taste aversion; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; ISO:RGD.
DR   GO; GO:0060179; P:male mating behavior; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0050905; P:neuromuscular process; ISO:RGD.
DR   GO; GO:0008355; P:olfactory learning; ISO:RGD.
DR   GO; GO:0021586; P:pons maturation; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IGI:ARUK-UCL.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:RGD.
DR   GO; GO:1902952; P:positive regulation of dendritic spine maintenance; IGI:ARUK-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:BHF-UCL.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IGI:ARUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISO:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0018964; P:propylene metabolic process; ISO:RGD.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IDA:RGD.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISO:RGD.
DR   GO; GO:0010646; P:regulation of cell communication; ISO:RGD.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; ISO:RGD.
DR   GO; GO:0051963; P:regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0007585; P:respiratory gaseous exchange; ISO:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:1905429; P:response to glycine; ISO:RGD.
DR   GO; GO:0043278; P:response to morphine; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0001967; P:suckling behavior; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR018882; CaM-bd_C0_NMDA_rcpt_NR1.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF10562; CaM_bdg_C0; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell junction;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Magnesium;
KW   Membrane; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    938       Glutamate receptor ionotropic, NMDA 1.
FT                                /FTId=PRO_0000011589.
FT   TOPO_DOM     19    559       Extracellular.
FT                                {ECO:0000269|PubMed:24876489}.
FT   TRANSMEM    560    580       Helical. {ECO:0000269|PubMed:24876489}.
FT   TOPO_DOM    581    602       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24876489}.
FT   INTRAMEM    603    624       Discontinuously helical.
FT                                {ECO:0000250|UniProtKB:A0A1L8F5J9}.
FT   TOPO_DOM    625    630       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24876489}.
FT   TRANSMEM    631    647       Helical. {ECO:0000269|PubMed:24876489}.
FT   TOPO_DOM    648    812       Extracellular.
FT                                {ECO:0000269|PubMed:24876489}.
FT   TRANSMEM    813    833       Helical. {ECO:0000269|PubMed:24876489}.
FT   TOPO_DOM    834    938       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24876489}.
FT   REGION      516    518       Glycine binding. {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ,
FT                                ECO:0000269|PubMed:24876489}.
FT   REGION      603    624       Pore-forming.
FT                                {ECO:0000250|UniProtKB:A0A1L8F5J9}.
FT   BINDING     523    523       Glycine. {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24876489}.
FT   BINDING     688    688       Glycine. {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24876489}.
FT   BINDING     732    732       Glycine. {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24876489}.
FT   MOD_RES     889    889       Phosphoserine; by PKC. {ECO:0000250}.
FT   MOD_RES     890    890       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:15936117}.
FT   MOD_RES     896    896       Phosphoserine; by PKC. {ECO:0000250}.
FT   MOD_RES     897    897       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:11588171}.
FT   CARBOHYD     61     61       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3Q41}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3Q41,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    239    239       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3Q41}.
FT   CARBOHYD    276    276       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3Q41,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    350    350       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    368    368       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3Q41,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    471    471       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     79    308       {ECO:0000244|PDB:3Q41,
FT                                ECO:0000244|PDB:4PE5}.
FT   DISULFID    420    454       {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:1PB8,
FT                                ECO:0000244|PDB:1PB9,
FT                                ECO:0000244|PDB:1PBQ,
FT                                ECO:0000244|PDB:1Y1M,
FT                                ECO:0000244|PDB:1Y1Z,
FT                                ECO:0000244|PDB:1Y20,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4KCC,
FT                                ECO:0000244|PDB:4KFQ,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5JTY,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ}.
FT   DISULFID    436    455       {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:1PB8,
FT                                ECO:0000244|PDB:1PB9,
FT                                ECO:0000244|PDB:1PBQ,
FT                                ECO:0000244|PDB:1Y1M,
FT                                ECO:0000244|PDB:1Y1Z,
FT                                ECO:0000244|PDB:1Y20,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4KCC,
FT                                ECO:0000244|PDB:4KFQ,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5JTY,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ}.
FT   DISULFID    744    798       {ECO:0000244|PDB:1PB7,
FT                                ECO:0000244|PDB:1PB8,
FT                                ECO:0000244|PDB:1PB9,
FT                                ECO:0000244|PDB:1PBQ,
FT                                ECO:0000244|PDB:1Y1Z,
FT                                ECO:0000244|PDB:1Y20,
FT                                ECO:0000244|PDB:4KCC,
FT                                ECO:0000244|PDB:4KFQ,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5U8C}.
FT   VAR_SEQ     190    190       K -> KSKKRNYENLDQLSYDNKRGPK (in isoform
FT                                B, isoform F and isoform G).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000140.
FT   VAR_SEQ     864    900       Missing (in isoform F and isoform C).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000141.
FT   VAR_SEQ     864    885       DRKSGRAEPDPKKKATFRAITS -> QYHPTDITGPLNLSD
FT                                PSVSTVV (in isoform E and isoform G).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000142.
FT   VAR_SEQ     886    938       Missing (in isoform E and isoform G).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000143.
FT   VAR_SEQ     901    938       STGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES ->
FT                                QYHPTDITGPLNLSDPSVSTVV (in isoform D).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000144.
FT   STRAND       26     35       {ECO:0000244|PDB:3Q41}.
FT   HELIX        36     50       {ECO:0000244|PDB:3Q41}.
FT   STRAND       59     66       {ECO:0000244|PDB:3Q41}.
FT   HELIX        71     80       {ECO:0000244|PDB:3Q41}.
FT   HELIX        83     85       {ECO:0000244|PDB:3Q41}.
FT   STRAND       87     92       {ECO:0000244|PDB:3Q41}.
FT   TURN         98    103       {ECO:0000244|PDB:3Q41}.
FT   HELIX       104    112       {ECO:0000244|PDB:3Q41}.
FT   TURN        113    115       {ECO:0000244|PDB:3Q41}.
FT   STRAND      118    122       {ECO:0000244|PDB:3Q41}.
FT   HELIX       126    129       {ECO:0000244|PDB:3Q41}.
FT   TURN        131    133       {ECO:0000244|PDB:3Q41}.
FT   STRAND      137    141       {ECO:0000244|PDB:3Q41}.
FT   HELIX       144    146       {ECO:0000244|PDB:3Q41}.
FT   HELIX       147    156       {ECO:0000244|PDB:3Q41}.
FT   HELIX       157    159       {ECO:0000244|PDB:3Q41}.
FT   STRAND      163    170       {ECO:0000244|PDB:3Q41}.
FT   HELIX       171    185       {ECO:0000244|PDB:3Q41}.
FT   TURN        186    188       {ECO:0000244|PDB:3Q41}.
FT   STRAND      192    197       {ECO:0000244|PDB:3Q41}.
FT   HELIX       205    212       {ECO:0000244|PDB:3Q41}.
FT   STRAND      218    222       {ECO:0000244|PDB:3Q41}.
FT   HELIX       225    237       {ECO:0000244|PDB:3Q41}.
FT   STRAND      246    248       {ECO:0000244|PDB:3Q41}.
FT   TURN        251    254       {ECO:0000244|PDB:3Q41}.
FT   TURN        256    260       {ECO:0000244|PDB:3Q41}.
FT   STRAND      267    271       {ECO:0000244|PDB:3Q41}.
FT   HELIX       277    296       {ECO:0000244|PDB:3Q41}.
FT   STRAND      298    300       {ECO:0000244|PDB:3Q41}.
FT   HELIX       317    326       {ECO:0000244|PDB:3Q41}.
FT   STRAND      334    336       {ECO:0000244|PDB:3Q41}.
FT   STRAND      338    340       {ECO:0000244|PDB:3Q41}.
FT   STRAND      342    344       {ECO:0000244|PDB:3Q41}.
FT   STRAND      351    357       {ECO:0000244|PDB:3Q41}.
FT   STRAND      360    363       {ECO:0000244|PDB:3Q41}.
FT   STRAND      365    367       {ECO:0000244|PDB:3Q41}.
FT   STRAND      372    374       {ECO:0000244|PDB:3Q41}.
FT   STRAND      397    402       {ECO:0000244|PDB:5U8C}.
FT   TURN        406    408       {ECO:0000244|PDB:5U8C}.
FT   STRAND      409    413       {ECO:0000244|PDB:5U8C}.
FT   TURN        416    418       {ECO:0000244|PDB:5I59}.
FT   STRAND      426    428       {ECO:0000244|PDB:4NF4}.
FT   STRAND      434    438       {ECO:0000244|PDB:5U8C}.
FT   STRAND      451    457       {ECO:0000244|PDB:5U8C}.
FT   HELIX       458    470       {ECO:0000244|PDB:5U8C}.
FT   STRAND      473    478       {ECO:0000244|PDB:5U8C}.
FT   STRAND      480    482       {ECO:0000244|PDB:5VIH}.
FT   STRAND      487    490       {ECO:0000244|PDB:5U8C}.
FT   STRAND      496    498       {ECO:0000244|PDB:5U8C}.
FT   HELIX       500    507       {ECO:0000244|PDB:5U8C}.
FT   STRAND      511    513       {ECO:0000244|PDB:5U8C}.
FT   HELIX       521    524       {ECO:0000244|PDB:5U8C}.
FT   STRAND      527    529       {ECO:0000244|PDB:5U8C}.
FT   STRAND      533    543       {ECO:0000244|PDB:5U8C}.
FT   STRAND      666    669       {ECO:0000244|PDB:5VII}.
FT   HELIX       670    673       {ECO:0000244|PDB:5U8C}.
FT   STRAND      677    679       {ECO:0000244|PDB:5VIJ}.
FT   HELIX       688    695       {ECO:0000244|PDB:5U8C}.
FT   HELIX       697    699       {ECO:0000244|PDB:5U8C}.
FT   HELIX       700    706       {ECO:0000244|PDB:5U8C}.
FT   TURN        707    709       {ECO:0000244|PDB:5U8C}.
FT   STRAND      711    713       {ECO:0000244|PDB:5U8C}.
FT   HELIX       714    722       {ECO:0000244|PDB:5U8C}.
FT   STRAND      727    732       {ECO:0000244|PDB:5U8C}.
FT   HELIX       733    742       {ECO:0000244|PDB:5U8C}.
FT   STRAND      746    758       {ECO:0000244|PDB:5U8C}.
FT   STRAND      761    763       {ECO:0000244|PDB:4NF8}.
FT   HELIX       769    781       {ECO:0000244|PDB:5U8C}.
FT   HELIX       784    792       {ECO:0000244|PDB:5U8C}.
SQ   SEQUENCE   938 AA;  105509 MW;  613D36E38F05BC73 CRC64;
     MSTMHLLTFA LLFSCSFARA ACDPKIVNIG AVLSTRKHEQ MFREAVNQAN KRHGSWKIQL
     NATSVTHKPN AIQMALSVCE DLISSQVYAI LVSHPPTPND HFTPTPVSYT AGFYRIPVLG
     LTTRMSIYSD KSIHLSFLRT VPPYSHQSSV WFEMMRVYNW NHIILLVSDD HEGRAAQKRL
     ETLLEERESK AEKVLQFDPG TKNVTALLME ARELEARVII LSASEDDAAT VYRAAAMLNM
     TGSGYVWLVG EREISGNALR YAPDGIIGLQ LINGKNESAH ISDAVGVVAQ AVHELLEKEN
     ITDPPRGCVG NTNIWKTGPL FKRVLMSSKY ADGVTGRVEF NEDGDRKFAN YSIMNLQNRK
     LVQVGIYNGT HVIPNDRKII WPGGETEKPR GYQMSTRLKI VTIHQEPFVY VKPTMSDGTC
     KEEFTVNGDP VKKVICTGPN DTSPGSPRHT VPQCCYGFCI DLLIKLARTM NFTYEVHLVA
     DGKFGTQERV NNSNKKEWNG MMGELLSGQA DMIVAPLTIN NERAQYIEFS KPFKYQGLTI
     LVKKEIPRST LDSFMQPFQS TLWLLVGLSV HVVAVMLYLL DRFSPFGRFK VNSEEEEEDA
     LTLSSAMWFS WGVLLNSGIG EGAPRSFSAR ILGMVWAGFA MIIVASYTAN LAAFLVLDRP
     EERITGINDP RLRNPSDKFI YATVKQSSVD IYFRRQVELS TMYRHMEKHN YESAAEAIQA
     VRDNKLHAFI WDSAVLEFEA SQKCDLVTTG ELFFRSGFGI GMRKDSPWKQ NVSLSILKSH
     ENGFMEDLDK TWVRYQECDS RSNAPATLTF ENMAGVFMLV AGGIVAGIFL IFIEIAYKRH
     KDARRKQMQL AFAAVNVWRK NLQDRKSGRA EPDPKKKATF RAITSTLASS FKRRRSSKDT
     STGGGRGALQ NQKDTVLPRR AIEREEGQLQ LCSRHRES
//
ID   5HT3A_RAT               Reviewed;         483 AA.
AC   P35563;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   20-DEC-2017, entry version 144.
DE   RecName: Full=5-hydroxytryptamine receptor 3A;
DE            Short=5-HT3-A;
DE            Short=5-HT3A;
DE   AltName: Full=5-hydroxytryptamine receptor 3;
DE            Short=5-HT-3;
DE            Short=5-HT3R;
DE   AltName: Full=Serotonin receptor 3A;
DE   AltName: Full=Serotonin-gated ion channel receptor;
DE   Flags: Precursor;
GN   Name=Htr3a; Synonyms=5ht3, Htr3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Miyake A., Mochizuki S., Akuzawa S., Kon G.;
RL   Submitted (FEB-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-483.
RX   PubMed=7509203;
RA   Isenberg K.E., Ukhun I.A., Holstad S.G., Jafri S., Uchida U.,
RA   Zorumski C.F., Yang J.;
RT   "Partial cDNA cloning and NGF regulation of a rat 5-HT3 receptor
RT   subunit.";
RL   NeuroReport 5:121-124(1993).
RN   [3]
RP   SUBUNIT, AND INDUCTION.
RX   PubMed=10854267; DOI=10.1046/j.1471-4159.2000.0750240.x;
RA   Hanna M.C., Davies P.A., Hales T.G., Kirkness E.F.;
RT   "Evidence for expression of heteromeric serotonin 5-HT(3) receptors in
RT   rodents.";
RL   J. Neurochem. 75:240-247(2000).
RN   [4]
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=12151552;
RA   Morales M., Wang S.-D.;
RT   "Differential composition of 5-hydroxytryptamine3 receptors
RT   synthesized in the rat CNS and peripheral nervous system.";
RL   J. Neurosci. 22:6732-6741(2002).
RN   [5]
RP   FUNCTION, AND REGION.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses in neurons. It is a cation-specific, but
CC       otherwise relatively nonselective, ion channel.
CC       {ECO:0000269|PubMed:12867984}.
CC   -!- SUBUNIT: Interacts with RIC3 (By similarity). Forms pentahomomeric
CC       complex as well as pentaheteromeric complex with HTR3B; homomeric
CC       complex is functional but exhibits low conductance with modified
CC       voltage dependence and antagonist affinity. {ECO:0000250,
CC       ECO:0000269|PubMed:10854267, ECO:0000269|PubMed:12151552}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in central and peripheral neurons.
CC       {ECO:0000269|PubMed:12151552}.
CC   -!- INDUCTION: By nerve growth factor in PC12 cells.
CC       {ECO:0000269|PubMed:10854267}.
CC   -!- MISCELLANEOUS: The HA-stretch region of HTR3A seems to be
CC       responsible for the low conductance of HTR3A homomers compared to
CC       that of HTR3A/HTR3B heteromers.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3A
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49395; BAA08388.1; -; mRNA.
DR   EMBL; U01227; AAA52182.1; -; mRNA.
DR   PIR; I58179; I58179.
DR   RefSeq; NP_077370.2; NM_024394.2.
DR   UniGene; Rn.55109; -.
DR   ProteinModelPortal; P35563; -.
DR   SMR; P35563; -.
DR   STRING; 10116.ENSRNOP00000008965; -.
DR   BindingDB; P35563; -.
DR   ChEMBL; CHEMBL2411; -.
DR   GuidetoPHARMACOLOGY; 373; -.
DR   TCDB; 1.A.9.2.2; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PhosphoSitePlus; P35563; -.
DR   PaxDb; P35563; -.
DR   Ensembl; ENSRNOT00000008965; ENSRNOP00000008965; ENSRNOG00000006595.
DR   GeneID; 79246; -.
DR   KEGG; rno:79246; -.
DR   UCSC; RGD:61818; rat.
DR   CTD; 3359; -.
DR   RGD; 61818; Htr3a.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; P35563; -.
DR   KO; K04819; -.
DR   OMA; EWLQVGY; -.
DR   OrthoDB; EOG091G06Q8; -.
DR   PhylomeDB; P35563; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-RNO-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P35563; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000006595; -.
DR   Genevisible; P35563; RN.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0032154; C:cleavage furrow; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1904602; C:serotonin-activated cation-selective channel complex; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0051378; F:serotonin binding; ISO:RGD.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IDA:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:RGD.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008133; 5HT3_rcpt_A.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01709; 5HT3ARECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    483       5-hydroxytryptamine receptor 3A.
FT                                /FTId=PRO_0000000410.
FT   TOPO_DOM     24    246       Extracellular. {ECO:0000255}.
FT   TRANSMEM    247    273       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    274    278       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    279    297       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    298    307       Extracellular. {ECO:0000255}.
FT   TRANSMEM    308    326       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    327    460       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    461    480       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    481    483       Extracellular. {ECO:0000255}.
FT   REGION      419    455       HA-stretch.
FT   CARBOHYD    109    109       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    175    175       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    162    176       {ECO:0000250}.
FT   CONFLICT     22     22       E -> K (in Ref. 2; AAA52182).
FT                                {ECO:0000305}.
FT   CONFLICT    306    306       G -> R (in Ref. 2; AAA52182).
FT                                {ECO:0000305}.
SQ   SEQUENCE   483 AA;  55428 MW;  ED85257BBCCF28A4 CRC64;
     MPLCIPQVLL ALFLSVLIAQ GEGSRRRATQ AHSTTQPALL RLSDHLLANY KKGVRPVRDW
     RKPTLVSIDV IMYAILNVDE KNQVLTTYIW YRQFWTDEFL QWTPEDFDNV TKLSIPTDSI
     WVPDILINEF VDVGKSPSIP YVYVHHQGEV QNYKPLQLVT ACSLDIYNFP FDVQNCSLTF
     TSWLHTIQDI NISLWRTPEE VRSDKSIFIN QGEWELLGVF TKFQEFSIET SNSYAEMKFY
     VVIRRRPLFY AVSLLLPSIF LMVVDIVGFC LPPDSGERVS FKITLLLGYS VFLIIVSDTL
     PATAIGTPLI GVYFVVCMAL LVISLAETIF IVQLVHKQDL QRPVPDWLRH LVLDRIAWLL
     CLGEQPMAHR PPATFQANKT DDCSAMGNHC SHVGSPQDLE KTSRSRDSPL PPPREASLAV
     RGLLQELSSI RHSLEKRDEM REVARDWLRV GYVLDRLLFR IYLLAVLAYS ITLVTLWSIW
     HYS
//
ID   LGC50_CAEEL             Reviewed;         491 AA.
AC   P41849;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2012, sequence version 3.
DT   25-OCT-2017, entry version 136.
DE   RecName: Full=Ligand-gated ion channel 50;
DE   Flags: Precursor;
GN   Name=lgc-50; ORFNames=T20B12.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO081094; CCD69080.1; -; Genomic_DNA.
DR   PIR; T16909; T16909.
DR   RefSeq; NP_498637.3; NM_066236.4.
DR   UniGene; Cel.10015; -.
DR   ProteinModelPortal; P41849; -.
DR   SMR; P41849; -.
DR   BioGrid; 53293; 1.
DR   STRING; 6239.T20B12.9; -.
DR   EPD; P41849; -.
DR   PaxDb; P41849; -.
DR   PeptideAtlas; P41849; -.
DR   EnsemblMetazoa; T20B12.9; T20B12.9; WBGene00020605.
DR   GeneID; 188633; -.
DR   KEGG; cel:CELE_T20B12.9; -.
DR   CTD; 188633; -.
DR   WormBase; T20B12.9; CE46014; WBGene00020605; lgc-50.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; P41849; -.
DR   OMA; VWSNFRL; -.
DR   OrthoDB; EOG091G07NS; -.
DR   PRO; PR:P41849; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00020605; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    491       Ligand-gated ion channel 50.
FT                                /FTId=PRO_0000076981.
FT   TRANSMEM    241    261       Helical. {ECO:0000255}.
FT   TRANSMEM    265    287       Helical. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TRANSMEM    465    485       Helical. {ECO:0000255}.
FT   CARBOHYD     55     55       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    101    101       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    157    171       {ECO:0000250}.
SQ   SEQUENCE   491 AA;  56200 MW;  446B254DCF62ED42 CRC64;
     MRFLLVLQLV FFYFSAATTN SPKKCSRNSI NLGKLIDTLL TDYDTHLLPE AEGVNVTIEL
     HVQGVSGISE ITGDFSLDVM YSEIWQDPRL SFKHLNVCAT NITLKSDFRK KIWTPDTCII
     NSKSSSIHSS PSENTFVILY ENGLVWSNFR LNVKTPCSVN LKMFPFDSLS CEIVLESYSF
     NTDEVRLMWH DVPITMMEKV ELPDFDLIGW STDHQRLEYP NGIWDRAKVK FTFARRYGFY
     LFQSYFPTSL TVISSWVGFF FDVRSVSARI TLGVSSLLAL TFQFGNVLRH LPRVSYIKCL
     DVWMIFSVIF IFCTLVELAI VCQLNRWERE RQIGSKVLGH WLNQIRKTRK KESKADEGGG
     GGVGGLLRKR IPVLAQLKAA ATDSNSGAAT AMTTAIQPPN TNLNSITNSD NSKLVANNFT
     SIEHETYAYE KKRGFSHCFQ RFVYAICPPD RDWTITSVQV DRCSMIMFPL SFLIFNVVYW
     SIYFMKMDRP M
//
ID   GRIK2_RAT               Reviewed;         908 AA.
AC   P42260;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   20-DEC-2017, entry version 163.
DE   RecName: Full=Glutamate receptor ionotropic, kainate 2;
DE            Short=GluK2;
DE   AltName: Full=Glutamate receptor 6;
DE            Short=GluR-6;
DE            Short=GluR6;
DE   Flags: Precursor;
GN   Name=Grik2; Synonyms=Glur6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=1648177; DOI=10.1038/351745a0;
RA   Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S.F.;
RT   "Cloning of a cDNA for a glutamate receptor subunit activated by
RT   kainate but not AMPA.";
RL   Nature 351:745-748(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=1322826; DOI=10.1016/0014-5793(92)80753-4;
RA   Lomeli H., Wisden W., Koehler M., Keinaenen K., Sommer B.,
RA   Seeburg P.H.;
RT   "High-affinity kainate and domoate receptors in rat brain.";
RL   FEBS Lett. 307:139-143(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 560-585, AND RNA EDITING.
RC   TISSUE=Brain;
RX   PubMed=7681676; DOI=10.1016/0896-6273(93)90336-P;
RA   Koehler M., Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Determinants of Ca2+ permeability in both TM1 and TM2 of high
RT   affinity kainate receptor channels: diversity by RNA editing.";
RL   Neuron 10:491-500(1993).
RN   [4]
RP   INTERACTION WITH DLG4.
RX   PubMed=11744724; DOI=10.1074/jbc.M109453200;
RA   Piserchio A., Pellegrini M., Mehta S., Blackman S.M., Garcia E.P.,
RA   Marshall J., Mierke D.F.;
RT   "The PDZ1 domain of SAP90. Characterization of structure and
RT   binding.";
RL   J. Biol. Chem. 277:6967-6973(2002).
RN   [5]
RP   INTERACTION WITH KLHL17, UBIQUITINATION, AND MUTAGENESIS OF VAL-883
RP   AND ILE-884.
RX   PubMed=17062563; DOI=10.1074/jbc.M608194200;
RA   Salinas G.D., Blair L.A., Needleman L.A., Gonzales J.D., Chen Y.,
RA   Li M., Singer J.D., Marshall J.;
RT   "Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate
RT   receptor subunits to the ubiquitin-proteasome pathway.";
RL   J. Biol. Chem. 281:40164-40173(2006).
RN   [6]
RP   SUMOYLATION AT LYS-886, FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LYS-886.
RX   PubMed=17486098; DOI=10.1038/nature05736;
RA   Martin S., Nishimune A., Mellor J.R., Henley J.M.;
RT   "SUMOylation regulates kainate-receptor-mediated synaptic
RT   transmission.";
RL   Nature 447:321-325(2007).
RN   [7]
RP   INTERACTION WITH NETO2.
RX   PubMed=19217376; DOI=10.1016/j.neuron.2008.12.014;
RA   Zhang W., St-Gelais F., Grabner C.P., Trinidad J.C., Sumioka A.,
RA   Morimoto-Tomita M., Kim K.S., Straub C., Burlingame A.L., Howe J.R.,
RA   Tomita S.;
RT   "A transmembrane accessory subunit that modulates kainate-type
RT   glutamate receptors.";
RL   Neuron 61:385-396(2009).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 429-806 IN COMPLEXES WITH
RP   GLUTAMATE; KAINATE; METHYLGLUTAMATE AND QUISQUALATE.
RX   PubMed=15721240; DOI=10.1016/j.neuron.2005.01.031;
RA   Mayer M.L.;
RT   "Crystal structures of the GluR5 and GluR6 ligand binding cores:
RT   molecular mechanisms underlying kainate receptor selectivity.";
RL   Neuron 45:539-552(2005).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.11 ANGSTROMS) OF 419-819 IN COMPLEX WITH
RP   DOMOATE, SUBUNIT, AND GLYCOSYLATION AT ASN-423 AND ASN-751.
RX   PubMed=15677325; DOI=10.1073/pnas.0409573102;
RA   Nanao M.H., Green T., Stern-Bach Y., Heinemann S.F., Choe S.;
RT   "Structure of the kainate receptor subunit GluR6 agonist-binding
RT   domain complexed with domoic acid.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1708-1713(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 663-806, FUNCTION, AND
RP   SUBUNIT.
RX   PubMed=17115050; DOI=10.1038/nsmb1178;
RA   Weston M.C., Schuck P., Ghosal A., Rosenmund C., Mayer M.L.;
RT   "Conformational restriction blocks glutamate receptor
RT   desensitization.";
RL   Nat. Struct. Mol. Biol. 13:1120-1127(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.91 ANGSTROMS) OF 32-420 IN COMPLEX WITH
RP   GRIK5, DISULFIDE BONDS, GLYCOSYLATION AT ASN-67; ASN-378 AND ASN-412,
RP   AND SUBUNIT.
RX   PubMed=21791290; DOI=10.1016/j.neuron.2011.05.038;
RA   Kumar J., Schuck P., Mayer M.L.;
RT   "Structure and assembly mechanism for heteromeric kainate receptors.";
RL   Neuron 71:319-331(2011).
CC   -!- FUNCTION: Ionotropic glutamate receptor. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. Binding of the excitatory neurotransmitter L-
CC       glutamate induces a conformation change, leading to the opening of
CC       the cation channel, and thereby converts the chemical signal to an
CC       electrical impulse. The receptor then desensitizes rapidly and
CC       enters a transient inactive state, characterized by the presence
CC       of bound agonist (PubMed:17115050, PubMed:17486098). May be
CC       involved in the transmission of light information from the retina
CC       to the hypothalamus. Modulates cell surface expression of NETO2
CC       (By similarity). {ECO:0000250|UniProtKB:P39087,
CC       ECO:0000269|PubMed:17115050, ECO:0000269|PubMed:17486098}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits. Tetramers may be formed by the dimerization of
CC       dimers. Assembles into a kainate-gated homomeric channel that does
CC       not bind AMPA (By similarity). GRIK2 associated to GRIK5 forms
CC       functional channels that can be gated by AMPA. Interacts with
CC       DLG4. Interacts with NETO2. Interacts (via C-terminus) with KLHL17
CC       (via kelch repeats); the interaction targets GRIK2 for degradation
CC       via ubiquitin-proteasome pathway. {ECO:0000250,
CC       ECO:0000269|PubMed:11744724, ECO:0000269|PubMed:15677325,
CC       ECO:0000269|PubMed:17062563, ECO:0000269|PubMed:17115050,
CC       ECO:0000269|PubMed:19217376, ECO:0000269|PubMed:21791290}.
CC   -!- INTERACTION:
CC       Self; NbExp=10; IntAct=EBI-7809795, EBI-7809795;
CC       Q66HA1:Map3k11; NbExp=2; IntAct=EBI-7809795, EBI-4279420;
CC       O70260:Pias3; NbExp=3; IntAct=EBI-7809795, EBI-7974636;
CC       Q5I0H3:Sumo1; NbExp=4; IntAct=EBI-7809795, EBI-7253100;
CC       P63281:Ube2i; NbExp=3; IntAct=EBI-7809795, EBI-7974723;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17486098};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:17486098}. Cell
CC       junction, synapse, postsynaptic cell membrane
CC       {ECO:0000269|PubMed:17486098}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:17486098}.
CC   -!- TISSUE SPECIFICITY: Highest expression is found in the olfactory
CC       lobe, piriform cortex, dentate gyrus, hippocampus, granular cell
CC       layer of the cerebellum, and in caudate-putamen.
CC   -!- PTM: Sumoylation mediates kainate receptor-mediated endocytosis
CC       and regulates synaptic transmission. Sumoylation is enhanced by
CC       PIAS3 and desumoylated by SENP1. {ECO:0000269|PubMed:17486098}.
CC   -!- PTM: Ubiquitinated. Ubiquitination regulates the GRIK2 levels at
CC       the synapse by leading kainate receptor degradation through
CC       proteasome. {ECO:0000269|PubMed:17062563}.
CC   -!- PTM: Phosphorylated by PKC at Ser-868 upon agonist activation,
CC       this directly enhance sumoylation. {ECO:0000250}.
CC   -!- RNA EDITING: Modified_positions=567 {ECO:0000269|PubMed:7681676},
CC       571 {ECO:0000269|PubMed:7681676}, 621
CC       {ECO:0000269|PubMed:7681676}; Note=Partially edited. The presence
CC       of Gln at position 621 (non-edited) determines channels with low
CC       calcium permeability, whereas an arginine residue (edited)
CC       determines a higher calcium permeability especially if the
CC       preceding sites are fully edited. This receptor is nearly
CC       completely edited in all gray matter structures (90% of the
CC       receptors).;
CC   -!- MISCELLANEOUS: The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds domoate > kainate > quisqualate >
CC       glutamate. It does not bind AMPA without coexpression with GRIK5.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIK2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11548; CAA77647.1; -; mRNA.
DR   EMBL; Z11715; CAA77778.1; -; mRNA.
DR   PIR; S19098; S19098.
DR   RefSeq; NP_062182.1; NM_019309.2.
DR   UniGene; Rn.87696; -.
DR   PDB; 1S50; X-ray; 1.65 A; A=428-806.
DR   PDB; 1S7Y; X-ray; 1.75 A; A/B=429-544, A/B=667-806.
DR   PDB; 1S9T; X-ray; 1.80 A; A/B=429-544, A/B=667-806.
DR   PDB; 1SD3; X-ray; 1.80 A; A/B=429-544, A/B=667-806.
DR   PDB; 1TT1; X-ray; 1.93 A; A/B=429-806.
DR   PDB; 1YAE; X-ray; 3.11 A; A/B/C/D/E/F=419-557, A/B/C/D/E/F=662-819.
DR   PDB; 2I0B; X-ray; 1.96 A; A/B/C=429-544, A/B/C=667-806.
DR   PDB; 2I0C; X-ray; 2.25 A; A/B=429-544, A/B=667-806.
DR   PDB; 2XXR; X-ray; 1.60 A; A/B=429-544, A/B=667-806.
DR   PDB; 2XXT; X-ray; 1.90 A; A/B=667-806.
DR   PDB; 2XXU; X-ray; 1.50 A; A/B=667-806.
DR   PDB; 2XXV; X-ray; 1.70 A; A/B=667-806.
DR   PDB; 2XXW; X-ray; 2.30 A; A/B=667-806.
DR   PDB; 2XXX; X-ray; 2.10 A; A/B/C/D=667-806.
DR   PDB; 2XXY; X-ray; 3.00 A; A/B/C/D=667-806.
DR   PDB; 3G3F; X-ray; 1.38 A; A/B=429-544, A/B=667-806.
DR   PDB; 3G3G; X-ray; 1.30 A; A/B=429-544, A/B=667-806.
DR   PDB; 3G3H; X-ray; 1.50 A; A/B=429-544, A/B=667-806.
DR   PDB; 3G3I; X-ray; 1.37 A; A/B=429-544, A/B=667-806.
DR   PDB; 3G3J; X-ray; 1.32 A; A/B=429-544, A/B=667-806.
DR   PDB; 3G3K; X-ray; 1.24 A; A/B=429-544, A/B=667-806.
DR   PDB; 3H6G; X-ray; 2.70 A; A/B=32-420.
DR   PDB; 3H6H; X-ray; 2.90 A; A/B=32-420.
DR   PDB; 3QLT; X-ray; 2.99 A; A/B=32-420.
DR   PDB; 3QLU; X-ray; 2.91 A; C/D=32-420.
DR   PDB; 3QLV; X-ray; 3.94 A; C/D/F/H/J=32-420.
DR   PDB; 4BDL; X-ray; 1.75 A; A/B=429-544, A/B=667-806.
DR   PDB; 4BDM; X-ray; 3.40 A; A/B/C/D=429-544, A/B/C/D=667-806.
DR   PDB; 4BDN; X-ray; 2.50 A; A/B/C/D=429-544, A/B/C/D=667-806.
DR   PDB; 4BDO; X-ray; 2.55 A; A/B/C/D=429-544, A/B/C/D=667-806.
DR   PDB; 4BDQ; X-ray; 1.90 A; A/B=429-544, A/B=667-806.
DR   PDB; 4BDR; X-ray; 1.65 A; A/B=429-544, A/B=667-806.
DR   PDB; 4H8I; X-ray; 2.00 A; A/B=429-544, A/B=667-806.
DR   PDB; 4UQQ; EM; 7.60 A; A/B/C/D=32-908.
DR   PDB; 5CMK; X-ray; 1.80 A; A/B=429-544, A/B=667-806.
DR   PDB; 5CMM; X-ray; 1.27 A; A=429-544.
DR   PDB; 5KUF; EM; 3.80 A; A/B/C/D=32-908.
DR   PDB; 5KUH; EM; 11.60 A; A/B/C/D=32-544, A/B/C/D=667-908.
DR   PDBsum; 1S50; -.
DR   PDBsum; 1S7Y; -.
DR   PDBsum; 1S9T; -.
DR   PDBsum; 1SD3; -.
DR   PDBsum; 1TT1; -.
DR   PDBsum; 1YAE; -.
DR   PDBsum; 2I0B; -.
DR   PDBsum; 2I0C; -.
DR   PDBsum; 2XXR; -.
DR   PDBsum; 2XXT; -.
DR   PDBsum; 2XXU; -.
DR   PDBsum; 2XXV; -.
DR   PDBsum; 2XXW; -.
DR   PDBsum; 2XXX; -.
DR   PDBsum; 2XXY; -.
DR   PDBsum; 3G3F; -.
DR   PDBsum; 3G3G; -.
DR   PDBsum; 3G3H; -.
DR   PDBsum; 3G3I; -.
DR   PDBsum; 3G3J; -.
DR   PDBsum; 3G3K; -.
DR   PDBsum; 3H6G; -.
DR   PDBsum; 3H6H; -.
DR   PDBsum; 3QLT; -.
DR   PDBsum; 3QLU; -.
DR   PDBsum; 3QLV; -.
DR   PDBsum; 4BDL; -.
DR   PDBsum; 4BDM; -.
DR   PDBsum; 4BDN; -.
DR   PDBsum; 4BDO; -.
DR   PDBsum; 4BDQ; -.
DR   PDBsum; 4BDR; -.
DR   PDBsum; 4H8I; -.
DR   PDBsum; 4UQQ; -.
DR   PDBsum; 5CMK; -.
DR   PDBsum; 5CMM; -.
DR   PDBsum; 5KUF; -.
DR   PDBsum; 5KUH; -.
DR   ProteinModelPortal; P42260; -.
DR   SMR; P42260; -.
DR   BioGrid; 248480; 6.
DR   DIP; DIP-29256N; -.
DR   ELM; P42260; -.
DR   IntAct; P42260; 5.
DR   MINT; MINT-8359884; -.
DR   STRING; 10116.ENSRNOP00000033070; -.
DR   BindingDB; P42260; -.
DR   ChEMBL; CHEMBL3607; -.
DR   GuidetoPHARMACOLOGY; 451; -.
DR   TCDB; 1.A.10.1.11; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; P42260; -.
DR   PhosphoSitePlus; P42260; -.
DR   PaxDb; P42260; -.
DR   PRIDE; P42260; -.
DR   Ensembl; ENSRNOT00000076234; ENSRNOP00000068172; ENSRNOG00000000368.
DR   GeneID; 54257; -.
DR   KEGG; rno:54257; -.
DR   UCSC; RGD:2733; rat.
DR   CTD; 2898; -.
DR   RGD; 2733; Grik2.
DR   eggNOG; KOG1054; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000234371; -.
DR   HOVERGEN; HBG051839; -.
DR   InParanoid; P42260; -.
DR   KO; K05202; -.
DR   OMA; DSDIQHS; -.
DR   OrthoDB; EOG091G02LN; -.
DR   PhylomeDB; P42260; -.
DR   Reactome; R-RNO-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-RNO-451308; Activation of Ca-permeable Kainate Receptor.
DR   EvolutionaryTrace; P42260; -.
DR   PRO; PR:P42260; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000368; -.
DR   ExpressionAtlas; P42260; baseline and differential.
DR   Genevisible; P42260; RN.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0032839; C:dendrite cytoplasm; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0032983; C:kainate selective glutamate receptor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; ISO:RGD.
DR   GO; GO:0015277; F:kainate selective glutamate receptor activity; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:RGD.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0001662; P:behavioral fear response; ISO:RGD.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISO:RGD.
DR   GO; GO:0006886; P:intracellular protein transport; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IDA:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; ISO:RGD.
DR   GO; GO:0043113; P:receptor clustering; IDA:UniProtKB.
DR   GO; GO:0046328; P:regulation of JNK cascade; IMP:UniProtKB.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Isopeptide bond; Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; RNA editing;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32    908       Glutamate receptor ionotropic, kainate 2.
FT                                /FTId=PRO_0000011546.
FT   TOPO_DOM     32    561       Extracellular. {ECO:0000255}.
FT   TRANSMEM    562    582       Helical. {ECO:0000255}.
FT   TOPO_DOM    583    638       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    639    659       Helical. {ECO:0000255}.
FT   TOPO_DOM    660    819       Extracellular. {ECO:0000255}.
FT   TRANSMEM    820    840       Helical. {ECO:0000255}.
FT   TOPO_DOM    841    908       Cytoplasmic. {ECO:0000255}.
FT   REGION      516    518       Glutamate binding.
FT   REGION      689    690       Glutamate binding.
FT   BINDING     523    523       Glutamate.
FT   BINDING     738    738       Glutamate.
FT   MOD_RES     846    846       Phosphoserine; by PKC.
FT                                {ECO:0000250|UniProtKB:Q13002}.
FT   MOD_RES     868    868       Phosphoserine; by PKC.
FT                                {ECO:0000250|UniProtKB:Q13002}.
FT   CARBOHYD     67     67       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21791290}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    378    378       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21791290}.
FT   CARBOHYD    412    412       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:21791290}.
FT   CARBOHYD    423    423       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15677325}.
FT   CARBOHYD    430    430       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    546    546       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    751    751       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15677325}.
FT   DISULFID     96    347       {ECO:0000269|PubMed:21791290}.
FT   CROSSLNK    886    886       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000269|PubMed:17486098}.
FT   VARIANT     567    567       I -> C (in RNA edited version).
FT   VARIANT     571    571       Y -> C (in RNA edited version).
FT   VARIANT     621    621       Q -> R (in RNA edited version).
FT   MUTAGEN     883    883       V->A: Abolishes interaction with KLHL17.
FT                                Abolishes actinfilin-mediated
FT                                degradation.
FT                                {ECO:0000269|PubMed:17062563}.
FT   MUTAGEN     884    884       I->A: Abolishes interaction with KLHL17.
FT                                Abolishes actinfilin-mediated
FT                                degradation.
FT                                {ECO:0000269|PubMed:17062563}.
FT   MUTAGEN     886    886       K->R: Abolishes sumoylation. Loss of
FT                                kainate-mediated endocytosis.
FT                                {ECO:0000269|PubMed:17486098}.
FT   STRAND       34     47       {ECO:0000244|PDB:3H6G}.
FT   HELIX        52     66       {ECO:0000244|PDB:3H6G}.
FT   STRAND       68     84       {ECO:0000244|PDB:3H6G}.
FT   HELIX        88    101       {ECO:0000244|PDB:3H6G}.
FT   HELIX       112    124       {ECO:0000244|PDB:3H6G}.
FT   STRAND      129    131       {ECO:0000244|PDB:3H6G}.
FT   STRAND      145    151       {ECO:0000244|PDB:3H6G}.
FT   HELIX       153    166       {ECO:0000244|PDB:3H6G}.
FT   STRAND      170    178       {ECO:0000244|PDB:3H6G}.
FT   HELIX       180    184       {ECO:0000244|PDB:3H6G}.
FT   HELIX       186    189       {ECO:0000244|PDB:3H6G}.
FT   HELIX       191    193       {ECO:0000244|PDB:3H6G}.
FT   STRAND      198    203       {ECO:0000244|PDB:3H6G}.
FT   HELIX       208    211       {ECO:0000244|PDB:3H6G}.
FT   HELIX       212    220       {ECO:0000244|PDB:3H6G}.
FT   STRAND      225    230       {ECO:0000244|PDB:3H6G}.
FT   HELIX       232    244       {ECO:0000244|PDB:3H6G}.
FT   STRAND      249    251       {ECO:0000244|PDB:3QLT}.
FT   STRAND      253    256       {ECO:0000244|PDB:3H6G}.
FT   HELIX       261    263       {ECO:0000244|PDB:3H6G}.
FT   TURN        267    271       {ECO:0000244|PDB:3H6G}.
FT   STRAND      275    280       {ECO:0000244|PDB:3H6G}.
FT   HELIX       287    298       {ECO:0000244|PDB:3H6G}.
FT   STRAND      309    311       {ECO:0000244|PDB:3QLT}.
FT   HELIX       318    335       {ECO:0000244|PDB:3H6G}.
FT   STRAND      347    349       {ECO:0000244|PDB:3H6H}.
FT   HELIX       351    357       {ECO:0000244|PDB:2XXU}.
FT   HELIX       359    362       {ECO:0000244|PDB:2XXU}.
FT   STRAND      364    366       {ECO:0000244|PDB:2XXU}.
FT   HELIX       367    372       {ECO:0000244|PDB:2XXU}.
FT   HELIX       374    377       {ECO:0000244|PDB:2XXU}.
FT   STRAND      378    385       {ECO:0000244|PDB:2XXU}.
FT   HELIX       386    393       {ECO:0000244|PDB:2XXU}.
FT   STRAND      399    404       {ECO:0000244|PDB:2XXU}.
FT   STRAND      409    411       {ECO:0000244|PDB:2XXU}.
FT   HELIX       424    429       {ECO:0000244|PDB:2XXU}.
FT   STRAND      433    437       {ECO:0000244|PDB:3G3K}.
FT   TURN        441    443       {ECO:0000244|PDB:3G3K}.
FT   STRAND      444    446       {ECO:0000244|PDB:3G3K}.
FT   HELIX       447    452       {ECO:0000244|PDB:2XXU}.
FT   HELIX       455    458       {ECO:0000244|PDB:3G3K}.
FT   STRAND      459    461       {ECO:0000244|PDB:3G3K}.
FT   HELIX       462    474       {ECO:0000244|PDB:3G3K}.
FT   STRAND      478    482       {ECO:0000244|PDB:3G3K}.
FT   TURN        493    495       {ECO:0000244|PDB:3G3K}.
FT   HELIX       500    506       {ECO:0000244|PDB:3G3K}.
FT   STRAND      511    513       {ECO:0000244|PDB:3G3K}.
FT   HELIX       521    524       {ECO:0000244|PDB:3G3K}.
FT   STRAND      527    529       {ECO:0000244|PDB:3G3K}.
FT   STRAND      533    536       {ECO:0000244|PDB:3G3K}.
FT   STRAND      538    544       {ECO:0000244|PDB:3G3K}.
FT   HELIX       671    675       {ECO:0000244|PDB:3G3K}.
FT   STRAND      678    685       {ECO:0000244|PDB:3G3K}.
FT   HELIX       689    696       {ECO:0000244|PDB:3G3K}.
FT   HELIX       700    711       {ECO:0000244|PDB:3G3K}.
FT   HELIX       713    716       {ECO:0000244|PDB:3G3K}.
FT   STRAND      717    720       {ECO:0000244|PDB:3G3K}.
FT   HELIX       721    730       {ECO:0000244|PDB:3G3K}.
FT   STRAND      731    738       {ECO:0000244|PDB:3G3K}.
FT   HELIX       739    748       {ECO:0000244|PDB:3G3K}.
FT   STRAND      752    757       {ECO:0000244|PDB:3G3K}.
FT   STRAND      762    764       {ECO:0000244|PDB:3G3K}.
FT   STRAND      767    769       {ECO:0000244|PDB:3G3K}.
FT   HELIX       774    787       {ECO:0000244|PDB:3G3K}.
FT   HELIX       790    799       {ECO:0000244|PDB:3G3K}.
SQ   SEQUENCE   908 AA;  102470 MW;  7F430E2D8B2E982B CRC64;
     MKIISPVLSN LVFSRSIKVL LCLLWIGYSQ GTTHVLRFGG IFEYVESGPM GAEELAFRFA
     VNTINRNRTL LPNTTLTYDT QKINLYDSFE ASKKACDQLS LGVAAIFGPS HSSSANAVQS
     ICNALGVPHI QTRWKHQVSD NKDSFYVSLY PDFSSLSRAI LDLVQFFKWK TVTVVYDDST
     GLIRLQELIK APSRYNLRLK IRQLPADTKD AKPLLKEMKR GKEFHVIFDC SHEMAAGILK
     QALAMGMMTE YYHYIFTTLD LFALDVEPYR YSGVNMTGFR ILNTENTQVS SIIEKWSMER
     LQAPPKPDSG LLDGFMTTDA ALMYDAVHVV SVAVQQFPQM TVSSLQCNRH KPWRFGTRFM
     SLIKEAHWEG LTGRITFNKT NGLRTDFDLD VISLKEEGLE KIGTWDPASG LNMTESQKGK
     PANITDSLSN RSLIVTTILE EPYVLFKKSD KPLYGNDRFE GYCIDLLREL STILGFTYEI
     RLVEDGKYGA QDDVNGQWNG MVRELIDHKA DLAVAPLAIT YVREKVIDFS KPFMTLGISI
     LYRKPNGTNP GVFSFLNPLS PDIWMYILLA YLGVSCVLFV IARFSPYEWY NPHPCNPDSD
     VVENNFTLLN SFWFGVGALM QQGSELMPKA LSTRIVGGIW WFFTLIIISS YTANLAAFLT
     VERMESPIDS ADDLAKQTKI EYGAVEDGAT MTFFKKSKIS TYDKMWAFMS SRRQSVLVKS
     NEEGIQRVLT SDYAFLMEST TIEFVTQRNC NLTQIGGLID SKGYGVGTPM GSPYRDKITI
     AILQLQEEGK LHMMKEKWWR GNGCPEEESK EASALGVQNI GGIFIVLAAG LVLSVFVAVG
     EFLYKSKKNA QLEKRSFCSA MVEELRMSLK CQRRLKHKPQ APVIVKTEEV INMHTFNDRR
     LPGKETMA
//
ID   ACHA9_RAT               Reviewed;         479 AA.
AC   P43144; Q6PW49;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-9;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-9;
DE            Short=NACHR alpha-9;
DE   Flags: Precursor;
GN   Name=Chrna9; Synonyms=Acra9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Olfactory epithelium;
RX   PubMed=7954834; DOI=10.1016/0092-8674(94)90555-X;
RA   Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., Heinemann S.F.;
RT   "Alpha 9: an acetylcholine receptor with novel pharmacological
RT   properties expressed in rat cochlear hair cells.";
RL   Cell 79:705-715(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10713500; DOI=10.1016/S0378-5955(99)00214-2;
RA   Katz E., Verbitsky M., Rothlin C.V., Vetter D.E., Heinemann S.F.,
RA   Elgoyhen A.B.;
RT   "High calcium permeability and calcium block of the alpha9 nicotinic
RT   acetylcholine receptor.";
RL   Hear. Res. 141:117-128(2000).
RN   [4]
RP   FUNCTION.
RX   PubMed=11044723; DOI=10.1016/S0028-3908(00)00124-6;
RA   Verbitsky M., Rothlin C.V., Katz E., Elgoyhen A.B.;
RT   "Mixed nicotinic-muscarinic properties of the alpha9 nicotinic
RT   cholinergic receptor.";
RL   Neuropharmacology 39:2515-2524(2000).
RN   [5]
RP   INTERACTION WITH CHRNA10, SUBUNIT, TISSUE SPECIFICITY, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11248107; DOI=10.1073/pnas.051622798;
RA   Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F.,
RA   Boulter J.;
RT   "Alpha10: a determinant of nicotinic cholinergic receptor function in
RT   mammalian vestibular and cochlear mechanosensory hair cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3501-3506(2001).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CHRNA10.
RX   PubMed=12117536; DOI=10.1016/S0378-5955(02)00380-5;
RA   Weisstaub N., Vetter D.E., Elgoyhen A.B., Katz E.;
RT   "The alpha9alpha10 nicotinic acetylcholine receptor is permeable to
RT   and is modulated by divalent cations.";
RL   Hear. Res. 167:122-135(2002).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12401316; DOI=10.1016/S0306-4522(02)00274-9;
RA   Lips K.S., Pfeil U., Kummer W.;
RT   "Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine
RT   receptors in rat dorsal root ganglion neurons.";
RL   Neuroscience 115:1-5(2002).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH CHRNA10.
RX   PubMed=14742688; DOI=10.1124/mol.65.2.453;
RA   Baker E.R., Zwart R., Sher E., Millar N.S.;
RT   "Pharmacological properties of alpha 9 alpha 10 nicotinic
RT   acetylcholine receptors revealed by heterologous expression of subunit
RT   chimeras.";
RL   Mol. Pharmacol. 65:453-460(2004).
RN   [9]
RP   SITE THR-86, AND MUTAGENESIS OF SER-36; SER-44; ALA-54; THR-86;
RP   ARG-101; SER-147 AND SER-166.
RX   PubMed=22774872; DOI=10.1111/j.1471-4159.2012.07867.x;
RA   Azam L., McIntosh J.M.;
RT   "Molecular basis for the differential sensitivity of rat and human
RT   alpha9alpha10 nAChRs to alpha-conotoxin RgIA.";
RL   J. Neurochem. 122:1137-1144(2012).
RN   [10]
RP   MUTAGENESIS OF TRP-176.
RX   PubMed=18295795; DOI=10.1016/j.jmb.2008.01.082;
RA   Ellison M., Feng Z.P., Park A.J., Zhang X., Olivera B.M.,
RA   McIntosh J.M., Norton R.S.;
RT   "Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR:
RT   structure and identification of key receptor-binding residues.";
RL   J. Mol. Biol. 377:1216-1227(2008).
RN   [11]
RP   SITE ASP-146, MUTAGENESIS OF THR-86 AND ASP-146, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [12]
RP   ERRATUM.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with
RT   the rat alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the
CC       modulation of auditory stimuli. Agonist binding induces a
CC       conformation change that leads to the opening of an ion-conducting
CC       channel across the plasma membrane. The channel is permeable to a
CC       range of divalent cations including calcium, the influx of which
CC       may activate a potassium current which hyperpolarizes the cell
CC       membrane. In the ear, this leads to a reduction in basilar
CC       membrane motion, altering the activity of auditory nerve fibers
CC       and reducing the range of dynamic hearing. This may protect
CC       against acoustic trauma. May also regulate keratinocyte adhesion.
CC       {ECO:0000269|PubMed:10713500, ECO:0000269|PubMed:11044723,
CC       ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688, ECO:0000269|PubMed:7954834,
CC       ECO:0000305}.
CC   -!- SUBUNIT: Can form homo- or heterooligomeric channels in
CC       conjunction with CHRNA10. The native outer hair cell receptor may
CC       be composed of CHRNA9-CHRNA10 heterooligomers. Interacts with the
CC       alpha-conotoxin RgIA (PubMed:25740413).
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688, ECO:0000269|PubMed:25740413,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000269|PubMed:10713500,
CC       ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:7954834}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in the nasal epithelium, in the outer
CC       hair cells of the cochlea, in the pars tuberalis of the
CC       hypophysis, and in the developing muscle of the tongue. Also
CC       expressed in the neurons of dorsal root ganglia.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12401316,
CC       ECO:0000269|PubMed:7954834}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9
CC       and CHRNA10 has an atypical pharmacological profile, binding
CC       several non-nicotinic ligands including strychnine (a glycine
CC       receptor antagonist) and atropine (a muscarinic acetylcholine
CC       receptor antagonist). {ECO:0000269|PubMed:7954834}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       9/CHRNA9 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U12336; AAA56720.1; -; mRNA.
DR   EMBL; AY574257; AAS90353.1; -; mRNA.
DR   PIR; A55382; A55382.
DR   RefSeq; NP_075219.1; NM_022930.1.
DR   UniGene; Rn.54463; -.
DR   ProteinModelPortal; P43144; -.
DR   MINT; MINT-4996733; -.
DR   STRING; 10116.ENSRNOP00000003382; -.
DR   BindingDB; P43144; -.
DR   ChEMBL; CHEMBL2585; -.
DR   GuidetoPHARMACOLOGY; 469; -.
DR   PhosphoSitePlus; P43144; -.
DR   PaxDb; P43144; -.
DR   PRIDE; P43144; -.
DR   DNASU; 65024; -.
DR   Ensembl; ENSRNOT00000003382; ENSRNOP00000003382; ENSRNOG00000002484.
DR   GeneID; 65024; -.
DR   KEGG; rno:65024; -.
DR   UCSC; RGD:621534; rat.
DR   CTD; 55584; -.
DR   RGD; 621534; Chrna9.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P43144; -.
DR   KO; K04810; -.
DR   OMA; ATKNVIM; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P43144; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-RNO-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   PRO; PR:P43144; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002484; -.
DR   Genevisible; P43144; RN.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:RGD.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0006812; P:cation transport; ISO:RGD.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; IEP:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    479       Neuronal acetylcholine receptor subunit
FT                                alpha-9.
FT                                /FTId=PRO_0000000372.
FT   TOPO_DOM     26    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    262       Helical. {ECO:0000255}.
FT   TRANSMEM    269    287       Helical. {ECO:0000255}.
FT   TRANSMEM    302    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    457       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    458    476       Helical. {ECO:0000255}.
FT   SITE         86     86       Key residue important for potent
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA (AC P0C1D0).
FT                                {ECO:0000269|PubMed:22774872}.
FT   SITE        146    146       Key residue important for potent
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA (AC P0C1D0).
FT                                {ECO:0000269|PubMed:25740413}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250|UniProtKB:Q9UGM1}.
FT   DISULFID    219    220       {ECO:0000250|UniProtKB:Q9UGM1}.
FT   MUTAGEN      36     36       S->N: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN      44     44       S->N: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10
FT                                receptorby the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN      54     54       A->K: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10
FT                                receptorby the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN      86     86       T->E: The CHRNA9-CHRNA10 receptor is 20-
FT                                fold less potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN      86     86       T->I: The CHRNA9-CHRNA10 receptor is
FT                                1700-fold less potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872,
FT                                ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     101    101       R->G: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN     146    146       D->L: Complete loss of inhibition of the
FT                                CHRNA9-CHRNA10 receptor by the alpha-
FT                                conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     147    147       S->A: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN     166    166       S->N: No significant change in potency of
FT                                inhibition of the CHRNA9-CHRNA10 receptor
FT                                by the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:22774872}.
FT   MUTAGEN     176    176       W->T: The CHRNA9-CHRNA10 receptor is 8.5-
FT                                fold less potently inhibited by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:18295795}.
FT   CONFLICT    425    425       T -> A (in Ref. 1; AAA56720).
FT                                {ECO:0000305}.
SQ   SEQUENCE   479 AA;  54526 MW;  CBB3E15E9DF68837 CRC64;
     MNRPHSCLSF CWMYFAASGI RAVETANGKY AQKLFSDLFE DYSSALRPVE DTDAVLNVTL
     QVTLSQIKDM DERNQILTAY LWIRQTWHDA YLTWDRDQYD RLDSIRIPSD LVWRPDIVLY
     NKADDESSEP VNTNVVLRYD GLITWDSPAI TKSSCVVDVT YFPFDSQQCN LTFGSWTYNG
     NQVDIFNALD SGDLSDFIED VEWEVHGMPA VKNVISYGCC SEPYPDVTFT LLLKRRSSFY
     IVNLLIPCVL ISFLAPLSFY LPAASGEKVS LGVTILLAMT VFQLMVAEIM PASENVPLIG
     KYYIATMALI TASTALTIMV MNIHFCGAEA RPVPHWAKVV ILKYMSRILF VYDVGESCLS
     PRHSQEPEQV TKVYSKLPES NLKTSRNKDL SRKKEVRKLL KNDLGYQGGI PQNTDSYCAR
     YEALTKNIEY IAKCLKDHKA TNSKGSEWKK VAKVIDRFFM WIFFAMVFVM TVLIIARAD
//
ID   ACHA4_HUMAN             Reviewed;         627 AA.
AC   P43681; Q4JGR7; Q4VAQ5; Q4VAQ6;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   25-OCT-2017, entry version 186.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-4;
DE   Flags: Precursor;
GN   Name=CHRNA4; Synonyms=NACRA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7721089; DOI=10.1016/0378-1119(94)00914-E;
RA   Monteggia L.M., Gopalakrishnan M., Touma E., Idler K.B., Nash N.,
RA   Arneric S.P., Sullivan J.P., Giordano T.;
RT   "Cloning and transient expression of genes encoding the human alpha-4
RT   and beta-2 neuronal nicotinic acetylcholine receptor (nAChR)
RT   subunits.";
RL   Gene 155:189-193(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8833159; DOI=10.1006/geno.1996.0119;
RA   Steinlein O.K., Weiland S., Stood J., Propping P.;
RT   "Exon-intron structure of the human neuronal nicotinic acetylcholine
RT   receptor alpha 4 subunit (CHRNA4).";
RL   Genomics 32:289-294(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=8906617; DOI=10.1007/BF02736842;
RA   Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A.,
RA   Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M.;
RT   "Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-
RT   beta 4 nicotinic acetylcholine receptor subunits and functional
RT   expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta
RT   4 subunits.";
RL   J. Mol. Neurosci. 7:217-228(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9009220; DOI=10.1016/S0014-5793(96)01383-X;
RA   Groot Kormelink P.J., Luyten W.H.M.L.;
RT   "Cloning and sequence of full-length cDNAs encoding the human neuronal
RT   nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and
RT   expression of seven nAChR subunits in the human neuroblastoma cell
RT   line SH-SY5Y and/or IMR-32.";
RL   FEBS Lett. 400:309-314(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-387 AND LEU-517.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-627 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Mamalaki A., Remoundos M., Tzartos S.;
RT   "Molecular cloning of human neuronal nicotinic acetylcholine receptor
RT   4-like subunit.";
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   INTERACTION WITH RIC3.
RX   PubMed=16120769; DOI=10.1124/mol.105.017459;
RA   Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R.,
RA   Gibb A.J., Millar N.S.;
RT   "RIC-3 enhances functional expression of multiple nicotinic
RT   acetylcholine receptor subtypes in mammalian cells.";
RL   Mol. Pharmacol. 68:1431-1438(2005).
RN   [10]
RP   INTERACTION WITH LYPD6.
RX   PubMed=27344019; DOI=10.1111/jnc.13718;
RA   Arvaniti M., Jensen M.M., Soni N., Wang H., Klein A.B., Thiriet N.,
RA   Pinborg L.H., Muldoon P.P., Wienecke J., Imad Damaj M.,
RA   Kohlmeier K.A., Gondre-Lewis M.C., Mikkelsen J.D., Thomsen M.S.;
RT   "Functional interaction between Lypd6 and nicotinic acetylcholine
RT   receptors.";
RL   J. Neurochem. 138:806-820(2016).
RN   [11]
RP   STRUCTURE BY NMR OF 242-625, SUBUNIT, AND FUNCTION.
RX   PubMed=22361591; DOI=10.1016/j.bbamem.2012.02.008;
RA   Bondarenko V., Mowrey D., Tillman T., Cui T., Liu L.T., Xu Y.,
RA   Tang P.;
RT   "NMR structures of the transmembrane domains of the alpha4beta2
RT   nAChR.";
RL   Biochim. Biophys. Acta 1818:1261-1268(2012).
RN   [12]
RP   VARIANT ENFL1 PHE-280.
RX   PubMed=7550350; DOI=10.1038/ng1095-201;
RA   Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A.,
RA   Sutherland G.R., Scheffer I.E., Berkovic S.F.;
RT   "A missense mutation in the neuronal nicotinic acetylcholine receptor
RT   alpha-4 subunit is associated with autosomal dominant nocturnal
RT   frontal lobe epilepsy.";
RL   Nat. Genet. 11:201-203(1995).
RN   [13]
RP   VARIANT ENFL1 LEU-280.
RX   PubMed=10563623; DOI=10.1212/WNL.53.8.1749;
RA   Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K.,
RA   Kaneko S., Mitsudome A.;
RT   "A novel mutation of CHRNA4 responsible for autosomal dominant
RT   nocturnal frontal lobe epilepsy.";
RL   Neurology 53:1749-1753(1999).
RN   [14]
RP   VARIANT ENFL1 LEU-280.
RX   PubMed=14623738; DOI=10.1001/archneur.60.11.1625;
RA   Cho Y.-W., Motamedi G.K., Laufenberg I., Sohn S.-I., Lim J.-G.,
RA   Lee H., Yi S.-D., Lee J.-H., Kim D.-K., Reba R., Gaillard W.D.,
RA   Theodore W.H., Lesser R.P., Steinlein O.K.;
RT   "A Korean kindred with autosomal dominant nocturnal frontal lobe
RT   epilepsy and mental retardation.";
RL   Arch. Neurol. 60:1625-1632(2003).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane permeable to sodium ions. {ECO:0000269|PubMed:22361591}.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of
CC       subunits: alpha and beta. Alpha-4 subunit can be combined to beta-
CC       2 or beta-4 to give rise to functional receptors, complexes with
CC       beta-2 may be heteropentamers (PubMed:22361591). Interacts with
CC       RIC3; which is required for proper folding and assembly
CC       (PubMed:16120769). Interacts with LYPD6 (PubMed:27344019). The
CC       heteropentamer alpha-4-beta-2 interacts with alpha-conotoxins
CC       PnIA, GID and MII (By similarity). {ECO:0000250|UniProtKB:P09483,
CC       ECO:0000269|PubMed:16120769, ECO:0000269|PubMed:22361591,
CC       ECO:0000269|PubMed:27344019}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein. Cell membrane {ECO:0000250}; Lipid-anchor
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P43681-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P43681-2; Sequence=VSP_054275, VSP_054276;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Epilepsy, nocturnal frontal lobe, 1 (ENFL1) [MIM:600513]:
CC       An autosomal dominant focal epilepsy characterized by nocturnal
CC       seizures with hyperkinetic automatisms and poorly organized
CC       stereotyped movements. {ECO:0000269|PubMed:10563623,
CC       ECO:0000269|PubMed:14623738, ECO:0000269|PubMed:7550350}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       4/CHRNA4 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/chrna4/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L35901; AAA64743.1; -; mRNA.
DR   EMBL; X89741; CAA61893.1; -; Genomic_DNA.
DR   EMBL; X89742; CAA61893.1; JOINED; Genomic_DNA.
DR   EMBL; X89743; CAA61893.1; JOINED; Genomic_DNA.
DR   EMBL; X89744; CAA61893.1; JOINED; Genomic_DNA.
DR   EMBL; X89745; CAA61893.1; JOINED; Genomic_DNA.
DR   EMBL; X89746; CAA61893.1; JOINED; Genomic_DNA.
DR   EMBL; U62433; AAB40111.1; -; mRNA.
DR   EMBL; Y08421; CAA69698.1; -; mRNA.
DR   EMBL; DQ093071; AAY88737.1; -; Genomic_DNA.
DR   EMBL; AL121827; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096290; AAH96290.1; -; mRNA.
DR   EMBL; BC096291; AAH96291.1; -; mRNA.
DR   EMBL; X87629; CAA60959.1; -; mRNA.
DR   CCDS; CCDS13517.1; -. [P43681-1]
DR   PIR; JC4021; JC4021.
DR   RefSeq; NP_000735.1; NM_000744.6. [P43681-1]
DR   RefSeq; NP_001243502.1; NM_001256573.1.
DR   RefSeq; XP_011526826.1; XM_011528524.1. [P43681-2]
DR   UniGene; Hs.10734; -.
DR   PDB; 2GVT; Model; -; A/C=38-241.
DR   PDB; 2LLY; NMR; -; A=240-339, A=598-626.
DR   PDB; 5KXI; X-ray; 3.94 A; A/D=27-364, A/D=586-627.
DR   PDBsum; 2GVT; -.
DR   PDBsum; 2LLY; -.
DR   PDBsum; 5KXI; -.
DR   ProteinModelPortal; P43681; -.
DR   SMR; P43681; -.
DR   BioGrid; 107559; 4.
DR   CORUM; P43681; -.
DR   IntAct; P43681; 4.
DR   MINT; MINT-3015931; -.
DR   STRING; 9606.ENSP00000359285; -.
DR   BindingDB; P43681; -.
DR   ChEMBL; CHEMBL1882; -.
DR   DrugBank; DB05458; ABT-089.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB09028; Cytisine.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB05740; RPI-78M.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB01273; Varenicline.
DR   GuidetoPHARMACOLOGY; 465; -.
DR   TCDB; 1.A.9.1.6; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P43681; -.
DR   PhosphoSitePlus; P43681; -.
DR   SwissPalm; P43681; -.
DR   BioMuta; CHRNA4; -.
DR   DMDM; 1351848; -.
DR   PaxDb; P43681; -.
DR   PeptideAtlas; P43681; -.
DR   PRIDE; P43681; -.
DR   Ensembl; ENST00000370263; ENSP00000359285; ENSG00000101204. [P43681-1]
DR   Ensembl; ENST00000615287; ENSP00000483388; ENSG00000101204. [P43681-2]
DR   GeneID; 1137; -.
DR   KEGG; hsa:1137; -.
DR   UCSC; uc002yes.4; human. [P43681-1]
DR   CTD; 1137; -.
DR   DisGeNET; 1137; -.
DR   EuPathDB; HostDB:ENSG00000101204.15; -.
DR   GeneCards; CHRNA4; -.
DR   GeneReviews; CHRNA4; -.
DR   HGNC; HGNC:1958; CHRNA4.
DR   HPA; CAB034064; -.
DR   MalaCards; CHRNA4; -.
DR   MIM; 118504; gene.
DR   MIM; 600513; phenotype.
DR   neXtProt; NX_P43681; -.
DR   OpenTargets; ENSG00000101204; -.
DR   Orphanet; 98784; Autosomal dominant nocturnal frontal lobe epilepsy.
DR   PharmGKB; PA26490; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P43681; -.
DR   KO; K04806; -.
DR   OMA; RTHTMPA; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P43681; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   ChiTaRS; CHRNA4; human.
DR   GeneWiki; CHRNA4; -.
DR   GenomeRNAi; 1137; -.
DR   PRO; PR:P43681; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101204; -.
DR   CleanEx; HS_CHRNA4; -.
DR   ExpressionAtlas; P43681; baseline and differential.
DR   Genevisible; P43681; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IC:UniProtKB.
DR   GO; GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0001508; P:action potential; ISS:UniProtKB.
DR   GO; GO:0042113; P:B cell activation; ISS:UniProtKB.
DR   GO; GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; NAS:UniProtKB.
DR   GO; GO:0050890; P:cognition; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IMP:UniProtKB.
DR   GO; GO:0035640; P:exploration behavior; IEA:Ensembl.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; ISS:UniProtKB.
DR   GO; GO:0006811; P:ion transport; NAS:UniProtKB.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0051899; P:membrane depolarization; ISS:UniProtKB.
DR   GO; GO:0050877; P:nervous system process; IMP:UniProtKB.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0014059; P:regulation of dopamine secretion; ISS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; ISS:UniProtKB.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0035094; P:response to nicotine; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISS:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Disease mutation; Disulfide bond; Epilepsy;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    627       Neuronal acetylcholine receptor subunit
FT                                alpha-4.
FT                                /FTId=PRO_0000000351.
FT   TOPO_DOM     29    242       Extracellular. {ECO:0000255}.
FT   TRANSMEM    243    267       Helical. {ECO:0000255}.
FT   TRANSMEM    275    293       Helical. {ECO:0000255}.
FT   TRANSMEM    309    330       Helical. {ECO:0000255}.
FT   TOPO_DOM    331    600       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    601    619       Helical. {ECO:0000255}.
FT   MOD_RES     424    424       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09483}.
FT   MOD_RES     538    538       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70174}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70174}.
FT   LIPID       271    271       S-palmitoyl cysteine. {ECO:0000250}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    161    175       {ECO:0000250}.
FT   DISULFID    225    226       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     57       MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLL
FT                                KKLFSGYNKWSRPVAN -> MRMSPPSASPPSSSGGRTSSS
FT                                TTTAGEPFWAGVLFAIRPHPGLSGRIVWTAGCPGEG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054275.
FT   VAR_SEQ      58    128       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054276.
FT   VARIANT     280    280       S -> F (in ENFL1; dbSNP:rs121909580).
FT                                {ECO:0000269|PubMed:7550350}.
FT                                /FTId=VAR_000295.
FT   VARIANT     280    280       S -> L (in ENFL1).
FT                                {ECO:0000269|PubMed:10563623,
FT                                ECO:0000269|PubMed:14623738}.
FT                                /FTId=VAR_017531.
FT   VARIANT     387    387       E -> G (in dbSNP:rs45604738).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023402.
FT   VARIANT     517    517       S -> L (in dbSNP:rs45622132).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023403.
FT   CONFLICT      4      4       G -> E (in Ref. 7; AAH96290).
FT                                {ECO:0000305}.
FT   HELIX       244    266       {ECO:0000244|PDB:2LLY}.
FT   HELIX       273    295       {ECO:0000244|PDB:2LLY}.
FT   STRAND      300    302       {ECO:0000244|PDB:2LLY}.
FT   HELIX       307    329       {ECO:0000244|PDB:2LLY}.
FT   HELIX       598    618       {ECO:0000244|PDB:2LLY}.
FT   TURN        622    624       {ECO:0000244|PDB:2LLY}.
SQ   SEQUENCE   627 AA;  69957 MW;  B3A0C0151E5A2AA8 CRC64;
     MELGGPGAPR LLPPLLLLLG TGLLRASSHV ETRAHAEERL LKKLFSGYNK WSRPVANISD
     VVLVRFGLSI AQLIDVDEKN QMMTTNVWVK QEWHDYKLRW DPADYENVTS IRIPSELIWR
     PDIVLYNNAD GDFAVTHLTK AHLFHDGRVQ WTPPAIYKSS CSIDVTFFPF DQQNCTMKFG
     SWTYDKAKID LVNMHSRVDQ LDFWESGEWV IVDAVGTYNT RKYECCAEIY PDITYAFVIR
     RLPLFYTINL IIPCLLISCL TVLVFYLPSE CGEKITLCIS VLLSLTVFLL LITEIIPSTS
     LVIPLIGEYL LFTMIFVTLS IVITVFVLNV HHRSPRTHTM PTWVRRVFLD IVPRLLLMKR
     PSVVKDNCRR LIESMHKMAS APRFWPEPEG EPPATSGTQS LHPPSPSFCV PLDVPAEPGP
     SCKSPSDQLP PQQPLEAEKA SPHPSPGPCR PPHGTQAPGL AKARSLSVQH MSSPGEAVEG
     GVRCRSRSIQ YCVPRDDAAP EADGQAAGAL ASRNTHSAEL PPPDQPSPCK CTCKKEPSSV
     SPSATVKTRS TKAPPPHLPL SPALTRAVEG VQYIADHLKA EDTDFSVKED WKYVAMVIDR
     IFLWMFIIVC LLGTVGLFLP PWLAGMI
//
ID   ACR7_CAEEL              Reviewed;         538 AA.
AC   P45963; Q9GQV0;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   25-OCT-2017, entry version 133.
DE   RecName: Full=Acetylcholine receptor subunit alpha-type acr-7;
DE   Flags: Precursor;
GN   Name=acr-7; ORFNames=T09A5.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Bristol N2;
RX   PubMed=10100329;
RA   Mongan N.P., Baylis H.A., Adcock C., Smith G.R., Sansom M.S.P.,
RA   Sattelle D.B.;
RT   "An extensive and diverse gene family of nicotinic acetylcholine
RT   receptor alpha subunits in Caenorhabditis elegans.";
RL   Recept. Channels 6:213-228(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-101, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000250}.
CC   -!- SUBUNIT: Forms a homooligomeric channel blocked by alpha-
CC       bungarotoxin. The structure is probably pentameric (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF187012; AAG35182.1; -; mRNA.
DR   EMBL; Z36753; CAA85338.2; -; Genomic_DNA.
DR   PIR; T24724; T24724.
DR   RefSeq; NP_495647.1; NM_063246.4.
DR   UniGene; Cel.19448; -.
DR   ProteinModelPortal; P45963; -.
DR   SMR; P45963; -.
DR   STRING; 6239.T09A5.3; -.
DR   iPTMnet; P45963; -.
DR   PaxDb; P45963; -.
DR   EnsemblMetazoa; T09A5.3; T09A5.3; WBGene00000046.
DR   GeneID; 174262; -.
DR   KEGG; cel:CELE_T09A5.3; -.
DR   UCSC; T09A5.3; c. elegans.
DR   CTD; 174262; -.
DR   WormBase; T09A5.3; CE28078; WBGene00000046; acr-7.
DR   eggNOG; KOG3646; Eukaryota.
DR   eggNOG; ENOG410Z6BY; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; P45963; -.
DR   KO; K05312; -.
DR   OMA; VINWIPP; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P45963; -.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   PRO; PR:P45963; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00000046; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    538       Acetylcholine receptor subunit alpha-type
FT                                acr-7.
FT                                /FTId=PRO_0000000400.
FT   TOPO_DOM     28    250       Extracellular. {ECO:0000255}.
FT   TRANSMEM    251    271       Helical. {ECO:0000255}.
FT   TRANSMEM    280    300       Helical. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    513       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    514    534       Helical. {ECO:0000255}.
FT   CARBOHYD     41     41       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    101    101       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   DISULFID    160    174       {ECO:0000250}.
FT   DISULFID    229    230       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   538 AA;  62823 MW;  A33C6514FF64F56C CRC64;
     MMVQSIQIVL PVALFFLIVF NGFTVEGSKK EAQLYRDLLT NYSYLVRPVR NPKKALTVTM
     KVFIQQVLLV DAKHQMIEVN AWLKYIWTDF RLRWNPLDYE NITSVRFQGE DQIWQPDILL
     YNRYIEDEQE SFDITYKTNA VAYSDGVINW IPPGIFKLSC KMDITLFPFD EQICFMKFGS
     WTYHGFALDL RLDVVKGQEP SADLSTYITN GEWHLLSAPA RREEKFYKCC KEPYPTVKFY
     LHLRRRTFYY VFNVVLPTLL VSFMSLLAFC LPATDLSEKI GLQTTILLSV CFFLTILSEM
     TPTTSEAVPL LGVFFSALTF IVAMSTTFTI LVLNIRYRQI TNHYLSPMFR SIFLECLPWL
     MMMKRPDHKF RRGSSYRDSS ADQCVQCAKN AELKSILRGT DNQQQIETNT FYPFPTETLS
     LNRKVGDGLF IQRRCQIHEE ARSEKFTHGM LACEKSLREN GSELANILVT ILKMYEVMVS
     QVERIRKRIA LKRKRKDIQD EWKFAAQAVD RFCLIIFTIV FIICCFIFVA IPPIKILD
//
ID   5HT3A_HUMAN             Reviewed;         478 AA.
AC   P46098; B4DSY6; G5E986; O60854; Q7KZM7; Q99918; Q9BSZ9;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   20-DEC-2017, entry version 182.
DE   RecName: Full=5-hydroxytryptamine receptor 3A;
DE            Short=5-HT3-A;
DE            Short=5-HT3A;
DE   AltName: Full=5-hydroxytryptamine receptor 3;
DE            Short=5-HT-3;
DE            Short=5-HT3R;
DE   AltName: Full=Serotonin receptor 3A;
DE   AltName: Full=Serotonin-gated ion channel receptor;
DE   Flags: Precursor;
GN   Name=HTR3A; Synonyms=5HT3R, HTR3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=7565620;
RA   Miyake A., Mochizuki S., Takemoto Y., Akuzawa S.;
RT   "Molecular cloning of human 5-hydroxytryptamine3 receptor:
RT   heterogeneity in distribution and function among species.";
RL   Mol. Pharmacol. 48:407-416(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=8848005;
RA   Belelli D., Balcarek J.M., Hope A.G., Peters J.A., Lambert J.J.,
RA   Blackburn T.P.;
RT   "Cloning and functional expression of a human 5-hydroxytryptamine type
RT   3AS receptor subunit.";
RL   Mol. Pharmacol. 48:1054-1062(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Hippocampus;
RX   PubMed=9928262; DOI=10.1111/j.1749-6632.1998.tb10196.x;
RA   Bruess M., Goethert M., Hayer M., Bonisch H.;
RT   "Molecular cloning of alternatively spliced human 5HT3 receptor
RT   cDNAs.";
RL   Ann. N. Y. Acad. Sci. 861:234-235(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=10670426; DOI=10.1016/S0028-3908(99)00116-1;
RA   Bruess M., Eucker T., Goethert M., Bonisch H.;
RT   "Exon-intron organization of the human 5-HT3A receptor gene.";
RL   Neuropharmacology 39:308-315(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=15028279; DOI=10.1016/j.ygeno.2003.09.023;
RA   Jin P., Fu G.K., Wilson A.D., Yang J., Chien D., Hawkins P.R.,
RA   Au-Young J., Stuve L.L.;
RT   "PCR isolation and cloning of novel splice variant mRNAs from known
RT   drug target genes.";
RL   Genomics 83:566-571(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=9950429; DOI=10.1038/16941;
RA   Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J.,
RA   Hales T.G., Kirkness E.F.;
RT   "The 5-HT3B subunit is a major determinant of serotonin-receptor
RT   function.";
RL   Nature 397:359-363(1999).
RN   [13]
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   PubMed=10521471; DOI=10.1074/jbc.274.43.30799;
RA   Dubin A.E., Huvar R., D'Andrea M.R., Pyati J., Zhu J.Y., Joy K.C.,
RA   Wilson S.J., Galindo J.E., Glass C.A., Luo L., Jackson M.R.,
RA   Lovenberg T.W., Erlander M.G.;
RT   "The pharmacological and functional characteristics of the serotonin
RT   5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor
RT   subunit.";
RL   J. Biol. Chem. 274:30799-30810(1999).
RN   [14]
RP   FUNCTION, REGION, AND MUTAGENESIS OF ARG-432; ARG-436 AND ARG-440.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
RN   [15]
RP   INTERACTION WITH RIC3.
RX   PubMed=15809299; DOI=10.1074/jbc.M414341200;
RA   Cheng A., McDonald N.A., Connolly C.N.;
RT   "Cell surface expression of 5-hydroxytryptamine type 3 receptors is
RT   promoted by RIC-3.";
RL   J. Biol. Chem. 280:22502-22507(2005).
RN   [16]
RP   SUBUNIT, AND MUTAGENESIS OF TRP-178.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [17]
RP   VARIANT THR-33.
RX   PubMed=15293096; DOI=10.1007/s10067-004-0927-2;
RA   Frank B., Niesler B., Bondy B., Spaeth M., Pongratz D.E.,
RA   Ackenheil M., Fischer C., Rappold G.;
RT   "Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in
RT   fibromyalgia patients.";
RL   Clin. Rheumatol. 23:338-344(2004).
RN   [18]
RP   VARIANTS HIS-344; ARG-391 AND GLN-409.
RX   PubMed=16487942; DOI=10.1016/j.biopsych.2005.11.008;
RA   Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T.,
RA   Takao H., Minabe Y., Nakatani N., Higuchi T., Detera-Wadleigh S.D.,
RA   Yoshikawa T.;
RT   "Distinguishable haplotype blocks in the HTR3A and HTR3B region in the
RT   Japanese reveal evidence of association of HTR3B with female major
RT   depression.";
RL   Biol. Psychiatry 60:192-201(2006).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses in neurons. It is a cation-specific, but
CC       otherwise relatively nonselective, ion channel.
CC       {ECO:0000269|PubMed:12867984, ECO:0000269|PubMed:9950429}.
CC   -!- SUBUNIT: Forms pentahomomeric complex as well as pentaheteromeric
CC       complex with HTR3B or HTR3C or HTR3D or HTR3E; homomeric complex
CC       is functional but exhibits low conductance with modified voltage
CC       dependence, and decreased agonist and antagonist affinity.
CC       Interacts with RIC3. {ECO:0000269|PubMed:10521471,
CC       ECO:0000269|PubMed:15809299, ECO:0000269|PubMed:17392525,
CC       ECO:0000269|PubMed:9950429}.
CC   -!- INTERACTION:
CC       Q8WXA8:HTR3C; NbExp=5; IntAct=EBI-9008743, EBI-9008753;
CC       Q70Z44:HTR3D; NbExp=5; IntAct=EBI-9008743, EBI-9008717;
CC       A5X5Y0-1:HTR3E; NbExp=5; IntAct=EBI-9008743, EBI-11174612;
CC       A5X5Y0-3:HTR3E; NbExp=3; IntAct=EBI-9008743, EBI-11163690;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=5-HT3R-AS;
CC         IsoId=P46098-1; Sequence=Displayed;
CC       Name=2; Synonyms=5-HT3R-AL;
CC         IsoId=P46098-2; Sequence=VSP_000078;
CC       Name=3;
CC         IsoId=P46098-3; Sequence=VSP_042214;
CC       Name=4;
CC         IsoId=P46098-4; Sequence=VSP_043484;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P46098-5; Sequence=VSP_043484, VSP_000078;
CC         Note=No experimental confirmation available. Ref.7 (CD014118)
CC         sequence is in conflict in position: 342:C->W. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Expressed in cerebral cortex, amygdala,
CC       hippocampus, and testis. Detected in monocytes of the spleen and
CC       tonsil, in small and large intestine, uterus, prostate, ovary and
CC       placenta. {ECO:0000269|PubMed:10521471}.
CC   -!- MISCELLANEOUS: The HA-stretch region of HTR3A seems to be
CC       responsible for the low conductance of HTR3A homomers compared to
CC       that of HTR3A/HTR3B heteromers.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3A
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49394; BAA08387.1; -; mRNA.
DR   EMBL; S82612; AAB37533.2; -; mRNA.
DR   EMBL; AJ003078; CAA05851.1; -; mRNA.
DR   EMBL; AJ003079; CAA05852.1; -; mRNA.
DR   EMBL; AJ005205; CAA06442.3; -; Genomic_DNA.
DR   EMBL; AF498984; AAM21131.1; -; mRNA.
DR   EMBL; BT007204; AAP35868.1; -; mRNA.
DR   EMBL; CD014118; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK299973; BAG61798.1; -; mRNA.
DR   EMBL; AP000908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67238.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67240.1; -; Genomic_DNA.
DR   EMBL; BC002354; AAH02354.1; -; mRNA.
DR   EMBL; BC004453; AAH04453.2; -; mRNA.
DR   CCDS; CCDS53710.1; -. [P46098-3]
DR   CCDS; CCDS8365.2; -. [P46098-4]
DR   CCDS; CCDS8366.2; -. [P46098-5]
DR   RefSeq; NP_000860.2; NM_000869.5. [P46098-4]
DR   RefSeq; NP_001155244.1; NM_001161772.2. [P46098-3]
DR   RefSeq; NP_998786.2; NM_213621.3. [P46098-5]
DR   UniGene; Hs.413899; -.
DR   ProteinModelPortal; P46098; -.
DR   SMR; P46098; -.
DR   BioGrid; 109591; 112.
DR   IntAct; P46098; 4.
DR   BindingDB; P46098; -.
DR   ChEMBL; CHEMBL1899; -.
DR   DrugBank; DB00969; Alosetron.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01238; Aripiprazole.
DR   DrugBank; DB01161; Chloroprocaine.
DR   DrugBank; DB04885; Cilansetron.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB05049; DDP733.
DR   DrugBank; DB00757; Dolasetron.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00889; Granisetron.
DR   DrugBank; DB00408; Loxapine.
DR   DrugBank; DB01043; Memantine.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB01233; Metoclopramide.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB00377; Palonosetron.
DR   DrugBank; DB00721; Procaine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB04917; Renzapride.
DR   DrugBank; DB00728; Rocuronium.
DR   DrugBank; DB06204; Tapentadol.
DR   DrugBank; DB13025; Tiapride.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB11699; Tropisetron.
DR   DrugBank; DB01199; Tubocurarine.
DR   DrugBank; DB09068; Vortioxetine.
DR   DrugBank; DB00246; Ziprasidone.
DR   GuidetoPHARMACOLOGY; 373; -.
DR   TCDB; 1.A.9.2.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; P46098; -.
DR   PhosphoSitePlus; P46098; -.
DR   BioMuta; HTR3A; -.
DR   DMDM; 1168222; -.
DR   PRIDE; P46098; -.
DR   DNASU; 3359; -.
DR   Ensembl; ENST00000299961; ENSP00000299961; ENSG00000166736. [P46098-3]
DR   Ensembl; ENST00000355556; ENSP00000347754; ENSG00000166736. [P46098-5]
DR   Ensembl; ENST00000375498; ENSP00000364648; ENSG00000166736. [P46098-4]
DR   Ensembl; ENST00000504030; ENSP00000424189; ENSG00000166736. [P46098-1]
DR   Ensembl; ENST00000506841; ENSP00000424776; ENSG00000166736. [P46098-2]
DR   GeneID; 3359; -.
DR   KEGG; hsa:3359; -.
DR   UCSC; uc010rxa.3; human. [P46098-1]
DR   CTD; 3359; -.
DR   DisGeNET; 3359; -.
DR   EuPathDB; HostDB:ENSG00000166736.11; -.
DR   GeneCards; HTR3A; -.
DR   HGNC; HGNC:5297; HTR3A.
DR   MIM; 182139; gene.
DR   neXtProt; NX_P46098; -.
DR   OpenTargets; ENSG00000166736; -.
DR   PharmGKB; PA29555; -.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; P46098; -.
DR   KO; K04819; -.
DR   OMA; EWLQVGY; -.
DR   OrthoDB; EOG091G06Q8; -.
DR   PhylomeDB; P46098; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; HTR3A; -.
DR   GenomeRNAi; 3359; -.
DR   PRO; PR:P46098; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000166736; -.
DR   CleanEx; HS_HTR3A; -.
DR   ExpressionAtlas; P46098; baseline and differential.
DR   Genevisible; P46098; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0032154; C:cleavage furrow; IDA:HGNC.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1904602; C:serotonin-activated cation-selective channel complex; IDA:GO_Central.
DR   GO; GO:0051378; F:serotonin binding; IDA:MGI.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IDA:GO_Central.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008133; 5HT3_rcpt_A.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01709; 5HT3ARECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    478       5-hydroxytryptamine receptor 3A.
FT                                /FTId=PRO_0000000408.
FT   TOPO_DOM     24    241       Extracellular. {ECO:0000255}.
FT   TRANSMEM    242    268       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    269    273       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    274    292       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    293    302       Extracellular. {ECO:0000255}.
FT   TRANSMEM    303    321       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    322    455       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    456    475       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    476    478       Extracellular. {ECO:0000255}.
FT   REGION      414    450       HA-stretch.
FT   CARBOHYD     28     28       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    186    186       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    157    171       {ECO:0000250}.
FT   VAR_SEQ       1     22       MLLWVQQALLALLLPTLLAQGE -> MHRSFLQ (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042214.
FT   VAR_SEQ       1      1       M -> MLGKLAM (in isoform 4 and isoform
FT                                5). {ECO:0000303|PubMed:15028279,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_043484.
FT   VAR_SEQ     306    306       G -> GKAPPGSRAQSGEKPAPSHLLHVSLASALGCTG
FT                                (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:15028279,
FT                                ECO:0000303|PubMed:9928262}.
FT                                /FTId=VSP_000078.
FT   VARIANT      33     33       A -> T (in dbSNP:rs117793058).
FT                                {ECO:0000269|PubMed:15293096}.
FT                                /FTId=VAR_037398.
FT   VARIANT     253    253       S -> N (in dbSNP:rs4938063).
FT                                /FTId=VAR_037399.
FT   VARIANT     344    344       R -> H (in dbSNP:rs35815285).
FT                                {ECO:0000269|PubMed:16487942}.
FT                                /FTId=VAR_037400.
FT   VARIANT     391    391       P -> R. {ECO:0000269|PubMed:16487942}.
FT                                /FTId=VAR_037401.
FT   VARIANT     409    409       R -> Q (in dbSNP:rs183698487).
FT                                {ECO:0000269|PubMed:16487942}.
FT                                /FTId=VAR_037402.
FT   MUTAGEN     178    178       W->S: Abolished ligand binding to the
FT                                heteromeric receptor.
FT                                {ECO:0000269|PubMed:17392525}.
FT   MUTAGEN     432    432       R->Q: Little effect on conductance.
FT                                Massive increase of conductance; when
FT                                associated with D-436 and A-440.
FT                                {ECO:0000269|PubMed:12867984}.
FT   MUTAGEN     436    436       R->D: Increased conductance. Massive
FT                                increase of conductance; when associated
FT                                with Q-432 and A-440.
FT                                {ECO:0000269|PubMed:12867984}.
FT   MUTAGEN     440    440       R->A: Increased conductance. Massive
FT                                increase of conductance; when associated
FT                                with Q-432 and D-436.
FT                                {ECO:0000269|PubMed:12867984}.
FT   CONFLICT     46     46       R -> T (in Ref. 2; AAB37533).
FT                                {ECO:0000305}.
FT   CONFLICT    125    125       F -> L (in Ref. 2; AAB37533).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       A -> T (in Ref. 2; AAB37533).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       S -> T (in Ref. 2; AAB37533).
FT                                {ECO:0000305}.
SQ   SEQUENCE   478 AA;  55280 MW;  24CA9A232286FBC9 CRC64;
     MLLWVQQALL ALLLPTLLAQ GEARRSRNTT RPALLRLSDY LLTNYRKGVR PVRDWRKPTT
     VSIDVIVYAI LNVDEKNQVL TTYIWYRQYW TDEFLQWNPE DFDNITKLSI PTDSIWVPDI
     LINEFVDVGK SPNIPYVYIR HQGEVQNYKP LQVVTACSLD IYNFPFDVQN CSLTFTSWLH
     TIQDINISLW RLPEKVKSDR SVFMNQGEWE LLGVLPYFRE FSMESSNYYA EMKFYVVIRR
     RPLFYVVSLL LPSIFLMVMD IVGFYLPPNS GERVSFKITL LLGYSVFLII VSDTLPATAI
     GTPLIGVYFV VCMALLVISL AETIFIVRLV HKQDLQQPVP AWLRHLVLER IAWLLCLREQ
     STSQRPPATS QATKTDDCSA MGNHCSHMGG PQDFEKSPRD RCSPPPPPRE ASLAVCGLLQ
     ELSSIRQFLE KRDEIREVAR DWLRVGSVLD KLLFHIYLLA VLAYSITLVM LWSIWQYA
//
ID   P2RX1_RAT               Reviewed;         399 AA.
AC   P47824;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=P2X purinoceptor 1;
DE            Short=P2X1;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
DE   AltName: Full=RP-2 protein;
GN   Name=P2rx1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Vas deferens;
RX   PubMed=7523951; DOI=10.1038/371516a0;
RA   Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A.,
RA   Buell G.N.;
RT   "A new class of ligand-gated ion channel defined by P2x receptor for
RT   extracellular ATP.";
RL   Nature 371:516-519(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 189-399.
RC   STRAIN=Sprague-Dawley; TISSUE=Thymus;
RX   PubMed=2072913; DOI=10.1128/MCB.11.8.4177;
RA   Owens G.P., Hahn W.E., Cohen J.J.;
RT   "Identification of mRNAs associated with programmed cell death in
RT   immature thymocytes.";
RL   Mol. Cell. Biol. 11:4177-4188(1991).
CC   -!- FUNCTION: Ligand-gated ion channel with relatively high calcium
CC       permeability. Binding to ATP mediates synaptic transmission
CC       between neurons and from neurons to smooth muscle. Seems to be
CC       linked to apoptosis, by increasing the intracellular concentration
CC       of calcium in the presence of ATP, leading to programmed cell
CC       death.
CC   -!- SUBUNIT: Homo- or heteropolymers.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: High levels in vas deferens and urinary
CC       bladder. Lower extent in spinal cord, coeliac ganglion, lung and
CC       spleen (probably in the smooth muscle part of both organs).
CC   -!- DEVELOPMENTAL STAGE: Expressed during apoptosis in thymocytes.
CC   -!- INDUCTION: By irradiation and dexamethasone (in thymocytes).
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X80477; CAA56647.1; -; mRNA.
DR   EMBL; BC061742; AAH61742.1; -; mRNA.
DR   EMBL; M80602; AAA42065.1; -; mRNA.
DR   PIR; S50860; S50860.
DR   RefSeq; NP_001135839.1; NM_001142367.2.
DR   RefSeq; NP_001272344.1; NM_001285415.1.
DR   RefSeq; NP_037129.1; NM_012997.3.
DR   UniGene; Rn.91176; -.
DR   SMR; P47824; -.
DR   STRING; 10116.ENSRNOP00000024068; -.
DR   BindingDB; P47824; -.
DR   ChEMBL; CHEMBL2530; -.
DR   GuidetoPHARMACOLOGY; 478; -.
DR   TCDB; 1.A.7.1.1; the atp-gated p2x receptor cation channel (p2x receptor) family.
DR   iPTMnet; P47824; -.
DR   PhosphoSitePlus; P47824; -.
DR   PaxDb; P47824; -.
DR   PRIDE; P47824; -.
DR   Ensembl; ENSRNOT00000024068; ENSRNOP00000024068; ENSRNOG00000017606.
DR   GeneID; 25505; -.
DR   KEGG; rno:25505; -.
DR   CTD; 5023; -.
DR   RGD; 3240; P2rx1.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; P47824; -.
DR   KO; K05215; -.
DR   OMA; FKYAEDM; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; P47824; -.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-418346; Platelet homeostasis.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P47824; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000017606; -.
DR   ExpressionAtlas; P47824; baseline and differential.
DR   Genevisible; P47824; RN.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0043234; C:protein complex; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0005261; F:cation channel activity; ISO:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:RGD.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISO:RGD.
DR   GO; GO:0007320; P:insemination; ISO:RGD.
DR   GO; GO:0006811; P:ion transport; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0030168; P:platelet activation; ISO:RGD.
DR   GO; GO:0043270; P:positive regulation of ion transport; ISO:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:0003056; P:regulation of vascular smooth muscle contraction; ISO:RGD.
DR   GO; GO:0019229; P:regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0033198; P:response to ATP; ISO:RGD.
DR   GO; GO:0010033; P:response to organic substance; ISO:RGD.
DR   GO; GO:0002554; P:serotonin secretion by platelet; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0042310; P:vasoconstriction; IMP:RGD.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003044; P2X1_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF9; PTHR10125:SF9; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01308; P2X1RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    399       P2X purinoceptor 1.
FT                                /FTId=PRO_0000161547.
FT   TOPO_DOM      1     28       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     29     50       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     51    338       Extracellular. {ECO:0000255}.
FT   TRANSMEM    339    358       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    359    399       Cytoplasmic. {ECO:0000255}.
FT   REGION      331    338       Pore-forming motif. {ECO:0000255}.
FT   COMPBIAS    351    354       Poly-Leu.
FT   MOD_RES     387    387       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51575}.
FT   MOD_RES     388    388       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51575}.
FT   MOD_RES     389    389       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P51575}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    210    210       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    117    165       {ECO:0000250}.
FT   DISULFID    126    149       {ECO:0000250}.
FT   DISULFID    132    159       {ECO:0000250}.
FT   DISULFID    217    227       {ECO:0000250}.
FT   DISULFID    261    270       {ECO:0000250}.
FT   CONFLICT    189    201       IKNSISFPRFKVN -> PQLAHGCYPCPPH (in Ref.
FT                                3). {ECO:0000305}.
SQ   SEQUENCE   399 AA;  44957 MW;  04B79E171D78AEC2 CRC64;
     MARRLQDELS AFFFEYDTPR MVLVRNKKVG VIFRLIQLVV LVYVIGWVFV YEKGYQTSSD
     LISSVSVKLK GLAVTQLQGL GPQVWDVADY VFPAHGDSSF VVMTNFIVTP QQTQGHCAEN
     PEGGICQDDS GCTPGKAERK AQGIRTGNCV PFNGTVKTCE IFGWCPVEVD DKIPSPALLR
     EAENFTLFIK NSISFPRFKV NRRNLVEEVN GTYMKKCLYH KIQHPLCPVF NLGYVVRESG
     QDFRSLAEKG GVVGITIDWK CDLDWHVRHC KPIYQFHGLY GEKNLSPGFN FRFARHFVQN
     GTNRRHLFKV FGIHFDILVD GKAGKFDIIP TMTTIGSGIG IFGVATVLCD LLLLHILPKR
     HYYKQKKFKY AEDMGPGEGE HDPVATSSTL GLQENMRTS
//
ID   GLRB_MOUSE              Reviewed;         496 AA.
AC   P48168; Q5U5X3;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Glycine receptor subunit beta;
DE   AltName: Full=Glycine receptor 58 kDa subunit;
DE   Flags: Precursor;
GN   Name=Glrb;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DISEASE, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7920630; DOI=10.1038/ng0694-136;
RA   Kingsmore S.F., Giros B., Suh D., Bieniarz M., Caron M.G.,
RA   Seldin M.F.;
RT   "Glycine receptor beta-subunit gene mutation in spastic mouse
RT   associated with LINE-1 element insertion.";
RL   Nat. Genet. 7:136-141(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANTS SPASTIC, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=BALB/cJ, and C57BL/6J; TISSUE=Brain, and Liver;
RX   PubMed=7946325; DOI=10.1016/0896-6273(94)90265-8;
RA   Muelhardt C., Fischer M., Gass P., Simon-Chazottes D., Guenet J.-L.,
RA   Kuhse J., Betz H., Becker C.M.;
RT   "The spastic mouse: aberrant splicing of glycine receptor beta subunit
RT   mRNA caused by intronic insertion of L1 element.";
RL   Neuron 13:1003-1015(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Hippocampus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   DISEASE, AND FUNCTION.
RX   PubMed=12809985; DOI=10.1016/S0304-3940(03)00499-3;
RA   von Wegerer J., Becker K., Glockenhammer D., Becker C.M.,
RA   Zeilhofer H.U., Swandulla D.;
RT   "Spinal inhibitory synaptic transmission in the glycine receptor mouse
RT   mutant spastic.";
RL   Neurosci. Lett. 345:45-48(2003).
RN   [7]
RP   DISEASE, AND FUNCTION.
RX   PubMed=16672662; DOI=10.1523/JNEUROSCI.3991-05.2006;
RA   Graham B.A., Schofield P.R., Sah P., Margrie T.W., Callister R.J.;
RT   "Distinct physiological mechanisms underlie altered glycinergic
RT   synaptic transmission in the murine mutants spastic, spasmodic, and
RT   oscillator.";
RL   J. Neurosci. 26:4880-4890(2006).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19723286; DOI=10.1111/j.1460-9568.2009.06903.x;
RA   Eichler S.A., Foerstera B., Smolinsky B., Juettner R., Lehmann T.N.,
RA   Faehling M., Schwarz G., Legendre P., Meier J.C.;
RT   "Splice-specific roles of glycine receptor alpha3 in the
RT   hippocampus.";
RL   Eur. J. Neurosci. 30:1077-1091(2009).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22592841; DOI=10.1002/cne.23139;
RA   Weltzien F., Puller C., O'Sullivan G.A., Paarmann I., Betz H.;
RT   "Distribution of the glycine receptor beta-subunit in the mouse CNS as
RT   revealed by a novel monoclonal antibody.";
RL   J. Comp. Neurol. 520:3962-3981(2012).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       GLRB does not form ligand-gated ion channels by itself, but is
CC       part of heteromeric ligand-gated chloride channels. Channel
CC       opening is triggered by extracellular glycine (PubMed:12809985).
CC       Heteropentameric channels composed of GLRB and GLRA1 are activated
CC       by lower glycine levels than homopentameric GLRA1. Plays an
CC       important role in the down-regulation of neuronal excitability.
CC       Contributes to the generation of inhibitory postsynaptic currents
CC       (PubMed:12809985, PubMed:16672662). {ECO:0000250|UniProtKB:P48167,
CC       ECO:0000269|PubMed:12809985, ECO:0000269|PubMed:16672662}.
CC   -!- SUBUNIT: Heteropentamer composed of GLRB and GLRA1. Heteropentamer
CC       composed of GLRB and GLRA2. Heteropentamer composed of GLRB and
CC       GLRA3. Heteropentamer composed of two GLRA1 and three GLRB
CC       subunits. Heteropentamer composed of three GLRA1 and two GLRB
CC       subunits. Interacts with GPHN. {ECO:0000250|UniProtKB:P48167}.
CC   -!- INTERACTION:
CC       Q03555:Gphn (xeno); NbExp=4; IntAct=EBI-7069198, EBI-349317;
CC       Q8BUV3:Gphn; NbExp=4; IntAct=EBI-7069198, EBI-771218;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:22592841}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:P48167}. Cell junction, synapse
CC       {ECO:0000269|PubMed:19723286, ECO:0000269|PubMed:22592841}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:19723286}. Cell membrane
CC       {ECO:0000269|PubMed:12809985}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23415}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P48167}. Note=Retained in the cytoplasm
CC       upon heterologous expression by itself. Coexpression with GPHN
CC       promotes expression at the cell membrane. Coexpression with GLRA1,
CC       GLRA2 or GLRA3 promotes expression at the cell membrane.
CC       {ECO:0000250|UniProtKB:P20781}.
CC   -!- TISSUE SPECIFICITY: Detected in spinal cord, brain and brain stem,
CC       especially in the periolivary region, spinal nuclei, trigeminal
CC       nucleus, medulla oblongata, pons and midbrain. Detected in the
CC       inner plexiform layer of the retina (at protein level)
CC       (PubMed:22592841). High levels of expression in cortex,
CC       hippocampus, thalamus and cerebellum (PubMed:7920630). Detected in
CC       spinal cord (PubMed:7946325). {ECO:0000269|PubMed:22592841,
CC       ECO:0000269|PubMed:7920630, ECO:0000269|PubMed:7946325}.
CC   -!- DISEASE: Note=Defects in Glrb cause the spastic condition which is
CC       characterized by muscle rigidity, tremors, myoclonic jerks,
CC       pronounced startle reaction, abnormal gait and impaired righting
CC       ability (PubMed:7920630). Neurons from the ventral horn of the
CC       spinal cord display reduced inhibitory postsynaptic currents
CC       (PubMed:12809985). Likewise, hypoglossal neurons display a
CC       dramatic reduction in the frequency and amplitude of postsynaptic
CC       inhibitory currents (PubMed:16672662).
CC       {ECO:0000269|PubMed:12809985, ECO:0000269|PubMed:16672662,
CC       ECO:0000269|PubMed:7920630}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. GLRB sub-
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09399; AAA61874.1; -; mRNA.
DR   EMBL; X81202; CAA57076.1; -; mRNA.
DR   EMBL; X81201; CAA57075.1; -; Genomic_DNA.
DR   EMBL; L32594; AAA65966.1; -; Genomic_DNA.
DR   EMBL; AK083251; BAC38831.1; -; mRNA.
DR   EMBL; CH466547; EDL15445.1; -; Genomic_DNA.
DR   EMBL; BC037605; AAH37605.1; -; mRNA.
DR   CCDS; CCDS17424.1; -.
DR   PIR; S46459; S46459.
DR   RefSeq; NP_001268898.1; NM_001281969.2.
DR   RefSeq; NP_001332884.1; NM_001345955.1.
DR   RefSeq; NP_001332885.1; NM_001345956.1.
DR   RefSeq; NP_001332886.1; NM_001345957.1.
DR   RefSeq; NP_001332887.1; NM_001345958.1.
DR   RefSeq; NP_001332888.1; NM_001345959.1.
DR   RefSeq; NP_001332925.1; NM_001345996.1.
DR   RefSeq; NP_034428.2; NM_010298.6.
DR   UniGene; Mm.275639; -.
DR   ProteinModelPortal; P48168; -.
DR   SMR; P48168; -.
DR   IntAct; P48168; 5.
DR   MINT; MINT-4787310; -.
DR   STRING; 10090.ENSMUSP00000029654; -.
DR   iPTMnet; P48168; -.
DR   PhosphoSitePlus; P48168; -.
DR   PaxDb; P48168; -.
DR   PRIDE; P48168; -.
DR   Ensembl; ENSMUST00000029654; ENSMUSP00000029654; ENSMUSG00000028020.
DR   GeneID; 14658; -.
DR   KEGG; mmu:14658; -.
DR   UCSC; uc008pog.2; mouse.
DR   CTD; 2743; -.
DR   MGI; MGI:95751; Glrb.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P48168; -.
DR   KO; K05196; -.
DR   OMA; PRLKLPN; -.
DR   OrthoDB; EOG091G0805; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-MMU-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P48168; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   Bgee; ENSMUSG00000028020; -.
DR   CleanEx; MM_GLRB; -.
DR   ExpressionAtlas; P48168; baseline and differential.
DR   Genevisible; P48168; MM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; ISA:MGI.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:MGI.
DR   GO; GO:0016935; C:glycine-gated chloride channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008144; F:drug binding; IPI:MGI.
DR   GO; GO:0016934; F:extracellular-glycine-gated chloride channel activity; IMP:MGI.
DR   GO; GO:0016933; F:extracellular-glycine-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IMP:MGI.
DR   GO; GO:0007340; P:acrosome reaction; IMP:MGI.
DR   GO; GO:0007628; P:adult walking behavior; IMP:MGI.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0097112; P:gamma-aminobutyric acid receptor clustering; IGI:MGI.
DR   GO; GO:0006811; P:ion transport; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0050905; P:neuromuscular process; IMP:MGI.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0043200; P:response to amino acid; IBA:GO_Central.
DR   GO; GO:0060013; P:righting reflex; IMP:MGI.
DR   GO; GO:0001964; P:startle response; ISS:UniProtKB.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IMP:MGI.
DR   GO; GO:0007601; P:visual perception; IMP:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR008060; Glycine_rcpt_B.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF29; PTHR18945:SF29; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01677; GLYRBETA.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Complete proteome; Cytoplasm; Disease mutation;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    496       Glycine receptor subunit beta.
FT                                /FTId=PRO_0000000424.
FT   TOPO_DOM     23    268       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    269    290       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    291    295       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    296    316       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    317    327       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    328    348       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    349    474       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    475    495       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   REGION      247    253       Strychnine-binding.
FT                                {ECO:0000250|UniProtKB:O93430}.
FT   SITE        307    307       Important for obstruction of the ion pore
FT                                in the closed conformation.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   MOD_RES     391    391       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P20781}.
FT   CARBOHYD     54     54       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    242    242       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    183    197       {ECO:0000250|UniProtKB:P23415}.
FT   DISULFID    243    255       {ECO:0000250|UniProtKB:P23415}.
FT   VARIANT      74     83       NFKGIPVDVV -> TTMLDIQPMI (in spastic 1).
FT                                {ECO:0000269|PubMed:7946325}.
FT   VARIANT      84    496       Missing (in spastic 1).
FT                                {ECO:0000269|PubMed:7946325}.
FT   VARIANT     143    151       LFFANEKSA -> VSMSWIYNR (in spastic 2).
FT                                {ECO:0000269|PubMed:7946325}.
FT   VARIANT     152    496       Missing (in spastic 2).
FT                                {ECO:0000269|PubMed:7946325}.
FT   CONFLICT    365    365       A -> R (in Ref. 1; AAA61874).
FT                                {ECO:0000305}.
SQ   SEQUENCE   496 AA;  55951 MW;  554840A6DE9DE7BE CRC64;
     MKFSLAISFF ILMSLLFEDA CAKEKSSKKG KGKKKQYLCP SQQSPEDLAR VPPNSTSNIL
     NRLLVSYDPR IRPNFKGIPV DVVVNIFINS FGSIQETTMD YRVNIFLRQK WNDPRLKLPS
     DFRGSDALTV DPTMYKCLWK PDLFFANEKS ANFHDVTQEN ILLFIFRDGD VLVSMRLSIT
     LSCPLDLTLF PMDTQRCKMQ LESFGYTTDD LRFIWQSGDP VQLEKIALPQ FDIKKEDIEY
     GNCTKYYKGT GYYTCVEVIF TLRRQVGFYM MGVYAPTLLI VVLSWLSFWI NPDASAARVP
     LGIFSVLSLA SECTTLAAEL PKVSYVKALD VWLIACLLFG FASLVEYAVV QVMLNNPKRV
     EAEKARIAKA EQADGKGGNA AKKNTVNGTG TPVHISTLQV GETRCKKVCT SKSDLRSNDF
     SIVGSLPRDF ELSNYDCYGK PIEVNNGLGK PQAKNKKPPP AKPVIPTAAK RIDLYARALF
     PFCFLFFNVI YWSIYL
//
ID   GBRA4_HUMAN             Reviewed;         554 AA.
AC   P48169; Q8IYR7;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   20-DEC-2017, entry version 169.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-4;
DE   AltName: Full=GABA(A) receptor subunit alpha-4;
DE   Flags: Precursor;
GN   Name=GABRA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   TISSUE=Brain cortex;
RX   PubMed=8719416; DOI=10.1016/0922-4106(95)90072-1;
RA   Yang W., Drewe J.A., Lan N.C.;
RT   "Cloning and characterization of the human GABAA receptor alpha 4
RT   subunit: identification of a unique diazepam-insensitive binding
RT   site.";
RL   Eur. J. Pharmacol. 291:319-325(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57.
RX   PubMed=7607683; DOI=10.1016/0888-7543(95)80178-O;
RA   McLean P.J., Farb D.H., Russek S.J.;
RT   "Mapping of the alpha 4 subunit gene (GABRA4) to human chromosome 4
RT   defines an alpha 2-alpha 4-beta 1-gamma 1 gene cluster: further
RT   evidence that modern GABAA receptor gene clusters are derived from an
RT   ancestral cluster.";
RL   Genomics 26:580-586(1995).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-516.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- INDUCTION: The alpha4 beta2 gamma 2L receptor is not repressed by
CC       diazepam. {ECO:0000269|PubMed:8719416}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA4 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Forbidden fruit - Issue
CC       56 of March 2005;
CC       URL="https://web.expasy.org/spotlight/back_issues/056";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U30461; AAB52519.1; -; mRNA.
DR   EMBL; AK090780; BAG52228.1; -; mRNA.
DR   EMBL; AC107383; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW93029.1; -; Genomic_DNA.
DR   EMBL; BC035055; AAH35055.1; -; mRNA.
DR   EMBL; U20166; AAA74743.1; -; Genomic_DNA.
DR   CCDS; CCDS3473.1; -.
DR   PIR; G01928; G01928.
DR   RefSeq; NP_000800.2; NM_000809.3.
DR   RefSeq; NP_001191195.1; NM_001204266.1.
DR   RefSeq; NP_001191196.1; NM_001204267.1.
DR   UniGene; Hs.248112; -.
DR   ProteinModelPortal; P48169; -.
DR   SMR; P48169; -.
DR   BioGrid; 108831; 3.
DR   IntAct; P48169; 1.
DR   STRING; 9606.ENSP00000264318; -.
DR   BindingDB; P48169; -.
DR   ChEMBL; CHEMBL2472; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB06579; Adipiplon.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01351; Amobarbital.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB01352; Aprobarbital.
DR   DrugBank; DB01483; Barbital.
DR   DrugBank; DB01496; Barbituric acid derivative.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00237; Butabarbital.
DR   DrugBank; DB00241; Butalbital.
DR   DrugBank; DB01353; Butethal.
DR   DrugBank; DB00475; Chlordiazepoxide.
DR   DrugBank; DB00349; Clobazam.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00628; Clorazepate.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB01215; Estazolam.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00189; Ethchlorvynol.
DR   DrugBank; DB00292; Etomidate.
DR   DrugBank; DB01205; Flumazenil.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB05087; Ganaxolone.
DR   DrugBank; DB01437; Glutethimide.
DR   DrugBank; DB00801; Halazepam.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01354; Heptabarbital.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00186; Lorazepam.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00463; Metharbital.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00849; Methylphenobarbital.
DR   DrugBank; DB01107; Methyprylon.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB00842; Oxazepam.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB01588; Prazepam.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00306; Talbutal.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB11582; Thiocolchicoside.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00273; Topiramate.
DR   DrugBank; DB00897; Triazolam.
DR   iPTMnet; P48169; -.
DR   PhosphoSitePlus; P48169; -.
DR   BioMuta; GABRA4; -.
DR   DMDM; 206729865; -.
DR   PaxDb; P48169; -.
DR   PeptideAtlas; P48169; -.
DR   PRIDE; P48169; -.
DR   TopDownProteomics; P48169; -.
DR   DNASU; 2557; -.
DR   Ensembl; ENST00000264318; ENSP00000264318; ENSG00000109158.
DR   GeneID; 2557; -.
DR   KEGG; hsa:2557; -.
DR   CTD; 2557; -.
DR   DisGeNET; 2557; -.
DR   EuPathDB; HostDB:ENSG00000109158.10; -.
DR   GeneCards; GABRA4; -.
DR   HGNC; HGNC:4078; GABRA4.
DR   MIM; 137141; gene.
DR   neXtProt; NX_P48169; -.
DR   OpenTargets; ENSG00000109158; -.
DR   PharmGKB; PA28492; -.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; P48169; -.
DR   KO; K05175; -.
DR   OMA; PNPFSHA; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; P48169; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   Reactome; R-HSA-977441; GABA A receptor activation.
DR   GeneWiki; GABRA4; -.
DR   GenomeRNAi; 2557; -.
DR   PRO; PR:P48169; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109158; -.
DR   CleanEx; HS_GABRA4; -.
DR   ExpressionAtlas; P48169; baseline and differential.
DR   Genevisible; P48169; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc.
DR   GO; GO:2001023; P:regulation of response to drug; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005434; GABBAa4_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01617; GABAARALPHA4.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     35       {ECO:0000255}.
FT   CHAIN        36    554       Gamma-aminobutyric acid receptor subunit
FT                                alpha-4.
FT                                /FTId=PRO_0000000441.
FT   TOPO_DOM     36    258       Extracellular. {ECO:0000305}.
FT   TRANSMEM    259    280       Helical. {ECO:0000305}.
FT   TRANSMEM    285    306       Helical. {ECO:0000305}.
FT   TRANSMEM    318    340       Helical. {ECO:0000305}.
FT   TOPO_DOM    341    523       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    524    543       Helical. {ECO:0000305}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    172    186       {ECO:0000250}.
FT   VARIANT      19     19       A -> T (in dbSNP:rs16859837).
FT                                /FTId=VAR_046552.
FT   VARIANT      26     26       L -> M (in dbSNP:rs2229940).
FT                                /FTId=VAR_046553.
FT   VARIANT     516    516       S -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036032.
FT   CONFLICT    316    316       A -> L (in Ref. 1; AAB52519).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       N -> D (in Ref. 1; AAB52519).
FT                                {ECO:0000305}.
FT   CONFLICT    463    463       Y -> H (in Ref. 1; AAB52519).
FT                                {ECO:0000305}.
SQ   SEQUENCE   554 AA;  61623 MW;  B159F9934FB02390 CRC64;
     MVSAKKVPAI ALSAGVSFAL LRFLCLAVCL NESPGQNQKE EKLCTENFTR ILDSLLDGYD
     NRLRPGFGGP VTEVKTDIYV TSFGPVSDVE MEYTMDVFFR QTWIDKRLKY DGPIEILRLN
     NMMVTKVWTP DTFFRNGKKS VSHNMTAPNK LFRIMRNGTI LYTMRLTISA ECPMRLVDFP
     MDGHACPLKF GSYAYPKSEM IYTWTKGPEK SVEVPKESSS LVQYDLIGQT VSSETIKSIT
     GEYIVMTVYF HLRRKMGYFM IQTYIPCIMT VILSQVSFWI NKESVPARTV FGITTVLTMT
     TLSISARHSL PKVSYATAMD WFIAVCFAFV FSALIEFAAV NYFTNIQMEK AKRKTSKPPQ
     EVPAAPVQRE KHPEAPLQNT NANLNMRKRT NALVHSESDV GNRTEVGNHS SKSSTVVQES
     SKGTPRSYLA SSPNPFSRAN AAETISAARA LPSASPTSIR TGYMPRKASV GSASTRHVFG
     SRLQRIKTTV NTIGATGKLS ATPPPSAPPP SGSGTSKIDK YARILFPVTF GAFNMVYWVV
     YLSKDTMEKS ESLM
//
ID   ACH1_CAEEL              Reviewed;         498 AA.
AC   P48180; Q8I932;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   25-OCT-2017, entry version 136.
DE   RecName: Full=Acetylcholine receptor subunit alpha-type acr-16;
DE   Flags: Precursor;
GN   Name=acr-16; Synonyms=Ce21; ORFNames=F25G6.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), AND FUNCTION.
RC   STRAIN=Bristol N2;
RX   PubMed=8627624; DOI=10.1006/jmbi.1996.0248;
RA   Ballivet M., Alliod C., Bertrand S., Bertrand D.;
RT   "Nicotinic acetylcholine receptors in the nematode Caenorhabditis
RT   elegans.";
RL   J. Mol. Biol. 258:261-269(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   STRAIN=Bristol N2;
RA   Kohara Y., Shin-i T., Suzuki Y., Sugano S., Thierry-Mieg D.,
RA   Thierry-Mieg J.;
RT   "The Caenorhabditis elegans transcriptome project, a complementary
RT   view of the genome.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15917232; DOI=10.1074/jbc.M502818200;
RA   Touroutine D., Fox R.M., Von Stetina S.E., Burdina A.,
RA   Miller D.M. III, Richmond J.E.;
RT   "acr-16 encodes an essential subunit of the levamisole-resistant
RT   nicotinic receptor at the Caenorhabditis elegans neuromuscular
RT   junction.";
RL   J. Biol. Chem. 280:27013-27021(2005).
RN   [5]
RP   SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15944127; DOI=10.1016/j.neuron.2005.04.010;
RA   Francis M.M., Evans S.P., Jensen M., Madsen D.M., Mancuso J.,
RA   Norman K.R., Maricq A.V.;
RT   "The Ror receptor tyrosine kinase CAM-1 is required for ACR-16-
RT   mediated synaptic transmission at the C. elegans neuromuscular
RT   junction.";
RL   Neuron 46:581-594(2005).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=17128266; DOI=10.1038/nn1810;
RA   Sieburth D., Madison J.M., Kaplan J.M.;
RT   "PKC-1 regulates secretion of neuropeptides.";
RL   Nat. Neurosci. 10:49-57(2007).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane (By similarity). A subunit of the levamisole-insensitive
CC       nicotinic receptor. {ECO:0000250, ECO:0000269|PubMed:15917232,
CC       ECO:0000269|PubMed:8627624}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:15944127}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:15944127}. Cell membrane
CC       {ECO:0000269|PubMed:15944127}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15944127}. Note=The cam-1 protein is required
CC       for correct localization.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=a;
CC         IsoId=P48180-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=P48180-2; Sequence=VSP_036472;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the body wall muscle.
CC       {ECO:0000269|PubMed:15917232}.
CC   -!- DISRUPTION PHENOTYPE: Uncoordinated movement and reduced body wall
CC       muscle currents. These phenotypes are probably related.
CC       {ECO:0000269|PubMed:15944127, ECO:0000269|PubMed:17128266}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83887; CAA58764.1; -; mRNA.
DR   EMBL; FO080489; CCD64102.1; -; Genomic_DNA.
DR   EMBL; FO080489; CCD64103.1; -; Genomic_DNA.
DR   EMBL; AY523511; AAR98633.1; -; mRNA.
DR   PIR; S68588; S68588.
DR   RefSeq; NP_505207.1; NM_072806.4. [P48180-1]
DR   UniGene; Cel.18045; -.
DR   ProteinModelPortal; P48180; -.
DR   STRING; 6239.F25G6.3a; -.
DR   PaxDb; P48180; -.
DR   EnsemblMetazoa; F25G6.3; F25G6.3; WBGene00000055. [P48180-1]
DR   GeneID; 179235; -.
DR   KEGG; cel:CELE_F25G6.3; -.
DR   UCSC; F25G6.3a.1; c. elegans.
DR   CTD; 179235; -.
DR   WormBase; F25G6.3; CE09639; WBGene00000055; acr-16. [P48180-1]
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; P48180; -.
DR   KO; K05312; -.
DR   OMA; IAEYFAT; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P48180; -.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   PRO; PR:P48180; -.
DR   Proteomes; UP000001940; Chromosome V.
DR   Bgee; WBGene00000055; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0042995; C:cell projection; IDA:WormBase.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:WormBase.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    498       Acetylcholine receptor subunit alpha-type
FT                                acr-16.
FT                                /FTId=PRO_0000000395.
FT   TOPO_DOM     20    230       Extracellular. {ECO:0000255}.
FT   TRANSMEM    231    252       Helical. {ECO:0000255}.
FT   TRANSMEM    261    279       Helical. {ECO:0000255}.
FT   TRANSMEM    295    314       Helical. {ECO:0000255}.
FT   TOPO_DOM    315    472       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    473    493       Helical. {ECO:0000255}.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     93     93       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    147    161       {ECO:0000250}.
FT   DISULFID    211    212       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   VAR_SEQ     470    480       VDRLCLYVFTI -> RTYISRKIENF (in isoform
FT                                b). {ECO:0000303|PubMed:8627624}.
FT                                /FTId=VSP_036472.
SQ   SEQUENCE   498 AA;  57169 MW;  E463ABB40AC9FA82 CRC64;
     MSVCTLLISC AILAAPTLGS LQERRLYEDL MRNYNNLERP VANHSEPVTV HLKVALQQII
     DVDEKNQVVY VNAWLDYTWN DYNLVWDKAE YGNITDVRFP AGKIWKPDVL LYNSVDTNFD
     STYQTNMIVY STGLVHWVPP GIFKISCKID IQWFPFDEQK CFFKFGSWTY DGYKLDLQPA
     TGGFDISEYI SNGEWALPLT TVERNEKFYD CCPEPYPDVH FYLHMRRRTL YYGFNLIMPC
     ILTTLMTLLG FTLPPDAGEK ITLQITVLLS ICFFLSIVSE MSPPTSEAVP LLGIFFTCCM
     IVVTASTVFT VYVLNLHYRT PETHDMGPWT RNLLLYWIPW ILRMKRPGHN LTYASLPSLF
     STKPNRHSES LIRNIKDNEH SLSRANSFDA DCRLNQYIMT QSVSNGLTSL GSIPSTMISS
     NGTTTDVSQQ ATLLILHRIY HELKIVTKRM IEGDKEEQAC NNWKFAAMVV DRLCLYVFTI
     FIIVSTIGIF WSAPYLVA
//
ID   ACH2_CAEEL              Reviewed;         493 AA.
AC   P48181; O02520; O02600; Q94014;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   22-NOV-2017, entry version 135.
DE   RecName: Full=Acetylcholine receptor subunit beta-type unc-29;
DE   AltName: Full=Uncoordinated protein 29;
DE   Flags: Precursor;
GN   Name=unc-29; ORFNames=T08G11.5;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Bristol N2;
RX   PubMed=8627624; DOI=10.1006/jmbi.1996.0248;
RA   Ballivet M., Alliod C., Bertrand S., Bertrand D.;
RT   "Nicotinic acetylcholine receptors in the nematode Caenorhabditis
RT   elegans.";
RL   J. Mol. Biol. 258:261-269(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9221782;
RA   Fleming J.T., Squire M.D., Barnes T.M., Tornoe C., Matsuda K.,
RA   Ahnn J., Fire A., Sulston J.E., Barnard E.A., Sattelle D.B.,
RA   Lewis J.A.;
RT   "Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and
RT   unc-38 encode functional nicotinic acetylcholine receptor subunits.";
RL   J. Neurosci. 17:5843-5857(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION, INTERACTION WITH LEV-1, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=15990870; DOI=10.1038/sj.emboj.7600741;
RA   Gottschalk A., Almedom R.B., Schedletzky T., Anderson S.D.,
RA   Yates J.R. III, Schafer W.R.;
RT   "Identification and characterization of novel nicotinic receptor-
RT   associated proteins in Caenorhabditis elegans.";
RL   EMBO J. 24:2566-2578(2005).
RN   [5]
RP   INTERACTION WITH OIG-4.
RX   PubMed=21252855; DOI=10.1038/emboj.2010.355;
RA   Rapti G., Richmond J., Bessereau J.L.;
RT   "A single immunoglobulin-domain protein required for clustering
RT   acetylcholine receptors in C. elegans.";
RL   EMBO J. 30:706-718(2011).
CC   -!- FUNCTION: Non-alpha subunit of nicotinic acetylcholine receptor
CC       (nAChR). Involved in nAChR sensitivity to nicotine and levasimole.
CC       {ECO:0000269|PubMed:15990870}.
CC   -!- SUBUNIT: Interacts with lev-1 (PubMed:15990870). Component of
CC       nicotinic acetylcholine receptor composed of 2 non-alpha subunits
CC       lev-1 and unc-29, and 3 alpha subunits unc-38, unc-63 and lev-8
CC       (PubMed:15990870). Interacts with oig-4 (PubMed:21252855).
CC       {ECO:0000269|PubMed:15990870, ECO:0000269|PubMed:21252855}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:15990870}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:15990870}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Co-localizes with unc-38 and lev-1 at nerve
CC       cord synapses. {ECO:0000269|PubMed:15990870}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes a resistance
CC       to nicotine-mediated paralysis and small impairment in mobility.
CC       {ECO:0000269|PubMed:15990870}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83888; CAA58765.1; -; mRNA.
DR   EMBL; U81144; AAB39358.1; -; Genomic_DNA.
DR   EMBL; Z80220; CAB02308.1; -; Genomic_DNA.
DR   PIR; S68587; S68587.
DR   PIR; T24695; T24695.
DR   RefSeq; NP_492399.1; NM_059998.4.
DR   UniGene; Cel.16649; -.
DR   ProteinModelPortal; P48181; -.
DR   BioGrid; 38136; 1.
DR   IntAct; P48181; 141.
DR   MINT; MINT-3383569; -.
DR   STRING; 6239.T08G11.5.2; -.
DR   DrugBank; DB00848; Levamisole.
DR   EPD; P48181; -.
DR   PaxDb; P48181; -.
DR   EnsemblMetazoa; T08G11.5.1; T08G11.5.1; WBGene00006765.
DR   EnsemblMetazoa; T08G11.5.2; T08G11.5.2; WBGene00006765.
DR   GeneID; 172703; -.
DR   KEGG; cel:CELE_T08G11.5; -.
DR   UCSC; T08G11.5; c. elegans.
DR   CTD; 172703; -.
DR   WormBase; T08G11.5; CE13451; WBGene00006765; unc-29.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; P48181; -.
DR   KO; K05312; -.
DR   OMA; RWMMEIP; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P48181; -.
DR   Reactome; R-CEL-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   PRO; PR:P48181; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00006765; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043005; C:neuron projection; IDA:WormBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:WormBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:WormBase.
DR   GO; GO:0045202; C:synapse; IDA:WormBase.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0040011; P:locomotion; IMP:WormBase.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IDA:WormBase.
DR   GO; GO:0014057; P:positive regulation of acetylcholine secretion, neurotransmission; IMP:UniProtKB.
DR   GO; GO:0006937; P:regulation of muscle contraction; IMP:UniProtKB.
DR   GO; GO:0046662; P:regulation of oviposition; IMP:WormBase.
DR   GO; GO:0043051; P:regulation of pharyngeal pumping; IGI:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    493       Acetylcholine receptor subunit beta-type
FT                                unc-29.
FT                                /FTId=PRO_0000000396.
FT   TOPO_DOM     27    232       Extracellular. {ECO:0000255}.
FT   TRANSMEM    233    254       Helical. {ECO:0000255}.
FT   TRANSMEM    262    280       Helical. {ECO:0000255}.
FT   TRANSMEM    296    317       Helical. {ECO:0000255}.
FT   TOPO_DOM    318    445       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    446    466       Helical. {ECO:0000255}.
FT   CARBOHYD     25     25       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    155    169       {ECO:0000250}.
FT   CONFLICT    355    355       S -> T (in Ref. 1; CAA58765).
FT                                {ECO:0000305}.
SQ   SEQUENCE   493 AA;  56497 MW;  EBE1D5CC40D25EB6 CRC64;
     MRTNRLSWIL VLSVVIFLVI INTINASDDE ERLMVDVFRG YNSLIQPVRN SSELPLIVKM
     ALQLVLLINV DEKDQVMHTN VWLTLQWHDF QMKWNPVNYG EIKQIRVSPD KVWLPDIVLF
     NNADGNYEVS FMCNVVINHK GDMLWVPPAI YKSSCIIDVE FFPFDEQVCT LVFGSWTYNE
     NEIKLEFVQA ELVDVSEYSA SSIWDVIDVP ASLVNKRSRI EFQVRIRRKT LFYTVVLIIP
     TVLMAFLSMA VFFLPTDSGE KITLTISVLL SIVVFLLLVS KILPPTSSTI PLMAKYLLLT
     FVLNVITILV TVIIINVYFR GPRTHRMPQW VRVVFLQFLP KLVCMKRPKS ASERSAVRSG
     MAQLPGVGQF TLSPSAHHPL CPSADDRTTT IRNTASNETS AYYPLSTDAL RAIDAIEYIT
     EHLKRDEQHK SFRDDWKYVA MIIDRLLLYV FFGITVGGTC GILFSAPHVF QRIDQQEMLD
     RLKEKYDTAS NIP
//
ID   ACR2_CAEEL              Reviewed;         575 AA.
AC   P48182;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   22-NOV-2017, entry version 137.
DE   RecName: Full=Acetylcholine receptor subunit beta-type acr-2;
DE   Flags: Precursor;
GN   Name=acr-2; ORFNames=K11G12.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH NICOTINIC
RP   ACETYLCHOLINE RECEPTOR.
RC   STRAIN=Bristol N2;
RX   PubMed=8581398;
RA   Squire M.D., Tornoe C.A., Baylis H.A., Fleming J.T., Barnard E.A.,
RA   Sattelle D.B.;
RT   "Molecular cloning and functional co-expression of a Caenorhabditis
RT   elegans nicotinic acetylcholine receptor subunit (acr-2).";
RL   Recept. Channels 3:107-115(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, INTERACTION WITH NICOTINIC ACETYLCHOLINE RECEPTOR, TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF VAL-309.
RX   PubMed=20027209; DOI=10.1371/journal.pbio.1000265;
RA   Jospin M., Qi Y.B., Stawicki T.M., Boulin T., Schuske K.R.,
RA   Horvitz H.R., Bessereau J.L., Jorgensen E.M., Jin Y.;
RT   "A neuronal acetylcholine receptor regulates the balance of muscle
RT   excitation and inhibition in Caenorhabditis elegans.";
RL   PLoS Biol. 7:E1000265-E1000265(2009).
RN   [4]
RP   FUNCTION, AND MUTAGENESIS OF VAL-309.
RX   PubMed=23658528; DOI=10.1371/journal.pgen.1003472;
RA   Stawicki T.M., Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Neuropeptides function in a homeostatic manner to modulate
RT   excitation-inhibition imbalance in C. elegans.";
RL   PLoS Genet. 9:E1003472-E1003472(2013).
RN   [5]
RP   FUNCTION.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Non-alpha subunit of nicotinic acetylcholine receptor
CC       (nAChR) (PubMed:8581398, PubMed:20027209). Acts in cholinergic
CC       motoneurons to regulate presynaptic neurotransmitter release,
CC       thereby ensuring normal level of excitation of cholinergic
CC       motoneurons during locomotion (PubMed:20027209, PubMed:23658528,
CC       PubMed:27782882). {ECO:0000269|PubMed:20027209,
CC       ECO:0000269|PubMed:23658528, ECO:0000269|PubMed:8581398}.
CC   -!- SUBUNIT: Component of nicotinic acetylcholine receptor. In
CC       cholinergic motoneurons, composed of 2 non-alpha subunits acr-2
CC       and acr-3, and 3 alpha subunits unc-38, unc-63 and acr-12.
CC       {ECO:0000269|PubMed:20027209, ECO:0000269|PubMed:8581398}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q23022}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q23022}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in cholinergic ventral
CC       cord motoneurons of the VA, VB, DA and DB classes but not AS and
CC       VC classes. Expressed in PVQ and DVC neurons in the tail.
CC       {ECO:0000269|PubMed:20027209}.
CC   -!- DEVELOPMENTAL STAGE: Expressed from L1 larval stage through
CC       adults. {ECO:0000269|PubMed:20027209}.
CC   -!- DISRUPTION PHENOTYPE: Locomotion is slower. Moderately resistant
CC       to paralysis induced by acetylcholine esterase inhibitor aldicarb
CC       but sensitivity to acetylcholine agonist levamisole is normal.
CC       Reduced both cholinergic and GABAergic motoneuron activities
CC       characterized by a reduction in miniature postsynaptic currents in
CC       muscles. {ECO:0000269|PubMed:20027209}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X86403; CAA60157.1; -; mRNA.
DR   EMBL; FO081325; CCD70794.1; -; Genomic_DNA.
DR   PIR; S57648; S57648.
DR   RefSeq; NP_509128.1; NM_076727.5.
DR   UniGene; Cel.18149; -.
DR   ProteinModelPortal; P48182; -.
DR   SMR; P48182; -.
DR   STRING; 6239.K11G12.2; -.
DR   TCDB; 1.A.9.1.2; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; P48182; -.
DR   EnsemblMetazoa; K11G12.2; K11G12.2; WBGene00000042.
DR   GeneID; 180936; -.
DR   KEGG; cel:CELE_K11G12.2; -.
DR   UCSC; K11G12.2; c. elegans.
DR   CTD; 180936; -.
DR   WormBase; K11G12.2; CE07380; WBGene00000042; acr-2.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; P48182; -.
DR   KO; K05312; -.
DR   OMA; PHVFDFV; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; P48182; -.
DR   Reactome; R-CEL-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   PRO; PR:P48182; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00000042; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043005; C:neuron projection; IDA:WormBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IDA:WormBase.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:WormBase.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0040012; P:regulation of locomotion; IMP:UniProtKB.
DR   GO; GO:0006937; P:regulation of muscle contraction; IMP:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    575       Acetylcholine receptor subunit beta-type
FT                                acr-2.
FT                                /FTId=PRO_0000000398.
FT   TOPO_DOM     21    270       Extracellular. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical. {ECO:0000255}.
FT   TRANSMEM    331    351       Helical. {ECO:0000255}.
FT   TOPO_DOM    352    527       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    528    548       Helical. {ECO:0000255}.
FT   CARBOHYD     41     41       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     42     42       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    131    131       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    185    199       {ECO:0000250}.
FT   MUTAGEN     309    309       V->M: In n2420; constitutively active.
FT                                Spontaneous convulsions and shrinking
FT                                behavior in response to touch.
FT                                Convulsions are suppressed in an unc-74,
FT                                unc-50, unc-38 or unc-63 mutant
FT                                background. Enhanced neurotransmitter
FT                                release by cholinergic motoneurons and
FT                                reduced neurotransmitter release by
FT                                GABAergic motoneurons. Increases
FT                                neuropeptide flp-18 expression in
FT                                cholinergic B-type motor neurons.
FT                                Increases sensitivity to paralysis
FT                                induced by acetylcholine esterase
FT                                inhibitor aldicarb or acetylcholine
FT                                agonist levamisole in L3-L4 larvae and
FT                                adults. {ECO:0000269|PubMed:20027209,
FT                                ECO:0000269|PubMed:23658528}.
SQ   SEQUENCE   575 AA;  65595 MW;  7EB24296100EEB05 CRC64;
     MKKTVKILLI LITVFLKVHC NGGHDDEAAD FLSHTNIDDP NNSSDPNKNS DQGDTMGEDE
     DRLVIDLFRE YNFLIRPVKN VSSPPVVVDF GVAMILLINV DEKNQILQTN VWLTMKWNDF
     QLAWNPAEYG NISNLHVPSD RVWLPDIVLF NNADGNYEVS FKSNVFVDHH GDVTWVPPAM
     FKSSCRIDVE WFPFDEQCCT LVFGSWTYNS EEVRLHWYNN IQAVQLHDYS YSGIWDVIDV
     PGQLVHKPDL KENKMVFNVV IRRKTLFYTV ILIIPTVLMA FLSVMAFYLP VDSGEKVSLT
     ISLLLALVVF LLLVSKILPP TSNIPLMGKY LLLAFVLNIT AVVGTVVIVN IYFRSALSHK
     MPTWVRKVFL EFLPHLLVMK RPERIPIFNG YFVEEYCASE IFDASLVMPS MTATMLPFLQ
     VTTNLKAASS TSSGQSSEHH ENCSKWKKRL SIRMSKRRAP RARLDDDSED IIDDTNGNHV
     DSLQEKISKE MKTTVEAIAY IAEHMKREMS LKKMRDDWKY VAMVLDRLIL LIFFGVTLGG
     TLGIICSAPH VFDFVDQEAI ISKLNAKYLP SDMYS
//
ID   ACHA6_CHICK             Reviewed;         494 AA.
AC   P49581; Q90709;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   25-OCT-2017, entry version 120.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-6;
DE   Flags: Precursor;
GN   Name=CHRNA6;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=White leghorn;
RA   Alliod C., Ballivet M.;
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9203638;
RA   Gerzanich V., Kuryatov A., Anand R., Lindstrom J.;
RT   "'Orphan' alpha6 nicotinic AChR subunit can form a functional
RT   heteromeric acetylcholine receptor.";
RL   Mol. Pharmacol. 51:320-327(1997).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and non-alpha (also called beta). A functional
CC       receptor seems to consist of two alpha-chains and three non-alpha
CC       chains.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       6/CHRNA6 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83889; CAA58766.1; -; mRNA.
DR   EMBL; U48860; AAA92122.1; -; mRNA.
DR   PIR; T09289; T09289.
DR   RefSeq; NP_990695.1; NM_205364.1.
DR   UniGene; Gga.340; -.
DR   ProteinModelPortal; P49581; -.
DR   STRING; 9031.ENSGALP00000036997; -.
DR   PaxDb; P49581; -.
DR   PRIDE; P49581; -.
DR   GeneID; 396321; -.
DR   KEGG; gga:396321; -.
DR   CTD; 8973; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; P49581; -.
DR   KO; K04808; -.
DR   PhylomeDB; P49581; -.
DR   PRO; PR:P49581; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32    494       Neuronal acetylcholine receptor subunit
FT                                alpha-6.
FT                                /FTId=PRO_0000000364.
FT   TOPO_DOM     32    240       Extracellular. {ECO:0000255}.
FT   TRANSMEM    241    265       Helical. {ECO:0000255}.
FT   TRANSMEM    272    290       Helical. {ECO:0000255}.
FT   TRANSMEM    306    327       Helical. {ECO:0000255}.
FT   TOPO_DOM    328    468       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    469    489       Helical. {ECO:0000255}.
FT   CARBOHYD     54     54       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    171    171       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    158    172       {ECO:0000250}.
FT   CONFLICT     97     97       R -> W (in Ref. 2; CAA58766/AAA92122).
FT                                {ECO:0000305}.
SQ   SEQUENCE   494 AA;  57495 MW;  195C9B2D27B86025 CRC64;
     MHPKRRLCWC LPASGAWAFM LTSLIADTTA CESEERLFHK LFSRYNQFIR PVENVSDPVT
     VHFELAITQL TNVDEVNQIM ETNLWLRHIW NDYKLRRDPR EYDGIEFVRV PADKIWKPDI
     VLYNNAVGDF QVEGKTKALL RYDGMITWTP PAIFKSSCPM DITFFPFDHQ NCSLKFGSWT
     YDKAKIDLLI IGSKVDMNEF WENSEWEIVD ASGYKHDIKY NCCEEIYTDI TYSFYIRRLP
     MFYTINLIIP CLFISFLTVL VFYLPSDCGE KVTLCISVLL SLTVFLLVIT ETIPSTSLVI
     PLVGEYLLFT MIFVTLSIVI TVFVLNIHYR TPTTHTMPKW VKTVFLSLLP KVLLMQRPLE
     QEKKNISKKT KKGSAKTSGK SKHSKHKDNK LHKEQRCCHC DKADDLTSTR RSRLSHQSLK
     WMAEHTEYSP EVKDVINNVQ FIAENMKSQN ETKEVEDDWK YVAMVIDRVF LWVFIILCVF
     GTAGLFIQPL IADT
//
ID   P2RX2_RAT               Reviewed;         472 AA.
AC   P49653; O54868;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   22-NOV-2017, entry version 140.
DE   RecName: Full=P2X purinoceptor 2;
DE            Short=P2X2;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7523952; DOI=10.1038/371519a0;
RA   Brake A.J., Wagenbach M.J., Julius D.;
RT   "New structural motif for ligand-gated ion channels defined by an
RT   ionotropic ATP receptor.";
RL   Nature 371:519-523(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=9119082; DOI=10.1016/S0014-5793(97)00128-2;
RA   Braendle U., Spielmanns P., Osteroth R., Sim J., Surprenant A.,
RA   Buell G., Ruppersberg J.P., Plinkert P.K., Zenner H.P., Glowatzki E.;
RT   "Desensitization of the P2X(2) receptor controlled by alternative
RT   splicing.";
RL   FEBS Lett. 404:294-298(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 326-340, AND ALTERNATIVE SPLICING.
RC   STRAIN=Sprague-Dawley, and Wistar; TISSUE=Vas deferens;
RX   PubMed=7542879; DOI=10.1006/bbrc.1995.1998;
RA   Housley G.D., Greenwood D., Bennett T., Ryan A.F.;
RT   "Identification of a short form of the P2xR1-purinoceptor subunit
RT   produced by alternative splicing in the pituitary and cochlea.";
RL   Biochem. Biophys. Res. Commun. 212:501-508(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ISOFORM P2RX2-3).
RC   STRAIN=Sprague-Dawley; TISSUE=Pituitary;
RA   Koshimizu T., Tomic M., van Goor F., Stojilkovic S.S.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   DISULFIDE BOND.
RX   PubMed=12921863; DOI=10.1016/S0014-2999(03)02038-7;
RA   Nakazawa K., Ojima H., Ishii-Nozawa R., Takeuchi K., Ohno Y.;
RT   "Intracellular disulfide bond that affects ATP responsiveness of
RT   P2X(2) receptor/channel.";
RL   Eur. J. Pharmacol. 474:205-208(2003).
CC   -!- FUNCTION: Ion channel gated by extracellular ATP involved in a
CC       variety of cellular responses, such as excitatory postsynaptic
CC       responses in sensory neurons, neuromuscular junctions (NMJ)
CC       formation, hearing, perception of taste and peristalsis. In the
CC       inner ear, regulates sound transduction and auditory
CC       neurotransmission, outer hair cell electromotility, inner ear gap
CC       junctions, and K(+) recycling. Mediates synaptic transmission
CC       between neurons and from neurons to smooth muscle (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homotrimer and heterotrimer; functional P2XRs are
CC       organized as homomeric and heteromeric trimers. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P51577:P2rx4; NbExp=4; IntAct=EBI-9511543, EBI-9511617;
CC       P51579:P2rx6; NbExp=4; IntAct=EBI-9511543, EBI-9511515;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=P2RX2-1;
CC         IsoId=P49653-1; Sequence=Displayed;
CC       Name=P2RX2-2;
CC         IsoId=P49653-2; Sequence=VSP_004501, VSP_004502;
CC       Name=P2RX2-3;
CC         IsoId=P49653-3; Sequence=VSP_004500;
CC   -!- TISSUE SPECIFICITY: High levels in pituitary and vas deferens.
CC       Lower extent in spinal cord, bladder, brain, adrenal, testis,
CC       sensory epithelia from the inner ear.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U14414; AAA50756.1; -; mRNA.
DR   EMBL; Y09910; CAA71046.1; -; Genomic_DNA.
DR   EMBL; L43511; AAC42067.1; -; mRNA.
DR   EMBL; AF020756; AAB94570.1; -; mRNA.
DR   PIR; S50859; S50859.
DR   RefSeq; NP_446108.2; NM_053656.2. [P49653-1]
DR   UniGene; Rn.88799; -.
DR   SMR; P49653; -.
DR   DIP; DIP-48329N; -.
DR   IntAct; P49653; 2.
DR   STRING; 10116.ENSRNOP00000053533; -.
DR   BindingDB; P49653; -.
DR   ChEMBL; CHEMBL2135; -.
DR   GuidetoPHARMACOLOGY; 479; -.
DR   TCDB; 1.A.7.1.2; the atp-gated p2x receptor cation channel (p2x receptor) family.
DR   iPTMnet; P49653; -.
DR   PhosphoSitePlus; P49653; -.
DR   PaxDb; P49653; -.
DR   PRIDE; P49653; -.
DR   Ensembl; ENSRNOT00000056693; ENSRNOP00000053532; ENSRNOG00000037456. [P49653-3]
DR   GeneID; 114115; -.
DR   KEGG; rno:114115; -.
DR   UCSC; RGD:620251; rat. [P49653-1]
DR   CTD; 22953; -.
DR   RGD; 620251; P2rx2.
DR   eggNOG; ENOG410IGJK; Eukaryota.
DR   eggNOG; ENOG410ZQ3M; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; P49653; -.
DR   KO; K05216; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; P49653; -.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-418346; Platelet homeostasis.
DR   PRO; PR:P49653; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000037456; -.
DR   ExpressionAtlas; P49653; baseline and differential.
DR   Genevisible; P49653; RN.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0016021; C:integral component of membrane; IDA:RGD.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0005622; C:intracellular; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0046870; F:cadmium ion binding; IDA:RGD.
DR   GO; GO:0050897; F:cobalt ion binding; IDA:RGD.
DR   GO; GO:0005507; F:copper ion binding; IDA:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:RGD.
DR   GO; GO:0045340; F:mercury ion binding; IDA:RGD.
DR   GO; GO:0016151; F:nickel cation binding; IDA:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IMP:RGD.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0003029; P:detection of hypoxic conditions in blood by carotid body chemoreceptor signaling; ISO:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0030432; P:peristalsis; ISO:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:RGD.
DR   GO; GO:0033198; P:response to ATP; ISO:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0010033; P:response to organic substance; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0050909; P:sensory perception of taste; ISO:RGD.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0014832; P:urinary bladder smooth muscle contraction; ISO:RGD.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003045; P2X2_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01309; P2X2RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    472       P2X purinoceptor 2.
FT                                /FTId=PRO_0000161550.
FT   TOPO_DOM      1     34       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     35     52       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     53    326       Extracellular. {ECO:0000255}.
FT   TRANSMEM    327    347       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    348    472       Cytoplasmic. {ECO:0000255}.
FT   REGION      309    322       Pore-forming motif. {ECO:0000255}.
FT   COMPBIAS    300    305       Poly-Thr.
FT   COMPBIAS    392    395       Poly-Pro.
FT   CARBOHYD    182    182       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    239    239       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    298    298       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID      9    430       {ECO:0000269|PubMed:12921863}.
FT   DISULFID    113    164       {ECO:0000250}.
FT   DISULFID    124    147       {ECO:0000250}.
FT   DISULFID    130    158       {ECO:0000250}.
FT   DISULFID    214    224       {ECO:0000250}.
FT   DISULFID    258    267       {ECO:0000250}.
FT   VAR_SEQ     173    199       Missing (in isoform P2RX2-3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_004500.
FT   VAR_SEQ     344    360       GSFLCDWILLTFMNKNK -> VRNPNSLGDLGQVGSVW
FT                                (in isoform P2RX2-2). {ECO:0000305}.
FT                                /FTId=VSP_004501.
FT   VAR_SEQ     361    472       Missing (in isoform P2RX2-2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_004502.
SQ   SEQUENCE   472 AA;  52617 MW;  AB53E09A2CADA6A2 CRC64;
     MVRRLARGCW SAFWDYETPK VIVVRNRRLG FVHRMVQLLI LLYFVWYVFI VQKSYQDSET
     GPESSIITKV KGITMSEDKV WDVEEYVKPP EGGSVVSIIT RIEVTPSQTL GTCPESMRVH
     SSTCHSDDDC IAGQLDMQGN GIRTGHCVPY YHGDSKTCEV SAWCPVEDGT SDNHFLGKMA
     PNFTILIKNS IHYPKFKFSK GNIASQKSDY LKHCTFDQDS DPYCPIFRLG FIVEKAGENF
     TELAHKGGVI GVIINWNCDL DLSESECNPK YSFRRLDPKY DPASSGYNFR FAKYYKINGT
     TTTRTLIKAY GIRIDVIVHG QAGKFSLIPT IINLATALTS IGVGSFLCDW ILLTFMNKNK
     LYSHKKFDKV RTPKHPSSRW PVTLALVLGQ IPPPPSHYSQ DQPPSPPSGE GPTLGEGAEL
     PLAVQSPRPC SISALTEQVV DTLGQHMGQR PPVPEPSQQD STSTDPKGLA QL
//
ID   P2RX1_HUMAN             Reviewed;         399 AA.
AC   P51575; Q9UK84;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   20-DEC-2017, entry version 158.
DE   RecName: Full=P2X purinoceptor 1;
DE            Short=P2X1;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2RX1; Synonyms=P2X1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Urinary bladder smooth muscle;
RX   PubMed=8834001;
RA   Valera S., Talabot F., Evans R.J., Gos A., Antonarakis S.E.,
RA   Morris M.A., Buell G.N.;
RT   "Characterization and chromosomal localization of a human P2X receptor
RT   from the urinary bladder.";
RL   Recept. Channels 3:283-289(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=8809107; DOI=10.1016/0167-4781(96)00112-1;
RA   Longhurst P.A., Schwegel T., Folander K., Swanson R.;
RT   "The human P2x1 receptor: molecular cloning, tissue distribution, and
RT   localization to chromosome 17.";
RL   Biochim. Biophys. Acta 1308:185-188(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Platelet;
RX   PubMed=9565569; DOI=10.1074/jbc.273.19.11544;
RA   Sun B., Li J., Okahara K., Kambayashi J.;
RT   "P2X1 purinoceptor in human platelets. Molecular cloning and
RT   functional characterization after heterologous expression.";
RL   J. Biol. Chem. 273:11544-11547(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-8.
RC   TISSUE=Placenta;
RA   Dhulipala P.D., Kotlikoff M.I.;
RT   "Regulation of human P2X1 promoter by bHLH factors in smooth muscle
RT   cells.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   DISULFIDE BONDS.
RX   PubMed=11809854; DOI=10.1124/mol.61.2.303;
RA   Ennion S.J., Evans R.J.;
RT   "Conserved cysteine residues in the extracellular loop of the human
RT   P2X(1) receptor form disulfide bonds and are involved in receptor
RT   trafficking to the cell surface.";
RL   Mol. Pharmacol. 61:303-311(2002).
RN   [7]
RP   PHOSPHORYLATION AT SER-387; SER-388 AND THR-389.
RX   PubMed=22971236; DOI=10.1111/jnc.12012;
RA   Roberts J.A., Bottrill A.R., Mistry S., Evans R.J.;
RT   "Mass spectrometry analysis of human P2X1 receptors; insight into
RT   phosphorylation, modelling and conformational changes.";
RL   J. Neurochem. 123:725-735(2012).
RN   [8]
RP   VARIANT LEU-351 DEL, AND CHARACTERIZATION OF VARIANT LEU-351 DEL.
RX   PubMed=10816552; DOI=10.1074/jbc.C000305200;
RA   Oury C., Toth-Zsamboki E., Van Geet C., Thys C., Wei L., Nilius B.,
RA   Vermylen J., Hoylaerts M.F.;
RT   "A natural dominant negative P2X1 receptor due to deletion of a single
RT   amino acid residue.";
RL   J. Biol. Chem. 275:22611-22614(2000).
CC   -!- FUNCTION: Ligand-gated ion channel with relatively high calcium
CC       permeability. Binding to ATP mediates synaptic transmission
CC       between neurons and from neurons to smooth muscle. Seems to be
CC       linked to apoptosis, by increasing the intracellular concentration
CC       of calcium in the presence of ATP, leading to programmed cell
CC       death (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homo- or heteropolymers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P2X receptor entry;
CC       URL="https://en.wikipedia.org/wiki/P2X_receptor";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P2RX1 entry;
CC       URL="https://en.wikipedia.org/wiki/P2RX1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83688; CAA58657.1; -; mRNA.
DR   EMBL; U45448; AAC50698.1; -; mRNA.
DR   EMBL; AF020498; AAC24494.1; -; mRNA.
DR   EMBL; BC044657; AAH44657.1; -; mRNA.
DR   EMBL; AF177472; AAD55395.1; -; Genomic_DNA.
DR   CCDS; CCDS11040.1; -.
DR   PIR; S71927; S71927.
DR   RefSeq; NP_002549.1; NM_002558.3.
DR   UniGene; Hs.41735; -.
DR   ProteinModelPortal; P51575; -.
DR   SMR; P51575; -.
DR   BioGrid; 111062; 16.
DR   IntAct; P51575; 2.
DR   STRING; 9606.ENSP00000225538; -.
DR   BindingDB; P51575; -.
DR   ChEMBL; CHEMBL2094; -.
DR   GuidetoPHARMACOLOGY; 478; -.
DR   iPTMnet; P51575; -.
DR   PhosphoSitePlus; P51575; -.
DR   DMDM; 1709519; -.
DR   EPD; P51575; -.
DR   PaxDb; P51575; -.
DR   PeptideAtlas; P51575; -.
DR   PRIDE; P51575; -.
DR   DNASU; 5023; -.
DR   Ensembl; ENST00000225538; ENSP00000225538; ENSG00000108405.
DR   GeneID; 5023; -.
DR   KEGG; hsa:5023; -.
DR   UCSC; uc002fww.4; human.
DR   CTD; 5023; -.
DR   DisGeNET; 5023; -.
DR   EuPathDB; HostDB:ENSG00000108405.3; -.
DR   GeneCards; P2RX1; -.
DR   HGNC; HGNC:8533; P2RX1.
DR   MalaCards; P2RX1; -.
DR   MIM; 600845; gene+phenotype.
DR   neXtProt; NX_P51575; -.
DR   OpenTargets; ENSG00000108405; -.
DR   PharmGKB; PA32861; -.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; P51575; -.
DR   KO; K05215; -.
DR   OMA; FKYAEDM; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; P51575; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-418346; Platelet homeostasis.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; P2RX1; human.
DR   GeneWiki; P2RX1; -.
DR   GenomeRNAi; 5023; -.
DR   PRO; PR:P51575; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108405; -.
DR   CleanEx; HS_P2RX1; -.
DR   ExpressionAtlas; P51575; baseline and differential.
DR   Genevisible; P51575; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0005261; F:cation channel activity; IDA:MGI.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IBA:GO_Central.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IDA:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:Ensembl.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0007320; P:insemination; IEA:Ensembl.
DR   GO; GO:0006811; P:ion transport; IDA:MGI.
DR   GO; GO:0019228; P:neuronal action potential; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0030168; P:platelet activation; IEA:Ensembl.
DR   GO; GO:0043270; P:positive regulation of ion transport; IEA:Ensembl.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0003056; P:regulation of vascular smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0033198; P:response to ATP; IEA:Ensembl.
DR   GO; GO:0002554; P:serotonin secretion by platelet; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0042310; P:vasoconstriction; IEA:Ensembl.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003044; P2X1_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF9; PTHR10125:SF9; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01308; P2X1RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Complete proteome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    399       P2X purinoceptor 1.
FT                                /FTId=PRO_0000161545.
FT   TOPO_DOM      1     28       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     29     50       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     51    338       Extracellular. {ECO:0000255}.
FT   TRANSMEM    339    358       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    359    399       Cytoplasmic. {ECO:0000255}.
FT   REGION      331    338       Pore-forming motif. {ECO:0000255}.
FT   COMPBIAS    351    354       Poly-Leu.
FT   MOD_RES     387    387       Phosphoserine.
FT                                {ECO:0000269|PubMed:22971236}.
FT   MOD_RES     388    388       Phosphoserine.
FT                                {ECO:0000269|PubMed:22971236}.
FT   MOD_RES     389    389       Phosphothreonine.
FT                                {ECO:0000269|PubMed:22971236}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    242    242       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    117    165       {ECO:0000269|PubMed:11809854}.
FT   DISULFID    126    149       {ECO:0000269|PubMed:11809854}.
FT   DISULFID    132    159       {ECO:0000269|PubMed:11809854}.
FT   DISULFID    217    227       {ECO:0000269|PubMed:11809854}.
FT   DISULFID    261    270       {ECO:0000269|PubMed:11809854}.
FT   VARIANT     351    351       Missing (in one patient presenting with
FT                                severe bleeding; somatic mutation;
FT                                results in a non-functional channel).
FT                                {ECO:0000269|PubMed:10816552}.
FT                                /FTId=VAR_025382.
FT   VARIANT     396    396       M -> V (in dbSNP:rs34617528).
FT                                /FTId=VAR_053552.
SQ   SEQUENCE   399 AA;  44980 MW;  8365466665522BF8 CRC64;
     MARRFQEELA AFLFEYDTPR MVLVRNKKVG VIFRLIQLVV LVYVIGWVFL YEKGYQTSSG
     LISSVSVKLK GLAVTQLPGL GPQVWDVADY VFPAQGDNSF VVMTNFIVTP KQTQGYCAEH
     PEGGICKEDS GCTPGKAKRK AQGIRTGKCV AFNDTVKTCE IFGWCPVEVD DDIPRPALLR
     EAENFTLFIK NSISFPRFKV NRRNLVEEVN AAHMKTCLFH KTLHPLCPVF QLGYVVQESG
     QNFSTLAEKG GVVGITIDWH CDLDWHVRHC RPIYEFHGLY EEKNLSPGFN FRFARHFVEN
     GTNYRHLFKV FGIRFDILVD GKAGKFDIIP TMTTIGSGIG IFGVATVLCD LLLLHILPKR
     HYYKQKKFKY AEDMGPGAAE RDLAATSSTL GLQENMRTS
//
ID   P2RX4_RAT               Reviewed;         388 AA.
AC   P51577;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   20-DEC-2017, entry version 135.
DE   RecName: Full=P2X purinoceptor 4;
DE            Short=P2X4;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Forebrain;
RX   PubMed=8551329;
RA   Seguela P., Haghighi A., Soghomonian J.J., Cooper E.;
RT   "A novel neuronal P2x ATP receptor ion channel with widespread
RT   distribution in the brain.";
RL   J. Neurosci. 16:448-455(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7498461; DOI=10.1016/0014-5793(95)01203-Q;
RA   Bo X., Zhang Y., Nassar M., Burnstock G., Schoepfer R.;
RT   "A P2X purinoceptor cDNA conferring a novel pharmacological profile.";
RL   FEBS Lett. 375:129-133(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pancreatic islet;
RX   PubMed=8602843; DOI=10.1006/bbrc.1996.0380;
RA   Wang C.-Z., Namba N., Gonoi T., Inagaki N., Seino S.;
RT   "Cloning and pharmacological characterization of a fourth P2X receptor
RT   subtype widely expressed in brain and peripheral tissues including
RT   various endocrine tissues.";
RL   Biochem. Biophys. Res. Commun. 220:196-202(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF GLU-249, FUNCTION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Superior cervical ganglion;
RX   PubMed=8598206;
RA   Buell G.N., Lewis C., Collo G., North R.A., Surprenant A.;
RT   "An antagonist-insensitive P2X receptor expressed in epithelia and
RT   brain.";
RL   EMBO J. 15:55-62(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8622997; DOI=10.1073/pnas.93.8.3684;
RA   Soto F., Garcia-Guzman M., Gomez-Hernandez J.M., Hollmann M.,
RA   Karschin C., Stuemer W.;
RT   "P2X4: an ATP-activated ionotropic receptor cloned from rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:3684-3688(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel. This receptor is insensitive to the antagonists PPADS and
CC       suramin. {ECO:0000269|PubMed:8598206}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-9511617, EBI-9511617;
CC       P49653:P2rx2; NbExp=4; IntAct=EBI-9511617, EBI-9511543;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99571};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Widespread distribution in the brain. Also
CC       expressed in epithelial cells. {ECO:0000269|PubMed:8598206}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U32497; AAC52380.1; -; mRNA.
DR   EMBL; X91200; CAA62607.1; -; mRNA.
DR   EMBL; U47031; AAA99777.1; -; mRNA.
DR   EMBL; X87763; CAA61037.1; -; mRNA.
DR   EMBL; X93565; CAA63778.1; -; mRNA.
DR   EMBL; BC078792; AAH78792.1; -; mRNA.
DR   PIR; JC6137; JC6137.
DR   RefSeq; NP_113782.1; NM_031594.1.
DR   UniGene; Rn.7176; -.
DR   PDB; 2BP5; X-ray; 2.80 A; P=375-384.
DR   PDB; 2RUP; NMR; -; A=111-167.
DR   PDBsum; 2BP5; -.
DR   PDBsum; 2RUP; -.
DR   SMR; P51577; -.
DR   BioGrid; 248281; 2.
DR   DIP; DIP-48411N; -.
DR   IntAct; P51577; 2.
DR   STRING; 10116.ENSRNOP00000001752; -.
DR   BindingDB; P51577; -.
DR   ChEMBL; CHEMBL2818; -.
DR   GuidetoPHARMACOLOGY; 481; -.
DR   PhosphoSitePlus; P51577; -.
DR   PaxDb; P51577; -.
DR   PRIDE; P51577; -.
DR   Ensembl; ENSRNOT00000001752; ENSRNOP00000001752; ENSRNOG00000001300.
DR   GeneID; 29659; -.
DR   KEGG; rno:29659; -.
DR   UCSC; RGD:62073; rat.
DR   CTD; 5025; -.
DR   RGD; 62073; P2rx4.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; P51577; -.
DR   KO; K05218; -.
DR   OMA; TMINVGS; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; P51577; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-418346; Platelet homeostasis.
DR   EvolutionaryTrace; P51577; -.
DR   PRO; PR:P51577; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001300; -.
DR   Genevisible; P51577; RN.
DR   GO; GO:0045177; C:apical part of cell; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0045296; F:cadherin binding; ISO:RGD.
DR   GO; GO:0005507; F:copper ion binding; IDA:BHF-UCL.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IDA:BHF-UCL.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0071318; P:cellular response to ATP; ISS:UniProtKB.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; ISO:RGD.
DR   GO; GO:0051899; P:membrane depolarization; ISO:RGD.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; ISO:RGD.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISO:RGD.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; ISO:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:RGD.
DR   GO; GO:0035590; P:purinergic nucleotide receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; ISO:RGD.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IDA:BHF-UCL.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; ISO:RGD.
DR   GO; GO:0033198; P:response to ATP; ISO:RGD.
DR   GO; GO:0034405; P:response to fluid shear stress; ISO:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; IMP:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0006810; P:transport; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; ISO:RGD.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003047; P2X4_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01311; P2X4RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Receptor; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    388       P2X purinoceptor 4.
FT                                /FTId=PRO_0000161554.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     55    338       Extracellular. {ECO:0000255}.
FT   TRANSMEM    339    359       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    360    388       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    199    199       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    208    208       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    116    165       {ECO:0000250}.
FT   DISULFID    126    149       {ECO:0000250}.
FT   DISULFID    132    159       {ECO:0000250}.
FT   DISULFID    217    227       {ECO:0000250}.
FT   DISULFID    261    270       {ECO:0000250}.
FT   MUTAGEN     249    249       E->K: Restores antagonism by PPADS.
FT                                {ECO:0000269|PubMed:8598206}.
FT   CONFLICT    136    137       SV -> LR (in Ref. 1; AAC52380).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       E -> G (in Ref. 4; CAA61037).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       G -> A (in Ref. 2; CAA62607).
FT                                {ECO:0000305}.
FT   STRAND      114    117       {ECO:0000244|PDB:2RUP}.
FT   TURN        129    131       {ECO:0000244|PDB:2RUP}.
FT   TURN        139    141       {ECO:0000244|PDB:2RUP}.
FT   STRAND      143    150       {ECO:0000244|PDB:2RUP}.
FT   STRAND      153    155       {ECO:0000244|PDB:2RUP}.
FT   STRAND      158    163       {ECO:0000244|PDB:2RUP}.
FT   STRAND      379    381       {ECO:0000244|PDB:2BP5}.
SQ   SEQUENCE   388 AA;  43501 MW;  C7B0FC9A94EF8D9A CRC64;
     MAGCCSVLGS FLFEYDTPRI VLIRSRKVGL MNRAVQLLIL AYVIGWVFVW EKGYQETDSV
     VSSVTTKAKG VAVTNTSQLG FRIWDVADYV IPAQEENSLF IMTNMIVTVN QTQSTCPEIP
     DKTSICNSDA DCTPGSVDTH SSGVATGRCV PFNESVKTCE VAAWCPVEND VGVPTPAFLK
     AAENFTLLVK NNIWYPKFNF SKRNILPNIT TSYLKSCIYN AQTDPFCPIF RLGTIVEDAG
     HSFQEMAVEG GIMGIQIKWD CNLDRAASLC LPRYSFRRLD TRDLEHNVSP GYNFRFAKYY
     RDLAGKEQRT LTKAYGIRFD IIVFGKAGKF DIIPTMINVG SGLALLGVAT VLCDVIVLYC
     MKKKYYYRDK KYKYVEDYEQ GLSGEMNQ
//
ID   P2RX5_RAT               Reviewed;         455 AA.
AC   P51578; Q64613;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-NOV-2017, entry version 119.
DE   RecName: Full=P2X purinoceptor 5;
DE            Short=P2X5;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Coeliac ganglion;
RX   PubMed=8786426;
RA   Collo G., Kawashima E., Pich E., Neidhart S., North R.A.,
RA   Surprenant A., Buell G.N.;
RT   "Cloning of P2X5 and P2X6 receptors and the distribution and
RT   properties of an extended family of ATP-gated ion channels.";
RL   J. Neurosci. 16:2495-2507(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=8690069; DOI=10.1016/0014-5793(96)00499-1;
RA   Garcia-Guzman M., Soto F., Laube B., Stuehmer W.;
RT   "Molecular cloning and functional expression of a novel rat heart P2X
RT   purinoceptor.";
RL   FEBS Lett. 388:123-127(1996).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in heart but are also
CC       present in brain, spinal cord and adrenal gland.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X92069; CAA63052.1; -; mRNA.
DR   EMBL; X97328; CAA65993.1; -; mRNA.
DR   PIR; S71344; S71344.
DR   RefSeq; NP_542958.2; NM_080780.2.
DR   UniGene; Rn.10257; -.
DR   SMR; P51578; -.
DR   STRING; 10116.ENSRNOP00000026156; -.
DR   BindingDB; P51578; -.
DR   ChEMBL; CHEMBL2495; -.
DR   GuidetoPHARMACOLOGY; 482; -.
DR   PaxDb; P51578; -.
DR   PRIDE; P51578; -.
DR   GeneID; 113995; -.
DR   KEGG; rno:113995; -.
DR   CTD; 5026; -.
DR   RGD; 620256; P2rx5.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; P51578; -.
DR   KO; K05219; -.
DR   PhylomeDB; P51578; -.
DR   PRO; PR:P51578; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:RGD.
DR   GO; GO:0005525; F:GTP binding; IDA:RGD.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0006812; P:cation transport; TAS:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:RGD.
DR   GO; GO:0043416; P:regulation of skeletal muscle tissue regeneration; IMP:RGD.
DR   GO; GO:0033198; P:response to ATP; IEA:InterPro.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; TAS:RGD.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003048; P2X5_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF12; PTHR10125:SF12; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01312; P2X5RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    455       P2X purinoceptor 5.
FT                                /FTId=PRO_0000161556.
FT   TOPO_DOM      1     30       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     31     51       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     52    341       Extracellular. {ECO:0000255}.
FT   TRANSMEM    342    362       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    363    455       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    118    169       {ECO:0000250}.
FT   DISULFID    129    152       {ECO:0000250}.
FT   DISULFID    135    163       {ECO:0000250}.
FT   DISULFID    220    229       {ECO:0000250}.
FT   DISULFID    263    272       {ECO:0000250}.
FT   CONFLICT    191    191       S -> F (in Ref. 2; CAA65993).
FT                                {ECO:0000305}.
FT   CONFLICT    396    396       R -> Q (in Ref. 2; CAA65993).
FT                                {ECO:0000305}.
SQ   SEQUENCE   455 AA;  51479 MW;  D4405BE440490F70 CRC64;
     MGQAAWKGFV LSLFDYKTAK FVVAKSKKVG LLYRVLQLII LLYLLIWVFL IKKSYQDIDT
     SLQSAVVTKV KGVAYTNTTM LGERLWDVAD FVIPSQGENV FFVVTNLIVT PNQRQGICAE
     REGIPDGECS EDDDCHAGES VVAGHGLKTG RCLRVGNSTR GTCEIFAWCP VETKSMPTDP
     LLKDAESFTI SIKNFIRFPK FNFSKANVLE TDNKHFLKTC HFSSTNLYCP IFRLGSIVRW
     AGADFQDIAL KGGVIGIYIE WDCDLDKAAS KCNPHYYFNR LDNKHTHSIS SGYNFRFARY
     YRDPNGVEFR DLMKAYGIRF DVIVNGKAGK FSIIPTVINI GSGLALMGAG AFFCDLVLIY
     LIRKSEFYRD KKFEKVRGQK EDANVEVEAN EMEQERPEDE PLERVRQDEQ SQELAQSGRK
     QNSNCQVLLE PARFGLRENA IVNVKQSQIL HPVKT
//
ID   P2RX6_RAT               Reviewed;         379 AA.
AC   P51579;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-NOV-2017, entry version 128.
DE   RecName: Full=P2X purinoceptor 6;
DE            Short=P2X6;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=P2XM;
DE   AltName: Full=Purinergic receptor;
DE   AltName: Full=Purinergic receptor P2X-like 1;
GN   Name=P2rx6; Synonyms=P2rxl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cervical ganglion;
RX   PubMed=8786426;
RA   Collo G., Kawashima E., Pich E., Neidhart S., North R.A.,
RA   Surprenant A., Buell G.N.;
RT   "Cloning of P2X5 and P2X6 receptors and the distribution and
RT   properties of an extended family of ATP-gated ion channels.";
RL   J. Neurosci. 16:2495-2507(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8670303; DOI=10.1006/bbrc.1996.0915;
RA   Soto F., Garcia-Guzman M., Karschin C., Stuehmer W.;
RT   "Cloning and tissue distribution of a novel P2X receptor from rat
RT   brain.";
RL   Biochem. Biophys. Res. Commun. 223:456-460(1996).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel.
CC   -!- SUBUNIT: Unlike most P2XRs, P2RX6 does not seem to form
CC       homotrimers or heterotrimers. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P49653:P2rx2; NbExp=4; IntAct=EBI-9511515, EBI-9511543;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X92070; CAA63053.1; -; mRNA.
DR   EMBL; X97376; CAA66044.1; -; mRNA.
DR   PIR; JC4843; JC4843.
DR   RefSeq; NP_036853.2; NM_012721.2.
DR   UniGene; Rn.10258; -.
DR   SMR; P51579; -.
DR   IntAct; P51579; 2.
DR   STRING; 10116.ENSRNOP00000002558; -.
DR   BindingDB; P51579; -.
DR   ChEMBL; CHEMBL2122; -.
DR   GuidetoPHARMACOLOGY; 483; -.
DR   PaxDb; P51579; -.
DR   PRIDE; P51579; -.
DR   GeneID; 25041; -.
DR   KEGG; rno:25041; -.
DR   CTD; 9127; -.
DR   RGD; 3243; P2rx6.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; P51579; -.
DR   KO; K05221; -.
DR   PhylomeDB; P51579; -.
DR   TreeFam; TF328633; -.
DR   PRO; PR:P51579; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; ISO:RGD.
DR   GO; GO:0033198; P:response to ATP; IEA:InterPro.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003049; P2X6_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF21; PTHR10125:SF21; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01313; P2X6RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    379       P2X purinoceptor 6.
FT                                /FTId=PRO_0000161559.
FT   TOPO_DOM      1     31       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     53    325       Extracellular. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    347    379       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      56     56       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O15547}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    187    187       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    119    169       {ECO:0000250}.
FT   DISULFID    130    153       {ECO:0000250}.
FT   DISULFID    136    163       {ECO:0000250}.
FT   DISULFID    220    230       {ECO:0000250}.
FT   DISULFID    264    273       {ECO:0000250}.
SQ   SEQUENCE   379 AA;  42451 MW;  6960A99D65C7191D CRC64;
     MASAVAAALV SWGFLDYKTE KYVMTRNCWV GISQRLLQLG VVVYVIGWAL LAKKGYQEWD
     MDPQISVITK LKGVSVTQVK ELEKRLWDVA DFVRPSQGEN VFFLVTNFLV TPAQVQGRCP
     EHPSVPLANC WADEDCPEGE MGTYSHGIKT GQCVAFNGTH RTCEIWSWCP VESSAVPRKP
     LLAQAKNFTL FIKNTVTFNK FNFSRTNALD TWDNTYFKYC LYDSLSSPYC PVFRIGDLVA
     MTGGDFEDLA LLGGAVGINI HWDCNLDTKG SDCSPQYSFQ LQERGYNFRT ANYWWAASGV
     ESRSLLKLYG IRFDILVTGQ AGKFALIPTA ITVGTGAAWL GMVTFLCDLL LLYVDREAGF
     YWRTKYEEAR APKATTNSA
//
ID   GLUCB_HAECO             Reviewed;         432 AA.
AC   P91730;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   25-OCT-2017, entry version 81.
DE   RecName: Full=Glutamate-gated chloride channel subunit beta;
DE            Short=Glu-Cl subunit beta;
DE   AltName: Full=Avermectin-sensitive glutamate-gated chloride channel subunit;
DE   AltName: Full=HG4;
DE   Flags: Precursor;
OS   Haemonchus contortus (Barber pole worm).
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Strongylida; Trichostrongyloidea; Haemonchidae; Haemonchinae;
OC   Haemonchus.
OX   NCBI_TaxID=6289;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9879896; DOI=10.1016/S0166-6851(98)00148-0;
RA   Delany N.S., Laughton D.L., Wolstenholme A.J.;
RT   "Cloning and localisation of an avermectin receptor-related subunit
RT   from Haemonchus contortus.";
RL   Mol. Biochem. Parasitol. 97:177-187(1998).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit; channel
CC       properties may be modulated by the formation of heteromeric
CC       channels. Glutamate binding triggers a rapidly reversible current,
CC       while the anti-helmintic drug ivermectin triggers a permanently
CC       open channel configuration. {ECO:0000250|UniProtKB:G5EBR3}.
CC   -!- SUBUNIT: Pentamer (By similarity). {ECO:0000250|UniProtKB:G5EBR3}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q94900}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q94900}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q94900}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q94900}.
CC   -!- TISSUE SPECIFICITY: Expressed in motor neuron commissures at the
CC       anterior portion of the worms. {ECO:0000269|PubMed:9879896}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glutamate-gated chloride channel (TC 1.A.9.4) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y09796; CAA70929.1; -; mRNA.
DR   ProteinModelPortal; P91730; -.
DR   ChEMBL; CHEMBL2363050; -.
DR   TCDB; 1.A.9.4.3; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR015680; Glu_Cl_Channel.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF504; PTHR18945:SF504; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    432       Glutamate-gated chloride channel subunit
FT                                beta.
FT                                /FTId=PRO_0000255717.
FT   TOPO_DOM     19    249       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    250    272       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    273    277       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    278    299       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    300    306       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    307    327       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    328    402       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    403    426       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    427    432       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      69     69       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      88     88       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     155    155       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     184    184       Glutamate; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    219    219       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    164    178       {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    226    237       {ECO:0000250|UniProtKB:G5EBR3}.
SQ   SEQUENCE   432 AA;  49626 MW;  AE6E7342FA8C883B CRC64;
     MSQYMMVAVA AVVAVAGSSQ ISRRSTGGTQ EQEILNELLS NYDMRVRPPP SNYSDPMGPV
     TVRVNIMIRM LSKIDVVNME YSMQLTFREQ WLDSRLAYAH LGYHNPPKFL TVPHIKSNLW
     IPDTFFPTEK AAHRHLIDTD NMFLRIHPDG KVLYSSRISI TSSCHMQLQL YPLDLQFCDF
     DLVSYAHTMK DIVYEWDPLA PVQLKPGVGS DLPNFQLTNI TTNDDCTSHT NTGSYACLRM
     QLTLKRQFSY YLVQLYGPTT MIVIVSWVSF WIDMHSTAGR VALGVTTLLT MTTMQAAINA
     KLPPVSYVKV VDVWLGACQT FVFGALLEYA FVSYQDSQRQ TEQAKSRAAR KAQKRRAKME
     LVEREQYQPP CTCHLYQDYE PSFRDRLRRY FTKPDYLPAK IDYYARFCVP LGFLAFNAIY
     WTSCLVMVSR LV
//
ID   NMDE1_RAT               Reviewed;        1464 AA.
AC   Q00959; O08948; Q63728;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 2.
DT   20-DEC-2017, entry version 170.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2A;
DE            Short=GluN2A {ECO:0000303|PubMed:27618671};
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-1;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2A;
DE            Short=NMDAR2A {ECO:0000303|PubMed:8428958};
DE            Short=NR2A {ECO:0000303|PubMed:1350383, ECO:0000303|PubMed:9509416};
DE   Flags: Precursor;
GN   Name=Grin2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, SUBUNIT,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1350383; DOI=10.1126/science.256.5060.1217;
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Heteromeric NMDA receptors: molecular and functional distinction of
RT   subtypes.";
RL   Science 256:1217-1221(1992).
RN   [2]
RP   SEQUENCE REVISION TO 595 AND 597-598.
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Forebrain;
RX   PubMed=8428958;
RA   Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H.,
RA   Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., Nakanishi S.;
RT   "Molecular characterization of the family of the N-methyl-D-aspartate
RT   receptor subunits.";
RL   J. Biol. Chem. 268:2836-2843(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Boulter J.;
RT   "Nucleotide sequence of rat NMDA receptor gene NMDAR2A.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH DLG4.
RX   PubMed=7569905; DOI=10.1126/science.7569905;
RA   Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H.;
RT   "Domain interaction between NMDA receptor subunits and the
RT   postsynaptic density protein PSD-95.";
RL   Science 269:1737-1740(1995).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9509416;
RA   Jin D.H., Jung Y.W., Ko B.H., Moon I.S.;
RT   "Immunoblot analyses on the differential distribution of NR2A and NR2B
RT   subunits in the adult rat brain.";
RL   Mol. Cells 7:749-754(1997).
RN   [7]
RP   INTERACTION WITH AIP1.
RX   PubMed=9694864; DOI=10.1074/jbc.273.33.21105;
RA   Hirao K., Hata Y., Ide N., Takeuchi M., Irie M., Yao I., Deguchi M.,
RA   Toyoda A., Suedhof T.C., Takai Y.;
RT   "A novel multiple PDZ domain-containing molecule interacting with N-
RT   methyl-d-aspartate receptors and neuronal cell adhesion proteins.";
RL   J. Biol. Chem. 273:21105-21110(1998).
RN   [8]
RP   INTERACTION WITH PATJ.
RX   PubMed=9647694; DOI=10.1006/mcne.1998.0679;
RA   Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J.;
RT   "CIPP, a novel multivalent PDZ domain protein, selectively interacts
RT   with Kir4.0 family members, NMDA receptor subunits, neurexins, and
RT   neuroligins.";
RL   Mol. Cell. Neurosci. 11:161-172(1998).
RN   [9]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH GRIN1 AND
RP   GRIN3A.
RX   PubMed=11160393;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A.,
RA   Trimmer J.S., Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of
RT   NR3A-containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN3A AND PPP2CB.
RX   PubMed=11588171;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B.,
RA   Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and
RT   NR2 subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA
RT   receptor in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
RN   [13]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH GRIN1 AND
RP   GRIN3B.
RX   PubMed=14602821;
RA   Matsuda K., Fletcher M., Kamiya Y., Yuzaki M.;
RT   "Specific assembly with the NMDA receptor 3B subunit controls surface
RT   expression and calcium permeability of NMDA receptors.";
RL   J. Neurosci. 23:10064-10073(2003).
RN   [14]
RP   INTERACTION WITH LRFN2.
RX   PubMed=16495444; DOI=10.1523/JNEUROSCI.3799-05.2006;
RA   Wang C.Y., Chang K., Petralia R.S., Wang Y.X., Seabold G.K.,
RA   Wenthold R.J.;
RT   "A novel family of adhesion-like molecules that interacts with the
RT   NMDA receptor.";
RL   J. Neurosci. 26:2174-2183(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-882; SER-890; SER-929;
RP   SER-1025; SER-1059; SER-1062; SER-1198 AND SER-1291, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=28384476; DOI=10.1016/j.neuron.2017.03.018;
RA   Sun W., Hansen K.B., Jahr C.E.;
RT   "Allosteric Interactions between NMDA Receptor Subunits Shape the
RT   Developmental Shift in Channel Properties.";
RL   Neuron 94:58-64(2017).
RN   [17] {ECO:0000244|PDB:2A5S, ECO:0000244|PDB:2A5T}
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 402-539 AND 661-802 IN
RP   COMPLEXES WITH GRIN1 AND GLUTAMATE, FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, DOMAIN, AND DISULFIDE BOND.
RX   PubMed=16281028; DOI=10.1038/nature04089;
RA   Furukawa H., Singh S.K., Mancusso R., Gouaux E.;
RT   "Subunit arrangement and function in NMDA receptors.";
RL   Nature 438:185-192(2005).
RN   [18] {ECO:0000244|PDB:4JWX}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 402-539 AND 661-802 IN
RP   COMPLEX WITH SYNTHETIC AGONIST, FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=23625947; DOI=10.1124/mol.113.085803;
RA   Hansen K.B., Tajima N., Risgaard R., Perszyk R.E., Jorgensen L.,
RA   Vance K.M., Ogden K.K., Clausen R.P., Furukawa H., Traynelis S.F.;
RT   "Structural determinants of agonist efficacy at the glutamate binding
RT   site of N-methyl-D-aspartate receptors.";
RL   Mol. Pharmacol. 84:114-127(2013).
RN   [19] {ECO:0000244|PDB:4NF4, ECO:0000244|PDB:4NF5, ECO:0000244|PDB:4NF6, ECO:0000244|PDB:4NF8}
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 402-539 AND 661-802 IN
RP   COMPLEXES WITH GRIN1 AND GLUTAMATE, FUNCTION, SUBUNIT, DISULFIDE
RP   BONDS, AND MUTAGENESIS OF PHE-416; TYR-730 AND VAL-734.
RX   PubMed=24462099; DOI=10.1016/j.neuron.2013.11.033;
RA   Jespersen A., Tajima N., Fernandez-Cuervo G., Garnier-Amblard E.C.,
RA   Furukawa H.;
RT   "Structural insights into competitive antagonism in NMDA receptors.";
RL   Neuron 81:366-378(2014).
RN   [20] {ECO:0000244|PDB:5I56, ECO:0000244|PDB:5I57, ECO:0000244|PDB:5I58, ECO:0000244|PDB:5I59, ECO:0000244|PDB:5JTY}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 402-539 AND 661-800 IN
RP   COMPLEX WITH GRIN1 AND GLUTAMATE, FUNCTION, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND DISULFIDE BONDS.
RX   PubMed=27618671; DOI=10.1016/j.neuron.2016.08.014;
RA   Yi F., Mou T.C., Dorsett K.N., Volkmann R.A., Menniti F.S.,
RA   Sprang S.R., Hansen K.B.;
RT   "Structural Basis for Negative Allosteric Modulation of GluN2A-
RT   Containing NMDA Receptors.";
RL   Neuron 91:1316-1329(2016).
RN   [21] {ECO:0000244|PDB:5TPW, ECO:0000244|PDB:5TQ0, ECO:0000244|PDB:5TQ2}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 34-393 IN COMPLEX WITH GRIN1
RP   AND ZINC, FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, SUBUNIT,
RP   MUTAGENESIS OF LYS-233; ASN-264 AND ASP-282, AND DISULFIDE BONDS.
RX   PubMed=27916457; DOI=10.1016/j.neuron.2016.11.006;
RA   Romero-Hernandez A., Simorowski N., Karakas E., Furukawa H.;
RT   "Molecular Basis for Subtype Specificity and High-Affinity Zinc
RT   Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.";
RL   Neuron 92:1324-1336(2016).
RN   [22] {ECO:0000244|PDB:5U8C}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 402-539 AND 661-802 IN
RP   COMPLEX WITH GRIN1 AND SYNTHETIC ANTAGONIST, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=28468946; DOI=10.1124/mol.116.107912;
RA   Romero-Hernandez A., Furukawa H.;
RT   "Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the
RT   Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed
RT   to NVP-AAM077.";
RL   Mol. Pharmacol. 92:22-29(2017).
RN   [23] {ECO:0000244|PDB:5DEX, ECO:0000244|PDB:5VIH, ECO:0000244|PDB:5VIJ}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 402-539 AND 566-800 IN
RP   COMPLEX WITH GRIN1, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   DISULFIDE BONDS.
RX   PubMed=28760974; DOI=10.1073/pnas.1707752114;
RA   Lind G.E., Mou T.C., Tamborini L., Pomper M.G., De Micheli C.,
RA   Conti P., Pinto A., Hansen K.B.;
RT   "Structural basis of subunit selectivity for competitive NMDA receptor
RT   antagonists with preference for GluN2A over GluN2B subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E6942-E6951(2017).
RN   [24] {ECO:0000244|PDB:5VII}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 402-539 AND 566-800 IN
RP   COMPLEX WITH GRIN1, SUBUNIT, AND DISULFIDE BONDS.
RA   Mou T.C., Sprang S.R., Hansen K.B.;
RT   "Crystal structure of GluN1/GluN2A NMDA receptor agonist binding
RT   domains with glycine and antagonist, phenyl-ACEPC.";
RL   Submitted (APR-2017) to the PDB data bank.
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium.
CC       Channel activation requires binding of the neurotransmitter
CC       glutamate to the epsilon subunit, glycine binding to the zeta
CC       subunit, plus membrane depolarization to eliminate channel
CC       inhibition by Mg(2+). Sensitivity to glutamate and channel
CC       kinetics depend on the subunit composition; channels containing
CC       GRIN1 and GRIN2A have higher sensitivity to glutamate and faster
CC       kinetics than channels formed by GRIN1 and GRIN2B
CC       (PubMed:28384476). Contributes to the slow phase of excitatory
CC       postsynaptic current, long-term synaptic potentiation, and
CC       learning (By similarity). {ECO:0000250|UniProtKB:P35436,
CC       ECO:0000269|PubMed:1350383, ECO:0000269|PubMed:16281028,
CC       ECO:0000269|PubMed:23625947, ECO:0000269|PubMed:24462099,
CC       ECO:0000269|PubMed:27618671, ECO:0000269|PubMed:27916457,
CC       ECO:0000269|PubMed:28384476, ECO:0000269|PubMed:28468946,
CC       ECO:0000269|PubMed:28760974, ECO:0000269|PubMed:8428958}.
CC   -!- ENZYME REGULATION: Channel activity is inhibited by nM
CC       concentrations of Zn(2+). {ECO:0000269|PubMed:27916457}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
CC       of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A,
CC       GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:1350383,
CC       PubMed:8428958, PubMed:28384476, PubMed:16281028, PubMed:23625947,
CC       PubMed:24462099, PubMed:27618671, PubMed:27916457,
CC       PubMed:28468946, PubMed:28760974, Ref.24). Can also form
CC       heterotetrameric channels that contain at least one zeta subunit
CC       (GRIN1), at least one epsilon subunit, plus GRIN3A or GRIN3B
CC       (PubMed:11160393, PubMed:11588171, PubMed:12391275,
CC       PubMed:11929923). In vivo, the subunit composition may depend on
CC       the expression levels of the different subunits (Probable). Found
CC       in a complex with GRIN1, GRIN3A and PPP2CB (PubMed:11588171).
CC       Found in a complex with GRIN1 and GRIN3B (PubMed:14602821).
CC       Interacts with AIP1 (PubMed:9694864). Interacts with HIP1 and
CC       NETO1. Interacts with SNX27 (via PDZ domain); the interaction is
CC       required for recycling to the plasma membrane when endocytosed and
CC       prevent degradation in lysosomes (By similarity). Interacts with
CC       PDZ domains of PATJ and DLG4 (PubMed:7569905, PubMed:9647694).
CC       Interacts with LRFN2 (PubMed:16495444).
CC       {ECO:0000250|UniProtKB:P35436, ECO:0000269|PubMed:11160393,
CC       ECO:0000269|PubMed:11588171, ECO:0000269|PubMed:11929923,
CC       ECO:0000269|PubMed:12391275, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:14602821, ECO:0000269|PubMed:16281028,
CC       ECO:0000269|PubMed:16495444, ECO:0000269|PubMed:23625947,
CC       ECO:0000269|PubMed:24462099, ECO:0000269|PubMed:27618671,
CC       ECO:0000269|PubMed:27916457, ECO:0000269|PubMed:28384476,
CC       ECO:0000269|PubMed:28468946, ECO:0000269|PubMed:28760974,
CC       ECO:0000269|PubMed:7569905, ECO:0000269|PubMed:8428958,
CC       ECO:0000269|PubMed:9647694, ECO:0000269|PubMed:9694864,
CC       ECO:0000269|Ref.24, ECO:0000305}.
CC   -!- INTERACTION:
CC       P31016:Dlg4; NbExp=5; IntAct=EBI-630970, EBI-375655;
CC       Q8R4I7:Neto1 (xeno); NbExp=4; IntAct=EBI-630970, EBI-2314926;
CC       P05480:Src (xeno); NbExp=5; IntAct=EBI-630970, EBI-298680;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11160393,
CC       ECO:0000269|PubMed:1350383, ECO:0000269|PubMed:14602821,
CC       ECO:0000269|PubMed:16281028, ECO:0000269|PubMed:23625947,
CC       ECO:0000269|PubMed:24462099, ECO:0000269|PubMed:27618671,
CC       ECO:0000269|PubMed:27916457, ECO:0000269|PubMed:28384476,
CC       ECO:0000269|PubMed:28468946, ECO:0000269|PubMed:28760974,
CC       ECO:0000269|PubMed:8428958}; Multi-pass membrane protein
CC       {ECO:0000305}. Cell junction, synapse, postsynaptic cell membrane
CC       {ECO:0000269|PubMed:9509416}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, olfactory bulb,
CC       hippocampus, striatum, thalamus, superior colliculus, inferior
CC       colliculus, midbrain and cerebellum (at protein level)
CC       (PubMed:9509416). Detected in brain cortex, hypothalamus and
CC       cerebellum. {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:9509416}.
CC   -!- DOMAIN: Contains an N-terminal domain, a ligand-binding domain and
CC       a transmembrane domain. Agonist binding to the extracellular
CC       ligand-binding domains triggers channel gating.
CC       {ECO:0000305|PubMed:16281028}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of
CC       a transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:B7ZSK1}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR2A/GRIN2A subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M91561; AAC03565.1; -; mRNA.
DR   EMBL; D13211; BAA02498.1; -; mRNA.
DR   EMBL; AF001423; AAB58801.1; -; mRNA.
DR   PIR; A43274; A43274.
DR   RefSeq; NP_036705.3; NM_012573.3.
DR   UniGene; Rn.9710; -.
DR   PDB; 2A5S; X-ray; 1.70 A; A=401-539.
DR   PDB; 2A5T; X-ray; 2.00 A; B=401-539.
DR   PDB; 4JWX; X-ray; 1.50 A; A=404-539, A=661-802.
DR   PDB; 4NF4; X-ray; 2.00 A; B=402-539, B=661-802.
DR   PDB; 4NF5; X-ray; 1.90 A; B=402-539, B=661-802.
DR   PDB; 4NF6; X-ray; 2.10 A; B=402-539, B=661-802.
DR   PDB; 4NF8; X-ray; 1.86 A; B=402-539, B=661-802.
DR   PDB; 5DEX; X-ray; 2.40 A; B=402-539, B=661-802.
DR   PDB; 5I56; X-ray; 2.28 A; B=402-539, B=661-800.
DR   PDB; 5I57; X-ray; 1.70 A; B=402-539, B=661-800.
DR   PDB; 5I58; X-ray; 2.52 A; B=402-539, B=661-800.
DR   PDB; 5I59; X-ray; 2.25 A; B=402-539, B=661-800.
DR   PDB; 5JTY; X-ray; 2.72 A; B=402-539, B=661-800.
DR   PDB; 5TPW; X-ray; 2.91 A; B=34-393.
DR   PDB; 5TQ0; X-ray; 2.70 A; B=34-393.
DR   PDB; 5TQ2; X-ray; 3.29 A; B=34-393.
DR   PDB; 5U8C; X-ray; 1.60 A; B=402-539, A=661-802.
DR   PDB; 5VIH; X-ray; 2.40 A; B=402-539, B=566-800.
DR   PDB; 5VII; X-ray; 1.95 A; B=402-539, B=566-800.
DR   PDB; 5VIJ; X-ray; 2.10 A; B=402-539, B=566-800.
DR   PDBsum; 2A5S; -.
DR   PDBsum; 2A5T; -.
DR   PDBsum; 4JWX; -.
DR   PDBsum; 4NF4; -.
DR   PDBsum; 4NF5; -.
DR   PDBsum; 4NF6; -.
DR   PDBsum; 4NF8; -.
DR   PDBsum; 5DEX; -.
DR   PDBsum; 5I56; -.
DR   PDBsum; 5I57; -.
DR   PDBsum; 5I58; -.
DR   PDBsum; 5I59; -.
DR   PDBsum; 5JTY; -.
DR   PDBsum; 5TPW; -.
DR   PDBsum; 5TQ0; -.
DR   PDBsum; 5TQ2; -.
DR   PDBsum; 5U8C; -.
DR   PDBsum; 5VIH; -.
DR   PDBsum; 5VII; -.
DR   PDBsum; 5VIJ; -.
DR   ProteinModelPortal; Q00959; -.
DR   SMR; Q00959; -.
DR   BioGrid; 246574; 7.
DR   CORUM; Q00959; -.
DR   DIP; DIP-34031N; -.
DR   IntAct; Q00959; 7.
DR   MINT; MINT-93314; -.
DR   STRING; 10116.ENSRNOP00000042235; -.
DR   BindingDB; Q00959; -.
DR   ChEMBL; CHEMBL310; -.
DR   TCDB; 1.A.10.1.6; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; Q00959; -.
DR   PhosphoSitePlus; Q00959; -.
DR   SwissPalm; Q00959; -.
DR   UniCarbKB; Q00959; -.
DR   PaxDb; Q00959; -.
DR   PRIDE; Q00959; -.
DR   GeneID; 24409; -.
DR   KEGG; rno:24409; -.
DR   UCSC; RGD:2737; rat.
DR   CTD; 2903; -.
DR   RGD; 2737; Grin2a.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   HOGENOM; HOG000113802; -.
DR   HOVERGEN; HBG052635; -.
DR   InParanoid; Q00959; -.
DR   KO; K05209; -.
DR   PhylomeDB; Q00959; -.
DR   EvolutionaryTrace; Q00959; -.
DR   PRO; PR:Q00959; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0099061; C:integral component of postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0051117; F:ATPase binding; IPI:RGD.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0005261; F:cation channel activity; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0016595; F:glutamate binding; IDA:RGD.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:RGD.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:RGD.
DR   GO; GO:0042165; F:neurotransmitter binding; IDA:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IPI:RGD.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0005102; F:receptor binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:BHF-UCL.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; IMP:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0001508; P:action potential; IMP:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IMP:RGD.
DR   GO; GO:0071359; P:cellular response to dsRNA; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071396; P:cellular response to lipid; IEP:RGD.
DR   GO; GO:0071286; P:cellular response to magnesium ion; IEP:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:RGD.
DR   GO; GO:0071294; P:cellular response to zinc ion; IMP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:RGD.
DR   GO; GO:0033058; P:directional locomotion; ISO:RGD.
DR   GO; GO:0042417; P:dopamine metabolic process; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0040011; P:locomotion; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0007613; P:memory; IDA:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:BHF-UCL.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0051262; P:protein tetramerization; IDA:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0051930; P:regulation of sensory perception of pain; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0060359; P:response to ammonium ion; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IMP:ARUK-UCL.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0009416; P:response to light stimulus; IEP:RGD.
DR   GO; GO:0010042; P:response to manganese ion; IEP:RGD.
DR   GO; GO:0051597; P:response to methylmercury; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0051707; P:response to other organism; IEP:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   GO; GO:0042428; P:serotonin metabolic process; ISO:RGD.
DR   GO; GO:0030431; P:sleep; ISO:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell junction; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Magnesium; Membrane;
KW   Metal-binding; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Zinc.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1464       Glutamate receptor ionotropic, NMDA 2A.
FT                                /FTId=PRO_0000011576.
FT   TOPO_DOM     23    555       Extracellular. {ECO:0000305}.
FT   TRANSMEM    556    576       Helical. {ECO:0000250|UniProtKB:B7ZSK1}.
FT   TOPO_DOM    577    600       Cytoplasmic. {ECO:0000305}.
FT   INTRAMEM    601    620       Discontinuously helical.
FT                                {ECO:0000250|UniProtKB:B7ZSK1}.
FT   TOPO_DOM    621    625       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    626    645       Helical. {ECO:0000250|UniProtKB:B7ZSK1}.
FT   TOPO_DOM    646    816       Extracellular. {ECO:0000305}.
FT   TRANSMEM    817    837       Helical. {ECO:0000250|UniProtKB:B7ZSK1}.
FT   TOPO_DOM    838   1464       Cytoplasmic. {ECO:0000305}.
FT   REGION      511    513       Glutamate binding. {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5JTY,
FT                                ECO:0000269|PubMed:16281028}.
FT   REGION      599    620       Pore-forming.
FT                                {ECO:0000250|UniProtKB:B7ZSK1}.
FT   REGION      689    690       Glutamate binding. {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24462099}.
FT   REGION      730    731       Glutamate binding. {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24462099}.
FT   MOTIF      1462   1464       PDZ-binding. {ECO:0000305}.
FT   METAL        44     44       Zinc; via tele nitrogen.
FT                                {ECO:0000244|PDB:5TPW,
FT                                ECO:0000269|PubMed:27916457}.
FT   METAL       128    128       Zinc; via tele nitrogen.
FT                                {ECO:0000244|PDB:5TPW,
FT                                ECO:0000269|PubMed:27916457}.
FT   METAL       266    266       Zinc. {ECO:0000244|PDB:5TPW,
FT                                ECO:0000269|PubMed:27916457}.
FT   METAL       282    282       Zinc. {ECO:0000244|PDB:5TPW,
FT                                ECO:0000269|PubMed:27916457}.
FT   BINDING     518    518       Glutamate. {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5JTY,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24462099,
FT                                ECO:0000269|PubMed:27618671}.
FT   SITE        614    614       Functional determinant of NMDA receptors.
FT                                {ECO:0000250}.
FT   MOD_RES     882    882       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     890    890       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     929    929       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1025   1025       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1059   1059       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1062   1062       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1198   1198       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1291   1291       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    340    340       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    443    443       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    444    444       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    541    541       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     87    320       {ECO:0000244|PDB:5TPW,
FT                                ECO:0000244|PDB:5TQ0,
FT                                ECO:0000244|PDB:5TQ2,
FT                                ECO:0000269|PubMed:27916457}.
FT   DISULFID    429    455       {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4JWX,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5JTY,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:24462099,
FT                                ECO:0000269|PubMed:27618671,
FT                                ECO:0000269|PubMed:28468946,
FT                                ECO:0000269|PubMed:28760974,
FT                                ECO:0000269|Ref.24}.
FT   DISULFID    436    456       {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4JWX,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:5DEX,
FT                                ECO:0000244|PDB:5I56,
FT                                ECO:0000244|PDB:5I57,
FT                                ECO:0000244|PDB:5I58,
FT                                ECO:0000244|PDB:5I59,
FT                                ECO:0000244|PDB:5JTY,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000244|PDB:5VIH,
FT                                ECO:0000244|PDB:5VII,
FT                                ECO:0000244|PDB:5VIJ,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:23625947,
FT                                ECO:0000269|PubMed:24462099,
FT                                ECO:0000269|PubMed:27618671,
FT                                ECO:0000269|PubMed:28468946,
FT                                ECO:0000269|PubMed:28760974}.
FT   DISULFID    745    800       {ECO:0000244|PDB:2A5S,
FT                                ECO:0000244|PDB:2A5T,
FT                                ECO:0000244|PDB:4JWX,
FT                                ECO:0000244|PDB:4NF4,
FT                                ECO:0000244|PDB:4NF5,
FT                                ECO:0000244|PDB:4NF6,
FT                                ECO:0000244|PDB:4NF8,
FT                                ECO:0000244|PDB:5U8C,
FT                                ECO:0000269|PubMed:16281028,
FT                                ECO:0000269|PubMed:23625947,
FT                                ECO:0000269|PubMed:24462099,
FT                                ECO:0000269|PubMed:28468946}.
FT   MUTAGEN     233    233       K->A,R: Nearly abolishes inhibition by
FT                                Zn(2+). {ECO:0000269|PubMed:27916457}.
FT   MUTAGEN     264    264       N->W: Nearly abolishes inhibition by
FT                                Zn(2+). {ECO:0000269|PubMed:27916457}.
FT   MUTAGEN     282    282       D->A,H: Nearly abolishes inhibition by
FT                                Zn(2+). {ECO:0000269|PubMed:27916457}.
FT   MUTAGEN     416    416       F->A: Decreased sensitivity to glutamate.
FT                                {ECO:0000269|PubMed:24462099}.
FT   MUTAGEN     730    730       Y->F,L,M: Strongly decreased sensitivity
FT                                to glutamate.
FT                                {ECO:0000269|PubMed:24462099}.
FT   MUTAGEN     734    734       V->A: Decreased sensitivity to glutamate.
FT                                {ECO:0000269|PubMed:24462099}.
FT   CONFLICT    246    246       L -> F (in Ref. 3; BAA02498).
FT                                {ECO:0000305}.
FT   CONFLICT    758    758       S -> T (in Ref. 3; BAA02498 and 4;
FT                                AAB58801). {ECO:0000305}.
FT   CONFLICT    990    990       E -> D (in Ref. 4; AAB58801).
FT                                {ECO:0000305}.
FT   STRAND       35     40       {ECO:0000244|PDB:5TQ0}.
FT   STRAND       42     44       {ECO:0000244|PDB:5TQ0}.
FT   STRAND       68     73       {ECO:0000244|PDB:5TQ0}.
FT   HELIX        79     91       {ECO:0000244|PDB:5TQ0}.
FT   STRAND       96    101       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       108    120       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      124    128       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       129    132       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      144    147       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       151    164       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      169    177       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       180    193       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      194    196       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      198    200       {ECO:0000244|PDB:5TPW}.
FT   STRAND      204    207       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       213    219       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      225    230       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       233    245       {ECO:0000244|PDB:5TQ0}.
FT   TURN        247    249       {ECO:0000244|PDB:5TQ2}.
FT   STRAND      253    257       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       259    262       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      277    281       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      284    286       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       288    309       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      310    312       {ECO:0000244|PDB:5TQ0}.
FT   TURN        335    337       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      338    340       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      341    343       {ECO:0000244|PDB:5TQ2}.
FT   STRAND      346    348       {ECO:0000244|PDB:5TQ2}.
FT   STRAND      354    358       {ECO:0000244|PDB:5TQ0}.
FT   STRAND      362    366       {ECO:0000244|PDB:5TQ0}.
FT   TURN        368    370       {ECO:0000244|PDB:5TPW}.
FT   STRAND      372    377       {ECO:0000244|PDB:5TQ0}.
FT   TURN        379    382       {ECO:0000244|PDB:5TQ0}.
FT   HELIX       402    404       {ECO:0000244|PDB:5U8C}.
FT   STRAND      406    410       {ECO:0000244|PDB:4JWX}.
FT   TURN        414    416       {ECO:0000244|PDB:4JWX}.
FT   STRAND      417    421       {ECO:0000244|PDB:4JWX}.
FT   TURN        424    426       {ECO:0000244|PDB:4JWX}.
FT   STRAND      434    447       {ECO:0000244|PDB:4JWX}.
FT   STRAND      449    458       {ECO:0000244|PDB:4JWX}.
FT   HELIX       459    471       {ECO:0000244|PDB:4JWX}.
FT   STRAND      475    479       {ECO:0000244|PDB:4JWX}.
FT   STRAND      482    485       {ECO:0000244|PDB:4JWX}.
FT   STRAND      488    491       {ECO:0000244|PDB:5I58}.
FT   HELIX       495    501       {ECO:0000244|PDB:4JWX}.
FT   STRAND      506    508       {ECO:0000244|PDB:4JWX}.
FT   HELIX       516    519       {ECO:0000244|PDB:4JWX}.
FT   STRAND      522    524       {ECO:0000244|PDB:4JWX}.
FT   STRAND      529    531       {ECO:0000244|PDB:4JWX}.
FT   STRAND      533    538       {ECO:0000244|PDB:4JWX}.
FT   HELIX       668    671       {ECO:0000244|PDB:4JWX}.
FT   HELIX       673    675       {ECO:0000244|PDB:4JWX}.
FT   STRAND      676    678       {ECO:0000244|PDB:4JWX}.
FT   STRAND      686    688       {ECO:0000244|PDB:5I59}.
FT   HELIX       689    697       {ECO:0000244|PDB:4JWX}.
FT   HELIX       699    705       {ECO:0000244|PDB:4JWX}.
FT   HELIX       706    708       {ECO:0000244|PDB:4JWX}.
FT   HELIX       713    721       {ECO:0000244|PDB:4JWX}.
FT   STRAND      726    731       {ECO:0000244|PDB:4JWX}.
FT   HELIX       732    740       {ECO:0000244|PDB:4JWX}.
FT   HELIX       743    745       {ECO:0000244|PDB:5VII}.
FT   STRAND      747    751       {ECO:0000244|PDB:4JWX}.
FT   HELIX       752    754       {ECO:0000244|PDB:5U8C}.
FT   HELIX       755    757       {ECO:0000244|PDB:4JWX}.
FT   STRAND      759    761       {ECO:0000244|PDB:4JWX}.
FT   STRAND      764    766       {ECO:0000244|PDB:4JWX}.
FT   HELIX       772    784       {ECO:0000244|PDB:4JWX}.
FT   HELIX       787    795       {ECO:0000244|PDB:4JWX}.
SQ   SEQUENCE   1464 AA;  165469 MW;  DC1528E1898DECA4 CRC64;
     MGRLGYWTLL VLPALLVWRD PAQNAAAEKG PPALNIAVLL GHSHDVTERE LRNLWGPEQA
     TGLPLDVNVV ALLMNRTDPK SLITHVCDLM SGARIHGLVF GDDTDQEAVA QMLDFISSQT
     FIPILGIHGG ASMIMADKDP TSTFFQFGAS IQQQATVMLK IMQDYDWHVF SLVTTIFPGY
     RDFISFIKTT VDNSFVGWDM QNVITLDTSF EDAKTQVQLK KIHSSVILLY CSKDEAVLIL
     SEARSLGLTG YDFFWIVPSL VSGNTELIPK EFPSGLISVS YDDWDYSLEA RVRDGLGILT
     TAASSMLEKF SYIPEAKASC YGQAEKPETP LHTLHQFMVN VTWDGKDLSF TEEGYQVHPR
     LVVIVLNKDR EWEKVGKWEN QTLSLRHAVW PRYKSFSDCE PDDNHLSIVT LEEAPFVIVE
     DIDPLTETCV RNTVPCRKFV KINNSTNEGM NVKKCCKGFC IDILKKLSRT VKFTYDLYLV
     TNGKHGKKVN NVWNGMIGEV VYQRAVMAVG SLTINEERSE VVDFSVPFVE TGISVMVSRS
     NGTVSPSAFL EPFSASVWVM MFVMLLIVSA IAVFVFEYFS PVGYNRNLAK GKAPHGPSFT
     IGKAIWLLWG LVFNNSVPVQ NPKGTTSKIM VSVWAFFAVI FLASYTANLA AFMIQEEFVD
     QVTGLSDKKF QRPHDYSPPF RFGTVPNGST ERNIRNNYPY MHQYMTRFNQ RGVEDALVSL
     KTGKLDAFIY DAAVLNYKAG RDEGCKLVTI GSGYIFASTG YGIALQKGSP WKRQIDLALL
     QFVGDGEMEE LETLWLTGIC HNEKNEVMSS QLDIDNMAGV FYMLAAAMAL SLITFIWEHL
     FYWKLRFCFT GVCSDRPGLL FSISRGIYSC IHGVHIEEKK KSPDFNLTGS QSNMLKLLRS
     AKNISNMSNM NSSRMDSPKR ATDFIQRGSL IVDMVSDKGN LIYSDNRSFQ GKDSIFGDNM
     NELQTFVANR HKDNLSNYVF QGQHPLTLNE SNPNTVEVAV STESKGNSRP RQLWKKSMES
     LRQDSLNQNP VSQRDEKTAE NRTHSLKSPR YLPEEVAHSD ISETSSRATC HREPDNNKNH
     KTKDNFKRSM ASKYPKDCSD VDRTYMKTKA SSPRDKIYTI DGEKEPSFHL DPPQFVENIT
     LPENVGFPDT YQDHNENFRK GDSTLPMNRN PLHNEDGLPN NDQYKLYAKH FTLKDKGSPH
     SEGSDRYRQN STHCRSCLSN LPTYSGHFTM RSPFKCDACL RMGNLYDIDE DQMLQETGNP
     ATREEVYQQD WSQNNALQFQ KNKLRINRQH SYDNILDKPR EIDLSRPSRS ISLKDRERLL
     EGNLYGSLFS VPSSKLLGNK SSLFPQGLED SKRSKSLLPD HASDNPFLHT YGDDQRLVIG
     RCPSDPYKHS LPSQAVNDSY LRSSLRSTAS YCSRDSRGHS DVYISEHVMP YAANKNTMYS
     TPRVLNSCSN RRVYKKMPSI ESDV
//
ID   NMDE2_RAT               Reviewed;        1482 AA.
AC   Q00960; Q62684;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   20-DEC-2017, entry version 169.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2B;
DE            Short=GluN2B;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-2;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2B;
DE            Short=NMDAR2B;
DE            Short=NR2B {ECO:0000303|PubMed:1350383};
DE   Flags: Precursor;
GN   Name=Grin2b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RC   TISSUE=Brain;
RX   PubMed=1350383; DOI=10.1126/science.256.5060.1217;
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Heteromeric NMDA receptors: molecular and functional distinction of
RT   subtypes.";
RL   Science 256:1217-1221(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7524561; DOI=10.1016/0896-6273(94)90258-5;
RA   Sullivan J.M., Traynelis S.F., Chen H.S., Escobar W., Heinemann S.F.,
RA   Lipton S.A.;
RT   "Identification of two cysteine residues that are required for redox
RT   modulation of the NMDA subtype of glutamate receptor.";
RL   Neuron 13:929-936(1994).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7513428;
RA   Moon I.S., Apperson M.L., Kennedy M.B.;
RT   "The major tyrosine-phosphorylated protein in the postsynaptic density
RT   fraction is N-methyl-D-aspartate receptor subunit 2B.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3954-3958(1994).
RN   [4]
RP   INTERACTION WITH DLG4.
RX   PubMed=7569905; DOI=10.1126/science.7569905;
RA   Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H.;
RT   "Domain interaction between NMDA receptor subunits and the
RT   postsynaptic density protein PSD-95.";
RL   Science 269:1737-1740(1995).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9509416;
RA   Jin D.H., Jung Y.W., Ko B.H., Moon I.S.;
RT   "Immunoblot analyses on the differential distribution of NR2A and NR2B
RT   subunits in the adult rat brain.";
RL   Mol. Cells 7:749-754(1997).
RN   [6]
RP   INTERACTION WITH PATJ.
RX   PubMed=9647694; DOI=10.1006/mcne.1998.0679;
RA   Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J.;
RT   "CIPP, a novel multivalent PDZ domain protein, selectively interacts
RT   with Kir4.0 family members, NMDA receptor subunits, neurexins, and
RT   neuroligins.";
RL   Mol. Cell. Neurosci. 11:161-172(1998).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN3A AND PPP2CB.
RX   PubMed=11588171;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=11160393;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A.,
RA   Trimmer J.S., Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of
RT   NR3A-containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B.,
RA   Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and
RT   NR2 subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA
RT   receptor in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-882; SER-886; SER-917;
RP   SER-920; TYR-1039; SER-1255; SER-1259 AND SER-1303, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND PRR7, AND INTERACTION WITH
RP   PRR7.
RX   PubMed=27458189; DOI=10.15252/embj.201593070;
RA   Kravchick D.O., Karpova A., Hrdinka M., Lopez-Rojas J., Iacobas S.,
RA   Carbonell A.U., Iacobas D.A., Kreutz M.R., Jordan B.A.;
RT   "Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and
RT   regulates NMDA-mediated excitotoxicity.";
RL   EMBO J. 35:1923-1934(2016).
RN   [13]
RP   INTERACTION WITH DLG3 AND DLG4, AND MUTAGENESIS OF SER-1413; LEU-1422
RP   AND SER-1450.
RX   PubMed=28283559; DOI=10.1523/JNEUROSCI.0827-16.2017;
RA   Liu S., Zhou L., Yuan H., Vieira M., Sanz-Clemente A., Badger J.D. II,
RA   Lu W., Traynelis S.F., Roche K.W.;
RT   "A Rare Variant Identified Within the GluN2B C-Terminus in a Patient
RT   with Autism Affects NMDA Receptor Surface Expression and Spine
RT   Density.";
RL   J. Neurosci. 37:4093-4102(2017).
RN   [14] {ECO:0000244|PDB:3JPW, ECO:0000244|PDB:3JPY}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 32-394, FUNCTION,
RP   SUBCELLULAR LOCATION, SUBUNIT, ENZYME REGULATION, GLYCOSYLATION AT
RP   ASN-74 AND ASN-341, MUTAGENESIS OF HIS-60; HIS-127; ASP-283; GLU-284;
RP   HIS-311 AND HIS-359, AND DISULFIDE BOND.
RX   PubMed=19910922; DOI=10.1038/emboj.2009.338;
RA   Karakas E., Simorowski N., Furukawa H.;
RT   "Structure of the zinc-bound amino-terminal domain of the NMDA
RT   receptor NR2B subunit.";
RL   EMBO J. 28:3910-3920(2009).
RN   [15] {ECO:0000244|PDB:3QEL, ECO:0000244|PDB:3QEM}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 31-394, FUNCTION,
RP   SUBCELLULAR LOCATION, SUBUNIT, ENZYME REGULATION, GLYCOSYLATION AT
RP   ASN-74 AND ASN-341, AND DISULFIDE BONDS.
RX   PubMed=21677647; DOI=10.1038/nature10180;
RA   Karakas E., Simorowski N., Furukawa H.;
RT   "Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B
RT   NMDA receptors.";
RL   Nature 475:249-253(2011).
RN   [16] {ECO:0000244|PDB:4PE5}
RP   X-RAY CRYSTALLOGRAPHY (3.96 ANGSTROMS) OF 27-852 IN COMPLEX WITH GRIN1
RP   AND GLUTAMATE, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT,
RP   GLYCOSYLATION AT ASN-74; ASN-341 AND ASN-688, AND DISULFIDE BONDS.
RX   PubMed=24876489; DOI=10.1126/science.1251915;
RA   Karakas E., Furukawa H.;
RT   "Crystal structure of a heterotetrameric NMDA receptor ion channel.";
RL   Science 344:992-997(2014).
RN   [17] {ECO:0000244|PDB:5B3J, ECO:0000244|PDB:5FXG, ECO:0000244|PDB:5FXH, ECO:0000244|PDB:5FXI, ECO:0000244|PDB:5FXJ, ECO:0000244|PDB:5FXK}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 31-394, STRUCTURE BY
RP   ELECTRON MICROSCOPY (6.1 ANGSTROMS) OF 27-852 IN COMPLEX WITH GRIN1,
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, TOPOLOGY, AND DISULFIDE
RP   BONDS.
RX   PubMed=27135925; DOI=10.1038/nature17679;
RA   Tajima N., Karakas E., Grant T., Simorowski N., Diaz-Avalos R.,
RA   Grigorieff N., Furukawa H.;
RT   "Activation of NMDA receptors and the mechanism of inhibition by
RT   ifenprodil.";
RL   Nature 534:63-68(2016).
RN   [18] {ECO:0000244|PDB:5TPZ}
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 32-393 IN COMPLEX WITH
RP   GRIN1, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, GLYCOSYLATION AT
RP   ASN-341, AND DISULFIDE BONDS.
RX   PubMed=27916457; DOI=10.1016/j.neuron.2016.11.006;
RA   Romero-Hernandez A., Simorowski N., Karakas E., Furukawa H.;
RT   "Molecular Basis for Subtype Specificity and High-Affinity Zinc
RT   Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.";
RL   Neuron 92:1324-1336(2016).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium.
CC       Channel activation requires binding of the neurotransmitter
CC       glutamate to the epsilon subunit, glycine binding to the zeta
CC       subunit, plus membrane depolarization to eliminate channel
CC       inhibition by Mg(2+) (PubMed:1350383, PubMed:19910922,
CC       PubMed:21677647, PubMed:24876489, PubMed:27135925,
CC       PubMed:27916457). Sensitivity to glutamate and channel kinetics
CC       depend on the subunit composition (Probable). In concert with
CC       DAPK1 at extrasynaptic sites, acts as a central mediator for
CC       stroke damage. Its phosphorylation at Ser-1303 by DAPK1 enhances
CC       synaptic NMDA receptor channel activity inducing injurious Ca2+
CC       influx through them, resulting in an irreversible neuronal death.
CC       Contributes to neural pattern formation in the developing brain.
CC       Plays a role in long-term depression (LTD) of hippocampus membrane
CC       currents and in synaptic plasticity (By similarity).
CC       {ECO:0000250|UniProtKB:Q01097, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27916457, ECO:0000305}.
CC   -!- ENZYME REGULATION: Channel activity is inhibited by micromolar
CC       levels of zinc ions (PubMed:19910922). Channel activity is
CC       inhibited by ifenprodil (PubMed:19910922, PubMed:21677647).
CC       {ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
CC       of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A,
CC       GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:1350383,
CC       PubMed:19910922, PubMed:21677647, PubMed:24876489,
CC       PubMed:27135925, PubMed:27916457). Can also form heterotetrameric
CC       channels that contain at least one zeta subunit (GRIN1), at least
CC       one epsilon subunit, plus GRIN3A or GRIN3B. In vivo, the subunit
CC       composition may depend on the expression levels of the different
CC       subunits. Found in a complex with GRIN1, GRIN3A and PPP2CB. Found
CC       in a complex with GRIN1 and GRIN3B. Interacts with MAGI3.
CC       Interacts with HIP1 and NETO1. Interacts with PDZ domains of PATJ,
CC       DLG3 and DLG4. Interacts with DAPK1 (By similarity). Found in a
CC       complex with GRIN1 and PRR7 (PubMed:27458189). Interacts with PRR7
CC       (PubMed:27458189). {ECO:0000250|UniProtKB:Q01097,
CC       ECO:0000250|UniProtKB:Q13224, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27458189, ECO:0000269|PubMed:27916457,
CC       ECO:0000269|PubMed:28283559}.
CC   -!- INTERACTION:
CC       P11275:Camk2a; NbExp=2; IntAct=EBI-396905, EBI-2640645;
CC       P11798:Camk2a (xeno); NbExp=3; IntAct=EBI-396905, EBI-400384;
CC       Q62936:Dlg3; NbExp=6; IntAct=EBI-396905, EBI-349596;
CC       P31016:Dlg4; NbExp=8; IntAct=EBI-396905, EBI-375655;
CC       P35439:Grin1; NbExp=12; IntAct=EBI-396905, EBI-877897;
CC       P35439-7:Grin1; NbExp=2; IntAct=EBI-396905, EBI-15932497;
CC       Q91977:grin1 (xeno); NbExp=6; IntAct=EBI-396905, EBI-15932423;
CC       Q460M5:Lrfn2; NbExp=2; IntAct=EBI-396905, EBI-877185;
CC       Q8R4I7:Neto1 (xeno); NbExp=2; IntAct=EBI-396905, EBI-2314926;
CC       Q63ZW7:Patj (xeno); NbExp=4; IntAct=EBI-396905, EBI-8366894;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27916457}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925}. Cell
CC       junction, synapse, postsynaptic cell membrane
CC       {ECO:0000269|PubMed:7513428, ECO:0000269|PubMed:9509416}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:24876489,
CC       ECO:0000269|PubMed:27135925}.
CC   -!- TISSUE SPECIFICITY: Detected in adult olfactory bulb, brain
CC       cortex, hippocampus, striatum, thalamus, superior colliculus, with
CC       much lower levels in inferior colliculus, midbrain and cerebellum.
CC       {ECO:0000269|PubMed:9509416}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of
CC       a transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000305|PubMed:24876489}.
CC   -!- PTM: Phosphorylated on tyrosine residues (PubMed:7513428).
CC       Phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA
CC       receptor channel activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q01097, ECO:0000269|PubMed:7513428}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR2B/GRIN2B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M91562; AAA41714.1; -; mRNA.
DR   EMBL; U11419; AAA50554.1; -; mRNA.
DR   PIR; B43274; B43274.
DR   RefSeq; NP_036706.1; NM_012574.1.
DR   UniGene; Rn.9711; -.
DR   PDB; 3JPW; X-ray; 2.80 A; A=32-394.
DR   PDB; 3JPY; X-ray; 3.21 A; A=32-394.
DR   PDB; 3QEL; X-ray; 2.60 A; B/D=31-394.
DR   PDB; 3QEM; X-ray; 3.00 A; B/D=31-394.
DR   PDB; 4PE5; X-ray; 3.96 A; B/D=27-852.
DR   PDB; 5B3J; X-ray; 2.90 A; C/D=31-394.
DR   PDB; 5FXG; EM; 6.80 A; B/D=27-852.
DR   PDB; 5FXH; EM; 6.10 A; B/D=27-852.
DR   PDB; 5FXI; EM; 6.40 A; B/D=27-852.
DR   PDB; 5FXJ; EM; 6.50 A; B/D=27-852.
DR   PDB; 5FXK; EM; 6.40 A; B/D=27-852.
DR   PDB; 5TPZ; X-ray; 3.10 A; D=32-393.
DR   PDBsum; 3JPW; -.
DR   PDBsum; 3JPY; -.
DR   PDBsum; 3QEL; -.
DR   PDBsum; 3QEM; -.
DR   PDBsum; 4PE5; -.
DR   PDBsum; 5B3J; -.
DR   PDBsum; 5FXG; -.
DR   PDBsum; 5FXH; -.
DR   PDBsum; 5FXI; -.
DR   PDBsum; 5FXJ; -.
DR   PDBsum; 5FXK; -.
DR   PDBsum; 5TPZ; -.
DR   ProteinModelPortal; Q00960; -.
DR   SMR; Q00960; -.
DR   BioGrid; 246575; 12.
DR   CORUM; Q00960; -.
DR   DIP; DIP-33702N; -.
DR   IntAct; Q00960; 18.
DR   MINT; MINT-104014; -.
DR   STRING; 10116.ENSRNOP00000011697; -.
DR   BindingDB; Q00960; -.
DR   ChEMBL; CHEMBL311; -.
DR   GuidetoPHARMACOLOGY; 457; -.
DR   TCDB; 1.A.10.1.6; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; Q00960; -.
DR   PhosphoSitePlus; Q00960; -.
DR   SwissPalm; Q00960; -.
DR   UniCarbKB; Q00960; -.
DR   PaxDb; Q00960; -.
DR   PRIDE; Q00960; -.
DR   GeneID; 24410; -.
DR   KEGG; rno:24410; -.
DR   UCSC; RGD:2738; rat.
DR   CTD; 2904; -.
DR   RGD; 2738; Grin2b.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   HOGENOM; HOG000113802; -.
DR   HOVERGEN; HBG052635; -.
DR   InParanoid; Q00960; -.
DR   KO; K05210; -.
DR   PhylomeDB; Q00960; -.
DR   EvolutionaryTrace; Q00960; -.
DR   PRO; PR:Q00960; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0043083; C:synaptic cleft; IDA:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:RGD.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0005261; F:cation channel activity; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:RGD.
DR   GO; GO:0031749; F:D2 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0008144; F:drug binding; IPI:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IDA:RGD.
DR   GO; GO:0016595; F:glutamate binding; IDA:UniProtKB.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISS:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; ISO:RGD.
DR   GO; GO:0005149; F:interleukin-1 receptor binding; IPI:RGD.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0042165; F:neurotransmitter binding; IDA:RGD.
DR   GO; GO:0099583; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; IMP:SynGO.
DR   GO; GO:0099529; F:neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0005102; F:receptor binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; IMP:RGD.
DR   GO; GO:0008306; P:associative learning; IMP:RGD.
DR   GO; GO:0001662; P:behavioral fear response; IMP:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0006812; P:cation transport; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEP:RGD.
DR   GO; GO:0071386; P:cellular response to corticosterone stimulus; IEP:RGD.
DR   GO; GO:1904644; P:cellular response to curcumin; IEP:RGD.
DR   GO; GO:0071359; P:cellular response to dsRNA; IEP:RGD.
DR   GO; GO:1904322; P:cellular response to forskolin; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071396; P:cellular response to lipid; IEP:RGD.
DR   GO; GO:0010350; P:cellular response to magnesium starvation; IEP:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0042596; P:fear response; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; TAS:RGD.
DR   GO; GO:0007616; P:long-term memory; IEP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0007613; P:memory; IDA:UniProtKB.
DR   GO; GO:0033555; P:multicellular organismal response to stress; IEP:RGD.
DR   GO; GO:1902951; P:negative regulation of dendritic spine maintenance; ISO:RGD.
DR   GO; GO:0098989; P:NMDA selective glutamate receptor signaling pathway; IMP:SynGO.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:RGD.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IDA:UniProtKB.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:1901216; P:positive regulation of neuron death; ISO:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:RGD.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0043113; P:receptor clustering; IDA:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0099566; P:regulation of postsynaptic cytosolic calcium ion concentration; IMP:SynGO.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0010738; P:regulation of protein kinase A signaling; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0060416; P:response to growth hormone; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:0010042; P:response to manganese ion; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0051597; P:response to methylmercury; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0010243; P:response to organonitrogen compound; IMP:RGD.
DR   GO; GO:0051707; P:response to other organism; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   GO; GO:0046960; P:sensitization; IMP:RGD.
DR   GO; GO:0007423; P:sensory organ development; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0001967; P:suckling behavior; ISO:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell junction; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Magnesium; Membrane; Metal-binding; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27   1482       Glutamate receptor ionotropic, NMDA 2B.
FT                                /FTId=PRO_0000011579.
FT   TOPO_DOM     27    557       Extracellular.
FT                                {ECO:0000269|PubMed:24876489}.
FT   TRANSMEM    558    576       Helical. {ECO:0000269|PubMed:24876489}.
FT   TOPO_DOM    577    603       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24876489}.
FT   INTRAMEM    604    623       Discontinuously helical.
FT                                {ECO:0000305|PubMed:24876489}.
FT   TOPO_DOM    624    630       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24876489}.
FT   TRANSMEM    631    646       Helical. {ECO:0000269|PubMed:24876489}.
FT   TOPO_DOM    647    817       Extracellular.
FT                                {ECO:0000269|PubMed:24876489}.
FT   TRANSMEM    818    837       Helical. {ECO:0000269|PubMed:24876489}.
FT   TOPO_DOM    838   1482       Cytoplasmic.
FT                                {ECO:0000269|PubMed:24876489}.
FT   REGION      604    623       Pore-forming.
FT                                {ECO:0000269|PubMed:24876489,
FT                                ECO:0000305|PubMed:24876489}.
FT   REGION      690    691       Glutamate binding.
FT                                {ECO:0000244|PDB:4PE5}.
FT   REGION     1292   1304       Interaction with DAPK1.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOTIF      1480   1482       PDZ-binding.
FT   COMPBIAS    984    989       Poly-His.
FT   METAL       127    127       Zinc. {ECO:0000244|PDB:3JPY,
FT                                ECO:0000305|PubMed:19910922}.
FT   METAL       284    284       Zinc. {ECO:0000244|PDB:3JPY,
FT                                ECO:0000305|PubMed:19910922}.
FT   BINDING     514    514       Glutamate. {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   BINDING     519    519       Glutamate. {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   BINDING     732    732       Glutamate. {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   SITE        615    615       Functional determinant of NMDA receptors.
FT                                {ECO:0000250}.
FT   MOD_RES     882    882       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     886    886       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     917    917       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     920    920       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES     962    962       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1039   1039       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1058   1058       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1061   1061       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1064   1064       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1109   1109       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1133   1133       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1143   1143       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1155   1155       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1255   1255       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1259   1259       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1303   1303       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1303   1303       Phosphoserine; by DAPK1.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   MOD_RES    1472   1472       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q01097}.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3JPW,
FT                                ECO:0000244|PDB:3JPY,
FT                                ECO:0000244|PDB:3QEL,
FT                                ECO:0000244|PDB:3QEM,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:19910922,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:3JPW,
FT                                ECO:0000244|PDB:3JPY,
FT                                ECO:0000244|PDB:3QEL,
FT                                ECO:0000244|PDB:3QEM,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5TPZ,
FT                                ECO:0000269|PubMed:19910922,
FT                                ECO:0000269|PubMed:24876489}.
FT   CARBOHYD    348    348       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    444    444       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    542    542       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    688    688       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   DISULFID     86    321       {ECO:0000244|PDB:3JPW,
FT                                ECO:0000244|PDB:3JPY,
FT                                ECO:0000244|PDB:3QEL,
FT                                ECO:0000244|PDB:3QEM,
FT                                ECO:0000244|PDB:4PE5,
FT                                ECO:0000244|PDB:5B3J,
FT                                ECO:0000244|PDB:5TPZ,
FT                                ECO:0000269|PubMed:19910922}.
FT   DISULFID    429    456       {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   DISULFID    436    457       {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   DISULFID    746    801       {ECO:0000244|PDB:4PE5,
FT                                ECO:0000269|PubMed:24876489}.
FT   MUTAGEN      60     60       H->A: Normal zinc binding.
FT                                {ECO:0000269|PubMed:19910922}.
FT   MUTAGEN     127    127       H->A: Reduced zinc binding.
FT                                {ECO:0000269|PubMed:19910922}.
FT   MUTAGEN     283    283       D->A: Slightly reduced zinc binding.
FT                                {ECO:0000269|PubMed:19910922}.
FT   MUTAGEN     284    284       E->A: Reduced zinc binding.
FT                                {ECO:0000269|PubMed:19910922}.
FT   MUTAGEN     311    311       H->A: Normal zinc binding.
FT                                {ECO:0000269|PubMed:19910922}.
FT   MUTAGEN     359    359       H->A: Normal zinc binding.
FT                                {ECO:0000269|PubMed:19910922}.
FT   MUTAGEN    1413   1413       S->L: Decreased localization to the cell
FT                                membrane. Decreased interaction with DLG3
FT                                and DLG4. No effect on glutamate-gated
FT                                calcium ion channel activity.
FT                                {ECO:0000269|PubMed:28283559}.
FT   MUTAGEN    1422   1422       L->F: No effect on localizationto the
FT                                cell membrane. Decreased interaction with
FT                                DLG3 and DLG4. No effect on glutamate-
FT                                gated calcium ion channel activity.
FT                                {ECO:0000269|PubMed:28283559}.
FT   MUTAGEN    1450   1450       S->F: No effect on localizationto the
FT                                cell membrane. Decreased interaction with
FT                                DLG3 and DLG4. No effect on glutamate-
FT                                gated calcium ion channel activity.
FT                                {ECO:0000269|PubMed:28283559}.
FT   CONFLICT   1256   1256       E -> K (in Ref. 2; AAA50554).
FT                                {ECO:0000305}.
FT   CONFLICT   1430   1431       VT -> SA (in Ref. 2; AAA50554).
FT                                {ECO:0000305}.
FT   STRAND       34     44       {ECO:0000244|PDB:3QEL}.
FT   HELIX        47     50       {ECO:0000244|PDB:3QEL}.
FT   HELIX        53     55       {ECO:0000244|PDB:3JPW}.
FT   STRAND       64     73       {ECO:0000244|PDB:3QEL}.
FT   HELIX        78     91       {ECO:0000244|PDB:3QEL}.
FT   STRAND       94    103       {ECO:0000244|PDB:3QEL}.
FT   HELIX       107    119       {ECO:0000244|PDB:3QEL}.
FT   STRAND      123    127       {ECO:0000244|PDB:3QEL}.
FT   HELIX       128    131       {ECO:0000244|PDB:3QEL}.
FT   STRAND      143    147       {ECO:0000244|PDB:3QEL}.
FT   HELIX       150    163       {ECO:0000244|PDB:3QEL}.
FT   STRAND      168    175       {ECO:0000244|PDB:3QEL}.
FT   HELIX       179    191       {ECO:0000244|PDB:3QEL}.
FT   STRAND      198    205       {ECO:0000244|PDB:3QEL}.
FT   STRAND      211    213       {ECO:0000244|PDB:3QEL}.
FT   HELIX       215    220       {ECO:0000244|PDB:3QEL}.
FT   STRAND      226    232       {ECO:0000244|PDB:3QEL}.
FT   HELIX       234    245       {ECO:0000244|PDB:3QEL}.
FT   TURN        246    248       {ECO:0000244|PDB:3QEL}.
FT   STRAND      251    253       {ECO:0000244|PDB:5B3J}.
FT   STRAND      255    258       {ECO:0000244|PDB:3QEL}.
FT   HELIX       260    263       {ECO:0000244|PDB:3QEL}.
FT   STRAND      265    267       {ECO:0000244|PDB:5TPZ}.
FT   STRAND      271    273       {ECO:0000244|PDB:5TPZ}.
FT   STRAND      275    281       {ECO:0000244|PDB:3JPW}.
FT   TURN        284    286       {ECO:0000244|PDB:3QEL}.
FT   HELIX       289    308       {ECO:0000244|PDB:3QEL}.
FT   TURN        309    311       {ECO:0000244|PDB:3QEL}.
FT   TURN        322    326       {ECO:0000244|PDB:3QEL}.
FT   HELIX       327    330       {ECO:0000244|PDB:3QEL}.
FT   HELIX       336    339       {ECO:0000244|PDB:3QEL}.
FT   STRAND      345    348       {ECO:0000244|PDB:5TPZ}.
FT   STRAND      355    359       {ECO:0000244|PDB:3QEL}.
FT   STRAND      362    367       {ECO:0000244|PDB:3QEL}.
FT   STRAND      369    371       {ECO:0000244|PDB:3JPY}.
FT   STRAND      373    379       {ECO:0000244|PDB:3QEL}.
FT   STRAND      384    387       {ECO:0000244|PDB:3QEL}.
SQ   SEQUENCE   1482 AA;  166071 MW;  AEF8B9DF3C1B0D5D CRC64;
     MKPSAECCSP KFWLVLAVLA VSGSKARSQK SPPSIGIAVI LVGTSDEVAI KDAHEKDDFH
     HLSVVPRVEL VAMNETDPKS IITRICDLMS DRKIQGVVFA DDTDQEAIAQ ILDFISAQTL
     TPILGIHGGS SMIMADKDES SMFFQFGPSI EQQASVMLNI MEEYDWYIFS IVTTYFPGYQ
     DFVNKIRSTI ENSFVGWELE EVLLLDMSLD DGDSKIQNQL KKLQSPIILL YCTKEEATYI
     FEVANSVGLT GYGYTWIVPS LVAGDTDTVP SEFPTGLISV SYDEWDYGLP ARVRDGIAII
     TTAASDMLSE HSFIPEPKSS CYNTHEKRIY QSNMLNRYLI NVTFEGRNLS FSEDGYQMHP
     KLVIILLNKE RKWERVGKWK DKSLQMKYYV WPRMCPETEE QEDDHLSIVT LEEAPFVIVE
     SVDPLSGTCM RNTVPCQKRI ISENKTDEEP GYIKKCCKGF CIDILKKISK SVKFTYDLYL
     VTNGKHGKKI NGTWNGMIGE VVMKRAYMAV GSLTINEERS EVVDFSVPFI ETGISVMVSR
     SNGTVSPSAF LEPFSADVWV MMFVMLLIVS AVAVFVFEYF SPVGYNRCLA DGREPGGPSF
     TIGKAIWLLW GLVFNNSVPV QNPKGTTSKI MVSVWAFFAV IFLASYTANL AAFMIQEEYV
     DQVSGLSDKK FQRPNDFSPP FRFGTVPNGS TERNIRNNYA EMHAYMGKFN QRGVDDALLS
     LKTGKLDAFI YDAAVLNYMA GRDEGCKLVT IGSGKVFAST GYGIAIQKDS GWKRQVDLAI
     LQLFGDGEME ELEALWLTGI CHNEKNEVMS SQLDIDNMAG VFYMLGAAMA LSLITFICEH
     LFYWQFRHCF MGVCSGKPGM VFSISRGIYS CIHGVAIEER QSVMNSPTAT MNNTHSNILR
     LLRTAKNMAN LSGVNGSPQS ALDFIRRESS VYDISEHRRS FTHSDCKSYN NPPCEENLFS
     DYISEVERTF GNLQLKDSNV YQDHYHHHHR PHSIGSTSSI DGLYDCDNPP FTTQPRSISK
     KPLDIGLPSS KHSQLSDLYG KFSFKSDRYS GHDDLIRSDV SDISTHTVTY GNIEGNAAKR
     RKQQYKDSLK KRPASAKSRR EFDEIELAYR RRPPRSPDHK RYFRDKEGLR DFYLDQFRTK
     ENSPHWEHVD LTDIYKERSD DFKRDSVSGG GPCTNRSHLK HGTGEKHGVV GGVPAPWEKN
     LTNVDWEDRS GGNFCRSCPS KLHNYSSTVA GQNSGRQACI RCEACKKAGN LYDISEDNSL
     QELDQPAAPV AVTSNASSTK YPQSPTNSKA QKKNRNKLRR QHSYDTFVDL QKEEAALAPR
     SVSLKDKGRF MDGSPYAHMF EMPAGESSFA NKSSVPTAGH HHNNPGSGYM LSKSLYPDRV
     TQNPFIPTFG DDQCLLHGSK SYFFRQPTVA GASKTRPDFR ALVTNKPVVV TLHGAVPGRF
     QKDICIGNQS NPCVPNNKNP RAFNGSSNGH VYEKLSSIES DV
//
ID   GLR1_DROME              Reviewed;         991 AA.
AC   Q03445; B6IDJ5; Q86PC2; Q9VRX9;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 2.
DT   27-SEP-2017, entry version 148.
DE   RecName: Full=Glutamate receptor 1;
DE   AltName: Full=Glutamate receptor I;
DE            Short=dGLUR-I;
DE   AltName: Full=Kainate-selective glutamate receptor;
DE   Flags: Precursor;
GN   Name=GluRIA; Synonyms=Glu-RI; ORFNames=CG8442;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Canton-S; TISSUE=Embryo;
RX   PubMed=1359540; DOI=10.1073/pnas.89.21.10484;
RA   Ultsch A., Schuster C.M., Laube B., Schloss P., Schmitt B., Betz H.;
RT   "Glutamate receptors of Drosophila melanogaster: cloning of a kainate-
RT   selective subunit expressed in the central nervous system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10484-10488(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W.,
RA   Booth B., Champe M., Chavez C., Dorsett V., Dresnek D., Farfan D.,
RA   Frise E., George R.A., Gonzalez M., Guarin H., Kronmiller B., Li P.W.,
RA   Liao G., Miranda A., Mungall C.J., Nunoo J., Pacleb J.M., Paragas V.,
RA   Park S., Patel S., Phouanenavong S., Wan K.H., Yu C., Lewis S.E.,
RA   Rubin G.M., Celniker S.E.;
RL   Submitted (NOV-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists (By similarity). Forms ligand-gated ion channels which
CC       are activated by kainate. {ECO:0000250,
CC       ECO:0000269|PubMed:1359540}.
CC   -!- SUBUNIT: Homooligomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1359540};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:1359540}. Cell
CC       junction, synapse, postsynaptic cell membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=A;
CC         IsoId=Q03445-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q03445-2; Sequence=VSP_014219;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Central nervous system.
CC       {ECO:0000269|PubMed:1359540}.
CC   -!- DEVELOPMENTAL STAGE: No expression is seen in early embryogenesis,
CC       whereas high expression occurs in late embryos. During larval
CC       development, expression decreases to undetectable levels in late
CC       larvae, resumes at the early pupal stage and gradually increases
CC       in late pupae and early adult flies. High levels of expression
CC       coincide with major stages of neurogenesis.
CC       {ECO:0000269|PubMed:1359540}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97192; AAA28575.1; -; mRNA.
DR   EMBL; AE014296; AAF50652.2; -; Genomic_DNA.
DR   EMBL; BT003218; AAO24973.1; -; mRNA.
DR   EMBL; BT050435; ACJ13142.1; -; mRNA.
DR   PIR; A46421; A46421.
DR   RefSeq; NP_476855.1; NM_057507.4. [Q03445-1]
DR   UniGene; Dm.6460; -.
DR   PDB; 5DT6; X-ray; 1.60 A; A=474-594, A=739-880.
DR   PDB; 5ICT; X-ray; 1.68 A; A=474-594, A=739-880.
DR   PDBsum; 5DT6; -.
DR   PDBsum; 5ICT; -.
DR   ProteinModelPortal; Q03445; -.
DR   SMR; Q03445; -.
DR   BioGrid; 64192; 1.
DR   IntAct; Q03445; 1.
DR   STRING; 7227.FBpp0076691; -.
DR   PaxDb; Q03445; -.
DR   PRIDE; Q03445; -.
DR   EnsemblMetazoa; FBtr0076982; FBpp0076691; FBgn0004619. [Q03445-1]
DR   GeneID; 38742; -.
DR   KEGG; dme:Dmel_CG8442; -.
DR   CTD; 38742; -.
DR   FlyBase; FBgn0004619; GluRIA.
DR   eggNOG; KOG1054; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   InParanoid; Q03445; -.
DR   KO; K05313; -.
DR   OMA; VEFFCRS; -.
DR   OrthoDB; EOG091G11CB; -.
DR   PhylomeDB; Q03445; -.
DR   Reactome; R-DME-204005; COPII (Coat Protein 2) Mediated Vesicle Transport.
DR   Reactome; R-DME-399710; Activation of AMPA receptors.
DR   Reactome; R-DME-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-DME-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-DME-5694530; Cargo concentration in the ER.
DR   GenomeRNAi; 38742; -.
DR   PRO; PR:Q03445; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0004619; -.
DR   Genevisible; Q03445; DM.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; IC:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; IBA:GO_Central.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0015277; F:kainate selective glutamate receptor activity; IDA:FlyBase.
DR   GO; GO:0006812; P:cation transport; IDA:FlyBase.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    991       Glutamate receptor 1.
FT                                /FTId=PRO_0000011555.
FT   TOPO_DOM     28    611       Extracellular. {ECO:0000255}.
FT   TRANSMEM    612    632       Helical. {ECO:0000255}.
FT   TOPO_DOM    633    710       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    711    731       Helical. {ECO:0000255}.
FT   TOPO_DOM    732    895       Extracellular. {ECO:0000255}.
FT   TRANSMEM    896    916       Helical. {ECO:0000255}.
FT   TOPO_DOM    917    991       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS     28     32       Poly-Gln.
FT   COMPBIAS    367    371       Poly-Ser.
FT   CARBOHYD     67     67       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    208    208       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    281    281       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    376    376       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    385    385       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    437    437       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    477    477       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    265       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_014219.
FT   CONFLICT     61     61       M -> L (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       S -> N (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   CONFLICT    309    316       GQSQSQNA -> AKAKARTQ (in Ref. 1;
FT                                AAA28575). {ECO:0000305}.
FT   CONFLICT    324    324       A -> P (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   CONFLICT    747    747       T -> A (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   CONFLICT    759    759       Y -> H (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   CONFLICT    916    916       M -> V (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   CONFLICT    944    944       A -> G (in Ref. 1; AAA28575).
FT                                {ECO:0000305}.
FT   STRAND      476    484       {ECO:0000244|PDB:5DT6}.
FT   TURN        488    490       {ECO:0000244|PDB:5DT6}.
FT   STRAND      491    493       {ECO:0000244|PDB:5DT6}.
FT   HELIX       504    507       {ECO:0000244|PDB:5DT6}.
FT   STRAND      508    510       {ECO:0000244|PDB:5DT6}.
FT   HELIX       511    523       {ECO:0000244|PDB:5DT6}.
FT   STRAND      526    531       {ECO:0000244|PDB:5DT6}.
FT   HELIX       550    556       {ECO:0000244|PDB:5DT6}.
FT   STRAND      561    563       {ECO:0000244|PDB:5DT6}.
FT   HELIX       571    574       {ECO:0000244|PDB:5DT6}.
FT   STRAND      577    579       {ECO:0000244|PDB:5DT6}.
FT   STRAND      583    586       {ECO:0000244|PDB:5DT6}.
FT   STRAND      588    593       {ECO:0000244|PDB:5DT6}.
FT   HELIX       743    746       {ECO:0000244|PDB:5DT6}.
FT   STRAND      753    755       {ECO:0000244|PDB:5DT6}.
FT   HELIX       761    768       {ECO:0000244|PDB:5DT6}.
FT   HELIX       772    783       {ECO:0000244|PDB:5DT6}.
FT   HELIX       784    787       {ECO:0000244|PDB:5DT6}.
FT   STRAND      788    791       {ECO:0000244|PDB:5DT6}.
FT   HELIX       792    801       {ECO:0000244|PDB:5DT6}.
FT   TURN        802    804       {ECO:0000244|PDB:5DT6}.
FT   STRAND      806    811       {ECO:0000244|PDB:5DT6}.
FT   HELIX       812    819       {ECO:0000244|PDB:5DT6}.
FT   STRAND      826    830       {ECO:0000244|PDB:5DT6}.
FT   STRAND      836    838       {ECO:0000244|PDB:5DT6}.
FT   STRAND      841    843       {ECO:0000244|PDB:5DT6}.
FT   HELIX       849    861       {ECO:0000244|PDB:5DT6}.
FT   HELIX       864    872       {ECO:0000244|PDB:5DT6}.
FT   HELIX       874    876       {ECO:0000244|PDB:5DT6}.
SQ   SEQUENCE   991 AA;  111668 MW;  C8917868ABA06F98 CRC64;
     MHSRLKFLAY LHFICASSIF WPEFSSAQQQ QQTVSLTEKI PLGAIFEQGT DDVQSAFKYA
     MLNHNLNVSS RRFELQAYVD VINTADAFKL SRLICNQFSR GVYSMLGAVS PDSFDTLHSY
     SNTFQMPFVT PWFPEKVLAP SSGLLDFAIS MRPDYHQAII DTIQYYGWQS IIYLYDSHDG
     LLRLQQIYQE LKPGNETFRV QMVKRIANVT MAIEFLHTLE DLGRFSKKRI VLDCPAEMAK
     EIIVQHVRDI KLGRRTYHYL LSGLVMDNHW PSDVVEFGAI NITGFRIVDS NRRAVRDFHD
     SRKRLEPSGQ SQSQNAGGPN SLPAISAQAA LMYDAVFVLV EAFNRILRKK PDQFRSNHLQ
     RRSHGGSSSS SATGTNESSA LLDCNTSKGW VTPWEQGEKI SRVLRKVEID GLSGEIRFDE
     DGRRINYTLH VVEMSVNSTL QQVAEWRDDA GLLPLHSHNY ASSSRSASAS TGDYDRNHTY
     IVSSLLEEPY LSLKQYTYGE SLVGNDRFEG YCKDLADMLA AQLGIKYEIR LVQDGNYGAE
     NQYAPGGWDG MVGELIRKEA DIAISAMTIT AERERVIDFS KPFMTLGISI MIKKPVKQTP
     GVFSFLNPLS QEIWISVILS YVGVSFVLYF VTRFPPYEWR IVRRPQADST AQQPPGIIGG
     ATLSEPQAHV PPVPPNEFTM LNSFWYSLAA FMQQGCDITP PSIAGRIAAA VWWFFTIILI
     SSYTANLAAF LTVERMVAPI KTPEDLTMQT DVNYGTLLYG STWEFFRRSQ IGLHNKMWEY
     MNANQHHSVH TYDEGIRRVR QSKGKYALLV ESPKNEYVNA RPPCDTMKVG RNIDTKGFGV
     ATPIGSPLRK RLNEAVLTLK ENGELLRIRN KWWFDKTECN LDQETSTPNE LSLSNVAGIY
     YILIGGLLLA VIVAIMEFFC RNKTPQLKSP GSNGSAGGVP GMLASSTYQR DSLSDAIMHS
     QAKLAMQASS EYDERLVGVE LASNVRYQYS M
//
ID   CNG_CAEEL               Reviewed;         733 AA.
AC   Q03611; P90800;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2002, sequence version 3.
DT   25-OCT-2017, entry version 146.
DE   RecName: Full=Cyclic nucleotide-gated cation channel;
DE   AltName: Full=Abnormal chemotaxis protein 4;
GN   Name=tax-4; ORFNames=ZC84.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=8893027; DOI=10.1016/S0896-6273(00)80202-0;
RA   Komatsu H., Mori I., Rhee J.S., Akaike N., Ohshima Y.;
RT   "Mutations in a cyclic nucleotide-gated channel lead to abnormal
RT   thermosensation and chemosensation in C. elegans.";
RL   Neuron 17:707-718(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION.
RX   PubMed=9486798;
RA   Coburn C.M., Mori I., Ohshima Y., Bargmann C.I.;
RT   "A cyclic nucleotide-gated channel inhibits sensory axon outgrowth in
RT   larval and adult Caenorhabditis elegans: a distinct pathway for
RT   maintenance of sensory axon structure.";
RL   Development 125:249-258(1998).
RN   [5]
RP   FUNCTION.
RX   PubMed=21173231; DOI=10.1073/pnas.1017354108;
RA   Hallem E.A., Spencer W.C., McWhirter R.D., Zeller G., Henz S.R.,
RA   Ratsch G., Miller D.M., Horvitz H.R., Sternberg P.W., Ringstad N.;
RT   "Receptor-type guanylate cyclase is required for carbon dioxide
RT   sensation by Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:254-259(2011).
RN   [6]
RP   FUNCTION.
RX   PubMed=23664973; DOI=10.1016/j.cub.2013.04.052;
RA   Murayama T., Takayama J., Fujiwara M., Maruyama I.N.;
RT   "Environmental alkalinity sensing mediated by the transmembrane
RT   guanylyl cyclase GCY-14 in C. elegans.";
RL   Curr. Biol. 23:1007-1012(2013).
RN   [7]
RP   FUNCTION.
RX   PubMed=25303524; DOI=10.1016/j.cell.2014.09.011;
RA   Meisel J.D., Panda O., Mahanti P., Schroeder F.C., Kim D.H.;
RT   "Chemosensation of bacterial secondary metabolites modulates
RT   neuroendocrine signaling and behavior of C. elegans.";
RL   Cell 159:267-280(2014).
RN   [8]
RP   FUNCTION.
RX   PubMed=25009271; DOI=10.1523/JNEUROSCI.0012-14.2014;
RA   Harris G., Shen Y., Ha H., Donato A., Wallis S., Zhang X., Zhang Y.;
RT   "Dissecting the signaling mechanisms underlying recognition and
RT   preference of food odors.";
RL   J. Neurosci. 34:9389-9403(2014).
CC   -!- FUNCTION: Required for normal thermosensation and chemosensation
CC       sensory behavior (PubMed:8893027). Required, downstream of
CC       receptor-type guanylate cyclase gcy-9, for CO2-mediated responses
CC       in BAG neurons (PubMed:21173231). Required, downstream of
CC       receptor-type guanylate cyclase gcy-14, for alkaline pH-mediated
CC       responses in ASE-left (ASEL) neurons (PubMed:23664973). Involved
CC       in the development of ASJ sensory neuron axon during late larval
CC       stages and in the maintenance of normal axon morphology in the
CC       adult. Regulates dauer formation (PubMed:9486798). In ASI and ASJ
CC       sensory neurons, controls behavioral response to P.aeruginosa by
CC       up-regulating the transcription of daf-7, a member of the TGF-beta
CC       family (PubMed:25303524). In AWB and AWC sensory neurons, mediates
CC       the recognition of food oders which subsequently allows for the
CC       detection of preferred food sources (PubMed:25009271).
CC       {ECO:0000269|PubMed:21173231, ECO:0000269|PubMed:23664973,
CC       ECO:0000269|PubMed:25009271, ECO:0000269|PubMed:25303524,
CC       ECO:0000269|PubMed:8893027, ECO:0000269|PubMed:9486798}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed at the sensory endings of
CC       thermosensory, gustatory, and olfactory neurons.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D86922; BAA13180.1; -; mRNA.
DR   EMBL; Z19157; CAB63418.2; -; Genomic_DNA.
DR   PIR; S28292; S28292.
DR   RefSeq; NP_499033.1; NM_066632.4.
DR   UniGene; Cel.19693; -.
DR   PDB; 5H3O; EM; 3.50 A; A/B/C/D=1-733.
DR   PDBsum; 5H3O; -.
DR   ProteinModelPortal; Q03611; -.
DR   SMR; Q03611; -.
DR   STRING; 6239.ZC84.2; -.
DR   TCDB; 1.A.1.5.20; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q03611; -.
DR   EnsemblMetazoa; ZC84.2; ZC84.2; WBGene00006526.
DR   GeneID; 176297; -.
DR   KEGG; cel:CELE_ZC84.2; -.
DR   UCSC; ZC84.2; c. elegans.
DR   CTD; 176297; -.
DR   WormBase; ZC84.2; CE27352; WBGene00006526; tax-4.
DR   eggNOG; KOG0500; Eukaryota.
DR   eggNOG; ENOG410YWWI; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000007898; -.
DR   InParanoid; Q03611; -.
DR   KO; K04950; -.
DR   OMA; CMYFAIS; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; Q03611; -.
DR   Reactome; R-CEL-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-CEL-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-CEL-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q03611; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00006526; -.
DR   GO; GO:0034703; C:cation channel complex; IDA:WormBase.
DR   GO; GO:0097543; C:ciliary inversin compartment; IDA:WormBase.
DR   GO; GO:0030425; C:dendrite; IDA:WormBase.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0097730; C:non-motile cilium; IDA:WormBase.
DR   GO; GO:0030553; F:cGMP binding; NAS:UniProtKB.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:WormBase.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:WormBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0009454; P:aerotaxis; IMP:WormBase.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0098655; P:cation transmembrane transport; IDA:WormBase.
DR   GO; GO:0007635; P:chemosensory behavior; IMP:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; IMP:CACAO.
DR   GO; GO:0003031; P:detection of carbon dioxide; IMP:UniProtKB.
DR   GO; GO:0050907; P:detection of chemical stimulus involved in sensory perception; IMP:UniProtKB.
DR   GO; GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IMP:UniProtKB.
DR   GO; GO:0048609; P:multicellular organismal reproductive process; IGI:WormBase.
DR   GO; GO:0010754; P:negative regulation of cGMP-mediated signaling; IMP:WormBase.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:WormBase.
DR   GO; GO:0042048; P:olfactory behavior; IMP:WormBase.
DR   GO; GO:0007602; P:phototransduction; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0040010; P:positive regulation of growth rate; IGI:WormBase.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:WormBase.
DR   GO; GO:0030516; P:regulation of axon extension; IMP:WormBase.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IMP:WormBase.
DR   GO; GO:0055093; P:response to hyperoxia; IMP:WormBase.
DR   GO; GO:0070482; P:response to oxygen levels; IMP:WormBase.
DR   GO; GO:0040040; P:thermosensory behavior; IMP:UniProtKB.
DR   GO; GO:0043052; P:thermotaxis; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032406; CLZ_dom.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF16526; CLZ; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cGMP; cGMP-binding; Chemotaxis; Complete proteome;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Neurogenesis; Nucleotide-binding; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    733       Cyclic nucleotide-gated cation channel.
FT                                /FTId=PRO_0000219328.
FT   TOPO_DOM      1    120       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    142    201       Extracellular. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    223    251       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    252    272       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    273    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    330       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    331    386       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    387    407       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    408    547       Extracellular. {ECO:0000255}.
FT   TRANSMEM    548    568       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    569    733       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     501    623       cAMP. {ECO:0000250}.
FT   BINDING     560    560       cAMP. {ECO:0000255}.
FT   BINDING     575    575       cAMP. {ECO:0000255}.
FT   HELIX       107    109       {ECO:0000244|PDB:5H3O}.
FT   STRAND      116    118       {ECO:0000244|PDB:5H3O}.
FT   HELIX       119    144       {ECO:0000244|PDB:5H3O}.
FT   STRAND      152    154       {ECO:0000244|PDB:5H3O}.
FT   TURN        174    177       {ECO:0000244|PDB:5H3O}.
FT   TURN        194    196       {ECO:0000244|PDB:5H3O}.
FT   HELIX       199    223       {ECO:0000244|PDB:5H3O}.
FT   HELIX       238    246       {ECO:0000244|PDB:5H3O}.
FT   HELIX       248    256       {ECO:0000244|PDB:5H3O}.
FT   HELIX       262    265       {ECO:0000244|PDB:5H3O}.
FT   STRAND      270    272       {ECO:0000244|PDB:5H3O}.
FT   HELIX       277    286       {ECO:0000244|PDB:5H3O}.
FT   HELIX       287    298       {ECO:0000244|PDB:5H3O}.
FT   HELIX       304    333       {ECO:0000244|PDB:5H3O}.
FT   STRAND      338    344       {ECO:0000244|PDB:5H3O}.
FT   TURN        348    350       {ECO:0000244|PDB:5H3O}.
FT   HELIX       359    374       {ECO:0000244|PDB:5H3O}.
FT   HELIX       386    416       {ECO:0000244|PDB:5H3O}.
FT   HELIX       419    437       {ECO:0000244|PDB:5H3O}.
FT   HELIX       442    457       {ECO:0000244|PDB:5H3O}.
FT   HELIX       465    470       {ECO:0000244|PDB:5H3O}.
FT   HELIX       473    489       {ECO:0000244|PDB:5H3O}.
FT   HELIX       492    496       {ECO:0000244|PDB:5H3O}.
FT   HELIX       502    505       {ECO:0000244|PDB:5H3O}.
FT   HELIX       506    508       {ECO:0000244|PDB:5H3O}.
FT   STRAND      510    514       {ECO:0000244|PDB:5H3O}.
FT   STRAND      529    536       {ECO:0000244|PDB:5H3O}.
FT   STRAND      538    547       {ECO:0000244|PDB:5H3O}.
FT   STRAND      550    552       {ECO:0000244|PDB:5H3O}.
FT   STRAND      557    559       {ECO:0000244|PDB:5H3O}.
FT   HELIX       560    563       {ECO:0000244|PDB:5H3O}.
FT   STRAND      568    570       {ECO:0000244|PDB:5H3O}.
FT   STRAND      576    583       {ECO:0000244|PDB:5H3O}.
FT   STRAND      585    591       {ECO:0000244|PDB:5H3O}.
FT   HELIX       592    599       {ECO:0000244|PDB:5H3O}.
FT   HELIX       603    618       {ECO:0000244|PDB:5H3O}.
SQ   SEQUENCE   733 AA;  83893 MW;  1EC7EB0179F9355E CRC64;
     MSTAEPAPDP TNPSTSGLAP TTNGIGSPPP TASAATKFSI LTKFLRRKNQ VHTTTAQQNE
     FMQKYMPNGN SNAVQPAATG GQPASSDGGS AIEVPPPKES YAVRIRKYLA NYTQDPSTDN
     FYYWTCVVTV AYIYNLLFVI ARQVFNDLIG PSSQSLCRFY NGTLNSTTQV ECTYNMLTNM
     KEMPTYSQYP DLGWSKYWHF RMLWVFFDLL MDCVYLIDTF LNYRMGYMDQ GLVVREAEKV
     TKAYWQSKQY RIDGISLIPL DYILGWPIPY INWRGLPILR LNRLIRYKRV RNCLERTETR
     SSMPNAFRVV VVVWYIVIII HWNACLYFWI SEWIGLGTDA WVYGHLNKQS LPDDITDTLL
     RRYVYSFYWS TLILTTIGEV PSPVRNIEYA FVTLDLMCGV LIFATIVGNV GSMISNMSAA
     RTEFQNKMDG IKQYMELRKV SKQLEIRVIK WFDYLWTNKQ SLSDQQVLKV LPDKLQAEIA
     MQVHFETLRK VRIFQDCEAG LLAELVLKLQ LQVFSPGDFI CKKGDIGREM YIVKRGRLQV
     VDDDGKKVFV TLQEGSVFGE LSILNIAGSK NGNRRTANVR SVGYTDLFVL SKTDLWNALR
     EYPDARKLLL AKGREILKKD NLLDENAPEE QKTVEEIAEH LNNAVKVLQT RMARLIVEHS
     STEGKLMKRI EMLEKHLSRY KALARRQKTM HGVSIDGGDI STDGVDERVR PPRLRQTKTI
     DLPTGTESES LLK
//
ID   ACHB3_HUMAN             Reviewed;         458 AA.
AC   Q05901; Q15827;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   25-OCT-2017, entry version 170.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-3;
DE   Flags: Precursor;
GN   Name=CHRNB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Substantia nigra;
RX   PubMed=8906617; DOI=10.1007/BF02736842;
RA   Elliott K.J., Ellis S.B., Berckhan K.J., Urrutia A.,
RA   Chavez-Noriega L.E., Johnson E.C., Velicelebi G., Harpold M.M.;
RT   "Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-
RT   beta 4 nicotinic acetylcholine receptor subunits and functional
RT   expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta
RT   4 subunits.";
RL   J. Mol. Neurosci. 7:217-228(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pons;
RX   PubMed=9009220; DOI=10.1016/S0014-5793(96)01383-X;
RA   Groot Kormelink P.J., Luyten W.H.M.L.;
RT   "Cloning and sequence of full-length cDNAs encoding the human neuronal
RT   nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and
RT   expression of seven nAChR subunits in the human neuroblastoma cell
RT   line SH-SY5Y and/or IMR-32.";
RL   FEBS Lett. 400:309-314(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Keddache M., Durner M., Greenberg D.A.;
RT   "Genomic structure and mutation analysis of the CHRNB3 gene.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-458.
RC   TISSUE=Brain stem;
RX   PubMed=7690916; DOI=10.1016/0304-3940(93)90691-D;
RA   Willoughby J.J., Ninkina N.N., Beech M.M., Latchman D.S., Wood J.N.;
RT   "Molecular cloning of a human neuronal nicotinic acetylcholine
RT   receptor beta 3-like subunit.";
RL   Neurosci. Lett. 155:136-139(1993).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and beta.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-
CC       3/CHRNB3 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U62438; AAB40116.1; -; mRNA.
DR   EMBL; Y08417; CAA69694.1; -; mRNA.
DR   EMBL; AF140765; AAD33063.1; -; Genomic_DNA.
DR   EMBL; AF140760; AAD33063.1; JOINED; Genomic_DNA.
DR   EMBL; AF140761; AAD33063.1; JOINED; Genomic_DNA.
DR   EMBL; AF140762; AAD33063.1; JOINED; Genomic_DNA.
DR   EMBL; AF140763; AAD33063.1; JOINED; Genomic_DNA.
DR   EMBL; AF140764; AAD33063.1; JOINED; Genomic_DNA.
DR   EMBL; BC069681; AAH69681.1; -; mRNA.
DR   EMBL; BC069703; AAH69703.1; -; mRNA.
DR   EMBL; BC069788; AAH69788.1; -; mRNA.
DR   EMBL; X67513; CAA47851.1; -; mRNA.
DR   CCDS; CCDS6134.1; -.
DR   PIR; I38056; I38056.
DR   RefSeq; NP_000740.1; NM_000749.4.
DR   UniGene; Hs.654576; -.
DR   ProteinModelPortal; Q05901; -.
DR   SMR; Q05901; -.
DR   BioGrid; 107564; 3.
DR   STRING; 9606.ENSP00000289957; -.
DR   BindingDB; Q05901; -.
DR   ChEMBL; CHEMBL2109233; -.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00674; Galantamine.
DR   DrugBank; DB00184; Nicotine.
DR   PhosphoSitePlus; Q05901; -.
DR   BioMuta; CHRNB3; -.
DR   DMDM; 2506128; -.
DR   MaxQB; Q05901; -.
DR   PaxDb; Q05901; -.
DR   PRIDE; Q05901; -.
DR   DNASU; 1142; -.
DR   Ensembl; ENST00000289957; ENSP00000289957; ENSG00000147432.
DR   GeneID; 1142; -.
DR   KEGG; hsa:1142; -.
DR   UCSC; uc003xpi.2; human.
DR   CTD; 1142; -.
DR   DisGeNET; 1142; -.
DR   EuPathDB; HostDB:ENSG00000147432.6; -.
DR   GeneCards; CHRNB3; -.
DR   HGNC; HGNC:1963; CHRNB3.
DR   HPA; HPA045555; -.
DR   MIM; 118508; gene.
DR   neXtProt; NX_Q05901; -.
DR   OpenTargets; ENSG00000147432; -.
DR   PharmGKB; PA26495; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q05901; -.
DR   KO; K04814; -.
DR   OMA; LLCMKGH; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q05901; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-HSA-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   ChiTaRS; CHRNB3; human.
DR   GeneWiki; CHRNB3; -.
DR   GenomeRNAi; 1142; -.
DR   PRO; PR:Q05901; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147432; -.
DR   CleanEx; HS_CHRNB3; -.
DR   ExpressionAtlas; Q05901; baseline and differential.
DR   Genevisible; Q05901; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042166; F:acetylcholine binding; IEA:Ensembl.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; TAS:ProtInc.
DR   GO; GO:0015267; F:channel activity; TAS:ProtInc.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    458       Neuronal acetylcholine receptor subunit
FT                                beta-3.
FT                                /FTId=PRO_0000000383.
FT   TOPO_DOM     25    232       Extracellular. {ECO:0000255}.
FT   TRANSMEM    233    257       Helical. {ECO:0000255}.
FT   TRANSMEM    265    282       Helical. {ECO:0000255}.
FT   TRANSMEM    299    320       Helical. {ECO:0000255}.
FT   TOPO_DOM    321    428       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    429    447       Helical. {ECO:0000255}.
FT   CARBOHYD     51     51       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    153    167       {ECO:0000250}.
FT   VARIANT     451    451       K -> E (in dbSNP:rs35327613).
FT                                /FTId=VAR_048173.
FT   CONFLICT     36     38       LFQ -> EWK (in Ref. 5; CAA47851).
FT                                {ECO:0000305}.
SQ   SEQUENCE   458 AA;  52729 MW;  D6E919E53CBD21F8 CRC64;
     MLPDFMLVLI VLGIPSSATT GFNSIAENED ALLRHLFQGY QKWVRPVLHS NDTIKVYFGL
     KISQLVDVDE KNQLMTTNVW LKQEWTDHKL RWNPDDYGGI HSIKVPSESL WLPDIVLFEN
     ADGRFEGSLM TKVIVKSNGT VVWTPPASYK SSCTMDVTFF PFDRQNCSMK FGSWTYDGTM
     VDLILINENV DRKDFFDNGE WEILNAKGMK GNRRDGVYSY PFITYSFVLR RLPLFYTLFL
     IIPCLGLSFL TVLVFYLPSD EGEKLSLSTS VLVSLTVFLL VIEEIIPSSS KVIPLIGEYL
     LFIMIFVTLS IIVTVFVINV HHRSSSTYHP MAPWVKRLFL QKLPKLLCMK DHVDRYSSPE
     KEESQPVVKG KVLEKKKQKQ LSDGEKVLVA FLEKAADSIR YISRHVKKEH FISQVVQDWK
     FVAQVLDRIF LWLFLIVSVT GSVLIFTPAL KMWLHSYH
//
ID   ACHA7_RAT               Reviewed;         502 AA.
AC   Q05941; Q53YK2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   22-NOV-2017, entry version 148.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-7;
DE   Flags: Precursor;
GN   Name=Chrna7; Synonyms=Acra7;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7678857;
RA   Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W.;
RT   "Molecular cloning, functional properties, and distribution of rat
RT   brain alpha 7: a nicotinic cation channel highly permeable to
RT   calcium.";
RL   J. Neurosci. 13:596-604(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Boulter J.;
RL   Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SEQUENCE REVISION TO 363.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Hartley M.;
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH RIC3, AND MUTAGENESIS OF LEU-433; LYS-435; VAL-440;
RP   ASN-445; ARG-446; PHE-447 AND ARG-448.
RX   PubMed=15927954; DOI=10.1074/jbc.M503746200;
RA   Castillo M., Mulet J., Gutierrez L.M., Ortiz J.A., Castelan F.,
RA   Gerber S., Sala S., Sala F., Criado M.;
RT   "Dual role of the RIC-3 protein in trafficking of serotonin and
RT   nicotinic acetylcholine receptors.";
RL   J. Biol. Chem. 280:27062-27068(2005).
RN   [6]
RP   INTERACTION WITH RIC3.
RX   PubMed=16120769; DOI=10.1124/mol.105.017459;
RA   Lansdell S.J., Gee V.J., Harkness P.C., Doward A.I., Baker E.R.,
RA   Gibb A.J., Millar N.S.;
RT   "RIC-3 enhances functional expression of multiple nicotinic
RT   acetylcholine receptor subtypes in mammalian cells.";
RL   Mol. Pharmacol. 68:1431-1438(2005).
RN   [7]
RP   MUTAGENESIS OF SER-81 AND LEU-141, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [8]
RP   ERRATUM.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with
RT   the rat alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. The channel is blocked by alpha-bungarotoxin.
CC   -!- SUBUNIT: Homopentamer (By similarity). Interacts with RIC3; which
CC       is required for proper folding and assembly (PubMed:15927954,
CC       PubMed:16120769). Interacts with LYPD6 (By similarity). Interacts
CC       with the alpha-conotoxin RgIA (PubMed:25740413). Interacts with
CC       alpha-conotoxins ImI and ImII (By similarity).
CC       {ECO:0000250|UniProtKB:P36544, ECO:0000250|UniProtKB:P54131,
CC       ECO:0000269|PubMed:15927954, ECO:0000269|PubMed:16120769,
CC       ECO:0000269|PubMed:25740413}.
CC   -!- INTERACTION:
CC       P60615:- (xeno); NbExp=4; IntAct=EBI-79422, EBI-7516391;
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       7/CHRNA7 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S53987; AAB25224.2; -; mRNA.
DR   EMBL; L31619; AAC33136.1; -; mRNA.
DR   EMBL; AY574256; AAS90352.1; -; mRNA.
DR   PIR; T01378; T01378.
DR   RefSeq; NP_036964.3; NM_012832.3.
DR   UniGene; Rn.9698; -.
DR   ProteinModelPortal; Q05941; -.
DR   SMR; Q05941; -.
DR   IntAct; Q05941; 3.
DR   STRING; 10116.ENSRNOP00000045255; -.
DR   BindingDB; Q05941; -.
DR   ChEMBL; CHEMBL4980; -.
DR   GuidetoPHARMACOLOGY; 468; -.
DR   iPTMnet; Q05941; -.
DR   PhosphoSitePlus; Q05941; -.
DR   SwissPalm; Q05941; -.
DR   PaxDb; Q05941; -.
DR   GeneID; 25302; -.
DR   KEGG; rno:25302; -.
DR   UCSC; RGD:2348; rat.
DR   CTD; 1139; -.
DR   RGD; 2348; Chrna7.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q05941; -.
DR   KO; K04809; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q05941; -.
DR   PRO; PR:Q05941; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:ARUK-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0030673; C:axolemma; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:ARUK-UCL.
DR   GO; GO:0014069; C:postsynaptic density; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISO:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IDA:ARUK-UCL.
DR   GO; GO:0008179; F:adenylate cyclase binding; IPI:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; IDA:RGD.
DR   GO; GO:0017081; F:chloride channel regulator activity; ISO:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0005216; F:ion channel activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IDA:RGD.
DR   GO; GO:0015643; F:toxic substance binding; ISO:RGD.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0000187; P:activation of MAPK activity; ISO:RGD.
DR   GO; GO:0008306; P:associative learning; ISO:RGD.
DR   GO; GO:0042113; P:B cell activation; ISO:RGD.
DR   GO; GO:0048149; P:behavioral response to ethanol; ISO:RGD.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0050890; P:cognition; ISO:RGD.
DR   GO; GO:0140059; P:dendrite arborization; ISO:RGD.
DR   GO; GO:0097061; P:dendritic spine organization; ISO:RGD.
DR   GO; GO:0042416; P:dopamine biosynthetic process; IEP:RGD.
DR   GO; GO:0006897; P:endocytosis; ISO:RGD.
DR   GO; GO:0030317; P:flagellated sperm motility; ISO:RGD.
DR   GO; GO:0060112; P:generation of ovulation cycle rhythm; ISO:RGD.
DR   GO; GO:0034220; P:ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006811; P:ion transport; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; ISO:RGD.
DR   GO; GO:0007613; P:memory; IDA:ARUK-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0098815; P:modulation of excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:1902430; P:negative regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0042698; P:ovulation cycle; ISO:RGD.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; ISO:RGD.
DR   GO; GO:1905920; P:positive regulation of CoA-transferase activity; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:ARUK-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0001988; P:positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:1905906; P:regulation of amyloid fibril formation; ISO:RGD.
DR   GO; GO:1902991; P:regulation of amyloid precursor protein catabolic process; ISO:RGD.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:MGI.
DR   GO; GO:1901214; P:regulation of neuron death; ISO:RGD.
DR   GO; GO:0014061; P:regulation of norepinephrine secretion; ISO:RGD.
DR   GO; GO:0032225; P:regulation of synaptic transmission, dopaminergic; ISO:RGD.
DR   GO; GO:1905144; P:response to acetylcholine; IDA:ARUK-UCL.
DR   GO; GO:1904645; P:response to amyloid-beta; ISO:RGD.
DR   GO; GO:0009409; P:response to cold; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0032094; P:response to food; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; IGI:ARUK-UCL.
DR   GO; GO:0050893; P:sensory processing; IDA:ARUK-UCL.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IMP:RGD.
DR   GO; GO:0042110; P:T cell activation; ISO:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    502       Neuronal acetylcholine receptor subunit
FT                                alpha-7.
FT                                /FTId=PRO_0000000369.
FT   TOPO_DOM     23    230       Extracellular. {ECO:0000255}.
FT   TRANSMEM    231    255       Helical. {ECO:0000255}.
FT   TRANSMEM    262    280       Helical. {ECO:0000255}.
FT   TRANSMEM    296    317       Helical. {ECO:0000255}.
FT   TOPO_DOM    318    469       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    470    490       Helical. {ECO:0000255}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     90     90       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    150    164       {ECO:0000250}.
FT   DISULFID    212    213       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   MUTAGEN      81     81       S->T: 10-fold more potently inhibited by
FT                                the alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     141    141       L->D: No change in inhibition by the
FT                                alpha-conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     433    433       L->A: Abolishes dependency on RIC3 for
FT                                functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   MUTAGEN     435    435       K->A: No effect on dependency on RIC3 for
FT                                functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   MUTAGEN     440    440       V->A: Impairs dependency on RIC3 for
FT                                functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   MUTAGEN     445    445       N->A: Slightly impairs dependency on RIC3
FT                                for functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   MUTAGEN     446    446       R->A: Impairs dependency on RIC3 for
FT                                functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   MUTAGEN     447    447       F->A: Impairs dependency on RIC3 for
FT                                functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   MUTAGEN     448    448       R->A: Impairs dependency on RIC3 for
FT                                functional expression.
FT                                {ECO:0000269|PubMed:15927954}.
FT   CONFLICT    447    447       F -> N (in Ref. 1; AAB25224).
FT                                {ECO:0000305}.
FT   CONFLICT    469    469       R -> P (in Ref. 1; AAB25224).
FT                                {ECO:0000305}.
SQ   SEQUENCE   502 AA;  56503 MW;  289A30498C7B9A58 CRC64;
     MCGGRGGIWL ALAAALLHVS LQGEFQRRLY KELVKNYNPL ERPVANDSQP LTVYFSLSLL
     QIMDVDEKNQ VLTTNIWLQM SWTDHYLQWN MSEYPGVKNV RFPDGQIWKP DILLYNSADE
     RFDATFHTNV LVNASGHCQY LPPGIFKSSC YIDVRWFPFD VQQCKLKFGS WSYGGWSLDL
     QMQEADISSY IPNGEWDLMG IPGKRNEKFY ECCKEPYPDV TYTVTMRRRT LYYGLNLLIP
     CVLISALALL VFLLPADSGE KISLGITVLL SLTVFMLLVA EIMPATSDSV PLIAQYFAST
     MIIVGLSVVV TVIVLRYHHH DPDGGKMPKW TRIILLNWCA WFLRMKRPGE DKVRPACQHK
     PRRCSLASVE LSAGAGPPTS NGNLLYIGFR GLEGMHCAPT PDSGVVCGRL ACSPTHDEHL
     MHGAHPSDGD PDLAKILEEV RYIANRFRCQ DESEVICSEW KFAACVVDRL CLMAFSVFTI
     ICTIGILMSA PNFVEAVSKD FA
//
ID   ACHD_HUMAN              Reviewed;         517 AA.
AC   Q07001; A8K661; B4DT92; Q52LH4;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   25-OCT-2017, entry version 173.
DE   RecName: Full=Acetylcholine receptor subunit delta;
DE   Flags: Precursor;
GN   Name=CHRND; Synonyms=ACHRD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2564429;
RA   Luther M.A., Schoepfer R., Whiting P., Casey B., Blatt Y.,
RA   Montal M.S., Montal M., Lindstrom J.;
RT   "A muscle acetylcholine receptor is expressed in the human cerebellar
RT   medulloblastoma cell line TE671.";
RL   J. Neurosci. 9:1082-1096(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pericardium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBUNIT.
RX   PubMed=15609996; DOI=10.1021/bi048918g;
RA   Ellison M., Gao F., Wang H.L., Sine S.M., McIntosh J.M., Olivera B.M.;
RT   "Alpha-conotoxins ImI and ImII target distinct regions of the human
RT   alpha7 nicotinic acetylcholine receptor and distinguish human
RT   nicotinic receptor subtypes.";
RL   Biochemistry 43:16019-16026(2004).
RN   [7]
RP   INVOLVEMENT IN CMS3C, VARIANT CMS3C LYS-402, AND CHARACTERIZATION OF
RP   VARIANT CMS3C LYS-402.
RX   PubMed=16916845; DOI=10.1093/brain/awl188;
RA   Mueller J.S., Baumeister S.K., Schara U., Cossins J., Krause S.,
RA   von der Hagen M., Huebner A., Webster R., Beeson D., Lochmueller H.,
RA   Abicht A.;
RT   "CHRND mutation causes a congenital myasthenic syndrome by impairing
RT   co-clustering of the acetylcholine receptor with rapsyn.";
RL   Brain 129:2784-2793(2006).
RN   [8]
RP   INVOLVEMENT IN CMS3C, VARIANTS CMS3B PRO-42 AND LYS-79, VARIANT
RP   LEU-114, CHARACTERIZATION OF VARIANTS CMS3B PRO-42 AND LYS-79, AND
RP   CHARACTERIZATION OF VARIANT LEU-114.
RX   PubMed=18398509; DOI=10.1172/JCI34527;
RA   Shen X.M., Fukuda T., Ohno K., Sine S.M., Engel A.G.;
RT   "Congenital myasthenia-related AChR delta subunit mutation interferes
RT   with intersubunit communication essential for channel gating.";
RL   J. Clin. Invest. 118:1867-1876(2008).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF VAL-290.
RX   PubMed=27375219; DOI=10.1002/humu.23043;
RA   Shen X.M., Okuno T., Milone M., Otsuka K., Takahashi K., Komaki H.,
RA   Giles E., Ohno K., Engel A.G.;
RT   "Mutations causing slow-channel myasthenia reveal that a valine ring
RT   in the channel pore of muscle AChR is optimized for stabilizing
RT   channel gating.";
RL   Hum. Mutat. 37:1051-1059(2016).
RN   [10]
RP   VARIANT CMS3A GLU-288.
RX   PubMed=8872460; DOI=10.1093/hmg/5.9.1217;
RA   Engel A.G., Ohno K., Milone M., Wang H.-L., Nakano S., Bouzat C.,
RA   Pruitt J.N. II, Hutchinson D.O., Brengman J.M., Bren N., Sieb J.P.,
RA   Sine S.M.;
RT   "New mutations in acetylcholine receptor subunit genes reveal
RT   heterogeneity in the slow-channel congenital myasthenic syndrome.";
RL   Hum. Mol. Genet. 5:1217-1227(1996).
RN   [11]
RP   VARIANT CMS3A PHE-289, AND CHARACTERIZATION OF VARIANT CMS3A PHE-289.
RX   PubMed=11782989; DOI=10.1002/ana.10077;
RA   Gomez C.M., Maselli R.A., Vohra B.P.S., Navedo M., Stiles J.R.,
RA   Charnet P., Schott K., Rojas L., Keesey J., Verity A., Wollmann R.W.,
RA   Lasalde-Dominicci J.;
RT   "Novel delta subunit mutation in slow-channel syndrome causes severe
RT   weakness by novel mechanisms.";
RL   Ann. Neurol. 51:102-112(2002).
RN   [12]
RP   VARIANT CMS3B LYS-80, AND CHARACTERIZATION OF VARIANT CMS3B LYS-80.
RX   PubMed=11435464; DOI=10.1172/JCI200112935;
RA   Brownlow S., Webster R., Croxen R., Brydson M., Neville B., Lin J.-P.,
RA   Vincent A., Newsom-Davis J., Beeson D.;
RT   "Acetylcholine receptor delta subunit mutations underlie a fast-
RT   channel myasthenic syndrome and arthrogryposis multiplex congenita.";
RL   J. Clin. Invest. 108:125-130(2001).
RN   [13]
RP   VARIANT CMS3B GLN-271, AND CHARACTERIZATION OF VARIANT CMS3B GLN-271.
RX   PubMed=12499478; DOI=10.1212/01.WNL.0000042422.87384.2F;
RA   Shen X.-M., Ohno K., Fukudome T., Tsujino A., Brengman J.M.,
RA   De Vivo D.C., Packer R.J., Engel A.G.;
RT   "Congenital myasthenic syndrome caused by low-expressor fast-channel
RT   AChR delta subunit mutation.";
RL   Neurology 59:1881-1888(2002).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-398.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANT LMPS LEU-95.
RX   PubMed=18252226; DOI=10.1016/j.ajhg.2007.11.006;
RA   Michalk A., Stricker S., Becker J., Rupps R., Pantzar T., Miertus J.,
RA   Botta G., Naretto V.G., Janetzki C., Yaqoob N., Ott C.-E., Seelow D.,
RA   Wieczorek D., Fiebig B., Wirth B., Hoopmann M., Walther M.,
RA   Koerber F., Blankenburg M., Mundlos S., Heller R., Hoffmann K.;
RT   "Acetylcholine receptor pathway mutations explain various fetal
RT   akinesia deformation sequence disorders.";
RL   Am. J. Hum. Genet. 82:464-476(2008).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. {ECO:0000269|PubMed:27375219}.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma (in immature muscle) or epsilon (in mature
CC       muscle) chains. The muscle heteropentamer composed of alpha-1,
CC       beta-1, delta, epsilon subunits interacts with the alpha-conotoxin
CC       ImII (PubMed:15609996). {ECO:0000269|PubMed:15609996}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q07001-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q07001-2; Sequence=VSP_046423;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Multiple pterygium syndrome, lethal type (LMPS)
CC       [MIM:253290]: Multiple pterygia are found infrequently in children
CC       with arthrogryposis and in fetuses with fetal akinesia syndrome.
CC       In lethal multiple pterygium syndrome there is intrauterine growth
CC       retardation, multiple pterygia, and flexion contractures causing
CC       severe arthrogryposis and fetal akinesia. Subcutaneous edema can
CC       be severe, causing fetal hydrops with cystic hygroma and lung
CC       hypoplasia. Oligohydramnios and facial anomalies are frequent.
CC       {ECO:0000269|PubMed:18252226}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 3A, slow-channel (CMS3A)
CC       [MIM:616321]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS3A is a slow-channel myasthenic syndrome. It is caused
CC       by kinetic abnormalities of the AChR, resulting in prolonged AChR
CC       channel opening episodes, prolonged endplate currents, and
CC       depolarization block. This is associated with calcium overload,
CC       which may contribute to subsequent degeneration of the endplate
CC       and postsynaptic membrane. {ECO:0000269|PubMed:11782989,
CC       ECO:0000269|PubMed:8872460}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 3B, fast-channel (CMS3B)
CC       [MIM:616322]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS3B is a fast-channel myasthenic syndrome. It is caused
CC       by kinetic abnormalities of the AChR, resulting in brief opening
CC       and activity of the channel, with a rapid decay in endplate
CC       current, failure to achieve threshold depolarization of the
CC       endplate and consequent failure to fire an action potential.
CC       {ECO:0000269|PubMed:11435464, ECO:0000269|PubMed:12499478,
CC       ECO:0000269|PubMed:18398509}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 3C, associated with
CC       acetylcholine receptor deficiency (CMS3C) [MIM:616323]: A form of
CC       congenital myasthenic syndrome, a group of disorders characterized
CC       by failure of neuromuscular transmission, including pre-synaptic,
CC       synaptic, and post-synaptic disorders that are not of autoimmune
CC       origin. Clinical features are easy fatigability and muscle
CC       weakness affecting the axial and limb muscles (with hypotonia in
CC       early-onset forms), the ocular muscles (leading to ptosis and
CC       ophthalmoplegia), and the facial and bulbar musculature (affecting
CC       sucking and swallowing, and leading to dysphonia). The symptoms
CC       fluctuate and worsen with physical effort. CMS3C is an autosomal
CC       recessive disorder of postsynaptic neuromuscular transmission, due
CC       to deficiency of AChR at the endplate that results in low
CC       amplitude of the miniature endplate potential and current.
CC       {ECO:0000269|PubMed:16916845, ECO:0000269|PubMed:18398509}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Delta/CHRND
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X55019; CAA38759.1; -; mRNA.
DR   EMBL; AK291526; BAF84215.1; -; mRNA.
DR   EMBL; AK300109; BAG61904.1; -; mRNA.
DR   EMBL; AK315297; BAG37703.1; -; mRNA.
DR   EMBL; AC092165; AAY24102.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW71003.1; -; Genomic_DNA.
DR   EMBL; BC093923; AAH93923.1; -; mRNA.
DR   EMBL; BC093925; AAH93925.1; -; mRNA.
DR   CCDS; CCDS2494.1; -. [Q07001-1]
DR   CCDS; CCDS58754.1; -. [Q07001-2]
DR   PIR; A60916; A60916.
DR   RefSeq; NP_000742.1; NM_000751.2. [Q07001-1]
DR   RefSeq; NP_001243586.1; NM_001256657.1. [Q07001-2]
DR   RefSeq; NP_001298124.1; NM_001311195.1.
DR   RefSeq; NP_001298125.1; NM_001311196.1.
DR   UniGene; Hs.156289; -.
DR   ProteinModelPortal; Q07001; -.
DR   BioGrid; 107566; 61.
DR   IntAct; Q07001; 1.
DR   STRING; 9606.ENSP00000258385; -.
DR   BindingDB; Q07001; -.
DR   ChEMBL; CHEMBL3011; -.
DR   DrugBank; DB00674; Galantamine.
DR   GuidetoPHARMACOLOGY; 476; -.
DR   TCDB; 1.A.9.1.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; Q07001; -.
DR   PhosphoSitePlus; Q07001; -.
DR   BioMuta; CHRND; -.
DR   DMDM; 543759; -.
DR   MaxQB; Q07001; -.
DR   PaxDb; Q07001; -.
DR   PeptideAtlas; Q07001; -.
DR   PRIDE; Q07001; -.
DR   Ensembl; ENST00000258385; ENSP00000258385; ENSG00000135902. [Q07001-1]
DR   Ensembl; ENST00000543200; ENSP00000438380; ENSG00000135902. [Q07001-2]
DR   GeneID; 1144; -.
DR   KEGG; hsa:1144; -.
DR   UCSC; uc002vsw.5; human. [Q07001-1]
DR   CTD; 1144; -.
DR   DisGeNET; 1144; -.
DR   EuPathDB; HostDB:ENSG00000135902.9; -.
DR   GeneCards; CHRND; -.
DR   GeneReviews; CHRND; -.
DR   HGNC; HGNC:1965; CHRND.
DR   MalaCards; CHRND; -.
DR   MIM; 100720; gene.
DR   MIM; 253290; phenotype.
DR   MIM; 616321; phenotype.
DR   MIM; 616322; phenotype.
DR   MIM; 616323; phenotype.
DR   neXtProt; NX_Q07001; -.
DR   OpenTargets; ENSG00000135902; -.
DR   Orphanet; 33108; Lethal multiple pterygium syndrome.
DR   Orphanet; 98913; Postsynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA26497; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006757; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q07001; -.
DR   KO; K04816; -.
DR   OMA; VLISFMI; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q07001; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   GeneWiki; CHRND; -.
DR   GenomeRNAi; 1144; -.
DR   PRO; PR:Q07001; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000135902; -.
DR   CleanEx; HS_CHRND; -.
DR   ExpressionAtlas; Q07001; baseline and differential.
DR   Genevisible; Q07001; HS.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; NAS:BHF-UCL.
DR   GO; GO:0042166; F:acetylcholine binding; IEA:Ensembl.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; TAS:ProtInc.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0098655; P:cation transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0050881; P:musculoskeletal movement; IMP:BHF-UCL.
DR   GO; GO:0050905; P:neuromuscular process; NAS:BHF-UCL.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0003009; P:skeletal muscle contraction; IEA:Ensembl.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; IMP:BHF-UCL.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Congenital myasthenic syndrome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Phosphoprotein; Polymorphism; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000250}.
FT   CHAIN        22    517       Acetylcholine receptor subunit delta.
FT                                /FTId=PRO_0000000322.
FT   TOPO_DOM     22    245       Extracellular. {ECO:0000255}.
FT   TRANSMEM    246    270       Helical. {ECO:0000255}.
FT   TRANSMEM    278    299       Helical. {ECO:0000255}.
FT   TRANSMEM    312    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    471       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    472    490       Helical. {ECO:0000255}.
FT   MOD_RES     390    390       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000250}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    164    164       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
FT   VAR_SEQ      67     81       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046423.
FT   VARIANT      42     42       L -> P (in CMS3B; results in reduced
FT                                gating efficiency; slows opening of the
FT                                channel; decreases probability that the
FT                                channel will open in response to ACh).
FT                                {ECO:0000269|PubMed:18398509}.
FT                                /FTId=VAR_073691.
FT   VARIANT      79     79       I -> K (in CMS3B; prevents expression of
FT                                the AChR on the cell surface; is a null
FT                                mutation; dbSNP:rs121909509).
FT                                {ECO:0000269|PubMed:18398509}.
FT                                /FTId=VAR_073692.
FT   VARIANT      80     80       E -> K (in CMS3B; reduced adult and fetal
FT                                AChR expression and a reduced probability
FT                                of both adult and fetal AChR being in the
FT                                open state; dbSNP:rs121909504).
FT                                {ECO:0000269|PubMed:11435464}.
FT                                /FTId=VAR_021210.
FT   VARIANT      95     95       F -> L (in LMPS; dbSNP:rs121909506).
FT                                {ECO:0000269|PubMed:18252226}.
FT                                /FTId=VAR_043905.
FT   VARIANT     114    114       V -> L (polymorphism; has no appreciable
FT                                kinetic effects; allows for robust AChR
FT                                expression; dbSNP:rs760395222).
FT                                {ECO:0000269|PubMed:18398509}.
FT                                /FTId=VAR_073693.
FT   VARIANT     271    271       P -> Q (in CMS3B; burst duration was
FT                                decreased and disassociation of ACh was
FT                                increased resulting in brief channel
FT                                opening episodes; shows abnormal
FT                                association with alpha CHRNA1 subunit
FT                                resulting in a decreased number of fully
FT                                assembled AChRs; dbSNP:rs121909503).
FT                                {ECO:0000269|PubMed:12499478}.
FT                                /FTId=VAR_021211.
FT   VARIANT     288    288       Q -> E (in CMS3A; a benign mutation or a
FT                                rare polymorphism; dbSNP:rs41265127).
FT                                {ECO:0000269|PubMed:8872460}.
FT                                /FTId=VAR_021212.
FT   VARIANT     289    289       S -> F (in CMS3A; delayed closure of AchR
FT                                ion channels, increasing the propensity
FT                                for open-channel block, as well as a
FT                                reduced rate of channel opening;
FT                                dbSNP:rs121909502).
FT                                {ECO:0000269|PubMed:11782989}.
FT                                /FTId=VAR_019566.
FT   VARIANT     398    398       D -> E (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036031.
FT   VARIANT     402    402       E -> K (in CMS3C; results in reduced
FT                                expression of the AChR at the cell
FT                                surface; impairs normal clustering of the
FT                                AChR channel with RAPSN;
FT                                dbSNP:rs145955590).
FT                                {ECO:0000269|PubMed:16916845}.
FT                                /FTId=VAR_073694.
FT   MUTAGEN     290    290       V->A: Increased length of channel
FT                                opening. {ECO:0000269|PubMed:27375219}.
SQ   SEQUENCE   517 AA;  58895 MW;  195CEF69358758BD CRC64;
     MEGPVLTLGL LAALAVCGSW GLNEEERLIR HLFQEKGYNK ELRPVAHKEE SVDVALALTL
     SNLISLKEVE ETLTTNVWIE HGWTDNRLKW NAEEFGNISV LRLPPDMVWL PEIVLENNND
     GSFQISYSCN VLVYHYGFVY WLPPAIFRSS CPISVTYFPF DWQNCSLKFS SLKYTAKEIT
     LSLKQDAKEN RTYPVEWIII DPEGFTENGE WEIVHRPARV NVDPRAPLDS PSRQDITFYL
     IIRRKPLFYI INILVPCVLI SFMVNLVFYL PADSGEKTSV AISVLLAQSV FLLLISKRLP
     ATSMAIPLIG KFLLFGMVLV TMVVVICVIV LNIHFRTPST HVLSEGVKKL FLETLPELLH
     MSRPAEDGPS PGALVRRSSS LGYISKAEEY FLLKSRSDLM FEKQSERHGL ARRLTTARRP
     PASSEQAQQE LFNELKPAVD GANFIVNHMR DQNNYNEEKD SWNRVARTVD RLCLFVVTPV
     MVVGTAWIFL QGVYNQPPPQ PFPGDPYSYN VQDKRFI
//
ID   GBRB3_DROME             Reviewed;         496 AA.
AC   Q08832; A4V4J6; Q9TX49; Q9VXL8;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   22-NOV-2017, entry version 156.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit beta-like;
DE   AltName: Full=GABA(A) receptor;
DE   Flags: Precursor;
GN   Name=Lcch3; ORFNames=CG17336;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Canton-S; TISSUE=Pupae;
RX   PubMed=7685594; DOI=10.1006/bbrc.1993.1648;
RA   Henderson J.E., Soderlund D.M., Knipple D.C.;
RT   "Characterization of a putative gamma-aminobutyric acid (GABA)
RT   receptor beta subunit gene from Drosophila melanogaster.";
RL   Biochem. Biophys. Res. Commun. 193:474-482(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 284-340.
RC   STRAIN=Canton-S;
RX   PubMed=8025558; DOI=10.1016/0965-1748(94)90029-9;
RA   Henderson J.E., Knipple D.C., Soderlund D.M.;
RT   "PCR-based homology probing reveals a family of GABA receptor-like
RT   genes in Drosophila melanogaster.";
RL   Insect Biochem. Mol. Biol. 24:363-371(1994).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH GRD.
RX   PubMed=15148245; DOI=10.1038/sj.bjp.0705818;
RA   Gisselmann G., Plonka J., Pusch H., Hatt H.;
RT   "Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric
RT   GABA-gated cation channels.";
RL   Br. J. Pharmacol. 142:409-413(2004).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel. Combines with the ligand-gated ion channel
CC       subunit GRD to form cation-selective GABA-gated ion channels when
CC       coexpressed in Xenopus laevis oocytes.
CC       {ECO:0000269|PubMed:15148245}.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho. Interacts
CC       with Grd (alpha chain). {ECO:0000269|PubMed:15148245}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L17436; AAA28559.1; -; mRNA.
DR   EMBL; S62717; AAB27090.1; -; mRNA.
DR   EMBL; AE014298; AAS65370.1; -; Genomic_DNA.
DR   EMBL; AY060660; AAL28208.1; -; mRNA.
DR   PIR; JN0603; JN0603.
DR   RefSeq; NP_996469.1; NM_206746.2.
DR   UniGene; Dm.6661; -.
DR   ProteinModelPortal; Q08832; -.
DR   SMR; Q08832; -.
DR   STRING; 7227.FBpp0089263; -.
DR   TCDB; 1.A.9.5.6; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q08832; -.
DR   PRIDE; Q08832; -.
DR   EnsemblMetazoa; FBtr0074129; FBpp0089263; FBgn0010240.
DR   GeneID; 32554; -.
DR   KEGG; dme:Dmel_CG17336; -.
DR   CTD; 32554; -.
DR   FlyBase; FBgn0010240; Lcch3.
DR   eggNOG; KOG3643; Eukaryota.
DR   eggNOG; ENOG410XPWH; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   InParanoid; Q08832; -.
DR   KO; K05181; -.
DR   OMA; SMPREGH; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q08832; -.
DR   Reactome; R-DME-977441; GABA A receptor activation.
DR   ChiTaRS; Lcch3; fly.
DR   GenomeRNAi; 32554; -.
DR   PRO; PR:Q08832; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0010240; -.
DR   Genevisible; Q08832; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR002289; GABAAb_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01160; GABAARBETA.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       Or 27. {ECO:0000255}.
FT   CHAIN        21    496       Gamma-aminobutyric acid receptor subunit
FT                                beta-like.
FT                                /FTId=PRO_0000000454.
FT   TOPO_DOM     21    258       Extracellular. {ECO:0000255}.
FT   TRANSMEM    259    280       Helical. {ECO:0000255}.
FT   TRANSMEM    285    306       Helical. {ECO:0000255}.
FT   TRANSMEM    318    342       Helical. {ECO:0000255}.
FT   TOPO_DOM    343    472       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    473    494       Helical. {ECO:0000255}.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    189    189       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    176    190       {ECO:0000250}.
FT   CONFLICT     12     12       G -> S (in Ref. 1; AAA28559/AAB27090).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       V -> C (in Ref. 5; no nucleotide entry).
FT                                {ECO:0000305}.
SQ   SEQUENCE   496 AA;  56597 MW;  62C9A9E97E8DF681 CRC64;
     MTCFTRVGVS CGLFFFLLGA QLQLIRCIRK DVLAGRLENV TQTISNILQG YDIRLRPNFG
     GEPLHVGMDL TIASFDAISE VNMDYTITMY LNQYWRDERL AFNIFGQYFD DENDDGISDV
     LTLSGDFAEK IWVPDTFFAN DKNSFLHDVT ERNKLVRLGG DGAVTYGMRF TTTLACMMDL
     HYYPLDSQNC TVEIESYGYT VSDVVMYWKP TPVRGVEDAE LPQFTIIGYE TNDRKERLAT
     GVYQRLSLSF KLQRNIGYFV FQTYLPSILI VMLSWVSFWI NHEATSARVA LGITTVLTMT
     TISTGVRSSL PRISYVKAID IYLVMCFVFV FAALLEYAAV NYTYWGKRAK KKIKKVKECC
     PGKIGKSERS ETCSTTEDII ELQDVRMSPI PSLRRGTYNA TLDSIGTETM NLGKFPPSFR
     ITRNYGTGHS QLRRRAQRGI STRPRMLHAL KRGASAIKAT IPKIKDVNII DKYSRMIFPI
     SFLAFNLGYW LFYILE
//
ID   GLRB4_CAEEL             Reviewed;         473 AA.
AC   Q09453;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   25-OCT-2017, entry version 127.
DE   RecName: Full=Glycine receptor subunit beta-type 4;
DE   Flags: Precursor;
GN   Name=ggr-1; Synonyms=gbr-4; ORFNames=C09G5.1/C09G5.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels.
CC       Channel opening is triggered by extracellular glycine. Contributes
CC       to the generation of inhibitory postsynaptic currents.
CC       {ECO:0000250|UniProtKB:P48168}.
CC   -!- SUBUNIT: Pentamer. {ECO:0000250|UniProtKB:P48167}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:P48168}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:P48167}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:P48168}. Cell membrane
CC       {ECO:0000250|UniProtKB:P48168}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23415}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glycine receptor (TC 1.A.9.3) subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z46791; CAA86760.2; -; Genomic_DNA.
DR   PIR; T19145; T19145.
DR   RefSeq; NP_496306.2; NM_063905.3.
DR   UniGene; Cel.25057; -.
DR   ProteinModelPortal; Q09453; -.
DR   STRING; 6239.C09G5.1; -.
DR   PaxDb; Q09453; -.
DR   EnsemblMetazoa; C09G5.1; C09G5.1; WBGene00001586.
DR   GeneID; 191636; -.
DR   KEGG; cel:CELE_C09G5.1; -.
DR   UCSC; C09G5.1; c. elegans.
DR   CTD; 191636; -.
DR   WormBase; C09G5.1; CE36915; WBGene00001586; ggr-1.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   InParanoid; Q09453; -.
DR   KO; K05273; -.
DR   OMA; EITHHII; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q09453; -.
DR   PRO; PR:Q09453; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00001586; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    473       Glycine receptor subunit beta-type 4.
FT                                /FTId=PRO_0000000426.
FT   TOPO_DOM     20    249       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    250    271       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    272    276       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    277    297       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    298    308       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    309    329       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    330    439       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TRANSMEM    440    460       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   TOPO_DOM    461    473       Extracellular.
FT                                {ECO:0000250|UniProtKB:P23415}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    166    180       {ECO:0000250|UniProtKB:P23415}.
SQ   SEQUENCE   473 AA;  55540 MW;  0290671D994F7307 CRC64;
     MHSLFLKILI YSLMQCVLGQ AEFWDYDENV TQIEEDFKID DVTRILKRVG NYNRNAYPLL
     DQDLATHVDI QMYIEGMSSF HAQSMDFQVD IYFQEKWVDH RLQHNNTKRI LVKDPKLFGL
     LWHPDLYFAN ARTASFHDVT QPNFLVWIYP NGTVWYDCRI SLTVLCMQDL ARYPLDSQNC
     GLRILSYAYD EEQLIIRWNG GNPVEVNRGI RMPDMHLKHI KFYTKRDKYA TGIWSSAVAE
     FHVDREITHH IIQSYIPTSL IVIISWFSFW LDVEAVPGRV SLSITTLLTL ATQSSAARMA
     LPQASDVKAI DVWMGTCMAF VFSAMIEFTV VNYCVRRKVR TKIKPRGLSE QVHDMVAQYR
     EKKDKFNNGN CEISYEMALQ PNEDNATVQR NFEKKEVREM NQASLFVRRS LLPTSKRKTI
     EDRINRVEEN RKNAQKIDRY SRALFPLAFI IFNIFYWIYY LKYAGSNSPE LLL
//
ID   GLR2_CAEEL              Reviewed;         977 AA.
AC   Q10914; Q86GT2; Q9BK24;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   15-AUG-2003, sequence version 3.
DT   25-OCT-2017, entry version 135.
DE   RecName: Full=Glutamate receptor 2;
DE   Flags: Precursor;
GN   Name=glr-2; ORFNames=B0280.12/K04G7.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND FUNCTION.
RX   PubMed=12467596; DOI=10.1016/S0896-6273(02)01088-7;
RA   Mellem J.E., Brockie P.J., Zheng Y., Madsen D.M., Maricq A.V.;
RT   "Decoding of polymodal sensory stimuli by postsynaptic glutamate
RT   receptors in C. elegans.";
RL   Neuron 36:933-944(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 491-920 (ISOFORMS A AND B), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11222641;
RA   Brockie P.J., Madsen D.M., Zheng Y., Mellem J., Maricq A.V.;
RT   "Differential expression of glutamate receptor subunits in the nervous
RT   system of Caenorhabditis elegans and their regulation by the
RT   homeodomain protein UNC-42.";
RL   J. Neurosci. 21:1510-1522(2001).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-566, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: L-glutamate acts as an excitatory neurotransmitter at
CC       many synapses in the central nervous system. The postsynaptic
CC       actions of glutamate are mediated by a variety of receptors that
CC       are named according to their selective agonists. Required for
CC       response to mechanical and osmotic stimuli.
CC       {ECO:0000269|PubMed:12467596}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=b;
CC         IsoId=Q10914-1; Sequence=Displayed;
CC       Name=a;
CC         IsoId=Q10914-2; Sequence=VSP_008031;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Command interneurons of the locomotory control
CC       circuit (AIA, AIB, AVA, AVD, AVE, PVC, RIA, RIG and RIR) and motor
CC       neurons (AVG, M1, RMDD and RMDV). {ECO:0000269|PubMed:11222641}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF318606; AAK01094.2; -; mRNA.
DR   EMBL; FO080148; CCD61608.1; -; Genomic_DNA.
DR   EMBL; FO080148; CCD61609.1; -; Genomic_DNA.
DR   PIR; T15306; T15306.
DR   RefSeq; NP_001021113.1; NM_001025942.1. [Q10914-2]
DR   RefSeq; NP_001021114.1; NM_001025943.1. [Q10914-1]
DR   UniGene; Cel.19346; -.
DR   ProteinModelPortal; Q10914; -.
DR   STRING; 6239.B0280.12b; -.
DR   iPTMnet; Q10914; -.
DR   PaxDb; Q10914; -.
DR   EnsemblMetazoa; B0280.12b; B0280.12b; WBGene00001613. [Q10914-1]
DR   GeneID; 175999; -.
DR   KEGG; cel:CELE_B0280.12; -.
DR   UCSC; B0280.12b; c. elegans. [Q10914-1]
DR   CTD; 175999; -.
DR   WormBase; B0280.12a; CE31400; WBGene00001613; glr-2.
DR   WormBase; B0280.12b; CE33547; WBGene00001613; glr-2.
DR   eggNOG; KOG1054; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000234372; -.
DR   InParanoid; Q10914; -.
DR   KO; K05313; -.
DR   OMA; RIASSCW; -.
DR   OrthoDB; EOG091G11CB; -.
DR   PhylomeDB; Q10914; -.
DR   Reactome; R-CEL-204005; COPII (Coat Protein 2) Mediated Vesicle Transport.
DR   Reactome; R-CEL-399710; Activation of AMPA receptors.
DR   Reactome; R-CEL-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-CEL-5694530; Cargo concentration in the ER.
DR   PRO; PR:Q10914; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00001613; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    977       Glutamate receptor 2.
FT                                /FTId=PRO_0000011591.
FT   TOPO_DOM     20    621       Extracellular. {ECO:0000255}.
FT   TRANSMEM    622    642       Helical. {ECO:0000255}.
FT   TOPO_DOM    643    695       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    696    716       Helical. {ECO:0000255}.
FT   TOPO_DOM    717    898       Extracellular. {ECO:0000255}.
FT   TRANSMEM    899    919       Helical. {ECO:0000255}.
FT   TOPO_DOM    920    977       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     36     36       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    291    291       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    427    427       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    532    532       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    566    566       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    783    783       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    895    895       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     238    306       Missing (in isoform a).
FT                                {ECO:0000303|PubMed:11222641}.
FT                                /FTId=VSP_008031.
SQ   SEQUENCE   977 AA;  111789 MW;  8D7A373BC70A8A42 CRC64;
     MNKNLLVFGF LIFVKIGETS KKFPLRAFVA STDIDNDTAH AIIEMLRLAE MTFNALSDVD
     FDVLLGTRDL PPMEMATMMW NLNRIICDEM KLGYMLMLAG TNFKNYGIYE DIANHMKMPL
     IDWEPSKSEN IGKTTENNPM IFSVAPSAEQ LLIDYIQYKG WRDVVYIHDG KNADRTLRTM
     FSYLHEKSPK YQLFVDNYVA PSDEEMFKEF LNEFHRRIST QHTLKSNDSS EEIDEPIPVN
     VIVDLEGSYR TRAFLRALEE SVLVKKEYHY VFSNFDVDET DLSGFHFSLI NITIFRIFDK
     NNKKFLKTRA EFHDVYRGGF SNTDSIPTAA AFAHDAILVA GKALQIAMNE HGKGIFDKSF
     VRHQLFNRGR KGLYCRPHED QTESRQFETF EHGKKIAEAI KKVVLTDKDG TLTGRIQFDK
     VTGKRTNFSA EIVEIKPGVN SLNSIWERFQ WAEGEGFLLG GERYVQEKKK DSSQTRKGIL
     PSKPWQLRFN VVTVLVKPFV MLKRRNPGEP ELKGNDRFEG YCIDLLNLLA KNITGFEYDV
     FISDGNKYGS RQADGSWDGM IGYLLNETAD VAVAPLTITQ ERERAVDFSK PFMTTGISIM
     IKKPEKQEFN IFSFMEPLGM TIWIFTLSSY FGVSLTIFLV SWFSPYEKRI EFKRGEFTVT
     NEFTLYNSLW FTLAAFMQQG TDILPRAVSG RIASSCWWFF TLIIVSSYTA NLAAFLTLER
     MTPPIESVED LANQNKILYG VNEGGSTAAF FEDSIVPLYK KMWNFMVSTT QKQIELEKQS
     ITNSTSNRIF VSSYADGIEK VRTSKGKYAF LLEETTNNYE SGRRPCDTMK VGQNLNTLGY
     GIATKIGNPL RVSLNLAILY LSEKGELKKL ENKWWYDRGQ CDTGTSDGGT SSSLNLSKVA
     GIFYILLAGM VLSMCTALVE FLFRKNKENR EKERNRMRSS RPLKPGILAS CERAKQKQLQ
     NRRTKSEEVS TPRSTLF
//
ID   CNGB1_HUMAN             Reviewed;        1251 AA.
AC   Q14028; H3BN09; O43636; Q13059; Q14029; Q9UMG2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 2.
DT   25-OCT-2017, entry version 158.
DE   RecName: Full=Cyclic nucleotide-gated cation channel beta-1;
DE   AltName: Full=Cyclic nucleotide-gated cation channel 4;
DE            Short=CNG channel 4;
DE            Short=CNG-4;
DE            Short=CNG4;
DE   AltName: Full=Cyclic nucleotide-gated cation channel gamma;
DE   AltName: Full=Cyclic nucleotide-gated cation channel modulatory subunit;
DE   AltName: Full=Cyclic nucleotide-gated channel beta-1;
DE            Short=CNG channel beta-1;
DE   AltName: Full=Glutamic acid-rich protein;
DE            Short=GARP;
GN   Name=CNGB1; Synonyms=CNCG2, CNCG3L, CNCG4, RCNC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS RCNC2A AND RCNC2B).
RC   TISSUE=Retina;
RX   PubMed=7682292; DOI=10.1038/362764a0;
RA   Chen T.-Y., Peng Y.-W., Dhallan R.S., Ahamed B., Reed R.R., Yau K.-W.;
RT   "A new subunit of the cyclic nucleotide-gated cation channel in
RT   retinal rods.";
RL   Nature 362:764-767(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GARP2), AND VARIANT HIS-100.
RC   TISSUE=Retina;
RX   PubMed=7590744; DOI=10.1006/geno.1995.1102;
RA   Ardell M.D., Makhija A.K., Oliveira L., Miniou P.,
RA   Viegas-Pequignot E., Pittler S.J.;
RT   "cDNA, gene structure, and chromosomal localization of human GAR1
RT   (CNCG3L), a homolog of the third subunit of bovine photoreceptor cGMP-
RT   gated channel.";
RL   Genomics 28:32-38(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM RCNC2B), AND VARIANT HIS-100.
RC   TISSUE=Retina;
RX   PubMed=8766832; DOI=10.1016/0014-5793(96)00588-1;
RA   Ardell M.D., Aragon I., Oliveira L., Porche G.E., Burke E.,
RA   Pittler S.J.;
RT   "The beta subunit of human rod photoreceptor cGMP-gated cation channel
RT   is generated from a complex transcription unit.";
RL   FEBS Lett. 389:213-218(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM RCNC2B), FUNCTION, AND VARIANT
RP   HIS-100.
RC   TISSUE=Retina;
RX   PubMed=9535905; DOI=10.1074/jbc.273.15.9148;
RA   Grunwald M.E., Yu W.P., Yu H.H., Yau K.W.;
RT   "Identification of a domain on the beta-subunit of the rod cGMP-gated
RT   cation channel that mediates inhibition by calcium-calmodulin.";
RL   J. Biol. Chem. 273:9148-9157(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   ALTERNATIVE SPLICING.
RX   PubMed=10717482; DOI=10.1016/S0378-1119(00)00023-8;
RA   Ardell M.D., Bedsole D.L., Schoborg R.V., Pittler S.J.;
RT   "Genomic organization of the human rod photoreceptor cGMP-gated cation
RT   channel beta-subunit gene.";
RL   Gene 245:311-318(2000).
RN   [8]
RP   MUTAGENESIS OF LEU-568.
RX   PubMed=15195096; DOI=10.1038/nn1266;
RA   Bradley J., Boenigk W., Yau K.-W., Frings S.;
RT   "Calmodulin permanently associates with rat olfactory CNG channels
RT   under native conditions.";
RL   Nat. Neurosci. 7:705-710(2004).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM GARP2), AND FUNCTION.
RX   PubMed=16407240; DOI=10.1074/jbc.M507488200;
RA   Pentia D.C., Hosier S., Cote R.H.;
RT   "The glutamic acid-rich protein-2 (GARP2) is a high affinity rod
RT   photoreceptor phosphodiesterase (PDE6)-binding protein that modulates
RT   its catalytic properties.";
RL   J. Biol. Chem. 281:5500-5505(2006).
RN   [10]
RP   CHARACTERIZATION OF THE GARPS PROTEINS.
RX   PubMed=16280326; DOI=10.1074/jbc.M505012200;
RA   Batra-Safferling R., Abarca-Heidemann K., Korschen H.G., Tziatzios C.,
RA   Stoldt M., Budyak I., Willbold D., Schwalbe H., Klein-Seetharaman J.,
RA   Kaupp U.B.;
RT   "Glutamic acid-rich proteins of rod photoreceptors are natively
RT   unfolded.";
RL   J. Biol. Chem. 281:1449-1460(2006).
RN   [11]
RP   ALTERNATIVE SPLICING (ISOFORM GARP2).
RA   Cote R.H.;
RL   Unpublished observations (MAY-2009).
RN   [12]
RP   VARIANT RP45 VAL-993.
RX   PubMed=11379879; DOI=10.1007/s004390100496;
RA   Bareil C., Hamel C.P., Delague V., Arnaud B., Demaille J.,
RA   Claustres M.;
RT   "Segregation of a mutation in CNGB1 encoding the beta-subunit of the
RT   rod cGMP-gated channel in a family with autosomal recessive retinitis
RT   pigmentosa.";
RL   Hum. Genet. 108:328-334(2001).
CC   -!- FUNCTION: Subunit of cyclic nucleotide-gated (CNG) channels,
CC       nonselective cation channels, which play important roles in both
CC       visual and olfactory signal transduction. When associated with
CC       CNGA1, it is involved in the regulation of ion flow into the rod
CC       photoreceptor outer segment (ROS), in response to light-induced
CC       alteration of the levels of intracellular cGMP.
CC   -!- FUNCTION: Isoform GARP2 is a high affinity rod photoreceptor
CC       phosphodiesterase (PDE6)-binding protein that modulates its
CC       catalytic properties: it is a regulator of spontaneous activation
CC       of rod PDE6, thereby serving to lower rod photoreceptor 'dark
CC       noise' and allowing these sensory cells to operate at the single
CC       photon detection limit.
CC   -!- SUBUNIT: Tetramer formed of three CNGA1 and one CNGB1 modulatory
CC       subunits. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q5ICW4:GRB14 (xeno); NbExp=2; IntAct=EBI-7959609, EBI-7639273;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=There is no evidence for an ortholog to bovine GARP1 in
CC         the human genome.;
CC       Name=RCNC2B;
CC         IsoId=Q14028-1; Sequence=Displayed;
CC       Name=RCNC2A;
CC         IsoId=Q14028-2; Sequence=VSP_001110;
CC       Name=GARP2; Synonyms=GARP;
CC         IsoId=Q14028-3; Sequence=VSP_037921, VSP_037922;
CC         Note=In the rod cells, the CNGB1 locus encodes the cyclic
CC         nucleotide-gated cation channel beta-1 subunit and several
CC         glutamic-acid-rich proteins (GARPs).;
CC       Name=4;
CC         IsoId=Q14028-4; Sequence=VSP_053421;
CC   -!- DISEASE: Retinitis pigmentosa 45 (RP45) [MIM:613767]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:11379879}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGB1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L15296; AAA65620.1; -; Genomic_DNA.
DR   EMBL; L15297; AAA65619.1; -; Genomic_DNA.
DR   EMBL; U18945; AAA91633.1; -; mRNA.
DR   EMBL; U58837; AAB63387.1; -; mRNA.
DR   EMBL; AF042498; AAC04830.1; -; mRNA.
DR   EMBL; AC010543; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW82957.1; -; Genomic_DNA.
DR   CCDS; CCDS42169.1; -. [Q14028-1]
DR   CCDS; CCDS45495.1; -. [Q14028-3]
DR   CCDS; CCDS67042.1; -. [Q14028-4]
DR   PIR; A57652; A57652.
DR   PIR; S32538; S32538.
DR   PIR; S69275; S69275.
DR   RefSeq; NP_001129111.1; NM_001135639.1. [Q14028-3]
DR   RefSeq; NP_001273059.1; NM_001286130.1. [Q14028-4]
DR   RefSeq; NP_001288.3; NM_001297.4. [Q14028-1]
DR   UniGene; Hs.147062; -.
DR   ProteinModelPortal; Q14028; -.
DR   SMR; Q14028; -.
DR   BioGrid; 107658; 2.
DR   IntAct; Q14028; 2.
DR   MINT; MINT-4853474; -.
DR   STRING; 9606.ENSP00000251102; -.
DR   TCDB; 1.A.1.5.3; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q14028; -.
DR   PhosphoSitePlus; Q14028; -.
DR   BioMuta; CNGB1; -.
DR   DMDM; 257051004; -.
DR   EPD; Q14028; -.
DR   PaxDb; Q14028; -.
DR   PeptideAtlas; Q14028; -.
DR   PRIDE; Q14028; -.
DR   DNASU; 1258; -.
DR   Ensembl; ENST00000251102; ENSP00000251102; ENSG00000070729. [Q14028-1]
DR   Ensembl; ENST00000311183; ENSP00000311670; ENSG00000070729. [Q14028-3]
DR   Ensembl; ENST00000564448; ENSP00000454633; ENSG00000070729. [Q14028-4]
DR   GeneID; 1258; -.
DR   KEGG; hsa:1258; -.
DR   UCSC; uc002emt.3; human. [Q14028-1]
DR   CTD; 1258; -.
DR   DisGeNET; 1258; -.
DR   EuPathDB; HostDB:ENSG00000070729.13; -.
DR   GeneCards; CNGB1; -.
DR   GeneReviews; CNGB1; -.
DR   H-InvDB; HIX0038536; -.
DR   HGNC; HGNC:2151; CNGB1.
DR   HPA; HPA039159; -.
DR   HPA; HPA060355; -.
DR   MalaCards; CNGB1; -.
DR   MIM; 600724; gene.
DR   MIM; 613767; phenotype.
DR   neXtProt; NX_Q14028; -.
DR   OpenTargets; ENSG00000070729; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA26662; -.
DR   eggNOG; KOG0499; Eukaryota.
DR   eggNOG; ENOG410ZJ5U; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000231425; -.
DR   HOVERGEN; HBG051038; -.
DR   InParanoid; Q14028; -.
DR   KO; K04952; -.
DR   OMA; WEDAHQD; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; Q14028; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-HSA-5620916; VxPx cargo-targeting to cilium.
DR   GeneWiki; CNGB1; -.
DR   GenomeRNAi; 1258; -.
DR   PRO; PR:Q14028; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000070729; -.
DR   CleanEx; HS_CNGB1; -.
DR   ExpressionAtlas; Q14028; baseline and differential.
DR   Genevisible; Q14028; HS.
DR   GO; GO:0060170; C:ciliary membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0017071; C:intracellular cyclic nucleotide activated cation channel complex; IEA:Ensembl.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:1902495; C:transmembrane transporter complex; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IDA:UniProtKB.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IEA:Ensembl.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:ProtInc.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; IDA:UniProtKB.
DR   GO; GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl.
DR   GO; GO:0035845; P:photoreceptor cell outer segment organization; IEA:Ensembl.
DR   GO; GO:0051290; P:protein heterotetramerization; IEA:Ensembl.
DR   GO; GO:0033365; P:protein localization to organelle; IEA:Ensembl.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0001895; P:retina homeostasis; IMP:UniProtKB.
DR   GO; GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032944; CNGB1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF386; PTHR10217:SF386; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cAMP; cAMP-binding; Complete proteome;
KW   Disease mutation; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding; Olfaction;
KW   Polymorphism; Reference proteome; Retinitis pigmentosa;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1   1251       Cyclic nucleotide-gated cation channel
FT                                beta-1.
FT                                /FTId=PRO_0000219323.
FT   TOPO_DOM    343    656       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    657    675       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    676    689       Extracellular. {ECO:0000255}.
FT   TRANSMEM    690    708       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    709    733       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    734    753       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    754    790       Extracellular. {ECO:0000255}.
FT   TRANSMEM    791    813       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    814    857       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    858    877       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    878    961       Extracellular. {ECO:0000255}.
FT   TRANSMEM    962    982       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    983   1251       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     970   1109       cAMP. {ECO:0000250}.
FT   MOTIF       568    578       IQ-like.
FT   COMPBIAS     23     63       Glu-rich.
FT   COMPBIAS    171    252       Pro-rich.
FT   COMPBIAS    351    371       Poly-Glu.
FT   BINDING    1030   1030       cAMP. {ECO:0000255}.
FT   BINDING    1042   1042       cAMP. {ECO:0000255}.
FT   VAR_SEQ       1    628       Missing (in isoform RCNC2A).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001110.
FT   VAR_SEQ     189    194       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_053421.
FT   VAR_SEQ     292    299       ISILPGGQ -> RVMGAGGL (in isoform GARP2).
FT                                {ECO:0000303|PubMed:7590744}.
FT                                /FTId=VSP_037921.
FT   VAR_SEQ     300   1251       Missing (in isoform GARP2).
FT                                {ECO:0000303|PubMed:7590744}.
FT                                /FTId=VSP_037922.
FT   VARIANT     100    100       R -> H (in dbSNP:rs13336595).
FT                                {ECO:0000269|PubMed:7590744,
FT                                ECO:0000269|PubMed:8766832,
FT                                ECO:0000269|PubMed:9535905}.
FT                                /FTId=VAR_058691.
FT   VARIANT     479    479       L -> I (in dbSNP:rs2303783).
FT                                /FTId=VAR_059225.
FT   VARIANT     535    535       V -> A (in dbSNP:rs12927214).
FT                                /FTId=VAR_059226.
FT   VARIANT     731    731       N -> K (in dbSNP:rs376270).
FT                                /FTId=VAR_059227.
FT   VARIANT     745    745       L -> I (in dbSNP:rs10459809).
FT                                /FTId=VAR_059228.
FT   VARIANT     911    911       K -> R (in dbSNP:rs2303785).
FT                                /FTId=VAR_059229.
FT   VARIANT     961    961       A -> S (in dbSNP:rs16942445).
FT                                /FTId=VAR_059230.
FT   VARIANT     993    993       G -> V (in RP45; dbSNP:rs121918532).
FT                                {ECO:0000269|PubMed:11379879}.
FT                                /FTId=VAR_060491.
FT   MUTAGEN     568    568       L->E: Loss of calcium/calmodulin
FT                                modulation.
FT                                {ECO:0000269|PubMed:15195096}.
FT   CONFLICT    128    128       I -> V (in Ref. 5; AC010543).
FT                                {ECO:0000305}.
FT   CONFLICT   1148   1149       QQ -> HE (in Ref. 2; AAB63387 and 1;
FT                                AAA65619/AAA65620). {ECO:0000305}.
FT   CONFLICT   1207   1208       RP -> SC (in Ref. 2; AAB63387 and 1;
FT                                AAA65619/AAA65620). {ECO:0000305}.
SQ   SEQUENCE   1251 AA;  139678 MW;  7A45CB399EB2B20C CRC64;
     MLGWVQRVLP QPPGTPRKTK MQEEEEVEPE PEMEAEVEPE PNPEEAETES ESMPPEESFK
     EEEVAVADPS PQETKEAALT STISLRAQGA EISEMNSPSR RVLTWLMKGV EKVIPQPVHS
     ITEDPAQILG HGSTGDTGCT DEPNEALEAQ DTRPGLRLLL WLEQNLERVL PQPPKSSEVW
     RDEPAVATGA ASDPAPPGRP QEMGPKLQAR ETPSLPTPIP LQPKEEPKEA PAPEPQPGSQ
     AQTSSLPPTR DPARLVAWVL HRLEMALPQP VLHGKIGEQE PDSPGICDVQ TISILPGGQV
     EPDLVLEEVE PPWEDAHQDV STSPQGTEVV PAYEEENKAV EKMPRELSRI EEEKEDEEEE
     EEEEEEEEEE EVTEVLLDSC VVSQVGVGQS EEDGTRPQST SDQKLWEEVG EEAKKEAEEK
     AKEEAEEVAE EEAEKEPQDW AETKEEPEAE AEAASSGVPA TKQHPEVQVE DTDADSCPLM
     AEENPPSTVL PPPSPAKSDT LIVPSSASGT HRKKLPSEDD EAEELKALSP AESPVVAWSD
     PTTPKDTDGQ DRAASTASTN SAIINDRLQE LVKLFKERTE KVKEKLIDPD VTSDEESPKP
     SPAKKAPEPA PDTKPAEAEP VEEEHYCDML CCKFKHRPWK KYQFPQSIDP LTNLMYVLWL
     FFVVMAWNWN CWLIPVRWAF PYQTPDNIHH WLLMDYLCDL IYFLDITVFQ TRLQFVRGGD
     IITDKKDMRN NYLKSRRFKM DLLSLLPLDF LYLKVGVNPL LRLPRCLKYM AFFEFNSRLE
     SILSKAYVYR VIRTTAYLLY SLHLNSCLYY WASAYQGLGS THWVYDGVGN SYIRCYYFAV
     KTLITIGGLP DPKTLFEIVF QLLNYFTGVF AFSVMIGQMR DVVGAATAGQ TYYRSCMDST
     VKYMNFYKIP KSVQNRVKTW YEYTWHSQGM LDESELMVQL PDKMRLDLAI DVNYNIVSKV
     ALFQGCDRQM IFDMLKRLRS VVYLPNDYVC KKGEIGREMY IIQAGQVQVL GGPDGKSVLV
     TLKAGSVFGE ISLLAVGGGN RRTANVVAHG FTNLFILDKK DLNEILVHYP ESQKLLRKKA
     RRMLRSNNKP KEEKSVLILP PRAGTPKLFN AALAMTGKMG GKGAKGGKLA HLRARLKELA
     ALEAAAKQQE LVEQAKSSQD VKGEEGSAAP DQHTHPKEAA TDPPAPRTPP EPPGSPPSSP
     PPASLGRPEG EEEGPAEPEE HSVRICMSPG PEPGEQILSV KMPEEREEKA E
//
ID   ITPR1_HUMAN             Reviewed;        2758 AA.
AC   Q14643; E7EPX7; E9PDE9; Q14660; Q99897;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 3.
DT   20-DEC-2017, entry version 198.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor type 1;
DE   AltName: Full=IP3 receptor isoform 1;
DE            Short=IP3R 1;
DE            Short=InsP3R1;
DE   AltName: Full=Type 1 inositol 1,4,5-trisphosphate receptor;
DE            Short=Type 1 InsP3 receptor;
GN   Name=ITPR1; Synonyms=INSP3R1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Myeloid, and Uterus;
RX   PubMed=7945203; DOI=10.1042/bj3020781;
RA   Yamada N., Makino Y., Clark R.A., Pearson D.W., Mattei M.-G.,
RA   Guenet J.-L., Ohama E., Fujino I., Miyawaki A., Furuichi T.,
RA   Mikoshiba K.;
RT   "Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1:
RT   structure, function, regulation of expression and chromosomal
RT   localization.";
RL   Biochem. J. 302:781-790(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND PHOSPHORYLATION.
RC   TISSUE=T-cell;
RX   PubMed=7852357; DOI=10.1074/jbc.270.6.2833;
RA   Harnick D.J., Jayaraman T., Ma Y., Mulieri P., Go L.O., Marks A.R.;
RT   "The human type 1 inositol 1,4,5-trisphosphate receptor from T
RT   lymphocytes. Structure, localization, and tyrosine phosphorylation.";
RL   J. Biol. Chem. 270:2833-2840(1995).
RN   [3]
RP   SEQUENCE REVISION TO 431; 1012-1017; 1460; 1823; 2324; 2330; 2334;
RP   2337; 2346; 2358; 2361; 2372; 2396; 2418; 2426; 2434 AND 2741.
RA   Marks A.;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=7500840; DOI=10.1016/0169-328X(95)00089-B;
RA   Nucifora F.C. Jr., Li S.-H., Danoff S., Ullrich A., Ross C.A.;
RT   "Molecular cloning of a cDNA for the human inositol 1,4,5-
RT   trisphosphate receptor type 1, and the identification of a third
RT   alternatively spliced variant.";
RL   Brain Res. Mol. Brain Res. 32:291-296(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1548-1723 (ISOFORMS 3 AND 4).
RX   PubMed=8648241; DOI=10.1080/095530096145544;
RA   Yan J., Khanna K.K., Lavin M.F.;
RT   "Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing
RT   radiation.";
RL   Int. J. Radiat. Biol. 69:539-546(1996).
RN   [7]
RP   INTERACTION WITH CABP1.
RX   PubMed=12032348; DOI=10.1073/pnas.102006299;
RA   Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K.,
RA   Haeseleer F., Foskett J.K.;
RT   "Identification of a family of calcium sensors as protein ligands of
RT   inositol trisphosphate receptor Ca(2+) release channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002).
RN   [8]
RP   INTERACTION WITH CABP1.
RX   PubMed=14685260; DOI=10.1038/sj.emboj.7600037;
RA   Kasri N.N., Holmes A.M., Bultynck G., Parys J.B., Bootman M.D.,
RA   Rietdorf K., Missiaen L., McDonald F., De Smedt H., Conway S.J.,
RA   Holmes A.B., Berridge M.J., Roderick H.L.;
RT   "Regulation of InsP3 receptor activity by neuronal Ca2+-binding
RT   proteins.";
RL   EMBO J. 23:312-321(2004).
RN   [9]
RP   INTERACTION WITH ERP44.
RX   PubMed=15652484; DOI=10.1016/j.cell.2004.11.048;
RA   Higo T., Hattori M., Nakamura T., Natsume T., Michikawa T.,
RA   Mikoshiba K.;
RT   "Subtype-specific and ER lumenal environment-dependent regulation of
RT   inositol 1,4,5-trisphosphate receptor type 1 by ERp44.";
RL   Cell 120:85-98(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   INTERACTION WITH AHCYL1, AND MUTAGENESIS OF ARG-241; LYS-249; ARG-265;
RP   THR-267; ARG-269; ARG-504; ARG-506; LYS-508; ARG-511; TYR-567; ARG-568
RP   AND LYS-569.
RX   PubMed=16793548; DOI=10.1016/j.molcel.2006.05.017;
RA   Ando H., Mizutani A., Kiefer H., Tsuzurugi D., Michikawa T.,
RA   Mikoshiba K.;
RT   "IRBIT suppresses IP3 receptor activity by competing with IP3 for the
RT   common binding site on the IP3 receptor.";
RL   Mol. Cell 22:795-806(2006).
RN   [12]
RP   INTERACTION WITH MRVI1.
RX   PubMed=16990611; DOI=10.1182/blood-2005-10-026294;
RA   Antl M., von Bruehl M.-L., Eiglsperger C., Werner M., Konrad I.,
RA   Kocher T., Wilm M., Hofmann F., Massberg S., Schlossmann J.;
RT   "IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation
RT   and thrombus formation.";
RL   Blood 109:552-559(2007).
RN   [13]
RP   INVOLVEMENT IN SCA15.
RX   PubMed=17590087; DOI=10.1371/journal.pgen.0030108;
RA   van de Leemput J., Chandran J., Knight M.A., Holtzclaw L.A.,
RA   Scholz S., Cookson M.R., Houlden H., Gwinn-Hardy K., Fung H.-C.,
RA   Lin X., Hernandez D., Simon-Sanchez J., Wood N.W., Giunti P.,
RA   Rafferty I., Hardy J., Storey E., Gardner R.J.M., Forrest S.M.,
RA   Fisher E.M.C., Russell J.T., Cai H., Singleton A.B.;
RT   "Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia
RT   15 in humans.";
RL   PLoS Genet. 3:1076-1082(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598 AND SER-1764, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   INTERACTION WITH AHCYL1 AND AHCYL2.
RX   PubMed=19220705; DOI=10.1111/j.1471-4159.2009.05979.x;
RA   Ando H., Mizutani A., Mikoshiba K.;
RT   "An IRBIT homologue lacks binding activity to inositol 1,4,5-
RT   trisphosphate receptor due to the unique N-terminal appendage.";
RL   J. Neurochem. 109:539-550(2009).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2512.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   INTERACTION WITH TESPA1.
RX   PubMed=23650607; DOI=10.1016/j.fob.2012.08.005;
RA   Matsuzaki H., Fujimoto T., Ota T., Ogawa M., Tsunoda T., Doi K.,
RA   Hamabashiri M., Tanaka M., Shirasawa S.;
RT   "Tespa1 is a novel inositol 1,4,5-trisphosphate receptor binding
RT   protein in T and B lymphocytes.";
RL   FEBS Open Bio 2:255-259(2012).
RN   [19]
RP   INTERACTION WITH BOK.
RX   PubMed=23884412; DOI=10.1074/jbc.M113.496570;
RA   Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.;
RT   "The Bcl-2 protein family member Bok binds to the coupling domain of
RT   inositol 1,4,5-trisphosphate receptors and protects them from
RT   proteolytic cleavage.";
RL   J. Biol. Chem. 288:25340-25349(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598 AND SER-1764, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1598, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   VARIANT SCA15 LEU-1059.
RX   PubMed=18579805; DOI=10.1212/01.wnl.0000311277.71046.a0;
RA   Hara K., Shiga A., Nozaki H., Mitsui J., Takahashi Y., Ishiguro H.,
RA   Yomono H., Kurisaki H., Goto J., Ikeuchi T., Tsuji S., Nishizawa M.,
RA   Onodera O.;
RT   "Total deletion and a missense mutation of ITPR1 in Japanese SCA15
RT   families.";
RL   Neurology 71:547-551(2008).
RN   [23]
RP   VARIANTS SCA29 ASP-602 AND MET-1562.
RX   PubMed=22986007; DOI=10.1186/1750-1172-7-67;
RA   Huang L., Chardon J.W., Carter M.T., Friend K.L., Dudding T.E.,
RA   Schwartzentruber J., Zou R., Schofield P.W., Douglas S., Bulman D.E.,
RA   Boycott K.M.;
RT   "Missense mutations in ITPR1 cause autosomal dominant congenital
RT   nonprogressive spinocerebellar ataxia.";
RL   Orphanet J. Rare Dis. 7:67-67(2012).
RN   [24]
RP   VARIANT SCA29 MET-1562.
RX   PubMed=26770814; DOI=10.1186/s40673-016-0040-8;
RA   Shadrina M.I., Shulskaya M.V., Klyushnikov S.A., Nikopensius T.,
RA   Nelis M., Kivistik P.A., Komar A.A., Limborska S.A.,
RA   Illarioshkin S.N., Slominsky P.A.;
RT   "ITPR1 gene p.Val1553Met mutation in Russian family with mild
RT   Spinocerebellar ataxia.";
RL   Cerebellum Ataxias 3:2-2(2016).
RN   [25]
RP   INVOLVEMENT IN GLSP, VARIANTS GLSP LEU-2601 AND LYS-2611 DEL,
RP   CHARACTERIZATION OF VARIANT GLSP LYS-2611 DEL, AND FUNCTION.
RX   PubMed=27108797; DOI=10.1016/j.ajhg.2016.03.004;
RA   Gerber S., Alzayady K.J., Burglen L., Bremond-Gignac D., Marchesin V.,
RA   Roche O., Rio M., Funalot B., Calmon R., Durr A.,
RA   Gil-da-Silva-Lopes V.L., Ribeiro Bittar M.F., Orssaud C., Heron B.,
RA   Ayoub E., Berquin P., Bahi-Buisson N., Bole C., Masson C., Munnich A.,
RA   Simons M., Delous M., Dollfus H., Boddaert N., Lyonnet S., Kaplan J.,
RA   Calvas P., Yule D.I., Rozet J.M., Fares Taie L.;
RT   "Recessive and dominant de novo ITPR1 mutations cause Gillespie
RT   syndrome.";
RL   Am. J. Hum. Genet. 98:971-980(2016).
RN   [26]
RP   INVOLVEMENT IN GLSP, VARIANTS GLSP GLN-2109; ARG-2554 AND LYS-2611
RP   DEL, AND SUBCELLULAR LOCATION.
RX   PubMed=27108798; DOI=10.1016/j.ajhg.2016.03.018;
RG   DDD Study;
RA   McEntagart M., Williamson K.A., Rainger J.K., Wheeler A.,
RA   Seawright A., De Baere E., Verdin H., Bergendahl L.T., Quigley A.,
RA   Rainger J., Dixit A., Sarkar A., Lopez Laso E., Sanchez-Carpintero R.,
RA   Barrio J., Bitoun P., Prescott T., Riise R., McKee S., Cook J.,
RA   McKie L., Ceulemans B., Meire F., Temple I.K., Prieur F., Williams J.,
RA   Clouston P., Nemeth A.H., Banka S., Bengani H., Handley M., Freyer E.,
RA   Ross A., van Heyningen V., Marsh J.A., Elmslie F., FitzPatrick D.R.;
RT   "A restricted repertoire of de novo mutations in ITPR1 cause Gillespie
RT   syndrome with evidence for dominant-negative effect.";
RL   Am. J. Hum. Genet. 98:981-992(2016).
CC   -!- FUNCTION: Intracellular channel that mediates calcium release from
CC       the endoplasmic reticulum following stimulation by inositol 1,4,5-
CC       trisphosphate (PubMed:27108797). Involved in the regulation of
CC       epithelial secretion of electrolytes and fluid through the
CC       interaction with AHCYL1 (By similarity). Plays a role in ER
CC       stress-induced apoptosis. Cytoplasmic calcium released from the ER
CC       triggers apoptosis by the activation of CaM kinase II, eventually
CC       leading to the activation of downstream apoptosis pathways (By
CC       similarity). {ECO:0000250|UniProtKB:P11881,
CC       ECO:0000269|PubMed:27108797}.
CC   -!- SUBUNIT: Homotetramer. Interacts with TRPC4. The PPXXF motif binds
CC       HOM1, HOM2 and HOM3. Interacts with RYR1, RYR2, ITPR1, SHANK1 and
CC       SHANK3. Interacts with ERP44 in a pH-, redox state- and calcium-
CC       dependent manner which results in the inhibition the calcium
CC       channel activity. The strength of this interaction inversely
CC       correlates with calcium concentration. Part of cGMP kinase
CC       signaling complex at least composed of ACTA2/alpha-actin,
CC       CNN1/calponin H1, PLN/phospholamban, PRKG1 and ITPR1. Interacts
CC       with MRVI1 and CABP1 (via N-terminus). Interacts with TESPA1.
CC       Interacts (when not phosphorylated) with AHCYL1 (when
CC       phosphorylated); the interaction suppresses inositol 1,4,5-
CC       trisphosphate binding to ITPR1 (PubMed:16793548). Interacts with
CC       AHCYL2 (with lower affinity than with AHCYL1) (PubMed:19220705).
CC       Interacts with BOK (via BH4 domain); protects ITPR1 from
CC       proteolysis by CASP3 during apoptosis (PubMed:23884412).
CC       {ECO:0000269|PubMed:12032348, ECO:0000269|PubMed:14685260,
CC       ECO:0000269|PubMed:15652484, ECO:0000269|PubMed:16793548,
CC       ECO:0000269|PubMed:16990611, ECO:0000269|PubMed:19220705,
CC       ECO:0000269|PubMed:23650607, ECO:0000269|PubMed:23884412}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=2; IntAct=EBI-465548, EBI-296087;
CC       P21796:VDAC1; NbExp=3; IntAct=EBI-465548, EBI-354158;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:27108798}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:Q9TU34}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:27108798}. Note=Endoplasmic reticulum and
CC       secretory granules (By similarity).
CC       {ECO:0000250|UniProtKB:Q9TU34}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=There is a combination of three alternatively spliced
CC         domains at site SI, SIII and site SII (A and C). Experimental
CC         confirmation may be lacking for some isoforms.;
CC       Name=1; Synonyms=SISIIISIIAC;
CC         IsoId=Q14643-1; Sequence=Displayed;
CC       Name=2; Synonyms=SI-SIIISIIAC;
CC         IsoId=Q14643-2; Sequence=VSP_002687;
CC       Name=3; Synonyms=SISIII-SII;
CC         IsoId=Q14643-3; Sequence=VSP_002688, VSP_002689, VSP_002690;
CC       Name=4; Synonyms=SI-SIII-SII;
CC         IsoId=Q14643-4; Sequence=VSP_002687, VSP_002688, VSP_002689,
CC                                  VSP_002690;
CC       Name=5; Synonyms=SI-SIII-SIIAC;
CC         IsoId=Q14643-5; Sequence=VSP_002687, VSP_002688;
CC       Name=6; Synonyms=SISIIISIIA;
CC         IsoId=Q14643-6; Sequence=VSP_002690;
CC       Name=7; Synonyms=SI-SIII-SIIA;
CC         IsoId=Q14643-7; Sequence=VSP_002687, VSP_002690;
CC       Name=8; Synonyms=SI-SIII-SIIA;
CC         IsoId=Q14643-8; Sequence=VSP_002687, VSP_002688, VSP_002690;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC   -!- PTM: Phosphorylated on tyrosine residues.
CC       {ECO:0000269|PubMed:7852357}.
CC   -!- PTM: Ubiquitination at multiple lysines targets ITPR1 for
CC       proteasomal degradation. Approximately 40% of the ITPR1-associated
CC       ubiquitin is monoubiquitin, and polyubiquitins are both 'Lys-
CC       48'- and 'Lys-63'-linked (By similarity).
CC       {ECO:0000250|UniProtKB:P29994}.
CC   -!- PTM: Phosphorylated by cAMP kinase (PKA). Phosphorylation prevents
CC       the ligand-induced opening of the calcium channels.
CC       Phosphorylation by PKA increases the interaction with inositol
CC       1,4,5-trisphosphate and decreases the interaction with AHCYL1.
CC       {ECO:0000250|UniProtKB:P11881}.
CC   -!- PTM: Palmitoylated by ZDHHC6 in immune cells, leading to regulate
CC       ITPR1 stability and function. {ECO:0000250|UniProtKB:P11881}.
CC   -!- DISEASE: Spinocerebellar ataxia 15 (SCA15) [MIM:606658]:
CC       Spinocerebellar ataxia is a clinically and genetically
CC       heterogeneous group of cerebellar disorders. Patients show
CC       progressive incoordination of gait and often poor coordination of
CC       hands, speech and eye movements, due to degeneration of the
CC       cerebellum with variable involvement of the brainstem and spinal
CC       cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It
CC       is very slow progressing form with a wide range of onset, ranging
CC       from childhood to adult. Most patients remain ambulatory.
CC       {ECO:0000269|PubMed:17590087, ECO:0000269|PubMed:18579805}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Spinocerebellar ataxia 29 (SCA29) [MIM:117360]: An
CC       autosomal dominant, congenital spinocerebellar ataxia
CC       characterized by early motor delay, hypotonia and mild cognitive
CC       delay. Affected individuals develop a very slowly progressive or
CC       non-progressive gait and limb ataxia associated with cerebellar
CC       atrophy on brain imaging. Additional variable features include
CC       nystagmus, dysarthria, and tremor. {ECO:0000269|PubMed:22986007,
CC       ECO:0000269|PubMed:26770814}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Gillespie syndrome (GLSP) [MIM:206700]: A rare disease
CC       characterized by bilateral iris hypoplasia, congenital hypotonia,
CC       non-progressive ataxia, progressive cerebellar atrophy, and mental
CC       retardation. {ECO:0000269|PubMed:27108797,
CC       ECO:0000269|PubMed:27108798}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Calcium appears to inhibit ligand binding to the
CC       receptor, most probably by interacting with a distinct calcium-
CC       binding protein which then inhibits the receptor.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -!- CAUTION: Alternative splice sites (AA 1053-1054) represent a non-
CC       canonical GA-AG donor-acceptor pair, but are well-supported by all
CC       available human transcripts, and by homologous transcripts in
CC       mouse, rat and cow. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26070; BAA05065.1; -; mRNA.
DR   EMBL; L38019; AAB04947.2; -; mRNA.
DR   EMBL; U23850; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC018816; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069248; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090944; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; S82269; AAD14386.1; -; mRNA.
DR   CCDS; CCDS46740.2; -. [Q14643-3]
DR   CCDS; CCDS54550.1; -. [Q14643-4]
DR   CCDS; CCDS54551.1; -. [Q14643-2]
DR   PIR; A55713; A55713.
DR   PIR; S54974; S54974.
DR   RefSeq; NP_001093422.2; NM_001099952.2. [Q14643-3]
DR   RefSeq; NP_001161744.1; NM_001168272.1. [Q14643-2]
DR   RefSeq; NP_002213.5; NM_002222.5. [Q14643-4]
DR   RefSeq; XP_011531985.1; XM_011533683.2. [Q14643-1]
DR   UniGene; Hs.567295; -.
DR   UniGene; Hs.715765; -.
DR   ProteinModelPortal; Q14643; -.
DR   BioGrid; 109913; 51.
DR   CORUM; Q14643; -.
DR   DIP; DIP-29714N; -.
DR   ELM; Q14643; -.
DR   IntAct; Q14643; 22.
DR   MINT; MINT-4991320; -.
DR   STRING; 9606.ENSP00000306253; -.
DR   BindingDB; Q14643; -.
DR   ChEMBL; CHEMBL4046; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB04077; Glycerol.
DR   GuidetoPHARMACOLOGY; 743; -.
DR   TCDB; 1.A.3.2.6; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q14643; -.
DR   PhosphoSitePlus; Q14643; -.
DR   BioMuta; ITPR1; -.
DR   DMDM; 519668682; -.
DR   EPD; Q14643; -.
DR   MaxQB; Q14643; -.
DR   PaxDb; Q14643; -.
DR   PeptideAtlas; Q14643; -.
DR   PRIDE; Q14643; -.
DR   Ensembl; ENST00000302640; ENSP00000306253; ENSG00000150995. [Q14643-2]
DR   Ensembl; ENST00000354582; ENSP00000346595; ENSG00000150995. [Q14643-1]
DR   Ensembl; ENST00000357086; ENSP00000349597; ENSG00000150995. [Q14643-3]
DR   Ensembl; ENST00000443694; ENSP00000401671; ENSG00000150995. [Q14643-2]
DR   Ensembl; ENST00000456211; ENSP00000397885; ENSG00000150995. [Q14643-4]
DR   GeneID; 3708; -.
DR   KEGG; hsa:3708; -.
DR   UCSC; uc003bqc.3; human. [Q14643-1]
DR   CTD; 3708; -.
DR   DisGeNET; 3708; -.
DR   EuPathDB; HostDB:ENSG00000150995.18; -.
DR   GeneCards; ITPR1; -.
DR   GeneReviews; ITPR1; -.
DR   HGNC; HGNC:6180; ITPR1.
DR   HPA; HPA014765; -.
DR   HPA; HPA016487; -.
DR   MalaCards; ITPR1; -.
DR   MIM; 117360; phenotype.
DR   MIM; 147265; gene.
DR   MIM; 206700; phenotype.
DR   MIM; 606658; phenotype.
DR   neXtProt; NX_Q14643; -.
DR   OpenTargets; ENSG00000150995; -.
DR   Orphanet; 98769; Spinocerebellar ataxia type 15/16.
DR   Orphanet; 208513; Spinocerebellar ataxia type 29.
DR   PharmGKB; PA29978; -.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000007660; -.
DR   HOVERGEN; HBG052158; -.
DR   InParanoid; Q14643; -.
DR   KO; K04958; -.
DR   OMA; DPDDHYQ; -.
DR   OrthoDB; EOG091G00T2; -.
DR   PhylomeDB; Q14643; -.
DR   TreeFam; TF312815; -.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-1489509; DAG and IP3 signaling.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-418457; cGMP effects.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; Q14643; -.
DR   SIGNOR; Q14643; -.
DR   ChiTaRS; ITPR1; human.
DR   GeneWiki; ITPR1; -.
DR   GenomeRNAi; 3708; -.
DR   PRO; PR:Q14643; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000150995; -.
DR   CleanEx; HS_ITPR1; -.
DR   ExpressionAtlas; Q14643; baseline and differential.
DR   Genevisible; Q14643; HS.
DR   GO; GO:0005955; C:calcineurin complex; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005637; C:nuclear inner membrane; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031088; C:platelet dense granule membrane; IDA:BHF-UCL.
DR   GO; GO:0031094; C:platelet dense tubular network; IDA:BHF-UCL.
DR   GO; GO:0031095; C:platelet dense tubular network membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019855; F:calcium channel inhibitor activity; IDA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015278; F:calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; NAS:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0042045; P:epithelial fluid transport; IEA:Ensembl.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0050849; P:negative regulation of calcium-mediated signaling; IDA:GO_Central.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0010506; P:regulation of autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0050882; P:voluntary musculoskeletal movement; IEA:Ensembl.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF48371; SSF48371; 4.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Calcium; Calcium channel;
KW   Calcium transport; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Disease mutation; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Isopeptide bond; Ligand-gated ion channel; Lipoprotein;
KW   Membrane; Mental retardation; Neurodegeneration; Palmitate;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Spinocerebellar ataxia; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   CHAIN         1   2758       Inositol 1,4,5-trisphosphate receptor
FT                                type 1.
FT                                /FTId=PRO_0000153920.
FT   TOPO_DOM      1   2282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2283   2303       Helical. {ECO:0000255}.
FT   TOPO_DOM   2304   2314       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2315   2335       Helical. {ECO:0000255}.
FT   TOPO_DOM   2336   2361       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2362   2382       Helical. {ECO:0000255}.
FT   TOPO_DOM   2383   2405       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2406   2426       Helical. {ECO:0000255}.
FT   TOPO_DOM   2427   2448       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2449   2469       Helical. {ECO:0000255}.
FT   TOPO_DOM   2470   2577       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2578   2598       Helical. {ECO:0000255}.
FT   TOPO_DOM   2599   2758       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      112    166       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      173    223       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      231    287       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      294    373       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      379    435       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      265    269       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      508    511       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      567    569       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION     2472   2537       Interaction with ERP44. {ECO:0000250}.
FT   MOD_RES     482    482       Phosphotyrosine. {ECO:0000255}.
FT   MOD_RES    1598   1598       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1764   1764       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2664   2664       Phosphotyrosine. {ECO:0000255}.
FT   LIPID        56     56       S-palmitoyl cysteine.
FT                                {ECO:0000250|UniProtKB:P11881}.
FT   LIPID       850    850       S-palmitoyl cysteine.
FT                                {ECO:0000250|UniProtKB:P11881}.
FT   CARBOHYD   2512   2512       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CROSSLNK    917    917       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK    972    972       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1581   1581       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1780   1780       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1893   1893       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1894   1894       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1895   1895       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1910   1910       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   1933   1933       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   2127   2127       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   CROSSLNK   2266   2266       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P29994}.
FT   VAR_SEQ     322    336       Missing (in isoform 2, isoform 4, isoform
FT                                5, isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:7500840,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002687.
FT   VAR_SEQ     919    927       Missing (in isoform 3, isoform 4, isoform
FT                                5 and isoform 8).
FT                                {ECO:0000303|PubMed:7852357,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002688.
FT   VAR_SEQ    1702   1725       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:7852357,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002689.
FT   VAR_SEQ    1726   1740       Missing (in isoform 3, isoform 4, isoform
FT                                6, isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:7852357,
FT                                ECO:0000303|PubMed:7945203,
FT                                ECO:0000303|PubMed:8648241}.
FT                                /FTId=VSP_002690.
FT   VARIANT     602    602       N -> D (in SCA29; dbSNP:rs397514536).
FT                                {ECO:0000269|PubMed:22986007}.
FT                                /FTId=VAR_069567.
FT   VARIANT     769    769       M -> V (in dbSNP:rs35789999).
FT                                /FTId=VAR_037005.
FT   VARIANT    1059   1059       P -> L (in SCA15).
FT                                {ECO:0000269|PubMed:18579805}.
FT                                /FTId=VAR_069568.
FT   VARIANT    1430   1430       I -> V (in dbSNP:rs3749383).
FT                                /FTId=VAR_037006.
FT   VARIANT    1562   1562       V -> M (in SCA29; dbSNP:rs397514535).
FT                                {ECO:0000269|PubMed:22986007,
FT                                ECO:0000269|PubMed:26770814}.
FT                                /FTId=VAR_069569.
FT   VARIANT    2109   2109       E -> Q (in GLSP).
FT                                {ECO:0000269|PubMed:27108798}.
FT                                /FTId=VAR_077462.
FT   VARIANT    2554   2554       G -> R (in GLSP; dbSNP:rs752281590).
FT                                {ECO:0000269|PubMed:27108798}.
FT                                /FTId=VAR_077463.
FT   VARIANT    2601   2601       F -> L (in GLSP; dbSNP:rs878853176).
FT                                {ECO:0000269|PubMed:27108797}.
FT                                /FTId=VAR_077464.
FT   VARIANT    2611   2611       Missing (in GLSP; alters calcium release
FT                                of isoform 3).
FT                                {ECO:0000269|PubMed:27108797,
FT                                ECO:0000269|PubMed:27108798}.
FT                                /FTId=VAR_077465.
FT   MUTAGEN     241    241       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     249    249       K->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     265    265       R->Q: No effect on interaction with
FT                                AHCYL1. {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     267    267       T->A: No effect on interaction with
FT                                AHCYL1. {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     269    269       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     504    504       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     506    506       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     508    508       K->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     511    511       R->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     567    567       Y->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     568    568       R->Q: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   MUTAGEN     569    569       K->A: Abolishes interaction with AHCYL1.
FT                                {ECO:0000269|PubMed:16793548}.
FT   CONFLICT   1557   1581       AIAIPVDLDSQVNNLFLKSHSIVQK -> HCHSRGPGQPSQ
FT                                QPLSQVPQHCAE (in Ref. 6; AAD14386).
FT                                {ECO:0000305}.
FT   CONFLICT   2302   2302       F -> L (in Ref. 2; AAB04947).
FT                                {ECO:0000305}.
FT   CONFLICT   2305   2305       F -> L (in Ref. 2; AAB04947).
FT                                {ECO:0000305}.
FT   CONFLICT   2448   2448       S -> A (in Ref. 4; U23850).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2758 AA;  313929 MW;  D29B072252B0D8E7 CRC64;
     MSDKMSSFLH IGDICSLYAE GSTNGFISTL GLVDDRCVVQ PETGDLNNPP KKFRDCLFKL
     CPMNRYSAQK QFWKAAKPGA NSTTDAVLLN KLHHAADLEK KQNETENRKL LGTVIQYGNV
     IQLLHLKSNK YLTVNKRLPA LLEKNAMRVT LDEAGNEGSW FYIQPFYKLR SIGDSVVIGD
     KVVLNPVNAG QPLHASSHQL VDNPGCNEVN SVNCNTSWKI VLFMKWSDNK DDILKGGDVV
     RLFHAEQEKF LTCDEHRKKQ HVFLRTTGRQ SATSATSSKA LWEVEVVQHD PCRGGAGYWN
     SLFRFKHLAT GHYLAAEVDP DFEEECLEFQ PSVDPDQDAS RSRLRNAQEK MVYSLVSVPE
     GNDISSIFEL DPTTLRGGDS LVPRNSYVRL RHLCTNTWVH STNIPIDKEE EKPVMLKIGT
     SPVKEDKEAF AIVPVSPAEV RDLDFANDAS KVLGSIAGKL EKGTITQNER RSVTKLLEDL
     VYFVTGGTNS GQDVLEVVFS KPNRERQKLM REQNILKQIF KLLQAPFTDC GDGPMLRLEE
     LGDQRHAPFR HICRLCYRVL RHSQQDYRKN QEYIAKQFGF MQKQIGYDVL AEDTITALLH
     NNRKLLEKHI TAAEIDTFVS LVRKNREPRF LDYLSDLCVS MNKSIPVTQE LICKAVLNPT
     NADILIETKL VLSRFEFEGV SSTGENALEA GEDEEEVWLF WRDSNKEIRS KSVRELAQDA
     KEGQKEDRDV LSYYRYQLNL FARMCLDRQY LAINEISGQL DVDLILRCMS DENLPYDLRA
     SFCRLMLHMH VDRDPQEQVT PVKYARLWSE IPSEIAIDDY DSSGASKDEI KERFAQTMEF
     VEEYLRDVVC QRFPFSDKEK NKLTFEVVNL ARNLIYFGFY NFSDLLRLTK ILLAILDCVH
     VTTIFPISKM AKGEENKGNN DVEKLKSSNV MRSIHGVGEL MTQVVLRGGG FLPMTPMAAA
     PEGNVKQAEP EKEDIMVMDT KLKIIEILQF ILNVRLDYRI SCLLCIFKRE FDESNSQTSE
     TSSGNSSQEG PSNVPGALDF EHIEEQAEGI FGGSEENTPL DLDDHGGRTF LRVLLHLTMH
     DYPPLVSGAL QLLFRHFSQR QEVLQAFKQV QLLVTSQDVD NYKQIKQDLD QLRSIVEKSE
     LWVYKGQGPD ETMDGASGEN EHKKTEEGNN KPQKHESTSS YNYRVVKEIL IRLSKLCVQE
     SASVRKSRKQ QQRLLRNMGA HAVVLELLQI PYEKAEDTKM QEIMRLAHEF LQNFCAGNQQ
     NQALLHKHIN LFLNPGILEA VTMQHIFMNN FQLCSEINER VVQHFVHCIE THGRNVQYIK
     FLQTIVKAEG KFIKKCQDMV MAELVNSGED VLVFYNDRAS FQTLIQMMRS ERDRMDENSP
     LMYHIHLVEL LAVCTEGKNV YTEIKCNSLL PLDDIVRVVT HEDCIPEVKI AYINFLNHCY
     VDTEVEMKEI YTSNHMWKLF ENFLVDICRA CNNTSDRKHA DSILEKYVTE IVMSIVTTFF
     SSPFSDQSTT LQTRQPVFVQ LLQGVFRVYH CNWLMPSQKA SVESCIRVLS DVAKSRAIAI
     PVDLDSQVNN LFLKSHSIVQ KTAMNWRLSA RNAARRDSVL AASRDYRNII ERLQDIVSAL
     EDRLRPLVQA ELSVLVDVLH RPELLFPENT DARRKCESGG FICKLIKHTK QLLEENEEKL
     CIKVLQTLRE MMTKDRGYGE KLISIDELDN AELPPAPDSE NATEELEPSP PLRQLEDHKR
     GEALRQVLVN RYYGNVRPSG RRESLTSFGN GPLSAGGPGK PGGGGGGSGS SSMSRGEMSL
     AEVQCHLDKE GASNLVIDLI MNASSDRVFH ESILLAIALL EGGNTTIQHS FFCRLTEDKK
     SEKFFKVFYD RMKVAQQEIK ATVTVNTSDL GNKKKDDEVD RDAPSRKKAK EPTTQITEEV
     RDQLLEASAA TRKAFTTFRR EADPDDHYQP GEGTQATADK AKDDLEMSAV ITIMQPILRF
     LQLLCENHNR DLQNFLRCQN NKTNYNLVCE TLQFLDCICG STTGGLGLLG LYINEKNVAL
     INQTLESLTE YCQGPCHENQ NCIATHESNG IDIITALILN DINPLGKKRM DLVLELKNNA
     SKLLLAIMES RHDSENAERI LYNMRPKELV EVIKKAYMQG EVEFEDGENG EDGAASPRNV
     GHNIYILAHQ LARHNKELQS MLKPGGQVDG DEALEFYAKH TAQIEIVRLD RTMEQIVFPV
     PSICEFLTKE SKLRIYYTTE RDEQGSKIND FFLRSEDLFN EMNWQKKLRA QPVLYWCARN
     MSFWSSISFN LAVLMNLLVA FFYPFKGVRG GTLEPHWSGL LWTAMLISLA IVIALPKPHG
     IRALIASTIL RLIFSVGLQP TLFLLGAFNV CNKIIFLMSF VGNCGTFTRG YRAMVLDVEF
     LYHLLYLVIC AMGLFVHEFF YSLLLFDLVY REETLLNVIK SVTRNGRSII LTAVLALILV
     YLFSIVGYLF FKDDFILEVD RLPNETAVPE TGESLASEFL FSDVCRVESG ENCSSPAPRE
     ELVPAEETEQ DKEHTCETLL MCIVTVLSHG LRSGGGVGDV LRKPSKEEPL FAARVIYDLL
     FFFMVIIIVL NLIFGVIIDT FADLRSEKQK KEEILKTTCF ICGLERDKFD NKTVTFEEHI
     KEEHNMWHYL CFIVLVKVKD STEYTGPESY VAEMIKERNL DWFPRMRAMS LVSSDSEGEQ
     NELRNLQEKL ESTMKLVTNL SGQLSELKDQ MTEQRKQKQR IGLLGHPPHM NVNPQQPA
//
ID   NMDE3_HUMAN             Reviewed;        1233 AA.
AC   Q14957; B2RTT1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   20-DEC-2017, entry version 166.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2C;
DE            Short=GluN2C;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-3;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2C;
DE            Short=NMDAR2C;
DE            Short=NR2C;
DE   Flags: Precursor;
GN   Name=GRIN2C; Synonyms=NMDAR2C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9037519; DOI=10.1016/S0169-328X(96)00146-5;
RA   Lin Y.J., Bovetto S., Carver J.M., Giordano T.;
RT   "Cloning of the cDNA for the human NMDA receptor NR2C subunit and its
RT   expression in the central nervous system and periphery.";
RL   Brain Res. Mol. Brain Res. 43:57-64(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH SNX27.
RX   PubMed=21300787; DOI=10.1128/MCB.01044-10;
RA   Cai L., Loo L.S., Atlashkin V., Hanson B.J., Hong W.;
RT   "Deficiency of sorting nexin 27 (SNX27) leads to growth retardation
RT   and elevated levels of N-methyl-D-aspartate receptor 2C (NR2C).";
RL   Mol. Cell. Biol. 31:1734-1747(2011).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=26875626; DOI=10.1016/j.neuron.2016.01.016;
RA   Hackos D.H., Lupardus P.J., Grand T., Chen Y., Wang T.M., Reynen P.,
RA   Gustafson A., Wallweber H.J., Volgraf M., Sellers B.D., Schwarz J.B.,
RA   Paoletti P., Sheng M., Zhou Q., Hanson J.E.;
RT   "Positive Allosteric Modulators of GluN2A-Containing NMDARs with
RT   Distinct Modes of Action and Impacts on Circuit Function.";
RL   Neuron 89:983-999(2016).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF PRO-550.
RX   PubMed=28095420; DOI=10.1371/journal.pgen.1006536;
RA   Ogden K.K., Chen W., Swanger S.A., McDaniel M.J., Fan L.Z., Hu C.,
RA   Tankovic A., Kusumoto H., Kosobucki G.J., Schulien A.J., Su Z.,
RA   Pecha J., Bhattacharya S., Petrovski S., Cohen A.E., Aizenman E.,
RA   Traynelis S.F., Yuan H.;
RT   "Molecular mechanism of disease-associated mutations in the pre-M1
RT   helix of NMDA receptors and potential rescue pharmacology.";
RL   PLoS Genet. 13:E1006536-E1006536(2017).
RN   [7]
RP   VARIANTS 18-TRP--VAL-1233 DEL; ILE-90; VAL-166; THR-573; THR-641;
RP   CYS-679; THR-863; ARG-871; SER-877; ILE-911; ALA-982; PRO-989;
RP   LEU-995; TYR-1079; ALA-1141; ARG-1180 AND ILE-1196.
RX   PubMed=22833210; DOI=10.1038/tp.2011.52;
RG   S2D team;
RA   Tarabeux J., Kebir O., Gauthier J., Hamdan F.F., Xiong L., Piton A.,
RA   Spiegelman D., Henrion E., Millet B., Fathalli F., Joober R.,
RA   Rapoport J.L., DeLisi L.E., Fombonne E., Mottron L., Forget-Dubois N.,
RA   Boivin M., Michaud J.L., Drapeau P., Lafreniere R.G., Rouleau G.A.,
RA   Krebs M.O.;
RT   "Rare mutations in N-methyl-D-aspartate glutamate receptors in autism
RT   spectrum disorders and schizophrenia.";
RL   Transl. Psychiatry 1:E55-E55(2011).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium.
CC       Channel activation requires binding of the neurotransmitter
CC       glutamate to the epsilon subunit, glycine binding to the zeta
CC       subunit, plus membrane depolarization to eliminate channel
CC       inhibition by Mg(2+) (PubMed:26875626). Sensitivity to glutamate
CC       and channel kinetics depend on the subunit composition (Probable).
CC       Plays a role in regulating the balance between excitatory and
CC       inhibitory activity of pyramidal neurons in the prefrontal cortex.
CC       Contributes to the slow phase of excitatory postsynaptic current,
CC       long-term synaptic potentiation, and learning (By similarity).
CC       {ECO:0000250|UniProtKB:Q01098, ECO:0000269|PubMed:26875626,
CC       ECO:0000269|PubMed:28095420, ECO:0000305}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed
CC       of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A,
CC       GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:26875626). In vivo,
CC       the subunit composition may depend on the expression levels of the
CC       different subunits (Probable). Interacts with PDZ domains of PATJ
CC       and DLG4 (By similarity). Interacts (via PDZ-binding motif) with
CC       SNX27 (via PDZ domain); the interaction is required for recycling
CC       to the plasma membrane when endocytosed and prevent degradation in
CC       lysosomes (PubMed:21300787). {ECO:0000250|UniProtKB:Q00961,
CC       ECO:0000269|PubMed:21300787, ECO:0000269|PubMed:26875626,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q62936:Dlg3 (xeno); NbExp=6; IntAct=EBI-8285963, EBI-349596;
CC       P78352:DLG4; NbExp=4; IntAct=EBI-8285963, EBI-80389;
CC       P31016:Dlg4 (xeno); NbExp=2; IntAct=EBI-8285963, EBI-375655;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26875626};
CC       Multi-pass membrane protein {ECO:0000305}. Cell junction, synapse,
CC       postsynaptic cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in brain with predominant
CC       expression is in the cerebellum, also present in the hippocampus,
CC       amygdala, caudate nucleus, corpus callosum, subthalamic nuclei and
CC       thalamus. Detected in the heart, skeletal muscle and pancreas.
CC       {ECO:0000269|PubMed:9037519}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of
CC       a transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:Q00960}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR2C/GRIN2C subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L76224; AAA88096.1; -; mRNA.
DR   EMBL; AC068874; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC140801; AAI40802.1; -; mRNA.
DR   CCDS; CCDS32724.1; -.
DR   RefSeq; NP_000826.2; NM_000835.4.
DR   UniGene; Hs.436980; -.
DR   ProteinModelPortal; Q14957; -.
DR   BioGrid; 109162; 3.
DR   IntAct; Q14957; 3.
DR   MINT; MINT-1776011; -.
DR   STRING; 9606.ENSP00000293190; -.
DR   BindingDB; Q14957; -.
DR   ChEMBL; CHEMBL4109; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB06741; Gavestinel.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB04896; Milnacipran.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01520; Tenocyclidine.
DR   GuidetoPHARMACOLOGY; 458; -.
DR   TCDB; 1.A.10.1.3; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; Q14957; -.
DR   PhosphoSitePlus; Q14957; -.
DR   DMDM; 313104210; -.
DR   PaxDb; Q14957; -.
DR   PeptideAtlas; Q14957; -.
DR   PRIDE; Q14957; -.
DR   Ensembl; ENST00000293190; ENSP00000293190; ENSG00000161509.
DR   GeneID; 2905; -.
DR   KEGG; hsa:2905; -.
DR   UCSC; uc002jlt.3; human.
DR   CTD; 2905; -.
DR   DisGeNET; 2905; -.
DR   EuPathDB; HostDB:ENSG00000161509.13; -.
DR   GeneCards; GRIN2C; -.
DR   H-InvDB; HIX0039170; -.
DR   HGNC; HGNC:4587; GRIN2C.
DR   MIM; 138254; gene.
DR   neXtProt; NX_Q14957; -.
DR   OpenTargets; ENSG00000161509; -.
DR   PharmGKB; PA28981; -.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   HOVERGEN; HBG052636; -.
DR   InParanoid; Q14957; -.
DR   KO; K05211; -.
DR   OMA; SAILYMM; -.
DR   OrthoDB; EOG091G09KH; -.
DR   PhylomeDB; Q14957; -.
DR   TreeFam; TF314731; -.
DR   Reactome; R-HSA-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-HSA-442729; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; R-HSA-442982; Ras activation uopn Ca2+ infux through NMDA receptor.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6794361; Neurexins and neuroligins.
DR   Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
DR   SignaLink; Q14957; -.
DR   GeneWiki; GRIN2C; -.
DR   GenomeRNAi; 2905; -.
DR   PRO; PR:Q14957; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000161509; -.
DR   CleanEx; HS_GRIN2C; -.
DR   ExpressionAtlas; Q14957; baseline and differential.
DR   Genevisible; Q14957; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; IDA:UniProtKB.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; IDA:UniProtKB.
DR   GO; GO:0033058; P:directional locomotion; IEA:Ensembl.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0008104; P:protein localization; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Magnesium; Membrane; Phosphoprotein;
KW   Polymorphism; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   1233       Glutamate receptor ionotropic, NMDA 2C.
FT                                /FTId=PRO_0000011580.
FT   TOPO_DOM     20    554       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TRANSMEM    555    573       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    574    600       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   INTRAMEM    601    620       Discontinuously helical.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    621    627       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TRANSMEM    628    643       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    644    814       Extracellular.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   TRANSMEM    815    834       Helical. {ECO:0000250|UniProtKB:Q00960}.
FT   TOPO_DOM    835   1233       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   REGION      509    511       Glutamate binding.
FT                                {ECO:0000250|UniProtKB:Q00959}.
FT   REGION      601    620       Pore-forming.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   REGION      687    688       Glutamate binding.
FT                                {ECO:0000250|UniProtKB:Q00959}.
FT   MOTIF      1231   1233       PDZ-binding.
FT   BINDING     511    511       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   BINDING     516    516       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00959}.
FT   BINDING     729    729       Glutamate.
FT                                {ECO:0000250|UniProtKB:Q00960}.
FT   SITE        612    612       Functional determinant of NMDA receptors.
FT                                {ECO:0000250}.
FT   MOD_RES     875    875       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01098}.
FT   MOD_RES     881    881       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q01098}.
FT   MOD_RES     912    912       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q00961}.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    337    337       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    438    438       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    539    539       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     82    317       {ECO:0000250|UniProtKB:Q00959}.
FT   DISULFID    426    453       {ECO:0000250|UniProtKB:Q00959}.
FT   DISULFID    433    454       {ECO:0000250|UniProtKB:Q00959}.
FT   DISULFID    743    798       {ECO:0000250|UniProtKB:Q00959}.
FT   VARIANT      18   1233       Missing (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079958.
FT   VARIANT      90     90       V -> I. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079959.
FT   VARIANT     166    166       A -> V. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079960.
FT   VARIANT     573    573       M -> T. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079961.
FT   VARIANT     641    641       A -> T. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079962.
FT   VARIANT     679    679       R -> C (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079963.
FT   VARIANT     863    863       I -> T (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079964.
FT   VARIANT     871    871       Q -> R. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079965.
FT   VARIANT     877    877       P -> S. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079966.
FT   VARIANT     911    911       S -> I. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079967.
FT   VARIANT     982    982       P -> A. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079968.
FT   VARIANT     989    989       S -> P (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079969.
FT   VARIANT     995    995       S -> L (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079970.
FT   VARIANT    1079   1079       H -> Y. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079971.
FT   VARIANT    1141   1141       P -> A. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079972.
FT   VARIANT    1180   1180       G -> R. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079973.
FT   VARIANT    1196   1196       T -> I. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079974.
FT   VARIANT    1209   1209       R -> S (in dbSNP:rs3744215).
FT                                /FTId=VAR_037634.
FT   MUTAGEN     550    550       P->R: Changed glutamate-gated calcium ion
FT                                channel activity characterized by
FT                                increased glutamate and glycine potency.
FT                                {ECO:0000269|PubMed:28095420}.
FT   CONFLICT   1048   1048       E -> EPPE (in Ref. 3; AAI40802).
FT                                {ECO:0000305}.
FT   CONFLICT   1057   1057       P -> K (in Ref. 1; AAA88096).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1233 AA;  134209 MW;  7B1F2F7995C0D689 CRC64;
     MGGALGPALL LTSLFGAWAG LGPGQGEQGM TVAVVFSSSG PPQAQFRARL TPQSFLDLPL
     EIQPLTVGVN TTNPSSLLTQ ICGLLGAAHV HGIVFEDNVD TEAVAQILDF ISSQTHVPIL
     SISGGSAVVL TPKEPGSAFL QLGVSLEQQL QVLFKVLEEY DWSAFAVITS LHPGHALFLE
     GVRAVADASH VSWRLLDVVT LELGPGGPRA RTQRLLRQLD APVFVAYCSR EEAEVLFAEA
     AQAGLVGPGH VWLVPNLALG STDAPPATFP VGLISVVTES WRLSLRQKVR DGVAILALGA
     HSYWRQHGTL PAPAGDCRVH PGPVSPAREA FYRHLLNVTW EGRDFSFSPG GYLVQPTMVV
     IALNRHRLWE MVGRWEHGVL YMKYPVWPRY SASLQPVVDS RHLTVATLEE RPFVIVESPD
     PGTGGCVPNT VPCRRQSNHT FSSGDVAPYT KLCCKGFCID ILKKLARVVK FSYDLYLVTN
     GKHGKRVRGV WNGMIGEVYY KRADMAIGSL TINEERSEIV DFSVPFVETG ISVMVARSNG
     TVSPSAFLEP YSPAVWVMMF VMCLTVVAIT VFMFEYFSPV SYNQNLTRGK KSGGPAFTIG
     KSVWLLWALV FNNSVPIENP RGTTSKIMVL VWAFFAVIFL ASYTANLAAF MIQEQYIDTV
     SGLSDKKFQR PQDQYPPFRF GTVPNGSTER NIRSNYRDMH THMVKFNQRS VEDALTSLKM
     GKLDAFIYDA AVLNYMAGKD EGCKLVTIGS GKVFATTGYG IAMQKDSHWK RAIDLALLQF
     LGDGETQKLE TVWLSGICQN EKNEVMSSKL DIDNMAGVFY MLLVAMGLAL LVFAWEHLVY
     WKLRHSVPNS SQLDFLLAFS RGIYSCFSGV QSLASPPRQA SPDLTASSAQ ASVLKMLQAA
     RDMVTTAGVS SSLDRATRTI ENWGGGRRAP PPSPCPTPRS GPSPCLPTPD PPPEPSPTGW
     GPPDGGRAAL VRRAPQPPGR PPTPGPPLSD VSRVSRRPAW EARWPVRTGH CGRHLSASER
     PLSPARCHYS SFPRADRSGR PFLPLFPELE DLPLLGPEQL ARREALLHAA WARGSRPRHA
     SLPSSVAEAF ARPSSLPAGC TGPACARPDG HSACRRLAQA QSMCLPIYRE ACQEGEQAGA
     PAWQHRQHVC LHAHAHLPFC WGAVCPHLPP CASHGSWLSG AWGPLGHRGR TLGLGTGYRD
     SGGLDEISRV ARGTQGFPGP CTWRRISSLE SEV
//
ID   CNGA3_HUMAN             Reviewed;         694 AA.
AC   Q16281; E9PF93; Q4VAP7; Q53RD2; Q6ZNA7; Q9UP64;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 2.
DT   20-DEC-2017, entry version 171.
DE   RecName: Full=Cyclic nucleotide-gated cation channel alpha-3;
DE   AltName: Full=Cone photoreceptor cGMP-gated channel subunit alpha;
DE   AltName: Full=Cyclic nucleotide-gated channel alpha-3;
DE            Short=CNG channel alpha-3;
DE            Short=CNG-3;
DE            Short=CNG3;
GN   Name=CNGA3; Synonyms=CNCG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9517456; DOI=10.1111/j.1460-9568.1997.tb01680.x;
RA   Wissinger B., Mueller F., Weyand I., Schuffenhauer S., Thanos S.,
RA   Kaupp U.B., Zrenner E.;
RT   "Cloning, chromosomal localization and functional expression of the
RT   gene encoding the alpha-subunit of the cGMP-gated channel in human
RT   cone photoreceptors.";
RL   Eur. J. Neurosci. 9:2512-2521(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 320-580.
RX   PubMed=7532814; DOI=10.1016/0028-3908(94)90027-2;
RA   Distler M., Biel M., Flockerzi V., Hofmann F.;
RT   "Expression of cyclic nucleotide-gated cation channels in non-sensory
RT   tissues and cells.";
RL   Neuropharmacology 33:1275-1282(1994).
RN   [6]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=10888875; DOI=10.1038/77162;
RA   Sundin O.H., Yang J.-M., Li Y., Zhu D., Hurd J.N., Mitchell T.N.,
RA   Silva E.D., Maumenee I.H.;
RT   "Genetic basis of total colourblindness among the Pingelapese
RT   islanders.";
RL   Nat. Genet. 25:289-293(2000).
RN   [7]
RP   SUBUNIT.
RX   PubMed=15134637; DOI=10.1016/S0896-6273(04)00225-9;
RA   Peng C., Rich E.D., Varnum M.D.;
RT   "Subunit configuration of heteromeric cone cyclic nucleotide-gated
RT   channels.";
RL   Neuron 42:401-410(2004).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 626-669, AND SUBUNIT
RP   STOICHIOMETRY.
RX   PubMed=21878911; DOI=10.1038/ncomms1466;
RA   Shuart N.G., Haitin Y., Camp S.S., Black K.D., Zagotta W.N.;
RT   "Molecular mechanism for 3:1 subunit stoichiometry of rod cyclic
RT   nucleotide-gated ion channels.";
RL   Nat. Commun. 2:457-457(2011).
RN   [9]
RP   VARIANTS ACHM2 LEU-163; GLN-283; TRP-283; ARG-291; TRP-410; MET-529;
RP   LEU-547 AND ARG-557, AND VARIANT MET-153.
RX   PubMed=9662398; DOI=10.1038/935;
RA   Kohl S., Marx T., Giddings I., Jaegle H., Jacobson S.G.,
RA   Apfelstedt-Sylla E., Zrenner E., Sharpe L.T., Wissinger B.;
RT   "Total colourblindness is caused by mutations in the gene encoding the
RT   alpha-subunit of the cone photoreceptor cGMP-gated cation channel.";
RL   Nat. Genet. 19:257-259(1998).
RN   [10]
RP   VARIANTS ACHM2 VAL-162; LEU-163; CYS-181; TYR-182; PHE-186; TYR-191;
RP   LYS-194; TRP-223; ARG-224; ASN-260; ASP-267; CYS-277; HIS-277;
RP   TRP-283; GLN-283; ARG-291; ILE-312 DEL; PRO-341; SER-369; SER-372;
RP   SER-380; THR-406; TRP-410; CYS-427; TRP-436; SER-471; VAL-485;
RP   SER-510; GLU-513; GLU-516; THR-522; ASP-525; MET-529; LEU-547;
RP   ARG-557; HIS-563; MET-565; HIS-569; CYS-573 AND LYS-593.
RX   PubMed=11536077; DOI=10.1086/323613;
RA   Wissinger B., Gamer D., Jaegle H., Giorda R., Marx T., Mayer S.,
RA   Tippmann S., Broghammer M., Jurklies B., Rosenberg T., Jacobson S.G.,
RA   Sener E.C., Tatlipinar S., Hoyng C.B., Castellan C., Bitoun P.,
RA   Andreasson S., Rudolph G., Kellner U., Lorenz B., Wolff G.,
RA   Verellen-Dumoulin C., Schwartz M., Cremers F.P.M.,
RA   Apfelstedt-Sylla E., Zrenner E., Salati R., Sharpe L.T., Kohl S.;
RT   "CNGA3 mutations in hereditary cone photoreceptor disorders.";
RL   Am. J. Hum. Genet. 69:722-737(2001).
RN   [11]
RP   VARIANTS ACHM2 TRP-223; TRP-436; LEU-547; ARG-548 AND HIS-569.
RX   PubMed=14757870; DOI=10.1136/jmg.2003.011437;
RA   Johnson S., Michaelides M., Aligianis I.A., Ainsworth J.R.,
RA   Mollon J.D., Maher E.R., Moore A.T., Hunt D.M.;
RT   "Achromatopsia caused by novel mutations in both CNGA3 and CNGB3.";
RL   J. Med. Genet. 41:E20-E20(2004).
RN   [12]
RP   CHARACTERIZATION OF VARIANTS ACHM2 CYS-277; SER-471 AND HIS-563.
RX   PubMed=15743887; DOI=10.1152/ajpcell.00490.2004;
RA   Liu C., Varnum M.D.;
RT   "Functional consequences of progressive cone dystrophy-associated
RT   mutations in the human cone photoreceptor cyclic nucleotide-gated
RT   channel CNGA3 subunit.";
RL   Am. J. Physiol. 289:C187-C198(2005).
RN   [13]
RP   VARIANTS ACHM2 TRP-223; SER-249; ASP-263; CYS-277; PRO-341; PRO-401;
RP   TRP-410; CYS-427; TRP-436; MET-529; MET-565 AND LYS-590, AND VARIANTS
RP   LEU-48 AND MET-153.
RX   PubMed=15712225; DOI=10.1002/humu.20142;
RA   Nishiguchi K.M., Sandberg M.A., Gorji N., Berson E.L., Dryja T.P.;
RT   "Cone cGMP-gated channel mutations and clinical findings in patients
RT   with achromatopsia, macular degeneration, and other hereditary cone
RT   diseases.";
RL   Hum. Mutat. 25:248-258(2005).
RN   [14]
RP   VARIANTS ACHM2 LYS-228; CYS-277; GLN-283; TRP-439; THR-469; LEU-547
RP   AND ARG-557, AND CHARACTERIZATION OF VARIANTS ACHM2 LYS-228; GLN-283;
RP   ARG-291; TRP-439; THR-469; LEU-547; ARG-557 AND LYS-590.
RX   PubMed=18521937; DOI=10.1002/humu.20790;
RG   Achromatopsia clinical study group;
RA   Reuter P., Koeppen K., Ladewig T., Kohl S., Baumann B., Wissinger B.;
RT   "Mutations in CNGA3 impair trafficking or function of cone cyclic
RT   nucleotide-gated channels, resulting in achromatopsia.";
RL   Hum. Mutat. 29:1228-1236(2008).
RN   [15]
RP   VARIANT MET-527.
RX   PubMed=21901789; DOI=10.1002/humu.21587;
RA   Wang X., Wang H., Cao M., Li Z., Chen X., Patenia C., Gore A.,
RA   Abboud E.B., Al-Rajhi A.A., Lewis A.R., Lupski J.R., Mardon G.,
RA   Zhang K., Muzny D., Gibbs R.A., Chen R.;
RT   "Whole-exome sequencing identifies ALMS1, IQCB1, CNGA3, and MYO7A
RT   mutations in patients with Leber congenital amaurosis.";
RL   Hum. Mutat. 32:1450-1459(2011).
RN   [16]
RP   VARIANT CYS-335.
RX   PubMed=23033978; DOI=10.1056/NEJMoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P.,
RA   Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B.,
RA   Brunner H.G., Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [17]
RP   VARIANTS ASP-120; LYS-198; ILE-224; MET-247; ARG-258; SER-330;
RP   PHE-334; HIS-533; ASN-570 AND HIS-646, AND VARIANTS ACHM2 CYS-171;
RP   TRP-223; GLN-223; ASN-260; LYS-274; HIS-277; CYS-277; PRO-278;
RP   TRP-283; SER-322; TRP-436; GLN-436; TRP-439; MET-529; 543-ASP--SER-545
RP   DEL AND LYS-590.
RX   PubMed=24903488; DOI=10.1001/jamaophthalmol.2014.1032;
RA   Li S., Huang L., Xiao X., Jia X., Guo X., Zhang Q.;
RT   "Identification of CNGA3 mutations in 46 Families: common cause of
RT   achromatopsia and cone-rod dystrophies in Chinese patients.";
RL   JAMA Ophthalmol. 132:1076-1083(2014).
RN   [18]
RP   VARIANTS ACHM2 ASP-323 AND HIS-569.
RX   PubMed=26493561; DOI=10.1186/s12967-015-0694-7;
RA   Li F.F., Huang X.F., Chen J., Yu X.D., Zheng M.Q., Lu F., Jin Z.B.,
RA   Gan D.K.;
RT   "Identification of novel mutations by targeted exome sequencing and
RT   the genotype-phenotype assessment of patients with achromatopsia.";
RL   J. Transl. Med. 13:334-334(2015).
CC   -!- FUNCTION: Visual signal transduction is mediated by a G-protein
CC       coupled cascade using cGMP as second messenger. This protein can
CC       be activated by cyclic GMP which leads to an opening of the cation
CC       channel and thereby causing a depolarization of cone
CC       photoreceptors. Induced a flickering channel gating, weakened the
CC       outward rectification in the presence of extracellular calcium,
CC       increased sensitivity for L-cis diltiazem and enhanced the cAMP
CC       efficacy of the channel when coexpressed with CNGB3 (By
CC       similarity). Essential for the generation of light-evoked
CC       electrical responses in the red-, green- and blue sensitive cones.
CC       {ECO:0000250, ECO:0000269|PubMed:10888875}.
CC   -!- SUBUNIT: Tetramer formed of three CNGA3 and one CNGB3 modulatory
CC       subunits. {ECO:0000269|PubMed:10888875,
CC       ECO:0000269|PubMed:15134637, ECO:0000269|PubMed:21878911}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16281-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16281-2; Sequence=VSP_042525;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q16281-3; Sequence=VSP_057075;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Prominently expressed in retina.
CC   -!- DOMAIN: The C-terminal coiled-coil domain mediates
CC       homotrimerization of CNGA subunits.
CC   -!- DISEASE: Achromatopsia 2 (ACHM2) [MIM:216900]: An ocular
CC       stationary disorder due to the absence of functioning cone
CC       photoreceptors in the retina. It is characterized by total
CC       colorblindness, low visual acuity, photophobia and nystagmus.
CC       {ECO:0000269|PubMed:11536077, ECO:0000269|PubMed:14757870,
CC       ECO:0000269|PubMed:15712225, ECO:0000269|PubMed:15743887,
CC       ECO:0000269|PubMed:18521937, ECO:0000269|PubMed:24903488,
CC       ECO:0000269|PubMed:26493561, ECO:0000269|PubMed:9662398}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGA3 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the CNGA3 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/cnga3mut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF065314; AAC17440.1; -; mRNA.
DR   EMBL; AK131300; BAD18468.1; -; mRNA.
DR   EMBL; AC092675; AAY24181.1; -; Genomic_DNA.
DR   EMBL; BC096298; AAH96298.1; -; mRNA.
DR   EMBL; BC096299; AAH96299.1; -; mRNA.
DR   EMBL; BC096300; AAH96300.1; -; mRNA.
DR   EMBL; S76069; AAD14208.1; -; Genomic_DNA.
DR   CCDS; CCDS2034.1; -. [Q16281-1]
DR   CCDS; CCDS42719.1; -. [Q16281-2]
DR   PIR; I78560; I78560.
DR   PIR; S74179; S74179.
DR   RefSeq; NP_001073347.1; NM_001079878.1. [Q16281-2]
DR   RefSeq; NP_001289.1; NM_001298.2. [Q16281-1]
DR   UniGene; Hs.234785; -.
DR   PDB; 3SWY; X-ray; 1.90 A; A/B/C=626-669.
DR   PDBsum; 3SWY; -.
DR   ProteinModelPortal; Q16281; -.
DR   SMR; Q16281; -.
DR   BioGrid; 107661; 27.
DR   IntAct; Q16281; 1.
DR   STRING; 9606.ENSP00000272602; -.
DR   GuidetoPHARMACOLOGY; 396; -.
DR   TCDB; 1.A.1.5.12; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q16281; -.
DR   PhosphoSitePlus; Q16281; -.
DR   BioMuta; CNGA3; -.
DR   DMDM; 13959682; -.
DR   PaxDb; Q16281; -.
DR   PeptideAtlas; Q16281; -.
DR   PRIDE; Q16281; -.
DR   Ensembl; ENST00000272602; ENSP00000272602; ENSG00000144191. [Q16281-1]
DR   Ensembl; ENST00000393504; ENSP00000377140; ENSG00000144191. [Q16281-1]
DR   Ensembl; ENST00000409937; ENSP00000386761; ENSG00000144191. [Q16281-3]
DR   Ensembl; ENST00000436404; ENSP00000410070; ENSG00000144191. [Q16281-2]
DR   GeneID; 1261; -.
DR   KEGG; hsa:1261; -.
DR   UCSC; uc002syt.4; human. [Q16281-1]
DR   CTD; 1261; -.
DR   DisGeNET; 1261; -.
DR   EuPathDB; HostDB:ENSG00000144191.11; -.
DR   GeneCards; CNGA3; -.
DR   GeneReviews; CNGA3; -.
DR   HGNC; HGNC:2150; CNGA3.
DR   MalaCards; CNGA3; -.
DR   MIM; 216900; phenotype.
DR   MIM; 600053; gene.
DR   neXtProt; NX_Q16281; -.
DR   OpenTargets; ENSG00000144191; -.
DR   Orphanet; 49382; Achromatopsia.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   PharmGKB; PA26660; -.
DR   eggNOG; KOG0500; Eukaryota.
DR   eggNOG; ENOG410YWWI; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000007898; -.
DR   HOVERGEN; HBG000281; -.
DR   InParanoid; Q16281; -.
DR   KO; K04950; -.
DR   OMA; YLWANRK; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; Q16281; -.
DR   TreeFam; TF319048; -.
DR   GeneWiki; Cyclic_nucleotide-gated_channel_alpha_3; -.
DR   GenomeRNAi; 1261; -.
DR   PRO; PR:Q16281; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000144191; -.
DR   CleanEx; HS_CNGA3; -.
DR   Genevisible; Q16281; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0042622; C:photoreceptor outer segment membrane; IEA:Ensembl.
DR   GO; GO:1902495; C:transmembrane transporter complex; IDA:UniProtKB.
DR   GO; GO:0030553; F:cGMP binding; IMP:UniProtKB.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IMP:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:ProtInc.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0031960; P:response to corticosteroid; IEA:Ensembl.
DR   GO; GO:0032026; P:response to magnesium ion; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032406; CLZ_dom.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF16526; CLZ; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cGMP; cGMP-binding; Coiled coil;
KW   Complete proteome; Disease mutation; Ion channel; Ion transport;
KW   Leber congenital amaurosis; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Polymorphism; Reference proteome;
KW   Sensory transduction; Transmembrane; Transmembrane helix; Transport;
KW   Vision.
FT   CHAIN         1    694       Cyclic nucleotide-gated cation channel
FT                                alpha-3.
FT                                /FTId=PRO_0000219317.
FT   TOPO_DOM      1    166       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    167    187       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    188    199       Extracellular. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    221    252       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    274    302       Extracellular. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    324    378       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    379    399       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    400    481       Extracellular. {ECO:0000255}.
FT   TRANSMEM    482    502       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    503    694       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     482    605       cGMP.
FT   COILED      626    669
FT   BINDING     549    549       cGMP. {ECO:0000255}.
FT   BINDING     564    564       cGMP. {ECO:0000255}.
FT   VAR_SEQ       1     71       MAKINTQYSHPSRTHLKVKTSDRDLNRAENGLSRAHSSSEE
FT                                TSSVLQPGIAMETRGLADSGQGSFTGQGIA -> METRGLA
FT                                DSGQGSFTGQGIARFGRIQKKSQPEKVVRAASRGRPLIGWT
FT                                QWCAEDGGDESEMALAGSPGCSSGPQG (in isoform
FT                                3). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057075.
FT   VAR_SEQ     132    150       SAWPLAKCNTNTSNNTEEE -> R (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042525.
FT   VARIANT      48     48       P -> L (in dbSNP:rs62156348).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047565.
FT   VARIANT     120    120       N -> D (in dbSNP:rs199859850).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071435.
FT   VARIANT     153    153       T -> M (in dbSNP:rs34314205).
FT                                {ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010902.
FT   VARIANT     162    162       D -> V (in ACHM2; dbSNP:rs747447519).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047566.
FT   VARIANT     163    163       P -> L (in ACHM2; dbSNP:rs104893612).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010903.
FT   VARIANT     171    171       W -> C (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs762773298).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071436.
FT   VARIANT     181    181       Y -> C (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047567.
FT   VARIANT     182    182       N -> Y (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047568.
FT   VARIANT     186    186       L -> F (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047569.
FT   VARIANT     191    191       C -> Y (in ACHM2; dbSNP:rs761554853).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047570.
FT   VARIANT     194    194       E -> K (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047571.
FT   VARIANT     198    198       E -> K (in dbSNP:rs2271041).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_021963.
FT   VARIANT     223    223       R -> Q (in ACHM2; dbSNP:rs762668060).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071438.
FT   VARIANT     223    223       R -> W (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs138958917).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:14757870,
FT                                ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047572.
FT   VARIANT     224    224       T -> I (probable disease-associated
FT                                mutation found in patients with cone-rod
FT                                dystrophy).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071439.
FT   VARIANT     224    224       T -> R (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047573.
FT   VARIANT     228    228       E -> K (in ACHM2; unknown pathological
FT                                significance; the dose-response
FT                                relationship for cGMP-activation is not
FT                                significantly different from that of
FT                                wild-type CNGA3; the dose-response
FT                                relationship of the mutant CNGA3 + CNGB3
FT                                is similar to that of the wild-type
FT                                protein; the channel density into the
FT                                cell membrane is considerably improved by
FT                                decreasing the cultivation temperature;
FT                                dbSNP:rs147415641).
FT                                {ECO:0000269|PubMed:18521937}.
FT                                /FTId=VAR_047574.
FT   VARIANT     247    247       T -> M (in dbSNP:rs148616345).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071440.
FT   VARIANT     249    249       F -> S (in ACHM2).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047575.
FT   VARIANT     258    258       P -> R (probable disease-associated
FT                                mutation found in patients with cone-rod
FT                                dystrophy).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071441.
FT   VARIANT     260    260       D -> N (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs374258471).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047576.
FT   VARIANT     263    263       Y -> D (in ACHM2; dbSNP:rs943314733).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047577.
FT   VARIANT     267    267       G -> D (in ACHM2; dbSNP:rs781673067).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047578.
FT   VARIANT     274    274       R -> K (in ACHM2).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071442.
FT   VARIANT     277    277       R -> C (in ACHM2; also found in patients
FT                                with cone-rod dystrophy; does not form
FT                                functional homomeric or heteromeric
FT                                channels; dbSNP:rs104893620).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:15743887,
FT                                ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047579.
FT   VARIANT     277    277       R -> H (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs778114016).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047580.
FT   VARIANT     278    278       L -> P (in ACHM2; dbSNP:rs763421555).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071443.
FT   VARIANT     283    283       R -> Q (in ACHM2; does not reveal any
FT                                detectable calcium influx upon agonist
FT                                application at 37 degrees Celsius; the
FT                                channel function could be restored by
FT                                incubating the transfected cells at 27
FT                                degrees Celsius; the dose-response
FT                                relationship for cGMP-activation is not
FT                                significantly different from that of
FT                                wild-type CNGA3; the dose-response
FT                                relationship of the mutant CNGA3 + CNGB3
FT                                is similar to that of the wild-type
FT                                protein; a substantial reduction of
FT                                macroscopic cGMP maximum current to only
FT                                one-third of the mean value for wild-type
FT                                CNGA3 + CNGB3 is observed for the mutant
FT                                CNGA3 + CNGB3; the channel density into
FT                                the cell membrane is considerably
FT                                improved by decreasing the cultivation
FT                                temparature; dbSNP:rs104893614).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010904.
FT   VARIANT     283    283       R -> W (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs104893613).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:24903488,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010905.
FT   VARIANT     291    291       T -> R (in ACHM2; does not reveal any
FT                                detectable calcium influx upon agonist
FT                                application at 37 degrees Celsius; the
FT                                channel function could be restored by
FT                                incubating the transfected cells at 27
FT                                degrees Celsius; the K(1/2) value is
FT                                shifted toward a higher cGMP
FT                                concentration by a factor of 1.8; no
FT                                positive influence of the CNGB3 subunit
FT                                in the cGMP sensitivity is observed; a
FT                                substantial reduction of macroscopic cGMP
FT                                maximum current to only one-third of the
FT                                mean value for wild-type CNGA3 + CNGB3 is
FT                                observed for the mutant CNGA3 + CNGB3;
FT                                the channel density into the cell
FT                                membrane is considerably improved by
FT                                decreasing the cultivation temparature;
FT                                dbSNP:rs104893616).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010906.
FT   VARIANT     312    312       Missing (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047581.
FT   VARIANT     322    322       F -> S (in ACHM2).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071444.
FT   VARIANT     323    323       A -> D (in ACHM2).
FT                                {ECO:0000269|PubMed:26493561}.
FT                                /FTId=VAR_075493.
FT   VARIANT     330    330       F -> S (probable disease-associated
FT                                mutation found in patients with cone-rod
FT                                dystrophy).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071445.
FT   VARIANT     334    334       S -> F (probable disease-associated
FT                                mutation found in patients with cone-rod
FT                                dystrophy).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071446.
FT   VARIANT     335    335       W -> C. {ECO:0000269|PubMed:23033978}.
FT                                /FTId=VAR_069398.
FT   VARIANT     341    341       S -> P (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047582.
FT   VARIANT     369    369       T -> S (in ACHM2; dbSNP:rs766637612).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047583.
FT   VARIANT     372    372       P -> S (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047584.
FT   VARIANT     380    380       F -> S (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047585.
FT   VARIANT     401    401       S -> P (in ACHM2; dbSNP:rs916035276).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047586.
FT   VARIANT     406    406       M -> T (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047587.
FT   VARIANT     410    410       R -> W (in ACHM2; dbSNP:rs137852608).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010910.
FT   VARIANT     427    427       R -> C (in ACHM2; dbSNP:rs141386891).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047588.
FT   VARIANT     436    436       R -> Q (in ACHM2; dbSNP:rs767083685).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071447.
FT   VARIANT     436    436       R -> W (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs104893621).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:14757870,
FT                                ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047589.
FT   VARIANT     439    439       R -> W (in ACHM2; also found in patients
FT                                with cone-rod dystrophy; does not reveal
FT                                any detectable calcium influx upon
FT                                agonist application at 37 degrees
FT                                Celsius; dbSNP:rs749842881).
FT                                {ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047590.
FT   VARIANT     469    469       A -> T (in ACHM2; the dose-response
FT                                relationship for cGMP-activation is
FT                                shifted toward a lower cGMP
FT                                concentration; the left shift in the
FT                                dose-response relationship of the mutant
FT                                CNGA3 is less distinctive than in
FT                                homomeric channels with this mutation
FT                                indicating a partial rescue effect of the
FT                                CNGB3 subunit; is in large part located
FT                                in the cell membrane at 37 and 27 degrees
FT                                Celsius; dbSNP:rs117522010).
FT                                {ECO:0000269|PubMed:18521937}.
FT                                /FTId=VAR_047591.
FT   VARIANT     471    471       N -> S (in ACHM2; mutant CNGA3 alone or
FT                                together with the CNGB3 subunit exhibit
FT                                an increase in apparent affinity for cGMP
FT                                and an increase in the relative agonist
FT                                efficacy of cAMP compared with cGMP; cell
FT                                surface expression levels is unchanged;
FT                                dbSNP:rs373954146).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15743887}.
FT                                /FTId=VAR_047592.
FT   VARIANT     485    485       D -> V (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047593.
FT   VARIANT     510    510       C -> S (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047594.
FT   VARIANT     513    513       G -> E (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047595.
FT   VARIANT     516    516       G -> E (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047596.
FT   VARIANT     522    522       I -> T (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047597.
FT   VARIANT     525    525       G -> D (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047598.
FT   VARIANT     527    527       L -> M (found in a patient with Leber
FT                                congenital amaurosis; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:21901789}.
FT                                /FTId=VAR_066860.
FT   VARIANT     529    529       V -> M (in ACHM2; also found in patients
FT                                with cone-rod dystrophy;
FT                                dbSNP:rs104893619).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:24903488,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010907.
FT   VARIANT     533    533       D -> H (probable disease-associated
FT                                mutation found in patients with cone-rod
FT                                dystrophy; dbSNP:rs775332304).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071448.
FT   VARIANT     543    545       Missing (in ACHM2).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071449.
FT   VARIANT     547    547       F -> L (in ACHM2; does not reveal any
FT                                detectable calcium influx upon agonist
FT                                application at 37 degrees Celsius; the
FT                                channel function could be restored by
FT                                incubating the transfected cells at 27
FT                                degrees Celsius; the dose-response
FT                                relationship for cGMP-activation is
FT                                shifted toward a lower cGMP
FT                                concentration; a substantial reduction of
FT                                macroscopic cGMP maximum current to only
FT                                one-third of the mean value for wild-type
FT                                CNGA3 + CNGB3 is observed for the mutant
FT                                CNGA3 + CNGB3; is in large part located
FT                                in the cell membrane at 37 and 27 degrees
FT                                Celsius; dbSNP:rs104893617).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:14757870,
FT                                ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010908.
FT   VARIANT     548    548       G -> R (in ACHM2; dbSNP:rs781227859).
FT                                {ECO:0000269|PubMed:14757870}.
FT                                /FTId=VAR_047599.
FT   VARIANT     557    557       G -> R (in ACHM2; the K(1/2) value is
FT                                shifted toward a higher cGMP
FT                                concentration by a factor of 3.0; no
FT                                positive influence of the CNGB3 subunit
FT                                in the cGMP sensitivity is observed;
FT                                average cGMP maximum current is decreased
FT                                to half of the mean wild-type value for
FT                                the mutant CNGA3 + CNGB3;
FT                                dbSNP:rs104893615).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:9662398}.
FT                                /FTId=VAR_010909.
FT   VARIANT     563    563       R -> H (in ACHM2; mutant CNGA3 alone or
FT                                together with the CNGB3 subunit exhibit
FT                                an increase in apparent affinity for cGMP
FT                                and an increase in the relative agonist
FT                                efficacy of cAMP compared with cGMP; cell
FT                                surface expression levels is
FT                                significantly reduced;
FT                                dbSNP:rs552069173).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15743887}.
FT                                /FTId=VAR_047600.
FT   VARIANT     565    565       T -> M (in ACHM2; dbSNP:rs201747279).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047601.
FT   VARIANT     569    569       R -> H (in ACHM2; dbSNP:rs201782746).
FT                                {ECO:0000269|PubMed:11536077,
FT                                ECO:0000269|PubMed:14757870,
FT                                ECO:0000269|PubMed:26493561}.
FT                                /FTId=VAR_047602.
FT   VARIANT     570    570       S -> N (probable disease-associated
FT                                mutation found in patients with cone-rod
FT                                dystrophy).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071450.
FT   VARIANT     573    573       Y -> C (in ACHM2).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047603.
FT   VARIANT     590    590       E -> K (in ACHM2; also found in patients
FT                                with cone-rod dystrophy; the dose-
FT                                response relationship for cGMP-activation
FT                                is shifted toward a lower cGMP
FT                                concentration; dbSNP:rs763041373).
FT                                {ECO:0000269|PubMed:15712225,
FT                                ECO:0000269|PubMed:18521937,
FT                                ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_047604.
FT   VARIANT     593    593       E -> K (in ACHM2; dbSNP:rs774676415).
FT                                {ECO:0000269|PubMed:11536077}.
FT                                /FTId=VAR_047605.
FT   VARIANT     646    646       R -> H (in dbSNP:rs141577844).
FT                                {ECO:0000269|PubMed:24903488}.
FT                                /FTId=VAR_071451.
FT   HELIX       626    668       {ECO:0000244|PDB:3SWY}.
SQ   SEQUENCE   694 AA;  78838 MW;  AE00B4EE760D70A0 CRC64;
     MAKINTQYSH PSRTHLKVKT SDRDLNRAEN GLSRAHSSSE ETSSVLQPGI AMETRGLADS
     GQGSFTGQGI ARLSRLIFLL RRWAARHVHH QDQGPDSFPD RFRGAELKEV SSQESNAQAN
     VGSQEPADRG RSAWPLAKCN TNTSNNTEEE KKTKKKDAIV VDPSSNLYYR WLTAIALPVF
     YNWYLLICRA CFDELQSEYL MLWLVLDYSA DVLYVLDVLV RARTGFLEQG LMVSDTNRLW
     QHYKTTTQFK LDVLSLVPTD LAYLKVGTNY PEVRFNRLLK FSRLFEFFDR TETRTNYPNM
     FRIGNLVLYI LIIIHWNACI YFAISKFIGF GTDSWVYPNI SIPEHGRLSR KYIYSLYWST
     LTLTTIGETP PPVKDEEYLF VVVDFLVGVL IFATIVGNVG SMISNMNASR AEFQAKIDSI
     KQYMQFRKVT KDLETRVIRW FDYLWANKKT VDEKEVLKSL PDKLKAEIAI NVHLDTLKKV
     RIFQDCEAGL LVELVLKLRP TVFSPGDYIC KKGDIGKEMY IINEGKLAVV ADDGVTQFVV
     LSDGSYFGEI SILNIKGSKS GNRRTANIRS IGYSDLFCLS KDDLMEALTE YPEAKKALEE
     KGRQILMKDN LIDEELARAG ADPKDLEEKV EQLGSSLDTL QTRFARLLAE YNATQMKMKQ
     RLSQLESQVK GGGDKPLADG EVPGDATKTE DKQQ
//
ID   GRIK5_HUMAN             Reviewed;         980 AA.
AC   Q16478; Q8WWG8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   25-OCT-2017, entry version 164.
DE   RecName: Full=Glutamate receptor ionotropic, kainate 5;
DE            Short=GluK5;
DE   AltName: Full=Excitatory amino acid receptor 2;
DE            Short=EAA2;
DE   AltName: Full=Glutamate receptor KA-2;
DE            Short=KA2;
DE   Flags: Precursor;
GN   Name=GRIK5; Synonyms=GRIK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=1321949;
RA   Kamboj R.K., Schoepp D.D., Nutt S., Shekter L., Korczak B., True R.A.,
RA   Zimmerman D.M., Wosnick M.A.;
RT   "Molecular structure and pharmacological characterization of humEAA2,
RT   a novel human kainate receptor subunit.";
RL   Mol. Pharmacol. 42:10-15(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Erythroleukemia;
RA   Langer A., Xu D., Kuehcke K., Fehse B., Abdallah S., Lother H.;
RT   "Myeloid progenitor cell growth and apoptosis involves known and cell-
RT   specific ionotropic glutamate receptors.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds kainate > quisqualate > domoate > L-
CC       glutamate >> AMPA >> NMDA = 1S,3R-ACPD.
CC   -!- SUBUNIT: Tetramer of two or more different subunits. Associates
CC       with GRIK1 (both edited and unedited versions), GRIK2, or GRIK3 to
CC       form functional channels. Homomeric associations do not produce
CC       any channel activity (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16478-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16478-2; Sequence=VSP_035585;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIK5 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S40369; AAB22591.1; -; mRNA.
DR   EMBL; AJ249209; CAC80547.1; -; mRNA.
DR   EMBL; CH471126; EAW57090.1; -; Genomic_DNA.
DR   CCDS; CCDS12595.1; -. [Q16478-1]
DR   CCDS; CCDS77305.1; -. [Q16478-2]
DR   PIR; I57936; I57936.
DR   RefSeq; NP_001287959.1; NM_001301030.1. [Q16478-2]
DR   RefSeq; NP_002079.3; NM_002088.4. [Q16478-1]
DR   RefSeq; XP_005258878.1; XM_005258821.3. [Q16478-1]
DR   RefSeq; XP_011525165.1; XM_011526863.2. [Q16478-2]
DR   UniGene; Hs.367799; -.
DR   ProteinModelPortal; Q16478; -.
DR   SMR; Q16478; -.
DR   BioGrid; 109158; 6.
DR   IntAct; Q16478; 4.
DR   MINT; MINT-1427286; -.
DR   STRING; 9606.ENSP00000262895; -.
DR   BindingDB; Q16478; -.
DR   ChEMBL; CHEMBL2675; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   iPTMnet; Q16478; -.
DR   PhosphoSitePlus; Q16478; -.
DR   BioMuta; GRIK5; -.
DR   DMDM; 209572626; -.
DR   PaxDb; Q16478; -.
DR   PeptideAtlas; Q16478; -.
DR   PRIDE; Q16478; -.
DR   DNASU; 2901; -.
DR   Ensembl; ENST00000262895; ENSP00000262895; ENSG00000105737. [Q16478-1]
DR   Ensembl; ENST00000301218; ENSP00000301218; ENSG00000105737. [Q16478-2]
DR   Ensembl; ENST00000593562; ENSP00000470251; ENSG00000105737. [Q16478-1]
DR   GeneID; 2901; -.
DR   KEGG; hsa:2901; -.
DR   UCSC; uc002osj.3; human. [Q16478-1]
DR   CTD; 2901; -.
DR   DisGeNET; 2901; -.
DR   EuPathDB; HostDB:ENSG00000105737.9; -.
DR   GeneCards; GRIK5; -.
DR   H-InvDB; HIX0022359; -.
DR   H-InvDB; HIX0027521; -.
DR   HGNC; HGNC:4583; GRIK5.
DR   MIM; 600283; gene.
DR   neXtProt; NX_Q16478; -.
DR   OpenTargets; ENSG00000105737; -.
DR   PharmGKB; PA28977; -.
DR   eggNOG; ENOG410ISR4; Eukaryota.
DR   eggNOG; ENOG410XRUE; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000234371; -.
DR   HOVERGEN; HBG051839; -.
DR   InParanoid; Q16478; -.
DR   KO; K05205; -.
DR   OMA; DMRDTNC; -.
DR   OrthoDB; EOG091G02LN; -.
DR   PhylomeDB; Q16478; -.
DR   TreeFam; TF334668; -.
DR   Reactome; R-HSA-451308; Activation of Ca-permeable Kainate Receptor.
DR   GeneWiki; GRIK5; -.
DR   GenomeRNAi; 2901; -.
DR   PRO; PR:Q16478; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105737; -.
DR   CleanEx; HS_GRIK2; -.
DR   CleanEx; HS_GRIK5; -.
DR   ExpressionAtlas; Q16478; baseline and differential.
DR   Genevisible; Q16478; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0032983; C:kainate selective glutamate receptor complex; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0015277; F:kainate selective glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; TAS:Reactome.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006621; P:protein retention in ER lumen; IEA:Ensembl.
DR   GO; GO:0043113; P:receptor clustering; IEA:Ensembl.
DR   GO; GO:0031630; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     14       {ECO:0000255}.
FT   CHAIN        15    980       Glutamate receptor ionotropic, kainate 5.
FT                                /FTId=PRO_0000011552.
FT   TOPO_DOM     15    544       Extracellular. {ECO:0000255}.
FT   TRANSMEM    545    565       Helical. {ECO:0000255}.
FT   TOPO_DOM    566    622       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    623    643       Helical. {ECO:0000255}.
FT   TOPO_DOM    644    803       Extracellular. {ECO:0000255}.
FT   TRANSMEM    804    824       Helical. {ECO:0000255}.
FT   TOPO_DOM    825    980       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    860    866       Poly-Arg.
FT   CARBOHYD    219    219       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    271    271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    285    285       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    372    372       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    394    394       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    400    400       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     36    292       {ECO:0000250}.
FT   DISULFID     83    334       {ECO:0000250}.
FT   DISULFID    165    170       {ECO:0000250}.
FT   VAR_SEQ     839    980       VSVCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRA
FT                                VREMRLSNGKLYSAGAGGDAGSAHGGPQRLLDDPGPPSGAR
FT                                PAAPTPCTHVRVCQECRRIQALRASGAGAPPRGLGVPAEAT
FT                                SPPRPRPGPAGPRELAEHE -> TPALHPAACQCSALGPRT
FT                                PLKEPSMLLVKVPSTRVQVAFSRTSLRQVCPFLLQHQLSSL
FT                                YWIQATNVQICCHFSSLKPSPDLTFPPSHRPLSSLLFTALA
FT                                AVGGLPDASSFFFPPISSCPPLQSGIGPCHSTEATLVTSNF
FT                                HV (in isoform 2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_035585.
FT   CONFLICT    436    436       A -> G (in Ref. 1; AAB22591).
FT                                {ECO:0000305}.
FT   CONFLICT    459    461       RFR -> PFP (in Ref. 1; AAB22591).
FT                                {ECO:0000305}.
FT   CONFLICT    711    711       R -> A (in Ref. 1; AAB22591).
FT                                {ECO:0000305}.
SQ   SEQUENCE   980 AA;  109265 MW;  72466FFF64079388 CRC64;
     MPAELLLLLI VAFASPSCQV LSSLRMAAIL DDQTVCGRGE RLALALAREQ INGIIEVPAK
     ARVEVDIFEL QRDSQYETTD TMCQILPKGV VSVLGPSSSP ASASTVSHIC GEKEIPHIKV
     GPEETPRLQY LRFASVSLYP SNEDVSLAVS RILKSFNYPS ASLICAKAEC LLRLEELVRG
     FLISKETLSV RMLDDSRDPT PLLKEIRDDK VSTIIIDANA SISHLILRKA SELGMTSAFY
     KYILTTMDFP ILHLDGIVED SSNILGFSMF NTSHPFYPEF VRSLNMSWRE NCEASTYLGP
     ALSAALMFDA VHVVVSAVRE LNRSQEIGVK PLACTSANIW PHGTSLMNYL RMVEYDGLTG
     RVEFNSKGQR TNYTLRILEK SRQGHREIGV WYSNRTLAMN ATTLDINLSQ TLANKTLVVT
     TILENPYVMR RPNFQALSGN ERFEGFCVDM LRELAELLRF RYRLRLVEDG LYGAPEPNGS
     WTGMVGELIN RKADLAVAAF TITAEREKVI DFSKPFMTLG ISILYRVHMG RKPGYFSFLD
     PFSPAVWLFM LLAYLAVSCV LFLAARLSPY EWYNPHPCLR ARPHILENQY TLGNSLWFPV
     GGFMQQGSEI MPRALSTRCV SGVWWAFTLI IISSYTANLA AFLTVQRMEV PVESADDLAD
     QTNIEYGTIH AGSTMTFFQN SRYQTYQRMW NYMQSKQPSV FVKSTEEGIA RVLNSRYAFL
     LESTMNEYHR RLNCNLTQIG GLLDTKGYGI GMPLGSPFRD EITLAILQLQ ENNRLEILKR
     KWWEGGRCPK EEDHRAKGLG MENIGGIFIV LICGLIIAVF VAVMEFIWST RRSAESEEVS
     VCQEMLQELR HAVSCRKTSR SRRRRRPGGP SRALLSLRAV REMRLSNGKL YSAGAGGDAG
     SAHGGPQRLL DDPGPPSGAR PAAPTPCTHV RVCQECRRIQ ALRASGAGAP PRGLGVPAEA
     TSPPRPRPGP AGPRELAEHE
//
ID   GLUCB_CAEEL             Reviewed;         434 AA.
AC   Q17328; O02524;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 132.
DE   RecName: Full=Glutamate-gated chloride channel subunit beta;
DE            Short=Glu-Cl subunit beta;
DE   AltName: Full=Avermectin-sensitive glutamate-gated chloride channel subunit;
DE   Flags: Precursor;
GN   Name=glc-2; ORFNames=F25F8.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, SUBUNIT,
RP   AND INTERACTION WITH GLC-1.
RC   STRAIN=Bristol N2;
RX   PubMed=7935817; DOI=10.1038/371707a0;
RA   Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S.,
RA   Van der Ploeg L.H.T., Schaeffer J.M., Arena J.P.;
RT   "Cloning of an avermectin-sensitive glutamate-gated chloride channel
RT   from Caenorhabditis elegans.";
RL   Nature 371:707-711(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-50, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Glutamate-gated chloride channel subunit; channel
CC       properties depend on the subunit composition. Glutamate binding
CC       triggers a rapidly reversible current in heteromeric channels
CC       formed by glc-1 and glc-2, while the anti-helmintic drug
CC       ivermectin and other avermectins trigger a permanently open
CC       channel configuration. Channels containing only glc-2 are
CC       activated by glutamate, but not by ivermectin (in vitro). The
CC       heteromeric channel formed by glc-1 and glc-2 is also activated by
CC       ibotenate, and it is blocked by picrotoxin and flufenamic acid
CC       (PubMed:7935817). {ECO:0000269|PubMed:7935817}.
CC   -!- SUBUNIT: Pentamer (By similarity). Homooligomer that can form
CC       functional heterooligomers with glc-1 (PubMed:7935817).
CC       {ECO:0000250|UniProtKB:G5EBR3, ECO:0000269|PubMed:7935817}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q94900}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q94900}. Cell membrane
CC       {ECO:0000255, ECO:0000269|PubMed:7935817}; Multi-pass membrane
CC       protein {ECO:0000255, ECO:0000269|PubMed:7935817}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Glutamate-gated chloride channel (TC 1.A.9.4) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U14525; AAA50786.1; -; mRNA.
DR   EMBL; FO080262; CCD62432.1; -; Genomic_DNA.
DR   PIR; S50865; S50865.
DR   RefSeq; NP_491470.1; NM_059069.3.
DR   UniGene; Cel.19753; -.
DR   ProteinModelPortal; Q17328; -.
DR   SMR; Q17328; -.
DR   BioGrid; 37565; 1.
DR   DIP; DIP-27494N; -.
DR   MINT; MINT-1047253; -.
DR   STRING; 6239.F25F8.2; -.
DR   iPTMnet; Q17328; -.
DR   PaxDb; Q17328; -.
DR   EnsemblMetazoa; F25F8.2; F25F8.2; WBGene00001592.
DR   GeneID; 172103; -.
DR   KEGG; cel:CELE_F25F8.2; -.
DR   UCSC; F25F8.2; c. elegans.
DR   CTD; 172103; -.
DR   WormBase; F25F8.2; CE09636; WBGene00001592; glc-2.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000118821; -.
DR   HOGENOM; HOG000231336; -.
DR   InParanoid; Q17328; -.
DR   KO; K05273; -.
DR   OMA; ENMFLRI; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q17328; -.
DR   Reactome; R-CEL-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:Q17328; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00001592; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008068; F:extracellular-glutamate-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR015680; Glu_Cl_Channel.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   PANTHER; PTHR18945:SF504; PTHR18945:SF504; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    434       Glutamate-gated chloride channel subunit
FT                                beta.
FT                                /FTId=PRO_0000255716.
FT   TOPO_DOM     23    246       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    247    269       Helical; Name=1.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    270    274       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    275    296       Helical; Name=2.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    297    303       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    304    324       Helical; Name=3.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    325    398       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TRANSMEM    399    422       Helical; Name=4.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   TOPO_DOM    423    434       Extracellular.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      66     66       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING      85     85       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     152    152       Glutamate.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   BINDING     181    181       Glutamate; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:G5EBR3}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    216    216       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    161    175       {ECO:0000250|UniProtKB:G5EBR3}.
FT   DISULFID    223    234       {ECO:0000250|UniProtKB:G5EBR3}.
SQ   SEQUENCE   434 AA;  49893 MW;  754B973359834F75 CRC64;
     MTTPSSFSIL LLLLLMPVVT NGEYSMQSEQ EILNALLKNY DMRVRPPPAN SSTEGAVNVR
     VNIMIRMLSK IDVVNMEYSI QLTFREQWID PRLAYENLGF YNPPAFLTVP HVKKSLWIPD
     TFFPTEKAAH RHLIDMENMF LRIYPDGKIL YSSRISLTSS CPMRLQLYPL DYQSCNFDLV
     SYAHTMNDIM YEWDPSTPVQ LKPGVGSDLP NFILKNYTTN ADCTSHTNTG SYGCLRMQLL
     FKRQFSYYLV QLYAPTTMIV IVSWVSFWID LHSTAGRVAL GVTTLLTMTT MQSAINAKLP
     PVSYVKVVDV WLGACQTFVF GALLEYAFVS YQDSVRQNDR SREKAARKAQ RRREKLEMVD
     AEVYQPPCTC HTFEARETFR DKVRRYFTKP DYLPAKIDFY ARFVVPLAFL AFNVIYWVSC
     LIMSANASTP ESLV
//
ID   ACC2_CAEEL              Reviewed;         445 AA.
AC   Q18812;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 142.
DE   RecName: Full=Acetylcholine-gated chloride channel subunit acc-2 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-2 {ECO:0000312|WormBase:C53D6.3};
GN   ORFNames=C53D6.3 {ECO:0000312|WormBase:C53D6.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=26705699; DOI=10.7554/eLife.12432;
RA   Pereira L., Kratsios P., Serrano-Saiz E., Sheftel H., Mayo A.E.,
RA   Hall D.H., White J.G., LeBoeuf B., Garcia L.R., Alon U., Hobert O.;
RT   "A cellular and regulatory map of the cholinergic nervous system of C.
RT   elegans.";
RL   Elife 4:12432-12477(2015).
RN   [4] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Acetylcholine-gated chloride channel subunit. Currents
CC       in channels are triggered in response to acetylcholine. Channel
CC       properties may be modulated by the formation of homomeric and
CC       heteromeric channels. {ECO:0000269|PubMed:15579462}.
CC   -!- SUBUNIT: Homopentamer (in vitro). May interact with either acc-3
CC       or acc-4; the interactions do not result in significant
CC       heteropentameric ion channel activity.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15579462};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in RIA, RIG, PHA and AIZ
CC       glutamatergic neurons, URX and RIH cholinergic neurons, and in
CC       male-specific MCM neurons. {ECO:0000269|PubMed:26705699}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284604; CAA94228.1; -; Genomic_DNA.
DR   PIR; T20190; T20190.
DR   RefSeq; NP_501567.1; NM_069166.1.
DR   UniGene; Cel.13246; -.
DR   ProteinModelPortal; Q18812; -.
DR   SMR; Q18812; -.
DR   STRING; 6239.C53D6.3; -.
DR   PaxDb; Q18812; -.
DR   EnsemblMetazoa; C53D6.3; C53D6.3; WBGene00008280.
DR   GeneID; 183758; -.
DR   KEGG; cel:CELE_C53D6.3; -.
DR   UCSC; C53D6.3; c. elegans.
DR   CTD; 183758; -.
DR   WormBase; C53D6.3; CE05488; WBGene00008280; acc-2.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q18812; -.
DR   OMA; IYITETW; -.
DR   OrthoDB; EOG091G07NS; -.
DR   PhylomeDB; Q18812; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00008280; -.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    445       Acetylcholine-gated chloride channel
FT                                subunit acc-2. {ECO:0000305}.
FT                                /FTId=PRO_5004186831.
FT   TOPO_DOM     27    258       Extracellular. {ECO:0000305}.
FT   TRANSMEM    259    279       Helical. {ECO:0000255}.
FT   TOPO_DOM    280    286       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    287    307       Helical. {ECO:0000255}.
FT   TOPO_DOM    308    326       Extracellular. {ECO:0000305}.
FT   TRANSMEM    327    347       Helical. {ECO:0000255}.
FT   TOPO_DOM    348    407       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    408    428       Helical. {ECO:0000255}.
FT   TOPO_DOM    429    445       Extracellular. {ECO:0000305}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    162    162       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    218    218       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    177    191       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   445 AA;  51686 MW;  3F60AE853A50F4FC CRC64;
     MIFTLLSTLP VLIITTELDY SELVHSAELV SSSSYIHHKT NKKPDNCTRD TDIIDRLLNG
     TGYNKFRIPQ EEGMTVVVEI WIQAITSIDE LTNDFDMDIY ITETWLDPAL NFQTMTPCKG
     NLSLNHQVLD RLWTPNSCFI NSKVAQIHNS PFRSVFLMLF PNGTVMVNYR VRVKGPCSLD
     LSNFPLDLQK CSLIYESFNY NRQEVEMRWS DAEHPVFNLS KIMLPDFDLF EIQTERRQEP
     YPAGMWDELH VTIIFERRFI WYFMQAYLPT YLTIFISWIS FSLGSRAIPA RTMLGVNSLL
     AIVFSFGNIM RNLPRVSYIK GIDVWMLVSM TFIFCSLLEL AIVGFMVRDE TVAKKKQQKK
     ISGNISREES PHGIISERRF MFPPGCSESS KSLSSCTSGW TPERIDSISS VMFPFSFFVF
     NIIYWFYYIH RKEIIKQNLI NRVDG
//
ID   ACC1_CAEEL              Reviewed;         466 AA.
AC   Q21005;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   20-DEC-2017, entry version 150.
DE   RecName: Full=Acetylcholine-gated chloride channel subunit acc-1 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-1 {ECO:0000312|WormBase:F58G6.4a};
GN   ORFNames=F58G6.4 {ECO:0000312|WormBase:F58G6.4a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=26705699; DOI=10.7554/eLife.12432;
RA   Pereira L., Kratsios P., Serrano-Saiz E., Sheftel H., Mayo A.E.,
RA   Hall D.H., White J.G., LeBoeuf B., Garcia L.R., Alon U., Hobert O.;
RT   "A cellular and regulatory map of the cholinergic nervous system of C.
RT   elegans.";
RL   Elife 4:12432-12477(2015).
RN   [4] {ECO:0000305}
RP   DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Acetylcholine-gated chloride channel subunit. Forms
CC       functional homopentameric (in vitro) and functional
CC       heteropentameric ion channels with acc-3 and acc-4 ion channel
CC       subunits. Currents in channels are triggered in response to
CC       acetylcholine, but not in response to GABA, glutamate, glycine,
CC       histamine or dopamine. {ECO:0000269|PubMed:15579462}.
CC   -!- SUBUNIT: Homopentamer (in vitro). Forms heteropentamers composed
CC       of acc-1 and acc-4 or acc-1 and acc-3. Both homopentamers and
CC       heteropentamers form functional ion channels.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15579462};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in a subset of cholinergic motor
CC       neurons including cholinergic motor neurons in the ventral cord,
CC       the retrovesicular ganglion and in head neurons such as the SMD,
CC       RMD motor neurons, the AVA and AVE command interneurons and the
CC       SAA neurons. Also expressed in a small number of glutamatergic
CC       neurons including the pharyngeal neurons MI and M3, the PLM
CC       neurons and a pair of neurons in the lateral ganglion.
CC       {ECO:0000269|PubMed:26705699}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284604; CAA92466.2; -; Genomic_DNA.
DR   PIR; T22947; T22947.
DR   RefSeq; NP_501715.1; NM_069314.4.
DR   UniGene; Cel.7828; -.
DR   ProteinModelPortal; Q21005; -.
DR   STRING; 6239.F58G6.4; -.
DR   PaxDb; Q21005; -.
DR   EnsemblMetazoa; F58G6.4a; F58G6.4a; WBGene00010275.
DR   GeneID; 177799; -.
DR   UCSC; F58G6.4; c. elegans.
DR   CTD; 177799; -.
DR   WormBase; F58G6.4a; CE28039; WBGene00010275; acc-1.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q21005; -.
DR   OMA; MELEQPY; -.
DR   PhylomeDB; Q21005; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00010275; -.
DR   ExpressionAtlas; Q21005; baseline and differential.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Chloride channel; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    466       Acetylcholine-gated chloride channel
FT                                subunit acc-1. {ECO:0000305}.
FT                                /FTId=PRO_5004199465.
FT   TOPO_DOM     25    242       Extracellular. {ECO:0000305}.
FT   TRANSMEM    243    263       Helical. {ECO:0000255}.
FT   TOPO_DOM    264    272       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    273    290       Helical. {ECO:0000255}.
FT   TOPO_DOM    291    304       Extracellular. {ECO:0000305}.
FT   TRANSMEM    305    325       Helical. {ECO:0000255}.
FT   TOPO_DOM    326    427       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    428    448       Helical. {ECO:0000255}.
FT   TOPO_DOM    449    466       Extracellular. {ECO:0000305}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    211    211       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    158    172       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   466 AA;  54967 MW;  2D6B40994889C80D CRC64;
     MSHPGWIMVS FLTELLSQSS KGIAQSLDNC ANDTEIINAL LKDSYNKHYI PSHPTHVRVD
     MWVQEVTSVS ELTQDFEIDL YINEFWEDPA LVYEDMNPCK RNISFDDKVL QRLWLPNTCF
     INSKSAAIHE SPFKNVFLMV FSNGTLWTNY RMKLTGPCDM KLKRFPFDKQ KCYLTFESFN
     YNTGEVRMQW NQPYPVILLK RIELPDFKLV NFSVIAVEQM YPAGWWDELT VAFVFERRYG
     WYVLQGYIPT MVTIVISWIS FYLGPRAIPA RTMLGVNSLL AMTFQFGNII RNLPRVSYVK
     AIDVWMLSGM LFIFLSLLEL AVVGFMSRNE GLPPKVKKRK RQEDDDEGFS WKSMQTSPHL
     ELRQFWVDKR VNSLRNDSAV PPVEDYAPME LEQPYQNITK RREKRKWMSG LRKKWRAMRE
     LRPETVDFYS AIFFPTAYML FNISYWSFYL TSLSEYFDED VNIDQP
//
ID   CNGA_DROME              Reviewed;         665 AA.
AC   Q24278; Q9V7L5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   25-OCT-2017, entry version 141.
DE   RecName: Full=Cyclic nucleotide-gated cation channel subunit A;
DE   AltName: Full=Cyclic nucleotide-gated ion channel subunit A;
DE            Short=CNG channel;
GN   Name=CngA; Synonyms=Cng; ORFNames=CG7779;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=7957070;
RA   Baumann A., Frings S., Godde M., Seifert R., Kaupp U.B.;
RT   "Primary structure and functional expression of a Drosophila cyclic
RT   nucleotide-gated channel present in eyes and antennae.";
RL   EMBO J. 13:5040-5050(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
CC   -!- FUNCTION: Approximately 50-fold more sensitive to cGMP than to
CC       cAMP. May be involved in transduction cascades of both
CC       invertebrate photoreceptors and olfactory sensillae.
CC       {ECO:0000269|PubMed:7957070}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in antennae and the visual system.
CC       {ECO:0000269|PubMed:7957070}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X89601; CAA61760.1; -; mRNA.
DR   EMBL; AE013599; AAF58033.1; -; Genomic_DNA.
DR   RefSeq; NP_477116.1; NM_057768.3.
DR   ProteinModelPortal; Q24278; -.
DR   SMR; Q24278; -.
DR   IntAct; Q24278; 2.
DR   STRING; 7227.FBpp0292051; -.
DR   TCDB; 1.A.1.5.18; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q24278; -.
DR   PRIDE; Q24278; -.
DR   EnsemblMetazoa; FBtr0302924; FBpp0292050; FBgn0261612.
DR   GeneID; 36806; -.
DR   KEGG; dme:Dmel_CG42701; -.
DR   CTD; 36806; -.
DR   FlyBase; FBgn0261612; CngA.
DR   eggNOG; KOG0500; Eukaryota.
DR   eggNOG; ENOG410YWWI; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   InParanoid; Q24278; -.
DR   KO; K04950; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; Q24278; -.
DR   Reactome; R-DME-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-DME-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-DME-5620916; VxPx cargo-targeting to cilium.
DR   GenomeRNAi; 36806; -.
DR   PRO; PR:Q24278; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0261612; -.
DR   ExpressionAtlas; Q24278; differential.
DR   Genevisible; Q24278; DM.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0017071; C:intracellular cyclic nucleotide activated cation channel complex; IDA:FlyBase.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; IDA:FlyBase.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; IDA:FlyBase.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IDA:FlyBase.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0001666; P:response to hypoxia; IMP:FlyBase.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032406; CLZ_dom.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF16526; CLZ; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   cGMP; cGMP-binding; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    665       Cyclic nucleotide-gated cation channel
FT                                subunit A.
FT                                /FTId=PRO_0000219327.
FT   TOPO_DOM      1    110       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    111    131       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    132    138       Extracellular. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    160    186       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    208    253       Extracellular. {ECO:0000255}.
FT   TRANSMEM    254    274       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    275    325       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    347    481       Extracellular. {ECO:0000255}.
FT   TRANSMEM    482    502       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    503    665       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     437    559       cGMP. {ECO:0000250}.
FT   BINDING     496    496       cGMP. {ECO:0000255}.
FT   BINDING     511    511       cGMP. {ECO:0000255}.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT     73     73       G -> R (in Ref. 1; CAA61760).
FT                                {ECO:0000305}.
SQ   SEQUENCE   665 AA;  75823 MW;  6EFFC9A7CA243660 CRC64;
     MRHFKVKAMV QSLDISAITG QQTDAEPSKR SKPSALRRTL QALRQRLTKR NRPKPPDWFL
     EKFSNTTNTD KIGKGCPAME DAALSSEIRG SSVLCNRLSV DPTLQSHYRW LAIVSLAVLY
     NIIFVVGRAV FWEINKSAPA FWYTLDYLCD FIYLLDTLVH MHEGFLDQGL LVRDAFRLRR
     HYFHTKGWYL DVLSMLPTDL AYIWWPPETC SSLYLPCPVI VRLNRLLRIN RLWEWFDRTE
     TATGYPNAFR ICKVVLAILV LIHWNACMYF AISYEIGFSS DSWVYNLNGT RNNTLQRQYI
     YSFYWSTLTL TTIGETPTPE NDVEYLFVVA DFLAGVLIFA TIVGNIGSMI SNMNVARVEF
     QNRMDGVKQY MAFRRVGHEL EARVIRWFAY TWSQSGALDE ERVLAALPDK LKAEIAIQVH
     MDTLKQVRIF HDTEPGLLEA LVLKLKLQVF SPGDYICRKG DVGKEMYIVK RGKLSVVGDD
     GITVLATLGA GSVFGEVSVL EIAGNRTGNR RTANVRSLGY SDLFCLAKRD LWETLSDYPE
     ARSTLTQRGC QLLRKDGLLD EQIFADSQRV HDSIEGGIEK LELSVENLNM RLARLLAEYT
     ASQAKIKQRL AKLEMNGGPG TWRLECEPQS RARSGRLYSL QPKRRPRSRP DATAKSSDAA
     KQNTL
//
ID   GBRAL_DROME             Reviewed;         686 AA.
AC   Q24352; Q9TX50; Q9VVL3;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 136.
DE   RecName: Full=Gamma-aminobutyric acid receptor alpha-like;
DE   AltName: Full=GABA(A) receptor alpha-like and glycine receptor-like subunit of Drosophila;
DE            Short=GRD;
DE   Flags: Precursor;
GN   Name=Grd; ORFNames=CG7446;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Berlin; TISSUE=Head, and Salivary gland;
RX   PubMed=8189252;
RA   Harvey R.J., Schmitt B., Hermans-Borgmeyer I., Gundelfinger E.D.,
RA   Betz H., Darlison M.G.;
RT   "Sequence of a Drosophila ligand-gated ion-channel polypeptide with an
RT   unusual amino-terminal extracellular domain.";
RL   J. Neurochem. 62:2480-2483(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH LCCH3.
RX   PubMed=15148245; DOI=10.1038/sj.bjp.0705818;
RA   Gisselmann G., Plonka J., Pusch H., Hatt H.;
RT   "Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric
RT   GABA-gated cation channels.";
RL   Br. J. Pharmacol. 142:409-413(2004).
CC   -!- FUNCTION: GABA, an inhibitory neurotransmitter, mediates neuronal
CC       inhibition by binding to the GABA receptor and opening an integral
CC       chloride channel. May combine with the ligand-gated ion channel
CC       subunit Lcch3 to form cation-selective GABA-gated ion channels.
CC       {ECO:0000269|PubMed:15148245}.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho. Interacts
CC       with Lcch3 (beta chain). {ECO:0000269|PubMed:15148245}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X78349; CAA55144.1; -; mRNA.
DR   EMBL; AE014296; AAF49298.2; -; Genomic_DNA.
DR   PIR; S60749; S60749.
DR   RefSeq; NP_524131.1; NM_079407.3.
DR   UniGene; Dm.2530; -.
DR   ProteinModelPortal; Q24352; -.
DR   SMR; Q24352; -.
DR   STRING; 7227.FBpp0074905; -.
DR   TCDB; 1.A.9.5.6; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q24352; -.
DR   PRIDE; Q24352; -.
DR   EnsemblMetazoa; FBtr0075139; FBpp0074905; FBgn0001134.
DR   GeneID; 39984; -.
DR   KEGG; dme:Dmel_CG7446; -.
DR   CTD; 39984; -.
DR   FlyBase; FBgn0001134; Grd.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   InParanoid; Q24352; -.
DR   KO; K05175; -.
DR   OMA; HPSEYSM; -.
DR   OrthoDB; EOG091G0805; -.
DR   PhylomeDB; Q24352; -.
DR   Reactome; R-DME-977441; GABA A receptor activation.
DR   GenomeRNAi; 39984; -.
DR   PRO; PR:Q24352; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0001134; -.
DR   Genevisible; Q24352; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005261; F:cation channel activity; IDA:UniProtKB.
DR   GO; GO:0016933; F:extracellular-glycine-gated ion channel activity; ISS:FlyBase.
DR   GO; GO:0004890; F:GABA-A receptor activity; IDA:UniProtKB.
DR   GO; GO:0022851; F:GABA-gated chloride ion channel activity; IDA:FlyBase.
DR   GO; GO:0022852; F:glycine-gated chloride ion channel activity; TAS:FlyBase.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:UniProtKB.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:1904456; P:negative regulation of neuronal action potential; IMP:FlyBase.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:FlyBase.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IGI:FlyBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     58       {ECO:0000255}.
FT   CHAIN        59    686       Gamma-aminobutyric acid receptor alpha-
FT                                like.
FT                                /FTId=PRO_0000000451.
FT   TOPO_DOM     97    393       Extracellular. {ECO:0000255}.
FT   TRANSMEM    394    414       Helical. {ECO:0000255}.
FT   TRANSMEM    424    441       Helical. {ECO:0000255}.
FT   TRANSMEM    456    476       Helical. {ECO:0000255}.
FT   TOPO_DOM    477    650       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    651    671       Helical. {ECO:0000255}.
FT   COMPBIAS    589    609       Ala-rich.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    233    247       {ECO:0000250}.
SQ   SEQUENCE   686 AA;  76558 MW;  E2BD771B7E3BAC7A CRC64;
     MCTMPATRDA SGSGDASTDL IAARSLSSHQ GQRSNLRIFK LLISCCLLML CIYPNAWPWS
     IGPGSGPFSV SADSIKGRGD THRLGEMGTS LSSSLPSSWL TQSNNHANIS ELLDNLLRGY
     DNSIRPDFGG PPATIEVDIM VRSMGPISEV DMTYSMDCYF RQSWVDKRLA FEGAQDTLAL
     SVSMLARIWK PDTYFYNGKQ SYLHTITTPN KFVRIYQNGR VLYSSRLTIK AGCPMNLADF
     PMDIQKCPLK FGSFGYTTSD VIYRWNKERP PVAIAEDMKL SQFDLVDCPA GNLTDIVYKA
     AAPRPQRRPF NNKDPPRPTS KVMTTFAGPA AKNQHVRGTG LKLDKGAFGT GRDATGGSGS
     TTGLSGTITL ETNHPSEYSM LMVNFHLQRH MGNFLIQVYG PCCLLVVLSW VSFWLNREAT
     ADRVSLGITT VLTMTFLGLE ARTDLPKVSY PTALDFFVFL SFGFIFATIL QFAVVHYYTK
     YGSGECYFII EELDSESGES ETEPLTSDFR GSTESKIYEV IPLSMCAISM PPPPTRLGML
     TSRNRRPRNR RHGLWSMKLL GLFDWRRRRK PPRADSDEDE DDEQTQLRAN EAPTTSAAAA
     AAQAAAQAAR ISPPTGGRRR MSYYRREEME ARRKGKRTPQ YNSVSKIDRA SRIVFPLLFI
     LINVFYWYGY LSRSSRILAN TPDAST
//
ID   NMDA1_DROME             Reviewed;         997 AA.
AC   Q24418;
DT   10-FEB-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 140.
DE   RecName: Full=Glutamate [NMDA] receptor subunit 1 {ECO:0000303|PubMed:15823532};
DE            Short=DNMDAR-I {ECO:0000303|PubMed:8508917};
DE            Short=dNR1 {ECO:0000303|PubMed:15823532};
DE   Flags: Precursor;
GN   Name=Nmdar1 {ECO:0000312|EMBL:AAF52016.1,
GN   ECO:0000312|FlyBase:FBgn0010399};
GN   Synonyms=nmr {ECO:0000312|EMBL:CAA50675.1},
GN   NR1 {ECO:0000303|PubMed:15823532}; ORFNames=CG2902;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAA50675.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   STRAIN=Berlin {ECO:0000312|EMBL:CAA50675.1}, and
RC   Canton-S {ECO:0000312|EMBL:CAA50675.1};
RC   TISSUE=Head {ECO:0000312|EMBL:CAA50675.1};
RX   PubMed=8508917; DOI=10.1016/0014-5793(93)81387-F;
RA   Ultsch A., Schuster C.M., Laube B., Betz H., Schmitt B.;
RT   "Glutamate receptors of Drosophila melanogaster. Primary structure of
RT   a putative NMDA receptor protein expressed in the head of the adult
RT   fly.";
RL   FEBS Lett. 324:171-177(1993).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11773617; DOI=10.1073/pnas.012318899;
RA   Chiang A.-S., Lin W.-Y., Liu H.-P., Pszczolkowski M.A., Fu T.-F.,
RA   Chiu S.-L., Holbrook G.L.;
RT   "Insect NMDA receptors mediate juvenile hormone biosynthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:37-42(2002).
RN   [3] {ECO:0000312|EMBL:AAF52016.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAF52016.1}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5] {ECO:0000312|EMBL:AAL48048.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAL48048.1};
RC   TISSUE=Embryo {ECO:0000269|PubMed:12537569};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH NMDAR2, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=15823532; DOI=10.1016/j.cub.2005.02.059;
RA   Xia S., Miyashita T., Fu T.-F., Lin W.-Y., Wu C.-L., Pyzocha L.,
RA   Lin I.-R., Saitoe M., Tully T., Chiang A.-S.;
RT   "NMDA receptors mediate olfactory learning and memory in Drosophila.";
RL   Curr. Biol. 15:603-615(2005).
RN   [7] {ECO:0000305}
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-693, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Oregon-R; TISSUE=Head {ECO:0000269|PubMed:17893096};
RX   PubMed=17893096; DOI=10.1093/glycob/cwm097;
RA   Koles K., Lim J.-M., Aoki K., Porterfield M., Tiemeyer M., Wells L.,
RA   Panin V.;
RT   "Identification of N-glycosylated proteins from the central nervous
RT   system of Drosophila melanogaster.";
RL   Glycobiology 17:1388-1403(2007).
CC   -!- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels
CC       with high calcium permeability and voltage-dependent sensitivity
CC       to magnesium. Mediated by glycine. This protein plays a key role
CC       in synaptic plasticity, synaptogenesis, excitotoxicity, memory
CC       acquisition and learning. It mediates neuronal functions in
CC       glutamate neurotransmission. Is involved in the cell surface
CC       targeting of NMDA receptors. Plays a role in associative learning
CC       and in long-term memory consolidation.
CC       {ECO:0000250|UniProtKB:P35439, ECO:0000269|PubMed:15823532}.
CC   -!- SUBUNIT: Forms a heteromeric NMDA channel with Nmdar2.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15823532};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:15823532}. Cell
CC       junction, synapse, postsynaptic cell membrane
CC       {ECO:0000269|PubMed:15823532}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000269|PubMed:15823532}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult heads: in the brain
CC       and ring gland. Low expression throughout the entire brain is also
CC       seen. Higher expression levels were observed in some scattered
CC       cell bodies and part of their fibers, including those from several
CC       pairs of DPM (dorsal-posterior-medial) neurons surrounding the
CC       calyx, DAL (dorsal-anterior-lateral) and DPL (dorsal-posterior-
CC       lateral) neurons in the lateral protocerebrum (LP), VAL (ventral-
CC       anterior-lateral) neurons in the anterior protocerebrum, and two
CC       pairs of VP (ventral-posterior) neurons in the posterior
CC       protocerebrum. Many cell bodies in the optic lobes show
CC       preferential expression. Punctuate expression is notably detected
CC       in many brain regions including the superior medial protocerebrum.
CC       Weakly expressed in the antennal lobes and central complex.
CC       {ECO:0000269|PubMed:11773617, ECO:0000269|PubMed:15823532,
CC       ECO:0000269|PubMed:8508917}.
CC   -!- DEVELOPMENTAL STAGE: Expression first seen in late embryos. Levels
CC       are low during larval development and increase in late pupae to
CC       persist through to adulthood. {ECO:0000269|PubMed:8508917}.
CC   -!- DISRUPTION PHENOTYPE: Flies exhibit disruption of olfactory
CC       learning. {ECO:0000269|PubMed:15823532}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X71790; CAA50675.1; -; mRNA.
DR   EMBL; AE014297; AAF52016.1; -; Genomic_DNA.
DR   EMBL; AY070577; AAL48048.1; -; mRNA.
DR   PIR; S33754; S33754.
DR   RefSeq; NP_730940.1; NM_169059.2.
DR   UniGene; Dm.3670; -.
DR   ProteinModelPortal; Q24418; -.
DR   BioGrid; 65872; 4.
DR   IntAct; Q24418; 6.
DR   STRING; 7227.FBpp0078410; -.
DR   iPTMnet; Q24418; -.
DR   PaxDb; Q24418; -.
DR   PRIDE; Q24418; -.
DR   EnsemblMetazoa; FBtr0078763; FBpp0078410; FBgn0010399.
DR   GeneID; 40665; -.
DR   KEGG; dme:Dmel_CG2902; -.
DR   UCSC; CG2902-RA; d. melanogaster.
DR   CTD; 40665; -.
DR   FlyBase; FBgn0010399; Nmdar1.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   HOGENOM; HOG000184780; -.
DR   InParanoid; Q24418; -.
DR   KO; K05208; -.
DR   OMA; SGFYHIP; -.
DR   OrthoDB; EOG091G0M5H; -.
DR   PhylomeDB; Q24418; -.
DR   Reactome; R-DME-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-DME-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-DME-442729; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; R-DME-8849932; Synaptic adhesion-like molecules.
DR   GenomeRNAi; 40665; -.
DR   PRO; PR:Q24418; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0010399; -.
DR   Genevisible; Q24418; DM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IDA:FlyBase.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; IPI:FlyBase.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; ISS:FlyBase.
DR   GO; GO:0008306; P:associative learning; IDA:FlyBase.
DR   GO; GO:0048149; P:behavioral response to ethanol; IMP:FlyBase.
DR   GO; GO:0055074; P:calcium ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:FlyBase.
DR   GO; GO:0007616; P:long-term memory; IMP:FlyBase.
DR   GO; GO:0072375; P:medium-term memory; IMP:FlyBase.
DR   GO; GO:0008355; P:olfactory learning; IMP:FlyBase.
DR   GO; GO:0042331; P:phototaxis; IDA:FlyBase.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0050975; P:sensory perception of touch; IMP:FlyBase.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR018882; CaM-bd_C0_NMDA_rcpt_NR1.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 2.
DR   Pfam; PF10562; CaM_bdg_C0; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Magnesium; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    997       Glutamate [NMDA] receptor subunit 1.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000363996.
FT   TOPO_DOM     27    573       Extracellular. {ECO:0000255}.
FT   TRANSMEM    574    594       Helical. {ECO:0000255}.
FT   TOPO_DOM    595    651       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    652    672       Helical. {ECO:0000255}.
FT   TOPO_DOM    673    831       Extracellular. {ECO:0000255}.
FT   TRANSMEM    832    852       Helical. {ECO:0000255}.
FT   TOPO_DOM    853    997       Cytoplasmic. {ECO:0000255}.
FT   REGION      530    532       Glycine binding.
FT                                {ECO:0000250|UniProtKB:P35439}.
FT   BINDING     537    537       Glycine. {ECO:0000250|UniProtKB:P35439}.
FT   BINDING     703    703       Glycine. {ECO:0000250|UniProtKB:P35439}.
FT   BINDING     747    747       Glycine. {ECO:0000250|UniProtKB:P35439}.
FT   CARBOHYD    258    258       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    314    314       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    345    345       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    454    454       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    481    481       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    501    501       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    693    693       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096}.
FT   DISULFID     93     93       Interchain.
FT                                {ECO:0000250|UniProtKB:Q05586}.
SQ   SEQUENCE   997 AA;  112288 MW;  ABBD0614E2DB3731 CRC64;
     MAMAEFVFCR PLFGLAIVLL VAPIDAAQRH TASDNPSTYN IGGVLSNSDS EEHFSTTIKH
     LNFDQQYVPR KVTYYDKTIR MDKNPIKTVF NVCDKLIENR VYAVVVSHEQ TSGDLSPAAV
     SYTSGFYSIP VIGISSRDAA FSDKNIHVSF LRTVPPYYHQ ADVWLEMLSH FAYTKVIIIH
     SSDTDGRAIL GRFQTTSQTY YDDVDVRATV ELIVEFEPKL ESFTEHLIDM KTAQSRVYLM
     YASTEDAQVI FRDAGEYNMT GEGHVWIVTE QALFSNNTPD GVLGLQLEHA HSDKGHIRDS
     VYVLASAIKE MISNETIAEA PKDCGDSAVN WESGKRLFQY LKSRNITGET GQVAFDDNGD
     RIYAGYDVIN IREQQKKHVV GKFSYDSMRA KMRMRINDSE IIWPGKQRRK PEGIMIPTHL
     RLLTIEEKPF VYVRRMGDDE FRCEPDERPC PLFNNSDATA NEFCCRGYCI DLLIELSKRI
     NFTYDLALSP DGQFGHYILR NNTGAMTLRK EWTGLIGELV NERADMIVAP LTINPERAEY
     IEFSKPFKYQ GITILEKKPS RSSTLVSFLQ PFSNTLWILV MVSVHVVALV LYLLDRFSPF
     GRFKLSHSDS NEEKALNLSS AVWFAWGVLL NSGIGEGTPR SFSARVLGMV WAGFAMIIVA
     SYTANLAAFL VLERPKTKLS GINDARLRNT MENLTCATVK GSSVDMYFRR QVELSNMYRT
     MEANNYATAE QAIQDVKKGK LMAFIWDSSR LEYEASKDCE LVTAGELFGR SGYGIGLQKG
     SPWTDAVTLA ILEFHESGFM EKLDKQWIFH GHVQQNCELF EKTPNTLGLK NMAGVFILVG
     VGIAGGVGLI IIEVIYKKHQ VKKQKRLDIA RHAADKWRGT IEKRKTIRAS LAMQRQYNVG
     LNSTHAPGTI SLAVDKRRYP RLGQRLGPER AWPGDAADVL RIRRPYELGN PGQSPKVMAA
     NQPGMPMPML GKTRPQQSVL PPRYSPGYTS DVSHLVV
//
ID   RYR_DROME               Reviewed;        5127 AA.
AC   Q24498; Q24321; Q24499; Q24500; Q24501; Q8MKS3; Q8MKS4; Q8MKS5;
AC   Q9V4Y7;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 3.
DT   22-NOV-2017, entry version 159.
DE   RecName: Full=Ryanodine receptor;
DE   AltName: Full=Ryanodine receptor 44F;
GN   Name=RyR {ECO:0000312|FlyBase:FBgn0011286};
GN   Synonyms=dry, Rya-r44F {ECO:0000312|FlyBase:FBgn0011286};
GN   ORFNames=CG10844 {ECO:0000312|FlyBase:FBgn0011286};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|EMBL:AAF59036.2};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS A; B; C AND D), FUNCTION,
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=8276118; DOI=10.1016/0014-5793(94)80634-9;
RA   Takeshima H., Nishi M., Iwabe N., Miyata T., Hosoya T., Masai I.,
RA   Hotta Y.;
RT   "Isolation and characterization of a gene for a ryanodine
RT   receptor/calcium release channel in Drosophila melanogaster.";
RL   FEBS Lett. 337:81-87(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3] {ECO:0000305}
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:12537572};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE OF 4619-5127, DEVELOPMENTAL STAGE, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain {ECO:0000269|PubMed:1338312};
RX   PubMed=1338312;
RA   Hasan G., Rosbash M.;
RT   "Drosophila homologs of two mammalian intracellular Ca(2+)-release
RT   channels: identification and expression patterns of the inositol
RT   1,4,5-triphosphate and the ryanodine receptor genes.";
RL   Development 116:967-975(1992).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10811919; DOI=10.1073/pnas.110145997;
RA   Sullivan K.M.C., Scott K., Zuker C.S., Rubin G.M.;
RT   "The ryanodine receptor is essential for larval development in
RT   Drosophila melanogaster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5942-5947(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1459, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
CC   -!- FUNCTION: Intracellular calcium channel that is required for
CC       proper muscle function during embryonic development and may be
CC       essential for excitation-contraction coupling in larval body wall
CC       muscles. {ECO:0000269|PubMed:10811919,
CC       ECO:0000269|PubMed:8276118}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Note=The
CC       number of predicted transmembrane domains varies between
CC       orthologs, but both N-terminus and C-terminus seem to be
CC       cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-2; Sequence=Displayed;
CC       Name=B {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-3; Sequence=VSP_050196;
CC       Name=C {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-4; Sequence=VSP_050195;
CC       Name=D {ECO:0000269|PubMed:8276118};
CC         IsoId=Q24498-5; Sequence=VSP_050195, VSP_050196;
CC   -!- TISSUE SPECIFICITY: During embryonic stages 9-10, expression is
CC       seen in mesoderm of all segments in progenitors of the cephalic
CC       and somatic muscles. Adults exhibit high expression in tubular
CC       'jump' muscles of thorax and leg, and lower expression in the
CC       brain, ventral ganglion, head muscles and proboscis muscles.
CC       {ECO:0000269|PubMed:10811919, ECO:0000269|PubMed:1338312,
CC       ECO:0000269|PubMed:8276118}.
CC   -!- DEVELOPMENTAL STAGE: Abundant in 6-12 hours embryos, reduced
CC       expression in second and third instar larval stages and adults.
CC       {ECO:0000269|PubMed:1338312, ECO:0000269|PubMed:8276118}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein resides in
CC       the cytoplasm. {ECO:0000305}.
CC   -!- MISCELLANEOUS: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high
CC       affinity and maintains the channel in an open conformation. The
CC       calcium release channel is modulated by calcium ions, magnesium
CC       ions, ATP and calmodulin (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D17389; BAA04212.1; -; Genomic_DNA.
DR   EMBL; D17389; BAA41469.1; -; Genomic_DNA.
DR   EMBL; D17389; BAA41470.1; -; Genomic_DNA.
DR   EMBL; D17389; BAA41471.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAF59036.2; -; Genomic_DNA.
DR   EMBL; AE013599; AAM71082.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM71083.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAM71084.1; -; Genomic_DNA.
DR   EMBL; Z18536; CAA79221.1; -; mRNA.
DR   PIR; B49131; B49131.
DR   PIR; S40450; S40450.
DR   RefSeq; NP_476991.1; NM_057643.4. [Q24498-2]
DR   RefSeq; NP_476992.1; NM_057644.4. [Q24498-3]
DR   RefSeq; NP_476993.1; NM_057645.3. [Q24498-4]
DR   RefSeq; NP_476994.1; NM_057646.4. [Q24498-5]
DR   UniGene; Dm.22868; -.
DR   ProteinModelPortal; Q24498; -.
DR   SMR; Q24498; -.
DR   BioGrid; 71972; 9.
DR   IntAct; Q24498; 13.
DR   STRING; 7227.FBpp0293114; -.
DR   BindingDB; Q24498; -.
DR   ChEMBL; CHEMBL6045; -.
DR   TCDB; 1.A.3.1.5; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q24498; -.
DR   PaxDb; Q24498; -.
DR   PRIDE; Q24498; -.
DR   EnsemblMetazoa; FBtr0088637; FBpp0087718; FBgn0011286. [Q24498-4]
DR   EnsemblMetazoa; FBtr0088638; FBpp0087719; FBgn0011286. [Q24498-3]
DR   EnsemblMetazoa; FBtr0088639; FBpp0087720; FBgn0011286. [Q24498-5]
DR   EnsemblMetazoa; FBtr0088640; FBpp0087721; FBgn0011286. [Q24498-2]
DR   GeneID; 49090; -.
DR   KEGG; dme:Dmel_CG10844; -.
DR   CTD; 49090; -.
DR   FlyBase; FBgn0011286; RyR.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   InParanoid; Q24498; -.
DR   KO; K04962; -.
DR   OrthoDB; EOG091G00T0; -.
DR   PhylomeDB; Q24498; -.
DR   GenomeRNAi; 49090; -.
DR   PRO; PR:Q24498; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0011286; -.
DR   ExpressionAtlas; Q24498; differential.
DR   Genevisible; Q24498; DM.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; TAS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; TAS:UniProtKB.
DR   GO; GO:0060047; P:heart contraction; IMP:FlyBase.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006936; P:muscle contraction; IMP:UniProtKB.
DR   GO; GO:0035206; P:regulation of hemocyte proliferation; IMP:FlyBase.
DR   GO; GO:0072347; P:response to anesthetic; IMP:FlyBase.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 2.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Complete proteome; Developmental protein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Sarcoplasmic reticulum; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   5127       Ryanodine receptor.
FT                                /FTId=PRO_0000219364.
FT   TOPO_DOM      1   4451       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4452   4472       Helical. {ECO:0000255}.
FT   TRANSMEM   4651   4671       Helical. {ECO:0000255}.
FT   TRANSMEM   4683   4703       Helical. {ECO:0000255}.
FT   TRANSMEM   4742   4762       Helical. {ECO:0000255}.
FT   TRANSMEM   4885   4905       Helical. {ECO:0000255}.
FT   TRANSMEM   4924   4944       Helical. {ECO:0000255}.
FT   INTRAMEM   4974   4983       Pore-forming. {ECO:0000250}.
FT   TRANSMEM   4984   5024       Helical. {ECO:0000255}.
FT   TOPO_DOM   5025   5127       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       94    148       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      155    200       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      210    264       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      270    328       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      336    394       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      577    803       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      845    956       1. {ECO:0000250|UniProtKB:Q15413}.
FT   REPEAT      957   1075       2. {ECO:0000250|UniProtKB:Q15413}.
FT   DOMAIN     1032   1217       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   DOMAIN     1452   1673       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     2822   2945       3. {ECO:0000250|UniProtKB:Q15413}.
FT   REPEAT     2946   3063       4. {ECO:0000250|UniProtKB:Q15413}.
FT   REGION      845   3063       4 X approximate repeats.
FT   COMPBIAS   4686   4711       Gly-rich.
FT   SITE       4162   4162       Important for activation by Ca(2+).
FT                                {ECO:0000250}.
FT   MOD_RES    1459   1459       Phosphoserine.
FT                                {ECO:0000269|PubMed:18327897}.
FT   VAR_SEQ    1135   1165       VTKMHAGSIEHFGVRYEAGDVIGCFIDVKEQ -> EEKVYG
FT                                GVSESFGKQCGPGDIVGVFLDLADH (in isoform C
FT                                and isoform D).
FT                                {ECO:0000303|PubMed:8276118}.
FT                                /FTId=VSP_050195.
FT   VAR_SEQ    1876   1889       Missing (in isoform B and isoform D).
FT                                {ECO:0000303|PubMed:8276118}.
FT                                /FTId=VSP_050196.
FT   CONFLICT    314    316       CLR -> SW (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   1045   1079       VRTLLVYGYVLDPPTGEGTEALLAEAQRLKFAGFR -> SA
FT                                NAPGLRICLGSSDGRRNGGTSGRGTTPQVRRIP (in
FT                                Ref. 1; BAA41469/BAA41470/BAA41471/
FT                                BAA04212). {ECO:0000305}.
FT   CONFLICT   2282   2282       L -> I (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   2550   2550       I -> S (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   2927   2927       A -> P (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   3214   3214       L -> Q (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   3361   3361       A -> G (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   4096   4096       T -> I (in Ref. 1; BAA41469/BAA41470/
FT                                BAA41471/BAA04212). {ECO:0000305}.
FT   CONFLICT   4633   4633       Y -> D (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   4695   4695       I -> T (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5022   5024       DAF -> AL (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5073   5073       M -> I (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5077   5077       M -> L (in Ref. 4). {ECO:0000305}.
FT   CONFLICT   5103   5127       WDFFPVGDCFRKQYEDELSGGGGGG -> GTSSQWETASAS
FT                                NTRMSFPAEAAAA (in Ref. 4). {ECO:0000305}.
SQ   SEQUENCE   5127 AA;  581012 MW;  01B637D778DECE6A CRC64;
     MAEAEGGSEQ DDVSFLRTED MVTLSCTATG ERVCLAAEGF GNRHCFLENI ADKNVPPDLS
     QCVFVIEQAL SVRALQELVT AAGSETGKGT GSGHRTLLYG NAILLRHHNS DMYLACLSTS
     SSNDKLSFDV GLQEHSQGEA CWWTVHPASK QRSEGEKVRV GDDLILVSVA TERYLHTTKE
     NEQSIVNASF HVTHWSVQPY GTGISRMKYV GYVFGGDVLR FFHGGDECLT IPSTWGREAG
     QNIVIYEGGV VMAQARSLWR LELARTKWTG GFINWYHPMR IRHITTGRYL GVNDSNELIL
     VKKEEASIAT TTFCLRQEKD DEKKVLEDKD LEVIGSPIIK YGDTTVIVQH CETSLWLSYK
     SYETKKKGVG KVEEKQAILH EEGKMDDCLD FSRSQEEESK TARVIRKCSS LFTQFITALE
     TLQSNRRHSI FFQKVNLNEM VMCLEDLINY FSQPEDDMEH EEKQNRFRAL RNRQDLFQEE
     GVLNLILEAI DKINIITSQG FLASFLAGDE TGQSWDLIST YLYQLLAAII KGNHTNCAQF
     ANSNRLNWLF SRLGSQASSE GSGMLDVLHC VLIDSPEALN MMRDEHIKVI ISLLEKHGRD
     PKVLDVLCSL CVGNGVAVRS SQNNICDFLL PGKNLLLQTL LVDHVASIRP NIFVGRVDGS
     SMYQKWYFEV TMDHIEQTTH MMPHLRIGWA NTSGYVPYPG GGKKWGGNGV GDDLYSFGFD
     GAFLWTGGRK TLVVDALPEE PFIRKGDVIG VAIDLSVPII TFTFNGVKVR GSFRDFNLDG
     MFFPVMSCSS KLSCRFLFGG DHGRLKFAPP MGFSALVQCL MPQQILSLDP CFYFGNLAKN
     VLAGPWLIED DTAFVPKPVD TTGVTLPSSV DQIKEKLAEN IHEMWALNKI EAGWSWGEHR
     DDYHRIHPCL THFEKLPAAE KRYDNQLAVQ TLKTIISLGY YITMDKPPAR IRPVRLPNEI
     FMQGNGYKPA PLDLSAVTLT PKLEELVDQL AENTHNLWAR ERIQQGWTYG LNEDSENHRS
     PHLVPYAKVD EAIKKANRDT ASETVRTLLV YGYVLDPPTG EGTEALLAEA QRLKFAGFRT
     YRVERNYAVT SGKWYFEFEV LTSGPMRVGW ARADCYPGAM LGSEDTSWAF DGHNVTKMHA
     GSIEHFGVRY EAGDVIGCFI DVKEQTISFS LNGELLMDAL GGETTFADVT AEGVGFVPAC
     TLGVGQKARL IYGQDVDSLK FFTTCGLQEG YEPFCVNMRR PVTHWYTKDQ PIFENTEEMP
     DCRIDVTRIP GGADTPPHLK ISHNTFETME KANWEFLRLS LPVTCMGEFI SEQEKARRWD
     EIKNRQYRLM REAEIAAQMQ VQTQAAHMDH MLKGGFNMND IKGLTRNFDE HADAEADHMM
     RGPNRPPRKG SLTRNITFET DMSAALDEMQ RSTSVLDMNG LGEEMDDKKK RGRSPFKFFS
     KKSRDQSREK MGARTLDTSL ERRNTVAHGR NVVNQQMTTR APTLRLNNAE IPPSPVPQGP
     KQLSGSNLGQ QPVETSGDEM FDAECLKLIN EYFYGVRIFP GQDPTHVYVG WVTTQYHLHS
     REFNKNKVRR GSVYIEDDYE MAIERIDRQS CYVVRADELF NEVTQDASGK GASQGMFVGC
     FVDTATGIIR FTCEGKDTSH RWMMEPDTKL FPAIFVEATS KEILQIELGR TPTTLPLSAA
     VLPTSDKHIN PQSPPRLKVQ CLRPHQWARV PNTALQVHAL KLSDVRGWSM LCEDPVSMLA
     LHIPEEDRCI DILELIEMDK LLSFHAHSLT LYAALCYQSN YRAAHALCQH VDQKQLLYAI
     RSEYMSGPLR QGFYDLLIAL HLESHATTME VCKNEYITPL GAELKELYSD EEMQHSLRSL
     VTESVRPQLR MTEITPPVIA TSSMPSVSSE PIPDIDQLYS PKFPLEVVRQ FVMEALKDAV
     EINQVHNRDP IGWTNENLFL PLIKLTDRLL LVGVLTDEDV QRLLVMIDPE TWDQAFEREG
     KDEHRKGLLT MKMAEGAKLQ MCYLLHHLYD TQLRHRVESI IAFSHDFVGD LQTDQLRRYI
     EIKQSDLPSA VAAKKTKEFR CPPREQMNQI LCFKNLEPDD QDNCTCGLEL RGRLGDFHDS
     LMQKVSLNAL QEPDGVEGTA IEEVKTGPIT KIYNFINTVK ELEEGPKEVE EPEKKTPEEV
     FRKVLIKTIV SWAEESQIEN PKLVREMFSL LLRQYDTVGE LVRALEKTYV INTRARDDVA
     EMWVGLSQIR ALLPVQMSQE EEELMRKRLW KLVNNATFFQ HPDLIRILRV HENVMAVMMN
     TLGRRAQAQS DAPTQSEVAE GAPSKEKDTS HEMVVACCRF LCYFCRTGRQ NQKAMFDHFD
     FLLDNANILL ARPSLRGSTP LDVAYSSLME NTELALALRE HYLEKIAVYL SRCGLQSNSE
     LVEKGYPDLG WDPVEGERYL DFLRYCVWVN GESVEENANL VIRLLIRRPE CLGPALRGEG
     EGLFRAIVEA NRMSERISDR CKMQDEAEGT IAGLNFTHPL PEGEEDEDYI DTGAAILNFY
     CTLVDLLGRC APDASVIEQG KNESLRARAI LRSLVPLEDL QGVLSLKFTL SQTAPGEEKP
     KSDMPSGLLP NNKQSIVLFL ERVYGIEAQD LFYRLLEDAF LPDLRTATIL DKSDGSESDM
     ALAMNRYIGN SILPLLIKHS KFYNEAENYA SLLDATLHTV YRLSKNRMLT KGQREAVSDF
     LVALTSQMQP AMLLKLLRKL TVDVSKLSEY TTVALRLLTL HFDRCAKYYG STQGQGSYGA
     SSDEEKRLTM LLFSNIFDSL SNMDYDPELF GKALPCLIAI GCALPPDYSL SKNTDEDYYG
     RQMGAPDQPQ YMPNPIDTNN VHLDNDLNSL VQKFSEHYHD AWASRRLEGG WTYGDIRSDN
     DRKHPRLKPY NMLSEYERER YRDPVRECLK GLLAIGWTVE HSEVEVALNH RGSTRRQSKP
     QINEFQNEGS PFNYNPHPVD MSNLTLSREM QNMAERLAEN SHDIWAKKKN EELNGCGGVI
     HPQLVPYDLL TDKEKKKDRE RSQEFLKYMQ YQGYKLHKPS KGGAVEEGGA TQAAVELRFS
     YSLLEKLIQY LDRATINMKL LKPSTTFSRR SSFKTATRDI KFFSKVVLPL MEKYFSTHRN
     YFIAIATATN NIGAASLKEK EMVASIFCKL AALLRNRLSA FGPDVRITVR CLQVLVKGID
     ARTLTKNCPE FIRTSMLTFF NQTSDDLGNT ILNLQDGKYS HLRGTHLKTS TSLGYVNQVV
     LPVLTAMFDH LAACDYGSDL LLDEIQVASY KILAALYHLG TDGTLTHDRK YLKTEIERHR
     PALGSCLGAY SSCFPVAFLE PHLNKHNQYS LLNRIADHSL EAQDIMVKME SCMPNLETIL
     AEVDQFVESD KTYNDAPHII DVILPLLCAY LPFWWSQGPD NVSPTSGNHV TMVTADHMNP
     LLRNVLKMIK KNIGNDNAPW MTRIAAYTQQ IIINTSEELL KDPFLPLAER VKKRTENMLH
     KEDSMRGFIK SATDDTSQVE TQLQEDWNLL VRDIYSFYPL LIKYVDLQRN HWLKDNIPEA
     EELYNHVAEI FNIWSKSQYF LKEEQNFISA NEIDNMALIM PTATRRSAIS EGAPAVGGKV
     KKKKKNRDKK RDKDKEVQAS LMVACLKRLL PVGLNLFAGR EQELVQHCKD RYLKKMPEYD
     VIEFARNQLT LPDKLDPSDE MSWQHYLYSK LGKTEEPVDE QALEKANVNS NEKGKDKTQE
     TVDRIVAMAK VLFGLHMIDH PQQQSKNVYR SVVSIQRKRA VIACFRQTSL HSLPRHRACN
     IFARSYYEQW LQEENVGQEV MVEDLTQTFE DSEKSKKEGE ETDSKPDPLT QLVTTFCRGA
     MTERSGALQE DLLYMSYAQI AAKSTGKEEE EGGDEEGGEG GEEGEGTSIH EQEMEKQKLL
     FHQARLSNRG VAEMVLLHIS ASKGIPSEMV MTTLNLGIAI LRGGNIDIQM GMLNHLKEKK
     DVGFFTSIAG LMNSCSVLDL DAFERNTKAE GLGVGSEGAA GEKNMHDAEF TCALFRFIQL
     TCEGHNLEWQ NYLRTQAGNT TTVNVVICTV DYLLRLQESI MDFYWHYSSK EIIDPAGKAN
     FFKAIEVASQ VFNTLTEVIQ GPCTLNQQAL AHSRLWDAVG GFLFLFSHMQ DKLSKHSSQV
     DLLKELLNLQ KDMITMMLSM LEGNVVNGTI GKQMVDTLVE SASNVELILK YFDMFLKLAD
     LIESPSFHEV DMKNEGWVTP KDFREKMEQS KNYTPEEMDF LLACCERNHE GKIDYRAFVE
     HFHEPSKEIG FNLAVLLTNL SEHMPNEPRL ARFLETAGSV LNYFEPFLGR IEILGSSKRI
     ERVYFEIKDS NIEQWEKPQI RESKRAFFYS IVTEGGDKEK LEAFVNFCED AIFEMTHASG
     LMATDDGGGN VKRDTAYSSY MSEEEEERAA RDPIRRTITA VKEGLKFGVH MLSPANIKHQ
     IGVMQTKSIP ELIVGFFKII FYIFYYTGYA HFCVVRYIFG ILLNLMRGPA PEQEEEPVVE
     EETFGRALPP LPLEEPPGTV QAFGLDINKE ENGMYKVVVH ESPANSSMEE GGESSPEDGA
     AASGELVEGE PHQEPISIVD LLGGEAAKKA AQERQEAQKA QEAAMASIEA EAKKSSSAPQ
     ETPAVHQIDF SQYTHRAVSF LARNFYNLKY VALVLAFSIN FMLLFYKVTS FTEEADSSAE
     EELILGSGSG GGADITGSGF GGSGDGGSGD GEMEDEIPEL VHVDEDFFYM EHVLRIAACL
     HSLVSLAMLI AYYHLKVPLA IFKREKEIAR RLEFEGLFIA EQPEDDDFKS HWDKLVISAK
     SFPVNYWDKF VKKKVRQKYS ETYDFDSISN LLGMEKSTFA AQESEETGIF KYIMNIDWRY
     QVWKAGVTFT DNAFLYSLWY FSFSVMGNFN NFFFAAHLLD VAVGFKTLRT ILQSVTHNGK
     QLVLTVMLLT IIVYIYTVIA FNFFRKFYIQ EEDEEVDKKC HDMLTCFVFH LYKGVRAGGG
     IGDEIGDPDG DDYEVYRIIF DITFFFFVII ILLAIIQGLI IDAFGELRDQ LESVKDNMES
     NCFICGMGKD FFDIVPHGFD THVQKEHNLA NYMFFLMHLI NKPDTEYTGQ ETYVWNMYQQ
     RSWDFFPVGD CFRKQYEDEL SGGGGGG
//
ID   ACH7_CAEEL              Reviewed;         507 AA.
AC   Q27218; O02278; Q19273;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 139.
DE   RecName: Full=Acetylcholine receptor subunit beta-type lev-1;
DE   AltName: Full=Levamisole-resistant protein 1;
DE   Flags: Precursor;
GN   Name=lev-1; ORFNames=F09E8.7;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9221782;
RA   Fleming J.T., Squire M.D., Barnes T.M., Tornoe C., Matsuda K.,
RA   Ahnn J., Fire A., Sulston J.E., Barnard E.A., Sattelle D.B.,
RA   Lewis J.A.;
RT   "Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and
RT   unc-38 encode functional nicotinic acetylcholine receptor subunits.";
RL   J. Neurosci. 17:5843-5857(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, INTERACTION WITH UNC-29, SUBCELLULAR LOCATION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=15990870; DOI=10.1038/sj.emboj.7600741;
RA   Gottschalk A., Almedom R.B., Schedletzky T., Anderson S.D.,
RA   Yates J.R. III, Schafer W.R.;
RT   "Identification and characterization of novel nicotinic receptor-
RT   associated proteins in Caenorhabditis elegans.";
RL   EMBO J. 24:2566-2578(2005).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-109, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Non-alpha subunit of nicotinic acetylcholine receptor
CC       (nAChR). Involved in nAChR sensitivity to nicotine.
CC       {ECO:0000269|PubMed:15990870}.
CC   -!- SUBUNIT: Interacts with unc-29. Component of nicotinic
CC       acetylcholine receptor composed of 2 non-alpha subunits lev-1 and
CC       unc-29, and 3 alpha subunits unc-38, unc-63 and lev-8.
CC       {ECO:0000269|PubMed:15990870}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:15990870}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:15990870}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Co-localizes with unc-29 and unc-38 at nerve
CC       cord synapses. {ECO:0000269|PubMed:15990870}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes a resistance
CC       to nicotine-mediated paralysis. {ECO:0000269|PubMed:15990870}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X98601; CAA67198.1; -; mRNA.
DR   EMBL; X98246; CAA66902.1; -; Genomic_DNA.
DR   EMBL; Z81093; CAB03148.2; -; Genomic_DNA.
DR   PIR; T22910; T22910.
DR   RefSeq; NP_001255705.1; NM_001268776.1.
DR   UniGene; Cel.19676; -.
DR   ProteinModelPortal; Q27218; -.
DR   IntAct; Q27218; 3.
DR   MINT; MINT-3383590; -.
DR   STRING; 6239.F09E8.7a; -.
DR   DrugBank; DB00848; Levamisole.
DR   iPTMnet; Q27218; -.
DR   PaxDb; Q27218; -.
DR   EnsemblMetazoa; F09E8.7a; F09E8.7a; WBGene00002974.
DR   GeneID; 178269; -.
DR   UCSC; F09E8.7; c. elegans.
DR   CTD; 178269; -.
DR   WormBase; F09E8.7a; CE24888; WBGene00002974; lev-1.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; Q27218; -.
DR   OMA; QDEYNDI; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q27218; -.
DR   Reactome; R-CEL-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   PRO; PR:Q27218; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00002974; -.
DR   ExpressionAtlas; Q27218; baseline.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043005; C:neuron projection; IDA:WormBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:WormBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:WormBase.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IMP:WormBase.
DR   GO; GO:0040012; P:regulation of locomotion; IMP:WormBase.
DR   GO; GO:0046662; P:regulation of oviposition; IMP:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32    507       Acetylcholine receptor subunit beta-type
FT                                lev-1.
FT                                /FTId=PRO_0000000403.
FT   TOPO_DOM     32    138       Extracellular. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   TRANSMEM    305    325       Helical. {ECO:0000255}.
FT   TRANSMEM    454    474       Helical. {ECO:0000255}.
FT   CARBOHYD     28     28       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    109    109       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   DISULFID    163    177       {ECO:0000250}.
SQ   SEQUENCE   507 AA;  58026 MW;  6111C3BC3984111E CRC64;
     MMLGGGGGCG AGGTWLGFLV FLAVSLRNHS TCEDIDAEDR LMVDLFRGYN SLVQPVRNRS
     ELPMIVKIGM QLVLLINVDE KEQVMHTNVW LTMKWDDFQL KWDPRDYANI TQIRVAPEKV
     WLPDIVLFNN ADGNYEVSFM CNVLILSTGT VLWVPPAIYK SSCIIDVEFF PFDDQLCSLT
     FGSWTYNRDE IKLDFLTSDR VDFSEYSTSS IWDMMDGPAV LTSDRSRIEF QIRIRRKTLF
     YTVVLILPTV LMAFLNVTVF YLPTASGEKM GLTMNVLLSI VVFLLLVSKI LPPTSSSIPL
     VAKYLLLTFV LNIITIMVTT IICNIYFRSP ITHRLPPWVR KVFLDILPLL MCMQRPHRKN
     VIQRSHRRLL ETGPSVEENP MRSGEHHPLC RHTHNQDSCR RVRIQSDELD DELSPEAQRA
     IDAIEFITEN RRDEEITKQF RDDWKFIASV VDRFLLYGFF GATVGGTIGI IFTAPSVFET
     FDENATLVKL KQLYDMGLAN DTVLGIF
//
ID   P2RX3_MOUSE             Reviewed;         397 AA.
AC   Q3UR32; A2AW02; Q8R1U4;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   22-NOV-2017, entry version 99.
DE   RecName: Full=P2X purinoceptor 3;
DE            Short=P2X3;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Corpora quadrigemina, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15961431; DOI=10.1113/jphysiol.2005.088435;
RA   Cockayne D.A., Dunn P.M., Zhong Y., Rong W., Hamilton S.G.,
RA   Knight G.E., Ruan H.Z., Ma B., Yip P., Nunn P., McMahon S.B.,
RA   Burnstock G., Ford A.P.;
RT   "P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role
RT   for the P2X2 receptor subunit in mediating multiple sensory effects of
RT   ATP.";
RL   J. Physiol. (Lond.) 567:621-639(2005).
RN   [5]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=16322458; DOI=10.1126/science.1118435;
RA   Finger T.E., Danilova V., Barrows J., Bartel D.L., Vigers A.J.,
RA   Stone L., Hellekant G., Kinnamon S.C.;
RT   "ATP signaling is crucial for communication from taste buds to
RT   gustatory nerves.";
RL   Science 310:1495-1499(2005).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel. {ECO:0000250, ECO:0000269|PubMed:15961431}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Simultaneous knockout of P2rx2 and P2rx3
CC       results in reduced pain-related behaviors in response to
CC       intraplantar injection of formalin and reduced urinary bladder
CC       reflexes and decreased pelvic afferent nerve activity in response
CC       to bladder distension. Neurons have minimal to no response to ATP
CC       (PubMed:15961431). Simultaneous knockout of P2rx2 and P2rx3
CC       results in defects in taste responses in the taste nerves and
CC       reduced behavioral responses to sweeteners, glutamate and bitter
CC       substances (PubMed:16322458). {ECO:0000269|PubMed:15961431,
CC       ECO:0000269|PubMed:16322458}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK140283; BAE24316.1; -; mRNA.
DR   EMBL; AK141847; BAE24856.1; -; mRNA.
DR   EMBL; AL935159; CAM18192.1; -; Genomic_DNA.
DR   EMBL; BC023089; AAH23089.1; -; mRNA.
DR   CCDS; CCDS16200.1; -.
DR   RefSeq; NP_663501.2; NM_145526.2.
DR   UniGene; Mm.440375; -.
DR   UniGene; Mm.448935; -.
DR   ProteinModelPortal; Q3UR32; -.
DR   SMR; Q3UR32; -.
DR   STRING; 10090.ENSMUSP00000028465; -.
DR   ChEMBL; CHEMBL2401608; -.
DR   iPTMnet; Q3UR32; -.
DR   PhosphoSitePlus; Q3UR32; -.
DR   MaxQB; Q3UR32; -.
DR   PaxDb; Q3UR32; -.
DR   PRIDE; Q3UR32; -.
DR   Ensembl; ENSMUST00000028465; ENSMUSP00000028465; ENSMUSG00000027071.
DR   GeneID; 228139; -.
DR   KEGG; mmu:228139; -.
DR   UCSC; uc008kjr.1; mouse.
DR   CTD; 5024; -.
DR   MGI; MGI:1097160; P2rx3.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; Q3UR32; -.
DR   KO; K05217; -.
DR   OMA; TENQVQG; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; Q3UR32; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-MMU-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-MMU-418346; Platelet homeostasis.
DR   PRO; PR:Q3UR32; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000027071; -.
DR   ExpressionAtlas; Q3UR32; baseline and differential.
DR   Genevisible; Q3UR32; MM.
DR   GO; GO:0030424; C:axon; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:MGI.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IGI:MGI.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0061368; P:behavioral response to formalin induced pain; IEA:Ensembl.
DR   GO; GO:0048266; P:behavioral response to pain; IMP:MGI.
DR   GO; GO:0006812; P:cation transport; IMP:MGI.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:MGI.
DR   GO; GO:0006811; P:ion transport; IMP:MGI.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IMP:MGI.
DR   GO; GO:0019228; P:neuronal action potential; IEA:Ensembl.
DR   GO; GO:0030432; P:peristalsis; IMP:MGI.
DR   GO; GO:1904058; P:positive regulation of sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IMP:MGI.
DR   GO; GO:0033198; P:response to ATP; IMP:MGI.
DR   GO; GO:0009743; P:response to carbohydrate; IMP:MGI.
DR   GO; GO:0009409; P:response to cold; IMP:MGI.
DR   GO; GO:0009408; P:response to heat; IMP:MGI.
DR   GO; GO:0001666; P:response to hypoxia; IMP:MGI.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:MGI.
DR   GO; GO:0010033; P:response to organic substance; IMP:MGI.
DR   GO; GO:0009266; P:response to temperature stimulus; IMP:MGI.
DR   GO; GO:0050909; P:sensory perception of taste; IGI:MGI.
DR   GO; GO:0014832; P:urinary bladder smooth muscle contraction; IMP:MGI.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003046; P2X3_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF8; PTHR10125:SF8; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01310; P2X3RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    397       P2X purinoceptor 3.
FT                                /FTId=PRO_0000269195.
FT   TOPO_DOM      1     22       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     23     43       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     44    317       Extracellular. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    339    397       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    194    194       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    107    153       {ECO:0000250}.
FT   DISULFID    116    137       {ECO:0000250}.
FT   DISULFID    122    147       {ECO:0000250}.
FT   DISULFID    203    213       {ECO:0000250}.
FT   DISULFID    247    256       {ECO:0000250}.
FT   CONFLICT    295    295       R -> P (in Ref. 3; AAH23089).
FT                                {ECO:0000305}.
SQ   SEQUENCE   397 AA;  44437 MW;  BFB90C740E5DD910 CRC64;
     MNCISDFFTY ETTKSVVVKS WTIGIINRAV QLLIISYFVG WVFLHEKAYQ VRDTAIESSV
     VTKVKGFGRY ANRVMDVSDY VTPPQGTSVF VIITKMIVTE NQMQGFCPEN EEKYRCVSDS
     QCGPERFPGG GILTGRCVNY SSVRRTCEIQ GWCPTEVDTV EMPIMMEAEN FTIFIKNSIR
     FPLFNFEKGN LLPNLTDKDI KKCRFHPEKA PFCPILRVGD VVKFAGQDFA KLARTGGVLG
     IKIGWVCDLD KAWDQCIPKY SFTRLDGVSE KSSVSPGYNF RFAKYYKMEN GSEYRTLLKA
     FGIRFDVLVY GNAGKFNIIP TIISSVAAFT SVGVGTVLCD IILLNFLKGA DHYKARKFEE
     VTETTLKGTA STNPVFTSDQ ATVEKQSTDS GAYSIGH
//
ID   ZACN_HUMAN              Reviewed;         412 AA.
AC   Q401N2; Q2TB29; Q6ZWK3; Q86YW4;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   25-OCT-2017, entry version 106.
DE   RecName: Full=Zinc-activated ligand-gated ion channel;
DE   AltName: Full=Ligand-gated ion channel zinc-activated 1;
DE   AltName: Full=Ligand-gated ion-channel receptor L2;
DE   Flags: Precursor;
GN   Name=ZACN; Synonyms=L2, LGICZ, LGICZ1, ZAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, FUNCTION,
RP   AND VARIANT THR-152.
RX   PubMed=12381728; DOI=10.1074/jbc.M208814200;
RA   Davies P.A., Wang W., Hales T.G., Kirkness E.F.;
RT   "A novel class of ligand-gated ion channel is activated by Zn2+.";
RL   J. Biol. Chem. 278:712-717(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND GLYCOSYLATION.
RC   TISSUE=Brain;
RX   PubMed=16083862; DOI=10.1016/j.bbrc.2005.07.079;
RA   Houtani T., Munemoto Y., Kase M., Sakuma S., Tsutsumi T., Sugimoto T.;
RT   "Cloning and expression of ligand-gated ion-channel receptor L2 in
RT   central nervous system.";
RL   Biochem. Biophys. Res. Commun. 335:277-285(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   THR-152.
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Zinc-activated ligand-gated ion channel.
CC       {ECO:0000269|PubMed:12381728}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16083862};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16083862}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q401N2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q401N2-2; Sequence=VSP_030911, VSP_030912;
CC       Name=3;
CC         IsoId=Q401N2-3; Sequence=VSP_030909, VSP_030910;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Detected in pancreas, brain, liver, placenta,
CC       trachea, kidney, spinal cord, stomach and fetal brain. In the
CC       adult brain region expression is detected in the hippocampus,
CC       striatum, amygdala and thalamus. {ECO:0000269|PubMed:12381728,
CC       ECO:0000269|PubMed:16083862}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:16083862}.
CC   -!- MISCELLANEOUS: The mouse and rat orthologous proteins do not
CC       exist.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-2 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI10598.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAO20969.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=EAW89365.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF512521; AAO20969.1; ALT_INIT; mRNA.
DR   EMBL; AB223030; BAE19924.1; -; mRNA.
DR   EMBL; AK122638; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC018665; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89365.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CH471099; EAW89366.1; -; Genomic_DNA.
DR   EMBL; BC110596; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC110597; AAI10598.1; ALT_INIT; mRNA.
DR   CCDS; CCDS11740.2; -. [Q401N2-1]
DR   RefSeq; NP_851321.2; NM_180990.3. [Q401N2-1]
DR   UniGene; Hs.714919; -.
DR   ProteinModelPortal; Q401N2; -.
DR   BioGrid; 131658; 71.
DR   STRING; 9606.ENSP00000334854; -.
DR   GuidetoPHARMACOLOGY; 587; -.
DR   TCDB; 1.A.9.11.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; Q401N2; -.
DR   BioMuta; ZACN; -.
DR   DMDM; 166991030; -.
DR   PaxDb; Q401N2; -.
DR   PRIDE; Q401N2; -.
DR   TopDownProteomics; Q401N2-3; -. [Q401N2-3]
DR   Ensembl; ENST00000334586; ENSP00000334854; ENSG00000186919. [Q401N2-1]
DR   Ensembl; ENST00000421794; ENSP00000391936; ENSG00000186919. [Q401N2-3]
DR   Ensembl; ENST00000425015; ENSP00000397489; ENSG00000186919. [Q401N2-2]
DR   GeneID; 353174; -.
DR   KEGG; hsa:353174; -.
DR   UCSC; uc002jqn.3; human. [Q401N2-1]
DR   CTD; 353174; -.
DR   DisGeNET; 353174; -.
DR   EuPathDB; HostDB:ENSG00000186919.12; -.
DR   GeneCards; ZACN; -.
DR   H-InvDB; HIX0027141; -.
DR   HGNC; HGNC:29504; ZACN.
DR   MIM; 610935; gene.
DR   neXtProt; NX_Q401N2; -.
DR   OpenTargets; ENSG00000186919; -.
DR   PharmGKB; PA162409377; -.
DR   eggNOG; ENOG410IKFM; Eukaryota.
DR   eggNOG; ENOG4111421; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000155757; -.
DR   HOVERGEN; HBG108756; -.
DR   InParanoid; Q401N2; -.
DR   KO; K16888; -.
DR   OMA; LVPCFQV; -.
DR   OrthoDB; EOG091G0CPT; -.
DR   PhylomeDB; Q401N2; -.
DR   TreeFam; TF315605; -.
DR   ChiTaRS; ZACN; human.
DR   GeneWiki; Zinc-activated_ion_channel; -.
DR   GenomeRNAi; 353174; -.
DR   PRO; PR:Q401N2; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000186919; -.
DR   CleanEx; HS_ZACN; -.
DR   Genevisible; Q401N2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HGNC.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:BHF-UCL.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IC:HGNC.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0010043; P:response to zinc ion; IDA:HGNC.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport; Zinc.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    412       Zinc-activated ligand-gated ion channel.
FT                                /FTId=PRO_0000317165.
FT   TOPO_DOM     26    233       Extracellular. {ECO:0000255}.
FT   TRANSMEM    234    254       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    255    265       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    287    298       Extracellular. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    320    368       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    369    389       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    390    412       Extracellular. {ECO:0000255}.
FT   COMPBIAS    224    318       Leu-rich.
FT   CARBOHYD     41     41       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     55     55       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_5000052473.
FT   DISULFID    157    171       {ECO:0000250}.
FT   VAR_SEQ      75    126       DILRYTMSSMLLLRLSWLDTRLAWNTSAHPRHAITLPWESL
FT                                WTPRLTILEAL -> SSVLPRATALHSHGDCSGSAPCSKAR
FT                                GSGCHGLTPGNHLKVQPPCINPSGDI (in isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030909.
FT   VAR_SEQ     127    412       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030910.
FT   VAR_SEQ     182    266       AMELEFQAHVVNEIVSVKREYVVYDLKTQVPPQQLVPCFQV
FT                                TLRLKNTALKSIIALLVPAEALLLADVCGGLLPLRAIERIG
FT                                YKV -> GADRAGAAGLRRGGGRWGRGTPRSVVQGQGAGQG
FT                                EGAKADRRRTPRSVFRAVYPRLRRAAPALPLRPPLEWQPIS
FT                                VLSGSLRAPL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030911.
FT   VAR_SEQ     267    412       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030912.
FT   VARIANT     152    152       A -> T (in dbSNP:rs2257020).
FT                                {ECO:0000269|PubMed:12381728,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_038483.
SQ   SEQUENCE   412 AA;  45816 MW;  B894A28F5163723F CRC64;
     MMALWSLLHL TFLGFSITLL LVHGQGFQGT AAIWPSLFNV NLSKKVQESI QIPNNGSAPL
     LVDVRVFVSN VFNVDILRYT MSSMLLLRLS WLDTRLAWNT SAHPRHAITL PWESLWTPRL
     TILEALWVDW RDQSPQARVD QDGHVKLNLA LATETNCNFE LLHFPRDHSN CSLSFYALSN
     TAMELEFQAH VVNEIVSVKR EYVVYDLKTQ VPPQQLVPCF QVTLRLKNTA LKSIIALLVP
     AEALLLADVC GGLLPLRAIE RIGYKVTLLL SYLVLHSSLV QALPSSSSCN PLLIYYFTIL
     LLLLFLSTIE TVLLAGLLAR GNLGAKSGPS PAPRGEQREH GNPGPHPAEE PSRGVKGSQR
     SWPETADRIF FLVYVVGVLC TQFVFAGIWM WAACKSDAAP GEAAPHGRRP RL
//
ID   P2XE_DICDI              Reviewed;         388 AA.
AC   Q54JH4;
DT   15-DEC-2009, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   25-OCT-2017, entry version 68.
DE   RecName: Full=P2X receptor E;
DE            Short=P2XE;
GN   Name=p2xE; ORFNames=DDB_G0288061;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18486207; DOI=10.1016/j.ceca.2008.04.001;
RA   Ludlow M.J., Traynor D., Fisher P.R., Ennion S.J.;
RT   "Purinergic-mediated Ca2+ influx in Dictyostelium discoideum.";
RL   Cell Calcium 44:567-579(2008).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19833731; DOI=10.1074/jbc.M109.045674;
RA   Ludlow M.J., Durai L., Ennion S.J.;
RT   "Functional characterization of intracellular Dictyostelium discoideum
RT   P2X receptors.";
RL   J. Biol. Chem. 284:35227-35239(2009).
CC   -!- FUNCTION: P2X receptors are ATP-gated ion channels that play a
CC       role in intracellular calcium signaling. Not required for the
CC       purinergic response to extracellular nucleotides. Not essential
CC       for osmoregulation. Inward currents evoked by intracellular ATP.
CC       ATP analog beta, gamma-imido-ATP is a weak partial agonist of
CC       p2xE. Exclusively selective for ATP over other nucleotides.
CC       Insensitive to copper and P2 receptor antagonists PPADS and
CC       suramin but strongly inhibited by sodium ions. More permeable to
CC       ammonium than either sodium or potassium ions and less permeable
CC       to choline. Permeable to calcium ions, but not chloride.
CC       {ECO:0000269|PubMed:18486207, ECO:0000269|PubMed:19833731}.
CC   -!- SUBCELLULAR LOCATION: Contractile vacuole membrane
CC       {ECO:0000269|PubMed:19833731}. Note=Ligand binding domain within
CC       the lumen of the vacuole.
CC   -!- DISRUPTION PHENOTYPE: Response to extracellular ATP remains the
CC       same in p2xE null strains. Null cells are still capable of
CC       osmoregulation and do not show any noticeable differences in their
CC       sensitivity to hypotonic conditions. Quintuple
CC       p2xA/p2xB/p2xC/p2xD/p2xE null cells displayed slight delay in
CC       their osmoregulatory response, but are still capable of regulating
CC       their cell volume in water. Extracellular purinergic response to
CC       ATP persists in the quintuple null cells with no alteration in the
CC       kinetics of the response, but the magnitude of the response is
CC       lower. Responses to the calmodulin antagonist calmidazolium are
CC       reduced and intracellular calcium signaling is disrupted in
CC       quintuple null cells. The presence of copper prevented both wild
CC       type and quintuple null cells from undergoing an osmoregulatory
CC       decrease in cell volume. No obvious morphological phenotype was
CC       apparent in the p2xE or quintuple p2x null strains. The quintuple
CC       p2x null strains grow slightly slower than wild type in shaking
CC       axenic cultures. {ECO:0000269|PubMed:18486207,
CC       ECO:0000269|PubMed:19833731}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000107; EAL63456.2; -; Genomic_DNA.
DR   RefSeq; XP_636957.2; XM_631865.2.
DR   PaxDb; Q54JH4; -.
DR   EnsemblProtists; EAL63456; EAL63456; DDB_G0288061.
DR   GeneID; 8626432; -.
DR   KEGG; ddi:DDB_G0288061; -.
DR   dictyBase; DDB_G0288061; p2xE.
DR   eggNOG; ENOG410IXHI; Eukaryota.
DR   eggNOG; ENOG4111IMV; LUCA.
DR   InParanoid; Q54JH4; -.
DR   OMA; RIIFIQT; -.
DR   PhylomeDB; Q54JH4; -.
DR   PRO; PR:Q54JH4; -.
DR   Proteomes; UP000002195; Chromosome 5.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0031164; C:contractile vacuolar membrane; IDA:dictyBase.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0035381; F:ATP-gated ion channel activity; IBA:GO_Central.
DR   GO; GO:0015278; F:calcium-release channel activity; IGI:dictyBase.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:dictyBase.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IGI:dictyBase.
DR   GO; GO:0071476; P:cellular hypotonic response; IGI:dictyBase.
DR   GO; GO:0006811; P:ion transport; IDA:dictyBase.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IGI:dictyBase.
DR   GO; GO:0033198; P:response to ATP; IEA:InterPro.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   InterPro; IPR028484; P2X_receptor_E.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF25; PTHR10125:SF25; 1.
DR   Pfam; PF00864; P2X_receptor; 2.
PE   3: Inferred from homology;
KW   Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Vacuole.
FT   CHAIN         1    388       P2X receptor E.
FT                                /FTId=PRO_0000390415.
FT   TOPO_DOM      1     28       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TOPO_DOM     50    312       Lumenal. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    388       Cytoplasmic. {ECO:0000255}.
FT   REGION      291    304       Pore-forming motif. {ECO:0000255}.
SQ   SEQUENCE   388 AA;  43829 MW;  8EB448F9E0A4D256 CRC64;
     MNFRNIDWDS LFSYSTIKIV RIRDKRLGIL HFAFLIGIIL YIIVGTIFLQ KKYLVLESPI
     GSIRTSLMAP SVKPTDLPYC LKNGTDTSYD GYPNKPCQYW DEYLVLYPPS EESSMFITTR
     CTQETQSTVN GCNLSEPTCV YNTTSSSDFY IANVENFTIL LDHTLSAPSL GIQYNGAQLN
     GQLLDTDGNP MSLPPPNIVG VKGSPDIMSL QGVLTAAGVE SLDSQGLANK SRTIRDDGIL
     ILCFITYSNT YTYNTGNYHY TYQFKLVQNT KYKIVEPVFT KDVEDRYIFD RHGVRIIFIQ
     TGQLGQFDFQ TMLLTFVSGI GLVTAASLIV DIIATRIMPQ RSRYQELKFQ DSSINNTQKT
     PTNDHTPLLK DNEDTINENS YQNNSYEK
//
ID   P2RX4_BOVIN             Reviewed;         388 AA.
AC   Q5E9U1;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   20-DEC-2017, entry version 84.
DE   RecName: Full=P2X purinoceptor 4;
DE            Short=P2X4;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2RX4;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16305752; DOI=10.1186/1471-2164-6-166;
RA   Harhay G.P., Sonstegard T.S., Keele J.W., Heaton M.P., Clawson M.L.,
RA   Snelling W.M., Wiedmann R.T., Van Tassell C.P., Smith T.P.L.;
RT   "Characterization of 954 bovine full-CDS cDNA sequences.";
RL   BMC Genomics 6:166-166(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Brain cortex;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel. This receptor is insensitive to the antagonists PPADS and
CC       suramin (By similarity). {ECO:0000250|UniProtKB:P51577,
CC       ECO:0000250|UniProtKB:Q99571}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99571};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT020829; AAX08846.1; -; mRNA.
DR   EMBL; BC120340; AAI20341.1; -; mRNA.
DR   RefSeq; NP_001029221.1; NM_001034049.1.
DR   UniGene; Bt.15997; -.
DR   SMR; Q5E9U1; -.
DR   STRING; 9913.ENSBTAP00000014321; -.
DR   PaxDb; Q5E9U1; -.
DR   PRIDE; Q5E9U1; -.
DR   Ensembl; ENSBTAT00000014321; ENSBTAP00000014321; ENSBTAG00000010812.
DR   GeneID; 338036; -.
DR   KEGG; bta:338036; -.
DR   CTD; 5025; -.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; Q5E9U1; -.
DR   KO; K05218; -.
DR   OMA; TMINVGS; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-BTA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-BTA-418346; Platelet homeostasis.
DR   Proteomes; UP000009136; Chromosome 17.
DR   Bgee; ENSBTAG00000010812; -.
DR   GO; GO:0030054; C:cell junction; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; IEA:Ensembl.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0071318; P:cellular response to ATP; ISS:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Ensembl.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IEA:Ensembl.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IEA:Ensembl.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IEA:Ensembl.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; IEA:Ensembl.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; IEA:Ensembl.
DR   GO; GO:0034405; P:response to fluid shear stress; IEA:Ensembl.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003047; P2X4_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01311; P2X4RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    388       P2X purinoceptor 4.
FT                                /FTId=PRO_0000269193.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     55    338       Extracellular. {ECO:0000255}.
FT   TRANSMEM    339    359       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    360    388       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    131    131       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    199    199       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    208    208       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    116    165       {ECO:0000250}.
FT   DISULFID    126    149       {ECO:0000250}.
FT   DISULFID    132    159       {ECO:0000250}.
FT   DISULFID    217    227       {ECO:0000250}.
FT   DISULFID    261    270       {ECO:0000250}.
SQ   SEQUENCE   388 AA;  43529 MW;  8421F3323FCFEDDC CRC64;
     MTGCCTVLGA FLFEYDTPRI VLIRSRKVGL MNRTVQLLIL AYVIGWVFVW EKGYQETDSV
     VSSVTVKAKG VTMTNTSKLG FRIWDVADYV IPAQEENSVF IMTNMVITMN QTQGLCPEIP
     GKTTVCETDA NCTAGSAGTH SSGVATGRCV SFNGTLKTCE VAAWCPVEDD TEVPKPAFLK
     AAENFTLLVK NNIWYPKFNF SKRNILPNIT TAYLKTCIYD AKTDPFCPIF RLGKIVESAG
     HSFQDIAIEG GIMGIQIKWN CNLDRAASFC LPRYSFRRLD TRDLAHNVSP GYNFRFAKYY
     SDLKGAEHRT LIKAYGIRFD IIVFGKAGKF DIIPTMINIG SGLALLGVAT VLCDVIVLYC
     MKKRYYYREK KYKYVEDYEQ GLGNQMEQ
//
ID   GRIK1_MOUSE             Reviewed;         836 AA.
AC   Q60934;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   25-OCT-2017, entry version 143.
DE   RecName: Full=Glutamate receptor ionotropic, kainate 1;
DE            Short=GluK1;
DE   AltName: Full=Glutamate receptor 5;
DE            Short=GluR-5;
DE            Short=GluR5;
DE   Flags: Precursor;
GN   Name=Grik1; Synonyms=Glur5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=8260617;
RA   Gregor P., O'Hara B.F., Yang X., Uhl G.R.;
RT   "Expression and novel subunit isoforms of glutamate receptor genes
RT   GluR5 and GluR6.";
RL   NeuroReport 4:1343-1346(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 584-695, AND RNA EDITING OF
RP   POSITION 621.
RC   STRAIN=BALB/cJ;
RX   PubMed=8700852; DOI=10.1073/pnas.93.5.1875;
RA   Herb A., Higuchi M., Sprengel R., Seeburg P.H.;
RT   "Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs
RT   requires distant intronic sequences.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:1875-1880(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 606-622, AND RNA EDITING OF POSITION 621.
RX   PubMed=1717158; DOI=10.1016/0092-8674(91)90568-J;
RA   Sommer B., Koehler M., Sprengel R., Seeburg P.H.;
RT   "RNA editing in brain controls a determinant of ion flow in glutamate-
RT   gated channels.";
RL   Cell 67:11-19(1991).
CC   -!- FUNCTION: Ionotropic glutamate receptor. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. Binding of the excitatory neurotransmitter L-
CC       glutamate induces a conformation change, leading to the opening of
CC       the cation channel, and thereby converts the chemical signal to an
CC       electrical impulse. The receptor then desensitizes rapidly and
CC       enters a transient inactive state, characterized by the presence
CC       of bound agonist. May be involved in the transmission of light
CC       information from the retina to the hypothalamus (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits. Tetramers may be formed by the dimerization of
CC       dimers (Probable). The unedited version (Q) assembles into a
CC       functional kainate-gated homomeric channel, whereas the edited
CC       version (R) is unable to produce channel activity when expressed
CC       alone. Both edited and unedited versions can form functional
CC       channels with GRIK4 and GRIK5. Interacts with KLHL17 (By
CC       similarity). {ECO:0000250, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=At least 2 isoforms are produced.;
CC       Name=1;
CC         IsoId=Q60934-1; Sequence=Displayed;
CC   -!- TISSUE SPECIFICITY: Most abundant in the cerebellum. Also present
CC       in the suprachiasmatic nuclei of the hypothalamus.
CC   -!- RNA EDITING: Modified_positions=621 {ECO:0000269|PubMed:1717158,
CC       ECO:0000269|PubMed:8700852}; Note=Partially edited.;
CC   -!- MISCELLANEOUS: The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds domoate > kainate > L-glutamate =
CC       quisqualate > CNQX = DNQX > AMPA > dihydrokainate > NMDA (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIK1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66118; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U31444; AAA85222.1; -; Genomic_DNA.
DR   PIR; A41053; A41053.
DR   UniGene; Mm.5134; -.
DR   ProteinModelPortal; Q60934; -.
DR   SMR; Q60934; -.
DR   STRING; 10090.ENSMUSP00000072107; -.
DR   iPTMnet; Q60934; -.
DR   PhosphoSitePlus; Q60934; -.
DR   PaxDb; Q60934; -.
DR   PRIDE; Q60934; -.
DR   UCSC; uc007zuw.2; mouse. [Q60934-1]
DR   MGI; MGI:95814; Grik1.
DR   eggNOG; KOG1054; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   HOVERGEN; HBG051839; -.
DR   InParanoid; Q60934; -.
DR   PRO; PR:Q60934; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_GRIK1; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IDA:MGI.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; IC:MGI.
DR   GO; GO:0032983; C:kainate selective glutamate receptor complex; IPI:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0014069; C:postsynaptic density; IDA:MGI.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:MGI.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0015277; F:kainate selective glutamate receptor activity; IDA:MGI.
DR   GO; GO:0030534; P:adult behavior; IMP:MGI.
DR   GO; GO:0048266; P:behavioral response to pain; IMP:MGI.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IMP:MGI.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; IMP:MGI.
DR   GO; GO:0051899; P:membrane depolarization; IMP:MGI.
DR   GO; GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IGI:MGI.
DR   GO; GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IMP:MGI.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IMP:MGI.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; TAS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IDA:MGI.
DR   GO; GO:0048172; P:regulation of short-term neuronal synaptic plasticity; TAS:UniProtKB.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IMP:MGI.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   RNA editing; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31    836       Glutamate receptor ionotropic, kainate 1.
FT                                /FTId=PRO_0000011542.
FT   TOPO_DOM     31    561       Extracellular. {ECO:0000255}.
FT   TRANSMEM    562    582       Helical. {ECO:0000255}.
FT   TOPO_DOM    583    638       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    639    659       Helical. {ECO:0000255}.
FT   TOPO_DOM    660    721       Extracellular. {ECO:0000255}.
FT   TRANSMEM    722    742       Helical. {ECO:0000255}.
FT   TOPO_DOM    743    836       Cytoplasmic. {ECO:0000255}.
FT   REGION      516    518       Glutamate binding. {ECO:0000250}.
FT   REGION      689    690       Glutamate binding. {ECO:0000250}.
FT   BINDING     523    523       Glutamate. {ECO:0000250}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    276    276       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    379    379       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    413    413       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    424    424       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    431    431       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    546    546       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     621    621       Q -> R (in RNA edited version).
SQ   SEQUENCE   836 AA;  95202 MW;  A8B6EC4B44FFDBFF CRC64;
     MERGTVLIQP GLWTRDTSWT LLYFLCYILP QTSPQVLRIG GIFETVENEP VNVEELAFKF
     AVTSINRNRT LMPNTTLTYD IQRINLFDSF EASRRACDQL ALGVAALFGP SHSSSVSAVQ
     SICNALEVPH IQTRWKHPSV DNRDLFYINL YPDYAAISRA VLDLVLYYNW KTVTVVYEDS
     TGLIRLQELI KAPSRYNIKI KIRQLPSGNK DAKPLLKEMK KGKEFYVIFD CSHETAAEIL
     KQILFMGMMT EYYHYFFTTL DLFALDLELY RYSGVNMTGF RLLNIDNPHV SSIIEKWSME
     RLQAPPRPET GLLDGVMTTE AALMYDAVYM VAIASHRASQ LTVSSLQCHR HKPWRLGPRF
     MNLIKEARWD GLTGRITFNK TDGLRKDFDL DIISLKEEGT EKIGIWNSNS GLNMTDGNRD
     RSNNITDSLA NRTLIVTTIL EEPYVMYRKS DKPLYGNDRF EGYCLDLLKE LSNILGFLYD
     VKLVPDGKYG AQNDKGEWNG MVKELIDHRA DLAVAPLTIT YVREKVIDFS KPFMTLGISI
     LYRKPNGTNP GVFSFLNPLS PDIWMYVLLA CLGVSCVLFV IARFTPYEWY NPHPCNPDSD
     VVENNFTLLN SFWFGVGALM QQGSELMPKA LSTRIVGGIW WFFTLIIISS YTANLAAFLT
     VERMESPIDS ADDLAKQTKI EYGAVRDGST MTFFKKSKIS TYEKMWAFMS SRQPSALGVE
     NIGGIFIVLA AGLVLSVFVA IGEFIYKSRK NNDIEQKGKS SRLRFYFRNK VRFHGSKTES
     LGVEKCLSFN AIMEELGISL KNQKKIKKKS RTKGKSSFTS ILTCHQRRTQ RKETVA
//
ID   ACH8_CAEBR              Reviewed;         481 AA.
AC   Q60S81; A8XZ53;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   25-OCT-2017, entry version 78.
DE   RecName: Full=Neuronal acetylcholine receptor subunit eat-2;
DE   Flags: Precursor;
GN   Name=eat-2 {ECO:0000250|UniProtKB:Q9U298}; ORFNames=CBG21000;
OS   Caenorhabditis briggsae.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6238;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AF16;
RX   PubMed=14624247; DOI=10.1371/journal.pbio.0000045;
RA   Stein L.D., Bao Z., Blasiar D., Blumenthal T., Brent M.R., Chen N.,
RA   Chinwalla A., Clarke L., Clee C., Coghlan A., Coulson A.,
RA   D'Eustachio P., Fitch D.H.A., Fulton L.A., Fulton R.E.,
RA   Griffiths-Jones S., Harris T.W., Hillier L.W., Kamath R.,
RA   Kuwabara P.E., Mardis E.R., Marra M.A., Miner T.L., Minx P.,
RA   Mullikin J.C., Plumb R.W., Rogers J., Schein J.E., Sohrmann M.,
RA   Spieth J., Stajich J.E., Wei C., Willey D., Wilson R.K., Durbin R.M.,
RA   Waterston R.H.;
RT   "The genome sequence of Caenorhabditis briggsae: a platform for
RT   comparative genomics.";
RL   PLoS Biol. 1:166-192(2003).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. Nicotinic acetylcholine receptor in the MC pharyngeal
CC       motor neuron involved in pharyngeal pumping. Has a role in the
CC       determination of life span possibly via calorific restriction
CC       which affects growth rate, although this is independent of
CC       metabolic activity (By similarity). {ECO:0000250|UniProtKB:P22770,
CC       ECO:0000250|UniProtKB:Q9U298}.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and beta. {ECO:0000250|UniProtKB:P22770}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC       Cell membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}. Note=MC motor neuron.
CC       {ECO:0000250|UniProtKB:Q9U298}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HE600928; CAP37920.1; -; Genomic_DNA.
DR   RefSeq; XP_002631787.1; XM_002631741.1.
DR   ProteinModelPortal; Q60S81; -.
DR   STRING; 6238.CBG21000; -.
DR   EnsemblMetazoa; CBG21000; CBG21000; WBGene00039891.
DR   GeneID; 8573786; -.
DR   KEGG; cbr:CBG21000; -.
DR   CTD; 8573786; -.
DR   WormBase; CBG21000; CBP37967; WBGene00039891; Cbr-eat-2.
DR   eggNOG; KOG3646; Eukaryota.
DR   eggNOG; ENOG410Z6BY; LUCA.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; Q60S81; -.
DR   KO; K05312; -.
DR   OrthoDB; EOG091G0R20; -.
DR   Proteomes; UP000008549; Chromosome II.
DR   Proteomes; UP000008549; Unassembled WGS sequence.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:EnsemblMetazoa.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; ISS:UniProtKB.
DR   GO; GO:0001508; P:action potential; IEA:EnsemblMetazoa.
DR   GO; GO:0008340; P:determination of adult lifespan; ISS:UniProtKB.
DR   GO; GO:0030536; P:larval feeding behavior; IEA:EnsemblMetazoa.
DR   GO; GO:0048609; P:multicellular organismal reproductive process; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:EnsemblMetazoa.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; ISS:UniProtKB.
DR   GO; GO:0043050; P:pharyngeal pumping; ISS:UniProtKB.
DR   GO; GO:1904000; P:positive regulation of eating behavior; IEA:EnsemblMetazoa.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:EnsemblMetazoa.
DR   GO; GO:0061063; P:positive regulation of nematode larval development; IEA:EnsemblMetazoa.
DR   GO; GO:0060378; P:regulation of brood size; IEA:EnsemblMetazoa.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; IEA:EnsemblMetazoa.
DR   GO; GO:0043051; P:regulation of pharyngeal pumping; IEA:EnsemblMetazoa.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   3: Inferred from homology;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    481       Neuronal acetylcholine receptor subunit
FT                                eat-2.
FT                                /FTId=PRO_0000306252.
FT   TOPO_DOM     20    235       Extracellular. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical. {ECO:0000255}.
FT   TOPO_DOM    313    443       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    444    464       Helical. {ECO:0000255}.
FT   CARBOHYD     93     93       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    147    161       {ECO:0000250|UniProtKB:P22770}.
SQ   SEQUENCE   481 AA;  56046 MW;  BA266277A5DE975D CRC64;
     MFLLLQILYI LLFLNLADTS DDEYRLLKDL REGYDPMERP VSDHMKPVNV KLRLILQQLV
     DVDEKNQVIT LVVWTQYTWN DYKMKWSPEE YGNITSLQIP FGTLWKPDIL LFNSANEHFD
     SSFPVNMVVS NDGNVLFAPP GIMQFSCSLS MTWFPYDEQV CYLKFGSWTY GKKLDLRIDD
     ADLPEGHKMD LQYYVPNGEF DLISTPAFRK STTFLDETYV ELYFHMHLKR RTMYYGLNWI
     IPSILISLSN ILGFTMPVEC GEKVTLQITN FLSIMVFLAM VSEVAPPTSE SIPIIAAFFS
     FAIVILGVSI CVSLITVNIF YRHPKMHRMG DWTRYIFLEW LPWFLLMSRP DHVFRKPKRE
     KKKEEEEDEE SNAGGKEEES ELISQKQQRP RLLVNSQIVM DSTIPYLEEV IGYLKVFKAK
     LDDDEEEEEE ILNWRFMAMV IDRASLFLFT GLIFGTTFVI FAACPNLFSA DQIIETEPVI
     T
//
ID   GRIK5_MOUSE             Reviewed;         979 AA.
AC   Q61626; G5E822;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   25-OCT-2017, entry version 141.
DE   RecName: Full=Glutamate receptor ionotropic, kainate 5;
DE            Short=GluK5;
DE   AltName: Full=Glutamate receptor KA-2;
DE            Short=KA2;
DE   AltName: Full=Glutamate receptor gamma-2;
DE            Short=GluR gamma-2;
DE   Flags: Precursor;
GN   Name=Grik5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Forebrain;
RX   PubMed=1310861; DOI=10.1016/0896-6273(92)90293-M;
RA   Sakimura K., Morita T., Kushiya E., Mishina M.;
RT   "Primary structure and expression of the gamma 2 subunit of the
RT   glutamate receptor channel selective for kainate.";
RL   Neuron 8:267-274(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. This receptor binds kainate > quisqualate = glutamate >>
CC       AMPA.
CC   -!- SUBUNIT: Tetramer of two or more different subunits. Associates
CC       with GRIK1 (both edited and unedited versions), GRIK2, or GRIK3 to
CC       form functional channels. Homomeric associations do not produce
CC       any channel activity (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIK5 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D10011; BAA00899.1; -; mRNA.
DR   EMBL; AC125468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466593; EDL24295.1; -; Genomic_DNA.
DR   CCDS; CCDS20970.1; -.
DR   PIR; JH0589; JH0589.
DR   RefSeq; NP_032194.2; NM_008168.2.
DR   UniGene; Mm.2879; -.
DR   ProteinModelPortal; Q61626; -.
DR   SMR; Q61626; -.
DR   BioGrid; 200066; 1.
DR   CORUM; Q61626; -.
DR   IntAct; Q61626; 1.
DR   STRING; 10090.ENSMUSP00000003468; -.
DR   iPTMnet; Q61626; -.
DR   PhosphoSitePlus; Q61626; -.
DR   PaxDb; Q61626; -.
DR   PRIDE; Q61626; -.
DR   Ensembl; ENSMUST00000003468; ENSMUSP00000003468; ENSMUSG00000003378.
DR   GeneID; 14809; -.
DR   KEGG; mmu:14809; -.
DR   UCSC; uc009frh.2; mouse.
DR   CTD; 2901; -.
DR   MGI; MGI:95818; Grik5.
DR   eggNOG; ENOG410ISR4; Eukaryota.
DR   eggNOG; ENOG410XRUE; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000234371; -.
DR   HOVERGEN; HBG051839; -.
DR   InParanoid; Q61626; -.
DR   KO; K05205; -.
DR   OMA; DMRDTNC; -.
DR   OrthoDB; EOG091G02LN; -.
DR   TreeFam; TF334668; -.
DR   Reactome; R-MMU-451308; Activation of Ca-permeable Kainate Receptor.
DR   ChiTaRS; Grik5; mouse.
DR   PRO; PR:Q61626; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000003378; -.
DR   ExpressionAtlas; Q61626; baseline and differential.
DR   Genevisible; Q61626; MM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0032983; C:kainate selective glutamate receptor complex; IPI:MGI.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:MGI.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0015277; F:kainate selective glutamate receptor activity; IGI:MGI.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IMP:MGI.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006621; P:protein retention in ER lumen; IEA:Ensembl.
DR   GO; GO:0043113; P:receptor clustering; IEA:Ensembl.
DR   GO; GO:0042391; P:regulation of membrane potential; IGI:MGI.
DR   GO; GO:0031630; P:regulation of synaptic vesicle fusion to presynaptic active zone membrane; IMP:MGI.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IMP:MGI.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     14       {ECO:0000255}.
FT   CHAIN        15    979       Glutamate receptor ionotropic, kainate 5.
FT                                /FTId=PRO_0000011553.
FT   TOPO_DOM     15    544       Extracellular. {ECO:0000255}.
FT   TRANSMEM    545    565       Helical. {ECO:0000255}.
FT   TOPO_DOM    566    622       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    623    643       Helical. {ECO:0000255}.
FT   TOPO_DOM    644    803       Extracellular. {ECO:0000255}.
FT   TRANSMEM    804    824       Helical. {ECO:0000255}.
FT   TOPO_DOM    825    979       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    860    866       Poly-Arg.
FT   CARBOHYD    219    219       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    271    271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    285    285       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    372    372       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    394    394       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    400    400       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     36    292       {ECO:0000250}.
FT   DISULFID     83    334       {ECO:0000250}.
FT   DISULFID    165    170       {ECO:0000250}.
FT   CONFLICT    610    610       I -> V (in Ref. 1; BAA00899).
FT                                {ECO:0000305}.
SQ   SEQUENCE   979 AA;  109276 MW;  313E2862746474B1 CRC64;
     MPAELLLLLI VAFANPSCQV LSSLRMAAIL DDQTVCGRGE RLALALAREQ INGIIEVPAK
     ARVEVDIFEL QRDSQYETTD TMCQILPKGV VSVLGPSSSP ASASTVSHIC GEKEIPHIKV
     GPEETPRLQY LRFASVSLYP SNEDVSLAVS RILKSFNYPS ASLICAKAEC LLRLEELVRG
     FLISKETLSV RMLDDSRDPT PLLKEIRDDK VSTIIIDANA SISHLVLRKA SELGMTSAFY
     KYILTTMDFP ILHLDGIVED SSNILGFSMF NTSHPFYPEF VRSLNMSWRE NCEASTYPGP
     ALSAALMFDA VHVVVSAVRE LNRSQEIGVK PLACTSANIW PHGTSLMNYL RMVEYDGLTG
     RVEFNSKGQR TNYTLRILEK SRQGHREIGV WYSNRTLAMN ATTLDINLSQ TLANKTLVVT
     TILENPYVMR RPNFQALSGN ERFEGFCVDM LRELAELLRF RYRLRLVEDG LYGAPEPNGS
     WTGMVGELIN RKADLAVAAF TITAEREKVI DFSKPFMTLG ISILYRVHMG RKPGYFSFLD
     PFSPAVWLFM LLAYLAVSCV LFLAARLSPY EWYNPHPCLR ARPHILENQY TLGNSLWFPV
     GGFMQQGSEI MPRALSTRCV SGVWWAFTLI IISSYTANLA AFLTVQRMEV PVESADDLAD
     QTNIEYGTIH AGSTMTFFQN SRYQTYQRMW NYMQSKQPSV FVKSTEEGIA RVLNSRYAFL
     LESTMNEYHR RLNCNLTQIG GLLDTKGYGI GMPLGSPFRD EITLAILQLQ ENNRLEILKR
     KWWEGGRCPK EEDHRAKGLG MENIGGIFVV LICGLIIAVF VAVMEFIWST RRSAESEEVS
     VCQEMLQELR HAVSCRKTSR SRRRRRPGGP SRALLSLRAV REMRLSNGKL YSAGAGGDAG
     AHGGPQRLLD DPGPPGGPRP QAPTPCTHVR VCQECRRIQA LRASGAGAPP RGLGTPAEAT
     SPPRPRPGPT GPRELTEHE
//
ID   GRID1_MOUSE             Reviewed;        1009 AA.
AC   Q61627; Q3UUL5;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   27-SEP-2017, entry version 138.
DE   RecName: Full=Glutamate receptor ionotropic, delta-1;
DE            Short=GluD1;
DE            Short=GluR delta-1 subunit;
DE   Flags: Precursor;
GN   Name=Grid1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=ICR; TISSUE=Forebrain;
RX   PubMed=1372507; DOI=10.1016/0006-291X(92)90566-4;
RA   Yamazaki M., Araki K., Shibata A., Mishina M.;
RT   "Molecular cloning of a cDNA encoding a novel member of the mouse
RT   glutamate receptor channel family.";
RL   Biochem. Biophys. Res. Commun. 183:886-892(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Hypothalamus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   INTERACTION WITH CBLN1 AND CBLN2.
RX   PubMed=22220752; DOI=10.1111/j.1471-4159.2012.07648.x;
RA   Wei P., Pattarini R., Rong Y., Guo H., Bansal P.K., Kusnoor S.V.,
RA   Deutch A.Y., Parris J., Morgan J.I.;
RT   "The Cbln family of proteins interact with multiple signaling
RT   pathways.";
RL   J. Neurochem. 121:717-729(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 21-436, DISULFIDE BONDS,
RP   INTERACTION WITH CBLN1, MUTAGENESIS OF PHE-73, SUBUNIT, SITE, AND
RP   REGION.
RX   PubMed=27418511; DOI=10.1126/science.aae0104;
RA   Elegheert J., Kakegawa W., Clay J.E., Shanks N.F., Behiels E.,
RA   Matsuda K., Kohda K., Miura E., Rossmann M., Mitakidis N.,
RA   Motohashi J., Chang V.T., Siebold C., Greger I.H., Nakagawa T.,
RA   Yuzaki M., Aricescu A.R.;
RT   "Structural basis for integration of GluD receptors within synaptic
RT   organizer complexes.";
RL   Science 353:295-299(2016).
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists.
CC   -!- SUBUNIT: Dimer (PubMed:27418511). Interacts (via extracellular N-
CC       terminal domain) with CBLN1 (via C1q domain), and more weakly with
CC       CBLN2 (PubMed:22220752, PubMed:27418511).
CC       {ECO:0000269|PubMed:22220752, ECO:0000269|PubMed:27418511}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Equally in forebrain and cerebellum.
CC       {ECO:0000269|PubMed:1372507}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRID1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D10171; BAA01041.1; -; mRNA.
DR   EMBL; AK138279; BAE23610.1; -; mRNA.
DR   EMBL; CT009532; CAX15538.1; -; Genomic_DNA.
DR   EMBL; AC114572; CAX15538.1; JOINED; Genomic_DNA.
DR   EMBL; AC154388; CAX15538.1; JOINED; Genomic_DNA.
DR   EMBL; AC154730; CAX15538.1; JOINED; Genomic_DNA.
DR   EMBL; AC163280; CAX15538.1; JOINED; Genomic_DNA.
DR   EMBL; AC169510; CAX15538.1; JOINED; Genomic_DNA.
DR   EMBL; CT030647; CAX15538.1; JOINED; Genomic_DNA.
DR   EMBL; CT030647; CAX15982.1; -; Genomic_DNA.
DR   EMBL; AC114572; CAX15982.1; JOINED; Genomic_DNA.
DR   EMBL; AC154388; CAX15982.1; JOINED; Genomic_DNA.
DR   EMBL; AC154730; CAX15982.1; JOINED; Genomic_DNA.
DR   EMBL; AC163280; CAX15982.1; JOINED; Genomic_DNA.
DR   EMBL; AC169510; CAX15982.1; JOINED; Genomic_DNA.
DR   EMBL; CT009532; CAX15982.1; JOINED; Genomic_DNA.
DR   EMBL; CH466573; EDL24889.1; -; Genomic_DNA.
DR   CCDS; CCDS26944.1; -.
DR   PIR; JH0266; JH0266.
DR   RefSeq; NP_032192.2; NM_008166.2.
DR   UniGene; Mm.121569; -.
DR   UniGene; Mm.413604; -.
DR   UniGene; Mm.483550; -.
DR   PDB; 5KC9; X-ray; 2.30 A; A/B/C=21-436.
DR   PDBsum; 5KC9; -.
DR   ProteinModelPortal; Q61627; -.
DR   SMR; Q61627; -.
DR   IntAct; Q61627; 1.
DR   MINT; MINT-1791814; -.
DR   STRING; 10090.ENSMUSP00000044009; -.
DR   iPTMnet; Q61627; -.
DR   PhosphoSitePlus; Q61627; -.
DR   MaxQB; Q61627; -.
DR   PaxDb; Q61627; -.
DR   PeptideAtlas; Q61627; -.
DR   PRIDE; Q61627; -.
DR   DNASU; 14803; -.
DR   Ensembl; ENSMUST00000043349; ENSMUSP00000044009; ENSMUSG00000041078.
DR   GeneID; 14803; -.
DR   KEGG; mmu:14803; -.
DR   UCSC; uc007tbj.1; mouse.
DR   CTD; 2894; -.
DR   MGI; MGI:95812; Grid1.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG410XQQV; LUCA.
DR   GeneTree; ENSGT00760000118920; -.
DR   HOGENOM; HOG000264260; -.
DR   HOVERGEN; HBG051840; -.
DR   InParanoid; Q61627; -.
DR   KO; K05206; -.
DR   OMA; KDSHWVY; -.
DR   OrthoDB; EOG091G010L; -.
DR   TreeFam; TF352434; -.
DR   ChiTaRS; Grid1; mouse.
DR   PRO; PR:Q61627; -.
DR   Proteomes; UP000000589; Chromosome 14.
DR   Bgee; ENSMUSG00000041078; -.
DR   CleanEx; MM_GRID1; -.
DR   Genevisible; Q61627; MM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0035176; P:social behavior; IMP:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21   1009       Glutamate receptor ionotropic, delta-1.
FT                                /FTId=PRO_0000011562.
FT   TOPO_DOM     21    562       Extracellular. {ECO:0000255}.
FT   TRANSMEM    563    583       Helical. {ECO:0000255}.
FT   TOPO_DOM    584    637       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    638    658       Helical. {ECO:0000255}.
FT   TOPO_DOM    659    830       Extracellular. {ECO:0000255}.
FT   TRANSMEM    831    851       Helical. {ECO:0000255}.
FT   TOPO_DOM    852   1009       Cytoplasmic. {ECO:0000255}.
FT   REGION       21    436       Interaction with CBLN1.
FT                                {ECO:0000269|PubMed:27418511}.
FT   SITE         73     73       Essential for dimerization.
FT                                {ECO:0000269|PubMed:27418511}.
FT   MOD_RES     882    882       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61625}.
FT   MOD_RES    1008   1008       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63226}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    422    422       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    498    498       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     80    351       {ECO:0000244|PDB:5KC9,
FT                                ECO:0000269|PubMed:27418511}.
FT   DISULFID     96    128       {ECO:0000244|PDB:5KC9,
FT                                ECO:0000269|PubMed:27418511}.
FT   DISULFID    294    306       {ECO:0000244|PDB:5KC9,
FT                                ECO:0000269|PubMed:27418511}.
FT   MUTAGEN      73     73       F->D: Abolishes dimerization. Weakly
FT                                interacts with C1q domain of CBLN1.
FT                                {ECO:0000269|PubMed:27418511}.
FT   CONFLICT    178    178       L -> F (in Ref. 1; BAA01041).
FT                                {ECO:0000305}.
FT   STRAND       23     33       {ECO:0000244|PDB:5KC9}.
FT   HELIX        35     51       {ECO:0000244|PDB:5KC9}.
FT   STRAND       53     55       {ECO:0000244|PDB:5KC9}.
FT   STRAND       59     67       {ECO:0000244|PDB:5KC9}.
FT   HELIX        72     84       {ECO:0000244|PDB:5KC9}.
FT   STRAND       90     93       {ECO:0000244|PDB:5KC9}.
FT   HELIX        96    109       {ECO:0000244|PDB:5KC9}.
FT   STRAND      113    115       {ECO:0000244|PDB:5KC9}.
FT   STRAND      140    142       {ECO:0000244|PDB:5KC9}.
FT   HELIX       149    159       {ECO:0000244|PDB:5KC9}.
FT   STRAND      163    169       {ECO:0000244|PDB:5KC9}.
FT   HELIX       175    178       {ECO:0000244|PDB:5KC9}.
FT   HELIX       179    187       {ECO:0000244|PDB:5KC9}.
FT   STRAND      191    196       {ECO:0000244|PDB:5KC9}.
FT   HELIX       201    211       {ECO:0000244|PDB:5KC9}.
FT   HELIX       214    223       {ECO:0000244|PDB:5KC9}.
FT   STRAND      226    231       {ECO:0000244|PDB:5KC9}.
FT   HELIX       233    245       {ECO:0000244|PDB:5KC9}.
FT   STRAND      254    258       {ECO:0000244|PDB:5KC9}.
FT   HELIX       264    273       {ECO:0000244|PDB:5KC9}.
FT   STRAND      275    283       {ECO:0000244|PDB:5KC9}.
FT   TURN        291    294       {ECO:0000244|PDB:5KC9}.
FT   TURN        304    306       {ECO:0000244|PDB:5KC9}.
FT   TURN        310    312       {ECO:0000244|PDB:5KC9}.
FT   HELIX       313    315       {ECO:0000244|PDB:5KC9}.
FT   HELIX       318    339       {ECO:0000244|PDB:5KC9}.
FT   STRAND      351    353       {ECO:0000244|PDB:5KC9}.
FT   HELIX       362    370       {ECO:0000244|PDB:5KC9}.
FT   STRAND      373    376       {ECO:0000244|PDB:5KC9}.
FT   STRAND      379    382       {ECO:0000244|PDB:5KC9}.
FT   STRAND      393    402       {ECO:0000244|PDB:5KC9}.
FT   TURN        403    405       {ECO:0000244|PDB:5KC9}.
FT   STRAND      406    416       {ECO:0000244|PDB:5KC9}.
FT   TURN        417    419       {ECO:0000244|PDB:5KC9}.
FT   STRAND      420    423       {ECO:0000244|PDB:5KC9}.
SQ   SEQUENCE   1009 AA;  112210 MW;  143243A1E3EBD660 CRC64;
     MEALTLWLLP WICQCVTVRA DSIIHIGAIF EENAAKDDRV FQLAVSDLSL NDDILQSEKI
     TYSIKVIEAN NPFQAVQEAC DLMTQGILAL VTSTGCASAN ALQSLTDAMH IPHLFVQRNP
     GGSPRTACHL NPSPDGEAYT LASRPPVRLN DVMLRLVTEL RWQKFVMFYD SEYDIRGLQS
     FLDQASRLGL DVSLQKVDKN ISHVFTSLFT TMKTEELNRY RDTLRRAILL LSPQGAHSFI
     NEAVETNLAS KDSHWVFVNE EISDPEILDL VHSALGRMTV VRQIFPSAKD NQKCMRNNHR
     ISSLLCDPQE GYLQMLQISN LYLYDSVLML ANAFHRKLED RKWHSMASLN CIRKSTKPWN
     GGRSMLDTIK KGHITGLTGV MEFREDSSNP YVQFEILGTT YSETFGKDMR KLATWDSEKG
     LNGSLQERPM GSRLQGLTLK VVTVLEEPFV MVAENILGQP KRYKGFSIDV LDALAKALGF
     KYEIYQAPDG RYGHQLHNTS WNGMIGELIS KRADLAISAI TITPERESVV DFSKRYMDYS
     VGILIKKPEE KISIFSLFAP FDFAVWACIA AAIPVVGVLI FVLNRIQAVR SQSATQPRPS
     ASATLHSAIW IVYGAFVQQG GESSVNSVAM RIVMGSWWLF TLIVCSSYTA NLAAFLTVSR
     MDNPIRTFQD LSKQLEMSYG TVRDSAVYEY FRAKGTNPLE QDSTFAELWR TISKNGGADN
     CVSNPSEGIR KAKKGNYAFL WDVAVVEYAA LTDDDCSVTV IGNSISSKGY GIALQHGSPY
     RDLFSQRILE LQDTGDLDVL KQKWWPHTGR CDLTSHSSTQ TEGKSLKLHS FAGVFCILAI
     GLLLACLVAA LELWWNSNRC HQETPKEDKE VNLEQVHRRI NSLMDEDIAH KQISPASIEL
     SALEMGGLAP SQALEPTREY QNTQLSVSTF LPEQSSHGTS RTLSSGPSSN LPLPLSSSAT
     MPSIQCKHRS PNGGLFRQSP VKTPIPMSFQ PVPGGVLPEA LDTSHGTSI
//
ID   ITPR3_RAT               Reviewed;        2670 AA.
AC   Q63269;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   20-DEC-2017, entry version 157.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor type 3;
DE   AltName: Full=IP3 receptor isoform 3;
DE            Short=IP3R 3;
DE            Short=InsP3R3;
DE   AltName: Full=Type 3 inositol 1,4,5-trisphosphate receptor;
DE            Short=Type 3 InsP3 receptor;
GN   Name=Itpr3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8388391;
RA   Blondel O., Takeda J., Janssen H., Seino S., Bell G.I.;
RT   "Sequence and functional characterization of a third inositol
RT   trisphosphate receptor subtype, IP3R-3, expressed in pancreatic
RT   islets, kidney, gastrointestinal tract, and other tissues.";
RL   J. Biol. Chem. 268:11356-11363(1993).
RN   [2]
RP   INTERACTION WITH SIGMAR1.
RX   PubMed=11149946; DOI=10.1073/pnas.98.2.491;
RA   Hayashi T., Su T.-P.;
RT   "Regulating ankyrin dynamics: roles of sigma-1 receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:491-496(2001).
RN   [3]
RP   INTERACTION WITH CABP1.
RX   PubMed=12032348; DOI=10.1073/pnas.102006299;
RA   Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K.,
RA   Haeseleer F., Foskett J.K.;
RT   "Identification of a family of calcium sensors as protein ligands of
RT   inositol trisphosphate receptor Ca(2+) release channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-934 AND SER-2669, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A.,
RA   Lundby C., Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14
RT   different rat organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   INTERACTION WITH BOK.
RX   PubMed=23884412; DOI=10.1074/jbc.M113.496570;
RA   Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.;
RT   "The Bcl-2 protein family member Bok binds to the coupling domain of
RT   inositol 1,4,5-trisphosphate receptors and protects them from
RT   proteolytic cleavage.";
RL   J. Biol. Chem. 288:25340-25349(2013).
CC   -!- FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second
CC       messenger that mediates the release of intracellular calcium.
CC   -!- SUBUNIT: Homotetramer. Interacts with TRPC1, TRPC3, TRPC4.
CC       Interacts with TRPV4 (By similarity). Interacts with SIGMAR1
CC       (PubMed:11149946). Interacts with AKT1 and PML. Interacts with
CC       LRMP (via coiled-coil domain) (By similarity). Interacts with
CC       CABP1 (PubMed:12032348). Interacts with TMBIM4/LFG4 (By
CC       similarity). Interacts with CEMIP (By similarity). Interacts with
CC       TESPA1 (By similarity). Interacts with TMEM203 (By similarity).
CC       Interacts with BOK; regulates ITPR3 expression (PubMed:23884412).
CC       {ECO:0000250|UniProtKB:P70227, ECO:0000250|UniProtKB:Q14573,
CC       ECO:0000269|PubMed:11149946, ECO:0000269|PubMed:12032348,
CC       ECO:0000269|PubMed:23884412}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC   -!- PTM: Phosphorylated on tyrosine residues. Phosphorylated by AKT1
CC       on serine and/or threonine residues (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L06096; AAA41446.1; -; mRNA.
DR   PIR; A46719; A46719.
DR   RefSeq; NP_037270.1; NM_013138.1.
DR   UniGene; Rn.11242; -.
DR   ProteinModelPortal; Q63269; -.
DR   BioGrid; 247708; 2.
DR   CORUM; Q63269; -.
DR   IntAct; Q63269; 1.
DR   STRING; 10116.ENSRNOP00000011516; -.
DR   ChEMBL; CHEMBL2846; -.
DR   TCDB; 1.A.3.2.5; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q63269; -.
DR   PhosphoSitePlus; Q63269; -.
DR   PaxDb; Q63269; -.
DR   PRIDE; Q63269; -.
DR   GeneID; 25679; -.
DR   KEGG; rno:25679; -.
DR   UCSC; RGD:2934; rat.
DR   CTD; 3710; -.
DR   RGD; 2934; Itpr3.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   HOGENOM; HOG000007660; -.
DR   HOVERGEN; HBG052158; -.
DR   InParanoid; Q63269; -.
DR   KO; K04960; -.
DR   PhylomeDB; Q63269; -.
DR   PRO; PR:Q63269; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0005903; C:brush border; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043209; C:myelin sheath; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005640; C:nuclear outer membrane; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; TAS:RGD.
DR   GO; GO:0015278; F:calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; IDA:RGD.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:RGD.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:RGD.
DR   GO; GO:0000822; F:inositol hexakisphosphate binding; IDA:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:RGD.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:RGD.
DR   GO; GO:0051592; P:response to calcium ion; ISO:RGD.
DR   GO; GO:0050913; P:sensory perception of bitter taste; ISO:RGD.
DR   GO; GO:0050916; P:sensory perception of sweet taste; ISO:RGD.
DR   GO; GO:0050917; P:sensory perception of umami taste; ISO:RGD.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Complete proteome;
KW   Endoplasmic reticulum; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   2670       Inositol 1,4,5-trisphosphate receptor
FT                                type 3.
FT                                /FTId=PRO_0000153930.
FT   TOPO_DOM      1   2201       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2202   2222       Helical. {ECO:0000255}.
FT   TOPO_DOM   2223   2233       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2234   2254       Helical. {ECO:0000255}.
FT   TOPO_DOM   2255   2263       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2264   2284       Helical. {ECO:0000255}.
FT   TOPO_DOM   2285   2324       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2325   2345       Helical. {ECO:0000255}.
FT   TOPO_DOM   2346   2367       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2368   2388       Helical. {ECO:0000255}.
FT   TOPO_DOM   2389   2495       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2496   2516       Helical. {ECO:0000255}.
FT   TOPO_DOM   2517   2670       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      113    173       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      174    224       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      232    288       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      295    372       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      378    434       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      266    270       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      507    510       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      567    569       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   MOD_RES     916    916       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES     934    934       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
FT   MOD_RES    1152   1152       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70227}.
FT   MOD_RES    1813   1813       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    1832   1832       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    1834   1834       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    2608   2608       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q14573}.
FT   MOD_RES    2669   2669       Phosphoserine.
FT                                {ECO:0000244|PubMed:22673903}.
SQ   SEQUENCE   2670 AA;  304286 MW;  13C787E4C2886E45 CRC64;
     MNEMSSFLHI GDIVSLYAEG SVNGFISTLG LVDDRCVVEP AAGDLDNPPK KFRDCLFKVC
     PMNRYSAQKQ YWKAKQTKQD KEKIADVVLL QKLQHAAQME QKQNDTENKK VHGDVVKYGS
     VIQLLHMKSN KYLTVNKRLP ALLEKNAMRV TLDATGNEGS WLFIQPFWKL RSNGDNVVVG
     DKVILNPVNA GQPLHASNYE LSDNVGCKEV NSVNCNTSWK INLFMQFRDH LEEVLKGGDV
     VRLFHAEQEK FLTCDEYRGK LQVFLRTTLR QSATSATSSN ALWEVEVVHH DPCRGGAGHW
     NGLYRFKHLA TGNYLAAEEN PSYKGDVSDP KAAGPGAQSR TGRRNAGEKI KYRLVAVPHG
     NDIASLFELD PTTLQKTDSF VPRNSYVRLR HLCTNTWIQS TNAPIDVEEE RPIRLMLGTC
     PTKEDKEAFA IVSVPVSEIR DLDFANDASS MLASAVEKLN EGFISQNDRR FVIQLLEDLV
     FFVSDVPNNG QNVLDIMVTK PNRERQKLMR DENILKQIFG ILKAPFRDKG GEGPLVRLEE
     LSDQKNAPYQ YMFRLCYRVL RHSQEDYRKN QEHIAKQFGM MQSQIGYDIL AEDTITALLH
     NNRKLLEKHI TKTEVETFVS LVRKNREPRF LDYLSDLCVS NRIAIPVTQE LICKCVLDPK
     NSDILIQTEL RPVKEMAQSH EYLSIEYSEE EVWLTWTDRN NEHHEKSVRQ LAQEARAGNA
     HDENVLSYYR YQLKLFARMC LDRQYLAIDE ISKQLGVELL FLCMADEMLP FDLRASFCHL
     MLHVHVDRDP QELVTPVKFA RLWTEIPTAI TIKDYDSNLN ASRDDKKNKF ASTMEFVEDY
     LNNVVGEAVP FANDEKNILT FEVVSLAHNL IYFGFYSFSE LLRLTRTLLG IIDCIQAPAA
     VLQAYEEPGG KNVRRSIQGV GHMMSTMVLS RKQSVFGASS LPTGVGVPEQ LDRSKFEDNE
     HTVVMETKLK ILEILQFILN VRLDYRISYL LSVFKKEFVE VFPMQDSGAD GTAPAFDSST
     ANMNLDRIGE QAEAMFGVGK TSSMLEVDDE GGRMFLRVLL HLTMHDYPPL VSGALQLLFK
     HFSQRQEAMH TFKQVQLLIS AQDVENYKVI KSELDRLRTM VEKSELWVDK KGSVKGEEGE
     AGASKDKKER PSDEEGFLQP HGEKSSENYQ IVKGILERLN KMCGVGEQMR KKQQRLLKNM
     DAHKVMLDLL QIPYDKNDNK MMEILRYTHQ FLQKFCAGNP GNQALLHKHL QLFLTPGLLE
     AETMQHIFLN NYQLCSEISE PVLQHFVHCW PTHGRHVQYL DFLHTVIKAE GKYVKKCQDM
     IMTELTNAGD DVVVFYNDKA SLAHLLDMMK AARDGVEDHS PLMYHISLVD LLAACAEGKN
     VYTEIKCTSL LPLEDVVSVV THEDCITEVK MAYVNFVNHC YVDTEVEMKE IYTSNHIWTL
     FENFTLDMAL VCNKREKRLS DPTLEKYVLT VVLDTISAFF SSPFSENSTS LQTHQTIVVQ
     LLQSTTRLLE CPWLQQQHKG SVEACVRTLA MVAKSRAILL PMDLDAHMSA LLSSGGSCSA
     AAQRSAANYK TATRTFPRVI PTANQWDYKN IIEKLQDIIT ALEERLKPLV QAELSVLVDM
     LHWPELLFLE GSEAYQRCES GGFLSKLIRH TKGLMESEEK LCVKVLRTLQ QMLQKKSKYG
     DRGNQLRKML LQNYLQNRKS GPRGELTDPT GSGVDQDWSA IAATQCRLDK EGATKLVCDL
     ITSTKNEKIF QESIGLAIRL LDGGNTEIQK SFYNLMTSDK KSERFFKVLH DRMKRAQQET
     KSTVAVNMSD LGSQPREDRE PADPTTKGRV SSFSMPSSSR YSLGPGLHRG HDVSERAQNN
     EMGTSVLIMR PILRFLQLLC ENHNRDLQNF LRCQNNKTNY NLVCETLQFL DIMCGSTTGG
     LGLLGLYINE DNVGLVIQTL ETLTEYCQGP CHENQTCIVT HESNGIDIIT ALILNDISPL
     CKYRMDLVLQ LKDNASKLLL ALMESRHDSE NAERILISLR PQELVDVIKK AYLQEEEREN
     SEVSPREVGH NIYILALQLS RHNKQLQHLL KPVKRIQEEE AEGISSMLSL NNKQLSQMLK
     SSAPAQEEEE DPLAYYENHT SQIEIVRQDR SMEQIVFPVP AICQFLTEET KHRLFTTTEQ
     DEQGSKVSDF FDQSSFLHNE MEWQRRLRSM PLIYWFSRRM TLWGSISFNL AVFINIIIAF
     FYPYVEGAST GVLGSPLISL LFWILICFSI AALFTKHYSV RPLIVALVLR SIYYLGIGPT
     LNILGALNLT NKIVFVVSFV GNRGTFIRGY KAMVMDMEFL YHVGYILTSV LGLFAHELFY
     SILLFDLIYR EETLFNVIKS VTRNGRSILL TALLALILVY LFSIVGFLFL KDDFILEVDR
     LPGNHSRAST LGMPHGAATF MGTCSGDKMD CVSEVSVPEI LEEDEELDST ERACDTLLMC
     IVTVMNHGLR NGGGVGDILR KPSKDESLFP ARVVYDLLFF FIVIIIVLNL IFGVIIDTFA
     DLRSEKQKKE EILKTTCFIC GLERDKFDNK TVSFEEHIKL EHNMWNYLYF IVLVRVKNKT
     DYTGPESYVA QMIKNKNLDW FPRMRAMSLV SGEGEGEQNE IRILQEKLGS TMKLVSHLTA
     QLNELKEQMT EQRKRRQRLG FVDVQNCMSR
//
ID   CNGA4_RAT               Reviewed;         575 AA.
AC   Q64359; Q6Q2I4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 123.
DE   RecName: Full=Cyclic nucleotide-gated cation channel alpha-4;
DE   AltName: Full=Cyclic nucleotide-gated channel alpha-4;
DE            Short=CNG channel alpha-4;
DE            Short=CNG-4;
DE            Short=CNG4;
DE   AltName: Full=Cyclic nucleotide-gated olfactory channel subunit OCNC2;
GN   Name=Cnga4; Synonyms=Cgn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=7522325; DOI=10.1073/pnas.91.19.8890;
RA   Bradley J., Li J., Davidson N., Lester H.A., Zinn K.;
RT   "Heteromeric olfactory cyclic nucleotide-gated channels: a subunit
RT   that confers increased sensitivity to cAMP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:8890-8894(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Olfactory neuroepithelium;
RX   PubMed=7522482; DOI=10.1016/0896-6273(94)90029-9;
RA   Liman E.R., Buck L.B.;
RT   "A second subunit of the olfactory cyclic nucleotide-gated channel
RT   confers high sensitivity to cAMP.";
RL   Neuron 13:611-621(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-191.
RC   STRAIN=Sprague-Dawley;
RA   Lozach A., Castel H.L.N., Garrel G., Vaudry H., Counis R.;
RT   "Characterization and functional expression of cyclic nucleotide-gated
RT   channels in rat pituitary gonadotrophs.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 7-35.
RC   STRAIN=Sprague-Dawley;
RA   Bradley J., Zhang Y., Bakin R., Lester H.A., Ronnett G., Zinn K.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   ENZYME REGULATION.
RX   PubMed=15195096; DOI=10.1038/nn1266;
RA   Bradley J., Boenigk W., Yau K.-W., Frings S.;
RT   "Calmodulin permanently associates with rat olfactory CNG channels
RT   under native conditions.";
RL   Nat. Neurosci. 7:705-710(2004).
RN   [6]
RP   SUBUNITS.
RX   PubMed=15134638; DOI=10.1016/S0896-6273(04)00253-3;
RA   Zheng J., Zagotta W.N.;
RT   "Stoichiometry and assembly of olfactory cyclic nucleotide-gated
RT   channels.";
RL   Neuron 42:411-421(2004).
CC   -!- FUNCTION: Second messenger, cAMP, causes the opening of cation-
CC       selective cyclic nucleotide-gated (CNG) channels and
CC       depolarization of the neuron (olfactory sensory neurons, OSNs).
CC       CNGA4 is the modulatory subunit of this channel which is known to
CC       play a central role in the transduction of odorant signals and
CC       subsequent adaptation. By accelerating the calcium-mediated
CC       negative feedback in olfactory signaling it allows rapid
CC       adaptation to odor stimulation and extends its range of odor
CC       detection (By similarity). {ECO:0000250}.
CC   -!- ENZYME REGULATION: Calcium-calmodulin exerts its inhibitory effect
CC       in cAMP sensitivity by binding to IQ-like motif of CNGA4 and
CC       preferably binds to the channel in the closed state. Inhibition by
CC       PIP3 of the CNG channel probably occurs via CGNA2 binding.
CC       {ECO:0000269|PubMed:15195096}.
CC   -!- SUBUNIT: Heterotetramer composed of two subunits of CNGA2, one of
CC       CNGA4 and one of CNGB1b. The complex forms the cyclic nucleotide-
CC       gated (CNG) channel of olfactory sensory neurons.
CC       {ECO:0000269|PubMed:15134638}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Olfactory neurons.
CC   -!- DOMAIN: The C-terminal coiled-coil domain mediates trimerization
CC       of CNGA subunits. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGA4 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U12623; AAA21464.1; -; mRNA.
DR   EMBL; U12425; AAA64748.1; -; mRNA.
DR   EMBL; AY564233; AAS87325.1; -; Genomic_DNA.
DR   EMBL; U76219; AAC17596.1; -; Genomic_DNA.
DR   PIR; I59327; I59327.
DR   RefSeq; NP_445948.2; NM_053496.2.
DR   UniGene; Rn.91104; -.
DR   ProteinModelPortal; Q64359; -.
DR   SMR; Q64359; -.
DR   DIP; DIP-61290N; -.
DR   IntAct; Q64359; 1.
DR   STRING; 10116.ENSRNOP00000023751; -.
DR   PaxDb; Q64359; -.
DR   PRIDE; Q64359; -.
DR   GeneID; 85258; -.
DR   KEGG; rno:85258; -.
DR   UCSC; RGD:619844; rat.
DR   CTD; 1262; -.
DR   RGD; 619844; Cnga4.
DR   eggNOG; KOG0500; Eukaryota.
DR   eggNOG; ENOG410YWWI; LUCA.
DR   HOGENOM; HOG000007898; -.
DR   HOVERGEN; HBG000281; -.
DR   InParanoid; Q64359; -.
DR   KO; K04951; -.
DR   PhylomeDB; Q64359; -.
DR   PRO; PR:Q64359; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0017071; C:intracellular cyclic nucleotide activated cation channel complex; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IDA:RGD.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:RGD.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:RGD.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; IDA:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007608; P:sensory perception of smell; ISO:RGD.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032406; CLZ_dom.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF16526; CLZ; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   cAMP; cAMP-binding; Coiled coil; Complete proteome; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Olfaction; Reference proteome; Sensory transduction; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    575       Cyclic nucleotide-gated cation channel
FT                                alpha-4.
FT                                /FTId=PRO_0000219322.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM     55     65       Extracellular. {ECO:0000255}.
FT   TRANSMEM     66     86       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM     87    112       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    134    168       Extracellular. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    190    218       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    240    244       Extracellular. {ECO:0000255}.
FT   TRANSMEM    245    265       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    266    575       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     348    471       cNMP.
FT   COILED      493    536       {ECO:0000250}.
FT   MOTIF       292    302       IQ-type. {ECO:0000250}.
SQ   SEQUENCE   575 AA;  65675 MW;  FCF01C563214F575 CRC64;
     MSQDGKVKTT ESTPPAPTKA RKWLPVLDPS GDYYYWWLNT MVFPIMYNLI IVVCRACFPD
     LQHSYLVAWF VLDYTSDLLY LLDIGVRFHT GFLEQGILVV DKGMIASRYV RTWSFLLDLA
     SLVPTDAAYV QLGPHIPTLR LNRFLRVPRL FEAFDRTETR TAYPNAFRIA KLMLYIFVVI
     HWNSCLYFAL SRYLGFGRDA WVYPDPAQPG FERLRRQYLY SFYFSTLILT TVGDTPLPDR
     EEEYLFMVGD FLLAVMGFAT IMGSMSSVIY NMNTADAAFY PDHALVKKYM KLQHVNKRLE
     RRVIDWYQHL QINKKMTNEV AILQHLPERL RAEVAVSVHL STLSRVQIFQ NCEASLLEEL
     VLKLQPQTYS PGEYVCRKGD IGREMYIIRE GQLAVVADDG VTQYAVLGAG LYFGEISIIN
     IKGNMSGNRR TANIKSLGYS DLFCLSKEDL REVLSEYPQA QAVMEEKGRE ILLKMNKLDV
     NAEAAEIALQ EATESRLKGL DQQLDDLQTK FARLLAELES SALKIAYRIE RLEWQTREWP
     MPEDMGEADD EAEPGEGTSK DGEGKAGQAG PSGIE
//
ID   5HT3D_HUMAN             Reviewed;         454 AA.
AC   Q70Z44; C9J2I6; J3QT78; Q495N5; Q495N6; Q7Z6B3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 3.
DT   20-DEC-2017, entry version 131.
DE   RecName: Full=5-hydroxytryptamine receptor 3D;
DE            Short=5-HT3-D;
DE            Short=5-HT3D;
DE   AltName: Full=Serotonin receptor 3D;
DE   Flags: Precursor;
GN   Name=HTR3D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12801637; DOI=10.1016/S0378-1119(03)00503-1;
RA   Niesler B., Frank B., Kapeller J., Rappold G.A.;
RT   "Cloning, physical mapping and expression analysis of the human 5-HT3
RT   serotonin receptor-like genes HTR3C, HTR3D and HTR3E.";
RL   Gene 310:101-111(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBUNIT, SUBCELLULAR LOCATION,
RP   AND VARIANT GLY-171.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANTS HIS-225 AND HIS-435.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex. {ECO:0000269|PubMed:17392525}.
CC   -!- INTERACTION:
CC       P46098:HTR3A; NbExp=5; IntAct=EBI-9008717, EBI-9008743;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17392525};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:17392525}.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q70Z44-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q70Z44-2; Sequence=VSP_029798, VSP_029799, VSP_029801;
CC       Name=3;
CC         IsoId=Q70Z44-3; Sequence=VSP_029797, VSP_029800, VSP_029801;
CC       Name=4;
CC         IsoId=Q70Z44-4; Sequence=VSP_044828, VSP_044829, VSP_044830,
CC                                  VSP_029801;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in liver, as well as fetal and adult
CC       colon and kidney. {ECO:0000269|PubMed:12801637}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3D
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ437318; CAD24817.1; -; mRNA.
DR   EMBL; AY159812; AAO38166.2; -; mRNA.
DR   EMBL; AC068644; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131235; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101090; AAI01091.1; -; mRNA.
DR   EMBL; BC101091; AAI01092.1; -; mRNA.
DR   CCDS; CCDS3249.1; -. [Q70Z44-2]
DR   CCDS; CCDS46966.1; -. [Q70Z44-4]
DR   CCDS; CCDS54685.1; -. [Q70Z44-1]
DR   RefSeq; NP_001138615.1; NM_001145143.1. [Q70Z44-4]
DR   RefSeq; NP_001157118.1; NM_001163646.1. [Q70Z44-1]
DR   RefSeq; NP_872343.2; NM_182537.2.
DR   RefSeq; XP_016861343.1; XM_017005854.1. [Q70Z44-3]
DR   UniGene; Hs.448004; -.
DR   ProteinModelPortal; Q70Z44; -.
DR   BioGrid; 128355; 4.
DR   IntAct; Q70Z44; 1.
DR   STRING; 9606.ENSP00000371929; -.
DR   BindingDB; Q70Z44; -.
DR   ChEMBL; CHEMBL2094132; -.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB13025; Tiapride.
DR   TCDB; 1.A.9.2.3; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   iPTMnet; Q70Z44; -.
DR   PhosphoSitePlus; Q70Z44; -.
DR   BioMuta; HTR3D; -.
DR   DMDM; 338817899; -.
DR   PaxDb; Q70Z44; -.
DR   PeptideAtlas; Q70Z44; -.
DR   PRIDE; Q70Z44; -.
DR   Ensembl; ENST00000382489; ENSP00000371929; ENSG00000186090. [Q70Z44-1]
DR   Ensembl; ENST00000428798; ENSP00000405409; ENSG00000186090. [Q70Z44-4]
DR   Ensembl; ENST00000453435; ENSP00000389268; ENSG00000186090. [Q70Z44-3]
DR   GeneID; 200909; -.
DR   KEGG; hsa:200909; -.
DR   UCSC; uc010hxp.4; human. [Q70Z44-1]
DR   CTD; 200909; -.
DR   DisGeNET; 200909; -.
DR   EuPathDB; HostDB:ENSG00000186090.10; -.
DR   GeneCards; HTR3D; -.
DR   HGNC; HGNC:24004; HTR3D.
DR   MIM; 610122; gene.
DR   neXtProt; NX_Q70Z44; -.
DR   OpenTargets; ENSG00000186090; -.
DR   PharmGKB; PA134866755; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; Q70Z44; -.
DR   KO; K04819; -.
DR   OMA; IWYNPFI; -.
DR   OrthoDB; EOG091G0DE5; -.
DR   PhylomeDB; Q70Z44; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; HTR3D; -.
DR   GenomeRNAi; 200909; -.
DR   PRO; PR:Q70Z44; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000186090; -.
DR   CleanEx; HS_HTR3D; -.
DR   ExpressionAtlas; Q70Z44; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IDA:CACAO.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    454       5-hydroxytryptamine receptor 3D.
FT                                /FTId=PRO_0000312293.
FT   TOPO_DOM     25    232       Extracellular. {ECO:0000255}.
FT   TRANSMEM    233    253       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    254    264       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    265    285       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    286    306       Extracellular. {ECO:0000255}.
FT   TRANSMEM    307    327       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    328    431       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    432    452       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    453    454       Extracellular. {ECO:0000255}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    219       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029797.
FT   VAR_SEQ       1    135       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17392525}.
FT                                /FTId=VSP_029798.
FT   VAR_SEQ       1     37       MQKHSPGPPALALLSQSLLTTGNGDTLIINCPGFGQH ->
FT                                MERGWFHGKGFLLGFILHLLLQDSHLQLVTSFLWLNM (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_044828.
FT   VAR_SEQ      38     98       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_044829.
FT   VAR_SEQ     171    171       A -> GERSPSALSPTQVT (in isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_044830.
FT   VAR_SEQ     172    220       RAWRRMSRSFQIHHRTSFRTRREWVLLGIQKRTIKVTVATN
FT                                QYEQAIFH -> ERSPSALSPTQ (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17392525}.
FT                                /FTId=VSP_029799.
FT   VAR_SEQ     220    220       H -> M (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029800.
FT   VAR_SEQ     295    306       APLALMQTPLPA -> RPHPSRDQKR (in isoform 2,
FT                                isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17392525}.
FT                                /FTId=VSP_029801.
FT   VARIANT     171    171       A -> G (in dbSNP:rs6443930).
FT                                {ECO:0000269|PubMed:17392525}.
FT                                /FTId=VAR_037478.
FT   VARIANT     225    225       R -> H (in dbSNP:rs1000952).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037479.
FT   VARIANT     435    435       R -> H (in dbSNP:rs6789754).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_037480.
FT   CONFLICT    155    155       S -> P (in Ref. 4; AAI01092).
FT                                {ECO:0000305}.
FT   CONFLICT    368    368       K -> R (in Ref. 2; AAO38166).
FT                                {ECO:0000305}.
SQ   SEQUENCE   454 AA;  50191 MW;  8B12F6CC31C4446C CRC64;
     MQKHSPGPPA LALLSQSLLT TGNGDTLIIN CPGFGQHRVD PAAFQAVFDR KAIGPVTNYS
     VATHVNISFT LSAIWNCYSR IHTFNCHHAR PWHNQFVQWN PDECGGIKKS GMATENLWLS
     DVFIEESVDQ TPAGLMASMS IVKATSNTIS QCGWSASANW TPSISPSMDR ARAWRRMSRS
     FQIHHRTSFR TRREWVLLGI QKRTIKVTVA TNQYEQAIFH VAIRRRCRPS PYVVNFLVPS
     GILIAIDALS FYLPLESGNC APFKMTVLLG YSVFLLMMND LLPATSTSSH ASLVAPLALM
     QTPLPAGVYF ALCLSLMVGS LLETIFITHL LHVATTQPLP LPRWLHSLLL HCTGQGRCCP
     TAPQKGNKGP GLTPTHLPGV KEPEVSAGQM PGPGEAELTG GSEWTRAQRE HEAQKQHSVE
     LWVQFSHAMD ALLFRLYLLF MASSIITVIC LWNT
//
ID   GLIC_GLOVI              Reviewed;         359 AA.
AC   Q7NDN8;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 1.
DT   20-DEC-2017, entry version 94.
DE   RecName: Full=Proton-gated ion channel;
DE   AltName: Full=GLIC;
DE   AltName: Full=Ligand-gated ion channel;
DE            Short=LGIC;
DE   Flags: Precursor;
GN   Name=glvI; OrderedLocusNames=glr4197;
OS   Gloeobacter violaceus (strain PCC 7421).
OC   Bacteria; Cyanobacteria; Gloeobacteria; Gloeobacterales;
OC   Gloeobacteraceae; Gloeobacter.
OX   NCBI_TaxID=251221;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PCC 7421;
RX   PubMed=14621292; DOI=10.1093/dnares/10.4.137;
RA   Nakamura Y., Kaneko T., Sato S., Mimuro M., Miyashita H., Tsuchiya T.,
RA   Sasamoto S., Watanabe A., Kawashima K., Kishida Y., Kiyokawa C.,
RA   Kohara M., Matsumoto M., Matsuno A., Nakazaki N., Shimpo S.,
RA   Takeuchi C., Yamada M., Tabata S.;
RT   "Complete genome structure of Gloeobacter violaceus PCC 7421, a
RT   cyanobacterium that lacks thylakoids.";
RL   DNA Res. 10:137-145(2003).
RN   [2]
RP   FUNCTION AS A PROTON-GATED ION CHANNEL, ION SELECTIVITY, ENZYME
RP   REGULATION, AND SUBUNIT.
RC   STRAIN=PCC 7421;
RX   PubMed=17167423; DOI=10.1038/nature05371;
RA   Bocquet N., Prado de Carvalho L., Cartaud J., Neyton J., Le Poupon C.,
RA   Taly A., Grutter T., Changeux J.P., Corringer P.J.;
RT   "A prokaryotic proton-gated ion channel from the nicotinic
RT   acetylcholine receptor family.";
RL   Nature 445:116-119(2007).
RN   [3]
RP   MODULATION BY ANESTHETICS, AND ENZYME REGULATION.
RC   STRAIN=PCC 7421;
RX   PubMed=19933531; DOI=10.1213/ANE.0b013e3181c4bc69;
RA   Weng Y., Yang L., Corringer P.J., Sonner J.M.;
RT   "Anesthetic sensitivity of the Gloeobacter violaceus proton-gated ion
RT   channel.";
RL   Anesth. Analg. 110:59-63(2010).
RN   [4]
RP   ANESTHETIC-BINDING, MUTAGENESIS STUDIES, AND FLUORESCENCE QUENCHING
RP   EXPERIMENTS.
RC   STRAIN=PCC 7421;
RX   PubMed=20858424; DOI=10.1016/j.bpj.2010.07.023;
RA   Chen Q., Cheng M.H., Xu Y., Tang P.;
RT   "Anesthetic binding in a pentameric ligand-gated ion channel: GLIC.";
RL   Biophys. J. 99:1801-1809(2010).
RN   [5]
RP   REVIEW.
RX   PubMed=19995852; DOI=10.1113/jphysiol.2009.183160;
RA   Corringer P.J., Baaden M., Bocquet N., Delarue M., Dufresne V.,
RA   Nury H., Prevost M., Van Renterghem C.;
RT   "Atomic structure and dynamics of pentameric ligand-gated ion
RT   channels: new insight from bacterial homologues.";
RL   J. Physiol. (Lond.) 588:565-572(2010).
RN   [6]
RP   GATING MECHANISM.
RX   PubMed=21041674; DOI=10.1073/pnas.1009313107;
RA   Zhu F., Hummer G.;
RT   "Pore opening and closing of a pentameric ligand-gated ion channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:19814-19819(2010).
RN   [7]
RP   ION SELECTIVITY MECHANISM.
RX   PubMed=21244835; DOI=10.1016/j.bpj.2010.11.077;
RA   Fritsch S., Ivanov I., Wang H., Cheng X.;
RT   "Ion selectivity mechanism in a bacterial pentameric ligand-gated ion
RT   channel.";
RL   Biophys. J. 100:390-398(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 44-359, AND SUBUNIT.
RC   STRAIN=PCC 7421;
RX   PubMed=18987633; DOI=10.1038/nature07462;
RA   Bocquet N., Nury H., Baaden M., Le Poupon C., Changeux J.P.,
RA   Delarue M., Corringer P.J.;
RT   "X-ray structure of a pentameric ligand-gated ion channel in an
RT   apparently open conformation.";
RL   Nature 457:111-114(2009).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 43-359 OF WILD-TYPE AND
RP   MUTANT ALA-264, SUBUNIT, AND MUTAGENESIS OF GLU-264.
RC   STRAIN=PCC 7421;
RX   PubMed=18987630; DOI=10.1038/nature07461;
RA   Hilf R.J., Dutzler R.;
RT   "Structure of a potentially open state of a proton-activated
RT   pentameric ligand-gated ion channel.";
RL   Nature 457:115-118(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 44-235, AND GATING
RP   MECHANISM.
RC   STRAIN=PCC 7421;
RX   PubMed=19917292; DOI=10.1016/j.jmb.2009.11.024;
RA   Nury H., Bocquet N., Le Poupon C., Raynal B., Haouz A.,
RA   Corringer P.J., Delarue M.;
RT   "Crystal structure of the extracellular domain of a bacterial ligand-
RT   gated ion channel.";
RL   J. Mol. Biol. 395:1114-1127(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 43-359 OF WILD-TYPE AND
RP   MUTANT ASP-264 IN COMPLEXES WITH POSITIVELY CHARGED INHIBITORS, ENZYME
RP   REGULATION, MUTAGENESIS OF GLU-264; THR-268 AND SER-272, AND
RP   MECHANISMS OF OPEN CHANNEL BLOCK.
RC   STRAIN=PCC 7421;
RX   PubMed=21037567; DOI=10.1038/nsmb.1933;
RA   Hilf R.J., Bertozzi C., Zimmermann I., Reiter A., Trauner D.,
RA   Dutzler R.;
RT   "Structural basis of open channel block in a prokaryotic pentameric
RT   ligand-gated ion channel.";
RL   Nat. Struct. Mol. Biol. 17:1330-1336(2010).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 44-359 OF MUTANT PHE-279.
RC   STRAIN=PCC 7421;
RX   PubMed=20308576; DOI=10.1073/pnas.1001832107;
RA   Nury H., Poitevin F., Van Renterghem C., Changeux J.P.,
RA   Corringer P.J., Delarue M., Baaden M.;
RT   "One-microsecond molecular dynamics simulation of channel gating in a
RT   nicotinic receptor homologue.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:6275-6280(2010).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 44-359 IN COMPLEXES WITH
RP   PROPOFOL AND DESFLURANE ANESTHETICS, AND MUTAGENESIS OF ILE-244;
RP   VAL-284 AND THR-297.
RC   STRAIN=PCC 7421;
RX   PubMed=21248852; DOI=10.1038/nature09647;
RA   Nury H., Van Renterghem C., Weng Y., Tran A., Baaden M., Dusfresne V.,
RA   Changeux J.P., Sonner J.M., Delarue M., Corringer P.J.;
RT   "X-ray structures of general anaesthetics bound to a pentameric
RT   ligand-gated ion channel.";
RL   Nature 469:428-431(2011).
CC   -!- FUNCTION: Cationic channel with similar permeabilities for Na(+)
CC       and K(+), that is activated by an increase of the proton
CC       concentration on the extracellular side. Displays no permeability
CC       for chloride ions. Shows slow kinetics of activation, no
CC       desensitization and a single channel conductance of 8 pS. Might
CC       contribute to adaptation to external pH change.
CC       {ECO:0000269|PubMed:17167423}.
CC   -!- ENZYME REGULATION: Tetraethylammonium (TEA) and tetrabutylammonium
CC       (TBA) inhibit the proton-activated currents in a dose- and
CC       voltage-dependent manner in vitro, whereas the blocker of acid
CC       sensing ion channels, amiloride, has no effect. Channel current of
CC       GLIC can be inhibited by inhaled and intravenous general
CC       anesthetics at and below concentrations used clinically. Ion
CC       conduction is also inhibited by lidocaine and by divalent
CC       transition metal ions such as cadmium ions.
CC       {ECO:0000269|PubMed:17167423, ECO:0000269|PubMed:19933531,
CC       ECO:0000269|PubMed:21037567}.
CC   -!- SUBUNIT: Homopentamer. {ECO:0000269|PubMed:17167423,
CC       ECO:0000269|PubMed:18987630, ECO:0000269|PubMed:18987633}.
CC   -!- INTERACTION:
CC       Self; NbExp=26; IntAct=EBI-8423601, EBI-8423601;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-
CC       pass membrane protein {ECO:0000305}.
CC   -!- DOMAIN: Consists of an N-terminal ligand-binding domain that
CC       encloses a wide aqueous vestibule and a transmembrane domain that
CC       forms a narrow channel.
CC   -!- MISCELLANEOUS: The homologous nature of GLIC to eukaryotic
CC       nicotinic acetylcholine receptors and other eukaryotic pentameric
CC       ligand-gated ion channels, and its sensitivity to general
CC       anesthetics, define GLIC as a structural and functional model of
CC       signal transduction in the nervous system, also relevant for
CC       exploring the molecular basis of anesthetic action.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000045; BAC92138.1; -; Genomic_DNA.
DR   RefSeq; NP_927143.1; NC_005125.1.
DR   RefSeq; WP_011144181.1; NC_005125.1.
DR   PDB; 2XQ3; X-ray; 3.50 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ4; X-ray; 3.60 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ5; X-ray; 3.50 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ6; X-ray; 3.70 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ7; X-ray; 3.40 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ8; X-ray; 3.60 A; A/B/C/D/E=43-359.
DR   PDB; 2XQ9; X-ray; 3.20 A; A/B/C/D/E=43-359.
DR   PDB; 2XQA; X-ray; 3.70 A; A/B/C/D/E=43-359.
DR   PDB; 3EAM; X-ray; 2.90 A; A/B/C/D/E=44-359.
DR   PDB; 3EHZ; X-ray; 3.10 A; A/B/C/D/E=50-359.
DR   PDB; 3EI0; X-ray; 3.50 A; A/B/C/D/E=50-359.
DR   PDB; 3IGQ; X-ray; 2.30 A; A/B/C/D/E/F=44-235.
DR   PDB; 3LSV; X-ray; 3.15 A; A/B/C/D/E=44-359.
DR   PDB; 3P4W; X-ray; 3.20 A; A/B/C/D/E=44-359.
DR   PDB; 3P50; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 3TLS; X-ray; 3.20 A; A/B/C/D/E=44-359.
DR   PDB; 3TLT; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 3TLU; X-ray; 2.85 A; A/B/C/D/E=44-359.
DR   PDB; 3TLV; X-ray; 2.90 A; A/B/C/D/E=44-359.
DR   PDB; 3TLW; X-ray; 2.60 A; A/B/C/D/E=44-359.
DR   PDB; 3UU3; X-ray; 3.15 A; A/B/C/D/E=44-359.
DR   PDB; 3UU4; X-ray; 3.05 A; A/B/C/D/E=44-359.
DR   PDB; 3UU5; X-ray; 2.90 A; A/B/C/D/E=44-359.
DR   PDB; 3UU6; X-ray; 2.98 A; A/B/C/D/E=44-359.
DR   PDB; 3UU8; X-ray; 3.25 A; A/B/C/D/E=44-359.
DR   PDB; 3UUB; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J=44-359.
DR   PDB; 4F8H; X-ray; 2.99 A; A/B/C/D/E=43-359.
DR   PDB; 4HFB; X-ray; 2.75 A; A/B/C/D/E=44-359.
DR   PDB; 4HFC; X-ray; 3.05 A; A/B/C/D/E=44-359.
DR   PDB; 4HFD; X-ray; 3.10 A; A/B/C/D/E=44-359.
DR   PDB; 4HFE; X-ray; 2.80 A; A/B/C/D/E=44-359.
DR   PDB; 4HFH; X-ray; 2.65 A; A/B/C/D/E=44-359.
DR   PDB; 4HFI; X-ray; 2.40 A; A/B/C/D/E=44-359.
DR   PDB; 4IL4; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 4IL9; X-ray; 2.83 A; A/B/C/D/E=44-358.
DR   PDB; 4ILA; X-ray; 3.50 A; A/B/C/D/E=44-358.
DR   PDB; 4ILB; X-ray; 3.15 A; A/B/C/D/E=44-358.
DR   PDB; 4ILC; X-ray; 2.99 A; A/B/C/D/E=44-358.
DR   PDB; 4IRE; X-ray; 3.19 A; A/B/C/D/E=43-359.
DR   PDB; 4LMJ; X-ray; 3.44 A; A/B/C/D/E=44-359.
DR   PDB; 4LMK; X-ray; 3.22 A; A/B/C/D/E=44-359.
DR   PDB; 4LML; X-ray; 3.80 A; A/B/C/D/E=44-359.
DR   PDB; 4NPP; X-ray; 3.35 A; A/B/C/D/E=44-359.
DR   PDB; 4NPQ; X-ray; 4.35 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T=44-359.
DR   PDB; 4QH1; X-ray; 3.40 A; A/B/C/D/E=44-359.
DR   PDB; 4QH4; X-ray; 3.20 A; A/B/C/D/E=44-359.
DR   PDB; 4QH5; X-ray; 3.00 A; A/B/C/D/E=44-359.
DR   PDB; 4X5T; X-ray; 3.50 A; A/B/C/D/E=44-235.
DR   PDB; 4YEU; X-ray; 4.60 A; A/B/C/D/E=236-357.
DR   PDB; 4ZZB; X-ray; 3.40 A; A/B/C/D/E=44-359.
DR   PDB; 4ZZC; X-ray; 3.10 A; A/B/C/D/E=43-359.
DR   PDB; 5HCJ; X-ray; 2.95 A; A/B/C/D/E=44-359.
DR   PDB; 5HCM; X-ray; 3.15 A; A/B/C/D/E=44-359.
DR   PDB; 5HEG; X-ray; 3.21 A; A/B/C/D/E=44-359.
DR   PDB; 5HEH; X-ray; 3.30 A; A/B/C/D/E=44-359.
DR   PDB; 5IUX; X-ray; 2.60 A; A/B/C/D/E=43-359.
DR   PDB; 5J0Z; X-ray; 3.25 A; A/B/C/D/E=47-357.
DR   PDB; 5L47; X-ray; 3.30 A; A/B/C/D/E=43-359.
DR   PDB; 5L4E; X-ray; 3.50 A; A/B/C/D/E=43-359.
DR   PDB; 5L4H; X-ray; 3.30 A; A/B/C/D/E=43-359.
DR   PDB; 5V6N; X-ray; 3.35 A; A/B/C/D/E=50-359.
DR   PDB; 5V6O; X-ray; 3.12 A; A/B/C/D/E=50-359.
DR   PDBsum; 2XQ3; -.
DR   PDBsum; 2XQ4; -.
DR   PDBsum; 2XQ5; -.
DR   PDBsum; 2XQ6; -.
DR   PDBsum; 2XQ7; -.
DR   PDBsum; 2XQ8; -.
DR   PDBsum; 2XQ9; -.
DR   PDBsum; 2XQA; -.
DR   PDBsum; 3EAM; -.
DR   PDBsum; 3EHZ; -.
DR   PDBsum; 3EI0; -.
DR   PDBsum; 3IGQ; -.
DR   PDBsum; 3LSV; -.
DR   PDBsum; 3P4W; -.
DR   PDBsum; 3P50; -.
DR   PDBsum; 3TLS; -.
DR   PDBsum; 3TLT; -.
DR   PDBsum; 3TLU; -.
DR   PDBsum; 3TLV; -.
DR   PDBsum; 3TLW; -.
DR   PDBsum; 3UU3; -.
DR   PDBsum; 3UU4; -.
DR   PDBsum; 3UU5; -.
DR   PDBsum; 3UU6; -.
DR   PDBsum; 3UU8; -.
DR   PDBsum; 3UUB; -.
DR   PDBsum; 4F8H; -.
DR   PDBsum; 4HFB; -.
DR   PDBsum; 4HFC; -.
DR   PDBsum; 4HFD; -.
DR   PDBsum; 4HFE; -.
DR   PDBsum; 4HFH; -.
DR   PDBsum; 4HFI; -.
DR   PDBsum; 4IL4; -.
DR   PDBsum; 4IL9; -.
DR   PDBsum; 4ILA; -.
DR   PDBsum; 4ILB; -.
DR   PDBsum; 4ILC; -.
DR   PDBsum; 4IRE; -.
DR   PDBsum; 4LMJ; -.
DR   PDBsum; 4LMK; -.
DR   PDBsum; 4LML; -.
DR   PDBsum; 4NPP; -.
DR   PDBsum; 4NPQ; -.
DR   PDBsum; 4QH1; -.
DR   PDBsum; 4QH4; -.
DR   PDBsum; 4QH5; -.
DR   PDBsum; 4X5T; -.
DR   PDBsum; 4YEU; -.
DR   PDBsum; 4ZZB; -.
DR   PDBsum; 4ZZC; -.
DR   PDBsum; 5HCJ; -.
DR   PDBsum; 5HCM; -.
DR   PDBsum; 5HEG; -.
DR   PDBsum; 5HEH; -.
DR   PDBsum; 5IUX; -.
DR   PDBsum; 5J0Z; -.
DR   PDBsum; 5L47; -.
DR   PDBsum; 5L4E; -.
DR   PDBsum; 5L4H; -.
DR   PDBsum; 5V6N; -.
DR   PDBsum; 5V6O; -.
DR   ProteinModelPortal; Q7NDN8; -.
DR   SMR; Q7NDN8; -.
DR   DIP; DIP-59040N; -.
DR   MINT; MINT-8425450; -.
DR   STRING; 251221.glr4197; -.
DR   TCDB; 1.A.9.8.1; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   EnsemblBacteria; BAC92138; BAC92138; BAC92138.
DR   GeneID; 2602600; -.
DR   KEGG; gvi:glr4197; -.
DR   eggNOG; ENOG4105TA1; Bacteria.
DR   eggNOG; ENOG4111U8M; LUCA.
DR   InParanoid; Q7NDN8; -.
DR   OMA; FRTTFCK; -.
DR   OrthoDB; POG091H13WE; -.
DR   PhylomeDB; Q7NDN8; -.
DR   EvolutionaryTrace; Q7NDN8; -.
DR   Proteomes; UP000000557; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Potassium; Potassium channel; Potassium transport; Receptor;
KW   Reference proteome; Signal; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     43       {ECO:0000255}.
FT   CHAIN        44    359       Proton-gated ion channel.
FT                                /FTId=PRO_0000412722.
FT   TOPO_DOM     44    235       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    236    258       Helical.
FT   TOPO_DOM    259    261       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    262    286       Helical.
FT   TOPO_DOM    287    294       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    295    323       Helical.
FT   TOPO_DOM    324    326       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    327    359       Helical.
FT   MUTAGEN     244    244       I->Y: Marked gain of function, with a
FT                                ten-fold shift of the proton dose-
FT                                response curve towards lower
FT                                concentrations.
FT                                {ECO:0000269|PubMed:21248852}.
FT   MUTAGEN     264    264       E->A: Decreases cation selectivity.
FT                                Decreases the binding affinity of TEA and
FT                                TBA. Nearly abolishes block by Cd(2+).
FT                                {ECO:0000269|PubMed:18987630,
FT                                ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     264    264       E->Q,D: Decreases binding affinity of
FT                                TBA. {ECO:0000269|PubMed:18987630,
FT                                ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     268    268       T->A: Increases the binding affinity of
FT                                TBA. Weakens block by Cd(2+).
FT                                {ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     272    272       S->A: Increases the binding affinity of
FT                                TBA. {ECO:0000269|PubMed:21037567}.
FT   MUTAGEN     284    284       V->M: Displays an increased sensitivity
FT                                to propofol but not to desflurane.
FT                                {ECO:0000269|PubMed:21248852}.
FT   MUTAGEN     297    297       T->A: Marked gain of function, with a
FT                                ten-fold shift of the proton dose-
FT                                response curve towards lower
FT                                concentrations. Shows also slower
FT                                apparent rate constants for activation
FT                                and deactivation. Displays an increased
FT                                sensitivity to propofol but a decreased
FT                                sensitivity to desflurane.
FT                                {ECO:0000269|PubMed:21248852}.
FT   STRAND       53     55       {ECO:0000244|PDB:4HFI}.
FT   STRAND       58     70       {ECO:0000244|PDB:3IGQ}.
FT   STRAND       76     90       {ECO:0000244|PDB:3IGQ}.
FT   HELIX        92     94       {ECO:0000244|PDB:3IGQ}.
FT   HELIX        98    101       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      104    107       {ECO:0000244|PDB:3TLW}.
FT   HELIX       110    112       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      118    126       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      128    136       {ECO:0000244|PDB:3IGQ}.
FT   TURN        138    140       {ECO:0000244|PDB:4F8H}.
FT   STRAND      141    153       {ECO:0000244|PDB:3IGQ}.
FT   TURN        159    162       {ECO:0000244|PDB:4HFI}.
FT   STRAND      165    174       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      178    180       {ECO:0000244|PDB:4QH5}.
FT   STRAND      182    186       {ECO:0000244|PDB:3IGQ}.
FT   HELIX       188    190       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      192    194       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      196    199       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      202    212       {ECO:0000244|PDB:3IGQ}.
FT   STRAND      219    221       {ECO:0000244|PDB:3EI0}.
FT   STRAND      225    234       {ECO:0000244|PDB:3IGQ}.
FT   HELIX       236    238       {ECO:0000244|PDB:5IUX}.
FT   HELIX       239    242       {ECO:0000244|PDB:4HFI}.
FT   HELIX       244    254       {ECO:0000244|PDB:4HFI}.
FT   HELIX       255    259       {ECO:0000244|PDB:4HFI}.
FT   HELIX       263    286       {ECO:0000244|PDB:4HFI}.
FT   HELIX       296    323       {ECO:0000244|PDB:4HFI}.
FT   HELIX       327    356       {ECO:0000244|PDB:4HFI}.
SQ   SEQUENCE   359 AA;  40986 MW;  6F9009F96172C025 CRC64;
     MFPTGWRPKL SESIAASRML WQPMAAVAVV QIGLLWFSPP VWGQDMVSPP PPIADEPLTV
     NTGIYLIECY SLDDKAETFK VNAFLSLSWK DRRLAFDPVR SGVRVKTYEP EAIWIPEIRF
     VNVENARDAD VVDISVSPDG TVQYLERFSA RVLSPLDFRR YPFDSQTLHI YLIVRSVDTR
     NIVLAVDLEK VGKNDDVFLT GWDIESFTAV VKPANFALED RLESKLDYQL RISRQYFSYI
     PNIILPMLFI LFISWTAFWS TSYEANVTLV VSTLIAHIAF NILVETNLPK TPYMTYTGAI
     IFMIYLFYFV AVIEVTVQHY LKVESQPARA ASITRASRIA FPVVFLLANI ILAFLFFGF
//
ID   GLR31_ARATH             Reviewed;         921 AA.
AC   Q7XJL2; F4IMH4; O49119; Q6RKN5; Q9ZT36;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   20-DEC-2017, entry version 110.
DE   RecName: Full=Glutamate receptor 3.1;
DE            Short=AtGLR2;
DE   AltName: Full=Ligand-gated ion channel 3.1;
DE   Flags: Precursor;
GN   Name=GLR3.1; Synonyms=ACL1, GLR2; OrderedLocusNames=At2g17260;
GN   ORFNames=F5J6.2;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9823891; DOI=10.1038/24066;
RA   Lam H.-M., Chiu J.C., Hsieh M.-H., Meisel L., Oliveira I.C., Shin M.,
RA   Coruzzi G.M.;
RT   "Glutamate-receptor genes in plants.";
RL   Nature 396:125-126(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19143998; DOI=10.1111/j.1365-313X.2009.03789.x;
RA   Cho D., Kim S.A., Murata Y., Lee S., Jae S.-K., Nam H.G., Kwak J.M.;
RT   "De-regulated expression of the plant glutamate receptor homolog
RT   AtGLR3.1 impairs long-term Ca2+-programmed stomatal closure.";
RL   Plant J. 58:437-449(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Liu L.-H., Tester M.;
RT   "A full length cDNA of AtGLR3.1 identified and sequenced from an
RT   EST.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells. Required for the long-term calcium oscillation-
CC       regulated stomatal movements. {ECO:0000269|PubMed:19143998}.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots. Firt
CC       detected in the vascular tissues of the cotyledons, and later in
CC       the vasculature of all organs. In leaves, preferentially expressed
CC       in guard cells. {ECO:0000269|PubMed:12082126,
CC       ECO:0000269|PubMed:19143998}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB92421.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAD09174.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAR88099.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AEC06604.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF079999; AAD09174.1; ALT_INIT; mRNA.
DR   EMBL; AF038557; AAB92421.1; ALT_INIT; mRNA.
DR   EMBL; AY495448; AAR88099.1; ALT_INIT; mRNA.
DR   EMBL; CP002685; AEC06604.1; ALT_INIT; Genomic_DNA.
DR   PIR; T51132; T51132.
DR   PIR; T51133; T51133.
DR   RefSeq; NP_001318239.1; NM_001335544.1.
DR   UniGene; At.10492; -.
DR   ProteinModelPortal; Q7XJL2; -.
DR   BioGrid; 1588; 2.
DR   STRING; 3702.AT2G17260.1; -.
DR   PaxDb; Q7XJL2; -.
DR   PRIDE; Q7XJL2; -.
DR   EnsemblPlants; AT2G17260.1; AT2G17260.1; AT2G17260.
DR   GeneID; 816231; -.
DR   Gramene; AT2G17260.1; AT2G17260.1; AT2G17260.
DR   KEGG; ath:AT2G17260; -.
DR   Araport; AT2G17260; -.
DR   eggNOG; ENOG410ISR7; Eukaryota.
DR   eggNOG; ENOG410Y9VH; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q7XJL2; -.
DR   KO; K05387; -.
DR   OrthoDB; EOG093601T8; -.
DR   PhylomeDB; Q7XJL2; -.
DR   PRO; PR:Q7XJL2; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q7XJL2; baseline and differential.
DR   Genevisible; Q7XJL2; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    921       Glutamate receptor 3.1.
FT                                /FTId=PRO_0000011605.
FT   TOPO_DOM     22    587       Extracellular. {ECO:0000255}.
FT   TRANSMEM    588    608       Helical. {ECO:0000255}.
FT   TOPO_DOM    609    617       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    618    638       Helical. {ECO:0000255}.
FT   TOPO_DOM    639    649       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    650    670       Helical. {ECO:0000255}.
FT   TOPO_DOM    671    827       Extracellular. {ECO:0000255}.
FT   TRANSMEM    828    848       Helical. {ECO:0000255}.
FT   TOPO_DOM    849    921       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    337    337       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    415    415       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    433    433       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    484    484       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    734    734       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    808    808       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT      1      1       M -> V (in Ref. 2; AAB92421).
FT                                {ECO:0000305}.
FT   CONFLICT      9      9       I -> M (in Ref. 2; AAB92421).
FT                                {ECO:0000305}.
FT   CONFLICT    826    827       HS -> RT (in Ref. 2; AAB92421).
FT                                {ECO:0000305}.
SQ   SEQUENCE   921 AA;  102613 MW;  AABD5D8DAD0FE2F3 CRC64;
     MNWVLLSFII VLGGGLLLSE GASSSRPPVI KVGAIFGLNT MYGETANIAF KAAEEDVNSD
     PSFLGGSKLR ILMNDAKRSG FLSIMGALQF METDVVAIIG PQTSIMAHVL SHLANELTVP
     MLSFTALDPT LSPLQFPFFV QTAPSDLFLM RAIAEMITYY GWSDVVALYN DDDNSRNGVT
     ALGDELEERR CKISYKAVLP LDVVITSPVE IIEELIKIRG MESRVIVVNT FPNTGKMIFK
     EAERLGMMEK GYVWIATTWL SSVLDSNLPL DTKLVNGVLT LRLHTPDSRK KRDFAARWKN
     KLSNNKTIGL NVYGLYAYDT VWIIARAVKT LLEAGGNLSF SNDAKLGSLK GEALNLSALS
     RFDQGSQLLD YIVHTKMSGL TGPVQFHPDR SMLQPSYDII NLVDDRVHQI GYWSNYSGLS
     IVPPESFYSK PPNRSSSNQH LNSVTWPGGT SVTPRGWIFR NNGRRLRIGV PDRASFKDFV
     SRVNGSSNKV QGYCIDVFEA AVKLLSYPVP HEFIFFGDGL TNPNYNELVN KVTTGVDFDA
     VVGDIAIVTK RTRIVDFTQP YIESGLVVVA PVTRLNENPW AFLRPFTLPM WAVTASFFVI
     VGAAIWILEH RINDEFRGPP RRQIITILWF TFSTMFFSHR ETTVSTLGRM VLLIWLFVVL
     IITSSYTASL TSILTVQQLN SPIKGVDTLI SSTGRIGFQV GSFAENYMTD ELNIASSRLV
     PLASPEEYAN ALQNGTVAAI VDERPYIDLF LSDYCKFAIR GQEFTRCGWG FAFPRDSPLA
     VDMSTAILGL SETGELQKIH DRWLSKSNCS SPHGSQSGDS EQLNVHSFWG MFLVVGIACL
     VALFIHFFKI IRDFCKDTPE VVVEEAIPSP KSSRLTKLQT FLAFVDEKEE ETKRRLKRKR
     NNDHSMNANS IISRTASRRP I
//
ID   GLR31_ORYSJ             Reviewed;         938 AA.
AC   Q7XP59;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   20-DEC-2017, entry version 78.
DE   RecName: Full=Glutamate receptor 3.1;
DE   AltName: Full=Ligand-gated ion channel 3.1;
DE   Flags: Precursor;
GN   Name=GLR3.1; OrderedLocusNames=Os04g0585200, LOC_Os04g49570;
GN   ORFNames=OSJNBa0013K16.8;
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza; Oryza sativa.
OX   NCBI_TaxID=39947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, TISSUE SPECIFICITY, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=16377757; DOI=10.1105/tpc.105.037713;
RA   Li J., Zhu S., Song X., Shen Y., Chen H., Yu J., Yi K., Liu Y.,
RA   Karplus V.J., Wu P., Deng X.W.;
RT   "A rice glutamate receptor-like gene is critical for the division and
RT   survival of individual cells in the root apical meristem.";
RL   Plant Cell 18:340-349(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12447439; DOI=10.1038/nature01183;
RA   Feng Q., Zhang Y., Hao P., Wang S., Fu G., Huang Y., Li Y., Zhu J.,
RA   Liu Y., Hu X., Jia P., Zhang Y., Zhao Q., Ying K., Yu S., Tang Y.,
RA   Weng Q., Zhang L., Lu Y., Mu J., Lu Y., Zhang L.S., Yu Z., Fan D.,
RA   Liu X., Lu T., Li C., Wu Y., Sun T., Lei H., Li T., Hu H., Guan J.,
RA   Wu M., Zhang R., Zhou B., Chen Z., Chen L., Jin Z., Wang R., Yin H.,
RA   Cai Z., Ren S., Lv G., Gu W., Zhu G., Tu Y., Jia J., Zhang Y.,
RA   Chen J., Kang H., Chen X., Shao C., Sun Y., Hu Q., Zhang X., Zhang W.,
RA   Wang L., Ding C., Sheng H., Gu J., Chen S., Ni L., Zhu F., Chen W.,
RA   Lan L., Lai Y., Cheng Z., Gu M., Jiang J., Li J., Hong G., Xue Y.,
RA   Han B.;
RT   "Sequence and analysis of rice chromosome 4.";
RL   Nature 420:316-320(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. Involved in root development. May
CC       regulate cell proliferation and cell death in the root apex.
CC       {ECO:0000269|PubMed:16377757}.
CC   -!- SUBUNIT: May form homomultimers. {ECO:0000269|PubMed:16377757}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in roots and leaves.
CC       {ECO:0000269|PubMed:16377757}.
CC   -!- INDUCTION: By abiotic stresses.
CC   -!- DISRUPTION PHENOTYPE: Plants are defective in root elongation and
CC       show reduced mitotic activity and increased cell death in the root
CC       apical meristem (RAM). {ECO:0000269|PubMed:16377757}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ305408; ABC33859.1; -; mRNA.
DR   EMBL; AL662957; CAE03759.1; -; Genomic_DNA.
DR   EMBL; AP014960; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   UniGene; Os.15729; -.
DR   UniGene; Os.88382; -.
DR   ProteinModelPortal; Q7XP59; -.
DR   SMR; Q7XP59; -.
DR   STRING; 39947.LOC_Os04g49570.1; -.
DR   PaxDb; Q7XP59; -.
DR   EnsemblPlants; OS04T0585200-02; OS04T0585200-02; OS04G0585200.
DR   Gramene; OS04T0585200-02; OS04T0585200-02; OS04G0585200.
DR   eggNOG; ENOG410ISR7; Eukaryota.
DR   eggNOG; ENOG410Y9VH; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q7XP59; -.
DR   OrthoDB; EOG093601T8; -.
DR   Proteomes; UP000059680; Chromosome 4.
DR   ExpressionAtlas; Q7XP59; baseline and differential.
DR   Genevisible; Q7XP59; OS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Stress response; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    938       Glutamate receptor 3.1.
FT                                /FTId=PRO_0000239742.
FT   TOPO_DOM     21    588       Extracellular. {ECO:0000255}.
FT   TRANSMEM    589    609       Helical. {ECO:0000255}.
FT   TOPO_DOM    610    618       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    619    639       Helical. {ECO:0000255}.
FT   TOPO_DOM    640    650       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    651    671       Helical. {ECO:0000255}.
FT   TOPO_DOM    672    830       Extracellular. {ECO:0000255}.
FT   TRANSMEM    831    851       Helical. {ECO:0000255}.
FT   TOPO_DOM    852    938       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     22     22       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     59     59       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    340    340       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    436    436       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    551    551       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   938 AA;  103267 MW;  17C0E936D22DF2ED CRC64;
     MKFIFYLFSI FCCLCSCAQS QNISGRPDAV RIGAQFARNS TIGRVAAVAV LAAVNDINND
     SNILPGTKLD LHMHDSSCNR FLGIVQALQF MEKDTVAIIG PLSSTTAHVL SHLANELHVP
     LMSFSATDPT LSSLEYPFFV RTTVSDQFQM TAVADLVEYY GWKQVTTIFV DNDYGRNAIS
     SLGDELSKRR SKILYKAPFR PGASNNEIAD VLIKVAMMES RVIILHANPD SGLVVFQQAL
     KLGMVSNGYA WIATDWLTSY LDPSVHLDIG LLSTMQGVLT LRHHTENTRR KSMLSSKWSE
     LLKEDSGHSR FLLSTYGLYA YDTVWMLAHA LDAFFNSGGN ISFSPDPKLN EISGRGLNLE
     ALSVFDGGQL LLEKIHQVDF LGATGPVKFD SGGNLIQPAY DIVSIIGSGL RTVGYWSNYS
     GLSVISPETL YKKPANRTRE TQKLHDVIWP GETINKPRGW VFPNNGNEIK IGVPDRVSYR
     QFVSVDSETG MVRGLCIDVF VAAINLLAYP VPYRFVPFGN NRENPSYSEL INKIITDDFD
     AVVGDVTIIT NRTKVVDFTQ PYVSSGLVVL TSVKRQNSGG WAFLQPFTIK MWTVTGLFFL
     IIGTVVWMLE HRINDEFRGP PAKQLITVFW FSFSTLFFAH REDTRSTLGR FVIIIWLFVV
     LIIQSSYTAS LTSILTVQQL TSPITGIDSL ITSDVPIGFQ VGSFAENYLA QELGVAHSRL
     KALGSPEEYK KALDLGPSKG GVAAIVDERP YIELFLYQNP KFAVVGSEFT KSGWGFAFPR
     DSPLSVDLST AILELSENGD LQRIHDKWLA SDMSSMSQAS ELDQDPDRLD VYSFSALFLI
     CGLACIFALA IHACNLFYQY SRHAAEEDPA ALQPSASDGS RSLSRRSKLQ SFLSFADRRE
     ADIRRAAKEK ASGLGGSGGS MSGVSFTSSG SGSTTASC
//
ID   TRPM1_HUMAN             Reviewed;        1603 AA.
AC   Q7Z4N2; D9IDV2; D9IDV3; F8W865; H0YN37; O75560; Q6PE48; Q7Z4N1;
AC   Q7Z4N3; Q7Z4N4; Q7Z4N5;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 2.
DT   22-NOV-2017, entry version 117.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 1;
DE   AltName: Full=Long transient receptor potential channel 1;
DE            Short=LTrpC1;
DE   AltName: Full=Melastatin-1;
GN   Name=TRPM1 {ECO:0000312|HGNC:HGNC:7146};
GN   Synonyms=LTRPC1, MLSN {ECO:0000303|PubMed:11535825},
GN   MLSN1 {ECO:0000312|EMBL:BAC80203.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC80000.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS THR-399 AND
RP   GLN-1498.
RC   TISSUE=Retina {ECO:0000312|EMBL:AAC80000.1};
RX   PubMed=9806836; DOI=10.1006/geno.1998.5549;
RA   Hunter J.J., Shao J., Smutko J.S., Dussault B.J., Nagle D.L.,
RA   Woolf E.A., Holmgren L.M., Moore K.J., Shyjan A.W.;
RT   "Chromosomal localization and genomic characterization of the mouse
RT   melastatin gene (Mlsn1).";
RL   Genomics 54:116-123(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 6).
RX   PubMed=19436059; DOI=10.1126/scisignal.2000146;
RA   Oancea E., Vriens J., Brauchi S., Jun J., Splawski I., Clapham D.E.;
RT   "TRPM1 forms ion channels associated with melanin content in
RT   melanocytes.";
RL   Sci. Signal. 2:RA21-RA21(2009).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAC80203.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Melanoma {ECO:0000312|EMBL:BAC80203.1};
RA   Sano M., Okabayashi K., Miyauchi A., Gonoi T.;
RT   "ProX human full-length cDNA cloning project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:BAC80203.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7), AND VARIANT
RP   ASN-32.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=9537257;
RA   Duncan L.M., Deeds J., Hunter J., Shao J., Holmgren L.M., Woolf E.A.,
RA   Tepper R.I., Shyjan A.W.;
RT   "Down-regulation of the novel gene melastatin correlates with
RT   potential for melanoma metastasis.";
RL   Cancer Res. 58:1515-1520(1998).
RN   [8] {ECO:0000305}
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11112417; DOI=10.1006/bbrc.2000.3894;
RA   Fang D., Setaluri V.;
RT   "Expression and up-regulation of alternatively spliced transcripts of
RT   melastatin, a melanoma metastasis-related gene, in human melanoma
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 279:53-61(2000).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11535825; DOI=10.1073/pnas.191360198;
RA   Xu X.-Z.S., Moebius F., Gill D.L., Montell C.;
RT   "Regulation of melastatin, a TRP-related protein, through interaction
RT   with a cytoplasmic isoform.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:10692-10697(2001).
RN   [10]
RP   FUNCTION, VARIANTS CSNB1C CYS-56; CYS-74; GLN-721; GLY-883 AND
RP   PHE-1002, AND VARIANTS TRP-6; ASN-32; MET-605; THR-962; ILE-1395 AND
RP   GLY-1438.
RX   PubMed=19878917; DOI=10.1016/j.ajhg.2009.10.003;
RA   Li Z., Sergouniotis P.I., Michaelides M., Mackay D.S., Wright G.A.,
RA   Devery S., Moore A.T., Holder G.E., Robson A.G., Webster A.R.;
RT   "Recessive mutations of the gene TRPM1 abrogate ON bipolar cell
RT   function and cause complete congenital stationary night blindness in
RT   humans.";
RL   Am. J. Hum. Genet. 85:711-719(2009).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND VARIANTS CSNB1C CYS-74; PRO-99;
RP   ARG-364; ARG-534 AND HIS-611.
RX   PubMed=19896109; DOI=10.1016/j.ajhg.2009.10.012;
RA   van Genderen M.M., Bijveld M.M., Claassen Y.B., Florijn R.J.,
RA   Pearring J.N., Meire F.M., McCall M.A., Riemslag F.C., Gregg R.G.,
RA   Bergen A.A., Kamermans M.;
RT   "Mutations in TRPM1 are a common cause of complete congenital
RT   stationary night blindness.";
RL   Am. J. Hum. Genet. 85:730-736(2009).
RN   [12]
RP   VARIANTS CSNB1C CYS-72; PRO-99; PRO-473 AND LYS-541, AND VARIANTS
RP   TRP-6; ASN-32; THR-399; MET-605; HIS-1161; THR-1229; THR-1379;
RP   ILE-1395; TRP-1422 AND GLN-1498.
RX   PubMed=19896113; DOI=10.1016/j.ajhg.2009.10.013;
RA   Audo I., Kohl S., Leroy B.P., Munier F.L., Guillonneau X.,
RA   Mohand-Said S., Bujakowska K., Nandrot E.F., Lorenz B., Preising M.,
RA   Kellner U., Renner A.B., Bernd A., Antonio A., Moskova-Doumanova V.,
RA   Lancelot M.E., Poloschek C.M., Drumare I., Defoort-Dhellemmes S.,
RA   Wissinger B., Leveillard T., Hamel C.P., Schorderet D.F., De Baere E.,
RA   Berger W., Jacobson S.G., Zrenner E., Sahel J.A., Bhattacharya S.S.,
RA   Zeitz C.;
RT   "TRPM1 is mutated in patients with autosomal-recessive complete
RT   congenital stationary night blindness.";
RL   Am. J. Hum. Genet. 85:720-729(2009).
CC   -!- FUNCTION: Cation channel essential for the depolarizing
CC       photoresponse of retinal ON bipolar cells. It is part of the GRM6
CC       signaling cascade. May play a role in metastasis suppression (By
CC       similarity). May act as a spontaneously active, calcium-permeable
CC       plasma membrane channel. {ECO:0000250,
CC       ECO:0000269|PubMed:11535825, ECO:0000269|PubMed:19878917,
CC       ECO:0000269|PubMed:19896109}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255}; Multi-pass
CC       membrane protein {ECO:0000255, ECO:0000269|PubMed:11535825}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1 {ECO:0000269|PubMed:16572171};
CC         IsoId=Q7Z4N2-1; Sequence=Displayed;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=2 {ECO:0000269|PubMed:9806836, ECO:0000269|Ref.3};
CC         IsoId=Q7Z4N2-2; Sequence=VSP_052748;
CC       Name=3 {ECO:0000269|Ref.3};
CC         IsoId=Q7Z4N2-3; Sequence=VSP_052749;
CC       Name=4 {ECO:0000269|Ref.3};
CC         IsoId=Q7Z4N2-4; Sequence=VSP_052750;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=5;
CC         IsoId=Q7Z4N2-5; Sequence=VSP_046786;
CC       Name=6;
CC         IsoId=Q7Z4N2-6; Sequence=VSP_046787;
CC       Name=7;
CC         IsoId=Q7Z4N2-7; Sequence=VSP_046788, VSP_046789;
CC   -!- TISSUE SPECIFICITY: Expressed in the retina where it localizes to
CC       the outer plexiform layer. Highly expressed in benign melanocytic
CC       nevi and diffusely expressed in various in situ melanomas, but not
CC       detected in melanoma metastases. Also expressed in melanocytes and
CC       pigmented metastatic melanoma cell lines. In melanocytes
CC       expression appears to be regulated at the level of transcription
CC       and mRNA processing. {ECO:0000269|PubMed:11112417,
CC       ECO:0000269|PubMed:19896109, ECO:0000269|PubMed:9537257}.
CC   -!- INDUCTION: Up-regulated by hexamethylene bisacetamide (HBMA).
CC       {ECO:0000269|PubMed:11112417}.
CC   -!- DISEASE: Night blindness, congenital stationary, 1C (CSNB1C)
CC       [MIM:613216]: A non-progressive retinal disorder characterized by
CC       impaired night vision, often associated with nystagmus and myopia.
CC       {ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109,
CC       ECO:0000269|PubMed:19896113}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       LTrpC subfamily. TRPM1 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TRPM1ID42707ch15q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF071787; AAC80000.1; -; mRNA.
DR   EMBL; HM135790; ADJ52077.1; -; mRNA.
DR   EMBL; HM135791; ADJ52078.1; -; mRNA.
DR   EMBL; AB115498; BAC80200.1; -; mRNA.
DR   EMBL; AB115499; BAC80201.1; -; mRNA.
DR   EMBL; AB115500; BAC80202.1; -; mRNA.
DR   EMBL; AB115501; BAC80203.1; -; mRNA.
DR   EMBL; AB115502; BAC80204.1; -; mRNA.
DR   EMBL; AC009562; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471216; EAW61261.1; -; Genomic_DNA.
DR   EMBL; BC058286; AAH58286.1; -; mRNA.
DR   CCDS; CCDS10024.2; -. [Q7Z4N2-1]
DR   CCDS; CCDS58345.1; -. [Q7Z4N2-7]
DR   CCDS; CCDS58346.1; -. [Q7Z4N2-6]
DR   CCDS; CCDS58347.1; -. [Q7Z4N2-5]
DR   RefSeq; NP_001238949.1; NM_001252020.1. [Q7Z4N2-5]
DR   RefSeq; NP_001238953.1; NM_001252024.1. [Q7Z4N2-6]
DR   RefSeq; NP_001238959.1; NM_001252030.1. [Q7Z4N2-7]
DR   RefSeq; NP_002411.3; NM_002420.5. [Q7Z4N2-1]
DR   UniGene; Hs.155942; -.
DR   UniGene; Hs.732541; -.
DR   ProteinModelPortal; Q7Z4N2; -.
DR   SMR; Q7Z4N2; -.
DR   BioGrid; 110453; 4.
DR   IntAct; Q7Z4N2; 2.
DR   STRING; 9606.ENSP00000380897; -.
DR   GuidetoPHARMACOLOGY; 493; -.
DR   TCDB; 1.A.4.5.2; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q7Z4N2; -.
DR   PhosphoSitePlus; Q7Z4N2; -.
DR   BioMuta; TRPM1; -.
DR   DMDM; 182701419; -.
DR   EPD; Q7Z4N2; -.
DR   MaxQB; Q7Z4N2; -.
DR   PaxDb; Q7Z4N2; -.
DR   PeptideAtlas; Q7Z4N2; -.
DR   PRIDE; Q7Z4N2; -.
DR   Ensembl; ENST00000256552; ENSP00000256552; ENSG00000134160. [Q7Z4N2-6]
DR   Ensembl; ENST00000397795; ENSP00000380897; ENSG00000134160. [Q7Z4N2-1]
DR   Ensembl; ENST00000542188; ENSP00000437849; ENSG00000134160. [Q7Z4N2-5]
DR   Ensembl; ENST00000559179; ENSP00000453851; ENSG00000134160. [Q7Z4N2-7]
DR   Ensembl; ENST00000560658; ENSP00000454077; ENSG00000134160. [Q7Z4N2-4]
DR   GeneID; 4308; -.
DR   KEGG; hsa:4308; -.
DR   UCSC; uc001zfm.4; human. [Q7Z4N2-1]
DR   CTD; 4308; -.
DR   DisGeNET; 4308; -.
DR   EuPathDB; HostDB:ENSG00000134160.13; -.
DR   GeneCards; TRPM1; -.
DR   HGNC; HGNC:7146; TRPM1.
DR   HPA; HPA014779; -.
DR   HPA; HPA014785; -.
DR   MalaCards; TRPM1; -.
DR   MIM; 603576; gene.
DR   MIM; 613216; phenotype.
DR   neXtProt; NX_Q7Z4N2; -.
DR   OpenTargets; ENSG00000134160; -.
DR   Orphanet; 215; Congenital stationary night blindness.
DR   PharmGKB; PA35496; -.
DR   eggNOG; KOG3614; Eukaryota.
DR   eggNOG; ENOG410XR5B; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOGENOM; HOG000230920; -.
DR   HOVERGEN; HBG055663; -.
DR   InParanoid; Q7Z4N2; -.
DR   KO; K04976; -.
DR   OMA; AVSRFQY; -.
DR   OrthoDB; EOG091G0DHL; -.
DR   PhylomeDB; Q7Z4N2; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   SIGNOR; Q7Z4N2; -.
DR   GeneWiki; TRPM1; -.
DR   GenomeRNAi; 4308; -.
DR   PRO; PR:Q7Z4N2; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000134160; -.
DR   CleanEx; HS_TRPM1; -.
DR   ExpressionAtlas; Q7Z4N2; baseline and differential.
DR   Genevisible; Q7Z4N2; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0035841; C:new growing cell tip; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; IDA:UniProtKB.
DR   GO; GO:0071482; P:cellular response to light stimulus; IMP:UniProtKB.
DR   GO; GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IEA:InterPro.
DR   GO; GO:0046548; P:retinal rod cell development; IEA:Ensembl.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; IMP:UniProtKB.
DR   Gene3D; 1.20.5.1010; -; 1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR029588; TRPM1.
DR   InterPro; IPR032415; TRPM_tetra.
DR   InterPro; IPR037162; TRPM_tetra_sf.
DR   PANTHER; PTHR13800:SF13; PTHR13800:SF13; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF16519; TRPM_tetra; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Coiled coil; Complete proteome;
KW   Congenital stationary night blindness; Disease mutation; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Sensory transduction; Transmembrane;
KW   Transmembrane helix; Transport; Vision.
FT   CHAIN         1   1603       Transient receptor potential cation
FT                                channel subfamily M member 1.
FT                                /FTId=PRO_0000328930.
FT   TOPO_DOM      1    524       Extracellular. {ECO:0000255}.
FT   TRANSMEM    525    545       Helical. {ECO:0000255}.
FT   TOPO_DOM    546    745       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    746    766       Helical. {ECO:0000255}.
FT   TOPO_DOM    767    830       Extracellular. {ECO:0000255}.
FT   TRANSMEM    831    851       Helical. {ECO:0000255}.
FT   TOPO_DOM    852    852       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    853    873       Helical. {ECO:0000255}.
FT   TOPO_DOM    874    897       Extracellular. {ECO:0000255}.
FT   TRANSMEM    898    918       Helical. {ECO:0000255}.
FT   TOPO_DOM    919    928       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    929    949       Helical. {ECO:0000255}.
FT   TOPO_DOM    950    961       Extracellular. {ECO:0000255}.
FT   TRANSMEM    962    982       Helical. {ECO:0000255}.
FT   TOPO_DOM    983   1054       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1055   1075       Helical. {ECO:0000255}.
FT   TOPO_DOM   1076   1105       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1106   1126       Helical. {ECO:0000255}.
FT   TOPO_DOM   1127   1603       Cytoplasmic. {ECO:0000255}.
FT   COILED     1179   1240       {ECO:0000255}.
FT   VAR_SEQ       1     70       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9806836,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_052748.
FT   VAR_SEQ       1      1       M -> MSSFKRGSLKSSTSGSQKGQKSWIEKTFCKRECIFV
FT                                IPSM (in isoform 5).
FT                                {ECO:0000303|PubMed:19436059}.
FT                                /FTId=VSP_046786.
FT   VAR_SEQ       1      1       M -> MGQKSWIEKTFCKRECIFVIPSM (in isoform
FT                                6). {ECO:0000303|PubMed:19436059}.
FT                                /FTId=VSP_046787.
FT   VAR_SEQ      72    136       YIRVSYDTKPDSLLHLMVKDWQLELPKLLISVHGGLQNFEM
FT                                QPKLKQVFGKGLIKAAMTTGAWIF -> VRKAFRHGATRIT
FT                                AFIGGQSPSPKLQIPGLLHGCGSIFLDISLKNQEIYLCTWL
FT                                LAMRLGNWTPL (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046788.
FT   VAR_SEQ     137   1603       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046789.
FT   VAR_SEQ     295    300       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_052749.
FT   VAR_SEQ     301   1603       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_052750.
FT   VARIANT       6      6       R -> W. {ECO:0000269|PubMed:19878917,
FT                                ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063173.
FT   VARIANT      32     32       S -> N (in dbSNP:rs2241493).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:19878917,
FT                                ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_052370.
FT   VARIANT      56     56       Y -> C (in CSNB1C).
FT                                {ECO:0000269|PubMed:19878917}.
FT                                /FTId=VAR_063174.
FT   VARIANT      72     72       Y -> C (in CSNB1C; dbSNP:rs200514769).
FT                                {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063175.
FT   VARIANT      74     74       R -> C (in CSNB1C; dbSNP:rs774365264).
FT                                {ECO:0000269|PubMed:19878917,
FT                                ECO:0000269|PubMed:19896109}.
FT                                /FTId=VAR_063176.
FT   VARIANT      99     99       L -> P (in CSNB1C; dbSNP:rs191205969).
FT                                {ECO:0000269|PubMed:19896109,
FT                                ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063177.
FT   VARIANT     364    364       L -> R (in CSNB1C; dbSNP:rs372608320).
FT                                {ECO:0000269|PubMed:19896109}.
FT                                /FTId=VAR_063178.
FT   VARIANT     399    399       P -> T (in dbSNP:rs141540242).
FT                                {ECO:0000269|PubMed:19896113,
FT                                ECO:0000269|PubMed:9806836}.
FT                                /FTId=VAR_063179.
FT   VARIANT     473    473       R -> P (in CSNB1C).
FT                                {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063180.
FT   VARIANT     534    534       G -> R (in CSNB1C; dbSNP:rs748043795).
FT                                {ECO:0000269|PubMed:19896109}.
FT                                /FTId=VAR_063181.
FT   VARIANT     541    541       M -> K (in CSNB1C).
FT                                {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063182.
FT   VARIANT     605    605       V -> M (in dbSNP:rs17815774).
FT                                {ECO:0000269|PubMed:19878917,
FT                                ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_052371.
FT   VARIANT     611    611       P -> H (in CSNB1C; dbSNP:rs267607139).
FT                                {ECO:0000269|PubMed:19896109}.
FT                                /FTId=VAR_063183.
FT   VARIANT     721    721       R -> Q (in CSNB1C; dbSNP:rs781460164).
FT                                {ECO:0000269|PubMed:19878917}.
FT                                /FTId=VAR_063184.
FT   VARIANT     883    883       E -> G (in CSNB1C; dbSNP:rs574652148).
FT                                {ECO:0000269|PubMed:19878917}.
FT                                /FTId=VAR_063185.
FT   VARIANT     962    962       M -> T (in a patient with night blindness
FT                                started in the third decade; associated
FT                                in cis with G-1438).
FT                                {ECO:0000269|PubMed:19878917}.
FT                                /FTId=VAR_063186.
FT   VARIANT    1002   1002       I -> F (in CSNB1C; dbSNP:rs369484186).
FT                                {ECO:0000269|PubMed:19878917}.
FT                                /FTId=VAR_063187.
FT   VARIANT    1161   1161       Q -> H (in dbSNP:rs182549235).
FT                                {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063188.
FT   VARIANT    1229   1229       N -> T (in dbSNP:rs17227996).
FT                                {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_052372.
FT   VARIANT    1305   1305       R -> H (in dbSNP:rs13380059).
FT                                /FTId=VAR_052373.
FT   VARIANT    1379   1379       P -> T (in dbSNP:rs61734298).
FT                                {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063189.
FT   VARIANT    1395   1395       V -> I (in dbSNP:rs3784588).
FT                                {ECO:0000269|PubMed:19878917,
FT                                ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_052374.
FT   VARIANT    1422   1422       R -> G (in dbSNP:rs3784587).
FT                                /FTId=VAR_052375.
FT   VARIANT    1422   1422       R -> W. {ECO:0000269|PubMed:19896113}.
FT                                /FTId=VAR_063190.
FT   VARIANT    1438   1438       R -> G (in a patient with night blindness
FT                                started in the third decade; associated
FT                                in cis with T-962).
FT                                {ECO:0000269|PubMed:19878917}.
FT                                /FTId=VAR_063191.
FT   VARIANT    1498   1498       H -> Q (in dbSNP:rs12898290).
FT                                {ECO:0000269|PubMed:19896113,
FT                                ECO:0000269|PubMed:9806836}.
FT                                /FTId=VAR_052376.
FT   CONFLICT      1      1       M -> T (in Ref. 2; ADJ52077).
FT                                {ECO:0000305}.
FT   CONFLICT    369    369       V -> L (in Ref. 3; BAC80200).
FT                                {ECO:0000305}.
FT   CONFLICT   1195   1195       R -> G (in Ref. 3; BAC80201).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1603 AA;  182178 MW;  8B9658FAE3F7B32F CRC64;
     MKDSNRCCCG QFTNQHIPPL PSATPSKNEE ESKQVETQPE KWSVAKHTQS YPTDSYGVLE
     FQGGGYSNKA MYIRVSYDTK PDSLLHLMVK DWQLELPKLL ISVHGGLQNF EMQPKLKQVF
     GKGLIKAAMT TGAWIFTGGV STGVISHVGD ALKDHSSKSR GRVCAIGIAP WGIVENKEDL
     VGKDVTRVYQ TMSNPLSKLS VLNNSHTHFI LADNGTLGKY GAEVKLRRLL EKHISLQKIN
     TRLGQGVPLV GLVVEGGPNV VSIVLEYLQE EPPIPVVICD GSGRASDILS FAHKYCEEGG
     IINESLREQL LVTIQKTFNY NKAQSHQLFA IIMECMKKKE LVTVFRMGSE GQQDIEMAIL
     TALLKGTNVS APDQLSLALA WNRVDIARSQ IFVFGPHWPP LGSLAPPTDS KATEKEKKPP
     MATTKGGRGK GKGKKKGKVK EEVEEETDPR KIELLNWVNA LEQAMLDALV LDRVDFVKLL
     IENGVNMQHF LTIPRLEELY NTRLGPPNTL HLLVRDVKKS NLPPDYHISL IDIGLVLEYL
     MGGAYRCNYT RKNFRTLYNN LFGPKRPKAL KLLGMEDDEP PAKGKKKKKK KKEEEIDIDV
     DDPAVSRFQY PFHELMVWAV LMKRQKMAVF LWQRGEESMA KALVACKLYK AMAHESSESD
     LVDDISQDLD NNSKDFGQLA LELLDQSYKH DEQIAMKLLT YELKNWSNST CLKLAVAAKH
     RDFIAHTCSQ MLLTDMWMGR LRMRKNPGLK VIMGILLPPT ILFLEFRTYD DFSYQTSKEN
     EDGKEKEEEN TDANADAGSR KGDEENEHKK QRSIPIGTKI CEFYNAPIVK FWFYTISYLG
     YLLLFNYVIL VRMDGWPSLQ EWIVISYIVS LALEKIREIL MSEPGKLSQK IKVWLQEYWN
     ITDLVAISTF MIGAILRLQN QPYMGYGRVI YCVDIIFWYI RVLDIFGVNK YLGPYVMMIG
     KMMIDMLYFV VIMLVVLMSF GVARQAILHP EEKPSWKLAR NIFYMPYWMI YGEVFADQID
     LYAMEINPPC GENLYDEEGK RLPPCIPGAW LTPALMACYL LVANILLVNL LIAVFNNTFF
     EVKSISNQVW KFQRYQLIMT FHDRPVLPPP MIILSHIYII IMRLSGRCRK KREGDQEERD
     RGLKLFLSDE ELKRLHEFEE QCVQEHFREK EDEQQSSSDE RIRVTSERVE NMSMRLEEIN
     ERETFMKTSL QTVDLRLAQL EELSNRMVNA LENLAGIDRS DLIQARSRAS SECEATYLLR
     QSSINSADGY SLYRYHFNGE ELLFEDTSLS TSPGTGVRKK TCSFRIKEEK DVKTHLVPEC
     QNSLHLSLGT STSATPDGSH LAVDDLKNAE ESKLGPDIGI SKEDDERQTD SKKEETISPS
     LNKTDVIHGQ DKSDVQNTQL TVETTNIEGT ISYPLEETKI TRYFPDETIN ACKTMKSRSF
     VYSRGRKLVG GVNQDVEYSS ITDQQLTTEW QCQVQKITRS HSTDIPYIVS EAAVQAEHKE
     QFADMQDEHH VAEAIPRIPR LSLTITDRNG MENLLSVKPD QTLGFPSLRS KSLHGHPRNV
     KSIQGKLDRS GHASSVSSLV IVSGMTAEEK KVKKEKASTE TEC
//
ID   P2XA_DICDI              Reviewed;         378 AA.
AC   Q86JM7; Q55A88;
DT   15-DEC-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   07-JUN-2017, entry version 80.
DE   RecName: Full=P2X receptor A;
DE            Short=DdP2X;
DE            Short=P2XA;
GN   Name=p2xA; ORFNames=DDB_G0272004;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, ENZYME
RP   REGULATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LYS-67; LYS-289
RP   AND ASP-330.
RX   PubMed=17625565; DOI=10.1038/nature05926;
RA   Fountain S.J., Parkinson K., Young M.T., Cao L., Thompson C.R.L.,
RA   North R.A.;
RT   "An intracellular P2X receptor required for osmoregulation in
RT   Dictyostelium discoideum.";
RL   Nature 448:200-203(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=12097910; DOI=10.1038/nature00847;
RA   Gloeckner G., Eichinger L., Szafranski K., Pachebat J.A.,
RA   Bankier A.T., Dear P.H., Lehmann R., Baumgart C., Parra G.,
RA   Abril J.F., Guigo R., Kumpf K., Tunggal B., Cox E.C., Quail M.A.,
RA   Platzer M., Rosenthal A., Noegel A.A.;
RT   "Sequence and analysis of chromosome 2 of Dictyostelium discoideum.";
RL   Nature 418:79-85(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18486207; DOI=10.1016/j.ceca.2008.04.001;
RA   Ludlow M.J., Traynor D., Fisher P.R., Ennion S.J.;
RT   "Purinergic-mediated Ca2+ influx in Dictyostelium discoideum.";
RL   Cell Calcium 44:567-579(2008).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19833731; DOI=10.1074/jbc.M109.045674;
RA   Ludlow M.J., Durai L., Ennion S.J.;
RT   "Functional characterization of intracellular Dictyostelium discoideum
RT   P2X receptors.";
RL   J. Biol. Chem. 284:35227-35239(2009).
CC   -!- FUNCTION: P2X receptors are ATP-gated ion channels that play a
CC       role in intracellular calcium signaling. Not required for the
CC       purinergic response to extracellular nucleotides. Inward currents
CC       evoked by intracellular ATP and ATP analogs. Exclusively selective
CC       for ATP over other nucleotides. Insensitive to P2 receptor
CC       antagonists PPADS, suramin and 2',3'-O-(2,4,6-trinitrophenyl)-ATP
CC       but inhibited by nanomolar concentrations of copper and sodium
CC       ion. More permeable to ammonium than either sodium or potassium
CC       ions and less permeable to choline. It has been reported that p2xA
CC       is not essential for osmoregulation (PubMed:19833731), however
CC       this information is in contradiction with another source
CC       (PubMed:17625565) which indicates that p2xA is required for
CC       osmoregulation. Found to be permeable to chloride ions. Inhibited
CC       by copper and sodium ions. {ECO:0000269|PubMed:17625565,
CC       ECO:0000269|PubMed:18486207, ECO:0000269|PubMed:19833731}.
CC   -!- SUBCELLULAR LOCATION: Contractile vacuole membrane
CC       {ECO:0000269|PubMed:17625565, ECO:0000269|PubMed:19833731}.
CC       Note=Ligand binding domain within the lumen of the vacuole.
CC   -!- DISRUPTION PHENOTYPE: Response to extracellular ATP remains the
CC       same in p2xA null strains. p2xA null cells have been reported to
CC       have compromised contractile vacuoles and defective
CC       osmoregulation, and exhibit cell swelling (PubMed:17625565). This
CC       is contradictory to other reports (PubMed:19833731). Quintuple
CC       p2xA/p2xB/p2XC/p2xd/p2xE null cells exhibit a slight delay in
CC       their osmoregulatory response, but are ultimately still capable of
CC       regulating their cell volume in water. Extracellular purinergic
CC       response to ATP persists in the quintuple null cells with no
CC       alteration in the kinetics of the response, but the magnitude of
CC       the response is lower. Responses to the calmodulin antagonist
CC       calmidazolium are reduced and intracellular calcium signaling is
CC       disrupted in quintuple null cells. The presence of copper prevents
CC       both wild type and quintuple null cells from undergoing an
CC       osmoregulatory decrease in cell volume. The quintuple null strains
CC       grow slightly slower than wild type in shaking axenic cultures.
CC       {ECO:0000269|PubMed:17625565, ECO:0000269|PubMed:18486207,
CC       ECO:0000269|PubMed:19833731}.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU047552; ABS88293.1; -; mRNA.
DR   EMBL; AAFI02000007; EAL71436.1; -; Genomic_DNA.
DR   RefSeq; XP_645378.1; XM_640286.1.
DR   STRING; 44689.DDB0238349; -.
DR   TCDB; 1.A.7.2.1; the atp-gated p2x receptor cation channel (p2x receptor) family.
DR   PaxDb; Q86JM7; -.
DR   EnsemblProtists; EAL71436; EAL71436; DDB_G0272004.
DR   GeneID; 8618267; -.
DR   KEGG; ddi:DDB_G0272004; -.
DR   dictyBase; DDB_G0272004; p2xA.
DR   eggNOG; ENOG410IXHI; Eukaryota.
DR   eggNOG; ENOG4111IMV; LUCA.
DR   InParanoid; Q86JM7; -.
DR   OMA; ETHSIRY; -.
DR   PhylomeDB; Q86JM7; -.
DR   PRO; PR:Q86JM7; -.
DR   Proteomes; UP000002195; Chromosome 2.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0031164; C:contractile vacuolar membrane; IDA:dictyBase.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IDA:dictyBase.
DR   GO; GO:0035381; F:ATP-gated ion channel activity; IMP:dictyBase.
DR   GO; GO:0015278; F:calcium-release channel activity; IMP:dictyBase.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:dictyBase.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:dictyBase.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:dictyBase.
DR   GO; GO:0071476; P:cellular hypotonic response; IGI:dictyBase.
DR   GO; GO:0009992; P:cellular water homeostasis; IMP:dictyBase.
DR   GO; GO:0070177; P:contractile vacuole discharge; IMP:dictyBase.
DR   GO; GO:0033298; P:contractile vacuole organization; IMP:dictyBase.
DR   GO; GO:0006971; P:hypotonic response; IMP:dictyBase.
DR   GO; GO:0006811; P:ion transport; IDA:dictyBase.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IDA:dictyBase.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IDA:dictyBase.
DR   GO; GO:0035590; P:purinergic nucleotide receptor signaling pathway; IMP:dictyBase.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IGI:dictyBase.
DR   GO; GO:0033198; P:response to ATP; IEA:InterPro.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   Pfam; PF00864; P2X_receptor; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Vacuole.
FT   CHAIN         1    378       P2X receptor A.
FT                                /FTId=PRO_0000390408.
FT   TOPO_DOM      1     27       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     28     48       Helical. {ECO:0000255}.
FT   TOPO_DOM     49    307       Lumenal. {ECO:0000255}.
FT   TRANSMEM    308    328       Helical. {ECO:0000255}.
FT   TOPO_DOM    329    378       Cytoplasmic. {ECO:0000255}.
FT   REGION      290    303       Pore-forming motif. {ECO:0000255}.
FT   MUTAGEN      67     67       K->A: More than ten-fold decrease in ATP
FT                                sensitivity.
FT                                {ECO:0000269|PubMed:17625565}.
FT   MUTAGEN     289    289       K->A: ATP elicits smaller currents.
FT                                {ECO:0000269|PubMed:17625565}.
FT   MUTAGEN     330    330       D->A: Loss of function.
FT                                {ECO:0000269|PubMed:17625565}.
SQ   SEQUENCE   378 AA;  42186 MW;  1DCBD07B25093094 CRC64;
     MGFSFDWDDI FQYSTVKIVR IRDRRLGILH LSFLVGIVAY IVVYSAIIKK GYLFTEVPIG
     SVRTSLKGPN TFASNLTYCS NQQHNGSTYP FTPLECNYWD EQLALFPVGQ DSTFTCTTRV
     RLSKQEANCN FTDPTCKFVD EPGSAKNIYI ADIESFTILI DHTMYASSSG SQFNAVDLHG
     YILNQDGDEV QIDANGTSIG VSGKPDIMTI GQLLSFGGVS LDQASPVDSN VSIRYDGVVL
     FVFITYSNTY TYSTSDFKYV YSVQQIANTI YDVPETIILE SIHSRLLYKR HGIRVIFIQT
     GTIGSFHFQT LLLTLVSGLG LLAVATTVVD QLAIRLLPQR KSYSSLKFQV TESMSNPMKK
     RITTDEGEDV LYTRIEGL
//
ID   GLR34_ARATH             Reviewed;         959 AA.
AC   Q8GXJ4; O23048; Q8LGM9; Q9SWD9;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   20-DEC-2017, entry version 127.
DE   RecName: Full=Glutamate receptor 3.4;
DE            Short=AtGLR4;
DE   AltName: Full=Ligand-gated ion channel 3.4;
DE   Flags: Precursor;
GN   Name=GLR3.4; Synonyms=GLR4, GLUR3; OrderedLocusNames=At1g05200;
GN   ORFNames=YUP8H12.19;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=cv. Columbia;
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-959 (ISOFORM 1), FUNCTION, TISSUE
RP   SPECIFICITY, INDUCTION BY ABIOTIC STRESSES, AND SUBCELLULAR LOCATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=15864638; DOI=10.1007/s00425-005-1551-3;
RA   Meyerhoff O., Mueller K., Roelfsema M.R.G., Latz A., Lacombe B.,
RA   Hedrich R., Dietrich P., Becker D.;
RT   "AtGLR3.4, a glutamate receptor channel-like gene is sensitive to
RT   touch and cold.";
RL   Planta 222:418-427(2005).
RN   [6]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18162597; DOI=10.1104/pp.107.108134;
RA   Stephens N.R., Qi Z., Spalding E.P.;
RT   "Glutamate receptor subtypes evidenced by differences in
RT   desensitization and dependence on the GLR3.3 and GLR3.4 genes.";
RL   Plant Physiol. 146:529-538(2008).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21110940; DOI=10.1016/j.bbabio.2010.11.008;
RA   Teardo E., Formentin E., Segalla A., Giacometti G.M., Marin O.,
RA   Zanetti M., Lo Schiavo F., Zoratti M., Szabo I.;
RT   "Dual localization of plant glutamate receptor AtGLR3.4 to plastids
RT   and plasmamembrane.";
RL   Biochim. Biophys. Acta 1807:359-367(2011).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel, at least in hypocotyls. Can be triggered
CC       by Ala, Asn, Gly, Ser and, to a lower extent, Cys and Glu. May be
CC       involved in light-signal transduction and calcium homeostasis via
CC       the regulation of calcium influx into cells. Plays an important
CC       role in the calcium-based fast transmission of environmental
CC       stress. {ECO:0000269|PubMed:15864638, ECO:0000269|PubMed:18162597,
CC       ECO:0000269|PubMed:21110940}.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Plastid, chloroplast.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=GLR3.4a;
CC         IsoId=Q8GXJ4-1; Sequence=Displayed;
CC       Name=2; Synonyms=GLR3.4b;
CC         IsoId=Q8GXJ4-2; Sequence=VSP_009219, VSP_009220;
CC         Note=May be due to an intron retention. No experimental
CC         confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in seedlings, cotyledons, roots
CC       (e.g. root hairs, epidermis and cortex cells), stems, leaves (e.g.
CC       vascular bundles and hydathodes), and siliques.
CC       {ECO:0000269|PubMed:12082126, ECO:0000269|PubMed:15864638}.
CC   -!- INDUCTION: The induction by glutamate, gamma-amino butiric acid
CC       (GABA), malate, aspartate, acetate, wounding, touch, and cold
CC       stress stimuli is abscisic acid (ABA)-independent, but calcium-
CC       dependent. Cold-mediated induction is rapid but transient.
CC       {ECO:0000269|PubMed:15864638}.
CC   -!- DISRUPTION PHENOTYPE: Impaired glutamate-triggered (and Ala, Asn,
CC       Cys, Gly, Ser-triggered) membrane depolarization and calcium rise.
CC       Slight reduction of photosynthetic yield of Photosystem II.
CC       {ECO:0000269|PubMed:18162597, ECO:0000269|PubMed:21110940}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB71458.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAD47833.1; Type=Erroneous termination; Positions=953; Note=Translated as Ser.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY072070; AAL61999.1; -; mRNA.
DR   EMBL; AC000098; AAB71458.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002684; AEE27803.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE27804.1; -; Genomic_DNA.
DR   EMBL; CP002684; ANM58387.1; -; Genomic_DNA.
DR   EMBL; CP002684; ANM58390.1; -; Genomic_DNA.
DR   EMBL; AK118206; BAC42828.1; -; mRNA.
DR   EMBL; AF167355; AAD47833.1; ALT_SEQ; mRNA.
DR   PIR; D86186; D86186.
DR   PIR; T51135; T51135.
DR   RefSeq; NP_001030971.1; NM_001035894.1. [Q8GXJ4-1]
DR   RefSeq; NP_001320828.1; NM_001331525.1. [Q8GXJ4-2]
DR   RefSeq; NP_001320831.1; NM_001331526.1. [Q8GXJ4-1]
DR   RefSeq; NP_172012.2; NM_100398.3. [Q8GXJ4-1]
DR   UniGene; At.10412; -.
DR   UniGene; At.66937; -.
DR   ProteinModelPortal; Q8GXJ4; -.
DR   BioGrid; 24503; 22.
DR   STRING; 3702.AT1G05200.1; -.
DR   TCDB; 1.A.10.1.10; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; Q8GXJ4; -.
DR   PaxDb; Q8GXJ4; -.
DR   PRIDE; Q8GXJ4; -.
DR   EnsemblPlants; AT1G05200.1; AT1G05200.1; AT1G05200. [Q8GXJ4-1]
DR   EnsemblPlants; AT1G05200.2; AT1G05200.2; AT1G05200. [Q8GXJ4-1]
DR   EnsemblPlants; AT1G05200.5; AT1G05200.5; AT1G05200. [Q8GXJ4-2]
DR   EnsemblPlants; AT1G05200.6; AT1G05200.6; AT1G05200. [Q8GXJ4-1]
DR   GeneID; 839268; -.
DR   Gramene; AT1G05200.1; AT1G05200.1; AT1G05200. [Q8GXJ4-1]
DR   Gramene; AT1G05200.2; AT1G05200.2; AT1G05200. [Q8GXJ4-1]
DR   Gramene; AT1G05200.5; AT1G05200.5; AT1G05200. [Q8GXJ4-2]
DR   Gramene; AT1G05200.6; AT1G05200.6; AT1G05200. [Q8GXJ4-1]
DR   KEGG; ath:AT1G05200; -.
DR   Araport; AT1G05200; -.
DR   TAIR; locus:2207165; AT1G05200.
DR   eggNOG; ENOG410ISQZ; Eukaryota.
DR   eggNOG; ENOG410ZZ8P; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q8GXJ4; -.
DR   KO; K05387; -.
DR   OMA; VCSQFSK; -.
DR   OrthoDB; EOG093601T8; -.
DR   PhylomeDB; Q8GXJ4; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q8GXJ4; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q8GXJ4; baseline and differential.
DR   Genevisible; Q8GXJ4; AT.
DR   GO; GO:0009507; C:chloroplast; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009536; C:plastid; IDA:TAIR.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; IMP:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IDA:TAIR.
DR   GO; GO:0006816; P:calcium ion transport; IDA:TAIR.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0071311; P:cellular response to acetate; IEP:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB.
DR   GO; GO:0070417; P:cellular response to cold; IEP:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0009611; P:response to wounding; IEP:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Chloroplast; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Plastid; Receptor; Reference proteome; Signal;
KW   Stress response; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     35       {ECO:0000255}.
FT   CHAIN        36    959       Glutamate receptor 3.4.
FT                                /FTId=PRO_0000011608.
FT   TOPO_DOM     36    613       Extracellular. {ECO:0000255}.
FT   TRANSMEM    614    634       Helical. {ECO:0000255}.
FT   TOPO_DOM    635    643       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    644    664       Helical. {ECO:0000255}.
FT   TOPO_DOM    665    675       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    676    696       Helical. {ECO:0000255}.
FT   TOPO_DOM    697    857       Extracellular. {ECO:0000255}.
FT   TRANSMEM    858    878       Helical. {ECO:0000255}.
FT   TOPO_DOM    879    959       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     42     42       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    365    365       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    378    378       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    404    404       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    443    443       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    576    576       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     656    669       FSFSTMFFSHRENT -> LVSQFLTLEPEFTF (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:11910074}.
FT                                /FTId=VSP_009219.
FT   VAR_SEQ     670    959       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11910074}.
FT                                /FTId=VSP_009220.
FT   CONFLICT     57     57       R -> G (in Ref. 5; AAD47833).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       L -> P (in Ref. 5; AAD47833).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       H -> Q (in Ref. 5; AAD47833).
FT                                {ECO:0000305}.
FT   CONFLICT    450    450       V -> A (in Ref. 4; BAC42828).
FT                                {ECO:0000305}.
FT   CONFLICT    733    733       Y -> N (in Ref. 5; AAD47833).
FT                                {ECO:0000305}.
FT   CONFLICT    897    897       A -> P (in Ref. 5; AAD47833).
FT                                {ECO:0000305}.
SQ   SEQUENCE   959 AA;  107207 MW;  0709B834A76FAFC0 CRC64;
     MGFLVMIREV SMAKAIRVVL LCVSVLWVVP KECACRSNFS RNSSSSSSSS LRPLRQRPSS
     VNVGALFTYD SFIGRAAKPA VKAAMDDVNA DQSVLKGIKL NIIFQDSNCS GFIGTMGALQ
     LMENKVVAAI GPQSSGIAHM ISYVANELHV PLLSFGATDP TLSSLQFPYF LRTTQNDYFQ
     MHAIADFLSY SGWRQVIAIF VDDECGRNGI SVLGDVLAKK RSRISYKAAI TPGADSSSIR
     DLLVSVNLME SRVFVVHVNP DSGLNVFSVA KSLGMMASGY VWIATDWLPT AMDSMEHVDS
     DTMDLLQGVV AFRHYTIESS VKRQFMARWK NLRPNDGFNS YAMYAYDSVW LVARALDVFF
     RENNNITFSN DPNLHKTNGS TIQLSALSVF NEGEKFMKII LGMNHTGVTG PIQFDSDRNR
     VNPAYEVLNL EGTAPRTVGY WSNHSGLSVV HPETLYSRPP NTSTANQRLK GIIYPGEVTK
     PPRGWVFPNN GKPLRIGVPN RVSYTDYVSK DKNPPGVRGY CIDVFEAAIE LLPYPVPRTY
     ILYGDGKRNP SYDNLVNEVV ADNFDVAVGD ITIVTNRTRY VDFTQPFIES GLVVVAPVKE
     AKSSPWSFLK PFTIEMWAVT GGFFLFVGAM VWILEHRFNQ EFRGPPRRQL ITIFWFSFST
     MFFSHRENTV SSLGRFVLII WLFVVLIINS SYTASLTSIL TIRQLTSRIE GIDSLVTSNE
     PIGVQDGTFA RNYLINELNI LPSRIVPLKD EEQYLSALQR GPNAGGVAAI VDELPYIEVL
     LTNSNCKFRT VGQEFTRTGW GFAFQRDSPL AVDMSTAILQ LSEEGELEKI HRKWLNYKHE
     CSMQISNSED SQLSLKSFWG LFLICGITCF MALTVFFWRV FWQYQRLLPE SADEERAGEV
     SEPSRSGRGS RAPSFKELIK VVDKREAEIK EILKQKSSKK LKSTQSAAGT SQSQHGEIT
//
ID   GLR27_ARATH             Reviewed;         952 AA.
AC   Q8LGN0; O81080; Q6RKN3; Q8RY02;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 3.
DT   20-DEC-2017, entry version 107.
DE   RecName: Full=Glutamate receptor 2.7;
DE   AltName: Full=Ligand-gated ion channel 2.7;
DE   Flags: Precursor;
GN   Name=GLR2.7; OrderedLocusNames=At2g29120; ORFNames=T9I4.20;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-952, AND TISSUE SPECIFICITY.
RC   STRAIN=cv. Columbia;
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 560-952.
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in leaves.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC33239.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY495450; AAR88101.1; -; mRNA.
DR   EMBL; AC005315; AAC33239.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002685; AEC08213.1; -; Genomic_DNA.
DR   EMBL; AY072069; AAL61998.1; -; mRNA.
DR   EMBL; AY080587; AAL85964.2; -; mRNA.
DR   PIR; T02742; T02742.
DR   RefSeq; NP_180476.3; NM_128469.4.
DR   UniGene; At.38520; -.
DR   ProteinModelPortal; Q8LGN0; -.
DR   BioGrid; 2810; 9.
DR   STRING; 3702.AT2G29120.1; -.
DR   PaxDb; Q8LGN0; -.
DR   EnsemblPlants; AT2G29120.1; AT2G29120.1; AT2G29120.
DR   GeneID; 817460; -.
DR   Gramene; AT2G29120.1; AT2G29120.1; AT2G29120.
DR   KEGG; ath:AT2G29120; -.
DR   Araport; AT2G29120; -.
DR   TAIR; locus:2066107; AT2G29120.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG410XQQV; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q8LGN0; -.
DR   KO; K05387; -.
DR   OMA; VEFFCRS; -.
DR   OrthoDB; EOG0936061T; -.
DR   PhylomeDB; Q8LGN0; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q8LGN0; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q8LGN0; baseline and differential.
DR   Genevisible; Q8LGN0; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005773; C:vacuole; IDA:TAIR.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     32       {ECO:0000255}.
FT   CHAIN        33    952       Glutamate receptor 2.7.
FT                                /FTId=PRO_0000011602.
FT   TOPO_DOM     33    582       Extracellular. {ECO:0000255}.
FT   TRANSMEM    583    603       Helical. {ECO:0000255}.
FT   TOPO_DOM    604    612       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    613    633       Helical. {ECO:0000255}.
FT   TOPO_DOM    634    637       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    638    658       Helical. {ECO:0000255}.
FT   TOPO_DOM    659    821       Extracellular. {ECO:0000255}.
FT   TRANSMEM    822    842       Helical. {ECO:0000255}.
FT   TOPO_DOM    843    952       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     34     34       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     60     60       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    546    546       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    664    664       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    728    728       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    748    748       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    784    784       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    809    809       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   952 AA;  107406 MW;  C3B17031880DD48C CRC64;
     MKVMNPRKTN NTFMYYFVLF VCGFVLMEGC LGQNQTTEIK VGVVLDLHTS FSKLCLTSIN
     ISLSDFYKYH SDYTTRLAIH IRDSMEDVVQ ASSAALDLIK NEQVSAIIGP RTSMQAEFMI
     RLADKSQVPT ITFSATCPLL TSINSPYFVR ATLDDSSQVK AIAAIVKSFG WRNVVAIYVD
     NEFGEGILPL LTDALQDVQA FVVNRCLIPQ EANDDQILKE LYKLMTMQTR VFVVHMPPTL
     GFRFFQKARE IGMMEEGYVW LLTDGVMNLL KSNERGSSLE NMQGVLGVRS HIPKSKKLKN
     FRLRWEKMFP KKGNDEEMNI FALRAYDSIT ALAMAVEKTN IKSLRYDHPI ASGNNKTNLG
     TLGVSRYGPS LLKALSNVRF NGLAGEFELI NGQLESSVFD VINIIGSEER IIGLWRPSNG
     IVNAKSKNTT SVLGERLGPV IWPGKSKDVP KGWQIPTNGK MLRVGIPVKK GFLEFVDAKI
     DPISNAMTPT GYCIEIFEAV LKKLPYSVIP KYIAFLSPDE NYDEMVYQVY TGAYDAVVGD
     VTIVANRSLY VDFTLPYTES GVSMMVPLKD NKNTWVFLRP WSLDLWVTTA CFFVFIGFIV
     WILEHRVNTD FRGPPHHQIG TSFWFAFSTM NFAHREKVVS NLARFVVLVW CFVVLVLIQS
     YTANLTSFFT VKLLQPTVTN WKDLIKFNKN IGYQRGTFVR ELLKSQGFDE SQLKPFGSAV
     ECDELFSNGT ITASFDEVAY IKVILSQNSS KYTMVEPSFK TAGFGFVFPK KSPLTDDVSR
     AILNVTQGEE MQHIENKWFK KPNNCPDLNT SLSSNHLSLS SFWGLFLIAG IASFLALLIF
     VANFLYEHKH TLFDDSENSF RGKLKFLVRN FDEKDIKSHM FKENAVHNVS SPITQGSSSP
     LTDQSTPLPR SPEQYRELEL RRVSSISSGE LFTTQSEQVE DEESAIIQCE GE
//
ID   GLR14_ARATH             Reviewed;         861 AA.
AC   Q8LGN1; Q8LGN2; Q9SRR4;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   20-DEC-2017, entry version 106.
DE   RecName: Full=Glutamate receptor 1.4;
DE   AltName: Full=Ligand-gated ion channel 1.4;
DE   Flags: Precursor;
GN   Name=GLR1.4; OrderedLocusNames=At3g07520; ORFNames=F21O3.23;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=cv. Columbia;
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M.,
RA   Fartmann B., Valle G., Bloecker H., Perez-Alonso M., Obermaier B.,
RA   Delseny M., Boutry M., Grivell L.A., Mache R., Puigdomenech P.,
RA   De Simone V., Choisne N., Artiguenave F., Robert C., Brottier P.,
RA   Wincker P., Cattolico L., Weissenbach J., Saurin W., Quetier F.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Benes V.,
RA   Wurmbach E., Drzonek H., Erfle H., Jordan N., Bangert S.,
RA   Wiedelmann R., Kranz H., Voss H., Holland R., Brandt P., Nyakatura G.,
RA   Vezzi A., D'Angelo M., Pallavicini A., Toppo S., Simionati B.,
RA   Conrad A., Hornischer K., Kauer G., Loehnert T.-H., Nordsiek G.,
RA   Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J., Climent J.,
RA   Navarro P., Collado C., Perez-Perez A., Ottenwaelder B., Duchemin D.,
RA   Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D.,
RA   Mannhaupt G., Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W.,
RA   Mayer K.F.X., Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J.,
RA   Rooney T., Rizzo M., Walts A., Utterback T., Fujii C.Y., Shea T.P.,
RA   Creasy T.H., Haas B., Maiti R., Wu D., Peterson J., Van Aken S.,
RA   Pai G., Militscher J., Sellers P., Gill J.E., Feldblyum T.V.,
RA   Preuss D., Lin X., Nierman W.C., Salzberg S.L., White O., Venter J.C.,
RA   Fraser C.M., Kaneko T., Nakamura Y., Sato S., Kato T., Asamizu E.,
RA   Sasamoto S., Kimura T., Idesawa K., Kawashima K., Kishida Y.,
RA   Kiyokawa C., Kohara M., Matsumoto M., Matsuno A., Muraki A.,
RA   Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:820-822(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [5]
RP   FUNCTION.
RX   PubMed=18625242; DOI=10.1016/j.jmb.2008.06.076;
RA   Tapken D., Hollmann M.;
RT   "Arabidopsis thaliana glutamate receptor ion channel function
RT   demonstrated by ion pore transplantation.";
RL   J. Mol. Biol. 383:36-48(2008).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. Can transport calcium ions. May be
CC       involved in light-signal transduction and calcium homeostasis via
CC       the regulation of calcium influx into cells.
CC       {ECO:0000269|PubMed:18625242}.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots and siliques.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- CAUTION: AAL61996 is a fragment and was originally reported as a
CC       spliced variant of AAL61995. {ECO:0000305|PubMed:12082126}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF02156.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY072066; AAL61995.1; -; mRNA.
DR   EMBL; AY072067; AAL61996.1; -; mRNA.
DR   EMBL; AC009853; AAF02156.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002686; AEE74553.1; -; Genomic_DNA.
DR   RefSeq; NP_187408.2; NM_111630.2.
DR   UniGene; At.40336; -.
DR   ProteinModelPortal; Q8LGN1; -.
DR   SMR; Q8LGN1; -.
DR   BioGrid; 5275; 11.
DR   MINT; MINT-8060398; -.
DR   STRING; 3702.AT3G07520.1; -.
DR   iPTMnet; Q8LGN1; -.
DR   PaxDb; Q8LGN1; -.
DR   EnsemblPlants; AT3G07520.1; AT3G07520.1; AT3G07520.
DR   GeneID; 819940; -.
DR   Gramene; AT3G07520.1; AT3G07520.1; AT3G07520.
DR   KEGG; ath:AT3G07520; -.
DR   Araport; AT3G07520; -.
DR   TAIR; locus:2079681; AT3G07520.
DR   eggNOG; ENOG410ISR3; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q8LGN1; -.
DR   KO; K05387; -.
DR   OMA; FVAHISE; -.
DR   OrthoDB; EOG093602FE; -.
DR   PhylomeDB; Q8LGN1; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q8LGN1; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q8LGN1; baseline and differential.
DR   Genevisible; Q8LGN1; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IDA:TAIR.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0030003; P:cellular cation homeostasis; IDA:TAIR.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30    861       Glutamate receptor 1.4.
FT                                /FTId=PRO_0000011595.
FT   TOPO_DOM     30    568       Extracellular. {ECO:0000255}.
FT   TRANSMEM    569    589       Helical. {ECO:0000255}.
FT   TOPO_DOM    590    598       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    599    619       Helical. {ECO:0000255}.
FT   TOPO_DOM    620    630       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    631    651       Helical. {ECO:0000255}.
FT   TOPO_DOM    652    800       Extracellular. {ECO:0000255}.
FT   TRANSMEM    801    821       Helical. {ECO:0000255}.
FT   TOPO_DOM    822    861       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    306    306       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    534    534       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    707    707       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   861 AA;  97760 MW;  0782EE543B78BA63 CRC64;
     MENCMIRNTG YFLTIFFLAF ISFAVTCSGT NQKDNVDRLP VVYEDVRIGL VVDMGSMEGK
     LVTTSISMAL SDFYHVNNGY RTRVSVLSRD SHGDPLQALA AAMDLLQTEQ VEALVGGQSL
     LEAKNLAELG EKTKVPVISS FQVPSSLSLA KYNYFIQATH DTSSEAKGIA ALFSNFDWRT
     AVLIYEDDDD WRESIQPLVG HFQQNAIHIE YKAEFSVSSN EECIMKQLRK FKASGIRIFV
     AHISERIANR LFPCARRLGM MEEGYAWILT ARSMNNFQDT NYLAKEEMEG VIGFKSYIPL
     TEELHNFTLR WKRSLRLEEV VTRMSVCSIW AHDIAWSLAR AAEVAKLPGL SVYDLLEAIP
     ESAKHKGLSG DIKFIDKKFI SDKFEIVNMI GRGERSVGLW NSGSFISNRR RRLSSTKALE
     TIIWPGGSTR IPKIRSLKEK RHGKKKKLRV LVPAGNITPQ ILEVKTDFKT GVTAATGYCI
     DVFETSILPF NYEVEYIPWP GAINYKNYND LVYTLYSQKD KYDAAVGDIT ITDNRSLYVD
     FTLPFTDMGL AVVTAKDKSM WIIFKPLTLS LWLTIASFFI LTGAIVWLIE RHDNADFQGS
     CFQQIGTLLC FGFSTLVFAH RERLQHNMSR FVVIVWIFAV LILTSNYTAT LTSVMTVQQI
     RGLKSNENIG FFSASIAANV VNDNPTFQGP RYKGLKTADD FTNALRNGTI SFIVDEVPYV
     KLFVAKHPSE FVIVETESVT NGFGFAFQKG SPLVQKVSRE IEKLRRTEKL KAIENWWFQR
     QTTSATSEDT FHPLTVYTFR GLFMITGVSF AFALIVYLIP WNREQRQVVL KHFHRYVSHR
     FAREIRPSPT TPNRQNENSV I
//
ID   CNGC5_ARATH             Reviewed;         717 AA.
AC   Q8RWS9; Q9XFS3;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   20-DEC-2017, entry version 135.
DE   RecName: Full=Probable cyclic nucleotide-gated ion channel 5;
DE            Short=AtCNGC5;
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 5;
GN   Name=CNGC5; OrderedLocusNames=At5g57940; ORFNames=MTI20.20;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=cv. Columbia;
RX   PubMed=10341447; DOI=10.1046/j.1365-313X.1999.00422.x;
RA   Koehler C., Merkle T., Neuhaus G.;
RT   "Characterisation of a novel gene family of putative cyclic
RT   nucleotide- and calmodulin-regulated ion channels in Arabidopsis
RT   thaliana.";
RL   Plant J. 18:97-104(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9734815; DOI=10.1093/dnares/5.3.203;
RA   Kotani H., Nakamura Y., Sato S., Asamizu E., Kaneko T., Miyajima N.,
RA   Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 5. VI.
RT   Sequence features of the regions of 1,367,185 bp covered by 19
RT   physically assigned P1 and TAC clones.";
RL   DNA Res. 5:203-216(1998).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
CC   -!- FUNCTION: Probable cyclic nucleotide-gated ion channel.
CC   -!- SUBUNIT: Homotetramer or heterotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8RWS9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8RWS9-2; Sequence=VSP_008987;
CC         Note=May be due to a competing acceptor splice site. No
CC         experimental confirmation available.;
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17913; CAB40130.1; -; mRNA.
DR   EMBL; AB013396; BAB08864.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96974.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96975.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED96976.1; -; Genomic_DNA.
DR   EMBL; AY091133; AAM14082.1; -; mRNA.
DR   EMBL; AY114053; AAM45101.1; -; mRNA.
DR   PIR; T52573; T52573.
DR   RefSeq; NP_200602.2; NM_125179.5. [Q8RWS9-1]
DR   RefSeq; NP_851209.1; NM_180878.2. [Q8RWS9-1]
DR   RefSeq; NP_974953.1; NM_203224.1. [Q8RWS9-2]
DR   UniGene; At.22566; -.
DR   ProteinModelPortal; Q8RWS9; -.
DR   SMR; Q8RWS9; -.
DR   BioGrid; 21149; 30.
DR   MINT; MINT-8066962; -.
DR   STRING; 3702.AT5G57940.1; -.
DR   PaxDb; Q8RWS9; -.
DR   PRIDE; Q8RWS9; -.
DR   EnsemblPlants; AT5G57940.1; AT5G57940.1; AT5G57940. [Q8RWS9-1]
DR   EnsemblPlants; AT5G57940.2; AT5G57940.2; AT5G57940. [Q8RWS9-1]
DR   EnsemblPlants; AT5G57940.3; AT5G57940.3; AT5G57940. [Q8RWS9-2]
DR   GeneID; 835905; -.
DR   Gramene; AT5G57940.1; AT5G57940.1; AT5G57940. [Q8RWS9-1]
DR   Gramene; AT5G57940.2; AT5G57940.2; AT5G57940. [Q8RWS9-1]
DR   Gramene; AT5G57940.3; AT5G57940.3; AT5G57940. [Q8RWS9-2]
DR   KEGG; ath:AT5G57940; -.
DR   Araport; AT5G57940; -.
DR   TAIR; locus:2174448; AT5G57940.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; Q8RWS9; -.
DR   KO; K05391; -.
DR   OMA; INAESKC; -.
DR   OrthoDB; EOG093603N1; -.
DR   PhylomeDB; Q8RWS9; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q8RWS9; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q8RWS9; baseline and differential.
DR   Genevisible; Q8RWS9; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:TAIR.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0005262; F:calcium channel activity; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:TAIR.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
DR   PROSITE; PS50096; IQ; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calmodulin-binding; cAMP; cAMP-binding;
KW   Cell membrane; cGMP; cGMP-binding; Complete proteome; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    717       Probable cyclic nucleotide-gated ion
FT                                channel 5.
FT                                /FTId=PRO_0000219333.
FT   TOPO_DOM      1    102       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    124    136       Extracellular. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    158    190       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    191    211       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    212    224       Extracellular. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    246    265       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    287    391       Extracellular. {ECO:0000255}.
FT   TRANSMEM    392    412       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    413    717       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      634    663       IQ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND     498    628       cNMP.
FT   REGION      614    629       Calmodulin-binding. {ECO:0000250}.
FT   BINDING     569    569       cNMP. {ECO:0000250}.
FT   VAR_SEQ      10     16       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10341447}.
FT                                /FTId=VSP_008987.
SQ   SEQUENCE   717 AA;  81969 MW;  444FF45621AE6BDF CRC64;
     MAGKRENFVR VDDLDSRLPS SSVAFQQNYA SNFSGQLHPI HASNETSRSF KKGIQKGSKG
     LKSIGRSLGF GVYRAVFPED LKVSEKKIFD PQDKFLLYCN KLFVASCILS VFVDPFFFYL
     PVINAESKCL GIDRKLAITA STLRTFIDVF YLAHMALQLR TAYIAPSSRV FGRGELVIDP
     AQIAKRYLQR WFIIDFLSVL PLPQIVVWRF LQSSNGSDVL ATKQALLFIV LVQYIPRFLR
     VLPLTSELKR TAGVFAETAW AGAAYYLLLY MLASHIVGAF WYLLALERND ACWQEACIDA
     GNCSTDFLYC GNQNMDGYAV WNRAKESVLK SKCRADLDDN NPPFDFGIYT QALSSGIVSS
     QNFIVKYCYC LWWGLQNLST LGQGLETSTY PMEIIFSISL AISGLILFAL LIGNMQTYLQ
     SLTIRLEEMR VKRRDSEQWM HHRMLPQDLR ERVRRYDQYK WLETRGVDEE YLVQNLPKDL
     RRDIKRHLCL ALVRRVPLFK SMDDKLLDAI CMRLKPCLFT ESTYLVREGD PVDEMLFIIR
     GRLESVTTDG GRSGFFNRSL LKEGEFCGEE LLTWALDPKS GVNLPSSTRT VKALTEVEAF
     ALTSEELKFV ASQFRRLHSR QVQHTFRFYS HQWRTWAACF IQAAWRRYCK RKKMEEAEAE
     AAAVSSSTAG PSYSIGAAFL ATKFAANALR TIHRNRNTKI RDLVKLQKPP EPDFTAD
//
ID   NMD3A_HUMAN             Reviewed;        1115 AA.
AC   Q8TCU5; B3DLF9; Q5VTR3; Q8TF29; Q8WXI6;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 2.
DT   20-DEC-2017, entry version 142.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 3A;
DE            Short=GluN3A;
DE   AltName: Full=N-methyl-D-aspartate receptor subtype 3A;
DE            Short=NMDAR3A;
DE            Short=NR3A;
DE   AltName: Full=NMDAR-L;
DE   Flags: Precursor;
GN   Name=GRIN3A; Synonyms=KIAA1973;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-487.
RC   TISSUE=Brain;
RX   PubMed=11735224; DOI=10.1006/geno.2001.6666;
RA   Andersson O., Stenqvist A., Attersand A., von Euler G.;
RT   "Nucleotide sequence, genomic organization, and chromosomal
RT   localization of genes encoding the human NMDA receptor subunits NR3A
RT   and NR3B.";
RL   Genomics 78:178-184(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS MET-362; ARG-487 AND ASN-835, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11880201; DOI=10.1016/S0304-3940(01)02524-1;
RA   Eriksson M., Nilsson A., Froelich-Fabre S., Aakesson E., Dunker J.,
RA   Seiger A., Folkesson R., Benedikz E., Sundstroem E.;
RT   "Cloning and expression of the human NMDA receptor subunit NR3A.";
RL   Neurosci. Lett. 321:177-181(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-1041.
RC   TISSUE=Brain;
RX   PubMed=11853319; DOI=10.1093/dnares/8.6.319;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXII.
RT   The complete sequences of 50 new cDNA clones which code for large
RT   proteins.";
RL   DNA Res. 8:319-327(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-1041.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=14684485; DOI=10.1196/annals.1300.049;
RA   Mueller H.T., Meador-Woodruff J.H.;
RT   "Expression of the NR3A subunit of the NMDA receptor in human fetal
RT   brain.";
RL   Ann. N. Y. Acad. Sci. 1003:448-451(2003).
RN   [7]
RP   INTERACTION WITH PPP2CB.
RX   PubMed=11588171;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [8]
RP   VARIANTS ILE-72; GLY-111; SER-116; 227-GLU--SER-1115 DEL; TRP-337;
RP   ARG-373; THR-375; PRO-434; PHE-493; 508-GLN--SER-1115 DEL; SER-565;
RP   ASN-586; LEU-641; SER-793; MET-921; HIS-956 AND ASN-1028.
RX   PubMed=22833210; DOI=10.1038/tp.2011.52;
RG   S2D team;
RA   Tarabeux J., Kebir O., Gauthier J., Hamdan F.F., Xiong L., Piton A.,
RA   Spiegelman D., Henrion E., Millet B., Fathalli F., Joober R.,
RA   Rapoport J.L., DeLisi L.E., Fombonne E., Mottron L., Forget-Dubois N.,
RA   Boivin M., Michaud J.L., Drapeau P., Lafreniere R.G., Rouleau G.A.,
RA   Krebs M.O.;
RT   "Rare mutations in N-methyl-D-aspartate glutamate receptors in autism
RT   spectrum disorders and schizophrenia.";
RL   Transl. Psychiatry 1:E55-E55(2011).
CC   -!- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels
CC       with reduced single-channel conductance, low calcium permeability
CC       and low voltage-dependent sensitivity to magnesium. Mediated by
CC       glycine. May play a role in the development of dendritic spines.
CC       May play a role in PPP2CB-NMDAR mediated signaling mechanism (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms heteromeric channel of a zeta subunit (GRIN1), a
CC       epsilon subunit (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and a third
CC       subunit (GRIN3A or GRIN3B). Does not form functional homomeric
CC       channels. Found in a complex with GRIN1, GRIN2A or GRIN2B and
CC       PPP2CB. Probably interacts with PPP2CB. No complex with PPP2CB is
CC       detected when NMDARs are stimulated by NMDA (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density {ECO:0000250}.
CC       Note=Enriched in postsynaptic plasma membrane and postsynaptic
CC       densities. Requires the presence of GRIN1 to be targeted at the
CC       plasma membrane (By similarity). {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal brain.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR3A/GRIN3A subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB85559.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF416558; AAL40734.1; -; mRNA.
DR   EMBL; AJ416950; CAC95229.2; -; mRNA.
DR   EMBL; AB075853; BAB85559.1; ALT_INIT; mRNA.
DR   EMBL; AL591377; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC167432; AAI67432.1; -; mRNA.
DR   CCDS; CCDS6758.1; -.
DR   RefSeq; NP_597702.2; NM_133445.2.
DR   UniGene; Hs.654783; -.
DR   ProteinModelPortal; Q8TCU5; -.
DR   BioGrid; 125508; 2.
DR   MINT; MINT-6630950; -.
DR   STRING; 9606.ENSP00000355155; -.
DR   ChEMBL; CHEMBL4787; -.
DR   DrugBank; DB00659; Acamprosate.
DR   DrugBank; DB06151; Acetylcysteine.
DR   DrugBank; DB00915; Amantadine.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB01161; Chloroprocaine.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00392; Ethopropazine.
DR   DrugBank; DB00949; Felbamate.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB06741; Gavestinel.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01221; Ketamine.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB01043; Memantine.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB04896; Milnacipran.
DR   DrugBank; DB04926; Neramexane.
DR   DrugBank; DB01173; Orphenadrine.
DR   DrugBank; DB00312; Pentobarbital.
DR   DrugBank; DB03575; Phencyclidine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01708; Prasterone.
DR   DrugBank; DB00721; Procaine.
DR   DrugBank; DB01549; Rolicyclidine.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01520; Tenocyclidine.
DR   DrugBank; DB00193; Tramadol.
DR   iPTMnet; Q8TCU5; -.
DR   PhosphoSitePlus; Q8TCU5; -.
DR   BioMuta; GRIN3A; -.
DR   DMDM; 212276445; -.
DR   PaxDb; Q8TCU5; -.
DR   PeptideAtlas; Q8TCU5; -.
DR   PRIDE; Q8TCU5; -.
DR   Ensembl; ENST00000361820; ENSP00000355155; ENSG00000198785.
DR   GeneID; 116443; -.
DR   KEGG; hsa:116443; -.
DR   UCSC; uc004bbp.3; human.
DR   CTD; 116443; -.
DR   DisGeNET; 116443; -.
DR   EuPathDB; HostDB:ENSG00000198785.4; -.
DR   GeneCards; GRIN3A; -.
DR   H-InvDB; HIX0008248; -.
DR   H-InvDB; HIX0125606; -.
DR   HGNC; HGNC:16767; GRIN3A.
DR   MIM; 606650; gene.
DR   neXtProt; NX_Q8TCU5; -.
DR   OpenTargets; ENSG00000198785; -.
DR   PharmGKB; PA28983; -.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   GeneTree; ENSGT00760000119186; -.
DR   HOGENOM; HOG000231528; -.
DR   HOVERGEN; HBG052634; -.
DR   InParanoid; Q8TCU5; -.
DR   KO; K05213; -.
DR   OMA; TQFGVMP; -.
DR   OrthoDB; EOG091G00PT; -.
DR   PhylomeDB; Q8TCU5; -.
DR   TreeFam; TF314731; -.
DR   GeneWiki; GRIN3A; -.
DR   GenomeRNAi; 116443; -.
DR   PRO; PR:Q8TCU5; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000198785; -.
DR   CleanEx; HS_GRIN3A; -.
DR   Genevisible; Q8TCU5; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IEA:Ensembl.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0016358; P:dendrite development; IEA:Ensembl.
DR   GO; GO:0060134; P:prepulse inhibition; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IDA:UniProtKB.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Cell membrane; Coiled coil; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Magnesium; Membrane; Polymorphism; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1115       Glutamate receptor ionotropic, NMDA 3A.
FT                                /FTId=PRO_0000011568.
FT   TOPO_DOM     24    674       Extracellular. {ECO:0000255}.
FT   TRANSMEM    675    695       Helical. {ECO:0000255}.
FT   TOPO_DOM    696    748       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    749    769       Helical. {ECO:0000255}.
FT   TOPO_DOM    770    930       Extracellular. {ECO:0000255}.
FT   TRANSMEM    931    951       Helical. {ECO:0000255}.
FT   TOPO_DOM    952   1115       Cytoplasmic. {ECO:0000255}.
FT   REGION      951    987       PPP2CB binding site. {ECO:0000250}.
FT   COILED     1058   1109       {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    285    285       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    296    296       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    439    439       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    549    549       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    565    565       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    886    886       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      72     72       S -> I. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079892.
FT   VARIANT     111    111       R -> G (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079893.
FT   VARIANT     116    116       G -> S. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079894.
FT   VARIANT     227   1115       Missing. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079895.
FT   VARIANT     337    337       R -> W. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079896.
FT   VARIANT     362    362       V -> M (in dbSNP:rs10989591).
FT                                {ECO:0000269|PubMed:11880201}.
FT                                /FTId=VAR_019672.
FT   VARIANT     373    373       G -> R (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079897.
FT   VARIANT     375    375       I -> T. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079898.
FT   VARIANT     434    434       S -> P. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079899.
FT   VARIANT     480    480       R -> H (in dbSNP:rs34755188).
FT                                /FTId=VAR_047150.
FT   VARIANT     487    487       G -> R (in dbSNP:rs10989589).
FT                                {ECO:0000269|PubMed:11735224,
FT                                ECO:0000269|PubMed:11880201}.
FT                                /FTId=VAR_019673.
FT   VARIANT     493    493       Y -> F. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079900.
FT   VARIANT     508   1115       Missing (probable disease-associated
FT                                mutation found in a patient with
FT                                schizophrenia).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079901.
FT   VARIANT     565    565       N -> S. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079902.
FT   VARIANT     586    586       K -> N. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079903.
FT   VARIANT     641    641       V -> L (found in a patient with autism
FT                                spectrum disorder; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079904.
FT   VARIANT     793    793       R -> S. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079905.
FT   VARIANT     835    835       D -> N (in dbSNP:rs10989563).
FT                                {ECO:0000269|PubMed:11880201}.
FT                                /FTId=VAR_019674.
FT   VARIANT     921    921       T -> M. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079906.
FT   VARIANT     956    956       Y -> H. {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079907.
FT   VARIANT    1028   1028       I -> N (found in a patient with
FT                                schizophrenia; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22833210}.
FT                                /FTId=VAR_079908.
FT   VARIANT    1041   1041       R -> Q (in dbSNP:rs3739722).
FT                                {ECO:0000269|PubMed:11853319,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_019675.
FT   CONFLICT    559    559       S -> N (in Ref. 1; AAL40734).
FT                                {ECO:0000305}.
FT   CONFLICT    977    977       Q -> R (in Ref. 1; AAL40734).
FT                                {ECO:0000305}.
FT   CONFLICT   1073   1073       N -> I (in Ref. 1; AAL40734).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1115 AA;  125465 MW;  0FEEC995F6AAF940 CRC64;
     MRRLSLWWLL SRVCLLLPPP CALVLAGVPS SSSHPQPCQI LKRIGHAVRV GAVHLQPWTT
     APRAASRAPD DSRAGAQRDE PEPGTRRSPA PSPGARWLGS TLHGRGPPGS RKPGEGARAE
     ALWPRDALLF AVDNLNRVEG LLPYNLSLEV VMAIEAGLGD LPLLPFSSPS SPWSSDPFSF
     LQSVCHTVVV QGVSALLAFP QSQGEMMELD LVSLVLHIPV ISIVRHEFPR ESQNPLHLQL
     SLENSLSSDA DVTVSILTMN NWYNFSLLLC QEDWNITDFL LLTQNNSKFH LGSIINITAN
     LPSTQDLLSF LQIQLESIKN STPTVVMFGC DMESIRRIFE ITTQFGVMPP ELRWVLGDSQ
     NVEELRTEGL PLGLIAHGKT TQSVFEHYVQ DAMELVARAV ATATMIQPEL ALIPSTMNCM
     EVETTNLTSG QYLSRFLANT TFRGLSGSIR VKGSTIVSSE NNFFIWNLQH DPMGKPMWTR
     LGSWQGGKIV MDYGIWPEQA QRHKTHFQHP SKLHLRVVTL IEHPFVFTRE VDDEGLCPAG
     QLCLDPMTND SSTLDSLFSS LHSSNDTVPI KFKKCCYGYC IDLLEKIAED MNFDFDLYIV
     GDGKYGAWKN GHWTGLVGDL LRGTAHMAVT SFSINTARSQ VIDFTSPFFS TSLGILVRTR
     DTAAPIGAFM WPLHWTMWLG IFVALHITAV FLTLYEWKSP FGLTPKGRNR SKVFSFSSAL
     NICYALLFGR TVAIKPPKCW TGRFLMNLWA IFCMFCLSTY TANLAAVMVG EKIYEELSGI
     HDPKLHHPSQ GFRFGTVRES SAEDYVRQSF PEMHEYMRRY NVPATPDGVE YLKNDPEKLD
     AFIMDKALLD YEVSIDADCK LLTVGKPFAI EGYGIGLPPN SPLTANISEL ISQYKSHGFM
     DMLHDKWYRV VPCGKRSFAV TETLQMGIKH FSGLFVLLCI GFGLSILTTI GEHIVYRLLL
     PRIKNKSKLQ YWLHTSQRLH RAINTSFIEE KQQHFKTKRV EKRSNVGPRQ LTVWNTSNLS
     HDNRRKYIFS DEEGQNQLGI RIHQDIPLPP RRRELPALRT TNGKADSLNV SRNSVMQELS
     ELEKQIQVIR QELQLAVSRK TELEEYQRTS RTCES
//
ID   NMD3B_RAT               Reviewed;        1002 AA.
AC   Q8VHN2;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 2.
DT   22-NOV-2017, entry version 112.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 3B;
DE            Short=GluN3B;
DE   AltName: Full=N-methyl-D-aspartate receptor subtype 3B;
DE            Short=NMDAR3B;
DE            Short=NR3B;
DE   Flags: Precursor;
GN   Name=Grin3b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11823786; DOI=10.1038/nature715;
RA   Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H.,
RA   Talantova M., Shin Y., Cui J., Tu S., Sevarino K.K.A., Nakanishi N.,
RA   Tong G., Lipton S.A., Zhang D.;
RT   "Excitatory glycine receptors containing the NR3 family of NMDA
RT   receptor subunits.";
RL   Nature 415:793-798(2002).
RN   [2]
RP   SEQUENCE REVISION.
RA   Chatterton J.E., Awobuluyi M., Cui J., Sevarino K.K.A., Lipton S.A.,
RA   Zhang D.;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=11735224; DOI=10.1006/geno.2001.6666;
RA   Andersson O., Stenqvist A., Attersand A., von Euler G.;
RT   "Nucleotide sequence, genomic organization, and chromosomal
RT   localization of genes encoding the human NMDA receptor subunits NR3A
RT   and NR3B.";
RL   Genomics 78:178-184(2001).
CC   -!- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels
CC       with reduced single-channel conductance, low calcium permeability
CC       and low voltage-dependent sensitivity to magnesium. Mediated by
CC       glycine.
CC   -!- SUBUNIT: Forms heteromeric channel of a zeta subunit (GRIN1), a
CC       epsilon subunit (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and a third
CC       subunit (GRIN3A or GRIN3B). Does not form functional homomeric
CC       channels. Found in a complex containing GRIN1 and GRIN2A (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Cell junction, synapse,
CC       postsynaptic cell membrane {ECO:0000250}. Note=Requires the
CC       presence of GRIN1 to be targeted at the plasma membrane.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in the hippocampus, the corpus
CC       callosum, in the facial and trigeminal nuclei of the brainstem and
CC       the ventral horn of the spinal cord. {ECO:0000269|PubMed:11735224,
CC       ECO:0000269|PubMed:11823786}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR3B/GRIN3B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF440691; AAL69893.2; -; mRNA.
DR   RefSeq; NP_579842.2; NM_133308.2.
DR   UniGene; Rn.162906; -.
DR   PDB; 2RCA; X-ray; 1.58 A; A/B=413-560, A/B=676-815.
DR   PDB; 2RCB; X-ray; 1.62 A; A/B=413-560, A/B=676-815.
DR   PDBsum; 2RCA; -.
DR   PDBsum; 2RCB; -.
DR   ProteinModelPortal; Q8VHN2; -.
DR   SMR; Q8VHN2; -.
DR   STRING; 10116.ENSRNOP00000017064; -.
DR   BindingDB; Q8VHN2; -.
DR   ChEMBL; CHEMBL1907608; -.
DR   PaxDb; Q8VHN2; -.
DR   PRIDE; Q8VHN2; -.
DR   GeneID; 170796; -.
DR   KEGG; rno:170796; -.
DR   UCSC; RGD:621705; rat.
DR   CTD; 116444; -.
DR   RGD; 621705; Grin3b.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   HOGENOM; HOG000231528; -.
DR   HOVERGEN; HBG052634; -.
DR   InParanoid; Q8VHN2; -.
DR   KO; K05214; -.
DR   PhylomeDB; Q8VHN2; -.
DR   EvolutionaryTrace; Q8VHN2; -.
DR   PRO; PR:Q8VHN2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005261; F:cation channel activity; IDA:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0016594; F:glycine binding; IDA:RGD.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0042165; F:neurotransmitter binding; IDA:RGD.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IDA:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IEA:GOC.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0051205; P:protein insertion into membrane; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell junction; Cell membrane; Coiled coil;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Magnesium; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25   1002       Glutamate receptor ionotropic, NMDA 3B.
FT                                /FTId=PRO_0000011572.
FT   TOPO_DOM     25    564       Extracellular. {ECO:0000255}.
FT   TRANSMEM    565    585       Helical. {ECO:0000255}.
FT   TOPO_DOM    586    648       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    649    669       Helical. {ECO:0000255}.
FT   TOPO_DOM    670    826       Extracellular. {ECO:0000255}.
FT   TRANSMEM    827    847       Helical. {ECO:0000255}.
FT   TOPO_DOM    848   1002       Cytoplasmic. {ECO:0000255}.
FT   REGION      951    984       Involved in the trafficking and surface
FT                                expression of NMDARs. {ECO:0000250}.
FT   COILED      944    985       {ECO:0000255}.
FT   COMPBIAS    914    993       Arg-rich.
FT   CARBOHYD     69     69       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    344    344       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    451    451       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    465    465       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    786    786       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   STRAND      416    421       {ECO:0000244|PDB:2RCA}.
FT   TURN        425    427       {ECO:0000244|PDB:2RCA}.
FT   STRAND      428    432       {ECO:0000244|PDB:2RCA}.
FT   STRAND      440    446       {ECO:0000244|PDB:2RCA}.
FT   HELIX       453    465       {ECO:0000244|PDB:2RCA}.
FT   HELIX       470    472       {ECO:0000244|PDB:2RCA}.
FT   STRAND      473    478       {ECO:0000244|PDB:2RCA}.
FT   HELIX       479    491       {ECO:0000244|PDB:2RCA}.
FT   STRAND      494    499       {ECO:0000244|PDB:2RCA}.
FT   HELIX       515    521       {ECO:0000244|PDB:2RCA}.
FT   STRAND      526    528       {ECO:0000244|PDB:2RCA}.
FT   HELIX       536    539       {ECO:0000244|PDB:2RCA}.
FT   STRAND      542    544       {ECO:0000244|PDB:2RCA}.
FT   STRAND      548    558       {ECO:0000244|PDB:2RCA}.
FT   HELIX       683    686       {ECO:0000244|PDB:2RCA}.
FT   HELIX       701    709       {ECO:0000244|PDB:2RCA}.
FT   HELIX       711    717       {ECO:0000244|PDB:2RCA}.
FT   STRAND      722    724       {ECO:0000244|PDB:2RCA}.
FT   HELIX       725    733       {ECO:0000244|PDB:2RCA}.
FT   STRAND      734    736       {ECO:0000244|PDB:2RCA}.
FT   STRAND      740    745       {ECO:0000244|PDB:2RCA}.
FT   HELIX       746    755       {ECO:0000244|PDB:2RCA}.
FT   STRAND      761    773       {ECO:0000244|PDB:2RCA}.
FT   STRAND      776    778       {ECO:0000244|PDB:2RCA}.
FT   HELIX       784    796       {ECO:0000244|PDB:2RCA}.
FT   HELIX       799    807       {ECO:0000244|PDB:2RCA}.
SQ   SEQUENCE   1002 AA;  109158 MW;  4AC840EF97E0AB83 CRC64;
     MESVRTLWLS VALALAVGSR VVRGHPQPCR VPTRAGASVR LAALLPRAPA ARARVLAALA
     TPAPRLPHNL SLELVAVASP TRDPASLARG LCQVLAPPGV VASIAFPEAR PELRLLQFLA
     AATETPVVSV LRREVRTALG APTPFHLQLD WASPLETILD VLVSLVRAHA WEDIALVLCR
     VRDPGSLVTL WTNHASQAPK FVLDLSRLDS RNDSLRAGLA LLGALEGGGT PVPAAVLLGC
     STARAHEVLE AAPPGPQWLL GTPLPAEALP TTGLPPGVLA LGETEQHSLE AVVHDMVELV
     AQALSSMALV HPERALLPAV VNCDDLKTGG SEATGRTLAR FLGNTSFQGR TGAVWVTGSS
     QVHVSRHFKV WSLRRDPLGA PAWATVGSWQ DGQLDFQPGA AALRVPSPSG TQARPKLRVV
     TLVEHPFVFT RESDEDGQCP AGQLCLDPGT NDSARLDALF AALVNGSVPR TLRRCCYGYC
     IDLLERLAED LAFDFELYIV GDGKYGALRD GRWTGLVGDL LAGRAHMAVT SFSINSARSQ
     VVDFTSPFFS TSLGIMVRTR DTASPIGAFM WPLHWSMWVG VFAALHLTAL FLTLYEWRSP
     YGLTPRGRNR GTVFSYSSAL NLCYAILFGR TVSSKTPKCP TGRFLMNLWA IFCLLVLSSY
     TANLAAVMVG DKTFEELSGI HDPKLHHPSQ GFRFGTVWES SAEAYIKASF PEMHAHMRRH
     SAPTTPHGVA MLTSDPPKLN AFIMDKSLLD YEVSIDADCK LLTVGKPFAI EGYGIGLPQN
     SPLTSNLSEF ISRYKSSGFI DLLHDKWYKM VPCGKRVFAV TETLQMGVYH FSGLFVLLCL
     GLGSALLTSL GEHVFYRLVL PRIRRGNKLQ YWLHTSQKIH RALNTGPPEG QQERAEQERS
     GPKDELPATD GAGRWRRVRR AVERERRVRF LLEPGEAGGD RPWLCSNGPG LQAELRELEL
     RIEAARERLR SALLRRGELR ALLGDGTRLR PLRLLHAAPA ES
//
ID   5HT3C_HUMAN             Reviewed;         447 AA.
AC   Q8WXA8; A2RRR5;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   20-DEC-2017, entry version 137.
DE   RecName: Full=5-hydroxytryptamine receptor 3C;
DE            Short=5-HT3-C;
DE            Short=5-HT3C;
DE   AltName: Full=Serotonin receptor 3C;
DE   Flags: Precursor;
GN   Name=HTR3C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS LYS-163
RP   AND ALA-405.
RC   TISSUE=Lung;
RX   PubMed=12801637; DOI=10.1016/S0378-1119(03)00503-1;
RA   Niesler B., Frank B., Kapeller J., Rappold G.A.;
RT   "Cloning, physical mapping and expression analysis of the human 5-HT3
RT   serotonin receptor-like genes HTR3C, HTR3D and HTR3E.";
RL   Gene 310:101-111(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J.,
RA   Rietdorf J., Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-
RT   HT3C, 5-HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-128.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not
CC       functional as a homomeric complex. {ECO:0000269|PubMed:17392525}.
CC   -!- INTERACTION:
CC       P46098:HTR3A; NbExp=5; IntAct=EBI-9008753, EBI-9008743;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17392525};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:17392525}.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues including adult
CC       brain, colon, intestine, lung, muscle and stomach as well as fetal
CC       colon and kidney. {ECO:0000269|PubMed:12801637}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3C
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF459285; AAL66182.1; -; mRNA.
DR   EMBL; CH471052; EAW78305.1; -; Genomic_DNA.
DR   EMBL; BC131799; AAI31800.1; -; mRNA.
DR   CCDS; CCDS3250.1; -.
DR   RefSeq; NP_570126.2; NM_130770.2.
DR   UniGene; Hs.632579; -.
DR   ProteinModelPortal; Q8WXA8; -.
DR   SMR; Q8WXA8; -.
DR   BioGrid; 128062; 85.
DR   IntAct; Q8WXA8; 1.
DR   STRING; 9606.ENSP00000322617; -.
DR   BindingDB; Q8WXA8; -.
DR   ChEMBL; CHEMBL2094132; -.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB13025; Tiapride.
DR   iPTMnet; Q8WXA8; -.
DR   PhosphoSitePlus; Q8WXA8; -.
DR   BioMuta; HTR3C; -.
DR   DMDM; 166198366; -.
DR   PaxDb; Q8WXA8; -.
DR   PeptideAtlas; Q8WXA8; -.
DR   PRIDE; Q8WXA8; -.
DR   Ensembl; ENST00000318351; ENSP00000322617; ENSG00000178084.
DR   GeneID; 170572; -.
DR   KEGG; hsa:170572; -.
DR   UCSC; uc003fmk.4; human.
DR   CTD; 170572; -.
DR   DisGeNET; 170572; -.
DR   EuPathDB; HostDB:ENSG00000178084.1; -.
DR   GeneCards; HTR3C; -.
DR   HGNC; HGNC:24003; HTR3C.
DR   MIM; 610121; gene.
DR   neXtProt; NX_Q8WXA8; -.
DR   OpenTargets; ENSG00000178084; -.
DR   PharmGKB; PA134925741; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; Q8WXA8; -.
DR   KO; K04819; -.
DR   OMA; DIFIMES; -.
DR   OrthoDB; EOG091G042C; -.
DR   PhylomeDB; Q8WXA8; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   GeneWiki; HTR3C; -.
DR   GenomeRNAi; 170572; -.
DR   PRO; PR:Q8WXA8; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000178084; -.
DR   CleanEx; HS_HTR3C; -.
DR   Genevisible; Q8WXA8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; IDA:CACAO.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:Reactome.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    447       5-hydroxytryptamine receptor 3C.
FT                                /FTId=PRO_0000312292.
FT   TOPO_DOM     28    248       Extracellular. {ECO:0000255}.
FT   TRANSMEM    249    269       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    270    282       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    304    306       Extracellular. {ECO:0000255}.
FT   TRANSMEM    307    329       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    330    424       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    425    445       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    446    447       Extracellular. {ECO:0000255}.
FT   DISULFID    162    176       {ECO:0000250}.
FT   VARIANT     128    128       V -> M (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs142791028).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_037552.
FT   VARIANT     163    163       N -> K (in dbSNP:rs6766410).
FT                                {ECO:0000269|PubMed:12801637}.
FT                                /FTId=VAR_037476.
FT   VARIANT     405    405       G -> A (in dbSNP:rs6807362).
FT                                {ECO:0000269|PubMed:12801637}.
FT                                /FTId=VAR_037477.
SQ   SEQUENCE   447 AA;  50220 MW;  E99260743598E596 CRC64;
     MEGGWPARQS ALLCLTVSLL LQGRGDAFTI NCSGFDQHGV DPAVFQAVFD RKAFRPFTNY
     SIPTRVNISF TLSAILGVDA QLQLLTSFLW MDLVWDNPFI NWNPKECVGI NKLTVLAENL
     WLPDIFIVES MDVDQTPSGL TAYISSEGRI KYDKPMRVTS ICNLDIFYFP FDQQNCTFTF
     SSFLYTVDSM LLGMDKEVWE ITDTSRKVIQ TQGEWELLGI NKATPKMSMG NNLYDQIMFY
     VAIRRRPSLY IINLLVPSSF LVAIDALSFY LPAESENRAP FKITLLLGYN VFLLMMNDLL
     PASGTPLISV YFALCLSLMV VSLLETVFIT YLLHVATTQP PPMPRWLHSL LLHCTSPGRC
     CPTAPQKGNK GLGLTLTHLP GPKEPGELAG KKLGPRETEP DGGSGWTKTQ LMELWVQFSH
     AMDTLLFRLY LLFMASSILT VIVLWNT
//
ID   GRIK2_XENLA             Reviewed;         285 AA.
AC   Q91755;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   27-SEP-2017, entry version 90.
DE   RecName: Full=Glutamate receptor ionotropic, kainate 2;
DE            Short=GluK2;
DE   AltName: Full=Glutamate receptor 6;
DE            Short=GluR-6;
DE            Short=GluR6;
DE   Flags: Fragment;
GN   Name=grik2; Synonyms=glur6;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8723645;
RA   Ishimaru H., Kamboj R., Ambrosini A., Henley J.M., Soloviev M.M.,
RA   Sudan H., Rossier J., Abutidze K., Rampersad V., Usherwood P.N.R.,
RA   Bateson A.N., Barnard E.A.;
RT   "A unitary non-NMDA receptor short subunit from Xenopus: DNA cloning
RT   and expression.";
RL   Recept. Channels 4:31-49(1996).
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists. {ECO:0000250|UniProtKB:Q13002}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. GRIK2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X94116; CAA63838.1; -; mRNA.
DR   UniGene; Xl.21633; -.
DR   ProteinModelPortal; Q91755; -.
DR   SMR; Q91755; -.
DR   HOVERGEN; HBG069349; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   Pfam; PF00060; Lig_chan; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00079; PBPe; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN        <1    285       Glutamate receptor ionotropic, kainate 2.
FT                                /FTId=PRO_0000186462.
FT   TRANSMEM     16     36       Helical. {ECO:0000255}.
FT   TRANSMEM    197    217       Helical. {ECO:0000255}.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   NON_TER       1      1
SQ   SEQUENCE   285 AA;  32041 MW;  6B44D17A8BB0877F CRC64;
     SELMPKALST RIVGGIWWFF TLIIISSYTA NLAAFLTVER MESPIDSADD LAKQTKIEYG
     AVQDGATMTF FKKSRIPTYE KMWAFMNSRS QSVLVKNNEE GIQRALTSDY AFLMESTTIE
     FVTQRNCNLT QIGGLIDSKG YGVGTPMGSP YRDKITIAIL QLQEEGVLHM MKEKWWRGNG
     CPEEESKEAS ALGVQNIGGI FIVLAAGLVL SVFVAVGEFL YKSKKNAQLE KRSFCSAMVE
     ELRMSLKCQR RLKHKPQPPV IVKTEEVINM HTFNDRRLPG KETMA
//
ID   GLRK_XENLA              Reviewed;         479 AA.
AC   Q91756; Q4PKI4;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-OCT-2017, entry version 98.
DE   RecName: Full=Glutamate receptor U1;
DE   AltName: Full=Kainate-binding protein;
DE   AltName: Full=Unitary non-NMDA glutamate receptor subunit 1;
DE   AltName: Full=XENU1;
DE   Flags: Precursor;
GN   Name=kbp;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8723645;
RA   Ishimaru H., Kamboj R., Ambrosini A., Henley J.M., Soloviev M.M.,
RA   Sudan H., Rossier J., Abutidze K., Rampersad V., Usherwood P.N.R.,
RA   Bateson A.N., Barnard E.A.;
RT   "A unitary non-NMDA receptor short subunit from Xenopus: DNA cloning
RT   and expression.";
RL   Recept. Channels 4:31-49(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bull L., Hollmann M.;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an
CC       excitatory neurotransmitter at many synapses in the central
CC       nervous system. The postsynaptic actions of Glu are mediated by a
CC       variety of receptors that are named according to their selective
CC       agonists (By similarity). This receptor binds domoate > kainate >
CC       AMPA > NBQX > glutamate. {ECO:0000250}.
CC   -!- SUBUNIT: Homomeric.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X93491; CAA63760.1; -; mRNA.
DR   EMBL; DQ073428; AAY81921.1; -; mRNA.
DR   RefSeq; NP_001081086.2; NM_001087617.1.
DR   UniGene; Xl.1198; -.
DR   ProteinModelPortal; Q91756; -.
DR   GeneID; 394374; -.
DR   KEGG; xla:394374; -.
DR   CTD; 394374; -.
DR   HOVERGEN; HBG104989; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    479       Glutamate receptor U1.
FT                                /FTId=PRO_0000011559.
FT   TOPO_DOM     18    163       Extracellular. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical. {ECO:0000255}.
FT   TOPO_DOM    185    229       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical. {ECO:0000255}.
FT   TOPO_DOM    251    414       Extracellular. {ECO:0000255}.
FT   TRANSMEM    415    435       Helical. {ECO:0000255}.
FT   TOPO_DOM    436    479       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   479 AA;  53406 MW;  588D4B3E1057C620 CRC64;
     MEKSLLFLFA VTLLSVGCTD AGESKGSIHK EKERSKRQAL KHLTVTTIME QPFSMKSESG
     MEGFCIDLLS ELSQSLGFNY TIKEVKDGRY GAKDQDGNWN GMVGEVLRKE VDLAVAPLTI
     TANRERELAF TKPFMQTGIS ILLRKEDASE NSFLFGFLTP FSKETWIGIL VAYMVTSLCL
     FLVGRLSPCE WTELSTEQNN FTFLNSLWFG AGAFTLQGAE PHPKSVSARI IAVIWWIFSI
     VLVAAYIASF AAFLNSDSVQ TTNIQTFEDL VNQRTLEFGT INSSSTFQFF KNSKNPTYRM
     IYEYMDKRKD ELLVKSFAEG VRRVRESNYA FLGESVMQDI MVAKHCELAR APQIIAGRGY
     GIAASIDSQL IKQLSIAILE QTESGNIEYL RKKWWDNTCS MKRSAGWNPV QPHTLGGIFL
     ILGIGLALGV IAALIELVLK ARNNADQQKK SCCSAFSEEM GERLGTNKEN QGAVDSVKS
//
ID   RYR2_HUMAN              Reviewed;        4967 AA.
AC   Q92736; Q15411; Q546N8; Q5T3P2;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   22-NOV-2017, entry version 194.
DE   RecName: Full=Ryanodine receptor 2;
DE            Short=RYR-2;
DE            Short=RyR2;
DE            Short=hRYR-2;
DE   AltName: Full=Cardiac muscle ryanodine receptor;
DE   AltName: Full=Cardiac muscle ryanodine receptor-calcium release channel;
DE   AltName: Full=Type 2 ryanodine receptor;
GN   Name=RYR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Heart muscle;
RX   PubMed=8809036; DOI=10.1042/bj3180477;
RA   Tunwell R.E.A., Wickenden C., Bertrand B.M.A., Shevchenko V.I.,
RA   Walsh M.B., Allen P.D., Lai F.A.;
RT   "The human cardiac muscle ryanodine receptor-calcium release channel:
RT   identification, primary structure and topological analysis.";
RL   Biochem. J. 318:477-487(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARVD2 GLN-176;
RP   PRO-433; ILE-2386 AND MET-2504.
RX   PubMed=11159936; DOI=10.1093/hmg/10.3.189;
RA   Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F.,
RA   Larderet G., Brahmbhatt B., Brown K., Bauce B., Muriago M., Basso C.,
RA   Thiene G., Danieli G.A., Rampazzo A.;
RT   "Identification of mutations in the cardiac ryanodine receptor gene in
RT   families affected with arrhythmogenic right ventricular cardiomyopathy
RT   type 2 (ARVD2).";
RL   Hum. Mol. Genet. 10:189-194(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-87 AND 533-681, DEVELOPMENTAL STAGE,
RP   AND INDUCTION BY TGFB1.
RC   TISSUE=Heart muscle, and Myometrium;
RX   PubMed=9148749; DOI=10.1042/bj3220777;
RA   Awad S.S., Lamb H.K., Morgan J.M., Dunlop W., Gillespie J.I.;
RT   "Differential expression of ryanodine receptor RyR2 mRNA in the non-
RT   pregnant and pregnant human myometrium.";
RL   Biochem. J. 322:777-783(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4292-4479, AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebellum, and Hippocampus;
RX   PubMed=9607712; DOI=10.1016/S0306-4522(97)00612-X;
RA   Martin C., Chapman K.E., Seckl J.R., Ashley R.H.;
RT   "Partial cloning and differential expression of ryanodine
RT   receptor/calcium-release channel genes in human tissues including the
RT   hippocampus and cerebellum.";
RL   Neuroscience 85:205-216(1998).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH FKBP1B; PP1; PP2A AKAP6 AND
RP   PKA, INTERACTION WITH FKBP1B; PKA; PP1 AND PP2A, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, MUTAGENESIS OF SER-2808, AND PHOSPHORYLATION AT
RP   SER-2808.
RX   PubMed=10830164; DOI=10.1016/S0092-8674(00)80847-8;
RA   Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D.,
RA   Rosemblit N., Marks A.R.;
RT   "PKA phosphorylation dissociates FKBP12.6 from the calcium release
RT   channel (ryanodine receptor): defective regulation in failing
RT   hearts.";
RL   Cell 101:365-376(2000).
RN   [7]
RP   INTERACTION WITH CALM AND S100A1.
RX   PubMed=18650434; DOI=10.1074/jbc.M804432200;
RA   Wright N.T., Prosser B.L., Varney K.M., Zimmer D.B., Schneider M.F.,
RA   Weber D.J.;
RT   "S100A1 and calmodulin compete for the same binding site on ryanodine
RT   receptor.";
RL   J. Biol. Chem. 283:26676-26683(2008).
RN   [8]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-2808 AND SER-2814.
RX   PubMed=20056922; DOI=10.1161/CIRCRESAHA.109.203836;
RA   Neef S., Dybkova N., Sossalla S., Ort K.R., Fluschnik N., Neumann K.,
RA   Seipelt R., Schondube F.A., Hasenfuss G., Maier L.S.;
RT   "CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+
RT   levels in right atrial myocardium of patients with atrial
RT   fibrillation.";
RL   Circ. Res. 106:1134-1144(2010).
RN   [9]
RP   REVIEW.
RX   PubMed=11805843; DOI=10.1038/415198a;
RA   Bers D.M.;
RT   "Cardiac excitation-contraction coupling.";
RL   Nature 415:198-205(2002).
RN   [10]
RP   REVIEW.
RX   PubMed=19482609; DOI=10.2741/3591;
RA   Currie S.;
RT   "Cardiac ryanodine receptor phosphorylation by CaM Kinase II: keeping
RT   the balance right.";
RL   Front. Biosci. 14:5134-5156(2009).
RN   [11]
RP   REVIEW.
RX   PubMed=21472222; DOI=10.3892/mmr_00000240;
RA   Ozawa T.;
RT   "Modulation of ryanodine receptor Ca2+ channels.";
RL   Mol. Med. Report. 3:199-204(2010).
RN   [12]
RP   REVIEW.
RX   PubMed=20961976; DOI=10.1101/cshperspect.a003996;
RA   Lanner J.T., Georgiou D.K., Joshi A.D., Hamilton S.L.;
RT   "Ryanodine receptors: structure, expression, molecular details, and
RT   function in calcium release.";
RL   Cold Spring Harb. Perspect. Biol. 2:E3996-E3996(2010).
RN   [13] {ECO:0000244|PDB:4JKQ}
RP   X-RAY CRYSTALLOGRAPHY (2.39 ANGSTROMS) OF 1-606, AND CHARACTERIZATION
RP   OF VARIANT CPVT1 PHE-419.
RX   PubMed=25372681; DOI=10.1107/S1399004714020343;
RA   Borko L., Bauerova-Hlinkova V., Hostinova E., Gasperik J., Beck K.,
RA   Lai F.A., Zahradnikova A., Sevcik J.;
RT   "Structural insights into the human RyR2 N-terminal region involved in
RT   cardiac arrhythmias.";
RL   Acta Crystallogr. D 70:2897-2912(2014).
RN   [14]
RP   VARIANTS CPVT1 LEU-2246; SER-2474; LYS-4104 AND CYS-4497.
RX   PubMed=11208676; DOI=10.1161/01.CIR.103.2.196;
RA   Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R.,
RA   Sorrentino V.V., Danieli G.A.;
RT   "Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie
RT   catecholaminergic polymorphic ventricular tachycardia.";
RL   Circulation 103:196-200(2001).
RN   [15]
RP   VARIANTS CPVT1 SER-2328; ARG-4201 AND PHE-4653, AND VARIANT ARG-2958.
RX   PubMed=11157710; DOI=10.1161/01.CIR.103.4.485;
RA   Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M.,
RA   Brahmbhatt B., Donarum E.A., Marino M., Tiso N., Viitasalo M.,
RA   Toivonen L., Stephan D.A., Kontula K.;
RT   "Mutations of the cardiac ryanodine receptor (RyR2) gene in familial
RT   polymorphic ventricular tachycardia.";
RL   Circulation 103:485-490(2001).
RN   [16]
RP   VARIANTS CPVT1 LEU-2246; ASP-2311; SER-2474; PHE-3778; SER-3946;
RP   SER-3946; LYS-4104; CYS-4497; ILE-4771; GLY-4860; MET-4867; ASP-4895
RP   AND LYS-4950.
RX   PubMed=12093772; DOI=10.1161/01.CIR.0000020013.73106.D8;
RA   Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F.,
RA   Gasparini M., DeSimone L., Coltorti F., Bloise R., Keegan R.,
RA   Cruz Filho F.E.S., Vignati G., Benatar A., DeLogu A.;
RT   "Clinical and molecular characterization of patients with
RT   catecholaminergic polymorphic ventricular tachycardia.";
RL   Circulation 106:69-74(2002).
RN   [17]
RP   VARIANTS CPVT1 GLN-176; TRP-420; PRO-433; ILE-2386; CYS-2392 AND
RP   MET-2504.
RX   PubMed=12106942; DOI=10.1016/S0735-1097(02)01946-0;
RA   Bauce B., Rampazzo A., Basso C., Bagattin A., Daliento L., Tiso N.,
RA   Turrini P., Thiene G., Danieli G.A., Nava A.;
RT   "Screening for ryanodine receptor type 2 mutations in families with
RT   effort-induced polymorphic ventricular arrhythmias and sudden death:
RT   early diagnosis of asymptomatic carriers.";
RL   J. Am. Coll. Cardiol. 40:341-349(2002).
RN   [18]
RP   VARIANTS CPVT1 ILE-2306; LEU-4902 AND GLN-4959.
RX   PubMed=14571276; DOI=10.1038/sj.ejhg.5201061;
RA   Laitinen P.J., Swan H., Kontula K.;
RT   "Molecular genetics of exercise-induced polymorphic ventricular
RT   tachycardia: identification of three novel cardiac ryanodine receptor
RT   mutations and two common calsequestrin 2 amino-acid polymorphisms.";
RL   Eur. J. Hum. Genet. 11:888-891(2003).
RN   [19]
RP   VARIANTS CPVT1 SER-164; LEU-414; PHE-419; THR-2403; CYS-4499;
RP   THR-4510; ARG-4671 AND VAL-4848.
RX   PubMed=15466642; DOI=10.1161/01.CIR.0000144471.98080.CA;
RA   Choi G., Kopplin L.J., Tester D.J., Will M.L., Haglund C.M.,
RA   Ackerman M.J.;
RT   "Spectrum and frequency of cardiac channel defects in swimming-
RT   triggered arrhythmia syndromes.";
RL   Circulation 110:2119-2124(2004).
RN   [20]
RP   VARIANTS CPVT1 ILE-4504 AND ALA-4880.
RX   PubMed=15046072;
RA   Bagattin A., Veronese C., Rampazzo A., Danieli G.A.;
RT   "Gene symbol: RYR2. Disease: effort-induced polymorphic ventricular
RT   arrhythmias.";
RL   Hum. Genet. 114:404-404(2004).
RN   [21]
RP   VARIANTS CPVT1 PRO-2387 AND PRO-4607.
RX   PubMed=15046073;
RA   Bagattin A., Veronese C., Rampazzo A., Danieli G.A.;
RT   "Gene symbol: RYR2. Disease: effort-induced polymorphic ventricular
RT   arrhythmias.";
RL   Hum. Genet. 114:405-405(2004).
RN   [22]
RP   VARIANTS CPVT1 TRP-420; LEU-2246; SER-4097; LYS-4146; PRO-4158 AND
RP   CYS-4497.
RX   PubMed=15544015; DOI=10.4065/79.11.1380;
RA   Tester D.J., Spoon D.B., Valdivia H.H., Makielski J.C., Ackerman M.J.;
RT   "Targeted mutational analysis of the RyR2-encoded cardiac ryanodine
RT   receptor in sudden unexplained death: a molecular autopsy of 49
RT   medical examiner/coroner's cases.";
RL   Mayo Clin. Proc. 79:1380-1384(2004).
RN   [23]
RP   VARIANTS CPVT1 GLN-176; LEU-414; PHE-419; ALA-466; THR-2403; PHE-3800;
RP   THR-4124; CYS-4499; THR-4510; THR-4556; VAL-4848 AND GLN-4959.
RX   PubMed=16188589; DOI=10.1016/j.hrthm.2005.07.012;
RA   Tester D.J., Kopplin L.J., Will M.L., Ackerman M.J.;
RT   "Spectrum and prevalence of cardiac ryanodine receptor (RyR2)
RT   mutations in a cohort of unrelated patients referred explicitly for
RT   long QT syndrome genetic testing.";
RL   Heart Rhythm 2:1099-1105(2005).
RN   [24]
RP   VARIANT GLU-4955.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C.,
RA   Patry L., Massicotte C., Ambalavanan A., Spiegelman D., Diallo O.,
RA   Henrion E., Dionne-Laporte A., Fougerat A., Pshezhetsky A.V.,
RA   Venkateswaran S., Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
RN   [25]
RP   CHARACTERIZATION OF VARIANT CPVT1 GLY-4860.
RX   PubMed=17984046; DOI=10.1073/pnas.0706573104;
RA   Jiang D., Chen W., Wang R., Zhang L., Chen S.R.W.;
RT   "Loss of luminal Ca(2+) activation in the cardiac ryanodine receptor
RT   is associated with ventricular fibrillation and sudden death.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:18309-18314(2007).
RN   [26]
RP   VARIANT CPVT1 PRO-4159.
RX   PubMed=24793461; DOI=10.1016/j.hrthm.2014.04.037;
RA   Di Pino A., Caruso E., Costanzo L., Guccione P.;
RT   "A novel RyR2 mutation in a 2-year-old baby presenting with atrial
RT   fibrillation, atrial flutter, and atrial ectopic tachycardia.";
RL   Heart Rhythm 11:1480-1483(2014).
RN   [27]
RP   VARIANT ASP-29.
RX   PubMed=25463374; DOI=10.1016/j.ijcard.2014.11.119;
RA   Cheung J.W., Meli A.C., Xie W., Mittal S., Reiken S., Wronska A.,
RA   Xu L., Steinberg J.S., Markowitz S.M., Iwai S., Lacampagne A.,
RA   Lerman B.B., Marks A.R.;
RT   "Short-coupled polymorphic ventricular tachycardia at rest linked to a
RT   novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under
RT   non-stress conditions.";
RL   Int. J. Cardiol. 180:228-236(2015).
RN   [28]
RP   CHARACTERIZATION OF VARIANT ASP-29.
RX   PubMed=26405799; DOI=10.1371/journal.pone.0139058;
RA   Xiao Z., Guo W., Yuen S.M., Wang R., Zhang L., Van Petegem F.,
RA   Chen S.R.;
RT   "The H29D nutation does not enhance cytosolic Ca2+ activation of the
RT   cardiac ryanodine receptor.";
RL   PLoS ONE 10:E0139058-E0139058(2015).
RN   [29]
RP   CHARACTERIZATION OF VARIANTS CVPT1 SER-3946; THR-4124; PRO-4158 AND
RP   PRO-4159, MUTAGENESIS OF GLY-3946; MET-3978 AND HIS-4108, AND
RP   FUNCTION.
RX   PubMed=27733687; DOI=10.1074/jbc.M116.756528;
RA   Xiao Z., Guo W., Sun B., Hunt D.J., Wei J., Liu Y., Wang Y., Wang R.,
RA   Jones P.P., Back T.G., Chen S.R.;
RT   "Enhanced cytosolic Ca2+ activation underlies a common defect of
RT   central domain cardiac ryanodine receptor mutations linked to
RT   arrhythmias.";
RL   J. Biol. Chem. 291:24528-24537(2016).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from
CC       the sarcoplasmic reticulum into the cytoplasm and thereby plays a
CC       key role in triggering cardiac muscle contraction. Aberrant
CC       channel activation can lead to cardiac arrhythmia. In cardiac
CC       myocytes, calcium release is triggered by increased Ca(2+) levels
CC       due to activation of the L-type calcium channel CACNA1C. The
CC       calcium channel activity is modulated by formation of
CC       heterotetramers with RYR3. Required for cellular calcium ion
CC       homeostasis. Required for embryonic heart development.
CC       {ECO:0000269|PubMed:10830164, ECO:0000269|PubMed:20056922,
CC       ECO:0000269|PubMed:27733687}.
CC   -!- ENZYME REGULATION: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high
CC       affinity. At low concentrations, ryanodine maintains the channel
CC       in an open conformation. High ryanodine concentrations inhibit
CC       channel activity. Channel activity is regulated by calmodulin
CC       (CALM). The calcium release is activated by increased cytoplasmic
CC       calcium levels, by nitric oxyde (NO), caffeine and ATP. Channel
CC       activity is inhibited by magnesium ions, possibly by competition
CC       for calcium binding sites. {ECO:0000250|UniProtKB:P11716}.
CC   -!- SUBUNIT: Homotetramer. Can also form heterotetramers with RYR1 and
CC       RYR3 (By similarity). Interacts with FKBP1A and FKBP1B; these
CC       interactions may stabilize the channel in its closed state and
CC       prevent Ca(2+) leaks. Interacts with CALM and S100A1; these
CC       interactions regulate channel activity. Identified in a complex
CC       composed of RYR2, FKBP1B, PKA catalytic subunit, PRKAR2A, AKAP6,
CC       and the protein phosphatases PP2A and PP1. Interacts directly with
CC       FKBP1B, PKA, PP1 and PP2A. Interacts with SELENON (By similarity).
CC       {ECO:0000250|UniProtKB:P30957, ECO:0000269|PubMed:10830164,
CC       ECO:0000269|PubMed:18650434}.
CC   -!- INTERACTION:
CC       P62942:FKBP1A; NbExp=2; IntAct=EBI-1170425, EBI-1027571;
CC       P68106:FKBP1B; NbExp=5; IntAct=EBI-1170425, EBI-6693977;
CC       Q00987:MDM2; NbExp=2; IntAct=EBI-1170425, EBI-389668;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10830164}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10830164}. Membrane
CC       {ECO:0000305|PubMed:10830164}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:10830164}. Sarcoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P30957}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but both N-
CC       terminus and C-terminus seem to be cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92736-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92736-2; Sequence=VSP_005953;
CC   -!- TISSUE SPECIFICITY: Detected in heart muscle (at protein level).
CC       Heart muscle, brain (cerebellum and hippocampus) and placenta.
CC       {ECO:0000269|PubMed:10830164, ECO:0000269|PubMed:9607712}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in myometrium during pregnancy.
CC       {ECO:0000269|PubMed:9148749}.
CC   -!- INDUCTION: By TGFB1. {ECO:0000269|PubMed:9148749}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein resides in
CC       the cytoplasm. {ECO:0000305}.
CC   -!- PTM: Channel activity is modulated by phosphorylation.
CC       Phosphorylation at Ser-2808 and Ser-2814 increases the open
CC       probability of the calcium channel. Phosphorylation is increased
CC       in failing heart, leading to calcium leaks and increased
CC       cytoplasmic Ca(2+) levels. {ECO:0000269|PubMed:10830164,
CC       ECO:0000269|PubMed:20056922}.
CC   -!- PTM: Phosphorylation at Ser-2031 by PKA enhances the response to
CC       lumenal calcium. {ECO:0000250}.
CC   -!- DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2
CC       (ARVD2) [MIM:600996]: A congenital heart disease characterized by
CC       infiltration of adipose and fibrous tissue into the right
CC       ventricle and loss of myocardial cells, resulting in ventricular
CC       and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Ventricular tachycardia, catecholaminergic polymorphic,
CC       1, with or without atrial dysfunction and/or dilated
CC       cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder
CC       characterized by stress-induced, bidirectional ventricular
CC       tachycardia that may degenerate into cardiac arrest and cause
CC       sudden death. Patients present with recurrent syncope, seizures,
CC       or sudden death after physical activity or emotional stress. CPVT1
CC       inheritance is autosomal dominant. {ECO:0000269|PubMed:11157710,
CC       ECO:0000269|PubMed:11208676, ECO:0000269|PubMed:12093772,
CC       ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:14571276,
CC       ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073,
CC       ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015,
CC       ECO:0000269|PubMed:16188589, ECO:0000269|PubMed:17984046,
CC       ECO:0000269|PubMed:24793461, ECO:0000269|PubMed:25372681,
CC       ECO:0000269|PubMed:27733687}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       RYR2 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH71369.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAH71393.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAH73918.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI14440.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI15350.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI15936.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC       Sequence=CAI22065.1; Type=Miscellaneous discrepancy; Note=Erroneous gene model prediction.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ryanodine receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Ryanodine_receptor";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=RYR2 entry;
CC       URL="https://en.wikipedia.org/wiki/RYR2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X98330; CAA66975.1; -; mRNA.
DR   EMBL; AJ300340; CAC18855.1; -; Genomic_DNA.
DR   EMBL; AJ300341; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300342; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300343; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300347; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300349; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300351; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300353; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300355; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300364; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300363; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300362; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300361; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300360; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300359; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300358; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300357; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300356; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300373; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300372; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300371; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300370; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300369; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300368; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300367; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300366; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300365; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300382; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300381; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300380; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300379; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300378; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300377; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300376; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300375; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300374; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300399; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300398; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300397; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300396; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300395; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300394; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300393; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300392; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300391; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300416; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300415; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300414; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300413; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300412; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300411; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300410; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300409; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300408; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300433; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300432; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300431; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300430; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300429; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300428; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300427; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300426; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300425; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300444; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300443; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300442; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300441; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300440; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300439; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300438; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300437; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300436; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300435; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300434; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300424; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300423; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300422; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300421; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300420; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300419; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300418; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300417; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300407; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300406; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300405; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300404; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300403; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300402; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300401; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300400; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300390; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300389; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300388; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300387; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300386; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300385; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300384; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300383; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300354; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300352; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300350; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300348; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300346; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300345; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AJ300344; CAC18855.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAH71369.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAH71369.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAH71393.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAH71393.1; JOINED; Genomic_DNA.
DR   EMBL; AL356773; CAH73918.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL359924; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAH73918.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI14440.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI14440.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI15350.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI15350.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI15936.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI15936.1; JOINED; Genomic_DNA.
DR   EMBL; AL359924; CAI22065.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356773; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL365332; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL391809; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL442065; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL445473; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; AL513130; CAI22065.1; JOINED; Genomic_DNA.
DR   EMBL; Y08218; CAA69395.1; -; mRNA.
DR   EMBL; X91869; CAA62975.1; -; mRNA.
DR   EMBL; AJ002511; CAA05502.1; -; mRNA.
DR   CCDS; CCDS55691.1; -. [Q92736-1]
DR   PIR; S72269; S72269.
DR   RefSeq; NP_001026.2; NM_001035.2. [Q92736-1]
DR   RefSeq; XP_006711868.1; XM_006711805.3. [Q92736-2]
DR   UniGene; Hs.109514; -.
DR   UniGene; Hs.738571; -.
DR   PDB; 4JKQ; X-ray; 2.39 A; A=1-606.
DR   PDBsum; 4JKQ; -.
DR   ProteinModelPortal; Q92736; -.
DR   SMR; Q92736; -.
DR   BioGrid; 112174; 26.
DR   DIP; DIP-38325N; -.
DR   IntAct; Q92736; 12.
DR   MINT; MINT-1201008; -.
DR   STRING; 9606.ENSP00000355533; -.
DR   ChEMBL; CHEMBL4403; -.
DR   DrugBank; DB09085; Tetracaine.
DR   GuidetoPHARMACOLOGY; 748; -.
DR   TCDB; 1.A.3.1.1; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   iPTMnet; Q92736; -.
DR   PhosphoSitePlus; Q92736; -.
DR   BioMuta; RYR2; -.
DR   DMDM; 308153558; -.
DR   EPD; Q92736; -.
DR   MaxQB; Q92736; -.
DR   PaxDb; Q92736; -.
DR   PeptideAtlas; Q92736; -.
DR   PRIDE; Q92736; -.
DR   Ensembl; ENST00000366574; ENSP00000355533; ENSG00000198626. [Q92736-1]
DR   GeneID; 6262; -.
DR   KEGG; hsa:6262; -.
DR   UCSC; uc001hyl.2; human. [Q92736-1]
DR   CTD; 6262; -.
DR   DisGeNET; 6262; -.
DR   EuPathDB; HostDB:ENSG00000198626.15; -.
DR   GeneCards; RYR2; -.
DR   GeneReviews; RYR2; -.
DR   HGNC; HGNC:10484; RYR2.
DR   HPA; HPA020028; -.
DR   MalaCards; RYR2; -.
DR   MIM; 180902; gene.
DR   MIM; 600996; phenotype.
DR   MIM; 604772; phenotype.
DR   neXtProt; NX_Q92736; -.
DR   OpenTargets; ENSG00000198626; -.
DR   Orphanet; 3286; Catecholaminergic polymorphic ventricular tachycardia.
DR   Orphanet; 293899; Familial isolated arrhythmogenic ventricular dysplasia, biventricular form.
DR   Orphanet; 293888; Familial isolated arrhythmogenic ventricular dysplasia, left dominant form.
DR   Orphanet; 293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000231428; -.
DR   HOVERGEN; HBG006699; -.
DR   InParanoid; Q92736; -.
DR   KO; K04962; -.
DR   OMA; EHMPNDT; -.
DR   OrthoDB; EOG091G00T0; -.
DR   PhylomeDB; Q92736; -.
DR   TreeFam; TF315244; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   SIGNOR; Q92736; -.
DR   ChiTaRS; RYR2; human.
DR   GeneWiki; Ryanodine_receptor_2; -.
DR   GenomeRNAi; 6262; -.
DR   PRO; PR:Q92736; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000198626; -.
DR   CleanEx; HS_RYR2; -.
DR   ExpressionAtlas; Q92736; baseline and differential.
DR   Genevisible; Q92736; HS.
DR   GO; GO:0034704; C:calcium channel complex; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0014701; C:junctional sarcoplasmic reticulum membrane; TAS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; ISS:BHF-UCL.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0048763; F:calcium-induced calcium release activity; IDA:BHF-UCL.
DR   GO; GO:0015278; F:calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:BHF-UCL.
DR   GO; GO:0044325; F:ion channel binding; ISS:BHF-UCL.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; IDA:BHF-UCL.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IDA:BHF-UCL.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0043924; F:suramin binding; IMP:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0006816; P:calcium ion transport; IDA:BHF-UCL.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; IDA:BHF-UCL.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IDA:BHF-UCL.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; ISS:BHF-UCL.
DR   GO; GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; IC:BHF-UCL.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:BHF-UCL.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; ISS:BHF-UCL.
DR   GO; GO:0005513; P:detection of calcium ion; IDA:BHF-UCL.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072599; P:establishment of protein localization to endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0003220; P:left ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL.
DR   GO; GO:1901896; P:positive regulation of calcium-transporting ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0010460; P:positive regulation of heart rate; ISS:BHF-UCL.
DR   GO; GO:0051284; P:positive regulation of sequestering of calcium ion; IDA:BHF-UCL.
DR   GO; GO:0098735; P:positive regulation of the force of heart contraction; IMP:BHF-UCL.
DR   GO; GO:0086029; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; ISS:BHF-UCL.
DR   GO; GO:0098910; P:regulation of atrial cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098904; P:regulation of AV node cell action potential; IMP:BHF-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:BHF-UCL.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISS:BHF-UCL.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:BHF-UCL.
DR   GO; GO:0098907; P:regulation of SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098911; P:regulation of ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
DR   GO; GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IMP:BHF-UCL.
DR   GO; GO:0031000; P:response to caffeine; IDA:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; ISS:BHF-UCL.
DR   GO; GO:0014850; P:response to muscle activity; IMP:BHF-UCL.
DR   GO; GO:0035994; P:response to muscle stretch; IMP:BHF-UCL.
DR   GO; GO:0051775; P:response to redox state; IDA:BHF-UCL.
DR   GO; GO:0070296; P:sarcoplasmic reticulum calcium ion transport; TAS:BHF-UCL.
DR   GO; GO:0097050; P:type B pancreatic cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0086005; P:ventricular cardiac muscle cell action potential; ISS:BHF-UCL.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Calmodulin-binding; Cardiomyopathy; Coiled coil;
KW   Complete proteome; Developmental protein; Disease mutation;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   4967       Ryanodine receptor 2.
FT                                /FTId=PRO_0000219361.
FT   TOPO_DOM      1   4281       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4282   4302       Helical. {ECO:0000255}.
FT   TRANSMEM   4504   4524       Helical. {ECO:0000255}.
FT   TRANSMEM   4580   4600       Helical. {ECO:0000255}.
FT   TRANSMEM   4730   4750       Helical. {ECO:0000255}.
FT   TRANSMEM   4769   4789       Helical. {ECO:0000255}.
FT   INTRAMEM   4820   4829       Pore-forming. {ECO:0000250}.
FT   TRANSMEM   4850   4870       Helical. {ECO:0000255}.
FT   TOPO_DOM   4871   4967       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      110    165       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      172    217       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      225    280       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      286    343       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      351    408       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      599    809       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      853    966       1.
FT   REPEAT      967   1080       2.
FT   DOMAIN     1025   1222       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   DOMAIN     1337   1562       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     2692   2810       3.
FT   REPEAT     2812   2925       4.
FT   REGION      853   2925       4 X approximate repeats.
FT   REGION     3581   3610       Interaction with CALM.
FT                                {ECO:0000269|PubMed:18650434}.
FT   COILED     4412   4445       {ECO:0000255}.
FT   COMPBIAS   4414   4455       Glu-rich (acidic).
FT   MOD_RES    1341   1341       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    1869   1869       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B0LPN4}.
FT   MOD_RES    2031   2031       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2369   2369       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2697   2697       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B0LPN4}.
FT   MOD_RES    2797   2797       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2808   2808       Phosphoserine; by CaMK2D and PKA.
FT                                {ECO:0000269|PubMed:10830164,
FT                                ECO:0000269|PubMed:20056922}.
FT   MOD_RES    2811   2811       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   MOD_RES    2814   2814       Phosphoserine; by CaMK2D.
FT                                {ECO:0000269|PubMed:20056922}.
FT   MOD_RES    2947   2947       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:E9Q401}.
FT   VAR_SEQ    3715   3715       E -> EVTGSQRSK (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_005953.
FT   VARIANT      29     29       H -> D (found in a patient with short-
FT                                coupled polymorphic ventricular
FT                                tachycardia at rest; unknown pathological
FT                                significance; no effect on cytosolic
FT                                Ca(2+) activation).
FT                                {ECO:0000269|PubMed:25463374,
FT                                ECO:0000269|PubMed:26405799}.
FT                                /FTId=VAR_075283.
FT   VARIANT     164    164       P -> S (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642}.
FT                                /FTId=VAR_044086.
FT   VARIANT     176    176       R -> Q (in ARVD2 and CPVT1;
FT                                dbSNP:rs794728708).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044087.
FT   VARIANT     414    414       R -> L (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044088.
FT   VARIANT     419    419       I -> F (in CPVT1; decreases protein
FT                                stability). {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589,
FT                                ECO:0000269|PubMed:25372681}.
FT                                /FTId=VAR_044089.
FT   VARIANT     420    420       R -> W (in CPVT1; dbSNP:rs190140598).
FT                                {ECO:0000269|PubMed:12106942,
FT                                ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_044090.
FT   VARIANT     433    433       L -> P (in ARVD2 and CPVT1;
FT                                dbSNP:rs121918602).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_011395.
FT   VARIANT     466    466       P -> A (in CPVT1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_079513.
FT   VARIANT     507    507       V -> I (in dbSNP:rs16835270).
FT                                /FTId=VAR_044091.
FT   VARIANT    1886   1886       G -> S (in dbSNP:rs3766871).
FT                                /FTId=VAR_022078.
FT   VARIANT    2246   2246       S -> L (in CPVT1; dbSNP:rs121918597).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_011396.
FT   VARIANT    2306   2306       V -> I (in CPVT1; dbSNP:rs794728746).
FT                                {ECO:0000269|PubMed:14571276}.
FT                                /FTId=VAR_023694.
FT   VARIANT    2311   2311       E -> D (in CPVT1; dbSNP:rs794728747).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044092.
FT   VARIANT    2328   2328       P -> S (in CPVT1; dbSNP:rs121918603).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011397.
FT   VARIANT    2386   2386       N -> I (in ARVD2 and CPVT1;
FT                                dbSNP:rs121918601).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_011398.
FT   VARIANT    2387   2387       A -> P (in CPVT1).
FT                                {ECO:0000269|PubMed:15046073}.
FT                                /FTId=VAR_044093.
FT   VARIANT    2392   2392       Y -> C (in CPVT1; dbSNP:rs772220753).
FT                                {ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_044094.
FT   VARIANT    2403   2403       A -> T (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044095.
FT   VARIANT    2474   2474       R -> S (in CPVT1; dbSNP:rs121918598).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_011399.
FT   VARIANT    2504   2504       T -> M (in ARVD2 and CPVT1;
FT                                dbSNP:rs769219555).
FT                                {ECO:0000269|PubMed:11159936,
FT                                ECO:0000269|PubMed:12106942}.
FT                                /FTId=VAR_044096.
FT   VARIANT    2958   2958       Q -> R (in dbSNP:rs34967813).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011590.
FT   VARIANT    3778   3778       L -> F (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044097.
FT   VARIANT    3800   3800       C -> F (in CPVT1).
FT                                {ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_079514.
FT   VARIANT    3946   3946       G -> S (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation;
FT                                dbSNP:rs794728777).
FT                                {ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_044098.
FT   VARIANT    4097   4097       N -> S (in CPVT1; dbSNP:rs794728784).
FT                                {ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_044099.
FT   VARIANT    4104   4104       N -> K (in CPVT1; dbSNP:rs121918599).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_011400.
FT   VARIANT    4124   4124       S -> T (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation).
FT                                {ECO:0000269|PubMed:16188589,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_079515.
FT   VARIANT    4146   4146       E -> K (in CPVT1).
FT                                {ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_044100.
FT   VARIANT    4158   4158       T -> P (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation).
FT                                {ECO:0000269|PubMed:15544015,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_044101.
FT   VARIANT    4159   4159       Q -> P (in CPVT1; changed ryanodine-
FT                                sensitive calcium-release channel
FT                                activity; increased sensitivity to
FT                                cytosolic calcium activation).
FT                                {ECO:0000269|PubMed:24793461,
FT                                ECO:0000269|PubMed:27733687}.
FT                                /FTId=VAR_079516.
FT   VARIANT    4201   4201       Q -> R (in CPVT1; dbSNP:rs121918605).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011401.
FT   VARIANT    4497   4497       R -> C (in CPVT1; dbSNP:rs121918600).
FT                                {ECO:0000269|PubMed:11208676,
FT                                ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:15544015}.
FT                                /FTId=VAR_011402.
FT   VARIANT    4499   4499       F -> C (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044102.
FT   VARIANT    4504   4504       M -> I (in CPVT1).
FT                                {ECO:0000269|PubMed:15046072}.
FT                                /FTId=VAR_044103.
FT   VARIANT    4510   4510       A -> T (in CPVT1; dbSNP:rs397516510).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044104.
FT   VARIANT    4556   4556       A -> T (in CPVT1).
FT                                {ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_079517.
FT   VARIANT    4607   4607       A -> P (in CPVT1).
FT                                {ECO:0000269|PubMed:15046073}.
FT                                /FTId=VAR_044105.
FT   VARIANT    4653   4653       V -> F (in CPVT1; dbSNP:rs121918604).
FT                                {ECO:0000269|PubMed:11157710}.
FT                                /FTId=VAR_011403.
FT   VARIANT    4671   4671       G -> R (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642}.
FT                                /FTId=VAR_044106.
FT   VARIANT    4771   4771       V -> I (in CPVT1; dbSNP:rs794728804).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044107.
FT   VARIANT    4848   4848       I -> V (in CPVT1).
FT                                {ECO:0000269|PubMed:15466642,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_044108.
FT   VARIANT    4860   4860       A -> G (in CPVT1; diminishes the response
FT                                to activation by luminal Ca(2+) but has
FT                                little effect on the sensitivity of the
FT                                channel to activation by cytosolic
FT                                Ca(2+); shows caffeine-induced Ca(2+)
FT                                release but exhibits no store-overload-
FT                                induced Ca(2+) release (SOICR); HL1
FT                                cardiac cells transfected with the G-4860
FT                                mutant displayed attenuated SOICR
FT                                activity compared to cells transfected
FT                                with wild-type RYR2; dbSNP:rs121918606).
FT                                {ECO:0000269|PubMed:12093772,
FT                                ECO:0000269|PubMed:17984046}.
FT                                /FTId=VAR_044109.
FT   VARIANT    4867   4867       I -> M (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044110.
FT   VARIANT    4880   4880       V -> A (in CPVT1).
FT                                {ECO:0000269|PubMed:15046072}.
FT                                /FTId=VAR_044111.
FT   VARIANT    4895   4895       N -> D (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044112.
FT   VARIANT    4902   4902       P -> L (in CPVT1).
FT                                {ECO:0000269|PubMed:14571276}.
FT                                /FTId=VAR_023695.
FT   VARIANT    4950   4950       E -> K (in CPVT1).
FT                                {ECO:0000269|PubMed:12093772}.
FT                                /FTId=VAR_044113.
FT   VARIANT    4955   4955       G -> E (probable disease-associated
FT                                mutation found in a patient with
FT                                intellectual disability, seizures, short
FT                                stature and severe atrial arrhythmias).
FT                                {ECO:0000269|PubMed:25356899}.
FT                                /FTId=VAR_078648.
FT   VARIANT    4959   4959       R -> Q (in CPVT1; dbSNP:rs794728811).
FT                                {ECO:0000269|PubMed:14571276,
FT                                ECO:0000269|PubMed:16188589}.
FT                                /FTId=VAR_023696.
FT   MUTAGEN    2808   2808       S->A: Abolishes phosphorylation by PKA.
FT                                {ECO:0000269|PubMed:10830164}.
FT   MUTAGEN    3946   3946       G->A: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   MUTAGEN    3978   3978       M->I: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   MUTAGEN    4108   4108       H->N: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   MUTAGEN    4108   4108       H->Q: Changed ryanodine-sensitive
FT                                calcium-release channel activity
FT                                characterized by increased sensitivity to
FT                                cytosolic calcium activation.
FT                                {ECO:0000269|PubMed:27733687}.
FT   CONFLICT   1037   1037       L -> P (in Ref. 1; CAA66975 and 2;
FT                                CAC18855). {ECO:0000305}.
FT   CONFLICT   2785   2789       WGWRI -> RTMRT (in Ref. 1; CAA66975 and
FT                                2; CAC18855). {ECO:0000305}.
FT   STRAND       19     28       {ECO:0000244|PDB:4JKQ}.
FT   STRAND       31     38       {ECO:0000244|PDB:4JKQ}.
FT   STRAND       48     51       {ECO:0000244|PDB:4JKQ}.
FT   TURN         53     57       {ECO:0000244|PDB:4JKQ}.
FT   HELIX        63     65       {ECO:0000244|PDB:4JKQ}.
FT   STRAND       67     73       {ECO:0000244|PDB:4JKQ}.
FT   TURN        108    110       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      118    127       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      129    132       {ECO:0000244|PDB:4JKQ}.
FT   TURN        139    141       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      145    151       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      159    166       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      180    185       {ECO:0000244|PDB:4JKQ}.
FT   TURN        186    188       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      191    196       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      198    208       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      212    218       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      233    238       {ECO:0000244|PDB:4JKQ}.
FT   TURN        239    242       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      243    246       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      250    252       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       256    258       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      261    263       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       265    269       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       271    273       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      275    280       {ECO:0000244|PDB:4JKQ}.
FT   TURN        283    286       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      295    299       {ECO:0000244|PDB:4JKQ}.
FT   TURN        300    302       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      305    308       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      310    312       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      314    317       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       319    321       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       324    327       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      329    336       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      340    342       {ECO:0000244|PDB:4JKQ}.
FT   TURN        356    358       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      360    365       {ECO:0000244|PDB:4JKQ}.
FT   TURN        366    368       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      371    375       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      388    396       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      403    407       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       410    437       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       442    444       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       449    462       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       472    491       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       494    506       {ECO:0000244|PDB:4JKQ}.
FT   STRAND      508    510       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       511    518       {ECO:0000244|PDB:4JKQ}.
FT   HELIX       520    541       {ECO:0000244|PDB:4JKQ}.
SQ   SEQUENCE   4967 AA;  564567 MW;  44984485F8677B42 CRC64;
     MADGGEGEDE IQFLRTDDEV VLQCTATIHK EQQKLCLAAE GFGNRLCFLE STSNSKNVPP
     DLSICTFVLE QSLSVRALQE MLANTVEKSE GQVDVEKWKF MMKTAQGGGH RTLLYGHAIL
     LRHSYSGMYL CCLSTSRSST DKLAFDVGLQ EDTTGEACWW TIHPASKQRS EGEKVRVGDD
     LILVSVSSER YLHLSYGNGS LHVDAAFQQT LWSVAPISSG SEAAQGYLIG GDVLRLLHGH
     MDECLTVPSG EHGEEQRRTV HYEGGAVSVH ARSLWRLETL RVAWSGSHIR WGQPFRLRHV
     TTGKYLSLME DKNLLLMDKE KADVKSTAFT FRSSKEKLDV GVRKEVDGMG TSEIKYGDSV
     CYIQHVDTGL WLTYQSVDVK SVRMGSIQRK AIMHHEGHMD DGISLSRSQH EESRTARVIR
     STVFLFNRFI RGLDALSKKA KASTVDLPIE SVSLSLQDLI GYFHPPDEHL EHEDKQNRLR
     ALKNRQNLFQ EEGMINLVLE CIDRLHVYSS AAHFADVAGR EAGESWKSIL NSLYELLAAL
     IRGNRKNCAQ FSGSLDWLIS RLERLEASSG ILEVLHCVLV ESPEALNIIK EGHIKSIISL
     LDKHGRNHKV LDVLCSLCVC HGVAVRSNQH LICDNLLPGR DLLLQTRLVN HVSSMRPNIF
     LGVSEGSAQY KKWYYELMVD HTEPFVTAEA THLRVGWAST EGYSPYPGGG EEWGGNGVGD
     DLFSYGFDGL HLWSGCIART VSSPNQHLLR TDDVISCCLD LSAPSISFRI NGQPVQGMFE
     NFNIDGLFFP VVSFSAGIKV RFLLGGRHGE FKFLPPPGYA PCYEAVLPKE KLKVEHSREY
     KQERTYTRDL LGPTVSLTQA AFTPIPVDTS QIVLPPHLER IREKLAENIH ELWVMNKIEL
     GWQYGPVRDD NKRQHPCLVE FSKLPEQERN YNLQMSLETL KTLLALGCHV GISDEHAEDK
     VKKMKLPKNY QLTSGYKPAP MDLSFIKLTP SQEAMVDKLA ENAHNVWARD RIRQGWTYGI
     QQDVKNRRNP RLVPYTLLDD RTKKSNKDSL REAVRTLLGY GYNLEAPDQD HAARAEVCSG
     TGERFRIFRA EKTYAVKAGR WYFEFETVTA GDMRVGWSRP GCQPDQELGS DERAFAFDGF
     KAQRWHQGNE HYGRSWQAGD VVGCMVDMNE HTMMFTLNGE ILLDDSGSEL AFKDFDVGDG
     FIPVCSLGVA QVGRMNFGKD VSTLKYFTIC GLQEGYEPFA VNTNRDITMW LSKRLPQFLQ
     VPSNHEHIEV TRIDGTIDSS PCLKVTQKSF GSQNSNTDIM FYRLSMPIEC AEVFSKTVAG
     GLPGAGLFGP KNDLEDYDAD SDFEVLMKTA HGHLVPDRVD KDKEATKPEF NNHKDYAQEK
     PSRLKQRFLL RRTKPDYSTS HSARLTEDVL ADDRDDYDFL MQTSTYYYSV RIFPGQEPAN
     VWVGWITSDF HQYDTGFDLD RVRTVTVTLG DEKGKVHESI KRSNCYMVCA GESMSPGQGR
     NNNGLEIGCV VDAASGLLTF IANGKELSTY YQVEPSTKLF PAVFAQATSP NVFQFELGRI
     KNVMPLSAGL FKSEHKNPVP QCPPRLHVQF LSHVLWSRMP NQFLKVDVSR ISERQGWLVQ
     CLDPLQFMSL HIPEENRSVD ILELTEQEEL LKFHYHTLRL YSAVCALGNH RVAHALCSHV
     DEPQLLYAIE NKYMPGLLRA GYYDLLIDIH LSSYATARLM MNNEYIVPMT EETKSITLFP
     DENKKHGLPG IGLSTSLRPR MQFSSPSFVS ISNECYQYSP EFPLDILKSK TIQMLTEAVK
     EGSLHARDPV GGTTEFLFVP LIKLFYTLLI MGIFHNEDLK HILQLIEPSV FKEAATPEEE
     SDTLEKELSV DDAKLQGAGE EEAKGGKRPK EGLLQMKLPE PVKLQMCLLL QYLCDCQVRH
     RIEAIVAFSD DFVAKLQDNQ RFRYNEVMQA LNMSAALTAR KTKEFRSPPQ EQINMLLNFK
     DDKSECPCPE EIRDQLLDFH EDLMTHCGIE LDEDGSLDGN SDLTIRGRLL SLVEKVTYLK
     KKQAEKPVES DSKKSSTLQQ LISETMVRWA QESVIEDPEL VRAMFVLLHR QYDGIGGLVR
     ALPKTYTING VSVEDTINLL ASLGQIRSLL SVRMGKEEEK LMIRGLGDIM NNKVFYQHPN
     LMRALGMHET VMEVMVNVLG GGESKEITFP KMVANCCRFL CYFCRISRQN QKAMFDHLSY
     LLENSSVGLA SPAMRGSTPL DVAAASVMDN NELALALREP DLEKVVRYLA GCGLQSCQML
     VSKGYPDIGW NPVEGERYLD FLRFAVFCNG ESVEENANVV VRLLIRRPEC FGPALRGEGG
     NGLLAAMEEA IKIAEDPSRD GPSPNSGSSK TLDTEEEEDD TIHMGNAIMT FYSALIDLLG
     RCAPEMHLIH AGKGEAIRIR SILRSLIPLG DLVGVISIAF QMPTIAKDGN VVEPDMSAGF
     CPDHKAAMVL FLDRVYGIEV QDFLLHLLEV GFLPDLRAAA SLDTAALSAT DMALALNRYL
     CTAVLPLLTR CAPLFAGTEH HASLIDSLLH TVYRLSKGCS LTKAQRDSIE VCLLSICGQL
     RPSMMQHLLR RLVFDVPLLN EHAKMPLKLL TNHYERCWKY YCLPGGWGNF GAASEEELHL
     SRKLFWGIFD ALSQKKYEQE LFKLALPCLS AVAGALPPDY MESNYVSMME KQSSMDSEGN
     FNPQPVDTSN ITIPEKLEYF INKYAEHSHD KWSMDKLANG WIYGEIYSDS SKVQPLMKPY
     KLLSEKEKEI YRWPIKESLK TMLAWGWRIE RTREGDSMAL YNRTRRISQT SQVSVDAAHG
     YSPRAIDMSN VTLSRDLHAM AEMMAENYHN IWAKKKKMEL ESKGGGNHPL LVPYDTLTAK
     EKAKDREKAQ DILKFLQING YAVSRGFKDL ELDTPSIEKR FAYSFLQQLI RYVDEAHQYI
     LEFDGGSRGK GEHFPYEQEI KFFAKVVLPL IDQYFKNHRL YFLSAASRPL CSGGHASNKE
     KEMVTSLFCK LGVLVRHRIS LFGNDATSIV NCLHILGQTL DARTVMKTGL ESVKSALRAF
     LDNAAEDLEK TMENLKQGQF THTRNQPKGV TQIINYTTVA LLPMLSSLFE HIGQHQFGED
     LILEDVQVSC YRILTSLYAL GTSKSIYVER QRSALGECLA AFAGAFPVAF LETHLDKHNI
     YSIYNTKSSR ERAALSLPTN VEDVCPNIPS LEKLMEEIVE LAESGIRYTQ MPHVMEVILP
     MLCSYMSRWW EHGPENNPER AEMCCTALNS EHMNTLLGNI LKIIYNNLGI DEGAWMKRLA
     VFSQPIINKV KPQLLKTHFL PLMEKLKKKA ATVVSEEDHL KAEARGDMSE AELLILDEFT
     TLARDLYAFY PLLIRFVDYN RAKWLKEPNP EAEELFRMVA EVFIYWSKSH NFKREEQNFV
     VQNEINNMSF LITDTKSKMS KAAVSDQERK KMKRKGDRYS MQTSLIVAAL KRLLPIGLNI
     CAPGDQELIA LAKNRFSLKD TEDEVRDIIR SNIHLQGKLE DPAIRWQMAL YKDLPNRTDD
     TSDPEKTVER VLDIANVLFH LEQKSKRVGR RHYCLVEHPQ RSKKAVWHKL LSKQRKRAVV
     ACFRMAPLYN LPRHRAVNLF LQGYEKSWIE TEEHYFEDKL IEDLAKPGAE PPEEDEGTKR
     VDPLHQLILL FSRTALTEKC KLEEDFLYMA YADIMAKSCH DEEDDDGEEE VKSFEEKEME
     KQKLLYQQAR LHDRGAAEMV LQTISASKGE TGPMVAATLK LGIAILNGGN STVQQKMLDY
     LKEKKDVGFF QSLAGLMQSC SVLDLNAFER QNKAEGLGMV TEEGSGEKVL QDDEFTCDLF
     RFLQLLCEGH NSDFQNYLRT QTGNNTTVNI IISTVDYLLR VQESISDFYW YYSGKDVIDE
     QGQRNFSKAI QVAKQVFNTL TEYIQGPCTG NQQSLAHSRL WDAVVGFLHV FAHMQMKLSQ
     DSSQIELLKE LMDLQKDMVV MLLSMLEGNV VNGTIGKQMV DMLVESSNNV EMILKFFDMF
     LKLKDLTSSD TFKEYDPDGK GVISKRDFHK AMESHKHYTQ SETEFLLSCA ETDENETLDY
     EEFVKRFHEP AKDIGFNVAV LLTNLSEHMP NDTRLQTFLE LAESVLNYFQ PFLGRIEIMG
     SAKRIERVYF EISESSRTQW EKPQVKESKR QFIFDVVNEG GEKEKMELFV NFCEDTIFEM
     QLAAQISESD LNERSANKEE SEKERPEEQG PRMAFFSILT VRSALFALRY NILTLMRMLS
     LKSLKKQMKK VKKMTVKDMV TAFFSSYWSI FMTLLHFVAS VFRGFFRIIC SLLLGGSLVE
     GAKKIKVAEL LANMPDPTQD EVRGDGEEGE RKPLEAALPS EDLTDLKELT EESDLLSDIF
     GLDLKREGGQ YKLIPHNPNA GLSDLMSNPV PMPEVQEKFQ EQKAKEEEKE EKEETKSEPE
     KAEGEDGEKE EKAKEDKGKQ KLRQLHTHRY GEPEVPESAF WKKIIAYQQK LLNYFARNFY
     NMRMLALFVA FAINFILLFY KVSTSSVVEG KELPTRSSSE NAKVTSLDSS SHRIIAVHYV
     LEESSGYMEP TLRILAILHT VISFFCIIGY YCLKVPLVIF KREKEVARKL EFDGLYITEQ
     PSEDDIKGQW DRLVINTQSF PNNYWDKFVK RKVMDKYGEF YGRDRISELL GMDKAALDFS
     DAREKKKPKK DSSLSAVLNS IDVKYQMWKL GVVFTDNSFL YLAWYMTMSV LGHYNNFFFA
     AHLLDIAMGF KTLRTILSSV THNGKQLVLT VGLLAVVVYL YTVVAFNFFR KFYNKSEDGD
     TPDMKCDDML TCYMFHMYVG VRAGGGIGDE IEDPAGDEYE IYRIIFDITF FFFVIVILLA
     IIQGLIIDAF GELRDQQEQV KEDMETKCFI CGIGNDYFDT VPHGFETHTL QEHNLANYLF
     FLMYLINKDE TEHTGQESYV WKMYQERCWE FFPAGDCFRK QYEDQLN
//
ID   P2RX5_HUMAN             Reviewed;         422 AA.
AC   Q93086; G5E981; O43450; O75540; Q308M5; Q59F38; Q8IXW4; Q93087;
AC   Q9NZV0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 4.
DT   22-NOV-2017, entry version 158.
DE   RecName: Full=P2X purinoceptor 5;
DE            Short=P2X5;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2RX5; Synonyms=P2X5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RA   Tokuyama Y., Mereu L., Chen X., Rouard M., Bell G.I.;
RT   "Cloning of human P2X purinoceptor new subtype (P2X5).";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9414125; DOI=10.1016/S0014-5793(97)01380-X;
RA   Le K.-T., Paquet M., Nouel D., Babinski K., Seguela P.;
RT   "Primary structure and expression of a naturally truncated human P2X
RT   ATP receptor subunit from brain and immune system.";
RL   FEBS Lett. 418:195-199(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10673275; DOI=10.1101/gr.10.2.165;
RA   Touchman J.W., Anikster Y., Dietrich N.L., Maduro V.V.B., McDowell G.,
RA   Shotelersuk V., Bouffard G.G., Beckstrom-Sternberg S.M., Gahl W.A.,
RA   Green E.D.;
RT   "The genomic region encompassing the nephropathic cystinosis gene
RT   (CTNS): complete sequencing of a 200-kb segment and discovery of a
RT   novel gene within the common cystinosis-causing deletion.";
RL   Genome Res. 10:165-173(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Li H., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Tang Z., Huang B., Lin L., Yang S.;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Erythroleukemia, and Mesangial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Leukocyte, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q93086-3; Sequence=Displayed;
CC       Name=2; Synonyms=A;
CC         IsoId=Q93086-1; Sequence=VSP_035587;
CC       Name=3; Synonyms=B;
CC         IsoId=Q93086-2; Sequence=VSP_004503, VSP_035587;
CC       Name=4;
CC         IsoId=Q93086-4; Sequence=VSP_035588;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=5;
CC         IsoId=Q93086-5; Sequence=VSP_004503;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in brain and immune
CC       system.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF43106.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AK307959; Type=Frameshift; Positions=112; Evidence={ECO:0000305};
CC       Sequence=BAD92860.1; Type=Frameshift; Positions=112; Evidence={ECO:0000305};
CC       Sequence=BC028084; Type=Frameshift; Positions=112; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P2X receptor entry;
CC       URL="https://en.wikipedia.org/wiki/P2X_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U49395; AAB08576.1; -; mRNA.
DR   EMBL; U49396; AAB08577.1; -; mRNA.
DR   EMBL; AF016709; AAC51931.1; -; mRNA.
DR   EMBL; AF168787; AAF43105.1; -; Genomic_DNA.
DR   EMBL; AF168787; AAF43106.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF070573; AAC28645.1; -; mRNA.
DR   EMBL; DQ234349; ABB29978.1; -; mRNA.
DR   EMBL; AK290889; BAF83578.1; -; mRNA.
DR   EMBL; AK307959; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB209623; BAD92860.1; ALT_FRAME; mRNA.
DR   EMBL; AC132942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90483.1; -; Genomic_DNA.
DR   EMBL; BC028084; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC039015; AAH39015.1; -; mRNA.
DR   CCDS; CCDS11034.1; -. [Q93086-3]
DR   CCDS; CCDS11035.1; -. [Q93086-2]
DR   CCDS; CCDS56014.1; -. [Q93086-5]
DR   CCDS; CCDS56015.1; -. [Q93086-1]
DR   RefSeq; NP_001191448.1; NM_001204519.1. [Q93086-1]
DR   RefSeq; NP_001191449.1; NM_001204520.1. [Q93086-5]
DR   RefSeq; NP_002552.2; NM_002561.3. [Q93086-3]
DR   RefSeq; NP_778255.1; NM_175080.2. [Q93086-2]
DR   UniGene; Hs.731607; -.
DR   ProteinModelPortal; Q93086; -.
DR   SMR; Q93086; -.
DR   BioGrid; 111065; 30.
DR   IntAct; Q93086; 2.
DR   STRING; 9606.ENSP00000225328; -.
DR   BindingDB; Q93086; -.
DR   ChEMBL; CHEMBL4942; -.
DR   iPTMnet; Q93086; -.
DR   PhosphoSitePlus; Q93086; -.
DR   BioMuta; P2RX5; -.
DR   DMDM; 209572778; -.
DR   PaxDb; Q93086; -.
DR   PeptideAtlas; Q93086; -.
DR   PRIDE; Q93086; -.
DR   DNASU; 5026; -.
DR   Ensembl; ENST00000225328; ENSP00000225328; ENSG00000083454. [Q93086-3]
DR   Ensembl; ENST00000345901; ENSP00000342161; ENSG00000083454. [Q93086-5]
DR   Ensembl; ENST00000547178; ENSP00000448355; ENSG00000083454. [Q93086-1]
DR   Ensembl; ENST00000551178; ENSP00000447545; ENSG00000083454. [Q93086-2]
DR   GeneID; 5026; -.
DR   KEGG; hsa:5026; -.
DR   UCSC; uc002fwi.4; human. [Q93086-3]
DR   CTD; 5026; -.
DR   DisGeNET; 5026; -.
DR   EuPathDB; HostDB:ENSG00000083454.21; -.
DR   GeneCards; P2RX5; -.
DR   HGNC; HGNC:8536; P2RX5.
DR   HPA; HPA021948; -.
DR   HPA; HPA067827; -.
DR   MIM; 602836; gene.
DR   neXtProt; NX_Q93086; -.
DR   OpenTargets; ENSG00000083454; -.
DR   PharmGKB; PA32865; -.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; Q93086; -.
DR   KO; K05219; -.
DR   OMA; AGAFFCD; -.
DR   PhylomeDB; Q93086; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-418346; Platelet homeostasis.
DR   ChiTaRS; P2RX5; human.
DR   GeneWiki; P2RX5; -.
DR   GenomeRNAi; 5026; -.
DR   PRO; PR:Q93086; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000083454; -.
DR   CleanEx; HS_P2RX5; -.
DR   ExpressionAtlas; Q93086; baseline and differential.
DR   Genevisible; Q93086; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; NAS:BHF-UCL.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IBA:GO_Central.
DR   GO; GO:0005216; F:ion channel activity; TAS:ProtInc.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; NAS:BHF-UCL.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; NAS:BHF-UCL.
DR   GO; GO:0033198; P:response to ATP; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003048; P2X5_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   PANTHER; PTHR10125:SF12; PTHR10125:SF12; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01312; P2X5RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Receptor; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    422       P2X purinoceptor 5.
FT                                /FTId=PRO_0000161555.
FT   TOPO_DOM      1     30       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     31     51       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     52    319       Extracellular. {ECO:0000255}.
FT   TRANSMEM    320    340       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    341    422       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    118    169       {ECO:0000250}.
FT   DISULFID    129    152       {ECO:0000250}.
FT   DISULFID    135    163       {ECO:0000250}.
FT   DISULFID    220    229       {ECO:0000250}.
FT   DISULFID    263    272       {ECO:0000250}.
FT   VAR_SEQ      97    120       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|Ref.1, ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_004503.
FT   VAR_SEQ     205    206       KS -> N (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9414125,
FT                                ECO:0000303|Ref.1, ECO:0000303|Ref.4}.
FT                                /FTId=VSP_035587.
FT   VAR_SEQ     421    422       ST -> LRTPSASPLHQE (in isoform 4).
FT                                {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_035588.
FT   CONFLICT     96     96       Q -> E (in Ref. 1; AAB08577).
FT                                {ECO:0000305}.
FT   CONFLICT     97     98       GE -> EK (in Ref. 1; AAB08576).
FT                                {ECO:0000305}.
FT   CONFLICT    156    156       E -> G (in Ref. 2; AAC51931).
FT                                {ECO:0000305}.
FT   CONFLICT    237    238       VI -> IV (in Ref. 2; AAC51931).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       E -> R (in Ref. 2; AAC51931).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       F -> S (in Ref. 1; AAB08576/AAB08577).
FT                                {ECO:0000305}.
FT   CONFLICT    350    350       K -> R (in Ref. 5; ABB29978).
FT                                {ECO:0000305}.
FT   CONFLICT    352    352       E -> Q (in Ref. 1; AAB08576/AAB08577).
FT                                {ECO:0000305}.
FT   CONFLICT    399    400       KR -> NV (in Ref. 1; AAB08576/AAB08577).
FT                                {ECO:0000305}.
SQ   SEQUENCE   422 AA;  47205 MW;  B122027A23B2A240 CRC64;
     MGQAGCKGLC LSLFDYKTEK YVIAKNKKVG LLYRLLQASI LAYLVVWVFL IKKGYQDVDT
     SLQSAVITKV KGVAFTNTSD LGQRIWDVAD YVIPAQGENV FFVVTNLIVT PNQRQNVCAE
     NEGIPDGACS KDSDCHAGEA VTAGNGVKTG RCLRRENLAR GTCEIFAWCP LETSSRPEEP
     FLKEAEDFTI FIKNHIRFPK FNFSKSNVMD VKDRSFLKSC HFGPKNHYCP IFRLGSVIRW
     AGSDFQDIAL EGGVIGINIE WNCDLDKAAS ECHPHYSFSR LDNKLSKSVS SGYNFRFARY
     YRDAAGVEFR TLMKAYGIRF DVMVNGKGAF FCDLVLIYLI KKREFYRDKK YEEVRGLEDS
     SQEAEDEASG LGLSEQLTSG PGLLGMPEQQ ELQEPPEAKR GSSSQKGNGS VCPQLLEPHR
     ST
//
ID   ACR3_CAEEL              Reviewed;         487 AA.
AC   Q93149;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   22-NOV-2017, entry version 138.
DE   RecName: Full=Acetylcholine receptor subunit beta-type acr-3;
DE   Flags: Precursor;
GN   Name=acr-3; ORFNames=K11G12.7;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH NICOTINIC
RP   ACETYLCHOLINE RECEPTOR.
RC   STRAIN=Bristol N2;
RX   PubMed=9606719;
RA   Baylis H.A., Matsuda K., Squire M.D., Fleming J.T., Harvey R.J.,
RA   Darlison M.G., Barnard E.A., Sattelle D.B.;
RT   "ACR-3, a Caenorhabditis elegans nicotinic acetylcholine receptor
RT   subunit. Molecular cloning and functional expression.";
RL   Recept. Channels 5:149-158(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH NICOTINIC ACETYLCHOLINE RECEPTOR.
RX   PubMed=20027209; DOI=10.1371/journal.pbio.1000265;
RA   Jospin M., Qi Y.B., Stawicki T.M., Boulin T., Schuske K.R.,
RA   Horvitz H.R., Bessereau J.L., Jorgensen E.M., Jin Y.;
RT   "A neuronal acetylcholine receptor regulates the balance of muscle
RT   excitation and inhibition in Caenorhabditis elegans.";
RL   PLoS Biol. 7:E1000265-E1000265(2009).
CC   -!- FUNCTION: Non-alpha subunit of nicotinic acetylcholine receptor
CC       (nAChR) (PubMed:9606719, PubMed:20027209). Probably acts in
CC       cholinergic motoneurons to regulate presynaptic neurotransmitter
CC       release, thereby ensuring normal level of excitation of
CC       cholinergic motoneurons during locomotion (PubMed:20027209).
CC       {ECO:0000269|PubMed:20027209, ECO:0000269|PubMed:9606719}.
CC   -!- SUBUNIT: Component of nicotinic acetylcholine receptor. In
CC       cholinergic motoneurons, composed of 2 non-alpha subunits acr-2
CC       and acr-3, and 3 alpha subunits unc-38, unc-63 and acr-12.
CC       {ECO:0000269|PubMed:20027209, ECO:0000269|PubMed:9606719}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q23022}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q23022}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y08637; CAA69927.1; -; mRNA.
DR   EMBL; FO081325; CCD70799.1; -; Genomic_DNA.
DR   RefSeq; NP_509129.1; NM_076728.3.
DR   UniGene; Cel.19671; -.
DR   ProteinModelPortal; Q93149; -.
DR   STRING; 6239.K11G12.7; -.
DR   TCDB; 1.A.9.1.2; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q93149; -.
DR   EnsemblMetazoa; K11G12.7; K11G12.7; WBGene00000043.
DR   GeneID; 180937; -.
DR   KEGG; cel:CELE_K11G12.7; -.
DR   UCSC; K11G12.7; c. elegans.
DR   CTD; 180937; -.
DR   WormBase; K11G12.7; CE28345; WBGene00000043; acr-3.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; Q93149; -.
DR   KO; K05312; -.
DR   OMA; IEYITTH; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q93149; -.
DR   Reactome; R-CEL-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   PRO; PR:Q93149; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00000043; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IDA:WormBase.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    487       Acetylcholine receptor subunit beta-type
FT                                acr-3.
FT                                /FTId=PRO_0000000401.
FT   TOPO_DOM     21    231       Extracellular. {ECO:0000255}.
FT   TRANSMEM    232    252       Helical. {ECO:0000255}.
FT   TRANSMEM    259    279       Helical. {ECO:0000255}.
FT   TRANSMEM    294    314       Helical. {ECO:0000255}.
FT   TOPO_DOM    315    439       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    440    460       Helical. {ECO:0000255}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
SQ   SEQUENCE   487 AA;  56245 MW;  15D3E8D1DBF7E0F8 CRC64;
     MQKIWLFSII TIFLITELQC YPNSAEERLL SYIFDGYNSL IRPVLNASSP PIEVFFSLAF
     VLLINVDEKN QIMQTNVWPT MKWNDYQMQW DPREFDGIKT IRVPPDKVWL PDIVLFNNAD
     GNYLVSFYSN VVVEHTGDML WVPPAVYKSS CLIDVEFFPF DEQVCSLTFG SWTFRKDELQ
     LSYLSGKRHV ELNDYLPSGV WDLIDAPGLL IDERSKISYQ IKIRRKALFY TVILIMPTVL
     MAFLSMMVFY LPAESSEKIT LAISILLALV VFLLVVSKIL PPTSSTIPLM AKYLLMTFIM
     NMITIMVSVI IINVYFRGPA THIMPNWVKT VFLKFLPVLF VMRRPESTEK ELAKMKREKR
     ERRSMKSALK TFFKRNDAKI SEQPKQTSRK DGSSSEEKLS SDAKKAIEAI EYITTHLTHD
     NAFKRQREEW KFVSVVIDRL LLYLFFAVTT GGTVGILLSA PNVFEQVNQT SVIERLKQQA
     AEEMLNS
//
ID   ACHA_DANRE              Reviewed;         456 AA.
AC   Q98880;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   25-OCT-2017, entry version 133.
DE   RecName: Full=Acetylcholine receptor subunit alpha;
DE   Flags: Precursor;
GN   Name=chrna1; Synonyms=nic1;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=9475746;
RA   Sepich D.S., Wegner J., O'Shea S., Westerfield M.;
RT   "An altered intron inhibits synthesis of the acetylcholine receptor
RT   alpha-subunit in the paralyzed zebrafish mutant nic1.";
RL   Genetics 148:361-372(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane.
CC   -!- SUBUNIT: Pentamer of two alpha chains, and one each of the beta,
CC       delta, and gamma chains.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       1/CHRNA1 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AH003668; AAB09701.1; -; Genomic_DNA.
DR   EMBL; U70437; AAB09770.1; -; Genomic_DNA.
DR   EMBL; U70438; AAB16917.1; -; mRNA.
DR   EMBL; BC081554; AAH81554.1; -; mRNA.
DR   RefSeq; NP_571520.1; NM_131445.1.
DR   UniGene; Dr.75091; -.
DR   ProteinModelPortal; Q98880; -.
DR   SMR; Q98880; -.
DR   STRING; 7955.ENSDARP00000021860; -.
DR   PaxDb; Q98880; -.
DR   Ensembl; ENSDART00000020261; ENSDARP00000021860; ENSDARG00000009021.
DR   GeneID; 30725; -.
DR   KEGG; dre:30725; -.
DR   CTD; 1134; -.
DR   ZFIN; ZDB-GENE-980526-137; chrna1.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q98880; -.
DR   KO; K04803; -.
DR   OMA; XVFIDTI; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q98880; -.
DR   TreeFam; TF315605; -.
DR   Reactome; R-DRE-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-DRE-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   PRO; PR:Q98880; -.
DR   Proteomes; UP000000437; Chromosome 6.
DR   Bgee; ENSDARG00000009021; -.
DR   ExpressionAtlas; Q98880; baseline.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:ZFIN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IEA:InterPro.
DR   GO; GO:0005261; F:cation channel activity; IDA:ZFIN.
DR   GO; GO:0003428; P:chondrocyte intercalation involved in growth plate cartilage morphogenesis; IMP:ZFIN.
DR   GO; GO:0086009; P:membrane repolarization; IMP:ZFIN.
DR   GO; GO:0008045; P:motor neuron axon guidance; IMP:ZFIN.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IDA:ZFIN.
DR   GO; GO:0043113; P:receptor clustering; IMP:ZFIN.
DR   GO; GO:0030516; P:regulation of axon extension; IMP:ZFIN.
DR   GO; GO:0035094; P:response to nicotine; IBA:GO_Central.
DR   GO; GO:0048741; P:skeletal muscle fiber development; IMP:ZFIN.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IMP:ZFIN.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IDA:ZFIN.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 2.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     20       {ECO:0000250}.
FT   CHAIN        21    456       Acetylcholine receptor subunit alpha.
FT                                /FTId=PRO_0000000309.
FT   TOPO_DOM     21    230       Extracellular. {ECO:0000255}.
FT   TRANSMEM    231    255       Helical. {ECO:0000255}.
FT   TRANSMEM    263    281       Helical. {ECO:0000255}.
FT   TRANSMEM    297    316       Helical. {ECO:0000255}.
FT   TOPO_DOM    317    428       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    429    447       Helical. {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    148    162       {ECO:0000250}.
FT   DISULFID    212    213       Associated with receptor activation.
FT                                {ECO:0000250}.
SQ   SEQUENCE   456 AA;  52100 MW;  336825C5E358C6F3 CRC64;
     MNYFILILPI LPYLYGPAVC SEDETRLVKT LFTGYNKVVR PVSHFKDPVV VTVGLQLIQL
     ISVDEVNQIV TSNVRLKQQW KDVHLQWNPD DYGGIRKIRI PSTDLWKPDL VLYNNADGDF
     AIVHETKVLL EHTGMITWTP PAIFKSYCEI VVLHFPFDLQ NCSMKLGTWT YDGNLVIINP
     DSDRPDLSNF MESGEWVMKD YRSWKHWVYY ACCPDTPYLD ITYHFLLLRL PLYFIVNVII
     PCMLFSFLTG LVFYLPTDSG EKMTLSISVL LSLTVFLLVI VELIPSTSSA VPLIGKYMLF
     TMIFVIASII ITVIVINTHH RSPSTHIMPA WVRKIFIDTI PNMMFFSTMK RPSQERQEKR
     LFPADFDISD ISGKPMPASV TYHSPITKNP DVRSAIEGVK YIADTMKSDE ESNNAAEEWK
     FVAMVLDHIL LCVFMAVCII GTLGVFAGRL IELSML
//
ID   CNGK1_RHILO             Reviewed;         355 AA.
AC   Q98GN8;
DT   14-OCT-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 1.
DT   25-OCT-2017, entry version 102.
DE   RecName: Full=Cyclic nucleotide-gated potassium channel mll3241;
DE   AltName: Full=MlotiK1 channel;
GN   OrderedLocusNames=mll3241;
OS   Rhizobium loti (strain MAFF303099) (Mesorhizobium loti).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhizobiales;
OC   Phyllobacteriaceae; Mesorhizobium.
OX   NCBI_TaxID=266835;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=MAFF303099;
RX   PubMed=11214968; DOI=10.1093/dnares/7.6.331;
RA   Kaneko T., Nakamura Y., Sato S., Asamizu E., Kato T., Sasamoto S.,
RA   Watanabe A., Idesawa K., Ishikawa A., Kawashima K., Kimura T.,
RA   Kishida Y., Kiyokawa C., Kohara M., Matsumoto M., Matsuno A.,
RA   Mochizuki Y., Nakayama S., Nakazaki N., Shimpo S., Sugimoto M.,
RA   Takeuchi C., Yamada M., Tabata S.;
RT   "Complete genome structure of the nitrogen-fixing symbiotic bacterium
RT   Mesorhizobium loti.";
RL   DNA Res. 7:331-338(2000).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 218-355 IN COMPLEXES WITH
RP   CAMP, FUNCTION, SUBUNIT, AND MUTAGENESIS OF TRP-227 AND ARG-348.
RX   PubMed=15550244; DOI=10.1016/j.cell.2004.10.030;
RA   Clayton G.M., Silverman W.R., Heginbotham L., Morais-Cabral J.H.;
RT   "Structural basis of ligand activation in a cyclic nucleotide
RT   regulated potassium channel.";
RL   Cell 119:615-627(2004).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS), MEMBRANE TOPOLOGY, AND
RP   MUTAGENESIS OF PHE-203 AND TYR-215.
RX   PubMed=18216238; DOI=10.1073/pnas.0711533105;
RA   Clayton G.M., Altieri S., Heginbotham L., Unger V.M.,
RA   Morais-Cabral J.H.;
RT   "Structure of the transmembrane regions of a bacterial cyclic
RT   nucleotide-regulated channel.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1511-1515(2008).
CC   -!- FUNCTION: Cyclic nucleotide-regulated potassium channel activated
CC       by cAMP. {ECO:0000269|PubMed:15550244}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:15550244}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-15658025, EBI-15658025;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the potassium channel family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000012; BAB50178.1; -; Genomic_DNA.
DR   RefSeq; WP_010911524.1; NC_002678.2.
DR   PDB; 1U12; X-ray; 2.70 A; A/B=218-355.
DR   PDB; 1VP6; X-ray; 1.70 A; A/C=218-355.
DR   PDB; 2K0G; NMR; -; A=216-355.
DR   PDB; 2KXL; NMR; -; A=216-355.
DR   PDB; 2ZD9; X-ray; 4.00 A; A/B/C/D=1-355.
DR   PDB; 3BEH; X-ray; 3.10 A; A/B/C/D=1-355.
DR   PDB; 3CL1; X-ray; 2.40 A; A/B=216-355.
DR   PDB; 3CLP; X-ray; 2.00 A; A/C=216-355.
DR   PDB; 3CO2; X-ray; 2.90 A; A/B/C/D=216-355.
DR   PDB; 4CHV; EM; 7.00 A; A/B/C/D=1-355.
DR   PDB; 4CHW; EM; 7.00 A; A/B/C/D=1-355.
DR   PDB; 4MUV; X-ray; 1.25 A; A/B=216-355.
DR   PDBsum; 1U12; -.
DR   PDBsum; 1VP6; -.
DR   PDBsum; 2K0G; -.
DR   PDBsum; 2KXL; -.
DR   PDBsum; 2ZD9; -.
DR   PDBsum; 3BEH; -.
DR   PDBsum; 3CL1; -.
DR   PDBsum; 3CLP; -.
DR   PDBsum; 3CO2; -.
DR   PDBsum; 4CHV; -.
DR   PDBsum; 4CHW; -.
DR   PDBsum; 4MUV; -.
DR   ProteinModelPortal; Q98GN8; -.
DR   SMR; Q98GN8; -.
DR   DIP; DIP-29507N; -.
DR   STRING; 266835.mll3241; -.
DR   DrugBank; DB02527; Cyclic Adenosine Monophosphate.
DR   DrugBank; DB04147; Lauryl Dimethylamine-N-Oxide.
DR   TCDB; 1.A.1.25.1; the voltage-gated ion channel (vic) superfamily.
DR   EnsemblBacteria; BAB50178; BAB50178; BAB50178.
DR   KEGG; mlo:mll3241; -.
DR   PATRIC; fig|266835.9.peg.2584; -.
DR   eggNOG; ENOG4105EYW; Bacteria.
DR   eggNOG; COG0664; LUCA.
DR   eggNOG; COG1226; LUCA.
DR   HOGENOM; HOG000271293; -.
DR   KO; K10716; -.
DR   OMA; MYFIAEG; -.
DR   OrthoDB; POG091H04JJ; -.
DR   EvolutionaryTrace; Q98GN8; -.
DR   Proteomes; UP000000552; Chromosome.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IEA:InterPro.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR028325; VG_K_chnl.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    355       Cyclic nucleotide-gated potassium channel
FT                                mll3241.
FT                                /FTId=PRO_0000351501.
FT   TOPO_DOM      1     12       Cytoplasmic.
FT   TRANSMEM     13     30       Helical; Name=Segment S1.
FT   TOPO_DOM     31     38       Periplasmic.
FT   TRANSMEM     39     61       Helical; Name=Segment S2.
FT   TOPO_DOM     62     74       Cytoplasmic.
FT   TRANSMEM     75     94       Helical; Name=Segment S3.
FT   TRANSMEM     95    112       Helical; Name=Segment S4.
FT   TOPO_DOM    113    129       Cytoplasmic.
FT   TRANSMEM    130    150       Helical; Name=Segment S5.
FT   TOPO_DOM    151    161       Periplasmic.
FT   INTRAMEM    162    180       Pore-forming.
FT   TOPO_DOM    181    185       Periplasmic.
FT   TRANSMEM    186    210       Helical; Name=Segment S6.
FT   TOPO_DOM    211    355       Cytoplasmic.
FT   NP_BIND     297    298       cAMP.
FT   NP_BIND     307    308       cAMP.
FT   MOTIF       175    180       Selectivity filter. {ECO:0000305}.
FT   BINDING     348    348       cAMP.
FT   MUTAGEN     203    203       F->A: Increased channel conductance.
FT                                {ECO:0000269|PubMed:18216238}.
FT   MUTAGEN     215    215       Y->A: Increased channel conductance.
FT                                {ECO:0000269|PubMed:18216238}.
FT   MUTAGEN     227    227       W->A: Loss of channel activity.
FT                                {ECO:0000269|PubMed:15550244}.
FT   MUTAGEN     348    348       R->A: Loss of cAMP binding. Loss of
FT                                channel activity.
FT                                {ECO:0000269|PubMed:15550244}.
FT   STRAND        9     12       {ECO:0000244|PDB:3BEH}.
FT   HELIX        13     28       {ECO:0000244|PDB:3BEH}.
FT   STRAND       30     32       {ECO:0000244|PDB:3BEH}.
FT   HELIX        35     61       {ECO:0000244|PDB:3BEH}.
FT   HELIX        72     90       {ECO:0000244|PDB:3BEH}.
FT   HELIX        95    105       {ECO:0000244|PDB:3BEH}.
FT   HELIX       107    110       {ECO:0000244|PDB:3BEH}.
FT   HELIX       115    124       {ECO:0000244|PDB:3BEH}.
FT   HELIX       126    151       {ECO:0000244|PDB:3BEH}.
FT   TURN        152    154       {ECO:0000244|PDB:3BEH}.
FT   HELIX       156    159       {ECO:0000244|PDB:3BEH}.
FT   HELIX       162    173       {ECO:0000244|PDB:3BEH}.
FT   STRAND      179    181       {ECO:0000244|PDB:3BEH}.
FT   HELIX       216    223       {ECO:0000244|PDB:4MUV}.
FT   HELIX       226    230       {ECO:0000244|PDB:4MUV}.
FT   HELIX       234    238       {ECO:0000244|PDB:4MUV}.
FT   HELIX       241    250       {ECO:0000244|PDB:4MUV}.
FT   STRAND      252    256       {ECO:0000244|PDB:4MUV}.
FT   STRAND      261    263       {ECO:0000244|PDB:4MUV}.
FT   STRAND      271    278       {ECO:0000244|PDB:4MUV}.
FT   STRAND      280    286       {ECO:0000244|PDB:4MUV}.
FT   STRAND      288    290       {ECO:0000244|PDB:4MUV}.
FT   STRAND      295    297       {ECO:0000244|PDB:3CLP}.
FT   HELIX       298    303       {ECO:0000244|PDB:4MUV}.
FT   STRAND      308    323       {ECO:0000244|PDB:4MUV}.
FT   HELIX       324    333       {ECO:0000244|PDB:4MUV}.
FT   HELIX       335    352       {ECO:0000244|PDB:4MUV}.
SQ   SEQUENCE   355 AA;  37735 MW;  35EE06373D563933 CRC64;
     MSVLPFLRIY APLNAVLAAP GLLAVAALTI PDMSGRSRLA LAALLAVIWG AYLLQLAATL
     LKRRAGVVRD RTPKIAIDVL AVLVPLAAFL LDGSPDWSLY CAVWLLKPLR DSTFFPVLGR
     VLANEARNLI GVTTLFGVVL FAVALAAYVI ERDIQPEKFG SIPQAMWWAV VTLSTTGYGD
     TIPQSFAGRV LAGAVMMSGI GIFGLWAGIL ATGFYQEVRR GDFVRNWQLV AAVPLFQKLG
     PAVLVEIVRA LRARTVPAGA VICRIGEPGD RMFFVVEGSV SVATPNPVEL GPGAFFGEMA
     LISGEPRSAT VSAATTVSLL SLHSADFQML CSSSPEIAEI FRKTALERRG AAASA
//
ID   P2RX4_HUMAN             Reviewed;         388 AA.
AC   Q99571; E7EPF7; F6RU17; O00450; O14722; Q5U089; Q5U090; Q8N4N1;
AC   Q9UBG9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   20-DEC-2017, entry version 165.
DE   RecName: Full=P2X purinoceptor 4;
DE            Short=P2X4;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2RX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-6.
RC   TISSUE=Brain;
RX   PubMed=9016352;
RA   Garcia-Guzman M., Soto F., Gomez-Hernandez J.M., Lund P.E.,
RA   Stuhmer W.;
RT   "Characterization of recombinant human P2X4 receptor reveals
RT   pharmacological differences to the rat homologue.";
RL   Mol. Pharmacol. 51:109-118(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RA   Yamagata K., Oda N., Furuta H., Vaxillaire M., Southam L., Boriraj V.,
RA   Chen X., Oda Y., Takeda J., Yamada S., Nishigori H., Lebeau M.M.,
RA   Lathrop M., Cox R.D., Bell G.I.;
RT   "Transcription map of the 5cM region surrounding the hepatocyte
RT   nuclear factor-1a/MODY3 gene on chromosome 12.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT SER-6.
RA   Korenaga R., Yamamoto K., Kamiya A., Ando J.;
RT   "Shear stress downregulates the expression of P2X4 receptor by human
RT   endothelial cells.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   SER-6.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-242.
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-388 (ISOFORM 1), AND VARIANT CYS-315.
RA   Takahashi K., Korenaga R., Kamiya A., Ando J.;
RT   "Human P2X purinoceptor.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 73-326 (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Chang A.S., Chang S.M.;
RT   "Cloning of P2X4 cDNA from human embryonic kidney (HEK) 293 cells.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10515189; DOI=10.1016/S0304-3940(99)00653-9;
RA   Carpenter D., Meadows H.J., Brough S., Chapman G., Clarke C.,
RA   Coldwell M., Davis R., Harrison D., Meakin J., McHale M., Rice S.Q.,
RA   Tomlinson W.J., Wood M., Sanger G.J.;
RT   "Site-specific splice variation of the human P2X4 receptor.";
RL   Neurosci. Lett. 273:183-186(1999).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   VARIANTS GLY-242 AND CYS-315, CHARACTERIZATION OF VARIANTS SER-6;
RP   GLY-242 AND CYS-315, MUTAGENESIS OF ILE-119, AND FUNCTION.
RX   PubMed=22068874; DOI=10.1161/HYPERTENSIONAHA.111.176180;
RA   Stokes L., Scurrah K., Ellis J.A., Cromer B.A., Skarratt K.K.,
RA   Gu B.J., Harrap S.B., Wiley J.S.;
RT   "A loss-of-function polymorphism in the human P2X4 receptor is
RT   associated with increased pulse pressure.";
RL   Hypertension 58:1086-1092(2011).
RN   [12]
RP   VARIANT CYS-315, CHARACTERIZATION OF VARIANT CYS-315, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=23303206; DOI=10.1096/fj.12-215368;
RA   Gu B.J., Baird P.N., Vessey K.A., Skarratt K.K., Fletcher E.L.,
RA   Fuller S.J., Richardson A.J., Guymer R.H., Wiley J.S.;
RT   "A rare functional haplotype of the P2RX4 and P2RX7 genes leads to
RT   loss of innate phagocytosis and confers increased risk of age-related
RT   macular degeneration.";
RL   FASEB J. 27:1479-1487(2013).
RN   [13]
RP   VARIANTS CYS-3; SER-135; GLY-242 AND CYS-315, CHARACTERIZATION OF
RP   VARIANT SER-135, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=28326637; DOI=10.1002/humu.23218;
RA   Sadovnick A.D., Gu B.J., Traboulsee A.L., Bernales C.Q.,
RA   Encarnacion M., Yee I.M., Criscuoli M.G., Huang X., Ou A.,
RA   Milligan C.J., Petrou S., Wiley J.S., Vilarino-Gueell C.;
RT   "Purinergic receptors P2RX4 and P2RX7 in familial multiple
RT   sclerosis.";
RL   Hum. Mutat. 38:736-744(2017).
CC   -!- FUNCTION: Receptor for ATP that acts as a ligand-gated ion
CC       channel. This receptor is insensitive to the antagonists PPADS and
CC       suramin. {ECO:0000269|PubMed:10515189,
CC       ECO:0000269|PubMed:22068874, ECO:0000269|PubMed:28326637}.
CC   -!- SUBUNIT: Functional P2XRs are organized as homomeric and
CC       heteromeric trimers. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P26371:KRTAP5-9; NbExp=3; IntAct=EBI-2828248, EBI-3958099;
CC       Q7Z3S9:NOTCH2NL; NbExp=5; IntAct=EBI-2828248, EBI-945833;
CC       Q9NQM4:PIH1D3; NbExp=3; IntAct=EBI-2828248, EBI-10239299;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10515189,
CC       ECO:0000269|PubMed:23303206, ECO:0000269|PubMed:28326637}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q99571-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99571-2; Sequence=VSP_053812;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q99571-3; Sequence=VSP_053813;
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P2X receptor entry;
CC       URL="https://en.wikipedia.org/wiki/P2X_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y07684; CAA68948.1; -; mRNA.
DR   EMBL; U87270; AAD00556.1; -; Genomic_DNA.
DR   EMBL; U85971; AAD00556.1; JOINED; Genomic_DNA.
DR   EMBL; U85972; AAD00556.1; JOINED; Genomic_DNA.
DR   EMBL; U85973; AAD00556.1; JOINED; Genomic_DNA.
DR   EMBL; U85974; AAD00556.1; JOINED; Genomic_DNA.
DR   EMBL; U85975; AAD00556.1; JOINED; Genomic_DNA.
DR   EMBL; U83993; AAD00553.1; -; mRNA.
DR   EMBL; AF191093; AAF06661.1; -; Genomic_DNA.
DR   EMBL; BT019738; AAV38543.1; -; mRNA.
DR   EMBL; BT019739; AAV38544.1; -; mRNA.
DR   EMBL; AC069209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033826; AAH33826.1; -; mRNA.
DR   EMBL; AF000234; AAB58405.1; -; mRNA.
DR   EMBL; AF012903; AAB66834.1; -; mRNA.
DR   CCDS; CCDS58282.1; -. [Q99571-2]
DR   CCDS; CCDS9214.1; -. [Q99571-1]
DR   RefSeq; NP_001243725.1; NM_001256796.1. [Q99571-2]
DR   RefSeq; NP_001248326.1; NM_001261397.1. [Q99571-3]
DR   RefSeq; NP_002551.2; NM_002560.2. [Q99571-1]
DR   UniGene; Hs.321709; -.
DR   ProteinModelPortal; Q99571; -.
DR   SMR; Q99571; -.
DR   BioGrid; 111064; 34.
DR   IntAct; Q99571; 8.
DR   STRING; 9606.ENSP00000336607; -.
DR   BindingDB; Q99571; -.
DR   ChEMBL; CHEMBL2104; -.
DR   DrugBank; DB09119; Eslicarbazepine acetate.
DR   GuidetoPHARMACOLOGY; 481; -.
DR   TCDB; 1.A.7.1.5; the atp-gated p2x receptor cation channel (p2x receptor) family.
DR   iPTMnet; Q99571; -.
DR   PhosphoSitePlus; Q99571; -.
DR   BioMuta; P2RX4; -.
DR   DMDM; 116242696; -.
DR   EPD; Q99571; -.
DR   MaxQB; Q99571; -.
DR   PaxDb; Q99571; -.
DR   PeptideAtlas; Q99571; -.
DR   PRIDE; Q99571; -.
DR   DNASU; 5025; -.
DR   Ensembl; ENST00000337233; ENSP00000336607; ENSG00000135124. [Q99571-1]
DR   Ensembl; ENST00000359949; ENSP00000353032; ENSG00000135124. [Q99571-2]
DR   Ensembl; ENST00000542067; ENSP00000438329; ENSG00000135124. [Q99571-3]
DR   GeneID; 5025; -.
DR   KEGG; hsa:5025; -.
DR   UCSC; uc001tzr.4; human. [Q99571-1]
DR   CTD; 5025; -.
DR   DisGeNET; 5025; -.
DR   EuPathDB; HostDB:ENSG00000135124.14; -.
DR   GeneCards; P2RX4; -.
DR   HGNC; HGNC:8535; P2RX4.
DR   HPA; HPA039494; -.
DR   MIM; 600846; gene.
DR   neXtProt; NX_Q99571; -.
DR   OpenTargets; ENSG00000135124; -.
DR   PharmGKB; PA32864; -.
DR   eggNOG; ENOG410IFJF; Eukaryota.
DR   eggNOG; ENOG410XR0C; LUCA.
DR   GeneTree; ENSGT00390000016028; -.
DR   HOGENOM; HOG000232042; -.
DR   HOVERGEN; HBG053086; -.
DR   InParanoid; Q99571; -.
DR   KO; K05218; -.
DR   OMA; TMINVGS; -.
DR   OrthoDB; EOG091G0A2U; -.
DR   PhylomeDB; Q99571; -.
DR   TreeFam; TF328633; -.
DR   Reactome; R-HSA-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-HSA-418346; Platelet homeostasis.
DR   ChiTaRS; P2RX4; human.
DR   GeneWiki; P2RX4; -.
DR   GenomeRNAi; 5025; -.
DR   PRO; PR:Q99571; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135124; -.
DR   CleanEx; HS_P2RX4; -.
DR   ExpressionAtlas; Q99571; baseline and differential.
DR   Genevisible; Q99571; HS.
DR   GO; GO:0030054; C:cell junction; IDA:BHF-UCL.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IC:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; IPI:BHF-UCL.
DR   GO; GO:0005507; F:copper ion binding; ISS:BHF-UCL.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; ISS:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; ISS:BHF-UCL.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:UniProtKB.
DR   GO; GO:0042118; P:endothelial cell activation; TAS:BHF-UCL.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051899; P:membrane depolarization; IDA:BHF-UCL.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IMP:BHF-UCL.
DR   GO; GO:0019228; P:neuronal action potential; IEA:Ensembl.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IMP:CAFA.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; NAS:BHF-UCL.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:BHF-UCL.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; IDA:BHF-UCL.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; IMP:CAFA.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; NAS:BHF-UCL.
DR   GO; GO:0032308; P:positive regulation of prostaglandin secretion; NAS:BHF-UCL.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0035590; P:purinergic nucleotide receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISS:BHF-UCL.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; IMP:BHF-UCL.
DR   GO; GO:0033198; P:response to ATP; IDA:BHF-UCL.
DR   GO; GO:0034405; P:response to fluid shear stress; IDA:BHF-UCL.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; IDA:BHF-UCL.
DR   GO; GO:0001894; P:tissue homeostasis; NAS:BHF-UCL.
DR   GO; GO:0006810; P:transport; IDA:BHF-UCL.
DR   Gene3D; 2.60.490.10; -; 1.
DR   InterPro; IPR003047; P2X4_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   PANTHER; PTHR10125; PTHR10125; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01311; P2X4RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   TIGRFAMs; TIGR00863; P2X; 1.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    388       P2X purinoceptor 4.
FT                                /FTId=PRO_0000161553.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     55    338       Extracellular. {ECO:0000255}.
FT   TRANSMEM    339    359       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    360    388       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    199    199       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    208    208       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    116    165       {ECO:0000250}.
FT   DISULFID    126    149       {ECO:0000250}.
FT   DISULFID    132    159       {ECO:0000250}.
FT   DISULFID    217    227       {ECO:0000250}.
FT   DISULFID    261    270       {ECO:0000250}.
FT   VAR_SEQ      45     45       G -> GCYHPHLAEVEMESPRR (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_053812.
FT   VAR_SEQ     149    175       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_053813.
FT   VARIANT       3      3       G -> C. {ECO:0000269|PubMed:28326637}.
FT                                /FTId=VAR_079856.
FT   VARIANT       6      6       A -> S (polymorphism; does not change
FT                                ATP-induced inward current; does not
FT                                change affinity for ATP;
FT                                dbSNP:rs1044249).
FT                                {ECO:0000269|PubMed:22068874,
FT                                ECO:0000269|PubMed:9016352,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.4}.
FT                                /FTId=VAR_028307.
FT   VARIANT     135    135       G -> S (polymorphism; does not change
FT                                protein expression; does not affect
FT                                membrane subcellular location; increases
FT                                ATP-induced inward current).
FT                                {ECO:0000269|PubMed:28326637}.
FT                                /FTId=VAR_079857.
FT   VARIANT     242    242       S -> G (polymorphism; does not change
FT                                ATP-induced inward current; does not
FT                                change affinity for ATP; dbSNP:rs25644).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:22068874,
FT                                ECO:0000269|PubMed:28326637}.
FT                                /FTId=VAR_014942.
FT   VARIANT     315    315       Y -> C (rare polymorphism; may influence
FT                                susceptibility to multiple sclerosis in
FT                                the presence of variants M-205 and S-361
FT                                in P2RX7; does not affect membrane
FT                                subcellular location; reduces ATP-induced
FT                                inward current; decreases affinity for
FT                                ATP). {ECO:0000269|PubMed:22068874,
FT                                ECO:0000269|PubMed:23303206,
FT                                ECO:0000269|PubMed:28326637,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_079858.
FT   MUTAGEN     119    119       I->V: Does not change ATP-induced inward
FT                                current. Does not change affinity for
FT                                ATP. {ECO:0000269|PubMed:22068874}.
FT   CONFLICT    121    121       D -> S (in Ref. 8; AAB66834).
FT                                {ECO:0000305}.
FT   CONFLICT    148    148       R -> W (in Ref. 8; AAB66834).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       L -> F (in Ref. 8; AAB66834).
FT                                {ECO:0000305}.
FT   CONFLICT    238    238       N -> I (in Ref. 8; AAB66834).
FT                                {ECO:0000305}.
SQ   SEQUENCE   388 AA;  43369 MW;  BA3BE7F30114C2A5 CRC64;
     MAGCCAALAA FLFEYDTPRI VLIRSRKVGL MNRAVQLLIL AYVIGWVFVW EKGYQETDSV
     VSSVTTKVKG VAVTNTSKLG FRIWDVADYV IPAQEENSLF VMTNVILTMN QTQGLCPEIP
     DATTVCKSDA SCTAGSAGTH SNGVSTGRCV AFNGSVKTCE VAAWCPVEDD THVPQPAFLK
     AAENFTLLVK NNIWYPKFNF SKRNILPNIT TTYLKSCIYD AKTDPFCPIF RLGKIVENAG
     HSFQDMAVEG GIMGIQVNWD CNLDRAASLC LPRYSFRRLD TRDVEHNVSP GYNFRFAKYY
     RDLAGNEQRT LIKAYGIRFD IIVFGKAGKF DIIPTMINIG SGLALLGMAT VLCDIIVLYC
     MKKRLYYREK KYKYVEDYEQ GLASELDQ
//
ID   GLR33_ARATH             Reviewed;         933 AA.
AC   Q9C8E7;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   25-OCT-2017, entry version 115.
DE   RecName: Full=Glutamate receptor 3.3;
DE   AltName: Full=Ligand-gated ion channel 3.3;
DE   Flags: Precursor;
GN   Name=GLR3.3; OrderedLocusNames=At1g42540; ORFNames=T8D8.1;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17012403; DOI=10.1104/pp.106.088989;
RA   Qi Z., Stephens N.R., Spalding E.P.;
RT   "Calcium entry mediated by GLR3.3, an Arabidopsis glutamate receptor
RT   with a broad agonist profile.";
RL   Plant Physiol. 142:963-971(2006).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18162597; DOI=10.1104/pp.107.108134;
RA   Stephens N.R., Qi Z., Spalding E.P.;
RT   "Glutamate receptor subtypes evidenced by differences in
RT   desensitization and dependence on the GLR3.3 and GLR3.4 genes.";
RL   Plant Physiol. 146:529-538(2008).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23969459; DOI=10.1038/nature12478;
RA   Mousavi S.A., Chauvin A., Pascaud F., Kellenberger S., Farmer E.E.;
RT   "GLUTAMATE RECEPTOR-LIKE genes mediate leaf-to-leaf wound
RT   signalling.";
RL   Nature 500:422-426(2013).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel, at least in roots and hypocotyls. Can be
CC       triggered by Ala, Asn, Cys, Glu, Gly, Ser and glutathione (a
CC       tripeptide consisting of Glu-Gly-Cys). Mediates leaf-to-leaf wound
CC       signaling. May be involved in light-signal transduction and
CC       calcium homeostasis via the regulation of calcium influx into
CC       cells. {ECO:0000269|PubMed:17012403, ECO:0000269|PubMed:18162597,
CC       ECO:0000269|PubMed:23969459}.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots and siliques.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- DISRUPTION PHENOTYPE: Impaired glutamate-triggered (and Ala, Asn,
CC       Cys, Gly, Ser and glutathione-triggered) membrane depolarization
CC       and calcium rise. Reduced wound-activated surface potential
CC       changes (WASP) duration in the wounded leaf, resulting in a
CC       decreased induction of the regulators of jasmonate-signaling in
CC       the systemic leaves. Glr3.3 and glr3.6 double mutant has no
CC       detectable changes in surface potential in systemic leaves and the
CC       induction of the regulators of jasmonate-signaling is more
CC       strongly decreased. {ECO:0000269|PubMed:17012403,
CC       ECO:0000269|PubMed:18162597, ECO:0000269|PubMed:23969459}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC025815; AAG51316.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE31925.1; -; Genomic_DNA.
DR   EMBL; CP002684; ANM59840.1; -; Genomic_DNA.
DR   EMBL; CP002684; ANM59841.1; -; Genomic_DNA.
DR   PIR; C96495; C96495.
DR   RefSeq; NP_001322169.1; NM_001333200.1.
DR   RefSeq; NP_001322170.1; NM_001333202.1.
DR   RefSeq; NP_174978.1; NM_103438.3.
DR   UniGene; At.39090; -.
DR   ProteinModelPortal; Q9C8E7; -.
DR   SMR; Q9C8E7; -.
DR   BioGrid; 26087; 2.
DR   STRING; 3702.AT1G42540.1; -.
DR   TCDB; 1.A.10.1.10; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   iPTMnet; Q9C8E7; -.
DR   PaxDb; Q9C8E7; -.
DR   PRIDE; Q9C8E7; -.
DR   EnsemblPlants; AT1G42540.1; AT1G42540.1; AT1G42540.
DR   EnsemblPlants; AT1G42540.2; AT1G42540.2; AT1G42540.
DR   EnsemblPlants; AT1G42540.4; AT1G42540.4; AT1G42540.
DR   GeneID; 840859; -.
DR   Gramene; AT1G42540.1; AT1G42540.1; AT1G42540.
DR   Gramene; AT1G42540.2; AT1G42540.2; AT1G42540.
DR   Gramene; AT1G42540.4; AT1G42540.4; AT1G42540.
DR   KEGG; ath:AT1G42540; -.
DR   Araport; AT1G42540; -.
DR   TAIR; locus:2206095; AT1G42540.
DR   eggNOG; ENOG410ISR9; Eukaryota.
DR   eggNOG; ENOG410YYDD; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q9C8E7; -.
DR   KO; K05387; -.
DR   OMA; FLIDCEV; -.
DR   OrthoDB; EOG093601T8; -.
DR   PhylomeDB; Q9C8E7; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q9C8E7; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q9C8E7; baseline and differential.
DR   Genevisible; Q9C8E7; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; IMP:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; IMP:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; IMP:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB.
DR   GO; GO:0050832; P:defense response to fungus; IMP:TAIR.
DR   GO; GO:0009630; P:gravitropism; IMP:TAIR.
DR   GO; GO:0009864; P:induced systemic resistance, jasmonic acid mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IMP:TAIR.
DR   GO; GO:0009611; P:response to wounding; IMP:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    933       Glutamate receptor 3.3.
FT                                /FTId=PRO_0000011607.
FT   TOPO_DOM     24    587       Extracellular. {ECO:0000255}.
FT   TRANSMEM    588    608       Helical. {ECO:0000255}.
FT   TOPO_DOM    609    616       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    617    637       Helical. {ECO:0000255}.
FT   TOPO_DOM    638    648       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    649    669       Helical. {ECO:0000255}.
FT   TOPO_DOM    670    828       Extracellular. {ECO:0000255}.
FT   TRANSMEM    829    849       Helical. {ECO:0000255}.
FT   TOPO_DOM    850    933       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     76     76       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    415    415       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    549    549       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    712    712       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   933 AA;  104689 MW;  BB6DD65FDB97F975 CRC64;
     MKQLWTFFFL SFLCSGLFRR THSEKPKVVK IGSIFSFDSV IGKVAKIAID EAVKDVNSNP
     DILSGTKFSV SMQNSNCSGF MGMVEALRFM EKDIVGIIGP QCSVVAHMIS HMANELRVPL
     LSFAVTDPVM SPLQFPYFIR TTQSDLYQMD AIASIVDFYG WKEVIAVFVD DDFGRNGVAA
     LNDKLASRRL RITYKAGLHP DTAVNKNEIM NMLIKIMLLQ PRIVVIHVYS ELGFAVFKEA
     KYLGMMGNGY VWIATDWLST NLDSSSPLPA ERLETIQGVL VLRPHTPDSD FKREFFKRWR
     KMSGASLALN TYGLYAYDSV MLLARGLDKF FKDGGNISFS NHSMLNTLGK SGNLNLEAMT
     VFDGGEALLK DILGTRMVGL TGQLQFTPDR SRTRPAYDII NVAGTGVRQI GYWSNHSGLS
     TVLPELLYTK EKPNMSTSPK LKHVIWPGET FTKPRGWVFS NNGKELKIGV PLRVSYKEFV
     SQIRGTENMF KGFCIDVFTA AVNLLPYAVP VKFIPYGNGK ENPSYTHMVE MITTGNFDGV
     VGDVAIVTNR TKIVDFTQPY AASGLVVVAP FKKLNSGAWA FLRPFNRLMW AVTGCCFLFV
     GIVVWILEHR TNDEFRGPPK RQCVTILWFS FSTMFFAHRE NTVSTLGRLV LIIWLFVVLI
     INSSYTASLT SILTVQQLSS PIKGIESLRE RDDPIGYQVG SFAESYLRNE LNISESRLVP
     LGTPEAYAKA LKDGPSKGGV AAIVDERPYV ELFLSSNCAY RIVGQEFTKS GWGFAFPRDS
     PLAIDLSTAI LELAENGDLQ RIHDKWLMKN ACTLENAELE SDRLHLKSFW GLFLICGVAC
     LLALFLYFVQ IIRQLYKKPT DDAIARDQQQ NHDSSSMRST RLQRFLSLMD EKEESKHESK
     KRKIDGSMND TSGSTRSRGF DRERSFNSVN PLD
//
ID   GBRA4_MOUSE             Reviewed;         552 AA.
AC   Q9D6F4;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 1.
DT   20-DEC-2017, entry version 137.
DE   RecName: Full=Gamma-aminobutyric acid receptor subunit alpha-4;
DE   AltName: Full=GABA(A) receptor subunit alpha-4;
DE   Flags: Precursor;
GN   Name=Gabra4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Hippocampus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
CC   -!- FUNCTION: GABA, the major inhibitory neurotransmitter in the
CC       vertebrate brain, mediates neuronal inhibition by binding to the
CC       GABA/benzodiazepine receptor and opening an integral chloride
CC       channel.
CC   -!- SUBUNIT: Generally pentameric. There are five types of GABA(A)
CC       receptor chains: alpha, beta, gamma, delta, and rho.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane; Multi-pass membrane protein. Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily.
CC       GABRA4 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK013727; BAB28975.1; -; mRNA.
DR   CCDS; CCDS39107.1; -.
DR   RefSeq; NP_034381.1; NM_010251.2.
DR   UniGene; Mm.248731; -.
DR   ProteinModelPortal; Q9D6F4; -.
DR   SMR; Q9D6F4; -.
DR   BioGrid; 199800; 1.
DR   STRING; 10090.ENSMUSP00000031121; -.
DR   ChEMBL; CHEMBL2094133; -.
DR   iPTMnet; Q9D6F4; -.
DR   PhosphoSitePlus; Q9D6F4; -.
DR   MaxQB; Q9D6F4; -.
DR   PaxDb; Q9D6F4; -.
DR   PRIDE; Q9D6F4; -.
DR   Ensembl; ENSMUST00000031121; ENSMUSP00000031121; ENSMUSG00000029211.
DR   GeneID; 14397; -.
DR   KEGG; mmu:14397; -.
DR   UCSC; uc008xqy.1; mouse.
DR   CTD; 2557; -.
DR   MGI; MGI:95616; Gabra4.
DR   eggNOG; KOG3642; Eukaryota.
DR   eggNOG; ENOG410XNQG; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000231337; -.
DR   HOVERGEN; HBG051707; -.
DR   InParanoid; Q9D6F4; -.
DR   KO; K05175; -.
DR   PhylomeDB; Q9D6F4; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-MMU-977441; GABA A receptor activation.
DR   PRO; PR:Q9D6F4; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000029211; -.
DR   ExpressionAtlas; Q9D6F4; baseline and differential.
DR   Genevisible; Q9D6F4; MM.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:1902711; C:GABA-A receptor complex; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0004890; F:GABA-A receptor activity; IEA:InterPro.
DR   GO; GO:0007417; P:central nervous system development; IMP:MGI.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro.
DR   GO; GO:2001023; P:regulation of response to drug; IMP:MGI.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR001390; GABAAa_rcpt.
DR   InterPro; IPR005434; GABBAa4_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01079; GABAARALPHA.
DR   PRINTS; PR01617; GABAARALPHA4.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 2.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Chloride; Chloride channel;
KW   Complete proteome; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     35       {ECO:0000255}.
FT   CHAIN        36    552       Gamma-aminobutyric acid receptor subunit
FT                                alpha-4.
FT                                /FTId=PRO_0000000442.
FT   TOPO_DOM     36    258       Extracellular. {ECO:0000305}.
FT   TRANSMEM    259    280       Helical. {ECO:0000305}.
FT   TRANSMEM    285    306       Helical. {ECO:0000305}.
FT   TRANSMEM    318    340       Helical. {ECO:0000305}.
FT   TOPO_DOM    341    521       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    522    541       Helical. {ECO:0000305}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    172    186       {ECO:0000250}.
SQ   SEQUENCE   552 AA;  60878 MW;  213C16C423D7F97B CRC64;
     MVSVQKVPAI ALCSGVSLAL LHFLCLAACL NESPGQNSKD EKLCPENFTR ILDSLLDGYD
     NRLRPGFGGP VTEVKTDIYV TSFGPVSDVE MEYTMDVFFR QTWIDKRLKY DGPIEILRLN
     NMMVTKVWTP DTFFRNGKKS VSHNMTAPNK LFRIMRNGTI LYTMRLTISA ECPMRLVDFP
     MDGHACPLKF GSYAYPKSEM IYTWTKGPEK SVEVPKESSS LVQYDLIGQT VSSETIKSIT
     GEYIVMTVYF HLRRKMGYFM IQTYIPCIMT VILSQVSFWI NKESVPARTV FGITTVLTMT
     TLSISARHSL PKVSYATAMD WFIAVCFAFV FSALIEFAAV NYFTNIQMQK AKKKISKPPP
     EVPAAPVLKE KHTETSLQNT HANLNMRKRT NALVHSESDV KSRTEVGNHS SKTSAVQESS
     EATPKAHLAS SPNPFSRANA AETMSAAARG LSSAASPSPH GTLRPASLGS ASTRPAFGSR
     LGRIKTTVNT TGAAGNVSAT PPPPAPPPSG SGTSKIDKYA RILFPVTFGA FNMVYWVVYL
     SKDTMEKSES LM
//
ID   TRPM3_HUMAN             Reviewed;        1732 AA.
AC   Q9HCF6; A2A3F6; A9Z1Y7; Q5VW02; Q5VW03; Q5VW04; Q5W5T7; Q86SH0;
AC   Q86SH6; Q86UL0; Q86WK1; Q86WK2; Q86WK3; Q86WK4; Q86YZ9; Q86Z00;
AC   Q86Z01; Q9H0X2;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 4.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 3;
DE   AltName: Full=Long transient receptor potential channel 3;
DE            Short=LTrpC-3;
DE            Short=LTrpC3;
DE   AltName: Full=Melastatin-2;
DE            Short=MLSN2;
GN   Name=TRPM3; Synonyms=KIAA1616, LTRPC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 10), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=12672799; DOI=10.1074/jbc.M300945200;
RA   Grimm C., Kraft R., Sauerbruch S., Schultz G., Harteneck C.;
RT   "Molecular and functional characterization of the melastatin-related
RT   cation channel TRPM3.";
RL   J. Biol. Chem. 278:21493-21501(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 12).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-324 (ISOFORM 11).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 154-1732 (ISOFORMS 1; 2; 3; 4; 5 AND 6),
RP   VARIANT THR-1732, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12672827; DOI=10.1074/jbc.M211232200;
RA   Lee N., Chen J., Sun L., Wu S., Gray K.R., Rich A., Huang M.,
RA   Lin J.-H., Feder J.N., Janovitz E.B., Levesque P.C., Blanar M.A.;
RT   "Expression and characterization of human transient receptor potential
RT   melastatin 3 (hTRPM3).";
RL   J. Biol. Chem. 278:20890-20897(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 154-1732 (ISOFORMS 1; 2; 4;
RP   7 AND 8), AND VARIANT THR-1732.
RC   TISSUE=Brain;
RA   Okabayashi K., Hirano K., Sano M., Murahashi Y., Miyauchi A.,
RA   Gonoi T.;
RT   "ProX human full-length cDNA cloning project.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 716-1732 (ISOFORMS
RP   1/2/3/4/5/7/8), AND VARIANTS LYS-1717 AND THR-1732.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
CC   -!- FUNCTION: Calcium channel mediating constitutive calcium ion
CC       entry. Its activity is increased by reduction in extracellular
CC       osmolarity, by store depletion and muscarinic receptor activation.
CC       {ECO:0000269|PubMed:12672799, ECO:0000269|PubMed:12672827}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:12672827};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:12672827}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC       Name=1; Synonyms=TRPM3f;
CC         IsoId=Q9HCF6-1; Sequence=Displayed;
CC       Name=2; Synonyms=TRPM3a;
CC         IsoId=Q9HCF6-2; Sequence=VSP_012826;
CC       Name=3; Synonyms=TRPM3b;
CC         IsoId=Q9HCF6-3; Sequence=VSP_012826, VSP_012828;
CC       Name=4; Synonyms=TRPM3d;
CC         IsoId=Q9HCF6-4; Sequence=VSP_012826, VSP_012829;
CC       Name=5; Synonyms=TRPM3e;
CC         IsoId=Q9HCF6-5; Sequence=VSP_012826, VSP_012828, VSP_012829;
CC       Name=6; Synonyms=TRPM3c;
CC         IsoId=Q9HCF6-6; Sequence=VSP_012826, VSP_012830;
CC       Name=7;
CC         IsoId=Q9HCF6-7; Sequence=VSP_012829;
CC       Name=8;
CC         IsoId=Q9HCF6-8; Sequence=VSP_012826, VSP_012827, VSP_012829;
CC       Name=10;
CC         IsoId=Q9HCF6-10; Sequence=VSP_012826, VSP_012831, VSP_012832;
CC       Name=11;
CC         IsoId=Q9HCF6-11; Sequence=VSP_039107;
CC       Name=12;
CC         IsoId=Q9HCF6-12; Sequence=VSP_043515, VSP_012826, VSP_043516;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in the kidney and, at
CC       lower levels, in brain, testis, ovary, pancreas and spinal cord.
CC       Expression in the brain and kidney was determined at protein
CC       level. In the kidney, expressed predominantly in the collecting
CC       tubular epithelium in the medulla, medullary rays, and
CC       periglomerular regions; in the brain, highest levels are found in
CC       the cerebellum, choroid plexus, the locus coeruleus, the posterior
CC       thalamus and the substantia nigra. Down-regulated in renal tumors
CC       compared to normal kidney. {ECO:0000269|PubMed:12672799,
CC       ECO:0000269|PubMed:12672827}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       LTrpC subfamily. TRPM3 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB66480.2; Type=Miscellaneous discrepancy; Note=Cloning artifact in C-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAM13096.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM13169.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM15782.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM17596.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAM22746.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ505025; CAD43604.1; -; mRNA.
DR   EMBL; AJ505026; CAD43605.1; -; mRNA.
DR   EMBL; AL159990; CAI12193.1; -; Genomic_DNA.
DR   EMBL; AL356318; CAI12193.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAI96096.1; -; Genomic_DNA.
DR   EMBL; AL159990; CAI96096.1; JOINED; Genomic_DNA.
DR   EMBL; AL159990; CAM13096.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161913; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM13096.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM13169.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM13169.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM15782.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM15782.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM17596.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM17596.1; JOINED; Genomic_DNA.
DR   EMBL; AL161913; CAM22746.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL159990; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL356318; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL358786; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL442645; CAM22746.1; JOINED; Genomic_DNA.
DR   EMBL; AL160273; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL391819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL592438; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC121821; AAI21822.2; -; mRNA.
DR   EMBL; BC134414; AAI34415.1; -; mRNA.
DR   EMBL; BC142972; AAI42973.1; -; mRNA.
DR   EMBL; AL136545; CAB66480.2; ALT_SEQ; mRNA.
DR   EMBL; AF536748; AAO49153.1; -; mRNA.
DR   EMBL; AF536749; AAO49154.1; -; mRNA.
DR   EMBL; AF536750; AAO49155.1; -; mRNA.
DR   EMBL; AF536751; AAO49156.1; -; mRNA.
DR   EMBL; AF536752; AAO49157.1; -; mRNA.
DR   EMBL; AF536753; AAO49158.1; -; mRNA.
DR   EMBL; AB099661; BAC55102.1; -; mRNA.
DR   EMBL; AB099662; BAC55103.1; -; mRNA.
DR   EMBL; AB099663; BAC55104.1; -; mRNA.
DR   EMBL; AB099664; BAC55105.1; -; mRNA.
DR   EMBL; AB099665; BAC55106.1; -; mRNA.
DR   EMBL; AB046836; BAB13442.1; -; mRNA.
DR   CCDS; CCDS43835.1; -. [Q9HCF6-2]
DR   CCDS; CCDS6637.1; -. [Q9HCF6-12]
DR   RefSeq; NP_001007472.2; NM_001007471.2. [Q9HCF6-2]
DR   RefSeq; NP_996831.1; NM_206948.2. [Q9HCF6-12]
DR   RefSeq; XP_011517340.1; XM_011519038.2. [Q9HCF6-1]
DR   RefSeq; XP_011517341.1; XM_011519039.2. [Q9HCF6-7]
DR   RefSeq; XP_011517343.1; XM_011519041.2. [Q9HCF6-3]
DR   RefSeq; XP_011517346.1; XM_011519044.2. [Q9HCF6-5]
DR   RefSeq; XP_011517348.1; XM_011519046.2. [Q9HCF6-4]
DR   RefSeq; XP_011517349.1; XM_011519047.2. [Q9HCF6-10]
DR   RefSeq; XP_016870631.1; XM_017015142.1. [Q9HCF6-11]
DR   UniGene; Hs.47288; -.
DR   ProteinModelPortal; Q9HCF6; -.
DR   SMR; Q9HCF6; -.
DR   BioGrid; 123085; 8.
DR   MINT; MINT-4713703; -.
DR   STRING; 9606.ENSP00000366314; -.
DR   GuidetoPHARMACOLOGY; 495; -.
DR   TCDB; 1.A.4.5.6; the transient receptor potential ca(2+) channel (trp-cc) family.
DR   iPTMnet; Q9HCF6; -.
DR   PhosphoSitePlus; Q9HCF6; -.
DR   BioMuta; TRPM3; -.
DR   DMDM; 322510140; -.
DR   MaxQB; Q9HCF6; -.
DR   PaxDb; Q9HCF6; -.
DR   PeptideAtlas; Q9HCF6; -.
DR   PRIDE; Q9HCF6; -.
DR   DNASU; 80036; -.
DR   Ensembl; ENST00000361823; ENSP00000355395; ENSG00000083067. [Q9HCF6-12]
DR   Ensembl; ENST00000377110; ENSP00000366314; ENSG00000083067. [Q9HCF6-2]
DR   Ensembl; ENST00000377111; ENSP00000366315; ENSG00000083067. [Q9HCF6-10]
DR   GeneID; 80036; -.
DR   KEGG; hsa:80036; -.
DR   UCSC; uc004aic.4; human. [Q9HCF6-1]
DR   CTD; 80036; -.
DR   DisGeNET; 80036; -.
DR   EuPathDB; HostDB:ENSG00000083067.22; -.
DR   GeneCards; TRPM3; -.
DR   HGNC; HGNC:17992; TRPM3.
DR   MIM; 608961; gene.
DR   neXtProt; NX_Q9HCF6; -.
DR   OpenTargets; ENSG00000083067; -.
DR   PharmGKB; PA38271; -.
DR   eggNOG; KOG3614; Eukaryota.
DR   eggNOG; ENOG410XR5B; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOGENOM; HOG000230920; -.
DR   HOVERGEN; HBG058254; -.
DR   InParanoid; Q9HCF6; -.
DR   KO; K04978; -.
DR   PhylomeDB; Q9HCF6; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   ChiTaRS; TRPM3; human.
DR   GeneWiki; TRPM3; -.
DR   GenomeRNAi; 80036; -.
DR   PRO; PR:Q9HCF6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000083067; -.
DR   ExpressionAtlas; Q9HCF6; baseline and differential.
DR   Genevisible; Q9HCF6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IEA:InterPro.
DR   GO; GO:0005262; F:calcium channel activity; TAS:Reactome.
DR   GO; GO:0005261; F:cation channel activity; IDA:MGI.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006812; P:cation transport; IDA:MGI.
DR   GO; GO:0016048; P:detection of temperature stimulus; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; IEA:InterPro.
DR   GO; GO:0050951; P:sensory perception of temperature stimulus; IEA:InterPro.
DR   Gene3D; 1.20.5.1010; -; 1.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR029583; TRPM3.
DR   InterPro; IPR032415; TRPM_tetra.
DR   InterPro; IPR037162; TRPM_tetra_sf.
DR   PANTHER; PTHR13800:SF7; PTHR13800:SF7; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF16519; TRPM_tetra; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Coiled coil; Complete proteome; Ion channel; Ion transport; Membrane;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1732       Transient receptor potential cation
FT                                channel subfamily M member 3.
FT                                /FTId=PRO_0000215328.
FT   TRANSMEM      4     24       Helical. {ECO:0000255}.
FT   TOPO_DOM     25    794       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    795    815       Helical. {ECO:0000255}.
FT   TOPO_DOM    816    897       Extracellular. {ECO:0000255}.
FT   TRANSMEM    898    918       Helical. {ECO:0000255}.
FT   TOPO_DOM    919    964       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    965    985       Helical. {ECO:0000255}.
FT   TOPO_DOM    986    995       Extracellular. {ECO:0000255}.
FT   TRANSMEM    996   1016       Helical. {ECO:0000255}.
FT   TOPO_DOM   1017   1028       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1029   1049       Helical. {ECO:0000255}.
FT   TOPO_DOM   1050   1116       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1117   1137       Helical. {ECO:0000255}.
FT   TOPO_DOM   1138   1732       Cytoplasmic. {ECO:0000255}.
FT   COILED     1241   1301       {ECO:0000255}.
FT   VAR_SEQ       1    153       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043515.
FT   VAR_SEQ       1     59       MPEPWGTVYFLGIAQVFSFLFSWWNLEGVMNQADAPRPLNW
FT                                TIRKLCHAAFLPSVRLLK -> MGKKWRDAAEMERGCSDRE
FT                                DNAESRRRSRSASRGRFAESWKRLSSKQGSTKRSGLPSQQT
FT                                P (in isoform 11).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_039107.
FT   VAR_SEQ     326    350       Missing (in isoform 2, isoform 3, isoform
FT                                4, isoform 5, isoform 6, isoform 8,
FT                                isoform 10 and isoform 12).
FT                                {ECO:0000303|PubMed:12672799,
FT                                ECO:0000303|PubMed:12672827,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012826.
FT   VAR_SEQ     409   1732       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043516.
FT   VAR_SEQ     535    552       Missing (in isoform 8).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012827.
FT   VAR_SEQ     569    569       K -> KREYPGFGWIYFK (in isoform 3 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:12672827}.
FT                                /FTId=VSP_012828.
FT   VAR_SEQ     617    626       Missing (in isoform 4, isoform 5, isoform
FT                                7 and isoform 8).
FT                                {ECO:0000303|PubMed:12672827,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012829.
FT   VAR_SEQ    1088   1088       P -> RKQVYDSHTPKSA (in isoform 6).
FT                                {ECO:0000303|PubMed:12672827}.
FT                                /FTId=VSP_012830.
FT   VAR_SEQ    1344   1350       GEETMSP -> EHPLYSV (in isoform 10).
FT                                {ECO:0000303|PubMed:12672799}.
FT                                /FTId=VSP_012831.
FT   VAR_SEQ    1351   1732       Missing (in isoform 10).
FT                                {ECO:0000303|PubMed:12672799}.
FT                                /FTId=VSP_012832.
FT   VARIANT    1653   1653       T -> I (in dbSNP:rs13440436).
FT                                /FTId=VAR_057305.
FT   VARIANT    1695   1695       R -> Q (in dbSNP:rs6560142).
FT                                /FTId=VAR_021257.
FT   VARIANT    1717   1717       R -> K (in dbSNP:rs41287373).
FT                                {ECO:0000269|PubMed:10997877}.
FT                                /FTId=VAR_061862.
FT   VARIANT    1732   1732       N -> T (in dbSNP:rs17535963).
FT                                {ECO:0000269|PubMed:10997877,
FT                                ECO:0000269|PubMed:12672827,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_057306.
FT   CONFLICT    335    335       R -> H (in Ref. 6; BAC55103).
FT                                {ECO:0000305}.
FT   CONFLICT    695    695       C -> Y (in Ref. 6; BAC55106).
FT                                {ECO:0000305}.
FT   CONFLICT   1032   1032       D -> E (in Ref. 6; BAC55106).
FT                                {ECO:0000305}.
FT   CONFLICT   1730   1730       K -> Q (in Ref. 6; BAC55104).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1732 AA;  197571 MW;  0D6BE312C56646A4 CRC64;
     MPEPWGTVYF LGIAQVFSFL FSWWNLEGVM NQADAPRPLN WTIRKLCHAA FLPSVRLLKA
     QKSWIERAFY KRECVHIIPS TKDPHRCCCG RLIGQHVGLT PSISVLQNEK NESRLSRNDI
     QSEKWSISKH TQLSPTDAFG TIEFQGGGHS NKAMYVRVSF DTKPDLLLHL MTKEWQLELP
     KLLISVHGGL QNFELQPKLK QVFGKGLIKA AMTTGAWIFT GGVNTGVIRH VGDALKDHAS
     KSRGKICTIG IAPWGIVENQ EDLIGRDVVR PYQTMSNPMS KLTVLNSMHS HFILADNGTT
     GKYGAEVKLR RQLEKHISLQ KINTRCLPFF SLDSRLFYSF WGSCQLDSVG IGQGVPVVAL
     IVEGGPNVIS IVLEYLRDTP PVPVVVCDGS GRASDILAFG HKYSEEGGLI NESLRDQLLV
     TIQKTFTYTR TQAQHLFIIL MECMKKKELI TVFRMGSEGH QDIDLAILTA LLKGANASAP
     DQLSLALAWN RVDIARSQIF IYGQQWPVGS LEQAMLDALV LDRVDFVKLL IENGVSMHRF
     LTISRLEELY NTRHGPSNTL YHLVRDVKKG NLPPDYRISL IDIGLVIEYL MGGAYRCNYT
     RKRFRTLYHN LFGPKRPKAL KLLGMEDDIP LRRGRKTTKK REEEVDIDLD DPEINHFPFP
     FHELMVWAVL MKRQKMALFF WQHGEEAMAK ALVACKLCKA MAHEASENDM VDDISQELNH
     NSRDFGQLAV ELLDQSYKQD EQLAMKLLTY ELKNWSNATC LQLAVAAKHR DFIAHTCSQM
     LLTDMWMGRL RMRKNSGLKV ILGILLPPSI LSLEFKNKDD MPYMSQAQEI HLQEKEAEEP
     EKPTKEKEEE DMELTAMLGR NNGESSRKKD EEEVQSKHRL IPLGRKIYEF YNAPIVKFWF
     YTLAYIGYLM LFNYIVLVKM ERWPSTQEWI VISYIFTLGI EKMREILMSE PGKLLQKVKV
     WLQEYWNVTD LIAILLFSVG MILRLQDQPF RSDGRVIYCV NIIYWYIRLL DIFGVNKYLG
     PYVMMIGKMM IDMMYFVIIM LVVLMSFGVA RQAILFPNEE PSWKLAKNIF YMPYWMIYGE
     VFADQIDPPC GQNETREDGK IIQLPPCKTG AWIVPAIMAC YLLVANILLV NLLIAVFNNT
     FFEVKSISNQ VWKFQRYQLI MTFHERPVLP PPLIIFSHMT MIFQHLCCRW RKHESDPDER
     DYGLKLFITD DELKKVHDFE EQCIEEYFRE KDDRFNSSND ERIRVTSERV ENMSMRLEEV
     NEREHSMKAS LQTVDIRLAQ LEDLIGRMAT ALERLTGLER AESNKIRSRT SSDCTDAAYI
     VRQSSFNSQE GNTFKLQESI DPAGEETMSP TSPTLMPRMR SHSFYSVNMK DKGGIEKLES
     IFKERSLSLH RATSSHSVAK EPKAPAAPAN TLAIVPDSRR PSSCIDIYVS AMDELHCDID
     PLDNSVNILG LGEPSFSTPV PSTAPSSSAY ATLAPTDRPP SRSIDFEDIT SMDTRSFSSD
     YTHLPECQNP WDSEPPMYHT IERSKSSRYL ATTPFLLEEA PIVKSHSFMF SPSRSYYANF
     GVPVKTAEYT SITDCIDTRC VNAPQAIADR AAFPGGLGDK VEDLTCCHPE REAELSHPSS
     DSEENEAKGR RATIAISSQE GDNSERTLSN NITVPKIERA NSYSAEEPSA PYAHTRKSFS
     ISDKLDRQRN TASLRNPFQR SKSSKPEGRG DSLSMRRLSR TSAFQSFESK HN
//
ID   5HT3B_RAT               Reviewed;         437 AA.
AC   Q9JJ16; Q9ERJ5;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 104.
DE   RecName: Full=5-hydroxytryptamine receptor 3B;
DE            Short=5-HT3-B;
DE            Short=5-HT3B;
DE   AltName: Full=Serotonin receptor 3B;
DE   Flags: Precursor;
GN   Name=Htr3b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, AND INDUCTION.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10854267; DOI=10.1046/j.1471-4159.2000.0750240.x;
RA   Hanna M.C., Davies P.A., Hales T.G., Kirkness E.F.;
RT   "Evidence for expression of heteromeric serotonin 5-HT(3) receptors in
RT   rodents.";
RL   J. Neurochem. 75:240-247(2000).
RN   [2]
RP   SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=12151552;
RA   Morales M., Wang S.-D.;
RT   "Differential composition of 5-hydroxytryptamine3 receptors
RT   synthesized in the rat CNS and peripheral nervous system.";
RL   J. Neurosci. 22:6732-6741(2002).
RN   [3]
RP   FUNCTION.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions
CC       as a neurotransmitter, a hormone, and a mitogen. This receptor is
CC       a ligand-gated ion channel, which when activated causes fast,
CC       depolarizing responses. It is a cation-specific, but otherwise
CC       relatively nonselective, ion channel.
CC       {ECO:0000269|PubMed:12867984}.
CC   -!- SUBUNIT: Forms pentahomomeric complex as well as pentaheteromeric
CC       complex with HTR3B; homomeric complex is functional but exhibits
CC       low conductance with modified voltage dependence and antagonist
CC       affinity. {ECO:0000269|PubMed:10854267,
CC       ECO:0000269|PubMed:12151552}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in peripheral neurons, but not in
CC       neurons of the central nervous system.
CC       {ECO:0000269|PubMed:12151552}.
CC   -!- INDUCTION: By nerve growth factor in PC12 cells.
CC       {ECO:0000269|PubMed:10854267}.
CC   -!- PTM: N-glycosylation is required for membrane localization.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3B
CC       sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF155044; AAF73283.1; -; mRNA.
DR   EMBL; AF303447; AAG30903.1; -; mRNA.
DR   RefSeq; NP_071525.1; NM_022189.1.
DR   UniGene; Rn.87106; -.
DR   ProteinModelPortal; Q9JJ16; -.
DR   STRING; 10116.ENSRNOP00000009574; -.
DR   BindingDB; Q9JJ16; -.
DR   ChEMBL; CHEMBL2094116; -.
DR   TCDB; 1.A.9.2.2; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   PaxDb; Q9JJ16; -.
DR   PRIDE; Q9JJ16; -.
DR   GeneID; 58963; -.
DR   KEGG; rno:58963; -.
DR   UCSC; RGD:61820; rat.
DR   CTD; 9177; -.
DR   RGD; 61820; Htr3b.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   HOGENOM; HOG000241519; -.
DR   HOVERGEN; HBG106638; -.
DR   InParanoid; Q9JJ16; -.
DR   KO; K04819; -.
DR   PhylomeDB; Q9JJ16; -.
DR   PRO; PR:Q9JJ16; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:InterPro.
DR   GO; GO:1904602; C:serotonin-activated cation-selective channel complex; ISO:RGD.
DR   GO; GO:0022850; F:serotonin-gated cation-selective channel activity; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IDA:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008134; 5HT3_rcpt_B.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01710; 5HT3BRECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    437       5-hydroxytryptamine receptor 3B.
FT                                /FTId=PRO_0000312291.
FT   TOPO_DOM     22    235       Extracellular. {ECO:0000255}.
FT   TRANSMEM    236    255       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    256    266       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    267    284       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    285    295       Extracellular. {ECO:0000255}.
FT   TRANSMEM    296    324       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    325    410       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    411    434       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    435    437       Extracellular. {ECO:0000255}.
FT   REGION      377    409       HA-stretch.
FT   CARBOHYD     25     25       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    165       {ECO:0000250}.
FT   CONFLICT    194    194       K -> E (in Ref. 1; AAG30903).
FT                                {ECO:0000305}.
FT   CONFLICT    217    217       S -> N (in Ref. 1; AAG30903).
FT                                {ECO:0000305}.
SQ   SEQUENCE   437 AA;  50336 MW;  633C2F4175FDB55A CRC64;
     MILLWSCLLV AVVGILGTAT PQPGNSSLHR LTRQLLQQYH KEVRPVYNWA EATTVYLDLC
     VHAVLDVDVQ NQKLKTSMWY REVWNDEFLS WNSSLFDDIQ EISLPLSAIW APDIIINEFV
     DVERSPDLPY VYVNSSGTIR NHKPIQVVSA CSLQTYAFPF DIQNCSLTFN SILHTVEDID
     LGFLRNQEDI ENDKRSFLND SEWQLLSVTS TYHIRQSSAG DFAQIRFNVV IRRCPLAYVV
     SLLIPSIFLM LVDLGSFYLP PNCRARIVFK TNVLVGYTVF RVNMSDEVPR SAGCTSLIGV
     FFTVCMALLV LSLSKSILLI KFLYEERHSE QERPLMCLRG DSDANESRLY LRAPCAEDTE
     SPVRQEHQVP SDTLKDFWFQ LQSINNSLRT RDQVYQKEVE WLAILCHFDQ LLFRIYLAVL
     GLYTVTLCSL WALWSRM
//
ID   TRPM5_MOUSE             Reviewed;        1158 AA.
AC   Q9JJH7; A3KN89; Q3TU14; Q7TPL4; Q99NF9; Q9EPM3; Q9EPM4;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-OCT-2017, entry version 109.
DE   RecName: Full=Transient receptor potential cation channel subfamily M member 5;
DE   AltName: Full=Long transient receptor potential channel 5;
DE            Short=LTrpC-5;
DE            Short=LTrpC5;
DE   AltName: Full=MLSN1- and TRP-related gene 1 protein;
GN   Name=Trpm5 {ECO:0000312|MGI:MGI:1861718};
GN   Synonyms=Ltrpc5 {ECO:0000312|EMBL:CAB94717.2},
GN   Mtr1 {ECO:0000312|EMBL:BAA96877.1};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAA96877.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10907850; DOI=10.1093/dnares/7.3.195;
RA   Yatsuki H., Watanabe H., Hattori M., Joh K., Soejima H., Komoda H.,
RA   Xin Z., Zhu X., Higashimoto K., Nishimura M., Kuratomi S., Sasaki H.,
RA   Sakaki Y., Mukai T.;
RT   "Sequence-based structural features between Kvlqt1 and Tapa1 on mouse
RT   chromosome 7F4/F5 corresponding to the Beckwith-Wiedemann syndrome
RT   region on human 11p15.5: long-stretches of unusually well conserved
RT   intronic sequences of kvlqt1 between mouse and human.";
RL   DNA Res. 7:195-206(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAF98120.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10903843; DOI=10.1006/geno.2000.6234;
RA   Enklaar T., Esswein M., Oswald M., Hilbert K., Winterpacht A.,
RA   Higgins M., Zabel B., Prawitt D.;
RT   "Mtr1, a novel biallelically expressed gene in the center of the mouse
RT   distal chromosome 7 imprinting cluster, is a member of the Trp gene
RT   family.";
RL   Genomics 67:179-187(2000).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:CAB94717.2}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RC   STRAIN=129/Sv {ECO:0000312|EMBL:CAB94717.2};
RX   PubMed=10915772; DOI=10.1093/hmg/9.12.1829;
RA   Paulsen M., El-Maarri O., Engemann S., Stroedicke M., Franck O.,
RA   Davies K., Reinhardt R., Reik W., Walter J.;
RT   "Sequence conservation and variability of imprinting in the Beckwith-
RT   Wiedemann syndrome gene cluster in human and mouse.";
RL   Hum. Mol. Genet. 9:1829-1841(2000).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAP44476.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), AND FUNCTION.
RC   TISSUE=Testis {ECO:0000312|EMBL:AAP44477.1};
RX   PubMed=12842017; DOI=10.1016/S0960-9822(03)00431-7;
RA   Hofmann T., Chubanov V., Gudermann T., Montell C.;
RT   "TRPM5 is a voltage-modulated and Ca(2+)-activated monovalent
RT   selective cation channel.";
RL   Curr. Biol. 13:1153-1158(2003).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAI33713.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:BAE36157.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 441-1158 (ISOFORM 1).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE36157.1};
RC   TISSUE=Embryonic liver {ECO:0000312|EMBL:BAE36157.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [7] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=12368808; DOI=10.1038/nn952;
RA   Perez C.A., Huang L., Rong M., Kozak J.A., Preuss A.K., Zhang H.,
RA   Max M., Margolskee R.F.;
RT   "A transient receptor potential channel expressed in taste receptor
RT   cells.";
RL   Nat. Neurosci. 5:1169-1176(2002).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=14657398; DOI=10.1073/pnas.2334159100;
RA   Liu D., Liman E.R.;
RT   "Intracellular Ca2+ and the phospholipid PIP2 regulate the taste
RT   transduction ion channel TRPM5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15160-15165(2003).
RN   [9] {ECO:0000305}
RP   ENZYME REGULATION.
RX   PubMed=15670874; DOI=10.1016/j.ceca.2004.11.001;
RA   Ullrich N.D., Voets T., Prenen J., Vennekens R., Talavera K.,
RA   Droogmans G., Nilius B.;
RT   "Comparison of functional properties of the Ca2+-activated cation
RT   channels TRPM4 and TRPM5 from mice.";
RL   Cell Calcium 37:267-278(2005).
RN   [10] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF GLU-831; HIS-897 AND HIS-935.
RX   PubMed=15731110; DOI=10.1074/jbc.M414072200;
RA   Liu D., Zhang Z., Liman E.R.;
RT   "Extracellular acid block and acid-enhanced inactivation of the Ca2+-
RT   activated cation channel TRPM5 involve residues in the S3-S4 and S5-S6
RT   extracellular domains.";
RL   J. Biol. Chem. 280:20691-20699(2005).
RN   [11] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=16355226; DOI=10.1038/nature04248;
RA   Talavera K., Yasumatsu K., Voets T., Droogmans G., Shigemura N.,
RA   Ninomiya Y., Margolskee R.F., Nilius B.;
RT   "Heat activation of TRPM5 underlies thermal sensitivity of sweet
RT   taste.";
RL   Nature 438:1022-1025(2005).
RN   [12] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=16935556; DOI=10.1016/j.bbalip.2006.07.005;
RA   Oike H., Wakamori M., Mori Y., Nakanishi H., Taguchi R., Misaka T.,
RA   Matsumoto I., Abe K.;
RT   "Arachidonic acid can function as a signaling modulator by activating
RT   the TRPM5 cation channel in taste receptor cells.";
RL   Biochim. Biophys. Acta 1761:1078-1084(2006).
RN   [13] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16436689; DOI=10.1093/chemse/bjj027;
RA   Damak S., Rong M., Yasumatsu K., Kokrashvili Z., Perez C.A.,
RA   Shigemura N., Yoshida R., Mosinger B. Jr., Glendinning J.I.,
RA   Ninomiya Y., Margolskee R.F.;
RT   "Trpm5 null mice respond to bitter, sweet, and umami compounds.";
RL   Chem. Senses 31:253-264(2006).
RN   [14] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=17610722; DOI=10.1186/1471-2202-8-49;
RA   Kaske S., Krasteva G., Koenig P., Kummer W., Hofmann T., Gudermann T.,
RA   Chubanov V.;
RT   "TRPM5, a taste-signaling transient receptor potential ion-channel, is
RT   a ubiquitous signaling component in chemosensory cells.";
RL   BMC Neurosci. 8:49-49(2007).
RN   [15] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=17522321; DOI=10.1523/JNEUROSCI.4973-06.2007;
RA   Zhang Z., Zhao Z., Margolskee R., Liman E.;
RT   "The transduction channel TRPM5 is gated by intracellular calcium in
RT   taste cells.";
RL   J. Neurosci. 27:5777-5786(2007).
RN   [16] {ECO:0000305}
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=17267604; DOI=10.1073/pnas.0610201104;
RA   Lin W., Margolskee R., Donnert G., Hell S.W., Restrepo D.;
RT   "Olfactory neurons expressing transient receptor potential channel M5
RT   (TRPM5) are involved in sensing semiochemicals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2471-2476(2007).
CC   -!- FUNCTION: Voltage-modulated Ca(2+)-activated, monovalent cation
CC       channel (VCAM) that mediates a transient membrane depolarization
CC       and plays a central role in taste transduction. Monovalent-
CC       specific, non-selective cation channel that mediates the transport
CC       of Na(+), K(+) and Cs(+) ions equally well. Activated directly by
CC       increases in intracellular Ca(2+), but is impermeable to it.
CC       Gating is voltage-dependent and displays rapid activation and
CC       deactivation kinetics upon channel stimulation even during
CC       sustained elevations in Ca(2+). Also activated by a fast
CC       intracellular Ca(2+) increase in response to inositol 1,4,5-
CC       triphosphate-producing receptor agonists. The channel is blocked
CC       by extracellular acidification. External acidification has 2
CC       effects, a fast reversible block of the current and a slower
CC       irreversible enhancement of current inactivation. Is a highly
CC       temperature-sensitive, heat activated channel showing a steep
CC       increase of inward currents at temperatures between 15 and 35
CC       degrees Celsius. Heat activation is due to a shift of the voltage-
CC       dependent activation curve to negative potentials. Activated by
CC       arachidonic acid in vitro. May be involved in perception of
CC       bitter, sweet and umami tastes. May also be involved in sensing
CC       semiochemicals. {ECO:0000269|PubMed:12842017,
CC       ECO:0000269|PubMed:14657398, ECO:0000269|PubMed:15731110,
CC       ECO:0000269|PubMed:16355226, ECO:0000269|PubMed:16436689,
CC       ECO:0000269|PubMed:16935556, ECO:0000269|PubMed:17267604,
CC       ECO:0000269|PubMed:17522321}.
CC   -!- ENZYME REGULATION: Phosphatidylinositol 4,5-bisphosphate (PIP2) is
CC       able to partially restore sensitivity to Ca(2+) after
CC       desensitization. Inhibited by flufenamic acid with an IC(50) of
CC       24.5 uM and spermine with an IC(50) of 37 uM.
CC       {ECO:0000269|PubMed:14657398, ECO:0000269|PubMed:15670874}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:Q8TD43, ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:10903843, ECO:0000269|PubMed:10907850,
CC       ECO:0000269|PubMed:10915772, ECO:0000269|PubMed:12842017,
CC       ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16141072};
CC         IsoId=Q9JJH7-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:10915772};
CC         IsoId=Q9JJH7-2; Sequence=VSP_052746, VSP_052747;
CC       Name=3 {ECO:0000269|PubMed:12842017};
CC         IsoId=Q9JJH7-3; Sequence=VSP_052744, VSP_052745;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in liver, heart, testis,
CC       brain and kidney. Detected in fetal liver, kidney, spleen, brain,
CC       heart and lung, and in adult skin, eyes, spleen, stomach, small
CC       intestine, colon, lung, bladder, pancreas and thymus.
CC       Biallelically expressed at all stages and tissues examined. Also
CC       expressed in subsets of taste receptor cells of the tongue, in
CC       olfactory sensory neurons of the main olfactory epithelium and in
CC       the vomeronasal organ. {ECO:0000269|PubMed:10903843,
CC       ECO:0000269|PubMed:12368808, ECO:0000269|PubMed:17267604,
CC       ECO:0000269|PubMed:17610722}.
CC   -!- DISRUPTION PHENOTYPE: Mice show diminished behavioral and nerve
CC       responses to bitter, sweet and umami tastes.
CC       {ECO:0000269|PubMed:16436689}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family.
CC       LTrpC subfamily. TRPM5 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB94717.2; Type=Frameshift; Positions=1130; Evidence={ECO:0000305};
CC       Sequence=CAC19456.1; Type=Frameshift; Positions=1130; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB039952; BAA96877.1; -; mRNA.
DR   EMBL; AF228681; AAF98120.1; -; mRNA.
DR   EMBL; AJ251835; CAC19456.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AJ251835; CAC19457.1; -; Genomic_DNA.
DR   EMBL; AJ271092; CAB94717.2; ALT_FRAME; mRNA.
DR   EMBL; AY280364; AAP44476.1; -; mRNA.
DR   EMBL; AY280365; AAP44477.1; -; mRNA.
DR   EMBL; BC133712; AAI33713.1; -; mRNA.
DR   EMBL; AK161030; BAE36157.1; -; mRNA.
DR   CCDS; CCDS52462.1; -. [Q9JJH7-1]
DR   RefSeq; NP_064673.2; NM_020277.2. [Q9JJH7-1]
DR   RefSeq; XP_006508708.1; XM_006508645.1. [Q9JJH7-1]
DR   RefSeq; XP_006508709.1; XM_006508646.3. [Q9JJH7-3]
DR   UniGene; Mm.286668; -.
DR   STRING; 10090.ENSMUSP00000009390; -.
DR   GuidetoPHARMACOLOGY; 497; -.
DR   iPTMnet; Q9JJH7; -.
DR   PhosphoSitePlus; Q9JJH7; -.
DR   PaxDb; Q9JJH7; -.
DR   PRIDE; Q9JJH7; -.
DR   Ensembl; ENSMUST00000009390; ENSMUSP00000009390; ENSMUSG00000009246. [Q9JJH7-1]
DR   Ensembl; ENSMUST00000150867; ENSMUSP00000114302; ENSMUSG00000009246. [Q9JJH7-3]
DR   GeneID; 56843; -.
DR   KEGG; mmu:56843; -.
DR   UCSC; uc009koz.1; mouse. [Q9JJH7-1]
DR   CTD; 29850; -.
DR   MGI; MGI:1861718; Trpm5.
DR   eggNOG; KOG3614; Eukaryota.
DR   eggNOG; ENOG410XR5B; LUCA.
DR   GeneTree; ENSGT00760000119127; -.
DR   HOVERGEN; HBG108337; -.
DR   InParanoid; Q9JJH7; -.
DR   KO; K04980; -.
DR   OMA; WRDLFLW; -.
DR   OrthoDB; EOG091G035A; -.
DR   PhylomeDB; Q9JJH7; -.
DR   TreeFam; TF314204; -.
DR   Reactome; R-MMU-3295583; TRP channels.
DR   PRO; PR:Q9JJH7; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000009246; -.
DR   ExpressionAtlas; Q9JJH7; baseline and differential.
DR   Genevisible; Q9JJH7; MM.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005227; F:calcium activated cation channel activity; IDA:MGI.
DR   GO; GO:0005267; F:potassium channel activity; IDA:MGI.
DR   GO; GO:0005272; F:sodium channel activity; IDA:MGI.
DR   GO; GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:MGI.
DR   GO; GO:0050909; P:sensory perception of taste; IEA:InterPro.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR029577; TRPM5.
DR   PANTHER; PTHR13800:SF5; PTHR13800:SF5; 1.
DR   Pfam; PF00520; Ion_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Coiled coil;
KW   Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1158       Transient receptor potential cation
FT                                channel subfamily M member 5.
FT                                /FTId=PRO_0000328934.
FT   TOPO_DOM      1    645       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    646    666       Helical. {ECO:0000255}.
FT   TOPO_DOM    667    732       Extracellular. {ECO:0000255}.
FT   TRANSMEM    733    753       Helical. {ECO:0000255}.
FT   TOPO_DOM    754    810       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    811    831       Helical. {ECO:0000255}.
FT   TOPO_DOM    832    834       Extracellular. {ECO:0000255}.
FT   TRANSMEM    835    855       Helical. {ECO:0000255}.
FT   TOPO_DOM    856    871       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    872    892       Helical. {ECO:0000255}.
FT   TOPO_DOM    893    953       Extracellular. {ECO:0000255}.
FT   TRANSMEM    954    974       Helical. {ECO:0000255}.
FT   TOPO_DOM    975   1158       Cytoplasmic. {ECO:0000255}.
FT   COILED      552    572       {ECO:0000255}.
FT   VAR_SEQ     978   1000       SYTFQVVQGNADMFWKFQRYHLI -> RVLTETGPMSWYFA
FT                                AVSSGLDLQ (in isoform 3).
FT                                {ECO:0000303|PubMed:12842017}.
FT                                /FTId=VSP_052744.
FT   VAR_SEQ    1001   1158       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12842017}.
FT                                /FTId=VSP_052745.
FT   VAR_SEQ    1108   1116       ANYCMLLLS -> SKYGFRPWE (in isoform 2).
FT                                {ECO:0000303|PubMed:10915772}.
FT                                /FTId=VSP_052746.
FT   VAR_SEQ    1117   1158       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10915772}.
FT                                /FTId=VSP_052747.
FT   MUTAGEN     831    831       E->Q: Reduces sensitivity to block by
FT                                extracellular acidification. Sensitivity
FT                                to block by low extracellular pH is
FT                                nearly abolished; when associated with N-
FT                                935. {ECO:0000269|PubMed:15731110}.
FT   MUTAGEN     897    897       H->N: Shows normal sensitivity to acid
FT                                block and significant recovery from acid-
FT                                enhanced inactivation.
FT                                {ECO:0000269|PubMed:15731110}.
FT   MUTAGEN     935    935       H->N: Reduces sensitivity to block by
FT                                extracellular acidification. Sensitivity
FT                                to block by low extracellular pH is
FT                                nearly abolished; when associated with Q-
FT                                831. {ECO:0000269|PubMed:15731110}.
FT   CONFLICT     24     24       C -> S (in Ref. 5; AAI33713).
FT                                {ECO:0000305}.
FT   CONFLICT    612    612       H -> P (in Ref. 3; CAB94717).
FT                                {ECO:0000305}.
FT   CONFLICT    871    871       D -> E (in Ref. 6; BAE36157).
FT                                {ECO:0000305}.
FT   CONFLICT    897    897       H -> N (in Ref. 5; AAI33713).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1158 AA;  130844 MW;  F0A5237EC67867CE CRC64;
     MQTTQSSCPG SPPDTEDGWE PILCRGEINF GGSGKKRGKF VKVPSSVAPS VLFELLLTEW
     HLPAPNLVVS LVGEERPLAM KSWLRDVLRK GLVKAAQSTG AWILTSALHV GLARHVGQAV
     RDHSLASTST KIRVVAIGMA SLDRILHRQL LDGVHQKEDT PIHYPADEGN IQGPLCPLDS
     NLSHFILVES GALGSGNDGL TELQLSLEKH ISQQRTGYGG TSCIQIPVLC LLVNGDPNTL
     ERISRAVEQA APWLILAGSG GIADVLAALV SQPHLLVPQV AEKQFREKFP SECFSWEAIV
     HWTELLQNIA AHPHLLTVYD FEQEGSEDLD TVILKALVKA CKSHSQEAQD YLDELKLAVA
     WDRVDIAKSE IFNGDVEWKS CDLEEVMTDA LVSNKPDFVR LFVDSGADMA EFLTYGRLQQ
     LYHSVSPKSL LFELLQRKHE EGRLTLAGLG AQQARELPIG LPAFSLHEVS RVLKDFLHDA
     CRGFYQDGRR MEERGPPKRP AGQKWLPDLS RKSEDPWRDL FLWAVLQNRY EMATYFWAMG
     REGVAAALAA CKIIKEMSHL EKEAEVARTM REAKYEQLAL DLFSECYGNS EDRAFALLVR
     RNHSWSRTTC LHLATEADAK AFFAHDGVQA FLTKIWWGDM ATGTPILRLL GAFTCPALIY
     TNLISFSEDA PQRMDLEDLQ EPDSLDMEKS FLCSRGGQLE KLTEAPRAPG DLGPQAAFLL
     TRWRKFWGAP VTVFLGNVVM YFAFLFLFTY VLLVDFRPPP QGPSGSEVTL YFWVFTLVLE
     EIRQGFFTDE DTHLVKKFTL YVEDNWNKCD MVAIFLFIVG VTCRMVPSVF EAGRTVLAID
     FMVFTLRLIH IFAIHKQLGP KIIIVERMMK DVFFFLFFLS VWLVAYGVTT QALLHPHDGR
     LEWIFRRVLY RPYLQIFGQI PLDEIDEARV NCSLHPLLLE SSASCPNLYA NWLVILLLVT
     FLLVTNVLLM NLLIAMFSYT FQVVQGNADM FWKFQRYHLI VEYHGRPALA PPFILLSHLS
     LVLKQVFRKE AQHKRQHLER DLPDPLDQKI ITWETVQKEN FLSTMEKRRR DSEGEVLRKT
     AHRVDLIAKY IGGLREQEKR IKCLESQANY CMLLLSSMTD TLAPGGTYSS SQNCGCRSQP
     ASARDREYLE SGLPPSDT
//
ID   CNGA3_MOUSE             Reviewed;         631 AA.
AC   Q9JJZ8; Q8CFV6; Q9WV01;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   25-OCT-2017, entry version 144.
DE   RecName: Full=Cyclic nucleotide-gated cation channel alpha-3;
DE   AltName: Full=Cone photoreceptor cGMP-gated channel subunit alpha;
DE   AltName: Full=Cyclic nucleotide-gated channel alpha-3;
DE            Short=CNG channel alpha-3;
DE            Short=CNG-3;
DE            Short=CNG3;
GN   Name=Cnga3; Synonyms=Cng3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Retina;
RX   PubMed=10813773;
RX   DOI=10.1002/(SICI)1096-9861(20000522)421:1<80::AID-CNE5>3.0.CO;2-O;
RA   Hirano A.A., Hack I., Waessle H., Duvoisin R.M.;
RT   "Cloning and immunocytochemical localization of a cyclic nucleotide-
RT   gated channel alpha-subunit to all cone photoreceptors in the mouse
RT   retina.";
RL   J. Comp. Neurol. 421:80-94(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 95-631.
RC   STRAIN=129/Sv;
RX   PubMed=10377453; DOI=10.1073/pnas.96.13.7553;
RA   Biel M., Seeliger M., Pfeifer A., Kohler K., Gerstner A., Ludwig A.,
RA   Jaissle G., Fauser S., Zrenner E., Hofmann F.;
RT   "Selective loss of cone function in mice lacking the cyclic
RT   nucleotide-gated channel CNG3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:7553-7557(1999).
RN   [4]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=10662822;
RA   Gerstner A., Zong X., Hofmann F., Biel M.;
RT   "Molecular cloning and functional characterization of a new modulatory
RT   cyclic nucleotide-gated channel subunit from mouse retina.";
RL   J. Neurosci. 20:1324-1332(2000).
CC   -!- FUNCTION: Visual signal transduction is mediated by a G-protein
CC       coupled cascade using cGMP as second messenger. This protein can
CC       be activated by cyclic GMP which leads to an opening of the cation
CC       channel and thereby causing a depolarization of cone
CC       photoreceptors. Essential for the generation of light-evoked
CC       electrical responses in the red-, green- and blue sensitive cones
CC       (By similarity). Induced a flickering channel gating, weakened the
CC       outward rectification in the presence of extracellular calcium,
CC       increased sensitivity for L-cis diltiazem and enhanced the cAMP
CC       efficacy of the channel when coexpressed with CNGB3. {ECO:0000250,
CC       ECO:0000269|PubMed:10662822}.
CC   -!- SUBUNIT: Tetramer formed of three CNGA3 and one CNGB3 modulatory
CC       subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Prominently expressed in retina.
CC   -!- DOMAIN: The C-terminal coiled-coil domain mediates
CC       homotrimerization of CNGA subunits. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGA3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243933; CAB89685.1; -; mRNA.
DR   EMBL; BC035272; AAH35272.1; -; mRNA.
DR   EMBL; BC049145; AAH49145.1; -; mRNA.
DR   EMBL; AJ238239; CAB42891.1; -; Genomic_DNA.
DR   EMBL; AJ238240; CAB42891.1; JOINED; Genomic_DNA.
DR   EMBL; AJ238241; CAB42891.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS14890.1; -.
DR   RefSeq; NP_001268939.1; NM_001282010.1.
DR   RefSeq; NP_034048.1; NM_009918.2.
DR   RefSeq; XP_017169234.1; XM_017313745.1.
DR   UniGene; Mm.214224; -.
DR   ProteinModelPortal; Q9JJZ8; -.
DR   SMR; Q9JJZ8; -.
DR   STRING; 10090.ENSMUSP00000027288; -.
DR   iPTMnet; Q9JJZ8; -.
DR   PhosphoSitePlus; Q9JJZ8; -.
DR   PaxDb; Q9JJZ8; -.
DR   PRIDE; Q9JJZ8; -.
DR   Ensembl; ENSMUST00000027288; ENSMUSP00000027288; ENSMUSG00000026114.
DR   Ensembl; ENSMUST00000194195; ENSMUSP00000142075; ENSMUSG00000026114.
DR   GeneID; 12790; -.
DR   KEGG; mmu:12790; -.
DR   UCSC; uc007ari.2; mouse.
DR   CTD; 1261; -.
DR   MGI; MGI:1341818; Cnga3.
DR   eggNOG; KOG0500; Eukaryota.
DR   eggNOG; ENOG410YWWI; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000007898; -.
DR   HOVERGEN; HBG000281; -.
DR   InParanoid; Q9JJZ8; -.
DR   KO; K04950; -.
DR   TreeFam; TF319048; -.
DR   PRO; PR:Q9JJZ8; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   Bgee; ENSMUSG00000026114; -.
DR   CleanEx; MM_CNGA3; -.
DR   ExpressionAtlas; Q9JJZ8; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0001750; C:photoreceptor outer segment; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:1902495; C:transmembrane transporter complex; ISO:MGI.
DR   GO; GO:0030553; F:cGMP binding; ISO:MGI.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; ISO:MGI.
DR   GO; GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; IPI:MGI.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; ISO:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0046549; P:retinal cone cell development; IMP:MGI.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032406; CLZ_dom.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF16526; CLZ; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   cGMP; cGMP-binding; Coiled coil; Complete proteome; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Sensory transduction; Transmembrane;
KW   Transmembrane helix; Transport; Vision.
FT   CHAIN         1    631       Cyclic nucleotide-gated cation channel
FT                                alpha-3.
FT                                /FTId=PRO_0000219318.
FT   TRANSMEM    112    133       Helical. {ECO:0000255}.
FT   TRANSMEM    244    264       Helical. {ECO:0000255}.
FT   TRANSMEM    320    340       Helical. {ECO:0000255}.
FT   NP_BIND     423    546       cGMP.
FT   COILED      567    610       {ECO:0000250}.
FT   BINDING     490    490       cGMP. {ECO:0000255}.
FT   BINDING     505    505       cGMP. {ECO:0000255}.
FT   CONFLICT    110    110       Y -> C (in Ref. 1; CAB89685).
FT                                {ECO:0000305}.
FT   CONFLICT    157    157       L -> V (in Ref. 3; CAB42891).
FT                                {ECO:0000305}.
SQ   SEQUENCE   631 AA;  72702 MW;  4FAD66E3A8A3FE6C CRC64;
     MAKVNTQCSQ PSPTQLSIKN ADRDLDHVEN GLGRVSRLII SIRAWASRHL HDEDQTPDSF
     LDRFHGSELK EVSTRESNAQ PNPGEQKPPD GGEGRKEEPI VVDPSSNIYY RWLTAIALPV
     FYNWCLLVCR ACFDELQSEH LTLWLVLDYS ADVLYVLDML VRARTGFLEQ GLMVRDTKRL
     WKHYTKTLHF KLDILSLIPT DLAYLKLGVN YPELRFNRLL KFSRLFEFFD RTETRTNYPN
     VFRIGNLVLY TLIIIHWNAC IYFAISKFIG FGTDSWVYPN TSKPEYARLS RKYIYSLYWS
     TLTLTTIGET PPPVKDEEYL FVVIDFLVGI LIFATIVGNV GSMISNMNAP RVEFQAKIDS
     VKQYMQFRKV TKDLETRVIR WFDYLWANRK TVDEKEVLKN LPDKLKAEIA INVHLDTLKK
     VRIFQDCEAG LLVELVLKLR PTVFSPGDYI CKKGDIGREM YIIKEGKLAV VADDGVTQFV
     VLSDGSYFGE ISILNIKGSK SGNRRTANIR SIGYSDLFCL SKDDLMEALT EYPDAKRALE
     EKGRQILMKD NLIDEDLVAA RVDTRDVEEK VEYLESSLDI LQTRFARLLA EYSASQMKLK
     QRLTRLESQM NRRCCGFSPD RENSEDASKT D
//
ID   CNGB3_MOUSE             Reviewed;         694 AA.
AC   Q9JJZ9;
DT   29-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-OCT-2017, entry version 122.
DE   RecName: Full=Cyclic nucleotide-gated cation channel beta-3;
DE   AltName: Full=Cone photoreceptor cGMP-gated channel subunit beta;
DE   AltName: Full=Cyclic nucleotide-gated cation channel modulatory subunit;
DE   AltName: Full=Cyclic nucleotide-gated channel beta-3;
DE            Short=CNG channel beta-3;
DE   AltName: Full=Cyclic nucleotide-gated channel subunit CNG6;
GN   Name=Cngb3; Synonyms=Cng6;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J; TISSUE=Retina;
RX   PubMed=10662822;
RA   Gerstner A., Zong X., Hofmann F., Biel M.;
RT   "Molecular cloning and functional characterization of a new modulatory
RT   cyclic nucleotide-gated channel subunit from mouse retina.";
RL   J. Neurosci. 20:1324-1332(2000).
CC   -!- FUNCTION: Visual signal transduction is mediated by a G-protein
CC       coupled cascade using cGMP as second messenger. This protein can
CC       be activated by cGMP which leads to an opening of the cation
CC       channel and thereby causing a depolarization of rod
CC       photoreceptors. Essential for the generation of light-evoked
CC       electrical responses in the red-, green- and blue sensitive cones
CC       (By similarity). Induced a flickering channel gating, weakened the
CC       outward rectification in the presence of extracellular calcium,
CC       increased sensitivity for L-cis diltiazem and enhanced the cAMP
CC       efficacy of the channel when coexpressed with CNGA3. {ECO:0000250,
CC       ECO:0000269|PubMed:10662822}.
CC   -!- SUBUNIT: Tetramer formed of three CNGA3 and one CNGB3 modulatory
CC       subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Small subset of retinal photorecptor cells and
CC       testis. {ECO:0000269|PubMed:10662822}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGB3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243572; CAB71152.1; -; mRNA.
DR   CCDS; CCDS17990.1; -.
DR   RefSeq; NP_038955.1; NM_013927.2.
DR   UniGene; Mm.445778; -.
DR   ProteinModelPortal; Q9JJZ9; -.
DR   SMR; Q9JJZ9; -.
DR   STRING; 10090.ENSMUSP00000100064; -.
DR   GuidetoPHARMACOLOGY; 399; -.
DR   iPTMnet; Q9JJZ9; -.
DR   PhosphoSitePlus; Q9JJZ9; -.
DR   PaxDb; Q9JJZ9; -.
DR   PeptideAtlas; Q9JJZ9; -.
DR   PRIDE; Q9JJZ9; -.
DR   Ensembl; ENSMUST00000102999; ENSMUSP00000100064; ENSMUSG00000056494.
DR   GeneID; 30952; -.
DR   KEGG; mmu:30952; -.
DR   UCSC; uc008sbx.1; mouse.
DR   CTD; 54714; -.
DR   MGI; MGI:1353562; Cngb3.
DR   eggNOG; KOG0499; Eukaryota.
DR   eggNOG; ENOG410ZJ5U; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000231425; -.
DR   HOVERGEN; HBG051038; -.
DR   InParanoid; Q9JJZ9; -.
DR   KO; K04953; -.
DR   OMA; VDLFKGC; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; Q9JJZ9; -.
DR   TreeFam; TF318250; -.
DR   PRO; PR:Q9JJZ9; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   Bgee; ENSMUSG00000056494; -.
DR   CleanEx; MM_CNGB3; -.
DR   Genevisible; Q9JJZ9; MM.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0001750; C:photoreceptor outer segment; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IC:MGI.
DR   GO; GO:1902495; C:transmembrane transporter complex; ISO:MGI.
DR   GO; GO:0030553; F:cGMP binding; ISO:MGI.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IPI:MGI.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; ISO:MGI.
DR   GO; GO:0009187; P:cyclic nucleotide metabolic process; IC:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032943; CNG6.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF385; PTHR10217:SF385; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   cGMP; cGMP-binding; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Sensory transduction; Transmembrane;
KW   Transmembrane helix; Transport; Vision.
FT   CHAIN         1    694       Cyclic nucleotide-gated cation channel
FT                                beta-3.
FT                                /FTId=PRO_0000219321.
FT   TOPO_DOM      1    209       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    210    230       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    231    242       Extracellular. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    264    294       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    295    315       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    316    351       Extracellular. {ECO:0000255}.
FT   TRANSMEM    352    372       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    373    409       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    410    430       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    431    568       Extracellular. {ECO:0000255}.
FT   TRANSMEM    569    589       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    590    694       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     524    668       cGMP. {ECO:0000250}.
FT   BINDING     584    584       cGMP. {ECO:0000250}.
FT   BINDING     596    596       cGMP. {ECO:0000250}.
FT   CARBOHYD    507    507       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   694 AA;  79722 MW;  0B9F9CF3B180DA82 CRC64;
     MLKSLTVKFN KVNPMEGRME KKLCPNLSSL SQPTIAQGDN QSEKEPLRSR TPITFEKSHS
     KEDNSTGENS LRDFTPNPDP ECRAELTRTM AEMEKTRTGK ERPVSFKTKV LETSIINEYT
     DAHLHNLVER MRERTALYKK TLTEEENFPE VEASSQTAMS TNISPKQENN SKLKEHQDTF
     SFKPQRVPVK EHLRRMILPR SIDSYTDRVY LLWLLLVTIA YNWNCWLLPV RLVFPCQTPD
     NKNYWIITDI VCDIIYLCDI LLIQPRLQFV RGGEIIVDSN ELKRNYRSST KFRMDVASLL
     PFEVLYIFFG VNPIFRANRI LKYTSFFEFN HHLESIMDKA YVYRVIRTTG YLLFLLHINA
     CVYYWASDYE GIGSTKWVYN GEGNKYLRCF YWAVRTLITI GGLPEPQTSF EIVFQFLNFF
     SGVFVFSSLI GQMRDVIGAA TANQNYFQAC MDHIIAYMNK YSIPQSVQYR VRTWLEYTWN
     SQRILDESNL LENLPTAMQL SIALDINFSI IDKVELFKGC DTQMIYDLLL RLKSTIYLPG
     DFVCKKGEIG KEMYIIKHGE VQVLGGPDGA QVLVTLKAGS VFGEISLLAK GGGNRRTADV
     VAHGFANLLT LDKKTLQEIL LHYPTSKKLL MKKAKILLSQ KGKTTQAIPA RPGPAFLFPP
     KEETPRMLKV LLGNTGKVDL GRLLKGKRKT TTQK
//
ID   HCN1_RAT                Reviewed;         910 AA.
AC   Q9JKB0;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
GN   Name=Hcn1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=11000485; DOI=10.1016/S0169-328X(00)00155-8;
RA   Monteggia L.M., Eisch A.J., Tang M.D., Kaczmarek L.K., Nestler E.J.;
RT   "Cloning and localization of the hyperpolarization-activated cyclic
RT   nucleotide-gated channel family in rat brain.";
RL   Brain Res. Mol. Brain Res. 81:129-139(2000).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11675786; DOI=10.1038/35098087;
RA   Stevens D.R., Seifert R., Bufe B., Mueller F., Kremmer E., Gauss R.,
RA   Meyerhof W., Kaupp U.B., Lindemann B.;
RT   "Hyperpolarization-activated channels HCN1 and HCN4 mediate responses
RT   to sour stimuli.";
RL   Nature 413:631-635(2001).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). May
CC       mediate responses to sour stimuli. {ECO:0000269|PubMed:11675786}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding promotes
CC       tetramerization and formation of an active channel. Compared to
CC       other family members, cAMP has less stimulatory effect on HCN1
CC       because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN2. The potassium
CC       channel is composed of a homo- or heterotetrameric complex of
CC       pore-forming subunits. Interacts with KCNE2. Interacts with the
CC       SH3 domain of CSK. {ECO:0000250|UniProtKB:O88704}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11675786};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11675786}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in cerebral cortex,
CC       cerebellum, throughout the hippocampus, in medial habenula,
CC       anterior dorsal nucleus in the thalamus, tenia tecta, several
CC       nuclei of the general motor system and in optic nerve layer.
CC       Detected in a subset of elongated cells in taste buds.
CC       {ECO:0000269|PubMed:11000485, ECO:0000269|PubMed:11675786}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:O60741}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF247450; AAF62173.1; -; mRNA.
DR   RefSeq; NP_445827.1; NM_053375.1.
DR   UniGene; Rn.21408; -.
DR   ProteinModelPortal; Q9JKB0; -.
DR   SMR; Q9JKB0; -.
DR   BioGrid; 249933; 2.
DR   STRING; 10116.ENSRNOP00000016142; -.
DR   iPTMnet; Q9JKB0; -.
DR   PhosphoSitePlus; Q9JKB0; -.
DR   PaxDb; Q9JKB0; -.
DR   PRIDE; Q9JKB0; -.
DR   GeneID; 84390; -.
DR   KEGG; rno:84390; -.
DR   CTD; 348980; -.
DR   RGD; 620688; Hcn1.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9JKB0; -.
DR   KO; K04954; -.
DR   PhylomeDB; Q9JKB0; -.
DR   PRO; PR:Q9JKB0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0098855; C:HCN channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0036477; C:somatodendritic compartment; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0030552; F:cAMP binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; IMP:RGD.
DR   GO; GO:0032403; F:protein complex binding; IPI:RGD.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; ISO:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0045176; P:apical protein localization; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IEP:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEP:RGD.
DR   GO; GO:0042711; P:maternal behavior; IEP:RGD.
DR   GO; GO:0045759; P:negative regulation of action potential; IMP:RGD.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:0003254; P:regulation of membrane depolarization; IDA:RGD.
DR   GO; GO:1902630; P:regulation of membrane hyperpolarization; IMP:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IDA:RGD.
DR   GO; GO:0072718; P:response to cisplatin; IEP:RGD.
DR   GO; GO:1902065; P:response to L-glutamate; IEP:RGD.
DR   GO; GO:0046549; P:retinal cone cell development; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR10217:SF373; PTHR10217:SF373; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   cAMP; cAMP-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    910       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                1.
FT                                /FTId=PRO_0000054110.
FT   TOPO_DOM      1    131       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    132    153       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    154    162       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    163    183       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    184    204       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    205    225       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    226    249       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    250    270       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    271    284       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    285    307       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    308    333       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   INTRAMEM    334    355       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    356    360       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    361    381       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    382    910       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   NP_BIND     528    531       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     538    539       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     579    582       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   REGION        1     82       Intrinsically disordered. {ECO:0000305}.
FT   MOTIF       347    351       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   COMPBIAS    715    777       Gln-rich.
FT   COMPBIAS    878    884       Poly-Pro.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   910 AA;  102422 MW;  11E32D2BE73F4528 CRC64;
     MEGGGKPNSA SNSRDDGNSV YPSKAPATGP AAADKRLGTP PGGGAAGKEH GNSVCFKVDG
     GGGEEPAGSF EDAEGPRRQY GFMQRQFTSM LQPGVNKFSL RMFGSQKAVE KEQERVKTAG
     FWIIHPYSDF RFYWDLIMLI MMVGNLVIIP VGITFFTEQT TTPWIIFNVA SDTVFLLDLI
     MNFRTGTVNE DSSEIILDPK VIKMNYLKSW FVVDFISSIP VDYIFLIVEK GMDSEVYKTA
     RALRIVRFTK ILSLLRLLRL SRLIRYIHQW EEIFHMTYDL ASAVVRIFNL IGMMLLLCHW
     DGCLQFLVPL LQDFPPDCWV SLNEMVNDSW GKQYSYALFK AMSHMLCIGY GAQAPVSMSD
     LWITMLSMIV GATCYAMFVG HATALIQSLD SSRRQYQEKY KQVEQYMSFH KLPADMRQKI
     HDYYEHRYQG KIFDEENILS ELNDPLREEI VNFNCRKLVA TMPLFANADP NFVTAMLSKL
     RFEVFQPGDY IIREGAVGKK MYFIQHGVAG VITKSSKEMK LTDGSYFGEI CLLTKGRRTA
     SVRADTYCRL YSLSVDNFNE VLEEYPMMRR AFETVAIDRL DRIGKKNSIL LQKFQKDLNT
     GVFNNQENEI LKQIVKHDRE MVQAIPPINY PQMTALNCTS STTTPTSRMR TQSPPVYTAT
     SLSHSNLHSP SPSTQTPQPS AILSPCSYTT AVCSPPIQSP LATRTFHYAS PTASQLSLMQ
     QPQPQLQQSQ VQQTQTQTQQ QQQQQQPQPQ PQQPQQQQQQ QQQQQQQQQQ QQQQQPQTPG
     SSTPKNEVHK STQALHNTHL TREVRPLSAS QPSLPHEVST MISRPHPTVG ESLASIPQPV
     ATVHSTGLQA GSRSTVPQRV TLFRQMSSGA IPPNRGVPPA PPPPAAVQRE SPSVLNKDPD
     AEKPRFASNL
//
ID   ACH10_RAT               Reviewed;         447 AA.
AC   Q9JLB5;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-10;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-10;
DE            Short=NACHR alpha-10;
DE   Flags: Precursor;
GN   Name=Chrna10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CHRNA9, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11248107; DOI=10.1073/pnas.051622798;
RA   Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F.,
RA   Boulter J.;
RT   "Alpha10: a determinant of nicotinic cholinergic receptor function in
RT   mammalian vestibular and cochlear mechanosensory hair cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3501-3506(2001).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH CHRNA9.
RX   PubMed=12117536; DOI=10.1016/S0378-5955(02)00380-5;
RA   Weisstaub N., Vetter D.E., Elgoyhen A.B., Katz E.;
RT   "The alpha9alpha10 nicotinic acetylcholine receptor is permeable to
RT   and is modulated by divalent cations.";
RL   Hear. Res. 167:122-135(2002).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=12401316; DOI=10.1016/S0306-4522(02)00274-9;
RA   Lips K.S., Pfeil U., Kummer W.;
RT   "Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine
RT   receptors in rat dorsal root ganglion neurons.";
RL   Neuroscience 115:1-5(2002).
RN   [4]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15356192; DOI=10.1523/JNEUROSCI.2102-04.2004;
RA   Katz E., Elgoyhen A.B., Gomez-Casati M.E., Knipper M., Vetter D.E.,
RA   Fuchs P.A., Glowatzki E.;
RT   "Developmental regulation of nicotinic synapses on cochlear inner hair
RT   cells.";
RL   J. Neurosci. 24:7814-7820(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH CHRNA9.
RX   PubMed=14742688; DOI=10.1124/mol.65.2.453;
RA   Baker E.R., Zwart R., Sher E., Millar N.S.;
RT   "Pharmacological properties of alpha 9 alpha 10 nicotinic
RT   acetylcholine receptors revealed by heterologous expression of subunit
RT   chimeras.";
RL   Mol. Pharmacol. 65:453-460(2004).
RN   [6]
RP   SITE HIS-31, AND SUBUNIT.
RX   PubMed=26395518; DOI=10.1038/srep14261;
RA   Xu S., Zhang T., Kompella S.N., Yan M., Lu A., Wang Y., Shao X.,
RA   Chi C., Adams D.J., Ding J., Wang C.;
RT   "Conotoxin alphaD-GeXXA utilizes a novel strategy to antagonize
RT   nicotinic acetylcholine receptors.";
RL   Sci. Rep. 5:14261-14268(2015).
RN   [7]
RP   MUTAGENESIS OF GLU-221 AND PRO-224, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [8]
RP   ERRATUM.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with
RT   the rat alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the
CC       modulation of auditory stimuli. Agonist binding may induce an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane. The channel is permeable to a range of divalent cations
CC       including calcium, the influx of which may activate a potassium
CC       current which hyperpolarizes the cell membrane. In the ear, this
CC       leads to a reduction in basilar membrane motion, altering the
CC       activity of auditory nerve fibers and reducing the range of
CC       dynamic hearing. This may protect against acoustic trauma.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688}.
CC   -!- SUBUNIT: Forms heterooligomeric channels in conjunction with
CC       CHRNA9. The native outer hair cell receptor may be composed of
CC       CHRNA9-CHRNA10 heterooligomers. Interacts with the conotoxin GeXXA
CC       (PubMed:26395518). Interacts with the alpha-conotoxin RgIA
CC       (PubMed:25740413). {ECO:0000269|PubMed:25740413,
CC       ECO:0000269|PubMed:26395518}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Cell membrane {ECO:0000305}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the outer hair cells of the
CC       cochlea and the neurons of dorsal root ganglia.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12401316}.
CC   -!- DEVELOPMENTAL STAGE: Expression in the inner hair cells of the ear
CC       is lost at the onset of hearing, around P12. This correlates with
CC       a loss of sensitivity of these cells to cholinergic stimuli.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:15356192}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9
CC       and CHRNA10 has an atypical pharmacological profile, binding
CC       several non-nicotinic ligands including strychnine (a glycine
CC       receptor antagonist) and atropine (a muscarinic acetylcholine
CC       receptor antagonist).
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-
CC       10/CHRNA10 sub-subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF196344; AAF27624.1; -; mRNA.
DR   RefSeq; NP_072161.1; NM_022639.1.
DR   RefSeq; XP_017445156.1; XM_017589667.1.
DR   UniGene; Rn.48767; -.
DR   ProteinModelPortal; Q9JLB5; -.
DR   SMR; Q9JLB5; -.
DR   STRING; 10116.ENSRNOP00000027506; -.
DR   BindingDB; Q9JLB5; -.
DR   ChEMBL; CHEMBL3461; -.
DR   GuidetoPHARMACOLOGY; 470; -.
DR   PaxDb; Q9JLB5; -.
DR   PRIDE; Q9JLB5; -.
DR   Ensembl; ENSRNOT00000027507; ENSRNOP00000027506; ENSRNOG00000020293.
DR   GeneID; 64574; -.
DR   KEGG; rno:64574; -.
DR   UCSC; RGD:620142; rat.
DR   CTD; 57053; -.
DR   RGD; 620142; Chrna10.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   HOVERGEN; HBG003756; -.
DR   InParanoid; Q9JLB5; -.
DR   KO; K04811; -.
DR   OMA; AQRCHED; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q9JLB5; -.
DR   TreeFam; TF315605; -.
DR   PRO; PR:Q9JLB5; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020293; -.
DR   Genevisible; Q9JLB5; RN.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IMP:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:RGD.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell junction;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    447       Neuronal acetylcholine receptor subunit
FT                                alpha-10.
FT                                /FTId=PRO_0000000377.
FT   TOPO_DOM     25    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    268    288       Helical. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TOPO_DOM    323    425       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   SITE         31     31       Involved in the interaction with the
FT                                conotoxin GeXXA.
FT                                {ECO:0000269|PubMed:26395518}.
FT   CARBOHYD     40     40       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     56     56       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    154    168       {ECO:0000250}.
FT   DISULFID    218    219       Associated with receptor activation.
FT                                {ECO:0000250}.
FT   MUTAGEN     221    221       E->Q: CHRNA9-CHRNA10 receptor is 25-fold
FT                                less potently inhibited by the alpha-
FT                                conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
FT   MUTAGEN     224    224       P->Q: CHRNA9-CHRNA10 receptor is 300-fold
FT                                less potently inhibited by the alpha-
FT                                conotoxin RgIA.
FT                                {ECO:0000269|PubMed:25740413}.
SQ   SEQUENCE   447 AA;  49820 MW;  EEE49D93490B698F CRC64;
     MGTRSHYLDL GFLLLLFLPA ECLGAEGRLA HKLFRDLFAN YTSALRPVAD TDQTLNVTLE
     VTLSQIIDMD ERNQVLTLYL WIRQEWTDAY LHWDPKAYGD LDAIRIPSRL VWRPDIVLYN
     KADTQPPASA STNVVVRHDG AVRWDAPAIT RSSCRVDVSA FPFDAQRCGL TFGSWTHGGH
     QLDVRPRGTS ASLADFVENV EWRVLGMPAR RRVLTYGCCS EPYPDVTFTL LLRRRAAAYV
     CNLLLPCVFI SLLAPLAFHL PADSGEKVSL GVTVLLALTV FQLILAESMP PAESVPLIGK
     YYMATMTMVT FSTALTILIM NLHYCGPNAH PVPAWARVLL LGHLAKGLCV RERGEPCGQS
     KPLESAPSLQ PPPASPAGPC HEPRCLCHQE ALLHHIASIA STFRSHRAAQ RRHEDWKRLA
     RVMDRFFLGI FFCMALVMSL IVLVQAL
//
ID   CNG20_ARATH             Reviewed;         764 AA.
AC   Q9LD37;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-OCT-2017, entry version 127.
DE   RecName: Full=Probable cyclic nucleotide-gated ion channel 20, chloroplastic;
DE   AltName: Full=Cyclic nucleotide-binding transporter 1;
DE   Flags: Precursor;
GN   Name=CNGC20; Synonyms=CNBT1; OrderedLocusNames=At3g17700;
GN   ORFNames=MKP6.28;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=cv. Columbia;
RA   Wolff P., Palme K.;
RT   "Two genes encoding putative cyclic nucleotide-binding ion
RT   transporters from Arabidopsis thaliana.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10819329; DOI=10.1093/dnares/7.2.131;
RA   Sato S., Nakamura Y., Kaneko T., Katoh T., Asamizu E., Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 3. I. Sequence
RT   features of the regions of 4,504,864 bp covered by sixty P1 and TAC
RT   clones.";
RL   DNA Res. 7:131-135(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
CC   -!- FUNCTION: Probable cyclic nucleotide-gated ion channel.
CC   -!- SUBUNIT: Homotetramer or heterotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Plastid, chloroplast thylakoid membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF148541; AAF73128.1; -; mRNA.
DR   EMBL; AF148542; AAF73130.1; -; Genomic_DNA.
DR   EMBL; AB022219; BAB02062.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE75994.1; -; Genomic_DNA.
DR   RefSeq; NP_566585.1; NM_112651.5.
DR   UniGene; At.6293; -.
DR   ProteinModelPortal; Q9LD37; -.
DR   BioGrid; 6370; 7.
DR   STRING; 3702.AT3G17700.1; -.
DR   TCDB; 1.A.1.5.24; the voltage-gated ion channel (vic) superfamily.
DR   PaxDb; Q9LD37; -.
DR   EnsemblPlants; AT3G17700.1; AT3G17700.1; AT3G17700.
DR   GeneID; 821037; -.
DR   Gramene; AT3G17700.1; AT3G17700.1; AT3G17700.
DR   KEGG; ath:AT3G17700; -.
DR   Araport; AT3G17700; -.
DR   TAIR; locus:2090572; AT3G17700.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; Q9LD37; -.
DR   KO; K05391; -.
DR   OMA; CGRGINI; -.
DR   OrthoDB; EOG093607MJ; -.
DR   PhylomeDB; Q9LD37; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q9LD37; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q9LD37; baseline and differential.
DR   Genevisible; Q9LD37; AT.
DR   GO; GO:0009535; C:chloroplast thylakoid membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0009624; P:response to nematode; IEP:TAIR.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00520; Ion_trans; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   Calmodulin-binding; cAMP; cAMP-binding; cGMP; cGMP-binding;
KW   Chloroplast; Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding; Plastid;
KW   Reference proteome; Thylakoid; Transit peptide; Transmembrane;
KW   Transmembrane helix; Transport.
FT   TRANSIT       1     25       Chloroplast. {ECO:0000255}.
FT   CHAIN        26    764       Probable cyclic nucleotide-gated ion
FT                                channel 20, chloroplastic.
FT                                /FTId=PRO_0000005556.
FT   TOPO_DOM     26    204       Stromal. {ECO:0000255}.
FT   TRANSMEM    205    225       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    226    242       Lumenal. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    264    295       Stromal. {ECO:0000255}.
FT   TRANSMEM    296    316       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    317    329       Lumenal. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    351    366       Stromal. {ECO:0000255}.
FT   TRANSMEM    367    387       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    388    488       Lumenal. {ECO:0000255}.
FT   TRANSMEM    489    509       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    510    764       Stromal. {ECO:0000255}.
FT   DOMAIN      734    763       IQ.
FT   NP_BIND     593    710       cNMP.
FT   REGION      713    729       Calmodulin-binding. {ECO:0000250}.
FT   BINDING     658    658       cNMP. {ECO:0000250}.
SQ   SEQUENCE   764 AA;  86950 MW;  FFFA8175DB76796E CRC64;
     MASHNENDDI PMLPISDPSS RTRARAFTSR SRSVSLSNPT SSIEGFDTST VVLGYTGPLR
     TQRRPPLVQM SGPLTSTRKH EPLFLPHPSS DSVGVSSQPE RYPSFAALEH KNSSEDEFVL
     KHANLLRSGQ LGMCNDPYCT TCPSYYNRKA AQIPTSRVSA LFDSTFHNAL YDDAKGWARR
     FASSVNRYLP GIMNPHAKEV QTWTKFFALS CLLAIFIDPL FFFLIKVQEQ NKCIMIDWPM
     TKAFVAVRSV TDVIFTMNIL LQFRLAYVAR ESTVVGAGQL VSHPKKIALH YLKGKFFLDL
     FIVMPLPQIL ILWIIPAHLG ASGANYAKNL LRAAVLFQYI PKLYRLLPFL AGQTPTGFIF
     ESAWANFVIN LLTFMLAGHV VGSCWYLFGL QRVNQCLRNA CGNFGRECQD LIDCGNGNSS
     VLVRATWKDN ASANACFQED GFPYGIYLKA VNLTNHSNLF TRYSYSLFWG FQQISTLAGN
     QVPSYFLGEV FFTMGIIGLG LLLFALLIGN MQNFLQALGK RNLEMTLRRR DVEQWMSHRR
     LPDGIRRRVR EAERFNWAAT RGVNEELLFE NMPDDLQRDI RRHLFKFLKK VRIFSLMDEP
     ILDAIRERLK QRTYIGSSTV LHRGGLVEKM VFIVRGEMES IGEDGSVLPL YEGDVCGEEL
     LTWCLERSSV NPDGTRIRMP SKGLLSSRNV RCVTNVEAFS LSVADLEDVT SLFSRFLRSH
     RVQGAIRYDS PYWRLRAARQ IQVAWRYRRR RLHRLCTPQS SYSL
//
ID   GLR25_ARATH             Reviewed;         918 AA.
AC   Q9LFN5; F4JWF9;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   25-OCT-2017, entry version 118.
DE   RecName: Full=Glutamate receptor 2.5;
DE   AltName: Full=Ligand-gated ion channel 2.5;
DE   Flags: Precursor;
GN   Name=GLR2.5; OrderedLocusNames=At5g11210; ORFNames=F2I11_100;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K.,
RA   Kohara M., Matsumoto M., Matsuno A., Muraki A., Nakayama S.,
RA   Nakazaki N., Naruo K., Okumura S., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Sato S., de la Bastide M.,
RA   Huang E., Spiegel L., Gnoj L., O'Shaughnessy A., Preston R.,
RA   Habermann K., Murray J., Johnson D., Rohlfing T., Nelson J.,
RA   Stoneking T., Pepin K., Spieth J., Sekhon M., Armstrong J., Becker M.,
RA   Belter E., Cordum H., Cordes M., Courtney L., Courtney W., Dante M.,
RA   Du H., Edwards J., Fryman J., Haakensen B., Lamar E., Latreille P.,
RA   Leonard S., Meyer R., Mulvaney E., Ozersky P., Riley A., Strowmatt C.,
RA   Wagner-McPherson C., Wollam A., Yoakum M., Bell M., Dedhia N.,
RA   Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D., Baker J.,
RA   Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S.,
RA   Langham S.-A., McCullagh B., Robben J., Grymonprez B., Zimmermann W.,
RA   Ramsperger U., Wedler H., Balke K., Wedler E., Peters S.,
RA   van Staveren M., Dirkse W., Mooijman P., Klein Lankhorst R.,
RA   Weitzenegger T., Bothe G., Rose M., Hauf J., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Villarroel R., Gielen J., Ardiles W.,
RA   Bents O., Lemcke K., Kolesov G., Mayer K.F.X., Rudd S., Schoof H.,
RA   Schueller C., Zaccaria P., Mewes H.-W., Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:823-826(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AED91648.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB96656.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL360314; CAB96656.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002688; AED91648.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002688; ANM70627.1; -; Genomic_DNA.
DR   RefSeq; NP_001318537.1; NM_001343162.1.
DR   RefSeq; NP_001332219.1; NM_001343168.1.
DR   UniGene; At.49415; -.
DR   ProteinModelPortal; Q9LFN5; -.
DR   STRING; 3702.AT5G11210.1; -.
DR   PaxDb; Q9LFN5; -.
DR   PRIDE; Q9LFN5; -.
DR   EnsemblPlants; AT5G11210.5; AT5G11210.5; AT5G11210.
DR   GeneID; 830991; -.
DR   Gramene; AT5G11210.5; AT5G11210.5; AT5G11210.
DR   KEGG; ath:AT5G11210; -.
DR   Araport; AT5G11210; -.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG410XQQV; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q9LFN5; -.
DR   KO; K05387; -.
DR   OrthoDB; EOG0936061T; -.
DR   PhylomeDB; Q9LFN5; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q9LFN5; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q9LFN5; baseline and differential.
DR   Genevisible; Q9LFN5; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0004930; F:G-protein coupled receptor activity; IEA:InterPro.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR000337; GPCR_3.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   PRINTS; PR00248; GPCRMGR.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31    918       Glutamate receptor 2.5.
FT                                /FTId=PRO_0000011600.
FT   TOPO_DOM     31    586       Extracellular. {ECO:0000255}.
FT   TRANSMEM    587    607       Helical. {ECO:0000255}.
FT   TOPO_DOM    608    616       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    617    637       Helical. {ECO:0000255}.
FT   TOPO_DOM    638    647       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    648    668       Helical. {ECO:0000255}.
FT   TOPO_DOM    669    828       Extracellular. {ECO:0000255}.
FT   TRANSMEM    829    849       Helical. {ECO:0000255}.
FT   TOPO_DOM    850    918       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    122    122       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    340    340       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    546    546       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    791    791       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   918 AA;  103541 MW;  75E0C00D1900D3F9 CRC64;
     MSLFHHLVSR FLSLWLLIFL VFLVLSLGKS QKEALQVKVG IVLGSNVTLA DLSLRAINMS
     LSEFYNTHNG FKTRIVLNVR DSKQTVVGAA ASALYLIKKR EVVAIIGPGT SMQAPFLINL
     GNQSKVPIIS FSATSPLLDS LRSPYFIRAT HDDSSQVQAI SAIIESFRWR EVVPIYVDNE
     FGEGILPNLV DAFQEINVRI RYRSAISLHY SDDQIKKELY KLMTMPTRVF IVHMLPDLGS
     RLFSIAKEID MLSKGYVWIV TNGIADLMSI MGESSLVNMH GVLGVKTYFA KSKELLHLEA
     RWQKRFGGEE LNNFACWAYD AATALAMSVE EIRHVNMSFN TTKEDTSRDD IGTDLDELGV
     ALSGPKLLDA LSTVSFKGVA GRFQLKNGKL EATTFKIINI EESGERTVGF WKSKVGLVKS
     LRVDKVSHSS RRLRPIIWPG DTIFVPKGWE FPTNAKKLRI AVPKKDGFNN FVEVTKDENT
     NVPTVTGFCI DVFNTVMSQM PYAVSYEYIP FDTPDGKPRG SYDEMVYNVF LGEFDGAVGD
     TTILANRSHY VDFALPYSET GIVFLVPVKD GKEKGEWVFL KPLTKELWLV TAASFLYIGI
     MVWIFEYQAD EEFREQMIID KISSVFYFSF STLFFAHRRP SESFFTRVLV VVWCFVLLIL
     TQSYTATLTS MLTVQELRPT VRHMDDLRKS GVNIGYQTGS FTFERLKQMR FDESRLKTYN
     SPEEMRELFL HKSSNGGIDA AFDEVAYIKL FMAKYCSEYS IIEPTFKADG FGFAFPLGSP
     LVSDISRQIL NITEGDAMKA IENKWFLGEK HCLDSTTSDS PIQLDHHSFE ALFLIVFVVS
     VILLLLMLAS RGYQERQHNA SPNLPNDQAN AAQEEVNEEG NVGDHIVEVD TALVRRKKLT
     SNTIPIRRVA PLSRLKSA
//
ID   GLR11_ARATH             Reviewed;         808 AA.
AC   Q9M8W7; Q9ZT37;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-SEP-2017, entry version 117.
DE   RecName: Full=Glutamate receptor 1.1;
DE            Short=AtGLR1;
DE   AltName: Full=Ligand-gated ion channel 1.1;
DE   Flags: Precursor;
GN   Name=GLR1.1; Synonyms=GLR1; OrderedLocusNames=At3g04110;
GN   ORFNames=T6K12.27;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=9823891; DOI=10.1038/24066;
RA   Lam H.-M., Chiu J.C., Hsieh M.-H., Meisel L., Oliveira I.C., Shin M.,
RA   Coruzzi G.M.;
RT   "Glutamate-receptor genes in plants.";
RL   Nature 396:125-126(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M.,
RA   Fartmann B., Valle G., Bloecker H., Perez-Alonso M., Obermaier B.,
RA   Delseny M., Boutry M., Grivell L.A., Mache R., Puigdomenech P.,
RA   De Simone V., Choisne N., Artiguenave F., Robert C., Brottier P.,
RA   Wincker P., Cattolico L., Weissenbach J., Saurin W., Quetier F.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Benes V.,
RA   Wurmbach E., Drzonek H., Erfle H., Jordan N., Bangert S.,
RA   Wiedelmann R., Kranz H., Voss H., Holland R., Brandt P., Nyakatura G.,
RA   Vezzi A., D'Angelo M., Pallavicini A., Toppo S., Simionati B.,
RA   Conrad A., Hornischer K., Kauer G., Loehnert T.-H., Nordsiek G.,
RA   Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J., Climent J.,
RA   Navarro P., Collado C., Perez-Perez A., Ottenwaelder B., Duchemin D.,
RA   Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D.,
RA   Mannhaupt G., Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W.,
RA   Mayer K.F.X., Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J.,
RA   Rooney T., Rizzo M., Walts A., Utterback T., Fujii C.Y., Shea T.P.,
RA   Creasy T.H., Haas B., Maiti R., Wu D., Peterson J., Van Aken S.,
RA   Pai G., Militscher J., Sellers P., Gill J.E., Feldblyum T.V.,
RA   Preuss D., Lin X., Nierman W.C., Salzberg S.L., White O., Venter J.C.,
RA   Fraser C.M., Kaneko T., Nakamura Y., Sato S., Kato T., Asamizu E.,
RA   Sasamoto S., Kimura T., Idesawa K., Kawashima K., Kishida Y.,
RA   Kiyokawa C., Kohara M., Matsumoto M., Matsuno A., Muraki A.,
RA   Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:820-822(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [5]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=12738881; DOI=10.1073/pnas.1030961100;
RA   Kang J., Turano F.J.;
RT   "The putative glutamate receptor 1.1 (AtGLR1.1) functions as a
RT   regulator of carbon and nitrogen metabolism in Arabidopsis thaliana.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6872-6877(2003).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15564521; DOI=10.1093/pcp/pch159;
RA   Kang J., Mehta S., Turano F.J.;
RT   "The putative glutamate receptor 1.1 (AtGLR1.1) in Arabidopsis
RT   thaliana regulates abscisic acid biosynthesis and signaling to control
RT   development and water loss.";
RL   Plant Cell Physiol. 45:1380-1389(2004).
RN   [9]
RP   FUNCTION.
RX   PubMed=18625242; DOI=10.1016/j.jmb.2008.06.076;
RA   Tapken D., Hollmann M.;
RT   "Arabidopsis thaliana glutamate receptor ion channel function
RT   demonstrated by ion pore transplantation.";
RL   J. Mol. Biol. 383:36-48(2008).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. Can transport sodium, potassium, and
CC       calcium ions. Functions as a carbon and nitrogen regulator and/or
CC       sensor that regulates carbon and nitrogen metabolism and distinct
CC       physiological process such as germination through the control of
CC       acid abscisic (ABA) biosynthesis. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells. Seems required for the regulation of the
CC       abscisic acid (ABA) signaling pathway that modulates many aspects
CC       of plant physiology such as seed germination and response to
CC       drought (e.g. stomata opening). {ECO:0000269|PubMed:12738881,
CC       ECO:0000269|PubMed:15564521, ECO:0000269|PubMed:18625242}.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots. First
CC       detected in the root-shoot junction, and later in lateral roots
CC       and at the margin of matures leaves.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- DISRUPTION PHENOTYPE: Increased sensitivity to exogenous abscisic
CC       acid (ABA) and higher ABA levels in leaves.
CC       {ECO:0000269|PubMed:15564521}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF079998; AAD09173.1; -; mRNA.
DR   EMBL; AC016829; AAF26802.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE74038.1; -; Genomic_DNA.
DR   EMBL; AK117584; BAC42242.1; -; mRNA.
DR   PIR; T51138; T51138.
DR   RefSeq; NP_187061.1; NM_111282.3.
DR   UniGene; At.18800; -.
DR   ProteinModelPortal; Q9M8W7; -.
DR   BioGrid; 4901; 26.
DR   STRING; 3702.AT3G04110.1; -.
DR   TCDB; 1.A.10.1.7; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   PaxDb; Q9M8W7; -.
DR   EnsemblPlants; AT3G04110.1; AT3G04110.1; AT3G04110.
DR   GeneID; 819566; -.
DR   Gramene; AT3G04110.1; AT3G04110.1; AT3G04110.
DR   KEGG; ath:AT3G04110; -.
DR   Araport; AT3G04110; -.
DR   TAIR; locus:2102975; AT3G04110.
DR   eggNOG; ENOG410ISR3; Eukaryota.
DR   eggNOG; ENOG410XPSH; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q9M8W7; -.
DR   KO; K05387; -.
DR   OMA; ENHMMNQ; -.
DR   OrthoDB; EOG093602FE; -.
DR   PhylomeDB; Q9M8W7; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q9M8W7; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q9M8W7; baseline and differential.
DR   Genevisible; Q9M8W7; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005261; F:cation channel activity; IDA:TAIR.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0005267; F:potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; IDA:UniProtKB.
DR   GO; GO:0009738; P:abscisic acid-activated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0030003; P:cellular cation homeostasis; IDA:TAIR.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0009737; P:response to abscisic acid; IMP:UniProtKB.
DR   GO; GO:0006814; P:sodium ion transport; IDA:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Abscisic acid signaling pathway; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    808       Glutamate receptor 1.1.
FT                                /FTId=PRO_0000011592.
FT   TOPO_DOM     20    541       Extracellular. {ECO:0000255}.
FT   TRANSMEM    542    562       Helical. {ECO:0000255}.
FT   TOPO_DOM    563    570       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    571    591       Helical. {ECO:0000255}.
FT   TOPO_DOM    592    602       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    603    623       Helical. {ECO:0000255}.
FT   TOPO_DOM    624    771       Extracellular. {ECO:0000255}.
FT   TRANSMEM    772    792       Helical. {ECO:0000255}.
FT   TOPO_DOM    793    808       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    288    288       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    339    339       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    504    504       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    564    564       S -> P (in Ref. 1; AAD09173).
FT                                {ECO:0000305}.
SQ   SEQUENCE   808 AA;  90509 MW;  9E556E313865A598 CRC64;
     MEILFSISIL ALLFSGVVAA PSDDDVFEEV RVGLVVDLSS IQGKILETSF NLALSDFYGI
     NNGYRTRVSV LVRDSQGDPI IALAAATDLL KNAKAEAIVG AQSLQEAKLL ATISEKAKVP
     VISTFLPNTL SLKKYDNFIQ WTHDTTSEAK GITSLIQDFS CKSVVVIYED ADDWSESLQI
     LVENFQDKGI YIARSASFAV SSSGENHMMN QLRKLKVSRA SVFVVHMSEI LVSRLFQCVE
     KLGLMEEAFA WILTARTMNY LEHFAITRSM QGVIGFKSYI PVSEEVKNFT SRLRKRMGDD
     TETEHSSVII GLRAHDIACI LANAVEKFSV SGKVEASSNV SADLLDTIRH SRFKGLSGDI
     QISDNKFISE TFEIVNIGRE KQRRIGLWSG GSFSQRRQIV WPGRSRKIPR HRVLAEKGEK
     KVLRVLVTAG NKVPHLVSVR PDPETGVNTV SGFCVEVFKT CIAPFNYELE FIPYRGNNDN
     LAYLLSTQRD KYDAAVGDIT ITSNRSLYVD FTLPYTDIGI GILTVKKKSQ GMWTFFDPFE
     KSLWLASGAF FVLTGIVVWL VERSVNPEFQ GSWGQQLSMM LWFGFSTIVF AHREKLQKMS
     SRFLVIVWVF VVLILTSSYS ANLTSTKTIS RMQLNHQMVF GGSTTSMTAK LGSINAVEAY
     AQLLRDGTLN HVINEIPYLS ILIGNYPNDF VMTDRVTNTN GFGFMFQKGS DLVPKVSREI
     AKLRSLGMLK DMEKKWFQKL DSLNVHSNTE EVASTNDDDE ASKRFTFREL RGLFIIAGAA
     HVLVLALHLF HTRQEVSRLC TKLQSFYK
//
ID   HCN1_RABIT              Reviewed;         822 AA.
AC   Q9MZS1; Q9TU38; Q9TUE2; Q9TUE3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   25-OCT-2017, entry version 95.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;
DE   AltName: Full=rbHCN1;
GN   Name=HCN1;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, ENZYME
RP   REGULATION, AND TISSUE SPECIFICITY.
RC   STRAIN=New Zealand white; TISSUE=Heart;
RX   PubMed=11328811; DOI=10.1074/jbc.M100830200;
RA   Moroni A., Gorza L., Beltrame M., Gravante B., Vaccari T.,
RA   Bianchi M.E., Altomare C., Longhi R., Heurteaux C., Vitadello M.,
RA   Malgaroli A., DiFrancesco D.;
RT   "Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a
RT   molecular determinant of the cardiac pacemaker current If.";
RL   J. Biol. Chem. 276:29233-29241(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 95-236, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10400919; DOI=10.1161/01.RES.85.1.e1;
RA   Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., Robinson R.B.,
RA   Dixon J.E., McKinnon D., Cohen I.S.;
RT   "Distribution and prevalence of hyperpolarization-activated cation
RT   channel (HCN) mRNA expression in cardiac tissues.";
RL   Circ. Res. 85:1-6(1999).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). May
CC       mediate responses to sour stimuli. {ECO:0000269|PubMed:11328811}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding promotes
CC       tetramerization and formation of an active channel. Compared to
CC       other family members, cAMP has less stimulatory effect on HCN1
CC       because part of the molecules already contain bound cAMP and form
CC       homotetramers when cAMP levels are low.
CC       {ECO:0000269|PubMed:11328811}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with HCN2. The potassium
CC       channel is composed of a homo- or heterotetrameric complex of
CC       pore-forming subunits. Interacts with KCNE2. Interacts with the
CC       SH3 domain of CSK. {ECO:0000250|UniProtKB:O88704}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11328811};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:11328811}.
CC   -!- TISSUE SPECIFICITY: Detected in myocytes in heart sinoatrial node
CC       (SAN) and in brain, in particular in the granule cell layer and in
CC       Purkinje neuron bodies in the cerebellum.
CC       {ECO:0000269|PubMed:10400919, ECO:0000269|PubMed:11328811}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position. {ECO:0000250|UniProtKB:O60741}.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-30 is the initiator.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF168122; AAF89636.2; -; mRNA.
DR   EMBL; AF155167; AAF01494.1; -; mRNA.
DR   RefSeq; NP_001075532.1; NM_001082063.1.
DR   UniGene; Ocu.2387; -.
DR   ProteinModelPortal; Q9MZS1; -.
DR   SMR; Q9MZS1; -.
DR   STRING; 9986.ENSOCUP00000014684; -.
DR   GeneID; 100008732; -.
DR   KEGG; ocu:100008732; -.
DR   CTD; 348980; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9MZS1; -.
DR   KO; K04954; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0098855; C:HCN channel complex; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; ISS:UniProtKB.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0022843; F:voltage-gated cation channel activity; ISS:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR030169; K/Na_HCN1.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF373; PTHR10217:SF373; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   cAMP; cAMP-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    822       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                1.
FT                                /FTId=PRO_0000054109.
FT   TOPO_DOM      1     78       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM     79    100       Helical; Name=Segment S1.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    101    109       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    110    130       Helical; Name=Segment S2.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    131    151       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    152    172       Helical; Name=Segment S3.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    173    196       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    197    217       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    218    231       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    232    254       Helical; Name=Segment S5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    255    280       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   INTRAMEM    281    302       Pore-forming; Name=Segment H5.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    303    307       Extracellular.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TRANSMEM    308    328       Helical; Name=Segment S6.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   TOPO_DOM    329    822       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   NP_BIND     475    478       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     485    486       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   NP_BIND     526    529       cAMP. {ECO:0000250|UniProtKB:O88704}.
FT   MOTIF       294    298       Selectivity filter.
FT                                {ECO:0000250|UniProtKB:O60741}.
FT   COMPBIAS    662    688       Gln-rich.
FT   COMPBIAS    789    795       Poly-Pro.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   822 AA;  92897 MW;  1BC67F5B35D46BD6 CRC64;
     MATASSPPRR PRRARGLEDA EGPRRQYGFM QRQFTSMLQP GVNKFSLRMF GSQKAVEKEQ
     ERVKTAGFWI IHPYSDFRFY WDLIMLIMMV GNLVIIPVGI TFFTEQTTTP WIIFNVASDT
     VFLLDLIMNF RTGTVNEDSS EIILDPKVIK MNYLKSWFVV DFISSIPVDY IFLIVEKGMD
     SEVYKTARAL RIVRFTKILS LLRLLRLSRL IRYIHQWEEI FHMTYDLASA VVRIFNLIGM
     MLLLCHWDGC LQFLVPLLQD FPPDCWVSLN EMVNDSWGKQ YSYALFKAMS HMLCIGYGAQ
     APVSMSDLWI TMLSMIVGAT CYAMFVGHAT ALIQSLDSSR RQYQEKYKQV EQYMSFHKLP
     ADMRQKIHDY YEHRYQGKIF DEENILNELN DPLREEIVNF NCRKLVATMP LFANADPNFV
     TAMLSKLRFE VFQPGDYIIR EGAVGKKMYF IQHGVAGVIT KSSKEMKLTD GSYFGEICLL
     TKGRRTASVR ADTYCRLYSL SVDNFNEVLE EYPMMRRAFE TVAIDRLDRI GKKNSILLQK
     FQKDLNTGVF NNQENEILKQ IVKHDREMVQ AIAPISYPQM TALNSTSSTA TPTSRMRTQS
     PPVYTATSLS HSNLHSPSPS TQTPQPSAIL SPCSYTTAVC SPPVQSPLAT RTFHYASPTA
     SQLSLMPQQQ QQPQAPQTQP QQPPQQPQTP GSATPKNEVH RSTQALPNTS LTREVRPLSA
     SQPSLPHEVS TLISRPHPTV GESLASIPQP VAAVHSAGLQ AAGRSTVPQR VTLFRQMSSG
     AIPPNRGVPP APPPPAAPLQ REASSVLNTD PEAEKPRFAS NL
//
ID   ACH6_CAEEL              Reviewed;         502 AA.
AC   Q9N587; Q964N6;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 2.
DT   25-OCT-2017, entry version 130.
DE   RecName: Full=Acetylcholine receptor subunit alpha-type unc-63;
DE   AltName: Full=Levamisole-resistant protein 7;
DE   AltName: Full=Uncoordinated protein 63;
DE   Flags: Precursor;
GN   Name=unc-63; Synonyms=lev-7; ORFNames=Y110A7A.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15280391; DOI=10.1074/jbc.M404370200;
RA   Culetto E., Baylis H.A., Richmond J.E., Jones A.K., Fleming J.T.,
RA   Squire M.D., Lewis J.A., Sattelle D.B.;
RT   "The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive
RT   nicotinic acetylcholine receptor alpha subunit.";
RL   J. Biol. Chem. 279:42476-42483(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, INTERACTION WITH NICOTINIC ACETYLCHOLINE RECEPTOR, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=15990870; DOI=10.1038/sj.emboj.7600741;
RA   Gottschalk A., Almedom R.B., Schedletzky T., Anderson S.D.,
RA   Yates J.R. III, Schafer W.R.;
RT   "Identification and characterization of novel nicotinic receptor-
RT   associated proteins in Caenorhabditis elegans.";
RL   EMBO J. 24:2566-2578(2005).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-136, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH NICOTINIC ACETYLCHOLINE RECEPTOR.
RX   PubMed=20027209; DOI=10.1371/journal.pbio.1000265;
RA   Jospin M., Qi Y.B., Stawicki T.M., Boulin T., Schuske K.R.,
RA   Horvitz H.R., Bessereau J.L., Jorgensen E.M., Jin Y.;
RT   "A neuronal acetylcholine receptor regulates the balance of muscle
RT   excitation and inhibition in Caenorhabditis elegans.";
RL   PLoS Biol. 7:E1000265-E1000265(2009).
RN   [6]
RP   INTERACTION WITH LEV-10.
RX   PubMed=21252855; DOI=10.1038/emboj.2010.355;
RA   Rapti G., Richmond J., Bessereau J.L.;
RT   "A single immunoglobulin-domain protein required for clustering
RT   acetylcholine receptors in C. elegans.";
RL   EMBO J. 30:706-718(2011).
CC   -!- FUNCTION: Alpha subunit of nicotinic acetylcholine receptor
CC       (nAChR) (PubMed:15280391, PubMed:15990870, PubMed:20027209).
CC       Probably acts in cholinergic motoneurons to regulate presynaptic
CC       neurotransmitter release, thereby ensuring normal level of
CC       excitation of cholinergic motoneurons during locomotion
CC       (PubMed:20027209). Involved in nAChR sensitivity to nicotine and
CC       levamisole (PubMed:15280391, PubMed:15990870).
CC       {ECO:0000269|PubMed:15280391, ECO:0000269|PubMed:15990870,
CC       ECO:0000269|PubMed:20027209}.
CC   -!- SUBUNIT: Component of nicotinic acetylcholine receptor
CC       (PubMed:15990870, PubMed:20027209). In muscles, composed of 2 non-
CC       alpha subunits lev-1 and unc-29, and 3 alpha subunits unc-38, unc-
CC       63 and lev-8 (PubMed:15990870). In cholinergic motoneurons,
CC       composed of 2 non-alpha subunits acr-2 and acr-3, and 3 alpha
CC       subunits unc-38, unc-63 and acr-12 (PubMed:20027209). Interacts
CC       with lev-10 (PubMed:21252855). {ECO:0000269|PubMed:15990870,
CC       ECO:0000269|PubMed:20027209, ECO:0000269|PubMed:21252855}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000250|UniProtKB:Q27218}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q27218}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in body wall muscles, in vulval
CC       muscles and in neurons. {ECO:0000269|PubMed:15280391}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes a resistance
CC       to nicotine-mediated paralysis. {ECO:0000269|PubMed:15990870}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF288374; AAK83056.1; -; mRNA.
DR   EMBL; FO080728; CCD66192.1; -; Genomic_DNA.
DR   RefSeq; NP_491533.2; NM_059132.4.
DR   UniGene; Cel.19329; -.
DR   ProteinModelPortal; Q9N587; -.
DR   DIP; DIP-42343N; -.
DR   IntAct; Q9N587; 1.
DR   MINT; MINT-3383641; -.
DR   STRING; 6239.Y110A7A.3; -.
DR   DrugBank; DB00848; Levamisole.
DR   iPTMnet; Q9N587; -.
DR   EPD; Q9N587; -.
DR   PaxDb; Q9N587; -.
DR   EnsemblMetazoa; Y110A7A.3; Y110A7A.3; WBGene00006797.
DR   GeneID; 172150; -.
DR   KEGG; cel:CELE_Y110A7A.3; -.
DR   UCSC; Y110A7A.3; c. elegans.
DR   CTD; 172150; -.
DR   WormBase; Y110A7A.3; CE30706; WBGene00006797; unc-63.
DR   eggNOG; KOG3645; Eukaryota.
DR   eggNOG; ENOG410XQGR; LUCA.
DR   GeneTree; ENSGT00760000118930; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; Q9N587; -.
DR   KO; K05312; -.
DR   OMA; PSYHWLE; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q9N587; -.
DR   Reactome; R-CEL-629587; Highly sodium permeable acetylcholine nicotinic receptors.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   PRO; PR:Q9N587; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00006797; -.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:WormBase.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:WormBase.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IDA:WormBase.
DR   GO; GO:0034220; P:ion transmembrane transport; IMP:WormBase.
DR   GO; GO:0040011; P:locomotion; IMP:WormBase.
DR   GO; GO:0009791; P:post-embryonic development; IMP:WormBase.
DR   GO; GO:0040012; P:regulation of locomotion; IMP:WormBase.
DR   GO; GO:0006937; P:regulation of muscle contraction; IGI:UniProtKB.
DR   GO; GO:0046662; P:regulation of oviposition; IMP:WormBase.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IMP:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 2.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    502       Acetylcholine receptor subunit alpha-type
FT                                unc-63.
FT                                /FTId=PRO_0000255715.
FT   TOPO_DOM     24    263       Extracellular. {ECO:0000255}.
FT   TRANSMEM    264    284       Helical. {ECO:0000255}.
FT   TRANSMEM    293    313       Helical. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical. {ECO:0000255}.
FT   TOPO_DOM    347    470       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    471    491       Helical. {ECO:0000255}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   DISULFID    151    165       {ECO:0000250}.
SQ   SEQUENCE   502 AA;  57391 MW;  3C09596F529DE6CB CRC64;
     MGPNDHGFAY ILIFLLLSPP THANRDANRL FEDLIADYNK LVRPVSENGE TLVVTFKLKL
     SQLLDVHEKN QIMTTNVWLQ HSWMDYKLRW DPVEYGGVEV LYVPSDTIWL PDVVLYNNAD
     GNYQVTIMTK AKLTYNGTVE WAPPAIYKSM CQIDVEFFPF DRQQCEMKFG SWTYGGLEVD
     LQHRDKHLEK EIEEDVEGVD GPTKEIVWVV DRGIDLSDYY PSVEWDILNV PGKRHSKRYP
     CCESPFIDIT YEIHLRRKTL FYTVNLIFPS VGISFLTALV FYLPSDGGEK ISLCISILIS
     LTVFFLLLVE IIPSTSLVIP LIGKYLLFTM VLVTLSVVVT VVTLNVHYRS PTTHTMPKWM
     KRLFVDFLPK YLLMTRPQPP GHHSKPNRKF DSRASTFSIG VNHVLGQNSE LLSPGLNSNR
     EESSFTLPRD NSPVRSAVES VAYIADHLKN EEDDKQVIED WKYISVVMDR IFLITFTFAC
     AFGTVVIIAR APSIYDNTPA LA
//
ID   IPLA_DICDI              Reviewed;        3177 AA.
AC   Q9NA13; Q54D11;
DT   22-SEP-2009, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   20-DEC-2017, entry version 94.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor-like protein A;
GN   Name=iplA; ORFNames=DDB_G0292564;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=AX2;
RX   PubMed=10970875; DOI=10.1093/emboj/19.17.4846;
RA   Traynor D., Milne J.L.S., Insall R.H., Kay R.R.;
RT   "Ca(2+) signalling is not required for chemotaxis in Dictyostelium.";
RL   EMBO J. 19:4846-4854(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12211100; DOI=10.1002/cm.10068;
RA   Levi S., Polyakov M.V., Egelhoff T.T.;
RT   "Myosin II dynamics in Dictyostelium: determinants for filament
RT   assembly and translocation to the cell cortex during chemoattractant
RT   responses.";
RL   Cell Motil. Cytoskeleton 53:177-188(2002).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15760480; DOI=10.1186/1471-2121-6-13;
RA   Schaloske R.H., Lusche D.F., Bezares-Roder K., Happle K., Malchow D.,
RA   Schlatterer C.;
RT   "Ca2+ regulation in the absence of the iplA gene product in
RT   Dictyostelium discoideum.";
RL   BMC Cell Biol. 6:13-13(2005).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17077123; DOI=10.1242/jcs.03248;
RA   Shanley L.J., Walczysko P., Bain M., MacEwan D.J., Zhao M.;
RT   "Influx of extracellular Ca2+ is necessary for electrotaxis in
RT   Dictyostelium.";
RL   J. Cell Sci. 119:4741-4748(2006).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18196962; DOI=10.4161/auto.5521;
RA   Lam D., Golstein P.;
RT   "A specific pathway inducing autophagic cell death is marked by an
RT   IP3R mutation.";
RL   Autophagy 4:349-350(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=17854889; DOI=10.1016/j.ceca.2007.08.002;
RA   Malchow D., Lusche D.F., De Lozanne A., Schlatterer C.;
RT   "A fast Ca2+-induced Ca2+-release mechanism in Dictyostelium
RT   discoideum.";
RL   Cell Calcium 43:521-530(2008).
RN   [8]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=18486207; DOI=10.1016/j.ceca.2008.04.001;
RA   Ludlow M.J., Traynor D., Fisher P.R., Ennion S.J.;
RT   "Purinergic-mediated Ca2+ influx in Dictyostelium discoideum.";
RL   Cell Calcium 44:567-579(2008).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18077554; DOI=10.1091/mbc.E07-08-0823;
RA   Lam D., Kosta A., Luciani M.F., Golstein P.;
RT   "The inositol 1,4,5-trisphosphate receptor is required to signal
RT   autophagic cell death.";
RL   Mol. Biol. Cell 19:691-700(2008).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19133302; DOI=10.1016/j.bbamcr.2008.12.005;
RA   Giusti C., Tresse E., Luciani M.-F., Golstein P.;
RT   "Autophagic cell death: Analysis in Dictyostelium.";
RL   Biochim. Biophys. Acta 1793:1422-1431(2009).
CC   -!- FUNCTION: May be a receptor for inositol 1,4,5 trisphosphate which
CC       governs calcium fluxes from the endoplasmic reticulum stores into
CC       the cytosol. May be involved in autophagic cell death.
CC       {ECO:0000269|PubMed:10970875, ECO:0000269|PubMed:12211100,
CC       ECO:0000269|PubMed:15760480, ECO:0000269|PubMed:17077123,
CC       ECO:0000269|PubMed:17854889, ECO:0000269|PubMed:18077554,
CC       ECO:0000269|PubMed:18196962, ECO:0000269|PubMed:19133302}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low during growth and rises to
CC       a peak at 9 hours of development when chemotactic aggregation to
CC       cyclic AMP is near its height; levels then decrease through the
CC       end of development. {ECO:0000269|PubMed:10970875}.
CC   -!- DISRUPTION PHENOTYPE: Null cells show abolition of calcium entry
CC       in response to chemoattractant, response to cyclic AMP and normal
CC       increase in free cytosolic calcium that follows chemotactic
CC       stimulation. Cells show formation of smaller fruiting bodies and
CC       abolition of autophagic cell death. Cells show absence of
CC       vacuolization. {ECO:0000269|PubMed:10970875,
CC       ECO:0000269|PubMed:12211100, ECO:0000269|PubMed:15760480,
CC       ECO:0000269|PubMed:17077123, ECO:0000269|PubMed:18077554,
CC       ECO:0000269|PubMed:18196962, ECO:0000269|PubMed:18486207,
CC       ECO:0000269|PubMed:19133302}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ277590; CAB97127.1; -; Genomic_DNA.
DR   EMBL; AAFI02000194; EAL61085.1; -; Genomic_DNA.
DR   RefSeq; XP_629509.1; XM_629507.1.
DR   ProteinModelPortal; Q9NA13; -.
DR   STRING; 44689.DDB0201571; -.
DR   PaxDb; Q9NA13; -.
DR   PRIDE; Q9NA13; -.
DR   EnsemblProtists; EAL61085; EAL61085; DDB_G0292564.
DR   GeneID; 8628760; -.
DR   KEGG; ddi:DDB_G0292564; -.
DR   dictyBase; DDB_G0292564; iplA.
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   InParanoid; Q9NA13; -.
DR   OMA; TEVICRE; -.
DR   Reactome; R-DDI-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-DDI-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-DDI-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-DDI-5578775; Ion homeostasis.
DR   PRO; PR:Q9NA13; -.
DR   Proteomes; UP000002195; Chromosome 6.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:dictyBase.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:dictyBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; ISS:dictyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:dictyBase.
DR   GO; GO:0005262; F:calcium channel activity; ISS:dictyBase.
DR   GO; GO:0005509; F:calcium ion binding; IMP:dictyBase.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; ISS:dictyBase.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:dictyBase.
DR   GO; GO:0031152; P:aggregation involved in sorocarp development; IMP:dictyBase.
DR   GO; GO:0048102; P:autophagic cell death; IMP:dictyBase.
DR   GO; GO:0006816; P:calcium ion transport; IMP:dictyBase.
DR   GO; GO:0097231; P:cell motility in response to calcium ion; IMP:dictyBase.
DR   GO; GO:0030244; P:cellulose biosynthetic process; IMP:dictyBase.
DR   GO; GO:0006935; P:chemotaxis; IMP:dictyBase.
DR   GO; GO:0034670; P:chemotaxis to arachidonic acid; IMP:dictyBase.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:dictyBase.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SUPFAM; SSF100909; SSF100909; 3.
DR   SUPFAM; SSF48371; SSF48371; 2.
PE   2: Evidence at transcript level;
KW   Calcium; Calcium channel; Calcium transport; Coiled coil;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   3177       Inositol 1,4,5-trisphosphate receptor-
FT                                like protein A.
FT                                /FTId=PRO_0000384448.
FT   TOPO_DOM      1   1175       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1176   1196       Helical. {ECO:0000255}.
FT   TOPO_DOM   1197   2723       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2724   2744       Helical. {ECO:0000255}.
FT   TOPO_DOM   2745   2769       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2770   2790       Helical. {ECO:0000255}.
FT   TOPO_DOM   2791   2853       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2854   2874       Helical. {ECO:0000255}.
FT   TOPO_DOM   2875   2896       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2897   2917       Helical. {ECO:0000255}.
FT   TOPO_DOM   2918   2995       Lumenal. {ECO:0000255}.
FT   TRANSMEM   2996   3016       Helical. {ECO:0000255}.
FT   TOPO_DOM   3017   3177       Cytoplasmic. {ECO:0000255}.
FT   REGION      289    293       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      608    611       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   REGION      692    694       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250}.
FT   COILED     3118   3177       {ECO:0000255}.
FT   COMPBIAS     69     72       Poly-Gln.
FT   COMPBIAS     89     99       Poly-Asn.
FT   COMPBIAS    102    105       Poly-Asn.
FT   COMPBIAS    108    116       Poly-Asn.
FT   COMPBIAS    336    342       Poly-Gln.
FT   COMPBIAS    367    406       Poly-Asn.
FT   COMPBIAS    544    551       Poly-Ser.
FT   COMPBIAS    571    575       Poly-Thr.
FT   COMPBIAS    581    608       Poly-Asn.
FT   COMPBIAS    964    973       Poly-Gly.
FT   COMPBIAS   1022   1026       Poly-Thr.
FT   COMPBIAS   1035   1048       Poly-Asn.
FT   COMPBIAS   1066   1076       Poly-Asn.
FT   COMPBIAS   1107   1119       Poly-Gln.
FT   COMPBIAS   1448   1457       Poly-Gln.
FT   COMPBIAS   1476   1492       Poly-Thr.
FT   COMPBIAS   1721   1731       Poly-Asn.
FT   COMPBIAS   2120   2137       Poly-Asn.
FT   COMPBIAS   2138   2146       Poly-Gly.
FT   COMPBIAS   2156   2160       Poly-Gly.
FT   COMPBIAS   2201   2204       Poly-Gln.
FT   COMPBIAS   2389   2401       Poly-Asn.
FT   CARBOHYD   1275   1275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1460   1460       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1591   1591       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1662   1662       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1678   1678       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1722   1722       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1725   1725       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1730   1730       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1731   1731       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1736   1736       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1745   1745       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1748   1748       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1768   1768       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1827   1827       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1833   1833       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1967   1967       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2035   2035       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2048   2048       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2057   2057       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2106   2106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2124   2124       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2170   2170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2173   2173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2370   2370       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2377   2377       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2392   2392       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2644   2644       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2967   2967       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   3177 AA;  360531 MW;  381ECEA20A7C84A2 CRC64;
     MEEKNVNLKT GDLVTFFSEQ EEEDGYFSKS HDSAVMSNNK SKDCVFKVYP FTQYTARKAL
     KKKAKRKLQQ QQADGADANN TNSSSGGGNS NNNNNNNSNS SNNNNSSNNN NNNNNNGTTN
     ANGENVNNEV TDLELKQLEE YQDLEDVSNE STLIQLEGRD LVYGQIVQLY QPSSNQFLFA
     RNNIVGFRQD GSQKCYFKIT PRFQNQDGCK VFSEDLVLLR HEKTGLFLNQ QNFIIDQGVF
     GIGLSENGTF WKMAVSDVDG KSGLNILKAN EPFRLFHREG GFVKVSNDKT TFTYNTKTPS
     SINSLFEIEF ENNNLISPLL RSQKDLQLQQ KDNTDQLQQQ QQKDKDKDNP LKQSYGSLSN
     SNILLQNNNN NNNNNNSNNN NNSNNNSNNS NGNNSNGNNN NNNSNNIFTS NEVHIGQSFW
     IRLVGTKKYL SLKESSDDSL KDNPLIVVTE DQKYSPSATF SFVKRDKANE DVIFGSFVRI
     QSLSKQYLHF ISDETFHHNG ELVGSKKYYK NDDFQIKQIP KSQLEDYGFV LSRINKIQNY
     LYQSSSNSSS SLMSSINGIG QSSFSSLAGA TTTTTNSGGS NNINNNNNNN NNNNNNNNNN
     NNNNNNNNID KKRATVQEIK AIIVEFIKFC TQSEVEDPLD REGTPIKTHQ KLLSHPSHLS
     VLLDYLKRLF EPFDPASILF VYRLLKQMAK SNIKNGIIIN EHLDQISPPS IRDKTIPLHF
     GAILYEVYKN NNILLEALTE DKVQEFINVI KQKKEPKYME LLSEICICYG KPIVKNQQYL
     CDLLLEKNSN LLFKTRVIGG SLEIERQNPA PKWVDITAFA LSVDEKTHRY FEQSLALYSN
     VSKGRNYNGI RLVGQRITHK ECLLALKEES LPYSLRGCYI NILIHVYMDC HPQHYVPQIN
     YVWNPSIVNN TKTIELLQLY QQYNITGSLH QRNSSIQNPY STVSNGNISI SSNNPISTTN
     TTTGSGGGGG GSGFMPTVGP SYGQASSPLS NGAIVNSLAS TNLNNQTPTS LNLFNLNSPN
     NTTTTTNNST NNTTNNNTNN NNNNNNTNSL ITSTTHLIQL VSPQQNNNSN NNNNNNILNS
     IPTSPIVGST NHGQLSHSGS NQTPLYQQQQ QQQQQQQQQN SLSLFREDDI FSTFVNLEIQ
     ADKEPSTTTQ LLISLLSKSE YFSNFNNGFP TSHRPQLAFF HKILIAVGYA FKFGFFRKKE
     RVLLKRLRYI LEFEHEPVNT FKEVDLGRTM GGSRMLEDES VIYVSIKIEI VNILHLMLSF
     QKKNIMDVFL YDFSNMSQSA FSQPENVKNQ LIDRLTTNYQ RDGHQDLSLC TVLFKLLKHE
     NNQLSSLSLS LLNRIYKYRS IYAMLWSPIQ KLFLLPNELT PTYKESLQKM ESLTVTCFAP
     LTDDSTQESL RSLAFFIHLV TDSDPIKLVK NQKLLHVIGV HKTIIGVLKI GCSLDDLILD
     QSQPQHSQQQ QQQHQQQPIN ISGSIDESSS TIPPLTTTTT TTTTTTTTTT TTQQSINFKS
     LLNSKTNSQS IHVAKIFRSC YEFLKVFCRD NRENQKVLFG EIEFLIGHLI RYGNVFGTVE
     TLIEVFKNNI ELAINFGNSP YLKLLVKFII NLSIDQLDPM FLRLLSVLIL PCNENSVIEN
     QISVTNLFKE YKSKISKLLV PISTMKEVMK DPKLLSKHYN VNSSNVYKLH LALQEILNHS
     LNDDGAGIGI GTTVIGGSII GGSITTTAQT NINTITNTPT NNNSNNSNNN NTTNNNGTIS
     HRHSNSTNTT QSVYPRLIRS SAKAQIVNSS VEILPKEFVI NLELILLLKA CSHGINTPTE
     VICREFLSMG ECFDILIVRS DGNGKENSSL MINETKEYLE NNLLFRFKSA YLSFLHEVFF
     NSDTLKGDLL ALQLNHDLWS LIDQFTNQLN HLVTICAMNQ MGQLYYVQMA RNIIIPMVSV
     LERFYSQCFY FDKATQIHLT YSGRLMASLM KLYWKDPSLT IPFNQQNTSR YQSSLNMSPT
     NYDDSDTSEG GYHPILQGLD PEERVNIYSN LVKCLKAMDR SALSPIVPAS VSTINISNVI
     KGCEDVINRT EHPNSRNRTE TIDSSNSSPP LILSKSSSIY IDFTRLNNFV KLSKIRGYTE
     IAMMVNQSLS ITPFIISHPN YNSNNSNNGN NNNNNNNGGG GNGNGGTIRS NSYISGGGGG
     STTKRRTSRN NSNISDISNS GKGGSTISNR FQNSFSNTFI QQQQIGITNQ RHINSGNTNI
     VTTVTSKSTN FLEILVFQLR NSLYDNDEMK INCIRILSSL LYINKERKPD IQNIMTDLYC
     HSAVIGLLSS KNIEIQFESL SLLLALLDDS VNVDNPLPNP KVKDDIQSHF SSSPDIQFFR
     DIYAMIERAK INLRDTKRNI HRIEHVKMGN NTVLGGNLTS KNSIKSSINN GNNSNNNNNR
     NGRVIDGCET NPYSTEFQLL QNIFRVLQLL CQGTTNIFKK SIRSQPDNYK SYDILKEMCQ
     FLKILETIVN IDSDSIELGL RFFACMKEIV KNTPENQIAV TNVQVCKAVC NILKKTKEND
     PSKELKELKY LDLKIEVVDF LLHVIDKEDP RVMSKLIPEL DYKVIESNTQ VISQRSNHET
     NEKSIKLASM TFRLIKILAD NDKSHNIQLE DCLLKCGEHC KSRIGRVELL YQNKLERIYF
     PIPNYSRRLI LEDKEQSKIK NDENLLQENL EEHFINNKIS WNKATEKIDA FMDYSEYKLI
     ELEHLHNLKL NSMSYYLVSH TDKFKFLSFF LALIINLLLI IYSINSPPDL KQFKSDISDD
     YGIASWWAGF LPLTILQTIC CILACVGFFL RKGPVLLYQN WVNYLKTHGH KKNFMFYTND
     QRMHSLRQTF KYKFIPLNAK FLMTDLKAVY NILAVICSVL GIIYSPYFFA FHIFQFSLNT
     KALSLVLKAI TMNKKTLLVM GVFILQAIYL LSIFSFVWFQ EHYKDDDSEY MCGSLLQCFI
     TNLYYGVPSQ GQLIQFIKYN FPNNYLNTTD STGSPTLEPI KTSNTVSARI IGWTVFNVAF
     YVVISLILLN VILGIIVDTF GQLRDQRAET EDYKSNVCFI CSIERETFQK NSIEFKKHIE
     DDHNKWHYLY FFAYLKERCT NNQMNQLSEL ECSIADGITN RSYISFFPIE MSMSLQGIEN
     ANRKKEESID QHAKLLDDVE KKITHNISTQ FNQSISLLID EIKNLRQQVS DLKQQQK
//
ID   CNGB3_HUMAN             Reviewed;         809 AA.
AC   Q9NQW8; C9JA51; Q9NRE9;
DT   29-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   25-OCT-2017, entry version 144.
DE   RecName: Full=Cyclic nucleotide-gated cation channel beta-3;
DE   AltName: Full=Cone photoreceptor cGMP-gated channel subunit beta;
DE   AltName: Full=Cyclic nucleotide-gated cation channel modulatory subunit;
DE   AltName: Full=Cyclic nucleotide-gated channel beta-3;
DE            Short=CNG channel beta-3;
GN   Name=CNGB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, VARIANT
RP   ACHM3 PHE-435, AND VARIANTS TRP-234; PRO-298 AND GLY-755.
RX   PubMed=10958649; DOI=10.1093/hmg/9.14.2107;
RA   Kohl S., Baumann B., Broghammer M., Jaegle H., Sieving P., Kellner U.,
RA   Spegal R., Anastasi M., Zrenner E., Sharpe L.T., Wissinger B.;
RT   "Mutations in the CNGB3 gene encoding the beta-subunit of the cone
RT   photoreceptor cGMP-gated channel are responsible for achromatopsia
RT   (ACHM3) linked to chromosome 8Q21.";
RL   Hum. Mol. Genet. 9:2107-2116(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 114-809 (ISOFORM 2), FUNCTION, SUBUNIT,
RP   AND VARIANT ACHM3 PHE-435.
RC   TISSUE=Retina;
RX   PubMed=10888875; DOI=10.1038/77162;
RA   Sundin O.H., Yang J.-M., Li Y., Zhu D., Hurd J.N., Mitchell T.N.,
RA   Silva E.D., Maumenee I.H.;
RT   "Genetic basis of total colourblindness among the Pingelapese
RT   islanders.";
RL   Nat. Genet. 25:289-293(2000).
RN   [4]
RP   SUBUNIT.
RX   PubMed=21878911; DOI=10.1038/ncomms1466;
RA   Shuart N.G., Haitin Y., Camp S.S., Black K.D., Zagotta W.N.;
RT   "Molecular mechanism for 3:1 subunit stoichiometry of rod cyclic
RT   nucleotide-gated ion channels.";
RL   Nat. Commun. 2:457-457(2011).
RN   [5]
RP   VARIANT ACHM3 GLU-148.
RX   PubMed=12357335; DOI=10.1038/sj.ejhg.5200856;
RA   Rojas C.V., Maria L.S., Santos J.L., Cortes F., Alliende M.A.;
RT   "A frameshift insertion in the cone cyclic nucleotide gated cation
RT   channel causes complete achromatopsia in a consanguineous family from
RT   a rural isolate.";
RL   Eur. J. Hum. Genet. 10:638-642(2002).
RN   [6]
RP   VARIANTS ACHM3 VAL-307 AND ASN-525.
RX   PubMed=14757870; DOI=10.1136/jmg.2003.011437;
RA   Johnson S., Michaelides M., Aligianis I.A., Ainsworth J.R.,
RA   Mollon J.D., Maher E.R., Moore A.T., Hunt D.M.;
RT   "Achromatopsia caused by novel mutations in both CNGA3 and CNGB3.";
RL   J. Med. Genet. 41:E20-E20(2004).
RN   [7]
RP   VARIANTS ACHM3 PHE-156; LEU-309; PHE-435 AND 720-GLN--LYS-726 DEL.
RX   PubMed=15657609; DOI=10.1038/sj.ejhg.5201269;
RA   Kohl S., Varsanyi B., Antunes G.A., Baumann B., Hoyng C.B., Jaegle H.,
RA   Rosenberg T., Kellner U., Lorenz B., Salati R., Jurklies B.,
RA   Farkas A., Andreasson S., Weleber R.G., Jacobson S.G., Rudolph G.,
RA   Castellan C., Dollfus H., Legius E., Anastasi M., Bitoun P., Lev D.,
RA   Sieving P.A., Munier F.L., Zrenner E., Sharpe L.T., Cremers F.P.M.,
RA   Wissinger B.;
RT   "CNGB3 mutations account for 50% of all cases with autosomal recessive
RT   achromatopsia.";
RL   Eur. J. Hum. Genet. 13:302-308(2005).
RN   [8]
RP   VARIANT MACULAR DEGENERATION GLN-403, VARIANT STGD1 ASP-469, VARIANTS
RP   ACHM3 ARG-107; LYS-199; GLN-203; THR-466; ASN-494; TYR-513; CYS-558;
RP   PHE-595 AND PRO-672, AND VARIANTS HIS-25; SER-27; PRO-298; VAL-307 AND
RP   GLY-755.
RX   PubMed=15712225; DOI=10.1002/humu.20142;
RA   Nishiguchi K.M., Sandberg M.A., Gorji N., Berson E.L., Dryja T.P.;
RT   "Cone cGMP-gated channel mutations and clinical findings in patients
RT   with achromatopsia, macular degeneration, and other hereditary cone
RT   diseases.";
RL   Hum. Mutat. 25:248-258(2005).
CC   -!- FUNCTION: Visual signal transduction is mediated by a G-protein
CC       coupled cascade using cGMP as second messenger. This protein can
CC       be activated by cGMP which leads to an opening of the cation
CC       channel and thereby causing a depolarization of rod
CC       photoreceptors. Induced a flickering channel gating, weakened the
CC       outward rectification in the presence of extracellular calcium,
CC       increased sensitivity for L-cis diltiazem and enhanced the cAMP
CC       efficiency of the channel when coexpressed with CNGA3 (By
CC       similarity). Essential for the generation of light-evoked
CC       electrical responses in the red-, green- and blue sensitive cones.
CC       {ECO:0000250, ECO:0000269|PubMed:10888875}.
CC   -!- SUBUNIT: Tetramer formed of three CNGA3 and one CNGB3 modulatory
CC       subunits. {ECO:0000269|PubMed:10888875,
CC       ECO:0000269|PubMed:21878911}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NQW8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQW8-2; Sequence=VSP_009742;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed specifically in the retina.
CC       {ECO:0000269|PubMed:10958649}.
CC   -!- DISEASE: Stargardt disease 1 (STGD1) [MIM:248200]: A common
CC       hereditary macular degeneration. It is characterized by decreased
CC       central vision, atrophy of the macula and underlying retinal
CC       pigment epithelium, and frequent presence of prominent flecks in
CC       the posterior pole of the retina. {ECO:0000269|PubMed:15712225}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Achromatopsia 3 (ACHM3) [MIM:262300]: An ocular
CC       stationary disorder due to the absence of functioning cone
CC       photoreceptors in the retina. It is characterized by total
CC       colorblindness, low visual acuity, photophobia and nystagmus.
CC       Achromatopsia type 3 patients manifest severe myopia.
CC       {ECO:0000269|PubMed:10888875, ECO:0000269|PubMed:10958649,
CC       ECO:0000269|PubMed:12357335, ECO:0000269|PubMed:14757870,
CC       ECO:0000269|PubMed:15657609, ECO:0000269|PubMed:15712225}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. CNGB3 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF80179.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF272900; AAF86274.1; -; mRNA.
DR   EMBL; AC013751; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090572; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF228520; AAF80179.1; ALT_INIT; mRNA.
DR   CCDS; CCDS6244.1; -. [Q9NQW8-1]
DR   RefSeq; NP_061971.3; NM_019098.4. [Q9NQW8-1]
DR   UniGene; Hs.154433; -.
DR   ProteinModelPortal; Q9NQW8; -.
DR   SMR; Q9NQW8; -.
DR   STRING; 9606.ENSP00000316605; -.
DR   iPTMnet; Q9NQW8; -.
DR   PhosphoSitePlus; Q9NQW8; -.
DR   BioMuta; CNGB3; -.
DR   DMDM; 311033366; -.
DR   PaxDb; Q9NQW8; -.
DR   PeptideAtlas; Q9NQW8; -.
DR   PRIDE; Q9NQW8; -.
DR   Ensembl; ENST00000320005; ENSP00000316605; ENSG00000170289. [Q9NQW8-1]
DR   GeneID; 54714; -.
DR   KEGG; hsa:54714; -.
DR   UCSC; uc003ydx.3; human. [Q9NQW8-1]
DR   CTD; 54714; -.
DR   DisGeNET; 54714; -.
DR   EuPathDB; HostDB:ENSG00000170289.12; -.
DR   GeneCards; CNGB3; -.
DR   GeneReviews; CNGB3; -.
DR   H-InvDB; HIX0034272; -.
DR   HGNC; HGNC:2153; CNGB3.
DR   HPA; HPA057244; -.
DR   MalaCards; CNGB3; -.
DR   MIM; 248200; phenotype.
DR   MIM; 262300; phenotype.
DR   MIM; 605080; gene.
DR   neXtProt; NX_Q9NQW8; -.
DR   OpenTargets; ENSG00000170289; -.
DR   Orphanet; 49382; Achromatopsia.
DR   Orphanet; 1871; Progressive cone dystrophy.
DR   Orphanet; 827; Stargardt disease.
DR   PharmGKB; PA26663; -.
DR   eggNOG; KOG0499; Eukaryota.
DR   eggNOG; ENOG410ZJ5U; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000231425; -.
DR   HOVERGEN; HBG051038; -.
DR   InParanoid; Q9NQW8; -.
DR   KO; K04953; -.
DR   OMA; VDLFKGC; -.
DR   OrthoDB; EOG091G03EW; -.
DR   PhylomeDB; Q9NQW8; -.
DR   TreeFam; TF318250; -.
DR   GeneWiki; Cyclic_nucleotide_gated_channel_beta_3; -.
DR   GenomeRNAi; 54714; -.
DR   PRO; PR:Q9NQW8; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000170289; -.
DR   CleanEx; HS_CNGB3; -.
DR   ExpressionAtlas; Q9NQW8; baseline and differential.
DR   Genevisible; Q9NQW8; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:1902495; C:transmembrane transporter complex; IDA:UniProtKB.
DR   GO; GO:0030553; F:cGMP binding; IDA:UniProtKB.
DR   GO; GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0006812; P:cation transport; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0006810; P:transport; NAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR032943; CNG6.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF385; PTHR10217:SF385; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS00889; CNMP_BINDING_2; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cGMP; cGMP-binding; Complete proteome;
KW   Disease mutation; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Sensory transduction; Stargardt disease;
KW   Transmembrane; Transmembrane helix; Transport; Vision.
FT   CHAIN         1    809       Cyclic nucleotide-gated cation channel
FT                                beta-3.
FT                                /FTId=PRO_0000219320.
FT   TOPO_DOM      1    216       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    238    250       Extracellular. {ECO:0000255}.
FT   TRANSMEM    251    271       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    272    302       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    324    359       Extracellular. {ECO:0000255}.
FT   TRANSMEM    360    380       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    381    417       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    418    438       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    439    504       Extracellular. {ECO:0000255}.
FT   TRANSMEM    505    525       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    526    809       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     532    676       cGMP. {ECO:0000250}.
FT   BINDING     592    592       cGMP. {ECO:0000250}.
FT   BINDING     604    604       cGMP. {ECO:0000250}.
FT   CARBOHYD    468    468       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     590    594       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10888875}.
FT                                /FTId=VSP_009742.
FT   VARIANT      25     25       R -> H (in dbSNP:rs141098074).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047606.
FT   VARIANT      27     27       N -> S (in dbSNP:rs35807406).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047607.
FT   VARIANT     107    107       G -> R (in ACHM3; unknown pathological
FT                                significance; dbSNP:rs146688972).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047608.
FT   VARIANT     148    148       K -> E (in ACHM3; dbSNP:rs369138501).
FT                                {ECO:0000269|PubMed:12357335}.
FT                                /FTId=VAR_047609.
FT   VARIANT     156    156       S -> F (in ACHM3; dbSNP:rs139207764).
FT                                {ECO:0000269|PubMed:15657609}.
FT                                /FTId=VAR_047610.
FT   VARIANT     199    199       E -> K (in ACHM3; unknown pathological
FT                                significance; dbSNP:rs114305748).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047611.
FT   VARIANT     203    203       R -> Q (in ACHM3; unknown pathological
FT                                significance; dbSNP:rs16916632).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_025524.
FT   VARIANT     234    234       C -> W (in dbSNP:rs6471482).
FT                                {ECO:0000269|PubMed:10958649}.
FT                                /FTId=VAR_018109.
FT   VARIANT     298    298       T -> P (in dbSNP:rs4961206).
FT                                {ECO:0000269|PubMed:10958649,
FT                                ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_018110.
FT   VARIANT     307    307       I -> V (in dbSNP:rs13265557).
FT                                {ECO:0000269|PubMed:14757870,
FT                                ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_024418.
FT   VARIANT     309    309       P -> L (in ACHM3).
FT                                {ECO:0000269|PubMed:15657609}.
FT                                /FTId=VAR_047612.
FT   VARIANT     403    403       R -> Q (found in macular degeneration;
FT                                unknown pathological significance;
FT                                dbSNP:rs147876778).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047613.
FT   VARIANT     435    435       S -> F (in ACHM3; dbSNP:rs121918344).
FT                                {ECO:0000269|PubMed:10888875,
FT                                ECO:0000269|PubMed:10958649,
FT                                ECO:0000269|PubMed:15657609}.
FT                                /FTId=VAR_018111.
FT   VARIANT     466    466       M -> T (in ACHM3; unknown pathological
FT                                significance; dbSNP:rs35010099).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047614.
FT   VARIANT     469    469       Y -> D (in STGD1; dbSNP:rs35365413).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047615.
FT   VARIANT     494    494       D -> N (in ACHM3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047616.
FT   VARIANT     513    513       D -> Y (in ACHM3; unknown pathological
FT                                significance; dbSNP:rs765884344).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047617.
FT   VARIANT     525    525       F -> N (in ACHM3; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:14757870}.
FT                                /FTId=VAR_047618.
FT   VARIANT     558    558       G -> C (in ACHM3; dbSNP:rs749413012).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047619.
FT   VARIANT     595    595       L -> F (in ACHM3).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047620.
FT   VARIANT     672    672       T -> P (in ACHM3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_047621.
FT   VARIANT     720    726       Missing (in ACHM3).
FT                                {ECO:0000269|PubMed:15657609}.
FT                                /FTId=VAR_047622.
FT   VARIANT     750    750       P -> S (in dbSNP:rs3735971).
FT                                /FTId=VAR_025525.
FT   VARIANT     755    755       E -> G (in dbSNP:rs3735972).
FT                                {ECO:0000269|PubMed:10958649,
FT                                ECO:0000269|PubMed:15712225}.
FT                                /FTId=VAR_018112.
SQ   SEQUENCE   809 AA;  92167 MW;  D16EE71A6149BDB5 CRC64;
     MFKSLTKVNK VKPIGENNEN EQSSRRNEEG SHPSNQSQQT TAQEENKGEE KSLKTKSTPV
     TSEEPHTNIQ DKLSKKNSSG DLTTNPDPQN AAEPTGTVPE QKEMDPGKEG PNSPQNKPPA
     APVINEYADA QLHNLVKRMR QRTALYKKKL VEGDLSSPEA SPQTAKPTAV PPVKESDDKP
     TEHYYRLLWF KVKKMPLTEY LKRIKLPNSI DSYTDRLYLL WLLLVTLAYN WNCCFIPLRL
     VFPYQTADNI HYWLIADIIC DIIYLYDMLF IQPRLQFVRG GDIIVDSNEL RKHYRTSTKF
     QLDVASIIPF DICYLFFGFN PMFRANRMLK YTSFFEFNHH LESIMDKAYI YRVIRTTGYL
     LFILHINACV YYWASNYEGI GTTRWVYDGE GNEYLRCYYW AVRTLITIGG LPEPQTLFEI
     VFQLLNFFSG VFVFSSLIGQ MRDVIGAATA NQNYFRACMD DTIAYMNNYS IPKLVQKRVR
     TWYEYTWDSQ RMLDESDLLK TLPTTVQLAL AIDVNFSIIS KVDLFKGCDT QMIYDMLLRL
     KSVLYLPGDF VCKKGEIGKE MYIIKHGEVQ VLGGPDGTKV LVTLKAGSVF GEISLLAAGG
     GNRRTANVVA HGFANLLTLD KKTLQEILVH YPDSERILMK KARVLLKQKA KTAEATPPRK
     DLALLFPPKE ETPKLFKTLL GGTGKASLAR LLKLKREQAA QKKENSEGGE EEGKENEDKQ
     KENEDKQKEN EDKGKENEDK DKGREPEEKP LDRPECTASP IAVEEEPHSV RRTVLPRGTS
     RQSLIISMAP SAEGGEEVLT IEVKEKAKQ
//
ID   HCN3_HUMAN              Reviewed;         774 AA.
AC   Q9P1Z3; D3DV90; Q4VX12; Q8N6W6; Q9BWQ2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   28-FEB-2003, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3;
GN   Name=HCN3; Synonyms=KIAA1535;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 64-774.
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 204-774.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND ENZYME
RP   REGULATION.
RX   PubMed=16043489; DOI=10.1074/jbc.M502508200;
RA   Stieber J., Stockl G., Herrmann S., Hassfurth B., Hofmann F.;
RT   "Functional expression of the human HCN3 channel.";
RL   J. Biol. Chem. 280:34635-34643(2005).
CC   -!- FUNCTION: Hyperpolarization-activated potassium channel. May also
CC       facilitate the permeation of sodium ions.
CC       {ECO:0000269|PubMed:16043489}.
CC   -!- ENZYME REGULATION: Inhibited by Cs(1+) and ZD7288. Is apparently
CC       not activated by cAMP. {ECO:0000269|PubMed:16043489}.
CC   -!- SUBUNIT: Homotetramer. The potassium channel is probably composed
CC       of a homo- or heterotetrameric complex of pore-forming subunits.
CC       Interacts with KCTD3 and PEX5L. {ECO:0000250|UniProtKB:O88705,
CC       ECO:0000250|UniProtKB:Q9UL51}.
CC   -!- INTERACTION:
CC       Q4ACU6-1:Shank3 (xeno); NbExp=3; IntAct=EBI-11178054, EBI-16201983;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16043489};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16043489}.
CC   -!- TISSUE SPECIFICITY: Detected in brain.
CC       {ECO:0000269|PubMed:16043489}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH28024.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL713999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB040968; BAA96059.2; -; mRNA.
DR   EMBL; CH471121; EAW53084.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53086.1; -; Genomic_DNA.
DR   EMBL; BC000066; AAH00066.1; -; mRNA.
DR   EMBL; BC028024; AAH28024.2; ALT_INIT; mRNA.
DR   CCDS; CCDS1108.1; -.
DR   RefSeq; NP_065948.1; NM_020897.2.
DR   UniGene; Hs.706960; -.
DR   ProteinModelPortal; Q9P1Z3; -.
DR   SMR; Q9P1Z3; -.
DR   BioGrid; 121691; 3.
DR   DIP; DIP-62039N; -.
DR   IntAct; Q9P1Z3; 2.
DR   STRING; 9606.ENSP00000357342; -.
DR   BindingDB; Q9P1Z3; -.
DR   ChEMBL; CHEMBL1795173; -.
DR   GuidetoPHARMACOLOGY; 402; -.
DR   iPTMnet; Q9P1Z3; -.
DR   PhosphoSitePlus; Q9P1Z3; -.
DR   DMDM; 29840780; -.
DR   PaxDb; Q9P1Z3; -.
DR   PeptideAtlas; Q9P1Z3; -.
DR   PRIDE; Q9P1Z3; -.
DR   DNASU; 57657; -.
DR   Ensembl; ENST00000368358; ENSP00000357342; ENSG00000143630.
DR   Ensembl; ENST00000575670; ENSP00000458364; ENSG00000263324.
DR   GeneID; 57657; -.
DR   KEGG; hsa:57657; -.
DR   UCSC; uc001fjz.3; human.
DR   CTD; 57657; -.
DR   DisGeNET; 57657; -.
DR   EuPathDB; HostDB:ENSG00000143630.9; -.
DR   GeneCards; HCN3; -.
DR   H-InvDB; HIX0001125; -.
DR   HGNC; HGNC:19183; HCN3.
DR   HPA; HPA026584; -.
DR   MIM; 609973; gene.
DR   neXtProt; NX_Q9P1Z3; -.
DR   OpenTargets; ENSG00000143630; -.
DR   PharmGKB; PA38821; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9P1Z3; -.
DR   KO; K04956; -.
DR   OMA; VMEQHLV; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; Q9P1Z3; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   ChiTaRS; HCN3; human.
DR   GeneWiki; HCN3; -.
DR   GenomeRNAi; 57657; -.
DR   PRO; PR:Q9P1Z3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143630; -.
DR   CleanEx; HS_HCN3; -.
DR   Genevisible; Q9P1Z3; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0044316; C:cone cell pedicle; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:1903351; P:cellular response to dopamine; IEA:Ensembl.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0072718; P:response to cisplatin; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   cAMP; cAMP-binding; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome; Sodium;
KW   Sodium channel; Sodium transport; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN         1    774       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                3.
FT                                /FTId=PRO_0000054114.
FT   TOPO_DOM      1     97       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     98    118       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    119    124       Extracellular. {ECO:0000255}.
FT   TRANSMEM    125    145       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    146    171       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    172    192       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    193    201       Extracellular. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    223    253       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    254    274       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    275    297       Extracellular. {ECO:0000255}.
FT   INTRAMEM    298    319       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    320    329       Extracellular. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    351    774       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     492    495       cAMP. {ECO:0000250}.
FT   NP_BIND     502    503       cAMP. {ECO:0000250}.
FT   NP_BIND     543    546       cAMP. {ECO:0000250}.
FT   REGION       46     91       Involved in subunit assembly.
FT                                {ECO:0000250}.
FT   REGION      354    774       Interaction with KCTD3.
FT                                {ECO:0000250|UniProtKB:O88705}.
FT   COMPBIAS    696    765       Pro-rich.
FT   MOD_RES     634    634       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88705}.
FT   CARBOHYD    291    291       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     630    630       P -> L (in dbSNP:rs35001694).
FT                                /FTId=VAR_048746.
FT   CONFLICT    206    206       A -> G (in Ref. 4; AAH00066).
FT                                {ECO:0000305}.
FT   CONFLICT    734    734       S -> T (in Ref. 3; BAA96059).
FT                                {ECO:0000305}.
SQ   SEQUENCE   774 AA;  86032 MW;  37B9BC13E5E2C097 CRC64;
     MEAEQRPAAG ASEGATPGLE AVPPVAPPPA TAASGPIPKS GPEPKRRHLG TLLQPTVNKF
     SLRVFGSHKA VEIEQERVKS AGAWIIHPYS DFRFYWDLIM LLLMVGNLIV LPVGITFFKE
     ENSPPWIVFN VLSDTFFLLD LVLNFRTGIV VEEGAEILLA PRAIRTRYLR TWFLVDLISS
     IPVDYIFLVV ELEPRLDAEV YKTARALRIV RFTKILSLLR LLRLSRLIRY IHQWEEIFHM
     TYDLASAVVR IFNLIGMMLL LCHWDGCLQF LVPMLQDFPP DCWVSINHMV NHSWGRQYSH
     ALFKAMSHML CIGYGQQAPV GMPDVWLTML SMIVGATCYA MFIGHATALI QSLDSSRRQY
     QEKYKQVEQY MSFHKLPADT RQRIHEYYEH RYQGKMFDEE SILGELSEPL REEIINFTCR
     GLVAHMPLFA HADPSFVTAV LTKLRFEVFQ PGDLVVREGS VGRKMYFIQH GLLSVLARGA
     RDTRLTDGSY FGEICLLTRG RRTASVRADT YCRLYSLSVD HFNAVLEEFP MMRRAFETVA
     MDRLLRIGKK NSILQRKRSE PSPGSSGGIM EQHLVQHDRD MARGVRGRAP STGAQLSGKP
     VLWEPLVHAP LQAAAVTSNV AIALTHQRGP LPLSPDSPAT LLARSAWRSA GSPASPLVPV
     RAGPWASTSR LPAPPARTLH ASLSRAGRSQ VSLLGPPPGG GGRRLGPRGR PLSASQPSLP
     QRATGDGSPG RKGSGSERLP PSGLLAKPPR TAQPPRPPVP EPATPRGLQL SANM
//
ID   NMD3A_RAT               Reviewed;        1135 AA.
AC   Q9R1M7; O09098; O09155; Q62800; Q63268; Q9Z2H0;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 131.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 3A;
DE            Short=GluN3A;
DE   AltName: Full=Glutamate receptor chi-1;
DE   AltName: Full=N-methyl-D-aspartate receptor;
DE   AltName: Full=N-methyl-D-aspartate receptor subtype 3A;
DE            Short=NMDAR3A;
DE            Short=NR3A;
DE   AltName: Full=NMDAR-L;
DE   AltName: Full=NMDAR-L1;
DE   Flags: Precursor;
GN   Name=Grin3a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CHARACTERIZATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain stem, and Spinal cord;
RX   PubMed=7472412;
RA   Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S.,
RA   Sevarino K.A.;
RT   "Cloning and characterization of chi-1: a developmentally regulated
RT   member of a novel class of the ionotropic glutamate receptor family.";
RL   J. Neurosci. 15:6498-6508(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CHARACTERIZATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Forebrain;
RX   PubMed=7472413;
RA   Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M.,
RA   Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A.;
RT   "Developmental and regional expression pattern of a novel NMDA
RT   receptor-like subunit (NMDAR-L) in the rodent brain.";
RL   J. Neurosci. 15:6509-6520(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Perez-Otano I., Contractor A., Schulteis C.T., Gibb A.,
RA   Heinemann S.F.;
RT   "Altered single channel properties of NMDA receptors containing a
RT   novel NMDA receptor subunit splice variant, NR3A-2.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 839-1122 (ISOFORMS 1/2), TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=9891978; DOI=10.1016/S0014-5793(98)01590-7;
RA   Sun L., Margolis F.L., Shipley M.T., Lidow M.S.;
RT   "Identification of a long variant of mRNA encoding the NR3 subunit of
RT   the NMDA receptor: its regional distribution and developmental
RT   expression in the rat brain.";
RL   FEBS Lett. 441:392-396(1998).
RN   [5]
RP   CHARACTERIZATION, SUBCELLULAR LOCATION, IDENTIFICATION IN A COMPLEX
RP   WITH GRIN1; GRIN2A OR GRIN2B AND PPP2CB, AND INTERACTION WITH PPP2CB.
RX   PubMed=11588171;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [6]
RP   CHARACTERIZATION, GLYCOSYLATION, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN2A OR GRIN2B.
RX   PubMed=11160393;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A.,
RA   Trimmer J.S., Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of
RT   NR3A-containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN2A OR GRIN2B.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B.,
RA   Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and
RT   NR2 subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [8]
RP   CHARACTERIZATION, ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), AND
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN2A OR GRIN2B.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA
RT   receptor in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
CC   -!- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels
CC       with reduced single-channel conductance, low calcium permeability
CC       and low voltage-dependent sensitivity to magnesium. Mediated by
CC       glycine. May play a role in the development of dendritic spines.
CC       May also play a role in PPP2CB-NMDAR mediated signaling mechanism.
CC   -!- SUBUNIT: Forms heteromeric channel of a zeta subunit (GRIN1), a
CC       epsilon subunit (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and a third
CC       subunit (GRIN3A or GRIN3B). Does not form functional homomeric
CC       channels. Found in a complex with GRIN1, GRIN2A or GRIN2B and
CC       PPP2CB. Probably interacts with PPP2CB. No complex with PPP2CB is
CC       detected when NMDARs are stimulated by NMDA.
CC       {ECO:0000269|PubMed:11160393, ECO:0000269|PubMed:11588171,
CC       ECO:0000269|PubMed:11929923, ECO:0000269|PubMed:12391275}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, synapse, postsynaptic cell membrane. Cell junction,
CC       synapse, postsynaptic cell membrane, postsynaptic density.
CC       Note=Enriched in postsynaptic plasma membrane and postsynaptic
CC       densities. Requires the presence of GRIN1 to be targeted at the
CC       plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NR3-long, NR3-l, NR3A-2;
CC         IsoId=Q9R1M7-1; Sequence=Displayed;
CC       Name=2; Synonyms=NR3-short, NR3-s;
CC         IsoId=Q9R1M7-2; Sequence=VSP_011512;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in
CC       olfactory bulb, frontal occipital, entorhinal and pyriform
CC       cortices, hippocampus, striatum, thalamus, cerebellum and spinal
CC       cord. {ECO:0000269|PubMed:7472412, ECO:0000269|PubMed:7472413,
CC       ECO:0000269|PubMed:9891978}.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 and isoform 2 are expressed in
CC       spinal cord, medulla, pons, tegmentum, thalamus and hypothalamus
CC       at 15 dpc onwards. {ECO:0000269|PubMed:7472412,
CC       ECO:0000269|PubMed:7472413, ECO:0000269|PubMed:9891978}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11160393}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. NR3A/GRIN3A subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L34938; AAA99501.1; -; mRNA.
DR   EMBL; U29873; AAB58957.1; -; mRNA.
DR   EMBL; AF073379; AAD41650.1; -; mRNA.
DR   EMBL; AF061945; AAD11811.1; -; mRNA.
DR   PIR; T31068; T31068.
DR   RefSeq; NP_001185512.1; NM_001198583.2. [Q9R1M7-2]
DR   RefSeq; NP_612555.1; NM_138546.2. [Q9R1M7-1]
DR   UniGene; Rn.180226; -.
DR   PDB; 2RC7; X-ray; 1.58 A; A/B=511-660, A/B=776-915.
DR   PDB; 2RC8; X-ray; 1.45 A; A/B=511-660, A/B=776-915.
DR   PDB; 2RC9; X-ray; 1.96 A; A/B=511-660, A/B=776-915.
DR   PDB; 4KCD; X-ray; 1.68 A; A/B=511-660, A/B=776-915.
DR   PDBsum; 2RC7; -.
DR   PDBsum; 2RC8; -.
DR   PDBsum; 2RC9; -.
DR   PDBsum; 4KCD; -.
DR   ProteinModelPortal; Q9R1M7; -.
DR   SMR; Q9R1M7; -.
DR   BioGrid; 251320; 1.
DR   CORUM; Q9R1M7; -.
DR   IntAct; Q9R1M7; 1.
DR   STRING; 10116.ENSRNOP00000007957; -.
DR   BindingDB; Q9R1M7; -.
DR   ChEMBL; CHEMBL342; -.
DR   iPTMnet; Q9R1M7; -.
DR   PhosphoSitePlus; Q9R1M7; -.
DR   PaxDb; Q9R1M7; -.
DR   PRIDE; Q9R1M7; -.
DR   GeneID; 191573; -.
DR   KEGG; rno:191573; -.
DR   UCSC; RGD:621704; rat. [Q9R1M7-1]
DR   CTD; 116443; -.
DR   RGD; 621704; Grin3a.
DR   eggNOG; KOG1053; Eukaryota.
DR   eggNOG; ENOG410XNUR; LUCA.
DR   HOGENOM; HOG000231528; -.
DR   HOVERGEN; HBG052634; -.
DR   InParanoid; Q9R1M7; -.
DR   KO; K05213; -.
DR   PhylomeDB; Q9R1M7; -.
DR   TreeFam; TF314731; -.
DR   EvolutionaryTrace; Q9R1M7; -.
DR   PRO; PR:Q9R1M7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IDA:RGD.
DR   GO; GO:0042165; F:neurotransmitter binding; IDA:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0016358; P:dendrite development; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell junction;
KW   Cell membrane; Coiled coil; Complete proteome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Magnesium;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1135       Glutamate receptor ionotropic, NMDA 3A.
FT                                /FTId=PRO_0000011569.
FT   TOPO_DOM     24    674       Extracellular. {ECO:0000255}.
FT   TRANSMEM    675    695       Helical. {ECO:0000255}.
FT   TOPO_DOM    696    748       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    749    769       Helical. {ECO:0000255}.
FT   TOPO_DOM    770    930       Extracellular. {ECO:0000255}.
FT   TRANSMEM    931    951       Helical. {ECO:0000255}.
FT   TOPO_DOM    952   1135       Cytoplasmic. {ECO:0000255}.
FT   REGION      951    987       PPP2CB binding site.
FT   COILED     1080   1129       {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    285    285       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    296    296       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    439    439       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    549    549       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    565    565       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    886    886       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ    1003   1022       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7472412,
FT                                ECO:0000303|PubMed:7472413}.
FT                                /FTId=VSP_011512.
FT   STRAND      513    519       {ECO:0000244|PDB:2RC8}.
FT   TURN        523    525       {ECO:0000244|PDB:2RC8}.
FT   STRAND      526    529       {ECO:0000244|PDB:2RC8}.
FT   STRAND      540    544       {ECO:0000244|PDB:2RC8}.
FT   HELIX       551    562       {ECO:0000244|PDB:2RC8}.
FT   STRAND      563    565       {ECO:0000244|PDB:2RC8}.
FT   HELIX       570    572       {ECO:0000244|PDB:2RC8}.
FT   STRAND      573    578       {ECO:0000244|PDB:2RC8}.
FT   HELIX       579    591       {ECO:0000244|PDB:2RC8}.
FT   STRAND      593    599       {ECO:0000244|PDB:2RC8}.
FT   HELIX       615    621       {ECO:0000244|PDB:2RC8}.
FT   STRAND      626    628       {ECO:0000244|PDB:2RC8}.
FT   HELIX       636    639       {ECO:0000244|PDB:2RC8}.
FT   STRAND      642    644       {ECO:0000244|PDB:2RC8}.
FT   STRAND      648    658       {ECO:0000244|PDB:2RC8}.
FT   HELIX       783    786       {ECO:0000244|PDB:2RC8}.
FT   HELIX       801    809       {ECO:0000244|PDB:2RC8}.
FT   HELIX       811    817       {ECO:0000244|PDB:2RC8}.
FT   HELIX       818    820       {ECO:0000244|PDB:2RC8}.
FT   STRAND      822    824       {ECO:0000244|PDB:2RC8}.
FT   HELIX       825    833       {ECO:0000244|PDB:2RC8}.
FT   STRAND      834    836       {ECO:0000244|PDB:2RC8}.
FT   STRAND      840    845       {ECO:0000244|PDB:2RC8}.
FT   HELIX       846    854       {ECO:0000244|PDB:2RC8}.
FT   STRAND      857    859       {ECO:0000244|PDB:2RC8}.
FT   STRAND      861    863       {ECO:0000244|PDB:2RC8}.
FT   STRAND      868    873       {ECO:0000244|PDB:2RC8}.
FT   HELIX       883    896       {ECO:0000244|PDB:2RC8}.
FT   HELIX       899    907       {ECO:0000244|PDB:2RC8}.
SQ   SEQUENCE   1135 AA;  127607 MW;  8EC1FEEAE50AB237 CRC64;
     MRRLSLWWLL SRVCLLLPPP CALVLAGVPS SSSHPQPCQI LKRIGHAVRV GAVHLQPWTT
     APRAASRAQE GGRAGAQRDD PESGTWRPPA PSQGARWLGS ALHGRGPPGS RKLGEGAGAE
     TLWPRDALLF AVENLNRVEG LLPYNLSLEV VMAIEAGLGD LPLMPFSSPS SPWSSDPFSF
     LQSVCHTVVV QGVSALLAFP QSQGEMMELD LVSSVLHIPV LSIVRHEFPR ESQNPLHLQL
     SLENSLSSDA DVTVSILTMN NWYNFSLLLC QEDWNITDFL LLTENNSKFH LESVINITAN
     LSSTKDLLSF LQVQMDNIRN STPTMVMFGC DMDSIRQIFE MSTQFGLSPP ELHWVLGDSQ
     NVEELRTEGL PLGLIAHGKT TQSVFEYYVQ DAMELVARAV ATATMIQPEL ALLPSTMNCM
     DVKTTNLTSG QYLSRFLANT TFRGLSGSIK VKGSTIISSE NNFFIWNLQH DPMGKPMWTR
     LGSWQGGRIV MDSGIWPEQA QRHKTHFQHP NKLHLRVVTL IEHPFVFTRE VDDEGLCPAG
     QLCLDPMTND SSMLDRLFSS LHSSNDTVPI KFKKCCYGYC IDLLEQLAED MNFDFDLYIV
     GDGKYGAWKN GHWTGLVGDL LSGTANMAVT SFSINTARSQ VIDFTSPFFS TSLGILVRTR
     DTAAPIGAFM WPLHWTMWLG IFVALHITAI FLTLYEWKSP FGMTPKGRNR NKVFSFSSAL
     NVCYALLFGR TAAIKPPKCW TGRFLMNLWA IFCMFCLSTY TANLAAVMVG EKIYEELSGI
     HDPKLHHPSQ GFRFGTVRES SAEDYVRQSF PEMHEYMRRY NVPATPDGVQ YLKNDPEKLD
     AFIMDKALLD YEVSIDADCK LLTVGKPFAI EGYGIGLPPN SPLTSNISEL ISQYKSHGFM
     DVLHDKWYKV VPCGKRSFAV TETLQMGIKH FSGLFVLLCI GFGLSILTTI GEHIVHRLLL
     PRIKNKSKLQ YWLHTSQRFH RALNTSFVEE KQPRSKTKRV EKSRWRRWTC KTEGDSELSL
     FPRSNLGPQQ LMVWNTSNLS HDNQRKYIFN DEEGQNQLGT QAHQDIPLPQ RRRELPASLT
     TNGKADSLNV TRSSVIQELS ELEKQIQVIR QELQLAVSRK TELEEYQKTN RTCES
//
ID   CNGC7_ARATH             Reviewed;         738 AA.
AC   Q9S9N5; F4I2R9;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   20-DEC-2017, entry version 129.
DE   RecName: Full=Putative cyclic nucleotide-gated ion channel 7;
DE   AltName: Full=Cyclic nucleotide- and calmodulin-regulated ion channel 7;
GN   Name=CNGC7; OrderedLocusNames=At1g15990; ORFNames=T24D18.9;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11500563; DOI=10.1104/pp.126.4.1646;
RA   Maeser P., Thomine S., Schroeder J.I., Ward J.M., Hirschi K., Sze H.,
RA   Talke I.N., Amtmann A., Maathuis F.J.M., Sanders D., Harper J.F.,
RA   Tchieu J., Gribskov M., Persans M.W., Salt D.E., Kim S.A.,
RA   Guerinot M.L.;
RT   "Phylogenetic relationships within cation transporter families of
RT   Arabidopsis.";
RL   Plant Physiol. 126:1646-1667(2001).
CC   -!- FUNCTION: Putative cyclic nucleotide-gated ion channel.
CC   -!- SUBUNIT: Homotetramer or heterotetramer. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- DOMAIN: The binding of calmodulin to the C-terminus might
CC       interfere with cyclic nucleotide binding and thus channel
CC       activation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide-gated cation channel
CC       (TC 1.A.1.5) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010924; AAF18496.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE29393.2; -; Genomic_DNA.
DR   PIR; E86294; E86294.
DR   RefSeq; NP_001319014.1; NM_001332197.1.
DR   UniGene; At.26234; -.
DR   ProteinModelPortal; Q9S9N5; -.
DR   SMR; Q9S9N5; -.
DR   STRING; 3702.AT1G15990.1; -.
DR   iPTMnet; Q9S9N5; -.
DR   PaxDb; Q9S9N5; -.
DR   EnsemblPlants; AT1G15990.1; AT1G15990.1; AT1G15990.
DR   GeneID; 838169; -.
DR   Gramene; AT1G15990.1; AT1G15990.1; AT1G15990.
DR   KEGG; ath:AT1G15990; -.
DR   Araport; AT1G15990; -.
DR   TAIR; locus:2200502; AT1G15990.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   HOGENOM; HOG000238338; -.
DR   InParanoid; Q9S9N5; -.
DR   KO; K05391; -.
DR   OrthoDB; EOG093603N1; -.
DR   PhylomeDB; Q9S9N5; -.
DR   Reactome; R-ATH-2485179; Activation of the phototransduction cascade.
DR   Reactome; R-ATH-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-ATH-5620916; VxPx cargo-targeting to cilium.
DR   PRO; PR:Q9S9N5; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q9S9N5; baseline and differential.
DR   Genevisible; Q9S9N5; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0090406; C:pollen tube; IDA:TAIR.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0009860; P:pollen tube growth; IGI:TAIR.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0046686; P:response to cadmium ion; IEP:TAIR.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   3: Inferred from homology;
KW   Calmodulin-binding; cAMP; cAMP-binding; Cell membrane; cGMP;
KW   cGMP-binding; Complete proteome; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    738       Putative cyclic nucleotide-gated ion
FT                                channel 7.
FT                                /FTId=PRO_0000219335.
FT   TOPO_DOM      1    104       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    105    125       Helical; Name=H1. {ECO:0000255}.
FT   TOPO_DOM    126    139       Extracellular. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical; Name=H2. {ECO:0000255}.
FT   TOPO_DOM    161    193       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    194    214       Helical; Name=H3. {ECO:0000255}.
FT   TOPO_DOM    215    227       Extracellular. {ECO:0000255}.
FT   TRANSMEM    228    248       Helical; Name=H4. {ECO:0000255}.
FT   TOPO_DOM    249    268       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical; Name=H5. {ECO:0000255}.
FT   TOPO_DOM    290    395       Extracellular. {ECO:0000255}.
FT   TRANSMEM    396    416       Helical; Name=H6. {ECO:0000255}.
FT   TOPO_DOM    417    738       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      638    667       IQ.
FT   NP_BIND     502    632       cNMP.
FT   REGION      618    633       Calmodulin-binding. {ECO:0000250}.
FT   BINDING     573    573       cNMP. {ECO:0000250}.
SQ   SEQUENCE   738 AA;  84634 MW;  369AB538E25959BF CRC64;
     MYKSQYISGQ REKFVRLDDI DSSSSPATGM MMQRNCFGFN LKNRGGEKKK ASKSFREGVK
     KIRSEGLITI GKSVTRAVFP EDLRITEKKI FDPQDKTLLV WNRLFVISCI LAVSVDPLFF
     YLPIVDNSGS SCIGIDTKLA VTTTTLRTIV DVFYLTRMAL QFRTAYIAPS SRVFGRGELV
     IDPAKIAERY LTRYFVVDFL AVLPLPQIAV WKFLHGSKGS DVLPTKTALL NIVIVQYIPR
     FVRFIPLTSE LKKTAGAFAE GAWAGAAYYL LWYMLASHIT GAFWYMLSVE RNDTCWRFAC
     KVQPDPRLCV QILYCGTKFV SSGETEWIKT VPELLKSNCS AKADDSKFNY GIYGQAISSG
     IVSSTTFFSK FCYCLWWGLQ NLSTLGQGLQ TSTFPGEVLF SIAIAIAGLL LFALLIGNMQ
     TYLQSLTVRL EEMRIKRRDS EQWMHHRSLP QNLRERVRRY DQYKWLETRG VDEENIVQSL
     PKDLRRDIKR HLCLNLVRRV PLFANMDERL LDAICERLKP SLFTESTYIV REGDPVNEMM
     FIIRGRLESV TTDGGRSGFF NRGLLKEGDF CGEELLTWAL DPKAGSNLPS STRTVKALTE
     VEAFALEAEE LKFVASQFRR LHSRQVQQTF RFYSQQWRTW ASCFIQAAWR RYSRRKNAEL
     RRIEEKEEEL GYEDEYDDES DKRPMVITRS ESSSRLRSTI FASRFAANAL KGHRLRSSES
     SKTLINLQKP PEPDFDAE
//
ID   GLR37_ARATH             Reviewed;         921 AA.
AC   Q9SDQ4; Q9ZV68;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 2.
DT   20-DEC-2017, entry version 121.
DE   RecName: Full=Glutamate receptor 3.7;
DE   AltName: Full=Ionotropic glutamate receptor GLR5;
DE   AltName: Full=Ligand-gated ion channel 3.7;
DE   Flags: Precursor;
GN   Name=GLR3.7; Synonyms=GLR5; OrderedLocusNames=At2g32400;
GN   ORFNames=T32F6.8;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], GENE FAMILY, AND NOMENCLATURE.
RC   STRAIN=cv. Columbia; TISSUE=Seedling;
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in leaves and
CC       siliques. Also detected in roots. {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF210701; AAF21042.1; -; mRNA.
DR   EMBL; AC005700; AAC69938.2; -; Genomic_DNA.
DR   EMBL; CP002685; AEC08679.1; -; Genomic_DNA.
DR   PIR; F84732; F84732.
DR   PIR; T51136; T51136.
DR   RefSeq; NP_565744.1; NM_128799.4.
DR   UniGene; At.13201; -.
DR   ProteinModelPortal; Q9SDQ4; -.
DR   BioGrid; 3148; 2.
DR   IntAct; Q9SDQ4; 1.
DR   STRING; 3702.AT2G32400.1; -.
DR   PaxDb; Q9SDQ4; -.
DR   EnsemblPlants; AT2G32400.1; AT2G32400.1; AT2G32400.
DR   GeneID; 817801; -.
DR   Gramene; AT2G32400.1; AT2G32400.1; AT2G32400.
DR   KEGG; ath:AT2G32400; -.
DR   Araport; AT2G32400; -.
DR   TAIR; locus:2062586; AT2G32400.
DR   eggNOG; ENOG410ISR7; Eukaryota.
DR   eggNOG; ENOG410Y9VH; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q9SDQ4; -.
DR   KO; K05387; -.
DR   OMA; FVGSCFG; -.
DR   OrthoDB; EOG093601T8; -.
DR   PhylomeDB; Q9SDQ4; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q9SDQ4; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q9SDQ4; baseline and differential.
DR   Genevisible; Q9SDQ4; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0009506; C:plasmodesma; IDA:TAIR.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 2.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    921       Glutamate receptor 3.7.
FT                                /FTId=PRO_0000011611.
FT   TOPO_DOM     26    580       Extracellular. {ECO:0000255}.
FT   TRANSMEM    581    601       Helical. {ECO:0000255}.
FT   TOPO_DOM    602    608       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    609    629       Helical. {ECO:0000255}.
FT   TOPO_DOM    630    640       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    641    661       Helical. {ECO:0000255}.
FT   TOPO_DOM    662    822       Extracellular. {ECO:0000255}.
FT   TRANSMEM    823    843       Helical. {ECO:0000255}.
FT   TOPO_DOM    844    921       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    369    369       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    396    396       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    568    568       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    385    385       V -> I (in Ref. 1; AAF21042).
FT                                {ECO:0000305}.
FT   CONFLICT    694    694       F -> V (in Ref. 1; AAF21042).
FT                                {ECO:0000305}.
FT   CONFLICT    858    858       T -> I (in Ref. 1; AAF21042).
FT                                {ECO:0000305}.
SQ   SEQUENCE   921 AA;  103514 MW;  80600BFE9C778EA1 CRC64;
     MGLGIDPSVA ITALIVVILV VPMDCQRPQL VNIGAVFAFD SVIGRAAKVA LEAAVSDVNN
     DKSFLKETEL RLLMEDSACN VFRGSFGAFE LLEKEVVAMI GPISSSVAHT ISDIAKGLHF
     PLVSFAATDP TLSALQFPFF LRTTPNDAHQ MSALVDLINF YGWKEVISVY SDDELGRNGV
     SALDDELYKK RSRISYKVPL SVHSDEKFLT NALNKSKSIG PRVYILHFGP DPLLRIFDIA
     QKLQMMTHEY VWLATDWLSV TLDSLSDKGT LKRLEGVVGL RQHIPESVKM EHFTHKLQSN
     RSMNAYALHA YDTVWMIAHG IEELLNEGIN ITFSYSEKLL HARGTKLHLE KIKFFNSGEL
     LLEKLLKVNF TGIAGQVQFG SGRNVIGCDY EIINVNKTDV HTVGFWSKNG GFSVVAPKTR
     HSQKKTSFVS DEKLGDITWP GGGREKPRGW VIADSADPLK IVVPRRVSFV EFVTEEKNSS
     HRIQGFCIDV FIEALKFVPY SVPYIFEPFG NGHSSPNYNH LIQMVTDGVY DAAVGDIAIV
     PSRSKLVDFS QPYASTGLVV VIPANDDNAT WIFLRPFTSR LWCVVLVSFL VIAVVIWILE
     HRINEDFRGP PRRQLSTMLL FSFSTLFKRN QEDTISNLAR LVMIVWLFLL MVLTASYTAN
     LTSILTVQQL PSAITGIDSL RASEVPIGYQ AGTFTLEYLT YSLGMARSRL VPLDSTEEYE
     KALKLGPTNW GGVAAIVDEL PYIELFLAER TGFKIVGEPF MHRGWGFAFK RDSPLAIDMS
     TAILKLSETR KLQEIRKKWL CKTNCAGKSN WNPEPNQLHL KSFKGLYLVC IAITVSAFLV
     FVLRMIRQFV RYRRMERTSS MPRASWSASP TLRLRELVFD FVEFVDEKEE AIKRMFRRSD
     DSNNNPSHVG EVQADTEVPR N
//
ID   GLR23_ARATH             Reviewed;         895 AA.
AC   Q9SHV2;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 110.
DE   RecName: Full=Glutamate receptor 2.3;
DE   AltName: Full=Ligand-gated ion channel 2.3;
DE   Flags: Precursor;
GN   Name=GLR2.3; OrderedLocusNames=At2g24710; ORFNames=F27A10.2;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   GENE FAMILY, AND NOMENCLATURE.
RX   PubMed=11379626; DOI=10.1126/science.292.5521.1486b;
RA   Lacombe B., Becker D., Hedrich R., DeSalle R., Hollmann M., Kwak J.M.,
RA   Schroeder J.I., Le Novere N., Nam H.G., Spalding E.P., Tester M.,
RA   Turano F.J., Chiu J., Coruzzi G.;
RT   "The identity of plant glutamate receptors.";
RL   Science 292:1486-1487(2001).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12082126; DOI=10.1093/oxfordjournals.molbev.a004165;
RA   Chiu J.C., Brenner E.D., DeSalle R., Nitabach M.N., Holmes T.C.,
RA   Coruzzi G.M.;
RT   "Phylogenetic and expression analysis of the glutamate-receptor-like
RT   gene family in Arabidopsis thaliana.";
RL   Mol. Biol. Evol. 19:1066-1082(2002).
CC   -!- FUNCTION: Glutamate-gated receptor that probably acts as non-
CC       selective cation channel. May be involved in light-signal
CC       transduction and calcium homeostasis via the regulation of calcium
CC       influx into cells.
CC   -!- SUBUNIT: May form heteromers. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in roots.
CC       {ECO:0000269|PubMed:12082126}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007266; AAD26894.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC07621.1; -; Genomic_DNA.
DR   PIR; A84640; A84640.
DR   RefSeq; NP_180047.1; NM_128032.1.
DR   UniGene; At.52897; -.
DR   ProteinModelPortal; Q9SHV2; -.
DR   STRING; 3702.AT2G24710.1; -.
DR   PaxDb; Q9SHV2; -.
DR   PRIDE; Q9SHV2; -.
DR   EnsemblPlants; AT2G24710.1; AT2G24710.1; AT2G24710.
DR   GeneID; 817007; -.
DR   Gramene; AT2G24710.1; AT2G24710.1; AT2G24710.
DR   KEGG; ath:AT2G24710; -.
DR   Araport; AT2G24710; -.
DR   TAIR; locus:2047251; AT2G24710.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG410XQQV; LUCA.
DR   HOGENOM; HOG000239558; -.
DR   InParanoid; Q9SHV2; -.
DR   KO; K05387; -.
DR   OMA; QASTICW; -.
DR   OrthoDB; EOG0936061T; -.
DR   PhylomeDB; Q9SHV2; -.
DR   Reactome; R-ATH-399710; Activation of AMPA receptors.
DR   Reactome; R-ATH-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-ATH-451307; Activation of Na-permeable kainate receptors.
DR   Reactome; R-ATH-500657; Presynaptic function of Kainate receptors.
DR   PRO; PR:Q9SHV2; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q9SHV2; baseline and differential.
DR   Genevisible; Q9SHV2; AT.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR017103; Iontropic_Glu_rcpt_pln.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR001638; Solute-binding_3/MltF_N.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF00497; SBP_bac_3; 1.
DR   PIRSF; PIRSF037090; Iontro_Glu-like_rcpt_pln; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    895       Glutamate receptor 2.3.
FT                                /FTId=PRO_0000011598.
FT   TOPO_DOM     24    582       Extracellular. {ECO:0000255}.
FT   TRANSMEM    583    603       Helical. {ECO:0000255}.
FT   TOPO_DOM    604    610       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    611    631       Helical. {ECO:0000255}.
FT   TOPO_DOM    632    635       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    636    656       Helical. {ECO:0000255}.
FT   TOPO_DOM    657    830       Extracellular. {ECO:0000255}.
FT   TRANSMEM    831    851       Helical. {ECO:0000255}.
FT   TOPO_DOM    852    895       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    477    477       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    542    542       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   895 AA;  100809 MW;  E86D1BADCD73AB94 CRC64;
     MRTEKLFFCI LLVFFFCLEF NRGQNNGKTL VDVGVVTDVD TSHSKVVMLC INMSISDFYS
     SNPQFETRLV VNVGDSKSDV VGAAIAALDL IKNKQVKAIL GPWTSMQAHF LIEIGQKSRV
     PIVSYSATSP ILTSLRSPYF LRATYEDSFQ VQPIKAIIKL FGWREVVPVY IDNTFGEGIM
     PRLTDALQDI NVRIPYRSVI AINATDHEIS VELLKMMNMP TRVFLVHMYY DLASRFFIKA
     KELGLMEPGY VWILTNGVID DLSLINETAV EAMEGVLGIK TYIPKSPDLE KFRSRWRSLF
     PRVELSVYGL WAYDATTALA VAIEEAGTNN MTFSKVVDTG RNVSELEALG LSQFGPKLLQ
     TLLTVQFRGL AGEFRFFRGQ LQPSVFEIVN IINTGEKSIG FWKEGNGLVK KLDQQASSIS
     ALSTWKDHLK HIVWPGEADS VPKGWQIPTK GKKLRIGVPK RTGYTDLVKV TRDPITNSTV
     VTGFCIDFFE AVIRELPYDV SYEFIPFEKP DGKTAGNYND LVYQVYLGRY DAVVGDTTIL
     VNRSSYVDFT FPFIKSGVGL IVEMTDPVKR DYILFMKPLS WKLWLTSFIS FFLVGCTVWV
     LEYKRNPDFS GPPRFQASTI CWFAFSTMVF APRERVFSFW ARALVIAWYF LVLVLTQSYT
     ASLASLLTSQ KLNPTITSMS SLLEKGETVG YQRTSFILGK LKERGFPQSS LVPFDTAEEC
     DELLSKGPKK GGVSGAFLEI PYLRLFLGQF CNTYKMVEEP FNVDGFGFVF PIGSPLVADV
     SRAILKVAES PKAMELERAW FKKKEQSCPD PITNPDPNPS FTSRQLDIDS FLFLFVGVLL
     VCVMALGNFT YCFLAKDQVS YLDKVEMSPC SSSQQMPVKR KTQLNMSQVH DQDSL
//
ID   RYR3_RABIT              Reviewed;        4872 AA.
AC   Q9TS33;
DT   22-FEB-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 118.
DE   RecName: Full=Ryanodine receptor 3;
DE            Short=RYR-3;
DE            Short=RyR3;
DE   AltName: Full=Brain ryanodine receptor-calcium release channel;
DE   AltName: Full=Brain-type ryanodine receptor;
DE   AltName: Full=Type 3 ryanodine receptor;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1330694; DOI=10.1016/0014-5793(92)80941-9;
RA   Hakamata Y., Nakai J., Takeshima H., Imoto K.;
RT   "Primary structure and distribution of a novel ryanodine
RT   receptor/calcium release channel from rabbit brain.";
RL   FEBS Lett. 312:229-235(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, SUBCELLULAR
RP   LOCATION, REGULATION BY RYANODINE; CALMODULIN; CALCIUM LEVELS;
RP   MAGNESIUM; ATP; CAFFEINE AND RUTHENIUM RED, AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=9305876; DOI=10.1074/jbc.272.39.24234;
RA   Chen S.R., Li X., Ebisawa K., Zhang L.;
RT   "Functional characterization of the recombinant type 3 Ca2+ release
RT   channel (ryanodine receptor) expressed in HEK293 cells.";
RL   J. Biol. Chem. 272:24234-24246(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), ALTERNATIVE
RP   SPLICING, FUNCTION, SUBUNIT, INTERACTION WITH RYR2, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=12471029; DOI=10.1074/jbc.M210410200;
RA   Jiang D., Xiao B., Li X., Chen S.R.;
RT   "Smooth muscle tissues express a major dominant negative splice
RT   variant of the type 3 Ca2+ release channel (ryanodine receptor).";
RL   J. Biol. Chem. 278:4763-4769(2003).
RN   [4]
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF GLU-3885.
RX   PubMed=9614063; DOI=10.1074/jbc.273.24.14675;
RA   Chen S.R., Ebisawa K., Li X., Zhang L.;
RT   "Molecular identification of the ryanodine receptor Ca2+ sensor.";
RL   J. Biol. Chem. 273:14675-14678(1998).
RN   [5]
RP   FUNCTION, SUBUNIT, DOMAIN, INTERACTION WITH FKBP1A, SUBCELLULAR
RP   LOCATION, MEMBRANE TOPOLOGY, ELECTRON MICROSCOPY, REGULATION BY
RP   RYANODINE; CALCIUM LEVELS; MAGNESIUM; ATP AND CAFFEINE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10358090; DOI=10.1074/jbc.274.24.17297;
RA   Murayama T., Oba T., Katayama E., Oyamada H., Oguchi K., Kobayashi M.,
RA   Otsuka K., Ogawa Y.;
RT   "Further characterization of the type 3 ryanodine receptor (RyR3)
RT   purified from rabbit diaphragm.";
RL   J. Biol. Chem. 274:17297-17308(1999).
RN   [6]
RP   INTERACTION WITH RYR2, AND FUNCTION.
RX   PubMed=12213830; DOI=10.1074/jbc.M208210200;
RA   Xiao B., Masumiya H., Jiang D., Wang R., Sei Y., Zhang L.,
RA   Murayama T., Ogawa Y., Lai F.A., Wagenknecht T., Chen S.R.;
RT   "Isoform-dependent formation of heteromeric Ca2+ release channels
RT   (ryanodine receptors).";
RL   J. Biol. Chem. 277:41778-41785(2002).
RN   [7]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16176801; DOI=10.1016/j.bbrc.2005.09.027;
RA   Conti A., Reggiani C., Sorrentino V.;
RT   "Selective expression of the type 3 isoform of ryanodine receptor Ca2+
RT   release channel (RyR3) in a subset of slow fibers in diaphragm and
RT   cephalic muscles of adult rabbits.";
RL   Biochem. Biophys. Res. Commun. 337:195-200(2005).
RN   [8]
RP   FUNCTION, INTERACTION WITH CALM, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16274254; DOI=10.1021/bi051251t;
RA   Yamaguchi N., Xu L., Pasek D.A., Evans K.E., Chen S.R., Meissner G.;
RT   "Calmodulin regulation and identification of calmodulin binding region
RT   of type-3 ryanodine receptor calcium release channel.";
RL   Biochemistry 44:15074-15081(2005).
RN   [9]
RP   INTERACTION WITH SELENON, AND SUBCELLULAR LOCATION.
RX   PubMed=18713863; DOI=10.1073/pnas.0806015105;
RA   Jurynec M.J., Xia R., Mackrill J.J., Gunther D., Crawford T.,
RA   Flanigan K.M., Abramson J.J., Howard M.T., Grunwald D.J.;
RT   "Selenoprotein N is required for ryanodine receptor calcium release
RT   channel activity in human and zebrafish muscle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12485-12490(2008).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from
CC       the sarcoplasmic reticulum into the cytoplasm in muscle and
CC       thereby plays a role in triggering muscle contraction. May
CC       regulate Ca(2+) release by other calcium channels. Calcium channel
CC       that mediates Ca(2+)-induced Ca(2+) release from the endoplasmic
CC       reticulum in non-muscle cells. Plays a role in cellular calcium
CC       signaling. Contributes to cellular calcium ion homeostasis.
CC       Isoform 2 lacks a predicted transmembrane segment and does not
CC       form functional calcium channels by itself; however, it can form
CC       tetramers with isoforms that contain the full complement of
CC       transmembrane segments and modulate their activity.
CC       {ECO:0000269|PubMed:10358090, ECO:0000269|PubMed:12213830,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:9305876, ECO:0000269|PubMed:9614063}.
CC   -!- SUBUNIT: Homotetramer. Isoform 2 can form tetramers with isoform
CC       1. Heterotetramer with RYR2. Interacts with FKBP1A. Interacts with
CC       CALM. Interacts with SELENON (PubMed:18713863).
CC       {ECO:0000269|PubMed:10358090, ECO:0000269|PubMed:12213830,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:18713863, ECO:0000269|PubMed:9614063}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-9542578, EBI-9542578;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane; Multi-pass
CC       membrane protein. Membrane; Multi-pass membrane protein. Microsome
CC       membrane; Multi-pass membrane protein. Sarcoplasmic reticulum
CC       {ECO:0000269|PubMed:18713863}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but both N-
CC       terminus and C-terminus seem to be cytoplasmic. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9TS33-1; Sequence=Displayed;
CC       Name=2; Synonyms=AS-8a;
CC         IsoId=Q9TS33-2; Sequence=VSP_042306;
CC         Note=Lacks a predicted transmembrane segment and does not form
CC         functional calcium channels.;
CC       Name=3;
CC         IsoId=Q9TS33-3; Sequence=VSP_042305;
CC       Name=4;
CC         IsoId=Q9TS33-4; Sequence=VSP_042307;
CC   -!- TISSUE SPECIFICITY: Detected in skeletal muscle from young rabbits
CC       and in adult diaphragm muscle (at protein level). Detected in
CC       brain, especially in corpus striatum, thalamus and hippocampus.
CC       Detected in taenia coli, uterus, vas deferens, aorta, stomach,
CC       small intestine, heart, diaphragm and ureter. Isoform 2 is highly
CC       expressed in uterus and aorta, and at much lower levels in heart,
CC       brain and diaphragm. {ECO:0000269|PubMed:10358090,
CC       ECO:0000269|PubMed:12471029, ECO:0000269|PubMed:1330694,
CC       ECO:0000269|PubMed:16176801, ECO:0000269|PubMed:16274254,
CC       ECO:0000269|PubMed:9305876}.
CC   -!- DEVELOPMENTAL STAGE: Ubiquitous in skeletal muscle in neonates and
CC       in 15 day old rabbits. In adult, detected in diaphragm muscle, and
CC       in a subset of skeletal muscles including digastricus,
CC       pterygoideus, tongue and masseter. {ECO:0000269|PubMed:16176801}.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-
CC       terminal region while the remaining part of the protein resides in
CC       the cytoplasm. {ECO:0000305|PubMed:10358090}.
CC   -!- MISCELLANEOUS: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open calcium-release channel with high
CC       affinity. At low concentrations, ryanodine maintains the channel
CC       in an open conformation. High ryanodine concentrations inhibit
CC       channel activity. Channel activity is regulated by calmodulin
CC       (CALM). The calcium release is activated by elevated cytoplasmic
CC       calcium levels in the micromolar range, by caffeine and adenine
CC       nucleotides, such as AMP and ATP. Inhibited by Mg(2+) and
CC       ruthenium red.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family.
CC       RYR3 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X68650; CAC16153.1; -; mRNA.
DR   PIR; S27272; S27272.
DR   RefSeq; NP_001076231.1; NM_001082762.1. [Q9TS33-1]
DR   UniGene; Ocu.3278; -.
DR   ProteinModelPortal; Q9TS33; -.
DR   STRING; 9986.ENSOCUP00000024658; -.
DR   GeneID; 100009545; -.
DR   KEGG; ocu:100009545; -.
DR   CTD; 6263; -.
DR   eggNOG; KOG2243; Eukaryota.
DR   eggNOG; ENOG410YCNW; LUCA.
DR   HOGENOM; HOG000231428; -.
DR   HOVERGEN; HBG006699; -.
DR   KO; K04963; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; TAS:UniProtKB.
DR   GO; GO:0071318; P:cellular response to ATP; IDA:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0071286; P:cellular response to magnesium ion; IDA:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; NAS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 3.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Complete proteome; Endoplasmic reticulum;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Microsome; Receptor; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   4872       Ryanodine receptor 3.
FT                                /FTId=PRO_0000415649.
FT   TOPO_DOM      1   4188       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   4189   4209       Helical. {ECO:0000255}.
FT   TRANSMEM   4412   4432       Helical. {ECO:0000255}.
FT   TRANSMEM   4487   4507       Helical. {ECO:0000255}.
FT   TRANSMEM   4612   4632       Helical. {ECO:0000255}.
FT   TRANSMEM   4635   4655       Helical. {ECO:0000255}.
FT   TRANSMEM   4674   4694       Helical. {ECO:0000255}.
FT   INTRAMEM   4725   4734       Pore-forming. {ECO:0000250}.
FT   TRANSMEM   4755   4775       Helical. {ECO:0000255}.
FT   TOPO_DOM   4776   4872       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      100    155       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      162    207       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      215    269       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      275    333       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      343    400       MIR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      585    796       B30.2/SPRY 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT      840    953       1.
FT   REPEAT      954   1068       2.
FT   DOMAIN     1012   1208       B30.2/SPRY 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   DOMAIN     1254   1466       B30.2/SPRY 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   REPEAT     2592   2710       3.
FT   REPEAT     2711   2823       4.
FT   REGION      840   2823       4 X approximate repeats.
FT   REGION     2325   2338       Interaction with FKBP1A. {ECO:0000250}.
FT   REGION     3472   3501       Interaction with CALM.
FT                                {ECO:0000269|PubMed:16274254}.
FT   SITE       3885   3885       Important for activation by Ca(2+).
FT   VAR_SEQ    3341   3345       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12471029,
FT                                ECO:0000303|PubMed:9305876}.
FT                                /FTId=VSP_042305.
FT   VAR_SEQ    4406   4434       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12471029}.
FT                                /FTId=VSP_042306.
FT   VAR_SEQ    4791   4841       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:12471029}.
FT                                /FTId=VSP_042307.
FT   MUTAGEN    3885   3885       E->A: Reduces calcium-sensitivity by over
FT                                10000-fold. {ECO:0000269|PubMed:9614063}.
SQ   SEQUENCE   4872 AA;  551929 MW;  D1DC6B85CD6B93E6 CRC64;
     MAEGGEGGED EIQFLRTEDE VVLQCIATVH KEQRKFCLAA EGLGNRLCFL EPTSEAKFIP
     PDLCVCNFVL EQSLSVRALQ EMLANTGENG GEGAAQGGGH RTLLYGHAIL LRHSFSGMYL
     TCLTTSRSQT DKLAFDVGLR EHATGEACWW TIHPASKQRS EGEKVRIGDD LILVSVSSER
     YLHLSISNGN IQVDASFMQT LWNVHPTCSG SSIEEGYLLG GHVVRLFHGH DECLTIPSTD
     QNDSQHRRIF YEAGGAGTRA RSLWRVEPLR ISWSGSNIRW GQAFRLRHLT TGHYLALTED
     QGLLLQDRGK ADTKSTAFSF RPSKETKEKL DSSHKRDIEG MGVPEIKYGD SVCFVQHIAS
     GLWVTYKAQD AKTSRLGPLK RKVILHQEGH MDDGLTLQRC QREESQAARI IRNTTALFSQ
     FVSGNNRTAA PVTLPIEEVL QTLHDLIAYF QPPEEEMQHE DKQNKLRSLK NRQNLFKEEG
     MLALVLNCID RLNIYNSVAH FAGIAREESG MAWKEVLSLL YKLLAALIRG NRNTCAQFSN
     NLDWLISKLD RLESSSGILE VLHCILIESP EALNLIAEGH IKSIISLLDK HGRNHKVLDV
     LCSLCLCNGV AVRANQNLIC DNLLPRRNLL LQTRLINDVT SIRPNIFLGV AEGSAQYKKW
     YFELIIDQVD PFLTAEPTHL RVGWASSSGY APYPGGGEGW GGNGVGDDLY SYGFDGLHLW
     SGRIPRAVAS INQHLLKSDD VVSCCLDLGV PSISFRINGQ PVQGMFENFN TDGLFFPVMS
     FSAGVKVRFL MGGRHGEFKF LPPSGYAPCY EALLPKEKMR LEPVKEYKRD AEGVRDLLGT
     TQFLSQASFI PCPIDTSQVV LPPHLEKIRD RLAENIHELW GMNKIELGWT FGKMRDDNKR
     QHPCLVEFSK LPETEKNYNL QMSTETLKTL LALGCHIAHV NPAAEEDLKK VKLPKNYMMS
     NGYKPAPLDL SDVKLLPPQE ILVDKLAENA HNVWAKDRIK QGWTYGIQQD LKNKRNPRLV
     PYALLDERTK KSNRDSLREA VRTFVGYGYN IEPSDQELAD PAVEKVSIDK IRFFRVERSY
     AVRSGKWYFE FEVVTGGDMR VGWARPGCRP DIELGPMTKP LCLKAAGASV GTKVVGILGV
     PWQPGDVVGC MINLDDASMI FTLNGELLIT NKGSELAFAD YEIENGFVPI CSLGLSQIGR
     MNLGTDASTF KFYTMCGLQE GFEPFAVNMN RDVAMWFSKR LPTFVNVPKD HPHIEVVRID
     GTMDSPPCLK VTHKTFGTQN SNANMIYCRL SMPVECHSSF SHSPCLDSEA FQKRKQMQEI
     LSHTTTQCFY SIRIFAGQDP SCVWVGWVTP DYHLYSEKFD LNKNCTVTVT LGDERGRVHE
     SVKRSNCYMV WGGDVVASSQ RSSRSNVDLE IGCLVDLAMG MLSFSANGKE LGTCYQVEPN
     TKVFPAVFLQ PTSTSLFQFE LGKLKNAMPL SAAIFKSEEK NPVPQCPPRL DVQTIQPVLW
     SRMPNSFLKV ETERVSERHG WVVQCLEPLQ MMALHIPEEN RCVDILELCE QEDLMQFHYH
     TLRLYSAVCA LGNSRVAYAL CSHVDLSQLF HAIDNKYLPG LLRSGFYDLL ISIHLANAKE
     RKLMMKNEYI IPITSTTRNI RLYPDESKKH GLPGVGPRTC LKPGFKFSTP CFVVTNEERQ
     KQSPEIPLEI LKMKALSMLT EAVQCSGAHI RDPVGGSVEF QFVPVLKLVG TLLVMGVFCD
     DDVRQILLLI DPSVFGEHSA DTEEGAEKEE VSQVEEKAVE AGEKTSKEAR KEAPVRGLLQ
     TRLPESVKLQ MCELLSYLCD CELQHRVEAI VAFGDIYVSK LQANQKFRYN ELMQALNMSA
     ALTARKTREF RSPPQEQINM LLNFQLGENC PCPEEIREEL YDFHEDLLVH CGVPLEEEEE
     EEEDTSWTGK LRTLVYKIKG PPKPEKEQPT EEEERCPTTL KELISQTMIR WAQEDQIQDA
     ELVRMMFNLL RRQYDSIGEL LQALRKTYTI SHASVSDTIN LLAALGQIRS LLSVRMGREE
     ELLMINGLGD IMNNKVFYQH PNLMRVLGMH ETVMEVMVNV LGTEKSQIAF PKMVASCCRF
     LCYFCRISRQ NQKAMFEHLS YLLENSSVGL ASPSMRGSTP LDVAASSVMD NNELALGLEE
     PDLEKVVTYL AGCGLQSCPM LLAKGYPDVG WNPIEGERYL SFLRFAVFVN SESVEENASV
     VVKLLIRRPE CFGPALRGEG GNGLLAAMQG AIKISESPAL DLPSQGYKRE VPEDGEEEEE
     IVHMGNAIMS FYSALIDLLG RCAPEMHLIQ TGKGEAIRIR SILRSLVPTE DLVGIISIPL
     KLPSLNKDGS VSEPDMAANF CPDHKAPMVL FLDRVYGIKD QTFLLHLLEV GFLPDLRASA
     SLDTVALSTT ESALALNRYI CSAVLPLLTR CAPLFAGTEH YTSLIDSTLQ TIYRLSKGRS
     LTKAQRDTIE ECLLAICNHL RPSMLQQLLR RLVFDVPQLN DYCKMPLKLL TNHFEQCWKY
     YCLPSGWGSY GLAVEEELHL TEKLFWGIFD SLSHKKYDPD LFRMSLPCLS AIAGALPPDY
     LDTRITATLE KQVSVDADGN FDPKPINTIN FSLPEKLEYI VTKYAEHSHD KWACEKSQSG
     WKYGISLDEN VKTHPLIRPF KTLTEKEKEI YRWPARESLK TMLAVGWTVE RTKEGEALVQ
     LRENEKLRSV SQTSQGNSYN PAPLDLSNVV LSRELQGMVE VVAENYHNIW AKKKKLELES
     KGGGSHPLLV PYDTLTAKEK FRDREKAQDL FKFLQVNGVI VSRGMKDMEL DAFSMEKRFA
     YKFLKKILKY VDSAQEFIAH LEAIVSSGKT EKSPHDQEIK FFAKVLLPLV DQYFTNHRLY
     FLSSPLKPLS SSGYASHKEK EMVASLFCKL AALVRHRISL FGSDSTTMVS CLHILAQTLD
     TRTVMKSGSE LVKAGLRAFF ESAAEDLEKT SENLKLGKFT HSRTQIKGVS QNINYTTVAL
     LPILTSIFEH VAQHQFGVDL LLGDVQISCY RILCSLYSLG TGKNIYVERQ RPALGECLAS
     LAAAIPVAFL EPTLNRYNAL SVFNTKTPRE RSILGMPDTV EEMCPDIPQL EGLMKEINDL
     AESGARYTEM PHVIEVILPM LCNYLSYWWE RGPENLSPST GPCCSKVTSE HLSLILGNIL
     KIINNNLGID EASWMKRIAV YAQPIISKAR PDLLRSHFIP TLEKLKKKAV KTVQEEEQLK
     ADGKGDTQEA ELLILDEFAI LCRDLYAFYP MLIRYVDNNR SNWLKSPDGD SDQLFRMVAE
     VFILWCKSHN FKREEQNFVI QNEINNLAFL TGDSKSKMSK AMQVKSGGQD QERKKTKRRG
     DLYSIQTSLI VAALKKMLPI GLNMCTPGDQ ELISLAKSRY SYRDTDEEVK EHLRNNLHLQ
     EKSDDPAVKW QLNLYKDVLK SEEPSNPEKT VERVQRISAA VFHLEQVEQP LRSKKAVWHK
     LLSKQRKRAV VACFRMAPLY NLPRHRSINL FLHGYQRFWI ETEEYSFEEK LVQDLAKSPK
     VEEEEEEEME KQPDPLHQII LHFSRNALTE RSKLEDDPLY TSYSSMMAKS CQSGEDEEEE
     DKEKTFEEKE MEKQKTLYQQ ARLHERGAAE MVLQMISASK GEMSPMVVET LKLGIAILNG
     GNAGVQQKML DYLKVKKDAG FFQSLSGLMQ SCSVLDLNAF ERQNKAEGLG MVTEEGTLIV
     RERGEKVLQN DEFTRDLFRF LQLLCEGHNS DFQNFLRTQM GNTTTVNVII STVDYLLRLQ
     ESISDFYWYY SGKDIIDESG QHNFSKALAV TKQIFNSLTE YIQGPCIGNQ QSLAHSRLWD
     AVVGFLHVFA NMQMKLSQDS SQIELLKELL DLLQDMVVML LSLLEGNVVN GTIGKQMVDT
     LVESSTNVEM ILKFFDMFLK LKDLTSSDTF KEYDPDGKGI ISKKEFQKAM EGQKQYTQSE
     IDFLLSCAEA DENDMFNYID FVDRFHEPAK DIGFNVAVLL TNLSEHMPND SRLKCLLDPA
     ESVLNYFEPY LGRIEIMGGA KKIERVYFEI SESSRTQWEK PQVKESKRQF IFDVVNEGGE
     QEKMELFVNF CEDTIFEMQL ASQISESDSA DRPEEEEGDE ESSYVLEING EEEEDKSFES
     ASAFAMACAS LKRNITNLLR KATLKNLRKQ YRNVKKMTAK ELVKVFFSFF WMLFVGLFQL
     FFTIVGGIFQ ILWSTVFGGG LVEGAKNIRV TKILGDMPDP TQFGIHDDAM EAERAEVAEA
     GITTELVHFV KGERGDTELM SDLFGLHPKK EGGVKHGPEV GLGDLSEIIG KDEPPTLEST
     VRKKRKAQAA ETKAEHEAEG KVESEKADLE DGEKEDKAKE EERAEYLWAE VTKKKKRRRG
     QKVEKPEAFM ANFFKGLEIY QTKLLHYLAR NFYNLRFLAL FVAFAINFIL LFYKVTEEPL
     EEETEDVANL WNSLNDEEEE EAMVFFVLQE STGYMAPTLR ALAVVHTIIS LVCVVGYYCL
     KVPLVVFKRE KEIARKLEFD GLYITEQPSE DDIKGQWDRL VINTPSFPHN YWDKFVKRKV
     INKYGDLYGA ERIAELLGLD KNALDFSPVE ETTAEAASLV SWLSSIDMKY HIWKLGVVFT
     DNSFLYLAWY TTMSVLGHYN NFFFAAHLLD IAMGFKTLRT ILSSVTHNGK QLVLTVGLLA
     VVVYLYTVVA FNFFRKFYNK SEDDDEPDMK CDDMMTCYLF HMYVGVRAGG GIGDEIEDPA
     GDPYEMYRIV FDITFFFFVI VILLAIIQGL IIDAFGELRD QQEQVREDME TKCFICGIGN
     DYFDTTPHGF ETHTLQEHNL ANYLFFLMYL INKDETEHTG QESYVWKMYQ ERCWDFFPAG
     DCFRKQYEDQ LG
//
ID   ACH8_CAEEL              Reviewed;         474 AA.
AC   Q9U298;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 122.
DE   RecName: Full=Neuronal acetylcholine receptor subunit eat-2;
DE   AltName: Full=Abnormal pharyngeal pumping eat-2;
DE   Flags: Precursor;
GN   Name=eat-2 {ECO:0000312|EMBL:CAB54450.1}; ORFNames=Y48B6A.4;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=Bristol N2 {ECO:0000269|PubMed:15020415};
RX   PubMed=15020415; DOI=10.1534/genetics.166.1.161;
RA   McKay J.P., Raizen D.M., Gottschalk A., Schafer W.R., Avery L.;
RT   "eat-2 and eat-18 are required for nicotinic neurotransmission in the
RT   Caenorhabditis elegans pharynx.";
RL   Genetics 166:161-169(2004).
RN   [2] {ECO:0000312|EMBL:CAB54450.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=8462849;
RA   Avery L.;
RT   "The genetics of feeding in Caenorhabditis elegans.";
RL   Genetics 133:897-917(1993).
RN   [4] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=8601480;
RA   Raizen D.M., Lee R.Y.N., Avery L.;
RT   "Interacting genes required for pharyngeal excitation by motor neuron
RT   MC in Caenorhabditis elegans.";
RL   Genetics 141:1365-1382(1995).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=9789046; DOI=10.1073/pnas.95.22.13091;
RA   Lakowski B., Hekimi S.;
RT   "The genetics of caloric restriction in Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:13091-13096(1998).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15141086; DOI=10.1073/pnas.0400848101;
RA   Huang C., Xiong C., Kornfeld K.;
RT   "Measurements of age-related changes of physiological processes that
RT   predict lifespan of Caenorhabditis elegans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8084-8089(2004).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and
CC       leads to opening of an ion-conducting channel across the plasma
CC       membrane (By similarity). Nicotinic acetylcholine receptor in the
CC       MC pharyngeal motor neuron involved in pharyngeal pumping. Has a
CC       role in the determination of life span possibly via calorific
CC       restriction which affects growth rate, although this is
CC       independent of metabolic activity. {ECO:0000250|UniProtKB:P22770,
CC       ECO:0000269|PubMed:15020415, ECO:0000269|PubMed:15141086,
CC       ECO:0000269|PubMed:8462849, ECO:0000269|PubMed:8601480,
CC       ECO:0000269|PubMed:9789046}.
CC   -!- SUBUNIT: Neuronal AChR seems to be composed of two different type
CC       of subunits: alpha and beta. {ECO:0000250|UniProtKB:P22770}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell
CC       membrane {ECO:0000269|PubMed:15020415}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:15020415}. Cell membrane
CC       {ECO:0000269|PubMed:15020415}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15020415}. Note=MC motor neuron.
CC       {ECO:0000269|PubMed:15020415}.
CC   -!- TISSUE SPECIFICITY: Expressed in pharyngeal muscle.
CC       {ECO:0000269|PubMed:15020415}.
CC   -!- DISRUPTION PHENOTYPE: Worms exhibit a lack of MC neurotransmission
CC       possibly explaining the observed reduction in pharyngeal pumping
CC       rate. Mutants show differences in their pharyngeal responses to
CC       nicotine. A variety of mutants show an increase in life span
CC       ranging from 29-57% longer than wild-type, extended self-fertile
CC       reproductive span, fast body movement, and a longer pharyngeal
CC       pumping span. The strongest allele (ad1113) shows retarded growth.
CC       {ECO:0000269|PubMed:15020415, ECO:0000269|PubMed:15141086}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. Acetylcholine receptor (TC 1.A.9.1) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL110490; CAB54450.1; -; Genomic_DNA.
DR   PIR; T27006; T27006.
DR   RefSeq; NP_496959.1; NM_064558.3.
DR   UniGene; Cel.8968; -.
DR   ProteinModelPortal; Q9U298; -.
DR   SMR; Q9U298; -.
DR   STRING; 6239.Y48B6A.4; -.
DR   PaxDb; Q9U298; -.
DR   EnsemblMetazoa; Y48B6A.4; Y48B6A.4; WBGene00001133.
DR   GeneID; 175072; -.
DR   KEGG; cel:CELE_Y48B6A.4; -.
DR   UCSC; Y48B6A.4; c. elegans.
DR   CTD; 175072; -.
DR   WormBase; Y48B6A.4; CE22119; WBGene00001133; eat-2.
DR   eggNOG; KOG3646; Eukaryota.
DR   eggNOG; ENOG410Z6BY; LUCA.
DR   GeneTree; ENSGT00790000122957; -.
DR   HOGENOM; HOG000006756; -.
DR   InParanoid; Q9U298; -.
DR   KO; K05312; -.
DR   OMA; FNSANEH; -.
DR   OrthoDB; EOG091G0R20; -.
DR   PhylomeDB; Q9U298; -.
DR   Reactome; R-CEL-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   PRO; PR:Q9U298; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00001133; -.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IMP:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:WormBase.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0022848; F:acetylcholine-gated cation-selective channel activity; IMP:UniProtKB.
DR   GO; GO:0001508; P:action potential; IMP:WormBase.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB.
DR   GO; GO:0030536; P:larval feeding behavior; IMP:UniProtKB.
DR   GO; GO:0048609; P:multicellular organismal reproductive process; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0043050; P:pharyngeal pumping; IMP:UniProtKB.
DR   GO; GO:1904000; P:positive regulation of eating behavior; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0061063; P:positive regulation of nematode larval development; IMP:UniProtKB.
DR   GO; GO:0060378; P:regulation of brood size; IMP:UniProtKB.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; IMP:WormBase.
DR   GO; GO:0043051; P:regulation of pharyngeal pumping; IMP:WormBase.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Complete proteome; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    474       Neuronal acetylcholine receptor subunit
FT                                eat-2. {ECO:0000255}.
FT                                /FTId=PRO_0000306253.
FT   TOPO_DOM     22    237       Extracellular. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TRANSMEM    303    323       Helical. {ECO:0000255}.
FT   TOPO_DOM    324    440       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    441    461       Helical. {ECO:0000255}.
FT   COMPBIAS    422    427       Poly-Glu. {ECO:0000255}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    149    163       {ECO:0000250|UniProtKB:P22770}.
SQ   SEQUENCE   474 AA;  55042 MW;  AAAA3786CEAEB02F CRC64;
     MTLKIAFFTL ILLVSIERVY SSDEEYRLLK DLREGYDPVE RPVADHRKPV NVKLRLILQQ
     LVDVDERNQV ITLVVWNQYT WNDYKLRWSP EEYGNITTLQ IPHGTLWKPD ILLFNSANEH
     FDASFPVHMV VSSNGDVLFA PPGIVSFSCS LSMTWFPYDQ QVCYLKFGSW TYGKKLDLQI
     DDSDLPDGHK MDLQYYIPNG EFDLLATPAF RKSTTFLDET YVELYFHMHL KRRTMYYGLN
     WIVPSILISL SNILGFTMPP ECGEKITLQI TNFLSVMVFL AMVSEVAPPT SESIPIIAAF
     FSLSIVILGL SICASLIIVN IFFRHPKTHR MGDWTRYVFL EWLPWFLLMS RPEHTFCRPR
     REEEKNDEEA GGDGTKLLEN QQHQPRPRLL VNSQLVMDST VPYLEEIIGY LKVFKAKLDD
     DEEEEEEILN WRFMAMVIDR LSLFLFTGLI FGTTALIFAF CPNLFTDSPI VDIE
//
ID   ACC4_CAEEL              Reviewed;         408 AA.
AC   Q9U358;
DT   22-NOV-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   20-DEC-2017, entry version 126.
DE   RecName: Full=Acetylcholine-gated ion channel acc-4 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=acc-4 {ECO:0000303|PubMed:15579462,
GN   ECO:0000312|WormBase:T27E9.9};
GN   ORFNames=T27E9.9 {ECO:0000312|WormBase:T27E9.9};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBUNIT.
RX   PubMed=15579462; DOI=10.1074/jbc.M412644200;
RA   Putrenko I., Zakikhani M., Dent J.A.;
RT   "A family of acetylcholine-gated chloride channel subunits in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 280:6392-6398(2005).
RN   [2] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=26705699; DOI=10.7554/eLife.12432;
RA   Pereira L., Kratsios P., Serrano-Saiz E., Sheftel H., Mayo A.E.,
RA   Hall D.H., White J.G., LeBoeuf B., Garcia L.R., Alon U., Hobert O.;
RT   "A cellular and regulatory map of the cholinergic nervous system of C.
RT   elegans.";
RL   Elife 4:12432-12477(2015).
RN   [4] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27782882; DOI=10.7554/eLife.21734;
RA   Takayanagi-Kiya S., Zhou K., Jin Y.;
RT   "Release-dependent feedback inhibition by a presynaptically localized
RT   ligand-gated anion channel.";
RL   Elife 5:21734-21749(2016).
CC   -!- FUNCTION: Probable acetylcholine-gated chloride channel subunit
CC       (PubMed:15579462). Does not have ion channel activity alone as a
CC       homopentamer, but forms a functional heteropentameric ion channel
CC       with acc-1 (PubMed:15579462). May function with lgc-46 to regulate
CC       synaptic transmission and synaptic vesicle release in response to
CC       acetylcholine in cholinergic motor neurons (PubMed:27782882).
CC       {ECO:0000269|PubMed:15579462, ECO:0000269|PubMed:27782882}.
CC   -!- SUBUNIT: Does not form a functional homopentameric ion channel.
CC       Forms a functional heteropentameric ion channel composed of acc-1
CC       and acc-4. May interact with acc-2; the interaction does not
CC       result in significant heteropentameric ion channel activity.
CC       {ECO:0000269|PubMed:15579462}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell
CC       membrane {ECO:0000269|PubMed:27782882}; Multi-pass membrane
CC       protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- TISSUE SPECIFICITY: Expressed in all cholinergic motor neurons
CC       except for ASJ and RIB neurons. Also expressed in AVF neurons.
CC       {ECO:0000269|PubMed:26705699}.
CC   -!- DISRUPTION PHENOTYPE: Grossly normal movement. In addition, in
CC       response to induced acetylcholine release, there is prolonged and
CC       slow decay of excitory postsynaptic currents which results in
CC       increased release of synaptic vesicles during that late phase of
CC       synaptic vesicle release in cholinergic motor neurons. Knockout in
CC       an lgc-46 gain of function mutant background suppresses the slow
CC       locomotion defect in the single lgc-46 gain of function mutant.
CC       Knockout together with gain of function mutations in lgc-46 and
CC       acr-2 suppresses the convulsion defects in the double lgc-46 and
CC       acr-2 double gain of function mutant.
CC       {ECO:0000269|PubMed:27782882}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX284603; CAB04879.2; -; Genomic_DNA.
DR   PIR; E88613; E88613.
DR   PIR; T25376; T25376.
DR   RefSeq; NP_499789.1; NM_067388.4.
DR   UniGene; Cel.8920; -.
DR   ProteinModelPortal; Q9U358; -.
DR   STRING; 6239.T27E9.9; -.
DR   PaxDb; Q9U358; -.
DR   EnsemblMetazoa; T27E9.9; T27E9.9; WBGene00012099.
DR   GeneID; 176778; -.
DR   KEGG; cel:CELE_T27E9.9; -.
DR   UCSC; T27E9.9; c. elegans.
DR   CTD; 176778; -.
DR   WormBase; T27E9.9; CE24020; WBGene00012099; acc-4.
DR   eggNOG; KOG3644; Eukaryota.
DR   eggNOG; ENOG410XP43; LUCA.
DR   GeneTree; ENSGT00760000119010; -.
DR   HOGENOM; HOG000016259; -.
DR   InParanoid; Q9U358; -.
DR   OMA; WILSSMA; -.
DR   OrthoDB; EOG091G07NS; -.
DR   PhylomeDB; Q9U358; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00012099; -.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro.
DR   Gene3D; 1.20.58.390; -; 1.
DR   Gene3D; 2.70.170.10; -; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945; PTHR18945; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF63712; SSF63712; 1.
DR   SUPFAM; SSF90112; SSF90112; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    408       Acetylcholine-gated ion channel acc-4.
FT                                {ECO:0000305}.
FT                                /FTId=PRO_5004333882.
FT   TOPO_DOM     18    262       Extracellular. {ECO:0000305}.
FT   TRANSMEM    263    283       Helical. {ECO:0000255}.
FT   TOPO_DOM    284    295       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    296    316       Helical. {ECO:0000255}.
FT   TOPO_DOM    317    325       Extracellular. {ECO:0000305}.
FT   TRANSMEM    326    346       Helical. {ECO:0000255}.
FT   TOPO_DOM    347    380       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    381    401       Helical. {ECO:0000255}.
FT   TOPO_DOM    402    408       Extracellular. {ECO:0000305}.
FT   CARBOHYD     39     39       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    223    223       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    178    192       {ECO:0000250|UniProtKB:P02712}.
SQ   SEQUENCE   408 AA;  46218 MW;  F2D7348DE2319081 CRC64;
     MRLIILVISI LISNAGSLLR SLEDDSNECM FNCPKRARNV SVPHTEKTCM GDDAIIAQIL
     DGYNKLDLPG GGHVVVSIEI WVQEVSKIIE ITSEFELDIY VTERWTDPSL AYSHLNPCKS
     NMSVDGATIL NKIWNPHACF VNSKLANIHE SPFKNIFLQI YSNGSIWHNY RIKLTGPCSS
     TLRTFPIDQQ RCMLFYESFT HNTDQVKMEW ITTVPPITIL KGNITLPDYV LVDFSSSSEL
     RLYPPGIFNE LIATFTFQRL YGFYILQVYV PAYISVFISW VSFTLGAEQI PSRTTVGVNS
     LLALTFQFGA VVNNLPKTSD VKAIDVWILS SMAFIFASLI ELAVVGYLSR DGQHGSIKCR
     CSWLCMNCKD WTALKIDQMS SIVFPVSFLA FNIWYWFIFL GKLLVRTI
//
ID   HCN2_HUMAN              Reviewed;         889 AA.
AC   Q9UL51; O60742; O60743; O75267; Q9UBS2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 3.
DT   25-OCT-2017, entry version 151.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2;
DE   AltName: Full=Brain cyclic nucleotide-gated channel 2;
DE            Short=BCNG-2;
GN   Name=HCN2; Synonyms=BCNG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10524219; DOI=10.1016/S0167-4781(99)00092-5;
RA   Vaccari T., Moroni A., Rocchi M., Gorza L., Bianchi M.E., Beltrame M.,
RA   DiFrancesco D.;
RT   "The human gene coding for HCN2, a pacemaker channel of the heart.";
RL   Biochim. Biophys. Acta 1446:419-425(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10228147; DOI=10.1093/emboj/18.9.2323;
RA   Ludwig A., Zong X., Stieber J., Hullin R., Hofmann F., Biel M.;
RT   "Two pacemaker channels from human heart with profoundly different
RT   activation kinetics.";
RL   EMBO J. 18:2323-2329(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 147-743, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9630217; DOI=10.1016/S0092-8674(00)81434-8;
RA   Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R.,
RA   Siegelbaum S.A., Tibbs G.R.;
RT   "Identification of a gene encoding a hyperpolarization-activated
RT   'pacemaker' channel of brain.";
RL   Cell 93:717-729(1998).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 470-672 IN COMPLEX WITH CAMP,
RP   NUCLEOTIDE-BINDING, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=22006928; DOI=10.1074/jbc.M111.297606;
RA   Lolicato M., Nardini M., Gazzarrini S., Moller S., Bertinetti D.,
RA   Herberg F.W., Bolognesi M., Martin H., Fasolini M., Bertrand J.A.,
RA   Arrigoni C., Thiel G., Moroni A.;
RT   "Tetramerization dynamics of C-terminal domain underlies isoform-
RT   specific cAMP gating in hyperpolarization-activated cyclic nucleotide-
RT   gated channels.";
RL   J. Biol. Chem. 286:44811-44820(2011).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak
CC       selectivity for potassium over sodium ions. Contributes to the
CC       native pacemaker currents in heart (If) and in neurons (Ih). Can
CC       also transport ammonium in the distal nephron. Produces a large
CC       instantaneous current. Modulated by intracellular chloride ions
CC       and pH; acidic pH shifts the activation to more negative voltages
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10524219}.
CC   -!- ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher
CC       concentrations, also by cGMP. cAMP binding causes a conformation
CC       change that leads to the assembly of an active tetramer and
CC       channel opening. Channel activity is modulated by intracellular
CC       chloride ions and pH; acidic pH shifts the activation to more
CC       negative voltages. {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:22006928}.
CC   -!- SUBUNIT: The potassium channel is composed of a homo- or
CC       heterotetrameric complex of pore-forming subunits. Heterotetramer
CC       with HCN1. Forms an obligate 4:4 complex with accessory subunit
CC       PEX5L. Interacts with KCNE2 (By similarity). Homotetramer.
CC       {ECO:0000250, ECO:0000269|PubMed:22006928}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1751885, EBI-1751885;
CC       Q4ACU6-1:Shank3 (xeno); NbExp=3; IntAct=EBI-1751885, EBI-16201983;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10524219}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10228147, ECO:0000269|PubMed:10524219}.
CC   -!- TISSUE SPECIFICITY: Highly expressed throughout the brain.
CC       Detected at low levels in heart. {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:9630217}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- PTM: Phosphorylation at Ser-668 by PRKG2 shifts the voltage-
CC       dependence to more negative voltages, hence counteracting the
CC       stimulatory effect of cGMP on gating. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Inhibited by extracellular cesium ions.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF065164; AAC28444.2; -; mRNA.
DR   EMBL; AJ012582; CAB42602.1; -; mRNA.
DR   EMBL; AJ133727; CAB42630.1; -; Genomic_DNA.
DR   EMBL; AJ133728; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133729; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133730; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133731; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133732; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133733; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AJ133734; CAB42630.1; JOINED; Genomic_DNA.
DR   EMBL; AC004449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005559; AAC33280.2; -; Genomic_DNA.
DR   EMBL; AF064877; AAC39760.1; -; mRNA.
DR   CCDS; CCDS12035.1; -.
DR   RefSeq; NP_001185.3; NM_001194.3.
DR   UniGene; Hs.124161; -.
DR   PDB; 2MPF; NMR; -; A=521-672.
DR   PDB; 3U10; X-ray; 2.30 A; A=470-672.
DR   PDBsum; 2MPF; -.
DR   PDBsum; 3U10; -.
DR   ProteinModelPortal; Q9UL51; -.
DR   SMR; Q9UL51; -.
DR   BioGrid; 107081; 4.
DR   DIP; DIP-52285N; -.
DR   IntAct; Q9UL51; 6.
DR   STRING; 9606.ENSP00000251287; -.
DR   BindingDB; Q9UL51; -.
DR   ChEMBL; CHEMBL1795172; -.
DR   DrugBank; DB02527; Cyclic Adenosine Monophosphate.
DR   DrugBank; DB02315; Cyclic Guanosine Monophosphate.
DR   GuidetoPHARMACOLOGY; 401; -.
DR   TCDB; 1.A.1.5.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9UL51; -.
DR   PhosphoSitePlus; Q9UL51; -.
DR   BioMuta; HCN2; -.
DR   DMDM; 108935843; -.
DR   MaxQB; Q9UL51; -.
DR   PaxDb; Q9UL51; -.
DR   PeptideAtlas; Q9UL51; -.
DR   PRIDE; Q9UL51; -.
DR   DNASU; 610; -.
DR   Ensembl; ENST00000251287; ENSP00000251287; ENSG00000099822.
DR   GeneID; 610; -.
DR   KEGG; hsa:610; -.
DR   UCSC; uc002lpe.3; human.
DR   CTD; 610; -.
DR   DisGeNET; 610; -.
DR   EuPathDB; HostDB:ENSG00000099822.2; -.
DR   GeneCards; HCN2; -.
DR   HGNC; HGNC:4846; HCN2.
DR   MIM; 602781; gene.
DR   neXtProt; NX_Q9UL51; -.
DR   OpenTargets; ENSG00000099822; -.
DR   PharmGKB; PA78; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039489; -.
DR   InParanoid; Q9UL51; -.
DR   KO; K04955; -.
DR   OMA; CPQVARP; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; Q9UL51; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   GeneWiki; HCN2; -.
DR   GenomeRNAi; 610; -.
DR   PRO; PR:Q9UL51; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000099822; -.
DR   CleanEx; HS_HCN2; -.
DR   Genevisible; Q9UL51; HS.
DR   GO; GO:0098855; C:HCN channel complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; IDA:UniProtKB.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cAMP; cAMP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    889       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                2.
FT                                /FTId=PRO_0000054111.
FT   TOPO_DOM      1    215       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    216    236       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    237    240       Extracellular. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    262    288       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    310    317       Extracellular. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    339    369       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    370    390       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    391    413       Extracellular. {ECO:0000255}.
FT   INTRAMEM    414    435       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    436    440       Extracellular. {ECO:0000255}.
FT   TRANSMEM    441    461       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    462    889       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     608    611       cAMP. {ECO:0000269|PubMed:22006928}.
FT   NP_BIND     618    619       cAMP. {ECO:0000269|PubMed:22006928}.
FT   NP_BIND     659    662       cAMP. {ECO:0000269|PubMed:22006928}.
FT   REGION      158    209       Involved in subunit assembly.
FT                                {ECO:0000250}.
FT   COMPBIAS     10    140       Pro-rich.
FT   COMPBIAS    715    861       Pro-rich.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     161    161       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     668    668       Phosphoserine; by PKG/PRKG2.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     754    754       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA9}.
FT   MOD_RES     756    756       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     771    771       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     779    779       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     786    786       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     866    866       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   MOD_RES     868    868       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88703}.
FT   CARBOHYD    407    407       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     527    527       R -> Q (in dbSNP:rs55687900).
FT                                /FTId=VAR_061106.
FT   CONFLICT     17     20       TPAP -> SPTT (in Ref. 1; AAC28444).
FT                                {ECO:0000305}.
FT   CONFLICT     29     29       A -> R (in Ref. 1; AAC28444).
FT                                {ECO:0000305}.
FT   CONFLICT     32     32       Q -> K (in Ref. 1; AAC28444).
FT                                {ECO:0000305}.
FT   CONFLICT    294    294       D -> V (in Ref. 4; AAC39760).
FT                                {ECO:0000305}.
FT   CONFLICT    713    713       L -> F (in Ref. 4; AAC39760).
FT                                {ECO:0000305}.
FT   CONFLICT    849    849       G -> R (in Ref. 2; CAB42602/CAB42630).
FT                                {ECO:0000305}.
FT   HELIX       471    489       {ECO:0000244|PDB:3U10}.
FT   HELIX       494    508       {ECO:0000244|PDB:3U10}.
FT   HELIX       515    520       {ECO:0000244|PDB:3U10}.
FT   HELIX       524    534       {ECO:0000244|PDB:3U10}.
FT   HELIX       536    540       {ECO:0000244|PDB:3U10}.
FT   TURN        543    547       {ECO:0000244|PDB:3U10}.
FT   HELIX       550    557       {ECO:0000244|PDB:3U10}.
FT   STRAND      561    565       {ECO:0000244|PDB:3U10}.
FT   STRAND      570    572       {ECO:0000244|PDB:3U10}.
FT   STRAND      576    578       {ECO:0000244|PDB:2MPF}.
FT   STRAND      580    586       {ECO:0000244|PDB:3U10}.
FT   STRAND      589    592       {ECO:0000244|PDB:3U10}.
FT   STRAND      598    601       {ECO:0000244|PDB:3U10}.
FT   STRAND      606    608       {ECO:0000244|PDB:3U10}.
FT   HELIX       610    614       {ECO:0000244|PDB:3U10}.
FT   STRAND      619    626       {ECO:0000244|PDB:3U10}.
FT   STRAND      628    634       {ECO:0000244|PDB:3U10}.
FT   HELIX       635    644       {ECO:0000244|PDB:3U10}.
FT   HELIX       646    661       {ECO:0000244|PDB:3U10}.
FT   TURN        662    664       {ECO:0000244|PDB:3U10}.
FT   HELIX       668    670       {ECO:0000244|PDB:3U10}.
SQ   SEQUENCE   889 AA;  96950 MW;  4B263E0C06C2A47D CRC64;
     MDARGGGGRP GESPGATPAP GPPPPPPPAP PQQQPPPPPP PAPPPGPGPA PPQHPPRAEA
     LPPEAADEGG PRGRLRSRDS SCGRPGTPGA ASTAKGSPNG ECGRGEPQCS PAGPEGPARG
     PKVSFSCRGA ASGPAPGPGP AEEAGSEEAG PAGEPRGSQA SFMQRQFGAL LQPGVNKFSL
     RMFGSQKAVE REQERVKSAG AWIIHPYSDF RFYWDFTMLL FMVGNLIIIP VGITFFKDET
     TAPWIVFNVV SDTFFLMDLV LNFRTGIVIE DNTEIILDPE KIKKKYLRTW FVVDFVSSIP
     VDYIFLIVEK GIDSEVYKTA RALRIVRFTK ILSLLRLLRL SRLIRYIHQW EEIFHMTYDL
     ASAVMRICNL ISMMLLLCHW DGCLQFLVPM LQDFPRNCWV SINGMVNHSW SELYSFALFK
     AMSHMLCIGY GRQAPESMTD IWLTMLSMIV GATCYAMFIG HATALIQSLD SSRRQYQEKY
     KQVEQYMSFH KLPADFRQKI HDYYEHRYQG KMFDEDSILG ELNGPLREEI VNFNCRKLVA
     SMPLFANADP NFVTAMLTKL KFEVFQPGDY IIREGTIGKK MYFIQHGVVS VLTKGNKEMK
     LSDGSYFGEI CLLTRGRRTA SVRADTYCRL YSLSVDNFNE VLEEYPMMRR AFETVAIDRL
     DRIGKKNSIL LHKVQHDLNS GVFNNQENAI IQEIVKYDRE MVQQAELGQR VGLFPPPPPP
     PQVTSAIATL QQAAAMSFCP QVARPLVGPL ALGSPRLVRR PPPGPAPAAA SPGPPPPASP
     PGAPASPRAP RTSPYGGLPA APLAGPALPA RRLSRASRPL SASQPSLPHG APGPAASTRP
     ASSSTPRLGP TPAARAAAPS PDRRDSASPG AAGGLDPQDS ARSRLSSNL
//
ID   IR93A_DROME             Reviewed;         868 AA.
AC   Q9VDH6; Q8IH81; Q8T0V7; Q9VDH7;
DT   15-FEB-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 3.
DT   25-OCT-2017, entry version 117.
DE   RecName: Full=Ionotropic receptor 93a {ECO:0000303|PubMed:27161501};
DE   Flags: Precursor;
GN   Name=Ir93a {ECO:0000303|PubMed:27161501,
GN   ECO:0000312|FlyBase:FBgn0259215};
GN   ORFNames=CG42315 {ECO:0000312|FlyBase:FBgn0259215};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000312|EMBL:AAL39173.1, ECO:0000312|EMBL:AAN71127.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 232-868 AND 344-868.
RC   STRAIN=Berkeley; TISSUE=Head, and Testis;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27161501; DOI=10.1016/j.cub.2016.03.049;
RA   Enjin A., Zaharieva E.E., Frank D.D., Mansourian S., Suh G.S.,
RA   Gallio M., Stensmyr M.C.;
RT   "Humidity Sensing in Drosophila.";
RL   Curr. Biol. 26:1352-1358(2016).
RN   [5] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=27656904; DOI=10.7554/eLife.17879;
RA   Knecht Z.A., Silbering A.F., Ni L., Klein M., Budelli G., Bell R.,
RA   Abuin L., Ferrer A.J., Samuel A.D., Benton R., Garrity P.A.;
RT   "Distinct combinations of variant ionotropic glutamate receptors
RT   mediate thermosensation and hygrosensation in Drosophila.";
RL   Elife 5:0-0(2016).
CC   -!- FUNCTION: Integral part of various neural sensory systems in the
CC       antenna that provide the neural basis for the response to
CC       environmental changes in temperature (thermosensation) and
CC       humidity (hygrosensation) (PubMed:27161501, PubMed:27656904).
CC       Together with Ir21a and Ir25a, mediates the response of the larval
CC       dorsal organ cool cells, a trio of cool-responsive neurons, to
CC       cooling and is required for cool avoidance behavior
CC       (PubMed:27656904, PubMed:27161501). Together with Ir25a and Ir40a,
CC       mediates the response of the hydrosensory sacculus neurons to
CC       changes in relative humidity, and is required for dry detection
CC       and humidiy preference behavior (PubMed:27656904,
CC       PubMed:27161501). {ECO:0000269|PubMed:27161501,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: In the antenna, detected in sacculus neurons
CC       which innervate the first and second chambers (at protein level)
CC       (PubMed:27656904). Expressed in multiple cells of the larval
CC       dorsal organ ganglion, including the dorsal organ cool cells where
CC       it is predominately localized to the dendritic bulbs (at protein
CC       level). {ECO:0000269|PubMed:27656904}.
CC   -!- DISRUPTION PHENOTYPE: Impaired response to environmental cues such
CC       as temperature and humidity (PubMed:27161501, PubMed:27656904).
CC       Response of dorsal organ cool cells to changes in temperature is
CC       abolished and consequently larvae fail to avoid cool temperatures
CC       (PubMed:27161501, PubMed:27656904). Response of sacculus neurons
CC       to changes in humidity is abolished and consequently larvae fail
CC       to move towards their preferred humidity (PubMed:27161501,
CC       PubMed:27656904). {ECO:0000269|PubMed:27161501,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN71127.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014297; AAF55817.3; -; Genomic_DNA.
DR   EMBL; AY069028; AAL39173.1; -; mRNA.
DR   EMBL; BT001372; AAN71127.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_650924.3; NM_142667.3.
DR   UniGene; Dm.2328; -.
DR   ProteinModelPortal; Q9VDH6; -.
DR   STRING; 7227.FBpp0288996; -.
DR   PaxDb; Q9VDH6; -.
DR   PRIDE; Q9VDH6; -.
DR   EnsemblMetazoa; FBtr0336970; FBpp0307913; FBgn0259215.
DR   GeneID; 42471; -.
DR   KEGG; dme:Dmel_CG42315; -.
DR   UCSC; CG42315-RA; d. melanogaster.
DR   CTD; 42471; -.
DR   FlyBase; FBgn0259215; Ir93a.
DR   eggNOG; ENOG410ISQY; Eukaryota.
DR   eggNOG; ENOG4110QDS; LUCA.
DR   GeneTree; ENSGT00740000116186; -.
DR   InParanoid; Q9VDH6; -.
DR   KO; K05313; -.
DR   OMA; APLKEMR; -.
DR   OrthoDB; EOG091G02L4; -.
DR   GenomeRNAi; 42471; -.
DR   PRO; PR:Q9VDH6; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0259215; -.
DR   Genevisible; Q9VDH6; DM.
DR   GO; GO:0016021; C:integral component of membrane; ISM:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; ISM:FlyBase.
DR   GO; GO:0007610; P:behavior; IEA:UniProtKB-KW.
DR   GO; GO:0050907; P:detection of chemical stimulus involved in sensory perception; IEP:FlyBase.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   Pfam; PF00060; Lig_chan; 1.
PE   1: Evidence at protein level;
KW   Behavior; Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Sensory transduction; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    868       Ionotropic receptor 93a. {ECO:0000255}.
FT                                /FTId=PRO_5004334488.
FT   TOPO_DOM     29    565       Extracellular. {ECO:0000305}.
FT   TRANSMEM    566    586       Helical. {ECO:0000255}.
FT   TOPO_DOM    587    642       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    643    663       Helical. {ECO:0000255}.
FT   TOPO_DOM    664    832       Extracellular. {ECO:0000305}.
FT   TRANSMEM    833    853       Helical. {ECO:0000255}.
FT   TOPO_DOM    854    868       Cytoplasmic. {ECO:0000305}.
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    294    294       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    432    432       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    475    475       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    499    499       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    543    543       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CONFLICT    494    494       T -> A (in Ref. 3; AAN71127).
FT                                {ECO:0000305}.
FT   CONFLICT    812    812       N -> S (in Ref. 3; AAN71127).
FT                                {ECO:0000305}.
SQ   SEQUENCE   868 AA;  99639 MW;  28BD2D1BDF1B46EF CRC64;
     MNPGEMRPSA CLLLLAGLQL SILVPTEAND FSSFLSANAS LAVVVDHEYM TVHGENILAH
     FEKILSDVIR ENLRNGGINV KYFSWNAVRL KKDFLAAITV TDCENTWNFY KNTQETSILL
     IAITDSDCPR LPLNRALMVP IVENGDEFPQ LILDAKVQQI LNWKTAVVFV DQTILEENAL
     LVKSIVHESI TNHITPISLI LYEINDSLRG QQKRVALRQA LSQFAPKKHE EMRQQFLVIS
     AFHEDIIEIA ETLNMFHVGN QWMIFVLDMV ARDFDAGTVT INLDEGANIA FALNETDPNC
     QDSLNCTISE ISLALVNAIS KITVEEESIY GEISDEEWEA IRFTKQEKQA EILEYMKEFL
     KTNAKCSSCA RWRVETAITW GKSQENRKFR STPQRDAKNR NFEFINIGYW TPVLGFVCQE
     LAFPHIEHHF RNITMDILTV HNPPWQILTK NSNGVIVEHK GIVMEIVKEL SRALNFSYYL
     HEASAWKEED SLSTSAGGNE SDELVGSMTF RIPYRVVEMV QGNQFFIAAV AATVEDPDQK
     PFNYTQPISV QKYSFITRKP DEVSRIYLFT APFTVETWFC LMGIILLTAP TLYAINRLAP
     LKEMRIVGLS TVKSCFWYIF GALLQQGGMY LPTADSGRLV VGFWWIVVIV LVTTYCGNLV
     AFLTFPKFQP GVDYLNQLED HKDIVQYGLR NGTFFERYVQ STTREDFKHY LERAKIYGSA
     QEEDIEAVKR GERINIDWRI NLQLIVQRHF EREKECHFAL GRESFVDEQI AMIVPAQSAY
     LHLVNRHIKS MFRMGFIERW HQMNLPSAGK CNGKSAQRQV TNHKVNMDDM QGCFLVLLLG
     FTLALLIVCG EFWYRRFRAS RKRRQFTN
//
ID   IR21A_DROME             Reviewed;         842 AA.
AC   Q9VPI2;
DT   06-JUL-2016, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   27-SEP-2017, entry version 115.
DE   RecName: Full=Ionotropic receptor 21a {ECO:0000312|EMBL:AAF51569.2};
DE   Flags: Precursor;
GN   Name=Ir21a {ECO:0000312|FlyBase:FBgn0031209};
GN   ORFNames=CG2657 {ECO:0000312|FlyBase:FBgn0031209};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=19135896; DOI=10.1016/j.cell.2008.12.001;
RA   Benton R., Vannice K.S., Gomez-Diaz C., Vosshall L.B.;
RT   "Variant ionotropic glutamate receptors as chemosensory receptors in
RT   Drosophila.";
RL   Cell 136:149-162(2009).
RN   [4] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=27126188; DOI=10.7554/eLife.13254;
RA   Ni L., Klein M., Svec K.V., Budelli G., Chang E.C., Ferrer A.J.,
RA   Benton R., Samuel A.D., Garrity P.A.;
RT   "The ionotropic receptors IR21a and IR25a mediate cool sensing in
RT   Drosophila.";
RL   Elife 5:0-0(2016).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=27656904; DOI=10.7554/eLife.17879;
RA   Knecht Z.A., Silbering A.F., Ni L., Klein M., Budelli G., Bell R.,
RA   Abuin L., Ferrer A.J., Samuel A.D., Benton R., Garrity P.A.;
RT   "Distinct combinations of variant ionotropic glutamate receptors
RT   mediate thermosensation and hygrosensation in Drosophila.";
RL   Elife 5:0-0(2016).
CC   -!- FUNCTION: Integral part of a neural sensory system in the antenna
CC       that provides the neural basis for the response to environmental
CC       changes in temperature (thermosensation) (PubMed:27126188,
CC       PubMed:27656904). Together with Ir25a and Ir93a, mediates the
CC       response of the dorsal organ cool cells, a trio of cool-responsive
CC       neurons, to cooling and is required for cool avoidance behavior
CC       (PubMed:27126188, PubMed:27656904). {ECO:0000269|PubMed:27126188,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in the dorsal organ cool cells
CC       (PubMed:27126188). In the antenna, expressed in approximately six
CC       neurons in the arista as well as five to ten neurons near the
CC       third chamber of the sacculus (PubMed:19135896).
CC       {ECO:0000269|PubMed:19135896, ECO:0000269|PubMed:27126188}.
CC   -!- DISRUPTION PHENOTYPE: Strong disruption of larval thermotaxis when
CC       exposed to a thermal gradient ranging from 13.5 to 21.5 degrees
CC       Celsius with mutants unable to navigate away from cooler
CC       temperatures and toward warmer temperatures (PubMed:27126188).
CC       Reduced response of dorsal organ cool cells to cooling
CC       (PubMed:27126188, PubMed:27656904). No effect on humidity
CC       preference (PubMed:27656904). {ECO:0000269|PubMed:27126188,
CC       ECO:0000269|PubMed:27656904}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC
CC       1.A.10.1) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE014134; AAF51569.2; -; Genomic_DNA.
DR   RefSeq; NP_001097043.1; NM_001103573.2.
DR   UniGene; Dm.32762; -.
DR   ProteinModelPortal; Q9VPI2; -.
DR   STRING; 7227.FBpp0111921; -.
DR   PaxDb; Q9VPI2; -.
DR   PRIDE; Q9VPI2; -.
DR   EnsemblMetazoa; FBtr0113008; FBpp0111921; FBgn0031209.
DR   GeneID; 33157; -.
DR   KEGG; dme:Dmel_CG2657; -.
DR   UCSC; CG2657-RB; d. melanogaster.
DR   CTD; 33157; -.
DR   FlyBase; FBgn0031209; Ir21a.
DR   eggNOG; KOG1052; Eukaryota.
DR   eggNOG; ENOG4110K6E; LUCA.
DR   InParanoid; Q9VPI2; -.
DR   OMA; NCKSYIL; -.
DR   OrthoDB; EOG091G039T; -.
DR   PhylomeDB; Q9VPI2; -.
DR   GenomeRNAi; 33157; -.
DR   PRO; PR:Q9VPI2; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0031209; -.
DR   Genevisible; Q9VPI2; DM.
DR   GO; GO:0016021; C:integral component of membrane; ISM:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; ISM:FlyBase.
DR   GO; GO:0007610; P:behavior; IEA:UniProtKB-KW.
DR   GO; GO:0050907; P:detection of chemical stimulus involved in sensory perception; IEP:FlyBase.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   Pfam; PF00060; Lig_chan; 1.
PE   2: Evidence at transcript level;
KW   Behavior; Cell membrane; Complete proteome; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL        1     15       {ECO:0000255}.
FT   CHAIN        16    842       Ionotropic receptor 21a.
FT                                /FTId=PRO_5004338393.
FT   TRANSMEM    405    425       Helical. {ECO:0000255}.
FT   TRANSMEM    437    457       Helical. {ECO:0000255}.
FT   TRANSMEM    479    499       Helical. {ECO:0000255}.
FT   TRANSMEM    680    700       Helical. {ECO:0000255}.
FT   CARBOHYD    325    325       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    469    469       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    533    533       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    558    558       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    583    583       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    588    588       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    765    765       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    797    797       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
SQ   SEQUENCE   842 AA;  95565 MW;  19BA304DEE4F8B2C CRC64;
     MSYYWVALVL FTAQAFSIEG DRSASYQEKC ISRRLINHYQ LNKEIFGVGM CDGNNENEFR
     QKRRIVPTFQ GNPRPRGELL ASKFHVNSYN FEQTNSLVGL VNKIAQEYLN KCPPVIYYDS
     FVEKSDGLIL ENLFKTIPIT FYHGEINADY EAKNKRFTSH IDCNCKSYIL FLSDPLMTRK
     ILGPQTESRV VLVSRSTQWR LRDFLSSELS SNIVNLLVIG ESLMADPMRE RPYVLYTHKL
     YADGLGSNTP VVLTSWIKGA LSRPHINLFP SKFQFGFAGH RFQISAANQP PFIFRIRTLD
     SSGMGQLRWD GVEFRLLTMI SKRLNFSIDI TETPTRSNTR GVVDTIQEQI IERTVDIGMS
     GIYITQERLM DSAMSVGHSP DCAAFITLAS KALPKYRAIM GPFQWPVWVA LICVYLGGIF
     PIVFTDRLTL SHLMGNWGEV ENMFWYVFGM FTNAFSFTGK YSWSNTRKNS TRLLIGAYWL
     FTIIITSCYT GSIIAFVTLP AFPDTVDSVL DLLGLFFRVG TLNNGGWETW FQNSTHIPTS
     RLYKKMEFVG SVDEGIGNVT QSFFWNYAFL GSKAQLEYLV QSNFSDENIS RRSALHLSEE
     CFALFQIGFL FPRESVYKIK IDSMILLAQQ SGLIAKINNE VSWVMQRSSS GRLLQASSSN
     SLREIIQEER QLTTADTEGM FLLMALGYFL GATALVSEIV GGITNKCRQI IKRSRKSAAS
     SWSSASSGSM LRTNAEQLSH DKRKANRREA AEVAQKMSFG MRELNLTRAT LREIYGSYGA
     PETDHGQLDI VHTEFPNSSA KLNNIEDEES REALESLQRL DEFMDQMDND GNPSSHTFRI
     DN
//
ID   ITPR_CAEEL              Reviewed;        2892 AA.
AC   Q9Y0A1; D3NQ87; G5EBF6; Q8MXI9; Q9U3B3; Q9Y0A0;
DT   16-OCT-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   20-DEC-2017, entry version 142.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor itr-1 {ECO:0000303|PubMed:10499793};
DE   AltName: Full=IP3 receptor {ECO:0000303|PubMed:10499793};
DE            Short=IP3R {ECO:0000303|PubMed:10499793};
DE            Short=InsP3R {ECO:0000303|PubMed:10610772};
DE   AltName: Full=LET-23 fertility effector 1 {ECO:0000303|PubMed:9491893};
GN   Name=itr-1 {ECO:0000312|EMBL:CCD63763.1,
GN   ECO:0000312|WormBase:F33D4.2a};
GN   Synonyms=dec-4 {ECO:0000303|PubMed:10499793},
GN   lfe-1 {ECO:0000303|PubMed:9491893}; ORFNames=F33D4.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAF05302.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM F), FUNCTION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF GLY-103 AND CYS-1571.
RC   STRAIN=Bristol N2 {ECO:0000269|PubMed:10499793};
RX   PubMed=10499793; DOI=10.1016/S0092-8674(00)81510-X;
RA   Dal Santo P., Logan M.A., Chisholm A.D., Jorgensen E.M.;
RT   "The inositol trisphosphate receptor regulates a 50-second behavioral
RT   rhythm in C. elegans.";
RL   Cell 98:757-767(1999).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAB45861.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; D; E AND F), FUNCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DOMAIN.
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CAB45861.1};
RX   PubMed=10610772; DOI=10.1006/jmbi.1999.3229;
RA   Baylis H.A., Furuichi T., Yoshikawa F., Mikoshiba K., Sattelle D.B.;
RT   "Inositol 1,4,5-trisphosphate receptors are strongly expressed in the
RT   nervous system, pharynx, intestine, gonad and excretory cell of
RT   Caenorhabditis elegans and are encoded by a single gene (itr-1).";
RL   J. Mol. Biol. 294:467-476(1999).
RN   [3] {ECO:0000312|EMBL:CCD63763.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CCD63763.1};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF ARG-371; ARG-557 AND SER-900.
RX   PubMed=9491893; DOI=10.1016/S0092-8674(00)80945-9;
RA   Clandinin T.R., DeModena J.A., Sternberg P.W.;
RT   "Inositol trisphosphate mediates a RAS-independent response to LET-23
RT   receptor tyrosine kinase activation in C. elegans.";
RL   Cell 92:523-533(1998).
RN   [5] {ECO:0000305}
RP   ALTERNATIVE SPLICING, ALTERNATIVE PROMOTER USAGE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11237590; DOI=10.1006/jmbi.2000.4388;
RA   Gower N.J., Temple G.R., Schein J.E., Marra M., Walker D.S.,
RA   Baylis H.A.;
RT   "Dissection of the promoter region of the inositol 1,4,5-trisphosphate
RT   receptor gene, itr-1, in C. elegans: a molecular basis for cell-
RT   specific expression of IP3R isoforms.";
RL   J. Mol. Biol. 306:145-157(2001).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF ARG-371; SER-900 AND CYS-1571.
RX   PubMed=11553721; DOI=10.1091/mbc.12.9.2835;
RA   Park B.J., Lee D.G., Yu J.R., Jung S.K., Choi K., Lee J., Lee J.,
RA   Kim Y.S., Lee J.I., Kwon J.Y., Lee J., Singson A., Song W.K.,
RA   Eom S.H., Park C.S., Kim D.H., Bandyopadhyay J., Ahnn J.;
RT   "Calreticulin, a calcium-binding molecular chaperone, is required for
RT   stress response and fertility in Caenorhabditis elegans.";
RL   Mol. Biol. Cell 12:2835-2845(2001).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH MYO-1; MYO-2; UNC-54 AND NMY-2.
RX   PubMed=12062062; DOI=10.1016/S0960-9822(02)00868-0;
RA   Walker D.S., Ly S., Lockwood K.C., Baylis H.A.;
RT   "A direct interaction between IP(3) receptors and myosin II regulates
RT   IP(3) signaling in C. elegans.";
RL   Curr. Biol. 12:951-956(2002).
RN   [8] {ECO:0000305}
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF ARG-557; LYS-625;
RP   ARG-628 AND CYS-1571.
RX   PubMed=11950942; DOI=10.1091/mbc.01-08-0422;
RA   Walker D.S., Gower N.J., Ly S., Bradley G.L., Baylis H.A.;
RT   "Regulated disruption of inositol 1,4,5-trisphosphate signaling in
RT   Caenorhabditis elegans reveals new functions in feeding and
RT   embryogenesis.";
RL   Mol. Biol. Cell 13:1329-1337(2002).
RN   [9] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15498499; DOI=10.1016/j.cub.2004.10.001;
RA   Thomas-Virnig C.L., Sims P.A., Simske J.S., Hardin J.;
RT   "The inositol 1,4,5-trisphosphate receptor regulates epidermal cell
RT   migration in Caenorhabditis elegans.";
RL   Curr. Biol. 14:1882-1887(2004).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF CYS-1571.
RX   PubMed=15013747; DOI=10.1016/S0014-5793(04)00107-3;
RA   Jee C., Lee J., Lee J.I., Lee W.H., Park B.J., Yu J.R., Park E.,
RA   Kim E., Ahnn J.;
RT   "SHN-1, a Shank homologue in C. elegans, affects defecation rhythm via
RT   the inositol-1,4,5-trisphosphate receptor.";
RL   FEBS Lett. 561:29-36(2004).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH IRI-1.
RX   PubMed=15133127; DOI=10.1091/mbc.E04-01-0039;
RA   Walker D.S., Ly S., Gower N.J., Baylis H.A.;
RT   "IRI-1, a LIN-15B homologue, interacts with inositol-1,4,5-
RT   triphosphate receptors and regulates gonadogenesis, defecation, and
RT   pharyngeal pumping in Caenorhabditis elegans.";
RL   Mol. Biol. Cell 15:3073-3082(2004).
RN   [12]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LEU-945 AND
RP   CYS-1571.
RX   PubMed=15194811; DOI=10.1091/mbc.E04-03-0198;
RA   Yin X., Gower N.J., Baylis H.A., Strange K.;
RT   "Inositol 1,4,5-trisphosphate signaling regulates rhythmic contractile
RT   activity of myoepithelial sheath cells in Caenorhabditis elegans.";
RL   Mol. Biol. Cell 15:3938-3949(2004).
RN   [13]
RP   FUNCTION.
RX   PubMed=16267094; DOI=10.1242/dev.02083;
RA   Corrigan C., Subramanian R., Miller M.A.;
RT   "Eph and NMDA receptors control Ca2+/calmodulin-dependent protein
RT   kinase II activation during C. elegans oocyte meiotic maturation.";
RL   Development 132:5225-5237(2005).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF ARG-557; LEU-945 AND CYS-1571.
RX   PubMed=16186564; DOI=10.1085/jgp.200509355;
RA   Espelt M.V., Estevez A.Y., Yin X., Strange K.;
RT   "Oscillatory Ca2+ signaling in the isolated Caenorhabditis elegans
RT   intestine: role of the inositol-1,4,5-trisphosphate receptor and
RT   phospholipases C beta and gamma.";
RL   J. Gen. Physiol. 126:379-392(2005).
RN   [15]
RP   FUNCTION, TISSUE SPECIFICITY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   CYS-1571.
RX   PubMed=15958491; DOI=10.1091/mbc.E05-02-0096;
RA   Gower N.J., Walker D.S., Baylis H.A.;
RT   "Inositol 1,4,5-trisphosphate signaling regulates mating behavior in
RT   Caenorhabditis elegans males.";
RL   Mol. Biol. Cell 16:3978-3986(2005).
RN   [16]
RP   FUNCTION.
RX   PubMed=18369461; DOI=10.1371/journal.pgen.1000043;
RA   Vazquez-Manrique R.P., Nagy A.I., Legg J.C., Bales O.A., Ly S.,
RA   Baylis H.A.;
RT   "Phospholipase C-epsilon regulates epidermal morphogenesis in
RT   Caenorhabditis elegans.";
RL   PLoS Genet. 4:E1000043-E1000043(2008).
RN   [17]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF CYS-1571.
RX   PubMed=19730689; DOI=10.1371/journal.pgen.1000636;
RA   Walker D.S., Vazquez-Manrique R.P., Gower N.J., Gregory E.,
RA   Schafer W.R., Baylis H.A.;
RT   "Inositol 1,4,5-trisphosphate signalling regulates the avoidance
RT   response to nose touch in Caenorhabditis elegans.";
RL   PLoS Genet. 5:E1000636-E1000636(2009).
RN   [18]
RP   FUNCTION.
RX   PubMed=21191812; DOI=10.1007/s10059-011-0007-9;
RA   Oh W.C., Song H.O., Cho J.H., Park B.J.;
RT   "ANK repeat-domain of SHN-1 is indispensable for in vivo SHN-1
RT   function in C. elegans.";
RL   Mol. Cells 31:79-84(2011).
RN   [19]
RP   FUNCTION.
RX   PubMed=23671426; DOI=10.1371/journal.pgen.1003510;
RA   Kovacevic I., Orozco J.M., Cram E.J.;
RT   "Filamin and phospholipase C-epsilon are required for calcium
RT   signaling in the Caenorhabditis elegans spermatheca.";
RL   PLoS Genet. 9:E1003510-E1003510(2013).
CC   -!- FUNCTION: Receptor for inositol 1,4,5-trisphosphate, a second
CC       messenger that regulates intracellular calcium homeostasis
CC       (PubMed:10499793, PubMed:10610772, PubMed:15194811,
CC       PubMed:16186564, PubMed:23671426). Binds in vitro to both inositol
CC       1,4,5-trisphosphate (1,4,5-InsP3) and inositol 2,4,5-trisphosphate
CC       (2,4,5-InsP3) with high affinity and does not discriminate between
CC       the phosphate at 1 or 2 position (PubMed:10610772). Can also bind
CC       inositol 1,3,4,5-tetrakisphosphate (1,3,4,5-InsP4) and inositol
CC       4,5-bisphosphate (4,5-InsP2), but with lower affinity
CC       (PubMed:10610772). Acts as a timekeeper/rhythm generator via
CC       calcium signaling, affecting the defecation cycle and pharyngeal
CC       pumping (PubMed:10499793, PubMed:11553721, PubMed:12062062,
CC       PubMed:11950942, PubMed:15013747, PubMed:15133127,
CC       PubMed:16186564, PubMed:21191812). Affects normal hermaphrodite
CC       and male fertility as a participant in intracellular signaling by
CC       acting downstream of let-23/lin-3 which regulates ovulation,
CC       spermathecal valve dilation and male mating behavior
CC       (PubMed:9491893, PubMed:15194811, PubMed:16267094,
CC       PubMed:15958491). Important for early embryonic development;
CC       controls epidermal cell migration and may also regulate filopodial
CC       protrusive activity during epithelial morphogenesis
CC       (PubMed:11950942, PubMed:15498499, PubMed:18369461). Component of
CC       inositol trisphosphate (IP3)-mediated downstream signaling
CC       pathways that controls amphid sensory neuronal (ASH)-mediated
CC       response to nose touch and benzaldehyde but not other ASH-mediated
CC       responses (PubMed:19730689). {ECO:0000269|PubMed:10499793,
CC       ECO:0000269|PubMed:10610772, ECO:0000269|PubMed:11553721,
CC       ECO:0000269|PubMed:11950942, ECO:0000269|PubMed:12062062,
CC       ECO:0000269|PubMed:15013747, ECO:0000269|PubMed:15133127,
CC       ECO:0000269|PubMed:15194811, ECO:0000269|PubMed:15498499,
CC       ECO:0000269|PubMed:15958491, ECO:0000269|PubMed:16186564,
CC       ECO:0000269|PubMed:16267094, ECO:0000269|PubMed:18369461,
CC       ECO:0000269|PubMed:19730689, ECO:0000269|PubMed:21191812,
CC       ECO:0000269|PubMed:23671426, ECO:0000269|PubMed:9491893}.
CC   -!- SUBUNIT: Interacts with myo-1, myo-2, unc-54/myo-4 and nmy-2. Also
CC       interacts with iri-1. {ECO:0000269|PubMed:12062062,
CC       ECO:0000269|PubMed:15133127}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10610772, ECO:0000269|PubMed:15498499}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:P11881,
CC       ECO:0000269|PubMed:10610772, ECO:0000269|PubMed:15498499}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=6;
CC       Name=a {ECO:0000269|PubMed:11237590};
CC         IsoId=Q9Y0A1-1; Sequence=Displayed;
CC         Note=Produced by alternative promoter usage.
CC         {ECO:0000269|PubMed:11237590};
CC       Name=d {ECO:0000269|PubMed:11237590};
CC         IsoId=Q9Y0A1-2; Sequence=VSP_053337;
CC         Note=Produced by alternative promoter usage.
CC         {ECO:0000269|PubMed:11237590};
CC       Name=e {ECO:0000269|PubMed:10610772, ECO:0000269|PubMed:11237590};
CC         IsoId=Q9Y0A1-3; Sequence=VSP_053338, VSP_053339, VSP_053340,
CC                                  VSP_053343, VSP_053344;
CC         Note=Produced by alternative promoter usage and alternative
CC         splicing. {ECO:0000269|PubMed:10610772,
CC         ECO:0000269|PubMed:11237590};
CC       Name=f {ECO:0000269|PubMed:10610772, ECO:0000269|PubMed:11237590};
CC         IsoId=Q9Y0A1-4; Sequence=VSP_053338, VSP_053339;
CC         Note=Produced by alternative promoter usage and alternative
CC         splicing. {ECO:0000269|PubMed:10610772,
CC         ECO:0000269|PubMed:11237590};
CC       Name=g {ECO:0000305};
CC         IsoId=Q9Y0A1-5; Sequence=VSP_053338, VSP_053339, VSP_053342,
CC                                  VSP_053345;
CC         Note=Produced by alternative promoter usage and alternative
CC         splicing. {ECO:0000305};
CC       Name=h {ECO:0000305};
CC         IsoId=Q9Y0A1-6; Sequence=VSP_053338, VSP_053339, VSP_053341;
CC         Note=Produced by alternative promoter usage and alternative
CC         splicing. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Isoform a is expressed in the anterior cells
CC       of the pharyngeal terminal bulb, vulva, rectal epithelial cells,
CC       spicule protractor muscles of the proctodeum and male-specific
CC       neuron CP8 or CP9. Isoform d is expressed in the spermatheca,
CC       excretory cell, amphid socket cells, PDA motor neuron, spicule
CC       retractor muscles, gubernaculum retractor muscles, posterior
CC       oblique muscles, diagonal muscles and the vas deferens. Also
CC       expressed in the intestine, pharynx, pharyngeal isthmus,
CC       pharyngeal intestinal valve, somatic gonad, hypodermal cells of
CC       the vulva, uterine sheath cells, tail, head, LUA motor neuron and
CC       the embryonic epidermis (at protein level).
CC       {ECO:0000269|PubMed:10499793, ECO:0000269|PubMed:10610772,
CC       ECO:0000269|PubMed:11237590, ECO:0000269|PubMed:15498499,
CC       ECO:0000269|PubMed:15958491}.
CC   -!- DOMAIN: The receptor contains a calcium channel in its C-terminal
CC       extremity. Its large N-terminal cytoplasmic region has the ligand-
CC       binding site in the N-terminus and modulatory sites in the middle
CC       portion immediately upstream of the channel region.
CC       {ECO:0000250|UniProtKB:P11881, ECO:0000269|PubMed:10610772,
CC       ECO:0000269|PubMed:11950942}.
CC   -!- DISRUPTION PHENOTYPE: Disrupted defecation rhythm with reduced
CC       pharyngeal pumping in the presence of food resulting in
CC       constipation. Disrupted reversal/avoidance response to nose touch.
CC       Hermaphrodites display endomitotic oocytes following spermathecal
CC       dilation defect and defective ovulation. Loss of male fertility
CC       due to defects in turning behavior, spicule insertion and sperm
CC       transfer. {ECO:0000269|PubMed:11950942,
CC       ECO:0000269|PubMed:15194811, ECO:0000269|PubMed:15958491,
CC       ECO:0000269|PubMed:19730689}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF168688; AAF05302.1; -; mRNA.
DR   EMBL; AJ243179; CAB45860.1; -; mRNA.
DR   EMBL; AJ243180; CAB45861.1; -; mRNA.
DR   EMBL; AJ243181; CAB45862.1; -; mRNA.
DR   EMBL; AJ243182; CAB45863.1; -; mRNA.
DR   EMBL; FO080445; CCD63763.1; -; Genomic_DNA.
DR   EMBL; FO080445; CCD63764.1; -; Genomic_DNA.
DR   EMBL; FO080445; CCD63765.1; -; Genomic_DNA.
DR   EMBL; FO080445; CCD63766.1; -; Genomic_DNA.
DR   EMBL; FO080445; CCD63767.1; -; Genomic_DNA.
DR   EMBL; FO080445; CCD63775.1; -; Genomic_DNA.
DR   RefSeq; NP_001023170.1; NM_001027999.3. [Q9Y0A1-1]
DR   RefSeq; NP_001023171.1; NM_001028000.3. [Q9Y0A1-2]
DR   RefSeq; NP_001023172.1; NM_001028001.2. [Q9Y0A1-3]
DR   RefSeq; NP_001023173.1; NM_001028002.2.
DR   RefSeq; NP_001023174.1; NM_001028003.2. [Q9Y0A1-5]
DR   RefSeq; NP_001255305.1; NM_001268376.1. [Q9Y0A1-6]
DR   UniGene; Cel.18369; -.
DR   ProteinModelPortal; Q9Y0A1; -.
DR   BioGrid; 42664; 11.
DR   STRING; 6239.F33D4.2a; -.
DR   TCDB; 1.A.3.2.16; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   EPD; Q9Y0A1; -.
DR   PaxDb; Q9Y0A1; -.
DR   PeptideAtlas; Q9Y0A1; -.
DR   PRIDE; Q9Y0A1; -.
DR   EnsemblMetazoa; F33D4.2a; F33D4.2a; WBGene00002173. [Q9Y0A1-1]
DR   GeneID; 177546; -.
DR   KEGG; cel:CELE_F33D4.2; -.
DR   UCSC; F33D4.2a.2; c. elegans.
DR   CTD; 177546; -.
DR   WormBase; F33D4.2a; CE37905; WBGene00002173; itr-1. [Q9Y0A1-1]
DR   WormBase; F33D4.2d; CE37906; WBGene00002173; itr-1. [Q9Y0A1-2]
DR   WormBase; F33D4.2e; CE28017; WBGene00002173; itr-1. [Q9Y0A1-3]
DR   WormBase; F33D4.2f; CE28018; WBGene00002173; itr-1. [Q9Y0A1-4]
DR   WormBase; F33D4.2g; CE31690; WBGene00002173; itr-1. [Q9Y0A1-5]
DR   WormBase; F33D4.2h; CE44684; WBGene00002173; itr-1. [Q9Y0A1-6]
DR   eggNOG; KOG3533; Eukaryota.
DR   eggNOG; ENOG410XR97; LUCA.
DR   GeneTree; ENSGT00760000119152; -.
DR   HOGENOM; HOG000007660; -.
DR   InParanoid; Q9Y0A1; -.
DR   KO; K04958; -.
DR   OMA; DPDDHYQ; -.
DR   OrthoDB; EOG091G00T2; -.
DR   PhylomeDB; Q9Y0A1; -.
DR   Reactome; R-CEL-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-CEL-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-CEL-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-CEL-5578775; Ion homeostasis.
DR   Reactome; R-CEL-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:Q9Y0A1; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00002173; -.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:WormBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:WormBase.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:WormBase.
DR   GO; GO:0017022; F:myosin binding; IPI:WormBase.
DR   GO; GO:0030421; P:defecation; IMP:WormBase.
DR   GO; GO:0048598; P:embryonic morphogenesis; IMP:WormBase.
DR   GO; GO:0048815; P:hermaphrodite genitalia morphogenesis; IGI:UniProtKB.
DR   GO; GO:0060179; P:male mating behavior; IMP:WormBase.
DR   GO; GO:0048609; P:multicellular organismal reproductive process; IGI:WormBase.
DR   GO; GO:0006936; P:muscle contraction; IMP:WormBase.
DR   GO; GO:0001556; P:oocyte maturation; IGI:WormBase.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:WormBase.
DR   GO; GO:0012501; P:programmed cell death; IGI:WormBase.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:WormBase.
DR   GO; GO:0051489; P:regulation of filopodium assembly; IMP:WormBase.
DR   GO; GO:0043051; P:regulation of pharyngeal pumping; IMP:WormBase.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IBA:GO_Central.
DR   GO; GO:0007622; P:rhythmic behavior; IMP:WormBase.
DR   GO; GO:0042713; P:sperm ejaculation; IMP:WormBase.
DR   Gene3D; 1.25.10.10; -; 1.
DR   Gene3D; 1.25.10.30; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR035910; IP3R_RIH_dom_sf.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_recept-rel.
DR   PANTHER; PTHR13715; PTHR13715; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50919; MIR; 4.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Alternative splicing; Complete proteome;
KW   Developmental protein; Endoplasmic reticulum; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   2892       Inositol 1,4,5-trisphosphate receptor
FT                                itr-1.
FT                                /FTId=PRO_0000424150.
FT   TOPO_DOM      1   2475       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2476   2496       Helical. {ECO:0000255}.
FT   TOPO_DOM   2497   2514       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2515   2535       Helical. {ECO:0000255}.
FT   TOPO_DOM   2536   2572       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2573   2593       Helical. {ECO:0000255}.
FT   TOPO_DOM   2594   2615       Extracellular. {ECO:0000255}.
FT   TRANSMEM   2616   2636       Helical. {ECO:0000255}.
FT   TOPO_DOM   2637   2735       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   2736   2756       Helical. {ECO:0000255}.
FT   TOPO_DOM   2757   2892       Extracellular. {ECO:0000255}.
FT   DOMAIN      192    246       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      319    379       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      386    466       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      490    551       MIR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   REGION      357    361       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250|UniProtKB:P11881}.
FT   REGION      625    628       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000269|PubMed:10610772}.
FT   REGION      689    691       Inositol 1,4,5-trisphosphate binding.
FT                                {ECO:0000250|UniProtKB:P11881}.
FT   VAR_SEQ       1     56       Missing (in isoform d).
FT                                {ECO:0000303|PubMed:10610772}.
FT                                /FTId=VSP_053337.
FT   VAR_SEQ       1     46       Missing (in isoform e, isoform f, isoform
FT                                g and isoform h).
FT                                {ECO:0000303|PubMed:10499793,
FT                                ECO:0000303|PubMed:10610772}.
FT                                /FTId=VSP_053338.
FT   VAR_SEQ      47     61       FDFDDFEEQIMRKSS -> MDYDYRRRVLERNIG (in
FT                                isoform e, isoform f, isoform g and
FT                                isoform h). {ECO:0000303|PubMed:10499793,
FT                                ECO:0000303|PubMed:10610772}.
FT                                /FTId=VSP_053339.
FT   VAR_SEQ     423    430       RASLIYSK -> PPLLSALSQKSRPMLER (in isoform
FT                                e). {ECO:0000303|PubMed:10610772}.
FT                                /FTId=VSP_053340.
FT   VAR_SEQ    1730   1730       K -> KMSQDSQSDYDSDSSQGPCQIS (in isoform
FT                                h). {ECO:0000305}.
FT                                /FTId=VSP_053341.
FT   VAR_SEQ    1731   1759       RLNRQNTLNPGHRLYGTSNSMTEHTSANV -> PVITLVVE
FT                                TQSSKYAQSWSSTLWNIKLYD (in isoform g).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_053342.
FT   VAR_SEQ    1760   2892       Missing (in isoform g). {ECO:0000305}.
FT                                /FTId=VSP_053345.
FT   VAR_SEQ    1853   1853       G -> GHRVYNSSVEKG (in isoform e).
FT                                {ECO:0000303|PubMed:10610772}.
FT                                /FTId=VSP_053343.
FT   VAR_SEQ    1998   2006       Missing (in isoform e).
FT                                {ECO:0000303|PubMed:10610772}.
FT                                /FTId=VSP_053344.
FT   MUTAGEN     103    103       G->E: In n2559; slow developmental rate
FT                                to adulthood, absence of ovulation,
FT                                sterility, absence of defecation cycle
FT                                and intestinal calcium oscillations.
FT                                {ECO:0000269|PubMed:10499793}.
FT   MUTAGEN     371    371       R->K: In sy331; reduced fertility and
FT                                brood size. {ECO:0000269|PubMed:11553721,
FT                                ECO:0000269|PubMed:9491893}.
FT   MUTAGEN     557    557       R->C: In sy290; gain of function. 2-fold
FT                                increase in ligand affinity. Increased
FT                                velocity of posterior-to-anterior calcium
FT                                wave. Reduced fertility, hyperactive
FT                                spermathecal dilation leading to
FT                                decreased brood size.
FT                                {ECO:0000269|PubMed:11950942,
FT                                ECO:0000269|PubMed:16186564,
FT                                ECO:0000269|PubMed:9491893}.
FT   MUTAGEN     625    625       K->Q: Abolishes ligand binding; when
FT                                associated with Q-628.
FT                                {ECO:0000269|PubMed:11950942}.
FT   MUTAGEN     628    628       R->Q: Abolishes ligand binding; when
FT                                associated with Q-625.
FT                                {ECO:0000269|PubMed:11950942}.
FT   MUTAGEN     900    900       S->F: In sy328; reduced fertility and
FT                                brood size. {ECO:0000269|PubMed:11553721,
FT                                ECO:0000269|PubMed:9491893}.
FT   MUTAGEN     945    945       L->F: In sy327; gain of function.
FT                                Increased velocity of posterior-to-
FT                                anterior calcium wave and enhanced sheath
FT                                contractile activity.
FT                                {ECO:0000269|PubMed:15194811,
FT                                ECO:0000269|PubMed:16186564}.
FT   MUTAGEN    1571   1571       C->Y: In sa73; slow developmental rate to
FT                                adulthood, reduced brood size, slow
FT                                intestinal calcium oscillations, slower
FT                                pharyngeal pumping, longer defecation
FT                                cycle, defective ovulation, reduced
FT                                myoepithelial sheath contractility and
FT                                reduced efficiency of sperm transfer.
FT                                {ECO:0000269|PubMed:10499793,
FT                                ECO:0000269|PubMed:11553721,
FT                                ECO:0000269|PubMed:11950942,
FT                                ECO:0000269|PubMed:15013747,
FT                                ECO:0000269|PubMed:15194811,
FT                                ECO:0000269|PubMed:15958491,
FT                                ECO:0000269|PubMed:16186564,
FT                                ECO:0000269|PubMed:19730689}.
SQ   SEQUENCE   2892 AA;  330837 MW;  B1C598FE554B83CF CRC64;
     MNPSYGRVRK KVSIISIPEF VPEHYEYENE TTASGGASGG GSTRIEFDFD DFEEQIMRKS
     SMALPSRKLT IANSIDHGNN GNLHIGDIIS LYTESSSNQE QRGFLSTLGL VDDRCIVELK
     DGRPESPPKK FRDCLFKVCP VNRYAAQKHL WTEQKRFQTG DSMFDDDLMN KLKVAADKER
     EENESEFQKT LGNVIQYGSM VQLLHVKSNK YITVQKNSPA KRERNAMKVY LDRAGNEGSW
     FIIEPAYKHY AIGDNVSAGN KISLIPNSVS TTQAGHVKSQ LHLSSFNLLD HQSAAEVNCL
     NEPTEWQVFM FLLFDENQQN SVKSGDVVRL FHADQQTFLT LDTIPKQNPP TDVVFLRMTN
     RPSAADATSS RALWEVQVVQ TNAYRGGTAK WNKAYRFKHL ATDMYLSAEP SQVQVKPAMN
     GRRASLIYSK TNNPMAMYSD GPNGVTNEST DTTQQNIPSV WVLGPTKSEF PEEDANLLFQ
     LDPSTFMKSN KEVPRRSYVR LLHQSSDKWV HATNATEKQN LHYSSKNEKG WVKVICEKNR
     VDKETFALLP VNPDEVRDLD FANDACKALR NFIKLIKIGQ VISKESINST TQLLIDCILF
     VTNSSDHLAD PLKISDFSPS RDRQKLLREQ EVLNQVFLLL KAPFLPRQGT TELGPLLSSP
     SELSDSRNEI FKTMFQLCYC LLKYSQVSYR KNQEFLAEKF GEIQEQIGFD LMAEDTMTAV
     LHNNPKLLEK YVKTPHVERF VELVRNNRQG KFLDYLADLC VCRGEANKKI QELICTSVLS
     SKHRDIFMDT KIIDGEIEVG WAPNFRKLVD IAEGAKSNSD DAEHLDYYRH QLDLLSQMCQ
     EQQYLAIDPP PERRLMNISQ QLPAELVLQC MSDNRLPYDL RGSFTRLMLH LHVVRGSPMS
     AIRHARLWWS IPENVNVSTY ESVSVEAYSD GSRMRIGEGI AHKVLATVET YLMGLRNQSM
     EERQSVNSSK LTYEIVNLAK ALAQFNFYSF NDLLQLTQNL LAIINEGPAT EQVPSHRAMV
     NAIRNMSKSM MRGGNKENSK DLAKTPSVTA EEAGRTKEGR ALNVKTKLIV AEILQFVMDV
     RRDYRITMAL SWFKNVFPCD EDGSLMHSAS INERMASELY DAIYRSSGHE LHLDGRDGQL
     LLAILLQMTM SDYPPLTSIA LKVFFRHFTQ YQELLEDLKQ VQLLVSNNDV ENYRQIDRDL
     FILKNLTEKS ELWVHGDRHH SIDTKEVDEK ERTTEHDLLD HDLKSPRAFD SGDSMEALMA
     VLNEHYPSIR NECLQLLNRL LIKDDRNDAA VALQELSDKA PLIAYPLIRQ MLVRLTGMCY
     RKGDPKPDTM NQQLLKNMRV YEVVLEFISV PHDKKHDHDM MKLITLSHEF LRSFCKTNKE
     NQSRLYKFIS YEKDAKEGML RVETIEEVGT LVAIFRNNRE LASNVPEELI AHIVGLIEHN
     SRNPIFLELL QALVCVYDKE IESGQEKVAN EICAASDEVR QLYVDNASFE ELEAMMKDEK
     ESKGRSSDSR RKLKYHIELV RLLAMCTRGK NGNTELKCAS QIPMDHIVRV VTAKQCLVEV
     KTVYLQLLLH CYIDTDAEMK DAYKTEYVDH ILNNLLEDIR SLRVEKLTGA ETATLEHYIC
     HTVTEVLIKF FEAPYSALQQ AKVDVHHHKK TFSEVLLELT YLEKGKLRGS KSSRNWYRVA
     ECIKRLTKWA EEHNITLPAT LAGPQMSGQT SVRQKWQQAA SSAKWIGIGK RLNRQNTLNP
     GHRLYGTSNS MTEHTSANVV TCYHMMIGEF KFYLHPLHAA EGSVLVEVLH TPELLFPEGS
     ALRDQCARGG VVAKLIQHCK TLMQNKQDNL CARVLQTLCK MCDCTKQQLT HQGQQLRQLL
     LQRYFGHHNN HHPPLDRQQS KIGEVIEAVK EKKEETWSQE RDLYAIQCKL NDAGASDLVT
     DIIIMEPSRE IFLKAIHLAR ALLHEGNDKV QHSFYMRMKQ KDIHEPFFKA ILTRIQTAQN
     RLKSDMMSCS DSKPKVSLSA TVSRRSSTVL TPLIDAGDTG FNGALFEVPQ QVRHPSISEM
     SQLSNDLTHS IPDLAPYQDE EKSTDALPPE VALVEPILRV LQLLCENHNS LLQNFLRKQS
     DRTNHNLVSE TLSFLDTVCG STKGSLGVFG EIGEHNFSLI TQTLATLTEF CQGPCHENQN
     TMAMQENGLN IIISLVLNEI KPLADDHMEL ALEIKSQASK LLLAIMESRH DGENANRVLR
     NMANMSGGPK QLVHAIKQAY EMTNSNHHML KSISRDLFRQ AEDDLKKKSG PQITVNTVTL
     PEINVDASGI VSIHTEKNIS SSLDDKFNDD DIPSVDPREV GHNIYILAHQ LAIHDGELEI
     WLDGSDEKKD DLTREALNYY KERTAQIEIV RRDRTLERVV FPINDICSYL TKDTKDYVYN
     NTERDNQGSK VTEFFDEWET MYHEMIWQRK LQDRKWLSWC AFRLPLWTRL SFHFAFIVNA
     LVARYYPLPE HSNSSISLGN LYSWFAVFSS FLLAHYLRHD KIYLHKTSLL ILASLCFLLL
     SSIGVTLTLY IFGILQLVNK IVHVVAFVSN KGLEDRPIAE ILACRNLHYL LVYLFICILG
     LLVHPMIYCI LLFDIIFTEE TLQNVIASVT RNYQSIVWTG LLALILLYFF SILGFLYFRH
     DFYLEVDPVE NDSSATISSG IPSETCPSEG CPGLQPSEKD DNDDEKKVKS CETLWMCILQ
     TGYQGLRNGG GIGDVLRNPA PWEDMFIWRV AYDMTFFVVL IVIVLNLIFG VIIDTFGDLR
     AEKNEKEQIL KNNCFICGLD RSRFDNRSVT FETHRETEHN IWHYLYYIVM LQIKDETEFT
     GPESYVAQCV KDRNLDWFPR MQALSLQDSE LDTDQSEVKQ MKDQLLQMMT LMREIISQNE
     ESRAFMEQFQ PR
//
ID   HCN4_HUMAN              Reviewed;        1203 AA.
AC   Q9Y3Q4; Q9UMQ7;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   25-OCT-2017, entry version 155.
DE   RecName: Full=Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4;
GN   Name=HCN4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=10228147; DOI=10.1093/emboj/18.9.2323;
RA   Ludwig A., Zong X., Stieber J., Hullin R., Hofmann F., Biel M.;
RT   "Two pacemaker channels from human heart with profoundly different
RT   activation kinetics.";
RL   EMBO J. 18:2323-2329(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Thalamus;
RX   PubMed=10430953; DOI=10.1073/pnas.96.16.9391;
RA   Seifert R., Scholten A., Gauss R., Mincheva A., Lichter P.,
RA   Kaupp U.B.;
RT   "Molecular characterization of a slowly gating human
RT   hyperpolarization-activated channel predominantly expressed in
RT   thalamus, heart, and testis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:9391-9396(1999).
RN   [3]
RP   FUNCTION, AND INVOLVEMENT IN BRGDA8.
RX   PubMed=19165230; DOI=10.1038/jhg.2008.16;
RA   Ueda K., Hirano Y., Higashiuesato Y., Aizawa Y., Hayashi T.,
RA   Inagaki N., Tana T., Ohya Y., Takishita S., Muratani H., Hiraoka M.,
RA   Kimura A.;
RT   "Role of HCN4 channel in preventing ventricular arrhythmia.";
RL   J. Hum. Genet. 54:115-121(2009).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 521-739 IN COMPLEX WITH CAMP,
RP   NUCLEOTIDE-BINDING, FUNCTION, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=20829353; DOI=10.1074/jbc.M110.152033;
RA   Xu X., Vysotskaya Z.V., Liu Q., Zhou L.;
RT   "Structural basis for the cAMP-dependent gating in the human HCN4
RT   channel.";
RL   J. Biol. Chem. 285:37082-37091(2010).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 521-723 IN COMPLEX WITH CAMP,
RP   NUCLEOTIDE-BINDING, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=22006928; DOI=10.1074/jbc.M111.297606;
RA   Lolicato M., Nardini M., Gazzarrini S., Moller S., Bertinetti D.,
RA   Herberg F.W., Bolognesi M., Martin H., Fasolini M., Bertrand J.A.,
RA   Arrigoni C., Thiel G., Moroni A.;
RT   "Tetramerization dynamics of C-terminal domain underlies isoform-
RT   specific cAMP gating in hyperpolarization-activated cyclic nucleotide-
RT   gated channels.";
RL   J. Biol. Chem. 286:44811-44820(2011).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 521-724, AND CHARACTERIZATION
RP   OF VARIANT SSS2 ARG-672.
RX   PubMed=23103389; DOI=10.1016/j.str.2012.09.017;
RA   Xu X., Marni F., Wu S., Su Z., Musayev F., Shrestha S., Xie C.,
RA   Gao W., Liu Q., Zhou L.;
RT   "Local and global interpretations of a disease-causing mutation near
RT   the ligand entry path in hyperpolarization-activated cAMP-gated
RT   channel.";
RL   Structure 20:2116-2123(2012).
RN   [7]
RP   VARIANT SSS2 ASN-553.
RX   PubMed=15123648; DOI=10.1074/jbc.M311953200;
RA   Ueda K., Nakamura K., Hayashi T., Inagaki N., Takahashi M.,
RA   Arimura T., Morita H., Higashiuesato Y., Hirano Y., Yasunami M.,
RA   Takishita S., Yamashina A., Ohe T., Sunamori M., Hiraoka M.,
RA   Kimura A.;
RT   "Functional characterization of a trafficking-defective HCN4 mutation,
RT   D553N, associated with cardiac arrhythmia.";
RL   J. Biol. Chem. 279:27194-27198(2004).
RN   [8]
RP   VARIANT SSS2 ARG-672, FUNCTION, ENZYME REGULATION, SUBCELLULAR
RP   LOCATION, AND CHARACTERIZATION OF VARIANT SSS2 ARG-672.
RX   PubMed=16407510; DOI=10.1056/NEJMoa052475;
RA   Milanesi R., Baruscotti M., Gnecchi-Ruscone T., DiFrancesco D.;
RT   "Familial sinus bradycardia associated with a mutation in the cardiac
RT   pacemaker channel.";
RL   N. Engl. J. Med. 354:151-157(2006).
RN   [9]
RP   VARIANT SSS2 VAL-485, AND CHARACTERIZATION OF VARIANT SSS2 VAL-485.
RX   PubMed=20662977; DOI=10.1111/j.1540-8167.2010.01844.x;
RA   Laish-Farkash A., Glikson M., Brass D., Marek-Yagel D., Pras E.,
RA   Dascal N., Antzelevitch C., Nof E., Reznik H., Eldar M., Luria D.;
RT   "A novel mutation in the HCN4 gene causes symptomatic sinus
RT   bradycardia in Moroccan Jews.";
RL   J. Cardiovasc. Electrophysiol. 21:1365-1372(2010).
CC   -!- FUNCTION: Hyperpolarization-activated ion channel with very slow
CC       activation and inactivation exhibiting weak selectivity for
CC       potassium over sodium ions. Contributes to the native pacemaker
CC       currents in heart (If) that regulate the rhythm of heart beat. May
CC       contribute to the native pacemaker currents in neurons (Ih). May
CC       mediate responses to sour stimuli. {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10430953, ECO:0000269|PubMed:16407510,
CC       ECO:0000269|PubMed:19165230, ECO:0000269|PubMed:20829353}.
CC   -!- ENZYME REGULATION: Activated by cAMP. cAMP binding causes a
CC       conformation change that leads to the assembly of an active
CC       tetramer and channel opening. {ECO:0000269|PubMed:16407510,
CC       ECO:0000269|PubMed:20829353, ECO:0000269|PubMed:22006928}.
CC   -!- SUBUNIT: Homotetramer. The potassium channel is composed of a
CC       homo- or heterotetrameric complex of pore-forming subunits.
CC       {ECO:0000269|PubMed:20829353, ECO:0000269|PubMed:22006928}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1753521, EBI-1753521;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10430953, ECO:0000269|PubMed:16407510}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:10228147,
CC       ECO:0000269|PubMed:10430953, ECO:0000269|PubMed:16407510}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in thalamus, testis and in
CC       heart, both in ventricle and atrium. Detected at much lower levels
CC       in amygdala, substantia nigra, cerebellum and hippocampus.
CC       {ECO:0000269|PubMed:10228147, ECO:0000269|PubMed:10430953}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at
CC       every third position.
CC   -!- DISEASE: Sick sinus syndrome 2 (SSS2) [MIM:163800]: The term 'sick
CC       sinus syndrome' encompasses a variety of conditions caused by
CC       sinus node dysfunction. The most common clinical manifestations
CC       are syncope, presyncope, dizziness, and fatigue. Electrocardiogram
CC       typically shows sinus bradycardia, sinus arrest, and/or sinoatrial
CC       block. Episodes of atrial tachycardias coexisting with sinus
CC       bradycardia ('tachycardia-bradycardia syndrome') are also common
CC       in this disorder. SSS occurs most often in the elderly associated
CC       with underlying heart disease or previous cardiac surgery, but can
CC       also occur in the fetus, infant, or child without heart disease or
CC       other contributing factors. SSS2 onset is in utero or at birth.
CC       {ECO:0000269|PubMed:15123648, ECO:0000269|PubMed:16407510,
CC       ECO:0000269|PubMed:20662977, ECO:0000269|PubMed:23103389}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Brugada syndrome 8 (BRGDA8) [MIM:613123]: A
CC       tachyarrhythmia characterized by right bundle branch block and ST
CC       segment elevation on an electrocardiogram (ECG). It can cause the
CC       ventricles to beat so fast that the blood is prevented from
CC       circulating efficiently in the body. When this situation occurs,
CC       the individual will faint and may die in a few minutes if the
CC       heart is not reset. {ECO:0000269|PubMed:19165230}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: Inhibited by extracellular cesium ions.
CC   -!- SIMILARITY: Belongs to the potassium channel HCN family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ132429; CAB42604.1; -; mRNA.
DR   EMBL; AJ238850; CAB52754.1; -; mRNA.
DR   CCDS; CCDS10248.1; -.
DR   RefSeq; NP_005468.1; NM_005477.2.
DR   UniGene; Hs.86941; -.
DR   PDB; 2MNG; NMR; -; A=579-707.
DR   PDB; 3OTF; X-ray; 2.40 A; A=521-739.
DR   PDB; 3U11; X-ray; 2.50 A; A/B=521-723.
DR   PDB; 4HBN; X-ray; 2.60 A; A=521-724.
DR   PDB; 4KL1; X-ray; 2.70 A; A/B/C/D=521-713.
DR   PDB; 4NVP; X-ray; 2.50 A; A=521-723.
DR   PDBsum; 2MNG; -.
DR   PDBsum; 3OTF; -.
DR   PDBsum; 3U11; -.
DR   PDBsum; 4HBN; -.
DR   PDBsum; 4KL1; -.
DR   PDBsum; 4NVP; -.
DR   ProteinModelPortal; Q9Y3Q4; -.
DR   SMR; Q9Y3Q4; -.
DR   BioGrid; 115338; 3.
DR   DIP; DIP-52325N; -.
DR   IntAct; Q9Y3Q4; 3.
DR   STRING; 9606.ENSP00000261917; -.
DR   BindingDB; Q9Y3Q4; -.
DR   ChEMBL; CHEMBL1250417; -.
DR   GuidetoPHARMACOLOGY; 403; -.
DR   TCDB; 1.A.1.5.10; the voltage-gated ion channel (vic) superfamily.
DR   TCDB; 1.A.1.5.11; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9Y3Q4; -.
DR   PhosphoSitePlus; Q9Y3Q4; -.
DR   BioMuta; HCN4; -.
DR   DMDM; 38605641; -.
DR   EPD; Q9Y3Q4; -.
DR   MaxQB; Q9Y3Q4; -.
DR   PaxDb; Q9Y3Q4; -.
DR   PeptideAtlas; Q9Y3Q4; -.
DR   PRIDE; Q9Y3Q4; -.
DR   DNASU; 10021; -.
DR   Ensembl; ENST00000261917; ENSP00000261917; ENSG00000138622.
DR   GeneID; 10021; -.
DR   KEGG; hsa:10021; -.
DR   UCSC; uc002avp.3; human.
DR   CTD; 10021; -.
DR   DisGeNET; 10021; -.
DR   EuPathDB; HostDB:ENSG00000138622.3; -.
DR   GeneCards; HCN4; -.
DR   GeneReviews; HCN4; -.
DR   HGNC; HGNC:16882; HCN4.
DR   MalaCards; HCN4; -.
DR   MIM; 163800; phenotype.
DR   MIM; 605206; gene.
DR   MIM; 613123; phenotype.
DR   neXtProt; NX_Q9Y3Q4; -.
DR   OpenTargets; ENSG00000138622; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 166282; Familial sick sinus syndrome.
DR   PharmGKB; PA394; -.
DR   eggNOG; KOG0498; Eukaryota.
DR   eggNOG; ENOG410XPSE; LUCA.
DR   GeneTree; ENSGT00900000140801; -.
DR   HOGENOM; HOG000230717; -.
DR   HOVERGEN; HBG039490; -.
DR   InParanoid; Q9Y3Q4; -.
DR   KO; K04957; -.
DR   OMA; AIPGQHV; -.
DR   OrthoDB; EOG091G0JQU; -.
DR   PhylomeDB; Q9Y3Q4; -.
DR   TreeFam; TF318250; -.
DR   Reactome; R-HSA-1296061; HCN channels.
DR   SIGNOR; Q9Y3Q4; -.
DR   EvolutionaryTrace; Q9Y3Q4; -.
DR   GeneWiki; HCN4; -.
DR   GenomeRNAi; 10021; -.
DR   PRO; PR:Q9Y3Q4; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000138622; -.
DR   CleanEx; HS_HCN4; -.
DR   Genevisible; Q9Y3Q4; HS.
DR   GO; GO:0098855; C:HCN channel complex; IDA:BHF-UCL.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0086041; F:voltage-gated potassium channel activity involved in SA node cell action potential depolarization; IMP:BHF-UCL.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProtKB.
DR   GO; GO:0008015; P:blood circulation; NAS:ProtInc.
DR   GO; GO:0006812; P:cation transport; IDA:BHF-UCL.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; IDA:UniProtKB.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0086046; P:membrane depolarization during SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0098909; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; IMP:BHF-UCL.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0002027; P:regulation of heart rate; IMP:UniProtKB.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0003254; P:regulation of membrane depolarization; IDA:BHF-UCL.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:UniProtKB.
DR   GO; GO:0086015; P:SA node cell action potential; IMP:BHF-UCL.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IMP:UniProtKB.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 1.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR030173; HCN4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR013621; Ion_trans_N.
DR   InterPro; IPR003938; K_chnl_volt-dep_EAG/ELK/ERG.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   PANTHER; PTHR10217:SF375; PTHR10217:SF375; 1.
DR   Pfam; PF00027; cNMP_binding; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF08412; Ion_trans_N; 1.
DR   PRINTS; PR01463; EAGCHANLFMLY.
DR   SMART; SM00100; cNMP; 1.
DR   SUPFAM; SSF51206; SSF51206; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 1.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Brugada syndrome; cAMP; cAMP-binding; Cell membrane;
KW   Complete proteome; Disease mutation; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Potassium; Potassium channel; Potassium transport;
KW   Reference proteome; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   1203       Potassium/sodium hyperpolarization-
FT                                activated cyclic nucleotide-gated channel
FT                                4.
FT                                /FTId=PRO_0000054117.
FT   TOPO_DOM      1    266       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    267    287       Helical; Name=Segment S1. {ECO:0000255}.
FT   TOPO_DOM    288    293       Extracellular. {ECO:0000255}.
FT   TRANSMEM    294    314       Helical; Name=Segment S2. {ECO:0000255}.
FT   TOPO_DOM    315    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical; Name=Segment S3. {ECO:0000255}.
FT   TOPO_DOM    362    368       Extracellular. {ECO:0000255}.
FT   TRANSMEM    369    389       Helical; Voltage-sensor; Name=Segment S4.
FT                                {ECO:0000255}.
FT   TOPO_DOM    390    420       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    421    441       Helical; Name=Segment S5. {ECO:0000255}.
FT   TOPO_DOM    442    464       Extracellular. {ECO:0000255}.
FT   INTRAMEM    465    486       Pore-forming; Name=Segment H5.
FT                                {ECO:0000255}.
FT   TOPO_DOM    487    496       Extracellular. {ECO:0000255}.
FT   TRANSMEM    497    517       Helical; Name=Segment S6. {ECO:0000255}.
FT   TOPO_DOM    518   1203       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     659    662       cAMP. {ECO:0000269|PubMed:20829353,
FT                                ECO:0000269|PubMed:22006928}.
FT   NP_BIND     669    670       cAMP. {ECO:0000269|PubMed:20829353,
FT                                ECO:0000269|PubMed:22006928}.
FT   NP_BIND     710    713       cAMP. {ECO:0000269|PubMed:20829353,
FT                                ECO:0000269|PubMed:22006928}.
FT   REGION      209    260       Involved in subunit assembly.
FT                                {ECO:0000250}.
FT   COMPBIAS    924   1076       Pro-rich.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JKA7}.
FT   MOD_RES    1105   1105       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70507}.
FT   MOD_RES    1108   1108       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70507}.
FT   CARBOHYD    458    458       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     485    485       A -> V (in SSS2; results in a significant
FT                                reduction of current density compared to
FT                                wild-type).
FT                                {ECO:0000269|PubMed:20662977}.
FT                                /FTId=VAR_066614.
FT   VARIANT     553    553       D -> N (in SSS2; dbSNP:rs104894485).
FT                                {ECO:0000269|PubMed:15123648}.
FT                                /FTId=VAR_026534.
FT   VARIANT     672    672       S -> R (in SSS2; results in decreased
FT                                affinity for cAMP but does not abolish
FT                                channel activation; shifts the current
FT                                activation range to hyperpolarized
FT                                voltages; slows channel opening and
FT                                speeds up channel closure;
FT                                dbSNP:rs104894488).
FT                                {ECO:0000269|PubMed:16407510,
FT                                ECO:0000269|PubMed:23103389}.
FT                                /FTId=VAR_026535.
FT   CONFLICT    110    110       S -> T (in Ref. 2; CAB52754).
FT                                {ECO:0000305}.
FT   HELIX       522    540       {ECO:0000244|PDB:3OTF}.
FT   HELIX       545    559       {ECO:0000244|PDB:3OTF}.
FT   HELIX       566    571       {ECO:0000244|PDB:3OTF}.
FT   HELIX       575    585       {ECO:0000244|PDB:3OTF}.
FT   HELIX       587    591       {ECO:0000244|PDB:3OTF}.
FT   HELIX       594    597       {ECO:0000244|PDB:3OTF}.
FT   HELIX       601    608       {ECO:0000244|PDB:3OTF}.
FT   STRAND      612    616       {ECO:0000244|PDB:3OTF}.
FT   STRAND      621    623       {ECO:0000244|PDB:3OTF}.
FT   STRAND      631    637       {ECO:0000244|PDB:3OTF}.
FT   STRAND      640    643       {ECO:0000244|PDB:3OTF}.
FT   STRAND      645    647       {ECO:0000244|PDB:3OTF}.
FT   STRAND      650    652       {ECO:0000244|PDB:3OTF}.
FT   HELIX       661    665       {ECO:0000244|PDB:3OTF}.
FT   STRAND      666    668       {ECO:0000244|PDB:4KL1}.
FT   STRAND      670    677       {ECO:0000244|PDB:3OTF}.
FT   STRAND      679    685       {ECO:0000244|PDB:3OTF}.
FT   HELIX       686    695       {ECO:0000244|PDB:3OTF}.
FT   HELIX       697    699       {ECO:0000244|PDB:3OTF}.
FT   HELIX       700    712       {ECO:0000244|PDB:3OTF}.
SQ   SEQUENCE   1203 AA;  129042 MW;  7EFDD2D69CF1F9D9 CRC64;
     MDKLPPSMRK RLYSLPQQVG AKAWIMDEEE DAEEEGAGGR QDPSRRSIRL RPLPSPSPSA
     AAGGTESRSS ALGAADSEGP ARGAGKSSTN GDCRRFRGSL ASLGSRGGGS GGTGSGSSHG
     HLHDSAEERR LIAEGDASPG EDRTPPGLAA EPERPGASAQ PAASPPPPQQ PPQPASASCE
     QPSVDTAIKV EGGAAAGDQI LPEAEVRLGQ AGFMQRQFGA MLQPGVNKFS LRMFGSQKAV
     EREQERVKSA GFWIIHPYSD FRFYWDLTML LLMVGNLIII PVGITFFKDE NTTPWIVFNV
     VSDTFFLIDL VLNFRTGIVV EDNTEIILDP QRIKMKYLKS WFMVDFISSI PVDYIFLIVE
     TRIDSEVYKT ARALRIVRFT KILSLLRLLR LSRLIRYIHQ WEEIFHMTYD LASAVVRIVN
     LIGMMLLLCH WDGCLQFLVP MLQDFPDDCW VSINNMVNNS WGKQYSYALF KAMSHMLCIG
     YGRQAPVGMS DVWLTMLSMI VGATCYAMFI GHATALIQSL DSSRRQYQEK YKQVEQYMSF
     HKLPPDTRQR IHDYYEHRYQ GKMFDEESIL GELSEPLREE IINFNCRKLV ASMPLFANAD
     PNFVTSMLTK LRFEVFQPGD YIIREGTIGK KMYFIQHGVV SVLTKGNKET KLADGSYFGE
     ICLLTRGRRT ASVRADTYCR LYSLSVDNFN EVLEEYPMMR RAFETVALDR LDRIGKKNSI
     LLHKVQHDLN SGVFNYQENE IIQQIVQHDR EMAHCAHRVQ AAASATPTPT PVIWTPLIQA
     PLQAAAATTS VAIALTHHPR LPAAIFRPPP GSGLGNLGAG QTPRHLKRLQ SLIPSALGSA
     SPASSPSQVD TPSSSSFHIQ QLAGFSAPAG LSPLLPSSSS SPPPGACGSP SAPTPSAGVA
     ATTIAGFGHF HKALGGSLSS SDSPLLTPLQ PGARSPQAAQ PSPAPPGARG GLGLPEHFLP
     PPPSSRSPSS SPGQLGQPPG ELSLGLATGP LSTPETPPRQ PEPPSLVAGA SGGASPVGFT
     PRGGLSPPGH SPGPPRTFPS APPRASGSHG SLLLPPASSP PPPQVPQRRG TPPLTPGRLT
     QDLKLISASQ PALPQDGAQT LRRASPHSSG ESMAAFPLFP RAGGGSGGSG SSGGLGPPGR
     PYGAIPGQHV TLPRKTSSGS LPPPLSLFGA RATSSGGPPL TAGPQREPGA RPEPVRSKLP
     SNL
//
